PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Schmidt, SLG; Gomes, XV; Burgers, PMJ				Schmidt, SLG; Gomes, XV; Burgers, PMJ			ATP utilization by yeast replication factor C III. The ATP-binding domains of Rfc2, Rfc3, and Rfc4 are essential for DNA recognition and clamp loading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLYMERASE-DELTA; SITE MUTANTS; PROTEIN; SUBUNIT; COMPLEX; MUTATIONS; OVERPRODUCTION; F1-ATPASE; HOMOLOGY	The conserved lysine in the Walker A motif of the ATP-binding domain encoded by the yeast RFC1, RFC2, RFC3, and RFC4 genes was mutated to glutamic acid. Complexes of replication factor C with a N-terminal truncation (Delta2-273) of the Rfc1 subunit (RFC) containing a single mutant subunit were overproduced in Escherichia coli for biochemical analysis. All of the mutant RFC complexes were capable of interacting with PCNA. Complexes containing a rfc1-K359E mutation were similar to wild type in replication activity and ATPase activity,however, the mutant complex showed increased susceptibility to proteolysis. In contrast, complexes containing either a rfc2-K71E mutation or a rfc3-K59E mutation were severely impaired in ATPase and clamp loading activity. In addition to their defects in ATP hydrolysis, these complexes were defective for DNA binding. A mutant complex containing the rfc4-K55E mutation performed as well as a wild type complex in clamp loading, but only at very high ATP concentrations. Mutant RFC complexes containing rfc2-K71R or rfc3-K59R, carrying a conservative lysine --> arginine mutation, had much milder clamp loading defects that could be partially (rfc2-K71R) or completely (rfc3-K59R) suppressed at high ATP concentrations.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		NIGMS NIH HHS [R01 GM032431, GM32431] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Cai JS, 1998, P NATL ACAD SCI USA, V95, P11607, DOI 10.1073/pnas.95.20.11607; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Hishida T, 1999, J BIOL CHEM, V274, P25335, DOI 10.1074/jbc.274.36.25335; LI XY, 1994, P NATL ACAD SCI USA, V91, P868, DOI 10.1073/pnas.91.3.868; LI XY, 1994, J BIOL CHEM, V269, P21880; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Mizushima T, 2000, GENE DEV, V14, P1631; Mizushima T, 1998, J BIOL CHEM, V273, P20847, DOI 10.1074/jbc.273.33.20847; Neuwald AF, 1999, GENOME RES, V9, P27; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; PARSONAGE D, 1988, J BIOL CHEM, V263, P4740; PODUST LM, 1994, NUCLEIC ACIDS RES, V22, P2970, DOI 10.1093/nar/22.15.2970; Podust VN, 1998, J BIOL CHEM, V273, P12935, DOI 10.1074/jbc.273.21.12935; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Schmidt SLG, 2001, J BIOL CHEM, V276, P34792, DOI 10.1074/jbc.M011671200; Smith CV, 1998, BIOCHEMISTRY-US, V37, P9658, DOI 10.1021/bi9801309; TAN CK, 1986, J BIOL CHEM, V261, P2310; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; XIAO H, 1995, J BIOL CHEM, V270, P13378, DOI 10.1074/jbc.270.22.13378; Yang G, 1997, BIOCHEMISTRY-US, V36, P4751, DOI 10.1021/bi9631677; You ZY, 1999, MOL CELL BIOL, V19, P8003	31	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34784	34791		10.1074/jbc.M011633200	http://dx.doi.org/10.1074/jbc.M011633200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432854	hybrid			2022-12-27	WOS:000171024600060
J	Andersen, PS; Geisler, C; Buus, S; Mariuzza, RA; Karjalainen, K				Andersen, PS; Geisler, C; Buus, S; Mariuzza, RA; Karjalainen, K			Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MOLECULES; MHC CLASS-II; ALANINE SCANNING MUTAGENESIS; STAPHYLOCOCCAL-ENTEROTOXIN-B; COMPLEX CLASS-II; CRYSTAL-STRUCTURE; BETA-CHAIN; 3-DIMENSIONAL STRUCTURE; SIGNAL-TRANSDUCTION; ANTIGEN RECOGNITION	Similar to native peptide/MHC ligands, bacterial superantigens have been found to bind with low affinity to the T cell receptor (TOR). It has been hypothesized that low ligand affinity is required to allow optimal TOR signaling. To test this, we generated variants of Staphylococcus enterotoxin C3 (SEC3) with up to a 150-fold increase in TOR affinity. By stimulating T cells with SEC3 molecules immobilized onto plastic surfaces, we demonstrate that increasing the affinity of the SEC3/TCR interaction caused a proportional increase in the ability of SEC3 to activate T cells. Thus, the potency of the SEC3 variants correlated with enhanced binding without any optimum in the binding range covered by native TCR ligands. Comparable studies using anti-TCR antibodies of known affinity confirmed these observations. By comparing the biological potency of the two sets of ligands, we found a significant correlation between ligand affinity and ligand potency indicating that it is the density of receptor-ligand complexes in the T cell contact area that determines TCR signaling strength.	Univ Copenhagen, Inst Med Microbiol & Immunol, DK-2200 Copenhagen, Denmark; Univ Maryland, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Basel Inst Immunol, CH-4005 Basel, Switzerland	University of Copenhagen	Andersen, PS (corresponding author), Univ Copenhagen, Inst Med Microbiol & Immunol, Blegdamsvej 3C, DK-2200 Copenhagen, Denmark.		Buus, Soren/F-5446-2010; Karjalainen, Klaus/A-2206-2011; Geisler, Carsten/A-7056-2012	Geisler, Carsten/0000-0002-8472-0771; Buus, Soren/0000-0001-8363-1999				Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; ALAM SM, 1996, NATURE, V381, P161; Andersen PS, 1999, IMMUNITY, V10, P473, DOI 10.1016/S1074-7613(00)80047-3; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Bot A, 1996, J IMMUNOL, V157, P3436; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Churchill HRO, 2000, J EXP MED, V191, P835, DOI 10.1084/jem.191.5.835; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; ENDRES RO, 1983, J IMMUNOL, V130, P781; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kim DT, 1996, J IMMUNOL, V156, P2737; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; MCCAFFERTY J, 1994, APPL BIOCHEM BIOTECH, V47, P157, DOI 10.1007/BF02787932; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; PAPAGEORGIOU AC, 1995, STRUCTURE, V3, P769, DOI 10.1016/S0969-2126(01)00212-X; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Redpath S, 1999, J IMMUNOL, V163, P6; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; Schuck P, 1997, CURR OPIN BIOTECH, V8, P498, DOI 10.1016/S0958-1669(97)80074-2; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sundberg E, 1999, NAT STRUCT BIOL, V6, P123; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; WALLNY HJ, 1995, EUR J IMMUNOL, V25, P1262, DOI 10.1002/eji.1830250520; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7	47	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33452	33457		10.1074/jbc.M103750200	http://dx.doi.org/10.1074/jbc.M103750200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11397806	hybrid			2022-12-27	WOS:000170910200023
J	Chatah, NEH; Abrams, CS				Chatah, NEH; Abrams, CS			G-protein-coupled receptor activation induces the membrane translocation and activation of phosphatidylinositol-4-phosphate 5-kinase I alpha by a Rac- and Rho-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PLECKSTRIN HOMOLOGY DOMAINS; GTP-BINDING PROTEINS; 4-PHOSPHATE 5-KINASE; PHOSPHOLIPASE-D; ADENOVIRUS INFECTION; 4,5-BISPHOSPHATE SYNTHESIS; DOWNSTREAM EFFECTOR; SIGNAL-TRANSDUCTION; ACID PHOSPHOLIPIDS	Phosphatidylinositol 4,5-bisphosphate (PI4,5P(2)) mediates cell motility and changes in cell shape in response to extracellular stimuli. In platelets, it is synthesized from P14P by PIP5K in response to stimulation of a G-protein-coupled receptor by an agonist, such as the thrombin. In the present study, we have addressed the pathway that induces PIP5K I alpha activation following the addition of thrombin. Under resting condition expressed PIP5K I alpha was predominantly localized in a perinuclear distribution. After stimulation of the thrombin receptor, PAR1, or overexpression of a constitutively active variant of G alpha (q), PIP5K I alpha translocated to the plasma membrane. Movement of PIP5K I alpha to the cell membrane was dependent on both GTP-bound Rac and Rho, but not Arf, because: 1) inactive GDP-bound variants of either Rac or Rho blocked the translocation induced by constitutively active G alpha (q), 2) constitutively GTP-bound active variants of Rac or Rho induced PIP5K I alpha translocation in the absence of other stimuli, and 3) constitutively active variants of Arf1 or Arf6 failed to induce membrane translocation of PIP5K I alpha. In addition, a dominant negative variant of Rho blocked the PIP5K I alpha membrane translocation induced by constitutively active Rac, whereas dominant negative variants of either Rac or Arf6 failed to block PIP5K I alpha membrane translocation induced by constitutively active Rho. This implies that the effect on PIP5K I alpha by Rac is indirect, and requires the activation of Rho. In contrast to the findings with PIP5K I alpha, the related lipid kinase PIP4K failed to undergo translocation after stimulation by small GTP-binding proteins Rac or Rho. We also tested whether membrane localization of PIP5K I alpha correlated with an increase in its lipid kinase activity and found that co-expressing of PIP5K I alpha with either constitutively active G alpha (q), Rac, or Rho led to a 5- to 7-fold increase in PIP5K I alpha activity. Thus, these findings suggest that stimulation of a G-protein-coupled receptor (PAR1) leads to the sequential activation of G alpha (q), Rac, Rho, and PIP5K I alpha. Once activated and translocated to the cell membrane, PIP5K I alpha becomes available to phosphorylate PI4P to generate P14,5P(2) on the plasma membrane.	Univ Penn, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Abrams, CS (corresponding author), Univ Penn, Div Hematol Oncol, Dept Med, 421 Curie Blvd,Basic Res Bldg 2-3,Rm 912, Philadelphia, PA 19104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL054500] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL54500, P01 HL40387] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAMS CS, 1995, J BIOL CHEM, V270, P14485, DOI 10.1074/jbc.270.24.14485; ANDERSON RA, 1985, NATURE, V318, P295, DOI 10.1038/318295a0; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; BELLETT AJD, 1989, J VIROL, V63, P303, DOI 10.1128/JVI.63.1.303-310.1989; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HASHIMOTO S, 1993, EXP CELL RES, V205, P270, DOI 10.1006/excr.1993.1086; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hinchliffe KA, 1996, EMBO J, V15, P6516, DOI 10.1002/j.1460-2075.1996.tb01042.x; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; HOXIE JA, 1993, J BIOL CHEM, V268, P13758; Itoh T, 1998, J BIOL CHEM, V273, P20292, DOI 10.1074/jbc.273.32.20292; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LENK R, 1980, VIROLOGY, V105, P19, DOI 10.1016/0042-6822(80)90152-X; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; MICHELL RH, 1965, BIOCHEM BIOPH RES CO, V21, P333, DOI 10.1016/0006-291X(65)90198-1; MORITZ A, 1992, J BIOL CHEM, V267, P7207; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; PERTILE P, 1995, J BIOL CHEM, V270, P5130, DOI 10.1074/jbc.270.10.5130; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; SMITH CD, 1989, J BIOL CHEM, V264, P3206; STAUFENBIEL M, 1986, J VIROL, V60, P1186, DOI 10.1128/JVI.60.3.1186-1191.1986; TERUI T, 1994, J BIOL CHEM, V269, P28130; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; URUMOW T, 1986, FEBS LETT, V207, P253, DOI 10.1016/0014-5793(86)81499-5; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; Westergren T, 1999, PLANT PHYSIOL, V121, P507, DOI 10.1104/pp.121.2.507; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; ZHANG J, 1993, J BIOL CHEM, V268, P22251; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756	60	67	67	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34059	34065		10.1074/jbc.M104917200	http://dx.doi.org/10.1074/jbc.M104917200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11431481	hybrid			2022-12-27	WOS:000170910200103
J	Khanna, R; Myers, MP; Laine, M; Papazian, DM				Khanna, R; Myers, MP; Laine, M; Papazian, DM			Glycosylation increases potassium channel stability and surface expression in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; TRANSMEMBRANE CONDUCTANCE REGULATOR; SHAKER K+ CHANNEL; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; LINKED OLIGOSACCHARIDES; SECRETORY PATHWAY; CYSTEINE RESIDUES; XENOPUS-OOCYTES; MOLECULAR-BASIS	N-linked glycosylation is not required for the cell surface expression of functional Shaker potassium channels in Xenopus oocytes (Santacruz-Toloza, L., Huang, Y., John, S. A., and Papazian, D. M. (1994) Biochemistry 33, 5607-5613). We have now investigated whether glycosylation increases the stability, cell surface expression, and proper folding of Shaker protein expressed in mammalian cells. The turnover rates of wild-type protein and an unglycosylated mutant (N259Q,N263Q) were compared in pulse-chase experiments. The wild-type protein was stable, showing little degradation after 48 h. In contrast, the unglycosylated mutant was rapidly degraded (t(1/2) = similar to 18 h). Lactacystin slowed the degradation of the mutant protein, implicating cytoplasmic proteasomes in its turnover. Rapid lactacystin-sensitive degradation could be conferred on wild-type Shaker by a glycosylation inhibitor. Expression of the unglycosylated mutant on the cell surface, assessed using immunofluorescence microscopy and biotinylation, was dramatically reduced compared with wild type. Folding and assembly were analyzed by oxidizing intersubunit disulfide bonds, which provides a fortuitous hallmark of the native structure. Surprisingly, formation of disulfide-bonded adducts was quantitatively similar in the wildtype and unglycosylated mutant proteins. Our results indicate that glycosylation increases the stability and cell surface expression of Shaker protein but has little effect on acquisition of the native structure.	Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Papazian, DM (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Box 951751, Los Angeles, CA 90095 USA.			Khanna, Rajesh/0000-0002-9066-2969	NIGMS NIH HHS [GM43459] Funding Source: Medline; NINDS NIH HHS [NS07101-20] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Basiry SS, 1999, J NEUROSCI, V19, P644; Bennett E, 1997, J GEN PHYSIOL, V109, P327, DOI 10.1085/jgp.109.3.327; Breuer P, 1998, J BIOL CHEM, V273, P33254, DOI 10.1074/jbc.273.50.33254; Chung DH, 2000, J BIOL CHEM, V275, P4981, DOI 10.1074/jbc.275.7.4981; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hille B., 1992, IONIC CHANNELS EXCIT; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nagaya N, 1999, RECEPTOR CHANNEL, V6, P229; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; RAPOSO G, 1995, J CELL BIOL, V131, P1403, DOI 10.1083/jcb.131.6.1403; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; Satler CA, 1998, HUM GENET, V102, P265, DOI 10.1007/s004390050690; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; SCHULTEIS CT, 1995, BIOCHEMISTRY-US, V34, P1725, DOI 10.1021/bi00005a029; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SCHWARZ TL, 1990, NEURON, V4, P119, DOI 10.1016/0896-6273(90)90448-O; Spiro RG, 2000, J BIOL CHEM, V275, P35657, DOI 10.1074/jbc.R000022200; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Wang J, 2000, BIOCHEMISTRY-US, V39, P8993, DOI 10.1021/bi000027v; WARD CL, 1994, J BIOL CHEM, V269, P25710; White AL, 1999, J LIPID RES, V40, P275; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Xiong XM, 1997, J CLIN INVEST, V100, P1079, DOI 10.1172/JCI119618; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	45	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34028	34034		10.1074/jbc.M105248200	http://dx.doi.org/10.1074/jbc.M105248200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11427541	hybrid			2022-12-27	WOS:000170910200099
J	Magez, S; Radwanska, M; Stijlemans, B; Van Xong, H; Pays, E; De Baetselier, P				Magez, S; Radwanska, M; Stijlemans, B; Van Xong, H; Pays, E; De Baetselier, P			A conserved flagellar pocket exposed high mannose moiety is used by African trypanosomes as a host cytokine binding molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; VARIANT SURFACE GLYCOPROTEINS; FACTOR-ALPHA; TRANSFERRIN-RECEPTOR; LINKED OLIGOSACCHARIDES; BLOOD-STREAM; BRUCEI; RESISTANCE; LECTIN; INTERLEUKIN-2	Trypanosomes use antigenic variation of their variant- specific surface glycoprotein (VSG) coat as defense against the host immune system. However, in order to sustain their growth, they need to expose conserved epitopes, allowing host macromolecule binding and receptor-mediated endocytosis. Here we show that Trypanosoma bruce! uses the conserved chitobiose-oligomannose G1(L)CNAc2-Man(5-9)) moieties of its VSG as a binding ligand for tumor necrosis factor TNF), a host cytokine with lectin-like properties. As endocytosis, in trypanosomes is restricted to the flagellar pocket, we show that soluble flagellar pocket extracts, and in particular soluble VSG, inhibit the binding of I-125-TNF to trypanosomes. The interaction between TNF and VSG is confirmed by affinity chromatography, biosensor, and dot-blot affinity measurements, and soluble VSG inhibition of TNF-mediated trypanolysis. In all approaches, removal of N-linked carbohydrates abrogates the TNF-VSG interaction. In addition, synthetic high mannose oligosaccharides can block TNF-VSG interactions, and a VSG glycopeptide carrying the G1(L)CNAc2-Man(5-9) moiety is shown to inhibit TNF-mediated trypanosome killing in mixed parasite macrophage cell cultures. Together, these results support the observation that TNF plays a role in growth control of trypanosomes and, moreover, suggest that, by the use of conserved VSG carbohydrates as lectin-binding epitopes, trypanosomes can limit the necessity to express large numbers of invariant surface exposed receptors.	Free Univ Brussels VIB, Dept Immunol Parasitol & Ultrastruct, B-1640 Rhode St Genese, Belgium; Free Univ Brussels, Inst Mol & Med Biol, Mol Parasitol Lab, B-6041 Gosselies, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Magez, S (corresponding author), Free Univ Brussels VIB, Dept Immunol Parasitol & Ultrastruct, Paardenstr 65, B-1640 Rhode St Genese, Belgium.	stemagez@vub.ac.be	De Baetselier, Patrick/D-3866-2014; Magez, Stefan/AAC-5682-2021; Radwanska, Magdalena/Q-4279-2018; Magez, Stefan/D-9497-2014; Stijlemans, Benoit/AAD-9122-2021	Magez, Stefan/0000-0003-3760-7968; Radwanska, Magdalena/0000-0002-0797-6001; Magez, Stefan/0000-0003-3760-7968; Stijlemans, Benoit/0000-0003-0082-9751				Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; Borst P, 1998, ANNU REV MICROBIOL, V52, P745, DOI 10.1146/annurev.micro.52.1.745; BRICKMAN MJ, 1990, J PROTOZOOL, V37, P219, DOI 10.1111/j.1550-7408.1990.tb01131.x; CROSS GAM, 1990, ANNU REV IMMUNOL, V8, P83, DOI 10.1146/annurev.iy.08.040190.000503; Daulouede S, 2001, J INFECT DIS, V183, P988, DOI 10.1086/319257; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; EDWARDS PR, 1995, J ANAL BIOCH, V321, P210; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; HERSHKOVIZ R, 1995, IMMUNOLOGY, V85, P125; Hertz CJ, 1999, CELL IMMUNOL, V192, P24, DOI 10.1006/cimm.1998.1429; Hertz CJ, 1998, J IMMUNOL, V161, P6775; Kaushik RS, 2000, CYTOKINE, V12, P1024, DOI 10.1006/cyto.2000.0685; LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; LUCAS R, 1994, SCIENCE, V263, P814, DOI 10.1126/science.8303299; Magez S, 1997, J CELL BIOL, V137, P715, DOI 10.1083/jcb.137.3.715; Magez S, 1999, INFECT IMMUN, V67, P3128, DOI 10.1128/IAI.67.6.3128-3132.1999; Mehlert A, 1998, MOL BIOCHEM PARASIT, V91, P145, DOI 10.1016/S0166-6851(97)00187-4; MUCHMORE AV, 1987, J IMMUNOL, V138, P2541; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Overath P, 1997, TRENDS CELL BIOL, V7, P27, DOI 10.1016/S0962-8924(97)10046-0; PAYS E, 1994, ANNU REV MICROBIOL, V48, P25, DOI 10.1146/annurev.mi.48.100194.000325; RIDER C, 1993, IMMUNOL TODAY, V14, P615, DOI 10.1016/0167-5699(93)90202-V; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; SEYFANG A, 1990, J PROTOZOOL, V37, P546, DOI 10.1111/j.1550-7408.1990.tb01263.x; SMITH MR, 1990, J IMMUNOL, V144, P162; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; TRESELER CB, 1992, INFECT IMMUN, V60, P183, DOI 10.1128/IAI.60.1.183-188.1992; WEBSTER P, 1993, PARASITOL TODAY, V9, P201, DOI 10.1016/0169-4758(93)90008-4; WOODS A, 1989, J CELL SCI, V93, P491; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x; Zanetta JP, 1996, BIOCHEM J, V318, P49, DOI 10.1042/bj3180049	33	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33458	33464		10.1074/jbc.M103412200	http://dx.doi.org/10.1074/jbc.M103412200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11404356	hybrid			2022-12-27	WOS:000170910200024
J	Montalvetti, A; Bailey, BN; Michael, MB; Severin, GW; Oldfield, E; Docampo, R				Montalvetti, A; Bailey, BN; Michael, MB; Severin, GW; Oldfield, E; Docampo, R			Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; NITROGEN-CONTAINING BISPHOSPHONATES; DIPHOSPHATE SYNTHASE; IN-VITRO; APOPTOSIS; BIOSYNTHESIS; EXPRESSION; CLONING; GROWTH; SITE	We report the cloning and sequencing of a gene encoding the farnesyl pyrophosphate synthase of Trypanosoma cruzi. The protein (T. cruzi farnesyl pyrophosphate synthase, TcFPPS) is an attractive target for drug development, since the growth of T. cruzi is inhibited by carbocation transition state/reactive intermediate analogs of its substrates, the nitrogen-containing bisphosphonates currently in use in bone resorption therapy. The protein predicted from the nucleotide sequence of the gene has 362 amino acids and a molecular mass of 41.2 kDa. Several sequence motifs found in other FPPSs are present in TeFPPS. Heterologous expression of TcFPPS in Escherichia coli produced a functional enzyme that was inhibited by the nitrogen-containing bisphosphonates alendronate, pamidronate, homorisedronate, and risedronate but was less sensitive to the non-nitrogen-containing bisphosphonate etidronate, which, unlike the nitrogen-containing bisphosphonates, does not affect parasite growth-The protein contains a unique 11-mer insertion located near the active site, together with other sequence differences that may facilitate the development of novel anti-Chagasic agents.	Univ Illinois, Coll Vet Med, Dept Pathobiol, Mol Parasitol Lab, Urbana, IL 61802 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Docampo, R (corresponding author), Univ Illinois, Coll Vet Med, Dept Pathobiol, Mol Parasitol Lab, 2001 S Lincoln Ave, Urbana, IL 61802 USA.	rodoc@uiuc.edu	Severin, Gregory/C-2230-2015; Severin, Gregory/AAN-1369-2021	Severin, Gregory/0000-0003-1189-7311; Severin, Gregory/0000-0003-1189-7311	NIGMS NIH HHS [GM-50694] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P285; Amin D, 1996, ARZNEIMITTEL-FORSCH, V46, P759; ASHBY MN, 1989, J BIOL CHEM, V264, P635; ATTUCCI S, 1995, ARCH BIOCHEM BIOPHYS, V321, P493, DOI 10.1006/abbi.1995.1422; AUSUBEL FM, 1987, CURRENT PROTOCOLS MO, pCH6; Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Brown DL, 1999, J CLIN PHARMACOL, V39, P651, DOI 10.1177/00912709922008272; COPPENS I, 1995, MOL BIOCHEM PARASIT, V69, P29, DOI 10.1016/0166-6851(94)00192-P; CORNILLON S, 1994, J CELL SCI, V107, P2691; Cromartie TH, 1999, PESTIC BIOCHEM PHYS, V63, P114, DOI 10.1006/pest.1999.2397; Danesi R, 1996, MOL PHARMACOL, V49, P972; DING VDH, 1991, BIOCHEM J, V275, P61, DOI 10.1042/bj2750061; DIXON M, 1972, BIOCHEM J, V129, P197, DOI 10.1042/bj1290197; Docampo R, 1997, PARASITOL TODAY, V13, P129, DOI 10.1016/S0169-4758(97)01021-1; Docampo R, 1999, PARASITOL TODAY, V15, P443, DOI 10.1016/S0169-4758(99)01531-8; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; Gaffe J, 2000, PLANT PHYSIOL, V123, P1351, DOI 10.1104/pp.123.4.1351; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grove JE, 2000, J BONE MINER RES, V15, P971, DOI 10.1359/jbmr.2000.15.5.971; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Keller RK, 1999, BIOCHEM BIOPH RES CO, V266, P560, DOI 10.1006/bbrc.1999.1849; Koyama T, 1996, BIOCHEMISTRY-US, V35, P9533, DOI 10.1021/bi960137v; Koyama T, 1999, BIOSCI BIOTECH BIOCH, V63, P1671, DOI 10.1271/bbb.63.1671; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Martin MB, 1999, BIOCHEM BIOPH RES CO, V263, P754, DOI 10.1006/bbrc.1999.1404; Martin MB, 2001, J MED CHEM, V44, P909, DOI 10.1021/jm0002578; Moreira MEC, 1996, J CELL PHYSIOL, V167, P305, DOI 10.1002/(SICI)1097-4652(199605)167:2&lt;305::AID-JCP15&gt;3.0.CO;2-6; OGURA K, 1985, METHOD ENZYMOL, V110, P167; Overhand M, 1998, BIOORG CHEM, V26, P269, DOI 10.1006/bioo.1998.1101; PENDERGAST GC, 1994, MOL CELL BIOL, V14, P4193; PEREZSALA D, 1994, BIOCHEM BIOPH RES CO, V199, P1209, DOI 10.1006/bbrc.1994.1359; QUESNEYHUNEEUS V, 1979, P NATL ACAD SCI USA, V76, P5056, DOI 10.1073/pnas.76.10.5056; RILLING HC, 1985, METHOD ENZYMOL, V110, P145; Rodan GA, 1998, ANNU REV PHARMACOL, V38, P375, DOI 10.1146/annurev.pharmtox.38.1.375; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rogers MJ, 1997, CANCER, V80, P1652, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z; SINENSKY M, 1985, P NATL ACAD SCI USA, V82, P3257, DOI 10.1073/pnas.82.10.3257; SKEIKY YAW, 1992, J EXP MED, V176, P201, DOI 10.1084/jem.176.1.201; SOMMER JM, 1994, ANNU REV MICROBIOL, V48, P105, DOI 10.1146/annurev.mi.48.100194.000541; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Supattapone S, 2000, J VIROL, V74, P11928, DOI 10.1128/JVI.74.24.11928-11934.2000; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Urbina JA, 1999, J BIOL CHEM, V274, P33609, DOI 10.1074/jbc.274.47.33609; van Beek E, 1999, BIOCHEM BIOPH RES CO, V264, P108, DOI 10.1006/bbrc.1999.1499; Welburn SC, 1997, PARASITOL TODAY, V13, P22, DOI 10.1016/S0169-4758(96)10076-4; Welburn SC, 1996, CELL DEATH DIFFER, V3, P229; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; Yokoyama K, 1998, MOL BIOCHEM PARASIT, V94, P87, DOI 10.1016/S0166-6851(98)00053-X; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	56	138	145	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33930	33937		10.1074/jbc.M103950200	http://dx.doi.org/10.1074/jbc.M103950200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435429	hybrid			2022-12-27	WOS:000170910200087
J	Neuss, M; Monticone, R; Lundberg, MS; Chesley, AT; Fleck, E; Crow, MT				Neuss, M; Monticone, R; Lundberg, MS; Chesley, AT; Fleck, E; Crow, MT			The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PERMEABILITY TRANSITION; KINASE; CYTOTOXICITY; ACTIVATION; INHIBITORS; INTERACTS; RECEPTOR; NECROSIS; PATHWAY	ARC is an apoptotic regulatory protein expressed almost exclusively in myogenic cells. It contains a caspase recruitment domain (CARD) through which it has been shown to block the activation of some initiator caspases. Because ARC also blocks caspase-independent events associated with apoptosis, such as hypoxia-induced cytochrome c release, we examined its role in cell death triggered by exposure to hydrogen peroxide (H2O2) in the myogenic cell line, H9c2. Cell death in this model was caspase-independent and characterized by dose-dependent reduction in ARC expression accompanied by disruption of the mitochondrial membrane potential (Delta psi (m)) and loss of plasma membrane integrity, typical of necrotic cell death. Ectopic expression of ARC prevented both H2O2-induced mitochondrial dysfunction and cell death without affecting the stress kinase response, suggesting that ARCs protective effects were downstream of early signaling events and not due to quenching of H2O2. ARC was also effective in blocking H2O2-induced loss of membrane integrity and/or disruption of Delta psi (m) in two human cell lines in which it is not normally expressed. These results demonstrate that, in addition to its ability to block caspase-dependent and -independent events in apoptosis, ARC also prevents necrosis-like cell death via the preservation of mitochondrial function.	NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; German Heart Inst, Dept Med Cardiol, D-13353 Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); German Heart Center Berlin	Crow, MT (corresponding author), NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.							BELLOMO G, 1983, FEBS LETT, V163, P136, DOI 10.1016/0014-5793(83)81180-6; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; BOLLI R, 1989, P NATL ACAD SCI USA, V86, P4695, DOI 10.1073/pnas.86.12.4695; Constantini P., 1996, J BIOL CHEM, V271, P6746; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Ekhterae D, 1999, CIRC RES, V85, pE70; GU J, 1994, BIOTECHNIQUES, V17, P257; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Kowaltowski AJ, 1996, FEBS LETT, V378, P150, DOI 10.1016/0014-5793(95)01449-7; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; LI P, 1997, CELL, V91, P4799; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; Rimpler MM, 1999, BIOCHEM J, V340, P291, DOI 10.1042/0264-6021:3400291; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Shimizu S, 1996, ONCOGENE, V12, P2045; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; Single B, 2001, EXP CELL RES, V262, P8, DOI 10.1006/excr.2000.5059; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Stoss O, 1999, J BIOL CHEM, V274, P10951, DOI 10.1074/jbc.274.16.10951; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; ZORATTI M, 1995, BIOCHIM BIOPHYS ACTA, V1241, P136; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	37	98	102	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33915	33922		10.1074/jbc.M104080200	http://dx.doi.org/10.1074/jbc.M104080200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11438535	hybrid			2022-12-27	WOS:000170910200085
J	Taggart, CC; Lowe, GJ; Greene, CM; Mulgrew, AT; O'Neill, SJ; Levine, RL; McElvaney, NG				Taggart, CC; Lowe, GJ; Greene, CM; Mulgrew, AT; O'Neill, SJ; Levine, RL; McElvaney, NG			Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE PROTEASE INHIBITOR; RESPIRATORY EPITHELIAL SURFACE; STABLE PROTEINASE-INHIBITOR; ALPHA-1-PROTEINASE INHIBITOR; LEUKOPROTEASE INHIBITOR; PSEUDOMONAS-AERUGINOSA; CYSTEINE PROTEASES; HUMAN-NEUTROPHIL; ELASTASE; METALLOPROTEINASES	A number of serine proteases, matrix metalloproteases, and cysteine proteases were evaluated for their ability to cleave and inactivate the antiprotease, secretory leueoprotease inhibitor (SLPI). None of the serine proteases or the matrix metalloproteases examined cleaved the SLPI protein. However, incubation with cathepsins B, L, and S resulted in the cleavage and inactivation of SLPI. All three cathepsins initially cleaved SLPI between residues Thr(67) and Tyr(68). The proteolytic cleavage of SLPI by all three cathepsins resulted in the loss of the active site of SLPI and the inactivation of SLPI anti-neutrophil elastase capacity. Cleavage and inactivation were catalytic with respect to the cathepsins, so that the majority of a 400-fold excess of SLPI was inactivated within 15 min by cathepsins L and S. Analysis of epithelial lining fluid samples from individuals with emphysema indicated the presence of cleaved SLPI in these samples whereas only intact SLPI was observed in control epithelial lining fluid samples. Active cathepsin L was shown to be present in emphysema epithelial lining fluid and inhibition of this protease prevented the cleavage of recombinant SLPI added to emphysema epithelial lining fluid. Taken together with previous data that demonstrates that cathepsin L inactivates alpha (1)-antitrypsin, these findings indicate the involvement of cathepsins in the diminution of the lung antiprotease screen possibly leading to lung destruction in emphysema.	Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Med,Pulm Res Div, Dublin 9, Ireland; NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Royal College of Surgeons - Ireland; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	McElvaney, NG (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Educ & Res Ctr, Dept Med,Pulm Res Div, Dublin 9, Ireland.		Taggart, Clifford C/G-4492-2014; Levine, Rodney L/D-9885-2011; Greene, Catherine M/D-3513-2012; McElvaney, Noel/A-6809-2010	Greene, Catherine M/0000-0003-2549-2569; Taggart, Clifford/0000-0002-9930-2978; mcelvaney, Noel/0000-0002-0152-4370	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225, Z01HL000225] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABE T, 1991, J CLIN INVEST, V87, P2207, DOI 10.1172/JCI115255; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; CHAPMAN HA, 1984, J CLIN INVEST, V74, P1693, DOI 10.1172/JCI111586; DESROCHERS PE, 1988, J CLIN INVEST, V81, P1646, DOI 10.1172/JCI113500; DESROCHERS PE, 1991, J CLIN INVEST, V87, P2258, DOI 10.1172/JCI115262; Draper D, 1998, J INFECT DIS, V178, P815, DOI 10.1086/515366; GAUTHIER F, 1982, BIOCHIM BIOPHYS ACTA, V700, P178, DOI 10.1016/0167-4838(82)90095-4; GRUTTER MG, 1988, EMBO J, V7, P345, DOI 10.1002/j.1460-2075.1988.tb02819.x; Hiemstra PS, 1998, EUR RESPIR J, V12, P1200, DOI 10.1183/09031936.98.12051200; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; JOHNSON DA, 1986, J BIOL CHEM, V261, P4748; KIRSCHKE H, 1994, METHOD ENZYMOL, V244, P500; KLECH H, 1989, EUR RESPIR J, V2, P561; KRAMPS JA, 1981, J HISTOCHEM CYTOCHEM, V29, P712, DOI 10.1177/29.6.6788837; KRAMPS JA, 1984, AM REV RESPIR DIS, V129, P959; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lentsch AB, 1999, AM J PATHOL, V154, P239, DOI 10.1016/S0002-9440(10)65270-4; MASON RW, 1986, BIOCHEM J, V233, P925, DOI 10.1042/bj2330925; MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994; MCELVANEY NG, 1997, LUNG, P2119; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; MORIHARA K, 1979, INFECT IMMUN, V24, P188, DOI 10.1128/IAI.24.1.188-193.1979; REILLY JJ, 1991, AM J PHYSIOL, V261, pL41, DOI 10.1152/ajplung.1991.261.2.L41; RUDOLPHUS A, 1991, CLIN SCI, V81, P777, DOI 10.1042/cs0810777; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; SEEMULLER U, 1986, FEBS LETT, V199, P43, DOI 10.1016/0014-5793(86)81220-0; Senior RM, 1998, FISHMANS PULMONARY D, P659; SHAPIRO SD, 1994, AM J RESP CRIT CARE, V150, pS160, DOI 10.1164/ajrccm/150.6_Pt_2.S160; SHI GP, 1992, J BIOL CHEM, V267, P7258; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; SPONER M, 1991, BIOL CHEM H-S, V372, P963, DOI 10.1515/bchm3.1991.372.2.963; Taggart C, 2000, J BIOL CHEM, V275, P27258; TAKEHASHI H, 1993, AM REV RESPIR DIS, V147, P1562; Takeyabu K, 1998, EUR RESPIR J, V12, P1033, DOI 10.1183/09031936.98.12051033; VISSERS MCM, 1988, J CLIN INVEST, V82, P706, DOI 10.1172/JCI113651; VOGELMEIER C, 1991, J CLIN INVEST, V87, P482, DOI 10.1172/JCI115021; Zhang YH, 1997, J CLIN INVEST, V99, P894, DOI 10.1172/JCI119254; ZHANG Z, 1994, BBA-GEN SUBJECTS, V1199, P224, DOI 10.1016/0304-4165(94)90119-8	38	143	146	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33345	33352		10.1074/jbc.M103220200	http://dx.doi.org/10.1074/jbc.M103220200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435427	hybrid, Green Submitted			2022-12-27	WOS:000170910200010
J	Baba, T; Mimura, J; Gradin, K; Kuroiwa, A; Watanabe, T; Matsuda, Y; Inazawa, J; Sogawa, K; Fujii-Kuriyama, Y				Baba, T; Mimura, J; Gradin, K; Kuroiwa, A; Watanabe, T; Matsuda, Y; Inazawa, J; Sogawa, K; Fujii-Kuriyama, Y			Structure and expression of the Ah receptor repressor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ARYL-HYDROCARBON RECEPTOR; HEAT-SHOCK PROTEIN; COOPERATIVE INTERACTION; DIOXIN RECEPTOR; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TRANSCRIPTION FACTORS; INDUCIBLE EXPRESSION; SIGNAL-TRANSDUCTION; INTERFERON-GAMMA	The aryl hydrocarbon receptor (AhR) repressor (AhRR) gene has been isolated and characterized from a mouse genomic library. The gene is distributed as 11 exons in a total length of about 60 kilobase pairs. Fluorescence in situ hybridization analysis has shown that the AhRR gene is located at mouse chromosome 13C2, at rat chromosome 1p11.2, and at human chromosome 5p15.3. The AhRR gene has a TATA-less promoter and several transcription start sites. In addition, putative regulatory DNA sequences such as xenobiotic responsive element (XRE), GC box, and NF-kappaB-binding sites have been identified in the 5'-upstream region of the AhRR gene. Transient transfection analyses of HeLa cells with reporter genes that contain deletions and point mutations in the AhRR promoter revealed that all three XREs mediated the inducible expression of the AhRR gene by 3-methylcholanthrene treatment, and furthermore, GC box sequences were indispensable for a high level of inducible expression and for constitutive expression. Moreover, by using gel mobility shift assays we were able to show that the AhR/Arnt heterodimer binds to the XREs with very low affinity, which is due to three varied nucleotides outside the XRE core sequence. We have also shown that Sp1 and Sp3 can bind to the GC boxes. Finally, both transient transfection analysis and gel mobility shift assay revealed that the AhRR gene is up-regulated by a p65/p50 heterodimer that binds to the NF-kappaB site when the cells has been exposed to 12-O-tetradecanoylphorbol-13-acetate, and this inducible expression was further enhanced by cotreatment of 12-O-tetradecanoylphorbol-13-acetate and 3-methylcholanthrene.	Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Japan Sci & Technol, Core Res Evolut Sci & Technol, Tokyo 1500002, Japan; Hokkaido Univ, Lab Cytogenet, Div Biosci, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Chromosome Res Unit, Fac Sci, Sapporo, Hokkaido 0600810, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo 1138519, Japan	Tohoku University; Japan Science & Technology Agency (JST); Hokkaido University; Hokkaido University; Tokyo Medical & Dental University (TMDU)	Fujii-Kuriyama, Y (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	ykfujii@mail.cc.tohoku.ac.jp	Mimura, Junsei/E-7893-2013	Kuroiwa, Asato/0000-0002-3942-3372				BARKER CW, 1992, J BIOL CHEM, V267, P8050; Calleja C, 1997, BIOCHEM BIOPH RES CO, V239, P273, DOI 10.1006/bbrc.1997.7468; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fitzgerald CT, 1998, DNA CELL BIOL, V17, P811, DOI 10.1089/dna.1998.17.811; Gradin K, 1999, J BIOL CHEM, V274, P13511, DOI 10.1074/jbc.274.19.13511; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; Heid SE, 2000, MOL PHARMACOL, V57, P82; INAZAWA J, 1991, GENOMICS, V10, P1075, DOI 10.1016/0888-7543(91)90202-P; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kobayashi A, 1996, J BIOL CHEM, V271, P12310, DOI 10.1074/jbc.271.21.12310; KRISHNAN V, 1995, MOL CELL BIOL, V15, P6710; Lyon M. F., 1996, Mammalian Genome, V94, P29; Maehara K, 1999, FEBS LETT, V449, P115, DOI 10.1016/S0014-5793(99)00408-1; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; MATSUDA Y, 1992, CYTOGENET CELL GENET, V61, P282, DOI 10.1159/000133423; MCGUIRE J, 1994, MOL CELL BIOL, V14, P2438, DOI 10.1128/MCB.14.4.2438; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; SATOH H, 1989, CYTOGENET CELL GENET, V50, P151, DOI 10.1159/000132747; Scheidereit C, 1998, NATURE, V395, P225, DOI 10.1038/26121; Serikawa T, 1998, EXP ANIM TOKYO, V47, P1, DOI 10.1538/expanim.47.1; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Xia CL, 1997, INT J BIOCHEM CELL B, V29, P1525, DOI 10.1016/S1357-2725(97)00083-6; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981	36	124	126	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33101	33110		10.1074/jbc.M011497200	http://dx.doi.org/10.1074/jbc.M011497200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11423533	hybrid			2022-12-27	WOS:000170746000096
J	Jang, GF; Van Hooser, JP; Kuksa, V; McBee, JK; He, YG; Janssen, JJM; Driessen, CAGG; Palczewski, K				Jang, GF; Van Hooser, JP; Kuksa, V; McBee, JK; He, YG; Janssen, JJM; Driessen, CAGG; Palczewski, K			Characterization of a dehydrogenase activity responsible for oxidation of 11-cis-retinol in the retinal pigment epithelium of mice with a disrupted RDH5 gene - A model for the human hereditary disease fundus albipunctatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES; BINDING PROTEIN GENE; ALL-TRANS-RETINOL; VISUAL CYCLE; TARGETED DISRUPTION; 9-CIS-RETINOIC ACID; BIOCHEMICAL ASPECTS; MEMBRANE TOPOLOGY; JAPANESE PATIENTS; PHASE PARTITION	In the vertebrate retina, the final step of visual chromophore production is the oxidation of 11-cis-retinol to 11-cis-retinal. This reaction is catalyzed by 11-cis-retinol dehydrogenases (11-cis-RDHs), prior to the chromophore rejoining with the visual pigment apo-proteins. The RDH5 gene encodes a dehydrogenase that is responsible for the majority of RDH activity. In humans, mutations in this gene are associated with fundus albipunctatus, a disease expressed by delayed dark adaptation of both cones and rods. In this report, an animal model for this disease, 11-cis-rdh-/- mice, was used to investigate the flow of retinoids after a bleach, and microsomal membranes from the retinal pigment epithelium of these mice were employed to characterize remaining enzymatic activities oxidizing 11-cis-retinol. Lack of 11-cis-RDH leads to an accumulation of cis-retinoids, particularly 13-cis-isomers. The analysis of 11-cis-rdh-/- mice showed that the RDH(s) responsible for the production of 11-cis-retinal displays NADP-dependent specificity toward 9-cis- and 11-cis-retinal but not 13-cis-retinal. The lack of 13-cis-RDH activity could be a reason why 13-cis-isomers accumulate in the retinal pigment epithelium of 11-cis-rdh-/- mice. Furthermore, our results provide detailed characterization of a mouse model for the human disease fundus albipunctatus and emphasize the importance of 11-cis-RDH in keeping the balance between different components of the retinoid cycle.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Nijmegen, Dept Ophthalmol, NL-6525 EX Nijmegen, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Radboud University Nijmegen	Driessen, CAGG (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.	C.Driessen@ohk.azn.nl; palezews@u.washington.edu			NEI NIH HHS [F32 EY007031, EY08061, EY07031, R01 EY008061, T32 EY007031] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY008061, R01EY008061] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; BERNSTEIN PS, 1986, BIOCHEMISTRY-US, V25, P6473, DOI 10.1021/bi00369a020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burstedt MSI, 1999, INVEST OPHTH VIS SCI, V40, P995; Chen P, 2001, J BIOL CHEM, V276, P21098, DOI 10.1074/jbc.M010441200; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; DRIESSEN CA, 2001, IN PRESS OPHTHALMOLO; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Driessen CAGG, 1998, FEBS LETT, V428, P135, DOI 10.1016/S0014-5793(98)00473-6; DRIESSEN CAGG, 1995, INVEST OPHTH VIS SCI, V36, P1988; Dryja TP, 2000, AM J OPHTHALMOL, V130, P547, DOI 10.1016/S0002-9394(00)00737-6; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gonzalez-Fernandez F, 1999, MOL VIS, V5, pU1; Gottesman ME, 2001, BIOESSAYS, V23, P409, DOI 10.1002/bies.1059; Hao WS, 2000, METHOD ENZYMOL, V316, P413; Hirose E, 2000, INVEST OPHTH VIS SCI, V41, P3933; Jang GF, 2000, J BIOL CHEM, V275, P28128; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KROOK M, 1992, EUR J BIOCHEM, V209, P233, DOI 10.1111/j.1432-1033.1992.tb17281.x; Kuroiwa S, 2000, AM J OPHTHALMOL, V130, P672, DOI 10.1016/S0002-9394(00)00765-0; Liou GI, 1998, J NEUROSCI, V18, P4511; MARGOLIS S, 1987, OPHTHALMOLOGY, V94, P1416; Mata NL, 1998, BBA-LIPID LIPID MET, V1394, P16, DOI 10.1016/S0005-2760(98)00078-2; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; MERCER EI, 1997, CONCISE ENCY BIOCH M; Mertz JR, 1997, J BIOL CHEM, V272, P11744, DOI 10.1074/jbc.272.18.11744; Morimura H, 1999, INVEST OPHTH VIS SCI, V40, P1000; Nakamura M, 2000, INVEST OPHTH VIS SCI, V41, P3925; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Paik J, 2000, BIOCHEMISTRY-US, V39, P8073, DOI 10.1021/bi992152g; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Rando RR, 1996, CHEM BIOL, V3, P255, DOI 10.1016/S1074-5521(96)90105-2; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ripps H, 2000, VISUAL NEUROSCI, V17, P97, DOI 10.1017/S095252380017110X; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2000, METHOD ENZYMOL, V316, P359; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; SAARI JC, 1988, EXP EYE RES, V46, P569, DOI 10.1016/S0014-4835(88)80013-7; SAARI JC, 1993, ANAL BIOCHEM, V213, P128, DOI 10.1006/abio.1993.1395; Simon A, 2000, METHOD ENZYMOL, V316, P344; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Simon A, 1999, J CELL SCI, V112, P549; Stecher H, 1999, BIOCHEMISTRY-US, V38, P13542, DOI 10.1021/bi9913294; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Su J, 1999, ENDOCRINOLOGY, V140, P5275, DOI 10.1210/endo.140.11.7137; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Tao L, 1998, Mol Vis, V4, P25; TREHAN A, 1990, BIOCHEMISTRY-US, V29, P309, DOI 10.1021/bi00454a001; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Wada Y, 2000, INVEST OPHTH VIS SCI, V41, P1894; Wang J, 1999, BIOCHEM J, V338, P23, DOI 10.1042/0264-6021:3380023; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; ZIMMERMAN WF, 1975, EXP EYE RES, V21, P325, DOI 10.1016/0014-4835(75)90043-3; ZIMMERMAN WF, 1976, J BIOL CHEM, V251, P4700; ZIMMERMAN WF, 1976, EXP EYE RES, V23, P159, DOI 10.1016/0014-4835(76)90199-8	64	53	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32456	32465		10.1074/jbc.M104949200	http://dx.doi.org/10.1074/jbc.M104949200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11418621	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000170746000013
J	Negishi, Y; Ui, N; Nakajima, M; Kawashima, K; Maruyama, K; Takizawa, T; Endo, H				Negishi, Y; Ui, N; Nakajima, M; Kawashima, K; Maruyama, K; Takizawa, T; Endo, H			p21(Cip-1/SDI-1/WAF-1) gene is involved in chondrogenic differentiation of ATDC5 cells in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; DEPENDENT KINASE INHIBITOR; CDK INHIBITOR; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVATION; DNA-SYNTHESIS; EXPRESSION; LINE; P21; P21(WAF1/CIP1)	Development of skeletal cartilage is characterized with coupling growth arrest and cell differentiation. Here, to understand the cyclin-dependent kinase inhibitors involved in the progression of chondrogenic differentiation, we examined changes in the expression levels of cyclin-dependent kinase inhibitor members using mouse ATDC5 prechondrocytes as a widely used in vitro model of cartilage differentiation. Up-regulation of p21 and p27 mRNA was observed following a decrease in growth rate of prechondrocytes, and both transcripts subsequently accumulated during chondrogenic differentiation; p15, p18, and p19 mRNA, in contrast, did not change during differentiation. Only the up-regulation of p21 mRNA during differentiation was prevented by the continuous treatment of early chondrogenic inhibitor, parathyroid hormone, indicating a close correlation between differentiation and p21 induction in ATDC5 cells. Therefore, to examine the role of p21 during chondrogenesis, we established stable cell lines overexpressing full-length p21 antisense RNA in ATDC5. The reduction of endogenous p21 in these cell lines caused inhibition of early chondrogenic differentiation in ATDC5, indicating that p21 gene plays an important role in this process of the cells in vitro. Furthermore, the level of p21 protein and p21-CDK2 complexes transiently increased during differentiation, but not in undifferentiated cells, leading to a decrease in CDK2-associated kinase. However, differentiation-dependent expressed p21 protein was degraded by a proteasome-dependent pathway. Thus, the progression of chondrogenic differentiation requires down-regulation of CDK2-associated kinase with an increase in p21 protein and subsequent degradation of this protein by a proteasomal pathway.	Teikyo Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Sagamiko, Kanagawa 1990195, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Sagamiko, Kanagawa 1990195, Japan	Teikyo University; Teikyo University	Negishi, Y (corresponding author), Teikyo Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Sagamiko, Kanagawa 1990195, Japan.	yo-negi@pharm.teikyo-u.ac.jp						ABE N, 1994, BBA-PROTEIN STRUCT M, V1204, P61, DOI 10.1016/0167-4838(94)90033-7; Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Chellappan SP, 1998, CURR TOP MICROBIOL, V227, P57; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Erhardt JA, 1998, J BIOL CHEM, V273, P23517, DOI 10.1074/jbc.273.36.23517; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Franklin DS, 1996, MOL BIOL CELL, V7, P1587, DOI 10.1091/mbc.7.10.1587; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Harper JW, 1996, CURR OPIN GENET DEV, V6, P56; HARPER JW, 1993, CELL, V75, P805; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; HIRAKI Y, 1987, MOL CELL BIOCHEM, V76, P185; HIRAKI Y, 1988, BIOCHIM BIOPHYS ACTA, V969, P91, DOI 10.1016/0167-4889(88)90092-4; HOWLETT CR, 1979, J ANAT, V128, P377; HUNTER T, 1993, CELL, V75, P839, DOI 10.1016/0092-8674(93)90528-X; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kihara-Negishi F, 1998, INT J CANCER, V76, P523, DOI 10.1002/(SICI)1097-0215(19980518)76:4<523::AID-IJC14>3.0.CO;2-8; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Negishi Y, 2000, BIOCHEM BIOPH RES CO, V268, P450, DOI 10.1006/bbrc.2000.2076; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1995, ONCOGENE, V11, P635; SCHNEIDER WC, 1957, METHOD ENZYMOL, V3, P680, DOI 10.1016/S0076-6879(57)03442-4; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; STOCUM DL, 1979, J EMBRYOL EXP MORPH, V54, P155; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Zabludoff SD, 1998, CELL GROWTH DIFFER, V9, P1	47	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33249	33256		10.1074/jbc.M010127200	http://dx.doi.org/10.1074/jbc.M010127200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11406616	hybrid			2022-12-27	WOS:000170746000111
J	Zeng, HY; Sanyal, S; Mukhopadhyay, D				Zeng, HY; Sanyal, S; Mukhopadhyay, D			Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; PHOSPHORYLATION SITES; EXTRACELLULAR-MATRIX; TUMOR-CELLS; FACTOR VEGF; IN-VIVO; ANGIOGENESIS; DOMAIN; KINASE; IDENTIFICATION	Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) exerts its multiple functions by activating two receptor tyrosine kinases, Flt-1 (VEGFR-1) and KDR (VFGFR-2), both of which are selectively expressed on primary vascular endothelium. To dissect the respective signaling pathways and biological functions mediated by these receptors in primary endothelial cells with two receptors intact, we, recently developed chimeric receptors (EGDR and EGLT) in which the extracellular domain of the epidermal growth factor receptor was fused to the transmembrane domain and intracellular domain of KDR and Flt-1, respectively. With these fusion receptors, we have shown that KDR is solely responsible for VPF/VEGF-induced human umbilical vein endothelial cell (HUVEC) proliferation and migration, whereas Flt-1 showed an inhibitory effect on KDR-mediated proliferation but not migration. To further characterize the VPF/VEGF-stimulated HUVEC proliferation and migration here, we have created several EGDR mutants by site-directed mutagenesis. We show that tyrosine residues 1059 and 951 of KDR are essential for VPF/VEGF-induced HUVEC proliferation and migration, respectively. Furthermore, the mutation of tyrosine 1059 to phenylanaline results in the complete loss of KDR/EGDR-mediated intracellular Ca2+ mobilization and MAPK phosphorylation, but the mutation of tyrosine 951 to phenylanaline did not affect these events. Our results suggest that KDR mediates different signaling pathways for HUVEC proliferation and migration and, moreover, intracellular Ca2+ mobilization and MAPK phosphorylation are not essential for VPF/VEGF-induced HUVEC migration.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University	Mukhopadhyay, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.				NCI NIH HHS [CA78383] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078383, R29CA078383] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENEZRA M, 1993, BLOOD, V81, P3324; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; BROCK TA, 1991, AM J PATHOL, V138, P213; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; Dvorak H.F., 1984, DEV ONCOL, V22, P96; DVORAK HF, 1990, PROG CLIN BIOL RES, V354, P317; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; DVORAK HF, 1979, J IMMUNOL, V122, P166; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 1996, SCI AM, V275, P150, DOI 10.1038/scientificamerican0996-150; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Ito N, 1998, J BIOL CHEM, V273, P23410, DOI 10.1074/jbc.273.36.23410; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SEETHARAM L, 1995, ONCOGENE, V10, P135; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SENGER DR, 1986, CANCER RES, V46, P5629; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Shibuya M, 1999, CURR TOP MICROBIOL, V237, P59; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200	36	124	138	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32714	32719		10.1074/jbc.M103130200	http://dx.doi.org/10.1074/jbc.M103130200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435426	hybrid			2022-12-27	WOS:000170746000046
J	Rau, A; Hogg, T; Marquardt, R; Hilgenfeld, R				Rau, A; Hogg, T; Marquardt, R; Hilgenfeld, R			A new lysozyme fold - Crystal structure of the muramidase from Streptomyces coelicolor at 1.65 angstrom resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; GENOME SEQUENCE; N,O-DIACETYLMURAMIDASE; PURIFICATION; MOLSCRIPT; BARREL; FORMS; GENE	Cellosyl is a bacterial muramidase from Streptomyces coelicolor. Similar to other lysozymes, the enzyme cleaves the beta -1,4-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine units, but it also exhibits a beta -1,4-N,6-O-diacetylmuramidase activity. The latter enables Cellosyl to degrade the cell walls of Staphylococcus aureus, which are not hydrolyzed by chicken-, goose-, or bacteriophage T4-type lysozymes. The enzymatic activity and amino acid sequence of Cellosyl group it with lysozymes of the Chalaropsis type, for which no detailed structural information has been available so far. The crystal structure of Cellosyl from S. coelicolor has been determined to a resolution of 1.65 Angstrom and refined to an R-factor of 15.2%. The enzyme is comprised of a single domain and possesses an unusual beta/alpha -barrel fold. The last strand, beta8, of the (beta/alpha)(5)beta (3)-barrel is found to be antiparallel to strands beta7 and beta1. Asp-9, Asp-98, and Glu-100 are located at the active site. The structure of Cellosyl exhibits a new lysozyme fold and represents a new class of polysaccharide-hydrolyzing beta/alpha -barrels.	Inst Mol Biotechnol, Dept Struct Biol & Crystallog, D-07745 Jena, Germany; Dechema EV, Dept Biotechnol, D-60486 Frankfurt, Germany		Hilgenfeld, R (corresponding author), Inst Mol Biotechnol, Dept Struct Biol & Crystallog, Beutenbergstr 11, D-07745 Jena, Germany.	hilgenfd@imb-jena.de	Hilgenfeld, Rolf/C-9675-2011					Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRAU B, 1991, APPL MICROBIOL BIOT, V34, P481; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHANG JJ, 1979, J BIOL CHEM, V254, P7772; CROUX C, 1991, GENE, V104, P25, DOI 10.1016/0378-1119(91)90460-S; Cutfield SM, 1999, J MOL BIOL, V294, P771, DOI 10.1006/jmbi.1999.3287; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FABER GK, 1990, TRENDS BIOCHEM SCI, V15, P228; Fastrez J, 1996, EXS, V75, P35; FELCH JW, 1975, J BIOL CHEM, V250, P3713; FOUCHE PB, 1978, J BIOL CHEM, V253, P6787; HARADA S, 1981, J BIOL CHEM, V256, P1600; HARADA S, 1989, J MOL BIOL, V207, P851, DOI 10.1016/0022-2836(89)90254-4; HASH JH, 1967, J BIOL CHEM, V242, P5586; HILGENFELD R, 1992, J CRYST GROWTH, V122, P330, DOI 10.1016/0022-0248(92)90265-K; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holtje J V, 1996, EXS, V75, P65; HUGHEY VL, 1987, APPL ENVIRON MICROB, V53, P2165, DOI 10.1128/AEM.53.9.2165-2170.1987; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEBIODA L, 1989, J BIOL CHEM, V264, P3685; LYNE JE, 1990, J BIOL CHEM, V265, P6928; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MORITA T, 1978, J BIOCHEM, V83, P893, DOI 10.1093/oxfordjournals.jbchem.a131987; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; REARDON D, 1995, FASEB J, V9, P497, DOI 10.1096/fasebj.9.7.7737457; Riboldi-Tunnicliffe A, 1999, J APPL CRYSTALLOGR, V32, P1003, DOI 10.1107/S0021889899008584; SANZ JM, 1992, BIOCHEMISTRY-US, V31, P8495, DOI 10.1021/bi00151a016; Shiba T, 2000, ACTA CRYSTALLOGR D, V56, P1462, DOI 10.1107/S0907444900010374; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; WEAVER LH, 1985, J MOL EVOL, V21, P97, DOI 10.1007/BF02100084; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907	39	53	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31994	31999		10.1074/jbc.M102591200	http://dx.doi.org/10.1074/jbc.M102591200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427528	hybrid			2022-12-27	WOS:000170613500072
J	Small, D; Kovalenko, D; Kacer, D; Liaw, L; Landriscina, M; Di Serio, C; Prudovsky, I; Maciag, T				Small, D; Kovalenko, D; Kacer, D; Liaw, L; Landriscina, M; Di Serio, C; Prudovsky, I; Maciag, T			Soluble jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VEIN ENDOTHELIAL-CELLS; GROWTH-FACTOR-I; V-SRC; TYROSINE PHOSPHORYLATION; NUCLEAR TRANSLOCATION; INTRACELLULAR DOMAIN; INDUCED ANGIOGENESIS; PROGENITOR CELLS; MAMMALIAN NOTCH; EPH RECEPTORS	We have previously demonstrated that the expression of the soluble extracellular domain of the transmembrane ligand for Notch receptors, Jagged 1 (sJ1), in NIH 3T3 cells results in the formation of a matrix-dependent chord-like phenotype, the loss of contact inhibition of growth, and an inhibition of pro-al(I) collagen expression. In an effort to define the mechanism by which sJ1 induces this phenotype, we report that sJ1 transfectants display biochemical and cytoskeletal alterations consistent with the activation of Src. Indeed, cotransfection of sJ1 transfectants with a dominant-negative mutant of Src resulted in the loss of matrix-dependent chord formation and correlated with the restoration of type I collagen expression and contact inhibition of growth. We also report that the sJ1-mediated induction of Src activity and related phenotypes, including chord formation, may result from. the inhibition of endogenous Jagged 1-mediated Notch signaling since it was not possible to detect an sJ1-dependent induction of CSL-dependent transcription in these cells. Interestingly, NIH 3T3 cells transfected with dominant-negative (but not constitutively active) mutants of either Notch I or Notch 2 displayed a similar Src-related phenotype as the sJ1 transfectants. These data suggest that the ability, of sJ1 to mediate chord formation is Src-dependent and requires the repression of endogenous Jagged 1-mediated Notch signaling, which is tolerant to the destabilization of the actin cytoskeleton, a mediator of cell migration.	Maine Med Ctr, Inst Res, Ctr Mol Med, Scarborough, ME 04074 USA; Univ Maine, Ctr Biophys Sci, Orono, ME 04469 USA	Maine Medical Center; University of Maine System; University of Maine Orono	Maciag, T (corresponding author), Maine Med Ctr, Inst Res, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	maciat@mmc.org	Prudovsky, Igor/GVU-1521-2022; Landriscina, Matteo/K-1092-2016	Landriscina, Matteo/0000-0003-0591-9799	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL003567] Funding Source: NIH RePORTER; NCRR NIH HHS [RR1555] Funding Source: Medline; NHLBI NIH HHS [HL3567] Funding Source: Medline; NINR NIH HHS [NRSA-CA92255] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BYERS HR, 1991, AM J PATHOL, V139, P423; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; DELAMO FF, 1993, GENOMICS, V15, P259, DOI 10.1006/geno.1993.1055; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fitzgerald K, 2000, ONCOGENE, V19, P4191, DOI 10.1038/sj.onc.1203766; FRANKFORT BJ, 1995, BIOCHEM BIOPH RES CO, V206, P916, DOI 10.1006/bbrc.1995.1130; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; Garfinkel S, 1996, J CELL BIOL, V134, P783, DOI 10.1083/jcb.134.3.783; Gray GE, 1999, AM J PATHOL, V154, P785, DOI 10.1016/S0002-9440(10)65325-4; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Hock B, 1998, P NATL ACAD SCI USA, V95, P9779, DOI 10.1073/pnas.95.17.9779; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huang CK, 1997, J BIOL CHEM, V272, P17, DOI 10.1074/jbc.272.1.17; Hubbard EJA, 1996, SCIENCE, V273, P112, DOI 10.1126/science.273.5271.112; Hukriede NA, 1997, DEVELOPMENT, V124, P3427; Ikeya T, 1999, DEVELOPMENT, V126, P4455; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Landriscina M, 2000, J BIOL CHEM, V275, P32753, DOI 10.1074/jbc.M002336200; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; LaVallee TM, 1998, J CELL BIOL, V141, P1647, DOI 10.1083/jcb.141.7.1647; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li LH, 1998, GENOMICS, V51, P45, DOI 10.1006/geno.1998.5330; LINDNER V, 2001, IN PRESS AM J PATHOL; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; MACIAG T, 1982, J CELL BIOL, V94, P511, DOI 10.1083/jcb.94.3.511; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; Meijne AML, 1997, EXP CELL RES, V234, P477, DOI 10.1006/excr.1997.3637; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Morrissette JJD, 2001, HUM MOL GENET, V10, P405, DOI 10.1093/hmg/10.4.405; NANUS DM, 1991, ONCOGENE, V6, P2105; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Shutter JR, 2000, GENE DEV, V14, P1313; Soriano JV, 2000, INT J CANCER, V86, P652; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Sun X, 1997, DEVELOPMENT, V124, P3439; Uyttendaele H, 2000, MICROVASC RES, V60, P91, DOI 10.1006/mvre.2000.2254; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Vincenti MP, 1998, MOL CARCINOGEN, V21, P194, DOI 10.1002/(SICI)1098-2744(199803)21:3<194::AID-MC7>3.0.CO;2-M; Weinmaster G, 1998, CURR OPIN GENET DEV, V8, P436, DOI 10.1016/S0959-437X(98)80115-9; Wong MKK, 2000, BIOCHEM BIOPH RES CO, V268, P853, DOI 10.1006/bbrc.2000.2173; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; ZHAN X, 1993, J BIOL CHEM, V268, P24427; ZHAN X, 1993, J BIOL CHEM, V268, P9611; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	60	101	104	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32022	32030		10.1074/jbc.M100933200	http://dx.doi.org/10.1074/jbc.M100933200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427524	hybrid			2022-12-27	WOS:000170613500076
J	Zhao, Y; Zhang, ZY				Zhao, Y; Zhang, ZY			The mechanism of dephosphorylation of extracellular signal-regulated kinase 2 by mitogen-activated protein kinase phosphatase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; OF-FUNCTION MUTATION; P42 MAP KINASE; TYROSINE-PHOSPHATASE; TRANSITION-STATE; CATALYTIC ACTIVATION; CRYSTAL-STRUCTURE; IN-VIVO; ERK2; PHOSPHORYLATION	The mitogen-activated protein (MAP) kinase phosphatase-3 (MKP3) is a dual specificity phosphatase that specifically inactivates one subfamily of MAP kinases, the extracellular signal-regulated kinases (ERKs). Inactivation of MAP kinases occurs by dephosphorylation of Thr(P) and Tyr(P) in the TXY kinase activation motif. To gain insight into the mechanism of ERK2 inactivation by MKP3, we have carried out an analysis of the MKP3-catalyzed dephosphorylation of the phosphorylated ERK2. We find that ERK2/pTpY dephosphorylation by MKP3 involves an ordered, distributive mechanism in which MKP3 binds the bisphosphorylated ERK2/pTpY, dephosphorylates Tyr(P) first, dissociates and releases the monophosphorylated ERK2/pT, which is then subjected to dephosphorylation by a second MKP3, yielding the fully dephosphorylated ERK2. The bisphosphorylated ERK2 is a highly specific substrate for MKP3 with a k(cat)/K-m of 3.8 x 10(6) m(-1) s(-1), which is more than 6 orders of magnitude higher than that for small molecule aryl phosphates and an ERK2-derived phosphopeptide encompassing the pTEpY motif. This strikingly high substrate specificity displayed by MKP3 may result from a combination of high affinity binding interactions between the N-terminal domain of MKP3 and ERK2 and specific ERK2-induced allosteric activation of the MKP3 C-terminal phosphatase domain.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Zhang, ZY (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	zyzhang@aecom.yu.edu			NCI NIH HHS [CA69202] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHN NG, 1991, J BIOL CHEM, V266, P4220; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHO HJ, 1992, J AM CHEM SOC, V114, P7296, DOI 10.1021/ja00044a052; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; Dunn D, 1996, J BIOL CHEM, V271, P168, DOI 10.1074/jbc.271.1.168; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Fox T, 1999, FEBS LETT, V461, P323, DOI 10.1016/S0014-5793(99)01488-X; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HAYSTEAD TAJ, 1992, FEBS LETT, V306, P17, DOI 10.1016/0014-5793(92)80828-5; HENGGE AC, 1995, BIOCHEMISTRY-US, V34, P13982, DOI 10.1021/bi00043a003; Hoff RH, 1999, J AM CHEM SOC, V121, P9514, DOI 10.1021/ja992361o; Hoff RH, 2000, BIOCHEMISTRY-US, V39, P46, DOI 10.1021/bi991570i; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Keng YF, 1999, EUR J BIOCHEM, V259, P809, DOI 10.1046/j.1432-1327.1999.00090.x; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KIRBY AJ, 1967, J AM CHEM SOC, V89, P415, DOI 10.1021/ja00978a044; KYTE J, 1995, STRUCTURE PROTEIN CH, P59; LUO KX, 1991, METHOD ENZYMOL, V201, P149; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mourey RJ, 1996, J BIOL CHEM, V271, P3795; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Sun H, 1998, METH MOL B, V84, P307; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wiland AM, 1996, J BIOL CHEM, V271, P33486, DOI 10.1074/jbc.271.52.33486; Wilsbacher JL, 1999, J BIOL CHEM, V274, P16988, DOI 10.1074/jbc.274.24.16988; Wu L, 1996, BIOCHEMISTRY-US, V35, P5426, DOI 10.1021/bi952885a; Yao Z, 2000, FEBS LETT, V468, P37, DOI 10.1016/S0014-5793(00)01191-1; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhang YL, 1999, BIOCHEMISTRY-US, V38, P12111, DOI 10.1021/bi990836i; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007; ZHENG CF, 1993, J BIOL CHEM, V268, P16116; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	60	153	157	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32382	32391		10.1074/jbc.M103369200	http://dx.doi.org/10.1074/jbc.M103369200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11432864	hybrid			2022-12-27	WOS:000170613500121
J	Shewmaker, F; Maskos, K; Simmerling, C; Landry, SJ				Shewmaker, F; Maskos, K; Simmerling, C; Landry, SJ			The disordered mobile loop of GroES folds into a defined beta-hairpin upon binding GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI GROEL; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; CHAPERONINS; HYDROLYSIS; MECHANISM; EXCHANGE; DYNAMICS	The GroES mobile loop is a stretch of similar to 16 amino acids that exhibits a high degree of flexible disorder in the free protein. This loop is responsible for the interaction between GroES and GroEL, and it undergoes a folding transition upon binding to GroEL. Results derived from a combination of transferred nuclear Overhauser effect NMR experiments and molecular dynamics simulations indicate that the mobile loop adopts a beta -hairpin structure with a Type I, G1 Bulge turn. This structure is distinct from the conformation of the loop in the cocrystal of GroES with GroEL-ADP but identical to the conformation of the bacteriophage-panned "strongly binding peptide" in the co-crystal with GroEL. Analysis of sequence conservation suggests that sequences of the mobile loop and strongly binding peptide were selected for the ability to adopt this hairpin conformation.	Tulane Univ, Hlth Sci Ctr, Dept Biochem, New Orleans, LA 70112 USA; SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Tulane University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Landry, SJ (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Biochem, 1430 Tulane Ave,Box SL-43, New Orleans, LA 70112 USA.		Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543				BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Braig K, 1998, CURR OPIN STRUC BIOL, V8, P159, DOI 10.1016/S0959-440X(98)80033-X; Castanie HP, 1997, ANAL BIOCHEM, V254, P150, DOI 10.1006/abio.1997.2423; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; DAVIS DG, 1985, J AM CHEM SOC, V107, P2821; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Horwich AL, 1999, P NATL ACAD SCI USA, V96, P11033, DOI 10.1073/pnas.96.20.11033; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KEPPEL F, 1990, GENE, V86, P19, DOI 10.1016/0378-1119(90)90109-5; KOVALENKO O, 1994, BIOCHEMISTRY-US, V33, P14974, DOI 10.1021/bi00254a004; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; MARION D, 1989, J MAGN RESON, V84, P425, DOI 10.1016/0022-2364(89)90391-0; McEvoy MM, 1998, P NATL ACAD SCI USA, V95, P7333, DOI 10.1073/pnas.95.13.7333; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; Richardson A, 1999, GENETICS, V152, P1449; Richardson A, 1999, J BIOL CHEM, V274, P52, DOI 10.1074/jbc.274.1.52; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; Wang JD, 1999, NAT STRUCT BIOL, V6, P597; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	37	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31257	31264		10.1074/jbc.M102765200	http://dx.doi.org/10.1074/jbc.M102765200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11395498	hybrid			2022-12-27	WOS:000170472900088
J	Norman, JT; Lindahl, GE; Shakib, K; En-Nia, A; Yilmaz, E; Mertens, PR				Norman, JT; Lindahl, GE; Shakib, K; En-Nia, A; Yilmaz, E; Mertens, PR			The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; C-MYC GENE; GELATINASE-A; CARDIAC FIBROBLASTS; EXPRESSION; ENHANCER; INTRON; ACTIVATION; SEQUENCES; CHK-YB-1B	Appropriate expression of collagen type I, a major component of connective tissue matrices, is dependent on tight transcriptional control and a number of transactivating and repressing factors have been characterized. Here we identify the Y-box binding protein-1 (YB-1) as a novel repressor of the collagen type alpha1(I) (COL1A1) gene. Collagen type I mRNA and protein levels decreased upon overexpression of YB-1 by transfection in NRK fibroblasts. The human, rat, and mouse COL1A1 promoter -220/+115 contains three putative Y-boxes, one of these sites, designated collagen Y-box element (CYE), includes a Y-box. plus an adjacent 3 ' inverted repeat. DNase-I footprinting and Southwestern blotting with fibroblast nuclear extract, demonstrated binding of several nuclear proteins across the CYE, one of which was identified as YB-1. Recombinant YB-1 bound the CYE sequence in gel shift assays with a preference for single-stranded templates. The entire sequence (-88/-48) was required for high affinity binding. Complex formation of endogenous YB-1 with the CYE was established by supershift studies. COL1A1 promoter-reporter constructs were suppressed up to 80% by cotransfection with YB-1 in a variety of cell types. In addition, CYE conferred YB-1 responsiveness on two heterologous promoters further demonstrating the importance of this repressor region. Mung bean nuclease sensitivity analysis suggested that repression is most likely exerted through changes in DNA conformation.	UCL Royal Free & Univ Coll Med Sch, Sir Jules Thorn Inst Clin Sci, Middlesex Hosp, Dept Med, London W1T 3AA, England; Univ Aachen, Dept Nephrol & Immunol, D-52057 Aachen, Germany	University of London; University College London; UCL Medical School; RWTH Aachen University	Mertens, PR (corresponding author), Rhein Westfal TH Aachen, Med Clin 2, Dept Nephrol & Immunol, Paulwelsstr 30, D-52057 Aachen, Germany.	pmertens@post.klinikam.rwth-aachen.de	Mertens, Peter/AAI-7310-2020		PHS HHS [5 RO1 K54602-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bornstein P, 1996, MATRIX BIOL, V15, P3, DOI 10.1016/S0945-053X(96)90121-3; Breault DT, 1997, J BIOL CHEM, V272, P31241, DOI 10.1074/jbc.272.50.31241; BUTT RP, 1995, EUR J CELL BIOL, V68, P330; CHEN NN, 1995, P NATL ACAD SCI USA, V92, P1087, DOI 10.1073/pnas.92.4.1087; Chernukhin IV, 2000, J BIOL CHEM, V275, P29915, DOI 10.1074/jbc.M001538200; Clark IM, 1997, BIOCHEM J, V324, P611, DOI 10.1042/bj3240611; Dhalla AK, 1998, BIOCHEM J, V336, P373, DOI 10.1042/bj3360373; Diamond P, 2001, J BIOL CHEM, V276, P7943, DOI 10.1074/jbc.M009836200; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; FRISCH SM, 1990, MOL CELL BIOL, V10, P6524, DOI 10.1128/MCB.10.12.6524; Galera P, 1996, J BIOL CHEM, V271, P21331, DOI 10.1074/jbc.271.35.21331; GRANT CE, 1993, MOL CELL BIOL, V13, P4186, DOI 10.1128/MCB.13.7.4186; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; Izumi H, 2001, NUCLEIC ACIDS RES, V29, P1200, DOI 10.1093/nar/29.5.1200; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; KARSENTY G, 1990, J BIOL CHEM, V265, P9934; KINNIBURGH AJ, 1994, GENE, V149, P93, DOI 10.1016/0378-1119(94)90416-2; Lee HW, 1998, J MOL CELL CARDIOL, V30, P2495, DOI 10.1006/jmcc.1998.0811; Levens D, 1997, CURR TOP MICROBIOL, V224, P33; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Mertens PR, 1999, J AM SOC NEPHROL, V10, P2480; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; NEHLS MC, 1991, MOL CELL BIOL, V11, P4065, DOI 10.1128/MCB.11.8.4065; Orphanides C, 1997, KIDNEY INT, V52, P637, DOI 10.1038/ki.1997.377; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; RAVAZZOLO R, 1991, J BIOL CHEM, V266, P7382; Safak M, 1999, J VIROL, V73, P10146, DOI 10.1128/JVI.73.12.10146-10157.1999; Safak R, 1999, MOL CELL BIOL, V19, P2712; Schwartzbauer G, 1998, J BIOL CHEM, V273, P24760, DOI 10.1074/jbc.273.38.24760; Stenina OI, 2000, J CLIN INVEST, V106, P579, DOI 10.1172/JCI9075; Stoddart JH, 2000, J CELL BIOCHEM, V77, P135, DOI 10.1002/(SICI)1097-4644(20000401)77:1<135::AID-JCB14>3.0.CO;2-X; Swamynathan SK, 1997, J VIROL, V71, P2873, DOI 10.1128/JVI.71.4.2873-2880.1997; Swamynathan SK, 2000, BIOCHEM J, V348, P297, DOI 10.1042/0264-6021:3480297; Swamynathan SK, 1998, FASEB J, V12, P515, DOI 10.1096/fasebj.12.7.515; Tomonaga T, 1998, MOL CELL, V1, P759, DOI 10.1016/S1097-2765(00)80075-1; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Trojanowska M, 1998, J MOL MED, V76, P266, DOI 10.1007/s001090050216; Wada MR, 1998, DEV GROWTH DIFFER, V40, P631; WOLFFE AP, 1992, NEW BIOL, V4, P290; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407	46	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29880	29890		10.1074/jbc.M103145200	http://dx.doi.org/10.1074/jbc.M103145200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395503	hybrid			2022-12-27	WOS:000170558000038
J	Richnau, N; Aspenstrom, P				Richnau, N; Aspenstrom, P			RICH, a rho GTPase-activating protein domain-containing protein involved in signaling by Cdc42 and Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; BINDING-PROTEINS; ACTIN; FAMILY; PEPTIDES; HOMOLOGY; DYNAMIN; SYSTEM; KINASE; PSTPIP	A previously unidentified Rho GTPase-activating protein (GAP) domain-containing protein was found in a yeast two-hybrid screen for cDNAs encoding proteins binding to the Src homology 3 domain of Cdc42-interacting protein 4 (CIP4). The protein was named RICH-1 (RhoGAP interacting with CIP4 homologues), and, in addition to the RhoGAP domain, it contained an N-terminal domain with endophilin homology and a C-terminal proline-rich domain. Transient transfections of RICH-1 indicated that it bound to CIP4 in vivo, as shown by co-immunoprecipitation experiments, as well as colocalization assays. In vitro assays demonstrated that the RhoGAP domain of RICH-1 catalyzed GTP hydrolysis on Cdc42 and Rac1, but not on RhoA. Ectopic expression of the RhoGAP domain as well as the full-length protein interfered with platelet-derived growth factor BB-induced membrane ruffling, but not with serum-induced stress fiber formation, further emphasizing the notion that, in vivo, RICH-1 is a GAP for Cdc42 and Rac1.	Ludwig Inst Canc Res, Ctr Biomed, S-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research	Aspenstrom, P (corresponding author), Ludwig Inst Canc Res, Ctr Biomed, Box 595, S-75124 Uppsala, Sweden.	pontus.aspenstrom@LICR.uu.se						Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Aspenstrom P, 1999, EXP CELL RES, V246, P20, DOI 10.1006/excr.1998.4300; ASPENSTROM P, 1995, METHOD ENZYMOL, V256, P228; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Burbelo PD, 1999, P NATL ACAD SCI USA, V96, P9083, DOI 10.1073/pnas.96.16.9083; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8; Gomez J, 1998, IMMUNOL CELL BIOL, V76, P125, DOI 10.1046/j.1440-1711.1998.00723.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Kriegler M., 1990, GENE TRANSFER EXPRES; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Merilainen J, 1997, J BIOL CHEM, V272, P23278, DOI 10.1074/jbc.272.37.23278; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Ochs HD, 1998, SPRINGER SEMIN IMMUN, V19, P435, DOI 10.1007/BF00792601; Pirone DM, 2000, J BIOL CHEM, V275, P22650, DOI 10.1074/jbc.M002832200; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sekimata M, 1999, J BIOL CHEM, V274, P17757, DOI 10.1074/jbc.274.25.17757; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Taylor JM, 1999, J CELL SCI, V112, P231; Tian L, 2000, J BIOL CHEM, V275, P7854, DOI 10.1074/jbc.275.11.7854; VAN AL, 1997, GENE DEV, V11, P2295; Vignal E, 2000, J BIOL CHEM, V275, P36457, DOI 10.1074/jbc.M003487200; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zalcman G, 1999, Prog Mol Subcell Biol, V22, P85; Zigmond SH, 2000, J CELL BIOL, V150, pF117, DOI 10.1083/jcb.150.6.F117	54	86	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					35060	35070		10.1074/jbc.M103540200	http://dx.doi.org/10.1074/jbc.M103540200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11431473	hybrid			2022-12-27	WOS:000171024600095
J	Oyarce, AM; Steveson, TC; Jin, LX; Eipper, BA				Oyarce, AM; Steveson, TC; Jin, LX; Eipper, BA			Dopamine beta-monooxygenase signal/anchor sequence alters trafficking of peptidylglycine alpha-hydroxylating monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND FORMS; ADRENAL CHROMAFFIN GRANULES; PEPTIDE PROCESSING ENZYME; UNCLEAVED SIGNAL PEPTIDE; AMIDATING MONOOXYGENASE; SECRETORY GRANULES; MESSENGER-RNA; ENDOPLASMIC-RETICULUM; NEUROENDOCRINE CELLS; MOLECULAR-CLONING	Dopamine beta -monooxygenase (DBM) and peptidylglycine a-hydroxylating monooxygenase (PHM) are essential for the biosynthesis of catecholamines and amidated peptides, respectively. The enzymes share a conserved catalytic core. We studied the role of the DBM signal sequence by appending it to soluble PHM (PHMs) and expressing the DBMsignal/PHMs chimera in AtT-20 and Chinese hamster ovary cells. PHMs produced as part of DBMsignal/PHMs was active. In vitro translated and cellular DBMsignal/PHMs had similar masses, indicating that the DBM signal was not removed. DBMsignaI/PHMs was membrane-associated and had the properties of an intrinsic membrane protein. After in vitro translation in the presence of microsomal membranes, trypsin treatment removed 2 kDa from DBMsignal/PHMs while PHMs was entirely protected. In addition, a Cys residue in DBMsignal/PHMs was accessible to Cys-directed biotinylation. Thus the chimera adopts the topology of a type Il membrane protein. Pulse-chase experiments indicate that DBMsignal/PHMs turns over rapidly after exiting the trans-Golgi network. Although PHMs is efficiently localized to secretory granules, DBMsignal/PHMs is largely localized to the endoplasmic reticulum in AtT-20 cells. On the basis of stimulated secretion, the small amount of PHMs generated is stored in secretory granules. In contrast, the expression of DBMsignal/PHMs in PC12 cells yields protein that is localized to secretory granules.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Oyarce, AM (corresponding author), Med Coll Ohio, Dept Pharmacol & Therapeut, BHSB 209, Toledo, OH 43614 USA.				NIDA NIH HHS [DA-11269, DA-00266] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266, R03DA011269] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BLOBEL G, 1976, BIOCHEM BIOPH RES CO, V68, P1, DOI 10.1016/0006-291X(76)90001-2; BON S, 1991, J NEUROCHEM, V57, P1100, DOI 10.1111/j.1471-4159.1991.tb08267.x; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Cubells JF, 1998, HUM GENET, V102, P533, DOI 10.1007/s004390050736; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; EIPPER BA, 1992, J BIOL CHEM, V267, P4008; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Emoto N, 1999, J BIOL CHEM, V274, P1509, DOI 10.1074/jbc.274.3.1509; FENG ZH, 1992, J BIOL CHEM, V267, P21808; GIBSON KR, 1993, J BIOL CHEM, V268, P9490; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HOUHOU L, 1995, J BIOL CHEM, V270, P12601, DOI 10.1074/jbc.270.21.12601; HURTLEY SM, 1993, J CELL SCI, V106, P649; HUSTEN EJ, 1991, J BIOL CHEM, V266, P17004; KENDALL DA, 1986, NATURE, V321, P706, DOI 10.1038/321706a0; KOBAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P1089, DOI 10.1093/nar/17.3.1089; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KULATHILA R, 1994, ARCH BIOCHEM BIOPHYS, V311, P191, DOI 10.1006/abbi.1994.1225; LADURON PM, 1975, FEBS LETT, V52, P132, DOI 10.1016/0014-5793(75)80654-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; LEWIS EJ, 1990, J BIOL CHEM, V265, P1021; LEWIS EJ, 1992, J BIOL CHEM, V267, P494; MAINS RE, 1995, MOL ENDOCRINOL, V9, P3, DOI 10.1210/me.9.1.3; MBIKAY M, 1995, EXP CELL RES, V220, P79, DOI 10.1006/excr.1995.1294; MCHUGH EM, 1985, J BIOL CHEM, V260, P4409; MCMAHON A, 1990, J NEUROSCI RES, V25, P395, DOI 10.1002/jnr.490250317; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MERKLER DJ, 1995, FEBS LETT, V366, P165, DOI 10.1016/0014-5793(95)00516-C; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; MOORE HPH, 1983, CELL, V35, P531, DOI 10.1016/0092-8674(83)90187-3; Murakami Y, 2000, BIOCHEM BIOPH RES CO, V267, P1, DOI 10.1006/bbrc.1999.1706; NAKANO T, 1992, BIOCHEM BIOPH RES CO, V189, P590, DOI 10.1016/0006-291X(92)91598-K; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OUAFIK L, 1993, GENOMICS, V18, P319, DOI 10.1006/geno.1993.1471; Oyarce AM, 2000, J BIOL CHEM, V275, P3270, DOI 10.1074/jbc.275.5.3270; Oyarce AM, 1996, J NEUROCHEM, V67, P229; OYARCE AM, 1995, J CELL SCI, V108, P287; PAPINI E, 1995, J BIOL CHEM, V270, P1332, DOI 10.1074/jbc.270.3.1332; Parks GD, 1996, J BIOL CHEM, V271, P7187, DOI 10.1074/jbc.271.12.7187; Partoens P, 1998, J CELL SCI, V111, P681; SABBAN EL, 1983, J BIOL CHEM, V258, P7812; SAXENA A, 1983, J BIOL CHEM, V258, P4147; SCHEELE G, 1980, J CELL BIOL, V87, P611, DOI 10.1083/jcb.87.3.611; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SOUTHAN C, 1989, FEBS LETT, V255, P116, DOI 10.1016/0014-5793(89)81072-5; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; TALJANIDISZ J, 1989, BIOCHEMISTRY-US, V28, P10054, DOI 10.1021/bi00452a026; Tanner VA, 1996, J HISTOCHEM CYTOCHEM, V44, P1481, DOI 10.1177/44.12.8985140; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; TAYLOR CS, 1989, J BIOL CHEM, V264, P14; Toyo-oka K, 1999, INT IMMUNOL, V11, P2043, DOI 10.1093/intimm/11.12.2043; WIKSTROM L, 1992, J BIOL CHEM, V267, P5; WINKLER H, 1986, NEUROSCIENCE, V18, P261, DOI 10.1016/0306-4522(86)90154-5; WU HJ, 1990, J NEUROCHEM, V55, P97, DOI 10.1111/j.1471-4159.1990.tb08826.x; YUN HY, 1993, ARCH BIOCHEM BIOPHYS, V301, P77, DOI 10.1006/abbi.1993.1117; ZHOU A, 1994, J BIOL CHEM, V269, P17440	64	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33265	33272		10.1074/jbc.M101088200	http://dx.doi.org/10.1074/jbc.M101088200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11418593	hybrid			2022-12-27	WOS:000170746000113
J	Gil-Henn, H; Volohonsky, G; Elson, A				Gil-Henn, H; Volohonsky, G; Elson, A			Regulation of protein-tyrosine phosphatases alpha and epsilon by calpain-mediated proteolytic cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; RPTP-ALPHA; PTP-ALPHA; INSULIN-RECEPTOR; DOWN-REGULATION; MAMMARY-TUMORS; EXPRESSION; INTEGRIN; ISOFORM; SIGNAL	The precise subcellular localization of non-receptor tyrosine phosphatases is a major factor in regulating their physiological functions. We have previously shown that cellular processing of protein-tyrosine phosphatase epsilon (PTP epsilon) generates a physiologically distinct, cytoplasmic form of this protein, p65 PTP epsilon. Here we describe a novel protein form of the related receptor-type tyrosine phosphatase alpha (RPTP alpha), p66 PTP alpha, which is detected in nearly all cell types where RPTPa is expressed. Both p66 PTP alpha and p65 PTP epsilon are produced by calpain-mediated proteolytic cleavage in vivo. Cleavage is inhibited in living cells by a variety of calpain inhibitors, can be induced in primary cortical neurons treated with calcium chloride, and is observed in lysates of brain or of cultured cells following addition of purified calpain. Cleavage occurs within the intracellular juxtamembrane domain of RPTPa, releasing the phosphatase catalytic domains from their membranal anchors and translocating them to the cytoplasm. Translocation reduces the ability of PTPa to act on membrane-associated substrates, as it loses its ability to dephosphorylate Src at its C-terminal regulatory site, and its ability to dephosphorylate the Kv2.1 voltage-gated potassium channel is severely impaired. In all, the data indicate that control of phosphatase function via post-translational processing occurs also among receptor-type phosphatases, and demonstrate the molecular complexity of regulating these parameters within the PTP alpha /PTP epsilon phosphatase subfamily.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Elson, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	ari.elson@weizmann.ac.il		Elson, Ari/0000-0001-9808-9135				Andersen JN, 2001, BIOCHEM J, V354, P581, DOI 10.1042/0264-6021:3540581; Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2000, J BIOL CHEM, V275, P12446, DOI 10.1074/jbc.275.17.12446; CHAMAK B, 1989, DEVELOPMENT, V106, P483; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAUM G, 1994, J BIOL CHEM, V269, P10524; den Hertog J, 1999, MECH DEVELOP, V85, P3, DOI 10.1016/S0925-4773(99)00089-1; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; Elson A, 1996, GENOMICS, V31, P373, DOI 10.1006/geno.1996.0061; Elson A, 1999, ONCOGENE, V18, P7535, DOI 10.1038/sj.onc.1203098; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Elson A, 1995, P NATL ACAD SCI USA, V92, P12235, DOI 10.1073/pnas.92.26.12235; Fischer EH, 1999, ADV ENZYME REGUL, V39, P359, DOI 10.1016/S0065-2571(98)00014-4; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gil-Henn H, 2000, ONCOGENE, V19, P4375, DOI 10.1038/sj.onc.1203790; Gu MX, 1996, J BIOL CHEM, V271, P27751, DOI 10.1074/jbc.271.44.27751; Gurd JW, 1999, J NEUROCHEM, V73, P1990; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jacob KK, 1998, J BIOL CHEM, V273, P4800, DOI 10.1074/jbc.273.8.4800; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Lammers R, 1998, BIOCHEM BIOPH RES CO, V242, P32, DOI 10.1006/bbrc.1997.7906; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Lammers R, 1997, FEBS LETT, V404, P37, DOI 10.1016/S0014-5793(97)00080-X; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; MAURO LJ, 1994, TRENDS BIOCHEM SCI, V19, P151, DOI 10.1016/0968-0004(94)90274-7; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Nakamura K, 1996, BIOCHEM BIOPH RES CO, V218, P726, DOI 10.1006/bbrc.1996.0129; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Nguyen TH, 1999, J NEUROCHEM, V73, P1995; Pariat M, 1997, MOL CELL BIOL, V17, P2806, DOI 10.1128/MCB.17.5.2806; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Petrone A, 2000, J CELL SCI, V113, P2345; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Rock MT, 1997, J BIOL CHEM, V272, P33377, DOI 10.1074/jbc.272.52.33377; Schaapveld R, 1997, MOL BIOL REP, V24, P247, DOI 10.1023/A:1006870016238; Stein-Gerlach M, 1998, INT J BIOCHEM CELL B, V30, P559, DOI 10.1016/S1357-2725(98)00002-8; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; TABITI K, 1995, CANCER LETT, V93, P239, DOI 10.1016/0304-3835(95)03816-F; Tanuma N, 1999, EUR J BIOCHEM, V259, P46, DOI 10.1046/j.1432-1327.1999.00004.x; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0; Zondag GCM, 1997, BIOCHIMIE, V79, P477, DOI 10.1016/S0300-9084(97)82739-3	55	49	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31772	31779		10.1074/jbc.M103395200	http://dx.doi.org/10.1074/jbc.M103395200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11429406	hybrid			2022-12-27	WOS:000170613500041
J	Hauser, F; Strassner, J; Schaller, A				Hauser, F; Strassner, J; Schaller, A			Cloning, expression, and characterization of tomato (Lycopersicon esculentum) aminopeptidase P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE SPECIFIC PEPTIDASES; ESCHERICHIA-COLI; BOVINE LUNG; METHIONINE AMINOPEPTIDASE; PURIFICATION; ENZYME; RAT; BRADYKININ; PROTEINS; POLYPEPTIDE	A cDNA (LeAPP2) was cloned from tomato coding for a 654 amino acid protein of 72.7 kDa. The deduced amino acid sequence was > 40% identical with that of mammalian aminopeptidase P, a metalloexopeptidase. All amino acids reported to be important for binding of the active site metals and catalytic activity, respectively, were conserved between LeAPP2 and its mammalian homologues. LeAPP2 was expressed in Escherichia coli in N-terminal fusion with glutathione S-transferase and was purified from bacterial extracts. LeAPP2 was verified as an aminopeptidase P, hydrolyzing the amino-terminal Xaa-Pro bonds of bradykinin and substance P. LeAPP2 also exhibited endoproteolytic activity cleaving, albeit at a reduced rate, the internal -Phe-Gly bond of substance P. Apparent K-m (15.2 +/- 2.4 muM) and K-m/k(cat) (0.94 +/- 0.11 mM(-1) x s(-1)) values were obtained for H-Lys(Abz)-Pro-Pro-pNA as the substrate. LeAPP2 activity was maximally stimulated by addition of 4 rom MnCl2 and to some extent also by Mg2+, Ca2+, and Co2+, whereas other divalent metal ions (Cu2+, Zn2+) were inhibitory. Chelating agents and thiolmodifying reagents inhibited the enzyme. The data are consistent with LeAPP2 being a Mn(II)-dependent metalloprotease. This is the first characterization of a plant aminopeptidase, P.	ETH Zurich, Inst Plant Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Schaller, A (corresponding author), ETH Zurich, Inst Plant Sci, Univ Str 2, CH-8092 Zurich, Switzerland.		, None/H-5163-2019; Schaller, Andreas/AAC-1940-2020; Hauser, Felix/M-9670-2013; Hauser, Felix/K-1030-2015	, None/0000-0001-6725-9760; Schaller, Andreas/0000-0001-6872-9576; Hauser, Felix/0000-0001-6725-9760; Hauser, Felix/0000-0001-6725-9760				Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P1394; BAZAN JF, 1994, P NATL ACAD SCI USA, V91, P2473, DOI 10.1073/pnas.91.7.2473; Blais C, 2000, PEPTIDES, V21, P1903, DOI 10.1016/S0196-9781(00)00348-X; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15129, DOI 10.1021/bi0015865; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Czirjak G, 1999, BBA-GENE STRUCT EXPR, V1444, P326, DOI 10.1016/S0167-4781(99)00005-6; D'souza VM, 2000, BIOCHEMISTRY-US, V39, P3817, DOI 10.1021/bi9925827; D'souza VM, 1999, BIOCHEMISTRY-US, V38, P11079, DOI 10.1021/bi990872h; Gorlach J, 1996, GENE, V170, P145, DOI 10.1016/0378-1119(95)00825-X; HARBECK HT, 1991, EUR J BIOCHEM, V198, P451, DOI 10.1111/j.1432-1033.1991.tb16035.x; HOOPER NM, 1990, BIOCHEM J, V267, P509, DOI 10.1042/bj2670509; Hyde RJ, 1996, BIOCHEM J, V319, P197, DOI 10.1042/bj3190197; Kim KS, 2000, J PHARMACOL EXP THER, V292, P295; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lloyd GS, 1996, BIOCHEM PHARMACOL, V52, P229, DOI 10.1016/0006-2952(96)00180-3; LLOYD GS, 1995, BIOCHEM SOC T, V33, pS60; MEDEIROS MS, 1994, BIOCHIMIE, V76, P283, DOI 10.1016/0300-9084(94)90159-7; MENTLEIN R, 1988, FEBS LETT, V234, P251, DOI 10.1016/0014-5793(88)80092-9; ORAWSKI AT, 1995, BIOCHEMISTRY-US, V34, P11227, DOI 10.1021/bi00035a032; ORAWSKI AT, 1987, MOL CELL BIOCHEM, V75, P123; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; RODERICK SL, 1993, BIOCHEMISTRY-US, V32, P3907, DOI 10.1021/bi00066a009; RUSU I, 1992, EUR J BIOCHEM, V210, P93, DOI 10.1111/j.1432-1033.1992.tb17395.x; Ryan CA, 2001, PLANT PHYSIOL, V125, P65, DOI 10.1104/pp.125.1.65; RYAN JW, 1992, BIOCHIM BIOPHYS ACTA, V1119, P140, DOI 10.1016/0167-4838(92)90384-P; RYAN JW, 1994, J PHARMACOL EXP THER, V269, P941; Sambrook J., 2002, MOL CLONING LAB MANU; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Schaller A, 1999, PLANT MOL BIOL, V40, P763, DOI 10.1023/A:1006279409687; SCHALLER A, 2001, IN PRESS BIOACTIVE N; SCHMID J, 1992, PLANT J, V2, P375; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; SMITH TA, 1991, P NATL ACAD SCI USA, V88, P5159, DOI 10.1073/pnas.88.12.5159; Sprinkle TJ, 2000, ARCH BIOCHEM BIOPHYS, V378, P51, DOI 10.1006/abbi.2000.1792; Stockel-Maschek A, 2000, BBA-PROTEIN STRUCT M, V1479, P15, DOI 10.1016/S0167-4838(00)00054-6; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Veneman RC, 1997, BBA-GENE STRUCT EXPR, V1354, P45, DOI 10.1016/S0167-4781(97)00126-7; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; YARON A, 1968, BIOCHEM BIOPH RES CO, V32, P658, DOI 10.1016/0006-291X(68)90289-1; YOSHIMOTO T, 1994, ARCH BIOCHEM BIOPHYS, V311, P28, DOI 10.1006/abbi.1994.1204; YOSHIMOTO T, 1988, J BIOCHEM, V104, P93, DOI 10.1093/oxfordjournals.jbchem.a122430	45	16	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31732	31737		10.1074/jbc.M103179200	http://dx.doi.org/10.1074/jbc.M103179200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423553	hybrid			2022-12-27	WOS:000170613500036
J	Kimura, T; Sato, K; Kuwabara, A; Tomura, H; Ishiwara, M; Kobayashi, I; Ui, M; Okajima, F				Kimura, T; Sato, K; Kuwabara, A; Tomura, H; Ishiwara, M; Kobayashi, I; Ui, M; Okajima, F			Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CULTURED HUMAN; RECEPTORS; ACTIVATION; KINASE; ATHEROSCLEROSIS; LYSOPHOSPHATIDYLCHOLINE; PROLIFERATION; PHOSPHOLIPIDS; MECHANISMS	Sphingosine 1-phosphate (S1P), a novel lipid mediator, is concentrated in the fraction of lipoproteins that include high density lipoprotein (EDL) and low density lipoprotein (LDL) in human plasma. Here, we show that oxidation of IDL resulted in a marked reduction in the S1P level in association with a marked accumulation of lysophosphatidylcholine (LPC). We therefore investigated the role of the lipoprotein-associated lipids especially S1P in the lipoprotein-induced cytoprotective or cytotoxic actions in human umbilical vein endothelial cells. The viability of the cells gradually decreased in the absence of serum or growth factors in the culture medium. The addition of oxidized LDL (ox-LDL) accelerated the decrease in the cell viability. LPC and 7-ketocholesterol mimicked ox-LDL actions. On the other hand, HDL and LDL almost completely reversed the serum deprivation- or ox-LDL-induced cytotoxicity. Exogenous S1P mimicked cytoprotective actions. Moreover, the S1P-rich fraction and chromatographically purified S1P from HDL exerted cytoprotective actions, but the rest of the fractions did not. The cytoprotective actions of HDL and S1P were associated with extracellular signal-regulated kinase (EM activation and were almost completely inhibited by pertussis toxin and PD98059, an ERK kinase inhibitor. The HDL-induced action was specifically desensitized in the S1P-pretreated cells. Taken together, these results indicate that the lipoprotein-associated S1P and the lipid receptor-mediated signal pathways may be responsible for the lipoprotein-induced cytoprotective actions. Furthermore, the decrease in the S1P content, in addition to the accumulation of cytotoxic substances such as LPC, may be important for the acquisition of the cytotoxic property to ox-LDL.	Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gumma 3718512, Japan; Gunma Univ, Sch Med, Dept Lab Med, Maebashi, Gumma 3718511, Japan; Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Gunma University; Gunma University; Tokyo Metropolitan Institute of Medical Science	Okajima, F (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, 3-39-15 Showa Machi, Maebashi, Gumma 3718512, Japan.	fokajima@showa.gunma-u.ac.jp		Sato, Koichi/0000-0001-7694-4014				An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Harada-Shiba M, 1998, J BIOL CHEM, V273, P9681, DOI 10.1074/jbc.273.16.9681; HEERY JM, 1995, J CLIN INVEST, V96, P2322, DOI 10.1172/JCI118288; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; KAWAKAMI K, 1989, CLIN CHIM ACTA, V185, P147, DOI 10.1016/0009-8981(89)90037-5; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; Kwon YG, 2001, J BIOL CHEM, V276, P10627, DOI 10.1074/jbc.M011449200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Murata N, 2000, ANAL BIOCHEM, V282, P115, DOI 10.1006/abio.2000.4580; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; PARTHASARATHY S, 1990, P NATL ACAD SCI USA, V87, P9741, DOI 10.1073/pnas.87.24.9741; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sachinidis A, 1999, ARTERIOSCL THROM VAS, V19, P2412, DOI 10.1161/01.ATV.19.10.2412; Sata M, 1998, J CLIN INVEST, V102, P1682, DOI 10.1172/JCI3531; Sato K, 1999, MOL PHARMACOL, V55, P126, DOI 10.1124/mol.55.1.126; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Suc I, 1997, ARTERIOSCL THROM VAS, V17, P2158, DOI 10.1161/01.ATV.17.10.2158; Sugano M, 2000, BIOCHEM BIOPH RES CO, V272, P872, DOI 10.1006/bbrc.2000.2877; Tamama K, 2001, BIOCHEM J, V353, P139, DOI 10.1042/bj3530139; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162	34	222	228	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31780	31785		10.1074/jbc.M104353200	http://dx.doi.org/10.1074/jbc.M104353200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427538	hybrid			2022-12-27	WOS:000170613500042
J	Lemoine, FJ; Marriott, SJ				Lemoine, FJ; Marriott, SJ			Accelerated G(1) phase progression induced by the human T cell leukemia virus type I (HTLV-I) tax oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CYCLIN-E; S-PHASE; HUMAN-LYMPHOCYTES; E2F COMPLEXES; PROTEIN; GENE; KINASE; EXPRESSION; TRANSITION; TRANSFORMATION	Tax, the human T cell leukemia virus type I oncoprotein, plays a crucial role in viral transformation and the development of the virally associated disease adult T cell leukemia. Because oncogenesis involves alterations in cell growth, it is important to examine the effects of Tax on cell cycle progression. Using a synchronized cell system, we have found that Tax expression accelerates G(1) phase progression and S phase entry with concomitant DNA replication. This accelerated progression is accompanied by an earlier onset of cdk2 kinase activity. In contrast to the shortening of G(1) phase, the length of S phase is unaffected by Tax expression. As a result of a more rapid cell cycle progression, cells expressing Tax exhibit faster growth kinetics and display an altered cell cycle distribution. Additionally, the decreased time allowed for growth in the presence of Tax results in a decreased cell size. Tax-associated acceleration of cell cycle progression may play a role in the ability of this viral oncoprotein to mediate cellular transformation and promote the development of human T cell leukemia virus type I-associated diseases.	Baylor Coll Med, Interdepartmental Program Cell & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Marriott, SJ (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.				NCI NIH HHS [CA-77371, CA09197] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077371] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akagi T, 1996, ONCOGENE, V12, P1645; Cereseto A, 1999, ONCOGENE, V18, P2441, DOI 10.1038/sj.onc.1202567; Cereseto A, 1996, BLOOD, V88, P1551, DOI 10.1182/blood.V88.5.1551.bloodjournal8851551; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; IKEDA MA, 1993, MOL CELL BIOL, V13, P7029, DOI 10.1128/MCB.13.11.7029; Kao SY, 2000, ONCOGENE, V19, P2240, DOI 10.1038/sj.onc.1203559; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; Low KG, 1997, J VIROL, V71, P1956, DOI 10.1128/JVI.71.3.1956-1962.1997; Mesnard JM, 1999, VIROLOGY, V257, P277, DOI 10.1006/viro.1999.9685; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Mulloy JC, 1998, J VIROL, V72, P8852, DOI 10.1128/JVI.72.11.8852-8860.1998; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; Neuveut C, 1998, MOL CELL BIOL, V18, P3620, DOI 10.1128/MCB.18.6.3620; NEVINS JR, 1992, SCIENCE, V258, P424; OAKAGI T, 1997, FEBS LETT, V406, P263; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; Santiago F, 1999, J VIROL, V73, P9917, DOI 10.1128/JVI.73.12.9917-9927.1999; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; Suzuki T, 1999, VIROLOGY, V259, P384, DOI 10.1006/viro.1999.9760; Suzuki T, 1996, EMBO J, V15, P1607, DOI 10.1002/j.1460-2075.1996.tb00505.x; TSAI LH, 1993, ONCOGENE, V8, P1593; van der Sman J, 1999, J BIOL CHEM, V274, P12009, DOI 10.1074/jbc.274.17.12009; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WIMMEL A, 1994, ONCOGENE, V9, P995	40	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31851	31857		10.1074/jbc.M105195200	http://dx.doi.org/10.1074/jbc.M105195200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11435441	hybrid			2022-12-27	WOS:000170613500053
J	Toyotome, T; Suzuki, T; Kuwae, A; Nonaka, T; Fukuda, H; Imajoh-Ohmi, S; Toyofuku, T; Hori, M; Sasakawa, C				Toyotome, T; Suzuki, T; Kuwae, A; Nonaka, T; Fukuda, H; Imajoh-Ohmi, S; Toyofuku, T; Hori, M; Sasakawa, C			Shigella protein IpaH(9.8) is secreted from bacteria within mammalian cells and transported to the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; EPITHELIAL-CELLS; III SECRETION; HOST-CELLS; MOLECULAR-BASIS; IPA INVASINS; FLEXNERI; VIRULENCE; PLASMID; GENES	Various pathogenic bacteria such as Shigella deliver effector proteins into mammalian cells via the type III secretion system. The delivered Shigella effectors have been shown to variously affect host functions required for efficient bacterial internalization into the cells. In the present study, we investigated the IpaH proteins for their ability to be secreted via the type III secretion system and their fate in mammalian cells. Upon incubation in a medium containing Congo red, the bacteria secrete IpaH into the medium, but secretion of IpaH occurs later than that of IpaBCD. Immunofluorescence microscopy indicated that IpaH(9.8) is secreted from intracellular bacteria and transported into the nucleus. On microinjection of the protein, intracellular IpaH(9.8) is accumulated at one place around the nucleus and transported into the nucleus. This movement seems to be dependent on the microtubule network, since nuclear accumulation of IpaH(9.8) is inhibited in cells treated with microtubule-destabilizing agents. In nuclear import assay, IpaH9.8 was efficiently transported into the nucleus, which was completely blocked by treatment with wheat germ agglutinin. The nuclear transport of IpaH(9.8) does not depend on host cytosolic factors but is partially dependent on ATP/GTP, suggesting that, like beta -catenin, IpaH(9.8) secreted from intracellular Shigella can be transported into the nucleus.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol,Div Bacterial Infect, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Div Cell Biol & Biochem,Dept Basic Med Sci, Minato Ku, Tokyo 1088639, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; Osaka University	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol,Div Bacterial Infect, Minato Ku, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403; Toyotome, Takahito/0000-0003-2822-2767				ADAM SA, 1992, METHOD ENZYMOL, V219, P97; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Alconada A, 1999, J VIROL, V73, P377, DOI 10.1128/JVI.73.1.377-387.1999; Bleves S, 2000, MICROBES INFECT, V2, P1451, DOI 10.1016/S1286-4579(00)01300-9; Bliska JB, 2000, TRENDS MICROBIOL, V8, P205, DOI 10.1016/S0966-842X(00)01738-8; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Celli J, 2000, CELL MICROBIOL, V2, P1, DOI 10.1046/j.1462-5822.2000.00033.x; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 2000, P NATL ACAD SCI USA, V97, P8778, DOI 10.1073/pnas.97.16.8778; Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894; DeVinney R, 1999, CURR OPIN MICROBIOL, V2, P83, DOI 10.1016/S1369-5274(99)80014-9; DeVinney R, 1999, CELL MOL LIFE SCI, V55, P961, DOI 10.1007/s000180050347; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fernandez-Prada CM, 2000, INFECT IMMUN, V68, P3608, DOI 10.1128/IAI.68.6.3608-3619.2000; Finlay BB, 2000, PHILOS T ROY SOC B, V355, P623, DOI 10.1098/rstb.2000.0603; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Goodson HV, 1997, CURR OPIN CELL BIOL, V9, P18, DOI 10.1016/S0955-0674(97)80147-0; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; HARTMAN AB, 1990, J BACTERIOL, V172, P1905, DOI 10.1128/jb.172.4.1905-1915.1990; HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x; Hoque M, 1999, J VIROL, V73, P7912, DOI 10.1128/JVI.73.9.7912-7915.1999; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; MAURELLI AT, 1984, INFECT IMMUN, V43, P397, DOI 10.1128/IAI.43.1.397-401.1984; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; NHIEU GTV, 1999, EMBO J, V18, P3249; Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; SASAKAWA C, 1993, J BACTERIOL, V175, P2334, DOI 10.1128/JB.175.8.2334-2346.1993; SASAKAWA C, 1986, INFECT IMMUN, V51, P470, DOI 10.1128/IAI.51.2.470-475.1986; SASAKAWA C, 1988, J BACTERIOL, V170, P2480, DOI 10.1128/jb.170.6.2480-2484.1988; Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; SORENY B, 1957, ACTA MICROBIOL HUNG, V4, P367; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; UCHIYA KI, 1995, MOL MICROBIOL, V17, P241, DOI 10.1111/j.1365-2958.1995.mmi_17020241.x; Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073/pnas.97.16.8799; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; VanNhieu GT, 1997, EMBO J, V16, P2717, DOI 10.1093/emboj/16.10.2717; VENKATESAN MM, 1991, MOL MICROBIOL, V5, P2435, DOI 10.1111/j.1365-2958.1991.tb02089.x; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7	53	64	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32071	32079		10.1074/jbc.M101882200	http://dx.doi.org/10.1074/jbc.M101882200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418613	hybrid			2022-12-27	WOS:000170613500083
J	van Eenennaam, H; Lugtenberg, D; Vogelzangs, JHP; van Venrooij, WJ; Pruijn, GJM				van Eenennaam, H; Lugtenberg, D; Vogelzangs, JHP; van Venrooij, WJ; Pruijn, GJM			hPop5, a protein subunit of the human RNase AMP and RNase P endoribonucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN RIBONUCLEASE-P; PRECURSOR RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; PROCESSING ENZYME; CDNA CLONING; MRP; RIBONUCLEOPROTEIN; NUCLEOLUS; ANTIBODIES; COMPONENT	The RNase MRP and RNase P particles both function as endoribonucleases. RNase AMP has been implicated in the processing of precursor-rRNA, whereas RNase P has been shown to function in the processing of pre-tRNA. Both ribonucleoprotein particles have an RNA component that can be folded into a similar secondary structure and share several protein components. We have identified human, rat, mouse, cow, and Drosophila homologues of the Pop5p protein subunit of the yeast RNase MRP and RNase P complexes. The human Pop5 cDNA encodes a protein of 163 amino acids with a predicted molecular mass of 18.8 kDa. Polyclonal antibodies raised against recombinant hPop5 identified a 19-kDa polypeptide in HeLa cells and showed that hPop5 is associated with both RNase MRP and RNase P. Using affinity-purified anti-hPop5 antibodies, we demonstrated that the endogenous hPop5 protein is localized in the nucleus and accumulates in the nucleolus, which is consistent with its association with RNase MRP and RNase P. Catalytically active RNase P was partially purified from HeLa cells, and hPop5 was shown to be associated with it. Finally, the evolutionarily conserved acidic C-terminal tail of hPop5 appeared to be required neither for complex formation nor for RNase P activity.	Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Pruijn, GJM (corresponding author), Univ Nijmegen, Dept Biochem 161, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Pruijn, Ger/D-6664-2012; Lugtenberg, Dorien/B-6338-2018					Altman S, 2000, RNA, V6, P1689, DOI 10.1017/S1355838200001783; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARTKIEWICZ M, 1989, GENE DEV, V3, P488, DOI 10.1101/gad.3.4.488; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Chu S, 1997, RNA, V3, P382; CHU S, 1994, P NATL ACAD SCI USA, V91, P659, DOI 10.1073/pnas.91.2.659; Collins LJ, 2000, J MOL EVOL, V51, P194, DOI 10.1007/s002390010081; Dichtl B, 1997, EMBO J, V16, P417, DOI 10.1093/emboj/16.2.417; Eder PS, 1997, P NATL ACAD SCI USA, V94, P1101, DOI 10.1073/pnas.94.4.1101; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GIRARD JP, 1994, J BIOL CHEM, V269, P18499; GOLD HA, 1989, SCIENCE, V245, P1377, DOI 10.1126/science.2476849; GOLD HA, 1988, P NATL ACAD SCI USA, V85, P5483, DOI 10.1073/pnas.85.15.5483; HARDIN JA, 1982, J CLIN INVEST, V70, P141, DOI 10.1172/JCI110587; Harlow E., 1988, ANTIBODIES LAB MANUA; HASHIMOTO C, 1983, J BIOL CHEM, V258, P1379; Jarrous N, 1998, RNA, V4, P407; Jarrous N, 1999, J CELL BIOL, V146, P559, DOI 10.1083/jcb.146.3.559; Jarrous N, 1999, RNA, V5, P153, DOI 10.1017/S135583829800185X; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Lee B, 1996, P NATL ACAD SCI USA, V93, P11471, DOI 10.1073/pnas.93.21.11471; Lygerou Z, 1996, EMBO J, V15, P5936, DOI 10.1002/j.1460-2075.1996.tb00980.x; LYGEROU Z, 1994, GENE DEV, V8, P1423, DOI 10.1101/gad.8.12.1423; Lygerou Z, 1996, SCIENCE, V272, P268, DOI 10.1126/science.272.5259.268; Pluk H, 1998, MOL CELL BIOL, V18, P488, DOI 10.1128/MCB.18.1.488; REDDY R, 1983, J BIOL CHEM, V258, P1383; REIMER G, 1988, EXP CELL RES, V176, P117, DOI 10.1016/0014-4827(88)90126-7; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; SCHMITT ME, 1994, GENE DEV, V8, P2617, DOI 10.1101/gad.8.21.2617; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; SILLEKENS PTG, 1987, EMBO J, V6, P3841, DOI 10.1002/j.1460-2075.1987.tb02721.x; Stolc V, 1998, P NATL ACAD SCI USA, V95, P6716, DOI 10.1073/pnas.95.12.6716; Stolc V, 1997, GENE DEV, V11, P2926, DOI 10.1101/gad.11.21.2926; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; van Eenennaam H, 1999, NUCLEIC ACIDS RES, V27, P2465, DOI 10.1093/nar/27.12.2465; van Eenennaam H, 2000, IUBMB LIFE, V49, P265; VERHEIJEN R, 1994, J IMMUNOL METHODS, V169, P173, DOI 10.1016/0022-1759(94)90261-5; YAN C, 1993, J CELL BIOL, V123, P1081, DOI 10.1083/jcb.123.5.1081	42	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31635	31641		10.1074/jbc.M103399200	http://dx.doi.org/10.1074/jbc.M103399200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11413139	Green Published, hybrid			2022-12-27	WOS:000170613500024
J	Zhang, BH; Tang, ED; Zhu, TQ; Greenberg, ME; Vojtek, AB; Guan, KL				Zhang, BH; Tang, ED; Zhu, TQ; Greenberg, ME; Vojtek, AB; Guan, KL			Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; MAP KINASE; SIGNALING PATHWAY; REQUIRES PHOSPHORYLATION; SERINE/THREONINE KINASE; ACTIVATION; IDENTIFICATION; INHIBITION; C-RAF-1; SITES	Phosphorylation can both positively and negatively regulate activity of the Raf kinases. Akt has been shown to phosphorylate and inhibit C-Raf activity. We have recently reported that Akt negatively regulates B-Raf kinase activation by phosphorylating multiple residues within its amino-terminal regulatory domain. Here we investigated the regulation of B-Raf by serum and glucocorticoid-inducible kinase, SGK, which shares close sequence identity with the catalytic domain of Akt but lacks the pleckstrin homology domain. We observed that SGK inhibits B-Raf activity. A comparison of substrate specificity between SGK and Akt indicates that SGK is a potent negative regulator of B-Raf. In contrast to Akt, SGK negatively regulates B-Raf kinase activity by phosphorylating only a single Akt consensus site, Ser(364). Under similar experimental conditions, SGK displays a measurably stronger inhibitory effect on B-Raf kinase activity than Akt, whereas Akt; exhibits a more inhibitory effect on the forkhead transcription factor, FKHR. The selective substrate specificity is correlated with an enhanced association between Akt or SGK and their preferred substrates, FKHR and B-Raf, respectively. These results indicate that B-Raf kinase activity is negatively regulated by Akt and SGK, suggesting that the cross-talk between the B-Raf and other signaling pathways can be mediated by both Akt and SGK.	Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Guan, KL (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Guan, Kun-Liang/ADK-7088-2022					Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Buse P, 1999, J BIOL CHEM, V274, P7253, DOI 10.1074/jbc.274.11.7253; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Gorman C, 1996, J BIOL CHEM, V271, P6713, DOI 10.1074/jbc.271.12.6713; Guan KL, 2000, J BIOL CHEM, V275, P27354; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; JANSEN HW, 1984, NATURE, V307, P281, DOI 10.1038/307281a0; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; MAGNUSON NS, 1994, SEMIN CANCER BIOL, V5, P247; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i; RESING KA, 1995, BIOCHEMISTRY-US, V34, P2610, DOI 10.1021/bi00008a027; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; SCHRAMM K, 1994, BIOCHEM BIOPH RES CO, V201, P740, DOI 10.1006/bbrc.1994.1763; Sidovar MF, 2000, J BIOL CHEM, V275, P28688, DOI 10.1074/jbc.M909351199; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Tamada M, 1997, ONCOGENE, V15, P2959, DOI 10.1038/sj.onc.1201582; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; VOJTEK AB, 1993, J CELL SCI, V105, P777; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	51	86	91	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31620	31626		10.1074/jbc.M102808200	http://dx.doi.org/10.1074/jbc.M102808200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11410590	hybrid			2022-12-27	WOS:000170613500022
J	Chen, M; He, HP; Zhan, SX; Krajewski, S; Reed, JC; Gottlieb, RA				Chen, M; He, HP; Zhan, SX; Krajewski, S; Reed, JC; Gottlieb, RA			Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING PROTEIN; VACUOLAR PROTON ATPASE; CYTOCHROME-C RELEASE; OXIDATIVE-PHOSPHORYLATION; CASPASE ACTIVATION; CELL-DEATH; APOPTOSIS; MITOCHONDRIA; ISCHEMIA; CARDIOMYOCYTES	Reperfusion after myocardial ischemia is associated with a rapid influx of calcium, leading to activation of various enzymes including calpain. Isolated perfused adult rabbit hearts subjected to global ischemia and reperfusion were studied. Calpain or a calpain-like activity was activated within 15 min after reperfusion, and preconditioning suppressed calpain activation. In contrast, caspase activation was not detected although cytochrome c was released after ischemia and reperfusion. The pro-apoptotic BH3-only Bcl-2 family member, Bid, was cleaved during ischemia/reperfusion in the adult rabbit heart. Recombinant Bid was cleaved by calpain to a fragment that was able to mediate cytochrome c release. The calpain cleavage site was mapped to a region within Bid that is extremely susceptible to proteolysis. These findings suggest that there is cross-talk between apoptotic and necrotic pathways in myocardial ischemia/reperfusion injury.	Scripps Res Inst, MEM220, La Jolla, CA 92037 USA; Burnham Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute	Gottlieb, RA (corresponding author), Scripps Res Inst, MEM220, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	robbieg@scripps.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036821] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36821] Funding Source: Medline; PHS HHS [60590] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Black SC, 1998, J MOL CELL CARDIOL, V30, P733, DOI 10.1006/jmcc.1998.0660; Borutaite V, 1995, BBA-MOL BASIS DIS, V1272, P154, DOI 10.1016/0925-4439(95)00080-1; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; de Moissac D, 2000, J MOL CELL CARDIOL, V32, P53, DOI 10.1006/jmcc.1999.1057; Di Lisa F, 1998, MOL CELL BIOCHEM, V184, P379, DOI 10.1023/A:1006810523586; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; DUAN JM, 1989, MOL CELL BIOCHEM, V90, P47; Ferrari C, 1996, ANNU REV FLUID MECH, V28, P1; FINEGAN BA, 1995, AM J PHYSIOL-HEART C, V269, pH1767, DOI 10.1152/ajpheart.1995.269.5.H1767; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Gao WD, 1996, CIRC RES, V78, P455; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Gottlieb RA, 2000, METHOD ENZYMOL, V322, P213; Gottlieb RA, 1996, J CLIN INVEST, V97, P2391, DOI 10.1172/JCI118683; KAHLES H, 1977, BASIC RES CARDIOL, V72, P563, DOI 10.1007/BF01907037; Kakkar R, 2001, CELL CALCIUM, V29, P59, DOI 10.1054/ceca.2000.0157; Kakkar R, 2000, J PATHOL, V191, P208, DOI 10.1002/(SICI)1096-9896(200006)191:2<208::AID-PATH618>3.0.CO;2-6; Karwatowska-Prokopczuk E, 1998, CIRC RES, V82, P1139, DOI 10.1161/01.RES.82.11.1139; Kobara M, 1996, J MOL CELL CARDIOL, V28, P417, DOI 10.1006/jmcc.1996.0038; MURRY CE, 1990, CIRC RES, V66, P913, DOI 10.1161/01.RES.66.4.913; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P2005, DOI 10.1006/jmcc.1996.0193; Piot CA, 1997, CIRCULATION, V96, P1598, DOI 10.1161/01.CIR.96.5.1598; Saraste A, 1997, CIRCULATION, V95, P320; STEENBERGEN C, 1993, CIRC RES, V72, P112, DOI 10.1161/01.RES.72.1.112; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Toleikis A, 1983, Adv Myocardiol, V4, P409; TSUCHIDA A, 1994, CIRC RES, V75, P576, DOI 10.1161/01.RES.75.3.576; Tsujimoto Yoshihide, 1997, Leukemia (Basingstoke), V11, P380; Veinot JP, 1997, HUM PATHOL, V28, P485, DOI 10.1016/S0046-8177(97)90039-3; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang KKW, 2000, TRENDS NEUROSCI, V23, P59, DOI 10.1016/S0166-2236(99)01536-2; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859	39	312	321	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30724	30728		10.1074/jbc.M103701200	http://dx.doi.org/10.1074/jbc.M103701200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11404357	hybrid			2022-12-27	WOS:000170472900020
J	Espey, MG; Miranda, KM; Thomas, DD; Wink, DA				Espey, MG; Miranda, KM; Thomas, DD; Wink, DA			Distinction between nitrosating mechanisms within human cells and aqueous solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; S-NITROSATION; KINETICS; OXIDATION; OXYGEN; NO; GLUTATHIONE; CHEMISTRY; INSIGHTS; THIOLS	The quintessential nitrosating species produced during NO autoxidation is N2O3. Nitrosation of amine, thiol, and hydroxyl residues can modulate critical cell functions. The biological mechanisms that control reactivity of nitrogen oxide species formed during autoxidation of nano- to micromolar levels of NO were examined using the synthetic donor NaEt2NN(O)NO (DEA/NO), hum an tumor cells, and 4,5-diaminofluorescein (DAF). Both the disappearance of NO and formation of nitrosated product from DAF in aerobic aqueous buffer followed second order processes; however, consumption of NO and nitrosation within intact cells were exponential. An optimal ratio of DEA/NO and 2-phenyl-4,4,5,5-tetramethylimidazole-1-oxyl 3-oxide (PTIO) was used to form N2O3 through the intermediacy of NO2. This route was found to be most reflective of the nitrosative mechanism within intact cells and was distinct from the process that occurred during autoxidation of NO in aqueous media. Manipulation of the endogenous scavengers ascorbate and glutathione indicated that the location, affinity, and concentration of these substances were key determinants in dictating nitrosative susceptibility of molecular targets. Taken together, these findings suggest that the functional effects of nitrosation may be organized to occur within discrete domains or compartments. Nitrosative stress may develop when scavengers are depleted and this architecture becomes compromised. Although NO2 was not a component of aqueous NO autoxidation, the results suggest that the intermediacy of this species may be a significant factor in the advent of either nitrosation or oxidation chemistry in biological systems.	NCI, Radiat Biol Branch, NIH, Div Clin Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Espey, MG (corresponding author), NCI, Radiat Biol Branch, NIH, Div Clin Sci, Bldg 10,Rm B3-B69, Bethesda, MD 20892 USA.	sp@nih.gov	Miranda, Katrina M/B-7823-2009	Thomas, Douglas/0000-0003-1252-0786; Wink, David/0000-0002-5652-7480; Azad, Mahan/0000-0002-8633-3513				Abu-Soud HM, 2000, J BIOL CHEM, V275, P17349, DOI 10.1074/jbc.M000050200; ABUSOUD HM, 1995, J BIOL CHEM, V270, P22997, DOI 10.1074/jbc.270.39.22997; Akaike T, 1996, METHOD ENZYMOL, V268, P211; AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; Al-Mehdi AB, 2000, J BIOL CHEM, V275, P39807, DOI 10.1074/jbc.C000702200; BONNER FT, 1996, METHODS NITRIC OXIDE, P1; Brown LA, 1999, J NEUROSCI METH, V92, P101, DOI 10.1016/S0165-0270(99)00098-9; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; CHALLIS BC, 1978, J CHEM SOC PERK T 2, P1296, DOI 10.1039/p29780001296; Christodoulou D, 1996, METHOD ENZYMOL, V268, P69; CZAPSKI G, 1995, FREE RADICAL BIO MED, V19, P785, DOI 10.1016/0891-5849(95)00081-8; Espey MG, 2000, J BIOL CHEM, V275, P11341, DOI 10.1074/jbc.275.15.11341; ESPEY MG, 2000, ANN NY ACAD SCI, V288, P209; ESPEY MG, 2000, OXIDAT STRESS DIS, V5, P523; FORD PC, 1993, FEBS LETT, V326, P1, DOI 10.1016/0014-5793(93)81748-O; Fukuto J M, 1995, Adv Pharmacol, V34, P1; Gbadegesin M, 1999, AM J PHYSIOL-CELL PH, V277, pC673, DOI 10.1152/ajpcell.1999.277.4.C673; GOLDSTEIN S, 1995, J AM CHEM SOC, V117, P12078, DOI 10.1021/ja00154a007; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030; Jourd'heuil D, 2000, FREE RADICAL BIO MED, V28, P409, DOI 10.1016/S0891-5849(99)00257-9; JUBERT AH, 1984, THEOR CHIM ACTA, V64, P313, DOI 10.1007/BF00551015; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Keshive M, 1996, CHEM RES TOXICOL, V9, P988, DOI 10.1021/tx960036y; KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; LAVAL F, 1994, CARCINOGENESIS, V15, P443, DOI 10.1093/carcin/15.3.443; LEWIS RS, 1994, CHEM RES TOXICOL, V7, P568, DOI 10.1021/tx00040a013; LIEBMANN JE, 1993, CANCER RES, V53, P2066; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Lopez-Figueroa MO, 2000, BIOCHEM BIOPH RES CO, V272, P129, DOI 10.1006/bbrc.2000.2748; MIRANDA KM, 2000, NITRIC OXIDE BIOL PA, P41; Ogawa R, 2001, FREE RADICAL BIO MED, V30, P268, DOI 10.1016/S0891-5849(00)00470-6; OLBREGTS J, 1985, INT J CHEM KINET, V17, P835, DOI 10.1002/kin.550170805; PIRES M, 1994, INT J CHEM KINET, V26, P1207, DOI 10.1002/kin.550261208; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; VEDIA LM, 1992, J BIOL CHEM, V267, P24929; Vidwans AS, 1999, J NEUROCHEM, V72, P1843, DOI 10.1046/j.1471-4159.1999.0721843.x; Wang X, 1999, J PHOTOCH PHOTOBIO A, V122, P1, DOI 10.1016/S1010-6030(99)00012-X; Williams D. L. H., 1988, NITROSATION; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; WINK DA, 1994, CARCINOGENESIS, V15, P2125, DOI 10.1093/carcin/15.10.2125; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; Wink DA, 1997, J BIOL CHEM, V272, P11147; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Wolin Michael S., 1996, Microcirculation (Philadelphia), V3, P1, DOI 10.3109/10739689609146778; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zharikov SI, 2001, AM J PHYSIOL-LUNG C, V280, pL465, DOI 10.1152/ajplung.2001.280.3.L465; Zhou XL, 2000, J BIOL CHEM, V275, P21241, DOI 10.1074/jbc.M904498199	52	125	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30085	30091		10.1074/jbc.M101723200	http://dx.doi.org/10.1074/jbc.M101723200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11404354	hybrid			2022-12-27	WOS:000170558000065
J	Nishizuka, M; Honda, K; Tsuchiya, T; Nishihara, T; Imagawa, M				Nishizuka, M; Honda, K; Tsuchiya, T; Nishihara, T; Imagawa, M			RGS2 promotes adipocyte differentiation in the presence of ligand for peroxisome proliferator-activated receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; 3T3-L1 CELLS; TRANSCRIPTIONAL REGULATION; ADIPOGENESIS; PROTEINS; OBESITY; CASCADE; FAMILY	The events at the earliest stage of adipocyte differentiation are yet to be fully elucidated. Previously, we cloned the genes that are induced at the beginning of the differentiation of mouse 3T3-L1 preadipocyte cells. We found that the gene expression of regulators of G protein signaling-2 (RGS2) rapidly increased after the addition of inducers and decreased at 3-12 h. The expression pattern of RGS2 mRNAs differed among growth-arrested and proliferating 3T3-L1 cells and NIH-3T3 cells, indicating a specificity for adipogenesis. Here we report that the ectopic expression of RGS2 using a retroviral system in mouse NIH-3T3 cells promotes adipogenesis only in the presence of BRL49653, which is a ligand for the peroxisome proliferator-activated receptor gamma (PPAR gamma). These results strongly suggest that RGS2 play a crucial role in the program of adipocyte differentiation and may contribute to the function of PPAR gamma.	Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, Nagoya, Aichi 4678603, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Lab Environm Biochem, Suita, Osaka 5650871, Japan	Nagoya City University; Osaka University	Imagawa, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	imagawa@phar.nagoya-cu.ac.jp						Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Brun RP, 1996, CURR OPIN CELL BIOL, V8, P826, DOI 10.1016/S0955-0674(96)80084-6; CHAPMAN AB, 1984, J BIOL CHEM, V259, P5548; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; DOGLIO A, 1986, BIOCHEM J, V238, P123, DOI 10.1042/bj2380123; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, GENE DEV, V14, P1293; SADOWSKI HB, 1992, J BIOL CHEM, V267, P4722; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Song L, 2001, BIOCHEM BIOPH RES CO, V283, P102, DOI 10.1006/bbrc.2001.4742; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	26	43	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29625	29627		10.1074/jbc.C100272200	http://dx.doi.org/10.1074/jbc.C100272200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11418611	hybrid			2022-12-27	WOS:000170558000005
J	Sasaki, Y; Sugamura, K				Sasaki, Y; Sugamura, K			Involvement of Hgs/Hrs in signaling for cytokine-mediated c-fos induction through interaction with TAK1 and Pak1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR-BETA-CHAIN; TRANSDUCING ADAPTER MOLECULE; ZINC-FINGER DOMAIN; N-TERMINAL KINASE; I-KAPPA-B; TYROSINE PHOSPHORYLATION; INTERLEUKIN-2 RECEPTOR; ENDOSOMAL LOCALIZATION; IL-2 RECEPTOR	Hgs/Hrs is a tyrosine-phosphorylated FYVE finger protein that is induced by stimulation with various cytokines and growth factors. Here we show that Hgs plays critical roles in the signaling pathway for the interleukin-2. induced activation of the serum-response element and cyclic AMP-response element of the c-fos promoter. We found that Hgs associated physically with transforming growth factor-beta -activated kinase 1 (TAK1) and p21-activated kinase 1 (Pak1), which mediate the activation of c-Jun N-terminal kinase and serum response factor, respectively, leading to transactivation via the serum-response element and cyclic AMP-response element. These results suggest that Hgs is involved in the TAK1-JNK and Pak1-serum response factor pathways for the c-fos induction that is initiated by cytokines.	Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; Program Japan Sci & Technol Corp, CREST, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Sugamura, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Aoba Ku, Seiryo Machi, Sendai, Miyagi 9858575, Japan.							Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; ASAO H, 1993, P NATL ACAD SCI USA, V90, P4127, DOI 10.1073/pnas.90.9.4127; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DESCHAMPS J, 1985, SCIENCE, V230, P1174, DOI 10.1126/science.3865371; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo K, 2000, FEBS LETT, V477, P55, DOI 10.1016/S0014-5793(00)01760-9; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HATAKEYAMA M, 1992, P NATL ACAD SCI USA, V89, P2022, DOI 10.1073/pnas.89.6.2022; Hayakawa A, 2000, J BIOL CHEM, V275, P29636, DOI 10.1074/jbc.M002696200; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Itoh T, 1996, J BIOL CHEM, V271, P7587, DOI 10.1074/jbc.271.13.7587; Kinoshita T, 1997, ONCOGENE, V15, P619, DOI 10.1038/sj.onc.1201234; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; POMPO CM, 1995, NATURE, V377, P750; RIDELY AJ, 1992, CELL, V70, P401; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; SUGAMURA K, 1995, ADV IMMUNOL, V59, P225, DOI 10.1016/S0065-2776(08)60632-X; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; TAKESHITA T, 1992, J IMMUNOL, V148, P2154; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	63	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29943	29952		10.1074/jbc.M104230200	http://dx.doi.org/10.1074/jbc.M104230200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397816	hybrid			2022-12-27	WOS:000170558000046
J	Sreenivas, A; Villa-Garcia, MJ; Henry, SA; Carman, GM				Sreenivas, A; Villa-Garcia, MJ; Henry, SA; Carman, GM			Phosphorylation of the yeast phospholipid synthesis regulatory protein Opi1p by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PHO4; SACCHAROMYCES-CEREVISIAE; INO1 GENE; SHUTTLE VECTORS; CELL-SURFACE; BIOSYNTHESIS; INOSITOL; ACTIVATION; IDENTIFICATION; SYNTHASE	Opi1p is a negative regulator of expression of phospholipid-synthesizing enzymes in the yeast Saccharomyces cerevisiae. In this work, we examined the phosphorylation of Opi1p by protein kinase C. Using a purified maltose-binding protein-Opi1p fusion protein as a substrate, protein kinase C activity was time- and dose-dependent, and dependent on the concentrations of Opi1p and ATP. Protein kinase C phosphorylated Opi1p on a serine residue. The Opi1p synthetic peptide GVLKQSCRQK, which contained a protein kinase C sequence motif at Ser(26), was a substrate for protein kinase C. Phosphorylation of a purified S26A mutant maltose-binding protein-Opi1p fusion protein by the kinase was reduced when compared with the wild-type protein. A major phosphopeptide present in purified wild-type Opi1p was absent from the purified S26A mutant protein. In vivo labeling experiments showed that the phosphorylation of Opi1p was physiologically relevant, and that the extent of phosphorylation of the S26A mutant protein was reduced by 50% when compared with the wild-type protein. The physiological consequence of the phosphorylation of Opi1p at Ser(26) was examined by measuring the effect of the S26A mutation on the expression of the phospholipid synthesis gene INO1. The beta -galactosidase activity driven by an INO1-CYC-lacI 'Z reporter gene in opi1 Delta mutant cells expressing the S26A mutant Opi1p was about 50% lower than that of cells expressing the wild-type Opi1p protein. These data supported the conclusion that phosphorylation of Opi1p at Ser(26) mediated the attenuation of the negative regulatory function of Opi1p on the expression of the INO1 gene.	Rutgers State Univ, New Jersey Agr Expt Stn, Cook Coll, Dept Food Sci, New Brunswick, NJ 08901 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Rutgers State University New Brunswick; Cornell University	Carman, GM (corresponding author), Rutgers State Univ, New Jersey Agr Expt Stn, Cook Coll, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Henry, Susan/K-5464-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, R01GM050679, R01GM019629] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-50679, GM-19629] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; BELL RM, 1991, J BIOL CHEM, V266, P4661; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calkhoven CF, 1996, BIOCHEM J, V317, P329, DOI 10.1042/bj3170329; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; CRAVEN GR, 1965, J BIOL CHEM, V240, P2468; CULBERTSON MR, 1975, GENETICS, V80, P23; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; DOWNES CP, 1990, EUR J BIOCHEM, V193, P1, DOI 10.1111/j.1432-1033.1990.tb19297.x; EXTON JH, 1990, J BIOL CHEM, V265, P1; Graves JA, 2000, GENETICS, V154, P1485; GRAVES JA, 1996, THESIS CARNEGIE MELL; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GREENBERG ML, 1982, GENETICS, V100, P19; HAID A, 1983, METHOD ENZYMOL, V96, P192; Harlow E., 1988, ANTIBODIES LAB MANUA; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Hung W, 1997, EUR J BIOCHEM, V245, P241, DOI 10.1111/j.1432-1033.1997.00241.x; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jiranek V, 1998, MICROBIOL-UK, V144, P2739, DOI 10.1099/00221287-144-10-2739; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; KAIBUCHI K, 1985, J BIOL CHEM, V260, P1366; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KLIG LS, 1984, P NATL ACAD SCI-BIOL, V81, P3816, DOI 10.1073/pnas.81.12.3816; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KODAKI T, 1991, J BACTERIOL, V173, P7992, DOI 10.1128/jb.173.24.7992-7995.1991; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Liu C, 2000, J BIOL CHEM, V275, P31972, DOI 10.1074/jbc.M003055200; LOEWY BS, 1984, MOL CELL BIOL, V4, P2479, DOI 10.1128/MCB.4.11.2479; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P1687, DOI 10.1093/nar/19.7.1687; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MCGEE TP, 1994, J BACTERIOL, V176, P6861, DOI 10.1128/JB.176.22.6861-6868.1994; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OGITA K, 1990, P NATL ACAD SCI USA, V87, P5011, DOI 10.1073/pnas.87.13.5011; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; ROZENGURT E, 1984, P NATL ACAD SCI-BIOL, V81, P5748, DOI 10.1073/pnas.81.18.5748; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON AJ, 1991, P ROY SOC B-BIOL SCI, V243, P165, DOI 10.1098/rspb.1991.0027; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wagner C, 1999, YEAST, V15, P843, DOI 10.1002/(SICI)1097-0061(199907)15:10A<843::AID-YEA424>3.0.CO;2-M; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Yang WL, 1996, J BIOL CHEM, V271, P11113, DOI 10.1074/jbc.271.19.11113	63	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29915	29923		10.1074/jbc.M105147200	http://dx.doi.org/10.1074/jbc.M105147200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395523	Green Submitted, hybrid			2022-12-27	WOS:000170558000042
J	Jensen, LE; Whitehead, AS				Jensen, LE; Whitehead, AS			IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IL-1 RECEPTOR; ADAPTER PROTEIN; MESSENGER-RNA; FAMILY; MYD88; ACTIVATION; PATHWAY; CELLS; PHOSPHORYLATION	Interleukin-1 (IL-1) is a pleiotropic cytokine essential for initiation of the immune response to infections and stress. IL-1 interacts with its type I receptor (IEL-M) and triggers a number of intracellular signaling cascades leading to activation of transcription factors, transcriptional up-regulation of target genes, and mRNA stabilization. IL-1RI-associated kinase-1 (IRAK1) is a membrane proximal serine-threonine kinase involved in IL-1 signaling that becomes phosphorylated and progressively degraded in response to IL-1 induction. We have identified a novel variant of IRAK1, which we have named IRAK1b, that arises from the use of an alternative 5 ' -acceptor splice site defined by sequence within exon 12 of IRAK1. IRAK1b mRNA exhibits wide tissue expression and is evolutionarily conserved in both mouse and human. IRAK1b can activate the transcription factor nuclear factor KB and interacts with the IL-1 signaling factors Toll-interacting protein and tumor necrosis factor receptor-associated factor 6. It forms homodimers and heterodimers with the previously described isoform of IRAK1. We show that the IRAK1b protein is kinase-inactive and that, unlike IRAK1, its levels remain constant after IL-1 induction. The presence of an alternative splice variant of IRAK1, which is functionally active and highly stable following IL-1 stimulation, adds further complexity to the control mechanisms that govern IL-1 signaling.	Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Pharmacogenet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Jensen, LE (corresponding author), Univ Penn, Dept Pharmacol, 156 Johnson Pavil,3620 Hamilton Walk, Philadelphia, PA 19104 USA.			Jensen, Liselotte/0000-0002-0267-8312				Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Greene C, 1999, BBA-MOL CELL RES, V1451, P109, DOI 10.1016/S0167-4889(99)00079-8; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Jensen LE, 1998, J IMMUNOL METHODS, V215, P45, DOI 10.1016/S0022-1759(98)00085-4; Jensen LE, 2000, J IMMUNOL, V164, P5277, DOI 10.4049/jimmunol.164.10.5277; Knop J, 1999, FEBS LETT, V448, P81, DOI 10.1016/S0014-5793(99)00322-1; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li XX, 1999, MOL CELL BIOL, V19, P4643; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Ling L, 2000, P NATL ACAD SCI USA, V97, P9567, DOI 10.1073/pnas.170279097; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Maschera B, 1999, BIOCHEM J, V339, P227, DOI 10.1042/0264-6021:3390227; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Trofimova M, 1996, J BIOL CHEM, V271, P17609, DOI 10.1074/jbc.271.30.17609; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	31	61	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29037	29044		10.1074/jbc.M103815200	http://dx.doi.org/10.1074/jbc.M103815200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11397809	hybrid			2022-12-27	WOS:000170346000055
J	Tao, JC; Malbon, CC; Wang, HY				Tao, JC; Malbon, CC; Wang, HY			Insulin stimulates tyrosine phosphorylation and inactivation of protein-tyrosine phosphatase 1B in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATOR; CRYSTAL-STRUCTURE; HUMAN-PLACENTA; ANTISENSE RNA; IN-VIVO; RESISTANCE; RECEPTOR; GROWTH; PURIFICATION; EXPRESSION	Protein-tyrosine phosphatase (PTP) 1B has been implicated in negative regulation of insulin action, although little is known of the ability of insulin to regulate PTP1B itself. The ability of insulin to regulate phosphorylation and activation of PTP1B was probed in vivo. Challenge with insulin in vivo provoked a transient, sharp increase in the phosphotyrosine content of PTP1B in fat and skeletal muscle that peaked within 15 min. Insulin stimulated a decline of 60-70% in PTP1B activity. In mouse adipocytes, the inhibition of PTP1B activity and increased tyrosine phosphorylation of the enzyme were blocked by the insulin receptor tyrosine kinase inhibitor AG1024. Phosphoserine content of PTP1B declined in response to insulin stimulation. Elevation of intracellular cyclic AMP provokes a sharp increase in PTP1B activity and leads to increased phosphorylation of serine residues and decreased tyrosine phosphorylation. Suppression of cyclic AMP levels or inhibition of protein kinase A leads to a sharp decline in PTP1B activity, a decrease in phosphoserine content, and an increase in PTP1B phosphotyrosine content. PTP1B appears to be a critical point for insulin and catecholamine counter-regulation.	SUNY Stony Brook, Med Ctr, Dept Physiol & Biophys, Physiol HSC, Stony Brook, NY 11794 USA; SUNY Stony Brook, Med Ctr, Diabet & Metab Dis Res Program, Stony Brook, NY 11794 USA; SUNY Stony Brook, Med Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, HY (corresponding author), SUNY Stony Brook, Med Ctr, Dept Physiol & Biophys, Physiol HSC, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020		NIDDK NIH HHS [DK30111] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030111] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMAD F, 1995, AM J PHYSIOL-ENDOC M, V268, pE932, DOI 10.1152/ajpendo.1995.268.5.E932; AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Brautigan David L., 1993, Molecular and Cellular Biochemistry, V127-128, P121, DOI 10.1007/BF01076763; BROWNSHIMER S, 1992, CANCER RES, V52, P478; BROWNSHIMER S, 1990, P NATL ACAD SCI USA, V87, P5148, DOI 10.1073/pnas.87.13.5148; Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841; Chen DH, 2000, COMPUT MED IMAG GRAP, V24, P283, DOI 10.1016/S0895-6111(00)00023-9; CICIRELLI MF, 1990, P NATL ACAD SCI USA, V87, P5514, DOI 10.1073/pnas.87.14.5514; Egawa K, 2001, J BIOL CHEM, V276, P10207, DOI 10.1074/jbc.M009489200; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FLINT AJ, 1993, EMBO J, V12, P1937, DOI 10.1002/j.1460-2075.1993.tb05843.x; HOPPE E, 1994, EUR J BIOCHEM, V223, P1069, DOI 10.1111/j.1432-1033.1994.tb19085.x; Hunter T, 1998, Harvey Lect, V94, P81; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kennedy BP, 2000, BIOCHEM PHARMACOL, V60, P877, DOI 10.1016/S0006-2952(00)00305-1; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; KUSARI J, 1994, J CLIN INVEST, V93, P1156, DOI 10.1172/JCI117068; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; Moxham CM, 1996, J BIOL CHEM, V271, P30765, DOI 10.1074/jbc.271.48.30765; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; MOXHAM CM, 1993, DEV GENET, V14, P266, DOI 10.1002/dvg.1020140404; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; SCHIEVELLA AR, 1993, CELL GROWTH DIFFER, V4, P239; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shifrin VI, 1997, J BIOL CHEM, V272, P2957, DOI 10.1074/jbc.272.5.2957; STADTMAUER L, 1986, J BIOL CHEM, V261, P3402; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; Van der Sar AM, 1999, INT J DEV BIOL, V43, P785; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Worm D, 1999, DIABETOLOGIA, V42, P1146	36	61	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29520	29525		10.1074/jbc.M103721200	http://dx.doi.org/10.1074/jbc.M103721200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11395511	hybrid			2022-12-27	WOS:000170346000116
J	Bai, LQ; Xu, H; Collins, JF; Ghishan, FK				Bai, LQ; Xu, H; Collins, JF; Ghishan, FK			Molecular and functional analysis of a novel neuronal vesicular glutamate transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC-PHOSPHATE COTRANSPORTER; GAMMA-AMINOBUTYRIC-ACID; BRAIN SYNAPTIC VESICLES; ENERGY-DEPENDENCE; ACTIVE-TRANSPORT; H+-ATPASE; LOCALIZATION; EXPRESSION; CLONING; NEUROTRANSMISSION	Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. Packaging and storage of glutamate into glutamatergic neuronal vesicles requires ATP-dependent vesicular glutamate uptake systems, which utilize the electrochemical proton gradient as a driving force. VGLUT1, the first identified vesicular glutamate transporter, is only expressed in a subset of glutamatergic neurons. We report here the molecular cloning and functional characterization of a novel glutamate transporter, VGLUT2, from mouse brain. VGLUT2 has all major functional characteristics of a synaptic vesicle glutamate transporter, including ATP dependence, chloride stimulation, substrate specificity, and substrate affinity. It has 75 and 79% amino acid identity with human and rat VGLUT1, respectively. However, expression patterns of VGLUT2 in brain are different from that of VGLUT1. In addition, VGLUT2 activity is dependent on both membrane potential and pH gradient of the electrochemical proton gradient, whereas VGLUT1 is primarily dependent on only membrane potential. The presence of VGLUT2 in brain regions lacking VGLUT1 suggests that the two isoforms together play an important role in vesicular glutamate transport in glutamatergic neurons.	Univ Arizona, Hlth Sci Ctr, Steele Mem Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA; Univ Arizona, Hlth Sci Ctr, Steele Mem Childrens Res Ctr, Dept Physiol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences	Ghishan, FK (corresponding author), Univ Arizona, Hlth Sci Ctr, Steele Mem Childrens Res Ctr, Dept Pediat, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	lqbai@yahoo.com; fghishan@peds.arizona.edu			NIDDK NIH HHS [2R01-R37DK-33209] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033209] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; ANDERSON DC, 1982, BIOCHEMISTRY-US, V21, P3037, DOI 10.1021/bi00256a001; BAI L, 2000, AM J PHYSIOL, V278, pC1131; Bai LQ, 1996, J BIOL CHEM, V271, P5171; Bai LQ, 1999, AM J PHYSIOL-REG I, V277, pR1112, DOI 10.1152/ajpregu.1999.277.4.R1112; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CARLSON MD, 1989, J BIOL CHEM, V264, P7369; CIDON S, 1989, J BIOL CHEM, V264, P8281; FISCHERBOVENKERK C, 1988, J NEUROCHEM, V51, P1054, DOI 10.1111/j.1471-4159.1988.tb03068.x; Forgac M, 2000, J EXP BIOL, V203, P71; Fykse EM, 1996, NEUROCHEM RES, V21, P1053, DOI 10.1007/BF02532415; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; HELL JW, 1990, J BIOL CHEM, V265, P2111; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KISH PE, 1989, P NATL ACAD SCI USA, V86, P3877, DOI 10.1073/pnas.86.10.3877; KISH PE, 1989, METHOD ENZYMOL, V174, P9; KNOTH J, 1981, BIOCHEMISTRY-US, V20, P6625, DOI 10.1021/bi00526a016; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; LOGAN WJ, 1972, BRAIN RES, V42, P413, DOI 10.1016/0006-8993(72)90540-9; Masson J, 1999, PHARMACOL REV, V51, P439; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MORIYAMA Y, 1990, J BIOCHEM, V108, P689, DOI 10.1093/oxfordjournals.jbchem.a123264; NAITO S, 1983, J BIOL CHEM, V258, P696; NAITO S, 1985, J NEUROCHEM, V44, P99, DOI 10.1111/j.1471-4159.1985.tb07118.x; Ni BH, 1996, J NEUROCHEM, V66, P2227; NI BH, 1995, J NEUROSCI, V15, P5789; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Ozkan ED, 1998, JPN J PHARMACOL, V77, P1, DOI 10.1254/jjp.77.1; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; TABB JS, 1992, J BIOL CHEM, V267, P15412; TABB JS, 1991, J NEUROSCI, V11, P1822; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070	35	164	174	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2001	276	39					36764	36769		10.1074/jbc.M104578200	http://dx.doi.org/10.1074/jbc.M104578200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	475XF	11432869	hybrid			2022-12-27	WOS:000171194500094
J	Vohradsky, J				Vohradsky, J			Neural model of the genetic network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-LAMBDA; SIMULATION; PROTEIN	Many cell control processes consist of networks of interacting elements that affect the state of each other over time. Such an arrangement resembles the principles of artificial neural networks, in which the state of a particular node depends on the combination of the states of other neurons. The A bacteriophage lysis/lysogeny decision circuit can be represented by such a network. It is used here as a model for testing the validity of a neural approach to the analysis of genetic networks. The model considers multigenic regulation including positive and negative feedback. It is used to simulate the dynamics of the lambda phage regulatory system; the results are compared with experimental observation. The comparison proves that the neural network model describes behavior of the system in full agreement with experiments; moreover, it predicts its function in experimentally inaccessible situations and explains the experimental observations. The application of the principles of neural networks to the cell control system leads to conclusions about the stability and redundancy of genetic networks and the cell functionality. Reverse engineering of the biochemical pathways from proteomics and DNA micro array data using the suggested neural network model is discussed.	Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Vohradsky, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Videnska 1083, CR-14220 Prague, Czech Republic.	vohr@biomed.cas.cz						Akutsu T, 1999, Pac Symp Biocomput, P17; Bose N.K., 1996, NEURAL NETWORK FUNDA; BOSE NK, 1996, NEURAL NETWORK FUNDA, P323; DAS A, 1992, J BACTERIOL, V174, P6711, DOI 10.1128/JB.174.21.6711-6716.1992; DasGupta B, 1996, NEURAL COMPUT, V8, P805, DOI 10.1162/neco.1996.8.4.805; ECHOLS H, 1983, LAMBDA, V2, P75; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HERSKOWITZ I, 1980, ANNU REV GENET, V14, P399, DOI 10.1146/annurev.ge.14.120180.002151; HOYT MA, 1982, CELL, V31, P565, DOI 10.1016/0092-8674(82)90312-9; KAUFFMAN SA, 1971, CURR TOP DEV BIOL, V6, P144; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; LEVINE A, 1979, J MOL BIOL, V131, P655, DOI 10.1016/0022-2836(79)90014-7; Liang S, 1998, Pac Symp Biocomput, P18; MARNELLOS G, 1998, PAC S BIOC, V5, P30; MARNELLOS G, 2000, PAC S BIOC, V12, P329; MATSUNO H, 2000, PAC S BIOC, V5, P341; McAdams HH, 2000, CURR BIOL, V10, pR318, DOI 10.1016/S0960-9822(00)00440-1; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; Patterson SD, 2000, PHYSIOL GENOMICS, V2, P59, DOI 10.1152/physiolgenomics.2000.2.2.59; PEARLMUTTER BA, 1995, IEEE T NEURAL NETWOR, V6, P1212, DOI 10.1109/72.410363; PINEDA FJ, 1987, PHYS REV LETT, V59, P2229, DOI 10.1103/PhysRevLett.59.2229; PTASHNE M, 1986, GENETIC SWITCH PHAGE, P54; PTASHNE M, 1986, GENETIC SWITCH PHAGE, P58; Somogyi R, 1996, COMPLEXITY, V1, P45, DOI DOI 10.1002/CPLX.6130010612; SZALLASI Z, 1998, PAC S BIOCOMPUT, V16, P66; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Vohradsky J, 2001, FASEB J, V15, P846, DOI 10.1096/fj.00-0361com; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Wessels L F, 2001, Pac Symp Biocomput, P508; Wuensche A, 1998, Pac Symp Biocomput, P89	33	100	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2001	276	39					36168	36173		10.1074/jbc.M104391200	http://dx.doi.org/10.1074/jbc.M104391200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	475XF	11395518	hybrid			2022-12-27	WOS:000171194500018
J	Gnoth, MJ; Rudloff, S; Kunz, C; Kinne, RKH				Gnoth, MJ; Rudloff, S; Kunz, C; Kinne, RKH			Investigations of the in vitro transport of human milk oligosaccharides by a Caco-2 monolayer using a novel high performance liquid chromatography-mass spectrometry technique	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELL LINE; TRANSEPITHELIAL TRANSPORT; MODEL; LACTOSE	Complex lactose-derived oligosaccharides belong to the main components of human milk and are believed to exert multiple functions in the breast-fed infant. Therefore, we investigated the transepithelial transport of human milk oligosaccharides over Caco-2 monolayers. Main human milk oligosaccharides (HMOs) in the apical, basolateral, or intracellular compartment were separated by high performance liquid chromatography using a Hypercarb(TM) column and analyzed on line by mass spectrometry. This method allowed the identification and quantification of these components in intra- and extracellular fractions without prior purification. Using this technique we were able to show that acidic and neutral HMOs cross the epithelial barrier. The transepithelial flux of neutral, but not acidic, oligosaccharides was temperature-sensitive and partly inhibited by brefeldin A and bafilomycin A. Furthermore, net flux from the apical to the basolateral compartment was only observed for the neutral components. Similarly, apical cellular uptake was only found for neutral components but not for acidic oligosaccharides. Intracellular concentrations of neutral HMOs were significantly increased by inhibitors of transcytosis such as brefeldin A, N-ethylmaleimide, or bafilomycin A. The cellular uptake was saturable, and an apparent K-m for lacto-N-facopentaose I of 1.7 +/- 0.1 mmol/liter and for lacto-N-tetraose of 1.8 +/- 0.4 mmol/liter was determined. Furthermore, the uptake of lacto-N-facopentaose I could be inhibited by the addition of the stereoisomer lacto-N-fucopentaose II but not by lacto-N-tetraose. These findings suggest that neutral HMOs are transported across the intestinal epithelium by receptor-mediated transcytosis as well as via paracellular pathways, whereas translocation of acidic HMOs solely represents paracellular flux.	Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; Inst Ernahrungswissensch, D-35392 Giessen, Germany	Max Planck Society	Kinne, RKH (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	rolf.kinne@mpi-dortmund.mpg.de						ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; BACHER A, 1992, EXP CELL RES, V200, P97, DOI 10.1016/S0014-4827(05)80076-X; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; DAVIES M, 1992, J CHROMATOGR, V609, P125, DOI 10.1016/0021-9673(92)80155-N; Delie F, 1997, CRIT REV THER DRUG, V14, P221; Finke B, 2000, ANAL BIOCHEM, V284, P256, DOI 10.1006/abio.2000.4680; Finke B, 1999, ANAL CHEM, V71, P3755, DOI 10.1021/ac990094z; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; GNOTH MJ, 2001, IN PRESS FOOD RES IN; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kunz C, 1999, BRIT J NUTR, V82, P391, DOI 10.1017/S0007114599001798; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; KUNZ C, 1993, ACTA PAEDIATR, V82, P903, DOI 10.1111/j.1651-2227.1993.tb12597.x; Maksymowych AB, 1998, J BIOL CHEM, V273, P21950, DOI 10.1074/jbc.273.34.21950; Mizuuchi H, 2000, PHARMACEUT RES, V17, P539, DOI 10.1023/A:1007560731098; MU JZ, 1994, BBA-MOL CELL RES, V1222, P483, DOI 10.1016/0167-4889(94)90058-2; Newburg DS, 1999, CURR MED CHEM, V6, P117; Obermeier S, 1999, ISOT ENVIRON HEALT S, V35, P119, DOI 10.1080/10256019908234084; Rudloff S, 1996, ACTA PAEDIATR, V85, P598, DOI 10.1111/j.1651-2227.1996.tb14095.x; Takata K, 1996, J ELECTRON MICROSC, V45, P275, DOI 10.1093/oxfordjournals.jmicro.a023443	22	83	87	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34363	34370		10.1074/jbc.M104805200	http://dx.doi.org/10.1074/jbc.M104805200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11423546	hybrid			2022-12-27	WOS:000171024600003
J	Liou, JY; Deng, WG; Gilroy, DW; Shyue, SK; Wu, KK				Liou, JY; Deng, WG; Gilroy, DW; Shyue, SK; Wu, KK			Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; SECRETORY PHOSPHOLIPASE A(2); INDUCIBLE CYCLOOXYGENASE; SCAFFOLDING DOMAIN; PROSTAGLANDIN; PROTEIN; MEMBRANE; INHIBITION; EXPRESSION; TRANSPORT	Results from our previous study suggest that cyclooxygenase-2 (COX-2) induced by phorbol 12-myristate 13-acetate (PMA) may be localized to caveolae-like structures (Liou, J.-Y., Shyue, S.-K., Tsai, M.-J., Chung, C.-L., Chu, K.-Y., and Wu, K. K. (2000) J. Biol. Chem. 275, 15314-15320). In this study, we determined subcellular localization of COX-2 and caveolin-1 by confocal microscopy. COX-2 in human foreskin fibroblasts stimulated by PMA (100 mM) or interleukin-1 beta (1 ng/ml) for 6 h was localized to plasma membrane in addition to endoplasmic reticulum and nuclear envelope. Caveolin-1 was localized to plasma membrane, and image overlay showed colocalization of COX-2 with caveolin-1. This was confirmed by the presence of COX-2 and caveolin-1 in the detergent-insoluble membrane fraction of cells stimulated by PMA. Immunoprecipitation showed complex formation of COX-2 with caveolin-1 in a time-dependent manner. A larger quantity of COX-2 was complexed with caveolin-1 in PMA-treated than in interleukin-Ig-treated cells. Purified COX-2 complexed with glutathione S-transferase-fused caveolin-1, which was not inhibited by the scaffolding domain peptide. Caveolin-1-bound COX-2 was catalytically active, and its activity was not inhibited by the scaffolding domain peptide. These results suggest that COX-2 induced by PMA and interleukin-10 is colocalized with caveolin-1 in the segregated caveolae compartment. Because caveolae, are rich in signaling molecules, this COX-2 compartment may play an important role in diverse pathophysiological processes.	Univ Texas, Sch Med, Vasc Biol Res Ctr, Houston, TX 77030 USA; Univ Texas, Sch Med, Div Hematol, Houston, TX 77030 USA; Acad Sinica, Inst Biomed Sci, Vasc Res Program, Taipei 115, Taiwan	University of Texas System; University of Texas System; Academia Sinica - Taiwan	Wu, KK (corresponding author), Univ Texas, Sch Med, Vasc Biol Res Ctr, 6431 Fannin,MSB 5-016, Houston, TX 77030 USA.	Kenneth.K.Wu@uth.tmc.edu	Wu, Kenneth Kun-Yu/B-1070-2010; Liou, Jun-Yang/B-1065-2010; Gilroy, Derek/AAP-7227-2020; Gilroy, Derek W/C-2588-2009; Shyue, Song-Kun/Q-2583-2018	Gilroy, Derek/0000-0003-3476-0844; Shyue, Song-Kun/0000-0002-1057-8696	NHLBI NIH HHS [R01 HL50675] Funding Source: Medline; NINDS NIH HHS [P50 NS23327] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023327] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; Bazan NG, 2001, NAT MED, V7, P414, DOI 10.1038/86477; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Engelman JA, 1998, AM J HUM GENET, V63, P1578, DOI 10.1086/302172; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Guzzi F, 2001, BIOCHEM J, V355, P323, DOI 10.1042/0264-6021:3550323; KARGMAN SL, 1995, CANCER RES, V55, P2556; KULMACZ RJ, 1989, J BIOL CHEM, V264, P14136; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kuwata H, 1999, ADV EXP MED BIOL, V469, P183; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liou JY, 2000, J BIOL CHEM, V275, P15314, DOI 10.1074/jbc.275.20.15314; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Santhamma KR, 2000, J BIOL CHEM, V275, P23253, DOI 10.1074/jbc.M000593200; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Schreiber S, 2000, J BIOL CHEM, V275, P24115, DOI 10.1074/jbc.M001876200; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; SMITH WL, 1991, PHARMACOL THERAPEUT, V49, P153, DOI 10.1016/0163-7258(91)90054-P; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Wu K K, 1995, Adv Pharmacol, V33, P179, DOI 10.1016/S1054-3589(08)60669-9; Xu XM, 1996, AM J PHYSIOL-CELL PH, V270, pC259, DOI 10.1152/ajpcell.1996.270.1.C259	32	86	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34975	34982		10.1074/jbc.M105946200	http://dx.doi.org/10.1074/jbc.M105946200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432874	hybrid			2022-12-27	WOS:000171024600084
J	James, CM; Ferguson, TK; Leykam, JF; Krzycki, JA				James, CM; Ferguson, TK; Leykam, JF; Krzycki, JA			The amber codon in the gene encoding the monomethylamine methyltransferase isolated from Methanosarcina barkeri is translated as a sense codon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE LEUKEMIA-VIRUS; RELEASE FACTOR-II; M METHYL TRANSFER; CORRINOID PROTEIN; READ-THROUGH; RECONSTITUTION; METHANOGENESIS; SELENOCYSTEINE; SUPPRESSION; METABOLISM	Each of the genes encoding the methyltransferases initiating methanogenesis from trimethylamine, dimethylamine, or monomethylamine by various Methanosarcina species possesses one naturally occurring in-frame amber codon that does not appear to act as a translation stop during synthesis of the biochemically characterized methyltransferase. To investigate the means by which suppression of the amber codon within these genes occurs, MtmB, a methyltransferase initiating metabolism of monomethylamine, was examined. The C-terminal sequence of MtmB indicated that synthesis of this mtmB1 gene product did not cease at the internal amber codon, but at the following ochre codon. Antibody raised against MtmB revealed that Escherichia coli transformed with mtmB1 produced the amber termination product. The same antibody detected primarily a 50-kDa protein in Methanosarcina barkeri, which is the mass predicted for the amber readthrough product of the mtmB1 gene. Sequencing of peptide fragments from MtmB by Edman degradation and mass spectrometry revealed no change in the reading frame during mtmB1 expression. The amber codon position corresponded to a lysyl residue using either sequencing technique. The amber codon is thus read through during translation at apparently high efficiency and corresponds to lysine in tryptic fragments of MtmB even though canonical lysine codon usage is encountered in other Methanosarcina genes.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Michigan State Univ, Dept Biochem, Macromol Struct Sequencing & Synth Facil, E Lansing, MI 48823 USA	University System of Ohio; Ohio State University; Michigan State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	Krzycki.1@osu.edu						Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; Boone David R., 1993, P35; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; CAO XJ, 1991, J BACTERIOL, V173, P5439, DOI 10.1128/jb.173.17.5439-5448.1991; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; Ferguson DJ, 1997, J BACTERIOL, V179, P846, DOI 10.1128/jb.179.3.846-852.1997; Ferguson DJ, 1996, J BIOL CHEM, V271, P5189; Ferguson DJ, 2000, J BIOL CHEM, V275, P29053, DOI 10.1074/jbc.M910218199; Ferry JG, 1999, FEMS MICROBIOL REV, V23, P13, DOI 10.1016/S0168-6445(98)00029-1; GELLER AI, 1980, NATURE, V283, P41, DOI 10.1038/283041a0; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Herr AJ, 2000, ANNU REV BIOCHEM, V69, P343, DOI 10.1146/annurev.biochem.69.1.343; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; KING GM, 1984, GEOMICROBIOL J, V3, P276; KRZYCKI JA, 1989, J BIOL CHEM, V264, P7217; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Persson BC, 1998, J BACTERIOL, V180, P3462, DOI 10.1128/JB.180.13.3462-3466.1998; Rother M, 2000, J MOL BIOL, V299, P351, DOI 10.1006/jmbi.2000.3756; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; TAYLOR JM, 1974, J BIOL CHEM, V249, P2188; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	32	58	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34252	34258		10.1074/jbc.M102929200	http://dx.doi.org/10.1074/jbc.M102929200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435424	hybrid			2022-12-27	WOS:000170910200128
J	Basak, A; Koch, P; Dupelle, M; Fricker, LD; Devi, LA; Chretien, M; Seidah, NG				Basak, A; Koch, P; Dupelle, M; Fricker, LD; Devi, LA; Chretien, M; Seidah, NG			Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROHORMONE CONVERTASE-1; SUBSTRATE-SPECIFICITY; SERINE PROTEINASES; ACTIVATION; PRECURSOR; FURIN; 7B2; IDENTIFICATION; EMBRYOGENESIS; POLYPEPTIDES	Prohormone convertase I (PCI), mediating the proteolytic processing of neural and endocrine precursors, is thought to be regulated by the neuroendocrine protein proSAAS. The PCI inhibitory sequence is mostly confined within a 10-12-amino acid segment near the C terminus of the conserved human proSAAS and contains the critical KR244 dibasic motif. Our results show that the decapeptide proSAAS-(235-244) (235)VLGALLRVKR(244) is the most potent reversible competitive PC1-inhibitor (K-i similar to9 nM). The C-terminally extended proSAAS-(235-246) exhibits a 5-6-fold higher K-i (similar to 51 nM). The additional LE sequence at P1'-P2', resulted in a competitive substrate cleaved by PCI at KR244 down arrow LE246. Systematic alanine scanning and in some cases lysine scanning tested the contribution of each residue within proSAAS(235-246) toward the PCI-inhibition's specificity and potency. The amino acids P1 Arg, P2 Lys, and P4 Arg are all critical for inhibition. Moreover, the aliphatic P3 Val and P5, P6, and P1' Leu significantly affect the degree of enzyme inactivation and PC1 specificity. Interestingly, a much longer N- and C-terminally extended endogenous rat proSAAS-(221-254) called little PenLen, was found to be a 3-fold less potent PCI inhibitor with reduced selectivity but a much better substrate than proSAAS-(235-246). Molecular modeling studies and circular dichroism analysis indicate an extended and poly-L-proline II type structural conformation for proSAAS-(235-244), the most potent PC1 inhibitor, a feature not present in poor PC1 inhibitors.	Ottawa Hosp, Loeb Hlth Res Inst, Ageing Ctr, Lab Mol Med & Dis, Ottawa, ON K1Y 4K9, Canada; Yeshiva Univ Albert Einstein Coll Med, Mol Pharmacol Lab, Bronx, NY 10461 USA; NYU, Sch Med, Pharmacol Lab, New York, NY 10016 USA; Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Ottawa; Ottawa Hospital Research Institute; Yeshiva University; Albert Einstein College of Medicine; New York University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Basak, A (corresponding author), Ottawa Hosp, Loeb Hlth Res Inst, Ageing Ctr, Lab Mol Med & Dis, 725 Parkdale Ave, Ottawa, ON K1Y 4K9, Canada.		Seidah, Nabil/I-3596-2013; Devi P, Lakshmi/GXM-5982-2022	Seidah, Nabil/0000-0001-6503-9342; Devi P, Lakshmi/0000-0001-9274-4776; CHRETIEN, Michel/0000-0002-8588-4460				Apletalina E, 1998, J BIOL CHEM, V273, P26589, DOI 10.1074/jbc.273.41.26589; Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; BASAK A, 1990, INT J PEPT PROT RES, V36, P7; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; Beynon R.J, 1989, PROTEOLYTIC ENZYMES, P83; Boudreault A, 1998, PROTEIN EXPRES PURIF, V14, P353, DOI 10.1006/prep.1998.0964; Boudreault A, 1998, J BIOL CHEM, V273, P31574, DOI 10.1074/jbc.273.47.31574; Cameron A, 2000, FEBS LETT, V473, P135, DOI 10.1016/S0014-5793(00)01511-8; CHRETIEN M, 1995, P ASSOC AM PHYSICIAN, V107, P47; CHRETIEN M, 1997, B CAN SOC BIOCH CELL, P86; COPELAND RA, 1996, ENZYMES PRACTICAL IN; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; LEDUC R, 1992, J BIOL CHEM, V267, P14304; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P5486, DOI 10.1021/bi00016a020; LIPKIND G, 1995, J BIOL CHEM, V270, P13277, DOI 10.1074/jbc.270.22.13277; MILHIET PE, 1992, ANAL BIOCHEM, V205, P57, DOI 10.1016/0003-2697(92)90578-U; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; Muller L, 2000, J BIOL CHEM, V275, P39213, DOI 10.1074/jbc.M003547200; Mzhavia N, 2001, J BIOL CHEM, V276, P6207, DOI 10.1074/jbc.M009067200; Qian YM, 2000, J BIOL CHEM, V275, P23596, DOI 10.1074/jbc.M001583200; ROTHE G, 1992, BIOL CHEM H-S, V373, P547, DOI 10.1515/bchm3.1992.373.2.547; Seebach D, 2000, HELV CHIM ACTA, V83, P2849, DOI 10.1002/1522-2675(20001108)83:11<2849::AID-HLCA2849>3.0.CO;2-R; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SEIDAH NG, 1983, ARCH BIOCHEM BIOPHYS, V225, P525, DOI 10.1016/0003-9861(83)90063-2; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; Tsuji A, 1999, J BIOCHEM, V126, P591, DOI 10.1093/oxfordjournals.jbchem.a022491; Williams J W, 1979, Methods Enzymol, V63, P437; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	34	49	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32720	32728		10.1074/jbc.M104064200	http://dx.doi.org/10.1074/jbc.M104064200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435430	hybrid			2022-12-27	WOS:000170746000047
J	Cho, W				Cho, W			Membrane targeting by C1 and C2 domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-C; CYTOSOLIC PHOSPHOLIPASE A(2); GREEN FLUORESCENT PROTEIN; PHORBOL ESTER BINDING; CYSTEINE-RICH DOMAINS; X-100 MIXED MICELLES; CRYSTAL-STRUCTURE; FUNCTIONAL DIVERSITY; LIVING CELLS; CALCIUM		Univ Illinois, Dept Chem MC 111, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, W (corresponding author), Univ Illinois, Dept Chem MC 111, 845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052598, R01GM053987] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52598, GM53987] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almholt K, 1999, BIOCHEM J, V337, P211, DOI 10.1042/0264-6021:3370211; Ball A, 1999, P NATL ACAD SCI USA, V96, P6637, DOI 10.1073/pnas.96.12.6637; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Bogi K, 1998, CANCER RES, V58, P1423; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Feng X, 2000, J BIOL CHEM, V275, P17024, DOI 10.1074/jbc.275.22.17024; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Grobler JA, 1996, NAT STRUCT BIOL, V3, P788, DOI 10.1038/nsb0996-788; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; HANNUN YA, 1986, J BIOL CHEM, V261, P9341; HANNUN YA, 1985, J BIOL CHEM, V260, P39; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johnson JE, 1997, J BIOL CHEM, V272, P30787, DOI 10.1074/jbc.272.49.30787; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lichtenbergova L, 1998, BIOCHEMISTRY-US, V37, P14128, DOI 10.1021/bi980888s; Lomasney JW, 1999, J BIOL CHEM, V274, P21995, DOI 10.1074/jbc.274.31.21995; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOSIOR M, 1995, J BIOL CHEM, V270, P25526, DOI 10.1074/jbc.270.43.25526; Nalefski EA, 1998, BIOCHEMISTRY-US, V37, P17642, DOI 10.1021/bi982372e; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nalefski EA, 1997, BIOCHEMISTRY-US, V36, P12011, DOI 10.1021/bi9717340; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; Pepio AM, 2001, J BIOL CHEM, V276, P3846, DOI 10.1074/jbc.M006339200; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Slater SJ, 1996, J BIOL CHEM, V271, P4627; SLATER SJ, 1994, J BIOL CHEM, V269, P4866; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995; Vallentin A, 2000, J BIOL CHEM, V275, P6014, DOI 10.1074/jbc.275.8.6014; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Wan QJ, 2000, J BIOL CHEM, V275, P12136, DOI 10.1074/jbc.275.16.12136; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512; Zheng L, 2000, J BIOL CHEM, V275, P19700, DOI 10.1074/jbc.M001945200	73	183	184	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32407	32410		10.1074/jbc.R100007200	http://dx.doi.org/10.1074/jbc.R100007200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432875	hybrid			2022-12-27	WOS:000170746000005
J	Kishida, M; Hino, S; Michiue, T; Yamamoto, H; Kishida, S; Fukui, A; Asashima, M; Kikuchi, A				Kishida, M; Hino, S; Michiue, T; Yamamoto, H; Kishida, S; Fukui, A; Asashima, M; Kikuchi, A			Synergistic activation of the Wnt signaling pathway by Dvl and casein kinase I epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR LEF-1; F-BOX PROTEIN; BETA-CATENIN; AXIS FORMATION; NEGATIVE REGULATOR; BINDING PROTEIN; POLARITY GENE; GSK-3-BETA-DEPENDENT PHOSPHORYLATION	Although casein kinase I epsilon (CKI epsilon) has been shown to regulate the Wnt signaling pathway positively, its mode of action is not clear. In this study we show that CKI epsilon activates the Wnt signaling pathway in co-operation with Dv1. CKI epsilon and Axin associated with different sites of Dv1, and CKI epsilon and Dv1 interacted with distinct regions on Axin. Therefore, these three proteins formed a ternary complex. Either low expression of Dv1 or CKI epsilon alone did not accumulate beta -catenin, but their co-expression accumulated greatly. Dv1 and CKI epsilon activated the transcriptional activity of T cell factor (Tcf) synergistically. Although the Dv1 mutant that binds to Axin but not to CKI epsilon activated Tcf, it did not synergize with CKI epsilon Another Dv1 mutant that does not bind to Axin did not activate Tcf irrespective of the presence of CKI epsilon Furthermore, Dv1 and CKI epsilon co-operatively induced axis duplication of Xenopus embryos. These results indicate that Dv1 and CKI epsilon synergistically activated the Writ signaling pathway and that the binding of the complex of Dv1 and CKI epsilon to Axin is necessary for their synergistic action.	Hiroshima Univ, Fac Med, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; Japan Sci & Technol Corp, PRESTO, Hiroshima, Japan; Univ Tokyo, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; Univ Tokyo, Crest Project, Meguro Ku, Tokyo 1538902, Japan	Hiroshima University; Japan Science & Technology Agency (JST); University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Kikuchi, A (corresponding author), Hiroshima Univ, Fac Med, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.			kishida, shosei/0000-0003-0405-851X				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Dale TC, 1998, BIOCHEM J, V329, P209; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Kadoya T, 2000, J BIOL CHEM, V275, P37030, DOI 10.1074/jbc.M005984200; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KREIG PA, 1984, NUCLEIC ACIDS RES, V12, P7057; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; THEISEN H, 1994, DEVELOPMENT, V120, P347; Tian Q, 1999, DEVELOPMENT, V126, P3371; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	69	95	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33147	33155		10.1074/jbc.M103555200	http://dx.doi.org/10.1074/jbc.M103555200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11425858	hybrid			2022-12-27	WOS:000170746000101
J	Smith, WL; Garavito, RM; Ferguson-Miller, S				Smith, WL; Garavito, RM; Ferguson-Miller, S			Membrane protein structural biology minireview series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DOMAIN		Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Smith, WL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Biochem Bldg,Rm 513, E Lansing, MI 48824 USA.							Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Prabhakar P, 2000, J BIOL CHEM, V275, P19416, DOI 10.1074/jbc.M001952200; Rees DC, 2000, J BIOL CHEM, V275, P713, DOI 10.1074/jbc.275.2.713; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129	7	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32393	32394		10.1074/jbc.R100044200	http://dx.doi.org/10.1074/jbc.R100044200			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432879	hybrid			2022-12-27	WOS:000170746000001
J	Tamm, LK; Arora, A; Kleinschmidt, JH				Tamm, LK; Arora, A; Kleinschmidt, JH			Structure and assembly of beta-barrel membrane proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI K-12; LIPID BILAYER; OUTER; INSERTION; OMPA; SKP; LIPOPOLYSACCHARIDES; CHAPERONE; EXPORT; FORMS		Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia	Tamm, LK (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, POB 800736, Charlottesville, VA 22908 USA.	lkt2e@virginia.edu	Kleinschmidt, Jörg H/G-3395-2012; Kleinschmidt, Jörg/B-9918-2011	Kleinschmidt, Jörg H/0000-0003-0986-334X; 	NIGMS NIH HHS [R01 GM051329, GM51329] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051329] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arora A, 2000, J BIOL CHEM, V275, P1594, DOI 10.1074/jbc.275.3.1594; Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; de Cock H, 1999, EUR J BIOCHEM, V259, P96, DOI 10.1046/j.1432-1327.1999.00010.x; deCock H, 1996, EMBO J, V15, P5567, DOI 10.1002/j.1460-2075.1996.tb00941.x; DORNMAIR K, 1990, J BIOL CHEM, V265, P18907; EISELE JL, 1990, J BIOL CHEM, V265, P10217; FREUDL R, 1986, J BIOL CHEM, V261, P1355; FREUDL R, 1985, EMBO J, V4, P3593, DOI 10.1002/j.1460-2075.1985.tb04122.x; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065, DOI 10.1110/ps.8.10.2065; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P4996, DOI 10.1021/bi9824644; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; PTITSYN OB, 1995, CURR OPIN STRUC BIOL, V5, P74, DOI 10.1016/0959-440X(95)80011-O; RODIONOVA NA, 1995, BIOCHEMISTRY-US, V34, P1921, DOI 10.1021/bi00006a013; Rumbley J, 2001, P NATL ACAD SCI USA, V98, P105, DOI 10.1073/pnas.98.1.105; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; SURREY T, 1995, J BIOL CHEM, V270, P28199; Surrey T, 1996, BIOCHEMISTRY-US, V35, P2283, DOI 10.1021/bi951216u; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; TAMM LK, 1990, FEBS LETT, V272, P29, DOI 10.1016/0014-5793(90)80441-K; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200	30	118	123	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32399	32402		10.1074/jbc.R100021200	http://dx.doi.org/10.1074/jbc.R100021200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432877	Green Published, hybrid			2022-12-27	WOS:000170746000003
J	Brosnan, JT; Brosnan, ME; Yudkoff, M; Nissim, H; Daikhin, Y; Lazarow, A; Horyn, O; Nissim, I				Brosnan, JT; Brosnan, ME; Yudkoff, M; Nissim, H; Daikhin, Y; Lazarow, A; Horyn, O; Nissim, I			Alanine metabolism in the perfused rat liver - Studies with N-15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-METABOLISM; GLUTAMINE-METABOLISM; CHROMATOGRAPHY; ENRICHMENT; UREA	We have utilized [N-15]alanine or (NH3)-N-15 as metabolic tracers in order to identify sources of nitrogen for hepatic ureagenesis in a liver perfusion system. Studies were done in the presence and absence of physiologic concentrations of portal venous ammonia in order to test the hypothesis that, when the NH4+:aspartate ratio is >1, increased hepatic proteolysis provides cytoplasmic aspartate in order to support ureagenesis. When 1 mM [N-15]alanine was the sole nitrogen source, the amino group was incorporated into both nitrogens of urea and both nitrogens of glutamine. However, when studies were done with 1 mM alanine and 0.3 mM NH4Cl, anine failed to provide aspartate at a rate that would have detoxified all administered ammonia. Under these circumstances, the presence of ammonia at a physiologic concentration stimulated hepatic proteolysis. In perfusions with alanine alone, similar to 400 nmol of nitrogen/min/g liver was needed to satisfy the balance between nitrogen intake and nitrogen output. When the model included alanine and NH4Cl, 1000 nmol of nitrogen/min/g liver were formed from an intra-hepatic source, presumably proteolysis. In this manner, the internal pool provided the cytoplasmic aspartate that allowed the liver to dispose of mitochondrial carbamyl phosphate that was rapidly produced from external ammonia. This information may be relevant to those clinical situations (renal failure, cirrhosis, starvation, low protein diet, and malignancy) when portal venous NH4+ greatly exceeds the concentration of aspartate. Under these circumstances, the liver must summon internal pools of protein in order to accommodate the ammonia burden.	Univ Penn, Sch Med, Dept Pediat, Abramson Res Ctr,Div Child Dev, Philadelphia, PA 19104 USA; Mem Univ Newfoundland, Dept Biochem, St John, NF A1B 3X9, Canada	University of Pennsylvania; Pennsylvania Medicine; Memorial University Newfoundland	Nissim, I (corresponding author), Univ Penn, Sch Med, Dept Pediat, Abramson Res Ctr,Div Child Dev, Rm 510, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053761, R56DK053761] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-53761] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROSNAN JT, 1970, BIOCHEM J, V117, P91, DOI 10.1042/bj1170091; Brosnan JT, 1996, J BIOL CHEM, V271, P16199, DOI 10.1074/jbc.271.27.16199; Butterworth RE, 2000, J HEPATOL, V32, P171, DOI 10.1016/S0168-8278(00)80424-9; Cordoba J, 1997, AM J GASTROENTEROL, V92, P1429; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; FORISSIER M, 1981, BIOCHEM J, V200, P27, DOI 10.1042/bj2000027; GEBHARDT R, 1983, EMBO J, V2, P567, DOI 10.1002/j.1460-2075.1983.tb01464.x; GEYER JW, 1971, ANAL BIOCHEM, V39, P412, DOI 10.1016/0003-2697(71)90431-3; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; KIRSTEN E, 1963, BIOCHEM Z, V337, P312; Lopez HW, 1998, J NUTR, V128, P1487, DOI 10.1093/jn/128.9.1487; MASTSUZAWA T, 1997, BIOCHIM BIOPHYS ACTA, V1340, P115; Nieto R, 1996, J MASS SPECTROM, V31, P289, DOI 10.1002/(SICI)1096-9888(199603)31:3<289::AID-JMS299>3.0.CO;2-Z; Nissim I, 1999, J BIOL CHEM, V274, P28958, DOI 10.1074/jbc.274.41.28958; Nissim I, 1996, J BIOL CHEM, V271, P31234, DOI 10.1074/jbc.271.49.31234; NISSIM I, 1992, ARCH BIOCHEM BIOPHYS, V292, P393, DOI 10.1016/0003-9861(92)90008-K; PATTERSON BW, 1993, BIOL MASS SPECTROM, V22, P518, DOI 10.1002/bms.1200220905; PISTERS PWT, 1990, ANNU REV NUTR, V10, P107, DOI 10.1146/annurev.nu.10.070190.000543; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Sies H, 1978, Methods Enzymol, V52, P48; SOUBA WW, 1993, J NUTR BIOCHEM, V4, P2, DOI 10.1016/0955-2863(93)90013-M; STOLL B, 1991, HEPATOLOGY, V13, P247, DOI 10.1002/hep.1840130208; Walser M, 2000, BLOOD PURIFICAT, V18, P304, DOI 10.1159/000014453; WATFORD M, 1994, BBA-GEN SUBJECTS, V1200, P73, DOI 10.1016/0304-4165(94)90029-9; Yang DW, 2000, AM J PHYSIOL-ENDOC M, V278, pE469, DOI 10.1152/ajpendo.2000.278.3.E469	25	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31876	31882		10.1074/jbc.M103890200	http://dx.doi.org/10.1074/jbc.M103890200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423541	hybrid			2022-12-27	WOS:000170613500057
J	Chao, SH; Price, DH				Chao, SH; Price, DH			Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; ELONGATION-FACTOR-B; HIV-1 TAT; KINASE INHIBITORS; CYCLIN T1; IN-VITRO; TRANSACTIVATION; PROTEIN; REPLICATION; PITALRE	Flavopiridol (L86-8275, HMR1275) is a cyclin-dependent kinase (Cdk) inhibitor in clinical trials as a cancer therapy that has been recently shown to block human immunodeficiency virus Tat transactivation and viral replication through inhibition of positive transcription elongation factor b (P-TEFb). Flavopiridol is the most potent P-TEFb inhibitor reported and the first Cdk inhibitor that is not competitive with ATP. We examined the ability of flavopiridol to inhibit P-TEFb (Cdk9/cyclin T1) phosphorylation of both RNA polymerase II and the large subunit of the 5, 6-dichloro-1-beta -D-ribofuranosyl-benzimidazole (DRB) sensitivity-inducing factor and found that the IC50 determined was directly related to the concentration of the enzyme. We concluded that the flavonoid associates with P-TEFb with 1:1 stoichiometry even at concentrations of enzyme in the low nanomolar range. These results indicate that the apparent lack of competition with ATP could be caused by a very tight binding of the drug. We developed a novel immobilized P-TEFb assay and demonstrated that the drug remains bound for minutes even in the presence of high salt. Flavopiridol remained bound in the presence of a 1000-fold excess of the commonly used inhibitor DRB, suggesting that the immobilized P-TEFb could be used in a simple screening assay that would allow the discovery or characterization of compounds with binding properties similar to flavopiridol. Finally, we compared the ability of flavopiridol and DRB to inhibit transcription in vivo using nuclear run-on assays and concluded that P-TEFb is required for transcription of most RNA polymerase II molecules in vivo.	Univ Iowa, Program Mol Biol, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Price, DH (corresponding author), Univ Iowa, Program Mol Biol, Iowa City, IA 52242 USA.		Price, David H/F-6173-2010	Price, David/0000-0002-5597-385X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43691] Funding Source: Medline; NIGMS NIH HHS [GM35500] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bieniasz PD, 1999, MOL CELL BIOL, V19, P4592, DOI 10.1128/mcb.19.7.4592; Carlson B, 1999, CANCER RES, V59, P4634; Carlson BA, 1996, CANCER RES, V56, P2973; Chang TC, 1997, BIOCHEM PHARMACOL, V53, P969, DOI 10.1016/S0006-2952(96)00868-4; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; DE AWJ, 1996, P NATL ACAD SCI USA, V93, P2735; De Falco G, 1998, J CELL PHYSIOL, V177, P501, DOI 10.1002/(SICI)1097-4652(199812)177:4<501::AID-JCP1>3.0.CO;2-4; Egyhazi E, 1996, CHROMOSOMA, V104, P422, DOI 10.1007/s004120050134; Flores OL, 1999, P NATL ACAD SCI USA, V96, P7208, DOI 10.1073/pnas.96.13.7208; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gold MO, 1998, J VIROL, V72, P4448, DOI 10.1128/JVI.72.5.4448-4453.1998; Gray N, 1999, CURR MED CHEM, V6, P859; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Kelland LR, 2000, EXPERT OPIN INV DRUG, V9, P2903, DOI 10.1517/13543784.9.12.2903; Kim KS, 2000, J MED CHEM, V43, P4126, DOI 10.1021/jm000231g; KIRN JB, 2001, J BIOL CHEM, V276, P12317; LOSIEWICZ MD, 1994, BIOCHEM BIOPH RES CO, V201, P589, DOI 10.1006/bbrc.1994.1742; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; Murthi KK, 2000, BIOORG MED CHEM LETT, V10, P1037, DOI 10.1016/S0960-894X(00)00156-6; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; REEDER RH, 1972, J MOL BIOL, V67, P433, DOI 10.1016/0022-2836(72)90461-5; Senderowicz AM, 2000, JNCI-J NATL CANCER I, V92, P376, DOI 10.1093/jnci/92.5.376; Senderowicz AM, 1998, J CLIN ONCOL, V16, P2986, DOI 10.1200/JCO.1998.16.9.2986; Taube R, 1999, VIROLOGY, V264, P245, DOI 10.1006/viro.1999.9944; Toledo LM, 1999, CURR MED CHEM, V6, P775; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	32	527	566	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31793	31799		10.1074/jbc.M102306200	http://dx.doi.org/10.1074/jbc.M102306200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11431468	hybrid			2022-12-27	WOS:000170613500044
J	Fernandes, RJ; Hirohata, S; Engle, JM; Colige, A; Cohn, DH; Eyre, DR; Apte, SS				Fernandes, RJ; Hirohata, S; Engle, JM; Colige, A; Cohn, DH; Eyre, DR; Apte, SS			Procollagen II amino propeptide processing by ADAMTS-3 - Insights on dermatosparaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; BOVINE DERMATOSPARAXIS; EXTRACELLULAR-MATRIX; FIBRILLAR COLLAGENS; DEXTRAN SULFATE; N-PROTEINASE; VII-C; CLEAVAGE; FAMILY; FIBROBLASTS	The amino and carboxyl propeptides of procollagens I and Il are removed by specific enzymes as a prerequisite for fibril assembly. Null mutations in procollagen I N-propeptidase (ADAMTS-2) cause dermatosparaxis in cattle and the Ehlers-Danlos syndrome (dermatosparactic type) in humans by preventing proteolytic excision of the N-propeptide of procollagen I. We have found that procollagen II is processed normally in dermatosparactic nasal cartilage, suggesting the existence of another N-propeptidase(s). We investigated such a role for ADAMTS-3 in Swarm rat chondrosarcoma RCS-LTC cells, which fail to process the procollagen II N-propeptide. Stable transfection of RCS-LTC cells with bovine ADAMTS-2 or human ADAMTS-3 partially rescued the, processing defect, suggesting that ADAMTS-3 has procollagen II N-propeptidase activity. Human skin and skin fibroblasts showed 30-fold higher mRNA levels of ADAMTS-2 than ADAMTS-3, whereas ADAMTS-3 mRNA was 5-fold higher than ADAMTS-2 mRNA in human cartilage. We propose that both ADAMTS-2 and ADAMTS-3 process procollagen II, but ADAMTS-3 is physiologically more relevant, given its preferred expression in cartilage. The findings provide an explanation for the sparing of cartilage in dermatosparaxis and, perhaps, for the relative sparing of some procollagen I-containing tissues.	Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Lab Biol Tissus Conjonctifs, B-4000 Sart Tilman Par Liege, Belgium; Univ Calif Los Angeles, Sch Med,Steven Spielberg Pediat Res Ctr, Ahmanson Dept Pediat, Burns & Allen Cedars Sinai Res Inst, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90048 USA	Cleveland Clinic Foundation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Apte, SS (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, ND-20,9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@bme.ri.ccf.org		Apte, Suneel/0000-0001-8441-1226	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R01AR036794, R37AR037318] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR036794, AR37318, R37 AR037318] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; BATEMAN JF, 1990, BIOCHEM J, V267, P573, DOI 10.1042/bj2670573; Birk DE., 1991, MATRIX ASSEMBLY, P221; Colige A, 1997, P NATL ACAD SCI USA, V94, P2374, DOI 10.1073/pnas.94.6.2374; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; DOMBROWSKI KE, 1988, J BIOL CHEM, V263, P16545; Fernandes RJ, 1997, EUR J BIOCHEM, V247, P620, DOI 10.1111/j.1432-1033.1997.00620.x; FERNANDES RJ, 1993, THESIS RUSH U CHICAG; Fertala A, 1996, J BIOL CHEM, V271, P14864, DOI 10.1074/jbc.271.25.14864; FERTALA A, 1994, J BIOL CHEM, V269, P11584; Fujimoto A, 1997, AM J MED GENET, V68, P25, DOI 10.1002/(SICI)1096-8628(19970110)68:1<25::AID-AJMG5>3.0.CO;2-X; FUKAI N, 1994, METHOD ENZYMOL, V245, P3; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; HANSET R, 1974, J HERED, V65, P356, DOI 10.1093/oxfordjournals.jhered.a108549; HOJIMA Y, 1994, ANAL BIOCHEM, V223, P173, DOI 10.1006/abio.1994.1569; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPIERE CM, 1993, ARCH DERMATOL, V129, P1316, DOI 10.1001/archderm.129.10.1316; LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054; LENAERS A, 1971, EUR J BIOCHEM, V23, P533, DOI 10.1111/j.1432-1033.1971.tb01651.x; Li SW, 2001, BIOCHEM J, V355, P271, DOI 10.1042/0264-6021:3550271; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; METSARANTA M, 1992, J CELL BIOL, V118, P203, DOI 10.1083/jcb.118.1.203; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Nardi JB, 1999, INSECT BIOCHEM MOLEC, V29, P883, DOI 10.1016/S0965-1748(99)00064-8; NUSGENS BV, 1992, NAT GENET, V1, P214, DOI 10.1038/ng0692-214; OHARA PJ, 1970, LAB INVEST, V23, P307; Olsen BR, 1991, CELL BIOL EXTRACELLU, P177; PETTY EM, 1993, ARCH DERMATOL, V129, P1310, DOI 10.1001/archderm.129.10.1310; Reardon W, 1995, Clin Dysmorphol, V4, P1; SMITH LT, 1992, AM J HUM GENET, V51, P235; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; WERTELECKI W, 1992, J PEDIATR-US, V121, P558, DOI 10.1016/S0022-3476(05)81144-8; WIESTNER M, 1982, EMBO J, V1, P513, DOI 10.1002/j.1460-2075.1982.tb01200.x	39	173	182	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31502	31509		10.1074/jbc.M103466200	http://dx.doi.org/10.1074/jbc.M103466200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11408482	hybrid			2022-12-27	WOS:000170613500006
J	Loo, TW; Clarke, DM				Loo, TW; Clarke, DM			Cross-linking of human multidrug resistance P-glycoprotein by the substrate, Tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING SITES; PREDICTED TRANSMEMBRANE DOMAIN; CYSTEINE-SCANNING MUTAGENESIS; HIV-1 PROTEASE INHIBITORS; BLOOD-BRAIN-BARRIER; DRUG-BINDING; FUNCTIONAL CONSEQUENCES; CATALYTIC CYCLE; LABELING SITES; TRANSPORTER	We identified a thiol-reactive substrate, Tris-(-2-maleimidoethyl)amine (TMEA), to explore the contribution of the TM segments 6 and 12 of the human multidrug resistance P-glycoprotein (P-gp) during transport. TMEA is a trifunctional maleimide and stimulated the ATPase activity of Cys-less P-gp about 7-fold. Cysteine-scanning mutagenesis of TM12 showed that the activity of mutant V982C was inhibited by TMEA. P-gp mutants containing V982C (TM12) and another cysteine in TM6 were constructed and tested for cross-linking with TAMA. A cross-linked product was observed in SDS-polyacrylamide gel electrophoresis for mutant L339C(TM6)/V982C(TM12). Cross-linking by TMEA also inhibited the ATPase activity of the mutant protein. Substrates such as cyclosporin A, vinblastine, colchicine, or verapamil inhibited cross-linking by TMEA. In the presence of ATP at 37 degreesC, cross-linking of mutant L339C/V982C was decreased. In contrast, there was enhanced cross-linking of mutant F343C(TM6)/V982C(TM12) in the presence of ATP. These results show that cross-linking must be within the drug-binding domain, that residues L339C(TM6)/V982C(TM12) must be at least 10 Angstrom, apart, and that ATP hydrolysis promotes rotation of one or both TM helices.	Univ Toronto, Dept Med, Canadian Inst Hlth, Res Grp Membrane Biol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, Canadian Inst Hlth, Res Grp Membrane Biol, Rm 7342,Med Res Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.		Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	NATIONAL CANCER INSTITUTE [R01CA080900] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA80900] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; CHAN HS, 1996, EUR J CANCER, V6, P1051; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen G, 1997, J BIOL CHEM, V272, P5974, DOI 10.1074/jbc.272.9.5974; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Demeule M, 1998, BIOCHEMISTRY-US, V37, P18110, DOI 10.1021/bi981992c; Demmer A, 1997, J BIOL CHEM, V272, P20913, DOI 10.1074/jbc.272.33.20913; DEVINE SE, 1992, P NATL ACAD SCI USA, V89, P4564, DOI 10.1073/pnas.89.10.4564; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Druley TE, 2001, BIOCHEMISTRY-US, V40, P4312, DOI 10.1021/bi001371v; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GREENBERGER LM, 1993, J BIOL CHEM, V268, P11417; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; Hafkemeyer P, 1998, BIOCHEMISTRY-US, V37, P16400, DOI 10.1021/bi980871+; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; Julien M, 2000, BIOCHEMISTRY-US, V39, P4559, DOI 10.1021/bi992744z; KAJIJI S, 1993, BIOCHEMISTRY-US, V32, P4185, DOI 10.1021/bi00067a005; Kast C, 1996, J BIOL CHEM, V271, P9240, DOI 10.1074/jbc.271.16.9240; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2000, J BIOL CHEM, V275, P19435, DOI 10.1074/jbc.C000222200; Loo TW, 1996, J BIOL CHEM, V271, P27488, DOI 10.1074/jbc.271.44.27488; Loo TW, 1999, BBA-BIOMEMBRANES, V1461, P315, DOI 10.1016/S0005-2736(99)00165-0; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; LOO TW, 1993, J BIOL CHEM, V268, P3143; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1994, J BIOL CHEM, V269, P7750; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; LOO TW, 1993, J BIOL CHEM, V268, P19965; Loo TW, 2000, JNCI-J NATL CANCER I, V92, P898, DOI 10.1093/jnci/92.11.898; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; MORRIS DI, 1994, MOL PHARMACOL, V46, P329; Pascaud C, 1998, BIOCHEM J, V333, P351, DOI 10.1042/bj3330351; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; Robert J, 1999, EUR J CLIN INVEST, V29, P536, DOI 10.1046/j.1365-2362.1999.00495.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1999, EUR J BIOCHEM, V259, P841, DOI 10.1046/j.1432-1327.1999.00098.x; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; Sonveaux N, 1996, J BIOL CHEM, V271, P24617, DOI 10.1074/jbc.271.40.24617; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Walmsley AR, 2001, J BIOL CHEM, V276, P6378, DOI 10.1074/jbc.M008105200; ZHANG XP, 1995, J BIOL CHEM, V270, P5441, DOI 10.1074/jbc.270.10.5441; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6; Zhou Y, 1999, MOL PHARMACOL, V56, P997, DOI 10.1124/mol.56.5.997	70	70	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31800	31805		10.1074/jbc.M103498200	http://dx.doi.org/10.1074/jbc.M103498200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11429407	hybrid			2022-12-27	WOS:000170613500045
J	Pan, Z; Bhat, MB; Nieminen, AL; Ma, J				Pan, Z; Bhat, MB; Nieminen, AL; Ma, J			Synergistic movements of Ca2+ and Bax in cells undergoing apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; INTRACELLULAR CALCIUM STORES; CHANNEL-FORMING ACTIVITY; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR; SKELETAL-MUSCLE; AMYLOID-BETA; BCL-2; MITOCHONDRIA; SIGNALS	Apoptosis is a physiological counterbalance to mitosis and plays important roles in tissue development and homeostasis. Cytosolic Ca2+ has been implicated as a proapoptotic second messenger involved in both triggering apoptosis and regulating cell death-specific enzymes. A critical early event in apoptosis is associated with the redistribution of Bax from cytosol to mitochondria and endoplasmic reticulum (ER) membranes; however, the molecular mechanism of Bax translocation and its relationship to Ca2+ is largely unknown. Here we provide functional evidence for a synergistic interaction between the movements of intracellular Ca2+ and cytosolic Bax in the induction of apoptosis. Overexpression of Bax in cultured cells causes a loss of ER Ca2+ content. Depletion of ER Ca2+ through activation of the ryanodine receptor enhances the participation of Bax into the mitochondrial membrane. Neither Bax translocation nor Bax-induced apoptosis is affected by buffering of cytosolic Ca2+ with 1,2-bis(2-aminophenoxy)-ethane-N,N N ' ,N ' -tetraacetic acid, suggesting that depletion of ER Ca2+ rather than elevation of cytosolic Ca2+ is the signal for cell apoptosis. This dynamic interplay of Ca2+ and Bax movements may serve as an amplifying factor in the initial signaling steps of apoptosis.	Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Ma, J (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 675 Hoes Lane, Piscataway, NJ 08854 USA.	jxm63@po.cwru.edu		Pan, Zui/0000-0003-4105-901X	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015556] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA85834] Funding Source: Medline; NCRR NIH HHS [S10-RR14690] Funding Source: Medline; NIA NIH HHS [R01-AG15556] Funding Source: Medline; NINDS NIH HHS [R01-NS39469] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Andjelic S, 1997, J IMMUNOL, V158, P2527; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; BAFFY G, 1993, J BIOL CHEM, V268, P6511; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bian XP, 1997, AM J PHYSIOL-CELL PH, V272, pC1241, DOI 10.1152/ajpcell.1997.272.4.C1241; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Guo Q, 1997, J NEUROSCI, V17, P4212; Hayek SM, 2000, BIOCHEM J, V351, P57, DOI 10.1042/0264-6021:3510057; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Ichimiya M, 1998, AM J PHYSIOL-CELL PH, V275, pC832, DOI 10.1152/ajpcell.1998.275.3.C832; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121; KAISER N, 1977, P NATL ACAD SCI USA, V74, P638, DOI 10.1073/pnas.74.2.638; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; Manjunatha B, 1997, J GEN PHYSIOL, V110, P749, DOI 10.1085/jgp.110.6.749; Margineantu D, 2000, BIOPHYS J, V79, P1833, DOI 10.1016/S0006-3495(00)76433-2; McGahon A. J., 1995, METHOD CELL BIOL, V46, P172; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Murphy KM, 1999, ONCOGENE, V18, P5991, DOI 10.1038/sj.onc.1203001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; Pawlowski J, 2000, P NATL ACAD SCI USA, V97, P529, DOI 10.1073/pnas.97.2.529; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Reynolds JE, 1996, EXP CELL RES, V225, P430, DOI 10.1006/excr.1996.0194; Reynolds JE, 1996, J BIOL CHEM, V271, P27739, DOI 10.1074/jbc.271.44.27739; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wei HF, 1998, J NEUROCHEM, V70, P2305; Williams SS, 2000, CANCER RES, V60, P4358; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	42	69	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32257	32263		10.1074/jbc.M100178200	http://dx.doi.org/10.1074/jbc.M100178200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11413128	hybrid			2022-12-27	WOS:000170613500106
J	Bernoud-Hubac, N; Davies, SS; Boutaud, O; Montine, TJ; Roberts, LJ				Bernoud-Hubac, N; Davies, SS; Boutaud, O; Montine, TJ; Roberts, LJ			Formation of highly reactive gamma-ketoaldehudes (Neuroketals) as products of the neuroprostane pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION PRODUCT; IMPAIRS GLUTAMATE TRANSPORT; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IN-VIVO; CEREBROSPINAL-FLUID; IMMUNOHISTOCHEMICAL DETECTION; HUNTINGTONS-DISEASE; ALDEHYDIC PRODUCT	Neuroprostanes are prostaglandin-like compounds produced by free radical-induced peroxidation of docosahexaenoic acid, which is highly enriched in the brain. We previously described the formation of highly reactive gamma -ketoaldehydes (isoketals) as products of the isoprostane pathway of free radical-induced peroxidation of arachidonic acid. We therefore explored whether isoketal-like compounds (neuroketals) are also formed via the neuroprostane pathway. Utilizing mass spectrometric analyses, neuroketals were found to be formed in abundance in vitro during oxidation of docosahexaenoic acid and were formed in greater abundance than isoketals during co-oxidation of docosahexaenoic and arachidonic acid. Neuroketals were shown to rapidly adduct to lysine, forming lactam and Schiff base adducts. Neuroketal lysyl-lactam protein adducts were detected in nonoxidized rat brain synaptosomes at a level of 0.09 ng(mg of protein, which increased 19-fold following oxidation in vitro. Neuroketal lysyl-lactam protein adducts were also detected in vivo in normal human brain at a level of 9.9 +/- 3.7 ng/g of brain tissue. These studies identify a new class of highly reactive molecules that may participate in the formation of protein adducts and protein-protein cross-links in neurodegenerative diseases and contribute to the injurious effects of other oxidative pathologies in the brain.	Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Roberts, LJ (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	jack.roberts@mcmail.vanderbilt.edu		Davies, Sean/0000-0001-9879-8062	NCI NIH HHS [CA68486] Funding Source: Medline; NIDDK NIH HHS [DK26657] Funding Source: Medline; NIGMS NIH HHS [GM42056, GM15431] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM042056, P50GM015431, R01GM042056, P01GM015431] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RE, 1970, EXP EYE RES, V10, P339, DOI 10.1016/S0014-4835(70)80046-X; BAZAN NG, 1990, UPSALA J MED SCI, P97; Bernoud N, 1998, J LIPID RES, V39, P1816; BLAKELY RD, 1986, J NEUROCHEM, V47, P1013; Blanc EM, 1997, J NEUROCHEM, V69, P570; Blanc EM, 1998, GLIA, V22, P149, DOI 10.1002/(SICI)1098-1136(199802)22:2<149::AID-GLIA6>3.0.CO;2-2; Boutaud O, 1999, BIOCHEMISTRY-US, V38, P9389, DOI 10.1021/bi990470+; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; de la Monte SM, 2000, CELL MOL LIFE SCI, V57, P1471, DOI 10.1007/PL00000630; Dratz E. A., 1986, Health effects of polyunsaturated fatty acids in seafoods, P319; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; GRAHAM DG, 1995, CRIT REV TOXICOL, V25, P91, DOI 10.3109/10408449509021609; IYER RS, 1989, PROSTAGLANDINS, V37, P471, DOI 10.1016/0090-6980(89)90096-8; JANOWSKY A, 1998, CURRENT PROTOCOLS NE; Jensen MM, 1996, BBA-LIPID LIPID MET, V1300, P203, DOI 10.1016/0005-2760(96)00007-0; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Knight JA, 1997, ANN CLIN LAB SCI, V27, P11; Lehning EJ, 2000, TOXICOL APPL PHARM, V165, P127, DOI 10.1006/taap.2000.8937; LONGMIRE AW, 1994, BIOCHEM PHARMACOL, V47, P1173, DOI 10.1016/0006-2952(94)90389-1; Lovell MA, 1997, NEUROBIOL AGING, V18, P457, DOI 10.1016/S0197-4580(97)00108-5; Makrides M, 1996, LIPIDS, V31, P115, DOI 10.1007/BF02522420; Mark RJ, 1997, J NEUROSCI, V17, P1046; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Montine KS, 1997, J NEUROPATH EXP NEUR, V56, P866, DOI 10.1097/00005072-199708000-00004; Montine KS, 1997, AM J PATHOL, V150, P437; Montine TJ, 1999, NEUROLOGY, V52, P1104, DOI 10.1212/WNL.52.5.1104; Montine TJ, 1998, ANN NEUROL, V44, P410, DOI 10.1002/ana.410440322; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Morrow JD, 1996, J BIOL CHEM, V271, P23185, DOI 10.1074/jbc.271.38.23185; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1994, J BIOL CHEM, V269, P4317; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; MURTHI KK, 1993, BIOCHEMISTRY-US, V32, P4090, DOI 10.1021/bi00066a034; Neely MD, 1999, J NEUROCHEM, V72, P2323, DOI 10.1046/j.1471-4159.1999.0722323.x; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; Nourooz-Zadeh J, 1998, BIOCHEM BIOPH RES CO, V242, P338, DOI 10.1006/bbrc.1997.7883; OBRIEN JS, 1965, J LIPID RES, V6, P537; Perry G, 2000, INT J DEV NEUROSCI, V18, P417, DOI 10.1016/S0736-5748(00)00006-X; Reich EE, 2001, AM J PATHOL, V158, P293, DOI 10.1016/S0002-9440(10)63968-5; Reich EE, 2000, BIOCHEMISTRY-US, V39, P2376, DOI 10.1021/bi992000l; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; SALOMON RG, 1984, J AM CHEM SOC, V106, P6049, DOI 10.1021/ja00332a049; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Smith RG, 1998, ANN NEUROL, V44, P696, DOI 10.1002/ana.410440419; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; Taber DF, 1997, PROSTAGLANDINS, V53, P63, DOI 10.1016/S0090-6980(97)00005-1; VANKUIJK FJGM, 1990, BIOCHIM BIOPHYS ACTA, V1043, P116, DOI 10.1016/0005-2760(90)90118-H; Werkman SH, 1996, LIPIDS, V31, P91, DOI 10.1007/BF02522417; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696	52	75	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30964	30970		10.1074/jbc.M103768200	http://dx.doi.org/10.1074/jbc.M103768200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413140	hybrid			2022-12-27	WOS:000170472900051
J	Mistry, SJ; Atweh, GF				Mistry, SJ; Atweh, GF			Stathmin inhibition enhances okadaic acid-induced mitotic arrest - A potential role for stathmin in mitotic exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE-REGULATED PHOSPHORYLATION; DEPENDENT PROTEIN-KINASE; INTACT-CELLS; MICROTUBULE DYNAMICS; PHOSPHOPROTEIN P18; LEUKEMIC-CELLS; ONCOPROTEIN-18; PHOSPHATASES; IDENTIFICATION; INVOLVEMENT	Stathmin is a microtubule-destabilizing phosphoprotein that plays a critical role in the regulation of mitosis. The microtubule-depolymerizing activity of stathmin is lost upon phosphorylation in mitosis. Although the role of phosphorylation of stathmin by p34(cdc2) kinase in the assembly of the mitotic spindle is well established, the role of dephosphorylation of stathmin in mitosis is unknown. In this study, we tested the hypothesis that dephosphorylation of stathmin may be critically important for the depolymerization of the mitotic spindle and the exit from mitosis. We compared the effects of okadaic acid, a specific inhibitor of serine/threonine protein phosphatases, on different parameters of mitotic progression in the presence or absence of stathmin deficiency. Because okadaic acid prevents dephosphorylation of stathmin and results in accumulation of the inactive phosphorylated form, exposure to okadaic acid would be expected to have a more profound effect on mitosis in the presence of relative stathmin deficiency. We found that inhibition of stathmin expression results in increased sensitivity to the antimitotic effects of okadaic acid. This was reflected by increased growth inhibition associated with mitotic arrest. A vast majority of the stathmin-inhibited cells were found to be arrested in late metaphase/anaphase and had severe mitotic spindle abnormalities. Exposure to okadaic acid also resulted in a bigger ratio of polymerized/unpolymerized tubulin in stathmin-inhibited cells relative to control cells. Because the only difference between the control and the stathmin-inhibited cells is the deficiency of stathmin in the latter, the increased susceptibility of the stathmin-inhibited cells to okadaic acid-induced mitotic arrest implies a role for stathmin in the later stages of mitosis.	Mt Sinai Sch Med, Div Hematol, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Atweh, GF (corresponding author), Mt Sinai Sch Med, Div Hematol, Dept Med, 1 Gustave L Levy Pl,Box 1079, New York, NY 10029 USA.	george.atweh@mssm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054184] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54184] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; CARON JM, 1989, J CELL PHYSIOL, V138, P603, DOI 10.1002/jcp.1041380322; DOONAN JH, 1989, CELL, V57, P987, DOI 10.1016/0092-8674(89)90337-1; EICHHORN JH, 1979, J CELL BIOL, V82, P572, DOI 10.1083/jcb.82.2.572; ENGELHARD HH, 1991, CYTOMETRY, V12, P68, DOI 10.1002/cyto.990120110; GHOSH S, 1992, EXP CELL RES, V200, P215, DOI 10.1016/S0014-4827(05)80091-6; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; Howell B, 1999, J CELL SCI, V112, P3713; Jeha S, 1996, CANCER RES, V56, P1445; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; LUO XN, 1994, J BIOL CHEM, V269, P10312; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Mistry SJ, 1998, BIOCHEM J, V334, P23, DOI 10.1042/bj3340023; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; PICARD A, 1989, J CELL BIOL, V109, P3347, DOI 10.1083/jcb.109.6.3347; SCHONTHAL A, 1992, NEW BIOL, V4, P16; SEGER M, 1984, J LEUKOCYTE BIOL, V35, P303; VANDOLAH FM, 1992, J CELL PHYSIOL, V152, P190, DOI 10.1002/jcp.1041520124; VANDRE DD, 1992, J CELL SCI, V101, P79; ZHENG B, 1991, J BIOL CHEM, V266, P10031	26	47	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31209	31215		10.1074/jbc.M011654200	http://dx.doi.org/10.1074/jbc.M011654200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418586	hybrid			2022-12-27	WOS:000170472900082
J	Mornet, E; Stura, E; Lia-Baldini, AS; Stigbrand, T; Menez, A; Le Du, MH				Mornet, E; Stura, E; Lia-Baldini, AS; Stigbrand, T; Menez, A; Le Du, MH			Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFANTILE HYPOPHOSPHATASIA; LETHAL HYPOPHOSPHATASIA; MISSENSE MUTATION; GENE; CALCIUM; LOCALIZATION; MECHANISM	The human tissue nonspecific alkaline phosphatase (TNAP) is found in liver, kidney, and bone. Mutations in the TNAP gene can lead to Hypophosphatasia, a rare inborn disease that is characterized by defective bone mineralization. TNAP is 74% homologous to human placental alkaline phosphatase (PLAP) whose crystal structure has been recently determined at atomic resolution (Le Du, M. H., Stigbrand, T., Taussig, M. J., Menez, A., and Stura, E. A. (2001) J. Biol. Chem, 276,9158-9165). The degree of homology allowed us to build a reliable TNAP model to investigate the relationship between mutations associated with hypophosphatasia and their probable consequences on the activity or the structure of the enzyme. The mutations are clustered within five crucial regions, namely the active site and its vicinity, the active site valley, the homodimer interface, the crown domain, and the metal-binding site. The crown domain and the metal-binding domain are mammalian-specific and were observed for the first time in the PLAP structure. The crown domain contains a collagen binding loop. A synchrotron radiation x-ray fluorescence study confirms that the metal in the metal-binding site is a calcium ion. Several severe mutations in TNAP occur around this calcium site, suggesting that calcium may be of critical importance for the TNAP function. The presence of this extra metal-binding site gives new insights on the controversial role observed for calcium.	CE Saclay, CEA, DIEP, F-91191 Gif Sur Yvette, France; Umea Univ, Dept Immunol, Umea, Sweden; Univ Versailles, Ctr Etud Biol Prenatale, SESEP, F-78000 Versailles, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Umea University; UDICE-French Research Universities; Universite Paris Saclay	Le Du, MH (corresponding author), CE Saclay, CEA, DIEP, F-91191 Gif Sur Yvette, France.	mhledu@cea.fr	Stura, Enrico A./A-2793-2010	Stura, Enrico A./0000-0001-6718-2118				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAMBYNEK W, 1972, REV MOD PHYS, V44, P716, DOI 10.1103/RevModPhys.44.716; BOSSI M, 1993, J BIOL CHEM, V268, P25409; Cai GM, 1998, J CLIN ENDOCR METAB, V83, P3936, DOI 10.1210/jc.83.11.3936; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; DEBERNARD B, 1986, J CELL BIOL, V103, P1615, DOI 10.1083/jcb.103.4.1615; Fukushi M, 1998, BIOCHEM BIOPH RES CO, V246, P613, DOI 10.1006/bbrc.1998.8674; GENGE BR, 1988, J BIOL CHEM, V263, P18513; Goseki-Sone M, 1998, HUM MUTAT, pS263; GREENBERG CR, 1990, AM J HUM GENET, V46, P286; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Henke B. L., 1982, Atomic Data and Nuclear Data Tables, V27, P1, DOI 10.1016/0092-640X(82)90002-X; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; HOLYAERTS MF, 1991, BIOCHEM J, V274, P91; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; Hu JCC, 2000, EUR J ORAL SCI, V108, P189, DOI 10.1034/j.1600-0722.2000.108003189.x; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Leone FA, 1997, J INORG BIOCHEM, V68, P123, DOI 10.1016/S0162-0134(97)00047-0; MILLAN JL, 1995, CRIT REV CL LAB SCI, V32, P1, DOI 10.3109/10408369509084680; MILLAN JL, 1992, CLIN CHIM ACTA, V209, P123, DOI 10.1016/0009-8981(92)90343-O; MILLAN JL, 1988, ANTICANCER RES, V8, P995; Mochizuki H, 2000, EUR J PEDIATR, V159, P375, DOI 10.1007/s004310051290; Mornet E, 1998, EUR J HUM GENET, V6, P308, DOI 10.1038/sj.ejhg.5200190; ORIMO H, 1994, HUM MOL GENET, V3, P1683, DOI 10.1093/hmg/3.9.1683; Orimo H, 1997, GENOMICS, V42, P364, DOI 10.1006/geno.1997.4733; Ozono K, 1996, J CLIN ENDOCR METAB, V81, P4458, DOI 10.1210/jc.81.12.4458; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 2000, METH MOL B, V143, P97; SCHWARTZ JH, 1961, P NATL ACAD SCI USA, V47, P1996, DOI 10.1073/pnas.47.12.1996; Shibata H, 1998, J BIOCHEM-TOKYO, V123, P968; Shinozaki T, 1996, J RHEUMATOL, V23, P677; Sugimoto N, 1998, J HUM GENET, V43, P160, DOI 10.1007/s100380050061; Taillandier A, 2000, Hum Mutat, V15, P293, DOI 10.1002/(SICI)1098-1004(200003)15:3<293::AID-HUMU11>3.0.CO;2-Q; Taillandier A, 1999, Hum Mutat, V13, P171, DOI 10.1002/(SICI)1098-1004(1999)13:2<171::AID-HUMU16>3.0.CO;2-T; TAILLANDIER A, 2001, IN PRESS HUM MUTAT; WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Zurutuza L, 1999, HUM MOL GENET, V8, P1039, DOI 10.1093/hmg/8.6.1039	42	147	168	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31171	31178		10.1074/jbc.M102788200	http://dx.doi.org/10.1074/jbc.M102788200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11395499	hybrid			2022-12-27	WOS:000170472900077
J	Rivolta, I; Abriel, H; Tateyama, M; Liu, HH; Memmi, M; Vardas, P; Napolitano, C; Priori, SG; Kass, RS				Rivolta, I; Abriel, H; Tateyama, M; Liu, HH; Memmi, M; Vardas, P; Napolitano, C; Priori, SG; Kass, RS			Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ST-SEGMENT ELEVATION; NA+ CHANNEL; MOLECULAR MECHANISM; LQT-3 MUTATION; ALPHA-SUBUNIT; SCN5A; ARRHYTHMIA; DEATH; DIAGNOSIS; THERAPY	Defects of the SCN5A gene encoding the cardiac sodium channel a-subunit are associated with both the long,QT-3 (LQT-3) subtype of long-QT syndrome and Brugada syndrome (BrS). One previously described SCN5A mutation (1795insD) in the C terminus results in a clinical phenotype combining QT prolongation and ST segment elevation, indicating a close interrelationship between the two disorders. Here we provide additional evidence that these two disorders are closely related. We report the analysis of two novel mutations on the same codon, Y1795C (LQT-3) and Y1795H (BrS), expressed in HEK 293 cells and characterized using whole-cell patch clamp procedures. We find marked and opposing effects on channel gating consistent with activity associated with the cellular basis of each clinical disorder. Y1795H speeds and Y1795C slows the onset of inactivation. The Y1795H, but not the Y1795C, mutation causes a marked negative shift in the voltage dependence of inactivation, and neither mutation affects the kinetics of the recovery from inactivation. Interestingly, both mutations increase the expression of sustained Na+ channel activity compared with wild type (WT) channels, although this effect is most pronounced for the Y1795C mutation, and both mutations promote entrance into an intermediate or a slowly developing inactivated state. These data confirm the key role of the C-terminal tail of the cardiac Na+ channel in the control of channel gating, illustrate how subtle changes in channel biophysics can have significant and distinct effects in human disease, and, additionally, provide further evidence of the close interrelationship between BrS and LQT-3 at the molecular level.	Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; IRCCS, Fdn Salvatore Maugeri, Mol Cardiol Lab, Pavia, Italy; Heraklion Univ Hosp, Dept Cardiol, Stavrakia, Crete, Greece	Columbia University; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; University Hospital of Heraklion	Kass, RS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St,PH 7W 318, New York, NY 10032 USA.		napolitano, carlo/ABI-4608-2020; Vardas, Panos/AAD-5219-2022; Priori, Silvia G G/A-6116-2014; Vardas, Panos/AAP-5694-2021; vardas, panos/ABF-7144-2020; memmi, mirella/AAB-9428-2020; Abriel, Hugues/B-9800-2009; Priori, Silvia G/ABH-6894-2020; Napolitano, Carlo/K-4760-2016	napolitano, carlo/0000-0002-7643-4628; Priori, Silvia G G/0000-0001-6877-0288; memmi, mirella/0000-0003-4006-5661; Abriel, Hugues/0000-0003-0465-5138; Priori, Silvia G/0000-0001-6877-0288; Napolitano, Carlo/0000-0002-7643-4628	NHLBI NIH HHS [HL-568105-04] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; An RH, 1996, CIRC RES, V79, P103, DOI 10.1161/01.RES.79.1.103; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; Antzelevitch C, 1999, CURR OPIN CARDIOL, V14, P274, DOI 10.1097/00001573-199905000-00013; Baroudi G, 2000, FEBS LETT, V487, P224, DOI 10.1016/S0014-5793(00)02360-7; Benhorin J, 1998, Hum Mutat, V12, P72, DOI 10.1002/(SICI)1098-1004(1998)12:1<72::AID-HUMU17>3.0.CO;2-Z; BENNETT PB, 1993, FEBS LETT, V326, P21, DOI 10.1016/0014-5793(93)81752-L; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina C, 1999, CIRC RES, V85, P1206; Bezzina CR, 2001, CARDIOVASC RES, V49, P257, DOI 10.1016/S0008-6363(00)00272-8; Brugada P, 2000, HEART, V84, P1, DOI 10.1136/heart.84.1.1; Brugada P, 2000, Curr Cardiol Rep, V2, P507, DOI 10.1007/s11886-000-0035-0; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Clayton RH, 2001, J THEOR BIOL, V208, P215, DOI 10.1006/jtbi.2000.2212; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; Grant AO, 2001, AM J MED, V110, P296, DOI 10.1016/S0002-9343(00)00714-2; Gussak I, 1999, J AM COLL CARDIOL, V33, P5, DOI 10.1016/S0735-1097(98)00528-2; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Priori SG, 2000, J CARDIOVASC ELECTR, V11, P1174, DOI 10.1111/j.1540-8167.2000.tb01766.x; Priori SG, 2000, CIRCULATION, V102, P945, DOI 10.1161/01.CIR.102.9.945; Priori SG, 2000, CIRCULATION, V102, P2509, DOI 10.1161/01.CIR.102.20.2509; Priori SG, 2000, LANCET, V355, P808, DOI 10.1016/S0140-6736(99)05277-0; Rook MB, 1999, CARDIOVASC RES, V44, P507, DOI 10.1016/S0008-6363(99)00350-8; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Schwartz PJ, 2000, NEW ENGL J MED, V343, P262, DOI 10.1056/NEJM200007273430405; SCHWARTZ PJ, 1995, CIRCULATION, V92, P3381, DOI 10.1161/01.CIR.92.12.3381; Swan H, 1998, J AM COLL CARDIOL, V32, P486, DOI 10.1016/S0735-1097(98)00248-4; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wehrens XHT, 2000, CIRCULATION, V102, P584; Wei J, 1999, CIRCULATION, V99, P3165, DOI 10.1161/01.CIR.99.24.3165; Wilde AAM, 2000, EUR HEART J, V21, P1483, DOI 10.1053/euhj.2000.2231; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; Zhang L, 2000, CIRCULATION, V102, P2849	38	139	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30623	30630		10.1074/jbc.M104471200	http://dx.doi.org/10.1074/jbc.M104471200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11410597	hybrid			2022-12-27	WOS:000170472900007
J	Zaccaro, MC; Ivanisevic, L; Perez, P; Meakin, SO; Saragovi, HU				Zaccaro, MC; Ivanisevic, L; Perez, P; Meakin, SO; Saragovi, HU			p75 co-receptors regulate ligand-dependent and ligand-independent Trk receptor activation, in part by altering Trk docking subdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; IMMUNOGLOBULIN-LIKE DOMAINS; HUMAN INSULIN-RECEPTOR; FACTOR BINDING-SITE; LEUCINE-RICH MOTIF; NEUROTROPHIN RECEPTORS; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODIES; KINASE DOMAIN	Neurotrophins signal via Trk tyrosine kinase receptors and a common receptor called p75. Nerve growth factor is the cognate ligand for TrkA, brain-derived neurotrophic factor for TrkB, and neurotrophin-3 (NT-3) for TrkC. NT-3 also binds TrkA and TrkB as a heterologous ligand. All neurotrophins bind p75, which regulates ligand affinity and Trk signals. Trk extracellular domain has five subdomains: a leucine-rich motif, two cysteine-rich clusters, and immunoglobulin-like subdomains IgG-C1 and IgG-C2. The IgG-C1 subdomain is surface exposed in the tertiary structure and regulates ligand-independent activation. The IgG-C2 subdomain is less exposed but regulates cognate ligand binding and Trk activation. NT-3 as a heterologous ligand of TrkA and TrkB optimally requires the IgG-C2 but also binds other subdomains of these receptors. When p75 is co-expressed, major changes are observed; NGF-TrkA activation can occur also via the cysteine I subdomain, and brain-derived neurotrophic factor-TrkB activation requires the TrkB leucine-rich motif and cysteine 2 subdomains. We propose a two-site model of Trk binding and activation, regulated conformationally by the IgG-C1 subdomain. Moreover, p75 affects Trk subdomain utilization in ligand-dependent activation, possibly by conformational or allosteric control.	McGill Univ, Montreal, PQ H3G 1Y6, Canada; Univ Salamanca, Salamanca 37007, Spain; John P Robarts Res Inst, London, ON N6A 5K8, Canada	McGill University; University of Salamanca; Western University (University of Western Ontario)	Zaccaro, MC (corresponding author), McGill Univ, 3655 Drummond St 1320, Montreal, PQ H3G 1Y6, Canada.		Meakin, Susan/K-8823-2013; Perez, Pilar/B-4948-2010	Meakin, Susan/0000-0003-2469-6615; Perez, Pilar/0000-0003-3557-2247				Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; COULIER F, 1990, MOL CELL BIOL, V10, P4202, DOI 10.1128/MCB.10.8.4202; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; EIDE FF, 1993, EXP NEUROL, V121, P200, DOI 10.1006/exnr.1993.1087; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Holden PH, 1997, NAT BIOTECHNOL, V15, P668, DOI 10.1038/nbt0797-668; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Kadari A, 1997, J NEUROSCI RES, V50, P402; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kohn J, 1999, J NEUROSCI, V19, P5393; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; MacDonald JIS, 1996, MOL CELL NEUROSCI, V7, P371, DOI 10.1006/mcne.1996.0027; MacPhee IJ, 1997, J BIOL CHEM, V272, P23547, DOI 10.1074/jbc.272.38.23547; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; MORGAN DO, 1986, BIOCHEMISTRY-US, V25, P1364, DOI 10.1021/bi00354a026; Mufson EJ, 1997, EXP NEUROL, V146, P91, DOI 10.1006/exnr.1997.6504; Ninkina N, 1997, J BIOL CHEM, V272, P13019, DOI 10.1074/jbc.272.20.13019; PEREZ P, 1995, MOL CELL NEUROSCI, V6, P97, DOI 10.1006/mcne.1995.1010; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Saragovi HU, 1999, EXPERT OPIN THER PAT, V9, P737, DOI 10.1517/13543776.9.6.737; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; SARAGOVI HU, 1992, BIO-TECHNOL, V10, P773, DOI 10.1038/nbt0792-773; SCHNEIDER R, 1991, ONCOGENE, V6, P1807; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Urfer R, 1998, J BIOL CHEM, V273, P5829, DOI 10.1074/jbc.273.10.5829; URFER R, 1995, EMBO J, V14, P2795, DOI 10.1002/j.1460-2075.1995.tb07279.x; Wells JA, 1996, SCIENCE, V273, P449, DOI 10.1126/science.273.5274.449; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WINDISCH JM, 1995, BIOCHEMISTRY-US, V34, P11256, DOI 10.1021/bi00035a035; WINDISCH JM, 1995, J BIOL CHEM, V270, P28133; Woo SB, 1998, PROTEIN SCI, V7, P1006	39	79	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31023	31029		10.1074/jbc.M104630200	http://dx.doi.org/10.1074/jbc.M104630200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11425862	hybrid			2022-12-27	WOS:000170472900058
J	Sheridan, AM; Sapirstein, A; Lemieux, N; Martin, BD; Kim, DK; Bonventre, JV				Sheridan, AM; Sapirstein, A; Lemieux, N; Martin, BD; Kim, DK; Bonventre, JV			Nuclear translocation of cytosolic phospholipase A(2) is induced by ATP depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ARACHIDONIC-ACID RELEASE; PROXIMAL TUBULAR CELLS; RENAL EPITHELIAL-CELLS; INTRACELLULAR PH; MDCK-CELLS; PHOSPHORYLATION SITES; INDUCED CYTOTOXICITY; MESANGIAL CELLS; CHEMICAL ANOXIA	Phospholipase A(2) (PLA(2)) enzymes may play a role in cellular injury due to ATP depletion. Renal Madin-Darby canine kidney cells were subjected to ATP depletion to assess the effects of cellular energy metabolism on cytosolic PLA(2) (cPLA(2)) regulation. ATP depletion results in a decrease in soluble cPLA2 activity and an increase in membrane-associated activity, which is reversed upon restoration of ATP levels by addition of dextrose. In ATP-depleted cells cPLA(2) mass shifts from cytosol to nuclear fractions. GFP-cPLA(2) is localized at the nuclear membrane of stably transfected ATP-depleted LLC-PK1 cells under conditions where [Ca2+](i) is known to increase. ePLA(2) translocation does not occur if the increase in [Ca2+](i) increase is inhibited. If [Ca2+](i) is allowed to increase when ATP is depleted and the cells are then lysed, cPLA2 remains associated with nuclear fractions even if the homogenate [Ca2+] is markedly reduced. In contrast, ePL(A)2, which becomes associated with the nucleus when [Ca2+], is increased using ionophore, readily dissociates from the nuclear fractions of ATP-replete cells upon reduction of homogenate [Ca2+]. Okadaic acid inhibits the ATP depletion-induced association of cPLA(2) with nuclear fractions. Thus energy deprivation results in [Ca2+]-induced nuclear translocation, which is partially prevented by a phosphatase inhibitor.	Massachusetts Gen Hosp, Med Serv, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Anesthesia Serv, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Anesthesia, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Sheridan, AM (corresponding author), Massachusetts Gen Hosp, Med Serv, 149-4002 13th Str, Charlestown, MA 02129 USA.	asheridan@partners.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039773, P01DK038452, K08DK002356, R37DK039773, R56DK054741, R01DK054741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS010828, P01NS010828] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 54741, DK 39773, DK 38452, DK 02356] Funding Source: Medline; NINDS NIH HHS [NS 10828] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BONVENTRE JV, 1992, J AM SOC NEPHROL, V3, P128; CARDELL M, 1990, NEUROSCI LETT, V119, P228, DOI 10.1016/0304-3940(90)90840-6; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987, DOI 10.1074/jbc.271.12.6987; DOLE VP, 1960, J BIOL CHEM, V235, P2595; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GRONICH JH, 1990, BIOCHEM J, V271, P37, DOI 10.1042/bj2710037; GRONICH JH, 1988, J BIOL CHEM, V263, P16645; HAJJAR RJ, 1991, J BIOL CHEM, V266, P21589; HAYAKAWA M, 1993, J BIOL CHEM, V268, P11290; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Jorgensen NK, 1999, J NEUROSCI RES, V56, P358; KIM DK, 1993, BIOCHEM J, V294, P261, DOI 10.1042/bj2940261; Klivenyi P, 1998, J NEUROCHEM, V71, P2634; KOBRYN CE, 1994, AM J PHYSIOL-CELL PH, V267, pC1073, DOI 10.1152/ajpcell.1994.267.4.C1073; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; KRAMER RM, 1995, J BIOL CHEM, V270, P14816, DOI 10.1074/jbc.270.24.14816; KROSHIAN VM, 1994, AM J PHYSIOL, V266, pF21, DOI 10.1152/ajprenal.1994.266.1.F21; Lieberthal W, 1997, J LAB CLIN MED, V129, P260, DOI 10.1016/S0022-2143(97)90148-7; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; MCCOY CE, 1988, J CLIN INVEST, V82, P1326, DOI 10.1172/JCI113734; NAKAMURA H, 1991, J CLIN INVEST, V87, P1810, DOI 10.1172/JCI115202; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Pickard RT, 1996, J BIOL CHEM, V271, P19225, DOI 10.1074/jbc.271.32.19225; PORTILLA D, 1992, AM J PHYSIOL, V262, pF354, DOI 10.1152/ajprenal.1992.262.3.F354; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; QIU ZH, 1993, J BIOL CHEM, V268, P24506; QIU ZH, 1994, J BIOL CHEM, V269, P19480; ROSSOMANDO EF, 1990, METHOD ENZYMOL, V182, P309; Sapirstein A, 1996, J BIOL CHEM, V271, P21505, DOI 10.1074/jbc.271.35.21505; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SELVAGGIO AM, 1986, AM J PHYSIOL, V251, pC558, DOI 10.1152/ajpcell.1986.251.4.C558; Sheridan AM, 1996, KIDNEY INT, V49, P88, DOI 10.1038/ki.1996.12; Sheridan AM, 2001, MOL CELL BIOL, V21, P4470, DOI 10.1128/MCB.21.14.4470-4481.2001; Sheridan AM, 2000, CURR OPIN NEPHROL HY, V9, P427, DOI 10.1097/00041552-200007000-00015; SHERIDAN AM, 1993, AM J PHYSIOL, V265, pF342, DOI 10.1152/ajprenal.1993.265.3.F342; Tapia R, 1999, NEUROCHEM RES, V24, P1423, DOI 10.1023/A:1022588808260; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; VENKATACHALAM MA, 1988, J CLIN INVEST, V81, P745, DOI 10.1172/JCI113380; VoelkelJohnson C, 1996, J IMMUNOL, V156, P201; XU XX, 1994, J BIOL CHEM, V269, P31693	51	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29899	29905		10.1074/jbc.M103758200	http://dx.doi.org/10.1074/jbc.M103758200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395512	hybrid			2022-12-27	WOS:000170558000040
J	Vallin, J; Thuret, R; Giacomello, E; Faraldo, MM; Thiery, JP; Broders, F				Vallin, J; Thuret, R; Giacomello, E; Faraldo, MM; Thiery, JP; Broders, F			Cloning and characterization of three Xenopus Slug promoters reveal direct regulation by Lef/beta-catenin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CREST CELLS; GENE-EXPRESSION; SNAIL FAMILY; FACTOR-BETA; INDUCTION; MIGRATION; RNA; IDENTIFICATION; MESENDODERM; SEQUENCES	In amphibians and birds, one of the first steps of neural crest cell (NCC) determination is expression of the transcription factor Slug. This marker has been used to demonstrate that BMP and Writ molecules play a major role in NCC induction. However, it is unknown whether Slug expression is directly or indirectly regulated by these signals. We report here the cloning and characterization of three Xenopus Slug promoters: that of the Xenopus tropicalis slug gene and those of two Xenopus laevis Slug pseudoalleles. Although the three genes encode proteins with almost identical amino acid sequences and are expressed with similar spatiotemporal patterns, their 5'-flanking regions are quite different. A striking difference is a deletion in the X. tropicalis gene located precisely at the transcription initiation site that results in the X.tropicalis promoter being inefficient in X. laevis. Additionally, we identified two regions common to the three promoters that are necessary and sufficient to drive specific expression in NCCs. Interestingly, one of the common regulatory regions presents a functional Lef/beta -catenin-binding site necessary for specific expression. As the Lef.beta -catenin complex is a downstream effector of Wnt signaling, these results suggest that Xenopus Slug is a direct, target of NGC determination signals.	Inst Curie, CNRS, UMR 144, Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Vallin, J (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, Paris 05, France.		Thiery, Jean Paul/M-9387-2019; Martin-Faraldo, Maria-Luisa/M-5811-2018; Giacomello, Emiliana/E-3080-2018; Thiery, Jean Paul/H-1550-2011	Faraldo, Marisa/0000-0001-9497-1171; Giacomello, Emiliana/0000-0003-3329-6269; Thiery, Jean Paul/0000-0003-0478-5020				Borchers A, 2000, DEV GENES EVOL, V210, P217, DOI 10.1007/s004270050307; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Carl TF, 1999, DEV BIOL, V213, P101, DOI 10.1006/dbio.1999.9320; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; DESA RO, 1990, MOL BIOL EVOL, V7, P365; ESSEX LJ, 1993, DEV DYNAM, V198, P108, DOI 10.1002/aja.1001980205; Faber J., 1994, NORMAL TABLE XENOPUS, P2; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HO L, 1994, MECH DEVELOP, V47, P53, DOI 10.1016/0925-4773(94)90095-7; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jiang RL, 1998, BBA-GENE STRUCT EXPR, V1443, P251, DOI 10.1016/S0167-4781(98)00225-5; KLOC M, 1993, SCIENCE, V262, P1712, DOI 10.1126/science.7505061; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 1999, NEURAL CREST, V2; Linker C, 2000, DEV BIOL, V224, P215, DOI 10.1006/dbio.2000.9723; Mancilla A, 1996, DEV BIOL, V177, P580, DOI 10.1006/dbio.1996.0187; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; Mayor R, 2000, MECH DEVELOP, V97, P47, DOI 10.1016/S0925-4773(00)00412-3; Mayor R, 1997, DEV BIOL, V189, P1, DOI 10.1006/dbio.1997.8634; MAYOR R, 1995, DEVELOPMENT, V121, P767; NIETO MA, 1992, DEVELOPMENT, V116, P227; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; SARGENT MG, 1990, DEVELOPMENT, V109, P967; Sefton M, 1998, DEVELOPMENT, V125, P3111; SIVE HL, 2000, EARLY DEV XENOPUS LA; SMITH DE, 1992, DEVELOPMENT, V116, P1038; STALDER J, 1988, J MOL EVOL, V28, P64, DOI 10.1007/BF02143498; Stegmann K, 1999, MUTAT RES-GENOMICS, V406, P63, DOI 10.1016/S1383-5726(99)00002-3; THISSE C, 1995, DEV BIOL, V172, P86, DOI 10.1006/dbio.1995.0007; TSUJIMURA A, 1995, BIOCHEM BIOPH RES CO, V214, P432, DOI 10.1006/bbrc.1995.2305; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630	37	140	145	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30350	30358		10.1074/jbc.M103167200	http://dx.doi.org/10.1074/jbc.M103167200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402039	Green Published, hybrid			2022-12-27	WOS:000170558000098
J	Qi, JF; Isupov, MN; Littlechild, JA; Anderson, LE				Qi, JF; Isupov, MN; Littlechild, JA; Anderson, LE			Chloroplast glyceraldehyde-3-phosphate dehydrogenase contains a single disulfide bond located in the C-terminal extension to the B subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADP-MALATE DEHYDROGENASE; CALVIN CYCLE ACTIVITY; CYSTEINE RESIDUES; CHEMICAL CLEAVAGE; LIGHT REGULATION; REDOX REGULATION; STRUCTURAL BASIS; ENZYME; PROTEINS; MODULATION	Mass mapping analysis based on cyanylation and CN-induced cleavage indicates that the two cysteine residues in the C-terminal extension of the B subunit of the light-activated pea leaf chloroplast glyceraldehyde-3-phosphate dehydrogenase form a disulfide bond. No evidence was found for a disulfide bond in the A subunit, nor was there any indication of a second disulfide bond in the B subunit. The availability of the structure of the extended glyceraldehyde-3-phosphate dehydrogenase from the archaeon Sulfolobus solfataricus allows modeling of the B subunit. As modeled, the two cysteine residues in the extension are positioned to form an interdomain disulfide cross-link.	Univ Illinois, Dept Biol Sci MC 066, Chicago, IL 60607 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Univ Exeter, Sch Chem Sci, Exeter EX4 4QG, Devon, England; Univ Exeter, Sch Biol Sci, Exeter EX4 4QG, Devon, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Michigan State University; University of Exeter; University of Exeter	Anderson, LE (corresponding author), Univ Illinois, Dept Biol Sci MC 066, 845 W Taylor St, Chicago, IL 60607 USA.	louise@uic.edu	Isupov, Mikhail/AAA-8280-2019; Littlechild, Jenny/AAE-4096-2020	Isupov, Michail/0000-0001-6842-4289				ANDERSON LE, 1986, ADV BOT RES, V12, P1, DOI 10.1016/S0065-2296(08)60192-5; ANDERSON LE, 1995, PLANTA, V196, P245; Baalmann E, 1996, PLANT MOL BIOL, V32, P505, DOI 10.1007/BF00019102; Buchanan BB, 1980, ANNU REV PLANT PHYS, V288, P1; CAREAGA CL, 1995, BIOCHEMISTRY-US, V34, P3048, DOI 10.1021/bi00009a036; Carr PD, 1999, STRUCTURE, V7, P461, DOI 10.1016/S0969-2126(99)80058-6; Chiadmi M, 1999, EMBO J, V18, P6809, DOI 10.1093/emboj/18.23.6809; Fleming TM, 1998, ACTA CRYSTALLOGR D, V54, P671, DOI 10.1107/S0907444997018076; HILBERT M, 1993, PROTEINS, V17, P138, DOI 10.1002/prot.340170204; Hutchison RS, 2000, BIOCHEMISTRY-US, V39, P6679, DOI 10.1021/bi0001978; Isupov MN, 1999, J MOL BIOL, V291, P651, DOI 10.1006/jmbi.1999.3003; JACOBSON GR, 1973, J BIOL CHEM, V248, P6583; Jacquot JP, 1997, FEBS LETT, V401, P143, DOI 10.1016/S0014-5793(96)01459-7; Johansson K, 1999, BIOCHEMISTRY-US, V38, P4319, DOI 10.1021/bi982876c; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li AD, 1997, PHOTOSYNTH RES, V51, P167; Li AD, 1997, PLANT PHYSIOL, V115, P1201, DOI 10.1104/pp.115.3.1201; LI D, 1994, BIOPHYS J, V67, P29, DOI 10.1016/S0006-3495(94)80484-9; Muslin EH, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P3583; Qi JF, 2001, BIOCHEMISTRY-US, V40, P4531, DOI 10.1021/bi002229x; SKARZYNSKI T, 1987, J MOL BIOL, V193, P171, DOI 10.1016/0022-2836(87)90635-8; SKARZYNSKI T, 1988, J MOL BIOL, V203, P1097, DOI 10.1016/0022-2836(88)90130-1; WAKSELMAN M, 1976, J CHEM SOC CHEM COMM, P21, DOI 10.1039/c39760000021; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; Wu J, 1998, ANAL BIOCHEM, V258, P268, DOI 10.1006/abio.1998.2596; Wu J, 1996, ANAL BIOCHEM, V235, P161, DOI 10.1006/abio.1996.0108	27	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2001	276	38					35247	35252		10.1074/jbc.M103855200	http://dx.doi.org/10.1074/jbc.M103855200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474LU	11438534	hybrid			2022-12-27	WOS:000171109300007
J	Gyles, SL; Burns, CJ; Whitehouse, BJ; Sugden, D; Marsh, PJ; Persaud, SJ; Jones, PM				Gyles, SL; Burns, CJ; Whitehouse, BJ; Sugden, D; Marsh, PJ; Persaud, SJ; Jones, PM			ERKs regulate cyclic AMP-induced steroid synthesis through transcription of the steroidogenic acute regulatory (StAR) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-I; GRANULOSA-CELLS; ANGIOTENSIN-II; MESSENGER-RNA; EXPRESSION; HORMONE; INHIBITOR; RECEPTORS; PHOSPHORYLATION	Cyclic AMP-dependent expression of the steroidogenic acute regulatory (StAR) protein is thought to be the controlling step for steroid production, but the mechanisms through which external signals are translated into increased transcription of the StAR gene are unknown. We demonstrate that cyclic AMP-induced steroid synthesis is dependent upon the phosphorylation and activation of ERKs and that ERK activation results in enhanced phosphorylation of SF-1 and increased steroid production through increased transcription of the StAR gene. Adenylate cyclase activation with forskolin (FSK) caused a time-dependent increase in ERK activity and translocation from cytoplasm to nucleus, which correlated with an increase in StAR mRNA levels, StAR protein accumulation, and steroidogenesis. Similarly, ERK inhibition led to a reduction in the levels of FSK-stimulated StAR mRNA, StAR protein, and steroid secretion. These effects were attributed to the finding that ERK activity is required for SF-1 phosphorylation, a transcription factor required for the regulation of StAR gene transcription. This conclusion was supported by our demonstration of an ERK-dependent increase in the binding of SF-1 from FSK-treated Y1 nuclei to three consensus double-stranded DNA sequences from the StAR promoter region. These observations suggest that the activation of ERK2/1 by increasing cAMP is an obligatory and regulated stage in the stimulation of steroid synthesis by cyclic AMP-generating stimuli.	Kings Coll London, GKT Sch Biomed Sci, Endocrinol & Reprod Res Grp, London SE1 1UL, England; Kings Coll London, GKT Sch Biomed Sci, Randall Ctr, London SE1 1UL, England	University of London; King's College London; University of London; King's College London	Jones, PM (corresponding author), Kings Coll London, GKT Sch Biomed Sci, Endocrinol & Reprod Res Grp, New Hunts House,3rd Fl N, London SE1 1UL, England.	peter.jones@kcl.ac.uk	Burns, Chris/D-9161-2013; Persaud, Shanta/AAH-3200-2021	Persaud, Shanta/0000-0002-4933-5958; Jones, Peter/0000-0003-1201-2335				AGUILERA G, 1980, ENDOCRINOLOGY, V107, P55, DOI 10.1210/endo-107-1-55; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ASCOLI M, 1981, J BIOL CHEM, V256, P179; Bose HS, 2000, J CLIN ENDOCR METAB, V85, P3636, DOI 10.1210/jc.85.10.3636; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns CJ, 2000, BIOCHEM BIOPH RES CO, V273, P35, DOI 10.1006/bbrc.2000.2890; Cameron MR, 1996, BIOL REPROD, V55, P111, DOI 10.1095/biolreprod55.1.111; Carlone DL, 1997, J STEROID BIOCHEM, V61, P223, DOI 10.1016/S0960-0760(97)80016-7; Caron KM, 1997, MOL ENDOCRINOL, V11, P138, DOI 10.1210/me.11.2.138; Christenson LK, 1998, J BIOL CHEM, V273, P30729, DOI 10.1074/jbc.273.46.30729; Christenson LK, 2000, BBA-MOL CELL BIOL L, V1529, P175, DOI 10.1016/S1388-1981(00)00147-5; Clark BJ, 1997, ENDOCRINOLOGY, V138, P4893, DOI 10.1210/en.138.11.4893; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; COOKE BA, 1990, MOL CELL ENDOCRINOL, V69, pC11, DOI 10.1016/0303-7207(90)90081-I; Das S, 1996, ENDOCRINOLOGY, V137, P967, DOI 10.1210/en.137.3.967; DEWI DA, 2000, J ENDOCRINOL, V167, p3C17; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Force T, 1998, HYPERTENSION, V31, P152, DOI 10.1161/01.HYP.31.1.152; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Jacob AL, 1998, J BIOL CHEM, V273, P13391, DOI 10.1074/jbc.273.22.13391; Jones PM, 2000, J MOL ENDOCRINOL, V24, P233, DOI 10.1677/jme.0.0240233; Kang SK, 2001, ENDOCRINOLOGY, V142, P671, DOI 10.1210/en.142.2.671; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Liu J, 1996, J ENDOCRINOL, V150, P43, DOI 10.1677/joe.0.1500043; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; Lotfi CFP, 2000, ENDOCR RES, V26, P873, DOI 10.3109/07435800009048611; Lotfi CFP, 1997, J BIOL CHEM, V272, P29886, DOI 10.1074/jbc.272.47.29886; Lotfi CFP, 2000, BRAZ J MED BIOL RES, V33, P1133, DOI 10.1590/S0100-879X2000001000002; Nalbant D, 1998, ENDOCRINOLOGY, V139, P272, DOI 10.1210/en.139.1.272; PARISSENTI AM, 1993, MOL ENDOCRINOL, V7, P283, DOI 10.1210/me.7.2.283; POTTS GO, 1978, STEROIDS, V32, P257, DOI 10.1016/0039-128X(78)90010-7; Reinhart AJ, 1999, MOL ENDOCRINOL, V13, P729, DOI 10.1210/me.13.5.729; Reyland ME, 2000, J BIOL CHEM, V275, P36637, DOI 10.1074/jbc.M006456200; Sandhoff TW, 1998, ENDOCRINOLOGY, V139, P4820, DOI 10.1210/en.139.12.4820; Schimmer B P, 1979, Methods Enzymol, V58, P570; SCHIMMER BP, 1981, FUNCTIONALLY DIFFERE, P61; Seger R, 2001, J BIOL CHEM, V276, P13957, DOI 10.1074/jbc.M006852200; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SIROIS J, 1993, J BIOL CHEM, V268, P21931; Stocco DM, 2000, BBA-MOL CELL BIOL L, V1486, P184, DOI 10.1016/S1388-1981(00)00056-1; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Stocco DM, 2000, NAT STRUCT BIOL, V7, P445, DOI 10.1038/75834; Stocco DM, 1998, REV REPROD, V3, P82, DOI 10.1530/ror.0.0030082; Sugawara T, 2000, ENDOCRINOLOGY, V141, P2895, DOI 10.1210/en.141.8.2895; SUGAWARA T, 1995, P NATL ACAD SCI USA, V92, P4778, DOI 10.1073/pnas.92.11.4778; Tai CJ, 2001, J CLIN ENDOCR METAB, V86, P375, DOI 10.1210/jc.86.1.375; Wang XJ, 2000, J BIOL CHEM, V275, P20204, DOI 10.1074/jbc.M003113200; Watanabe G, 1996, J BIOL CHEM, V271, P22570, DOI 10.1074/jbc.271.37.22570; Watanabe G, 1997, J BIOL CHEM, V272, P20063, DOI 10.1074/jbc.272.32.20063; WONG M, 1989, J BIOL CHEM, V264, P12867; Wooton-Kee CR, 2000, ENDOCRINOLOGY, V141, P1345, DOI 10.1210/en.141.4.1345; Yarwood SJ, 1996, BIOCHEM BIOPH RES CO, V224, P734, DOI 10.1006/bbrc.1996.1092; Zenkert S, 2000, EUR J ENDOCRINOL, V142, P294, DOI 10.1530/eje.0.1420294; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147	55	149	153	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34888	34895		10.1074/jbc.M102063200	http://dx.doi.org/10.1074/jbc.M102063200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11410589	hybrid			2022-12-27	WOS:000171024600073
J	Nix, DA; Fradelizi, J; Bockholt, S; Menichi, B; Louvard, D; Friederich, E; Beckerle, MC				Nix, DA; Fradelizi, J; Bockholt, S; Menichi, B; Louvard, D; Friederich, E; Beckerle, MC			Targeting of zyxin to sites of actin membrane interaction and to the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; CYSTEINE-RICH PROTEIN; LIM DOMAIN; LISTERIA-MONOCYTOGENES; FOCAL ADHESION; ALPHA-ACTININ; GENE-EXPRESSION; ENA/VASP FAMILY; CELL-ADHESION; BETA-CATENIN	The localization of proteins to particular intracellular compartments often regulates their functions. Zyxin is a LIM protein found prominently at sites of cell adhesion, faintly in leading lamellipodia, and transiently in cell nuclei. Here we have performed a domain analysis to identify regions in zyxin that are responsible for targeting it to different subcellular locations. The N-terminal proline-rich region of zyxin, which harbors binding sites for alpha -actinin and members of the Ena/VASP family, concentrates in lamellipodial extensions and weakly in focal adhesions. The LIM region of zyxin displays robust targeting to focal adhesions. When overexpressed in cells, the LIM region of zyxin causes displacement of endogenous zyxin from focal adhesions. Upon mislocalization of full-length zyxin, at least one member of the Ena/VASP family is also displaced, and the organization of the actin cytoskeleton is perturbed. Zyxin also has the capacity to shuttle between the nucleus and focal adhesion sites. When nuclear export is inhibited, zyxin accumulates in cell nuclei. The nuclear accumulation of zyxin occurs asynchronously with approximately half of the cells exhibiting nuclear localization of zyxin within 2.3 h of initiating leptomycin B treatment. Our results provide insight into the functions of different zyxin domains.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Inst Curie, Lab Morphogenesis & Cellular Signaling, CNRS, UMR 144, F-75248 Paris, France	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Beckerle, MC (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050877] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM050877, GM50877] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Aplin AE, 1998, PHARMACOL REV, V50, P197; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; ASHAR HR, 1995, CELL, V82, P57; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; BECKERLE MC, 1986, J CELL BIOL, V103, P1679, DOI 10.1083/jcb.103.5.1679; Beckerle MC, 1998, CELL, V95, P741, DOI 10.1016/S0092-8674(00)81697-9; BENDORI R, 1989, J CELL BIOL, V108, P2383, DOI 10.1083/jcb.108.6.2383; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; CARY LA, 1999, FRONT BIOSCI, V4, P102; CRAWFORD AW, 1991, J BIOL CHEM, V266, P5847; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Drees BE, 1999, J CELL BIOL, V147, P1549, DOI 10.1083/jcb.147.7.1549; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fradelizi J, 1999, BIOTECHNIQUES, V26, P484; Geese M, 2000, J CELL SCI, V113, P1415; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Golsteyn RM, 1997, J CELL SCI, V110, P1893; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; LIEBL EC, 1992, ONCOGENE, V7, P2417; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; Macalma T, 1996, J BIOL CHEM, V271, P31470, DOI 10.1074/jbc.271.49.31470; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; MCCLURE DB, 1982, GROWTH CELLS HORMONA, P345; MEIGS JB, 1986, J CELL BIOL, V102, P1430, DOI 10.1083/jcb.102.4.1430; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NUCKOLLS GH, 1990, J CELL BIOL, V110, P1635, DOI 10.1083/jcb.110.5.1635; PAINE PL, 1972, EXP CELL RES, V74, P81, DOI 10.1016/0014-4827(72)90483-1; PEREZALVARADO GC, 1994, NAT STRUCT BIOL, V1, P388, DOI 10.1038/nsb0694-388; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Purich DL, 1997, BIOCHEM BIOPH RES CO, V231, P686, DOI 10.1006/bbrc.1997.6158; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Stronach BE, 1996, J CELL BIOL, V134, P1179, DOI 10.1083/jcb.134.5.1179; Thomas SM, 1999, J CELL SCI, V112, P181; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yao X, 1999, BIOCHEMISTRY-US, V38, P5701, DOI 10.1021/bi982036y; Yi JS, 1998, GENOMICS, V49, P314, DOI 10.1006/geno.1998.5248; Zeile WL, 1998, P NATL ACAD SCI USA, V95, P13917, DOI 10.1073/pnas.95.23.13917; Zhao MK, 1999, GENE EXPRESSION, V8, P207	57	117	121	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34759	34767		10.1074/jbc.M102820200	http://dx.doi.org/10.1074/jbc.M102820200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11395501	hybrid			2022-12-27	WOS:000171024600057
J	Barnakov, AN; Barnakova, LA; Hazelbauer, GL				Barnakov, AN; Barnakova, LA; Hazelbauer, GL			Location of the receptor-interaction site on CheB, the methylesterase response regulator of bacterial chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; COVALENT MODIFICATION; SENSORY TRANSDUCER; ASPARTATE RECEPTOR; PROTEIN METHYLTRANSFERASE; FLAGELLAR SWITCH; DOCKING SITE; GENE-PRODUCT; METHYLATION	Sensory adaptation in bacterial chemotaxis is mediated by covalent modification of chemoreceptors, specifically methylation and demethylation of glutamates catalyzed by methyltransferase CheR and methylesterase CheB. The methylesterase is a two-domain response regulator in which phosphorylation of the regulatory domain enhances activity of the catalytic domain. In Escherichia coli and Salmonella typhimurium, a crucial determinant of efficient methylation and demethylation is a specific pentapeptide sequence at the chemoreceptor carboxyl terminus, a position distant from sites of enzymatic action. Each enzyme binds pentapeptide, but the site of binding has been located only for CheR. Here we locate the pentapeptide-binding site on CheB by assessing catalytic activity and pentapeptide binding of CheB fragments, protection of CheB from proteolysis by pentapeptide, and interference with pentapeptide-CheB interaction by a CheB segment. The results place the binding site near the hinge between regulatory and catalytic domains, in a segment spanning the carboxyl-terminal end of the regulatory domain and the beginning of the linker that stretches to the catalytic domain. This location is quite different from the catalytic domain location of the pentapeptide-binding site on CheR and is likely to reflect the rather different ways in which pentapeptide binding enhances enzymatic action for the methyltransferase and the methylesterase.	Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Hazelbauer, GL (corresponding author), Univ Missouri, Dept Biochem, 117 Schweitzer Hall, Columbia, MO 65211 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029963] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29963] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand GS, 2000, PROTEIN SCI, V9, P898, DOI 10.1110/ps.9.5.898; BARAK R, 1992, BIOCHEMISTRY-US, V31, P10099, DOI 10.1021/bi00156a033; Barnakov AN, 1999, P NATL ACAD SCI USA, V96, P10667, DOI 10.1073/pnas.96.19.10667; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; BORKOVICH KA, 1989, P NATL ACAD SCI USA, V86, P1208, DOI 10.1073/pnas.86.4.1208; Djordjevic S, 1998, NAT STRUCT BIOL, V5, P446, DOI 10.1038/nsb0698-446; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Feng XH, 1999, J BACTERIOL, V181, P3164, DOI 10.1128/JB.181.10.3164-3171.1999; Feng XH, 1997, J BACTERIOL, V179, P6714, DOI 10.1128/jb.179.21.6714-6720.1997; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; HAZELBAUER GL, 1989, P NATL ACAD SCI USA, V86, P1448, DOI 10.1073/pnas.86.5.1448; HAZELBAUER GL, 1980, NATURE, V283, P98, DOI 10.1038/283098a0; HAZELBAUER GL, 1999, ENCY NEUROSCIENCE, P181; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; Hughes CA, 2001, J MOL BIOL, V307, P967, DOI 10.1006/jmbi.2001.4523; Jasuja R, 1999, BIOPHYS J, V76, P1706, DOI 10.1016/S0006-3495(99)77329-7; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; Kim C, 2001, J MOL BIOL, V307, P119, DOI 10.1006/jmbi.2000.4389; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; LeMoual H, 1997, BIOCHEMISTRY-US, V36, P13441, DOI 10.1021/bi9713207; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; NINFA EG, 1991, J BIOL CHEM, V266, P9764; NOWLIN DM, 1988, PROTEINS, V3, P102, DOI 10.1002/prot.340030205; NOWLIN DM, 1987, J BIOL CHEM, V262, P6039; Okumura H, 1998, J BACTERIOL, V180, P1862, DOI 10.1128/JB.180.7.1862-1868.1998; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RICE MS, 1991, J BIOL CHEM, V266, P9746; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; SHAPIRO MJ, 1995, P NATL ACAD SCI USA, V92, P1053, DOI 10.1073/pnas.92.4.1053; SIMMS SA, 1985, J BIOL CHEM, V260, P161; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; SPRINGER WR, 1977, P NATL ACAD SCI USA, V74, P533, DOI 10.1073/pnas.74.2.533; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; TERWILLIGER TC, 1986, J BIOL CHEM, V261, P814; TERWILLIGER TC, 1986, P NATL ACAD SCI USA, V83, P6707, DOI 10.1073/pnas.83.18.6707; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; Weerasuriya S, 1998, J BACTERIOL, V180, P914, DOI 10.1128/JB.180.4.914-920.1998; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; YAMAMOTO K, 1990, J BACTERIOL, V172, P383, DOI 10.1128/JB.172.1.383-388.1990; 2000, LIFE SCI NEWS, V6, P10	46	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32984	32989		10.1074/jbc.M105925200	http://dx.doi.org/10.1074/jbc.M105925200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435446	hybrid			2022-12-27	WOS:000170746000082
J	Daiho, T; Yamasaki, K; Saino, T; Kamidochi, M; Satoh, K; Iizuka, H; Suzuki, H				Daiho, T; Yamasaki, K; Saino, T; Kamidochi, M; Satoh, K; Iizuka, H; Suzuki, H			Mutations of either or both Cys(876) and Cys(888) residues of sarcoplasmic reticulum Ca2+-ATPase result in a complete loss of Ca2+ transport activity without a loss of Ca2+-dependent ATPase activity - Role of the Cys(876)-Cys(888) disulfide bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR LINKED FUNCTIONS; SITE-DIRECTED MUTAGENESIS; AMINO-ACID-SEQUENCE; ADENOSINE-TRIPHOSPHATASE; MOLECULAR-CLONING; SKELETAL-MUSCLE; PHOSPHOENZYME INTERMEDIATE; INORGANIC-PHOSPHATE; COMPLEMENTARY-DNA; CA-2+ ATPASE	Disulfide-containing peptides in pepsin digest of sarcoplasmic reticulum vesicles were identified by using a fluorogenic thiol-specific reagent 4-fluoro-7-sulfamoylbenzofurazan and a reductant tributylphosphine. Sequencing of the purified peptides revealed the presence of a Cys(876)-Cys(888) disulfide bond on the luminal loop connecting the 7th and 8th transmembrane helices (loop 7-8) of the Ca2+-ATPase (SERCA1a). We substituted either or both of these cysteine residues with alanine and made three mutants (C876A, C888A, C876A/C888A), in which the disulfide bond is disrupted. The mutants and the wild type were expressed in COS-1 cells, and functional analysis was performed with the microsomes isolated from the cells. Electrophoresis performed under reducing and non-reducing conditions confirmed the presence of Cys(876)-Cys(888) disulfide bond in the expressed wild type. All the three mutants possessed high Ca2+-ATPase activity. In contrast, no Ca2+ transport activity was detected with these mutants. These mutants formed almost the same amount of phosphoenzyme intermediate as the wild type from ATP and from Pi. Detailed kinetic analysis showed that the three mutants hydrolyze ATP in the mechanism well accepted for the Ca2+-ATPase; activation of the catalytic site upon high affinity Ca2+ binding, formation of ADP-sensitive phosphoenzyme, subsequent rate-limiting transition to ADP-insensitive phosphoenzyme, and hydrolysis of the latter phosphoenzyme. It is likely that the pathway for delivery of Ca2+ from the binding sites into the lumen of vesicles is disrupted by disruption of the Cys(876)-Cys(888) disulfide bond, and therefore that the loop 7-8 having the disulfide bond is important for formation of the proper structure of the Ca2+ pathway.	Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College; Asahikawa Medical College	Daiho, T (corresponding author), Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	daiho@asahikawa-med.ac.jp						ALLEN G, 1976, FEBS LETT, V63, P188, DOI 10.1016/0014-5793(76)80223-2; ANDERSEN JP, 1995, J BIOL CHEM, V270, P908, DOI 10.1074/jbc.270.2.908; BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; BASTIDE F, 1973, J BIOL CHEM, V248, P8485; BENESCH RE, 1955, J AM CHEM SOC, V77, P5877, DOI 10.1021/ja01627a030; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BURK SE, 1989, J BIOL CHEM, V264, P18561; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; Daiho T, 1999, J BIOL CHEM, V274, P23910, DOI 10.1074/jbc.274.34.23910; DAIHO T, 1994, J BIOL CHEM, V269, P11060; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; DEGANI C, 1973, J BIOL CHEM, V248, P8222; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; Dixon M, 1923, P R SOC LOND B-CONTA, V94, P266, DOI 10.1098/rspb.1923.0005; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; GREEN NM, 1985, BIOCHEM J, V231, P425, DOI 10.1042/bj2310425; HASHIMOTOGOTOH T, 1995, GENE, V152, P271, DOI 10.1016/0378-1119(94)00750-M; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INESI G, 1992, ADV ENZYMOL RAMB, V65, P185; INESI G, 1992, ANN NY ACAD SCI, V671, P32, DOI 10.1111/j.1749-6632.1992.tb43782.x; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V68, P593, DOI 10.1093/oxfordjournals.jbchem.a129392; KANAZAWA T, 1973, J BIOL CHEM, V248, P3163; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; KIRLEY TL, 1989, ANAL BIOCHEM, V180, P231, DOI 10.1016/0003-2697(89)90422-3; KUBOTA T, 1993, BIOCHIM BIOPHYS ACTA, V1163, P131, DOI 10.1016/0167-4838(93)90174-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBERER E, 1989, P NATL ACAD SCI USA, V86, P6047, DOI 10.1073/pnas.86.16.6047; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYTTON J, 1988, J BIOL CHEM, V263, P15024; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MAEDA M, 1990, J BIOL CHEM, V265, P9027; MAKINOSE M, 1967, PFLUG ARCH GES PHYS, V294, pR82; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MYUNG J, 1994, BIOCHEMISTRY-US, V33, P8775, DOI 10.1021/bi00195a020; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; Rice WJ, 1997, J BIOL CHEM, V272, P31412, DOI 10.1074/jbc.272.50.31412; Ruegg U T, 1977, Methods Enzymol, V47, P111; Ruiz-Perez VL, 1999, HUM MOL GENET, V8, P1621, DOI 10.1093/hmg/8.9.1621; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SPACKMAN DH, 1960, J BIOL CHEM, V235, P648; THORLEYLAWSON DA, 1977, BIOCHEM J, V167, P739, DOI 10.1042/bj1670739; TOYOOKA T, 1984, ANAL CHEM, V56, P2461, DOI 10.1021/ac00277a044; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VERMA AK, 1988, J BIOL CHEM, V263, P14152; Webb RJ, 2000, J BIOL CHEM, V275, P977, DOI 10.1074/jbc.275.2.977; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMAMOTO T, 1967, J BIOCHEM-TOKYO, V62, P558, DOI 10.1093/oxfordjournals.jbchem.a128706; Yamasaki K, 1997, J BIOL CHEM, V272, P30627, DOI 10.1074/jbc.272.49.30627	56	27	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32771	32778		10.1074/jbc.M101229200	http://dx.doi.org/10.1074/jbc.M101229200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438520	hybrid			2022-12-27	WOS:000170746000054
J	Matsumoto, M; Hisatake, K; Nogi, Y; Tsujimoto, M				Matsumoto, M; Hisatake, K; Nogi, Y; Tsujimoto, M			Regulation of receptor activator of NF-kappa B ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4 - Synergism with microphthalmia transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; OSTEOCLAST DIFFERENTIATION; INTERFERON-GAMMA; BONE-RESORPTION; PROTEIN-KINASE; KEY REGULATOR; FACTOR FAMILY; CELL-GROWTH; STEM-CELLS; OSTEOPETROSIS	The receptor activator of NF-kappaB ligand induces the expression of tartrate-resistant acid phosphatase (TRAP) and transcription factor, PU.1-interacting protein (Pip), during osteoclastogenesis. In this paper, we have examined the role of transcription factors in the regulation of TRAP gene expression employing reporter constructs containing the promoter region of TRAP gene. Transient transfection of RAW264 cells with sequential 5'-deletions of mouse TRAP gene promoter-luciferase fusion constructs indicated that at least two sites are required for the full promoter activity. Deletion and site-directed mutation studies revealed that M-box and interferon regulatory factor element sites are critical for TRAP gene expression in the cell, suggesting that microphthalmia transcription factor (MITF) and Pip could induce the gene expression independently. Moreover, the overexpression of MITF and Pip functionally stimulated TRAP promoter activity in a synergistic manner. Analysis of the deletion mutants of Pip protein indicated that both N-terminal DNA-binding and C-terminal regulatory domains are indispensable to the promoter-enhancing activity. Subcellular localization of green fluorescence protein-fused Pip and its mutant proteins indicated that the C-terminal domain is required for the translocation of Pip into the nucleus. These results suggest that Pip regulates and acts synergistically with MITF to induce the promoter activity of TRAP gene.	RIKEN, Inst Phys & Chem Res, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; Saitama Med Sch, Dept Biochem, Iruma, Saitama 3500495, Japan	RIKEN; Saitama Medical University	Tsujimoto, M (corresponding author), RIKEN, Inst Phys & Chem Res, Lab Cellular Biochem, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.			Hisatake, Koji/0000-0002-5795-3115				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Harada H, 1998, BIOCHIMIE, V80, P641, DOI 10.1016/S0300-9084(99)80017-0; Hayashi SI, 1998, BIOCHEM CELL BIOL, V76, P911; Hayman AR, 1996, DEVELOPMENT, V122, P3151; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Kawaguchi N, 2000, EXP CELL RES, V260, P284, DOI 10.1006/excr.2000.5020; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; KURIHARA N, 1990, ENDOCRINOLOGY, V126, P2733, DOI 10.1210/endo-126-5-2733; KURIHARA N, 1989, BLOOD, V74, P1295; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; REDDY SV, 1993, J BONE MINER RES, V8, P1263; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Rosenbauer F, 1999, BLOOD, V94, P4274, DOI 10.1182/blood.V94.12.4274.424k05_4274_4281; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; TAKAHASHI N, 1994, DEV BIOL, V163, P212, DOI 10.1006/dbio.1994.1137; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Tanaka N, 2000, SEMIN CANCER BIOL, V10, P73, DOI 10.1006/scbi.2000.0310; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yamano Y, 1998, BIOSCI BIOTECH BIOCH, V62, P237, DOI 10.1271/bbb.62.237; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	42	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33086	33092		10.1074/jbc.M104299200	http://dx.doi.org/10.1074/jbc.M104299200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11425859	hybrid			2022-12-27	WOS:000170746000094
J	Kojima, T; Zama, T; Wada, K; Onogi, H; Hagiwara, M				Kojima, T; Zama, T; Wada, K; Onogi, H; Hagiwara, M			Cloning of human PRP4 reveals interaction with Clk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SPECIFIC KINASE; SPLICING FACTOR SF2/ASF; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SR PROTEINS; CELL-CYCLE; INTRANUCLEAR DISTRIBUTION; SUBCELLULAR-LOCALIZATION; FUNCTIONAL-ANALYSIS; SERINE-RICH	Prp4 is a protein kinase of Schizosaccharomyces pombe identified through its role in pre-mRNA splicing, and belongs to a kinase family including mammalian serine/arginine-rich protein-specific kinases and Clks, whose substrates are serine/arginine-rich proteins. We cloned human PRP4 (hPRP4) full-length cDNA and the antiserum raised against a partial peptide of hPRP4 recognized 170-kDa polypeptide in HeLa S3 cell extracts. Northern blot analysis revealed that hPRP4 mRNA was ubiquitously expressed in multiple tissues. The extended NH2-terminal region of hPRP4 contains an arginine/serine-rich domain and putative nuclear localization signals. hPRP4 phosphorylated and interacted with SF2/ASF, one of the essential splicing factors. Indirect immunofluorescence analysis revealed that endogenous hPRP4 was distributed in a nuclear speckled pattern and colocalized with SF2/ASF in HeLa S3 cells. Furthermore, hPRP4 interacted directly with Clk1 on its COOH terminus, and the arginine/serine-rich domain of hPRP4 was phosphorylated by Clk1 in vitro. Overexpression of Clk1 caused redistribution of hPRP4, from the speckled to the diffuse pattern in nucleoplasm, whereas inactive mutant of Clk1 caused no change of hPRP4 localization. These findings suggest that the NH2-terminal region of hPRP4 may play regulatory roles under an unidentified signal transduction pathway through Clk1.	Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Bunkyo Ku, Tokyo 1138510, Japan; Keio Univ, Sch Med, Dept Med, Shinjuku Ku, Tokyo 1600016, Japan; Tokai Univ, Sch Med, Inst Med Sci, Isehara, Kanagawa 2591193, Japan; Tokai Univ, Sch Med, Dept Med, Isehara, Kanagawa 2591193, Japan	Tokyo Medical & Dental University (TMDU); Keio University; Tokai University; Tokai University	Hagiwara, M (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.		Wada, Kazuhiro/A-6548-2012					ALAHARI SK, 1993, NUCLEIC ACIDS RES, V21, P4079, DOI 10.1093/nar/21.17.4079; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; BENDER J, 1994, P NATL ACAD SCI USA, V91, P12105, DOI 10.1073/pnas.91.25.12105; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Gilbert W, 2001, RNA, V7, P302, DOI 10.1017/S1355838201002369; Gross T, 1997, NUCLEIC ACIDS RES, V25, P1028, DOI 10.1093/nar/25.5.1028; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; HANES J, 1994, J MOL BIOL, V244, P665, DOI 10.1006/jmbi.1994.1763; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; Huang Y, 2000, BIOCHEM BIOPH RES CO, V271, P456, DOI 10.1006/bbrc.2000.2651; JOHNSON KW, 1991, J BIOL CHEM, V266, P3402; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Kuroyanagi H, 2000, MECH DEVELOP, V99, P51, DOI 10.1016/S0925-4773(00)00477-9; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; OKAJIMA T, 1996, BIOIMAGES, V4, P117; Okamoto Y, 1998, BIOCHEM BIOPH RES CO, V249, P872, DOI 10.1006/bbrc.1998.9247; POTASHKIN J, 1989, EMBO J, V8, P551, DOI 10.1002/j.1460-2075.1989.tb03409.x; Prasad J, 1999, MOL CELL BIOL, V19, P6991; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Schmidt H, 1999, GENETICS, V153, P1183; Schwelnus W, 2001, EMBO REP, V2, P35, DOI 10.1093/embo-reports/kve009; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; TAKEUCHI M, 1993, MOL BIOL CELL, V4, P247, DOI 10.1091/mbc.4.3.247; Tang ZH, 1998, J BIOL CHEM, V273, P5963, DOI 10.1074/jbc.273.10.5963; Tate P, 1998, J CELL SCI, V111, P2575; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; WOPPMANN A, 1993, NUCLEIC ACIDS RES, V21, P2815, DOI 10.1093/nar/21.12.2815; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yoshida K, 1998, MOL BRAIN RES, V57, P241, DOI 10.1016/S0169-328X(98)00089-8; YUN B, 1994, GENE DEV, V8, P1160, DOI 10.1101/gad.8.10.1160; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	48	53	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32247	32256		10.1074/jbc.M103790200	http://dx.doi.org/10.1074/jbc.M103790200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418604	hybrid			2022-12-27	WOS:000170613500105
J	Maeshima, Y; Yerramalla, UL; Dhanabal, M; Holthaus, KA; Barbashov, S; Kharbanda, S; Reimer, C; Manfredi, M; Dickerson, WM; Kalluri, R				Maeshima, Y; Yerramalla, UL; Dhanabal, M; Holthaus, KA; Barbashov, S; Kharbanda, S; Reimer, C; Manfredi, M; Dickerson, WM; Kalluri, R			Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTINCT ANTITUMOR PROPERTIES; BASEMENT-MEMBRANE COLLAGEN; IV COLLAGEN; ALPHA-3(IV) CHAIN; TUMOR-GROWTH; NONCOLLAGENOUS DOMAINS; MELANOMA-CELLS; IN-VITRO; APOPTOSIS; AUTOANTIBODIES	Angiogenesis is associated with several pathological disorders as well as with normal physiological maintenance. Components of vascular basement membrane are speculated to regulate angiogenesis in both positive and negative manner. Recently, we reported that tumstatin (the NC1 domain of alpha3 chain of type IV collagen) and its deletion mutant tum-5 possess anti-angiogenic activity. In the present study, we confirm that the anti-angiogenic activity of tumstatin and tum-5 is independent of disulfide bond requirement. This property of tum-5 allowed us to use overlapping synthetic peptide strategy to identify peptide sequence(s) which possess anti-angiogenic activity. Among these peptides, only the T3 peptide (69-88 amino acids) and T7 peptide (74-98 amino acids) inhibited proliferation and induced apoptosis specifically in endo. thelial cells. The peptides, similar to tumstatin and the tum-5 domain, bind and function via alpha (v)beta (3) in an RGD-independent manner. Restoration of a disulfide bond be. tween two cysteines within the peptide did not alter the anti-angiogenic activity. Additionally, these studies show that tumstatin peptides can inhibit proliferation of endothelial cells in the presence of vitronectin, fibronectin, and collagen I. Anti-angiogenic effect of the peptides was further confirmed in vivo using a Matrigel plug assay in C57BL/6 mice. Collectively, these experiments suggest that the anti-angiogenic activity of tumstatin is localized to a 25-amino acid region of tumstatin and it is independent of disulfide bond linkage. Structural features and potency of the tumstatin peptide make it highly feasible as a potential anti-cancer drug.	Beth Israel Deaconess Med Ctr, Dept Med, Program Matrix Biol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; ILEX Oncol Inc, Prod Res & Dev Div, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Program Matrix Biol, RW 514,330 Brookline Ave, Boston, MA 02215 USA.		Peng, Chunwei/F-6788-2010; Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X	NIDDK NIH HHS [DK-55001, DK-51711] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051711] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; CHERESH DA, 1987, J BIOL CHEM, V262, P1434; Colorado PC, 2000, CANCER RES, V60, P2520; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; Dhanabal M, 1999, BIOCHEM BIOPH RES CO, V258, P345, DOI 10.1006/bbrc.1999.0595; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Han J, 1997, J BIOL CHEM, V272, P20395, DOI 10.1074/jbc.272.33.20395; HERLYN D, 1990, CANCER RES, V50, P2296; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; KALLURI R, 1991, J BIOL CHEM, V266, P24018; Kalluri R, 1996, J BIOL CHEM, V271, P9062, DOI 10.1074/jbc.271.15.9062; Kalluri R, 2000, CURR OPIN NEPHROL HY, V9, P413, DOI 10.1097/00041552-200007000-00013; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Madri JA, 1997, TRANSPL IMMUNOL, V5, P179, DOI 10.1016/S0966-3274(97)80035-4; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 1998, J CLIN INVEST, V101, P2589, DOI 10.1172/JCI429; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; NEILSON EG, 1993, J BIOL CHEM, V268, P8402; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Shahan TA, 1999, CANCER RES, V59, P4584; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R	36	178	213	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31959	31968		10.1074/jbc.M103024200	http://dx.doi.org/10.1074/jbc.M103024200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11399763	hybrid			2022-12-27	WOS:000170613500068
J	Paik, J; During, A; Harrison, EH; Mendelsohn, CL; Lai, K; Blaner, WS				Paik, J; During, A; Harrison, EH; Mendelsohn, CL; Lai, K; Blaner, WS			Expression and characterization of a murine enzyme able to cleave beta-carotene - The formation of retinoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; 15,15'-DIOXYGENASE ACTIVITY; DIOXYGENASE ACTIVITY; INTESTINAL-MUCOSA; ESCHERICHIA-COLI; ACID RECEPTORS; IN-VITRO; METABOLISM; PROTEIN; ABSORPTION	Because animals are not able to synthesize retinoids de novo, ultimately they must derive them from dietary provitamin A carotenoids through a process known as carotene cleavage. The enzyme responsible for catalyzing carotene cleavage (beta -carotene 15,15 ' -dioxygenase) has been characterized primarily in rat intestinal scrapings. Using a recently reported cDNA sequence for a carotene cleavage enzyme from Drosophila, we identified a cDNA encoding a mouse homolog of this enzyme. When the cDNA was expressed in either Escherichia coli or Chinese hamster ovary cells, expression conferred upon bacterial and Chinese hamster ovary cell homogenates the ability to cleave beta -carotene to retinal. Several lines of evidence obtained upon kinetic analyses of the recombinant enzyme suggested that carotene cleavage enzyme interacts with other proteins present within cell or tissue homogenates. This was confirmed by pull-down experiments upon incubation of recombinant enzyme with tissue 12,000 x g supernatants. Matrix-assisted laser desorption ionization-mass spectrometry analysis of pulled-down proteins indicates that an atypical testis-specific isoform of lactate de-hydrogenase associates with recombinant carotene cleavage enzyme. mRNA transcripts for the carotene cleavage enzyme were detected by reverse transcription-polymerase chain reaction in mouse testes, liver, kidney, and intestine. In situ hybridization studies demonstrated that carotene cleavage enzyme is expressed prominently in maternal tissue surrounding the embryo but not in embryonic tissues at 7.5 and 8.5 days postcoitus. This work offers new insights for understanding the biochemistry of carotene cleavage to retinoids.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Urol, New York, NY 10032 USA; USDA ARS, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA	Columbia University; Columbia University; United States Department of Agriculture (USDA)	Blaner, WS (corresponding author), Columbia Univ, Dept Med, HHSB Rm 502,701 W 168th St, New York, NY 10032 USA.		During, Alexandrine/I-5405-2015; Harrison, Earl H/AAN-5378-2021; Mendelsohn, Cathy/H-4280-2016; During, Alexandrine/AAA-2931-2021	During, Alexandrine/0000-0002-6878-0870; Mendelsohn, Cathy/0000-0002-4026-4073; 	NATIONAL EYE INSTITUTE [R01EY012858] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK082963, R01DK044498, R01DK061459, R01DK065719, R01DK061310] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY12858] Funding Source: Medline; NHLBI NIH HHS [R01 HL49879, R01 HL049879] Funding Source: Medline; NIDDK NIH HHS [R01 DK061310, R01 DK061459-07S1, R01 DK061459-09, R01 DK061459, R56 DK082963-01, R01 DK061459-06, R56 DK082963, R01 DK061459-07, R01 DK061459-08, R01 DK44498, R01 DK065719] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLANCO A, 1976, BIOCHEM J, V153, P165, DOI 10.1042/bj1530165; Blaner W.S., 1999, HANDB EXP PHARM, P117; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; During A, 1998, J NUTR, V128, P1614, DOI 10.1093/jn/128.10.1614; During A, 1998, BIOCHEM BIOPH RES CO, V249, P467, DOI 10.1006/bbrc.1998.9160; Duszka C, 1996, J NUTR, V126, P2550, DOI 10.1093/jn/126.10.2550; FIDGE NH, 1969, BIOCHEM J, V114, P689, DOI 10.1042/bj1140689; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; GOODMAN DS, 1969, AM J CLIN NUTR, V22, P963; GOODMAN DS, 1967, J BIOL CHEM, V242, P3543; GOODMAN DS, 1966, J BIOL CHEM, V241, P1929; GOODMAN DWS, 1966, J CLIN INVEST, V45, P1615, DOI 10.1172/JCI105468; Grolier P, 1997, ARCH BIOCHEM BIOPHYS, V348, P233, DOI 10.1006/abbi.1997.0388; LAKSHMAN MR, 1993, J NUTR BIOCHEM, V4, P659, DOI 10.1016/0955-2863(93)90040-4; Lakshman MR, 1996, NUTR CANCER, V26, P49, DOI 10.1080/01635589609514462; LEVIN MS, 1990, METHOD ENZYMOL, V189, P506; LI E, 1987, J BIOL CHEM, V262, P13773; Mangelsdorf David J., 1994, P319; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; NAPOLI JL, 1986, METHOD ENZYMOL, V123, P112, DOI 10.1016/S0076-6879(86)23015-3; OLSON JA, 1961, J BIOL CHEM, V236, P349; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Olson JA., 1991, HDB VITAMINS, P1; Ong David E., 1994, P283; PEMRICK SM, 1994, LEUKEMIA, V8, P1; PETKOVICH M, 1992, ANNU REV NUTR, V12, P443, DOI 10.1146/annurev.nu.12.070192.002303; Rock CL, 1997, PHARMACOL THERAPEUT, V75, P185, DOI 10.1016/S0163-7258(97)00054-5; Saari John C., 1994, P351; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SINGH H, 1974, BIOCHIM BIOPHYS ACTA, V370, P49, DOI 10.1016/0005-2744(74)90030-8; SKLAN D, 1983, BRIT J NUTR, V50, P417, DOI 10.1079/BJN19830109; Sporn M.B., 1994, RETINOIDS BIOL CHEM; STAHL W, 1992, ARCH BIOCHEM BIOPHYS, V294, P173, DOI 10.1016/0003-9861(92)90153-N; Tajima S, 1999, LIFE SCI, V65, P841, DOI 10.1016/S0024-3205(99)00311-2; THOMAS K, 1990, DEVELOPMENT, V109, P483; THOMPSON SY, 1950, BRIT J NUTR, V4, P398, DOI 10.1079/BJN19500063; vanVliet T, 1996, INT J VITAM NUTR RES, V66, P77; vanVliet T, 1996, J NUTR, V126, P499, DOI 10.1093/jn/126.2.499; Vieira AV, 1998, SUB CELL BIOCHEM, V30, P29; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; VOGEL S, 1999, HANDB EXP PHARM, V139, P31; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619	45	123	127	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32160	32168		10.1074/jbc.M010086200	http://dx.doi.org/10.1074/jbc.M010086200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418584	Green Submitted, hybrid			2022-12-27	WOS:000170613500094
J	Lavigne, M; Polomack, L; Buc, H				Lavigne, M; Polomack, L; Buc, H			Structures of complexes formed by HIV-1 reverse transcriptase at a termination site of DNA synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; STRAND TRANSFER-REACTIONS; RNASE-H; DRUG-RESISTANCE; NUCLEOCAPSID PROTEIN; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURES; POLYPURINE TRACT; KINETIC-ANALYSIS; RIBONUCLEASE-H	This study presents structural parameters associated with termination of human immunodeficiency virus, type 1 (HIV-1) reverse transcriptase (RT) at Ter2, the major termination site located in the center of the HIV-1 genome. DNA footprinting studies of various elongation complexes formed by RT around wild type and mutant Ter2 sites have revealed two major structural transformations of these complexes when the enzyme gets closer to Ter2. First, the interactions between RT and the DNA duplex are less extended, although the global affinity of the enzyme for this duplex is only decreased by 2-fold. Second, there is an atypical positioning of the RT RNase H domain on the DNA duplex. We interpret our data as indicating that the A(n)T(m) motif located upstream of Ter2 prevents a classical positioning of the enzyme on the double-stranded part of the DNA duplex at some precise positions of elongation downstream of this motif. Instead, novel species of binary and/or ternary complexes, characterized by atypical footprints, are formed. The new rate-limiting step of the reaction, characterized in the preceding paper (Lavigne, M., Polomack, L., and Buc, H. (2001) J. BioL Chem. 276,31429-31438), would be a transition leading from these new species to a catalytically competent ternary complex.	Inst Pasteur, Unite Physicochim Macromol Biol, CNRS, URA 1773, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lavigne, M (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Wellman 10,Fruit St, Boston, MA 02114 USA.			LAVIGNE, Marc/0000-0002-3131-2539				Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Canard B, 1997, P NATL ACAD SCI USA, V94, P11279, DOI 10.1073/pnas.94.21.11279; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DeStefano J, 1998, J BIOL CHEM, V273, P1483, DOI 10.1074/jbc.273.3.1483; Diaz L, 2000, ARCH VIROL, V145, P1117, DOI 10.1007/s007050070113; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Gabbara S, 1999, BIOCHEMISTRY-US, V38, P13070, DOI 10.1021/bi991085n; Gao HQ, 1998, J MOL BIOL, V277, P559, DOI 10.1006/jmbi.1998.1624; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209; HERMANN T, 1994, NUCLEIC ACIDS RES, V22, P4625, DOI 10.1093/nar/22.22.4625; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JAGER J, 1994, STRUCTURE, V2, P869, DOI 10.1016/S0969-2126(94)00087-5; Jager Joachim, 1999, Current Opinion in Structural Biology, V9, P21, DOI 10.1016/S0959-440X(99)80004-9; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kim JK, 1997, J BIOL CHEM, V272, P16769, DOI 10.1074/jbc.272.27.16769; Kunkel TA, 1998, NAT STRUCT BIOL, V5, P95, DOI 10.1038/nsb0298-95; Lanchy JM, 1998, J BIOL CHEM, V273, P24425, DOI 10.1074/jbc.273.38.24425; Lanchy JM, 2000, J BIOL CHEM, V275, P12306, DOI 10.1074/jbc.275.16.12306; Larder BA, 1999, NAT STRUCT BIOL, V6, P103, DOI 10.1038/5787; Lavigne M, 1997, J MOL BIOL, V266, P507, DOI 10.1006/jmbi.1996.0805; LAVIGNE M, 1994, EMBO J, V13, P4983, DOI 10.1002/j.1460-2075.1994.tb06825.x; Lavigne M, 2001, J BIOL CHEM, V276, P31429, DOI 10.1074/jbc.M102974200; Lavigne M, 1999, J MOL BIOL, V285, P977, DOI 10.1006/jmbi.1998.2367; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; NEGRONI M, 1995, P NATL ACAD SCI USA, V92, P6971, DOI 10.1073/pnas.92.15.6971; Negroni M, 1999, J MOL BIOL, V286, P15, DOI 10.1006/jmbi.1998.2460; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Palaniappan C, 1997, J BIOL CHEM, V272, P11157, DOI 10.1074/jbc.272.17.11157; Palaniappan C, 1998, J BIOL CHEM, V273, P3808, DOI 10.1074/jbc.273.7.3808; PALANIAPPAN C, 1995, J BIOL CHEM, V270, P4861, DOI 10.1074/jbc.270.9.4861; Powell MD, 1999, J BIOL CHEM, V274, P19885, DOI 10.1074/jbc.274.28.19885; Powell MD, 1996, J VIROL, V70, P5288, DOI 10.1128/JVI.70.8.5288-5296.1996; Raja A, 1999, BIOCHEMISTRY-US, V38, P5178, DOI 10.1021/bi9828019; Rausch JW, 2000, J BIOL CHEM, V275, P16015, DOI 10.1074/jbc.M909808199; REARDON JE, 1993, J BIOL CHEM, V268, P8743; Ricchetti M, 1996, BIOCHEMISTRY-US, V35, P14970, DOI 10.1021/bi961274v; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Sarafianos SG, 1999, CHEM BIOL, V6, pR137, DOI 10.1016/S1074-5521(99)80071-4; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12468, DOI 10.1021/bi971218+; Thrall SH, 1998, BIOCHEMISTRY-US, V37, P13349; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; UNGE T, 1990, AIDS RES HUM RETROV, V6, P1297, DOI 10.1089/aid.1990.6.1297; UNGE T, 1994, STRUCTURE, V2, P953, DOI 10.1016/S0969-2126(94)00097-2; Vaccaro JA, 1999, BIOCHEMISTRY-US, V38, P15978, DOI 10.1021/bi990945x; WOHRL BM, 1995, BIOCHEMISTRY-US, V34, P5343; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	60	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31439	31448		10.1074/jbc.M102976200	http://dx.doi.org/10.1074/jbc.M102976200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402037	hybrid			2022-12-27	WOS:000170472900110
J	Venning, JD; Rodrigues, DJ; Weston, CJ; Cotton, NPJ; Quirk, PG; Errington, N; Finet, S; White, SA; Jackson, JB				Venning, JD; Rodrigues, DJ; Weston, CJ; Cotton, NPJ; Quirk, PG; Errington, N; Finet, S; White, SA; Jackson, JB			The heterotrimer of the membrane-peripheral components of transhydrogenase and the alternating-site mechanism of proton translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; ESCHERICHIA-COLI TRANSHYDROGENASE; RHODOSPIRILLUM-RUBRUM; NADP(H)-BINDING COMPONENT; SOLUTION SCATTERING; HYDRIDE TRANSFER; DOMAIN-III; RECOMBINANT; BINDING; ENZYME	Transhydrogenase undergoes conformational changes to couple the redox reaction between NAD(H) and NADP(H) to proton translocation across a membrane. The protein comprises three components: dI, which binds NAD(H); dIII, which binds NADP(H); and dII, which spans the membrane. Experiments using isothermal titration calorimetry, analytical ultracentrifugation, and small angle x-ray scattering show that, as in the crystalline state, a mixture of recombinant dI and dIII from Rhodospirillum rubrum transhydrogenase readily forms a dI(2)dIII(1) heterotrimer in solution, but we could find no evidence for the formation of a dI(2)dIII(2) tetramer using these techniques. The asymmetry of the complex suggests that there is an alternation of conformations at the nucleotide-binding sites during proton translocation by the complete enzyme. The characteristics of nucleotide interaction with the isolated dl and dIII components and with the dI(2)dIII(1) heterotrimer were investigated. (a) The rate of release of NADP(+) from dIII was decreased 5-fold when the component was incorporated into the heterotrimer. (b) The binding affinity of one of the two nucleotide-binding sites for NADH on the dI dimer was decreased about 17-fold in the dI(2)dIII(1), complex; the other binding site was unaffected. These observations lend strong support to the alternating-site mechanism.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England; European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Birmingham; University of Nottingham; European Synchrotron Radiation Facility (ESRF)	Jackson, JB (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.		White, Scott/C-6684-2008	White, Scott/0000-0002-0202-6154				ANDERSON WM, 1978, ARCH BIOCHEM BIOPHYS, V187, P180, DOI 10.1016/0003-9861(78)90021-8; Bizouarn T, 1996, EUR J BIOCHEM, V239, P737, DOI 10.1111/j.1432-1033.1996.0737u.x; Bizouarn T, 1996, BBA-BIOENERGETICS, V1273, P4, DOI 10.1016/0005-2728(95)00125-5; Buckley PA, 2000, STRUCTURE, V8, P809, DOI 10.1016/S0969-2126(00)00171-4; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; DIGGLE C, 1995, EUR J BIOCHEM, V232, P315, DOI 10.1111/j.1432-1033.1995.tb20814.x; DIGGLE C, 1995, EUR J BIOCHEM, V228, P719, DOI 10.1111/j.1432-1033.1995.0719m.x; Diggle C, 1996, EUR J BIOCHEM, V241, P162, DOI 10.1111/j.1432-1033.1996.0162t.x; Fjellstrom O, 1997, BIOCHEMISTRY-US, V36, P11331, DOI 10.1021/bi970958f; Guinier A., 1955, SMALL ANGLE SCATTERI; HOEK JB, 1988, BIOCHEM J, V254, P1; HOU C, 1990, BIOCHIM BIOPHYS ACTA, V1018, P61, DOI 10.1016/0005-2728(90)90110-P; Jackson JB, 1999, FEBS LETT, V464, P1, DOI 10.1016/S0014-5793(99)01644-0; Jeeves M, 2000, BBA-BIOENERGETICS, V1459, P248, DOI 10.1016/S0005-2728(00)00159-6; Johansson C, 1999, FEBS LETT, V458, P180, DOI 10.1016/S0014-5793(99)01156-4; Kozin MB, 1997, J APPL CRYSTALLOGR, V30, P811, DOI 10.1107/S0021889897001830; MEJBAUMKATZENELLENBOGEN W, 1959, CLIN CHIM ACTA, V4, P515, DOI 10.1016/0009-8981(59)90158-5; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Meuller J, 1999, J BIOL CHEM, V274, P19072, DOI 10.1074/jbc.274.27.19072; Peake SJ, 1999, BBA-BIOENERGETICS, V1413, P81, DOI 10.1016/S0005-2728(99)00084-5; Peake SJ, 1999, BBA-BIOENERGETICS, V1411, P159, DOI 10.1016/S0005-2728(99)00013-4; PERSSON B, 1987, ARCH BIOCHEM BIOPHYS, V259, P341, DOI 10.1016/0003-9861(87)90500-5; PHELPS DC, 1984, BIOCHEMISTRY-US, V23, P4475, DOI 10.1021/bi00314a037; PHELPS DC, 1985, BIOCHEMISTRY-US, V24, P3503, DOI 10.1021/bi00335a017; Prasad GS, 1999, NAT STRUCT BIOL, V6, P1126; Quirk PG, 1999, FEBS LETT, V446, P127, DOI 10.1016/S0014-5793(99)00198-2; Rodrigues DJ, 2001, EUR J BIOCHEM, V268, P1430, DOI 10.1046/j.1432-1327.2001.02008.x; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Svedberg T, 1940, THE ULTRACENTRIFUGE; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1996, ACTA CRYSTALLOGR A, V52, P419, DOI 10.1107/S0108767396000177; Venning JD, 2000, J BIOL CHEM, V275, P19490, DOI 10.1074/jbc.M000577200; Venning JD, 1998, EUR J BIOCHEM, V257, P202, DOI 10.1046/j.1432-1327.1998.2570202.x; Weston CJ, 2001, FEBS LETT, V488, P51, DOI 10.1016/S0014-5793(00)02386-3; White SA, 2000, STRUCT FOLD DES, V8, P1, DOI 10.1016/S0969-2126(00)00075-7; YAMAGUCHI M, 1993, J BIOL CHEM, V268, P17871; YAMAGUCHI M, 1990, BIOCHEMISTRY-US, V29, P4136, DOI 10.1021/bi00469a017; YAMAGUCHI M, 1995, J BIOL CHEM, V270, P28165; Yamaguchi M, 1997, BBA-BIOENERGETICS, V1318, P225, DOI 10.1016/S0005-2728(96)00139-9	40	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30678	30685		10.1074/jbc.M104429200	http://dx.doi.org/10.1074/jbc.M104429200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11399770	hybrid			2022-12-27	WOS:000170472900014
J	Bell-Parikh, LC; Eipper, BA; Mains, RE				Bell-Parikh, LC; Eipper, BA; Mains, RE			Response of an integral granule membrane protein to changes in pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; PEPTIDE-PROCESSING ENZYME; CYTOSOLIC ROUTING DETERMINANTS; IMMATURE SECRETORY GRANULES; COOH-TERMINAL DOMAIN; ATT-20 CELLS; CHROMOGRANIN-A; PROHORMONE CONVERTASE; NEUROENDOCRINE CELLS; CARBOXYPEPTIDASE-E	A key feature of the regulated secretory pathway in neuroendocrine cells is lumenal pH, which decreases between trans-Golgi network and mature secretory granules. Because peptidylglycine a-amidating monooxygenase, (PA-ML) is one of the few membrane-spanning proteins concentrated. in secretory granules and is a known effector of regulated secretion, we examined its sensitivity to pH. Based on antibody binding experiments, the noncatalytic linker regions between the two enzymatic domains of PAM show pH-dependent conformational changes; these changes occur in the presence or absence of a transmembrane domain. Integral membrane PAM-1 solubilized from rat anterior pituitary or from transfected AtT-20 cells aggregates reversibly at pH 5.5 while retaining enzyme activity. Over 35% of the PAM-1 in anterior pituitary extracts aggregates at pH 5.5, whereas only about 5% aggregates at pH 7.5. PAM-1 recovered from secretory granules and endosomes is highly responsive to low pl-l-induced aggregation, whereas PAM-1 recovered from a light, intracellular recycling compartment is not. Mutagenesis studies indicate that a transmembrane domain is necessary but not sufficient for low pH-induced aggregation and reveal a short lumenal, juxtamembrane segment that also contributes to pH-dependent aggregation. Taken together, these results demonstrate that several properties of membrane PAM serve as indicators of granule pH in neuroendocrine cells.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Mains, RE (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, MC3401,263 Farmington Ave, Farmington, CT 06030 USA.	mains@uchc.edu			NIDDK NIH HHS [DK32949, DK09945, DK32948] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032948, R01DK032949, R37DK032949, R37DK032948, R56DK032949, R01DK032948] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam MR, 2001, MOL BIOL CELL, V12, P629, DOI 10.1091/mbc.12.3.629; Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; Bruzzaniti A, 1999, J BIOL CHEM, V274, P24703, DOI 10.1074/jbc.274.35.24703; Caldwell BD, 1999, J BIOL CHEM, V274, P34646, DOI 10.1074/jbc.274.49.34646; CASEY RP, 1977, BIOCHEMISTRY-US, V16, P972, DOI 10.1021/bi00624a025; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; CHAPMAN RE, 1994, EMBO J, V13, P2305, DOI 10.1002/j.1460-2075.1994.tb06514.x; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; Dittie AS, 1999, J CELL SCI, V112, P3955; EIPPER BA, 1995, BIOCHEMISTRY-US, V34, P2857, DOI 10.1021/bi00009a016; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; El Meskini R, 2001, J BIOL CHEM, V276, P3384, DOI 10.1074/jbc.M008062200; HUSTEN EJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P487, DOI 10.1006/abbi.1994.1336; JAMIESON JD, 1971, J CELL BIOL, V48, P503, DOI 10.1083/jcb.48.3.503; JOHNSON RG, 1976, J BIOL CHEM, V251, P2189; Lee MS, 2001, J BIOL CHEM, V276, P715, DOI 10.1074/jbc.M008530200; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P5486, DOI 10.1021/bi00016a020; Mains RE, 1999, J BIOL CHEM, V274, P2929, DOI 10.1074/jbc.274.5.2929; Mains Richard E., 1999, P363; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Marx R, 1999, J NEUROSCI, V19, P8300; Meskini RE, 2000, ENDOCRINOLOGY, V141, P3020; Milgram SL, 1996, J BIOL CHEM, V271, P17526, DOI 10.1074/jbc.271.29.17526; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; ORCI L, 1987, CELL, V51, P1039, DOI 10.1016/0092-8674(87)90590-3; OYARCE AM, 1995, J CELL SCI, V108, P287; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Ratovitski EA, 1999, J BIOL CHEM, V274, P993, DOI 10.1074/jbc.274.2.993; Rindler MJ, 1998, J BIOL CHEM, V273, P31180, DOI 10.1074/jbc.273.47.31180; SCHMIDT WK, 1995, MOL BIOL CELL, V6, P1271, DOI 10.1091/mbc.6.10.1271; Scougall K, 1998, BIOCHEM J, V334, P531, DOI 10.1042/bj3340531; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SHENNAN KIJ, 1994, J BIOL CHEM, V269, P18646; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SONG LX, 1995, J BIOL CHEM, V270, P7963, DOI 10.1074/jbc.270.14.7963; STEINER DF, 1973, NATURE, V243, P528, DOI 10.1038/243528a0; Stoeckelhuber M, 1996, J CELL SCI, V109, P1825; TAUSK FA, 1992, MOL ENDOCRINOL, V6, P2185, DOI 10.1210/me.6.12.2185; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; YI Z, 1993, J BIOL CHEM, V268, P5615; YOO SH, 1994, J BIOL CHEM, V269, P12001; YOO SH, 1990, J BIOL CHEM, V265, P14414; Yoo SH, 1996, J BIOL CHEM, V271, P1558; Yoo SH, 1997, FEBS LETT, V406, P259, DOI 10.1016/S0014-5793(97)00276-7; YUN HY, 1993, ARCH BIOCHEM BIOPHYS, V301, P77, DOI 10.1006/abbi.1993.1117; YUN HY, 1995, J BIOL CHEM, V270, P30075; YUN HY, 1995, J BIOL CHEM, V270, P15412, DOI 10.1074/jbc.270.25.15412; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	62	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29854	29863		10.1074/jbc.M103936200	http://dx.doi.org/10.1074/jbc.M103936200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395514	hybrid			2022-12-27	WOS:000170558000035
J	Gladyshev, VN; Liu, AM; Novoselov, SV; Krysan, K; Sun, QA; Kryukov, VM; Kryukov, GV; Lou, MF				Gladyshev, VN; Liu, AM; Novoselov, SV; Krysan, K; Sun, QA; Kryukov, VM; Kryukov, GV; Lou, MF			Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; MOLECULAR-CLONING; SWISS-MODEL; THIOREDOXIN; PROTEIN; STRESS; GENE; SELENOCYSTEINE; PURIFICATION; PEROXIDASE	A thiol/disulfide oxidoreductase component of the GSH system, glutaredoxin (Grx), is involved in the reduction of GSH-based mixed disulfides and participates in a variety of cellular redox pathways. A single cytosolic Grx (Grx1) was previously described in mammals. We now report identification and characterization of a second mammalian Grx, designated Grx2. Grx2 exhibited 36% identity with Grx1 and had a disulfide active center containing the Cys-Ser-Tyr-Cys motif. Grx2 was encoded in the, genomes of mammals and birds and expressed in a variety of cell types. The gene for human Grx2 consisted of four exons and three introns, spanned 10 kilobase pairs, and localized to chromosome 1q31.2-31.3. The coding sequence was present in all exons, with the first exon encoding a mitochondrial signal peptide. The mitochondrial leader sequence was also present in mouse and rat Grx2 sequences and was shown to direct either Grx2 or green fluorescent protein to mitochondria. Alternative splicing forms. of mammalian Grx2 mRNAs were identified that differed in sequences upstream of exon 2. To functionally characterize the new protein, human and mouse Grx2 proteins were expressed in Escherichia coli, and the purified proteins were shown to reduce mixed disulfides formed between GSH and S-sulfocysteine, hydroxyethyldisulfide, or cystine. Grx1 and Grx2 were sensitive to inactivation by iodoacetamide and H2O2 and exhibited similar pH dependence of catalytic activity. However, H2O2-inactivated Grx2 could only be reactivated with 5 mM GSH, whereas Grx1 could also be reactivated with dithiothreitol or thioredoxin/thioredoxin reductase. The Grx2 structural model suggested a common reaction mechanism for this class of proteins. The data provide the first example of a mitochondrial Grx and also indicate the occurrence of a second functional Grx in mammals.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Dept Vet & Biomed Sci, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; Kryukov, Gregory V/A-9592-2008; Gladyshev, Vadim N/A-9894-2013	Novoselov, Sergey/0000-0003-0104-6492; Kryukov, Gregory/0000-0002-6131-9483; Gladyshev, Vadim/0000-0002-0372-7016				Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; Aslund F, 1999, J BACTERIOL, V181, P1375; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; KATTI SK, 1995, PROTEIN SCI, V4, P1998, DOI 10.1002/pro.5560041005; Kelner MJ, 2000, BIOCHEM BIOPH RES CO, V269, P366, DOI 10.1006/bbrc.2000.2267; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lou MF, 2000, J OCUL PHARMACOL TH, V16, P137, DOI 10.1089/jop.2000.16.137; LUNDBERG M, 2001, J BIOL CHEM; MIEYAL JJ, 1991, BIOCHEMISTRY-US, V30, P6088, DOI 10.1021/bi00239a002; MIEYAL JJ, 1991, BIOCHEMISTRY-US, V30, P8883, DOI 10.1021/bi00100a023; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; QIAO FY, 2000, INVEST OPHTH VIS SCI, V42, P743; Raghavachari N, 1999, EXP EYE RES, V68, P715, DOI 10.1006/exer.1999.0659; Raghavachari N, 1996, EXP EYE RES, V63, P433, DOI 10.1006/exer.1996.0133; Rhee SG, 1999, BIOFACTORS, V10, P207, DOI 10.1002/biof.5520100218; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; SAMBROOC J, 1989, MOL CLONING LAB MANU; Sun CH, 1998, J MOL BIOL, V280, P687, DOI 10.1006/jmbi.1998.1913; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504	32	183	190	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30374	30380		10.1074/jbc.M100020200	http://dx.doi.org/10.1074/jbc.M100020200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397793	hybrid, Green Published			2022-12-27	WOS:000170558000101
J	Memon, RA; Moser, AH; Shigenaga, JK; Grunfeld, C; Feingold, KR				Memon, RA; Moser, AH; Shigenaga, JK; Grunfeld, C; Feingold, KR			In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response - Potential role of hepatocyte nuclear factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; BILE-ACID BIOSYNTHESIS; MESSENGER-RNA LEVELS; RETINOID-X-RECEPTOR; OXYSTEROL 7-ALPHA-HYDROXYLASE; DOWN-REGULATION; TRANSCRIPTIONAL REGULATION; CYP7A1 TRANSCRIPTION; DECREASED EXPRESSION; SERUM-LIPOPROTEINS	The host response to infection is associated with several alterations in lipid metabolism that promote lipoprotein production. These changes can be reproduced by lipopolysaccharide (LPS) administration. LPS stimulates hepatic cholesterol synthesis and suppresses the conversion of cholesterol to bile acids. LPS down-regulates hepatic cholesterol 7 alpha -hydroxylase, the rate-limiting enzyme in the classic pathway of bile acid synthesis. We now demonstrate that LPS markedly decreases the activity of sterol 27-hydroxylase, the rate-limiting enzyme in the alternate pathway of bile acid synthesis, in the liver of Syrian hamsters. Moreover, LPS progressively decreases hepatic sterol 27-hydroxylase mRNA levels by 75% compared with controls over a 24-h treatment period. LPS also decreases oxysterol 7 alpha -hydroxylase mRNA levels in mouse liver. In vitro studies in HepG2 cells demonstrate that tumor necrosis factor and interleukin (IL)-1 decrease sterol 27-hydroxylase MRNA levels by 48 and 80%, respectively, whereas IL-6 has no such effect. The IL-1-induced decrease in sterol 27-hydroxylase mRNA expression occurs early, is sustained for 48 h, and requires very low doses. In vivo IL-1 treatment also lowers hepatic sterol 27-hydroxylase mRNA levels in Syrian hamsters. Studies investigating the molecular mechanisms of LPS-induced decrease in sterol 27-hydroxylase show that LPS markedly decreases mRNA and protein levels of hepatocyte nuclear factor-1 a transcription factor that regulates sterol 27-hydroxylase, in the liver. Moreover, LPS decreases the binding activity of HNF-1 by 70% in nuclear extracts in hamster liver, suggesting that LPS may down-regulate sterol 27-hydroxylase by decreasing the binding of HNF-1 to its promoter. Coupled with our earlier studies on cholesterol 7 alpha -hydroxylase, these data indicate that LPS suppresses both the classic and alternate pathways of bile acid synthesis. A decrease in bile acid synthesis mi liver would reduce cholesterol catabolism and thereby contribute to the increase in hepatic lipoprotein production that is induced by LPS and cytokines.	Dept Vet Affairs Med Ctr, Metab Sect 111F, Dept Med, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA	University of California System; University of California San Francisco	Memon, RA (corresponding author), Dept Vet Affairs Med Ctr, Metab Sect 111F, Dept Med, 4150 Clement St, San Francisco, CA 94121 USA.							Akiyama TE, 2000, J BIOL CHEM, V275, P27117; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; BURKE PA, 1994, SURGERY, V116, P285; Burke PA, 1996, SURGERY, V120, P374, DOI 10.1016/S0039-6060(96)80312-6; CABANA VG, 1989, J LIPID RES, V30, P39; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DeFabiani E, 1996, BIOCHEM BIOPH RES CO, V226, P663, DOI 10.1006/bbrc.1996.1412; Feingold KR, 1996, J LIPID RES, V37, P223; FEINGOLD KR, 1993, J LIPID RES, V34, P2147; FEINGOLD KR, 1995, J LIPID RES, V36, P1474; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Grunfeld C, 1996, J CLIN INVEST, V97, P2152, DOI 10.1172/JCI118653; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; HAGAN DL, 1994, J BIOL CHEM, V269, P28737; Hardardottir Ingibjorg, 1994, Current Opinion in Lipidology, V5, P207, DOI 10.1097/00041433-199405030-00008; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; HILL M, 1991, J CLIN INVEST, V88, P811, DOI 10.1172/JCI115381; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; JAVITT NB, 1994, FASEB J, V8, P1308, DOI 10.1096/fasebj.8.15.8001744; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9838, DOI 10.1073/pnas.87.24.9838; LANZAJACOBY S, 1990, AM J PHYSIOL, V258, pE678, DOI 10.1152/ajpendo.1990.258.4.E678; Lee HY, 2000, J BIOL CHEM, V275, P32193, DOI 10.1074/jbc.M005490200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liao W, 1996, BIOCHEM J, V313, P873, DOI 10.1042/bj3130873; LOPESVIRELLA MF, 1993, EUR HEART J, V14, P118; Magee TR, 1998, J BIOL CHEM, V273, P30024, DOI 10.1074/jbc.273.45.30024; Marrapodi M, 2000, J LIPID RES, V41, P514; Memon RA, 1997, J LIPID RES, V38, P1620; Memon RA, 1999, BBA-MOL CELL BIOL L, V1440, P118, DOI 10.1016/S1388-1981(99)00120-1; Metz RP, 2000, MOL PHARMACOL, V58, P319, DOI 10.1124/mol.58.2.319; Muller M, 2000, SEMIN LIVER DIS, V20, P323, DOI 10.1055/s-2000-9387; Navasa M, 1998, J LIPID RES, V39, P1220; NEISH AS, 1995, J BIOL CHEM, V270, P28903, DOI 10.1074/jbc.270.48.28903; NOLTEN LA, 1995, MOL ENDOCRINOL, V9, P1488, DOI 10.1210/me.9.11.1488; Pandak WM, 1997, J LIPID RES, V38, P2483; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; QIAN XB, 1995, MOL CELL BIOL, V15, P1364; Rao YP, 1999, J STEROID BIOCHEM, V70, P1, DOI 10.1016/S0960-0760(99)00099-0; Repa JJ, 1999, CURR OPIN BIOTECH, V10, P557, DOI 10.1016/S0958-1669(99)00031-2; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Souidi M, 1999, LIFE SCI, V64, P1585, DOI 10.1016/S0024-3205(99)00089-2; SPADY DK, 1995, J CLIN INVEST, V96, P700, DOI 10.1172/JCI118113; Spady DK, 1998, J BIOL CHEM, V273, P126, DOI 10.1074/jbc.273.1.126; SPITZER JJ, 1958, J PAREN ENTER NUTR, V12, P53; Stravitz RT, 1996, J STEROID BIOCHEM, V57, P337, DOI 10.1016/0960-0760(95)00282-0; Su GL, 1995, CRIT REV IMMUNOL, V15, P201, DOI 10.1615/CritRevImmunol.v15.i3-4.10; Trauner M, 1999, J GASTROEN HEPATOL, V14, P946, DOI 10.1046/j.1440-1746.1999.01982.x; TRONCHE F, 1989, MOL CELL BIOL, V9, P4759, DOI 10.1128/MCB.9.11.4759; Vlahcevic ZR, 1997, GASTROENTEROLOGY, V113, P1949, DOI 10.1016/S0016-5085(97)70015-5; Vlahcevic ZR, 1999, GASTROENTEROL CLIN N, V28, P1, DOI 10.1016/S0889-8553(05)70041-8; Vlahcevic ZR, 1996, AM J PHYSIOL-GASTR L, V270, pG646, DOI 10.1152/ajpgi.1996.270.4.G646; Watson AM, 1999, J BIOCHEM MOL TOXIC, V13, P63, DOI 10.1002/(SICI)1099-0461(1999)13:2<63::AID-JBT1>3.3.CO;2-9; Wu ZL, 1999, J LIPID RES, V40, P2195; YANUKAKASHLES O, 1994, MOL CELL BIOL, V14, P7124, DOI 10.1128/MCB.14.11.7124	65	69	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30118	30126		10.1074/jbc.M102516200	http://dx.doi.org/10.1074/jbc.M102516200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11406622	hybrid			2022-12-27	WOS:000170558000070
J	Reguenga, C; Oliveira, MEM; Gouveia, AMM; Sa-Miranda, C; Azevedo, JE				Reguenga, C; Oliveira, MEM; Gouveia, AMM; Sa-Miranda, C; Azevedo, JE			Characterization of the mammalian peroxisomal import machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; RAT-LIVER PEROXISOMES; PTS1 RECEPTOR PEX5P; TARGETING SIGNAL; SACCHAROMYCES-CEREVISIAE; CELL MUTANT; FUNCTIONAL COMPLEMENTATION; CDNA CLONING; DOCKING	Although many of the proteins involved in the biogenesis of the mammalian peroxisome have already been identified, our knowledge of the architecture of all this machinery is still very limited. In this work we used native gel electrophoresis and sucrose gradient sedimentation analysis in combination with immunoprecipitation experiments to address this issue. After solubilization of rat liver peroxisomes with the mild detergent digitonin, comigration of Pex5p, Pex14p, and a fraction of Pex12p was observed upon native electrophoresis and sucrose gradient sedimentation. The existence of a complex comprising Pex2p, Pex5p, Pex12p, and Pex14p was demonstrated by preparative coimmunoprecipitation experiments using an antibody directed to Pex14p. No stoichiometric amounts of Pex13p were detected in the Pex2p-Pex5p-Pex12p-Pex14p complex, although the presence of a small fraction of Pex13p in this complex could be demonstrated by Western blot analysis. Pex13p is also a component of a high molecular mass complex. Strikingly, partial purification of this Pex13p-containing complex revealed Pex13p as the major (if not the only) component. Taken together, our data indicate that Pex2p, Pex5p, Pex12p, and Pex14p, on one side, and Pex13p, on the other, are subunits of two stable protein complexes that probably interact with each other in the peroxisomal membrane.	Univ Porto, Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4150180 Oporto, Portugal; Inst Genet Med Jacinto Magalhaes, P-4050466 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Azevedo, JE (corresponding author), IBMC UP, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	Jazevedo@ibmc.up.pt	Gouveia, Alexandra/P-3525-2016; Azevedo, Jorge E/A-4113-2008; sá Miranda, Maria Clara/K-3920-2013	Gouveia, Alexandra/0000-0001-8784-4246; Azevedo, Jorge E/0000-0001-7714-5302; sá Miranda, Maria Clara/0000-0003-0123-5525; Oliveira, Marcia/0000-0003-2437-2004; Reguenga, Carlos/0000-0003-1219-9961				Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Chang CC, 1999, J CELL BIOL, V147, P761, DOI 10.1083/jcb.147.4.761; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; HARTL FU, 1985, ARCH BIOCHEM BIOPHYS, V237, P124, DOI 10.1016/0003-9861(85)90261-9; Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7; Huang Y, 2000, BIOCHEM BIOPH RES CO, V270, P717, DOI 10.1006/bbrc.2000.2510; KIMURA C, 1984, J BIOCHEM, V96, P1463, DOI 10.1093/oxfordjournals.jbchem.a134975; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YF, 1999, AM J HUM GENET, V65, P621, DOI 10.1086/302534; MERRIL CR, 1990, METHOD ENZYMOL, V182, P477; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Rehling P, 2000, J BIOL CHEM, V275, P3593, DOI 10.1074/jbc.275.5.3593; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17299; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Will GK, 1999, MOL CELL BIOL, V19, P2265	32	78	78	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29935	29942		10.1074/jbc.M104114200	http://dx.doi.org/10.1074/jbc.M104114200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397814	hybrid			2022-12-27	WOS:000170558000045
J	Germain, RN				Germain, RN			The T cell receptor for antigen: Signaling and ligand discrimination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PEPTIDE-MHC COMPLEXES; IMMUNOLOGICAL SYNAPSE; BINDING-SITE; CLASS-I; TYROSINE KINASES; MEMBRANE DOMAINS; LIPID RAFTS; ACTIVATION; CD4; TRANSDUCTION		NIAID, Immunol Lab, Lymphocyte Biol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Immunol Lab, Lymphocyte Biol Sect, NIH, Bldg 10,Rm 11N311,10 Ctr Dr,MSC-1892, Bethesda, MD 20892 USA.	rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019					Bosselut R, 1999, J EXP MED, V190, P1517, DOI 10.1084/jem.190.10.1517; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; Catipovic B, 1996, J BIOL CHEM, V271, P9698, DOI 10.1074/jbc.271.16.9698; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1992, CURR OPIN IMMUNOL, V4, P246, DOI 10.1016/0952-7915(92)90072-M; Chan C, 2001, P NATL ACAD SCI USA, V98, P5758, DOI 10.1073/pnas.101113698; Chau LA, 1998, J EXP MED, V187, P1699, DOI 10.1084/jem.187.10.1699; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Delon J, 2000, CURR BIOL, V10, pR214, DOI 10.1016/S0960-9822(00)00392-4; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; JAMESON SC, 1995, IMMUNITY, V2, P1, DOI 10.1016/1074-7613(95)90074-8; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Krummel M, 2000, PHILOS T ROY SOC B, V355, P1071, DOI 10.1098/rstb.2000.0644; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MAX EE, 1999, FUNDAMENTAL IMMUNOLO, P111; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; PORTOLES P, 1989, IMMUNOL REV, V109, P77; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; Shaw A, 1991, CURR OPIN CELL BIOL, V3, P862, DOI 10.1016/0955-0674(91)90061-3; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Ward ES, 1997, CURR OPIN IMMUNOL, V9, P97, DOI 10.1016/S0952-7915(97)80165-3; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 2000, SEMIN IMMUNOL, V12, P35, DOI 10.1006/smim.2000.0205	68	53	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2001	276	38					35223	35226		10.1074/jbc.R100025200	http://dx.doi.org/10.1074/jbc.R100025200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474LU	11435448	hybrid			2022-12-27	WOS:000171109300001
J	Gupta-Rossi, N; Le Bail, O; Gonen, H; Brou, C; Logeat, F; Six, E; Ciechanover, A; Israel, A				Gupta-Rossi, N; Le Bail, O; Gonen, H; Brou, C; Logeat, F; Six, E; Ciechanover, A; Israel, A			Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RBP-J-KAPPA; INTRACELLULAR DOMAIN; UBIQUITIN LIGASE; SIGNAL-TRANSDUCTION; PROTEOLYTIC RELEASE; NEOPLASTIC LESIONS; BETA-TRCP; IN-VIVO; CLEAVAGE; TRANSCRIPTION	The Notch signaling pathway is essential in many cell fate decisions in invertebrates as well as in vertebrates. After ligand binding, a two-step proteolytic cleavage releases the intracellular part of the receptor which translocates to the nucleus and acts as a transcriptional activator. Although Notch-induced transcription of genes has been reported extensively, its endogenous nuclear form has been seldom visualized. We report that the nuclear intracellular domain of Notch1 is stabilized by proteasome inhibitors and is a substrate for polyubiquitination in vitro. SEL-10, an F-box protein of the Cdc4 family, was isolated in a genetic screen for Lin12/Notch-negative regulators in Caenorhabditis elegans. We isolated human and murine counterparts of SEL-10 and investigated the role of a dominant-negative form of this protein, deleted of the F-box, on Notch1 stability and activity. This molecule could stabilize intracellular Notch1 and enhance its transcriptional activity but had no effect on inactive membrane-anchored forms of the receptor. We then demonstrated that SEL-10 specifically interacts with nuclear forms of Notch1 and that this interaction requires a phosphorylation event. Taken together, these data suggest that SEL-10 is involved in shutting off Notch signaling by ubiquitin-proteasome-mediated degradation of the Active transcriptional factor after a nuclear phosphorylation event.	Inst Pasteur, CNRS, FRE 2364, Unite Biol Mol Express Gen, F-75724 Paris 15, France; Technion Israel Inst Technol, Fac Med, Dept Biochem, IL-31096 Haifa, Israel	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Israel, A (corresponding author), Inst Pasteur, CNRS, FRE 2364, Unite Biol Mol Express Gen, 25 Rue Dr Roux, F-75724 Paris 15, France.	aisrael@pasteur.fr	Six, Emmanuelle/H-7891-2017; Ciechanover, Aaron J/C-9166-2017; Gupta-Rossi, Neetu/AAE-3117-2022	Six, Emmanuelle/0000-0001-7806-0968; Gupta-Rossi, Neetu/0000-0003-0043-264X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 1997, J BIOL CHEM, V272, P11336; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray S, 1998, CELL, V93, P499, DOI 10.1016/S0092-8674(00)81180-0; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Cornell M, 1999, GENETICS, V152, P567; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Floyd ZE, 2001, J BIOL CHEM, V276, P22468, DOI 10.1074/jbc.M009388200; Gridley T, 1997, MOL CELL NEUROSCI, V9, P103, DOI 10.1006/mcne.1997.0610; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; NYE JS, 1994, DEVELOPMENT, V120, P2421; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Ronchini C, 2000, ONCOGENE, V19, P3914, DOI 10.1038/sj.onc.1203719; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 1999, P NATL ACAD SCI USA, V96, P11382, DOI 10.1073/pnas.96.20.11382; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wu GY, 1998, P NATL ACAD SCI USA, V95, P15787, DOI 10.1073/pnas.95.26.15787; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414	53	297	302	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34371	34378		10.1074/jbc.M101343200	http://dx.doi.org/10.1074/jbc.M101343200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11425854	hybrid			2022-12-27	WOS:000171024600004
J	Han, YW; Iwasaki, H; Miyata, T; Mayanagi, K; Yamada, K; Morikawa, K; Shinagawa, H				Han, YW; Iwasaki, H; Miyata, T; Mayanagi, K; Yamada, K; Morikawa, K; Shinagawa, H			A unique beta-hairpin protruding from AAA(+) ATPase domain of RuvB motor protein is involved in the interaction with RuvA DNA recognition protein for branch migration of Holliday junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RUVA; CRYSTAL-STRUCTURE; HEXAMERIC RINGS; RECOMBINATION; BINDING; COMPLEX; REPAIR	The Escherichia coh RuvB protein is a motor protein that forms a complex with RuvA and promotes branch migration of Holliday junctions during homologous recombination. This study describes the characteristics of two RuvB mutants, I148T and I150T, that do not promote branch migration in the presence of RuvA. These RuvB mutants hydrolyzed ATP and bound duplex DNA with the same efficiency as wild-type RuvB, but the mutants did not form a complex with RuvA and were defective in loading onto junction DNA in a RuvA-assisted manner. A recent crystallographic study revealed that Ile(148) and Ile(150) are in a unique beta -hairpin that protrudes from the AAA(+) ATPase domain of RuvB. We propose that this beta -hairpin interacts with hydrophobic residues in the mobile third domain of RuvA and that this interaction is vital for the RuvA-assisted loading of RuvB onto Holliday junction DNA.	Osaka Univ, Microbial Dis Res Inst, Osaka 5650871, Japan; Japan Sci & Technol Corp, Precursory Res Embyron Sci & Technol, Osaka 5650871, Japan; Biomol Engn Res Inst, Osaka 5650874, Japan	Osaka University; Japan Science & Technology Agency (JST)	Iwasaki, H (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.		Han, Yong-Woon/L-2426-2017; Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873				Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Hishida T, 1999, J BIOL CHEM, V274, P25335, DOI 10.1074/jbc.274.36.25335; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Iwasaki H, 2000, MOL MICROBIOL, V36, P528, DOI 10.1046/j.1365-2958.2000.01842.x; IWASAKI H, 1992, GENE DEV, V6, P2214, DOI 10.1101/gad.6.11.2214; MITCHELL AH, 1994, J MOL BIOL, V243, P208, DOI 10.1006/jmbi.1994.1648; Miyata T, 2000, J STRUCT BIOL, V131, P83, DOI 10.1006/jsbi.2000.4290; Nishino T, 1998, STRUCTURE, V6, P11, DOI 10.1016/S0969-2126(98)00003-3; Nishino T, 2000, J MOL BIOL, V298, P407, DOI 10.1006/jmbi.2000.3675; Ohnishi T, 2000, GENES GENET SYST, V75, P233, DOI 10.1266/ggs.75.233; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Sambrook J., 2002, MOL CLONING LAB MANU; SHIBA T, 1993, MOL GEN GENET, V237, P395, DOI 10.1007/BF00279443; SHIBA T, 1991, P NATL ACAD SCI USA, V88, P8445, DOI 10.1073/pnas.88.19.8445; Shinagawa H, 1996, TRENDS BIOCHEM SCI, V21, P107, DOI 10.1016/0968-0004(96)10014-1; STASIAK A, 1994, P NATL ACAD SCI USA, V91, P7618, DOI 10.1073/pnas.91.16.7618; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Yamada K, 1999, MOL GEN GENET, V261, P1001, DOI 10.1007/s004380051049; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yu X, 1997, J MOL BIOL, V266, P217, DOI 10.1006/jmbi.1996.0799	24	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					35024	35028		10.1074/jbc.M103611200	http://dx.doi.org/10.1074/jbc.M103611200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11427534	hybrid			2022-12-27	WOS:000171024600090
J	Lindorff-Larsen, K; Lerche, MH; Poulsen, FM; Roepstorff, P; Winther, JR				Lindorff-Larsen, K; Lerche, MH; Poulsen, FM; Roepstorff, P; Winther, JR			Barley lipid transfer protein, LTP1, contains a new type of lipid-like post-translational modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; STRUCTURAL CHARACTERIZATION; SPOROTHRIX FLOCCULOSA; MASS-SPECTROMETRY; BINDING; GENE; SPECTROSCOPY; EXPRESSION; FAMILY; BEER	In plants a group of proteins termed nonspecific lipid transfer proteins are found. These proteins bind and catalyze transfer of lipids in vitro, but their in vivo function is unknown. They have been suggested to be involved in different aspects of plant physiology and cell biology, including the formation of cutin and involvement in stress and pathogen responses, but there is yet no direct demonstration of an in vivo function. We have found and characterized a novel post-translational modification of the barley nonspecific lipid transfer protein, LTP1. The protein-modification bond is of a new type in which an aspartic acid in LTP1 is bound to the modification through what most likely is an ester bond. The chemical structure of the modification has been characterized by means of two-dimensional homo- and heteronuclear nuclear magnetic resonance spectroscopy as well as mass spectrometry and is found to be lipid-like in nature. The modification does not resemble any standard lipid post-translational modification but is similar to a compound with known antimicrobial activity.	Carlsberg Lab, Dept Yeast Genet, DK-2500 Copenhagen, Denmark; Inst Mol Biol, Dept Prot Chem, DK-1353 Copenhagen K, Denmark; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Southern Denmark	Winther, JR (corresponding author), Carlsberg Lab, Dept Yeast Genet, Gamle Carlsberg Vej 10, DK-2500 Copenhagen, Denmark.	jnv@crc.dk	Poulsen, Flemming M/E-6848-2010; Lindorff-Larsen, Kresten/K-6469-2014; Winther, Jakob R./K-4451-2014; Lerche, Mathilde Hauge/J-5487-2017	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Winther, Jakob R./0000-0001-6995-9154; Lerche, Mathilde Hauge/0000-0002-5899-2781				Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Avis TJ, 2001, APPL ENVIRON MICROB, V67, P956, DOI 10.1128/AEM.67.2.956-960.2001; BELL RP, 1941, ACID BASE CATALYSIS, P1; Benyagoub M, 1996, J CHEM ECOL, V22, P405, DOI 10.1007/BF02033644; BIZZOZERO OA, 1995, METHOD ENZYMOL, V250, P361; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; BOX A, 1986, J AM CHEM SOC, V108, P2093; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CHOUDHURY SR, 1994, J NAT PROD, V57, P700, DOI 10.1021/np50108a003; Douliez JP, 2000, BBA-BIOMEMBRANES, V1467, P65, DOI 10.1016/S0005-2736(00)00197-8; Douliez JP, 2000, J CEREAL SCI, V32, P1, DOI 10.1006/jcrs.2000.0315; Douliez JP, 2001, J AGR FOOD CHEM, V49, P1805, DOI 10.1021/jf001327m; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUNN MA, 1991, MOL GEN GENET, V229, P389, DOI 10.1007/BF00267460; Evans DE, 1999, J I BREWING, V105, P159; Han GW, 2001, J MOL BIOL, V308, P263, DOI 10.1006/jmbi.2001.4559; Heinemann B, 1996, PROTEIN SCI, V5, P13; Jegou S, 2000, J AGR FOOD CHEM, V48, P5023, DOI 10.1021/jf000075m; Kader JC, 1997, TRENDS PLANT SCI, V2, P66, DOI 10.1016/S1360-1385(97)82565-4; KADER JC, 1975, BIOCHIM BIOPHYS ACTA, V380, P31, DOI 10.1016/0005-2760(75)90042-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUMAR A, 1981, J AM CHEM SOC, V103, P3654, DOI 10.1021/ja00403a008; Kupce E, 2001, J MAGN RESON, V148, P115, DOI 10.1006/jmre.2000.2224; Lerche MH, 1997, STRUCTURE, V5, P291, DOI 10.1016/S0969-2126(97)00186-X; Lerche MH, 1998, PROTEIN SCI, V7, P2490, DOI 10.1002/pro.5560071202; LUSK LT, 1995, J AM SOC BREW CHEM, V53, P93; MOLINA A, 1993, FEBS LETT, V316, P119, DOI 10.1016/0014-5793(93)81198-9; MUNDY J, 1986, PLANTA, V169, P51, DOI 10.1007/BF01369775; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Roepstorff P, 1997, CURR OPIN BIOTECH, V8, P6, DOI 10.1016/S0958-1669(97)80151-6; SATTLER W, 1991, ANAL BIOCHEM, V198, P184, DOI 10.1016/0003-2697(91)90526-Y; SHAPIRO S, 1996, ORAL MICROBIOL IMMUN, V5, P350; SORENSEN SB, 1993, MBAA TECH Q, V30, P136; STERK P, 1991, PLANT CELL, V3, P907, DOI 10.1105/tpc.3.9.907; SVENSSON B, 1986, CARLSBERG RES COMMUN, V51, P493, DOI 10.1007/BF02906891; TORRESSCHUMANN S, 1992, PLANT MOL BIOL, V18, P749, DOI 10.1007/BF00020016; Trevino MB, 1998, PLANT PHYSIOL, V116, P1461, DOI 10.1104/pp.116.4.1461; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wheelan P, 1996, J AM SOC MASS SPECTR, V7, P129, DOI 10.1016/1044-0305(95)00629-X; WHEELAN P, 1993, BIOL MASS SPECTROM, V22, P465, DOI 10.1002/bms.1200220808; Zachowski A, 1998, EUR J BIOCHEM, V257, P443, DOI 10.1046/j.1432-1327.1998.2570443.x; [No title captured]	45	36	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33547	33553		10.1074/jbc.M104841200	http://dx.doi.org/10.1074/jbc.M104841200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435437	hybrid			2022-12-27	WOS:000170910200036
J	Ryser, S; Tortola, S; van Haasteren, G; Muda, M; Li, SL; Schlegel, W				Ryser, S; Tortola, S; van Haasteren, G; Muda, M; Li, SL; Schlegel, W			MAP kinase phosphatase-1 gene transcription in rat neuroendocrine cells is modulated by a calcium-sensitive block to elongation in the first exon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; THYROTROPIN-RELEASING-HORMONE; FOS MESSENGER-RNA; C-FOS; PITUITARY-CELLS; CATALYTIC ACTIVATION; TYROSINE-PHOSPHATASE; EXPRESSION; INDUCTION; CA2+	Transcriptional elongation of many eukaryotic, prokaryotic, and viral genes is tightly controlled, which contributes to gene regulation. Here we describe this phenomenon for the MAP kinase phosphatase 1 (MKP-1) immediate early gene. In rat GH4C1 pituitary cells, MKP-1 mRNA is rapidly and transiently induced by the thyrotropin-releasing hormone (TRH) and the epidermal growth factor EGF via transcriptional activation of the gene. Ca2+ signals are necessary for the induction of MKP-1 in response to TRH but not to EGF. Reporter gene analysis with the newly cloned rat promoter sequence shows only limited induction in response to various stimuli, including TRH or EGF. By nuclear run-on assays we demonstrate that in basal conditions, a strong block to elongation in the first exon regulates the MKP-1 gene and that stimulation with either TRH or EGF overcomes the block. Ca2+ signals are important to release the MKP-1 elongation block in a manner similar to the c-fos oncogene. These results suggest that a common mechanism of intragenic regulation may be conserved between MKP-1 and c-fos in mammalian cells.	Univ Geneva, Fondat Rech Med, CH-1211 Geneva, Switzerland	University of Geneva	Schlegel, W (corresponding author), Univ Geneva, Fondat Rech Med, 64 Av Roseraie, CH-1211 Geneva, Switzerland.	werner.schlegel@medecine.unige.ch						BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BIRAGYN A, 1995, J IMMUNOL, V155, P674; BIUNNO I, 1988, BRIT J CANCER, V57, P464, DOI 10.1038/bjc.1988.108; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; CARR FE, 1993, ENDOCRINOLOGY, V133, P1700, DOI 10.1210/en.133.4.1700; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CHARLES CH, 1992, ONCOGENE, V7, P187; COLLART MA, 1987, J IMMUNOL, V139, P949; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Coulon V, 1999, J BIOL CHEM, V274, P30439, DOI 10.1074/jbc.274.43.30439; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; EICK D, 1994, ANAL BIOCHEM, V218, P347, DOI 10.1006/abio.1994.1190; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GOURDJI D, 1982, FRONT NEUROENDOCRIN, V7, P317; Guo YL, 1998, J BIOL CHEM, V273, P10362, DOI 10.1074/jbc.273.17.10362; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KWAK SP, 1994, J BIOL CHEM, V269, P3596; Laderoute KR, 1999, J BIOL CHEM, V274, P12890, DOI 10.1074/jbc.274.18.12890; Leav I, 1996, LAB INVEST, V75, P361; LEE G, 1994, MOL CELL BIOL, V14, P4579, DOI 10.1128/MCB.14.7.4579; Li SL, 1996, J MOL ENDOCRINOL, V16, P229, DOI 10.1677/jme.0.0160229; LI SL, 1994, J MOL ENDOCRINOL, V13, P303, DOI 10.1677/jme.0.0130303; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; Loda M, 1996, AM J PATHOL, V149, P1553; Magi-Galluzzi C, 1998, VIRCHOWS ARCH, V432, P407, DOI 10.1007/s004280050184; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; PASSEGUE E, 1995, MOL CELL ENDOCRINOL, V107, P29, DOI 10.1016/0303-7207(94)03417-R; Pinaud S, 1998, J MOL BIOL, V280, P785, DOI 10.1006/jmbi.1998.1905; PLET A, 1995, ONCOGENE, V10, P319; SCHLEGEL W, 1987, NATURE, V329, P719, DOI 10.1038/329719a0; SCHLEGEL W, 1984, J CELL BIOL, V99, P83, DOI 10.1083/jcb.99.1.83; Scimeca JC, 1997, ONCOGENE, V15, P717, DOI 10.1038/sj.onc.1201231; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0; SPENCER CA, 1990, ONCOGENE, V5, P777; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Susini S, 2000, FASEB J, V14, P128, DOI 10.1096/fasebj.14.1.128; Tashjian A H Jr, 1979, Methods Enzymol, V58, P527; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; URABE A, 1992, J PATHOL, V168, P281, DOI 10.1002/path.1711680307; van Haasteren G, 2000, NEUROENDOCRINOLOGY, V72, P368, DOI 10.1159/000054606; WALKER RA, 1991, J PATHOL, V163, P323, DOI 10.1002/path.1711630409; WERLEN G, 1993, J BIOL CHEM, V268, P16596	52	45	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33319	33327		10.1074/jbc.M102326200	http://dx.doi.org/10.1074/jbc.M102326200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11423551	hybrid			2022-12-27	WOS:000170910200007
J	Silverman, GA; Bird, PI; Carrell, RW; Church, FC; Coughlin, PB; Gettins, PGW; Irving, JA; Lomas, DA; Luke, CJ; Moyer, RW; Pemberton, PA; Remold-O'Donnell, E; Salvesen, GS; Travis, J; Whisstock, JC				Silverman, GA; Bird, PI; Carrell, RW; Church, FC; Coughlin, PB; Gettins, PGW; Irving, JA; Lomas, DA; Luke, CJ; Moyer, RW; Pemberton, PA; Remold-O'Donnell, E; Salvesen, GS; Travis, J; Whisstock, JC			The serpins are an expanding superfamily of structurally similar but functionally diverse proteins - Evolution, mechanism of inhibition, novel functions, and a revised nomenclature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PLASMINOGEN-ACTIVATOR INHIBITOR-2; CROSS-CLASS INHIBITION; ELASTASE INHIBITOR; INDUCED APOPTOSIS; POTENT INHIBITOR; TYPE-2; IDENTIFICATION; ANGIOGENESIS; NEUROSERPIN; INSERTION		Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat,Div Newborn Med, Boston, MA 02115 USA; Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England; Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge Inst Med Res, Dept Med, Cambridge CB2 2XY, England; Univ N Carolina, Div Hematol Oncol Med, Chapel Hill, NC 27599 USA; Monash Univ, Box Hill Hosp, Dept Med, Melbourne, Vic 3128, Australia; Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60612 USA; Univ Florida, Coll Med, Dept Microbiol & Mol Genet, Gainesville, FL 32610 USA; Arriva Pharmaceut, Alameda, CA 94501 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Burnham Inst, La Jolla, CA 92037 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Monash University; University of Cambridge; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; Box Hill Hospital; Monash University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Sanford Burnham Prebys Medical Discovery Institute; University System of Georgia; University of Georgia	Silverman, GA (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat,Div Newborn Med, 300 Longwood Ave,Enders 970, Boston, MA 02115 USA.		Silverman, Gary/AAJ-1269-2020; Irving, James/P-3860-2019; Irving, James A/I-8467-2015	Irving, James/0000-0003-3204-6356; Bird, Phillip/0000-0002-6695-606X; Whisstock, James/0000-0003-4200-5611				BELIN D, 1993, THROMB HAEMOSTASIS, V70, P144; Bird PI, 1999, IMMUNOL CELL BIOL, V77, P47, DOI 10.1046/j.1440-1711.1999.00787.x; Chuang TL, 1999, J BIOL CHEM, V274, P11194, DOI 10.1074/jbc.274.16.11194; Dahlen JR, 1998, J BIOL CHEM, V273, P1851, DOI 10.1074/jbc.273.4.1851; Dahlen JR, 1997, BIOCHEM BIOPH RES CO, V238, P329, DOI 10.1006/bbrc.1997.7282; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Duggan C, 1997, BRIT J CANCER, V76, P622, DOI 10.1038/bjc.1997.435; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; Gettins PGW, 2000, GENOME RES, V10, P1833, DOI 10.1101/gr.168900; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janciauskiene S, 1998, BIOESSAYS, V20, P1039, DOI 10.1002/(SICI)1521-1878(199812)20:12<1039::AID-BIES10>3.0.CO;2-Z; JENSEN PH, 1994, J BIOL CHEM, V269, P15394; Kaslik G, 1997, BIOCHEMISTRY-US, V36, P5455, DOI 10.1021/bi962931m; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Mikus P, 1996, J BIOL CHEM, V271, P10048, DOI 10.1074/jbc.271.17.10048; O'Reilly MS, 1999, SCIENCE, V285, P1926, DOI 10.1126/science.285.5435.1926; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Rees DD, 1999, AM J RESP CELL MOL, V20, P69, DOI 10.1165/ajrcmb.20.1.3306; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Renatus M, 2000, STRUCT FOLD DES, V8, P789, DOI 10.1016/S0969-2126(00)00165-9; Riewald M, 1996, J BIOL CHEM, V271, P14526, DOI 10.1074/jbc.271.24.14526; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schwartz BS, 1999, J BIOL CHEM, V274, P15278, DOI 10.1074/jbc.274.21.15278; Scott FL, 1999, GENOMICS, V62, P490, DOI 10.1006/geno.1999.6021; SHIEH BH, 1989, J BIOL CHEM, V264, P13420; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Tsujimoto M, 1997, J BIOL CHEM, V272, P15373, DOI 10.1074/jbc.272.24.15373; Yepes M, 2000, BLOOD, V96, P569; Yoo BC, 2000, J BIOL CHEM, V275, P35122, DOI 10.1074/jbc.M006060200; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	41	1000	1039	0	76	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33293	33296		10.1074/jbc.R100016200	http://dx.doi.org/10.1074/jbc.R100016200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435447	hybrid			2022-12-27	WOS:000170910200001
J	Jedrzejas, MJ; Lamani, E; Becker, RS				Jedrzejas, MJ; Lamani, E; Becker, RS			Characterization of selected strains of pneumococcal surface protein A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-REACTIVE ANTIBODIES; STREPTOCOCCUS-PNEUMONIAE; SECONDARY STRUCTURE; SEQUENCE-ANALYSIS; PSPA; PNEUMOLYSIN; PROTECTION; INFECTION; MICE; IMMUNOGENICITY	Several proteins, in addition to the polysaccharide capsule, have recently been implicated in the full virulence of the Streptococcus pneumoniae bacterial pathogen. One of these novel virulence factors of S. pneumoniae is pneumococcal surface protein A (PspA). The N-terminal, cell surface exposed, and functional part of PspA is essential for full pneumococcal virulence, as evidenced by the fact that antibodies raised against this part of the protein are protective against pneumococcal infections. PspA has recently been implicated in anticomplementary function as it reduces complement-mediated clearance and phagocytosis of pneumococci. Several recombinant N-terminal fragments of PspA from different strains of pneumococci, Px1, BG9739, BG6380, EF3296, and EF5668, were analyzed using circular dichroism, analytical ultracentrifugation sedimentation velocity and equilibrium methods, and sequence homology. Uniformly, all strains of PspA molecules studied have a high a-helical secondary structure content and they adopt predominantly a coiled-coil structure with an elongated, likely rod-like shape. No beta -sheet structures were detected for any of the PspA molecules analyzed. All PspAs were found to be monomeric in solution with the exception of the BG9739 strain which had the propensity to partially aggregate but only into a tetrameric form. These structural properties were correlated with the functional, anti-complementary properties of PspA molecules based on the polar distribution of highly charged termini of its coiled-coil domain. The recombinant Rx1 PspA is currently under consideration for pneumococcal vaccine development.	Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Aventis Pasteur, Swiftwater, PA 18370 USA	University of Alabama System; University of Alabama Birmingham; Sanofi-Aventis	Jedrzejas, MJ (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	mjedrzejas@chori.org						ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAQUERO F, 1991, J ANTIMICROB CHEMOTH, V28, P31, DOI 10.1093/jac/28.suppl_C.31; Becker RS, 1997, VACCINES, P39; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; BLANCHET C, 1997, IBCP CNRS UPR, V412; BOULNOIS GJ, 1992, J GEN MICROBIOL, V138, P249, DOI 10.1099/00221287-138-2-249; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briles DE, 1997, MICROB DRUG RESIST, V3, P401, DOI 10.1089/mdr.1997.3.401; Briles DE, 1998, CLIN MICROBIOL REV, V11, P645, DOI 10.1128/CMR.11.4.645; Briles DE, 1996, VACCINE, V14, P858, DOI 10.1016/0264-410X(96)82948-3; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRAIN MJ, 1990, INFECT IMMUN, V58, P3293, DOI 10.1128/IAI.58.10.3293-3299.1990; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; FELDMAN C, 1991, AM J RESP CELL MOL, V5, P416, DOI 10.1165/ajrcmb/5.5.416; FISCHETTI VA, 1993, INFORM PROCESS LETT, V45, P11, DOI 10.1016/0020-0190(93)90245-5; Jedrzejas MJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P116, DOI 10.1006/abbi.1999.1544; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KIRSCHENBAUM I, 1951, PHYSICAL PROPERTIES, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBOWITZ J, 1994, PROTEIN SCI, V3, P1374, DOI 10.1002/pro.5560030903; LINKER A, 1956, J BIOL CHEM, V219, P13; LOCK RA, 1988, MICROB PATHOGENESIS, V5, P461, DOI 10.1016/0882-4010(88)90007-1; MCDANIEL LS, 1984, J EXP MED, V160, P386, DOI 10.1084/jem.160.2.386; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; MCDANIEL LS, 1991, INFECT IMMUN, V59, P222, DOI 10.1128/IAI.59.1.222-228.1991; McRorie D. K., 1993, SELF ASS SYSTEMS ANA; MUFSON MA, 1990, PRINCIPLES PRACTICE, P1539; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Ralston G., 1993, INTRO ANAL ULTRACENT; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SAMPSON JS, 1994, INFECT IMMUN, V62, P319, DOI 10.1128/IAI.62.1.319-324.1994; SPIKA JS, 1991, J INFECT DIS, V163, P1273, DOI 10.1093/infdis/163.6.1273; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STANSFIELD SK, 1987, PEDIATR INFECT DIS J, V6, P622, DOI 10.1097/00006454-198707000-00002; Tuomanen E, 1999, CURR OPIN MICROBIOL, V2, P35, DOI 10.1016/S1369-5274(99)80006-X; VANHOLDE KE, 1985, PHYSICAL BIOCH; WALTMAN WD, 1990, MICROB PATHOGENESIS, V8, P61, DOI 10.1016/0882-4010(90)90008-E; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; YOTHER J, 1994, J BACTERIOL, V176, P2976, DOI 10.1128/JB.176.10.2976-2985.1994; 1985, LANCET, V2, P699	47	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33121	33128		10.1074/jbc.M103304200	http://dx.doi.org/10.1074/jbc.M103304200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11413137	hybrid			2022-12-27	WOS:000170746000098
J	Pan, L; Xie, YH; Black, TA; Jones, CA; Pruitt, SC; Gross, KW				Pan, L; Xie, YH; Black, TA; Jones, CA; Pruitt, SC; Gross, KW			An Abd-B class HOX center dot PBX recognition sequence is required for expression from the mouse Ren-1(c) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN-SYSTEM; COOPERATIVE DNA-BINDING; SEGMENTAL EXPRESSION; NUCLEAR IMPORT; MURINE REN-1; PROTEINS; SPECIFICITY; EXTRADENTICLE; COMPLEXES; ENHANCER	Expression from the mouse Ren-1(c) gene in As4.1 cells is dependent on a proximal promoter element (PPE) located at approximately -60 and a 241-base pair enhancer region located at -2625 relative to the transcription start site. The PPE (TAATAAATCAA) is identical to a consensus HOX-PBX binding sequence. Further, PBX1b has been shown to be a component of a PPE-specific binding complex present in nuclear extracts from As4.1 cells. The binding affinities of different paralog HOX members to the PPE were examined in the absence or presence of PBX1b. HOXB6, -B7, and -C8 failed to bind the PPE alone but showed weak affinity in the presence of PBX1b. In contrast, HOXD10 and to a lesser degree HOXB9 bound the PPE with high affinities regardless of whether PBX1b was present. Abd-B HOX members, including HOXD10, -A10, -A9, -B9, and -C9, are expressed in As4.1 cells. The ability of HOX and PBX1b to form a ternary complex with PREP1 on the PPE is also demonstrated both in vivo and in vitro. Point mutations in either the HOX or PBX half-site of the PPE disrupted the formation of the HOX-PBX complex and dramatically decreased transcriptional activity of the Ren-1(c) gene demonstrating that both the HOX and PBX half-sites are critical for mouse renin gene expression. These results strongly implicate Abd-B class Hox genes and their cofactors as major determinants of the sites of renin expression.	Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Gross, KW (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.	gross@acsu.buffalo.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036416] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048459] Funding Source: NIH RePORTER; NCI NIH HHS [CA16056] Funding Source: Medline; NHLBI NIH HHS [HL48459] Funding Source: Medline; NICHD NIH HHS [HD36416] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABEL KJ, 1990, GENETICS, V124, P937; ABEL KJ, 1988, NUCLEIC ACIDS RES, V16, P2111, DOI 10.1093/nar/16.5.2111; Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Botas J, 1993, CURR OPIN CELL BIOL, V5, P1015, DOI 10.1016/0955-0674(93)90086-6; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; de Gasparo M, 2000, PHARMACOL REV, V52, P415; FABIAN JR, 1989, J BIOL CHEM, V264, P17589; Ferretti E, 2000, DEVELOPMENT, V127, P155; Gomez RA, 1998, KIDNEY INT, V54, pS12, DOI 10.1046/j.1523-1755.1998.06703.x; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Jones CA, 1997, EUR J BIOCHEM, V243, P181, DOI 10.1111/j.1432-1033.1997.0181a.x; JONES CA, 1990, MOL ENDOCRINOL, V4, P375, DOI 10.1210/mend-4-3-375; Li XL, 1999, DEVELOPMENT, V126, P5581; Lu Q, 1996, MOL CELL BIOL, V16, P1632; LU QA, 1995, MOL CELL BIOL, V15, P3786; MARTIN KJ, 1990, NATURE, V346, P147, DOI 10.1038/346147a0; Neuteboom STC, 1997, MOL CELL BIOL, V17, P4696, DOI 10.1128/MCB.17.8.4696; Nishimura H, 1999, INTERNAL MED, V38, P315, DOI 10.2169/internalmedicine.38.315; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Penkov D, 2000, J BIOL CHEM, V275, P16681, DOI 10.1074/jbc.M909345199; Petrovic N, 1996, J BIOL CHEM, V271, P22499, DOI 10.1074/jbc.271.37.22499; Phelan ML, 1997, J BIOL CHEM, V272, P8635, DOI 10.1074/jbc.272.13.8635; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Schutz S, 1996, AM J PATHOL, V149, P2067; SCOTT MP, 1993, NUCLEIC ACIDS RES, V21, P1687, DOI 10.1093/nar/21.8.1687; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shen WF, 1999, MOL CELL BIOL, V19, P3051; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; SIGMUND CD, 1991, HYPERTENSION, V18, P446, DOI 10.1161/01.HYP.18.4.446; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; SUN JD, 1993, J BIOL CHEM, V268, P1505; White RAH, 2000, MECH DEVELOP, V91, P217, DOI 10.1016/S0925-4773(99)00306-8; WILSON JX, 1984, ENDOCR REV, V5, P45, DOI 10.1210/edrv-5-1-45; Wintour EM, 1997, TRENDS ENDOCRIN MET, V8, P199	46	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32489	32494		10.1074/jbc.M011541200	http://dx.doi.org/10.1074/jbc.M011541200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432851	hybrid			2022-12-27	WOS:000170746000017
J	Winkler, GS; Petrakis, TG; Ethelberg, S; Tokunaga, M; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Winkler, GS; Petrakis, TG; Ethelberg, S; Tokunaga, M; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ			RNA polymerase II elongator holoenzyme is composed of two discrete subcomplexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; HISTONE ACETYLTRANSFERASE; PROTEIN; MEDIATOR; YEAST; SENSITIVITY; COMPLEXES; SUBUNIT; ROLES	Elongator is a histone acetyltransferase complex that associates with the elongating form of RNA polymerase IL We purified Elongator to virtual homogeneity via a rapid three-step procedure based largely on affinity chromatography. The purified factor, holo-Elongator, is a labile six-subunit factor composed of two discrete subcomplexes: one comprised of the previously identified Elp1, Elp2, and Elp3 proteins and another comprised of three novel polypeptides, termed Elp4, Elp5, and Elp6. Disruption of the yeast genes encoding the new Elongator proteins confers phenotypes indistinguishable from those previously described for the other elp mutants, and concomitant disruption of genes encoding proteins in either subcomplex does not confer new phenotypes. Taken together, our results indicate that holo-Elongator is a functional entity in vitro as well as in vivo. Metazoan homologues of Elp1 and Elp3 have previously been reported. We cloned the human homologue of yeast ELP4 and show that this gene is ubiquitously expressed in human tissues.	Imperial Canc Res Fund, Clare Hall Labs, Mechanisms Gene Transcript Lab, S Mimms EN6 3LD, Herts, England; Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Kagoshima University; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Mechanisms Gene Transcript Lab, Blanche Lane, S Mimms EN6 3LD, Herts, England.			Tempst, Paul/0000-0002-6680-3987; Svejstrup, Jesper/0000-0003-4964-6147; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Winkler, Sebastiaan/0000-0002-0476-162X; Ethelberg, Steen/0000-0002-9709-356X	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fellows J, 2000, J BIOL CHEM, V275, P12896, DOI 10.1074/jbc.275.17.12896; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; JONES EW, 1977, GENETICS, V85, P23; Lui M, 1996, ANAL BIOCHEM, V241, P156, DOI 10.1006/abio.1996.0393; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Miles C, 1998, P NATL ACAD SCI USA, V95, P13068, DOI 10.1073/pnas.95.22.13068; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; SIKORSKI RS, 1989, GENETICS, V122, P19; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOKUNAGA M, 1989, NUCLEIC ACIDS RES, V17, P3435, DOI 10.1093/nar/17.9.3435; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; USHEVA A, 1992, CELL, V69, P871, DOI 10.1016/0092-8674(92)90297-P; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yajima H, 1997, BIOSCI BIOTECH BIOCH, V61, P704, DOI 10.1271/bbb.61.704; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	26	136	149	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32743	32749		10.1074/jbc.M105303200	http://dx.doi.org/10.1074/jbc.M105303200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435442	hybrid			2022-12-27	WOS:000170746000050
J	Beall, MJ; Pearce, EJ				Beall, MJ; Pearce, EJ			Human transforming growth factor-beta activates a receptor serine/threonine kinase from the intravascular parasite Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I RECEPTOR; SIGNAL-TRANSDUCTION; LARVAL DEVELOPMENT; SMAD PROTEINS; SCID MICE; ACTIVIN; PHOSPHORYLATION; IDENTIFICATION; SPECIFICITY; COMPLEXES	The biology of the helminth parasite Schistosoma mansoni is closely integrated with that of its mammalian host. SmRK1, a divergent type I transforming growth factor-beta (TGF-beta) receptor of unknown ligand specificity, was previously identified as a candidate for a receptor that allows schistosomes to respond to host-derived growth factors. The TGF-beta family includes activin, bone morphogenetic proteins (BMPs), and TGF-beta, all of which can play crucial roles in metazoan development. The downstream signaling protein of receptors that respond to TGF-beta and activin is Smad2, whereas the receptors that respond to BMPs signal via Smad1. When a constitutively active mutant of SmRK1 was overexpressed with either schistosome Smad1 (SmSmad1) or SmSmad2, a receptor-dependent modulation of SmSmad phosphorylation and luciferase reporter activity occurred only with SmSmad2. To evaluate potential ligand activators of SmRK1, a chimeric receptor containing the extracellular domain of SmRK1 joined to the intracellular. lar domain of the human type I TGF-beta receptor was used. The chimeric receptor bound radiolabeled TGF-beta and could activate a luciferase reporter gene in response to both TGF-beta1 and TGF-beta3 but not BMP7. Confirmatory results were obtained using full-length SmRK1. These experiments implicate TGF-beta as a ligand for SmRK1 and as a potential host-derived regulator of parasite growth and development.	Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA	Cornell University	Pearce, EJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.				NIAID NIH HHS [AI30985, F32-AI10513] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI030985, F32AI010513] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Basch P, 1991, SCHISTOSOMES DEV REP; Beall MJ, 2000, MOL BIOCHEM PARASIT, V111, P131, DOI 10.1016/S0166-6851(00)00307-8; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Cheever AW, 1999, INFECT IMMUN, V67, P2201, DOI 10.1128/IAI.67.5.2201-2208.1999; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Das P, 1999, GENES CELLS, V4, P123, DOI 10.1046/j.1365-2443.1999.00244.x; Davies SJ, 1998, J BIOL CHEM, V273, P11234, DOI 10.1074/jbc.273.18.11234; Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; GomezEscobar N, 1997, GENE, V199, P101, DOI 10.1016/S0378-1119(97)00353-3; Gunther CV, 2000, DEVELOPMENT, V127, P3337; Kawabata M, 1999, J BIOCHEM, V125, P9, DOI 10.1093/oxfordjournals.jbchem.a022273; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McGonigle S, 2001, MOL BIOCHEM PARASIT, V114, P119, DOI 10.1016/S0166-6851(01)00232-8; McGonigle S, 2001, FEBS LETT, V490, P65, DOI 10.1016/S0014-5793(01)02133-0; Mehra A, 2000, METH MOL B, V142, P67; Nakao A, 1997, J BIOL CHEM, V272, P2896, DOI 10.1074/jbc.272.5.2896; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Osman A, 2001, J BIOL CHEM, V276, P10072, DOI 10.1074/jbc.M005933200; Pearce E. J., 1994, Parasitic infections and the immune system., P203; Persson U, 1997, J BIOL CHEM, V272, P21187, DOI 10.1074/jbc.272.34.21187; VIVIEN D, 1995, J BIOL CHEM, V270, P7134, DOI 10.1074/jbc.270.13.7134; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1	35	58	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31613	31619		10.1074/jbc.M104685200	http://dx.doi.org/10.1074/jbc.M104685200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11406634	hybrid			2022-12-27	WOS:000170613500021
J	De la Cruz, EM; Ostap, EM; Sweeney, HL				De la Cruz, EM; Ostap, EM; Sweeney, HL			Kinetic mechanism and regulation of myosin VI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED ATP HYDROLYSIS; UNCONVENTIONAL MYOSIN; F-ACTIN; PHOSPHORYLATION; KINESIN; MOTOR; HEAD; BINDING; DOMAIN; KINASE	Myosin VI is the only pointed end-directed myosin identified and is likely regulated by heavy chain phosphorylation (HCP) at the actin-binding site in vivo. We undertook a detailed kinetic analysis of the actomyosin VI ATPase cycle to determine whether there are unique adaptations to support reverse directionality and to determine the molecular basis of regulation by HCP. ADP release is the rate-limiting step in the cycle. ATP binds slowly and with low affinity. At physiological nucleotide concentrations, myosin VI is strongly bound to actin and populates the nucleotide-free (rigor) and ADP-bound states. Therefore, myosin VI is a high duty ratio motor adapted for maintaining tension and has potential to be processive. A mutant mimicking HCP increases the rate of P-i release, which lowers the K-ATPase, but does not affect ADP release. These measurements are the first to directly measure the steps regulated by HCP for any myosin. Measurements with double-headed myosin VI demonstrate that the heads are not independent, and the native dimer hydrolyzes multiple ATPs per diffusional encounter with an actin filament. We propose an alternating site model for the stepping and processivity of two-headed high duty ratio myosins.	Univ Penn, Sch Med, Dept Physiol, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania	Sweeney, HL (corresponding author), Univ Penn, Sch Med, Dept Physiol, Penn Muscle Inst, A700 Richards Bldg,3700 Hamilton Walk, Philadelphia, PA 19104 USA.		Sweeney, H Lee/F-1862-2010		NIAMS NIH HHS [AR35661] Funding Source: Medline; NIGMS NIH HHS [GM57247, R01 GM057247] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057247, R01GM057247] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBANESI JP, 1983, J BIOL CHEM, V258, P176; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; Brzeska H, 1996, J BIOL CHEM, V271, P27056, DOI 10.1074/jbc.271.43.27056; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Kelleher JF, 2000, CURR BIOL, V10, P1489, DOI 10.1016/S0960-9822(00)00828-9; Mehta A, 2001, J CELL SCI, V114, P1981; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERMALL V, 1994, NATURE, V369, P560, DOI 10.1038/369560a0; Ostap EM, 1996, J CELL BIOL, V132, P1053, DOI 10.1083/jcb.132.6.1053; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang ZY, 1998, P NATL ACAD SCI USA, V95, P15200, DOI 10.1073/pnas.95.26.15200; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wu CL, 1996, J BIOL CHEM, V271, P31787, DOI 10.1074/jbc.271.50.31787; Xing J, 2000, J BIOL CHEM, V275, P35413, DOI 10.1074/jbc.M004232200; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; YOUNT RG, 1995, BIOPHYS J, V68, pS44	36	190	191	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32373	32381		10.1074/jbc.M104136200	http://dx.doi.org/10.1074/jbc.M104136200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423557	hybrid			2022-12-27	WOS:000170613500120
J	Kansra, V; Groves, C; Gutierrez-Ramos, JC; Polakiewicz, RD				Kansra, V; Groves, C; Gutierrez-Ramos, JC; Polakiewicz, RD			Phosphatidylinositol 3-kinase-dependent extracellular calcium influx is essential for CX(3)CR1-mediated activation of the mitogen-activated protein kinase cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; SIGNAL-REGULATED KINASE; CA2+ CHANNELS; PHOSPHOINOSITIDE 3-KINASE; CHEMOKINE RECEPTORS; COUPLED RECEPTORS; GAMMA; CELLS; INHIBITION; PATHWAY	Fractalkine, the first member of the CX3C chemokine family, induces leukocyte chemotaxis through activation of its high affinity receptor, CX(3)CR1. Like other chemokine receptors, CX(3)CR1 is coupled to a pertussis toxin-sensitive heterotrimeric G(i) protein, which is necessary for rapid rise in the concentration of intracellular calcium. Using a Chinese hamster ovary cell line stably transfected with the CX(3)CR1 receptor, we show that the source of calcium mobilized by fractalkine stimulation is the extracellular pool. Calcium influx is blocked by extracellular calcium chelators, as well as by divalent heavy metals such as Ni2+, Co2+, and Cd2+ without affecting the integrity of intracellular stores. Remarkably, selective phosphoinositide 3-kinase (PI3K) inhibitors, wortmannin and LY294002, abolish the wave extracellular calcium, suggesting that an active PI3K is necessary for this event. The influx of extracellular calcium is in turn required to trigger the activation of the p42/44 mitogen-activated protein/extracellular signal-regulated kinase pathway, but is not necessary for other signals downstream to PI3K, such as phosphorylation of Akt. The potential role of this signaling cascade in fractalkine-mediated chemotaxis is discussed.	Cell Signaling Technol, Beverly, MA 01915 USA; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Polakiewicz, RD (corresponding author), Cell Signaling Technol, Beverly, MA 01915 USA.	rpolakiewicz@cellsignal.com						Barritt GJ, 1999, BIOCHEM J, V337, P153, DOI 10.1042/0264-6021:3370153; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Blaheta RA, 1998, IMMUNOLOGY, V94, P213, DOI 10.1046/j.1365-2567.1998.00504.x; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; CHEN CF, 1988, SCIENCE, V239, P1024, DOI 10.1126/science.2449730; Chen SH, 1998, J EXP MED, V188, P193, DOI 10.1084/jem.188.1.193; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hsu AL, 2000, J BIOL CHEM, V275, P16242, DOI 10.1074/jbc.M002077200; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lijnen P, 1998, AM J HYPERTENS, V11, P1461, DOI 10.1016/S0895-7061(98)00179-4; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Monteil A, 2000, J BIOL CHEM, V275, P6090, DOI 10.1074/jbc.275.9.6090; Mulvaney JM, 1999, J BIOL CHEM, V274, P29796, DOI 10.1074/jbc.274.42.29796; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Polakiewicz RD, 1998, J BIOL CHEM, V273, P12402, DOI 10.1074/jbc.273.20.12402; Polakiewicz RD, 1998, J BIOL CHEM, V273, P23534, DOI 10.1074/jbc.273.36.23534; Ricci A, 1996, EUR J PHARMACOL, V301, P189, DOI 10.1016/0014-2999(96)00016-7; Ruiz-Velasco V, 2000, J NEUROSCI, V20, P2183; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sorin B, 1998, J BIOL CHEM, V273, P28461, DOI 10.1074/jbc.273.43.28461; Sotsios Y, 1999, J IMMUNOL, V163, P5954; SOZZANI S, 1993, J IMMUNOL, V150, P1544; Strobeck MW, 1999, J BIOL CHEM, V274, P15694, DOI 10.1074/jbc.274.22.15694; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; Tytgat J, 1996, EUR J PHARMACOL, V296, P189, DOI 10.1016/0014-2999(95)00691-5; Viard P, 1999, FASEB J, V13, P685, DOI 10.1096/fasebj.13.6.685; VINCENTEMANNZAN.M, 1999, J IMMUNOL, V163, P4001	49	45	46	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31831	31838		10.1074/jbc.M009374200	http://dx.doi.org/10.1074/jbc.M009374200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11432847	hybrid			2022-12-27	WOS:000170613500050
J	Castro-Rivera, E; Samudio, I; Safe, S				Castro-Rivera, E; Samudio, I; Safe, S			Estrogen-regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-D GENE; TRANSCRIPTION FACTOR SP1; CAMP-RESPONSIVE ELEMENT; FACTOR-KAPPA-B; GROWTH-FACTOR; MCF-7 CELLS; PROGESTERONE-RECEPTOR; INDEPENDENT ACTIVATION; PHASE PROGRESSION; DEPENDENT KINASES	Cyclin D1 gene expression is induced by 17 beta -estradiol (E2) in human breast cancer cells and is important for progression of cells through the G(1) phase of the cell cycle. The mechanism of activation of cyclin D1 is mitogen- and cell context-dependent, and this study describes the role of multiple promoter elements required for induction of cyclin D1 by E2 in estrogen receptor (ER)-positive ZR-75 breast cancer cells. Transcriptional activation of cyclin DI by E2 was dependent, in part, on a proximal cAMP-response element at -66, and this was linked to induction of protein kinase A-dependent pathways. These results contrasted to a recent report showing that induction of cyclin DI by E2 in ER-positive MCF-7 and HeLa cells was due to up-regulation of c-jun and subsequent interaction of c-Jun-ATF-2 with the CRE. Moreover, further examination of the proximal region of the cyclin D1 promoter showed that three GC-rich Spl-binding sites at -143 to -110 were also E2-responsive, and interaction of ER alpha and Sp1 proteins at these sites was confirmed by electromobility shift and chromatin immunoprecipitation assays. Thus, induction of cyclin D1 by E2 in ZR-75 cells is regulated through nuclear ER alpha /Sp1 and epigenetic protein kinase A activation pathways, and our results suggest that this mechanism may be cell context-dependent even among ER-positive breast cancer cell lines.	Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, 4466 TAMU, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu	Samudio, Ismael/D-3581-2013	Samudio, Ismael/0000-0001-8676-1035	NATIONAL CANCER INSTITUTE [R01CA076636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106, R01ES009253] Funding Source: NIH RePORTER; NCI NIH HHS [CA76636] Funding Source: Medline; NIEHS NIH HHS [ES09253, ES09106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adnane J, 1999, ONCOGENE, V18, P239, DOI 10.1038/sj.onc.1202297; Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Altucci L, 1996, ONCOGENE, V12, P2315; ARONICA SM, 1991, ENDOCRINOLOGY, V128, P2045, DOI 10.1210/endo-128-4-2045; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; CAVAILLES V, 1989, MOL ENDOCRINOL, V3, P552, DOI 10.1210/mend-3-3-552; CAVAILLES V, 1993, P NATL ACAD SCI USA, V90, P203, DOI 10.1073/pnas.90.1.203; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; ElTanani MKK, 1997, MOL ENDOCRINOL, V11, P928, DOI 10.1210/me.11.7.928; Foster JS, 1996, MOL ENDOCRINOL, V10, P488, DOI 10.1210/me.10.5.488; Gillesby BE, 1997, BIOCHEMISTRY-US, V36, P6080, DOI 10.1021/bi962131b; Hulit J, 2000, J BIOL CHEM, V275, P21203, DOI 10.1074/jbc.M000321200; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; KRISHNAN V, 1995, MOL CELL BIOL, V15, P6710; KRISHNAN V, 1994, J BIOL CHEM, V269, P15912; Kyo S, 1999, CANCER RES, V59, P5917; Lech JJ, 1996, FUND APPL TOXICOL, V30, P229, DOI 10.1006/faat.1996.0060; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; LEVENSON AS, 1994, J STEROID BIOCHEM, V51, P229, DOI 10.1016/0960-0760(94)90035-3; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; McMahon C, 1999, P NATL ACAD SCI USA, V96, P5382, DOI 10.1073/pnas.96.10.5382; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MUSGROVE EA, 1993, MOL CELL BIOL, V13, P3577, DOI 10.1128/MCB.13.6.3577; Nagata D, 2001, J BIOL CHEM, V276, P662, DOI 10.1074/jbc.M005522200; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Nurse P, 1998, NAT MED, V4, P1103, DOI 10.1038/2594; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Petz LN, 2000, MOL ENDOCRINOL, V14, P972, DOI 10.1210/me.14.7.972; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Planas-Silva MD, 1999, CANCER RES, V59, P4788; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Qin CH, 1999, ENDOCRINOLOGY, V140, P2501, DOI 10.1210/en.140.6.2501; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Salvatori L, 2000, ENDOCRINOLOGY, V141, P2266, DOI 10.1210/en.141.6.2266; Samudio I, 2001, ENDOCRINOLOGY, V142, P1000, DOI 10.1210/en.142.3.1000; Sathya G, 1997, MOL ENDOCRINOL, V11, P1994, DOI 10.1210/me.11.13.1994; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; SAVOURET JF, 1991, EMBO J, V10, P1875, DOI 10.1002/j.1460-2075.1991.tb07713.x; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sherr CJ, 2000, CANCER RES, V60, P3689; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Stoner M, 2000, J BIOL CHEM, V275, P22769, DOI 10.1074/jbc.M002188200; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; Suzuki Y, 1999, BLOOD, V93, P4264, DOI 10.1182/blood.V93.12.4264.412k27_4264_4276; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Wang F, 1998, NUCLEIC ACIDS RES, V26, P3044, DOI 10.1093/nar/26.12.3044; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Wang WL, 1998, ARCH BIOCHEM BIOPHYS, V356, P239, DOI 10.1006/abbi.1998.0782; Watanabe G, 1998, MOL CELL BIOL, V18, P3212, DOI 10.1128/MCB.18.6.3212; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097; Xie W, 2000, ENDOCRINOLOGY, V141, P2439, DOI 10.1210/en.141.7.2439; Xie W, 1999, ENDOCRINOLOGY, V140, P219, DOI 10.1210/en.140.1.219; ZACHAREWSKI TR, 1994, CANCER RES, V54, P2707; ZWIJSEN RM, 1988, GENE DEV, V12, P3488; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	81	161	173	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30853	30861		10.1074/jbc.M103339200	http://dx.doi.org/10.1074/jbc.M103339200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11410592	hybrid			2022-12-27	WOS:000170472900037
J	Corps, E; Carter, C; Karecla, P; Ahrens, T; Evans, P; Kilshaw, P				Corps, E; Carter, C; Karecla, P; Ahrens, T; Evans, P; Kilshaw, P			Recognition of E-cadherin by integrin alpha(E)beta(7) - Requirement for cadherin dimerization and implications for cadherin and integrin function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; INTRAEPITHELIAL LYMPHOCYTES; (CD103)-DEFICIENT MICE; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; CALCIUM-BINDING; TERMINAL DOMAIN; UVOMORULIN; SITE; HOMOASSOCIATION	We have investigated the importance of dimerization of E-cadherin in the heterophilic adhesive interaction between E-cadherin and integrin alpha (E)beta (7). Dimerization of cadherin molecules in parallel alignment is known to be essential for homophilic adhesion and has been attributed to Ca2+-dependent interactions in the domain 1-2 junction or to cross-intercalation of Trp2 from one molecule to the other. We have disrupted either or both of these proposed mechanisms by point mutations in E-cadherin-Fc and have tested the modified proteins for alpha (E)beta (7)-mediated cell adhesion. Prevention of Trp2 intercalation had no adverse effect on integrin-mediated adhesion, whereas disruption of Ca2+ binding permitted adhesion but with reduced efficiency. Both modifications in combination abolished recognition by alpha (E)beta (7). In EGTA, alpha (E)beta (7) adhered to wild type E-cadherin but not to the Trp2 deletion mutant. Independent evidence that the mutations prevented either or both mechanisms for dimerization is presented. The data show that dimerization is required for recognition by alpha (E)beta (7) and that it can take place by either of two mechanisms. Implications for the roles of the alpha (E) and beta (7) integrin subunits in ligand binding and for Trp2 and Ca2+ in the assembly of cadherin complexes are discussed.	Babraham Inst, Mol Immunol Programme, Cambridge CB2 4AT, England; Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Basel	Kilshaw, P (corresponding author), Babraham Inst, Mol Immunol Programme, Cambridge CB2 4AT, England.							Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1; ANDREW DP, 1994, J IMMUNOL, V153, P3847; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Beagley KW, 1998, CRIT REV IMMUNOL, V18, P237, DOI 10.1615/CritRevImmunol.v18.i3.40; Berg RW, 1999, IMMUNOL CELL BIOL, V77, P337, DOI 10.1046/j.1440-1711.1999.00832.x; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; GONZALEZ AL, 1995, TRENDS GENET, V11, P216, DOI 10.1016/S0168-9525(00)89051-4; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; Higgins JMG, 2000, J BIOL CHEM, V275, P25652, DOI 10.1074/jbc.M001228200; Huber O, 1999, J CELL SCI, V112, P4415; Karecla PI, 1996, J BIOL CHEM, V271, P30909, DOI 10.1074/jbc.271.48.30909; KARECLA PI, 1995, EUR J IMMUNOL, V25, P852, DOI 10.1002/eji.1830250333; KILSHAW PJ, 1988, IMMUNOL LETT, V18, P149, DOI 10.1016/0165-2478(88)90056-9; Kitagawa M, 2000, BIOCHEM BIOPH RES CO, V271, P358, DOI 10.1006/bbrc.2000.2636; Klingelhofer J, 2000, J CELL SCI, V113, P2829; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nakashima A, 1999, J NEURAL TRANSM, V106, P819, DOI 10.1007/s007020050202; OZAWA M, 1990, MECH DEVELOP, V33, P49, DOI 10.1016/0925-4773(90)90134-8; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; PURZONMCLAUGHLI.W, 2000, J BIOL CHEM, V275, P7795; Schon MP, 2000, J IMMUNOL, V165, P6583, DOI 10.4049/jimmunol.165.11.6583; Schon MP, 1999, J IMMUNOL, V162, P6641; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245; Strauch UG, 2001, J IMMUNOL, V166, P3506, DOI 10.4049/jimmunol.166.5.3506; Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Taraszka KS, 2000, J EXP MED, V191, P1555, DOI 10.1084/jem.191.9.1555; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; Tidswell M, 1997, J IMMUNOL, V159, P1497; Tolosa E, 1996, J IMMUNOL METHODS, V192, P165, DOI 10.1016/0022-1759(96)00042-7; Troyanovsky RB, 1999, J CELL SCI, V112, P4379; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; WEARNE SJ, 1990, FEBS LETT, V263, P23, DOI 10.1016/0014-5793(90)80696-G; Zang Q, 2000, J BIOL CHEM, V275, P22202, DOI 10.1074/jbc.M002883200	47	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30862	30870		10.1074/jbc.M101712200	http://dx.doi.org/10.1074/jbc.M101712200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413131	hybrid			2022-12-27	WOS:000170472900038
J	Ni, YG; Chen, JG; Androutsellis-Theotokis, A; Huang, CJ; Moczydlowski, E; Rudnick, G				Ni, YG; Chen, JG; Androutsellis-Theotokis, A; Huang, CJ; Moczydlowski, E; Rudnick, G			A lithium-induced conformational change in serotonin transporter alters cocaine binding, ion conductance, and reactivity of Cds-109	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DOPAMINE TRANSPORTER; CLONING; NOREPINEPHRINE; ACCESSIBILITY; EXPRESSION; PERMEATION; SUBSTRATE; RESIDUES; CYSTEINE; CHANNEL	Inactivation of serotonin transporter (SERT) expressed in HeLa cells by [2-(trimethylammonium)ethyl]-methanethiosulfonate (MTSET) occurred much more readily when Na+ in the reaction medium was replaced with Li+. This did not result from a protective effect of Na+ but rather from a Li+-specific increase in the reactivity of Cys-109 in the first external loop of the transporter. Li+ alone of the alkali cations caused this increase in reactivity. Replacing Na+ with N-methyl-D-glucamine (NMDG(+)) did not reduce the affinity of cocaine for SERT, as measured by displacement of a high affinity cocaine analog, but replacement of Na+ with Li+ led to a 2-fold increase in the KD for cocaine. The addition of either cocaine or serotonin (5-HT) protected SERT against MTSET inactivation. When SERT was expressed in Xenopus oocytes, inward currents were elicited by superfusing the cell with 5-HT (in the presence of Na+) or by replacing Na+ with Li+ but not NMDG(+). MTSET treatment of oocytes in Li+ but not in Na+ decreased both 5-HT and Li+ induced currents, although 5-HT-induced currents were inhibited to a greater extent. Na+ antagonized the effects of Li+ on both inactivation and current. These results are consistent with Li+ inducing a conformational change that exposes Cys-109, decreases cocaine affinity, and increases the uncoupled inward current.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University	Rudnick, G (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06510 USA.		Moczydlowski, Edward G/D-1734-2013	Androutsellis-Theotokis, Andreas/0000-0002-1985-4589				BLAKELY RD, 1994, J EXP BIOL, V196, P263; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen NH, 2000, J BIOL CHEM, V275, P1608, DOI 10.1074/jbc.275.3.1608; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GU H, 1994, J BIOL CHEM, V269, P7124; Gu HH, 1996, J BIOL CHEM, V271, P6911, DOI 10.1074/jbc.271.12.6911; HOFFMAN BJ, 1991, SCIENCE, V254, P579, DOI 10.1126/science.1948036; HUMPHREYS CJ, 1991, BIOCHEM SOC T, V19, P95, DOI 10.1042/bst0190095; HUMPHREYS CJ, 1994, BIOCHEMISTRY-US, V33, P9118, DOI 10.1021/bi00197a014; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P358; Kamdar G, 2001, J BIOL CHEM, V276, P4038, DOI 10.1074/jbc.M008483200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Nelson N, 1998, J NEUROCHEM, V71, P1785; PEERCE BE, 1984, J BIOL CHEM, V259, P4105; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Sonders MS, 1997, J NEUROSCI, V17, P960; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; WALL SC, 1993, MOL PHARMACOL, V43, P264	29	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30942	30947		10.1074/jbc.M104653200	http://dx.doi.org/10.1074/jbc.M104653200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11408487	hybrid			2022-12-27	WOS:000170472900048
J	Berezovska, O; Jack, C; Deng, A; Gastineau, N; Rebeck, GW; Hyman, BT				Berezovska, O; Jack, C; Deng, A; Gastineau, N; Rebeck, GW; Hyman, BT			Notch1 and amyloid precursor protein are competitive substrates for presenilin1-dependent gamma-secretase cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; CELL FATE; PRESENILIN-1 MUTATIONS; NUCLEAR TRANSLOCATION; INTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; PROTEOLYTIC RELEASE; IN-VIVO; NEURONS	Proteolytic processing of the amyloid precursor protein (APP) by beta- and gamma -secretases results in the production of a highly amyloidogenic A beta peptide, which deposits in the brains of Alzheimer's disease patients. Similar gamma -secretase processing occurs in another transmembrane protein, Notch1, releasing a potent signaling molecule, the Notch C-terminal domain. It has been shown that both events are dependent on a presenilin-dependent protease. We now test the hypothesis that activated Notch1 and APP are competitive substrates for the same proteolytic activity in neurons. Treatment of neurons with the native Notch ligand, Delta, induces endogenous Notch1 intramembraneous cleavage. and diminishes A beta production in a dose-dependent manner. Complementary experiments showed that the converse was also true. Overexpressing human APP (APP(695SW)) in neurons leads to a decrease in endogenous Notch1 signal transduction, as assessed by a CBF1 luciferase transcription assay, by Notch C-terminal domain nuclear translocation in vitro and by analysis of Notch C-terminal domain generation and Notch1 staining in vivo. In summary, two complementary approaches suggest that APP and Notch1 are physiologically relevant competitive substrates for gamma -secretase activity.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Alzheimers Dis Res Lab,Alzheimers Dis Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Alzheimers Dis Res Lab,Alzheimers Dis Unit, Rm 2009,114-16th St, Charlestown, MA 02129 USA.		Jack, Clifford R/F-2508-2010; Rebeck, George William/J-2192-2012	Jack, Clifford R/0000-0001-7916-622X; Rebeck, George William/0000-0001-6276-248X	NIA NIH HHS [P01 AG15379, AG14744] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG015379, R01AG014744] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Aster JC, 1997, J BIOL CHEM, V272, P11336; Baumeister R, 1997, Genes Funct, V1, P149; Berezovska O, 1999, MOL BRAIN RES, V69, P273, DOI 10.1016/S0169-328X(99)00119-9; Berezovska O, 1997, J NEUROPATH EXP NEUR, V56, P40, DOI 10.1097/00005072-199701000-00004; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Berezovska O, 1998, J NEUROPATH EXP NEUR, V57, P738, DOI 10.1097/00005072-199808000-00003; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chitnis AB, 1999, CURR OPIN NEUROBIOL, V9, P18, DOI 10.1016/S0959-4388(99)80003-8; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Gridley T, 1997, MOL CELL NEUROSCI, V9, P103, DOI 10.1006/mcne.1997.0610; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Jack C, 2001, MOL BRAIN RES, V87, P166, DOI 10.1016/S0169-328X(01)00010-9; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kulic L, 2000, P NATL ACAD SCI USA, V97, P5913, DOI 10.1073/pnas.100049897; LEEM J, 2000, SOC NEUR M NEW ORL A; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Nitsch RM, 2000, ANN NEUROL, V48, P913, DOI 10.1002/1531-8249(200012)48:6<913::AID-ANA12>3.3.CO;2-J; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Sudoh S, 1998, J NEUROCHEM, V71, P1535; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Wittenburg N, 2000, NATURE, V406, P306, DOI 10.1038/35018575; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	54	76	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30018	30023		10.1074/jbc.M008268200	http://dx.doi.org/10.1074/jbc.M008268200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11408475	hybrid			2022-12-27	WOS:000170558000055
J	Curcio, C; Baqui, MMA; Salvatore, D; Rihn, BH; Mohr, S; Harney, JW; Larsen, PR; Bianco, AC				Curcio, C; Baqui, MMA; Salvatore, D; Rihn, BH; Mohr, S; Harney, JW; Larsen, PR; Bianco, AC			The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING SUBUNIT; II 5-DEIODINASE; RAT-BRAIN; CLONING; DEGRADATION; ASTROCYTES; FAMILY; GENE	Types 1 and 3 iodothyronine deiodinases are known to be selenocysteine-containing enzymes. Although a putative human type 2 iodothyronine deiodinase (D2) gene (hDio2) encoding a similar selenoprotein has been identified, basal D2 activity is not selenium (Se)-dependent nor has D2 been labeled with Se-75. A human mesothelioma cell line (MSTO-211H) has recently been shown to have similar to 40-fold higher levels of hDio2 mRNA than mesothelial cells. Mesothelioma cell lysates activate thyroxine (T-4) to 3,5,3 ' -triiodothyronine with typical characteristics of D2 such as low K-m (T-4), 1.3 mi, resistance to propylthiouracil, and a short half-life (similar to 30 min). D2 activity is similar to 30-fold higher in Se-supplemented than in Se-depleted medium. An antiserum prepared against a peptide deduced from the Dio2 mRNA sequence precipitates a Se-75 protein of the predicted 31-kDa size from Se-75-labeled mesothelioma cells. Bromoadenosine 3 '5 ' cyclic monophosphate increases D2 activity and Se-75-p31 similar to2.5-fold whereas substrate (T-4) reduces both D2 activity and Se-75-p31 similar to2-3-fold. MG132 or lactacystin (10 muM), inhibitors of the proteasome pathway by which D2 is degraded, increase both D2 activity and Se-75-p31 3-4-fold and prevent the loss of D2 activity during cycloheximide or substrate (T-4) exposure. Immunocytochemical studies with affinity-purified anti-hD2 antibody show a Se-dependent increase in immunofluorescence. Thus, human D2 is encoded by hDio2 and is a member of the selenodeiodinase family accounting for its highly catalytic efficiency in T-4 activation.	Brigham & Womens Hosp, Dept Med, Div Thyroid, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Inst Natl Rech & Secur, F-54501 Vandoeuvre Les Nancy, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bianco, AC (corresponding author), Brigham & Womens Hosp, Dept Med, Div Thyroid, 77 Ave Louis Pasteur,HIM Bldg 550, Boston, MA 02115 USA.	abianco@rics.bwh.harvard.edu	Salvatore, Domenico/D-4881-2013; Bianco, Antonio C/A-4965-2008; Baqui, Munira M. A/H-5243-2013; Bianco, Antonio/AAK-6336-2020	Bianco, Antonio C/0000-0001-7737-6813; Baqui, Munira M. A/0000-0002-7945-2899; Bianco, Antonio/0000-0001-7737-6813; SALVATORE, DOMENICO/0000-0002-4556-7620	NIDDK NIH HHS [DK36256, DK58538] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036256, R01DK058538] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baqui MMA, 2000, ENDOCRINOLOGY, V141, P4309, DOI 10.1210/en.141.11.4309; Bartha T, 2000, ENDOCRINOLOGY, V141, P229, DOI 10.1210/en.141.1.229; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Buettner C, 1998, J BIOL CHEM, V273, P33374, DOI 10.1074/jbc.273.50.33374; CHANOINE JP, 1992, ENDOCRINOLOGY, V131, P1787, DOI 10.1210/en.131.4.1787; CHANOINE JP, 1992, ENDOCRINOLOGY, V131, P479, DOI 10.1210/en.131.1.479; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; FARWELL AP, 1989, J BIOL CHEM, V264, P20561; Farwell AP, 1996, J BIOL CHEM, V271, P16369, DOI 10.1074/jbc.271.27.16369; Gereben B, 2000, MOL ENDOCRINOL, V14, P1697, DOI 10.1210/me.14.11.1697; Gereben B, 1999, J BIOL CHEM, V274, P13768, DOI 10.1074/jbc.274.20.13768; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Huang SA, 2000, NEW ENGL J MED, V343, P185, DOI 10.1056/NEJM200007203430305; Kohrle J, 2000, ACTA MED AUST, V27, P1; Kohrle J, 2000, CELL MOL LIFE SCI, V57, P1853, DOI 10.1007/PL00000667; Leonard DM, 2000, J BIOL CHEM, V275, P25194, DOI 10.1074/jbc.M002036200; Leonard JL, 1999, ENDOCRINOLOGY, V140, P2206, DOI 10.1210/en.140.5.2206; LEONARD JL, 1981, SCIENCE, V214, P571, DOI 10.1126/science.7291997; LEONARD JL, 1988, BIOCHEM BIOPH RES CO, V151, P1164, DOI 10.1016/S0006-291X(88)80488-1; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Pallud S, 1997, J BIOL CHEM, V272, P18104, DOI 10.1074/jbc.272.29.18104; Rihn BH, 2000, FEBS LETT, V480, P95, DOI 10.1016/S0014-5793(00)01913-X; Safran M, 1996, J BIOL CHEM, V271, P16363, DOI 10.1074/jbc.271.27.16363; SAFRAN M, 1993, J BIOL CHEM, V268, P14224; SAFRAN M, 1991, J BIOL CHEM, V266, P13477; SAFRAN M, 1991, J BIOL CHEM, V266, P3233; Salvatore D, 1999, BIOCHIMIE, V81, P535, DOI 10.1016/S0300-9084(99)80106-0; Salvatore D, 1996, ENDOCRINOLOGY, V137, P3308, DOI 10.1210/en.137.8.3308; Salvatore D, 1996, J CLIN INVEST, V98, P962, DOI 10.1172/JCI118880; SANDSTROM BE, 1990, BIOCHEM J, V271, P17, DOI 10.1042/bj2710017; SCHNEIDER M, 2000, 12 INT THYROID C KYO; Stachelek SJ, 2000, J BIOL CHEM, V275, P31701, DOI 10.1074/jbc.M004221200; Steinsapir J, 2000, ENDOCRINOLOGY, V141, P1127, DOI 10.1210/en.141.3.1127; Steinsapir J, 1998, J CLIN INVEST, V102, P1895, DOI 10.1172/JCI4672; STGERMAIN DL, 1986, ENDOCRINOLOGY, V119, P840; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767	38	72	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30183	30187		10.1074/jbc.C100325200	http://dx.doi.org/10.1074/jbc.C100325200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11425850	hybrid			2022-12-27	WOS:000170558000078
J	Lund, AA; Rhoads, DM; Lund, AL; Cerny, RL; Elthon, TE				Lund, AA; Rhoads, DM; Lund, AL; Cerny, RL; Elthon, TE			In vivo modifications of the maize mitochondrial small heat stress protein, HSP22	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZEA-MAYS L; SHOCK-PROTEIN; DIFFERENTIAL DISPLAY; OXIDATIVE STRESS; WATER-STRESS; EXPRESSION; PHOSPHORYLATION; GENES; EMBRYOGENESIS; SEQUENCE	A maize (Zea mays L.) small heat shock protein (HSP), HSP22, was previously shown to accumulate to high levels in mitochondria during, heat stress. Here we have purified native HSP22 and resolved the protein into three peaks using reverse phase high performance liquid chromatography. Mass spectrometry (MS) of the first two peaks revealed the presence of two HSP22 forms in each peak which differed in mass by 80 daltons (Da), indicative of a monophosphorylation. Phosphorylation of HSP22 by [gamma-P-32]ATP was also observed in mitochondria labeled in vitro, but not when purified native HSP22 was similarly used, demonstrating that HSP22 does not autophosphorylate, implicating a kinase involvement hz. vivo. Collisionally induced dissociation tandem MS (CID MS/MS) identified Ser(59) as the phosphorylated residue. We have also observed forms of HSP22 that result from alternative intron splicing. The two HSP22 proteins in the first peak were similar to 57 Da larger than the two HSP22 proteins in the second peak. MS analysis. revealed that the +57-Da forms have an additional Gly residue directly N-terminal of the expected Asp(84) which had been converted to an Asn residue. These results are the first demonstrations of phosphorylation and alternative intron splicing of a plant small RSP.	Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA; Univ Nebraska, Nebraska Ctr Mass Spectrometry, Lincoln, NE 68588 USA; Arizona State Univ, Dept Plant Biol, Tempe, AZ 85287 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Arizona State University; Arizona State University-Tempe	Elthon, TE (corresponding author), Univ Nebraska, Sch Biol Sci, E249 Beadle Ctr, Lincoln, NE 68588 USA.	telthon@biocomp.unl.edu		Lund, Adrian/0000-0002-1267-2926				Almoguera C, 1998, PLANT J, V13, P437, DOI 10.1046/j.1365-313X.1998.00044.x; ANDERSON JV, 1994, PLANT PHYSIOL, V104, P1359, DOI 10.1104/pp.104.4.1359; ATKINSON BG, 1993, DEV GENET, V14, P15, DOI 10.1002/dvg.1020140104; Banzet N, 1998, PLANT J, V13, P519, DOI 10.1046/j.1365-313X.1998.00056.x; Barent RL, 1992, PLANT MOL BIOL REP, V10, P338, DOI 10.1007/BF02668910; Carranco R, 1997, J BIOL CHEM, V272, P27470, DOI 10.1074/jbc.272.43.27470; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Chiesa R, 1997, EXP EYE RES, V65, P223, DOI 10.1006/exer.1997.0324; CLARKE AK, 1994, PHYSIOL PLANTARUM, V92, P118, DOI 10.1111/j.1399-3054.1994.tb06663.x; Clerk A, 1998, BIOCHEM J, V333, P581, DOI 10.1042/bj3330581; Coca MA, 1996, PLANT MOL BIOL, V31, P863, DOI 10.1007/BF00019473; Dong JZ, 1996, PLANTA, V200, P85; Downs CA, 1998, FEBS LETT, V430, P246, DOI 10.1016/S0014-5793(98)00669-3; DUPUIS I, 1990, PLANT PHYSIOL, V94, P665, DOI 10.1104/pp.94.2.665; ELTHON TE, 1986, PLANT PHYSIOL, V82, P1, DOI 10.1104/pp.82.1.1; ENGEL K, 1995, J CELL BIOCHEM, V57, P321, DOI 10.1002/jcb.240570216; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HAYES MK, 1991, PLANT PHYSIOL, V97, P1381, DOI 10.1104/pp.97.4.1381; Helm KW, 1997, PLANT PHYSIOL, V114, P1477, DOI 10.1104/pp.114.4.1477; HOPF N, 1992, PLANT MOL BIOL, V19, P623, DOI 10.1007/BF00026788; Kadyrzhanova DK, 1998, PLANT MOL BIOL, V36, P885, DOI 10.1023/A:1005954909011; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KNACK G, 1989, NUCLEIC ACIDS RES, V17, P5380, DOI 10.1093/nar/17.13.5380; LaFayette PR, 1996, PLANT MOL BIOL, V30, P159, DOI 10.1007/BF00017810; LARSON E, 1986, ANAL BIOCHEM, V155, P243, DOI 10.1016/0003-2697(86)90432-X; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; LENNE C, 1995, BIOCHEM J, V311, P805, DOI 10.1042/bj3110805; LENNE C, 1994, PLANT PHYSIOL, V105, P1255, DOI 10.1104/pp.105.4.1255; Leshem YY, 1996, BIOL PLANTARUM, V38, P1, DOI 10.1007/BF02879625; LUETHY MH, 1991, PLANT PHYSIOL, V97, P1317, DOI 10.1104/pp.97.4.1317; LUETHY MH, 1995, J PLANT PHYSIOL, V145, P443, DOI 10.1016/S0176-1617(11)81768-2; Lund AA, 1998, PLANT PHYSIOL, V116, P1097, DOI 10.1104/pp.116.3.1097; LURIE S, 1994, NATO ADV SCI INST SE, V86, P201; Martin JL, 1999, GENE EXPRESSION, V7, P349; MEDYNSKI D, 1992, BIO-TECHNOL, V10, P1002, DOI 10.1038/nbt0992-1002; MEHLEN P, 1993, EUR J BIOCHEM, V215, P277, DOI 10.1111/j.1432-1033.1993.tb18032.x; MING Z, 1993, J BIOL CHEM, V268, P35; NEVEN LG, 1993, PLANT MOL BIOL, V21, P291, DOI 10.1007/BF00019945; NOVER L, 1984, EUR J BIOCHEM, V139, P303, DOI 10.1111/j.1432-1033.1984.tb08008.x; Sabehat A, 1998, PLANT PHYSIOL, V117, P651, DOI 10.1104/pp.117.2.651; SCRUTTON NS, 1992, SCIENCE, V258, P1140, DOI 10.1126/science.1439821; Suzuki TC, 1998, PLANT PHYSIOL, V116, P1151, DOI 10.1104/pp.116.3.1151; Visioli G, 1997, PLANT MOL BIOL, V34, P517, DOI 10.1023/A:1005824314022; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; WILLETT DA, 1996, PLANT PHYSIOL, V112, P1399	45	38	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29924	29929		10.1074/jbc.M103373200	http://dx.doi.org/10.1074/jbc.M103373200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397800	hybrid			2022-12-27	WOS:000170558000043
J	Kinoshita, M; Nukada, T; Asano, T; Mori, Y; Akaike, A; Satoh, M; Kaneko, S				Kinoshita, M; Nukada, T; Asano, T; Mori, Y; Akaike, A; Satoh, M; Kaneko, S			Binding of G alpha(o) N terminus is responsible for the voltage-resistant inhibition of alpha(1A)(P/Q-type, Ca(v)2.1) Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; G-PROTEIN-ALPHA; RAT SYMPATHETIC NEURONS; I-II LOOP; CALCIUM CHANNELS; XENOPUS-OOCYTES; AMINO-TERMINUS; BOVINE BRAIN; DIFFERENTIAL INTERACTIONS; SYNAPTIC TRANSMISSION	G-protein-mediated inhibition of presynaptic voltage-dependent Ca2+ channels is comprised of voltage-dependent and -resistant components. The former is caused by a direct interaction of Ca2+ channel alpha1 subunits with G beta gamma, whereas the latter has not been characterized well. Here, we show that the N terminus of G alpha (o), is critical for the interaction with the C terminus of the alpha (1A) channel subunit, and that the binding induces the voltage-resistant inhibition. An alpha (1A) C-terminal peptide, an antiserum raised against G alpha (o) N terminus, and a G alpha (o) N-terminal peptide all attenuated the voltage-resistant inhibition of alpha (1A) currents. Furthermore, the N terminus of G alpha (o) bound to the C terminus of alpha (1A) in vitro, which was prevented either by the alpha (1A) channel C-terminal or G alpha (o) N-terminal peptide. Although the C-terminal domain of the alpha (1B) channel showed similar ability in the binding with G alpha (o) N terminus, the above mentioned treatments were ineffective in the alpha (1B) channel current. These findings demonstrate that the voltage-resistant inhibition of the P/Q-type, alpha (1A) channel is caused by the interaction between the C-terminal domain of Ca2+ channel alpha (1A) subunit and the N-terminal region of G alpha (o).	Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; Tokyo Inst Psychiat, Dept Neurochem, Setagaya Ku, Tokyo 1568585, Japan; Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Kasugai, Aichi 4800392, Japan; Okazaki Natl Res Inst, Natl Inst Physiol Sci, Ctr Integrat Biosci, Okazaki, Aichi 4448585, Japan; Okazaki Natl Res Inst, Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan	Kyoto University; Kyoto University; Kyoto University; Tokyo Institute of Psychiatry; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Kaneko, S (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Sakyo Ku, Kyoto 6068501, Japan.		Kaneko, Shuji/AAR-1005-2021	Kaneko, Shuji/0000-0001-5152-5809				BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Brody DL, 2000, J NEUROSCI, V20, P889, DOI 10.1523/JNEUROSCI.20-03-00889.2000; Brody DL, 1997, J PHYSIOL-LONDON, V499, P637, DOI 10.1113/jphysiol.1997.sp021956; Colecraft HM, 2000, J GEN PHYSIOL, V115, P175, DOI 10.1085/jgp.115.2.175; Currie KPM, 1997, J NEUROSCI, V17, P4570; Delmas P, 1999, J PHYSIOL-LONDON, V518, P23, DOI 10.1111/j.1469-7793.1999.0023r.x; Delmas P, 2000, NAT NEUROSCI, V3, P670, DOI 10.1038/76621; DENKER BM, 1992, J BIOL CHEM, V267, P6272; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DiversePierluissi M, 1997, P NATL ACAD SCI USA, V94, P5417, DOI 10.1073/pnas.94.10.5417; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Furukawa T, 1998, J BIOL CHEM, V273, P17595, DOI 10.1074/jbc.273.28.17595; Furukawa T, 1998, J BIOL CHEM, V273, P17585, DOI 10.1074/jbc.273.28.17585; GRIECO F, 1992, BIOTECHNIQUES, V13, P856; Hepler JR, 1996, J BIOL CHEM, V271, P496, DOI 10.1074/jbc.271.1.496; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Kammermeier PJ, 2000, J NEUROSCI, V20, P5623, DOI 10.1523/JNEUROSCI.20-15-05623.2000; Kaneko S, 1999, JPN J PHARMACOL, V81, P324, DOI 10.1254/jjp.81.324; Kaneko S, 1997, BRIT J PHARMACOL, V121, P806, DOI 10.1038/sj.bjp.0701181; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LINDER ME, 1991, J BIOL CHEM, V266, P4654; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; MOISES HC, 1994, J NEUROSCI, V14, P3842; Nakamura K, 1996, J BIOCHEM, V120, P996; PADRELL E, 1991, J BIOL CHEM, V266, P9771; Page KM, 1998, J NEUROSCI, V18, P4815; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; SCHULTZ AM, 1987, BIOCHEM BIOPH RES CO, V146, P1234, DOI 10.1016/0006-291X(87)90780-7; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Sun QQ, 1998, J PHYSIOL-LONDON, V510, P103, DOI 10.1111/j.1469-7793.1998.103bz.x; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wiley JW, 1997, J NEUROPHYSIOL, V77, P1338, DOI 10.1152/jn.1997.77.3.1338; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9	43	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					28731	28738		10.1074/jbc.M104806200	http://dx.doi.org/10.1074/jbc.M104806200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11395521	hybrid			2022-12-27	WOS:000170346000013
J	Li, W; Belsham, GJ; Proud, CG				Li, W; Belsham, GJ; Proud, CG			Eukaryotic initiation factors 4A (eIF4A) and 4G (eIF4G) mutually interact in a 1 : 1 ratio in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX RNA HELICASE; PROTEIN-SYNTHESIS; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; CRYSTAL-STRUCTURE; CORE DOMAIN; FACTOR 4F; TRANSLATION; YEAST; SEQUENCE	mRNA translation in eukaryotic cells involves a set of proteins termed translation initiation factors (eIFs), several of which are involved in the binding of ribosomes to mRNA. These include eIF4G, a modular scaffolding protein, and eIF4A, an RNA helicase, of which two closely related forms are known in mammals, eIF4A(I) and eIF4A(II). In mammals, eIF4G possesses two independent sites for binding eIF4A, whereas in other eukaryotes (e.g. yeast) only one site appears to be present, thus raising the issue of the stoichiometry of eIF4G.eIF4A complexes in different eukaryotes. We show that in human embryonic kidney cells eIF4G is associated with eIF4A(I) or eIF4A(II) but not with both simultaneously, suggesting a stoichiometry of 1:1 rather than 1:2. To confirm this, eIF4A(I) or eIF4A(II) was expressed in a tagged form in these cells, and complexes with eIF4G were again isolated. Complexes containing tagged eIF4A(I) or eIF4A(II) contained no endogenous eIF4A, supporting the notion that eIF4G binds only one molecule of eIF4A. Each binding site in eIF4G can bind either eIF4A(I) or eIF4A(II). The data imply that the second binding site in mammalian eIF4A does not bind an additional eIF4A molecule and that initiation factor complexes in different eukaryotes contain one eIF4A per eIF4G.	Univ Dundee, Sch Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; AFRC, Inst Anim Hlth, Pirbright Lab, Biotechnol & Biol Sci Res Council, Woking GU24 0NF, Surrey, England	University of Dundee; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute	Proud, CG (corresponding author), Univ Dundee, Sch Life Sci, Div Mol Physiol, Dow St, Dundee DD1 5EH, Scotland.	c.g.proud@clundee.ac.uk	Belsham, Graham/J-3132-2019; Belsham, Graham J./H-8589-2019	Belsham, Graham/0000-0003-1187-4873; Belsham, Graham J./0000-0003-1187-4873; Proud, Christopher/0000-0003-0704-6442				ALLEN ML, 1992, J BIOL CHEM, V267, P23232; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; CONROY SC, 1990, ARCH BIOCHEM BIOPHYS, V282, P363, DOI 10.1016/0003-9861(90)90130-Q; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Dominguez D, 1999, J BIOL CHEM, V274, P26720, DOI 10.1074/jbc.274.38.26720; Dominguez D, 2001, BIOCHEM J, V355, P223, DOI 10.1042/0264-6021:3550223; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GOYER C, 1989, J BIOL CHEM, V264, P7603; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; Hernandez G, 1998, EUR J BIOCHEM, V253, P27, DOI 10.1046/j.1432-1327.1998.2530027.x; Holzmann K, 2000, BIOCHEM BIOPH RES CO, V267, P339, DOI 10.1006/bbrc.1999.1973; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Li QY, 1999, MOL CELL BIOL, V19, P7336; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Neff CL, 1999, MOL CELL BIOL, V19, P5557; NIELSEN PJ, 1988, EMBO J, V7, P2097, DOI 10.1002/j.1460-2075.1988.tb03049.x; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PRAT A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P140, DOI 10.1016/0167-4781(90)90155-U; PRICE NT, 1989, BIOCHIM BIOPHYS ACTA, V1008, P177, DOI 10.1016/0167-4781(80)90005-6; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Svitkin YV, 2001, RNA, V7, P1743; ZAPATA JM, 1994, J BIOL CHEM, V269, P18047	30	33	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29111	29115		10.1074/jbc.C100284200	http://dx.doi.org/10.1074/jbc.C100284200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11408474	hybrid			2022-12-27	WOS:000170346000065
J	Dierks, H; Kolanus, J; Kolanus, W				Dierks, H; Kolanus, J; Kolanus, W			Actin cytoskeletal association of cytohesin-1 is regulated by specific phosphorylation of its carboxyl-terminal polybasic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PH DOMAIN; T-CELL; SIGNALING MOLECULES; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; PLECKSTRIN; INTEGRINS; MEMBRANE; ADHESION	Cell adhesion mediated by integrin receptors is controlled by intracellular signal transduction cascades. Cytohesin-1 is an integrin-binding protein and guanine nucleotide exchange factor that activates binding of the leukocyte integrin leukocyte function antigen-1 to its ligand, intercellular adhesion molecule 1. Cytohesin-1 bears a carboxyl-terminal pleckstrin homology domain that aids in reversible membrane recruitment and functional regulation of the protein. Although phosphoinositide-dependent membrane attachment of cytohesin-1 is mediated primarily by the pleckstrin homology domain, this function is further strengthened by a short carboxyl-terminal polybasic amino acid sequence. We show here that a serine/threonine motif within the short polybasic stretch of cytohesin-1 is phosphorylated by purified protein kinase CS in vitro. Furthermore the respective residues are also found to be phosphorylated after phorbol ester stimulation in vivo. Biochemical and functional analyses show that phosphorylated cytohesin-1 is able to tightly associate with the actin cytoskeleton, and we further demonstrate that phosphorylation of the protein is required for maximal leukocyte function antigen-1-mediated adhesion of Jurkat cells to intercellular adhesion molecule 1. These data suggest that both phosphatidylinositol 3-kinase and protein kinase C-dependent intracellular pathways that stimulate beta (2)-integrin-mediated adhesion of T lymphocytes converge on cytohesin-1 as functional integrator.	Univ Munich, Genzentrum, Mol Biol Lab, D-81377 Munich, Germany	University of Munich	Kolanus, W (corresponding author), Univ Munich, Genzentrum, Mol Biol Lab, Feodor Lynen Str 25, D-81377 Munich, Germany.	kolanus@lmb.uni-muenchen.de						AUSUBEL FM, 1987, CURRENT PROTOCOL S15, V1; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; DANIELIAN S, 1990, BIOCHIMIE, V72, P315, DOI 10.1016/0300-9084(90)90026-D; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Hmama Z, 1999, J BIOL CHEM, V274, P1050, DOI 10.1074/jbc.274.2.1050; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Kolanus W, 1998, CURR TOP MICROBIOL, V231, P33; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; LUB M, 1995, IMMUNOL TODAY, V16, P479, DOI 10.1016/0167-5699(95)80031-X; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Meller N, 1996, MOL CELL BIOL, V16, P5782; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nagel W, 1998, J BIOL CHEM, V273, P14853, DOI 10.1074/jbc.273.24.14853; Nagel WG, 1998, MOL BIOL CELL, V9, P1981, DOI 10.1091/mbc.9.8.1981; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; ROMEO C, 1991, CELL, V64, P1037, DOI 10.1016/0092-8674(91)90327-U; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; Venkateswarlu K, 1999, J CELL SCI, V112, P1957	44	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	2001	276	40					37472	37481		10.1074/jbc.M101502200	http://dx.doi.org/10.1074/jbc.M101502200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478YD	11438522	hybrid			2022-12-27	WOS:000171375700081
J	Geddis, AE; Fox, NE; Kaushansky, K				Geddis, AE; Fox, NE; Kaushansky, K			Phosphatidylinositol 3-kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mp1-bearing cell lines as well as in primary megakaryocytic progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CYCLIN D1 EXPRESSION; TYROSINE PHOSPHORYLATION; PI 3-KINASE; AKT KINASE; G1 PHASE; C-MPL; RECEPTOR; INHIBITION; PATHWAY	Thrombopoietin and its receptor (Mpl) support survival and proliferation in megakaryocyte progenitors and in BaF3 cells engineered to stably express Mpl (BaF3/Mpl). The binding of thrombopoietin to Mpl activates multiple kinase pathways, including the Jak/STAT, Ras/Raf/MAPK, and phosphatidylinositol 3-kinase pathways, but it is not clear how these kinases promote cell cycling. Here, we show that thrombopoietin induces phosphatidylinositol 3-kinase and that phosphatidylinositol 3-kinase is required for thrombopoietin-induced cell cycling in BaF3/Mpl cells and in primary megakaryocyte progenitors. Treatment of BaF3/Mpl cells and megakaryocytes with the phosphatidylinositol 3-kinase inhibitor LY294002 inhibited mitotic and endomitotic cell cycl-ing. BaF3/Mpl cells treated with thrombopoietin and LY294002 were blocked in G(1), whereas megakaryocyte progenitors treated with thrombopoietin and LY294002 showed both a G(1) and a G(2) cell cycle block. Expression of constitutively active Akt in BaF3/Mpl cells restored the ability of thrombopoietin to promote cell cycling in the presence of LY294002. Constitutively active Akt was not sufficient to drive proliferation of BaF3/Mpl cells in the absence of thrombopoietin. We conclude that in BaF3/Mpl cells and megakaryocyte progenitors, thrombopoietin-induced phosphatidylinositol 3-kinase activity is necessary but not sufficient for thrombopoietin-induced cell cycle progression. Phosphatidylinositol 3-kinase activity is likely to be involved in regulating the G(1)/S transition.	Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Pediat Hematol Oncol, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Kaushansky, K (corresponding author), Univ Washington, Dept Med, Div Hematol, Box 357710, Seattle, WA 98195 USA.	kkaushan@u.washington.edu						Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Alexander WS, 1996, EMBO J, V15, P6531, DOI 10.1002/j.1460-2075.1996.tb01044.x; ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; BACON CM, 1995, FEBS LETT, V370, P63, DOI 10.1016/0014-5793(95)00796-C; Bacqueville D, 1998, BIOCHEM BIOPH RES CO, V244, P630, DOI 10.1006/bbrc.1997.7885; Beslu N, 1996, J BIOL CHEM, V271, P20075, DOI 10.1074/jbc.271.33.20075; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Carow CE, 2001, J CELL PHYSIOL, V188, P291, DOI 10.1002/jcp.1120; Casagrande F, 1998, FEBS LETT, V422, P385, DOI 10.1016/S0014-5793(98)00043-X; Cerezo A, 1998, MOL BIOL CELL, V9, P3107, DOI 10.1091/mbc.9.11.3107; COREY S, 1993, EMBO J, V12, P2681, DOI 10.1002/j.1460-2075.1993.tb05929.x; COUGHLIN SR, 1989, SCIENCE, V243, P1191; Craddock BL, 1999, J BIOL CHEM, V274, P10633, DOI 10.1074/jbc.274.15.10633; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; DAMEN JE, 1995, J BIOL CHEM, V270, P23402, DOI 10.1074/jbc.270.40.23402; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dong F, 2000, BLOOD, V95, P1656, DOI 10.1182/blood.V95.5.1656.005k29_1656_1662; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; DRACHMAN JG, 1995, J BIOL CHEM, V270, P4979, DOI 10.1074/jbc.270.10.4979; Drachman JG, 1997, P NATL ACAD SCI USA, V94, P2350, DOI 10.1073/pnas.94.6.2350; Drachman JG, 1999, METHODS, V17, P238, DOI 10.1006/meth.1998.0734; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; Ferby IM, 1996, J BIOL CHEM, V271, P11684, DOI 10.1074/jbc.271.20.11684; FERBY IM, 1994, J BIOL CHEM, V269, P30485; Grewe M, 1999, CANCER RES, V59, P3581; Haseyama Y, 1999, BLOOD, V94, P1568, DOI 10.1182/blood.V94.5.1568.417a07_1568_1577; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; Izzard RA, 1999, CANCER RES, V59, P2581; Jaster R, 1997, CELL SIGNAL, V9, P175, DOI 10.1016/S0898-6568(96)00138-6; JHUN BH, 1994, MOL CELL BIOL, V14, P7466, DOI 10.1128/MCB.14.11.7466; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; KAUSHANSKY K, 1995, BLOOD, V86, P419, DOI 10.1182/blood.V86.2.419.bloodjournal862419; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Minshall C, 1996, J IMMUNOL, V156, P939; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; Rojnuckarin P, 1999, BLOOD, V94, P1273, DOI 10.1182/blood.V94.4.1273.416k04_1273_1282; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Roy L, 2001, BLOOD, V97, P2238, DOI 10.1182/blood.V97.8.2238; Sattler M, 1997, J CELL PHYSIOL, V171, P28; Scheid MP, 1996, J BIOL CHEM, V271, P18134, DOI 10.1074/jbc.271.30.18134; Shigematsu H, 1997, J BIOL CHEM, V272, P14334, DOI 10.1074/jbc.272.22.14334; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Takuwa N, 1999, MOL CELL BIOL, V19, P1346; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Vitrat N, 1998, BLOOD, V91, P3711; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WANG ZY, 1995, BLOOD, V86, P3783, DOI 10.1182/blood.V86.10.3783.bloodjournal86103783; WENDLING F, 1986, VIROLOGY, V149, P242, DOI 10.1016/0042-6822(86)90125-X; Yagi M, 1999, P NATL ACAD SCI USA, V96, P8126, DOI 10.1073/pnas.96.14.8126; YAMADA M, 1995, BIOCHEM BIOPH RES CO, V217, P230, DOI 10.1006/bbrc.1995.2768; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zhang X, 1997, LEUKEMIA RES, V21, P849, DOI 10.1016/S0145-2126(97)00055-6; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248	62	66	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34473	34479		10.1074/jbc.M105178200	http://dx.doi.org/10.1074/jbc.M105178200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11418622	hybrid			2022-12-27	WOS:000171024600018
J	Gomes, XV; Burgers, PMJ				Gomes, XV; Burgers, PMJ			ATP utilization by yeast replication factor C I. ATP-mediated interaction with DNA and with proliferating cell nuclear antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LARGE SUBUNIT; COMPLEX-FORMATION; ESCHERICHIA-COLI; POLYMERASE-DELTA; SLIDING CLAMP; PROTEIN COMPLEX; BINDING; GENE; IDENTIFICATION	Eukaryotic replication factor C is the heteropentameric complex that loads the replication clamp proliferating cell nuclear antigen (PCNA) onto primed DNA. In this study we used a derivative, designated RFC, with a N-terminal truncation of the Rfc1 subunit removing a DNA-binding domain not required for clamp loading. Interactions of yeast RFC with PCNA and DNA were studied by surface plasmon resonance. Binding of RFC to PCNA was stimulated by either adenosine (3-thiotriphosphate) (ATP gammaS) or ATP. RFC bound only to primer-template DNA coated with the single-stranded DNA-binding protein RPA if ATP gammaS was also present. Binding occurred without dissociation of RPA. ATP did not stimulate binding of RFC to DNA, suggesting that hydrolysis of ATP dissociated DNA-bound RFC. However, when RFC and PCNA together were flowed across the DNA chip in the presence of ATP, a signal was observed suggesting loading of PCNA by RFC. With ATP gammaS present instead of ATP, long-lived response signals were observed indicative of loading complexes arrested on the DNA. A primer with a 3' single-stranded extension also allowed loading of PCNA, yet turnover of the reaction intermediates was dramatically slowed down. Filter binding experiments and analysis of proteins bound to DNA-magnetic beads confirmed the conclusions drawn from the surface plasmon resonance studies.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032431, GM32431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen BL, 1998, NUCLEIC ACIDS RES, V26, P3877, DOI 10.1093/nar/26.17.3877; Ason B, 2000, J BIOL CHEM, V275, P3006, DOI 10.1074/jbc.275.4.3006; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BUNZ F, 1993, P NATL ACAD SCI USA, V90, P11014, DOI 10.1073/pnas.90.23.11014; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Cai JS, 1997, J BIOL CHEM, V272, P18974, DOI 10.1074/jbc.272.30.18974; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Fotedar R, 1996, EMBO J, V15, P4423, DOI 10.1002/j.1460-2075.1996.tb00815.x; Gary SL, 1995, NUCLEIC ACIDS RES, V23, P4986, DOI 10.1093/nar/23.24.4986; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; HOWELL EA, 1994, MOL CELL BIOL, V14, P255, DOI 10.1128/MCB.14.1.255; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; KOUPRINA N, 1994, GENETICS, V138, P1067; Latham GJ, 1996, J MOL BIOL, V264, P426, DOI 10.1006/jmbi.1996.0651; LEE SH, 1991, J BIOL CHEM, V266, P594; LI XY, 1994, P NATL ACAD SCI USA, V91, P868, DOI 10.1073/pnas.91.3.868; LI XY, 1994, J BIOL CHEM, V269, P21880; Mossi R, 1997, J BIOL CHEM, V272, P1769, DOI 10.1074/jbc.272.3.1769; NOSKOV V, 1994, NUCLEIC ACIDS RES, V22, P1527, DOI 10.1093/nar/22.9.1527; PAN ZQ, 1993, P NATL ACAD SCI USA, V90, P6, DOI 10.1073/pnas.90.1.6; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Schmidt SLG, 2001, J BIOL CHEM, V276, P34792, DOI 10.1074/jbc.M011671200; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Schuck P, 1997, CURR OPIN BIOTECH, V8, P498, DOI 10.1016/S0958-1669(97)80074-2; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P609, DOI 10.1128/MCB.9.2.609; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Uhlmann F, 1997, J BIOL CHEM, V272, P10065; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Waga S, 1998, MOL CELL BIOL, V18, P4177, DOI 10.1128/MCB.18.7.4177; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yao N, 2000, J BIOL CHEM, V275, P11440, DOI 10.1074/jbc.275.15.11440; YODER BL, 1991, J BIOL CHEM, V266, P22689; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189	45	112	113	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34768	34775		10.1074/jbc.M011631200	http://dx.doi.org/10.1074/jbc.M011631200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432853	hybrid			2022-12-27	WOS:000171024600058
J	Heuberger, EHML; Smits, E; Poolman, B				Heuberger, EHML; Smits, E; Poolman, B			Xyloside transport by XylP, a member of the galactoside-pentoside-hexuronide family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINOPROTEIN GLUCOSE-DEHYDROGENASE; SUGAR SPECIFICITY MUTATIONS; ACINETOBACTER-CALCOACETICUS; LACTOBACILLUS-PENTOSUS; LACTOSE TRANSPORT; STREPTOCOCCUS-THERMOPHILUS; MEMBRANE-PROTEINS; LACTOCOCCUS-LACTIS; RECONSTITUTION; PERMEASE	This paper describes the functional characterization of the xyloside transporter, XylP, of Lactobacillus pentosus with the aid of a spectroscopy-based assay system. In order to monitor the transport reaction, the natural xyloside isoprimeverose, a building block of hemicellulose, and the analogue methyl-isoprimeverose were chemically synthesized by a new and efficient procedure. The XylP protein was purified by metal affinity chromatography, following high level expression in Lactococcus lactis from. the nisin-inducible promoter. The purified XylP protein was incorporated into liposomes, in which the glucose dehydrogenase from Acinetobacter calcoaceticus (sGDH) was entrapped. sGDH can oxidize aldose sugars in the presence of dichlorophenol-indophenol as electron acceptor. The coupled assay thus involves XyIP-mediated isoprimeverose uptake followed by internal oxidation of the sugar by sGDH, which can be monitored from the reduction of 2,6-dichlorophenol-indophenol at 600 run. The uptake of isoprimeverose was stimulated by the presence of the non-oxidizable methyl-isoprimeverose on the trans-side of the membrane, indicating that exchange transport is faster than unidirectional downhill uptake. Unlike other members of the galactoside-pentoside-hexuronide family, XylP does not transport monosaccharides (xylose) but requires a glycosidic linkage at the anomeric carbon position. Consistent with a proton motive force-driven mechanism, the uptake was stimulated by a membrane potential (inside negative relative to outside) and inhibited by a pH gradient (inside acidic relative to outside). The advantages of the here-described transport assay for studies of carbohydrate transport are discussed.	Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of Groningen	Poolman, B (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@chem.rug.nl	Poolman, Bert/D-1882-2012					BARON C, 1975, BIOCHIM BIOPHYS ACTA, V382, P276, DOI 10.1016/0005-2736(75)90270-9; BROOKER RJ, 1991, J BIOL CHEM, V266, P4131; Chaillou S, 1998, J BACTERIOL, V180, P4011, DOI 10.1128/JB.180.15.4011-4014.1998; Chaillou S, 1998, J BACTERIOL, V180, P2312, DOI 10.1128/JB.180.9.2312-2320.1998; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; EELKEMA JA, 1991, J BIOL CHEM, V266, P4139; Friesen RHE, 2000, J BIOL CHEM, V275, P40658; GEIGER O, 1989, BIOCHEM J, V261, P415, DOI 10.1042/bj2610415; HAUGE JG, 1964, J BIOL CHEM, V239, P3630; HELFERICH B, 1927, LIEBIGS ANN CHEM, V455, P168; Heuberger EHML, 2000, EUR J BIOCHEM, V267, P228, DOI 10.1046/j.1432-1327.2000.00993.x; JENNINGS HJ, 1968, CAN J CHEMISTRY, V46, P2799, DOI 10.1139/v68-464; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; LOKMAN BC, 1991, MOL GEN GENET, V230, P161, DOI 10.1007/BF00290664; Lokman BC, 1997, J BACTERIOL, V179, P5391, DOI 10.1128/jb.179.17.5391-5397.1997; LOLKEMA JS, 1995, J BIOL CHEM, V270, P12670, DOI 10.1074/jbc.270.21.12670; MATSUSHITA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1548, DOI 10.1271/bbb.59.1548; Olsthoorn AJJ, 1998, EUR J BIOCHEM, V255, P255, DOI 10.1046/j.1432-1327.1998.2550255.x; Olsthoorn AJJ, 1996, ARCH BIOCHEM BIOPHYS, V336, P42, DOI 10.1006/abbi.1996.0530; Picon A, 2000, J BACTERIOL, V182, P1600, DOI 10.1128/JB.182.6.1600-1608.2000; POOLMAN B, 1983, EUR J BIOCHEM, V135, P41, DOI 10.1111/j.1432-1033.1983.tb07615.x; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; POOLMAN B, 1995, J BIOL CHEM, V270, P12995, DOI 10.1074/jbc.270.22.12995; POSNO M, 1991, APPL ENVIRON MICROB, V57, P2764, DOI 10.1128/AEM.57.9.2764-2766.1991; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; RIGAUD JL, 1988, BIOCHEMISTRY-US, V27, P2677, DOI 10.1021/bi00408a007; RIGAUD JL, 1995, LIPOSOMES TOOLS BASI, P71; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; Zemplen G, 1939, BER DTSCH CHEM GES, V72, P1160, DOI 10.1002/cber.19390720607	32	14	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34465	34472		10.1074/jbc.M105460200	http://dx.doi.org/10.1074/jbc.M105460200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11408491	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000171024600017
J	Liu, XF; Fernandez, M; Wouters, MA; Heyberger, S; Husain, A				Liu, XF; Fernandez, M; Wouters, MA; Heyberger, S; Husain, A			Arg(1098) is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE; ACTIVATION; SPECIFICITIES; SUBSTRATE; CHYMASE; BINDING	Angiotensin (Ang) 1-converting enzyme (ACE) is a Zn2+ metalloprotease with two homologous catalytic domains. Both the N- and C-terminal domains are peptidyl dipeptidases. Hydrolysis by ACE of its decapeptide substrate Ang I is increased by Cl-, but the molecular mechanism of this regulation is unclear. A search for single substitutions to Gln among all conserved basic residues (Lys/Arg) in human ACE C-domain identified R1098Q as the sole: mutant that lacked Cl- dependence. Cl- dependence is also lost when the equivalent Arg in the N-domain, Arg(500), is substituted with Gln. The Arg(1098) to Lys substitution reduced Cl- binding affinity by similar to 100-fold. In the absence of Cl-, substrate binding affinity (1/K-m) of and catalytic, efficiency (k(cat)/K-m) for Ang I hydrolysis are increased 6.9- and 32-fold, respectively, by the Arg(1098) to Gln substitution, and are similar (<2-foId difference) to the respective wild-type C-domain catalytic constants in the presence of optimal [Cl-]. The Arg(1098) to Gln substitution also eliminates Cl- dependence for hydrolysis of tetrapeptide substrates, but activity toward these substrates is similar to that of the Wildtype C-domain in the absence of Cl-. These findings indicate that: 1) Arg(1098) is a critical residue of the C-domain Cl--binding site and 2) a basic side chain is necessary for Cl- dependence. For tetrapeptide substrates, the inability of R1098Q to recreate the high affinity state generated by the Cl-C-domain interaction suggests that substrate interactions with the enzyme-bound Cl- are much more important for the hydrolysis of short substrates than for Ang 1. Since Cl- concentrations are saturating under physiological conditions and Arg(1098) is not critical for Ang I hydrolysis, we speculate that the evolutionary pressure for the maintenance of the Cl--binding site is its ability to allow cleavage of short cognate peptide substrates at high catalytic efficiencies.	Victor Chang Cardiac Res Inst, Enzyme Res Unit, Sydney, NSW 2010, Australia; Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2033, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Husain, A (corresponding author), Victor Chang Cardiac Res Inst, Enzyme Res Unit, 384 Victoria St, Sydney, NSW 2010, Australia.		Wouters, Merridee A/G-2481-2015; Wouters, Merridee/F-4310-2010; Wouters, Merridee/D-2046-2012; Husain, Ahsan/J-6861-2012	Wouters, Merridee A/0000-0002-2121-912X; Husain, Ahsan/0000-0003-3426-3469				BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P992; BRAYER GD, 1995, PROTEIN SCI, V4, P1730, DOI 10.1002/pro.5560040908; BUNNING P, 1983, BIOCHEMISTRY-US, V22, P110, DOI 10.1021/bi00270a016; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; CORVOL P, 1998, HDB PROTEOLYTIC ENZY, P1066; CREIGHTON TE, 1984, PROTEINS STRUCTURAL, P2; Desiraju G.R., 1999, WEAK HYDROGEN BOND S, P246; Feller G, 1996, J BIOL CHEM, V271, P23836, DOI 10.1074/jbc.271.39.23836; Fernandez M, 2001, J BIOL CHEM, V276, P4998, DOI 10.1074/jbc.M009009200; HUBERT C, 1991, J BIOL CHEM, V266, P15377; JASPARD E, 1993, J BIOL CHEM, V268, P9496; KIM YA, 1992, J BIOL CHEM, V267, P12330; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; KUBY SA, 1991, STUDY ENZYMES ENZYME, V1, P299; Lamango NS, 1996, BIOCHEM J, V314, P639, DOI 10.1042/bj3140639; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sanker S, 1997, J BIOL CHEM, V272, P2963, DOI 10.1074/jbc.272.5.2963; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P5315, DOI 10.1021/bi00292a010; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P3850, DOI 10.1021/bi00285a021; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Sturrock ED, 1997, BIOCHEM BIOPH RES CO, V236, P16, DOI 10.1006/bbrc.1997.6841; WEI L, 1991, J BIOL CHEM, V266, P9002; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001	24	49	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33518	33525		10.1074/jbc.M101495200	http://dx.doi.org/10.1074/jbc.M101495200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11432860	Green Published, hybrid			2022-12-27	WOS:000170910200032
J	Pessach, I; Leto, TL; Malech, HL; Levy, R				Pessach, I; Leto, TL; Malech, HL; Levy, R			Essential requirement of cytosolic phospholipase A(2) for stimulation of NADPH oxidase-associated diaphorase activity in granulocyte-like cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SUPEROXIDE-GENERATING SYSTEM; GTP-GAMMA-S; HUMAN-NEUTROPHILS; CONFORMATIONAL-CHANGES; ACTIN POLYMERIZATION; SUBUNIT P47(PHOX); H+ CHANNEL; PERMEABILIZED NEUTROPHILS; INDEPENDENT ACTIVATION	We have previously established a model of cytosolic phospholipase A(2) (cPLA(2))-deficient differentiated PLB-985 cells (PLB-D cells) and demonstrated that cPLA(2)-generated arachidonic acid (AA) is essential for NADPH oxidase activation. In this study we used this model to investigate the physiological role of cPLA2 in regulation of NADPH oxidase-associated diaphorase activity. A novel diaphorase activity assay, using 4-iodonitrotetrazolium. violet as an electron acceptor, was used in permeabilized neutrophils and PLB-985 cells differentiated toward the granulocytic or monocytic phenotypes. Phorbol 12-myristate 13-acetate, guanosine 5'-3-O-(thio)triphosphate (GTP gammaS), or FMLP stimulated a similar diphenylene iodonium-sensitive diaphorase activity pattern in neutrophils and in differentiated parent PLB-985 cells. This diaphorase activity was not detected in undifferentiated cells, but developed during differentiation. Furthermore, diaphorase activity could not be stimulated in permeabilized neutrophils from X-linked CGD patients and in differentiated gp91(phox)-targeted PLB-985 cells that lacked normal expression of gp91(phox), but was restored to these cells following transduction with retrovirus encoding gp91(phox). The differentiated PLB-D cells showed no diaphorase activity when stimulated by either GTP gammaS or FMLP, and only partial activation when stimulated with phorbol 12-myristate 13-acetate. Diaphorase activity in response to either agonists was fully restored by the addition of 10 muM free AA. The permeabilized cell 4-iodonitrotetrazolium violet reduction assay offers a unique tool for the evaluation of NADPH oxidase-associated diaphorase activity in stimulated whole cells. These results establish an essential and specific physiological requirement of cPLA(2)-generated AA in activation of electron transfer through the FAD reduction center of NADPH oxidase.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Infect Dis Lab, IL-84105 Beer Sheva, Israel; Soroka Med Ctr, IL-84105 Beer Sheva, Israel; NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	Ben Gurion University; Ben Gurion University; Soroka Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Levy, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Infect Dis Lab, IL-84105 Beer Sheva, Israel.			Malech, Harry/0000-0001-5874-5775	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000614, ZIAAI000614, ZIAAI000644, Z01AI000644] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BRENNER S, 2001, MOL THER, V3, pS223; CROSS AR, 1985, BIOCHEM J, V226, P881, DOI 10.1042/bj2260881; CROSS AR, 1984, BIOCHEM J, V223, P337, DOI 10.1042/bj2230337; CROSS AR, 1982, BIOCHEM J, V204, P479, DOI 10.1042/bj2040479; CROSS AR, 1995, J BIOL CHEM, V270, P6543, DOI 10.1074/jbc.270.12.6543; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Cross AR, 1999, J BIOL CHEM, V274, P15519, DOI 10.1074/jbc.274.22.15519; CROSS AR, 1994, J BIOL CHEM, V269, P21448; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; DOUSSIERE J, 1991, BIOCHEM BIOPH RES CO, V175, P143, DOI 10.1016/S0006-291X(05)81212-4; DOUSSIERE J, 1992, EUR J BIOCHEM, V208, P61, DOI 10.1111/j.1432-1033.1992.tb17159.x; Doussiere J, 1999, BIOCHEMISTRY-US, V38, P3694, DOI 10.1021/bi9823481; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; ELLIS JA, 1989, BIOCHEM J, V262, P575, DOI 10.1042/bj2620575; ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4; FUJII H, 1991, BIOCHIM BIOPHYS ACTA, V1095, P201, DOI 10.1016/0167-4889(91)90100-C; GREEN TR, 1990, J BIOL CHEM, V265, P19324; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Hata K, 1998, J BIOL CHEM, V273, P4232, DOI 10.1074/jbc.273.7.4232; HAZAV P, 1989, CANCER RES, V49, P72; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; Henderson LM, 1997, BIOCHEM J, V325, P701, DOI 10.1042/bj3250701; KAPUS A, 1992, BIOCHEM J, V281, P697, DOI 10.1042/bj2810697; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Koshkin V, 1995, BBA-BIOENERGETICS, V1232, P225, DOI 10.1016/0005-2728(95)00123-9; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; LAPORTE F, 1990, EUR J BIOCHEM, V194, P301, DOI 10.1111/j.1432-1033.1990.tb19457.x; Leto TL., 1999, INFLAMMATION BASIC P, P769; LEVY R, 1990, J IMMUNOL, V145, P2595; LI F, 1994, BLOOD, V84, P53, DOI 10.1182/blood.V84.1.53.bloodjournal84153; Li JR, 1997, BIOCHEMISTRY-US, V36, P5529, DOI 10.1021/bi963013r; Lowenthal A, 1999, J BIOL CHEM, V274, P21603, DOI 10.1074/jbc.274.31.21603; LU DJ, 1990, J BIOL CHEM, V265, P13721; MIKI T, 1992, J BIOL CHEM, V267, P18695; MUKHERJEE G, 1994, J LEUKOCYTE BIOL, V55, P685, DOI 10.1002/jlb.55.6.685; NANDA A, 1993, P NATL ACAD SCI USA, V90, P760, DOI 10.1073/pnas.90.2.760; NISIMOTO Y, 1990, BIOCHIM BIOPHYS ACTA, V1040, P260, DOI 10.1016/0167-4838(90)90085-T; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; Park HS, 1998, BBA-PROTEIN STRUCT M, V1387, P406, DOI 10.1016/S0167-4838(98)00152-6; Park HS, 1999, BIOCHEM BIOPH RES CO, V259, P38, DOI 10.1006/bbrc.1999.0721; Park HS, 1998, ARCH BIOCHEM BIOPHYS, V360, P165, DOI 10.1006/abbi.1998.0938; REDMOND T, 1994, J BIOL CHEM, V269, P21657; RUBINEK T, 1993, BIOCHIM BIOPHYS ACTA, V1176, P51, DOI 10.1016/0167-4889(93)90176-P; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; TARDIF M, 1995, J BIOL CHEM, V270, P28075; Yu LX, 1999, BLOOD, V94, P2497, DOI 10.1182/blood.V94.7.2497.419k11_2497_2504; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	52	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33495	33503		10.1074/jbc.M011417200	http://dx.doi.org/10.1074/jbc.M011417200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11432850	hybrid			2022-12-27	WOS:000170910200029
J	van der Wel, H; Morris, HR; Panico, M; Paxton, T; North, SJ; Dell, A; Thomson, JM; West, CM				van der Wel, H; Morris, HR; Panico, M; Paxton, T; North, SJ; Dell, A; Thomson, JM; West, CM			A non-golgi alpha 1,2-fucosyltransferase that modifies Skp1 in the cytoplasm of Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE; GENES; IDENTIFICATION; CLASSIFICATION; GLYCOSYLATION; BIOSYNTHESIS; PURIFICATION; EXPRESSION; PROTEINS; PATHWAY	Skp1 is a subunit of the SCF-E3 ubiquitin ligase that targets cell cycle and other regulatory factors for degradation. In Dictyostelium, Skp1 is modified by a pentasaccharide containing the type I blood group H trisaccharide at its core. To address how the third sugar, fucose alpha1,2-linked to galactose, is attached, a proteomics strategy was applied to determine the primary structure of FT85, previously shown to copurify with the GDPFuc:Skp1 alpha1,2-fucosyltransferase. Tryptic-generated peptides of FT85 were sequenced de novo using Q-TOF tandem mass spectrometry. Degenerate primers were used to amplify FT85 genomic. DNA, which was further extended by a novel linker polymerase chain reaction method to yield an intronless open reading frame of 768 amino acids. Disruption of the FT85 gene by homologous recombination resulted in viable cells, which had altered light scattering properties as revealed by flow cytometry. FT85 was necessary and sufficient for Skp1 fucosylation, based on biochemical analysis of FT85 mutant cells and Escherichia coli that express FT85 recombinantly. FT85 lacks sequence motifs that characterize all other known alpha1,2-fucosyltransferases and lacks the signal-anchor sequence that targets them to the secretory pathway. The C-terminal region of FT85 harbors motifs found in inverting Family 2 glycosyltransferase domains, and its expression in FT85 mutant cells restores fucosyltransferase activity toward a simple disaccharide substrate. Whereas most prokaryote and eukaryote Family 2 glycosyltransferases are membrane-bound and oriented toward the cytoplasm where they glycosylate lipid-linked or polysaccharide precursors prior to membrane translocation, the soluble, eukaryotic Skp1-fucosyltransferase modifies a protein that resides in the cytoplasm and nucleus.	Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England	State University System of Florida; University of Florida; Imperial College London	West, CM (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, 1600 SW Archer Rd,Rm B1-3, Gainesville, FL 32610 USA.	westcm@college.med.ufl.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-37539] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALONSO MD, 1995, FASEB J, V9, P1126, DOI 10.1096/fasebj.9.12.7672505; Breton C, 1998, J BIOCHEM, V123, P1000; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Garinot-Schneider C, 2000, J BIOL CHEM, V275, P31407, DOI 10.1074/jbc.M004524200; GONZALEZYANES B, 1992, J BIOL CHEM, V267, P9595; GONZALEZYANES B, 1989, DEV BIOL, V133, P576, DOI 10.1016/0012-1606(89)90060-2; Gstaiger M, 1999, EXP CELL RES, V247, P554, DOI 10.1006/excr.1999.4386; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; KOZAROV E, 1995, J BIOL CHEM, V270, P3022, DOI 10.1074/jbc.270.7.3022; Kreil DP, 2000, TRENDS BIOCHEM SCI, V25, P270, DOI 10.1016/S0968-0004(00)01594-2; Linton D, 2000, MOL MICROBIOL, V37, P501, DOI 10.1046/j.1365-2958.2000.02020.x; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; Morris HR, 1997, J PROTEIN CHEM, V16, P469, DOI 10.1023/A:1026309410737; MORRIS HR, 1998, MASS SPECTROMETRY BI, V2, P53; NELLEN W, 1987, METHOD CELL BIOL, V28, P67; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Puta F, 1998, FOLIA BIOL-PRAGUE, V44, P185; Roux Kenneth H., 1995, P53; SALZMAN GC, 1975, ACTA CYTOL, V19, P374; Sassi S, 2001, GLYCOBIOLOGY, V11, P283, DOI 10.1093/glycob/11.4.283; SATIR BH, 1990, J CELL BIOL, V111, P901, DOI 10.1083/jcb.111.3.901; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; STEEL LF, 1991, DEV GENET, V12, P98, DOI 10.1002/dvg.1020120117; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Teng-umnuay P, 1999, J BIOL CHEM, V274, P36392, DOI 10.1074/jbc.274.51.36392; Tiede A, 1999, BIOL CHEM, V380, P503, DOI 10.1515/BC.1999.066; Trinchera M, 1996, FEBS LETT, V395, P68, DOI 10.1016/0014-5793(96)01003-4; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; WANG IN, 1993, P NATL ACAD SCI USA, V90, P3840, DOI 10.1073/pnas.90.9.3840; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; West CM, 1996, J BIOL CHEM, V271, P12024, DOI 10.1074/jbc.271.20.12024; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Yamasaki S, 1999, GENE, V237, P321, DOI 10.1016/S0378-1119(99)00344-3; Zhang YY, 1999, J CELL SCI, V112, P4367	47	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33952	33963		10.1074/jbc.M102555200	http://dx.doi.org/10.1074/jbc.M102555200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11423539	hybrid			2022-12-27	WOS:000170910200090
J	Haines, WR; Migita, K; Cox, JA; Egan, TM; Voigt, MM				Haines, WR; Migita, K; Cox, JA; Egan, TM; Voigt, MM			The first transmembrane domain of the P2X receptor subunit participates in the agonist-induced gating of the channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP; IDENTIFICATION; NUCLEOTIDES; EFFICACY; BINDING; CELLS	Based on pharmacological properties, the P2X receptor family can be subdivided into those homo-oligomers that are sensitive to the ATP analog alpha beta -methylene ATP(alpha beta meATP) (P2X(1) and P2X(3)) and those that are not (P2X(2), P2X(4), P2X(5), P2X(6), and P2X(7)). We exploited this dichotomy through the construction of chimeric receptors and site-directed mutagenesis in order to identify domains responsible for these differences in the abilities of extracellular agonists to gate P2X receptors. Replacement of the extracellular domain of the alpha beta meATP-sensitive rat P2X(1) subunit with that of the alpha beta meATP-insensitive rat P2X2 subunit resulted in a receptor that was still alpha beta meATP-sensitive, suggesting a non-extracellular domain was responsible for the differential gating of P2X receptors by various agonists. Replacement of the first transmembrane domain of the rat P2X2 subunit with one from an alpha beta meATP-sensitive subunit (either rat P2X(1) or P2X3 subunit) converted the resulting chimera to alpha beta meATP sensitivity. This conversion did not occur when the first transmembrane domain came from a non-alpha beta meATP-sensitive subunit. Site-directed mutagenesis indicated that the C-terminal portion of the first transmembrane domain was important in determining the agonist selectivity of channel gating for these chimeras. These results suggest that the first transmembrane domain plays an important role in the agonist operation of the P2X receptor.	St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	Saint Louis University	Voigt, MM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.		Migita, Keisuke/E-8274-2013	Egan, Terrance/0000-0002-7249-3161	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035534] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56236] Funding Source: Medline; NINDS NIH HHS [NS35534] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 1996, CIBA F SYMP, V198, P1; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2000, FEBS LETT, V475, P287, DOI 10.1016/S0014-5793(00)01685-9; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; FRIEL DD, 1988, J GEN PHYSIOL, V91, P1, DOI 10.1085/jgp.91.1.1; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Haines WR, 1999, MOL PHARMACOL, V56, P720; HAINES WR, 2001, IN PRESS J NEUROSCI, V21; HORN R, 1992, METHOD ENZYMOL, V207, P149; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Khakh BS, 2001, PHARMACOL REV, V53, P107; Le KT, 1998, J NEUROSCI, V18, P7152; MIGITA KM, 2001, IN PRESS J BIOL CHEM, V276; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; O'Shea SM, 2000, J BIOL CHEM, V275, P22764, DOI 10.1074/jbc.M001299200; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Torres GE, 1998, FEBS LETT, V425, P19, DOI 10.1016/S0014-5793(98)00179-3; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Virginio C, 1998, MOL PHARMACOL, V53, P969	23	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32793	32798		10.1074/jbc.M104216200	http://dx.doi.org/10.1074/jbc.M104216200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438537	hybrid			2022-12-27	WOS:000170746000057
J	Demarchi, F; Verardo, R; Varnum, B; Brancolini, C; Schneider, C				Demarchi, F; Verardo, R; Varnum, B; Brancolini, C; Schneider, C			Gas6 anti-apoptotic signaling requires NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE RECEPTOR; SURVIVAL ACTIVITIES; CELL-SURVIVAL; GROWTH-FACTOR; PC12 CELLS; EXPRESSION; INDUCTION; PROTEIN; FIBROBLASTS; INSULIN	The growth arrest-specific 6 gene product Gas6 is a growth and survival factor related to protein S. Gas6 is the ligand of AxI receptor tyrosine kinase; upon binding to its receptor Gas6 activates the phosphatidylinositol 3-OH kinase (PI3K) and its downstream targets S6K and Akt. Gas6 anti-apoptotic signaling was previously shown to require functional PI3K and Akt and to involve Bad phosphorylation in serum-starved NIH 3T3 cells. Here we demonstrate that Gas6 induces a rapid and transient increase in nuclear NF-kappaB binding activity coupled to transcription activation from NF-kappaB-responsive promoters and increase in Bcl-x(L) protein level. Gas6 survival function is impaired in cells lacking p65/RelA and in NIH 3T3 cells transfected with a dominant negative I kappaB, indicating that NF-kappaB activation plays a central role in promoting survival in this system. Moreover, NF-kappaB activation can be blocked by a dominant negative Akt and by wortmannin, an inhibitor of PI3K, thus suggesting that NF-kappaB activation is a downstream event with respect to PI3K and Akt, as already described for other growth factors. In addition, we show that glycogen synthase kinase 3, which is phosphorylated in response to Gas6, can physically associate with NFKB1/p105 in living cells and can phosphorylate it in vitro. Furthermore, Gas6 treatment is coupled to a decrease in p105 protein level. Altogether these data suggest the involvement of NF-kappaB and glycogen synthase kinase 3 in Gas6 anti-apoptotic signaling and unveil a possible link between these survival pathways.	Lab Nazl Consorzio Interuniv Biotechnol, I-34012 Trieste, Italy; Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy; Amgen Inc, Thousand Oaks, CA 91320 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine; Amgen	Schneider, C (corresponding author), Lab Nazl Consorzio Interuniv Biotechnol, AREA Sci Pk,Padriciano 99, I-34012 Trieste, Italy.			BRANCOLINI, Claudio/0000-0002-6597-5373; Demarchi, Francesca/0000-0003-1565-3162				Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bellosta P, 1997, ONCOGENE, V15, P2387, DOI 10.1038/sj.onc.1201419; Bertrand F, 1998, J BIOL CHEM, V273, P2931, DOI 10.1074/jbc.273.5.2931; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; Dormady SP, 2000, P NATL ACAD SCI USA, V97, P12260, DOI 10.1073/pnas.97.22.12260; Evans-Storms RB, 2000, ENDOCRINOLOGY, V141, P1854, DOI 10.1210/en.141.5.1854; Foo SY, 1999, TRENDS GENET, V15, P229; FUJIMOTO J, 1994, ONCOGENE, V9, P693; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; Glasgow JN, 2000, J NEUROCHEM, V75, P1377, DOI 10.1046/j.1471-4159.2000.0751377.x; Goruppi S, 1999, ONCOGENE, V18, P4224, DOI 10.1038/sj.onc.1202788; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Goruppi S, 1996, ONCOGENE, V12, P471; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Grumont RJ, 1999, GENE DEV, V13, P400, DOI 10.1101/gad.13.4.400; Harhaj E, 1996, VIROLOGY, V216, P284, DOI 10.1006/viro.1996.0062; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Katagiri M, 2001, J BIOL CHEM, V276, P7376, DOI 10.1074/jbc.M007393200; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; Li RH, 1996, J NEUROSCI, V16, P2012; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Maggirwar SB, 2000, J NEUROCHEM, V74, P527, DOI 10.1046/j.1471-4159.2000.740527.x; Mantovani F, 1998, NUCLEIC ACIDS RES, V26, P1433, DOI 10.1093/nar/26.6.1433; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; O'Donnell K, 1999, AM J PATHOL, V154, P1171, DOI 10.1016/S0002-9440(10)65369-2; Oldereid NB, 2001, MOL HUM REPROD, V7, P403, DOI 10.1093/molehr/7.5.403; Ozes ON, 1999, NATURE, V401, P82; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Prieto AL, 2000, J COMP NEUROL, V425, P295; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yang CH, 2001, J BIOL CHEM, V276, P13756, DOI 10.1074/jbc.M011006200; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	51	89	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31738	31744		10.1074/jbc.M104457200	http://dx.doi.org/10.1074/jbc.M104457200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11425860	hybrid			2022-12-27	WOS:000170613500037
J	Ford, LP; Zou, Y; Pongracz, K; Gryaznov, S; Shay, JW; Wright, WE				Ford, LP; Zou, Y; Pongracz, K; Gryaznov, S; Shay, JW; Wright, WE			Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMORTAL HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; MECHANISM; DNA; YEAST; CHROMOSOMES; ELONGATION; SENESCENCE; RNA	Telomere length can be maintained by telomerase or by a recombination-based pathway. Because individual telomeres in cells using the recombination-based pathway of telomere maintenance appear to periodically become extremely short, cells using this pathway to maintain telomeres may be faced with a continuous state of crisis. We expressed telomerase in a human cell line that uses the recombination-based pathway of telomere maintenance to test whether telomerase would prevent telomeres from becoming critically short and examine the effects that this might have on the recombination-based pathway of telomere maintenance. In these. cells, telomerase maintains the length of the shortest telomeres. In some cases, the long heterogeneous telomeres are completely lost, and the cells now permanently contain short telomeres after only 40 population doublings. This corresponds to a telomere reduction rate of 500 base pairs/population doubling, a rate that is much faster than expected for normal telomere shortening but is consistent with the rapid telomere deletion events observed in cells using the recombination-based. pathway of telomere maintenance (Murnane, J. P., Sabatier, L., Marder, B. A., and Morgan, W. F. (1994) EMBO J. 13, 4953-4962). We also observed reductions in the fraction of cells containing alternative lengthening of telomere-associated promyelocytic leukemia bodies and extrachromosomal telomere repeats; however, no alterations in the rate of sister chromatid exchange were observed. Our results demonstrate that human cells using the recombination-based pathway of telomere maintenance retain factors required for telomerase to maintain telomeres and that once the telomerase-based pathway of telomere length regulation is engaged, recombination-based elongation of telomeres can be functionally inhibited.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Geron Corp, Menlo Park, CA 94024 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Geron Corporation	Shay, JW (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Shay, Jerry W/F-7878-2011	Zou, Ying/0000-0003-2787-1917	NATIONAL INSTITUTE ON AGING [R37AG001228, R01AG007992, R01AG001228] Funding Source: NIH RePORTER; NIA NIH HHS [AG01228, AG07992] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Colgin LM, 2000, NEOPLASIA, V2, P426, DOI 10.1038/sj.neo.7900112; Ford LP, 2000, MOL CELL BIOL, V20, P9084, DOI 10.1128/MCB.20.23.9084-9091.2000; Fouladi B, 2000, NEOPLASIA, V2, P540, DOI 10.1038/sj.neo.7900107; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Gryaznov SM, 1999, BBA-GENE STRUCT EXPR, V1489, P131, DOI 10.1016/S0167-4781(99)00151-7; Hande MP, 2001, HUM MOL GENET, V10, P519, DOI 10.1093/hmg/10.5.519; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kipling D, 1999, NAT BIOTECHNOL, V17, P313, DOI 10.1038/7827; Le S, 1999, GENETICS, V152, P143; Li BB, 1996, GENE DEV, V10, P1310, DOI 10.1101/gad.10.11.1310; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; MASON JM, 1995, TRENDS GENET, V11, P58, DOI 10.1016/S0168-9525(00)88998-2; McChesney Patricia A., 2000, Molecular Cell Biology Research Communications, V3, P312, DOI 10.1006/mcbr.2000.0229; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; NICHOLS WW, 1978, CANCER RES, V38, P960; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Ogino H, 1998, BIOCHEM BIOPH RES CO, V248, P223, DOI 10.1006/bbrc.1998.8875; Roth CW, 1997, MOL CELL BIOL, V17, P5176, DOI 10.1128/MCB.17.9.5176; Saretzki G, 1999, ONCOGENE, V18, P5148, DOI 10.1038/sj.onc.1202898; Smith CD, 1999, J CELL BIOL, V145, P203, DOI 10.1083/jcb.145.2.203; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(00)00092-7; Teng SC, 1999, MOL CELL BIOL, V19, P8083; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Yeager TR, 1999, CANCER RES, V59, P4175; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388	34	78	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32198	32203		10.1074/jbc.M104469200	http://dx.doi.org/10.1074/jbc.M104469200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11395519	hybrid			2022-12-27	WOS:000170613500099
J	Heiss, E; Herhaus, C; Klimo, K; Bartsch, H; Gerhauser, C				Heiss, E; Herhaus, C; Klimo, K; Bartsch, H; Gerhauser, C			Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; DNA-BINDING ACTIVITY; COLON-CANCER CELLS; TRANSCRIPTION FACTOR; BACTERIAL LIPOPOLYSACCHARIDE; RAW-264.7 MACROPHAGES; CYCLOOXYGENASE-2 GENE; SIGNAL-TRANSDUCTION; INTERFERON-GAMMA	Sulforaphane (SFN), an aliphatic isothiocyanate, is a known cancer chemopreventive agent. Aiming to investigate anti-inflammatory mechanisms of SFN, we here report a potent decrease in lipopolysaccharide (LPS)induced secretion of pro-inflammatory and pro-careinogenic signaling factors in cultured Raw 264.7 macrophages after SFN treatment, i.e. NO, prostaglandin E-2, and tumor necrosis factor a. SFN did not directly interact with NO, nor did it inhibit inducible nitric-oxide synthase enzymatic activity. Western blot analyses revealed time- and dose-dependent reduction of LPS-induced inducible nitric-oxide synthase as well as Cox-2 protein expression, which was suppressed at the transcriptional level. To reveal the target of SFN beyond its anti-inflammatory action, we performed electrophoretic mobility shift assay analyses of transcription factor-DNA binding. Consequently, nuclear factor kappaB (NF-kappaB), a pivotal transcription factor in LPS-stimulated proinflammatory response, was identified as the key mediator. SFN selectively reduced DNA binding of NF-kappaB without interfering with LPS-induced degradation of the inhibitor of NF-kappaB nor with nuclear translocation of NF-kappaB. Because SFN can interact with thiol. groups by dithiocarbamate formation, it may impair the redox-sensitive DNA binding and transactivation of NF-kappaB. Sulforaphane could either directly inactivate NF-kappaB subunits by binding to essential Cys residues or interact with glutathione or other redox regulators like thioredoxin and Ref-1 relevant for NF-kappaB function. Our data provide novel evidence that anti-inflammatory mechanisms contribute to sulforaphane-mediated cancer chemoprevention.	Deutsch Krebsforschungszentrum, Div Toxicol & Canc Risk Factors, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Gerhauser, C (corresponding author), Deutsch Krebsforschungszentrum, Div Toxicol & Canc Risk Factors, C0202 Chemoprevent,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Heiss, Elke/B-6086-2015	Heiss, Elke/0000-0001-7618-5505; Gerhauser, Clarissa/0000-0002-5792-3901				Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BENAV P, 1995, FEBS LETT, V372, P83, DOI 10.1016/0014-5793(95)00956-A; BUCHMULLERROUILLER Y, 1995, CELL IMMUNOL, V164, P73, DOI 10.1006/cimm.1995.1144; Chen CC, 1997, FEBS LETT, V412, P30, DOI 10.1016/S0014-5793(97)00697-2; Chen CC, 1998, J IMMUNOL, V161, P6206; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; DING AH, 1988, J IMMUNOL, V141, P2407; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fahey JW, 1999, FOOD CHEM TOXICOL, V37, P973, DOI 10.1016/S0278-6915(99)00082-4; Fujiki H, 2000, CANCER DETECT PREV, V24, P91; FUJIKI H, 1994, J BIOCHEM-TOKYO, V115, P1; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gerhaeuser C., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P359; Gerhauser C, 1997, CANCER RES, V57, P272; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Graziewicz M, 1996, CARCINOGENESIS, V17, P2501, DOI 10.1093/carcin/17.11.2501; Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017; Hiramoto M, 1998, J IMMUNOL, V160, P810; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Holmes-McNary M, 2000, CANCER RES, V60, P3477; HOOPER DC, 1997, P NATL ACAD SCI USA, V94, P2328; KIM S, 1986, J ORG CHEM, V51, P2613, DOI 10.1021/jo00363a046; Lee SK, 1999, ANTICANCER RES, V19, P35; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; Liu GY, 1998, MOL CARCINOGEN, V22, P235, DOI 10.1002/(SICI)1098-2744(199808)22:4<235::AID-MC5>3.0.CO;2-I; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MITOMO K, 1994, GENE, V145, P197; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OHSHIMA H, 1994, MUTAT RES, V305, P253, DOI 10.1016/0027-5107(94)90245-3; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMID H, 1948, HELV CHIM ACTA, V31, P1497, DOI 10.1002/hlca.19480310608; Schmidt TJ, 1999, BIOORGAN MED CHEM, V7, P2849, DOI 10.1016/S0968-0896(99)00234-5; Sen CK, 2000, CURR TOP CELL REGUL, V36, P1; Sheng HM, 1998, CANCER RES, V58, P362; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPORN MB, 1979, FED PROC, V38, P2528; SPORN MB, 1986, J CLIN INVEST, V78, P329, DOI 10.1172/JCI112580; Steer JH, 2000, J BIOL CHEM, V275, P18432, DOI 10.1074/jbc.M906304199; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Subbaramaiah K, 1997, P SOC EXP BIOL MED, V216, P201; Subbaramaiah K, 2000, CANCER RES, V60, P2399; Suh N, 1998, CANCER RES, V58, P717; Takahashi M, 1997, CANCER RES, V57, P1233; Tsai SH, 1999, BRIT J PHARMACOL, V126, P673, DOI 10.1038/sj.bjp.0702357; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Xia CL, 1997, INT J BIOCHEM CELL B, V29, P1525, DOI 10.1016/S1357-2725(97)00083-6; Xie QW, 1997, J BIOL CHEM, V272, P14867, DOI 10.1074/jbc.272.23.14867; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Yuan CJ, 2000, CANCER RES, V60, P1084; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175; ZHENG S, 1991, BIOCHEM BIOPH RES CO, V175, P48, DOI 10.1016/S0006-291X(05)81198-2	68	505	526	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32008	32015		10.1074/jbc.M104794200	http://dx.doi.org/10.1074/jbc.M104794200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11410599	hybrid			2022-12-27	WOS:000170613500074
J	Klekotka, PA; Santoro, SA; Wang, HC; Zutter, MM				Klekotka, PA; Santoro, SA; Wang, HC; Zutter, MM			Specific residues within the alpha(2) integrin subunit cytoplasmic domain regulate migration and cell cycle progression via distinct MAPK pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CASCADE; GROWTH-FACTOR ACTIVATION; FOCAL ADHESION KINASE; MEDIATED ACTIVATION; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ALPHA-2-BETA-1 INTEGRIN; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CANCER-CELLS	The alpha (2) integrin subunit cytoplasmic domain is necessary for epidermal growth factor (EGF)-stimulated chemotactic migration and insulin-dependent entry into S-phase of mammary epithelial cells adherent to type I collagen. Truncation mutants revealed that the seven amino acids, KYEKMTK, in addition to the GFFKR motif were sufficient for these functions. Mutation of tyrosine 1134 to alanine inhibited the ability of the cells to phosphorylate p38 MAPK and to migrate in response to EGF but had only a modest effect on the ability of the cells to induce sustained phosphorylation of the ERK MAPK, to up-regulate cyclin E and cdk2 expression, and to enter S-phase when adherent to type I collagen. Conversely, mutation of the lysine 1136 inhibited the ability of the cells to increase cyclin E and cdk2 expression, to maintain long term phosphorylation of the ERK MAPK, and to enter S-phase but had no effect on the ability of the cells to phosphorylate the p38 MAPK or to migrate on type I collagen in response to EGF. Methionine 1137 was essential for both migration and entry into S-phase. Thus, distinctly different structural elements of the a2 integrin cytoplasmic domain are-required to engage the signaling pathways leading to cell migration or cell cycle progression.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Zutter, MM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid,Box 8118, St Louis, MO 63110 USA.				NCI NIH HHS [CA83690, CA70275] Funding Source: Medline; NHLBI NIH HHS [HL63446] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083690, R01CA070275] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063446] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Aplin AE, 1999, J BIOL CHEM, V274, P31223, DOI 10.1074/jbc.274.44.31223; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bottazzi ME, 1997, TRENDS CELL BIOL, V7, P348, DOI 10.1016/S0962-8924(97)01114-8; Chen QM, 1996, J BIOL CHEM, V271, P18122, DOI 10.1074/jbc.271.30.18122; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COPPOLINO M, 1995, J BIOL CHEM, V270, P23132, DOI 10.1074/jbc.270.39.23132; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Fishman DA, 1998, INVAS METAST, V18, P15, DOI 10.1159/000024495; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gotwals PJ, 1996, J CLIN INVEST, V97, P2469, DOI 10.1172/JCI118693; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Howe AK, 1998, J BIOL CHEM, V273, P27268, DOI 10.1074/jbc.273.42.27268; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; IGNATIUS MJ, 1990, J CELL BIOL, V111, P709, DOI 10.1083/jcb.111.2.709; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; KASSNER PD, 1994, J BIOL CHEM, V269, P19859; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kieffer JD, 1995, BIOCHEM BIOPH RES CO, V217, P466, DOI 10.1006/bbrc.1995.2799; Klekotka PA, 2001, J BIOL CHEM, V276, P9503, DOI 10.1074/jbc.M006286200; KLEKOTKA PA, 2001, IN PRESS AM J PATHOL; Lang SH, 1997, CLIN EXP METASTAS, V15, P218, DOI 10.1023/A:1018465213641; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee D, 1998, J BIOL CHEM, V273, P13022, DOI 10.1074/jbc.273.21.13022; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Lundstrom A, 1998, BIOCHEM BIOPH RES CO, V250, P735, DOI 10.1006/bbrc.1998.9389; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; SANTORO SA, 1994, METHOD ENZYMOL, V245, P147; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; Sato M, 1996, CANCER LETT, V102, P183, DOI 10.1016/0304-3835(96)04158-4; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; STAATZ WD, 1990, J BIOL CHEM, V265, P4778; TLSTY T, 1995, METHOD ENZYMOL, V254, P125; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Werr J, 2000, BLOOD, V95, P1804, DOI 10.1182/blood.V95.5.1804.005k11_1804_1809; Wixler V, 1999, FEBS LETT, V445, P351, DOI 10.1016/S0014-5793(99)00151-9; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; YU FX, 1992, J BIOL CHEM, V267, P14616; Zutter MM, 1999, AM J PATHOL, V155, P927, DOI 10.1016/S0002-9440(10)65192-9; ZUTTER MM, 1995, P NATL ACAD SCI USA, V92, P7411, DOI 10.1073/pnas.92.16.7411	54	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32353	32361		10.1074/jbc.M101921200	http://dx.doi.org/10.1074/jbc.M101921200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418614	hybrid			2022-12-27	WOS:000170613500118
J	Lakkaraju, A; Dubinsky, JM; Low, WC; Rahman, YE				Lakkaraju, A; Dubinsky, JM; Low, WC; Rahman, YE			Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CATIONIC LIPOSOME; GENE-TRANSFER; DNA; PHOSPHOLIPIDS; TRANSFECTION; ACTIVATION; EXPRESSION; APOPTOSIS; MEMBRANES	The potential of anionic liposomes for oligonucleotide delivery was explored because the requirement for a net-positive charge on transfection-competent cationic liposome-DNA complexes is ambiguous. Liposomes composed of phosphatidylglycerol and phosphatidylcholine were monodisperse and encapsulated oligonucleotides with 40-60% efficiency. Ionic strength, bilayer charge density, and oligonucleotide chemistry influenced encapsulation. To demonstrate the biological efficacy of this vector, antisense oligonucleotides to p53 delivered in anionic liposomes were tested in an in vitro model of excitotoxicity. Exposure of hippocampal neurons to glutamate increased p53 protein expression 4-fold and decreased neuronal survival to similar to 35%. Treatment with 1 muM p53 antisense oligonucleotides in anionic liposomes prevented glutamate-induced up-regulation of p53 and increased neuronal survival to similar to 35%. Encapsulated phosphorothioate p53 antisense oligonucleotides were neuroprotective at 5-10-fold lower concentrations than when unencapsulated. Replacing the anionic lipid with phosphatidylserine significantly decreased neuroprotection. p53 antisense oligonucleotides complexed with cationic liposomes were ineffective. Neuroprotection by p53 antisense oligonucleotides in anionic liposomes was comparable with that by glutamate receptor antagonists and a chemical inhibitor of p53. Anionic liposomes were also capable of delivering plasmids and inducing transgene expression in neurons. Anionic liposome-mediated internalization of Cy3-labeled oligonucleotides by neurons and several other cell lines demonstrated the universal applicability of this vector.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pharmaceut, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dubinsky, JM (corresponding author), Univ Minnesota, Dept Neurosci, 6-145 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	dubin001@tc.umn.edu			NIA NIH HHS [AG10034] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG010034] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKHTAR S, 1991, NUCLEIC ACIDS RES, V19, P5551, DOI 10.1093/nar/19.20.5551; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AZZAZY HME, 1995, BRAIN RES, V695, P231, DOI 10.1016/0006-8993(95)00710-8; Bally MB, 1999, ADV DRUG DELIVER REV, V38, P291, DOI 10.1016/S0169-409X(99)00034-4; Bandyopadhyay S, 1999, J PHYS CHEM B, V103, P10075, DOI 10.1021/jp9927496; BELL RM, 1991, J BIOL CHEM, V266, P4661; BROSIUS B, 1986, J BIOMOL STRUCT DYN, V4, P271, DOI 10.1080/07391102.1986.10506346; Buchner K, 1999, MOL BRAIN RES, V64, P222, DOI 10.1016/S0169-328X(98)00324-6; Chen RW, 1999, J NEUROSCI, V19, P9654; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; DUBINSKY JM, 1995, J NEUROSCI, V15, P7071; DUBINSKY JM, 1993, J NEUROSCI, V13, P623; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Hartmann G, 1998, J PHARMACOL EXP THER, V285, P920; HUGHES JA, 1994, J PHARM SCI, V83, P597, DOI 10.1002/jps.2600830431; JAASKELAINEN I, 1994, BBA-BIOMEMBRANES, V1195, P115, DOI 10.1016/0005-2736(94)90017-5; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; Jordan J, 1997, J NEUROSCI, V17, P1397; Kaech S, 1996, MOL BRAIN RES, V35, P344, DOI 10.1016/0169-328X(95)00238-N; Kodama M, 1996, COLLOID SURFACE A, V109, P283, DOI 10.1016/0927-7757(95)03461-7; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Malghani MS, 1998, J PHYS CHEM B, V102, P8930, DOI 10.1021/jp982413g; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Monnard PA, 1999, LANGMUIR, V15, P7504, DOI 10.1021/la990068w; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Morrison RS, 1996, J NEUROSCI, V16, P1337; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schwartz B, 1995, HUM GENE THER, V6, P1515, DOI 10.1089/hum.1995.6.12-1515; SINGER VL, 1995, FASEB J, V9, pA1422; Son KK, 2000, BBA-BIOMEMBRANES, V1466, P11, DOI 10.1016/S0005-2736(00)00176-0; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11384, DOI 10.1093/nar/16.23.11384; Stein CA, 1999, NAT BIOTECHNOL, V17, P209, DOI 10.1038/6909; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; TAKENAKA I, 1995, J BIOL CHEM, V270, P5405, DOI 10.1074/jbc.270.10.5405; Wangerek LA, 2001, J GENE MED, V3, P72, DOI 10.1002/1521-2254(200101/02)3:1<72::AID-JGM157>3.0.CO;2-M; WINTERHALTER M, 1993, CHEM PHYS LIPIDS, V64, P35, DOI 10.1016/0009-3084(93)90056-9; Xiang H, 1996, J NEUROSCI, V16, P6753; Xu YH, 1999, BIOPHYS J, V77, P341, DOI 10.1016/S0006-3495(99)76894-3; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; Zelphati O, 1996, J CONTROL RELEASE, V41, P99, DOI 10.1016/0168-3659(96)01361-2; Zhang YP, 1997, BIOPHYS J, V72, P779, DOI 10.1016/S0006-3495(97)78712-5	43	55	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32000	32007		10.1074/jbc.M100138200	http://dx.doi.org/10.1074/jbc.M100138200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11406618	hybrid			2022-12-27	WOS:000170613500073
J	Pathan, N; Marusawa, H; Krajewska, M; Matsuzawa, S; Kim, H; Okada, K; Tori, S; Kitada, S; Krajewski, S; Welsh, K; Pio, F; Godzik, A; Reed, JC				Pathan, N; Marusawa, H; Krajewska, M; Matsuzawa, S; Kim, H; Okada, K; Tori, S; Kitada, S; Krajewski, S; Welsh, K; Pio, F; Godzik, A; Reed, JC			TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH PROTEASE; CYTOCHROME-C; APOPTOSIS; ACTIVATION; APAF-1; CARD	Caspase-associated recruitment domains (CARDs) are protein interaction domains that participate in activation or suppression of CARD-carrying members of the caspase family of apoptosis-inducing proteases. A novel CARD-containing protein was identified that is overexpressed in some types of cancer and that binds and suppresses activation of procaspase-9, which we term TUCAN (tumor-upregulated CARD-containing antagonist of caspase nine). The CARD domain of TUCAN selectively binds itself and procaspase-9. TUCAN interferes with binding of Apaf1 to procaspase-9 and suppresses caspase activation induced by the Apaf1 activator, cytochrome c. Overexpression of TUCAN in cells by stable or transient transfection inhibits apoptosis and caspase activation induced by Apaf1/ caspase-9-dependent stimuli, including Bax, VP16, and staurosporine, but not by Apafl/caspase-9-independent stimuli, Fas and granzyme B. High levels of endogenous TUCAN protein were detected in several tumor cell lines and in colon cancer specimens, correlating with shorter patient survival. Thus, TUCAN represents a new member of the CARD family that selectively suppresses apoptosis induced via the mitochondrial pathway for caspase activation.	Burnham Inst, La Jolla, CA 92037 USA; Yonsei Univ, Coll Med, Dept Pathol, Seoul 120749, South Korea	Sanford Burnham Prebys Medical Discovery Institute; Yonsei University; Yonsei University Health System	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Godzik, Adam/AAW-1467-2020; Godzik, Adam/A-7279-2009	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Marusawa, Hiroyuki/0000-0002-4286-2712; pio, frederic/0000-0003-2050-847X	NCI NIH HHS [CA69381] Funding Source: Medline; NIA NIH HHS [AG15402] Funding Source: Medline; NINDS NIH HHS [NS36821] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015402] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Krajewska M, 1997, CANCER RES, V57, P1605; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LI W, 2001, IN PRESS BIOINFORMAT; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; RENTROP M, 1986, HISTOCHEM J, V18, P271, DOI 10.1007/BF01676237; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WEINSTEIN J, 1997, SCIENCE, V17, P343; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	32	86	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32220	32229		10.1074/jbc.M100433200	http://dx.doi.org/10.1074/jbc.M100433200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11408476	hybrid			2022-12-27	WOS:000170613500102
J	Sim, SP; Liu, LF				Sim, SP; Liu, LF			Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-TOPOISOMERASE-II; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; DOUBLE-STRAND BREAKS; CHROMOSOME TRANSLOCATIONS; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; 11Q23 TRANSLOCATIONS; BINDING-SITES; MLL GENE	VP-16 (etoposide) has recently been shown to induce topoisomerase II (TOP2)-mediated DNA cleavage within the mixed lineage leukemia (MLL) breakpoint cluster region (ber), suggesting a role of TOP2 in MLL gene rearrangement. In our current studies, we have compared the induction of DNA cleavage within the MLL bcr in different cell lines after treatment with various anticancer drugs. All anticancer drugs tested including VP-16 (a TOP2-directed drug), camptothecin (a topoisomerase I-directed drug), 5-fluorouracil and methotrexate (antimetabolites), and vinblastine (a microtubule inhibitor) induced the same site-specific cleavage within the MLL her. This cleavage was shown to nuclease-mediated but not TOP2-mediated by the following observations: 1) drug- induced cleavage within the MLL her was not protein-linked; 2) unlike TOP2-mediated cleavage, drug-induced DNA cleavage with the MLL her was kinetically slow and coincided with the formation of the apoptotic nucleosomal DNA ladder; 3) drug-induced cleavage within the I ML ber was unaffected in cells with reduced nuclear TOP2; and 4) drug-induced cleavage within the MLL ber was abolished by the caspase inhibitor, Z-Asp(OCH3)-Glu(OCH3)-Val-Asp(OCH3)-FMK. The possibility that an apoptotic, nuclease may be involved in cleavage of the MLL her and MLL gene translocation is discussed.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Canc Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Ln, Piscataway, NJ 08854 USA.		Sim, Sai-Peng/N-6455-2018	Sim, Sai-Peng/0000-0002-0256-2803; Liu, Leroy/0000-0001-9396-763X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027731] Funding Source: NIH RePORTER; NCI NIH HHS [CA39962] Funding Source: Medline; NIGMS NIH HHS [GM27731] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aratani Y, 1996, MUTAT RES-DNA REPAIR, V362, P181, DOI 10.1016/0921-8777(95)00049-6; BAE YS, 1991, GENE, V101, P285; BODLEY AL, 1993, MOL CELL BIOL, V13, P6190, DOI 10.1128/MCB.13.10.6190; Broeker PLS, 1996, BLOOD, V87, P1912, DOI 10.1182/blood.V87.5.1912.bloodjournal8751912; CHEN GL, 1984, J BIOL CHEM, V259, P3560; CIMINO G, 1991, CANCER RES, V51, P6712; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; DOMER PH, 1995, LEUKEMIA, V9, P1305; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FELIX CA, 1995, CANCER RES, V55, P4287; FELIX CA, 1995, BLOOD, V85, P3250, DOI 10.1182/blood.V85.11.3250.bloodjournal85113250; Fujimaki K, 1996, SOMAT CELL MOLEC GEN, V22, P279, DOI 10.1007/BF02369567; GU Y, 1994, CANCER RES, V54, P2327; GU Y, 1992, P NATL ACAD SCI USA, V89, P10464, DOI 10.1073/pnas.89.21.10464; HARKER WG, 1989, CANCER RES, V49, P4542; HARKER WG, 1995, CANCER RES, V55, P1707; HSIANG YH, 1989, J BIOL CHEM, V264, P9713; HUNGER SP, 1993, BLOOD, V81, P3197; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; KOBAYASHI Y, 1995, LEUKEMIA LYMPHOMA, V17, P391, DOI 10.3109/10428199509056849; KUBOTA M, 1994, ACTA HAEMATOL-BASEL, V92, P33; Labhart P, 1999, EUR J BIOCHEM, V265, P849, DOI 10.1046/j.1432-1327.1999.00805.x; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; LIM M, 1986, CELL BIOL TOXICOL, V2, P485, DOI 10.1007/BF00117850; Martins LM, 1997, BLOOD, V90, P4283, DOI 10.1182/blood.V90.11.4283.4283_4283_4296; Masuda Y, 1997, BIOCHEM BIOPH RES CO, V234, P641, DOI 10.1006/bbrc.1997.6690; NEGRINI M, 1993, CANCER RES, V53, P4489; PEDERSENBJERGAARD J, 1991, BLOOD, V78, P1147; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; PUI CH, 1989, NEW ENGL J MED, V321, P136, DOI 10.1056/NEJM198907203210302; PUI CH, 1990, LANCET, V336, P417, DOI 10.1016/0140-6736(90)91956-B; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; ROWLEY JD, 1993, SEMIN CANCER BIOL, V4, P377; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sathees CR, 1999, MUTAT RES-DNA REPAIR, V433, P1, DOI 10.1016/S0921-8777(98)00055-X; SMITH MA, 1994, MED PEDIATR ONCOL, V23, P86, DOI 10.1002/mpo.2950230205; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; SUPER HJG, 1993, BLOOD, V82, P3705; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Tsukamoto Y, 1998, GENES CELLS, V3, P135, DOI 10.1046/j.1365-2443.1998.00180.x; Wang HM, 2001, BIOCHEMISTRY-US, V40, P3316, DOI 10.1021/bi002786j; YANG L, 1985, CANCER RES, V45, P5872; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	50	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31590	31595		10.1074/jbc.M103962200	http://dx.doi.org/10.1074/jbc.M103962200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11406628	hybrid, Green Submitted			2022-12-27	WOS:000170613500018
J	Goossens, A; Dever, TE; Pascual-Ahuir, A; Serrano, R				Goossens, A; Dever, TE; Pascual-Ahuir, A; Serrano, R			The protein kinase Gcn2p mediates sodium toxicity in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; UNCHARGED TRANSFER-RNA; MEMBRANE H+-ATPASE; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL REGULATION; SALT TOLERANCE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ION HOMEOSTASIS; FACTOR EIF2B	Phosphorylation of the a-subunit of eukaryotic initiation factor 2 (eIF2 alpha) is a conserved mechanism regulating protein synthesis in response to various stresses. A screening for negative factors in yeast salt stress tolerance has led to the identification of Gcn2p, the single yeast eIF2a kinase that is activated by amino acid starvation in the general amino acid control response. Mutation of other components of this regulatory circuit such as GCN1 and GCN3 also resulted in improved NaCl tolerance. The gcn2 phenotype was not accompanied by changes in sodium or potassium homeostasis. NaCl induced a Gcn2p-dependent phosphorylation of eIF2a and translational activation of Gcn4p, the transcription factor that mediates the general amino acid control response. Mutations that activate Gcn4p function, such as gcd7-201, cpc2, and deletion of the translational regulatory region of the GCN4 gene, also cause salt sensitivity. It can be postulated that sodium activation of the Gcn2p pathway has toxic effects on growth under NaCl stress and that this novel mechanism of sodium toxicity may be of general significance in eukaryotes.	Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; NICHHD, Lab Eukaryotic Gene Regulat, Bethesda, MD 20892 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Serrano, R (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Camino Vera S-N, Valencia 46022, Spain.	serrano@ibmcp.upv.es	Pascual-ahuir, Amparo/K-1338-2014	PASCUAL-AHUIR, AMPARO/0000-0001-6173-1526; Dever, Thomas/0000-0001-7120-9678; Goossens, Alain/0000-0002-1599-551X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; BONNET J, 1975, FEBS LETT, V53, P154, DOI 10.1016/0014-5793(75)80008-1; BONNET J, 1975, EUR J BIOCHEM, V58, P193, DOI 10.1111/j.1432-1033.1975.tb02364.x; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; BUSHMAN JL, 1993, MOL CELL BIOL, V13, P1920, DOI 10.1128/MCB.13.3.1920; DEALDANA CRV, 1994, MOL CELL BIOL, V14, P7920; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; ENGELBERG D, 1994, CELL, V77, P381, DOI 10.1016/0092-8674(94)90153-8; FLORENTZ C, 1990, FEBS LETT, V261, P335, DOI 10.1016/0014-5793(90)80585-7; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; GAXIOLA R, 1992, EMBO J, V11, P3157, DOI 10.1002/j.1460-2075.1992.tb05392.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Guthrie C, 1991, GUIDE YEAST GENETICS; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hoffmann B, 1999, MOL MICROBIOL, V31, P807, DOI 10.1046/j.1365-2958.1999.01219.x; Hohmann S., 1997, YEAST STRESS RESPONS, P101; Jia MH, 2000, PHYSIOL GENOMICS, V3, P83, DOI 10.1152/physiolgenomics.2000.3.2.83; LANKER S, 1992, CELL, V70, P647, DOI 10.1016/0092-8674(92)90433-D; Marquez JA, 1996, FEBS LETT, V382, P89, DOI 10.1016/0014-5793(96)00157-3; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; MURGUIA JR, 1995, SCIENCE, V267, P232; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Norbeck J, 1998, FEMS MICROBIOL LETT, V158, P121, DOI 10.1016/S0378-1097(97)00511-9; Norbeck J, 2000, YEAST, V16, P121, DOI 10.1002/(SICI)1097-0061(20000130)16:2<121::AID-YEA511>3.0.CO;2-A; OCONNELL KF, 1995, MOL CELL BIOL, V15, P1879; Pascual-Ahuir M, 2001, MOL CELL BIOL, V21, P16, DOI 10.1128/MCB.21.1.16-25.2001; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Prior C, 1996, FEBS LETT, V387, P89, DOI 10.1016/0014-5793(96)00470-X; Qiu HF, 2000, MOL CELL BIOL, V20, P2505, DOI 10.1128/MCB.20.7.2505-2516.2000; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; ROLFES RJ, 1993, MOL CELL BIOL, V13, P5099, DOI 10.1128/MCB.13.8.5099; SEIN KT, 1971, ARCH BIOCHEM BIOPHYS, V145, P164, DOI 10.1016/0003-9861(71)90023-3; Serrano R, 1999, J EXP BOT, V50, P1023, DOI 10.1093/jexbot/50.suppl_1.1023; SMITH DWE, 1969, J BIOL CHEM, V244, P896; Tavernarakis N, 1996, GENE, V179, P271, DOI 10.1016/S0378-1119(96)00379-4; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TZAMARIAS D, 1989, CELL, V57, P947, DOI 10.1016/0092-8674(89)90333-4; VALLEJO CG, 1989, YEAST, V5, P307, DOI 10.1002/yea.320050411; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Yang WM, 1996, MOL CELL BIOL, V16, P6603	57	55	58	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30753	30760		10.1074/jbc.M102960200	http://dx.doi.org/10.1074/jbc.M102960200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11408481	hybrid			2022-12-27	WOS:000170472900024
J	Kurokawa, K; Mochizuki, N; Ohba, Y; Mizuno, H; Miyawaki, A; Matsuda, M				Kurokawa, K; Mochizuki, N; Ohba, Y; Mizuno, H; Miyawaki, A; Matsuda, M			A pair of fluorescent resonance energy transfer-based probes for tyrosine phosphorylation of the CrkII adaptor protein in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH3 DOMAINS; C-CRK; V-CRK; CELL-MIGRATION; LIVING CELLS; IN-VIVO; IDENTIFICATION; ASSOCIATION; KINASE; INDICATOR	An adaptor protein, CrkII, which is involved in a variety of signaling cascades such as cell growth, migration, and apoptosis, becomes phosphorylated on Tyr.. upon stimulation. Here, we report on a fluorescent resonance energy transfer-based sensor, which consists of CrkII sandwiched with cyan- and yellow-emitting variants of green fluorescent protein. This protein enabled us to monitor rapid and transient phosphorylation of CrkII upon epidermal growth factor stimulation in a living cell. However, rapid diffusion of the probes prevented us from specifying where the phosphorylation started within the cell. To overcome this problem, we fused the CAAX box of Ki-Ras to the carboxyl terminus of this probe and restricted its localization mostly to the plasma membrane. With this modified probe, we found that epidermal growth factor-induced phosphorylation of CrkII was initiated at the peripheral plasma membrane, moving toward the center of the cell. Moreover, this CAAX box-fused probe showed improvement in sensitivity and time resolution of the monitoring of CrkII phosphorylation. Thus, this pair of CrkII probes visualizes dynamic changes in the total and local levels of the tyrosine phosphorylation of CrkII in a living cell.	Osaka Univ, Res Inst Microbial Dis, Dept Tumor Virol, Suita, Osaka 5650871, Japan; Natl Cardiovasc Res Inst, Dept Struct Anal, Suita, Osaka 5658565, Japan; RIKEN, Brain Sci Inst, Lab Cell Funct & Dynam, Wako, Saitama 3510198, Japan	Osaka University; National Cerebral & Cardiovascular Center - Japan; RIKEN	Matsuda, M (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Tumor Virol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.		Miyawaki, Atsushi/K-3569-2014; Ohba, Yusuke/E-7944-2011; Kurokawa, Kazuo/E-9130-2013; Mizuno, Hideaki/AAH-5737-2021	Miyawaki, Atsushi/0000-0002-2329-3235; Kurokawa, Kazuo/0000-0003-3549-4795; Mizuno, Hideaki/0000-0002-6983-5255; Matsuda, Michiyuki/0000-0002-5876-9969				BEITNERJOHNSON D, 1995, J BIOL CHEM, V270, P5187, DOI 10.1074/jbc.270.10.5187; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Blakesley VA, 1997, J BIOL CHEM, V272, P16211, DOI 10.1074/jbc.272.26.16211; Cotton GJ, 2000, CHEM BIOL, V7, P253, DOI 10.1016/S1074-5521(00)00100-9; Escalante M, 2000, J BIOL CHEM, V275, P24787, DOI 10.1074/jbc.M000711200; EVANS GA, 1995, J BIOL CHEM, V270, P28858, DOI 10.1074/jbc.270.48.28858; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Galletta BJ, 1999, GENE, V228, P243, DOI 10.1016/S0378-1119(99)00010-4; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Hashimoto Y, 1998, J BIOL CHEM, V273, P17186, DOI 10.1074/jbc.273.27.17186; Honda A, 2001, P NATL ACAD SCI USA, V98, P2437, DOI 10.1073/pnas.051631298; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MAYER BJ, 1990, P NATL ACAD SCI USA, V87, P2638, DOI 10.1073/pnas.87.7.2638; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nagai Y, 2000, NAT BIOTECHNOL, V18, P313, DOI 10.1038/73767; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Ribon V, 1996, J BIOL CHEM, V271, P7375, DOI 10.1074/jbc.271.13.7375; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345	33	118	133	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31305	31310		10.1074/jbc.M104341200	http://dx.doi.org/10.1074/jbc.M104341200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11406630	hybrid			2022-12-27	WOS:000170472900094
J	Vila, R; Ponte, I; Collado, M; Arrondo, JLR; Suau, P				Vila, R; Ponte, I; Collado, M; Arrondo, JLR; Suau, P			Induction of secondary structure in a COOH-terminal peptide of histone H1 by interaction with the DNA - An infrared spectroscopy study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; TRANSCRIPTION IN-VIVO; GLOBULAR DOMAIN; GENE-EXPRESSION; AQUEOUS-SOLUTION; LINKER HISTONES; ALPHA-HELICES; PROTEINS; BINDING; CHROMATIN	We have studied the conformation of the peptide Ac-EPKRSVAFKKTKKEVKKVATPKK (CH-1), free in solution and bound to the DNA, by Fourier-transform infrared spectroscopy. The peptide belongs to the COOH-terminal domain of histone H1(0) (residues 99-121) and is adjacent to the central globular domain of the protein. In aqueous (D2O) solution the amide I ' is dominated by component bands at 1643 cm(-1) and 1662 cm(-1), which have been assigned to random coil conformations and turns, respectively. In accordance with previous NMR results, the latter component has been interpreted as arising in turn-like conformations in rapid equilibrium with unfolded states. The peptide becomes fully structured either in 90% trifluoroethanol (TFE) solution or upon interaction with the DNA. In these conditions, the contributions of turn (1662 cm(-1)) and random coil components virtually disappear. In TFE, the spectrum is dominated by the a-helical component (1654 cm(-1)). The band at 1662 cm(-1) shifts to 1670 cm(-1), and has been assigned to the COOH-terminal TPKK motif in a more stable turn conformation. A band at 1637 cm(-1), also present in TFE, has been assigned to 3(10) helical structure. The amide I ' band of the complexes with the DNA retains the components that were attributed to 3(10) helix and the TPKK turn. In the complexes with the DNA, the a-helical component observed in TFE splits into two components at 1657 cm(-1) and 1647 cm(-1). Both components are inside the spectral region of alpha -helical structures. Our results support the presence of inducible helical and turn elements, both sharing the character of DNA-binding motifs.	Univ Autonoma Barcelona, Fac Ciencias, Dept Bioquim & Biol Mol, Barcelona 08193, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain	Autonomous University of Barcelona; University of Barcelona; University of Basque Country	Suau, P (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Dept Bioquim & Biol Mol, Barcelona 08193, Spain.	Pere.Suau@uab.es	Vila, Roger/A-1817-2012; Ponte, Inma/AGN-5337-2022; Ponte, Inma/E-6848-2015; Suau, Pedro/D-2695-2009	Vila, Roger/0000-0002-2447-4388; Ponte, Inma/0000-0002-9448-6915; Suau, Pedro/0000-0001-6673-8209				ABBOTT TP, 1991, APPL SPECTROSC, V45, P1665, DOI 10.1366/0003702914335265; ALVAREZ J, 1987, BIOCHIM BIOPHYS ACTA, V916, P5, DOI 10.1016/0167-4838(87)90204-4; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; BOUVET P, 1994, GENE DEV, V8, P1147, DOI 10.1101/gad.8.10.1147; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CERF C, 1993, BIOCHEMISTRY-US, V32, P11345, DOI 10.1021/bi00093a011; CLARK DJ, 1988, EMBO J, V7, P69, DOI 10.1002/j.1460-2075.1988.tb02784.x; CLORE GM, 1987, EMBO J, V6, P1833, DOI 10.1002/j.1460-2075.1987.tb02438.x; Crane-Robinson C, 1999, BIOESSAYS, V21, P367, DOI 10.1002/(SICI)1521-1878(199905)21:5<367::AID-BIES2>3.0.CO;2-4; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; DWIVEDI AM, 1984, BIOPOLYMERS, V23, P2025, DOI 10.1002/bip.360231016; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; Galan A, 2001, J BIOL CHEM, V276, P957, DOI 10.1074/jbc.M006861200; GOORMAGHTIGH E, 1989, BIOCHIM BIOPHYS ACTA, V1006, P147, DOI 10.1016/0005-2760(89)90338-X; HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404; HARTMAN PG, 1977, EUR J BIOCHEM, V77, P45, DOI 10.1111/j.1432-1033.1977.tb11639.x; HERZYK E, 1987, BIOCHIM BIOPHYS ACTA, V922, P145, DOI 10.1016/0005-2760(87)90148-2; HILL CS, 1989, EMBO J, V8, P2591, DOI 10.1002/j.1460-2075.1989.tb08398.x; HOLLOWAY PW, 1989, BIOCHEMISTRY-US, V28, P931, DOI 10.1021/bi00429a002; Howe L, 1998, BIOCHEMISTRY-US, V37, P7077, DOI 10.1021/bi980410o; JACKSON M, 1992, BIOCHEMISTRY-US, V31, P7289, DOI 10.1021/bi00147a012; JACKSON M, 1991, BIOCHEMISTRY-US, V30, P9681, DOI 10.1021/bi00104a016; KHOCHBIN S, 1994, EUR J BIOCHEM, V225, P501, DOI 10.1111/j.1432-1033.1994.00501.x; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; MIICK SM, 1992, NATURE, V359, P653, DOI 10.1038/359653a0; MORAN F, 1985, BIOPHYS CHEM, V22, P125, DOI 10.1016/0301-4622(85)80033-8; PRESTRELSKI SJ, 1991, INT J PEPT PROT RES, V37, P508; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SUREWICZ WK, 1990, BIOCHEMISTRY-US, V29, P8106, DOI 10.1021/bi00487a017; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Susi H., 1969, STRUCTURE STABILITY, P575; SUZUKI M, 1993, PROTEIN ENG, V6, P565, DOI 10.1093/protein/6.6.565; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; Vermaak D, 1998, CURR BIOL, V8, P533, DOI 10.1016/S0960-9822(98)70206-4; Vila R, 2000, PROTEIN SCI, V9, P627; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; ZLATANOVA J, 1992, J CELL SCI, V103, P889	39	61	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30898	30903		10.1074/jbc.M104189200	http://dx.doi.org/10.1074/jbc.M104189200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413144	hybrid			2022-12-27	WOS:000170472900043
J	Hosono, H; Aoki, J; Nagai, Y; Bandoh, K; Ishida, M; Taguchi, R; Arai, H; Inoue, K				Hosono, H; Aoki, J; Nagai, Y; Bandoh, K; Ishida, M; Taguchi, R; Arai, H; Inoue, K			Phosphatidylserine-specific phospholipase A(1) stimulates histamine release from rat peritoneal mast cells through production of 2-acyl-1-lysophosphatidylserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PHOSPHOLIPASE; ACTIVATED PLATELETS; CONCANAVALIN-A; LYSOPHOSPHATIDYLSERINE; LYSOPHOSPHOLIPIDS; A(2)	Lysophosphatidylserine (1-acyl-24-lso-PS) has been shown to stimulate histamine release from rat peritoneal mast cells (RPMC) triggered by Fc epsilon RI (high affinity receptor for IgE) cross-linking, although the precise mechanism of lyso-PS production has been obscure. In the present study we show that phosphatidylserine-specific. phospholipase A(1), PS-PLA(1), stimulates histamine release from RPMC through production of 2-acyl-1-lyso-PS in the presence of Fc epsilon RI cross-linker. The potency of 2-acyl-1-lyso-PS was almost equal to that of 1-acyl-2-lyso-PS. A catalytically inactive PS-PLA, in which an active serine residue (Ser(166)) was replaced with an alanine residue did not show such activity. sPLA(2)-IIA, another secretory PLA(2) that is capable of producing lyso-PS in vitro, was also a poor histamine inducer against RPMC. PS-PLA(1) significantly stimulated histamine release from crude RPMC, indicating that lyso-PS is mainly derived from cells other than mast cells. In agreement with this phenomenon, the enzyme stimulated the histamine release more efficiently when RPMC were mixed with apoptotic Jurkat cells. Under these conditions, lyso-PS with unsaturated fatty acid was released from the apoptotic cells treated with PS-PLA(1). Finally, heparin, which has affinity for PS-PLA(1) completely blocked. the stimulatory effect of the enzyme. In conclusion, PS-PLA(1) may bind to heparan sulfate proteoglycan, efficiently hydrolyze PS appearing on plasma membranes of apoptotic cells, and stimulate mast cell activation mediated by 2-acyl-1-lyso-PS.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Nagoya City Univ, Fac Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4670027, Japan	University of Tokyo; Nagoya City University	Aoki, J (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.			Aoki, Junken/0000-0001-9435-1896				BELLINI F, 1993, FEBS LETT, V316, P1, DOI 10.1016/0014-5793(93)81724-E; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; HARA K, 1994, BIOL PHARM BULL, V17, P1121; HIGASHI S, 1988, J BIOCHEM-TOKYO, V103, P442, DOI 10.1093/oxfordjournals.jbchem.a122289; HORIGOME K, 1987, J BIOCHEM-TOKYO, V101, P625, DOI 10.1093/jb/101.3.625; HORIGOME K, 1986, J BIOCHEM-TOKYO, V100, P571, DOI 10.1093/oxfordjournals.jbchem.a121748; KATAYAMA S, 1978, MICROBIOL IMMUNOL, V22, P89, DOI 10.1111/j.1348-0421.1978.tb00352.x; KOMADA M, 1989, J BIOCHEM-TOKYO, V106, P545, DOI 10.1093/oxfordjournals.jbchem.a122890; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; KUDO I, 1989, DERMATOLOGICA, V179, P72, DOI 10.1159/000248454; Liliom K, 1998, AM J PHYSIOL-CELL PH, V274, pC1065, DOI 10.1152/ajpcell.1998.274.4.C1065; Lourenssen S, 1998, NEUROSCI LETT, V248, P77, DOI 10.1016/S0304-3940(98)00275-4; MARTIN TW, 1978, P NATL ACAD SCI USA, V75, P4997, DOI 10.1073/pnas.75.10.4997; MARTIN TW, 1979, NATURE, V279, P250, DOI 10.1038/279250a0; MIETTO L, 1987, BIOCHIM BIOPHYS ACTA, V930, P145, DOI 10.1016/0167-4889(87)90026-7; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; MURAKAMI M, 1993, J IMMUNOL, V151, P5675; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Nagai Y, 1999, J BIOL CHEM, V274, P11053, DOI 10.1074/jbc.274.16.11053; Sato T, 1997, J BIOL CHEM, V272, P2192; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; SHORE P, 1956, J PHARMACOL EXP THER, V127, P182; SMITH GA, 1979, FEBS LETT, V105, P58, DOI 10.1016/0014-5793(79)80887-X; SUZUKINISHIMURA T, 1991, JPN J PHARMACOL, V57, P79, DOI 10.1254/jjp.57.79; Taguchi R, 2000, J MASS SPECTROM, V35, P953, DOI 10.1002/1096-9888(200008)35:8<953::AID-JMS23>3.0.CO;2-4; TAMORINATORI Y, 1986, J BIOCHEM-TOKYO, V100, P581, DOI 10.1093/oxfordjournals.jbchem.a121749; XU Y, 1995, J CELL PHYSIOL, V163, P441, DOI 10.1002/jcp.1041630303; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; YOKOYAMA K, 1995, J BIOCHEM-TOKYO, V117, P1280, DOI 10.1093/oxfordjournals.jbchem.a124856	30	63	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29664	29670		10.1074/jbc.M104597200	http://dx.doi.org/10.1074/jbc.M104597200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395520	hybrid			2022-12-27	WOS:000170558000011
J	Liu, XB; Ambudkar, IS				Liu, XB; Ambudkar, IS			Characteristics of a store-operated calcium-permeable channel - Sarcoendoplasmic reticulum calcium pump function controls channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CA2+ ENTRY; POTENTIAL CHANNELS; CAPACITATIVE CA2+; ACTIVATION; DEPLETION; CELLS; MECHANISM; PROTEIN; INSP(3)	We examined the single channel properties and regulation of store-operated calcium channels (SOCC). In human submandibular gland cells, carbachol (CCh) induced flickery channel activity while thapsigargin (Tg) induced burst-like activity, with relatively lower open probability (NPo) and longer mean open time. Tg- and CCh-activated channels were permeable to Na+ and Ba2+, but not to NTUDG, in the absence of Ca2+. The channels exhibited similar Ca2+, Na2+, and Ba2+ conductances and were inhibited by 2-aminoethoxydiphenylborate, xestospongin C, Gd3+, and La3+. CCh stimulated flickery activity changed to burst-like activity by (i) addition of Tg, (ii) using Na+ instead of Ca2+, (iii) using Ca2+-free bath solution, or (iv) buffering [Ca2+](i) with BAPTA-AM. Buffering [Ca2+](i) induced a 2-fold increase in NPo of Tg-stimulated SOCC. Reducing free [Ca2+] in the endoplasmic reticulum with the divalent cation chelator, N,N,N ' ,N ' -tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), induced burst-like channel activity similar to that seen with CCh + Tg. Thus, SOCC is activated by stimulation of muscarinic receptors, inhibition of the sarcoendoplasmic Ca2+ pump, and lowering [Ca2+] in the internal store. Importantly, SOCC activity depends on [Ca2+](i) and the free [Ca2+] in the internal store. These novel findings reveal that SERCA plays a major role in the gating of SOCC by (i) refilling the internal Ca2+ store(s) and (ii) decreasing the [Ca2+](i)-dependent inhibition.	NIDCR, GTTB, Secretory Physiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ambudkar, IS (corresponding author), NIDCR, GTTB, Secretory Physiol Sect, NIH, Bldg 10,Rm 1N-113, Bethesda, MD 20892 USA.	ambudkar@yoda.nidcr.nih.gov			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000438] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ambudkar IS, 2000, CRIT REV ORAL BIOL M, V11, P4, DOI 10.1177/10454411000110010301; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Broad LM, 1999, J BIOL CHEM, V274, P32881, DOI 10.1074/jbc.274.46.32881; CAMELLO P, 1999, J PHYSIOL-LONDON, V490, P585; Fierro L, 2000, PFLUG ARCH EUR J PHY, V440, P580, DOI 10.1007/s004240050009; FORMINA AF, 2000, J CELL BIOL, V150, P1435; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Holda JR, 1998, NEWS PHYSIOL SCI, V13, P157; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kaznacheyeva E, 2000, J BIOL CHEM, V275, P4561, DOI 10.1074/jbc.275.7.4561; Kerschbaum HH, 1998, J GEN PHYSIOL, V111, P521, DOI 10.1085/jgp.111.4.521; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Liu XB, 1998, J BIOL CHEM, V273, P33295, DOI 10.1074/jbc.273.50.33295; Liu XB, 1998, AM J PHYSIOL-CELL PH, V275, pC571, DOI 10.1152/ajpcell.1998.275.2.C571; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Luo DL, 2001, J BIOL CHEM, V276, P20186, DOI 10.1074/jbc.M100327200; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhu X, 1998, NEWS PHYSIOL SCI, V13, P211; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	39	45	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29891	29898		10.1074/jbc.M103283200	http://dx.doi.org/10.1074/jbc.M103283200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395504	hybrid			2022-12-27	WOS:000170558000039
J	Stewart, JJ; Stargell, LA				Stewart, JJ; Stargell, LA			The stability of the TFIIA-TBP-DNA complex is dependent on the sequence of the TATAAA element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; BINDING PROTEIN; CRYSTAL-STRUCTURE; MINOR-GROOVE; YEAST TRANSCRIPTION; REINITIATION RATE; IN-VIVO; ACTIVATION; PROMOTER; INITIATION	To determine the mechanistic differences between canonical and noncanonical TATA elements, we compared the functional activity of two sequences: TATAAA (canonical) and CATAAA (noncanonical). The TATAAA element can support high levels of transcription in vivo, whereas the CATAAA element is severely defective for this function.. This dramatic functional difference is not likely to be due to a difference in TBP (TATA-binding protein) binding efficiency because protein-DNA complex studies in vitro indicate little difference between the two DNA sequences in the formation and stability of the TBP-DNA complex. In addition, the binding and stability of the TFIIB-TBP-DNA complex is similar for the two elements. In striking contrast, the TFIIA-TBP-DNA complex is significantly less stable on the CATAAA element when compared with the TATAAA element. A role for TFIIA in distinguishing between TATAAA and CATAAA in vivo was tested by fusing. a subunit of TFIIA to TBP. We found that fusion of TFIIA to TBP dramatically increases transcription from CATAAA, in yeast cells. Taken together, these results indicate that the stability of the TFIIA-TBP complex depends strongly on the sequence of the core promoter element and that the TFIIA-TBP complex plays an important function in recognizing optimal promoters in vivo.	Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; Univ Hawaii, Pacific Biomed Res Ctr, Honolulu, HI 96813 USA	Colorado State University; University of Hawaii System	Stargell, LA (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	lstargel@lamar.colostate.edu	Stargell, Laurie/GWC-7423-2022		NIGMS NIH HHS [GM56884] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056884] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Campbell KM, 2000, BIOCHEMISTRY-US, V39, P2633, DOI 10.1021/bi9922998; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; Chi TH, 1996, GENE DEV, V10, P2540, DOI 10.1101/gad.10.20.2540; Clemens KE, 1996, MOL CELL BIOL, V16, P4656; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Damania B, 1998, MOL CELL BIOL, V18, P3926, DOI 10.1128/MCB.18.7.3926; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; Hoopes BC, 1998, J MOL BIOL, V277, P1015, DOI 10.1006/jmbi.1998.1651; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; IMBALZANO AN, 1994, J BIOL CHEM, V269, P8280; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; IYER V, 1995, MOL CELL BIOL, V15, P7059; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KLAGES N, 1995, NATURE, V374, P822, DOI 10.1038/374822a0; KLEIN C, 1994, SCIENCE, V266, P280, DOI 10.1126/science.7939664; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; LEE DK, 1991, CELL, V67, P1241, DOI 10.1016/0092-8674(91)90300-N; Lemaire M, 2000, MOL MICROBIOL, V36, P163, DOI 10.1046/j.1365-2958.2000.01839.x; LI WZ, 1991, MOL CELL BIOL, V11, P666, DOI 10.1128/MCB.11.2.666; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Liu Q, 1999, MOL CELL BIOL, V19, P8673; MAHADEVAN S, 1990, MOL CELL BIOL, V10, P4447, DOI 10.1128/MCB.10.9.4447; MARTINEZ E, 1994, EMBO J, V13, P3115, DOI 10.1002/j.1460-2075.1994.tb06610.x; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; Ozer J, 1998, MOL CELL BIOL, V18, P2559, DOI 10.1128/MCB.18.5.2559; Patikoglou G, 1997, ANNU REV BIOPH BIOM, V26, P289, DOI 10.1146/annurev.biophys.26.1.289; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; PONTICELLI AS, 1990, MOL CELL BIOL, V10, P2832, DOI 10.1128/MCB.10.6.2832; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; ROY A, 1990, MOL CELL BIOL, V10, P5257, DOI 10.1128/MCB.10.10.5257; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; STARGELL LA, 1995, SCIENCE, V269, P75, DOI 10.1126/science.7604282; Stargell LA, 2000, J BIOL CHEM, V275, P12374, DOI 10.1074/jbc.275.17.12374; STARR DB, 1991, CELL, V67, P1231, DOI 10.1016/0092-8674(91)90299-E; STARR DB, 1995, J MOL BIOL, V250, P434; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; STRUHL K, 1986, MOL CELL BIOL, V6, P3847, DOI 10.1128/MCB.6.11.3847; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Weideman CA, 1997, J MOL BIOL, V271, P61, DOI 10.1006/jmbi.1997.1152; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; XIAO H, 1995, MOL CELL BIOL, V15, P5757; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; Yean D, 1997, MOL CELL BIOL, V17, P3809, DOI 10.1128/MCB.17.7.3809; Yean D, 1999, NUCLEIC ACIDS RES, V27, P831, DOI 10.1093/nar/27.3.831; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	73	42	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30078	30084		10.1074/jbc.M105276200	http://dx.doi.org/10.1074/jbc.M105276200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402056	hybrid			2022-12-27	WOS:000170558000064
J	Trent, JT; Watts, RA; Hargrove, MS				Trent, JT; Watts, RA; Hargrove, MS			Human neuroglobin, a hexacoordinate hemoglobin that reversibly binds oxygen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; LIGAND-BINDING; HEME POCKET; MYOGLOBIN; LEGHEMOGLOBIN; KINETICS; GENE; CYANOBACTERIUM; COOPERATIVITY; GLOBIN	Neuroglobin is a newly discovered mammalian hemoglobin that is expressed predominately in the brain (Burmester, T., Welch, B., Reinhardt, S., and Hankeln, T. (2000) Nature 407, 520-523). Neuroglobin has less than 25% identity with other vertebrate globins and shares less than 30% identity with the annelid nerve myoglobin it most closely resembles among known hemoglobins. Spectroscopic and kinetic experiments with the recombinant protein indicate that human neuroglobin is the first example of a hexacoordinate hemoglobin in vertebrates and is similar to plant and bacterial hexacoordinate, hemoglobins in several respects. The ramifications of hexacoordination and potential physiological roles are explored in light of the determination of an O-2 affinity that precludes neuroglobin from functioning in traditional O-2 storage and transport.	Iowa State Univ Sci & Technol, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; CSIRO, Div Plant Ind, Canberra, ACT 2601, Australia	Iowa State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hargrove, MS (corresponding author), Iowa State Univ Sci & Technol, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.		Watts, Richard A/D-2744-2009					APPLEBY CA, 1984, ANNU REV PLANT PHYS, V35, P443, DOI 10.1146/annurev.pp.35.060184.002303; Arredondo-Peter R, 1998, PLANT PHYSIOL, V118, P1121, DOI 10.1104/pp.118.4.1121; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Barrick D, 1997, NAT STRUCT BIOL, V4, P78, DOI 10.1038/nsb0197-78; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Couture M, 1999, J BIOL CHEM, V274, P6898, DOI 10.1074/jbc.274.11.6898; Couture M, 2000, EUR J BIOCHEM, V267, P4770, DOI 10.1046/j.1432-1327.2000.01531.x; Dewilde S, 1996, J BIOL CHEM, V271, P19865, DOI 10.1074/jbc.271.33.19865; Duff SMG, 1997, J BIOL CHEM, V272, P16746, DOI 10.1074/jbc.272.27.16746; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Goodman MD, 2001, J BIOL CHEM, V276, P6834, DOI 10.1074/jbc.M009254200; HANKELN T, 1988, GENE, V64, P297, DOI 10.1016/0378-1119(88)90344-7; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; Hargrove MS, 1997, J MOL BIOL, V266, P1032, DOI 10.1006/jmbi.1996.0833; Hargrove MS, 2000, STRUCTURE, V8, P1005, DOI 10.1016/S0969-2126(00)00194-5; Merx Marc W., 2001, FASEB Journal, V15, P1077; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; MOORE EG, 1976, J BIOL CHEM, V251, P2788; MURRAY JD, 1971, J BIOL CHEM, V246, P5903; Olson J S, 1981, Methods Enzymol, V76, P631; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; POTTS M, 1992, SCIENCE, V256, P1690, DOI 10.1126/science.256.5064.1690; Royer WE, 2001, TRENDS BIOCHEM SCI, V26, P297, DOI 10.1016/S0968-0004(01)01811-4; Sowa AW, 1998, P NATL ACAD SCI USA, V95, P10317, DOI 10.1073/pnas.95.17.10317; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; TAYLOR ER, 1994, PLANT MOL BIOL, V24, P853, DOI 10.1007/BF00014440; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Trevaskis B, 1997, P NATL ACAD SCI USA, V94, P12230, DOI 10.1073/pnas.94.22.12230; WATTS R, 1999, THESIS AUSTR NATL U; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; WEBSTER DA, 1988, ADV INORG BIOCHEM, V7, P245; WHITAKER TL, 1995, BIOCHEMISTRY-US, V34, P8221, DOI 10.1021/bi00026a002; WITTENBE.JB, 1966, J BIOL CHEM, V241, P104; WITTENBERG JB, 1972, J BIOL CHEM, V247, P527; WYMAN J, 1966, J BIOL CHEM, V241, P115	42	213	222	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30106	30110		10.1074/jbc.C100300200	http://dx.doi.org/10.1074/jbc.C100300200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11429401	hybrid			2022-12-27	WOS:000170558000068
J	Mittelstadt, PR; Ashwell, JD				Mittelstadt, PR; Ashwell, JD			Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NUCLEAR RECEPTOR COACTIVATOR; STEROID-HORMONE RECEPTORS; FAS LIGAND EXPRESSION; T-CELL HYBRIDOMA; TRANSCRIPTION FACTORS; DNA-BINDING; NEGATIVE REGULATION; C-JUN; FUNCTIONAL ANTAGONISM	The immunosuppressive effects of glucocorticoids arise largely by inhibition of cytokine gene expression, which has been ascribed to interference between the glucocorticoid receptor and transcription factors such as AP-1 and NF-kappaB as well as by competition for common coactivators. Here we show that glucocorticoid-induced inhibition of interleukin-2 mRNA expression in activated normal T cells required new protein synthesis, suggesting that this phenomenon is secondary to expression of glucocorticoid-regulated genes. One of the most prominent glucocorticoid-induced genes is glucocorticoid-induced leucine zipper (GILZ), which has been reported to inhibit activation-induced up-regulation of Fas ligand (FasL) mRNA. Indeed, transient expression of GILZ in Jurkat T cells blocked induction of a reporter construct driven by the FasL promoter. This could be accounted for by GILZ-mediated inhibition of Egr-2 and Egr-3, NFAT/AP-1-inducible transcription factors that bind a regulatory element in the FasL promoter and up-regulate FasL expression. GILZ also potently inhibited AP-1-driven and IL-2 promoter-driven reporter constructs, and recombinant GILZ specifically interacted with c-Fos and c-Jun in vitro and inhibited the binding of active AP-1 to its target DNA. Whereas homodimerization of GILZ required the presence of its leucine zipper, the interaction with c-Fos and c-Jun occurred through the N-terminal 60-amino acid region of GILZ. Thus, GILZ represents a glucocorticoid-induced gene product that can inhibit a variety of activation-induced events, at least in part by direct interference with AP-1, and is therefore a candidate for a mediator of glucocorticoid-induced immunosuppression.	NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Rm 1B-40,Bdg 10, Bethesda, MD 20892 USA.							AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; CRISPE IN, 1994, IMMUNITY, V1, P347; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; GILLIS S, 1979, J IMMUNOL, V123, P1624; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kester HA, 1999, J BIOL CHEM, V274, P27439, DOI 10.1074/jbc.274.39.27439; Klein-Hitpass L, 1998, J MOL MED, V76, P490, DOI 10.1007/s001090050243; KONIG H, 1992, EMBO J, V11, P2241, DOI 10.1002/j.1460-2075.1992.tb05283.x; KRONKE M, 1985, J EXP MED, V161, P1593, DOI 10.1084/jem.161.6.1593; KUTOH E, 1992, MOL CELL BIOL, V12, P4960, DOI 10.1128/MCB.12.11.4960; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Li-Weber M, 1999, EUR J IMMUNOL, V29, P3017, DOI 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R; LU W, 1995, AIDS, V9, P35, DOI 10.1097/00002030-199501000-00005; Mages HW, 1998, MOL CELL BIOL, V18, P7157, DOI 10.1128/MCB.18.12.7157; Matsui K, 1998, J IMMUNOL, V161, P3469; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; MORDACQ JC, 1989, GENE DEV, V3, P760, DOI 10.1101/gad.3.6.760; Nakamura H, 1998, AM J PHYSIOL-LUNG C, V275, pL601, DOI 10.1152/ajplung.1998.275.3.L601; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; ONATE SA, 1995, SCIENCE, V270, P1354; ONO S, 1995, IMMUNITY, V2, P639, DOI 10.1016/1074-7613(95)90008-X; PETRAK D, 1994, J IMMUNOL, V153, P2046; PONTA H, 1992, BIOCHIM BIOPHYS ACTA, V1129, P255, DOI 10.1016/0167-4781(92)90501-P; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; SILLARD R, 1993, EUR J BIOCHEM, V216, P429, DOI 10.1111/j.1432-1033.1993.tb18160.x; STEIN B, 1995, MOL CELL BIOL, V15, P4971; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; VACCA A, 1990, J BIOL CHEM, V265, P8075; WRIGHT APH, 1990, J BIOL CHEM, V265, P14763; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Zhang GR, 1997, DNA CELL BIOL, V16, P145, DOI 10.1089/dna.1997.16.145	59	220	235	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29603	29610		10.1074/jbc.M101522200	http://dx.doi.org/10.1074/jbc.M101522200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11397794	hybrid			2022-12-27	WOS:000170346000127
J	Samuel, W; Kutty, RK; Nagineni, S; Gordon, JS; Prouty, SM; Chandraratna, RAS; Wiggert, B				Samuel, W; Kutty, RK; Nagineni, S; Gordon, JS; Prouty, SM; Chandraratna, RAS; Wiggert, B			Regulation of stearoyl coenzyme a desaturase expression in human retinal pigment epithelial cells by retinoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED GENE-EXPRESSION; COA DESATURASE; RECEPTOR-ALPHA; FATTY-ACIDS; DIFFERENTIAL DISPLAY; 3T3-L1 PREADIPOCYTES; X RECEPTOR; HETERODIMERS; LIGAND; LIVER	Stearoyl-CoA desaturase (SCD) is a regulatory enzyme involved in the synthesis of the monounsaturated fatty acids palmitoleate and oleate. The regulation of SCD is of physiological importance because the ratio of saturated fatty acids to unsaturated fatty acids is thought to modulate membrane fluidity. Differential display analysis of retinal pigment epithelial (ARPE-19) cells identified SCD as a gene regulated by retinoic acid. Two SCD transcripts of 3.9 and 5.2 kilobases in size were found to be expressed in these cells by Northern blot analysis. All-trans-retinoic acid (all-trans-RA) increased SCD mRNA expression in a dose- and time-dependent manner; a similar to7-fold increase was observed with 1 mum all-trans-RA at 48 h. SCD m-RNA expression was also increased by 9-cis-retinoic acid (9-cis-RA) as well as 4-(E-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid (TT-NPB), a retinoic acid receptor (RAR)-specific agonist. AGN194301, a RAR alpha -specific antagonist, suppressed the SCD expression induced by all-trans-RA, TTNPB, and 9-cis-RA. These results indicate the involvement of RAR alpha in the induction of SCD expression by retinoic acid. However, AGN194204, a RXR (retinoid X receptor) pan agonist, also increased SCD mRNA expression. This increase was not blocked by AGN194301, suggesting that an RAR-independent mechanism may also be involved. Thus, SCD expression in retinal pigment epithelial cells is regulated by retinoic acid, and the regulation appears to be mediated through RAR and RXR.	NEI, Biochem Sect, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20878 USA; Johnson & Johnson Consumer Prod Inc, Skin Biol Tech Resource Ctr, Skillman, NJ 08558 USA; Allergan Pharmaceut Inc, Retinoid Res, Dept Chem, Irvine, CA 92713 USA; Allergan Pharmaceut Inc, Retinoid Res, Dept Biol, Irvine, CA 92713 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johnson & Johnson; Johnson & Johnson USA; AbbVie; Allergan; AbbVie; Allergan	Samuel, W (corresponding author), NEI, LRCMB, NIH, Rm 338,6 Ctr Dr, Bethesda, MD 20892 USA.	william@helix.nih.gov			NATIONAL EYE INSTITUTE [Z01EY000070] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BISSONNETTE RP, 1995, MOL CELL BIOL, V15, P5576; BOK D, 1993, J CELL SCI, P189; BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955; deVries JE, 1997, J LIPID RES, V38, P1384; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; DORAN TI, 1991, J INVEST DERMATOL, V96, P341, DOI 10.1111/1523-1747.ep12465246; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Ershov AV, 2000, J NEUROSCI RES, V60, P328, DOI 10.1002/(SICI)1097-4547(20000501)60:3<328::AID-JNR7>3.0.CO;2-5; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Gravesen A, 2000, MICROBIOL-UK, V146, P1381, DOI 10.1099/00221287-146-6-1381; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Hovik KE, 1997, BBA-LIPID LIPID MET, V1349, P251, DOI 10.1016/S0005-2760(97)00135-5; KAESTNER KH, 1989, J BIOL CHEM, V264, P14755; KASTURI R, 1982, J BIOL CHEM, V257, P2224; Kurebayashi S, 1997, DIABETES, V46, P2115, DOI 10.2337/diabetes.46.12.2115; Kutty RK, 2001, J BIOL CHEM, V276, P2831, DOI 10.1074/jbc.M007421200; Le XF, 1999, J BIOL CHEM, V274, P21651, DOI 10.1074/jbc.274.31.21651; LEROY P, 1991, EMBO J, V10, P59, DOI 10.1002/j.1460-2075.1991.tb07921.x; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1994, NUTR REV, V52, P32; Matz M, 1997, NUCLEIC ACIDS RES, V25, P2541, DOI 10.1093/nar/25.12.2541; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; Miller CW, 1997, BIOCHEM BIOPH RES CO, V231, P206, DOI 10.1006/bbrc.1997.6070; Nagpal S, 2000, CURR PHARM DESIGN, V6, P919, DOI 10.2174/1381612003400146; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Ntambi JM, 1999, J LIPID RES, V40, P1549; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; PAN DA, 1994, J NUTR, V124, P1555, DOI 10.1093/jn/124.9.1555; PARTHASARATHY S, 1990, P NATL ACAD SCI USA, V87, P3894, DOI 10.1073/pnas.87.10.3894; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Standeven AM, 1996, TOXICOL APPL PHARM, V138, P169, DOI 10.1006/taap.1996.0110; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; THIEDE MA, 1986, J BIOL CHEM, V261, P3230; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Zhang L, 1999, BIOCHEM J, V340, P255, DOI 10.1042/0264-6021:3400255	42	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					28744	28750		10.1074/jbc.M103587200	http://dx.doi.org/10.1074/jbc.M103587200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11397803	hybrid			2022-12-27	WOS:000170346000015
J	Gelkop, S; Babichev, Y; Isakov, N				Gelkop, S; Babichev, Y; Isakov, N			T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT SIGNALING PATHWAYS; GROWTH-FACTOR RECEPTOR; PROTOONCOGENE C-CBL; SYK TYROSINE KINASE; ANTIGEN-RECEPTOR; SH3 DOMAIN; IMMUNOLOGICAL SYNAPSE; NEGATIVE REGULATOR; NUCLEAR FACTOR; V-CRK	The Crk adapter proteins are assumed to play a role in T lymphocyte activation because of their induced association with tyrosine-phosphorylated proteins, such as ZAP-70 and Cbl, and with the phosphatidylinositol 3-kinase regulatory subunit, p85, following engagement of the T cell antigen receptor. Although the exact mechanism of interaction between these molecules has not been fully defined, it has been generally accepted that Crk, ZAP-70, and p85 interact with tyrosine-phosphorylated Cbl, which serves as a major scaffold protein in activated T lymphocytes. Our present results demonstrate a cell activation-dependent reciprocal co-Immunoprecipitation of CrkII and p85 from lysates of Jurkat T cells and a direct binding of CrkII to p85 in an overlay assay. The use of bead-immobilized GST fusion proteins indicated a complex mechanism of interaction between CrkII and p85 involving two distinct and mutually independent regions in each molecule. A relatively high affinity binding of the CrkII-SH3(N) domain to p85 and the p85-proline-B cell receptor-proline (PBP) region to CrkII was observed in lysates of either resting or activated T cells. Direct physical interaction between the CrkII-SH3(N) and the p85-PBP domain was demonstrated using recombinant fusion proteins and was further substantiated by binding competition studies. In addition, immobilized fusion proteins possessing the CrkII-SH2 and p85-SH3 domains were found to pull down p85 and CrkII, respectively, but only from lysates of activated T cells. Nevertheless, the GST-CrkII-SH2 fusion protein was unable to mediate direct association with p85 from lysates of either resting or activated T cells. Our results support a model in which T cell activation dependent conformational changes in CrkII and/or p85 promote an initial direct or indirect low affinity interaction between the two molecules, which is then stabilized by a secondary high affinity interaction mediated by direct binding of the CrkII-SH3(N) to the p85-PBP domain.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Isakov, N (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol & Immunol, POB 653, IL-84105 Beer Sheva, Israel.	noah@bgumail.bgu.ac.il	ISAKOV, NOAH/F-1659-2012	Isakov, Noah/0000-0002-1412-0957				Anafi M, 1996, J BIOL CHEM, V271, P21365, DOI 10.1074/jbc.271.35.21365; Andoniou CE, 1996, ONCOGENE, V12, P1981; Barber DL, 1997, BLOOD, V89, P3166, DOI 10.1182/blood.V89.9.3166; BEITNERJOHNSON D, 1995, J BIOL CHEM, V270, P5187, DOI 10.1074/jbc.270.10.5187; BOOKER GW, 1993, CELL, V73, P813, DOI 10.1016/0092-8674(93)90259-S; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Buday L, 1996, J BIOL CHEM, V271, P6159, DOI 10.1074/jbc.271.11.6159; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Evans EK, 1997, EMBO J, V16, P230, DOI 10.1093/emboj/16.2.230; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Gelkop S, 1999, J BIOL CHEM, V274, P21519, DOI 10.1074/jbc.274.31.21519; Gesbert F, 1998, J BIOL CHEM, V273, P3986, DOI 10.1074/jbc.273.7.3986; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARTLEY D, 1995, J BIOL CHEM, V270, P18260, DOI 10.1074/jbc.270.31.18260; Hashimoto Y, 1998, J BIOL CHEM, V273, P17186, DOI 10.1074/jbc.273.27.17186; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; Hunter S, 1999, J BIOL CHEM, V274, P2097, DOI 10.1074/jbc.274.4.2097; Husson H, 1997, ONCOGENE, V14, P2331, DOI 10.1038/sj.onc.1201074; Isakov N, 1998, ADV IMMUNOL, V69, P183, DOI 10.1016/S0065-2776(08)60608-2; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JENKINS MK, 1991, ADV EXP MED BIOL, V292, P167; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KizakaKondoh S, 1996, P NATL ACAD SCI USA, V93, P12177, DOI 10.1073/pnas.93.22.12177; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Liu YC, 1997, J BIOL CHEM, V272, P168; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Peterson EJ, 1998, CURR OPIN IMMUNOL, V10, P337, DOI 10.1016/S0952-7915(98)80173-8; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; Reif K, 1997, CURR BIOL, V7, P285, DOI 10.1016/S0960-9822(06)00151-5; Rellahan BL, 1997, J BIOL CHEM, V272, P30806, DOI 10.1074/jbc.272.49.30806; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SAKODA T, 1992, ONCOGENE, V7, P1705; Sattler M, 1997, J BIOL CHEM, V272, P10248; Sawasdikosol S, 1996, J IMMUNOL, V157, P110; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Sorokin A, 1998, ONCOGENE, V16, P2425, DOI 10.1038/sj.onc.1201781; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; TANAKA S, 1993, MOL CELL BIOL, V13, P4409, DOI 10.1128/MCB.13.7.4409; TENG KK, 1995, J BIOL CHEM, V270, P20677, DOI 10.1074/jbc.270.35.20677; TSUCHIE H, 1989, ONCOGENE, V4, P1281; van Leeuwen JEM, 1999, J BIOL CHEM, V274, P5153, DOI 10.1074/jbc.274.8.5153; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Zhang ZH, 1999, J BIOL CHEM, V274, P4883, DOI 10.1074/jbc.274.8.4883; Zwartkruis FJT, 1999, EXP CELL RES, V253, P157, DOI 10.1006/excr.1999.4695; [No title captured]	65	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2001	276	39					36174	36182		10.1074/jbc.M100731200	http://dx.doi.org/10.1074/jbc.M100731200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	475XF	11418612	hybrid			2022-12-27	WOS:000171194500019
J	Hosoda, T; Monzen, K; Hiroi, Y; Oka, T; Takimoto, E; Yazaki, Y; Nagai, R; Komuro, I				Hosoda, T; Monzen, K; Hiroi, Y; Oka, T; Takimoto, E; Yazaki, Y; Nagai, R; Komuro, I			A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE DOMAIN; GROWTH-FACTOR RECEPTOR; HEART TUBE FORMATION; FACTOR PDGF RECEPTOR; TRANSCRIPTION FACTOR; MESSENGER-RNA; BINDING-SITE; MUSCLE DIFFERENTIATION; VENTRAL MORPHOGENESIS; IN-VITRO	Although several cardiac-specific transcription factors have been shown to play vital roles in various steps during the heart formation, the precise mechanism of the early stage of cardiogenesis has yet to be elucidated. By differential display technique, we tried to identify molecules that are expressed earlier than cardiac transcription factors such as CSX-/NKX2-5 and GATA-4 and are involved in cardiomyocyte differentiation using the P19CL6 cell line, which efficiently differentiates into cardiomyocytes when treated with dimethyl sulfoxide. We isolated a novel gene designated Midori. Its deduced amino acid sequence contained an ATP/GTP-binding site, Ig-like domain, and Kringle-like domain. Northern blot analysis revealed that expression of Midori was restricted to the fetal and adult heart and adult skeletal muscle in mice. In whole mount in situ hybridization, Midori was expressed in cardiac crescent and developing heart but not in somites. The MIDORI protein was localized in the nucleus and overexpression of Midori induced expression of endogenous Midori itself, suggesting that MIDORI may act as a transcriptional regulator. Permanent P19CL6 cell lines overexpressing Midori more efficiently differentiated into cardiomyocytes than did parental cells, whereas those overexpressing the antisense Midori less efficiently differentiated. These results suggest that Midori may promote the differentiation of P19CL6 into cardiomyocytes.	Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan; Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; Shinshu Univ, Sch Med, Dept Med 1, Matsumoto, Nagano 3908621, Japan; Int Med Ctr Japan, Tokyo 1628655, Japan	Chiba University; University of Tokyo; Shinshu University; National Center for Global Health & Medicine - Japan	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.		Hosoda, Toru/G-1873-2010	Hosoda, Toru/0000-0002-7273-0630				Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; BODMER R, 1993, DEVELOPMENT, V118, P719; Bush EW, 1996, J BIOL CHEM, V271, P548, DOI 10.1074/jbc.271.1.548; CHAN AML, 1991, SCIENCE, V254, P1382, DOI 10.1126/science.1720571; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Chirgadze DY, 1998, FEBS LETT, V430, P126, DOI 10.1016/S0014-5793(98)00558-4; Cioce V, 1996, J BIOL CHEM, V271, P13110, DOI 10.1074/jbc.271.22.13110; Davis-Smyth T, 1998, J BIOL CHEM, V273, P3216, DOI 10.1074/jbc.273.6.3216; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; Dietz UH, 1996, J BIOL CHEM, V271, P3311, DOI 10.1074/jbc.271.6.3311; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Herley MT, 1999, BIOCHEM BIOPH RES CO, V262, P731, DOI 10.1006/bbrc.1999.1282; Hosoda T, 1999, JPN CIRC J, V63, P425, DOI 10.1253/jcj.63.425; Iyemere VP, 1998, NUCLEIC ACIDS RES, V26, P2098, DOI 10.1093/nar/26.9.2098; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lokker NA, 1997, J BIOL CHEM, V272, P33037, DOI 10.1074/jbc.272.52.33037; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; MAHADEVAN D, 1995, J BIOL CHEM, V270, P27595, DOI 10.1074/jbc.270.46.27595; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MIMA T, 1995, P NATL ACAD SCI USA, V92, P467, DOI 10.1073/pnas.92.2.467; Miyazaki T, 1996, J BIOL CHEM, V271, P14567, DOI 10.1074/jbc.271.24.14567; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Monzen K, 1999, MOL CELL BIOL, V19, P7096; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; SUGI Y, 1993, DEV BIOL, V157, P28, DOI 10.1006/dbio.1993.1109; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Wang XK, 1996, J BIOL CHEM, V271, P24286, DOI 10.1074/jbc.271.39.24286; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174	39	42	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 21	2001	276	38					35978	35989		10.1074/jbc.M100485200	http://dx.doi.org/10.1074/jbc.M100485200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474LU	11418590	hybrid			2022-12-27	WOS:000171109300100
J	Xu, XL; Bittman, R; Duportail, G; Heissler, D; Vilcheze, C; London, E				Xu, XL; Bittman, R; Duportail, G; Heissler, D; Vilcheze, C; London, E			Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; MEMBRANE DOMAINS; TRITON X-100; LIPID DOMAINS; CHOLESTEROL; CERAMIDE; PHOSPHATIDYLCHOLINE; ASSOCIATION; PHASE; MODEL	Ordered lipid domains enriched in sphingolipids and cholesterol (lipid rafts) have been implicated in numerous functions in biological membranes. We recently found that lipid domain/raft formation is dependent on the sterol component having a structure that allows tight packing with lipids having saturated acyl chains (Xu, X., and London, E. (2000) Biochemistry 39, 844-849). In this study, the domain-promoting activities of various natural sterols were compared with that of cholesterol using both fluorescence quenching and detergent insolubility methods. Using model membranes, it was shown that, like cholesterol, both plant and fungal sterols promote the formation of tightly packed, ordered lipid domains by lipids with saturated acyl chains. Surprisingly ergosterol, a fungal sterol, and 7-dehydrocholesterol, a sterol present in elevated levels in Smith-Lemli-Opitz syndrome, were both significantly more strongly domain-promoting than cholesterol. Domain formation was also affected by the structure of the sphingolipid (or that of an equivalent "saturated" phospholipid) component. Sterols had pronounced effects on domain formation by sphingomyelin and dipalmitoylphosphatidyleholine but only a weak influence on the ability of cerebrosides to form domains. Strikingly it was found that a small amount of ceramide (3 mol %) significantly stabilized domain/raft format-ion. The molecular basis for, and the implications of, the effects of different sterols and sphingolipids (especially ceramide) on the behavior and biological function of rafts are discussed.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA; Univ Strasbourg 1, Fac Pharm, CNRS, UMR 7034, F-67401 Illkirch Graffenstaden, France; Univ Strasbourg, Fac Chim, CNRS, UMR 7509, F-67008 Strasbourg, France	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; Queens College NY (CUNY); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@sunysb.edu	DUPORTAIL, Guy/E-6068-2012		NHLBI NIH HHS [HL 16660] Funding Source: Medline; NIGMS NIH HHS [GM 48596] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016660, R01HL016660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048596] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; BECK A, 1991, TETRAHEDRON, V47, P1459, DOI 10.1016/S0040-4020(01)86422-X; BECK A, 1993, CHEM PHYS LIPIDS, V66, P135, DOI 10.1016/0009-3084(93)90038-5; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Carrer DC, 1999, J LIPID RES, V40, P1978; CLEJAN S, 1985, J BIOL CHEM, V260, P2884; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Dhanvantari S, 2000, J BIOL CHEM, V275, P29887, DOI 10.1074/jbc.M005364200; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HECHTBERGER P, 1994, EUR J BIOCHEM, V225, P641, DOI 10.1111/j.1432-1033.1994.00641.x; Holopainen JM, 2000, BIOPHYS J, V78, P2459, DOI 10.1016/S0006-3495(00)76790-7; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Kubler E, 1996, J BIOL CHEM, V271, P32975, DOI 10.1074/jbc.271.51.32975; LENTZ BR, 1976, BIOCHEMISTRY-US, V15, P4529, DOI 10.1021/bi00665a030; Liu PS, 2000, J BIOL CHEM, V275, P31648, DOI 10.1074/jbc.M004599200; LONDON E, 1981, BIOCHIM BIOPHYS ACTA, V649, P89, DOI 10.1016/0005-2736(81)90012-2; London E, 2000, METHOD ENZYMOL, V312, P272; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Massey JB, 2001, BBA-BIOMEMBRANES, V1510, P167, DOI 10.1016/S0005-2736(00)00344-8; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Ostermeyer AG, 1999, J BIOL CHEM, V274, P34459, DOI 10.1074/jbc.274.48.34459; Peskan T, 2000, EUR J BIOCHEM, V267, P6989, DOI 10.1046/j.1432-1327.2000.01776.x; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Rousso I, 2000, P NATL ACAD SCI USA, V97, P13523, DOI 10.1073/pnas.240459697; RUOCCO MJ, 1984, BIOPHYS J, V46, P695, DOI 10.1016/S0006-3495(84)84068-0; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; SILVIUS JR, 1992, BIOCHEMISTRY-US, V31, P3398, DOI 10.1021/bi00128a014; Silvius JR, 1996, BIOCHEMISTRY-US, V35, P15198, DOI 10.1021/bi9615506; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SLOTTE JP, 1994, BBA-BIOMEMBRANES, V1190, P435, DOI 10.1016/0005-2736(94)90105-8; Tint G S, 1997, Subcell Biochem, V28, P117; Venkataraman K, 2000, TRENDS CELL BIOL, V10, P408, DOI 10.1016/S0962-8924(00)01830-4; Wang TY, 2000, BIOPHYS J, V79, P919, DOI 10.1016/S0006-3495(00)76347-8; Waterham HR, 2000, BBA-MOL CELL BIOL L, V1529, P340, DOI 10.1016/S1388-1981(00)00159-1; Wolf AA, 1998, J CELL BIOL, V141, P917, DOI 10.1083/jcb.141.4.917; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v	47	445	461	0	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33540	33546		10.1074/jbc.M104776200	http://dx.doi.org/10.1074/jbc.M104776200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11432870	hybrid			2022-12-27	WOS:000170910200035
J	Brown, LS; Dioumaev, AK; Lanyi, JK; Spudich, EN; Spudich, JL				Brown, LS; Dioumaev, AK; Lanyi, JK; Spudich, EN; Spudich, JL			Photochemical reaction cycle and proton transfers in neurospora rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIORHODOPSIN PHOTOCYCLE; N-INTERMEDIATE; SCHIFF-BASE; ASPARTIC ACID-96; INFRARED-SPECTRA; NATRONOBACTERIUM-PHARAONIS; CHROMOPHORE STRUCTURE; VIBRATIONAL ANALYSIS; RAMAN-SPECTROSCOPY; STRUCTURAL-CHANGES	It was recently found that NOP-1, a membrane protein of Neurospora crassa, shows homology to haloarchaeal rhodopsins and binds retinal after heterologous expression in Pichia pastoris. We report on spectroscopic properties of the Neurospora rhodopsin (NR). The photocycle was studied with flash photolysis and time-resolved Fourier-transform infrared spectroscopy in the pH range 5-8. Proton release and uptake during the photocycle were monitored with the pH-sensitive dye, pyranine. Kinetic and spectral analysis revealed six distinct states in the NR photocycle, and we describe their spectral properties and pH-dependent kinetics in the visible and infrared ranges. The phenotypes of the mutant NR proteins, D131E and E142Q, in which the homologues of the key carboxylic acids of the light-driven proton pump bacteriorhodopsin, Asp-85 and Asp-96, were replaced, show that Glu-142 is not involved in reprotonation of the Schiff base but Asp-131 may be. This implies that, if the NR photocycle is associated with proton transport, it has a low efficiency, similar to that of haloarchaeal sensory rhodopsin II. Fourier-transform Raman spectroscopy revealed unexpected differences between NR and bacteriorhodopsin in the configuration of the retinal chromophore, which may contribute to the less effective reprotonation switch of NR.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of California System; University of California Irvine; University of Texas System	Brown, LS (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	lsbrown@uci.edu	Brown, Leonid/X-7445-2019; Lanyi, Janos/C-3808-2011; Brown, Leonid/A-1050-2008	Brown, Leonid/0000-0002-5614-8317; Brown, Leonid/0000-0002-5614-8317	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029498, R01GM029498, R37GM027750, R01GM027750] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29498, GM27750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Althaus T, 1995, ISRAEL J CHEM, V35, P227; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bergo V, 2000, BIOCHEMISTRY-US, V39, P2823, DOI 10.1021/bi991676d; Bergo V, 2000, BIOPHYS J, V78, p477A; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; Bieszke JA, 1999, BIOCHEMISTRY-US, V38, P14138, DOI 10.1021/bi9916170; BIVIN DB, 1986, J GEN MICROBIOL, V132, P2167; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; BRAIMAN MS, 1991, P NATL ACAD SCI USA, V88, P2388, DOI 10.1073/pnas.88.6.2388; Brown LS, 1997, P NATL ACAD SCI USA, V94, P5040, DOI 10.1073/pnas.94.10.5040; Brown LS, 1998, BIOPHYS J, V75, P1455, DOI 10.1016/S0006-3495(98)74064-0; Brown LS, 1998, BIOCHEMISTRY-US, V37, P3982, DOI 10.1021/bi9728396; BROWN LS, 1995, J BIOL CHEM, V270, P27122, DOI 10.1074/jbc.270.45.27122; BUTT HJ, 1989, EMBO J, V8, P1657, DOI 10.1002/j.1460-2075.1989.tb03556.x; CASADIO R, 1980, BIOCHEMISTRY-US, V19, P3374, DOI 10.1021/bi00555a043; CHEN BW, 1994, BIOTECHNIQUES, V17, P657; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Dioumaev AK, 1997, BIOPHYS CHEM, V67, P1, DOI 10.1016/S0301-4622(96)02268-5; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Dioumaev AK, 1999, BIOCHEMISTRY-US, V38, P10070, DOI 10.1021/bi990873+; DUNN R, 1981, P NATL ACAD SCI-BIOL, V78, P6744, DOI 10.1073/pnas.78.11.6744; Engelhard M, 1996, FEBS LETT, V395, P195, DOI 10.1016/0014-5793(96)01041-1; ENGELHARD M, 1985, BIOCHEMISTRY-US, V24, P400, DOI 10.1021/bi00323a024; FODOR SPA, 1988, BIOCHEMISTRY-US, V27, P7097, DOI 10.1021/bi00418a064; GRZESIEK S, 1986, FEBS LETT, V208, P337, DOI 10.1016/0014-5793(86)81045-6; HESSLING B, 1993, BIOPHYS J, V65, P1929, DOI 10.1016/S0006-3495(93)81264-5; HOLZ M, 1989, P NATL ACAD SCI USA, V86, P2167, DOI 10.1073/pnas.86.7.2167; Hu JG, 1998, BIOCHEMISTRY-US, V37, P8088, DOI 10.1021/bi973168e; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; IMAMOTO Y, 1992, PHOTOCHEM PHOTOBIOL, V56, P1129, DOI 10.1111/j.1751-1097.1992.tb09737.x; KAKITANI H, 1983, J PHYS CHEM-US, V87, P3620, DOI 10.1021/j100242a011; KALISKY O, 1977, BIOPHYS J, V19, P185, DOI 10.1016/S0006-3495(77)85579-3; KATAOKA M, 1994, J MOL BIOL, V243, P621, DOI 10.1016/0022-2836(94)90037-X; LANYI JK, 1992, BIOCHIM BIOPHYS ACTA, V1099, P102, DOI 10.1016/0167-4838(92)90458-P; LAZAREV YA, 1980, BIOCHIM BIOPHYS ACTA, V590, P324, DOI 10.1016/0005-2728(80)90203-0; LITVIN FF, 1975, BIOORG KHIM+, V1, P1767; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; MARINETTI T, 1989, P NATL ACAD SCI USA, V86, P529, DOI 10.1073/pnas.86.2.529; NAGLE JF, 1981, J CHEM PHYS, V74, P1367, DOI 10.1063/1.441199; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Oesterhelt D, 1974, Methods Enzymol, V31, P667; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; PFEFFERLE JM, 1991, BIOCHEMISTRY-US, V30, P6548, DOI 10.1021/bi00240a027; Richter HT, 1996, BIOCHEMISTRY-US, V35, P15461, DOI 10.1021/bi9612430; Sasaki J, 1999, BIOPHYS J, V77, P2145, DOI 10.1016/S0006-3495(99)77055-4; SASAKI J, 1994, BIOCHEMISTRY-US, V33, P3178, DOI 10.1021/bi00177a006; SAWATZKI J, 1990, P NATL ACAD SCI USA, V87, P5903, DOI 10.1073/pnas.87.15.5903; Schmies G, 2000, BIOPHYS J, V78, P967, DOI 10.1016/S0006-3495(00)76654-9; Schmies G, 2001, P NATL ACAD SCI USA, V98, P1555, DOI 10.1073/pnas.031562298; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141; SMITH SO, 1987, J PHYS CHEM-US, V91, P804, DOI 10.1021/j100288a011; SMITH SO, 1987, J AM CHEM SOC, V109, P3108, DOI 10.1021/ja00244a038; SMITH SO, 1983, BIOCHEMISTRY-US, V22, P6141, DOI 10.1021/bi00295a016; Spudich JL, 1996, CURR OPIN CELL BIOL, V8, P452, DOI 10.1016/S0955-0674(96)80020-2; Spudich JL, 1998, MOL MICROBIOL, V28, P1051, DOI 10.1046/j.1365-2958.1998.00859.x; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Sudo Y, 2001, BIOPHYS J, V80, P916, DOI 10.1016/S0006-3495(01)76070-5; VARO G, 1990, BIOCHEMISTRY-US, V29, P6858, DOI 10.1021/bi00481a015; VARO G, 1991, BIOCHEMISTRY-US, V30, P5008, DOI 10.1021/bi00234a024; Zhang WS, 1996, P NATL ACAD SCI USA, V93, P8230, DOI 10.1073/pnas.93.16.8230; Zimanyi L, 1997, J PHYS CHEM B, V101, P1930, DOI 10.1021/jp963346y; ZIMANYI L, 1989, BIOCHEMISTRY-US, V28, P1656, DOI 10.1021/bi00430a034; Zscherp C, 1997, J PHYS CHEM B, V101, P10542, DOI 10.1021/jp971047i	69	61	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32495	32505		10.1074/jbc.M102652200	http://dx.doi.org/10.1074/jbc.M102652200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435422	hybrid			2022-12-27	WOS:000170746000018
J	Sanbe, A; Gulick, J; Fewell, J; Robbins, J				Sanbe, A; Gulick, J; Fewell, J; Robbins, J			Examining the in vivo role of the amino terminus of the essential myosin light chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SKELETAL-MUSCLE; SHORTENING VELOCITY; TRANSGENIC MICE; N-TERMINUS; F-ACTIN; HEAVY; ISOFORMS; MOTOR; HEART	The functional significance of the actin binding region at the amino terminus of the cardiac essential myosin light chain (ELC) remains obscure. Previous experiments carried out in vitro indicated that modulation of residues 5-14 could induce an inotropic effect, increasing maximal ATPase activity at submaximal Ca2+ concentrations (Rarick, H. M., Opgenorth, T. J., von Geldern, T. W., Wu-Wong, J. R., and Solaro, R. J. (1996) J. Biol. Chem. 271, 27039-27043). Using transgenesis, we effected a cardiac-specific replacement of ELC with a protein containing a 10-amino acid deletion at positions 5-14. Both the ventricular (ELC1v Delta5-14) and atrial (ELC1a Delta5-14) isoforms lacking this peptide were stably incorporated into the sarcomere at high efficiencies. Surprisingly when the kinetics of skinned fibers isolated from the ELC1v Delta5-14 or ELC1a Delta5-14 mice were examined, no alterations in either unloaded shortening or maximum shortening velocities were apparent. Myofibrillar Mg2+-ATPase activity was also unchanged in these preparations. No significant changes in the fiber kinetics in the cognate compartments were observed when either deletion-containing protein replaced endogenous ELC1v or ELC1a. The data indicate that the previously postulated importance of this region in mediating critical protein interactions between the cardiac ELCs and the carboxyl-terminal residues of actin in vivo should be reassessed.	Childrens Hosp Res Fdn, Div Mol Cardiovasc Res, Dept Pediat, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Robbins, J (corresponding author), Childrens Hosp Res Fdn, Div Mol Cardiovasc Res, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.				NHLBI NIH HHS [HL56370, HL52318, HL56620, HL60546, HL41496] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052318, P01HL041496, R01HL056620, R01HL056370, R01HL060546] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreev OA, 1999, BIOCHEMISTRY-US, V38, P2480, DOI 10.1021/bi981706x; Andreev OA, 1997, CIRC RES, V81, P688; BOTTINELLI R, 1994, J MUSCLE RES CELL M, V15, P413, DOI 10.1007/BF00122115; Fewell JG, 1998, J CLIN INVEST, V101, P2630, DOI 10.1172/JCI2825; James J, 1999, TRANSGENIC RES, V8, P9, DOI 10.1023/A:1008894507995; JOHARA M, 1993, P NATL ACAD SCI USA, V90, P2127, DOI 10.1073/pnas.90.6.2127; LOWEY S, 1993, J BIOL CHEM, V268, P20414; MCAULIFFE JJ, 1990, CIRC RES, V66, P1204, DOI 10.1161/01.RES.66.5.1204; MORANO I, 1995, CIRC RES, V76, P720, DOI 10.1161/01.RES.76.5.720; Morano I, 1997, FEBS LETT, V408, P71, DOI 10.1016/S0014-5793(97)00390-6; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Rarick HM, 1996, J BIOL CHEM, V271, P27039, DOI 10.1074/jbc.271.43.27039; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Robbins J, 2000, ANNU REV PHYSIOL, V62, P261, DOI 10.1146/annurev.physiol.62.1.261; Sanbe A, 2000, CIRC RES, V87, P296, DOI 10.1161/01.RES.87.4.296; Sanbe A, 2000, AM J PHYSIOL-HEART C, V279, pH1355, DOI 10.1152/ajpheart.2000.279.3.H1355; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Schaub MC, 1998, CARDIOVASC RES, V37, P381, DOI 10.1016/S0008-6363(97)00258-7; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sweeney H. L., 1995, BIOPHYS J, V68, p112S; SWEENEY HL, 1988, J BIOL CHEM, V263, P9034; Timson DJ, 1998, EUR J BIOCHEM, V255, P654, DOI 10.1046/j.1432-1327.1998.2550654.x; Timson DJ, 1997, FEBS LETT, V400, P31, DOI 10.1016/S0014-5793(96)01314-2; Yang QL, 1998, J CLIN INVEST, V102, P1292, DOI 10.1172/JCI3880	25	9	11	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32682	32686		10.1074/jbc.M009975200	http://dx.doi.org/10.1074/jbc.M009975200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432848	hybrid			2022-12-27	WOS:000170746000042
J	Schmutte, C; Sadoff, MM; Shim, KS; Acharya, S; Fishel, R				Schmutte, C; Sadoff, MM; Shim, KS; Acharya, S; Fishel, R			The interaction of DNA mismatch repair proteins with human exonuclease I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; SACCHAROMYCES-CEREVISIAE EXO1; ESCHERICHIA-COLI; MICROSATELLITE INSTABILITY; PROMOTER HYPERMETHYLATION; MUTATION AVOIDANCE; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; SLIDING CLAMP; MUTL HOMOLOGS	Exonucleolytic degradation of DNA is an essential part of many DNA metabolic processes including DNA mismatch repair (MMR) and recombination. Human exonuclease I (hExoI) is a member of a family of conserved 5' --> 3' exonucleases, which are implicated in these processes by genetic studies. Here, we demonstrate that hExoI binds strongly to hMLH1, and we describe interaction regions between hExoI and the MMR proteins hMSH2, hMSH3, and hMLH1. In addition, hExoI forms an immunoprecipitable complex with hMLH1/hPMS2 in vivo. The study of interaction regions suggests a biochemical mechanism of the involvement of hExoI as a downstream effector in MMR and/or DNA recombination.	Thomas Jefferson Univ, Kimmel Canc Ctr, Genet & Mol Biol Program, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Schmutte, C (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Genet & Mol Biol Program, Dept Microbiol & Immunol, BLSB933,233 S 10th St, Philadelphia, PA 19107 USA.	eschmutte@lac.jci.tju.edu; rfishel@hendrix.jci.tju.edu			NATIONAL CANCER INSTITUTE [R01CA067007, R01CA056542] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA067007, CA56542] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bjornson KP, 2000, BIOCHEMISTRY-US, V39, P3176, DOI 10.1021/bi992286u; Bowers J, 2001, J MOL BIOL, V306, P957, DOI 10.1006/jmbi.2001.4467; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; CHI NW, 1994, J BIOL CHEM, V269, P29984; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Digilio FA, 1996, DEV BIOL, V178, P90, DOI 10.1006/dbio.1996.0200; Esteller M, 1998, ONCOGENE, V17, P2413, DOI 10.1038/sj.onc.1202178; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Fishel R, 1999, NAT MED, V5, P1239, DOI 10.1038/15191; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Galio L, 1999, NUCLEIC ACIDS RES, V27, P2325, DOI 10.1093/nar/27.11.2325; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Harris RS, 1998, J BACTERIOL, V180, P989, DOI 10.1128/JB.180.4.989-993.1998; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; HIRAOKA LR, 1995, GENOMICS, V25, P220, DOI 10.1016/0888-7543(95)80129-A; Iaccarino I, 2000, J BIOL CHEM, V275, P2080, DOI 10.1074/jbc.275.3.2080; Jiricny J, 1998, MUTAT RES-DNA REPAIR, V409, P107, DOI 10.1016/S0921-8777(98)00056-1; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kane MF, 1997, CANCER RES, V57, P808; KOI M, 1994, CANCER RES, V54, P4308; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LAHUE RS, 1987, P NATL ACAD SCI USA, V84, P1482, DOI 10.1073/pnas.84.6.1482; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lee BI, 1999, NUCLEIC ACIDS RES, V27, P4114, DOI 10.1093/nar/27.20.4114; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nakagawa T, 1999, P NATL ACAD SCI USA, V96, P14186, DOI 10.1073/pnas.96.25.14186; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; PROLLA TA, 1994, MOL CELL BIOL, V14, P407, DOI 10.1128/MCB.14.1.407; QIU J, 1998, NUCL ACIDS RES, V26; Qiu JZ, 1999, J BIOL CHEM, V274, P17893, DOI 10.1074/jbc.274.25.17893; ROBINS P, 1994, J BIOL CHEM, V269, P28535; Schmutte C, 1998, CANCER RES, V58, P4537; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; SZANKASI P, 1992, J BIOL CHEM, V267, P3014; Tishkoff DX, 1998, CANCER RES, V58, P5027; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Viswanathan M, 1998, GENETICS, V149, P7; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wheeler JMD, 1999, P NATL ACAD SCI USA, V96, P10296, DOI 10.1073/pnas.96.18.10296; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu TH, 1999, J BIOL CHEM, V274, P5948, DOI 10.1074/jbc.274.9.5948; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197	61	126	132	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33011	33018		10.1074/jbc.M102670200	http://dx.doi.org/10.1074/jbc.M102670200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11427529	hybrid			2022-12-27	WOS:000170746000085
J	Hama, T; Maruyama, M; Katoh-Semba, R; Takizawa, M; Iwashima, M; Nara, K				Hama, T; Maruyama, M; Katoh-Semba, R; Takizawa, M; Iwashima, M; Nara, K			Identification and molecular cloning of a novel brain-specific receptor protein that binds to brain injury-derived neurotrophic peptide - Possible role for neuronal survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONOTROPHIC ACTIVITY; MESSENGER-RNA; RAT-BRAIN; LIMBIC SEIZURES; EXPRESSION; DEATH; ANTIBIOTICS; EXTRACTION; SEQUENCE; INCREASE	Brain injury-derived neurotrophic peptide (BIN-P) is a synthetic 13-mer peptide that supports neuronal survival and protects hippocampal neurons in primary cultures from cell death caused by glutamate. We have developed a monoclonal antibody named mAb 6A22 against the 40-kDa BINP-binding protein, p40BBP. mAb 6A22 inhibits binding between BINP and rat brain synaptosomes and abolishes the protective effect of BINP. The antigen of mAb 6A22 should be the BINP-binding protein that mediates the neuroprotective action of BINP. Using an expression cloning approach with mAb 6A22, we isolated a cDNA encoding a novel receptor protein that shows binding activity of BINP. COS7 cells transfected with the cloned cDNA show binding of BIN-P and cell surfaces that are stained by 6A22. The mRNA for p40BBP is specific for the rat brain and is increased after birth. From immunohistochemical studies using mAb 6A22, p40BBP increased after kainic acid treatment in rat hippocampal neurons.	Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; Inst Dev Res, Aichi Human Serv Ctr, Kasugai, Aichi 4800392, Japan; Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Institute of Infectious Diseases (NIID)	Hama, T (corresponding author), Mitsubishi Kagaku Inst Life Sci, 11 Minamiooya, Machida, Tokyo 1948511, Japan.	hama@libra.ls.m-kagaku.co.jp						AEBI R, 1989, ZOOTECNICA INT, V3, P31; ATTWOOD TK, 1994, PROTEIN ENG, V7, P841, DOI 10.1093/protein/7.7.841; Attwood TK, 1999, NUCLEIC ACIDS RES, V27, P220, DOI 10.1093/nar/27.1.220; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barrett GL, 2000, PROG NEUROBIOL, V61, P205, DOI 10.1016/S0301-0082(99)00056-8; BERGER J, 1951, J AM CHEM SOC, V73, P5295, DOI 10.1021/ja01155a084; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Casaccia-Bonnefil P, 1999, MICROSC RES TECHNIQ, V45, P217, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<217::AID-JEMT5>3.0.CO;2-5; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; FARDE JM, 1993, BIOESSAYS, V20, P137; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; HAMA T, 1995, J BIOL CHEM, V270, P29067, DOI 10.1074/jbc.270.49.29067; Hama T, 2000, NEUROSCIENCE, V98, P567, DOI 10.1016/S0306-4522(00)00136-6; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; HIGASHIDA H, 1981, BRAIN RES, V214, P287, DOI 10.1016/0006-8993(81)91195-1; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kato K, 1999, J NEUROCHEM, V73, P229, DOI 10.1046/j.1471-4159.1999.0730229.x; Kihara D, 1998, PROTEIN ENG, V11, P961, DOI 10.1093/protein/11.11.961; MACDERMOT J, 1979, P NATL ACAD SCI USA, V76, P1135, DOI 10.1073/pnas.76.3.1135; Majdan M, 1999, INT J DEV NEUROSCI, V17, P153, DOI 10.1016/S0736-5748(99)00016-7; MANTHORPE M, 1983, BRAIN RES, V267, P47, DOI 10.1016/0006-8993(83)91038-7; Maruyama M, 1999, NEUROSCIENCE, V89, P149, DOI 10.1016/S0306-4522(98)00297-8; NARA K, 1994, P NATL ACAD SCI USA, V91, P7952, DOI 10.1073/pnas.91.17.7952; NIETOSAMPEDRO M, 1982, SCIENCE, V217, P860, DOI 10.1126/science.7100931; NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; REED PW, 1982, POLYETHER ANTIBIOTIC, V1, P185; SAFRAN N, 1993, TOXICOL IN VITRO, V7, P345, DOI 10.1016/0887-2333(93)90026-2; Safran N, 1996, NEUROTOXICOLOGY, V17, P883; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; TAMATANI T, 1993, EUR J IMMUNOL, V23, P2181, DOI 10.1002/eji.1830230920; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; WALLACE JC, 1992, COMPUT APPL BIOSCI, V8, P249; WATANABE T, 1992, BIOCHIM BIOPHYS ACTA, V1131, P321, DOI 10.1016/0167-4781(92)90033-V; Westley J W, 1977, Adv Appl Microbiol, V22, P177, DOI 10.1016/S0065-2164(08)70163-1; Yoon SO, 1998, J NEUROSCI, V18, P3273	42	7	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31929	31935		10.1074/jbc.M100617200	http://dx.doi.org/10.1074/jbc.M100617200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11399754	hybrid			2022-12-27	WOS:000170613500064
J	Lawrence, JW; Li, Y; Chen, SY; DeLuca, JG; Berger, JP; Umbenhauer, DR; Moller, DE; Zhou, GC				Lawrence, JW; Li, Y; Chen, SY; DeLuca, JG; Berger, JP; Umbenhauer, DR; Moller, DE; Zhou, GC			Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha - PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; COA OXIDASE GENE; SPECIES-DIFFERENCES; BETA-OXIDATION; GUINEA-PIG; CULTURED RAT; FATTY-ACIDS; HUMAN LIVER; C-III; MECHANISM	We compared the ability of rat and human hepatocytes to respond to fenofibric acid and a novel potent phenylacetic acid peroxisome proliferator-activated receptor (PPAR) a agonist (compound 1). Fatty acyl-CoA oxidase (FACO) activity and mRNA were increased after treatment with either fenofibric acid or compound I in rat hepatocytes. In addition, apolipoprotein CIII mRNA was decreased by both fenofibric acid and compound I in rat hepatocytes. Both agonists decreased apolipoprotein CIII mRNA in human hepatocytes; however, very little change in FACO activity or mRNA was observed. Furthermore, other peroxisome proliferation (PP)-associated genes including peroxisomal 3-oxoacyl-CoA thiolase (THIO), peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (HD), peroxisomal membrane protein-70 (PMP-70) were not regulated by PPAR alpha agonists in human hepatocytes. Moreover, other genes that are regulated by PPAR alpha ligands in human hepatocytes such as mitochondrial HMG-CoA synthase and carnitine palmitoyl transferase-1 (CPT-1) were also regulated in HepG2 cells by PPAR alpha agonists. Several stably transfected HepG2 cell lines were established that overexpressed human PPAR alpha to levels between 6- and 26-fold over normal human hepatocytes. These PPAR alpha -overexpressing cells had higher basal mRNA levels of mitochondrial EIMG-CoA synthase and CPT-1; however, basal FACO mRNA levels and other PP-associated genes including THIO, HD, or PMP-70 m-RNA were not substantially affected. In addition, FACO, THIO, HD, and PMP-70 mRNA levels did not increase in response to PPAR alpha agonist treatment in the PPAR alpha -overexpressing cells, although mitochondrial HMG-CoA synthase and CPT-1 mRNAs were both induced. These results suggest that other factors besides PPAR alpha levels determine the species-specific response of human and rat hepatocytes to the induction of PP.	Merck & Co Inc, Dept Metab Disorders, Merck Res Labs, Rahway, NJ 07065 USA; Merck & Co Inc, Merck Res Labs, Dept Safety Assessment, West Point, PA USA	Merck & Company; Merck & Company	Lawrence, JW (corresponding author), Merck & Co Inc, Dept Metab Disorders, Merck Res Labs, RY80N-C31,POB 2000, Rahway, NJ 07065 USA.	jeff_lawrence@merck.com; gaochao_zhou@merck.com						Berger J, 1999, J BIOL CHEM, V274, P6718, DOI 10.1074/jbc.274.10.6718; BLAAUBOER BJ, 1990, BIOCHEM PHARMACOL, V40, P521, DOI 10.1016/0006-2952(90)90551-U; Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786; EACHO PI, 1986, TOXICOL APPL PHARM, V83, P430, DOI 10.1016/0041-008X(86)90225-5; ELCOMBE CR, 1986, ENVIRON HEALTH PERSP, V70, P211, DOI 10.2307/3430357; FOXWORTHY PS, 1990, TOXICOL APPL PHARM, V104, P386, DOI 10.1016/0041-008X(90)90160-V; FOXWORTHY PS, 1986, TOXICOL LETT, V30, P189; Gervois P, 1999, MOL ENDOCRINOL, V13, P1535, DOI 10.1210/me.13.9.1535; Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702; HADDAD IA, 1986, J BIOL CHEM, V261, P3268; Hasmall SC, 2000, ARCH TOXICOL, V74, P85, DOI 10.1007/s002040050657; Hertz R, 1998, TOXICOL LETT, V103, P85, DOI 10.1016/S0378-4274(98)00290-2; Holden PR, 1999, J MOL ENDOCRINOL, V22, P1, DOI 10.1677/jme.0.0220001; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; LAKE BG, 1989, TOXICOL APPL PHARM, V99, P148, DOI 10.1016/0041-008X(89)90120-8; Lambe KG, 1999, TOXICOL LETT, V110, P119, DOI 10.1016/S0378-4274(99)00151-4; LAWRENCE JW, 1998, TOXICOLOGY LIVER, P125; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macdonald N, 1999, CANCER RES, V59, P4776; MUKHERJEE R, 1994, J STEROID BIOCHEM, V51, P157, DOI 10.1016/0960-0760(94)90089-2; Palmer CNA, 1998, MOL PHARMACOL, V53, P14, DOI 10.1124/mol.53.1.14; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; POOSCH MS, 1986, BIOCHIM BIOPHYS ACTA, V884, P585, DOI 10.1016/0304-4165(86)90211-4; Roberts RA, 2000, TOXICOL LETT, V112, P49, DOI 10.1016/S0378-4274(99)00243-X; Roberts RA, 1999, ARCH TOXICOL, V73, P413, DOI 10.1007/s002040050629; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; SHARPE CR, 1984, NUCLEIC ACIDS RES, V12, P3917, DOI 10.1093/nar/12.9.3917; Shu H, 2000, BIOCHEM BIOPH RES CO, V267, P345, DOI 10.1006/bbrc.1999.1968; STAELS B, 1995, J CLIN INVEST, V95, P705, DOI 10.1172/JCI117717; Stier H, 1998, DIFFERENTIATION, V64, P55, DOI 10.1046/j.1432-0436.1998.6410055.x; Tugwood JD, 1996, ANN NY ACAD SCI, V804, P252, DOI 10.1111/j.1749-6632.1996.tb18620.x; Tugwood JD, 1998, ARCH TOXICOL, V72, P169, DOI 10.1007/s002040050483; WANDERS RJA, 1991, BIOCHIM BIOPHYS ACTA, V1115, P54, DOI 10.1016/0304-4165(91)90011-5; Woodyatt NJ, 1999, CARCINOGENESIS, V20, P369, DOI 10.1093/carcin/20.3.369; Yu GS, 1998, J BIOL CHEM, V273, P32901, DOI 10.1074/jbc.273.49.32901; Zhou GC, 1998, MOL ENDOCRINOL, V12, P1594, DOI 10.1210/me.12.10.1594	37	159	160	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31521	31527		10.1074/jbc.M103306200	http://dx.doi.org/10.1074/jbc.M103306200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418601	hybrid			2022-12-27	WOS:000170613500009
J	Shaked, GM; Shaked, Y; Kariv-Inbal, Z; Halimi, M; Avraham, I; Gabizon, R				Shaked, GM; Shaked, Y; Kariv-Inbal, Z; Halimi, M; Avraham, I; Gabizon, R			A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE PRION; LIBYAN JEWS; INFECTIVITY; MUTATION; PATHOGENESIS; BRAINS; GENE; REPLICATION; FIBRILS	Prion protein (PrP)(Sc), the only known component of the prion, is present mostly in the brains of animals and humans affected with prion diseases. We now show that a protease-resistant PrP isoform can also be detected in the urine of hamsters, cattle, and humans suffering from transmissible spongiform encephalopathies. Most important, this PrP isoform (UPrPSc) was also found in the urine of hamsters inoculated with prions long before the appearance of clinical signs. Interestingly, intracerebrally inoculation of hamsters with UPrPSc did not cause clinical signs of prion disease even after 270 days, suggesting it differs in its pathogenic properties from brain PrPSc. We propose that the detection of UPrPSc can be used to diagnose humans and animals incubating prion diseases, as well as to increase our understanding on the metabolism of PrPSc in vivo.	Hadassah Univ Hosp, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Gabizon, R (corresponding author), Hadassah Univ Hosp, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, IL-91120 Jerusalem, Israel.							Berne R. M., 1998, PHYSIOLOGY, P677; Bradley R, 1992, Rev Sci Tech, V11, P605; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CHATELAIN J, 1989, EUR J EPIDEMIOL, V5, P113, DOI 10.1007/BF00145057; CZUB M, 1986, J GEN VIROL, V67, P2005, DOI 10.1099/0022-1317-67-9-2005; CZUB M, 1988, J GEN VIROL, V69, P1753, DOI 10.1099/0022-1317-69-7-1753; De Armond S J, 1989, Prog Clin Biol Res, V317, P601; Fisher E, 1998, MAMM GENOME, V9, P497, DOI 10.1007/s003359900807; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; GABIZON R, 1993, AM J HUM GENET, V53, P828; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; GOLDFARB LG, 1990, LANCET, V336, P637, DOI 10.1016/0140-6736(90)93443-S; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; HOPE J, 1988, NATURE, V336, P390, DOI 10.1038/336390a0; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Ironside JW, 2000, HISTOPATHOLOGY, V37, P1, DOI 10.1046/j.1365-2559.2000.00946.x; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meri S, 1996, BIOCHEM J, V316, P923, DOI 10.1042/bj3160923; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Miele G, 2001, NAT MED, V7, P361, DOI 10.1038/85515; NAKANO Y, 1994, ARCH BIOCHEM BIOPHYS, V311, P117, DOI 10.1006/abbi.1994.1216; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; Rosenmann H, 1997, NEUROLOGY, V49, P593, DOI 10.1212/WNL.49.2.593; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Shaked GM, 1999, J BIOL CHEM, V274, P17981, DOI 10.1074/jbc.274.25.17981; SHAKED GM, 2001, J BIOL CHEM, V4, P4; Simon ES, 2000, ANN NEUROL, V47, P257, DOI 10.1002/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580; Zeidler M, 1997, LANCET, V350, P908, DOI 10.1016/S0140-6736(97)03148-6	37	134	146	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31479	31482		10.1074/jbc.C100278200	http://dx.doi.org/10.1074/jbc.C100278200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423531	hybrid			2022-12-27	WOS:000170613500002
J	Spizz, G; Blackshear, PJ				Spizz, G; Blackshear, PJ			Overexpression of the myristoylated alanine-rich C-kinase substrate inhibits cell adhesion to extracellular matrix components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TYROSINE PHOSPHORYLATION; CHONDROITIN SULFATE PROTEOGLYCANS; MEMBRANE ASSOCIATION; MARCKS PROTEIN; CYTOCHALASIN-B; MEDIATED PHOSPHORYLATION; CALMODULIN-BINDING; MOLECULAR-CLONING; ACTIN; FAMILY	Mice lacking the myristoylated alanine-rich C-kinase substrate, or MARCKS protein, exhibit abnormalities consistent with a defect in the ability of neurons to migrate appropriately during forebrain development. To investigate the possibility that this phenotype could be due to disruption of normal cellular adhesion to extracellular matrix, an assay was developed in which 293 cells co-expressing MARCKS and green fluorescent protein were tested for their adhesion competence on various substrates. Fluorescence-activated cell sorting of adherent and non-adherent green fluorescent protein-expressing cells demonstrated that wild-type MARCKS inhibited adhesion of cells to fibronectin, whereas a non-myristoylated mutant did not inhibit adhesion of cells to a variety of substrates. The fibronectin competitive inhibitor RGD peptide inhibited adhesion of cells expressing all MARCKS variants equally. Cytochalasin D inhibited the adhesion of cells expressing non-myristoylated MARCKS, but did not further decrease the adhesion of cells expressing adhesion-inhibitory proteins. Confocal microscopy demonstrated the presence of inhibitory, myristoylated MARCKS at the. plasma membrane, suggesting that localization at this region might be important for MARCKS to inhibit cellular adhesion. These data suggest a possible myristoylation-dependent function of MARCKS to inhibit cellular adhesion to extracellular matrix proteins, indicating a potential mechanism for the cell migration defects seen in the MARCKS-deficient. mice.	NIEHS, Off Clin Res, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, Off Clin Res, NIH, 111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529				ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Blackshear PJ, 1997, EXP NEUROL, V145, P46, DOI 10.1006/exnr.1997.6475; Blackshear PJ, 1996, DEV BRAIN RES, V96, P62, DOI 10.1016/S0165-3806(96)00097-1; BLIOKH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P5919, DOI 10.1073/pnas.77.10.5919; BODARY SC, 1990, J BIOL CHEM, V265, P5938; Bubb MR, 1999, J BIOL CHEM, V274, P36472, DOI 10.1074/jbc.274.51.36472; BYERS DM, 1993, J NEUROCHEM, V60, P1414, DOI 10.1111/j.1471-4159.1993.tb03303.x; Chen HC, 1998, J BIOL CHEM, V273, P25777, DOI 10.1074/jbc.273.40.25777; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DOHERTY DE, 1994, J IMMUNOL, V153, P241; GEORGE DJ, 1992, J BIOL CHEM, V267, P24879; GODFREY K, 1985, NEW ENGL J MED, V313, P1450, DOI 10.1056/NEJM198512053132305; GRAFF JM, 1989, MOL ENDOCRINOL, V3, P1903, DOI 10.1210/mend-3-11-1903; GRAFF JM, 1991, J BIOL CHEM, V266, P14390; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Harlow E., 1988, ANTIBODIES LAB MANUA; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HINRICHSEN RD, 1993, P NATL ACAD SCI USA, V90, P1585, DOI 10.1073/pnas.90.4.1585; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; KIM JY, 1994, J BIOL CHEM, V269, P28214; KIM JY, 1994, BIOPHYS J, V67, P227, DOI 10.1016/S0006-3495(94)80473-4; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; LIESI P, 1990, EXPERIENTIA, V46, P900, DOI 10.1007/BF01939382; Lin XH, 1996, MOL BIOL CELL, V7, P1977, DOI 10.1091/mbc.7.12.1977; LOBAUGH LA, 1990, J BIOL CHEM, V265, P18393; MANENTI S, 1993, J BIOL CHEM, V268, P6878; Manenti S, 1997, FEBS LETT, V419, P95, DOI 10.1016/S0014-5793(97)01438-5; MCILROY BK, 1991, J BIOL CHEM, V266, P4959; MCKEEHAN WL, 1976, J CELL BIOL, V71, P727, DOI 10.1083/jcb.71.3.727; MENKO AS, 1983, MOL CELL BIOL, V3, P113, DOI 10.1128/MCB.3.1.113; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; Needham LK, 1998, J BIOL CHEM, V273, P14626, DOI 10.1074/jbc.273.23.14626; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; Palmantier R, 1996, CANCER RES, V56, P2206; PETER K, 1995, J EXP MED, V181, P315, DOI 10.1084/jem.181.1.315; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Porumb T, 1997, EUR BIOPHYS J BIOPHY, V25, P239, DOI 10.1007/s002490050036; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Spizz G, 1997, J BIOL CHEM, V272, P23833, DOI 10.1074/jbc.272.38.23833; Spizz G, 1996, J BIOL CHEM, V271, P553, DOI 10.1074/jbc.271.1.553; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; STUMPO DJ, 1989, NUCLEIC ACIDS RES, V17, P3987, DOI 10.1093/nar/17.10.3987; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Swierczynski SL, 1996, J BIOL CHEM, V271, P23424, DOI 10.1074/jbc.271.38.23424; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; TANIGUCHI H, 1993, J BIOL CHEM, V268, P9960; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; URBANIK E, 1989, ARCH BIOCHEM BIOPHYS, V269, P181, DOI 10.1016/0003-9861(89)90098-2; VERGHESE GM, 1994, J BIOL CHEM, V269, P9361; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Zhang ZY, 1999, J BIOL CHEM, V274, P25093, DOI 10.1074/jbc.274.35.25093; Zhou XM, 2000, J BIOL CHEM, V275, P20217, DOI 10.1074/jbc.M909129199	64	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32264	32273		10.1074/jbc.M103960200	http://dx.doi.org/10.1074/jbc.M103960200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11413143	hybrid			2022-12-27	WOS:000170613500107
J	Cheng, JJ; Wung, BS; Chao, YJ; Wang, DL				Cheng, JJ; Wung, BS; Chao, YJ; Wang, DL			Sequential activation of protein kinase C (PKC)-alpha and PKC-epsilon contributes to sustained Raf/ERK1/2 activation in endothelial cells under mechanical strain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE-1 EXPRESSION; SIGNAL-REGULATED KINASE; EPIDERMAL GROWTH-FACTOR; SHEAR-STRESS; GENE-EXPRESSION; TRANSLOCATION; RAF-1; ALPHA; DIACYLGLYCEROL; TRANSDUCTION	Endothelial cells (ECs) are constantly subjected to hemodynamic forces including cyclic pressure-induced strain. The role of protein kinase C (PKC) in cyclic strain-treated ECs was studied. PKC activities were induced as cyclic strain was initiated. Cyclic strain to ECs caused activation of PKC-alpha and -epsilon. The translocation of PKC-a and -e but not PKC-beta from the cytosolic to membrane fraction was observed. An early transient activation of PKC-a versus a late but sustained activation of PKC-E was shown after the onset of cyclic strain. Consistently, a sequential association of PKC-alpha and -epsilon with the signaling molecule Raf-1 was shown. ECs treated with a PKC inhibitor (calphostin C) abolished the cyclic strain-induced Raf-1 activation. ECs under cyclic strain induced a sustained activation of extracellular signal-regulated protein kinases (ERK1/2), which was inhibited by treating ECs with calphostin C. ECs treated with a specific Ca2+-dependent PKC inhibitor (Go 6976) showed an inhibition in the early phase of ERK1/2 activation but not in the late and sustained phase. ECs transfected with the antisense to PKC-a, the antisense to PKC-epsilon, or the inhibition peptide to PKC-c reduced strain-induced ERK1/2 phosphorylation in a temporal manner. PKC-a mediated mainly the early ERK1/2 activation, whereas PKC-e was involved in the sustained ERK1/2 activation. Strained ECs increased transcriptional activity of Elk1 (an ERK1/2 substrate). ECs transfected with the antisense to each PKC isoform reduced Elk1 and monocyte chemotactic protein-1 promotor activity. Our findings conclude that a sequential activation of PKC isoforin (alpha and epsilon contribute to Raf/ERK1/2 activation, and PKC-epsilon appears to play a key role in endothelial adaptation to hemodynamic environment.	Acad Sinica, Inst Biomed Sci, Div Cardiovasc, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Wang, DL (corresponding author), Acad Sinica, Inst Biomed Sci, Div Cardiovasc, Taipei 11529, Taiwan.	lingwang@ibms.sinica.edu.tw						APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; Bao XP, 1999, ARTERIOSCL THROM VAS, V19, P996, DOI 10.1161/01.ATV.19.4.996; Berk BC, 1999, THROMB HAEMOSTASIS, V82, P810; Berk BC, 1995, J BIOMECH, V28, P1439, DOI 10.1016/0021-9290(95)00092-5; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Cheng JJ, 1996, HYPERTENSION, V28, P386, DOI 10.1161/01.HYP.28.3.386; Cheng JJ, 1998, HYPERTENSION, V31, P125, DOI 10.1161/01.HYP.31.1.125; Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162; Chiu JJ, 1997, ARTERIOSCL THROM VAS, V17, P3570, DOI 10.1161/01.ATV.17.12.3570; DEAN NM, 1994, P NATL ACAD SCI USA, V91, P11762, DOI 10.1073/pnas.91.24.11762; EVANS L, 1997, J PHYSL, V272, pC650; GILBERT JA, 1994, J BIOMECH, V27, P1169, DOI 10.1016/0021-9290(94)90057-4; HA KS, 1993, J BIOL CHEM, V268, P10534; Haller H, 1996, ARTERIOSCL THROM VAS, V16, P678, DOI 10.1161/01.ATV.16.5.678; Hempel A, 1997, CIRC RES, V81, P363, DOI 10.1161/01.RES.81.3.363; Hu YL, 1997, J HISTOCHEM CYTOCHEM, V45, P237, DOI 10.1177/002215549704500209; Ito WD, 1997, CIRC RES, V80, P829; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Liang FQ, 2000, HYPERTENSION, V35, P188, DOI 10.1161/01.HYP.35.1.188; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Mills I, 1997, J CELL PHYSIOL, V170, P228, DOI 10.1002/(SICI)1097-4652(199703)170:3<228::AID-JCP2>3.0.CO;2-Q; Morawietz H, 2000, J PHYSIOL-LONDON, V525, P761, DOI 10.1111/j.1469-7793.2000.00761.x; MORITA T, 1994, CIRC RES, V75, P630, DOI 10.1161/01.RES.75.4.630; Neri LM, 1998, J BIOL CHEM, V273, P29738, DOI 10.1074/jbc.273.45.29738; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Rosales OR, 1997, BIOCHEM J, V326, P385, DOI 10.1042/bj3260385; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Sajan MP, 1999, J BIOL CHEM, V274, P30495, DOI 10.1074/jbc.274.43.30495; Sattler M, 1999, BLOOD, V93, P2928; Schwachtgen JL, 1998, J CLIN INVEST, V101, P2540, DOI 10.1172/JCI1404; SHYY JYJ, 1995, P NATL ACAD SCI USA, V92, P8069, DOI 10.1073/pnas.92.17.8069; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Takahashi M, 1996, J CLIN INVEST, V98, P2623, DOI 10.1172/JCI119083; Takei T, 1997, J CELL BIOCHEM, V67, P327, DOI 10.1002/(SICI)1097-4644(19971201)67:3<327::AID-JCB5>3.0.CO;2-Y; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Traub O, 1997, J BIOL CHEM, V272, P31251, DOI 10.1074/jbc.272.50.31251; Ueffing M, 1997, ONCOGENE, V15, P2921, DOI 10.1038/sj.onc.1201477; WANG DL, 1995, J CELL PHYSIOL, V163, P400, DOI 10.1002/jcp.1041630220; WANG DL, 1995, CIRC RES, V77, P294, DOI 10.1161/01.RES.77.2.294; Ward NE, 1998, J BIOL CHEM, V273, P12558, DOI 10.1074/jbc.273.20.12558; Wung BS, 1996, AM J PHYSIOL-HEART C, V270, pH1462, DOI 10.1152/ajpheart.1996.270.4.H1462; Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1; Wung BS, 1999, CIRC RES, V84, P804; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zou YP, 1998, INT J MOL MED, V1, P827	50	72	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31368	31375		10.1074/jbc.M011317200	http://dx.doi.org/10.1074/jbc.M011317200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11399752	hybrid			2022-12-27	WOS:000170472900101
J	Khatib, AM; Siegfried, G; Prat, A; Luis, J; Chretien, M; Metrakos, P; Seidah, NG				Khatib, AM; Siegfried, G; Prat, A; Luis, J; Chretien, M; Metrakos, P; Seidah, NG			Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells - Importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPROTEASE FURIN CONTROLS; HUMAN BREAST-CANCER; FACTOR-I; SECRETORY PATHWAY; MATRIX-METALLOPROTEINASE; STRUCTURAL DETERMINANTS; SIGNAL TRANSDUCTION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; TYROSINE KINASE	Proprotein convertases (PCs) of the subtilisin/kexin family are responsible for the activation of prohormones, protrophic factors, and their receptors. We sought to determine whether loss of PC-mediated activities might affect the malignant phenotypes of cancer cells. Stable transfectants of alpha (1)-antitrypsin Portland (alpha (1)-PDX) cDNA, coding for a potent PC inhibitor, were analyzed in model HT-29 cells (HT-29/PDX) and in other cell lines. Expression of alpha (1)-PDX resulted in a proinsulin-like growth factor-1 receptor (pro-IGF-IR) processing blockade, hence inhibiting the ability of exogenous IGF-1 to induce tyrosine phosphorylation of its beta -subunit and insulin-related substrate-1. Coexpression of IGF-1R with four different PCs or the novel convertase SKI-1 in the furin-defective LoVo-C5 cells demonstrated that pro-IGF-1R (similar to 200 kDa) cleavage into IGF-1R (beta -subunit, similar to 105 kDa) can be achieved by furin and PC5A, but not by PACE4, PC7, or SKI-1. Expression of alpha (1)-PDX resulted in reduction of DNA synthesis and in anchorage-independent growth. Following serum deprivation, the alpha (1)-PDX transfectants exhibited an enhanced apoptotic phenotype and were insensitive to IGF-1-mediated [H-3]thymidine incorporation and protection against apoptosis. These cells showed reduced invasiveness that paralleled decreased mRNA levels of urokinase-type plasminogen activator and its receptor, tissue-type plasminogen activator, and plasminogen activator inhibitor-1. Comparative subcutaneous inoculation of cells in nude mice revealed that animals injected with HT-29/PDX cells exhibited delayed and lower incidence of tumor development as well as reduced tumor size. Immunohistochemical analysis of CD31 antigen expression, a marker of endothelial cells, revealed reduced HT-29/PDX tumor vascularization. These findings indicate that PCs actively contribute to the growth and malignant phenotypes of HT-29 tumors, suggesting that PC inhibition strategies may be a useful adduct to the arsenal of colorectal anticancer gene therapies.	Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; Fac Pharm Marseille, Biochim Cellulaire Lab, CNRS UPRESA 6032, F-13385 Marseille 5, France; Ottawa Civic Hosp, Mol Med & Dis Aging Ctr, Loeb Hlth Res Inst, Ottawa, ON K1Y 4K9, Canada; Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Surg, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute; McGill University; Royal Victoria Hospital; McGill University; McGill University	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.		KHATIB, Abdel-Majid/A-9948-2015; LUIS, José/M-3071-2013; Siegfried, Géraldine/N-6017-2018; Prat, Annik/S-6757-2018; metrakos, peter/D-3726-2013; Seidah, Nabil/I-3596-2013	KHATIB, Abdel-Majid/0000-0001-6957-0384; Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; siegfried, geraldine/0000-0002-6346-5206; CHRETIEN, Michel/0000-0002-8588-4460				Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Akagi Y, 1998, CANCER RES, V58, P4008; ALARCON C, 1994, BIOCHEM J, V301, P257, DOI 10.1042/bj3010257; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Baserga Renato, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P47; Bassi DE, 2000, MOL CARCINOGEN, V28, P63, DOI 10.1002/1098-2744(200006)28:2<63::AID-MC1>3.3.CO;2-3; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Berthet V, 2000, J BIOL CHEM, V275, P33308, DOI 10.1074/jbc.M004834200; Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263; Campan M, 1996, BIOCHEMISTRY-US, V35, P3797, DOI 10.1021/bi952552d; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; Cheng M, 2001, J MOL ENDOCRINOL, V26, P95, DOI 10.1677/jme.0.0260095; CHRETIEN M, 1995, P ASSOC AM PHYSICIAN, V107, P47; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; CULOUSCOU JM, 1987, INT J CANCER, V40, P646, DOI 10.1002/ijc.2910400513; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Duguay SJ, 1999, HORM METAB RES, V31, P43, DOI 10.1055/s-2007-978697; Duguay SJ, 1997, J BIOL CHEM, V272, P6663, DOI 10.1074/jbc.272.10.6663; Dunn SE, 2000, MOL CARCINOGEN, V27, P10, DOI 10.1002/(SICI)1098-2744(200001)27:1<10::AID-MC3>3.0.CO;2-Z; Feldser D, 1999, CANCER RES, V59, P3915; GANESH S, 1994, LANCET, V344, P401, DOI 10.1016/S0140-6736(94)91427-3; Gil-Ad I, 1999, GROWTH HORM IGF RES, V9, P458, DOI 10.1054/ghir.1999.0130; Harvey SR, 1999, AM J PATHOL, V155, P1115, DOI 10.1016/S0002-9440(10)65214-5; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jung YK, 1996, J BIOL CHEM, V271, P5112; Kayo T, 1997, DIABETES, V46, P1296, DOI 10.2337/diabetes.46.8.1296; Kayo T, 1996, J BIOL CHEM, V271, P10731, DOI 10.1074/jbc.271.18.10731; Kimura I, 2000, JPN J PHARMACOL, V83, P47, DOI 10.1254/jjp.83.47; Kinoshita T, 1996, CANCER RES, V56, P2535; Konda Y, 1997, J CLIN INVEST, V99, P1842, DOI 10.1172/JCI119351; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kuhn C, 1999, INT J CANCER, V80, P431, DOI 10.1002/(SICI)1097-0215(19990129)80:3<431::AID-IJC16>3.3.CO;2-X; KYRIAZIS AP, 1982, AM J PATHOL, V106, P250; LAHM H, 1994, INT J CANCER, V58, P452, DOI 10.1002/ijc.2910580325; Lebrun P, 1998, J BIOL CHEM, V273, P32244, DOI 10.1074/jbc.273.48.32244; Lehmann M, 1998, ENDOCRINOLOGY, V139, P3763, DOI 10.1210/en.139.9.3763; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Lissitzky JC, 2000, BIOCHEM J, V346, P133, DOI 10.1042/0264-6021:3460133; LIU B, 1995, INT J CANCER, V63, P276, DOI 10.1002/ijc.2910630222; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; LONG L, 1995, CANCER RES, V55, P1006; Long L, 1998, EXP CELL RES, V238, P116, DOI 10.1006/excr.1997.3814; Lopez-Perez E, 1999, J NEUROCHEM, V73, P2056; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; MBIKAY M, 1993, ANN NY ACAD SCI, V680, P13, DOI 10.1111/j.1749-6632.1993.tb19671.x; MCCUE JL, 1991, BRIT J SURG, V78, P921, DOI 10.1002/bjs.1800780808; MIELE C, 1995, J BIOL CHEM, V270, P15844, DOI 10.1074/jbc.270.26.15844; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Remacle-Bonnet MM, 2000, CANCER RES, V60, P2007; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; RODRIGUES GA, 1994, ONCOGENE, V9, P2019; Santavicca M, 1996, BIOCHEM J, V315, P953, DOI 10.1042/bj3150953; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; TRAINER DL, 1988, INT J CANCER, V41, P287, DOI 10.1002/ijc.2910410221; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Valentinis, 1997, BIOCHIM BIOPHYS ACTA, V1332, P105; VIEAU D, 1994, J CLIN ENDOCR METAB, V79, P1503, DOI 10.1210/jc.79.5.1503; Vollenweider F, 1996, BIOCHEM J, V314, P521, DOI 10.1042/bj3140521; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WHITE MF, 1997, DIABETOLOGIA, V40, P2; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	74	141	147	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30686	30693		10.1074/jbc.M101725200	http://dx.doi.org/10.1074/jbc.M101725200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402025	hybrid			2022-12-27	WOS:000170472900015
J	Pitt, GS; Zuhlke, RD; Hudmon, A; Schulman, H; Reuter, H; Tsien, RW				Pitt, GS; Zuhlke, RD; Hudmon, A; Schulman, H; Reuter, H; Tsien, RW			Molecular basis of calmodulin tethering and Ca2+-dependent inactivation of L-type Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-HAND MOTIF; CA2+-SENSITIVE INACTIVATION; ALPHA(1C) SUBUNIT; CALCIUM-CHANNEL; EXONS 40-42; DETERMINANTS; FACILITATION; VOLTAGE; BINDING; RECOGNITION	Ca2+-dependent inactivation (CDI) of L-type Ca2+ channels plays a critical role in controlling Ca2+ entry and downstream signal transduction in excitable cells. Ca2+-insensitive forms of calmodulin (CaM) act as dominant negatives to prevent CDI, suggesting that CaM acts as a resident Ca2+ sensor. However, it is not known how the Ca2+ sensor is constitutively tethered. We have found that the tethering of Ca2+-insensitive CaM was localized to the C-terminal tail of arc, close to the CDI effector motif, and that it depended on nanomolar Ca2+ concentrations, likely attained in quiescent cells. Two stretches of amino acids were found to support the tethering and to contain putative CaM-binding sequences close to or overlapping residues previously shown to affect CDI and Ca2+-independent inactivation. Synthetic peptides containing these sequences displayed differences in CaM-binding properties, both in affinity and Ca2+ dependence, leading us to propose a novel mechanism for CDI. In contrast to a traditional disinhibitory scenario, we suggest that apoCaM is tethered at two sites and signals actively to slow inactivation. When the C-terminal lobe of CaM binds to the nearby CaM effector sequence (IQ motif), the braking effect is relieved, and CDI is accelerated.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Bern, Dept Pharmacol, CH-3010 Bern, Switzerland	Stanford University; Stanford University; University of Bern	Pitt, GS (corresponding author), Columbia Univ, Sch Med, Dept Pharmacol, 630 E 168th St,PH 7W-318, New York, NY 10032 USA.	gp2004@columbia.edu	Pitt, Geoffrey/L-4927-2019; Tuluc, Petronel/C-2527-2011		NHLBI NIH HHS [K08 HL003743-05, K08 HL003743-06, K08 HL003743-04, K08 HL03743, K08 HL003743-03] Funding Source: Medline; NIGMS NIH HHS [GM58234] Funding Source: Medline; NINDS NIH HHS [NS24067] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams B, 1997, J GEN PHYSIOL, V110, P379, DOI 10.1085/jgp.110.4.379; BEELER GW, 1970, J PHYSIOL-LONDON, V207, P191, DOI 10.1113/jphysiol.1970.sp009056; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dzhura I, 2000, NAT CELL BIOL, V2, P173, DOI 10.1038/35004052; Ehlers MD, 1999, NATURE, V399, P105, DOI 10.1038/20079; HAACK JA, 1994, BIOPHYS J, V66, P1051, DOI 10.1016/S0006-3495(94)80886-0; Hofer GF, 1997, BIOPHYS J, V73, P1857, DOI 10.1016/S0006-3495(97)78216-X; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KINCAID RL, 1982, J BIOL CHEM, V257, P638; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; LADANT D, 1988, J BIOL CHEM, V263, P2612; Lemaire S, 1998, BASIC RES CARDIOL, V93, P51; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Meyers MB, 1998, J BIOL CHEM, V273, P18930, DOI 10.1074/jbc.273.30.18930; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; NEWTON DL, 1984, J BIOL CHEM, V259, P4419; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Soldatov NM, 1998, J BIOL CHEM, V273, P957, DOI 10.1074/jbc.273.2.957; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	37	233	241	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30794	30802		10.1074/jbc.M104959200	http://dx.doi.org/10.1074/jbc.M104959200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11408490	hybrid			2022-12-27	WOS:000170472900030
J	Scholz, GM; Cartledge, K; Hall, NE				Scholz, GM; Cartledge, K; Hall, NE			Identification and characterization of harc, a novel Hsp90-associating relative of Cdc37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HSP90 MOLECULAR CHAPERONE; CELL-FREE SYSTEM; IN-VIVO; GLUCOCORTICOID RECEPTOR; PROGESTERONE-RECEPTOR; TYROSINE KINASE; BINDING-SITE; P50(CDC37); COMPLEX	Although little is known about the precise mechanisms by which the molecular chaperone Hsp90 recognizes its client proteins, Cdc37 has been shown to play a critical role in the targeting of Hsp90 to client protein kinases. Described here is the identification and characterization of a novel 35-kDa human protein that is 31% identical to Cde37. We have named this novel protein Rare ((H) under bar sp90-(a) under bar ssociating (r) under bar elative of (C) under bar dc37). Northern blot analysis revealed the presence of Hare mRNA in several human tissues, including liver, skeletal muscle, and kidney. Biochemical fractionation and immunofluorescent localization of epitope-tagged Hare (ie. FLAG-Hare) indicated that it is present in the cytoplasm of cells. FLAG-Harc binds Hsp90 but unlike Cdc37 does not bind Src family kinases or Raf-l. Mapping experiments indicate that the central 120 amino acids of both Hare and Cdc37 constitute a Hsp90-binding domain not described previously. FLAG-Harc is basally serine-phosphorylated and hyperphosphorylated when co-expressed with an activated mutant of the Src family kinase Hck. Notably, FLAG-Harc forms complexes with Hsp90, Hsp70, p60Hop, immunophilins, and an unidentified p22 protein but not with the Hsp90 co-chaperone p23. Thus Hare likely represents a novel participant in Hsp90-mediated protein folding, potentially targeting Hsp90 to Hsp70-client protein heterocomplexes.	Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia	Ludwig Institute for Cancer Research; Royal Melbourne Hospital	Scholz, GM (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, POB 2008, Parkville, Vic 3050, Australia.	Glen.Scholz@ludwig.edu.au		Scholz, Glen/0000-0003-2722-6344; Hall, Nathan/0000-0001-8942-0498				Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; Bohen SP, 1998, MOL CELL BIOL, V18, P3330, DOI 10.1128/MCB.18.6.3330; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; Freeman BC, 2000, GENE DEV, V14, P422; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; HARTSON SD, 1994, BIOCHEMISTRY-US, V33, P8912, DOI 10.1021/bi00196a008; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Nair SC, 1996, CELL STRESS CHAPERON, V1, P237, DOI 10.1379/1466-1268(1996)001<0237:APOMCI>2.3.CO;2; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; OWENSGRILLO JK, 1995, J BIOL CHEM, V270, P20479, DOI 10.1074/jbc.270.35.20479; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; RAO J, 2000, J BIOL CHEM; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; REED SI, 1980, GENETICS, V95, P561; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Scholz G, 2000, MOL CELL BIOL, V20, P6984, DOI 10.1128/MCB.20.18.6984-6995.2000; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; WHITELAW ML, 1991, J BIOL CHEM, V266, P16436; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Yue L, 1999, GENETICS, V151, P1065	50	31	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30971	30979		10.1074/jbc.M103889200	http://dx.doi.org/10.1074/jbc.M103889200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413142	hybrid			2022-12-27	WOS:000170472900052
J	Lee, S; Furuya, T; Kiyota, T; Takami, N; Murata, K; Niidome, Y; Bredesen, DE; Ellerby, HM; Sugihara, G				Lee, S; Furuya, T; Kiyota, T; Takami, N; Murata, K; Niidome, Y; Bredesen, DE; Ellerby, HM; Sugihara, G			De novo-designed peptide transforms Golgi-specific lipids into Golgi-like nanotubules.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC-HYDROPHILIC BALANCE; MEMBRANE DYNAMICS; VESICULATION	Cellular organelles, such as the Golgi apparatus and the endoplasmic reticulum, adopt characteristic structures depending on their function. While the tubular shapes of these structures result from complex protein-lipid interactions that are not fully understood, some fundamental machinery must be required. We show here that a de novo-designed 18-mer amphipathic a-helical peptide, Hel 13-5, transforms spherical liposomes made from a Golgi-specific phospholipid mixture into nanotubules on the scale of and resembling the shape of the nanotubules that form the Golgi apparatus. Furthermore, we show that that the size and the shape of such nanotubules depend on lipid composition and peptide properties such as length and the ratio of hydrophobic to hydrophilic amino acids. Although the question of precisely how nature engineers organellar membranes remains unknown, our simple novel system provides a basic set of tools to begin addressing this question.	Fukuoka Univ, Sch Med, Dept Chem, Fac Sci, Fukuoka 8140180, Japan; Fukuoka Univ, Sch Med, Radioisotope Ctr, Fukuoka 8140180, Japan; Fukuoka Univ, Sch Med, Cent Lab Infect Dis, Fukuoka 8140180, Japan; Kyushu Univ, Dept Mat Phys & Chem, Grad Sch Engn, Fukuoka 8128581, Japan; Buck Inst Age Res, Novato, CA 94945 USA	Fukuoka University; Fukuoka University; Fukuoka University; Kyushu University; Buck Institute for Research on Aging	Lee, S (corresponding author), Fukuoka Univ, Sch Med, Dept Chem, Fac Sci, Fukuoka 8140180, Japan.		Niidome, Yasuro/C-8516-2009	Niidome, Yasuro/0000-0002-1086-8036	NCI NIH HHS [1RO1CA/AG84262-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084262] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTS B, 1994, MOL BIOL CELL, P601; COCHRANE CG, 1991, SCIENCE, V254, P566, DOI 10.1126/science.1948032; Kitamura A, 1999, BIOPHYS J, V76, P1457, DOI 10.1016/S0006-3495(99)77306-6; Kiyota T, 1996, BIOCHEMISTRY-US, V35, P13196, DOI 10.1021/bi961289t; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MIYATA H, 1992, P NATL ACAD SCI USA, V89, P11547, DOI 10.1073/pnas.89.23.11547; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; Presley JF, 1998, MOL BIOL CELL, V9, P1617, DOI 10.1091/mbc.9.7.1617; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; WEIDMAN P, 1993, CELL, V75, P123, DOI 10.1016/S0092-8674(05)80089-3	13	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 2	2001	276	44					41224	41228		10.1074/jbc.M104705200	http://dx.doi.org/10.1074/jbc.M104705200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	488FM	11406635	hybrid			2022-12-27	WOS:000171925600113
J	Lu, HS; Chai, JJ; Li, M; Huang, BR; He, CH; Bi, RC				Lu, HS; Chai, JJ; Li, M; Huang, BR; He, CH; Bi, RC			Crystal structure of human epidermal growth factor and its dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRELIMINARY-X-RAY; B-LOOP; CRYSTALLIZATION; NMR; ACTIVATION; MOLECULES; COMPLEX; PROTEIN	Epidermal growth factor (EGF) is a typical growth-stimulating peptide and functions by binding to specific cell-surface receptors and inducing dimerization of the receptors. Little is known about the molecular mechanism of EGF-induced dimerization of EGF receptors. The crystal structure of human EGF has been determined at pH 8.1. There are two human EGF molecules A and B in the asymmetric unit of the crystals, which form a potential dimer. Importantly, a number of residues known to be indispensable for EGF binding to its receptor are involved in the interface between the two EGF molecules, suggesting a crucial role of EGF dimerization in the EGF-induced dimerization of receptors. In addition, the crystal structure of EGF shares the main features of the NMR structure of mouse EGF determined at pH 2.0, but structural comparisons between different models have revealed new detailed features and properties of the EGF structure.	Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China; Beijing Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Bi, RC (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.	rebi@iname.com	lankarani, kamran b/D-5901-2012; Lankarani, Kamran B/P-5336-2019; Lankarani, Kamran Bagheri/P-2066-2017	Lankarani, Kamran B/0000-0002-7524-9017; Lankarani, Kamran Bagheri/0000-0002-7524-9017; Chai, Jijie/0000-0001-7591-3873				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Blanco-Aparicio C, 1998, J BIOL CHEM, V273, P12370, DOI 10.1074/jbc.273.20.12370; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Campbell I D, 1989, Prog Growth Factor Res, V1, P13, DOI 10.1016/0955-2235(89)90038-0; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARPENTER G, 1978, NATURE, V276, P409, DOI 10.1038/276409a0; Chai JJ, 2000, ACTA CRYSTALLOGR D, V56, P62, DOI 10.1107/S0907444999012615; COLMAN PM, 1976, CRYSTALLOGRAPHIC COM, P248; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; Degenhardt M, 1998, ACTA CRYSTALLOGR D, V54, P999, DOI 10.1107/S0907444998001851; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; HIGUCHI Y, 1988, J BIOCHEM-TOKYO, V103, P905, DOI 10.1093/oxfordjournals.jbchem.a122385; HOMMEL U, 1992, J MOL BIOL, V227, P271, DOI 10.1016/0022-2836(92)90697-I; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P11928, DOI 10.1021/bi00162a036; KOHDA D, 1988, J BIOCHEM-TOKYO, V103, P741, DOI 10.1093/oxfordjournals.jbchem.a122338; KRAULIS PJ, 1993, J APPL CRYSTALLOGR, V26, P283; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; MASSAGUE J, 1983, J BIOL CHEM, V258, P3614; MATSUNAMI RK, 1991, J CELL BIOCHEM, V46, P242, DOI 10.1002/jcb.240460307; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MONTELIONE GT, 1992, BIOCHEMISTRY-US, V31, P236, DOI 10.1021/bi00116a033; MONTELIONE GT, 1987, P NATL ACAD SCI USA, V84, P5226, DOI 10.1073/pnas.84.15.5226; OTWINOWSKI Z, 1993, OSCILLATION DATA RED, P56; PHILO J, 1994, J BIOL CHEM, V269, P27840; RICHTER A, 1995, J BIOL CHEM, V270, P1612, DOI 10.1074/jbc.270.4.1612; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Van Zoelen E J, 2000, Vitam Horm, V59, P99, DOI 10.1016/S0083-6729(00)59005-0; vandePoll MLM, 1997, BIOCHEMISTRY-US, V36, P7425, DOI 10.1021/bi970227f; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; 黄秉仁, 1998, 中国生物化学与分子生物学报, V14, P512	33	60	66	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34913	34917		10.1074/jbc.M102874200	http://dx.doi.org/10.1074/jbc.M102874200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11438527	hybrid			2022-12-27	WOS:000171024600076
J	Ueno, N; Murakami, M; Tanioka, T; Fujimori, K; Tanabe, T; Urade, Y; Kudo, I				Ueno, N; Murakami, M; Tanioka, T; Fujimori, K; Tanabe, T; Urade, Y; Kudo, I			Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN D-2 GENERATION; ENDOPEROXIDE-H SYNTHASE-1; ARACHIDONIC-ACID RELEASE; MAST-CELLS; PROSTACYCLIN SYNTHASE; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; E-2 BIOSYNTHESIS; GENE DISRUPTION; DELAYED PHASE	We have recently shown that two distinct prostaglandin (PG) E-2 synthases show preferential functional coupling with upstream cyclooxygenase (COX)-1 and COX-2 in PGE(2) biosynthesis. To investigate whether other lineage-specific PG synthases also show preferential coupling with either COX isozyme, we introduced these enzymes alone or in combination into 293 cells to reconstitute their functional interrelationship. As did the membrane-bound PGE2 synthase, the perinuclear enzymes thromboxane synthase and PGI(2) synthase generated their respective products via COX-2 in preference to COX-1 in both the A23187-induced immediate and interleukin-1-induced delayed responses. Hematopoietic PGD(2) synthase preferentially used COX-1 and COX-2 in the A23187-induced immediate and interleukin-1-induced delayed PGD(2)-biosynthetic responses, respectively. This enzyme underwent stimulus-dependent translocation from the cytosol to perinuclear compartments, where COX-1 or COX-2 exists. COX selectivity of these lineage-specific PG synthases was also significantly affected by the concentrations of arachidonate, which was added exogenously to the cells or supplied endogenously by the action of cytosolic or secretory phospholipase A(2). Collectively, the efficiency of coupling between COXs and specific PG synthases may be crucially influenced by their spatial and temporal compartmentalization and by the amount of arachidonate supplied by PLA(2)s at a moment when PG production takes place.	Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; Japan Sci & Technol Corp, CREST, Osaka Biosci Inst, Osaka 5650874, Japan; Natl Cardiovasc Ctr, Res Inst, Dept Pharmacol, Osaka 5658565, Japan	Showa University; Japan Science & Technology Agency (JST); National Cerebral & Cardiovascular Center - Japan	Murakami, M (corresponding author), Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.		Fujimori, Ko/AAD-5428-2021	Fujimori, Ko/0000-0002-2506-0769				Balsinde J, 2000, J IMMUNOL, V164, P5398, DOI 10.4049/jimmunol.164.10.5398; Balsinde J, 1999, J BIOL CHEM, V274, P25967, DOI 10.1074/jbc.274.37.25967; Beuckmann CT, 2000, NEUROCHEM RES, V25, P733, DOI 10.1023/A:1007579507804; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Bingham CO, 1996, J BIOL CHEM, V271, P25936, DOI 10.1074/jbc.271.42.25936; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660; CAPDEVILA JH, 1996, J BIOL CHEM, V271, P30041; Chen QR, 1997, J BIOL CHEM, V272, P5952, DOI 10.1074/jbc.272.9.5952; Clancy R, 2000, J IMMUNOL, V165, P1582, DOI 10.4049/jimmunol.165.3.1582; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; HARA S, 1994, J BIOL CHEM, V269, P19897; Harada Y, 1996, PROSTAG OTH LIPID M, V51, P19, DOI 10.1016/0090-6980(95)00168-9; Healy AM, 1999, J BIOL CHEM, V274, P29812, DOI 10.1074/jbc.274.42.29812; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; KULMACZ RJ, 1995, J BIOL CHEM, V270, P24019, DOI 10.1074/jbc.270.41.24019; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lin YZ, 1998, ARCH BIOCHEM BIOPHYS, V352, P78, DOI 10.1006/abbi.1998.0599; Liou JY, 2000, J BIOL CHEM, V275, P15314, DOI 10.1074/jbc.275.20.15314; Marnett LJ, 2000, J BIOL CHEM, V275, P13427, DOI 10.1074/jbc.275.18.13427; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; MIYATA A, 1994, BIOCHEM BIOPH RES CO, V200, P1728, DOI 10.1006/bbrc.1994.1652; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; MURAKAMI M, 1995, J IMMUNOL, V155, P4445; Murakami M, 1997, J BIOL CHEM, V272, P19891, DOI 10.1074/jbc.272.32.19891; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; MURAKAMI M, 1994, J BIOL CHEM, V269, P22269; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; MURAKAMI M, 1988, J BIOCHEM-TOKYO, V104, P884, DOI 10.1093/oxfordjournals.jbchem.a122577; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; Naraba H, 1998, J IMMUNOL, V160, P2974; OHASHI K, 1992, J BIOL CHEM, V267, P789; Penglis PS, 2000, J IMMUNOL, V165, P1605, DOI 10.4049/jimmunol.165.3.1605; Pinzar E, 2000, J BIOL CHEM, V275, P31239, DOI 10.1074/jbc.M000750200; REDDY ST, 1994, J BIOL CHEM, V269, P15473; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Shitashige M, 1998, BBA-LIPID LIPID MET, V1389, P57, DOI 10.1016/S0005-2760(97)00129-X; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Suzuki T, 1999, J BIOL CHEM, V274, P241, DOI 10.1074/jbc.274.1.241; Tada K, 1998, J IMMUNOL, V161, P5008; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Thoren S, 2000, EUR J BIOCHEM, V267, P6428, DOI 10.1046/j.1432-1327.2000.01735.x; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WATANABE K, 1985, J BIOL CHEM, V260, P7035	65	159	160	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34918	34927		10.1074/jbc.M100429200	http://dx.doi.org/10.1074/jbc.M100429200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11418589	hybrid			2022-12-27	WOS:000171024600077
J	Bishop, B; Koay, DC; Sartorelli, AC; Regan, L				Bishop, B; Koay, DC; Sartorelli, AC; Regan, L			Reengineering granulocyte colony-stimulating factor for enhanced stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPO RECEPTOR COMPLEX; HYDROPHOBIC CORE; 4-HELIX-BUNDLE PROTEIN; ALANINE SUBSTITUTIONS; PEPTIDE; DESIGN; DIFFERENTIATION; BINDING; HELICES; GLYCINE	Granulocyte colony-stimulating factor is a long-chain cytokine that has both biological and therapeutic applications. It is involved in the production and maturation of neutrophilic progenitor cells and neutrophils and is administered to stimulate the production of white blood cells to reduce the risk of serious infection in immunocompromised patients. We have reengineered granulocyte colony-stimulating factor to improve the thermodynamic stability of the protein, focusing on enhancing the alpha-helix propensity of residues in the antiparallel 4-helix bundle of the protein. These redesigns resulted in proteins with substantially enhanced stability while retaining wild-type levels of biological activity, measured as the ability of the reengineered proteins to stimulate the proliferation of murine myeloid cells transfected with the granulocyte colony-stimulating factor receptor.	Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ctr Canc, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ctr Canc, Dev Therapeut Program, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Regan, L (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.		Khanikaev, Alexander B/F-5438-2010	Khanikaev, Alexander B/0000-0002-7689-216X				Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; AUSUBEL FM, 1989, SHORT PROTOCOLS MOL, P3; BABIOR BM, 1994, HEMATOLOGY PATHOPHYS, P279; Baldwin E, 1996, J MOL BIOL, V259, P542, DOI 10.1006/jmbi.1996.0338; Ballinger MD, 1999, NAT BIOTECHNOL, V17, P1199, DOI 10.1038/70746; BLABER M, 1995, J MOL BIOL, V246, P317, DOI 10.1006/jmbi.1994.0087; Chaiken IM, 1996, TRENDS BIOTECHNOL, V14, P369, DOI 10.1016/0167-7799(96)10050-0; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; DEMETRI GD, 1991, BLOOD, V78, P2791; Domingues H, 1999, NAT STRUCT BIOL, V6, P652; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; GANTER C, 1990, BIOCHEMISTRY-US, V29, P9395, DOI 10.1021/bi00492a013; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; HARBURY PB, 1995, P NATL ACAD SCI U S, V92, P3408; HECHT M H, 1986, Proteins Structure Function and Genetics, V1, P43, DOI 10.1002/prot.340010108; KITA Y, 1994, BIOCHEMISTRY-US, V33, P15178, DOI 10.1021/bi00254a029; Koay DC, 1999, BLOOD, V93, P3774, DOI 10.1182/blood.V93.11.3774.411a31_3774_3784; Kolvenbach CG, 1997, J PEPT RES, V50, P310; Lauffenburger DA, 1998, CHEM BIOL, V5, pR257, DOI 10.1016/S1074-5521(98)90110-7; LEE KH, 1991, J EXP MED, V173, P1257, DOI 10.1084/jem.173.5.1257; LI JM, 1993, J CELL BIOL, V120, P1481, DOI 10.1083/jcb.120.6.1481; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; LIM WA, 1991, J MOL BIOL, V219, P359, DOI 10.1016/0022-2836(91)90570-V; LIM WA, 1994, P NATL ACAD SCI USA, V91, P423, DOI 10.1073/pnas.91.1.423; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; MARGARIT I, 1992, PROTEIN ENG, V5, P543, DOI 10.1093/protein/5.6.543; MARQUSEE S, 1991, Current Biology, V1, P207, DOI 10.1016/0960-9822(91)90057-4; MOTT HR, 1995, CURR OPIN STRUC BIOL, V5, P114, DOI 10.1016/0959-440X(95)80016-T; MUNOZ V, 1994, PROTEINS, V20, P301, DOI 10.1002/prot.340200403; MUNSON M, 1994, PROTEIN SCI, V3, P2015, DOI 10.1002/pro.5560031114; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PREDKI PF, 1995, CELL, V80, P41, DOI 10.1016/0092-8674(95)90449-2; Predki PF, 1996, NAT STRUCT BIOL, V3, P54, DOI 10.1038/nsb0196-54; Quan C, 1998, BIOPOLYMERS, V47, P265, DOI 10.1002/(SICI)1097-0282(1998)47:4<265::AID-BIP2>3.0.CO;2-K; ReidhaarOlson JF, 1996, BIOCHEMISTRY-US, V35, P9034, DOI 10.1021/bi952705x; Rohl CA, 1999, P NATL ACAD SCI USA, V96, P3682, DOI 10.1073/pnas.96.7.3682; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; Young DC, 1997, PROTEIN SCI, V6, P1228, DOI 10.1002/pro.5560060611; ZINK T, 1994, BIOCHEMISTRY-US, V33, P8453, DOI 10.1021/bi00194a009; [No title captured]	50	48	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33465	33470		10.1074/jbc.M104494200	http://dx.doi.org/10.1074/jbc.M104494200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11406632	hybrid			2022-12-27	WOS:000170910200025
J	Castrillo, A; Mojena, M; Hortelano, S; Bosca, L				Castrillo, A; Mojena, M; Hortelano, S; Bosca, L			Peroxisome proliferator-activated receptor-gamma-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449 - Comparison with the effects of 15-deoxy-Delta(12,14)-prostaglandin J(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; PPAR-GAMMA; CYCLOPENTENONE PROSTAGLANDINS; BACTERIAL LIPOPOLYSACCHARIDE; TERMINAL KINASE; IN-VITRO; APOPTOSIS; ALPHA; INFLAMMATION	The effects of L-796,449 (3-chloro-4-(3-(3-phenyl-7-propylbenzofuran-6-yloxy)propylthio)phenylacetic acid; referred to henceforth as compound G), a thiazolidinedione-unrelated peroxisome proliferator activated-receptor-gamma (PPAR-gamma) agonist, on early signaling in lipopolysaccharide-activated RAW 264.7 macrophages were analyzed and compared with those elicited by 15-deoxy-Delta (12,14)-prostaglandin J(2) and the thiazolidinedione rosiglitazone. Compound G inhibited the activation of nuclear factor kappaB through the impairment of the targeting and degradation of I kappaB proteins and promoted a redistribution of I kappaB alpha and I kappaB beta in the nucleus of activated cells. Compound G inhibited I kappaB kinase (IKK) activity both in vivo and in vitro, suggesting a direct mechanism of interaction between this molecule and the IKK complex. The effect of compound G on IKK activity was independent of PPAR-gamma engagement because RAW 264.7 cells expressed negligible levels of this nuclear receptor, and rosiglitazone failed to mimic these actions. Moreover, treatment of activated macrophages with compound G enhanced the synthesis of superoxide anion, which, in combination with the NO produced under activation conditions, triggered apoptosis through the intracellular synthesis of peroxynitrite. These results suggest that compound G might contribute to the resolution of inflammation by favoring the induction of apoptosis through mechanisms independent of PPAR-gamma engagement.	Univ Complutense Madrid, Fac Farm, CSIC, Ctr Mixto,Inst Bioquim, E-28040 Madrid, Spain; Merck Sharp & Dohme Ltd, CIBE, Madrid 28027, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Merck & Company	Bosca, L (corresponding author), Univ Complutense Madrid, Fac Farm, CSIC, Ctr Mixto,Inst Bioquim, E-28040 Madrid, Spain.		Bosca, Lisardo/A-2059-2008; Hortelano, Sonsoles/A-7954-2010	Bosca, Lisardo/0000-0002-0253-5469; Hortelano, Sonsoles/0000-0003-2528-0072; Mojena, Marina/0000-0002-5371-8118				Albina JE, 1998, CANCER METAST REV, V17, P39, DOI 10.1023/A:1005904704618; Anderson GP, 1996, TRENDS PHARMACOL SCI, V17, P438, DOI 10.1016/S0165-6147(96)01004-8; Berger J, 1999, J BIOL CHEM, V274, P6718, DOI 10.1074/jbc.274.10.6718; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Castrillo A, 2000, MOL CELL BIOL, V20, P1692, DOI 10.1128/MCB.20.5.1692-1698.2000; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung SW, 2000, J BIOL CHEM, V275, P32681, DOI 10.1074/jbc.M002577200; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; DiazGuerra MJM, 1996, J BIOL CHEM, V271, P30114, DOI 10.1074/jbc.271.47.30114; Eguchi Y, 1997, P NATL ACAD SCI USA, V94, P14689, DOI 10.1073/pnas.94.26.14689; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Glass CK, 2000, GENE DEV, V14, P121; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; Harada-Shiba M, 1998, J BIOL CHEM, V273, P9681, DOI 10.1074/jbc.273.16.9681; Hortelano S, 2000, J IMMUNOL, V165, P6525, DOI 10.4049/jimmunol.165.11.6525; Hortelano S, 1999, BRIT J PHARMACOL, V126, P1139, DOI 10.1038/sj.bjp.0702422; Hortelano S, 1997, FEBS LETT, V410, P373, DOI 10.1016/S0014-5793(97)00623-6; Hortelano S, 1999, FASEB J, V13, P2311, DOI 10.1096/fasebj.13.15.2311; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kawahito Y, 2000, J CLIN INVEST, V106, P189, DOI 10.1172/JCI9652; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Procyk KJ, 2000, BLOOD, V96, P2592; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Ricote M, 1999, J LEUKOCYTE BIOL, V66, P733, DOI 10.1002/jlb.66.5.733; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Thieringer R, 2000, J IMMUNOL, V164, P1046, DOI 10.4049/jimmunol.164.2.1046; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Tontonoz P, 1999, CURR OPIN LIPIDOL, V10, P485, DOI 10.1097/00041433-199912000-00002; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; XIE QW, 1994, J BIOL CHEM, V269, P4705; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	54	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34082	34088		10.1074/jbc.M102472200	http://dx.doi.org/10.1074/jbc.M102472200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11438523	hybrid			2022-12-27	WOS:000170910200106
J	Farzaneh-Far, A; Davies, JD; Braam, LA; Spronk, HM; Proudfoot, D; Chan, SW; O'Shaughnessy, KM; Weissberg, PL; Vermeer, C; Shanahan, CM				Farzaneh-Far, A; Davies, JD; Braam, LA; Spronk, HM; Proudfoot, D; Chan, SW; O'Shaughnessy, KM; Weissberg, PL; Vermeer, C; Shanahan, CM			A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; GLA PROTEIN; C-FOS; VASCULAR CALCIFICATION; MOUSE KERATINOCYTES; REGULATING PROTEINS; EXPRESSION; GENE; CALCIUM; JUN	Matrix gamma -carboxyglutamic acid protein (MGP) is a mineral-binding extracellular matrix protein synthesized by vascular smooth muscle cells (VSMCs) and chondrocytes that is thought to be a key regulator of tissue calcification. In this study, we identified four polymorphisms in the promoter region of the human MGP gene. Transfection studies showed that the G-7A and T-138C polymorphisms have an important impact on in vitro promoter activity when transiently transfected into VSMCs. We found that one of these polymorphisms (T-138C) is significantly correlated with serum MGP levels in human subjects. Promoter deletion analysis showed that this polymorphism lies in a region of the promoter critical for transcription in VSMCs. This region contains a potential activating protein-1 (AP-1) binding element located between -142 and -136. We have demonstrated that the T-138C polymorphism results in altered binding of an AP-1 complex to this region. The -138T allelic variant binds AP-1 complexes consisting primarily of c-Jun, JunB and its partners Fra-1 and Fra-2 in rat VSMC. Furthermore, the -138T variant form of the promoter was induced following phorbol 12-myristate 13-acetate treatment, while the -138C variant was refractive to phorbol 12-myristate 13-acetate treatment, confirming that AP-1 factors preferentially bind to the -138T variant. This study therefore suggests that a common polymorphism of the MGP promoter influences binding of the AP-1 complex, which may lead to altered transcription and serum levels. This could have important implications for diseases such as atherosclerosis and aortic valve stenosis, since it strongly suggests a genetic basis for regulation of tissue calcification.	Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; Univ Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; Univ Maastricht, Cardiovasc Res Inst, NL-6200 MD Maastricht, Netherlands	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Maastricht University; Maastricht University	Farzaneh-Far, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, ACCI Level 6,Hills Rd, Cambridge CB2 2QQ, England.			Spronk, Henri/0000-0002-3858-334X				Braam LAJLM, 2000, ARTERIOSCL THROM VAS, V20, P1257, DOI 10.1161/01.ATV.20.5.1257; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Farzaneh-Far A, 2000, BIOCHEM BIOPH RES CO, V277, P736, DOI 10.1006/bbrc.2000.3747; Farzaneh-Far A, 2001, Z Kardiol, V90 Suppl 3, P38; Farzaneh-Far A, 2001, HEART, V85, P13, DOI 10.1136/heart.85.1.13; GRAINGER DJ, 1991, BIOCHEM J, V277, P145, DOI 10.1042/bj2770145; Herrmann SM, 2000, ARTERIOSCL THROM VAS, V20, P2386, DOI 10.1161/01.ATV.20.11.2386; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KERPPOLA TK, 1994, ONCOGENE, V9, P3149; Kirfel J, 1997, P NATL ACAD SCI USA, V94, P2227, DOI 10.1073/pnas.94.6.2227; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mohler ER, 2000, LANCET, V356, P524, DOI 10.1016/S0140-6736(00)02572-1; Neuman W.F., 1980, FUNDAMENTAL CLIN BON; Ng DC, 2000, J BIOL CHEM, V275, P24080, DOI 10.1074/jbc.M002508200; PRICE PA, 1985, J BIOL CHEM, V260, P4971; Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379; Rutberg SE, 1997, ONCOGENE, V15, P1337, DOI 10.1038/sj.onc.1201293; Rutberg SE, 1996, ONCOGENE, V13, P167; Schinke T, 1999, NAT GENET, V21, P150, DOI 10.1038/5928; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shanahan CM, 1998, CRIT REV EUKAR GENE, V8, P357, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.60; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	32	92	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32466	32473		10.1074/jbc.M104909200	http://dx.doi.org/10.1074/jbc.M104909200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11425864	hybrid			2022-12-27	WOS:000170746000014
J	Adachi, J; Mori, Y; Matsui, S; Takigami, H; Fujino, J; Kitagawa, H; Miller, CA; Kato, T; Saeki, K; Matsuda, T				Adachi, J; Mori, Y; Matsui, S; Takigami, H; Fujino, J; Kitagawa, H; Miller, CA; Kato, T; Saeki, K; Matsuda, T			Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AH RECEPTOR; CELL-CYCLE; RETINOBLASTOMA PROTEIN; HEPATOMA-CELLS; INDUCTION; CYP1A1; CYTOCHROME-P450; TRANSCRIPTION	Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates genes involved in xenobiotic metabolism, cellular proliferation, and differentiation. Numerous xenobiotic and biological compounds are known to interact with AhR, but it remains an orphan receptor, because its physiological ligand is unknown. We identified AhR ligands in human urine using a yeast AhR signaling assay and then characterized their properties. Two ligands, indirubin and indigo, were both present at average concentrations of similar to0.2 ml in the urine of normal donors. Indirubin was also detected in fetal bovine serum and contributed half of the total AhR ligand activity. The activities of indirubin and indigo were comparable with or more potent than that of the archetypal ligand, 2,3,7,8-tetrachlorodibenzo-p-dioxin, in yeast AhR activation assays. We suggest that the endogenous levels and potencies of indirubin and indigo are such that they activate AhR-mediated signaling mechanisms in vivo.	Kyoto Univ, Res Ctr Environm Qual Control, Otsu, Shiga 5200811, Japan; Kyoto Univ, Dept Environm Engn, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan; Tulane Univ, Sch Publ Hlth & Trop Med, Dept Environm Hlth Sci, New Orleans, LA 70112 USA; Tulane Univ, Sch Publ Hlth & Trop Med, Tulane Xavier Ctr Bioenvironm Res, New Orleans, LA 70112 USA; Nagoya City Univ, Fac Pharmaceut Sci, Nagoya, Aichi 4678603, Japan	Kyoto University; Kyoto University; Tulane University; Tulane University; Xavier University of Louisiana; Nagoya City University	Matsuda, T (corresponding author), Kyoto Univ, Res Ctr Environm Qual Control, 1-2 Yumihama, Otsu, Shiga 5200811, Japan.		Miller, Charles A/I-3978-2019; Adachi, Jun/H-2813-2014	Miller, Charles A/0000-0003-0644-7455; Adachi, Jun/0000-0003-1220-3246	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES009055] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES09055] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BLANZ J, 1989, RES COMMUN CHEM PATH, V64, P145; CHEN YH, 1995, J BIOL CHEM, V270, P22548, DOI 10.1074/jbc.270.38.22548; Ge NL, 1998, J BIOL CHEM, V273, P22708, DOI 10.1074/jbc.273.35.22708; Gillam EMJ, 2000, BIOCHEMISTRY-US, V39, P13817, DOI 10.1021/bi001229u; Gillam EMJ, 1999, BIOCHEM BIOPH RES CO, V265, P469, DOI 10.1006/bbrc.1999.1702; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; HAYATSU H, 1992, J CHROMATOGR, V597, P37, DOI 10.1016/0021-9673(92)80095-C; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; HUFF J, 1994, ANNU REV PHARMACOL, V34, P343; JACKSON AH, 1988, CLIN CHIM ACTA, V172, P245, DOI 10.1016/0009-8981(88)90330-0; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Miller CA, 1999, TOXICOL APPL PHARM, V160, P297, DOI 10.1006/taap.1999.8769; MILLER CA, 1997, J BIOL CHEM, V272, P32834; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Reiners JJ, 1999, CARCINOGENESIS, V20, P1561, DOI 10.1093/carcin/20.8.1561; RENNUG U, 1992, MUTAT RES, V282, P219; SAPIRA JD, 1971, METABOLISM, V20, P474, DOI 10.1016/0026-0495(71)90123-5; Savouret JF, 2001, J BIOL CHEM, V276, P3054, DOI 10.1074/jbc.M005988200; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Sinal CJ, 1997, MOL PHARMACOL, V52, P590, DOI 10.1124/mol.52.4.590; Sogawa K, 1997, J BIOCHEM, V122, P1075; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7	25	306	326	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31475	31478		10.1074/jbc.C100238200	http://dx.doi.org/10.1074/jbc.C100238200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11425848	hybrid			2022-12-27	WOS:000170613500001
J	Boettiger, D; Lynch, L; Blystone, S; Huber, F				Boettiger, D; Lynch, L; Blystone, S; Huber, F			Distinct ligand-binding modes for integrin alpha(v)beta(3)-mediated adhesion to fibronectin versus vitronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CYCLIC RGD PEPTIDES; CELL-ADHESION; CYTOPLASMIC DOMAIN; AFFINITY; ALPHA-5-BETA-1; ALPHA-V-BETA-3; RECEPTOR; CYTOSKELETON; ACTIVATION	Cell surface integrins can adopt distinct conformations in response to ligand binding and intracellular signals. Several integrins including alpha (v)beta (3). can bind to multiple ligands. The binding of alpha (v)beta (3) to fibronectin and vitronectin was used as a model to determine whether the same or distinct forms of the receptor were utilized in strong binding to the two different ligands. A spinning-dise device was used to measure the relative strength of the alpha (v)beta (3)-ligand bonds. The initial binding reaction for both ligands occurred in the absence of metabolic energy and resulted in a strong adhesion to fibronectin but a weak adhesion to vitronectin. Increases in the strength of the alpha (v)beta (3)-vitronectin bond required phosphorylation of the 13, cytoplasmic domain, intracellular signals, and the binding of cytoskeletal proteins to cytoplasmic domains of beta (3) controlled by Tyr-747 and Tyr-759. In contrast, alpha (v)beta (3)-mediated adhesion to fibronectin was unaffected by phorbol 12-myristate 13-acetate, mutations of Tyr-747 and Tyr-759 to phenylalanine, or availability of metabolic energy. This suggests that strong adhesion to fibronectin used the initial binding conformation, whereas strong binding to vitronectin required signaling-induced changes in the conformation of alpha (v)beta (3).	Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; SUNY Syracuse, Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY USA	University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Boettiger, D (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.		Huber, Francois/G-6245-2011		NATIONAL CANCER INSTITUTE [R01CA016502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057388] Funding Source: NIH RePORTER; NCI NIH HHS [CA16502] Funding Source: Medline; NIGMS NIH HHS [GM57388] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barillari G, 1999, BLOOD, V94, P663; Bennett JS, 1999, J BIOL CHEM, V274, P25301, DOI 10.1074/jbc.274.36.25301; Blystone SD, 1996, J BIOL CHEM, V271, P31458, DOI 10.1074/jbc.271.49.31458; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; BLYSTONE SD, 1995, J CELL BIOL, V130, P745, DOI 10.1083/jcb.130.3.745; Boettiger D, 2001, MOL BIOL CELL, V12, P1227, DOI 10.1091/mbc.12.5.1227; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; DENIS C, 1993, BLOOD, V82, P3622; ENOMOTOIWAMOTO M, 1993, CELL ADHES COMMUN, V1, P191, DOI 10.3109/15419069309097253; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2; Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710; Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2; Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; Locardi E, 1999, J PEPT SCI, V5, P491, DOI 10.1002/(SICI)1099-1387(199911)5:11<491::AID-PSC218>3.0.CO;2-8; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Nath D, 1999, J CELL SCI, V112, P579; Neff S, 1998, J VIROL, V72, P3587, DOI 10.1128/JVI.72.5.3587-3594.1998; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	38	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31684	31690		10.1074/jbc.M103997200	http://dx.doi.org/10.1074/jbc.M103997200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423542	hybrid			2022-12-27	WOS:000170613500030
J	Ciaffoni, F; Salvioli, R; Tatti, M; Arancia, G; Crateri, P; Vaccaro, AM				Ciaffoni, F; Salvioli, R; Tatti, M; Arancia, G; Crateri, P; Vaccaro, AM			Saposin D solubilizes anionic phospholipid-containing membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN A-I; L-ALPHA-DIMYRISTOYLPHOSPHATIDYLCHOLINE; ACTIVATOR PROTEIN-DEFICIENCY; PROSAPOSIN; COMPLEXES; VESICLES; DISEASE; GLUCOSYLCERAMIDASE; RECONSTITUTION; PATIENT	Saposin (Sap) D is a late endosomal/lysosomal small protein, generated together with three other similar proteins, Sap A, B, and C, from the common precursor, prosaposin. Although the functions of saposins such as Sap B and C are well known (Sap B promotes the hydrolysis of sulfatides and Sap C that of glucosylceramide), neither the physiological function nor the mechanism of action of Sap D are yet fully understood. We previously found that a dramatic increase of Sap D superficial hydrophobicity, occurring at the low pH values characteristic of the late endosomal/lysosomal environment, triggers the interaction of the saposin with anionic phospholipid-containing vesicles. We have presently found that, upon lipid binding, Sap D solubilizes the membranes, as shown by the clearance of the vesicles turbidity. The results of gel filtration, density gradient centrifugation, and negative staining electron microscopy demonstrate that this effect is due to the transformation of large vesicles to smaller particles. The solubilizing effect of Sap D is highly dependent on pH, the lipid/saposin ratio, and the presence of anionic phospholipids; small variations in each of these conditions markedly influences the activity of Sap D. The present study documents the interaction of Sap D with membranes as a complex process. Anionic phospholipids attract Sap D from the medium; when the concentration of the saposin on the lipid surface reaches a critical value, the membrane breaks down into recombinant small particles enriched in anionic phospholipids. Our results suggest that the role played by Sap D is more general than promoting sphingolipid degradation, e.g. the saposin might also be a key mediator of the solubilization of intralysosomal/late endosomal anionic phospholipidcontaining membranes.	Ist Super Sanita, Dept Metab & Pathol Biochem, I-00161 Rome, Italy; Ist Super Sanita, Dept Ultrastruct, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Vaccaro, AM (corresponding author), Ist Super Sanita, Dept Metab & Pathol Biochem, Viale Regina Elena 299, I-00161 Rome, Italy.		tatti, Massimo/N-1382-2017					AZUMA N, 1994, ARCH BIOCHEM BIOPHYS, V311, P354, DOI 10.1006/abbi.1994.1248; BRADOVA V, 1993, HUM GENET, V92, P143, DOI 10.1007/BF00219682; CHRISTOMANOU H, 1989, KLIN WOCHENSCHR, V67, P999, DOI 10.1007/BF01716064; FURST W, 1992, BIOCHIM BIOPHYS ACTA, V1126, P1, DOI 10.1016/0005-2760(92)90210-M; HARZER K, 1989, EUR J PEDIATR, V149, P31, DOI 10.1007/BF02024331; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; JONAS A, 1981, J BIOL CHEM, V256, P2420; JONAS A, 1980, J BIOL CHEM, V255, P2183; JONAS A, 1980, J BIOL CHEM, V255, P2190; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KLEIN A, 1994, BIOCHEM BIOPH RES CO, V200, P1440, DOI 10.1006/bbrc.1994.1612; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linke T, 2001, J BIOL CHEM, V276, P5760, DOI 10.1074/jbc.M006846200; MORIMOTO S, 1988, BIOCHEM BIOPH RES CO, V156, P403, DOI 10.1016/S0006-291X(88)80855-6; MUNFORD RS, 1995, J LIPID RES, V36, P1653; OBRIEN JS, 1995, FASEB J, V9, P681, DOI 10.1096/fasebj.9.8.7768361; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Salvioi R, 2000, FEBS LETT, V472, P17, DOI 10.1016/S0014-5793(00)01417-4; SANDHOFF K, 1995, METABOLIC MOL BASES, P2427; SCHLOTE W, 1991, EUR J PEDIATR, V150, P584, DOI 10.1007/BF02072213; SCHNABEL D, 1992, J BIOL CHEM, V267, P3312; SUREWICZ WK, 1986, J BIOL CHEM, V261, P6191; SWANEY JB, 1980, J BIOL CHEM, V255, P877; Tatti M, 1999, EUR J BIOCHEM, V263, P486, DOI 10.1046/j.1432-1327.1999.00521.x; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; Vaccaro AM, 1999, NEUROCHEM RES, V24, P307, DOI 10.1023/A:1022530508763; VACCARO AM, 1993, FEBS LETT, V336, P159, DOI 10.1016/0014-5793(93)81631-9; Vaccaro AM, 1995, J BIOL CHEM, V270, P30576, DOI 10.1074/jbc.270.51.30576; Vaccaro AM, 1997, J BIOL CHEM, V272, P16862, DOI 10.1074/jbc.272.27.16862; VACCARO AM, 1995, J BIOL CHEM, V270, P9953, DOI 10.1074/jbc.270.17.9953; VANDEURS B, 1993, EUR J CELL BIOL, V61, P208; WENGER DA, 1989, AM J MED GENET, V33, P255, DOI 10.1002/ajmg.1320330223	33	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31583	31589		10.1074/jbc.M102736200	http://dx.doi.org/10.1074/jbc.M102736200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11406625	hybrid			2022-12-27	WOS:000170613500017
J	Saparov, SM; Kozono, D; Rothe, U; Agre, P; Pohl, P				Saparov, SM; Kozono, D; Rothe, U; Agre, P; Pohl, P			Water and ion permeation of aquaporin-1 in planar lipid bilayers - Major differences in structural determinants and stoichiometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL CHIP28 PROTEIN; HUMAN RED-CELLS; UNSTIRRED LAYERS; XENOPUS OOCYTES; PH PROFILES; CHANNEL; PERMEABILITY; TRANSPORT; MEMBRANE; EXPRESSION	The aquaporin-1 (AQP1) water channel protein is known to facilitate the rapid movement of water across cell membranes, but a proposed secondary role as an ion channel is still unsettled. Here we describe a method to simultaneously measure water permeability and ion conductance of purified human AQP1 after reconstitution into planar lipid bilayers. Water permeability was determined by measuring Na+ concentrations adjacent to the membrane. Comparisons with the known single channel water permeability of AQP1 indicate that the planar lipid bilayers contain from 10(6) to 10(7) water channels. Addition of cGMP induced ion conductance in planar bilayers containing AQP1, whereas cAMP was without effect. The number of water channels exceeded the number of active ion channels by approximately 1 million-fold, yet p-chloromethylbenzenesulfonate inhibited the water permeability but not ion conductance. Identical ion channel parameters were achieved with AQP1 purified from human red blood cells or AQP1 heterologously expressed in Saccharomyces cerevisae and affinity purified with either N- or C-terminal poly-histidine tags. Rp-8-Br-cGMP inhibited all of the observed conductance levels of the cation selective channel (2, 6, and 10 pS in 100 mM Na+ or K+). Deletion of the putative cGMP binding motif at the C terminus by introduction of a stop codon at position 237 yielded a truncated AQP1 protein that was still permeated by water but not by ions. Our studies demonstrate a method for simultaneously measuring water permeability and ion conductance of AQP1 reconstituted into planar lipid bilayers. The ion conductance occurs (i) through a pathway distinct from the aqueous pathway, (ii) when stimulated directly by cGMP, and (iii) in only an exceedingly small fraction of AQP1 molecules.	Forschungsinst Mol Pharmakol, Nachwuchsgrp Biophys, D-13125 Berlin, Germany; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Univ Halle Wittenberg, Fak Med, Inst Physiol Chem, D-06097 Halle, Germany	Johns Hopkins University; Johns Hopkins University; Martin Luther University Halle Wittenberg	Agre, P (corresponding author), Forschungsinst Mol Pharmakol, Nachwuchsgrp Biophys, Robert Rossle Str 10, D-13125 Berlin, Germany.	pagre@bs.jhmi.edu; pohl@fmp-berlin.de	Pohl, Peter/A-5361-2008	Pohl, Peter/0000-0002-1792-2314	NEI NIH HHS [EY11239] Funding Source: Medline; NHLBI NIH HHS [HL48268, HL33991] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033991, R01HL048268, R37HL048268] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agre P, 1997, SCIENCE, V275, P1490, DOI 10.1126/science.275.5305.1490; Agre P, 1999, Methods Enzymol, V294, P550; Amman D., 1986, ION SELECTIVE MICROE; Anthony TL, 2000, MOL PHARMACOL, V57, P576, DOI 10.1124/mol.57.3.576; ANTONENKO YN, 1993, BIOPHYS J, V64, P1701, DOI 10.1016/S0006-3495(93)81542-X; Cho MR, 1999, BIOPHYS J, V76, P1136, DOI 10.1016/S0006-3495(99)77278-4; Coury LA, 1998, AM J PHYSIOL-RENAL, V274, pF34, DOI 10.1152/ajprenal.1998.274.1.F34; DAINTY J, 1966, J PHYSIOL-LONDON, V182, P66, DOI 10.1113/jphysiol.1966.sp007809; DEAMER DW, 1986, CHEM PHYS LIPIDS, V40, P167, DOI 10.1016/0009-3084(86)90069-1; Duquette PP, 2001, P NATL ACAD SCI USA, V98, P3796, DOI 10.1073/pnas.071245198; FETTIPLACE R, 1980, PHYSIOL REV, V60, P510, DOI 10.1152/physrev.1980.60.2.510; Finkelstein A., 1987, WATER MOVEMENT LIPID; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; HANAI T, 1966, J THEOR BIOL, V11, P370, DOI 10.1016/0022-5193(66)90099-3; Hill AE, 1995, INT REV CYTOL, V163, P1, DOI 10.1016/S0074-7696(08)62208-1; JANSEN M, 1995, BIOPHYS J, V68, P997, DOI 10.1016/S0006-3495(95)80275-4; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; JUNG JS, 1994, J BIOL CHEM, V269, P14648; King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304; Lear JD, 1997, J AM CHEM SOC, V119, P3212, DOI 10.1021/ja9629672; Loo DDF, 1996, P NATL ACAD SCI USA, V93, P13367, DOI 10.1073/pnas.93.23.13367; Loo DDF, 1999, J PHYSIOL-LONDON, V518, P195, DOI 10.1111/j.1469-7793.1999.0195r.x; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MACEY RI, 1970, BIOCHIM BIOPHYS ACTA, V211, P104, DOI 10.1016/0005-2736(70)90130-6; Miller C, 1997, NATURE, V389, P328, DOI 10.1038/38599; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; PATTUS F, 1978, BIOCHIM BIOPHYS ACTA, V507, P62, DOI 10.1016/0005-2736(78)90374-7; Pohl P, 1997, BIOPHYS J, V72, P1711, DOI 10.1016/S0006-3495(97)78817-9; POHL P, 1993, BIOCHIM BIOPHYS ACTA, V1152, P155, DOI 10.1016/0005-2736(93)90242-R; Pohl P, 2000, BIOPHYS J, V78, P2426, DOI 10.1016/S0006-3495(00)76786-5; Pohl P, 1998, BIOPHYS J, V75, P1403, DOI 10.1016/S0006-3495(98)74058-5; POHL P, 2001, IN PRESS P NATL ACAD; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Saparov SM, 2000, BIOPHYS J, V79, P2526, DOI 10.1016/S0006-3495(00)76493-9; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHINDLER H, 1989, METHOD ENZYMOL, V171, P225; SCHINDLER H, 1979, BIOCHIM BIOPHYS ACTA, V555, P316, DOI 10.1016/0005-2736(79)90171-8; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Spring KR, 1999, NEWS PHYSIOL SCI, V14, P92; Sui HX, 2000, ACTA CRYSTALLOGR D, V56, P1198, DOI 10.1107/S0907444900008143; Unger VM, 2000, NAT STRUCT BIOL, V7, P1082, DOI 10.1038/81914; Vallon V, 2000, AM J PHYSIOL-RENAL, V278, pF1030, DOI 10.1152/ajprenal.2000.278.6.F1030; WALZ T, 1994, J BIOL CHEM, V269, P1583; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002	51	95	102	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31515	31520		10.1074/jbc.M104267200	http://dx.doi.org/10.1074/jbc.M104267200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11410596	hybrid			2022-12-27	WOS:000170613500008
J	Smith, ER; Smedberg, JL; Rula, ME; Hamilton, TC; Xu, XX				Smith, ER; Smedberg, JL; Rula, ME; Hamilton, TC; Xu, XX			Disassociation of MAPK activation and c-Fos expression in F9 embryonic carcinoma cells following retinoic acid-induced endoderm differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN ADENOCARCINOMA CELLS; GROWTH-FACTOR; TARGETED DISRUPTION; PROTEIN PHOSPHATASE; SIGNAL-TRANSDUCTION; PARIETAL ENDODERM; TRANSCRIPTION; KINASE; GENE; DOMAIN	Retinoic, acid induces cell differentiation and suppresses cell growth in a wide spectrum of cell lines, and down-regulation of activator protein-1 activity by retinoic acid contributes to these effects. In embryonic stem cell-like F9 teratocarcinoma cells, which are widely used to study retinoic acid actions on gene regulation and early embryonic differentiation, retinoic acid treatment for 4 days resulted in suppression of cell growth and differentiation into primitive and then visceral endoderm-like cells, accompanied by a suppression of serum-induced c-Fos expression. The ALAPK (ERK) pathway was involved in mitogenic signaling in F9 cells stimulated with serum. Surprisingly, although c-Fos expression was reduced, the MAPK activity was not decreased by retinoic acid treatment. We found that retinoic acid treatment inhibited the phosphorylation of Elk-1, a target of activated MAPK required for c-Fos transcription. In F9 cells, the MAPK/MEK inhibitor PD98059 suppressed Elk-1 phosphorylation and c-Fos expression, indicating that MAPK activity is required for Elk-1 phosphorylation/activation. Phosphoprotein phosphatase 2B (calcineurin), the major phosphatase for activated Elk-1, is not the target in the disassociation of MAPK activation and c-Fos expression since its inhibition by cyclosporin A or activation by ionomycin had no significant effects on serum-stimulated c-Fos expression and Elk-1 phosphorylation. Thus, we conclude that retinoic acid treatment to induce F9 cell differentiation uncouples Ras/MAPK activation from c-Fos expression by reduction of Elk-1 phosphorylation through a mechanism not involving the activation of phosphoprotein phosphatase 2B.	Fox Chase Canc Ctr, Div Med Sci, Ovarian Canc Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Xu, XX (corresponding author), Fox Chase Canc Ctr, Div Med Sci, Ovarian Canc Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	X_XU@fccc.edu			NATIONAL CANCER INSTITUTE [R01CA079716, P50CA083638, R01CA075389] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA83638, R01 CA79716, CA75389] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Arteaga CL, 1996, CANCER RES, V56, P1098; Brown JR, 1998, MOL CELL BIOL, V18, P5609, DOI 10.1128/MCB.18.9.5609; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chen YC, 1999, ONCOGENE, V18, P139, DOI 10.1038/sj.onc.1202272; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Cho SY, 1999, MOL CELLS, V9, P179; Clements D, 2001, INT REV CYTOL, V203, P383; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; CURRAN T, 1985, CANCER SURV, V4, P655; DE LUCA LM, 1991, FASEB J, V5, P2924; EDWARDS SA, 1988, DEV BIOL, V129, P91, DOI 10.1016/0012-1606(88)90164-9; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Faria TN, 1998, MOL CELL ENDOCRINOL, V143, P155, DOI 10.1016/S0303-7207(98)00127-0; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Gajovic S, 1998, EXP CELL RES, V242, P138, DOI 10.1006/excr.1998.4058; GREEN JBA, 1990, BIOESSAYS, V12, P437, DOI 10.1002/bies.950120907; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Han GR, 1997, J BIOL CHEM, V272, P13711, DOI 10.1074/jbc.272.21.13711; HE J, 2001, IN PRESS J BIOL CHEM, V276; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; HOGAN BLM, 1981, NATURE, V291, P235, DOI 10.1038/291235a0; Holt J, 1992, Cancer Treat Res, V63, P301; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Iwata A, 2001, J NEUROCHEM, V77, P239, DOI 10.1046/j.1471-4159.2001.t01-1-00232.x; JAFFEY P, 1992, CANCER RES, V52, P2384; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; LEVI BZ, 1988, CELL DIFFER DEV, V25, P95, DOI 10.1016/0922-3371(88)90105-0; Lin F, 2000, CANCER RES, V60, P3271; LOCKETT TJ, 1987, EXP CELL RES, V173, P370, DOI 10.1016/0014-4827(87)90277-1; Maden M, 1999, BIOESSAYS, V21, P809, DOI 10.1002/(SICI)1521-1878(199910)21:10<809::AID-BIES2>3.0.CO;2-0; MARTIN CA, 1990, MOL CELL ENDOCRINOL, V71, P27, DOI 10.1016/0303-7207(90)90071-F; MASON I, 1985, DIFFERENTIATION, V30, P76, DOI 10.1111/j.1432-0436.1985.tb00516.x; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; McCaffery P, 2000, CYTOKINE GROWTH F R, V11, P233, DOI 10.1016/S1359-6101(00)00002-2; Minucci S, 1996, CURR OPIN GENET DEV, V6, P567, DOI 10.1016/S0959-437X(96)80085-2; Mok SC, 1998, ONCOGENE, V16, P2381, DOI 10.1038/sj.onc.1201769; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrisey EE, 2000, J BIOL CHEM, V275, P19949, DOI 10.1074/jbc.M001331200; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; MULLER R, 1985, BIOCHIM BIOPHYS ACTA, V823, P207; Ozeki A, 1999, BBA-MOL CELL RES, V1450, P308, DOI 10.1016/S0167-4889(99)00063-4; PAWSON T, 1993, DEV GENET, V14, P333, DOI 10.1002/dvg.1020140502; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; SHERMAN MI, 1978, DEV BIOL, V63, P27, DOI 10.1016/0012-1606(78)90110-0; Soprano DR, 1996, ONCOGENE, V12, P577; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; TANAKA S, 1993, J BIOL CHEM, V268, P8862; Tian JM, 1999, J BIOL CHEM, V274, P15173, DOI 10.1074/jbc.274.21.15173; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; Verheijen MHG, 1999, J BIOL CHEM, V274, P1487, DOI 10.1074/jbc.274.3.1487; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Wu SJ, 1997, EXP CELL RES, V232, P277, DOI 10.1006/excr.1997.3495; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Xu XX, 1998, ONCOGENE, V16, P1561, DOI 10.1038/sj.onc.1201678; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; YANG-YEN H-F, 1990, New Biologist, V2, P351; Zhao CM, 1999, J BIOL CHEM, V274, P19649, DOI 10.1074/jbc.274.28.19649	71	26	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32094	32100		10.1074/jbc.M105009200	http://dx.doi.org/10.1074/jbc.M105009200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11402055	hybrid			2022-12-27	WOS:000170613500085
J	Davey, GE; Murmann, P; Heizmann, CW				Davey, GE; Murmann, P; Heizmann, CW			Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; GLYCATION END-PRODUCTS; IN-VITRO; CULTURED ASTROCYTES; S100-BETA PROTEIN; NEURITE EXTENSION; RECEPTOR; SURVIVAL; PHOSPHORYLATION; PROLIFERATION	In recent years, protein translocation has been implicated as the mechanism that controls assembly of signaling complexes and induction of signaling cascades. Several members of the multifunctional Ca2+ (Zn2+ - and Cu2+)-binding S100 proteins appear to translocate upon cellular stimulation, and some are even secreted from cells, exerting extracellular functions. We transfected cells with S100B-green fluorescent fusion proteins and followed the relocation in real time. A small number of cells underwent translocation spontaneously. However, the addition of thapsigargin, which increases Ca2+ levels, intensified ongoing translocation and secretion or induced these processes in resting cells. On the other hand, EGTA or BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N ' ,N ' -tetraacetic acid), the Ca2+-chelating agents, inhibited these processes. In contrast, relocation of S100B seemed to be negatively dependent on Zn2+ levels. Treatment of cells with TPEN (NNN ' ,N ' -tetrakis(2-pyridylmethyl)ethylenediamine), a Zn2+-binding drug, resulted in a dramatic redistribution and translocation of S100B. Secretion of S100B, when measured by ELISA, was dependent on cell density. As cells reached confluence the secretion drastically declined. However, an increase in Ca2+ levels, and even more so, a decrease in Zn2+ concentration, reactivated secretion of S100B. On the other hand, secretion did not decrease by treatment with brefeldin A, supporting the view that this process is independent of the endoplasmic reticulum-Golgi classical secretion pathway.	Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland	University of Zurich	Heizmann, CW (corresponding author), Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	heizmann@kispi.unizh.ch						Alexanian AR, 1999, FASEB J, V13, P1611, DOI 10.1096/fasebj.13.12.1611; Barber KR, 1999, J BIOL CHEM, V274, P1502, DOI 10.1074/jbc.274.3.1502; BARGER SW, 1992, J BIOL CHEM, V267, P9689; BAUDIER J, 1986, J BIOL CHEM, V261, P8192; BHATTACHARYYA A, 1992, J NEUROBIOL, V23, P451, DOI 10.1002/neu.480230410; Camby I, 1996, NEUROPEPTIDES, V30, P433, DOI 10.1016/S0143-4179(96)90006-2; CARON JM, 1985, NATURE, V317, P648, DOI 10.1038/317648a0; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; Curry BJ, 1999, MELANOMA RES, V9, P557, DOI 10.1097/00008390-199912000-00004; Davey GE, 2000, BBA-MOL CELL RES, V1498, P220, DOI 10.1016/S0167-4889(00)00098-7; De Hauwer C, 1998, J NEUROBIOL, V37, P373, DOI 10.1002/(SICI)1097-4695(19981115)37:3<373::AID-NEU3>3.0.CO;2-H; DeHauwer C, 1997, BIOCHEM BIOPH RES CO, V232, P267, DOI 10.1006/bbrc.1997.6291; Deloulme JC, 2000, J BIOL CHEM, V275, P35302, DOI 10.1074/jbc.M003943200; Delphin C, 1999, J BIOL CHEM, V274, P10539, DOI 10.1074/jbc.274.15.10539; DIARRA A, 1992, PFLUG ARCH EUR J PHY, V422, P40, DOI 10.1007/BF00381511; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Gattaz WF, 2000, SCHIZOPHR RES, V43, P91, DOI 10.1016/S0920-9964(99)00146-2; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Goncalves DS, 2000, NEUROREPORT, V11, P807, DOI 10.1097/00001756-200003200-00030; Griffin WST, 1998, NEUROBIOL AGING, V19, P401, DOI 10.1016/S0197-4580(98)00074-8; GROMADA J, 1995, FEBS LETT, V360, P303, DOI 10.1016/0014-5793(95)00131-R; Hack NJ, 2000, J NEUROSCI METH, V95, P177, DOI 10.1016/S0165-0270(99)00178-8; Hauschild A, 1999, MELANOMA RES, V9, P155, DOI 10.1097/00008390-199904000-00008; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hu JR, 1996, BBA-MOL CELL RES, V1313, P239, DOI 10.1016/0167-4889(96)00095-X; Hu JR, 1999, BRAIN RES, V842, P46, DOI 10.1016/S0006-8993(99)01804-1; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ikura M, 2000, NAT STRUCT BIOL, V7, P525, DOI 10.1038/76721; Ilg EC, 1996, INT J CANCER, V68, P325, DOI 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7; Jareb M, 1997, J NEUROSCI, V17, P8955; Kilby PM, 1997, PROTEIN SCI, V6, P2494; Kimura K, 2000, INT J ONCOL, V16, P1125; KISS R, 1995, CYTOMETRY, V20, P118, DOI 10.1002/cyto.990200204; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Kursula P, 2000, MOL BRAIN RES, V76, P407, DOI 10.1016/S0169-328X(00)00018-8; Landriscina M, 2000, J BIOL CHEM, V275, P32753, DOI 10.1074/jbc.M002336200; Li YK, 2000, J NEUROCHEM, V74, P143; Li YK, 1998, J NEUROCHEM, V71, P1421; LIN LH, 1994, MOL BRAIN RES, V25, P297, DOI 10.1016/0169-328X(94)90165-1; Mandinova A, 1998, J CELL SCI, V111, P2043; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; Meplan C, 2000, ONCOGENE, V19, P5227, DOI 10.1038/sj.onc.1203907; Meyer T, 2000, TRENDS CELL BIOL, V10, P238, DOI 10.1016/S0962-8924(00)01764-5; Mueller A, 1999, HISTOCHEM CELL BIOL, V111, P453, DOI 10.1007/s004180050381; Passey RJ, 1999, J LEUKOCYTE BIOL, V66, P549, DOI 10.1002/jlb.66.4.549; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; Platt-Higgins AM, 2000, INT J CANCER, V89, P198, DOI 10.1002/(SICI)1097-0215(20000320)89:2<198::AID-IJC16>3.0.CO;2-L; Rammes A, 1997, J BIOL CHEM, V272, P9496; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Scotto C, 1999, MOL CELL BIOL, V19, P7168; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SHENG JG, 1994, J NEUROSCI RES, V39, P398, DOI 10.1002/jnr.490390406; Sheng JG, 2000, J NEUROCHEM, V74, P295, DOI 10.1046/j.1471-4159.2000.0740295.x; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Sorci G, 2000, NEUROSCIENCE, V99, P773, DOI 10.1016/S0306-4522(00)00238-4; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; VANELDIK LJ, 1991, BRAIN RES, V542, P280, DOI 10.1016/0006-8993(91)91579-P; Wang GZ, 2000, J BIOL CHEM, V275, P11141, DOI 10.1074/jbc.275.15.11141; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Xiong ZG, 2000, EXP CELL RES, V257, P281, DOI 10.1006/excr.2000.4902; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009; Zhang ZY, 1999, J BIOL CHEM, V274, P25093, DOI 10.1074/jbc.274.35.25093; ZHU XY, 1999, CRC METH SIG TRANS, P129	72	81	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30819	30826		10.1074/jbc.M103541200	http://dx.doi.org/10.1074/jbc.M103541200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402046	hybrid			2022-12-27	WOS:000170472900033
J	Hohl, M; Christensen, O; Kunz, C; Naegeli, H; Fleck, O				Hohl, M; Christensen, O; Kunz, C; Naegeli, H; Fleck, O			Binding and repair of mismatched DNA mediated by Rhp14, the fission yeast homologue of human XPA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCISION-REPAIR; SCHIZOSACCHAROMYCES-POMBE; DAMAGE-RECOGNITION; GENE; PROTEIN; MUTATIONS; ADDUCTS; RECOMBINATION; INVOLVEMENT; NUCLEASE	Rhp14 of Schizosaccharomyces pombe is homologous to human XPA and Saccharomyces cerevisiae Rad14, which act in nucleotide excision repair of DNA damages induced by ultraviolet light and chemical agents. Cells with disrupted rhp14 were highly sensitive to ultraviolet light, and epistasis analysis with swi10 (nucleotide excision repair) and rad2 (Uve1-dependent ultraviolet light damage repair pathway) revealed that Rhp14 is an important component of nucleotide excision repair for ultraviolet light-induced damages. Moreover, defective rhp14 caused instability of a GT repeat, similar to swi10 and synergistically with msh2 and exo10. Recombinant Rhp14 with an N-terminal hexahistidine tag was purified from Escherichia coli. Complementation studies with a rhp14 mutant demonstrated that the tagged Rhp14 is functional in repair of ultraviolet radiation-induced damages and in mitotic mutation avoidance. In bandshift assays, Rhp14 showed a preference to substrates with mismatched and unpaired nucleotides. Similarly, XPA bound more efficiently to C/C, A/C, and T/C mismatches than to homoduplex DNA. Our data show that mismatches and loops in DNA are substrates of nucleotide excision repair. Rhp14 is likely part of the recognition complex but alone is not sufficient for the high discrimination of nucleotide excision repair for modified DNA.	Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; Univ Zurich, Inst Pharmacol & Toxicol, Tierspital, CH-8008 Zurich, Switzerland	University of Bern; University of Zurich	Fleck, O (corresponding author), Univ Bern, Inst Cell Biol, Baltzerstr 4, CH-3012 Bern, Switzerland.	fleck@izb.unibe.ch		Fleck, Oliver/0000-0003-0550-6513; Kunz, Christophe/0000-0002-0511-3915				Alleva JL, 2000, BIOCHEMISTRY-US, V39, P2659, DOI 10.1021/bi992751n; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Bhui-Kaur A, 1998, MOL CELL BIOL, V18, P1436, DOI 10.1128/MCB.18.3.1436; Burns JL, 1996, J BIOL CHEM, V271, P11607, DOI 10.1074/jbc.271.20.11607; Buschta-Hedayat N, 1999, P NATL ACAD SCI USA, V96, P6090, DOI 10.1073/pnas.96.11.6090; CARPENTER ATC, 1982, P NATL ACAD SCI-BIOL, V79, P5961, DOI 10.1073/pnas.79.19.5961; Fleck O, 1999, NAT GENET, V21, P314, DOI 10.1038/6838; FLECK O, 1994, NUCLEIC ACIDS RES, V22, P5289, DOI 10.1093/nar/22.24.5289; Fleck O, 1998, J BIOL CHEM, V273, P30398, DOI 10.1074/jbc.273.46.30398; Greene CN, 1997, MOL CELL BIOL, V17, P2844, DOI 10.1128/MCB.17.5.2844; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Gutz H., 1974, HDB GENETICS, V1, P395; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Hess MT, 1997, P NATL ACAD SCI USA, V94, P6664, DOI 10.1073/pnas.94.13.6664; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lehmann AR, 1996, MUTAT RES-DNA REPAIR, V363, P147, DOI 10.1016/0921-8777(96)00017-1; Mansour AA, 2001, GENETICS, V158, P77; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Moggs JG, 1997, NUCLEIC ACIDS RES, V25, P480, DOI 10.1093/nar/25.3.480; MONTELONE BA, 1994, YEAST, V10, P13, DOI 10.1002/yea.320100103; MONTELONE BA, 1992, MUTAT RES, V267, P55, DOI 10.1016/0027-5107(92)90110-N; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; Reardon JT, 1996, J BIOL CHEM, V271, P19451, DOI 10.1074/jbc.271.32.19451; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; RODEL C, 1992, NUCLEIC ACIDS RES, V20, P6347, DOI 10.1093/nar/20.23.6347; Rudolph C, 1998, CURR GENET, V34, P343, DOI 10.1007/s002940050405; Rudolph C, 1999, MOL CELL BIOL, V19, P241; Sancar A, 1999, NAT GENET, V21, P247, DOI 10.1038/6753; SCHAR P, 1993, GENETICS, V133, P825; Schar P, 1997, GENETICS, V146, P1275; SEKELSKY JJ, 1995, GENETICS, V141, P619; Sia EA, 1997, MUTAT RES-DNA REPAIR, V383, P61, DOI 10.1016/S0921-8777(96)00046-8; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Tornier C, 2001, GENETICS, V158, P65; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; Wakasugi M, 1999, J BIOL CHEM, V274, P18759, DOI 10.1074/jbc.274.26.18759; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; Yonemasu R, 1997, NUCLEIC ACIDS RES, V25, P1553, DOI 10.1093/nar/25.8.1553	49	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30766	30772		10.1074/jbc.M104039200	http://dx.doi.org/10.1074/jbc.M104039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11408483	Green Accepted, hybrid			2022-12-27	WOS:000170472900026
J	Koglin, M; Vehse, K; Budaeus, L; Scholz, H; Behrends, S				Koglin, M; Vehse, K; Budaeus, L; Scholz, H; Behrends, S			Nitric oxide activates the beta(2) subunit of soluble guanylyl cyclase in the absence of a second subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; ACTIVITY REQUIRES; ALPHA(2) SUBUNIT; ENZYME SUBUNITS; RAT-KIDNEY; EXPRESSION; ADENYLYL; CONTAINS; FORM	Previously characterized mammalian soluble guanylyl cyclases form alpha/beta heterodimers that can be activated by the gaseous messenger, nitric oxide, and the novel guanylyl cyclase modulator YC-1. Four mammalian subunits have been cloned named alpha (1), beta (1), alpha (2), and beta (2). The alpha (1)/beta (1) and alpha (2)/beta (1) heterodimeric enzyme isoforms have been rigorously characterized. The role of the beta (2) subunit has remained elusive. Here we isolate a novel variant of this subunit and show that the beta (2) subunit does not need to form heterodimers for catalytic activity because enzyme activity can be measured when it is expressed alone in Sf9 cells. In analogy to the beta (3) subunit recently isolated from the insect Manduca sexta, activity was dependent on the presence of 4 mm free Mn2+. The EC50 values for the NO-donor diethylamine/NO were shifted to the left by I order of magnitude as compared with the alpha (1)/beta (1) heterodimeric form. In the presence of the detergent Tween, NO sensitivity of beta (2) was abolished, but the enzyme could be activated by protoporphyrin IX, indicating removal of a prosthetic heme group and exchange for the heme precursor. We suggest that the beta (2) subunit is the first mammalian NO-sensitive guanylyl cyclase lacking a heterodimeric structure.	Univ Hamburg, Inst Expt & Klin Pharmacol, D-20251 Hamburg, Germany	University of Hamburg	Behrends, S (corresponding author), Univ Hamburg, Inst Expt & Klin Pharmacol, Martinistr 52, D-20251 Hamburg, Germany.		Behrends, Sönke/A-2551-2010	Behrends, Sönke/0000-0002-9068-0729				Behrends S, 2000, BIOCHEM BIOPH RES CO, V271, P64, DOI 10.1006/bbrc.2000.2596; BEHRENDS S, 1995, J BIOL CHEM, V270, P21109, DOI 10.1074/jbc.270.36.21109; BUECHLER WA, 1991, BIOCHEM BIOPH RES CO, V174, P351, DOI 10.1016/0006-291X(91)90527-E; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; Foerster J, 1996, EUR J BIOCHEM, V240, P380, DOI 10.1111/j.1432-1033.1996.0380h.x; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; GIUILI G, 1992, FEBS LETT, V304, P83, DOI 10.1016/0014-5793(92)80594-7; Gupta G, 1997, J CLIN INVEST, V100, P1488, DOI 10.1172/JCI119670; HARTENECK C, 1991, FEBS LETT, V292, P217, DOI 10.1016/0014-5793(91)80871-Y; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; Koesling D, 1999, Rev Physiol Biochem Pharmacol, V135, P41, DOI 10.1007/BFb0033669; Koglin M, 2000, BBA-GENE STRUCT EXPR, V1494, P286, DOI 10.1016/S0167-4781(00)00211-6; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; MUNDEL P, 1995, HISTOCHEM CELL BIOL, V103, P75, DOI 10.1007/BF01464478; Nighorn A, 1999, J BIOL CHEM, V274, P2525, DOI 10.1074/jbc.274.4.2525; Russwurm M, 1998, BIOCHEM J, V335, P125, DOI 10.1042/bj3350125; WEDEL B, 1995, J BIOL CHEM, V270, P24871, DOI 10.1074/jbc.270.42.24871; Wedel BJ, 1997, P NATL ACAD SCI USA, V94, P459, DOI 10.1073/pnas.94.2.459; YUEN PST, 1990, BIOCHEMISTRY-US, V29, P10872, DOI 10.1021/bi00501a002; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	22	72	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30737	30743		10.1074/jbc.M102549200	http://dx.doi.org/10.1074/jbc.M102549200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11406623	hybrid			2022-12-27	WOS:000170472900022
J	Langer, MR; Tanner, KG; Denu, JM				Langer, MR; Tanner, KG; Denu, JM			Mutational analysis of conserved residues in the GCN5 family of histone acetyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME CONDENSATION; TRANSCRIPTIONAL COACTIVATOR; P300/CBP-ASSOCIATED FACTOR; H3 PHOSPHORYLATION; PARTITION ANALYSIS; KINETIC MECHANISM; CRYSTAL-STRUCTURE; COENZYME-A; ACETYLATION; YEAST	GCN5 is a critical transcriptional co-activator and is the defining member of a large superfamily of N-acetyl-transferases. GCN5 catalyzes the transfer of an acetyl group from acetyl-CoA to the epsilon -amino of lysine 14 within the core H3 histone protein. Previous biochemical analyses have indicated a fully ordered kinetic mechanism. Recent structural studies have implicated several conserved residues in catalysis and substrate binding. Here the roles of Glu-173, His-145, and Asp-214 in yeast GCN5 have been evaluated using site-directed mutagenesis, steady state and pre-steady state kinetics, pH analysis, isotope partitioning, and equilibrium binding studies. The results with wild type and E173Q, H145A, and D214A mutants are consistent with chemical catalysis being rate-determining in turnover. All mutants exhibited Kd values (3.5-8.5 mum) for AcCoA that were similar to wild type enzyme, indicating no functional role for these residues in AcCoA binding. The E173Q mutant demonstrated a similar to 500-600-fold decreases in k(cat) and k(cat)/K-m,(H3), consistent with Glu-173 acting as the general base catalyst as proposed previously. No significant effect was observed on substrate binding steps. His-145 was identified as a residue in the peptide binding cleft that must be unprotonated (pK(a) = 5.8) for peptide binding and likely hydrogen-bonds to the Ser-10 hydroxyl of histone H3. His-145 also contributes to lowering the pK(a) value (by 0.8 units) of general base Glu-173 through a water-mediated hydrogen bond to the carboxylate side chain. Analysis of D214A revealed an obligate protein isomerization step that occurs after AcCoA binding and permits efficient peptide binding. Asp-214 is part of a conformationally flexible loop that mediates the isomerization by stabilizing distinct conformers of the protein.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Denu, JM (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, 3180 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059785] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK07680] Funding Source: Medline; NIGMS NIH HHS [GM59785] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Kim Y, 2000, ANAL BIOCHEM, V280, P308, DOI 10.1006/abio.2000.4546; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lau OD, 2000, J BIOL CHEM, V275, P21953, DOI 10.1074/jbc.M003219200; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Rose I A, 1980, Methods Enzymol, V64, P47; ROSE IA, 1974, J BIOL CHEM, V249, P5163; ROSE IA, 1995, METHOD ENZYMOL, V249, P315; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P11961, DOI 10.1021/bi001272h; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	39	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31321	31331		10.1074/jbc.M103839200	http://dx.doi.org/10.1074/jbc.M103839200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11397810	hybrid			2022-12-27	WOS:000170472900096
J	Lesley, JA; Waldburger, CD				Lesley, JA; Waldburger, CD			Comparison of the Pseudomonas aeruginosa and Escherichia coli PhoQ sensor domains - Evidence for distinct mechanisms of signal detection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM VIRULENCE; 2-COMPONENT REGULATORY SYSTEM; RESISTANCE; PEPTIDES	The PhoP-PhoQ two-component system is present in a number of Gram-negative bacteria where it has roles in Mg2+ homeostasis and virulence. PhoQ is a transmembrane histidine kinase that activates PhoP-mediated regulation of a set of genes when the extracellular concentration of divalent cations is low. Divalent cations are thought to interact directly with the periplasmic PhoQ sensor domain. The PhoP-PhoQ systems of Escherichia coli and Pseudomonas aeruginosa are similar in their biological response to extracellular divalent cations; however, their sensor domains display little sequence identity. Here we have begun to explore the consequences of this sequence divergence by comparing the biophysical properties of the P. aeruginosa PhoQ sensor domain with the corresponding E. coli sensor domain. Unlike the E. coli protein, the P. aeruginosa PhoQ sensor domain undergoes changes in the circular dichroism and fluorescence spectra as well as destabilization of its dimeric form in response to divalent cations. These results suggest that distinct mechanisms of signal detection are utilized by these proteins. A hybrid protein in which the E. coli sensor domain has been substituted with the corresponding P. aeruginosa sensor domain responds normally to the presence of extracellular divalent cations in vivo in E. coli. Thus, despite apparent differences in the structural response to its stimulus, the P. aeruginosa sensor domain transduces signals to the E. coli PhoQ cytoplasmic kinase domain in a manner that mimics normal E. coli PhoQ function.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University	Waldburger, CD (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	cdwl5@columbia.edu			NCRR NIH HHS [RR12848] Funding Source: Medline; NIAID NIH HHS [AI41566] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041566] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; FASMAN GD, 1975, HDB BIOCH MOL BIOL, V1, P187; Flego D, 2000, MOL PLANT MICROBE IN, V13, P447, DOI 10.1094/MPMI.2000.13.4.447; GARCIAVESCOVI E, 1997, J BIOL CHEM, V272, P1440; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hohmann EL, 1996, VACCINE, V14, P19, DOI 10.1016/0264-410X(95)00173-X; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; KASAHARA M, 1992, J BACTERIOL, V174, P492, DOI 10.1128/jb.174.2.492-498.1992; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Macfarlane ELA, 2000, MICROBIOL-SGM, V146, P2543, DOI 10.1099/00221287-146-10-2543; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; SALAMOV AA, 1995, J MOL BIOL, V247, P11, DOI 10.1006/jmbi.1994.0116; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1977, J BIOL CHEM, V252, P7850; TEALE FWJ, 1960, BIOCHEM J, V76, P381, DOI 10.1042/bj0760381; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Waldburger CD, 1996, J BIOL CHEM, V271, P26630, DOI 10.1074/jbc.271.43.26630	25	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30827	30833		10.1074/jbc.M104262200	http://dx.doi.org/10.1074/jbc.M104262200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11404360	hybrid			2022-12-27	WOS:000170472900034
J	Viscomi, C; Altomare, C; Bucchi, A; Camatini, E; Baruscotti, M; Moroni, A; DiFrancesco, D				Viscomi, C; Altomare, C; Bucchi, A; Camatini, E; Baruscotti, M; Moroni, A; DiFrancesco, D			C terminus-mediated control of voltage and cAMP gating of hyperpolarization-activated cyclic nucleotide-gated channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACEMAKER CHANNELS; HCN2; FAMILY	The hyperpolarization-activated cyclic nucleotide-gated (RON) family of "pacemaker" channels includes 4 isoforms, the kinetics and cAMP-induced modulation of which differ quantitatively. Because HCN isoforms are highly homologous. in the central region, but diverge more substantially in the N and C termini, we asked whether these latter regions could contribute to the determination of channel properties. To this aim, we analyzed activation/deactivation. kinetics and the response to cAMP of heterologously expressed isoforms mHCN1 and rbHCN4 and verified that mHCN1 has much faster kinetics and lower cAMP sensitivity than rbHCN4. We then constructed rbHCN4 chimeras by replacing either the N or the C terminus, or both, with the analogous domains from mHCN1. We found that: 1) replacement of the N terminus (chimera N1-4) did not substantially modify either the kinetics or cAMP dependence of wildtype channels; 2) replacement of the C terminus, on the contrary, resulted in a chimeric channel (4-Cl), the kinetics of which were strongly accelerated compared with rbHCN4, and that was fully insensitive to cAMP; 3) replacement of both N and C termini led to the same results as replacement of the C terminus alone. These results indicate that the C terminus of rbHCN4 contributes to the regulation of voltage- and cAMP-dependent channel gating, possibly through interaction with other intracellular regions not belonging to the N terminus.	Unita Milano Univ, Dipartimento Fisiol & Biochim Gen, Lab Fisiol Mol & Neurobiol, I-20133 Milan, Italy; Unita Milano Univ, INFM, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Milan	DiFrancesco, D (corresponding author), Unita Milano Univ, Dipartimento Fisiol & Biochim Gen, Lab Fisiol Mol & Neurobiol, Via Celoria 26, I-20133 Milan, Italy.	dario.difrancesco@unimi.it	Bucchi, Annalisa/B-1882-2017; viscomi, Carlo/R-1940-2016; DiFrancesco, Dario/G-8408-2017; moroni, anna/H-2097-2014; BARUSCOTTI, MIRKO/D-7017-2017	Bucchi, Annalisa/0000-0002-5303-4242; DiFrancesco, Dario/0000-0002-7322-1790; moroni, anna/0000-0002-1860-406X; BARUSCOTTI, MIRKO/0000-0002-6155-8388; Viscomi, Carlo/0000-0001-6050-0566; Altomare, Claudia/0000-0001-8743-9080	Telethon [971] Funding Source: Medline	Telethon(Fondazione Telethon)		Accili EA, 1996, PFLUG ARCH EUR J PHY, V431, P757; Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Clapham DE, 1998, NEURON, V21, P5, DOI 10.1016/S0896-6273(00)80508-5; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1994, HDB MEMBRANE CHANNEL, P335; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Ludwig A, 1999, CELL PHYSIOL BIOCHEM, V9, P179, DOI 10.1159/000016315; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Moroni A, 2000, PFLUG ARCH EUR J PHY, V439, P618, DOI 10.1007/s004240050985; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Vaca L, 2000, FEBS LETT, V479, P35, DOI 10.1016/S0014-5793(00)01837-8; Vaccari T, 1999, BBA-GENE STRUCT EXPR, V1446, P419, DOI 10.1016/S0167-4781(99)00092-5	27	54	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29930	29934		10.1074/jbc.M103971200	http://dx.doi.org/10.1074/jbc.M103971200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397812	hybrid			2022-12-27	WOS:000170558000044
J	Loussouarn, G; Pike, LJ; Ashcroft, FM; Makhina, EN; Nichols, CG				Loussouarn, G; Pike, LJ; Ashcroft, FM; Makhina, EN; Nichols, CG			Dynamic sensitivity of ATP-sensitive K+ channels to ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-B-CELLS; POTASSIUM CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; NUCLEOTIDE SENSITIVITY; SULFONYLUREA RECEPTOR; VENTRICULAR MYOCYTES; KIR6.2 SUBUNIT; HEART-MUSCLE; WORTMANNIN; ADP	ATP and MgADP regulate K-ATP channel activity and hence potentially couple cellular metabolism to membrane electrical activity in various cell types. Using recombinant K-ATP channels that lack sensitivity to MgADP, expressed in COSm6 cells, we demonstrate that similar on-cell activity can be observed with widely varying apparent submembrane [ATP] ([ATP](sub)). Metabolic inhibition leads to a biphasic change in the channel activity; activity first increases, presumably in response to a fast decrease in [ATP](sub), and then declines. The secondary decrease in channel activity reflects a marked increase in ATP sensitivity and is correlated with a fall in polyphosphoinositides (PPIs), including phosphatidylinositol. 4,5-bisphosphate, probed using equilibrium labeling of cells with [H-3]myo-inositol. Both ATP sensitivity and PPIs rapidly recover following removal of metabolic inhibition, and in both cases recovery is blocked by wortmannin. These data are consistent with metabolism having a dual effect on K-ATP channel activity: rapid activation of channels because of relief of ATP inhibition and much slower reduction of channel activity mediated by a fall in PPIs. These two mechanisms constitute a feedback system that will tend to render K-ATP channel activity transiently responsive to a change in [ATP](sub) over a wide range of steady state concentrations.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	Washington University (WUSTL); Washington University (WUSTL); University of Oxford	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.		Loussouarn, Gildas/ABH-6043-2020; Loussouarn, Gildas/D-3590-2015; Nichols, Colin/D-6336-2012	Loussouarn, Gildas/0000-0001-8007-5931; Loussouarn, Gildas/0000-0001-8007-5931; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055282] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55282] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; DEUTSCH N, 1993, J PHYSIOL-LONDON, V465, P163, DOI 10.1113/jphysiol.1993.sp019671; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; FINDLAY I, 1991, FEBS LETT, V279, P95, DOI 10.1016/0014-5793(91)80259-6; FINDLAY I, 1988, J MEMBRANE BIOL, V101, P83, DOI 10.1007/BF01872823; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; GROSS GJ, 1995, BASIC RES CARDIOL, V90, P85, DOI 10.1007/BF00789438; Gross GJ, 1999, CIRC RES, V84, P973, DOI 10.1161/01.RES.84.9.973; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Jovanovic N, 1999, FASEB J, V13, P923, DOI 10.1096/fasebj.13.8.923; KAKEI M, 1986, FEBS LETT, V208, P63, DOI 10.1016/0014-5793(86)81533-2; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Light PE, 1999, CAN J CARDIOL, V15, P1123; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Miki T, 1999, J MOL ENDOCRINOL, V22, P113, DOI 10.1677/jme.0.0220113; MISLER S, 1986, P NATL ACAD SCI USA, V83, P7119, DOI 10.1073/pnas.83.18.7119; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; NICHOLS CG, 1991, AM J PHYSIOL, V261, pH1675, DOI 10.1152/ajpheart.1991.261.6.H1675; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; PIKE LJ, 1987, J BIOL CHEM, V262, P1644; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 2000, P NATL ACAD SCI USA, V97, P937, DOI 10.1073/pnas.97.2.937; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sippel CJ, 1997, J BIOL CHEM, V272, P18290, DOI 10.1074/jbc.272.29.18290; Tanabe K, 1999, J BIOL CHEM, V274, P3931, DOI 10.1074/jbc.274.7.3931; THIERFELDER S, 1994, FEBS LETT, V351, P365, DOI 10.1016/0014-5793(94)00886-8; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Xie LH, 1999, J PHYSIOL-LONDON, V514, P655, DOI 10.1111/j.1469-7793.1999.655ad.x; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292	37	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29098	29103		10.1074/jbc.M102365200	http://dx.doi.org/10.1074/jbc.M102365200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11395495	hybrid			2022-12-27	WOS:000170346000063
J	Krogh, BO; Claeboe, CD; Hecht, SM; Shuman, S				Krogh, BO; Claeboe, CD; Hecht, SM; Shuman, S			Effect of 2 '-5 ' phosphodiesters on DNA transesterification by vaccinia topoisomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXONUCLEASE-III; COVALENT; SITE; PHOSPHOROTHIOATE; MECHANISM; CLEAVAGE; STRAND; ENZYME; IB	Vaccinia topoisomerase forms a covalent DNA-(3'-phosphotyrosyl)-enzyme intermediate at a pentapyrimidine target site 5'-CCCTTp down arrow in duplex DNA. By introducing single 2'-5' phosphodiesters in lieu of a standard 3'-5' phosphodiester linkage, we illuminate the contributions of phosphodiester connectivity to DNA transesterification, We find that the DNA cleavage reaction was slowed by more than six orders of magnitude when a 2'-5' linkage was present at the scissile phosphodiester (CCCTT(2')p down arrow (5).A). Thus, vaccinia topoisomerase is unable to form a DNA-(2'-phosphotyrosyl)-enzyme intermediate. We hypothesize that the altered geometry of the 2'-5' phosphodiester limits the ability of the tyrosine nucleophile tea attain a requisite, presumably apical orientation with respect to the 5'-OH leaving group. A 2'-5' phosphodiester located to the 3' side of the cleavage site (CCCTTp down arrowN(2')p(5),N) reduced the rate of transesterification by a factor of 500, In contrast, 2'-5' phosphodiesters at four other sites in the scissile strand (TpCGCCCTpT down arrow ATpTpC) and five positions in the nonscissile strand (3'-GGGpApApTpApA) had no effect on transesterification rate, The DNAs containing 2'-5' phosphodiesters were protected from digestion by exonuclease III. We found that exonuclease III was consistently arrested at positions 1 and 2 nucleotides prior to the encounter of its active site with the modified 2'-5' phosphodiester and that the 2'-5' linkage itself was poorly hydrolyzed by exonuclease III.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22901 USA	Memorial Sloan Kettering Cancer Center; University of Virginia; University of Virginia	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.				NCI NIH HHS [CA78415] Funding Source: Medline; NIGMS NIH HHS [GM46330] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046330, R01GM046330] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arslan T, 1998, J BIOL CHEM, V273, P12383, DOI 10.1074/jbc.273.20.12383; Arslan T, 1998, NUCLEOS NUCLEOT NUCL, V17, P515, DOI 10.1080/07328319808005195; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Cheng CH, 1999, BIOCHEMISTRY-US, V38, P16599, DOI 10.1021/bi992001d; Cheng CH, 1997, J BIOL CHEM, V272, P8263, DOI 10.1074/jbc.272.13.8263; DOUGHERTY JP, 1992, J AM CHEM SOC, V114, P6254, DOI 10.1021/ja00041a058; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2000, BIOCHEMISTRY-US, V39, P6422, DOI 10.1021/bi000184u; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Petersen BO, 1997, J BIOL CHEM, V272, P3891, DOI 10.1074/jbc.272.7.3891; Porter KW, 1997, NUCLEIC ACIDS RES, V25, P1611, DOI 10.1093/nar/25.8.1611; PUTNEY SD, 1981, P NATL ACAD SCI-BIOL, V78, P7350, DOI 10.1073/pnas.78.12.7350; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; RIZZO CJ, 1992, TETRAHEDRON LETT, V33, P4129, DOI 10.1016/S0040-4039(00)74670-3; Sekiguchi J, 1996, EMBO J, V15, P3448, DOI 10.1002/j.1460-2075.1996.tb00711.x; SEKIGUCHI J, 1994, J BIOL CHEM, V269, P31731; Sekiguchi J, 1996, J BIOL CHEM, V271, P19436, DOI 10.1074/jbc.271.32.19436; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; Shuman S, 1998, BBA-GENE STRUCT EXPR, V1400, P321, DOI 10.1016/S0167-4781(98)00144-4; SHUMAN S, 1993, J BIOL CHEM, V268, P18943; Stivers JT, 2000, BIOCHEMISTRY-US, V39, P5561, DOI 10.1021/bi992429c; Wittschieben J, 1997, NUCLEIC ACIDS RES, V25, P3001, DOI 10.1093/nar/25.15.3001	22	13	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20907	20912		10.1074/jbc.M102312200	http://dx.doi.org/10.1074/jbc.M102312200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11399773	hybrid			2022-12-27	WOS:000169297900017
J	Hotta, K; Funahashi, T; Matsukawa, Y; Takahashi, M; Nishizawa, H; Kishida, K; Matsuda, M; Kuriyama, H; Kihara, S; Nakamura, T; Tochino, Y; Bodkin, NL; Hansen, BC; Matsuzawa, Y				Hotta, K; Funahashi, T; Matsukawa, Y; Takahashi, M; Nishizawa, H; Kishida, K; Matsuda, M; Kuriyama, H; Kihara, S; Nakamura, T; Tochino, Y; Bodkin, NL; Hansen, BC; Matsuzawa, Y			Galectin-12, an adipose-expressed galectin-like molecule possessing apoptosis-inducing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-BINDING LECTIN; MESSENGER-RNA; INSULIN SENSITIVITY; DIABETES-MELLITUS; GENE-EXPRESSION; PROTEIN GENE; BODY-WEIGHT; T-CELLS; CLONING; FAMILY	Galectins constitute a family of proteins that bind to beta -galactoside residues and have diverse physiological functions. Here we report on the identification of a galectin-like molecule, galectin-12, in a human adipose tissue cDNA library. The protein contained two potential carbohydrate-recognition domains with the second carbohydrate-recognition domain being less conserved compared with other galectins. In vitro translated galectin-12 bound to a lactosyl-agarose column far less efficiently than galectin-8. Galectin-12 mRNA was predominantly expressed in adipose tissue of human and mouse and in differentiated 3T3-L1 adipocytes. Caloric restriction and treatment of obese animals with troglitazone increased galectin-12 mRNA levels and decreased the average size of the cells in adipose tissue. The induction of galectin-12 expression by the thiazolidinedione, troglitazone, was paralleled by an increase in the number of apoptotic cells in adipose tissue. Immunocytochemical analysis revealed that galectin-12 was localized in the nucleus of adipocytes, and transfection with galectin-12 cDNA induced apoptosis of COS-1 cells. These results suggest that galectin-12, an adipose-expressed galectin-like molecule, may participate in the apoptosis of adipocytes.	Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Suita, Osaka 5650871, Japan; Univ Maryland, Sch Med, Obes & Diabet Res Ctr, Baltimore, MD 21201 USA	Osaka University; University System of Maryland; University of Maryland Baltimore	Funahashi, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tohru@imed2.med.osaka-u.ac.jp	Hansen, Barbara C/J-8723-2012	Hansen, Barbara C/0000-0001-9646-3525; Hotta, Kikuko/0000-0003-2427-6354	NIA NIH HHS [AG62100] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akahani S, 1997, CANCER RES, V57, P5272; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; BODKIN NL, 1989, AM J PHYSIOL, V256, pE676, DOI 10.1152/ajpendo.1989.256.5.E676; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHERAYIL BJ, 1990, P NATL ACAD SCI USA, V87, P7324, DOI 10.1073/pnas.87.18.7324; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Colnot C, 1998, IMMUNOLOGY, V94, P290, DOI 10.1046/j.1365-2567.1998.00517.x; Dunphy JL, 2000, J BIOL CHEM, V275, P32106, DOI 10.1074/jbc.M003739200; Dyer KD, 1997, GENOMICS, V40, P217, DOI 10.1006/geno.1996.4590; Gavin JR, 1997, DIABETES CARE, V20, P1183; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gitt MA, 1998, J BIOL CHEM, V273, P2961, DOI 10.1074/jbc.273.5.2961; GITT MA, 1986, P NATL ACAD SCI USA, V83, P7603, DOI 10.1073/pnas.83.20.7603; GITT MA, 1992, J BIOL CHEM, V267, P10601; GITT MA, 1995, J BIOL CHEM, V270, P5032, DOI 10.1074/jbc.270.10.5032; Hadari YR, 2000, J CELL SCI, V113, P2385; HADARI YR, 1995, J BIOL CHEM, V270, P3447, DOI 10.1074/jbc.270.7.3447; HANSEN BC, 1990, AM J PHYSIOL, V259, pR612, DOI 10.1152/ajpregu.1990.259.3.R612; HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809; HANSEN BC, 1986, DIABETOLOGIA, V29, P713, DOI 10.1007/BF00870281; HANSEN BC, 1995, OBES RES, V3, pS199, DOI 10.1002/j.1550-8528.1995.tb00464.x; Hansen BC, 1999, TOXICOL SCI, V52, P56, DOI 10.1093/toxsci/52.suppl_1.56; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; HERRERA R, 1989, MOL CELL BIOL, V9, P5331, DOI 10.1128/MCB.9.12.5331; Hotta K, 1996, J BIOL CHEM, V271, P25327, DOI 10.1074/jbc.271.41.25327; Huflejt ME, 1997, J BIOL CHEM, V272, P14294, DOI 10.1074/jbc.272.22.14294; JOHNSON PF, 1993, MOL CELL BIOL, V13, P6919, DOI 10.1128/MCB.13.11.6919; Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200; Kuriyama H, 1997, BIOCHEM BIOPH RES CO, V241, P53, DOI 10.1006/bbrc.1997.7769; MADSEN P, 1995, J BIOL CHEM, V270, P5823, DOI 10.1074/jbc.270.11.5823; Maeda K, 1997, GENE, V190, P227, DOI 10.1016/S0378-1119(96)00730-5; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Magun R, 1998, DIABETES, V47, P1948, DOI 10.2337/diabetes.47.12.1948; Menon RP, 1999, EUR J BIOCHEM, V264, P569, DOI 10.1046/j.1432-1327.1999.00671.x; Miner JL, 2001, OBES RES, V9, P129, DOI 10.1038/oby.2001.16; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Pace KE, 1999, J IMMUNOL, V163, P3801; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Qian H, 1998, ENDOCRINOLOGY, V139, P791, DOI 10.1210/en.139.2.791; Rabinovich GA, 2000, CELL DEATH DIFFER, V7, P747, DOI 10.1038/sj.cdd.4400708; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Sorisky A, 2000, INT J OBESITY, V24, pS3, DOI 10.1038/sj.ijo.0801491; Su ZZ, 1996, P NATL ACAD SCI USA, V93, P7252, DOI 10.1073/pnas.93.14.7252; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; WADE R, 1990, DEV BIOL, V142, P270, DOI 10.1016/0012-1606(90)90348-M; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200	60	89	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34089	34097		10.1074/jbc.M105097200	http://dx.doi.org/10.1074/jbc.M105097200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435439	hybrid			2022-12-27	WOS:000170910200107
J	Kretsovali, A; Spilianakis, C; Dimakopoulos, A; Makatounakis, T; Papamatheakis, J				Kretsovali, A; Spilianakis, C; Dimakopoulos, A; Makatounakis, T; Papamatheakis, J			Self-association of class II transactivator correlates with its intracellular localization and transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARE LYMPHOCYTE SYNDROME; CREB BINDING-PROTEIN; NF-KAPPA-B; NUCLEAR-LOCALIZATION; CIITA INTERACTS; GTP-BINDING; EXPRESSION; TRANSCRIPTION; COACTIVATOR; ACTIVATION	Class II transactivator (CIITA) is the master regulator of major histocompatibility complex class II genes that regulates both B lymphocyte-specific and interferon gamma -inducible expression. Here we identify protein regions and examine mechanisms that determine the intracellular distribution of CIITA. We show that two separate regions of CIITA mediate nuclear export: amino acids 1-114 and 408-550. Both regions interact with the export receptor CRM-1. The CIITA region spanning amino acids 408-550 of CIITA also determines its ability for homotypic self-association as well as heterotypic interactions with other regions residing at the amino and carboxyl termini of the protein. These observations are in line with data demonstrating that co-expression of amino- and carboxyl-terminal parts of CIITA promote subcellular relocalization and, remarkably, rescue transcriptional activation by individually inert molecules. CIITA point mutations that impair nuclear import and abolish its activation function show reduced self-association. We propose that the concerted action of homo- and heterotypic interactions of CIITA determine proper protein configuration that in turn controls its nucleocytoplasmic trafficking.	Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; Univ Crete, Dept Biol, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete	Kretsovali, A (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, POB 1527, Iraklion 71110, Crete, Greece.	kretsova@imbb.forth.gr; papamath@imbb.forth.gr	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923				BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Bontron S, 1997, MOL CELL BIOL, V17, P4249, DOI 10.1128/MCB.17.8.4249; Brown JA, 1998, NUCLEIC ACIDS RES, V26, P4128, DOI 10.1093/nar/26.18.4128; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; CRESSWELL P, 1994, CURR BIOL, V4, P541, DOI 10.1016/S0960-9822(00)00119-6; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1999, MOL CELL BIOL, V19, P941; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gourley TS, 2001, J IMMUNOL, V166, P2917, DOI 10.4049/jimmunol.166.5.2917; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kim HJ, 1999, MOL CELL BIOL, V19, P6323; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; MACHOVEC GS, 1996, ONLINE LIB MICROCOMP, V14, P1; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; Masternak K, 2000, GENE DEV, V14, P1156; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Quan V, 1999, IMMUNOGENETICS, V49, P957, DOI 10.1007/s002510050579; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Sisk TJ, 2001, MOL CELL BIOL, V21, P4919, DOI 10.1128/MCB.21.15.4919-4928.2001; Sisk TJ, 2000, J IMMUNOL, V165, P2511, DOI 10.4049/jimmunol.165.5.2511; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Yun S, 1997, INT IMMUNOL, V9, P1545, DOI 10.1093/intimm/9.10.1545; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zhou H, 1997, J IMMUNOL, V158, P4741; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473; Zhu XS, 2000, MOL CELL BIOL, V20, P6051, DOI 10.1128/MCB.20.16.6051-6061.2000	39	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32191	32197		10.1074/jbc.M103164200	http://dx.doi.org/10.1074/jbc.M103164200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11413136	hybrid			2022-12-27	WOS:000170613500098
J	Reyes-Cruz, G; Hu, JX; Goldsmith, PK; Steinbach, PJ; Spiegel, AM				Reyes-Cruz, G; Hu, JX; Goldsmith, PK; Steinbach, PJ; Spiegel, AM			Human Ca2+ receptor extracellular domain - Analysis of function of lobe I loop deletion mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSING RECEPTOR; CELL-SURFACE EXPRESSION; N-LINKED GLYCOSYLATION; SIGNAL-TRANSDUCTION; IDENTIFICATION; DIMERIZATION; MUTATIONS	The G protein-coupled Ca2+ receptor (CaR) possesses an similar to 600-residue extracellular domain involved in ligand binding and receptor activation. Based on an alignment of the amino acid sequence of the CaR with that of bacterial periplasmic-binding proteins, the first similar to 530 residues of the extracellular domain are believed to form a domain resembling a bilobed Venus's flytrap (VFT). Four insertions in the CaR sequence that do not align with those of bacterial periplasmic-binding proteins correspond to four loops within lobe I of the VFT. We constructed a series of deletion mutants of these four loops and tested their ability to form fully processed CaR as well as their ability to be activated by Ca2+. As many as 21 residues (365-385) of loop III could be deleted without impairing receptor expression or activation. Deletion of portions of either loops I (50-59) or IV (438-445) did not impair receptor expression but significantly reduced Ca2+ activation. Deletion of the entire loop II (117-137) abolished receptor expression and function, but the replacement of even a single residue within this deletion mutant led to expression of a monomeric form of the receptor showing increased Ca2+ sensitivity but reduced maximal activation. Our results reveal that certain residues within loops I and IV are dispensable in formation of the VFT domain but are critical for Ca2+ activation of the receptor. In contrast, the residues in loop II are critical for maintaining the inactive state of the CaR. We discuss these results in light of the recently defined crystal structure of the homologous domain of the type 1 metabotropic glutamate receptor.	NIH, CIT, Ctr Mol Modeling, Bethesda, MD 20892 USA; NIDCD, Mol Pathophysiol Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Reyes-Cruz, G (corresponding author), NIH, CIT, Ctr Mol Modeling, Bldg 10,Room 8C101, Bethesda, MD 20892 USA.				CENTER FOR INFORMATION TECHNOLOGY [ZIACT000265, Z01CT000265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000061] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 1999, AM J MED, V106, P238, DOI 10.1016/S0002-9343(98)00418-5; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; Fan GF, 1998, FEBS LETT, V436, P353, DOI 10.1016/S0014-5793(98)01165-X; Goldsmith PK, 1999, J BIOL CHEM, V274, P11303, DOI 10.1074/jbc.274.16.11303; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; Hu JX, 2000, J BIOL CHEM, V275, P16382, DOI 10.1074/jbc.M000277200; Jensen AA, 2000, J BIOL CHEM, V275, P29547, DOI 10.1074/jbc.M910023199; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ray K, 1999, J BIOL CHEM, V274, P27642, DOI 10.1074/jbc.274.39.27642; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Springer TA, 2000, CELL, V102, P275, DOI 10.1016/S0092-8674(00)00033-7	19	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32145	32151		10.1074/jbc.M102977200	http://dx.doi.org/10.1074/jbc.M102977200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11399760	hybrid			2022-12-27	WOS:000170613500092
J	Wulff, H; Gutman, GA; Cahalan, MD; Chandy, KG				Wulff, H; Gutman, GA; Cahalan, MD; Chandy, KG			Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; HUMAN T-LYMPHOCYTES; CHLORIDE SECRETION; EPITHELIAL-CELLS; CA CHANNEL; GENE; PROLIFERATION; INHIBITION; EFFICACY; ROLES	Selective and potent triarylmethane blockers of the intermediate conductance calcium-activated potassium channel, IKCa1, have therapeutic use in sickle cell disease and secretory diarrhea and as immunosuppressants. Clotrimazole, a membrane-permeant triarylmethane, blocked IKCa1 with equal affinity when applied externally or internally, whereas a membrane-impermeant derivative TRAM-30 blocked the channel only when applied to the cytoplasmic side, indicating an internal drug-binding site. Introduction of the S5-P-S6 region of the triarylmethane-insensitive small conductance calcium-activated potassium channel SKCa3 into IKCa1 rendered the channel resistant to triarylmethanes. Replacement of Thr(250) or Val(275) in IKCa1 with the cot-responding SKCa3 residues selectively abolished triarylmethane sensitivity without affecting the affinity of the channel for tetraethylammonium, charybdotoxin, and nifedipine. Introduction of these two residues into SKCa3 rendered the channel sensitive to triarylmethanes. In a molecular model of IKCa1, Thr(250) and Val(275) line a water-filled cavity just below the selectivity filter. Structure-activity studies suggest that the side chain methyl groups of Thr(250) and Val(275) may lock the triarylmethanes in place via hydrophobic interactions with the pi -electron clouds of the phenyl rings. The heterocyclic moiety may project into the selectivity filter and obstruct the ion-conducting pathway from the inside.	Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Chandy, KG (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Room 291,Joan Irvine Smith Hall, Irvine, CA 92697 USA.		wulff, Heike/Z-2056-2019		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609, R01NS014609] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59222] Funding Source: Medline; NINDS NIH HHS [NS14609] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brugnara C, 1997, Curr Opin Hematol, V4, P122; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Chandy KG, 1998, MOL PSYCHIATR, V3, P32, DOI 10.1038/sj.mp.4000353; COGHLAN MJ, 2001, J MED CHEM, V44, P1; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dunn PM, 1998, J MEMBRANE BIOL, V165, P133, DOI 10.1007/s002329900427; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Ghanshani S, 1998, GENOMICS, V51, P160, DOI 10.1006/geno.1998.5333; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Rauer H, 2000, J BIOL CHEM, V275, P1201, DOI 10.1074/jbc.275.2.1201; Rufo PA, 1996, J CLIN INVEST, V98, P2066, DOI 10.1172/JCI119012; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SAWYER PR, 1975, DRUGS, V9, P424, DOI 10.2165/00003495-197509060-00003; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151	22	111	123	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32040	32045		10.1074/jbc.M105231200	http://dx.doi.org/10.1074/jbc.M105231200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11425865	hybrid			2022-12-27	WOS:000170613500078
J	Yuan, PX; Huang, LD; Jiang, YM; Gutkind, JS; Manji, HK; Chen, G				Yuan, PX; Huang, LD; Jiang, YM; Gutkind, JS; Manji, HK; Chen, G			The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBGENUAL PREFRONTAL CORTEX; HUMAN NEUROBLASTOMA-CELLS; DNA-BINDING ACTIVITY; OUTGROWTH IN-VITRO; C-JUN; TRANSCRIPTION FACTOR; TYROSINE-HYDROXYLASE; GENE-EXPRESSION; MAP KINASE; PC12 CELLS	The mood-stabilizing agents lithium and valproic acid (VPA) increase DNA binding activity and transactivation activity of AP-1 transcription factors, as wen as the expression of genes regulated by AP-1, in cultured cells and brain regions involved in mood regulation. In the present study, we found that VPA activated extracellular signal-regulated kinase (ERK), a kinase known to regulate AP-1 function and utilized by neurotrophins to mediate their diverse effects, including neuronal differentiation, neuronal survival, long term neuroplasticity, and potentially learning and memory. VPA-induced activation of ERK was blocked by the mitogen-activated protein kinase/ERK kinase inhibitor PD098059 and dominant-negative Ras and Raf mutants but not by dominant-negative stress-activated protein kinase/ERK kinase and mitogen-activated protein kinase kinase 6 mutants. VPA also increased the expression of genes regulated by the ERK pathway, including growth cone-associated protein 43 and Bcl-2, promoted neurite growth and cell survival, and enhanced norepinephrine uptake and release. These data demonstrate that VPA is an ERK pathway activator and produces neurotrophic effects.	NIMH, Unit Mol Neurotherapeut, Mol Pathophysiol Lab, NIH, Bethesda, MD 20892 USA; Wayne State Univ, Sch Med, Mol Pathophysiol Lab, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA; NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chen, G (corresponding author), NIMH, Unit Mol Neurotherapeut, Mol Pathophysiol Lab, NIH, Bldg 49,Rm B1EE16,49 Convert Dr, MSC 4405, Bethesda, MD 20892 USA.		Gutkind, J. Silvio/A-1053-2009; Chen, Guang/A-2570-2017; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057743] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57743] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asghari V, 1998, MOL BRAIN RES, V58, P95, DOI 10.1016/S0169-328X(98)00107-7; Bassa BV, 1999, AM J PHYSIOL-RENAL, V277, pF328, DOI 10.1152/ajprenal.1999.277.3.F328; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOWDEN CL, 1994, JAMA-J AM MED ASSOC, V271, P918, DOI 10.1001/jama.271.12.918; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chen G, 1998, J NEUROCHEM, V70, P1768; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; CHEN G, 1994, J NEUROCHEM, V63, P2361; Chen G, 1997, NEUROPSYCHOPHARMACOL, V16, P238; Chen G, 1999, MOL BRAIN RES, V64, P52, DOI 10.1016/S0169-328X(98)00303-9; Cieslik K, 2001, J BIOL CHEM, V276, P1211, DOI 10.1074/jbc.M005305200; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; FUKUDA M, 1995, ONCOGENE, V11, P239; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HANADA M, 1993, CANCER RES, V53, P4978; Ji L, 1996, J BIOL CHEM, V271, P22687, DOI 10.1074/jbc.271.37.22687; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Katoh S, 1996, BIOCHEM BIOPH RES CO, V229, P653, DOI 10.1006/bbrc.1996.1859; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; MCELROY SL, 1995, TXB PSYCHOPHARMACOLO, P351; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Moore GJ, 2000, BIOL PSYCHIAT, V48, P1, DOI 10.1016/S0006-3223(00)00252-3; MURPHY NP, 1991, J NEUROCHEM, V56, P1810, DOI 10.1111/j.1471-4159.1991.tb02085.x; NILSSON M, 1990, NEUROCHEM RES, V15, P763, DOI 10.1007/BF00968551; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Ozaki N, 1997, J NEUROCHEM, V69, P2336; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; POST RM, 2000, COMPREHENSIVE TXB PS, V1, P1385; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; PULVERER BJ, 1993, ONCOGENE, V8, P407; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; RECIOPINTO E, 1984, BRAIN RES, V302, P323, DOI 10.1016/0006-8993(84)90246-4; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Sands SA, 2000, NEUROPSYCHOPHARMACOL, V22, P27, DOI 10.1016/S0893-133X(99)00072-X; SATO N, 1994, J NEUROBIOL, V25, P1227, DOI 10.1002/neu.480251005; Siafaka-Kapadai A, 1998, BIOCHEM PHARMACOL, V56, P207, DOI 10.1016/S0006-2952(98)00148-8; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wlodarczyk BC, 1996, TERATOLOGY, V54, P284, DOI 10.1002/(SICI)1096-9926(199612)54:6<284::AID-TERA3>3.3.CO;2-J; XU I, 1997, STRATEGIES, V10, P1; Yuan PX, 1999, J NEUROCHEM, V73, P2299, DOI 10.1046/j.1471-4159.1999.0732299.x; Yuan PX, 1998, MOL BRAIN RES, V58, P225, DOI 10.1016/S0169-328X(98)00114-4; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504; Zigova T, 1999, EXP NEUROL, V157, P251, DOI 10.1006/exnr.1999.7054	57	279	291	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31674	31683		10.1074/jbc.M104309200	http://dx.doi.org/10.1074/jbc.M104309200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418608	hybrid			2022-12-27	WOS:000170613500029
J	Chang, C; Gonzalez, F; Rothermel, B; Sun, LP; Johnston, SA; Kodadek, T				Chang, C; Gonzalez, F; Rothermel, B; Sun, LP; Johnston, SA; Kodadek, T			The Gal4 activation domain binds Sug2 protein, a proteasome component, in vivo and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; UBIQUITIN-MEDIATED PROTEOLYSIS; SACCHAROMYCES-CEREVISIAE; REGULATORY PARTICLE; CROSS-LINKING; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; ESCHERICHIA-COLI; 2-HYBRID SYSTEM; YEAST	An in vivo protein interaction assay was used to search a yeast cDNA library for proteins that bind to the acidic activation domain (AD) of the yeast Ga14 protein. Sug2 protein, a component of the 19 S regulatory particle of the 26 S proteasome, was one of seven proteins identified in this screen. In vitro binding assays confirm a direct interaction between these proteins. SUG2 and SUG1, another 19 S component, were originally discovered as a mutation able to suppress the phenotype of a Gal4 truncation mutant (Gal4(D)p) lacking much of its AD. Sug1p has previously been shown to bind the Gal4 AD in vitro. Taken together, these genetic and biochemical data suggest a biologically significant interaction between the Gal4 protein and the 19 S regulatory particle of the proteasome. Indeed, it is demonstrated here that the Gal4 AD interacts specifically with immunopurified 19 S complex. The proteasome regulatory particle has been shown recently to play a direct role in RNA polymerase II transcription and the activator-19 S interaction could be important in recruiting this large complex to transcriptionally active GAL genes.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Stratagene Inc, La Jolla, CA 92037 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chang, C (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Kodadek, Thomas/0000-0003-1930-4795				Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Blau J, 1996, MOL CELL BIOL, V16, P2044; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; CHASMAN DI, 1990, MOL CELL BIOL, V10, P2916, DOI 10.1128/MCB.10.6.2916; CHUPING M, 1994, J BIOL CHEM, V369, P3539; COHEN S, 1981, NATURE, V294, P182, DOI 10.1038/294182a0; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Fancy DA, 1998, BIOCHEM BIOPH RES CO, V247, P420, DOI 10.1006/bbrc.1998.8558; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Fancy DA, 1996, CHEM BIOL, V3, P551, DOI 10.1016/S1074-5521(96)90146-5; FASSLER JS, 1989, MOL CELL BIOL, V9, P5602, DOI 10.1128/MCB.9.12.5602; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; FRANKEL A, 1989, MOL CELL BIOL, V9, P415, DOI 10.1128/MCB.9.2.415; GIMBLE FS, 1989, J MOL BIOL, V206, P29, DOI 10.1016/0022-2836(89)90521-4; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Hays LB, 2000, BIOTECHNIQUES, V29, P288, DOI 10.2144/00292st04; Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749; Horwich AL, 1999, P NATL ACAD SCI USA, V96, P11033, DOI 10.1073/pnas.96.20.11033; Huang WD, 2001, BIOTECHNIQUES, V30, P94, DOI 10.2144/01301st06; JOHNSTON SA, 1982, P NATL ACAD SCI-BIOL, V79, P6971, DOI 10.1073/pnas.79.22.6971; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; KIRCHHAUSEN T, 1990, MOL CELL BIOL, V10, P6089, DOI 10.1128/MCB.10.11.6089; KODADEK T, 1990, BIOCHEM BIOPH RES CO, V172, P804, DOI 10.1016/0006-291X(90)90746-A; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Laser H, 2000, P NATL ACAD SCI USA, V97, P13732, DOI 10.1073/pnas.250400997; Lee YC, 1999, MOL CELL BIOL, V19, P2967; LEUTHER KK, 1992, SCIENCE, V256, P1333, DOI 10.1126/science.1598579; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; LONG RM, 1991, MOL CELL BIOL, V11, P2311, DOI 10.1128/MCB.11.4.2311; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Marsolier MC, 1997, J MOL BIOL, V268, P243, DOI 10.1006/jmbi.1997.0979; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Melcher K, 2000, J MOL BIOL, V301, P1097, DOI 10.1006/jmbi.2000.4034; MELCHER K, 1995, MOL CELL BIOL, V15, P2839; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; PARTHUN MR, 1992, MOL CELL BIOL, V12, P4981, DOI 10.1128/MCB.12.11.4981; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; POON D, 1993, J BIOL CHEM, V268, P15325; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Russell SJ, 1996, J BIOL CHEM, V271, P32810, DOI 10.1074/jbc.271.51.32810; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; SAKURAI H, 1993, P NATL ACAD SCI USA, V90, P8382, DOI 10.1073/pnas.90.18.8382; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Sil AK, 1999, MOL CELL BIOL, V19, P7828; Sterner DE, 1999, MOL CELL BIOL, V19, P86; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2	65	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30956	30963		10.1074/jbc.M102254200	http://dx.doi.org/10.1074/jbc.M102254200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418596	hybrid			2022-12-27	WOS:000170472900050
J	Frang, H; Cockcroft, V; Karskela, T; Scheinin, M; Marjamaki, A				Frang, H; Cockcroft, V; Karskela, T; Scheinin, M; Marjamaki, A			Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA(2A)-ADRENERGIC RECEPTOR; MEMBRANE-SPANNING SEGMENT; ALPHA-2-ADRENERGIC RECEPTOR; SITE CREVICE; ALPHA(2)-ADRENOCEPTOR SUBTYPES; CONSTITUTIVE ACTIVATION; LIGAND-BINDING; AMINO-ACIDS; CLONING; GENE	Phenoxybenzamine (PB), a classical a-adrenergic antagonist, binds irreversibly to the a-adrenergic receptors (ARs). Amino acid sequence alignments and the predicted helical arrangement of the seven transmembrane (TM) domains suggested an accessible cysteine residue in transmembrane 3 of the alpha (2)-ARs, in position C-3.36 (in subtypes A, B, and C corresponding to amino acid residue numbers 117/96/135, respectively), as a possible site for the PB interaction. Irreversible binding of PB to recombinant human a2-ARs (90 nm, 30 min) reduced the ligand binding capacity of alpha (2A)-, alpha (2B)-, and alpha (2C)-AR by 81, 96, and 77%. When the TM3 cysteine, Cys(117), of alpha (2A)-AR was mutated to valine (alpha (2A)-C117V), the receptor became resistant to PB (inactivation, 10%). The beta (2)-AR contains a valine in this position (V-3.36; position number 117) and a cysteine in the preceding position (Cys(116)) and was not inactivated by PB (10 mum, 30 min) (inactivation 26%). The helical orientation of TM3 was tested by exchanging the amino acids at positions 116 and 117 of the alpha (2A)-AR and beta (2)-AR. The alpha (2A)-F116C/C117V mutant was resistant to PB (inactivation, 7%), whereas beta (2)-V117C was irreversibly inactivated (inactivation, 93%), confirming that position 3.36 is exposed to receptor ligands, and position 3.35 is not exposed in the binding pocket.	Univ Turku, Dept Pharmacol & Clin Pharmacol, FIN-20520 Turku, Finland; Univ Turku, Dept Bio Organ Chem, FIN-20520 Turku, Finland; Orion Pharma, FIN-20101 Turku, Finland	University of Turku; University of Turku; Orion Corporation	Scheinin, M (corresponding author), Univ Turku, Dept Pharmacol & Clin Pharmacol, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.		Karskela, Tuomas/H-2171-2012	Karskela, Tuomas/0000-0001-6352-5283; Scheinin, Mika/0000-0001-7579-9126				Almaula N, 1996, J BIOL CHEM, V271, P14672, DOI 10.1074/jbc.271.25.14672; BALLESTEROS JA, 1995, RECEPTOR MOL BIOL, P366; Cockcroft V, 2000, J NEUROCHEM, V74, P1705, DOI 10.1046/j.1471-4159.2000.0741705.x; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; HALME M, 1995, BBA-MOL CELL RES, V1266, P207, DOI 10.1016/0167-4889(95)90410-I; Hoffman B.B., 1996, PHARMACOL BASIS THER, P199; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; Javitch JA, 1996, MOL PHARMACOL, V49, P692; JENKINSON DH, 1996, TXB RECEPTOR PHARM, P3; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KOBILKA BK, 1995, PHARM COMMUN, V6, P119; LOMASNEY JW, 1991, BIOCHIM BIOPHYS ACTA, V1095, P127, DOI 10.1016/0167-4889(91)90075-9; LOMASNEY JW, 1990, P NATL ACAD SCI USA, V87, P5094, DOI 10.1073/pnas.87.13.5094; Marjamaki A, 1999, J BIOL CHEM, V274, P21867, DOI 10.1074/jbc.274.31.21867; Marjamaki A, 1998, MOL PHARMACOL, V53, P370, DOI 10.1124/mol.53.3.370; MICHEL MC, 1993, MOL PHARMACOL, V44, P1165; Nyronen T, 2001, MOL PHARMACOL, V59, P1343, DOI 10.1124/mol.59.5.1343; PEPPERL JD, 1994, HDB RECEPTORS CHANNE, P45; Perez DM, 1996, MOL PHARMACOL, V49, P112; PHILLIPS D, 1980, HDB EXPT PHARM ADREN, P3; Pohjanoksa K, 1997, EUR J PHARMACOL, V335, P53, DOI 10.1016/S0014-2999(97)01154-0; Porter JE, 1999, J BIOL CHEM, V274, P34535, DOI 10.1074/jbc.274.49.34535; REGAN JW, 1988, P NATL ACAD SCI USA, V85, P6301, DOI 10.1073/pnas.85.17.6301; RUFFOLO RR, 1995, J MED CHEM, V38, P3681, DOI 10.1021/jm00019a001; Salminen T, 1999, J BIOL CHEM, V274, P23405, DOI 10.1074/jbc.274.33.23405; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Shulman-Roskes EM, 1998, J MED CHEM, V41, P515, DOI 10.1021/jm9704659; WANG CD, 1991, MOL PHARMACOL, V40, P168	32	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31279	31284		10.1074/jbc.M104167200	http://dx.doi.org/10.1074/jbc.M104167200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11395517	hybrid			2022-12-27	WOS:000170472900091
J	Liang, XQ; Nazarian, A; Erdjument-Bromage, H; Bornmann, W; Tempst, P; Resh, MD				Liang, XQ; Nazarian, A; Erdjument-Bromage, H; Bornmann, W; Tempst, P; Resh, MD			Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; T-CELL-RECEPTOR; ALPHA-SUBUNITS; PALMITOYLATION; P59(FYN); MYRISTOYLATION; ARACHIDONATE; TERMINUS; LAT	Fatty acylation of Src family kinases is essential for localization of the modified proteins to the plasma membrane and to plasma membrane rafts. It has been suggested that the presence of saturated fatty acyl chains on proteins is conducive for their insertion into liquid ordered lipid domains present in rafts. The ability of unsaturated dietary fatty acids to be attached to Src family kinases has not been investigated. Here we demonstrate that heterogeneous fatty acylation of Src family kinases occurs and that the nature of the attached fatty acid influences raft-mediated signal transduction. By using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, we show that in addition to 14:0 (myristate), 14:1 and 14:2 fatty acids can be attached to the N-terminal glycine of the Src family kinase Fyn when the growth media are supplemented with these dietary fatty acids. Moreover, we synthesized novel iodinated analogs of oleate and stearate, and we showed that heterogeneous S-acylation can occur on cysteine residues within Fyn as well as G alpha, GAP43, and Ras. Modification of Fyn with unsaturated or polyunsaturated fatty acids reduced its raft localization and resulted in decreased T cell signal transduction. These studies establish that heterogeneous fatty acylation is a widespread occurrence that serves to regulate signal transduction by membrane-bound proteins.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Organ Synth Core Lab, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Resh, MD (corresponding author), Sloan Kettering Inst Canc Res, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10021 USA.	m-resh@ski.mskcc.org		Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Resh, Marilyn/0000-0001-6118-9466	NATIONAL CANCER INSTITUTE [P01CA029502, P30CA029502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966] Funding Source: NIH RePORTER; NCI NIH HHS [CA29502] Funding Source: Medline; NIGMS NIH HHS [GM57966] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAND L, 1994, J BIOL CHEM, V269, P16701; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; DeMar JC, 1997, J BIOL CHEM, V272, P31362, DOI 10.1074/jbc.272.50.31362; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; FUJIMOTO T, 1993, J BIOL CHEM, V268, P11394; HALLAK H, 1994, J BIOL CHEM, V269, P4713; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MUSZBEK L, 1993, J BIOL CHEM, V268, P18243; Muszbek L, 1999, LIPIDS, V34, pS331, DOI 10.1007/BF02562334; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; PESECKIS SM, 1994, J BIOL CHEM, V269, P30888; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; ZENG FY, 1995, J BIOL CHEM, V270, P21382, DOI 10.1074/jbc.270.36.21382; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	34	173	179	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30987	30994		10.1074/jbc.M104018200	http://dx.doi.org/10.1074/jbc.M104018200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11423543	hybrid			2022-12-27	WOS:000170472900054
J	Coulombe, R; Yue, KQ; Ghisla, S; Vrielink, A				Coulombe, R; Yue, KQ; Ghisla, S; Vrielink, A			Oxygen access to the active site of cholesterol oxidase through a narrow channel is gated by an Arg-Glu pair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; CRYSTAL-STRUCTURE; BREVIBACTERIUM-STEROLICUM; BOLL-WEEVIL; SUBSTRATE; BINDING; MECHANISM; FAD	Cholesterol oxidase is a monomeric flavoenzyme that catalyzes the oxidation and isomerization of cholesterol to cholest-4-en-3-one. Two forms of the enzyme are known, one containing the cofactor non-covalently bound to the protein and one in which the cofactor is covalently linked to a histidine residue. The x-ray structure of the enzyme from Brevibacterium sterolicum containing covalently bound FAD has been determined and refined to 1.7-Angstrom resolution. The active site consists of a cavity sealed off from the exterior of the protein. A model for the steroid substrate, cholesterol, can be positioned in the pocket revealing the structural factors that result in different substrate binding affinities between the two known forms of the enzyme. The structure suggests that Glu(475), located at the active site cavity, may act as the base for both the oxidation and the isomerization steps of the catalytic reaction. A water-filled channel extending toward the Ravin moiety, inside the substrate-binding cavity, may act as the entry point for molecular oxygen for the oxidative half-reaction. An arginine and a glutamate residue at the active site, found in two conformations are proposed to control oxygen access to the cavity from the channel. These concerted side chain movements provide an explanation for the biphasic mode of reaction with dioxygen and the ping-pong kinetic mechanism exhibited by the enzyme.	Univ Calif Santa Cruz, Dept Biol, Sinsheimer Lab, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Chem, Sinsheimer Lab, Santa Cruz, CA 95064 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Montreal Joint Ctr Struct Biol, Montreal, PQ H3G 1Y6, Canada; Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; McGill University; McGill University; University of Konstanz	Vrielink, A (corresponding author), Univ Calif Santa Cruz, Dept Biol, Sinsheimer Lab, 1156 High St, Santa Cruz, CA 95064 USA.	vrielink@biology.ucsc.edu	Vrielink, Alice/D-3652-2013	Vrielink, Alice/0000-0001-8197-3725	NIGMS NIH HHS [GM60535] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BENSON TE, 1995, NAT STRUCT BIOL, V2, P644, DOI 10.1038/nsb0895-644; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CORBIN DR, 1994, APPL ENVIRON MICROB, V60, P4239, DOI 10.1128/AEM.60.12.4239-4244.1994; Corbin DR, 1998, HORTSCIENCE, V33, P614, DOI 10.21273/HORTSCI.33.4.614; Croteau N, 1996, J STRUCT BIOL, V116, P317, DOI 10.1006/jsbi.1996.0047; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Fraaije MW, 1998, TRENDS BIOCHEM SCI, V23, P206, DOI 10.1016/S0968-0004(98)01210-9; Ghoshroy KB, 1997, BIOCHEMISTRY-US, V36, P6133, DOI 10.1021/bi962190p; GREENPLATE JT, 1995, ENTOMOL EXP APPL, V74, P253, DOI 10.1007/BF02381789; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kass IJ, 1998, BIOORG MED CHEM LETT, V8, P2663, DOI 10.1016/S0960-894X(98)00478-8; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; MATHEWS FS, 1991, BIOCHEMISTRY-US, V30, P238, DOI 10.1021/bi00215a034; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Pollegioni L, 1999, EUR J BIOCHEM, V264, P140, DOI 10.1046/j.1432-1327.1999.00586.x; PURCELL JP, 1993, BIOCHEM BIOPH RES CO, V196, P1406, DOI 10.1006/bbrc.1993.2409; Riistama S, 1996, BBA-BIOENERGETICS, V1275, P1, DOI 10.1016/0005-2728(96)00040-0; Riistama S, 2000, BIOCHEMISTRY-US, V39, P6365, DOI 10.1021/bi000123w; Sampson NS, 1998, BIOCHEMISTRY-US, V37, P5770, DOI 10.1021/bi973067g; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Vrielink A, 1994, FLAVINS AND FLAVOPROTEINS 1993, P175; VRIELINK A, 1991, J MOL BIOL, V219, P533, DOI 10.1016/0022-2836(91)90192-9; Yue QK, 1999, BIOCHEMISTRY-US, V38, P4277, DOI 10.1021/bi982497j	32	91	93	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30435	30441		10.1074/jbc.M104103200	http://dx.doi.org/10.1074/jbc.M104103200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397813	hybrid, Green Submitted			2022-12-27	WOS:000170558000109
J	Landriscina, M; Soldi, R; Bagala, C; Micucci, I; Bellum, S; Tarantini, F; Prudovsky, I; Maciag, T				Landriscina, M; Soldi, R; Bagala, C; Micucci, I; Bellum, S; Tarantini, F; Prudovsky, I; Maciag, T			S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CALCIUM-BINDING PROTEINS; DISTINCT ANTIALLERGIC DRUGS; CELL-GROWTH; SUBCELLULAR-LOCALIZATION; CHEMOTACTIC PROTEIN; T-PA; SYNAPTOTAGMIN-1; AMLEXANOX; FAMILY	S100A13, a member of the S100 gene family of Ca2+-binding proteins has been previously characterized as a component of a brain-derived heparin-binding multiprotein aggregate/complex containing fibroblast growth factor 1 (FGF1). We report that while expression of S100A13 in NIH 3T3 cells results in the constitutive release of S100A13 into the extracellular compartment at 37 degreesC, co expression of S100A13 with FGF1 represses the constitutive release of S100A13 and enables NIH 3T3 cells to release S100A13 in response to temperature stress. S100A13 release in response to stress occurs with kinetics similar to that observed for the stress-induced release of FGF1, but S100A13 expression is able to reverse the sensitivity of FGF1 release to inhibitors of transcription and translation. The release of FGF1 and S100A13 in response to heat shock, results in the solubility of FGF1 at 100% (w/v) ammonium sulfate saturation, and the expression of a S100A13 deletion mutant lacking its novel basic residue-rich domain acts as a dominant negative effector of FGF1 release in vitro. Surprisingly, the expression of S100A13 also results in the stress-induced release of a Cys-free FGF1 mutant, which is normally not released from NM: 3T3 cells in response to heat shock. These data suggest that S100A13 may be a component of the pathway for the release of the signal peptide-less polypeptide, FGF1, and may involve a role for S100A13 in the formation of a noncovalent FGF1 homodimer.	Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	Maine Medical Center	Maciag, T (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	maciat@mmc.org	Landriscina, Matteo/K-1092-2016; Bagalà, Cinzia/AAB-8981-2019; Tarantini, Francesca/I-6332-2012; Prudovsky, Igor/GVU-1521-2022	TARANTINI, FRANCESCA/0000-0002-1390-2965; Landriscina, Matteo/0000-0003-0591-9799	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032348] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32348] Funding Source: Medline; NIA NIH HHS [AG98503] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrejevic S, 1997, INT J NEUROSCI, V89, P153, DOI 10.3109/00207459708988471; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1993, J NEUROSCI, V13, P1701; Bergmeyer H.U., 1965, METHODS ENZYMATIC AN, P736, DOI [10.1016/b978-0-12-395630-9.50134-1, DOI 10.1016/B978-0-12-395630-9.50134-1]; Bevers EM, 1996, LUPUS, V5, P480, DOI 10.1177/096120339600500531; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; BURGESS WH, 1985, J BIOL CHEM, V260, P1389; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; CARREIRA CM, 2001, IN PRESS GROWTH FACT; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Damer CK, 1996, J NEUROCHEM, V67, P1661; DAS BK, 1992, BIOCHEM INT, V28, P775; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Duarte WR, 1998, J DENT RES, V77, P1694, DOI 10.1177/00220345980770090501; ENGLEKA KA, 1992, J BIOL CHEM, V267, P11307; Friesel R, 1999, THROMB HAEMOSTASIS, V82, P748; Geczy C, 1996, BBA-MOL CELL RES, V1313, P246, DOI 10.1016/0167-4889(96)00096-1; Hajjar KA, 1999, TRENDS CARDIOVAS MED, V9, P128, DOI 10.1016/S1050-1738(99)00020-1; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hou XE, 1998, J NEUROCYTOL, V27, P441, DOI 10.1023/A:1006988528655; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; HUANG B, 1988, J CELL BIOL, V107, P121, DOI 10.1083/jcb.107.1.121; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Kang HM, 1997, BIOCHEMISTRY-US, V36, P2041, DOI 10.1021/bi962569b; Kassam G, 1998, BIOCHEMISTRY-US, V37, P16958, DOI 10.1021/bi981713l; Landriscina M, 2000, J BIOL CHEM, V275, P32753, DOI 10.1074/jbc.M002336200; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; LaVallee TM, 1998, J BIOL CHEM, V273, P22217, DOI 10.1074/jbc.273.35.22217; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Mailliard WS, 1996, J BIOL CHEM, V271, P719, DOI 10.1074/jbc.271.2.719; Mandinova A, 1998, J CELL SCI, V111, P2043; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nishikawa T, 1997, J BIOL CHEM, V272, P23037, DOI 10.1074/jbc.272.37.23037; Oyama Y, 1997, BIOCHEM BIOPH RES CO, V240, P341, DOI 10.1006/bbrc.1997.7476; Porta AR, 1996, MOL BRAIN RES, V41, P81; Rammes A, 1997, J BIOL CHEM, V272, P9496; Ridinger K, 2000, J BIOL CHEM, V275, P8686, DOI 10.1074/jbc.275.12.8686; SANO H, 1990, J CELL BIOL, V110, P1417, DOI 10.1083/jcb.110.4.1417; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schafer BW, 2000, J BIOL CHEM, V275, P30623, DOI 10.1074/jbc.M002260200; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; SHASHOUA VE, 1984, J NEUROCHEM, V42, P1536, DOI 10.1111/j.1471-4159.1984.tb12739.x; Shin JT, 1996, BBA-MOL CELL RES, V1312, P27, DOI 10.1016/0167-4889(96)00013-4; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; STASIA MJ, 1989, BIOCHEMISTRY-US, V28, P9659, DOI 10.1021/bi00451a018; Tarantini F, 1998, J BIOL CHEM, V273, P22209, DOI 10.1074/jbc.273.35.22209; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; Tarantini F, 2001, J BIOL CHEM, V276, P5147, DOI 10.1074/jbc.C000714200; THOMAS KA, 1985, P NATL ACAD SCI USA, V82, P6409, DOI 10.1073/pnas.82.19.6409; VANELDIK LJ, 1987, BRAIN RES, V436, P367, DOI 10.1016/0006-8993(87)91681-7; Wicki R, 1996, BIOCHEM BIOPH RES CO, V227, P594, DOI 10.1006/bbrc.1996.1551; Yen T, 1997, BLOOD, V90, P4812, DOI 10.1182/blood.V90.12.4812.4812_4812_4821; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446	61	71	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22544	22552		10.1074/jbc.M100546200	http://dx.doi.org/10.1074/jbc.M100546200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11410600	hybrid			2022-12-27	WOS:000169412700077
J	Spencer, VA; Davie, JR				Spencer, VA; Davie, JR			Dynamically acetylated histone association with transcriptionally active and competent genes in the avian adult beta-globin gene domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICKEN ERYTHROCYTES; NUCLEAR MATRIX; NUCLEOTIDE-SEQUENCE; CHROMATIN; IMMATURE; HYPERACETYLATION; SOLUBILITY; CELLS; RATES; RNA	In chicken immature erythrocytes, class 1 acetylated histones are rapidly tri- and tetra-acetylated and rapidly deacetylated. Class 2 acetylated H3 and H4 are rapidly acetylated to mono- and di-acetylated isoforms and slowly deacetylated. Our previous studies suggested that class 1 acetylated histones were primarily associated with transcriptionally active DNA (beta (A)-globin) but not competent DNA (epsilon -globin). Chromatin salt solubility (chromatin fiber oligomerization) is directly influenced by hyperacetylation. In this study we investigated the association of class 1 histones with beta (A)- and epsilon -globin DNA by measuring their loss of solubility rates in 150 mM NaCl and 3 mM MgCl2 as a function of hyperacetylated histone deacetylation. Expressed and competent chromatin was associated with class I acetylated histones. As most active chromatin and hyperacetylated histones are associated with the low salt-insoluble residual nuclear material containing the nuclear matrix, we investigated whether hyperacetylated histones are bound to the beta (A)- and epsilon -globin DNA in this fraction. In chromatin. immunoprecipitation assays, we found that the beta (A)- and epsilon -globin coding regions are bound to hyperacetylated H3 and H4. Our observations are consistent with a model in which nuclear matrix-associated histone acetyltransferases and deacetylases mediate a dynamic attachment between active and competent chromatin and the nuclear matrix.	Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	Davie, JR (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.	Davie@cc.umaritoba.ca		Davie, James/0000-0002-0420-6888				ALONSO WR, 1987, NUCLEIC ACIDS RES, V15, P9325, DOI 10.1093/nar/15.22.9325; Davie JR, 1999, J CELL BIOCHEM, P141; DELCUVE GP, 1989, BIOCHEM J, V263, P179, DOI 10.1042/bj2630179; DODGSON JB, 1983, J BIOL CHEM, V258, P2685; DOLAN M, 1983, J BIOL CHEM, V258, P3983; FERENZ CR, 1985, NUCLEIC ACIDS RES, V13, P1977, DOI 10.1093/nar/13.6.1977; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; HENDZEL MJ, 1994, J BIOL CHEM, V269, P22894; HENDZEL MJ, 1991, J BIOL CHEM, V266, P21936; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nickerson JA, 1997, P NATL ACAD SCI USA, V94, P4446, DOI 10.1073/pnas.94.9.4446; RIDSDALE JA, 1990, J BIOL CHEM, V265, P5150; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Walia H, 1998, J BIOL CHEM, V273, P14516, DOI 10.1074/jbc.273.23.14516; Wang XY, 2001, J BIOL CHEM, V276, P12764, DOI 10.1074/jbc.M100501200; ZHANG DE, 1988, BIOCHEM J, V250, P241, DOI 10.1042/bj2500241; ZHANG DE, 1988, BIOCHEM J, V250, P233, DOI 10.1042/bj2500233; ZHANG DE, 1986, BIOCHEM J, V240, P857, DOI 10.1042/bj2400857	19	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34810	34815		10.1074/jbc.M104886200	http://dx.doi.org/10.1074/jbc.M104886200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11435438	hybrid			2022-12-27	WOS:000171024600063
J	Cho, SY; Tian, Y; Benjamin, TL				Cho, SY; Tian, Y; Benjamin, TL			Binding of p300/CBP co-activators by polyoma large T antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; PROTEIN PHOSPHATASE-2A; COACTIVATORS P300; TUMOR-INDUCTION; MIDDLE-T; TRANSCRIPTIONAL COACTIVATORS; HISTONE ACETYLTRANSFERASES; PHOSPHORYLATED CREB; RAT FIBROBLASTS; E6 ONCOPROTEIN	Small DNA tumor viruses such as simian virus 40 (SV40) and polyomavirus (Py) take advantage of host cell proteins to transcribe and replicate their DNA. Interactions between the viral T antigens and host proteins result in cell transformation and tumor induction. Large T antigen of SV40 interacts with p53, pRb/p107/ p130 family members, and the cyclic AMP-responsive element-binding protein (CREB)-binding protein (CBP)/ p300. Py large T antigen is known to interact only with pRb and p300 among these proteins. Here we report that Py large T binds to CBP in vivo and in vitro. In cotransfection assays, Py large T inhibits the co-activation functions of CBP/p300 in CREB-mediated transactivation but not in NF-kappaB-mediated transactivation. p53 appears not to be involved in the functions of CREB-mediated transactivation and is not essential for large T:CBP interaction. Mutations introduced into a region of Py large T with homology to adenovirus EIA and SV40 large T prevent binding to the co-activators. These mutant large T antigens fail to inhibit CREB-mediated transactivation. The CBP/p300-binding Py mutants are able to transform established rat embryo fibroblasts but are restricted in their ability to induce tumors in the newborn mouse, indicating that interaction of large T with the co-activators may be essential for virus replication and spread in the intact host.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Benjamin, TL (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [P01CA050661, R35CA044343] Funding Source: NIH RePORTER; NCI NIH HHS [R35 CA 44343, P01 CA50661] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexiadis V, 1997, CHROMOSOMA, V105, P324; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; BOWLUS CL, 1991, J BIOL CHEM, V266, P1122; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen YC, 1999, ONCOGENE, V18, P139, DOI 10.1038/sj.onc.1202272; Cho-Chung YS, 2000, MOL CELL BIOCHEM, V212, P29, DOI 10.1023/A:1007144618589; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DAWE CJ, 1987, AM J PATHOL, V127, P243; Dey DC, 2000, CELL GROWTH DIFFER, V11, P231; Doherty J, 1997, ONCOGENE, V14, P1923, DOI 10.1038/sj.onc.1201025; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, MOL CELL BIOL, V16, P3454; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FREUND R, 1994, J VIROL, V68, P7227, DOI 10.1128/JVI.68.11.7227-7234.1994; FREUND R, 1992, ONCOGENE, V7, P1979; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Grand RJA, 1998, VIROLOGY, V244, P330, DOI 10.1006/viro.1998.9102; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; LAROSE A, 1991, J VIROL, V65, P2308, DOI 10.1128/JVI.65.5.2308-2313.1991; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lill NL, 1997, J VIROL, V71, P129, DOI 10.1128/JVI.71.1.129-137.1997; LUKACHER AE, 1993, VIROLOGY, V196, P241, DOI 10.1006/viro.1993.1472; Marcellus RC, 1996, CELL GROWTH DIFFER, V7, P1643; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nemethova M, 1999, J VIROL, V73, P1734, DOI 10.1128/JVI.73.2.1734-1739.1999; Nicot C, 2000, MOL CELL BIOL, V20, P8580, DOI 10.1128/MCB.20.22.8580-8589.2000; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PETERSON SR, 1995, CANCER RES, V55, P4651; RAPTIS L, 1985, MOL CELL BIOL, V5, P2476, DOI 10.1128/MCB.5.9.2476; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; RONAI Z, 1994, ENVIRON MOL MUTAGEN, V23, P157, DOI 10.1002/em.2850230302; SCHAFFHAUSEN BS, 1976, P NATL ACAD SCI USA, V73, P1092, DOI 10.1073/pnas.73.4.1092; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Van Orden K, 2000, GENE EXPRESSION, V9, P29; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; Wang L, 2000, P NATL ACAD SCI USA, V97, P430, DOI 10.1073/pnas.97.1.430; WHEAT WH, 1994, MOL CELL BIOL, V14, P5881, DOI 10.1128/MCB.14.9.5881; WONG HK, 1994, J VIROL, V68, P4910, DOI 10.1128/JVI.68.8.4910-4920.1994; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; ZHENG DQ, 1994, ONCOGENE, V9, P3345; Zimmermann H, 1999, J VIROL, V73, P6209, DOI 10.1128/JVI.73.8.6209-6219.1999	57	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33533	33539		10.1074/jbc.M102906200	http://dx.doi.org/10.1074/jbc.M102906200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11438528	hybrid			2022-12-27	WOS:000170910200034
J	Li, B; Trueb, B				Li, B; Trueb, B			Analysis of the alpha-actinin/zyxin interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CONTACT PROTEIN; ZYXIN-RELATED PROTEIN; DOMAIN; BINDING; IDENTIFICATION; ACTIN; PDZ; PURIFICATION; ADHESION; CRP1	The yeast two-hybrid system was used to search for interaction partners of human zyxin. Screening of two different cDNA libraries, one prepared from human placenta, the other from human heart, yielded several positive clones that occurred in both searches, including clones coding for cyclophilin, nebulette, and a-actinin. The zyxin/alpha -actinin interaction was analyzed in detail. By site-directed mutagenesis, a linear motif of 6 amino acids (Phe-Gly-Pro-Val-Val-Ala) present at the N terminus of zyxin was found to play a critical role. Replacement of a single amino acid within this motif abolished binding to a-actinin in blot overlays as well as in living cells. On the other hand, the interaction site in a-actinin was mapped to a conformational. determinant present in the center of the protein as demonstrated by a fragment deletion analysis. This binding site involved a tandem array of two complete spectrin-like domains. Only fragments that were able to dimerize in yeast also bound to zyxin, suggesting that dimerization of ix-actinin is essential for zyxin binding.	Univ Bern, ME Muller Inst Biomech, CH-3010 Bern, Switzerland	University of Bern	Trueb, B (corresponding author), Univ Bern, ME Muller Inst Biomech, POB 30, CH-3010 Bern, Switzerland.	trueb@mem.unibe.ch	Trueb, Beat/AAL-9621-2020	Trueb, Beat/0000-0001-8684-6856				Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; COSTA GL, 1995, STRATAGENE STRATEGIE, V8, P6; CRAWFORD AW, 1991, J BIOL CHEM, V266, P5847; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; CRITCHLEY DR, 1999, GUIDEBOOK EXTRACELLU, P17; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Drees BE, 1999, J CELL BIOL, V147, P1549, DOI 10.1083/jcb.147.7.1549; DRESS BE, 1999, GUIDEBOOK EXTRACELLU, P95; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Golsteyn RM, 1997, J CELL SCI, V110, P1893; Hobert O, 1996, ONCOGENE, V12, P1577; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Macalma T, 1996, J BIOL CHEM, V271, P31470, DOI 10.1074/jbc.271.49.31470; MILLAKE DB, 1989, NUCLEIC ACIDS RES, V17, P6725, DOI 10.1093/nar/17.16.6725; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; Murthy KK, 1999, J BIOL CHEM, V274, P20679, DOI 10.1074/jbc.274.29.20679; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nieset JE, 1997, J CELL SCI, V110, P1013; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; Pomies P, 1997, J CELL BIOL, V139, P157, DOI 10.1083/jcb.139.1.157; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; Schenker T, 2000, BBA-GENE STRUCT EXPR, V1493, P255, DOI 10.1016/S0167-4781(00)00167-6; Schmeichel KL, 1998, BIOCHEM J, V331, P885, DOI 10.1042/bj3310885; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; WILLIMANN TE, 1994, J BIOL CHEM, V269, P332; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Zumbrunn J, 1996, EUR J BIOCHEM, V241, P657, DOI 10.1111/j.1432-1033.1996.00657.x	35	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33328	33335		10.1074/jbc.M100789200	http://dx.doi.org/10.1074/jbc.M100789200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11423549	hybrid			2022-12-27	WOS:000170910200008
J	Tikhomirov, O; Carpenter, G				Tikhomirov, O; Carpenter, G			Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90-BASED CHAPERONE SYSTEM; TYROSINE KINASE-ACTIVITY; CARCINOMA CELL-LINES; HUMAN-BREAST-CANCER; HEAT-SHOCK-PROTEIN; INDUCED APOPTOSIS; AUTOPHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; DOWN-REGULATION; GENE-PRODUCT	The geldanamycin-induced degradation of ErbB-2 produces a 23-kDa carboxyl-terminal fragment, which has been isolated and subjected to amino-terminal microsequencing. The obtained sequence indicates that the amino terminus of this fragment corresponds to Gly-1126 of ErbB-2. Analysis of the residues immediately before Gly-1126 suggests that cleavage may involve caspase activity. Site-directed mutagenesis of Asp-1125 in ErbB-2 prevents geldanamycin-provoked formation of the 23-kDa fragment, consistent with the requirement of this residue for caspase-dependent cleavage in known substrates. Also, the addition of the pan-caspase inhibitor Z-VAD-FMK blocks formation of the 23-kDa ErbB-2 fragment in cells exposed to geldanamycin. Interestingly, staurosporin and curcumin are also shown to provoke the degradation of ErbB-2 with formation of the 23-kDa carboxyl-terminal fragment. The generation of this fragment by staurosporin or curcumin is likewise blocked by caspase inhibition. Caspase inhibition does not prevent accelerated degradation of the 185-kDa native ErbB-2 in geldanamycin-treated cells but does significantly prevent staurosporin-stimulated metabolic loss of ErbB-2.	Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Carpenter, G (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	grahamcarpenter@mcmail.vanderbilt.edu						Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Andersson M, 2000, INVEST OPHTH VIS SCI, V41, P2623; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Chavany C, 1996, J BIOL CHEM, V271, P4974; Chen H, 1999, ANTICANCER RES, V19, P3675; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Davis MA, 1999, TOXICOL APPL PHARM, V161, P59, DOI 10.1006/taap.1999.8765; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DIMARCO E, 1990, MOL CELL BIOL, V11, P3191; HAZAN R, 1990, CELL GROWTH DIFFER, V1, P3; Hong RL, 1999, CLIN CANCER RES, V5, P1884; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Khan SM, 2000, FERTIL STERIL, V74, P359, DOI 10.1016/S0015-0282(00)00633-6; Khar A, 1999, FEBS LETT, V445, P165, DOI 10.1016/S0014-5793(99)00114-3; Klapper LN, 2000, ADV CANCER RES, V77, P25; Kominsky SL, 2000, CANCER RES, V60, P3904; KUMAR R, 1991, MOL CELL BIOL, V11, P979, DOI 10.1128/MCB.11.2.979; Kuo CT, 1996, MATH PROBL ENG, V3, P95, DOI 10.1155/S1024123X97000501; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Mandler R, 2000, J NATL CANCER I, V92, P1573, DOI 10.1093/jnci/92.19.1573; Margolin N, 1997, J BIOL CHEM, V272, P7223, DOI 10.1074/jbc.272.11.7223; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; McColl KS, 1998, MOL CELL ENDOCRINOL, V139, P229, DOI 10.1016/S0303-7207(98)00051-3; MILLER P, 1994, CANCER RES, V54, P2724; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nimmanapalli R, 2001, CANCER RES, V61, P1799; Ochel HJ, 1999, MOL GENET METAB, V66, P24, DOI 10.1006/mgme.1998.2774; OMURA S, 1979, J ANTIBIOT, V32, P255, DOI 10.7164/antibiotics.32.255; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; Ramachandran C, 1999, BREAST CANCER RES TR, V54, P269, DOI 10.1023/A:1006170224414; Revillion F, 1998, EUR J CANCER, V34, P791, DOI 10.1016/S0959-8049(97)10157-5; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Roh H, 2000, CANCER RES, V60, P560; Rokhlin OW, 1998, CANCER RES, V58, P5870; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; SEGATTO O, 1988, MOL CELL BIOL, V8, P5570, DOI 10.1128/MCB.8.12.5570; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tikhomirov O, 2000, J BIOL CHEM, V275, P26625, DOI 10.1074/jbc.M003114200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; You XL, 1998, ONCOGENE, V17, P3177, DOI 10.1038/sj.onc.1202246; Zhou BP, 2000, J BIOL CHEM, V275, P8027, DOI 10.1074/jbc.275.11.8027	53	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33675	33680		10.1074/jbc.M101394200	http://dx.doi.org/10.1074/jbc.M101394200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11402024	hybrid			2022-12-27	WOS:000170910200053
J	Torrents, E; Eliasson, R; Wolpher, H; Graslund, A; Reichard, P				Torrents, E; Eliasson, R; Wolpher, H; Graslund, A; Reichard, P			The anaerobic ribonucleotide reductase from Lactococcus lactis - Interactions between the two proteins NrdD and NrdG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CENTER; ELECTRON-PARAMAGNETIC-RESONANCE; PYRUVATE FORMATE-LYASE; ESCHERICHIA-COLI; LYSINE 2,3-AMINOMUTASE; BIOTIN SYNTHASE; ENZYME; EVOLUTION; CLUSTERS; 2FE-2S	Deoxyribonucleotide synthesis by anaerobic class III ribonucleotide reductases requires two proteins, NrdD and NrdG. NrdD contains catalytic and allosteric sites and, in its active form, a stable glycyl radical. This radical is generated by NrdG with its [4Fe-4S](+) cluster and S-adenosylmethionine. We now find that. NrdD and NrdG from Lactobacillus lactis anaerobically form a tight alpha (2)beta (2) complex, suggesting that radical generation by NrdG and radical transfer to the specific glycine residue of NrdD occurs within the complex. Activated NrdD was separated from NrdG by anaerobic affinity chromatography on dATP-Sepharose without loss of its glycyl radical NrdD alone then catalyzed the reduction of CTP with formate, as the electron donor and ATP as the allosteric effector. The reaction required Mg2+ and was stimulated by K+ but not by dithiothreitol. Thus NrdD is the actual reductase, and NrdG is an activase, making class III reductases highly similar to pyruvate formate lyase and its activase and suggesting a common root for the two anaerobic enzymes during early evolution. Our results further support the contention that ribonucleotide reduction during transition from an RNA world to a DNA world started with a class III-like enzyme from which other reductases evolved when oxygen appeared on earth.	Karolinska Inst, MBB, Med Nobel Inst, Dept Biochem, SE-17177 Stockholm, Sweden; Univ Autonoma Barcelona, Bacterial Mol Genet Inst Biotecnol & Biomed, E-08193 Bellaterra, Spain; Univ Stockholm, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Karolinska Institutet; Autonomous University of Barcelona; Stockholm University	Reichard, P (corresponding author), Karolinska Inst, Dept Biochem 1, SE-17177 Stockholm, Sweden.	peter.reichard@mbb.ki.se	Torrents, Eduard/C-7184-2008	Torrents, Eduard/0000-0002-3010-1609				Becker A, 1999, NAT STRUCT BIOL, V6, P969; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cosper NJ, 2000, BIOCHEMISTRY-US, V39, P15668, DOI 10.1021/bi0022184; Duin EC, 1997, BIOCHEMISTRY-US, V36, P11811, DOI 10.1021/bi9706430; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FONTECAVE M, 1992, ADV ENZYMOL RAMB, V65, P147; FONTECAVE M, 1989, P NATL ACAD SCI USA, V86, P2147, DOI 10.1073/pnas.86.7.2147; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; KESSLER D, 1996, ESCHERICHIA COLI SAL, P1999; KING TE, 1976, METHOD ENZYMOL, V110, P634; Krieger CJ, 2001, J BIOL CHEM, V276, P12924, DOI 10.1074/jbc.M009453200; Lieder KW, 1998, BIOCHEMISTRY-US, V37, P2578, DOI 10.1021/bi972417w; Liu A, 2000, J BIOL CHEM, V275, P12367, DOI 10.1074/jbc.275.17.12367; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Magnusson OT, 1999, J AM CHEM SOC, V121, P9764, DOI 10.1021/ja9925507; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; MULLIEZ E, 1995, P NATL ACAD SCI USA, V92, P8759, DOI 10.1073/pnas.92.19.8759; Ollagnier S, 1996, J BIOL CHEM, V271, P9410, DOI 10.1074/jbc.271.16.9410; Ollagnier S, 1999, J AM CHEM SOC, V121, P6344, DOI 10.1021/ja990073m; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Ollagnier-de Choudens S, 2000, BIOCHEMISTRY-US, V39, P4165, DOI 10.1021/bi992090u; Reichard P, 1997, TRENDS BIOCHEM SCI, V22, P81, DOI 10.1016/S0968-0004(97)01003-7; REICHARD P, 1993, J BIOL CHEM, V268, P8383; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stuber F, 1998, PROD PLAN CONTROL, V9, P705, DOI 10.1080/095372898233713; Tamarit J, 1999, J BIOL CHEM, V274, P31291, DOI 10.1074/jbc.274.44.31291; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996	32	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33488	33494		10.1074/jbc.M103743200	http://dx.doi.org/10.1074/jbc.M103743200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11427536	hybrid			2022-12-27	WOS:000170910200028
J	Church, WB; Inglis, AS; Tseng, A; Duell, R; Lei, PW; Bryant, KJ; Scott, KF				Church, WB; Inglis, AS; Tseng, A; Duell, R; Lei, PW; Bryant, KJ; Scott, KF			A novel approach to the design of inhibitors of human secreted phospholipase A(2) based on native peptide inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; RATIONAL DESIGN; SEPTIC SHOCK; MAST-CELLS; EXPRESSION; PROTEIN; POTENT; INFLAMMATION; PATHWAYS	Human Type IIA secreted phospholipase A(2) (sPIA(2)-IIA) is an important modulator of cytokine-dependent inflammatory responses and a member of a growing superfamily of structurally related phospholipases. We have previously shown that sPLA(2)-IIA is inhibited by a pentapeptide sequence comprising residues 70-74 of the native sPLA2-IIA protein and that peptides derived from the equivalent region of different sPLA(2)-IIA species specifically inhibit the enzyme from which they are derived. We have now used an analogue screen of the human pentapeptide (70)FLSyK(74) in which side-chain residues were substituted, together with molecular docking approaches that modeled low-energy conformations of (FLSYK74)-F-70 bound to human sPLA(2)-IIA, to generate inhibitors with improved potency. Importantly, the modeling studies showed a close association between the NH2 and COOH termini of the peptide, predicting significant enhancement of the potency of inhibition by cyclization. Cyclic compounds were synthesized and indeed showed 5-50-fold increased potency over the linear peptide in an Escherichia coli membrane assay. Furthermore, the potency of inhibition correlated with steady-state binding of the cyclic peptides to sPIA2-IIA as determined by surface plasmon resonance studies. Two potential peptide interaction sites were identified on sPLA(2)-IIA from the modeling studies, one in the NH2-terminal helix and the other in the beta -wing region, and in vitro association assays support the potential for interaction of the peptides with these sites. The inhibitors were effective at nanomolar concentrations in blocking sPLA(2)-IIA-mediated amplification of cytokine-induced prostaglandin synthesis in human rheumatoid synoviocytes in culture. These studies provide an example where native peptide sequences can be used for the development of potent and selective inhibitors of enzyme function.	Univ New S Wales, St Vincents Hosp, Sch Clin, Dept Med, Sydney, NSW 2010, Australia; Univ New S Wales, St Vincents Hosp, Garvan Inst Med Res, Arthrit & Inflammat Res Programme, Sydney, NSW 2010, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Scott, KF (corresponding author), Univ New S Wales, St Vincents Hosp, Sch Clin, Dept Med, L10 Garvan Bldg,384 Victoria St, Sydney, NSW 2010, Australia.		Bryant, Katherine/E-8574-2010; Church, William/H-6040-2013	Bryant, Katherine/0000-0002-8686-623X; Church, William/0000-0002-8033-5518; Scott, Kieran/0000-0002-6012-4107				ANDERSEN S, 1994, INFLAMMATION, V18, P1, DOI 10.1007/BF01534593; Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; BAYBURT T, 1993, BIOCHEMISTRY-US, V32, P573, DOI 10.1021/bi00053a024; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bidgood MJ, 2000, J IMMUNOL, V165, P2790, DOI 10.4049/jimmunol.165.5.2790; BOMALASKI JS, 1991, J IMMUNOL, V146, P3904; Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; CIRINO G, 1994, J RHEUMATOL, V21, P824; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; Gelb MH, 2000, J BIOL CHEM, V275, P39823, DOI 10.1074/jbc.C000671200; GREEN JA, 1991, INFLAMMATION, V15, P355, DOI 10.1007/BF00917352; Jamal OS, 1998, ANN RHEUM DIS, V57, P550, DOI 10.1136/ard.57.9.550; KIM DK, 1995, AM J PHYSIOL, V269, P109; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812; Lin MKS, 1996, J RHEUMATOL, V23, P1162; MINAMI T, 1994, GUT, V35, P1593, DOI 10.1136/gut.35.11.1593; *MOL SIM INC, 1995, INS 2 DISC US GUID V; MONTGOMERY JA, 1993, J MED CHEM, V36, P55, DOI 10.1021/jm00053a008; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1351; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; REICH SH, 1992, J MED CHEM, V35, P847, DOI 10.1021/jm00083a007; RICE GE, 1992, EICOSANOIDS, V5, P9; Sawada H, 1999, EUR J BIOCHEM, V263, P826, DOI 10.1046/j.1432-1327.1999.00565.x; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; Scott KF, 1999, J LEUKOCYTE BIOL, V66, P535, DOI 10.1002/jlb.66.4.535; Shen BJ, 1996, EUR J BIOCHEM, V240, P252, DOI 10.1111/j.1432-1033.1996.0252h.x; SMITH GM, 1992, BRIT J RHEUMATOL, V31, P175; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Tada K, 1998, J IMMUNOL, V161, P5008; Tseng A, 1996, J BIOL CHEM, V271, P23992, DOI 10.1074/jbc.271.39.23992; VADAS P, 1984, J LAB CLIN MED, V104, P873; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Valentin E, 1999, J BIOL CHEM, V274, P19152, DOI 10.1074/jbc.274.27.19152; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0	39	38	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33156	33164		10.1074/jbc.M101272200	http://dx.doi.org/10.1074/jbc.M101272200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11427527	hybrid			2022-12-27	WOS:000170746000102
J	Garavito, RM; Ferguson-Miller, S				Garavito, RM; Ferguson-Miller, S			Detergents as tools in membrane biochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYTOCHROME-C-OXIDASE; MOLECULAR-DYNAMICS SIMULATIONS; PHOTOSYNTHETIC REACTION-CENTER; PROTEIN CRYSTALLIZATION; ANGSTROM RESOLUTION; SARCOPLASMIC-RETICULUM; OMPF PORIN; BACTERIORHODOPSIN CRYSTALS; RHODOBACTER-SPHAEROIDES; SURFACTANT ASSOCIATION	Detergents are invaluable tools for studying membrane proteins. However, these deceptively simple, amphipathic molecules exhibit complex behavior when they self-associate and interact with other molecules. The phase behavior and assembled structures of detergents are markedly influenced not only by their unique chemical and physical properties but also by concentration, ionic conditions, and the presence of other lipids and proteins. In this minireview, we discuss the various aggregate forms detergents assume and some misconceptions about their structure. The distinction between detergents and the membrane lipids that they may (or may not) replace is emphasized in the most recent high resolution structures of membrane proteins. Detergents are clearly friends and foes, but with the knowledge of how they work, we can use the increasing variety of detergents to our advantage.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Garavito, RM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	garavito@msu.edu; fergus20@msu.edu			NHLBI NIH HHS [HL56773] Funding Source: Medline; NIGMS NIH HHS [P01 GM57323] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057323] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214; BANERJEE P, 1995, CHEM PHYS LIPIDS, V77, P65, DOI 10.1016/0009-3084(95)02455-R; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bogusz S, 2000, J PHYS CHEM B, V104, P5462, DOI 10.1021/jp000159y; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Briggs J, 1996, J PHYS II, V6, P723, DOI 10.1051/jp2:1996208; DEFORESTA B, 1994, EUR J BIOCHEM, V223, P359; DEGRIP WJ, 1982, METHOD ENZYMOL, V81, P256; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Garavito RM, 1996, J BIOENERG BIOMEMBR, V28, P13, DOI 10.1007/BF02150674; GARAVITO RM, 1986, J CRYST GROWTH, V76, P701, DOI 10.1016/0022-0248(86)90187-9; GUNNARSSON G, 1980, J PHYS CHEM-US, V84, P3114, DOI 10.1021/j100460a029; Haneskog L, 1996, BBA-BIOMEMBRANES, V1282, P39, DOI 10.1016/0005-2736(96)00031-4; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; Helenius A, 1979, Methods Enzymol, V56, P734; Hitscherich C, 2000, PROTEIN SCI, V9, P1559, DOI 10.1110/ps.9.8.1559; HORVATH LI, 1993, BIOPHYS J, V64, P622, DOI 10.1016/S0006-3495(93)81421-8; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kragh-Hansen U, 1998, BIOPHYS J, V75, P2932, DOI 10.1016/S0006-3495(98)77735-5; KUHLBRANDT W, 1988, Q REV BIOPHYS, V21, P429, DOI 10.1017/S0033583500004625; Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; LEMAIRE M, 1983, EUR J BIOCHEM, V129, P525; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; LUND S, 1989, J BIOL CHEM, V264, P4907; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MAHAPATRO SN, 1990, BIOCHEMISTRY-US, V29, P764, DOI 10.1021/bi00455a025; Marone PA, 1999, J CRYST GROWTH, V207, P214, DOI 10.1016/S0022-0248(99)00372-3; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706; MENGER FM, 1979, ACCOUNTS CHEM RES, V12, P111, DOI 10.1021/ar50136a001; MICHEL H, 1982, EMBO J, V1, P1267, DOI 10.1002/j.1460-2075.1982.tb00023.x; MITCHELL DJ, 1983, J CHEM SOC FARAD T 1, V79, P975, DOI 10.1039/f19837900975; Musatov A, 2000, BIOCHEMISTRY-US, V39, P12996, DOI 10.1021/bi000884z; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; NILSSON PG, 1983, J PHYS CHEM-US, V87, P1377, DOI 10.1021/j100231a021; Nollert P, 1999, FEBS LETT, V457, P205, DOI 10.1016/S0014-5793(99)01014-5; Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PEBAYPEYROULA E, 1995, STRUCTURE, V3, P1051, DOI 10.1016/S0969-2126(01)00241-6; Penel S, 1998, BIOCHIMIE, V80, P543, DOI 10.1016/S0300-9084(00)80019-X; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rosen MJ., 2004, SURFACTANTS INTERFAC, V3rd edn; ROTH M, 1991, BIOCHEMISTRY-US, V30, P9403, DOI 10.1021/bi00103a003; ROTH M, 1989, NATURE, V340, P659, DOI 10.1038/340659a0; Sivars U, 2000, BBA-GEN SUBJECTS, V1474, P133, DOI 10.1016/S0304-4165(99)00208-1; TANFORD C, 1976, BIOCHIM BIOPHYS ACTA, V457, P133, DOI 10.1016/0304-4157(76)90009-5; TANFORD C, 1980, HYDROPHOBIC EFFECT; Tanio M, 1998, BBA-BIOMEMBRANES, V1375, P84, DOI 10.1016/S0005-2736(98)00151-5; THIYAGARAJAN P, 1994, J PHYS CHEM-US, V98, P10343, DOI 10.1021/j100091a058; Thomas MJ, 1999, BBA-BIOMEMBRANES, V1417, P144, DOI 10.1016/S0005-2736(98)00254-5; THOMPSON DA, 1983, BIOCHEMISTRY-US, V22, P3178, DOI 10.1021/bi00282a022; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; TIMMINS PA, 1991, FEBS LETT, V280, P115, DOI 10.1016/0014-5793(91)80217-Q; TIMMINS PA, 1988, FEBS LETT, V238, P361, DOI 10.1016/0014-5793(88)80513-1; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; WECKSTROM K, 1985, FEBS LETT, V192, P220, DOI 10.1016/0014-5793(85)80111-3; WENNERSTROM H, 1979, PHYS REP, V52, P1, DOI 10.1016/0370-1573(79)90087-5; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Zhou C, 1997, BBA-LIPID LIPID MET, V1348, P273, DOI 10.1016/S0005-2760(97)00066-0; ZULAUF M, 1983, J PHYS CHEM-US, V87, P856, DOI 10.1021/j100228a032; ZULAUF M, 1991, CRYSTALLIZATION MEMB, P54	64	429	438	3	111	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32403	32406		10.1074/jbc.R100031200	http://dx.doi.org/10.1074/jbc.R100031200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432878	hybrid			2022-12-27	WOS:000170746000004
J	Parker, LM; Fierro-Monti, I; Mathews, MB				Parker, LM; Fierro-Monti, I; Mathews, MB			Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA VIRUS K3L; BINDING PROTEIN; TRANSCRIPTION FACTOR; CELLULAR ACTIVATOR; T-CELLS; IN-VIVO; PKR; INTERFERON; DOMAINS; IDENTIFICATION	Nuclear factor 90 (NF90) is a member of an expanding family of double-stranded (ds) RNA-binding proteins thought to be involved in gene expression. Originally identified in complex with nuclear factor 45 (NF45) as a sequence-specific DNA-binding protein, NF90 contains two double stranded RNA-binding motifs (dsRBMs) and interacts with highly structured RNAs as well as the dsRNA-activated protein kinase, PKR. In this report, we characterize the biochemical interactions between these two dsRBM containing proteins. NF90 binds to PKR through two independent mechanisms: an RNA-independent interaction occurs between the N terminus of NF90 and the C-terminal region of PKR, and an RNA-dependent interaction is mediated by the dsRBMs of the two proteins. Co-immunoprecipitation analysis demonstrates that NF90, NF45, and PKR form a complex in both nuclear and cytosolic extracts, and both proteins serve as substrates for PKR in vitro. NF90 is phosphorylated by PKR in its RNA-binding domain, and this reaction is partially blocked by the NF90 N-terminal region. The C-terminal region also inhibits PKR function, probably through competitive binding to dsRNA. A model for NF90-PKR interactions is proposed.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Mathews, MB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.	mathews@umdnj.edu	Fierro-Monti, Ivo/AAH-3595-2020	/0000-0002-5460-2117	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034552] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34552] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; BASS BL, 1994, CURR BIOL, V4, P301, DOI 10.1016/S0960-9822(00)00069-5; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bergeron J, 2000, CANCER RES, V60, P6800; Buaas FW, 1999, MAMM GENOME, V10, P451, DOI 10.1007/s003359901022; Coolidge CJ, 2000, NUCLEIC ACIDS RES, V28, P1407, DOI 10.1093/nar/28.6.1407; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475; Demarchi F, 1999, J VIROL, V73, P7080, DOI 10.1128/JVI.73.8.7080-7086.1999; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; Gale M, 1996, MOL CELL BIOL, V16, P4172; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; JEFFREY IW, 1995, EXP CELL RES, V218, P17, DOI 10.1006/excr.1995.1126; JIMENEZGARCIA LF, 1993, J CELL SCI, V106, P11; KAO PN, 1994, J BIOL CHEM, V269, P20691; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455, DOI 10.1091/mbc.7.9.1455; Meagher MJ, 1999, GENE, V228, P197, DOI 10.1016/S0378-1119(98)00615-5; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Orford RL, 1998, MOL CELL BIOL, V18, P5557, DOI 10.1128/MCB.18.9.5557; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pe'ery T, 2000, COLD SPRING HARBOR M, V39, P371; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Petryshyn R, 1996, ARCH BIOCHEM BIOPHYS, V326, P290, DOI 10.1006/abbi.1996.0078; Raine DA, 1998, FEBS LETT, V436, P343, DOI 10.1016/S0014-5793(98)01163-6; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Satoh M, 1999, J BIOL CHEM, V274, P34598, DOI 10.1074/jbc.274.49.34598; SCHUMACHER JM, 1995, J CELL BIOL, V129, P1023, DOI 10.1083/jcb.129.4.1023; Setzer DR, 1996, RNA, V2, P1254; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Tian B, 2001, J BIOL CHEM, V276, P9936, DOI 10.1074/jbc.M007328200; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Xu YH, 1999, MOL GENET METAB, V68, P441, DOI 10.1006/mgme.1999.2934; Xu YH, 2000, MOL GENET METAB, V70, P106, DOI 10.1006/mgme.2000.3010; Zhai G, 2001, BIOCHEMISTRY-US, V40, P2032, DOI 10.1021/bi001941r; Zhu SH, 1997, J BIOL CHEM, V272, P14434, DOI 10.1074/jbc.272.22.14434	49	76	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32522	32530		10.1074/jbc.M104408200	http://dx.doi.org/10.1074/jbc.M104408200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438540	hybrid			2022-12-27	WOS:000170746000021
J	Senga, T; Iwamoto, T; Kitamura, T; Miyake, Y; Hamaguchi, M				Senga, T; Iwamoto, T; Kitamura, T; Miyake, Y; Hamaguchi, M			JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE RECEPTOR GP130; RAS; STAT3; SIGNALS; FAMILY; EXPRESSION; EFFECTOR; CLONING; ROLES; GENE	The Ras-related GTPase (Ral) is converted to the GTP-bound form by Ral guanine nucleotide dissociation stimulator (RalGDS), a putative effector protein of Ras. Recently, it was proven that Ral regulates c-Src activity and subsequent phosphorylation of its substrate, STAT3. Here, we show that STAT3 inversely regulates activation of Ral through induction of expression of RalGDS. To identify new leukemia inhibitory factor-induced genes, we have performed representational difference analysis using M1 mouse myeloid leukemia cells and cloned RalGDS. The expression of RalGDS and subsequent activation of RalA were clearly suppressed by a dominant negative form of STAT3 and a JAK inhibitor, JAB/SOCS1/SSI-1, indicating that RalGDS/RalA signaling requires the activation of the JAK/STAT3 pathway. An experiment using a Ras inhibitor demonstrated that full activation of RalA also requires activation of Ras. These results suggest a novel cross-talk between JAW STAT3 and the Ras/RalGDS/Ral signaling pathways through gp130.	Nagoya Univ, Sch Med, Radioisotope Res Ctr, Div Med,Showa Ku, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi 4668550, Japan; Nagoya Univ, Sch Med, Dept Mol Pathogenesis, Showa Ku, Nagoya, Aichi 4668550, Japan; Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factors, Minato Ku, Tokyo 1088639, Japan	Nagoya University; Nagoya University; Nagoya University; University of Tokyo	Iwamoto, T (corresponding author), Nagoya Univ, Sch Med, Radioisotope Res Ctr, Div Med,Showa Ku, 65 Tsurumai cho, Nagoya, Aichi 4668550, Japan.	iwamoto@med.nagoya-u.ac.jp	Kitamura, Toshio/AAA-2071-2021					ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; CHARDIN P, 1986, EMBO J, V5, P2203, DOI 10.1002/j.1460-2075.1986.tb04485.x; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Feig LA, 1996, TRENDS BIOCHEM SCI, V21, P438, DOI 10.1016/S0968-0004(96)10058-X; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Goi T, 1999, MOL CELL BIOL, V19, P1731; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; HOFER F, 1994, P NATL ACAD SCI USA, V91, P4578; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Ihara S, 1997, EMBO J, V16, P5345, DOI 10.1093/emboj/16.17.5345; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Kitamura T, 2000, METH MOL B, V134, P143; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; O'Farrell AM, 2000, J IMMUNOL, V164, P4607, DOI 10.4049/jimmunol.164.9.4607; Park SH, 1995, ONCOGENE, V11, P2349; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Wolthuis RMF, 1999, CURR OPIN GENET DEV, V9, P112, DOI 10.1016/S0959-437X(99)80016-1; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Wolthuis RMF, 1996, ONCOGENE, V13, P353	31	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32678	32681		10.1074/jbc.M105749200	http://dx.doi.org/10.1074/jbc.M105749200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432872	hybrid			2022-12-27	WOS:000170746000041
J	Wu, MM; Grabe, M; Adams, S; Tsien, RY; Moore, HPH; Machen, TE				Wu, MM; Grabe, M; Adams, S; Tsien, RY; Moore, HPH; Machen, TE			Mechanisms of pH regulation in the regulated secretory pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; GREEN FLUORESCENT PROTEINS; LIVING CELLS; SYNAPTIC VESICLES; SECRETOGRANIN-II; MEMBRANE; ACIDIFICATION; GRANULE; COMPLEX; INSULIN	A precise pH gradient between organelles of the regulated secretory pathway is required for sorting and processing of prohormones. We studied pH regulation in live endocrine cells by targeting biotin-based pH indicators to cellular organelles expressing avidin-chimera proteins. In AtT-20 cells, we found that steady-state pH decreased from the endoplasmic reticulum (ER) (pH(ER) = 7.4 +/- 0.2, mean +/- S.D.) to Golgi (pH(G) = 6.2 +/- 0.4) to mature secretory granules (MSGs) (pH(MSG) = 5.5 +/- 0.4). Golgi and MSGs required active H+ v-ATPases for acidification. ER, Golgi, and MSG steady-state pH values were also dependent upon the different H+ leak rates across each membrane. However, neither steady-state pH(MSG) nor rates of passive H+ leak were affected by Cl--free solutions or valinomycin, indicating that MSG membrane potential was small and not a determinant of pH(MSG). Therefore, our data do not support earlier suggestions that organelle acidification is primarily regulated by Cl- conductances. Measurements of H+ leak rates, buffer capacities, and estimates of surface areas and volumes of these organelles were applied to a mathematical model to determine the H+ permeability (PH+) of each organelle membrane. We found that PH+ decreased progressively from ER to Golgi to MSGs, and proper acidification of Golgi and MSGs required gradual decreases in PH+ and successive increases in the active H+ pump density.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Machen, TE (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, 231 Life Sci Addit, Berkeley, CA 94720 USA.		Grabe, Michael/B-3705-2009		NCRR NIH HHS [R24RR14891] Funding Source: Medline; NIDDK NIH HHS [DK51799] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051799] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BARASCH J, 1988, J CELL BIOL, V107, P2137, DOI 10.1083/jcb.107.6.2137; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; CHAVEZ RA, 1994, METHOD CELL BIOL, V43, P263; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; GUMBINER B, 1981, P NATL ACAD SCI-BIOL, V78, P318, DOI 10.1073/pnas.78.1.318; HARTMANN T, 1990, BIOPHYS J, V58, P391, DOI 10.1016/S0006-3495(90)82385-7; HUTTON JC, 1982, BIOCHEM J, V204, P171, DOI 10.1042/bj2040171; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; LANGRIDGESMITH JE, 1986, J MEMBRANE BIOL, V94, P197, DOI 10.1007/BF01869715; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; ORCI L, 1994, J CELL BIOL, V126, P1149, DOI 10.1083/jcb.126.5.1149; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; Paula S, 1996, BIOPHYS J, V70, P339, DOI 10.1016/S0006-3495(96)79575-9; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; SCHMIDT WK, 1995, MOL BIOL CELL, V6, P1271, DOI 10.1091/mbc.6.10.1271; SCHWARTZ AL, 1985, EMBO J, V4, P899, DOI 10.1002/j.1460-2075.1985.tb03716.x; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; TAGA R, 1993, ARCH HISTOL CYTOL, V58, P517; TAYLOR JR, 1982, INTRO ERROR ANAL, P141; Teter K, 1998, J BIOL CHEM, V273, P19625, DOI 10.1074/jbc.273.31.19625; Urbe S, 1997, BIOCHEM J, V321, P65, DOI 10.1042/bj3210065; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0	40	205	206	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33027	33035		10.1074/jbc.M103917200	http://dx.doi.org/10.1074/jbc.M103917200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11402049	hybrid			2022-12-27	WOS:000170746000087
J	Dan, C; Kelly, A; Bernard, O; Minden, A				Dan, C; Kelly, A; Bernard, O; Minden, A			Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; ACTIN STRESS FIBERS; P21-ACTIVATED KINASE; FOCAL COMPLEXES; JUN KINASE; RHO; RAC; GTPASES; CDC42; PHOSPHORYLATION	PAK4 is the most recently identified member of the PAR family of serine/threonine kinases. PAK4 differs from other members of the PAK family in sequence and in many of its functions. Previously, we have shown that an important function of this kinase is to mediate the induction of filopodia in response to the Rho GTPase Cdc42. Here we show that PAR4 also regulates the activity of the protein kinase LIM kinase 1 (LIMK1). PAK4 was shown to interact specifically with LIMK1 in binding assays. Immune complex kinase assays revealed that both wild-type and constitutively active PAK4 phosphorylated LIMK1 even more strongly than PAK1, and activated PAK4 stimulated LIMK1's ability to phosphorylate cofilin. Immunofluorescence experiments revealed that PAK4 and LIMK1 cooperate to induce cytoskeletal changes in C2C12 cells. Furthermore, dominant negative LIMK1 and a mutant cofilin inhibited the specific cytoskeletal and cell shape changes that were induced in response to a recently characterized constitutively activated PAK4 mutant.	Columbia Univ, Sherman Fairchild Ctr, Dept Biol Sci, New York, NY 10027 USA; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Mol Neurobiol Lab, Melbourne, Vic 3050, Australia	Columbia University; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Minden, A (corresponding author), Columbia Univ, Sherman Fairchild Ctr, Dept Biol Sci, Biol Sci MC 2460,Rm 813,1212 Amsterdam Ave, New York, NY 10027 USA.		Bernard, Olivier/J-1133-2014	Bernard, Olivier/0000-0003-2539-9014; Dan, Chuntao/0000-0002-8951-4248	NCI NIH HHS [R01 CA76342] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076342] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dutartre H, 1996, J CELL SCI, V109, P367; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NUNOUE K, 1995, ONCOGENE, V11, P701; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Stanyon CA, 1999, INT J BIOCHEM CELL B, V31, P389, DOI 10.1016/S1357-2725(98)00116-2; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Zeng Q, 2000, J CELL SCI, V113, P471; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	43	210	224	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32115	32121		10.1074/jbc.M100871200	http://dx.doi.org/10.1074/jbc.M100871200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11413130	hybrid			2022-12-27	WOS:000170613500088
J	Orsi, A; Sparvoli, F; Ceriotti, A				Orsi, A; Sparvoli, F; Ceriotti, A			Role of individual disulfide bonds in the structural maturation of a low molecular weight glutenin subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHEAT STORAGE PROTEINS; 11S SEED GLOBULINS; ENDOPLASMIC-RETICULUM; XENOPUS-OOCYTES; INFLUENZA HEMAGGLUTININ; HETEROTYPIC AGGREGATION; CONSERVED CYSTEINES; SECRETORY PROTEINS; MEMBRANE-PROTEINS; ESCHERICHIA-COLI	Gliadins and glutenins are the major storage proteins that accumulate in wheat endosperm cells during seed development. Although gliadins are mainly monomeric, glutenins consist of very large disulfide-linked polymers made up of high molecular weight and low molecular weight subunits. These polymers are among the largest protein molecules known in nature and are the most important determinants of the viscoelastic properties of gluten. As a first step toward the elucidation of the folding and assembly pathways that lead to glutenin polymer formation, we have exploited an in vitro system composed of wheat germ extract and bean microsomes to examine the role of disulfide bonds in the structural maturation of a low molecular weight glutenin subunit. When conditions allowing the formation of disulfide bonds were established, the in vitro synthesized low molecular weight glutenin subunit was recovered in monomeric form containing intrachain disulfide bonds. Conversely, synthesis under conditions that did not favor the formation of disulfide bonds led to the production of large aggregates from which the polypeptides could not be rescued by the post-translational generation of a more oxidizing environment. These results indicate that disulfide bond formation is essential for the conformational maturation of the low molecular weight glutenin subunit and suggest that early folding steps may play an important role in this process, allowing the timely pairing of critical cysteine residues. To determine which cysteines were important to maintain the protein in monomeric form, we prepared a set of mutants containing selected cysteine to serine substitutions. Our results show that two conserved cysteine residues form a critical disulfide bond that is essential in preventing the exposure of adhesive domains and the consequent formation of aberrant aggregates.	CNR, Ist Biosintesi Vegetali, Via Bassini 15, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR)	Ceriotti, A (corresponding author), CNR, Ist Biosintesi Vegetali, Via Bassini 15, I-20133 Milan, Italy.	aldo.ceriotti@ibv.mi.cnr.it	Ceriotti, Aldo/A-1448-2016; Sparvoli, Francesca/G-8372-2015	Ceriotti, Aldo/0000-0002-8230-8863; Orsi, Andrea/0000-0003-2839-1640; Sparvoli, Francesca/0000-0002-3304-7548				ALTSCHULER Y, 1994, J BIOL CHEM, V269, P6677; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; BULLEID NJ, 1988, BIOCHEM J, V254, P805, DOI 10.1042/bj2540805; CERIOTTI A, 1991, EUR J BIOCHEM, V202, P959, DOI 10.1111/j.1432-1033.1991.tb16456.x; Ceriotti A, 1995, METHOD CELL BIOL, V50, P295, DOI 10.1016/S0091-679X(08)61038-9; CERIOTTI A, 1990, J CELL BIOL, V111, P409, DOI 10.1083/jcb.111.2.409; DICKINSON CD, 1987, P NATL ACAD SCI USA, V84, P5525, DOI 10.1073/pnas.84.16.5525; DOvidio R, 1997, THEOR APPL GENET, V95, P1119, DOI 10.1007/s001220050671; DOvidio R, 1997, J CEREAL SCI, V25, P1, DOI 10.1006/jcrs.1996.0065; Egorov TA, 1996, FEBS LETT, V396, P285, DOI 10.1016/0014-5793(96)01117-9; Elliott JG, 1997, J BIOL CHEM, V272, P13849, DOI 10.1074/jbc.272.21.13849; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Galili G, 1998, PLANT MOL BIOL, V38, P1, DOI 10.1023/A:1006011919671; Galili G, 1996, PLANT PHYSIOL BIOCH, V34, P245; HILLE A, 1989, J BIOL CHEM, V264, P13460; Jung R, 1997, PLANT CELL, V9, P2037, DOI 10.1105/tpc.9.11.2037; Jung R, 1998, PLANT CELL, V10, P343, DOI 10.1105/tpc.10.3.343; KECK B, 1995, Z LEBENSM UNTERS FOR, V200, P432, DOI 10.1007/BF01193253; KOHLER P, 1993, Z LEBENSM UNTERS FOR, V196, P239, DOI 10.1007/BF01202740; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVANONY H, 1992, J CELL BIOL, V119, P1117, DOI 10.1083/jcb.119.5.1117; Lupattelli F, 1997, PLANT CELL, V9, P597, DOI 10.1105/tpc.9.4.597; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; MARQUARDT T, 1993, J BIOL CHEM, V268, P19618; MARTY I, 1991, PLANT MOL BIOL, V17, P143, DOI 10.1007/BF00036817; Muller S, 1998, J CEREAL SCI, V27, P23, DOI 10.1006/jcrs.1997.0146; Muller S, 1998, J CEREAL SCI, V27, P109, DOI 10.1006/jcrs.1997.0158; MULLER S, 1995, J CEREAL SCI, V22, P21, DOI 10.1016/S0733-5210(05)80004-9; Muller S, 1997, J CEREAL SCI, V26, P169, DOI 10.1006/S0733-5210(97)90100-4; Nam YW, 1997, PLANT PHYSIOL, V115, P1629, DOI 10.1104/pp.115.4.1629; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OKITA TW, 1985, J BIOL CHEM, V260, P8203; PHAM DQD, 1992, GENE, V122, P345, DOI 10.1016/0378-1119(92)90224-D; RIVERAMADRID R, 1995, P NATL ACAD SCI USA, V92, P5620, DOI 10.1073/pnas.92.12.5620; ROBINSON R, 1989, BIOCHEM J, V263, P497, DOI 10.1042/bj2630497; SAWYER JT, 1994, J BIOL CHEM, V269, P22440; SCHEELE G, 1982, J BIOL CHEM, V257, P2277; SHANI N, 1994, J BIOL CHEM, V269, P8924; Shewry PR, 1997, J CEREAL SCI, V25, P207, DOI 10.1006/jcrs.1996.0100; Shimoni Y, 1996, J BIOL CHEM, V271, P18869, DOI 10.1074/jbc.271.31.18869; Sparvoli R, 2000, PLANT J, V24, P825, DOI 10.1046/j.1365-313x.2000.00933.x; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; THOMPSON S, 1994, J AGR FOOD CHEM, V42, P426, DOI 10.1021/jf00038a035; YILLA M, 1992, J CELL BIOL, V118, P245, DOI 10.1083/jcb.118.2.245	48	31	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32322	32329		10.1074/jbc.M103833200	http://dx.doi.org/10.1074/jbc.M103833200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418605	hybrid			2022-12-27	WOS:000170613500114
J	Tsang, WY; Sayles, LC; Grad, LI; Pilgrim, DB; Lemire, BD				Tsang, WY; Sayles, LC; Grad, LI; Pilgrim, DB; Lemire, BD			Mitochondrial respiratory chain deficiency in Caenorhabditis elegans results in developmental arrest and increased life span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL GENOMIC ANALYSIS; COMPLEX-I; C-ELEGANS; UBIQUINONE OXIDOREDUCTASE; SACCHAROMYCES-CEREVISIAE; RNA INTERFERENCE; OXIDATIVE STRESS; REVERSE GENETICS; ATP SYNTHASE; DISEASES	The growth and development of Caenorhabditis elegans are energy-dependent and rely on the mitochondrial respiratory chain (MRC) as the major source of ATP. The MRC is composed of similar to 70 nuclear, and 12 mitochondrial gene products. Complexes I and V are multisubunit proteins of the MRC. The nuo-1 gene encodes the NADH- and FAIN-binding subunit of complex I, the NADH-ubiquinone oxidoreductase. The atp-2 gene en. codes the active-site subunit of complex V, the ATP synthase. The nuo-1 (ua1) and atp-2(ua2) mutations are both lethal. They result in developmental arrest at the third larval stage (L3), arrest of gonad development at the second larval stage (L2), and impaired mobility, pharyngeal pumping, and defecation. Surprisingly, the nuo-1 and atp-2 mutations significantly lengthen the life spans of the arrested animals. When MRC biogenesis is blocked by chloramphenicol or doxycycline (inhibitors of mitochondrial translation), a quantitative and homogeneous developmental arrest as L3 larvae also results. The common phenotype induced by the mutations and drugs suggests that the L3-to-L4 transition may involve an energy-sensing developmental checkpoint. Since similar to 200 gene products are needed for MRC assembly and mtDNA replication, transcription, and translation, we predict that L3 arrest will be characteristic of mutations in these genes.	Univ Alberta, Dept Biochem, Canadian Inst Hlth, Res Grp Mol Biol Membrane Prot, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Sci Biol, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	Lemire, BD (corresponding author), Univ Alberta, Dept Biochem, Canadian Inst Hlth, Res Grp Mol Biol Membrane Prot, Edmonton, AB T6G 2H7, Canada.	bernard.lemire@ualberta.ca	Pilgrim, David B/A-2676-2014	Pilgrim, David B/0000-0001-7820-7915; Tsang, William/0000-0002-1584-616X				Aboobaker AA, 2000, ANN MED, V32, P23, DOI 10.3109/07853890008995906; ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Anderson P, 1995, METHOD CELL BIOL, V48, P31; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; CULOTTI JG, 1978, GENETICS, V90, P243; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; DiMauro S, 2000, BRAIN PATHOL, V10, P431; FECKE W, 1994, EUR J BIOCHEM, V220, P551, DOI 10.1111/j.1432-1033.1994.tb18655.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Houstek J, 1999, HUM MOL GENET, V8, P1967; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kayser EB, 1999, ANESTHESIOLOGY, V90, P545, DOI 10.1097/00000542-199902000-00031; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LUFT R, 1995, J INTERN MED, V238, P405, DOI 10.1111/j.1365-2796.1995.tb01218.x; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; MURFITT RR, 1976, COMP BIOCHEM PHYS B, V53, P423, DOI 10.1016/0305-0491(76)90191-7; Nijtmans LGJ, 1995, BBA-MOL BASIS DIS, V1272, P190, DOI 10.1016/0925-4439(95)00087-9; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; OKIMOTO R, 1992, GENETICS, V130, P471; PIKO L, 1973, J CELL BIOL, V58, P357, DOI 10.1083/jcb.58.2.357; Plasterk RHA, 1995, METHOD CELL BIOL, V48, P59; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Rubio-Gozalbo ME, 2000, HUM MUTAT, V15, P522, DOI 10.1002/1098-1004(200006)15:6<522::AID-HUMU4>3.0.CO;2-Y; SCHEDL T, 1997, C ELEGANS, V2, P241; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432; Sue CM, 2000, BRAIN PATHOL, V10, P442; SULSTON J, 1988, NEMATODE CAENORHABDI, P123; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; Vanfleteren JR, 1996, J EXP ZOOL, V274, P93, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;93::AID-JEZ2&gt;3.0.CO;2-8; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wood WB, 1988, NEMATODE CAENORHABDI, P1; Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133	55	113	124	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32240	32246		10.1074/jbc.M103999200	http://dx.doi.org/10.1074/jbc.M103999200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11410594	hybrid			2022-12-27	WOS:000170613500104
J	Abrami, L; Fivaz, M; Kobayashi, T; Kinoshita, T; Parton, RG; van der Goot, FG				Abrami, L; Fivaz, M; Kobayashi, T; Kinoshita, T; Parton, RG; van der Goot, FG			Cross-talk between caveolae and glycosylphosphatidylinositol-rich domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING TOXIN; GPI-ANCHORED PROTEINS; CELL-SURFACE; DEPENDENT RETENTION; MEMBRANE-PROTEIN; MAMMALIAN-CELLS; PLASMA-MEMBRANE; LIPID RAFTS; CHOLESTEROL; BIOSYNTHESIS	Most mammalian cells have in their plasma membrane at least two types of lipid microdomains, non-invaginated lipid rafts and caveolae. Glycosylphosphatidylinositol (GPI)-anchored proteins constitute a class of proteins that are enriched in rafts but not caveolae at steady state. We have analyzed the effects of abolishing GPI biosynthesis on rafts, caveolae, and cholesterol levels. GPI-deficient cells were obtained by screening for resistance to the pore-forming toxin aerolysin, which uses this class of proteins as receptors. Despite the absence of GPI-anchored proteins, mutant cells still contained lipid rafts, indicating that GPI-anchored proteins are not crucial structural elements of these domains. Interestingly, the caveolae-specific membrane proteins, caveolin-1 and 2, were up-regulated in GPI-deficient cells, in contrast to flotillin-I and GM1, which were expressed at normal levels. Additionally, the number of surface caveolae was increased. This effect was specific since recovery of GPI biosynthesis by gene recomplementation restored caveolin expression and the number of surface caveolae to wild type levels. The inverse correlation between the expression of GPI-anchored proteins and caveolin-1 was confirmed by the observation that overexpression of caveolin-1 in wild type cells led to a decrease in the expression of GPI-anchored proteins. In cells lacking caveolae, the absence of GPI-anchored proteins caused an increase in cholesterol levels, suggesting a possible role of GPI-anchored proteins in cholesterol homeostasis, which in some cells, such as Chinese hamster ovary cells, can be compensated by caveolin up-regulation.	Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; RIKEN, Frontier Res Syst, Supramol Syst Res Grp, Wako, Saitama 3510198, Japan; Osaka Univ, Dept Immunoregulat, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Univ Queensland, Inst Mol Biosci, Ctr Microscopy & Microanal, Brisbane, Qld 1072, Australia; Univ Queensland, Inst Mol Biosci, Ctr Microscopy & Microanal, Brisbane, Qld 1072, Australia; Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 1072, Australia	University of Geneva; RIKEN; Osaka University; University of Queensland; University of Queensland; University of Queensland	van der Goot, FG (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	gisou.vandergoot@biochem.unige.ch	Parton, Robert G/C-5673-2009; van der Goot, Gisou G/B-2279-2012; Kinoshita, Taroh/C-7353-2009; KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015	Parton, Robert G/0000-0002-7494-5248; van der Goot, Gisou G/0000-0002-8522-274X; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Fivaz, Marc/0000-0003-1003-7934; ABRAMI, laurence/0000-0002-1774-0481				Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Bagnoli M, 2000, ONCOGENE, V19, P4754, DOI 10.1038/sj.onc.1203839; Baumann NA, 2000, J BIOL CHEM, V275, P7378, DOI 10.1074/jbc.275.10.7378; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Brodsky RA, 1999, BLOOD, V93, P1749, DOI 10.1182/blood.V93.5.1749.405k09_1749_1756; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BUCKLEY JT, 1990, BIOCHEM CELL BIOL, V68, P221, DOI 10.1139/o90-029; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fielding CJ, 1997, J LIPID RES, V38, P1503; Fivaz M, 2000, ELECTROPHORESIS, V21, P3351, DOI 10.1002/1522-2683(20001001)21:16<3351::AID-ELPS3351>3.3.CO;2-B; Fivaz M, 1999, TRENDS CELL BIOL, V9, P212, DOI 10.1016/S0962-8924(99)01567-6; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; FRA AM, 1994, J BIOL CHEM, V269, P30745; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Hailstones D, 1998, J LIPID RES, V39, P369; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Ikonen E, 2000, TRAFFIC, V1, P212, DOI 10.1034/j.1600-0854.2000.010303.x; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kasahara K, 2000, J BIOL CHEM, V275, P34701, DOI 10.1074/jbc.M003163200; Kinoshita T, 1997, J BIOCHEM-TOKYO, V122, P251; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kreis TE, 1995, ANNU REV CELL DEV BI, V11, P677, DOI 10.1146/annurev.cb.11.110195.003333; KUGE O, 1985, P NATL ACAD SCI USA, V82, P1926, DOI 10.1073/pnas.82.7.1926; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lipardi C, 1998, J CELL BIOL, V140, P617, DOI 10.1083/jcb.140.3.617; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Maeda Y, 1998, EMBO J, V17, P4920, DOI 10.1093/emboj/17.17.4920; Maxfield FR, 1997, ADV EXP MED BIOL, V419, P355; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Muniz M, 2000, EMBO J, V19, P10, DOI 10.1093/emboj/19.1.10; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nozaki M, 1999, LAB INVEST, V79, P293; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Pasquali C, 1997, ELECTROPHORESIS, V18, P2573, DOI 10.1002/elps.1150181413; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Schlegel A, 2000, FRONT BIOSCI-LANDMRK, V5, pD929, DOI 10.2741/schlegel; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; STEVENS VL, 1995, BIOCHEM J, V310, P361, DOI 10.1042/bj3100361; Stevens VL, 1996, BIOCHEM J, V313, P253, DOI 10.1042/bj3130253; SUGIYAMA E, 1991, J BIOL CHEM, V266, P12119; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; VANDERGOOT FG, 1994, J BIOL CHEM, V269, P30496; VANTHOF W, 1995, J BIOL CHEM, V270, P24150; Vogel U, 1998, J CELL SCI, V111, P825; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Yang CPH, 1998, FEBS LETT, V439, P368, DOI 10.1016/S0014-5793(98)01354-4; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	68	79	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30729	30736		10.1074/jbc.M102039200	http://dx.doi.org/10.1074/jbc.M102039200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11406621	hybrid			2022-12-27	WOS:000170472900021
J	Awasthi, S; Palmer, R; Castro, M; Mobarak, CD; Ruby, SW				Awasthi, S; Palmer, R; Castro, M; Mobarak, CD; Ruby, SW			New roles for the Snp1 and Exo84 proteins in yeast pre-mRNA splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMALL NUCLEAR RIBONUCLEOPROTEIN; U1 SNRNP PROTEIN; SACCHAROMYCES-CEREVISIAE; 2-HYBRID SYSTEM; REQUIRES ATP; CELL-SURFACE; PRP8 PROTEIN; 70K PROTEIN; SPLICEOSOME; IDENTIFICATION	The mammalian 70K protein, a component of the U1 small nuclear ribonucleoprotein involved in pre-mRNA splicing, interacts with a number of proteins important for regulating constitutive and alternative splicing. Similar proteins that interact with the yeast homolog of the 70K protein, Snp1p, have yet to be identified. We used the two-hybrid system to find four (U) under bar1-(S) under bar np1 (a) under bar ssociating (Usa) proteins. Two of these proteins physically associate with Snp1p as assayed by coimmunoprecipitation. One is Prp8p, a known, essential spliceosomal component. This interaction suggests some novel functions for Snp1p and the U1 small nuclear ribonucleoprotein late in spliceosome development. The other, Exo84p, is a conserved subunit of the exocyst, an eight-protein complex functioning in secretion. We show here that Exo84p is also involved in pre-mRNA splicing. A temperature-sensitive exo84 mutation caused increased ratios of pre-mRNA to mRNA for the Rp130 and actin transcripts in cells incubated at the non-permissive temperature. The mutation also led to a defect in splicing and prespliceosome formation in vitro; an indication that Exo84p has a direct role in splicing. The results elucidate a surprising link between splicing and secretion.	Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Ruby, SW (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Canc Res & Treatment Ctr, 900 Camino Salud NE, Albuquerque, NM 87131 USA.	sruby@unm.edu						Abovich N, 1997, CELL, V89, P403, DOI 10.1016/S0092-8674(00)80221-4; ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Alexieva KI, 1999, INT J BIOCHEM CELL B, V31, P903, DOI 10.1016/S1357-2725(99)00044-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1991, Methods Enzymol, V194, P1; Ast G, 1997, RNA, V3, P371; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; Beggs JD, 1995, J CELL SCI, P101; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; BROWN JD, 1992, EMBO J, V11, P3721, DOI 10.1002/j.1460-2075.1992.tb05457.x; CABIB E, 1989, J CELL BIOL, V108, P1665, DOI 10.1083/jcb.108.5.1665; Cao WH, 1998, J BIOL CHEM, V273, P20629, DOI 10.1074/jbc.273.32.20629; CHANG TH, 1988, MOL CELL BIOL, V8, P2379, DOI 10.1128/MCB.8.6.2379; Chen EJ, 1998, MOL CELL BIOL, V18, P7139, DOI 10.1128/MCB.18.12.7139; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; CHENG SC, 1986, P NATL ACAD SCI USA, V83, P2387, DOI 10.1073/pnas.83.8.2387; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cody R.P., 1991, APPL STAT SAS PROGRA; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ENTIAN KD, 1999, MOL GEN GENET, V262; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609; Fortes P, 1999, GENE DEV, V13, P2425, DOI 10.1101/gad.13.18.2425; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; FU XD, 1995, RNA, V1, P663; *GEN COMP GROUP, 1999, WISC PACK VERS 10; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; HEINRICHS V, 1990, SCIENCE, V247, P69, DOI 10.1126/science.2136774; HILLEREN PJ, 1995, MOL CELL BIOL, V15, P6341; HODGES PE, 1995, YEAST, V11, P337; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; KAO HY, 1992, NUCLEIC ACIDS RES, V20, P4009, DOI 10.1093/nar/20.15.4009; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; Kuhn AN, 2000, GENETICS, V155, P1667; Kuhn AN, 1999, MOL CELL, V3, P65, DOI 10.1016/S1097-2765(00)80175-6; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; LEGRAIN P, 1994, NUCLEIC ACIDS RES, V22, P3241, DOI 10.1093/nar/22.15.3241; LESSER CF, 1993, GENETICS, V133, P851; Luo HBR, 1999, RNA, V5, P893, DOI 10.1017/S1355838299990520; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lussier M, 1997, GENETICS, V147, P435; LUSTIG AJ, 1986, CELL, V47, P953, DOI 10.1016/0092-8674(86)90810-X; Lybarger S, 1999, MOL CELL BIOL, V19, P577; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MATTAJ IW, 1988, STRUCTURE FUNCTION M, P100; Misteli T, 1999, CURR BIOL, V9, pR198, DOI 10.1016/S0960-9822(99)80128-6; Mizuta K, 1998, NUCLEIC ACIDS RES, V26, P1063, DOI 10.1093/nar/26.4.1063; MIZUTA K, 1994, MOL CELL BIOL, V14, P2493, DOI 10.1128/MCB.14.4.2493; Nanduri J, 1999, J BIOL CHEM, V274, P33785, DOI 10.1074/jbc.274.47.33785; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; NEWMAN AJ, 1994, CURR OPIN GENET DEV, V4, P298, DOI 10.1016/S0959-437X(05)80057-7; ODay CL, 1996, J BIOL CHEM, V271, P33261, DOI 10.1074/jbc.271.52.33261; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7; Pruyne D, 2000, J CELL SCI, V113, P365; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; ROMAC JMJ, 1995, GENE DEV, V9, P1400, DOI 10.1101/gad.9.11.1400; ROMAC JMJ, 1994, MOL CELL BIOL, V14, P4662, DOI 10.1128/MCB.14.7.4662; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RUBY SW, 1991, TRENDS GENET, V7, P79; Ruby SW, 1997, J BIOL CHEM, V272, P17333, DOI 10.1074/jbc.272.28.17333; RUBY SW, 1993, GENE DEV, V7, P1909, DOI 10.1101/gad.7.10.1909; RUBY SW, 1985, MOL CELL BIOL, V5, P75, DOI 10.1128/MCB.5.1.75; Ruby SW, 1999, METH MOL B, V118, P365; Ruby SW, 1999, METH MOL B, V118, P323; RUBY SW, 1988, SCIENCE, V242, P1028, DOI 10.1126/science.2973660; RYMOND BC, 1990, METHOD ENZYMOL, V181, P122; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwer B, 1996, RNA, V2, P574; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH V, 1991, EMBO J, V10, P2627, DOI 10.1002/j.1460-2075.1991.tb07805.x; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; STRAUSS EJ, 1991, GENE DEV, V5, P629, DOI 10.1101/gad.5.4.629; Tacke R, 1999, P SOC EXP BIOL MED, V220, P59, DOI 10.1046/j.1525-1373.1999.d01-10.x; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wiest DK, 1996, J BIOL CHEM, V271, P33268, DOI 10.1074/jbc.271.52.33268; Winer B.J., 1991, STAT PRINCIPLES EXPT; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOPPMANN A, 1993, NUCLEIC ACIDS RES, V21, P2815, DOI 10.1093/nar/21.12.2815; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhang D, 1999, GENE DEV, V13, P581, DOI 10.1101/gad.13.5.581; Zhang WJ, 1998, MOL CELL BIOL, V18, P676, DOI 10.1128/MCB.18.2.676	104	26	29	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31004	31015		10.1074/jbc.M100022200	http://dx.doi.org/10.1074/jbc.M100022200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11425851	hybrid			2022-12-27	WOS:000170472900056
J	Beuning, PJ; Musier-Forsyth, K				Beuning, PJ; Musier-Forsyth, K			Species-specific differences in amino acid editing by class II prolyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI; MOLECULAR RECOGNITION; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; DISCRIMINATION; AMINOACYLATION; ISOLEUCINE; YEAST; SIEVE	Aminoacyl-tRNA synthetases are a family of enzymes responsible for ensuring the accuracy of the genetic code by specifically attaching a particular amino acid to their cognate tRNA substrates. Through primary sequence alignments, prolyl-tRNA synthetases (ProRSs) have been divided into two phylogenetically divergent groups. We have been interested in understanding whether the unusual evolutionary pattern of ProRSs corresponds to functional differences as well. Previously, we showed that some features of tRNA recognition and aminoacylation are indeed group-specific. Here, we examine the species-specific differences in another enzymatic activity, namely amino acid editing. Proofreading or editing provides a mechanism by which incorrectly activated amino acids are hydrolyzed and thus prevented from misincorporation into proteins. "Prokaryotic-like" Escherichia coli ProRS has recently been shown to be capable of misactivating alanine and possesses both pretransfer and post-transfer hydrolytic editing activity against this noncognate amino acid. We now find that two ProRSs belonging to the "eukaryotic-like" group exhibit differences in their hydrolytic editing activity. Whereas ProRS from Methanococcus jannaschii is similar to E. coli in its ability to hydrolyze misactivated alanine via both pretransfer and post-transfer editing pathways, human ProRS lacks these activities. These results have implications for the selection or design of antibiotics that specifically target the editing active site of the prokaryotic-like group of ProRSs.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Musier-Forsyth, K (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.				NIGMS NIH HHS [GM49928] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049928, R01GM049928, R55GM049928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAN C, 1991, MOL CELL BIOCHEM, V130, P149; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Burke B, 2000, BIOCHEMISTRY-US, V39, P15540, DOI 10.1021/bi001835p; BURKE B, 2001, J BIOL CHEM, V276; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Cusack S, 1998, STRUCTURE, V6, P101, DOI 10.1016/S0969-2126(98)00011-2; DEPOUPLANA LR, IN PRESS J MOL ECOL; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1238, DOI 10.1021/bi00574a019; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FOWDEN L, 1963, BIOCHIM BIOPHYS ACTA, V71, P459, DOI 10.1016/0006-3002(63)91104-1; FREIST W, 1985, BIOCHEMISTRY-US, V24, P7014, DOI 10.1021/bi00345a040; FREIST W, 1994, EUR J BIOCHEM, V220, P745, DOI 10.1111/j.1432-1033.1994.tb18675.x; Freist W, 1998, J THEOR BIOL, V193, P19, DOI 10.1006/jtbi.1998.0672; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; GABIUS HJ, 1983, BIOCHEMISTRY-US, V22, P2331, DOI 10.1021/bi00279a005; Hamann CS, 1999, J BACTERIOL, V181, P5880, DOI 10.1128/JB.181.18.5880-5884.1999; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hendrickson TL, 2000, BIOCHEMISTRY-US, V39, P8180, DOI 10.1021/bi0004798; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; IGLOI GL, 1978, BIOCHEMISTRY-US, V17, P3459, DOI 10.1021/bi00610a006; JAKUBOWSKI H, 1980, BIOCHEMISTRY-US, V19, P5071, DOI 10.1021/bi00563a021; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Lin L, 1996, BIOCHEMISTRY-US, V35, P5596, DOI 10.1021/bi960011y; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; LINCECUM TL, 2000, SAAS B BIOCH BIOTECH, V13, P25; Lipman RSA, 2000, BIOCHEMISTRY-US, V39, P7792, DOI 10.1021/bi0004955; Liu HJ, 1996, J AM CHEM SOC, V118, P2523, DOI 10.1021/ja954062e; LIU HJ, 1995, NUCLEIC ACIDS RES, V23, P165, DOI 10.1093/nar/23.1.165; LIU HJ, 1994, BIOCHEMISTRY-US, V33, P12708, DOI 10.1021/bi00208a023; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Musier-Forsyth K, 1999, ACCOUNTS CHEM RES, V32, P368, DOI 10.1021/ar970148w; MUSIERFORSYTH K, 1991, P NATL ACAD SCI USA, V88, P209, DOI 10.1073/pnas.88.1.209; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; PROENZA AM, 1995, LIFE SCI, V57, P1589; RABINOVITZ M, 1969, J BACTERIOL, V99, P336, DOI 10.1128/JB.99.1.336-338.1969; RAUHUT R, 1985, J BIOL CHEM, V260, P182; RAUNIO R, 1970, ACTA CHEM SCAND, V24, P2737, DOI 10.3891/acta.chem.scand.24-2737; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; SCHMIDT E, 1995, BIOCHEMISTRY-US, V34, P11204, DOI 10.1021/bi00035a028; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Stathopoulos C, 2000, SCIENCE, V287, P479, DOI 10.1126/science.287.5452.479; Stathopoulos C, 2001, BIOCHEMISTRY-US, V40, P46, DOI 10.1021/bi002108x; Stehlin C, 1998, BIOCHEMISTRY-US, V37, P8605, DOI 10.1021/bi980364s; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yaremchuk A, 2000, EMBO J, V19, P4745, DOI 10.1093/emboj/19.17.4745; YARUS M, 1972, P NATL ACAD SCI USA, V69, P1915, DOI 10.1073/pnas.69.7.1915; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y	57	68	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30779	30785		10.1074/jbc.M104761200	http://dx.doi.org/10.1074/jbc.M104761200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11408489	hybrid			2022-12-27	WOS:000170472900028
J	Lee, L; Sadowski, PD				Lee, L; Sadowski, PD			Directional resolution of synthetic Holliday structures by the Cre recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; INTEGRASE FAMILY; FLP PROTEIN; IN-VITRO; DNA; SIMILARITIES; INTERMEDIATE; JUNCTIONS; PRODUCTS; SYNAPSE	The Cre recombinase of bacteriophage P1 cleaves its target site, loxP, in a defined order. Recombination is initiated on one pair of strands to form a Holliday intermediate, which is then resolved by cleavage and exchange of the other pair of strands to yield recombinant products. To investigate the influence of the loxP sequence on the directionality of resolution, we constructed synthetic Holliday (chi) structures containing either wild-type or mutant lox sites. We found that Cre preferentially resolved the synthetic wild-type chi structures on a particular pair of strands. The bias in the direction of resolution was dictated by the asymmetric loxP sequence since the resolution bias was abolished with symmetric lox sites. Systematic substitutions of the loxP site revealed that the bases immediately 5 ' to the scissile phosphodiester bonds were primarily responsible for the directionality of resolution. Interchanging these base pairs was sufficient to reverse the resolution bias. The Cre-lox co-crystal structures show that Lys(86) makes a base-specific contact with guanine immediately 5 ' to one of the scissile phosphates. Substituting Lys(86) with alanine resulted in a reduction of the resolution bias, indicating that this amino acid is important for establishing the bias in resolution.	Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto	Sadowski, PD (corresponding author), Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada.							ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; ARCISZEWSKA LK, 1995, EMBO J, V14, P2112, DOI 10.1002/j.1460-2075.1995.tb07203.x; ARGOS P, 1986, EMBO J, V5, P433, DOI 10.1002/j.1460-2075.1986.tb04229.x; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Azaro MA, 1997, EMBO J, V16, P3744, DOI 10.1093/emboj/16.12.3744; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colloms SD, 1996, EMBO J, V15, P1172, DOI 10.1002/j.1460-2075.1996.tb00456.x; DIXON JE, 1993, J MOL BIOL, V234, P522, DOI 10.1006/jmbi.1993.1608; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Guo F, 1999, P NATL ACAD SCI USA, V96, P7143, DOI 10.1073/pnas.96.13.7143; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hallet B, 1999, MOL CELL, V4, P949, DOI 10.1016/S1097-2765(00)80224-5; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HOESS R, 1987, P NATL ACAD SCI USA, V84, P6840, DOI 10.1073/pnas.84.19.6840; HOESS RH, 1982, P NATL ACAD SCI-BIOL, V79, P3398, DOI 10.1073/pnas.79.11.3398; HOESS RH, 1990, STRUCTURE METHODS, V1, P203; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; JAYARAM M, 1988, P NATL ACAD SCI USA, V85, P7902, DOI 10.1073/pnas.85.21.7902; KITTS PA, 1987, NATURE, V329, P346, DOI 10.1038/329346a0; KITTS PA, 1988, NUCLEIC ACIDS RES, V16, P6839, DOI 10.1093/nar/16.14.6839; KITTS PA, 1988, J MOL BIOL, V204, P95, DOI 10.1016/0022-2836(88)90602-X; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; MEYERLEON L, 1988, MOL CELL BIOL, V8, P3784, DOI 10.1128/MCB.8.9.3784; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; NUNESDUBY SE, 1987, CELL, V50, P779, DOI 10.1016/0092-8674(87)90336-9; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; SADOWSKI PD, 1995, PROG NUCLEIC ACID RE, V51, P53, DOI 10.1016/S0079-6603(08)60876-4; Sambrook J., 2002, MOL CLONING LAB MANU; Shaikh AC, 1997, J BIOL CHEM, V272, P5695, DOI 10.1074/jbc.272.9.5695; SHERRATT DJ, 1995, PHILOS T ROY SOC B, V347, P37, DOI 10.1098/rstb.1995.0006; Tribble G, 2000, J BIOL CHEM, V275, P22255, DOI 10.1074/jbc.M908261199; WIERZBICKI A, 1987, J MOL BIOL, V195, P785, DOI 10.1016/0022-2836(87)90484-0; Zerbib D, 1997, J MOL BIOL, V270, P663, DOI 10.1006/jmbi.1997.1157	34	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31092	31098		10.1074/jbc.M103739200	http://dx.doi.org/10.1074/jbc.M103739200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11406627	hybrid			2022-12-27	WOS:000170472900067
J	Verkhusha, VV; Otsuna, H; Awasaki, T; Oda, H; Tsukita, S; Ito, K				Verkhusha, VV; Otsuna, H; Awasaki, T; Oda, H; Tsukita, S; Ito, K			An enhanced mutant of red fluorescent protein DsRed for double labeling and developmental timer of neural fiber bundle formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA MUSHROOM BODIES; MELANOGASTER; NEURONS; CORAL; CHROMOPHORE; EXPRESSION; CELLS; BODY	We developed a new variant of coral-derived red fluorescent protein, DsRed S197Y, which is brighter and essentially free from secondary fluorescence peak. This makes it an ideal reporter for double labeling with green fluorescent protein (GFP). Though purified protein shows only 20% stronger fluorescence emission, culture cells that express DsRed S197Y exhibit a 3-3.5 times higher level of fluorescence than the cells that express wild-type DsRed. The much slower fluorescence maturation of DsRed than that of GFP is a beneficial feature for a fluorescent developmental timer application. When GFP and DsRed S197Y are expressed simultaneously, emissions start at different latency. This provides information about the time after the onset of expression. It reflects the order of cell differentiation if the expression is activated upon differentiation of certain types of cells. We applied this system to the developing brain of Drosophila and visualized, for the first time, the formation order of neural fibers within a large bundle. Our results showed that newly extending fibers of the mushroom body neurons mainly run into the core rather than to the periphery of the existing bundle. DsRed-based timer thus presents an indispensable tool for developmental biology and genetics of model organisms.	Japan Sci & Technol Corp, Exploratory Res Adv Technol, Tsukita Cell Axis Project, Kyoto 600813, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Nagoya Univ, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Kyoto Univ, Fac Med, Dept Cell Biol, Kyoto 6068501, Japan; JST, Precursory Res Embryon Sci & Technol, Okazaki, Aichi 4448585, Japan	Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; Kyoto University; Japan Science & Technology Agency (JST)	Verkhusha, VV (corresponding author), Japan Sci & Technol Corp, Exploratory Res Adv Technol, Tsukita Cell Axis Project, Kyoto Res Pk, Kyoto 600813, Japan.		AWASAKI, Takeshi/AAO-7579-2021; Verkhusha, Vladislav/AAU-7784-2020; Oda, Hiroki/AAC-2559-2019	AWASAKI, Takeshi/0000-0003-2662-6389; Verkhusha, Vladislav/0000-0002-2083-8121; 				Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Fradkov AF, 2000, FEBS LETT, V479, P127, DOI 10.1016/S0014-5793(00)01895-0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Hinke W., 1961, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V50, P81, DOI 10.1007/BF00407351; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Lee T, 1999, DEVELOPMENT, V126, P4065; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6; Vrzheshch PV, 2000, FEBS LETT, V487, P203, DOI 10.1016/S0014-5793(00)02344-9; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; WOLFF T, 1993, DEV DROSOPHILA MELAN, V2, P1277; YANG MY, 1995, NEURON, V15, P45	28	88	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29621	29624		10.1074/jbc.C100200200	http://dx.doi.org/10.1074/jbc.C100200200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11408473	hybrid			2022-12-27	WOS:000170558000004
J	Bhattacharyya, AM; Horowitz, PM				Bhattacharyya, AM; Horowitz, PM			The aggregation state of rhodanese during folding influences the ability of GroEL to assist reactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE-DENATURED RHODANESE; ATP HYDROLYSIS; PROTEIN; ASSOCIATION; DETERGENT; SHOW	The in vitro folding of rhodanese involves a competition between formation of properly folded enzyme and off-pathway inactive species. Co-solvents like glycerol or low temperature, e.g. refolding at 10 degreesC, successfully retard the off-pathway formation of large inactive aggregates, but the process does not yield 100% active enzyme. These data suggest that mis-folded species are formed from early folding intermediates. GroEL can capture early folding intermediates, and it loses the ability to capture and reactivate rhodanese if the enzyme is allowed first to spontaneously fold for longer times before it is presented to GroEL, a process that leads to the formation of unproductive intermediates. In addition, GroEL cannot reverse large aggregates once they are formed, but it could capture some folding intermediates and activate them, even though they are not capable of forming active enzyme if left to spontaneous refolding. The interaction between GroEL and rhodanese substantially but not completely inhibits intra-protein inactivation, which is responsible for incomplete activation during unassisted refolding. Thus, GroEL not only decreases aggregation, but it gives the highest reactivation of any method of assistance. The results are interpreted using a previously suggested model based on studies of the spontaneous folding of rhodanese (Gorovits, B. M., McGee, W. A., and Horowitz, P. M. (1998) Biochim Biophys. Acta 1382, 120-128 and Panda, M., Gorovits, B. M., and Horowitz, P. M. (2000) J. BioL Chem 275, 63-70).	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Horowitz, PM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.				NIGMS NIH HHS [GM 5177] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Bhattacharyya AM, 2000, J BIOL CHEM, V275, P14860, DOI 10.1074/jbc.275.20.14860; BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; CHRUNYK BA, 1990, BIOCHEMISTRY-US, V29, P2149, DOI 10.1021/bi00460a027; Clark AC, 1996, BIOCHEMISTRY-US, V35, P5893, DOI 10.1021/bi953051v; Ellis R J, 1990, Semin Cell Biol, V1, P1; FISCHER G, 1990, BIOCHEMISTRY-US, V29, P2205, DOI 10.1021/bi00461a001; Gorovits BM, 1998, BBA-PROTEIN STRUCT M, V1382, P120, DOI 10.1016/S0167-4838(97)00158-1; HAGIHARA Y, 1998, MOL CHAPERONES LIFE, P1; HOROWITZ PM, 1989, J BIOL CHEM, V264, P3311; HOROWITZ PM, 1993, J BIOL CHEM, V268, P2500; HOROWITZ PM, 1990, J BIOL CHEM, V265, P2576; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; Jaenicke Rainer, 1997, V50, P1; Klibanov AM, 1997, TRENDS BIOTECHNOL, V15, P97, DOI 10.1016/S0167-7799(97)01013-5; MENDOZA JA, 1991, J BIOL CHEM, V266, P13587; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MENDOZA JA, 1991, J BIOL CHEM, V266, P16973; MILLER DM, 1991, J BIOL CHEM, V266, P4686; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Panda M, 2000, J BIOL CHEM, V275, P63, DOI 10.1074/jbc.275.1.63; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Shibatani T, 1999, J BIOL CHEM, V274, P33795, DOI 10.1074/jbc.274.47.33795; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; STANIFORTH RA, 1994, FEBS LETT, V344, P129, DOI 10.1016/0014-5793(94)00348-3; TANDON S, 1989, J BIOL CHEM, V264, P9859; TANDON S, 1986, J BIOL CHEM, V261, P5615; TANDON S, 1987, J BIOL CHEM, V262, P4486; Timasheff S N, 1995, Methods Mol Biol, V40, P253; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003	33	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					28739	28743		10.1074/jbc.M102500200	http://dx.doi.org/10.1074/jbc.M102500200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11397797	hybrid			2022-12-27	WOS:000170346000014
J	Zhang, DW; Cole, SPC; Deeley, RG				Zhang, DW; Cole, SPC; Deeley, RG			Identification of a nonconserved amino acid residue in multidrug resistance protein 1 important for determining substrate specificity - Evidence for functional interaction between transmembrane helices 14 and 17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; PLASMA-MEMBRANE VESICLES; PHARMACOLOGICAL CHARACTERIZATION; VINCRISTINE TRANSPORT; MEDIATED TRANSPORT; LEUKOTRIENE C-4; MRP; GLUTATHIONE; CELLS; MURINE	Murine multidrug resistance protein 1 (mrp1), differs from its human ortholog (MRP1) in that it fails to confer anthracycline resistance and transports the MRP1 substrate, 17 beta -estradiol 17-(beta -D-glucuronide) (E(2)17 betaG), very poorly. By mutating variant residues in mrp1 to those present in MRP1, we identified Glu(1089) of MRP1 as being critical for anthracycline resistance. However, Glu(1089) mutations had no effect on E(2)17 betaG transport. We have now identified a nonconserved amino acid within the highly conserved COOH-proximal transmembrane helix of MRP1/mrp1 that is important for transport of the conjugated estrogen. Converting Ala(1239) in mrp1 to Thr, as in the corresponding position (1242) in MRP1, increased E(2)17 betaG transport 3-fold. Any mutation of mrp1 Ala(1239), including substitution with Thr, decreased resistance to vincristine and VP-16 without altering anthracycline resistance. However, introduction of a second murine to human mutation, Q1086E, which alone selectively increases anthracycline resistance, into mrp1A1239T restored resistance to both vincristine and VP-16. To confirm the importance of MRP1 Thr(1242) for E(2)17 betaG transport and drug resistance, we mutated this residue to Ala, Cys, Ser, Leu, and Lys. These mutations decreased E(2)17 betaG transport 2-fold. Conversion to Asp eliminated transport of the estrogen conjugate and also decreased leukotriene C-4 transport similar to2-fold. The mutations also reduced the ability of MRP1 to confer resistance to all drugs tested. As with mrp1, introduction of a second mutation based on the murine sequence to create MRP1E1089Q/ T1242A restored resistance to vincristine and VP-16, but not anthracyclines, without affecting transport of leukotriene C-4 and E(2)17 betaG. These results demonstrate the important role of Thr(1242) for E(2)17 betaG transport. They also reveal a highly specific functional relationship between nonconserved amino acids in TM helices 14 and 17 of both mrp1 and MRP1 that enables both proteins to confer similar levels of resistance to vincristine and VP-16.	Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Deeley, RG (corresponding author), Queens Univ, Canc Res Labs, Botterell Hall, Kingston, ON K7L 3N6, Canada.		Deeley, Roger/J-4828-2012; Cole, Susan P.C./I-6389-2017; Zhang, Dawei/ABD-8990-2022	Cole, Susan P.C./0000-0001-6571-6884; Zhang, Dawei/0000-0001-8279-8041				Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Daoud R, 2001, J BIOL CHEM, V276, P12324, DOI 10.1074/jbc.M009782200; Deeley RG, 1997, SEMIN CANCER BIOL, V8, P193, DOI 10.1006/scbi.1997.0070; Ding GY, 1999, ANTICANCER RES, V19, P3243; GRANT CE, 1994, CANCER RES, V54, P357; Hafkemeyer P, 1998, BIOCHEMISTRY-US, V37, P16400, DOI 10.1021/bi980871+; Higgins CF, 1997, SEMIN CANCER BIOL, V8, P135, DOI 10.1006/scbi.1997.0067; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1998, BRIT J CANCER, V78, P1134, DOI 10.1038/bjc.1998.642; Hipfner DR, 1996, CANCER RES, V56, P3307; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Ito K, 2001, MOL PHARMACOL, V59, P1077, DOI 10.1124/mol.59.5.1077; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Jedlitschky G, 1996, CANCER RES, V56, P988; Keppler D, 1999, ADV ENZYME REGUL, V39, P237, DOI 10.1016/S0065-2571(98)00015-6; Leslie EM, 2001, J BIOL CHEM, V276, P27846, DOI 10.1074/jbc.M102453200; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; LOO TW, 1993, J BIOL CHEM, V268, P19965; Mao QC, 2000, J BIOL CHEM, V275, P34166, DOI 10.1074/jbc.M004584200; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Renes J, 1999, BRIT J PHARMACOL, V126, P681, DOI 10.1038/sj.bjp.0702360; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Ryu S, 2000, J BIOL CHEM, V275, P39617, DOI 10.1074/jbc.M005149200; Sakamoto H, 1999, CANCER LETT, V135, P113; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; SCHLEMMER SR, 1994, J BIOL CHEM, V269, P31059; Seelig A, 2000, INT J CLIN PHARM TH, V38, P111; Sharom FJ, 1999, BBA-BIOMEMBRANES, V1461, P327, DOI 10.1016/S0005-2736(99)00166-2; Stride BD, 1999, J BIOL CHEM, V274, P22877, DOI 10.1074/jbc.274.32.22877; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; Stride BD, 1996, MOL PHARMACOL, V49, P962; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; WILSON GM, 1995, PLASMID, V33, P198, DOI 10.1006/plas.1995.1021; Zhang DW, 2001, J BIOL CHEM, V276, P13231, DOI 10.1074/jbc.M010008200	41	64	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34966	34974		10.1074/jbc.M105063200	http://dx.doi.org/10.1074/jbc.M105063200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11429411	hybrid			2022-12-27	WOS:000171024600083
J	Baulande, S; Lasnier, F; Lucas, M; Pairault, J				Baulande, S; Lasnier, F; Lucas, M; Pairault, J			Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME GENE-EXPRESSION; ADIPOCYTE DIFFERENTIATION; RIBONUCLEIC-ACID; MESSENGER-RNA; CELL-LINE; SENSITIVITY; INSULIN; PREADIPOCYTE; CONVERSION; INVITRO	We have used a mRNA differential display technique to identify new genes involved in the reprogramming of gene expression during the adipose conversion of mouse 3T3 preadipocyte, cell lines. We report here on the identification and cloning of a novel adipose-specific cDNA encoding a predicted membrane protein of 413 amino acids. The level of the corresponding 3.2-kilobase mRNA is tremendously increased during 3T3-L1 and 3T3-F442A differentiation into adipocytes. A single, very abundant 3.2-kilobase transcript is also found in inguinal and epididymal white adipose tissues and in interscapular brown adipose tissue but not in any other tissues examined. Its expression in adipose tissue is under tight nutritional regulation. The level of this novel 3.2-kilobase transcript becomes virtually nondetectable during fasting but is dramatically increased when fasted mice are refed a high carbohydrate diet. Based on its adipose specificity and dietary regulation, the novel gene product; has been designated adiponutrin. The expression of adiponutrin mRNA is also 50-fold elevated in genetically obese fa/fa rats, indicating a link between adiponutrin and obesity. Western blot and confocal imagery analyses with epitope-tagged protein transiently expressed in 3T3-L1 adipocytes, and COS cells show that adiponutrin strictly localizes to membranes and is absent from. the cytosol. Sequence analysis reveals homologies with several other members of related eukaryotic proteins, including a human paralog, which has been recently described in vesicular transport mechanisms. This leads us to suggest that adiponutrin could be involved in vesicular targeting and protein transport restricted to the adipocyte function.	Univ Paris 06, CNRS, UMR Physiol & Physiopathol, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Pairault, J (corresponding author), Univ Paris 06, CNRS, UMR Physiol & Physiopathol, 15 Rue Ecole Med, F-75270 Paris 06, France.			BAULANDE, Sylvain/0000-0003-3104-1684				CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLARKE SD, 1990, J NUTR, V120, P218, DOI 10.1093/jn/120.2.218; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; COUPE C, 1990, AM J PHYSIOL, V258, pE126, DOI 10.1152/ajpendo.1990.258.1.E126; ElHadri K, 1996, EUR J PHARMACOL, V297, P107, DOI 10.1016/0014-2999(95)00723-7; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; Frohman Michael A., 1995, P381; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo XM, 2000, GENE, V251, P45, DOI 10.1016/S0378-1119(00)00192-X; Jones BH, 1998, BIOCHEM J, V335, P405, DOI 10.1042/bj3350405; JUMP DB, 1985, ENDOCRINOLOGY, V117, P2259, DOI 10.1210/endo-117-6-2259; KELLER A, 1981, J NEUROCHEM, V36, P1389, DOI 10.1111/j.1471-4159.1981.tb00577.x; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Kim S, 2000, J NUTR, V130, p3110S; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; RUBIN CS, 1977, J BIOL CHEM, V252, P3554; SADOWSKI HB, 1992, J BIOL CHEM, V267, P4722; Sambrook J., 2002, MOL CLONING LAB MANU; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WATERS KM, 1994, J BIOL CHEM, V269, P27773; WELSH J, 1992, NUCLEIC ACIDS RES, V20, P4965, DOI 10.1093/nar/20.19.4965; [No title captured]	33	193	206	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33336	33344		10.1074/jbc.M105193200	http://dx.doi.org/10.1074/jbc.M105193200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11431482	hybrid			2022-12-27	WOS:000170910200009
J	Lin, L; Schmidt, B; Teckman, J; Perlmutter, DH				Lin, L; Schmidt, B; Teckman, J; Perlmutter, DH			A naturally occurring nonpolymerogenic mutant of alpha 1-antitrypsin characterized by prolonged retention in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(1)-ANTITRYPSIN DEFICIENCY; MUTATION; LIVER; VARIANTS; DEGRADATION; SECRETION; REQUIRES; DISEASE; DEFECT; GENE	The classical form of alphal-antitrypsin (alphal-AT) deficiency is associated with a mutant alpha1-ATZ molecule that polymerizes in the endoplasmic reticulum (ER) of liver cells. A subgroup of individuals homozygous for the protease inhibitor (PI) Z allele develop chronic liver injury and are predisposed to hepatocellular carcinoma. In this study we evaluated the primary structure of alphal-AT in a family in which three affected members had severe liver disease associated with alphal-AT deficiency. We discovered that one sibling was a compound heterozygote with one PI Z allele and a second allele, the PI Z + saar allele, bearing the mutation that characterizes alphal-ATZ as well as the mutation that characterizes alphal-AT Saarbrucken (alphal-AT saar). The mutation in PI saar introduces a premature termination codon resulting in an alphal-AT protein truncated for 19 amino acids at its carboxyl terminus. Studies of a second sib with severe liver disease and other living family members did not reveal the presence of the alphal-AT saar mutation and therefore do not substantiate a role for this mutation in the liver disease phenotype of this family. However, studies of alphal-AT saar and alphal-ATZ + saar expressed in heterologous cells show that there is prolonged intracellular retention of these mutants even though they do not have polymerogenic properties. These results therefore have important implications for further understanding the fate of mutant alphal-AT molecules, the mechanism of ER retention, and the pathogenesis of liver injury in alphal-AT deficiency.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; St Louis Childrens Hosp, Div Gastroenterol & Nutr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Perlmutter, DH (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.			Schmidt, Bela Z/0000-0003-1085-9372; Teckman, Jeffrey/0000-0002-4870-2621				Brantly M, 1997, AM J RESP CELL MOL, V16, P225, DOI 10.1165/ajrcmb.16.3.9070606; BRODBECK RM, 1992, J BIOL CHEM, V267, P294; Carrell R, 1997, ADV EXP MED BIOL, V425, P207; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; FOREMAN RC, 1984, FEBS LETT, V169, P84; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JEPPSSON JO, 1976, FEBS LETT, V65, P195, DOI 10.1016/0014-5793(76)80478-4; Kang HA, 1997, J BIOL CHEM, V272, P510; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; KIM JH, 1995, J BIOL CHEM, V270, P8597, DOI 10.1074/jbc.270.15.8597; Knight K R, 1997, Respirology, V2, P91, DOI 10.1111/j.1440-1843.1997.tb00060.x; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; MCELVANEY NG, 1997, LUNG SCI FDN, P2537; OWEN MC, 1976, FEBS LETT, V79, P247; PERLMUTTER DH, 1985, P NATL ACAD SCI USA, V82, P6918, DOI 10.1073/pnas.82.20.6918; PERLMUTTER DH, 1999, SCHIFFS DIS LIVER, P1131; PERLMUTTER DH, 2001, IN PRESS LIVER BIOL; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; SIDHAR SK, 1995, J BIOL CHEM, V270, P8393, DOI 10.1074/jbc.270.15.8393; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SVEGER T, 1995, HEPATOLOGY, V22, P514, DOI 10.1002/hep.1840220221; SVEGER T, 1978, PEDIATRICS, V62, P22; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014	25	45	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33893	33898		10.1074/jbc.M105226200	http://dx.doi.org/10.1074/jbc.M105226200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11427540	hybrid			2022-12-27	WOS:000170910200082
J	Muhlenhoff, M; Manegold, A; Windfuhr, M; Gotza, B; Gerardy-Schahn, R				Muhlenhoff, M; Manegold, A; Windfuhr, M; Gotza, B; Gerardy-Schahn, R			The impact of N-glycosylation on the functions of polysialyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; DEVELOPMENTALLY-REGULATED MEMBER; POLYSIALIC ACID SYNTHASE; CENTRAL-NERVOUS-SYSTEM; ALPHA-MANNOSIDASE-II; 2 POLYSIALYLTRANSFERASES; OLFACTORY-BULB; ADULT-RAT; EXPRESSION; POLYSIALYLATION	Poly-alpha -2,8-sialic acid (polysialic acid) is a post-translational modification of the neural cell adhesion molecule (NCAM) and an important regulator of neuronal cell-cell interactions. The synthesis of polysialic acid depends on the two polysialyltransferases ST8SiaII and ST8SiaIV. Understanding the catalytic mechanisms of the polysialyltransferases is critical toward the aim of influencing physiological and pathophysiological functions mediated by polysialic acid. We recently demonstrated that polysialyltransferases are bifunctional enzymes exhibiting auto- and NCAM polysialylation activity. Autopolysialylation occurs on N-glycans of the enzymes, and glycosylation variants lacking sialic acid and galactose were found to be inactive for both auto- and NCAM polysialylation. In the present study, we have analyzed the number and functional importance of N-linked oligosaccharides present on polysialyltransferases. We demonstrate that autopolysialylation depends on specific N-glycans attached to Asn(74) in ST8SiaIV and Asn(89) and Asn(219) in ST8SiaII. Deletion of polysialic acid acceptor sites by site-directed mutagenesis rendered the polysialyltransferases inactive in vitro and in vivo. The inactivity of autopolysialylation-negative polysialyltransferases in vivo was not caused by the absence or default targeting of the enzymes. The data presented in this study clearly show that active polysialyltransferases are competent to perform autopolysialylation and provide strong evidence for a tight functional link between the two catalytic functions.	Hannover Med Sch, Inst Physiol Chem, D-30625 Hannover, Germany	Hannover Medical School	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Physiol Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de						Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2001, J BIOL CHEM, V276, P15369, DOI 10.1074/jbc.M100576200; Baboval T, 2000, BBA-GEN SUBJECTS, V1475, P383, DOI 10.1016/S0304-4165(00)00094-5; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Breton C, 1998, GLYCOBIOLOGY, V8, P87, DOI 10.1093/glycob/8.1.87; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Chen C, 2000, GLYCOBIOLOGY, V10, P531, DOI 10.1093/glycob/10.5.531; Christensen LL, 2000, GLYCOBIOLOGY, V10, P931, DOI 10.1093/glycob/10.9.931; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Daniel L, 2000, CANCER RES, V60, P80; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; FINNE J, 1985, J BIOL CHEM, V260, P1265; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fukuda M, 1996, CANCER RES, V56, P2237; GERARDYSCHAHN R, 1995, MOL MICROBIOL, V16, P441, DOI 10.1111/j.1365-2958.1995.tb02409.x; GERARDYSCHAHN R, 1994, INT J CANCER, P38; Gluer S, 1998, BRIT J CANCER, V78, P106, DOI 10.1038/bjc.1998.450; HARAGUCHI M, 1995, BIOCHEM J, V312, P273, DOI 10.1042/bj3120273; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Inoue S, 2000, J BIOL CHEM, V275, P29968, DOI 10.1074/jbc.M004150200; Kojima N, 1997, J BIOCHEM-TOKYO, V122, P1265; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Kurosawa N, 1997, J NEUROCHEM, V69, P494; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; MIRAGALL F, 1990, J NEUROCYTOL, V19, P899, DOI 10.1007/BF01186818; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Murakami S, 2000, J COMP NEUROL, V420, P171; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; SANCHEZLOPEZ R, 1988, J BIOL CHEM, V263, P11892; SCHNEIDEGGER EP, 1994, LAB INVEST, V70, P95; Seidenfaden R, 2000, EUR J CELL BIOL, V79, P680, DOI 10.1078/0171-9335-00093; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Windfuhr M, 2000, J BIOL CHEM, V275, P32861, DOI 10.1074/jbc.M003507200; YANG PF, 1994, J BIOL CHEM, V269, P23039	49	41	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34066	34073		10.1074/jbc.M101022200	http://dx.doi.org/10.1074/jbc.M101022200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11418591	hybrid			2022-12-27	WOS:000170910200104
J	Calugaru, SV; Swanson, R; Olson, ST				Calugaru, SV; Swanson, R; Olson, ST			The pH dependence of serpin-proteinase complex dissociation reveals a mechanism of complex stabilization involving inactive and active conformational states of the proteinase which are perturbable by calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE CENTER LOOP; INCREASED STRUCTURAL FLEXIBILITY; HUMAN ANTITHROMBIN-III; BOVINE BETA-TRYPSIN; ALPHA(1)-PROTEINASE INHIBITOR; KINETIC CHARACTERIZATION; ALPHA-CHYMOTRYPSIN; PLASMINOGEN-ACTIVATOR; TARGET PROTEINASES; SERINE PROTEASES	Serpin family protein proteinase inhibitors trap proteinases at the acyl-intermediate stage of cleavage of the serpin as a proteinase substrate by undergoing a dramatic conformational change, which is thought to distort the proteinase active site and slow deacylation. To investigate the extent to which proteinase catalytic function I. Ls defective in the serpin-proteinase complex, we compared the pH dependence of dissociation of several serpin-proteinase acyl-complexes with that of normal guanidinobenzoyl-proteinase acyl-intermediate complexes. Whereas the apparent rate constant for dissociation of guanidinobenzoyl-proteinase complexes (k(diss, app)) showed a pH dependence characteristic of His-57 catalysis of complex deacylation, the pH dependence of k(diss, app) for the serpin-proteinase complexes showed no evidence for His-57 involvement in complex deacylation and was instead characteristic of a hydroxide-mediated deacylation similar to that observed for the hydrolysis of tosylarginine methyl ester. Hydroxylamine enhanced the rate of serpin-proteinase complex dissociation but with a rate constant for nucleophilic attack on the acyl bond several orders of magnitude slower than that of hydroxide, implying limited accessibility of the acyl bond in the complex. The addition of 10-100 mm Ca2+ ions stimulated up to 80-fold the dissociation rate constant of several serpin-trypsin complexes in a saturable manner at neutral pH and altered the pH dependence to a pattern characteristic of His-57-catalyzed complex deacylation. These results support a mechanism of kinetic stabilization of serpin-proteinase complexes wherein the complex is trapped as an acyl-intermediate by a serpin conformational change-induced inactivation of the proteinase catalytic function, but suggest that the inactive proteinase conformation in the complex is in equilibrium with an active proteinase conformation that can be stabilized by the preferential binding of an allosteric ligand such as Ca2+.	Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olson, ST (corresponding author), Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Rm 530E,Dent MC 860,801 S Paulina St, Chicago, IL 60612 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064013] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01-HL-64013] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASCENZI P, 1982, BIOCHEMISTRY-US, V21, P2483, DOI 10.1021/bi00539a030; BJORK I, 1992, J BIOL CHEM, V267, P19047; BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501; BLOOM JW, 1978, J BIOL CHEM, V253, P547; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BODE W, 1975, FEBS LETT, V56, P139, DOI 10.1016/0014-5793(75)80128-1; ChaillanHuntington CE, 1997, BIOCHEMISTRY-US, V36, P9562, DOI 10.1021/bi970651g; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; CHURCH FC, 1997, CHEM BIOL SERPINS; COREY DR, 1992, J AM CHEM SOC, V114, P1784, DOI 10.1021/ja00031a037; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DANIELSSON A, 1983, BIOCHEM J, V213, P345, DOI 10.1042/bj2130345; DEJERSEY J, 1980, ARCH BIOCHEM BIOPHYS, V205, P536, DOI 10.1016/0003-9861(80)90136-8; DICERA E, 1991, BIOCHEMISTRY-US, V30, P7913, DOI 10.1021/bi00246a007; Egelund R, 1998, BIOCHEMISTRY-US, V37, P6375, DOI 10.1021/bi973043+; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Fa M, 2000, STRUCT FOLD DES, V8, P397, DOI 10.1016/S0969-2126(00)00121-0; FERSHT AR, 1973, BIOCHEMISTRY-US, V12, P2035, DOI 10.1021/bi00735a002; FERSHT AR, 1974, BIOCHEMISTRY-US, V13, P1416, DOI 10.1021/bi00704a016; Futamura A, 1998, BIOCHEMISTRY-US, V37, P13110, DOI 10.1021/bi981234m; GERTLER A, 1974, BIOCHEMISTRY-US, V13, P1302, DOI 10.1021/bi00703a038; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; Han JH, 1998, BIOCHEMISTRY-US, V37, P3203, DOI 10.1021/bi9722195; HERVE M, 1991, ARCH BIOCHEM BIOPHYS, V285, P142, DOI 10.1016/0003-9861(91)90341-F; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Kaslik G, 1999, ARCH BIOCHEM BIOPHYS, V362, P254, DOI 10.1006/abbi.1998.1035; KASLIK G, 1995, FEBS LETT, V370, P179, DOI 10.1016/0014-5793(95)00816-R; Kaslik G, 1997, BIOCHEMISTRY-US, V36, P5455, DOI 10.1021/bi962931m; KAY J, 1971, J BIOL CHEM, V246, P6661; Kvassman JO, 1998, BIOCHEMISTRY-US, V37, P15491, DOI 10.1021/bi9814787; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATALLO ZS, 1986, THROMB RES, V43, P507, DOI 10.1016/0049-3848(86)90071-X; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; MANGEL WF, 1990, BIOCHEMISTRY-US, V29, P8351, DOI 10.1021/bi00488a022; MELHADO LL, 1982, J AM CHEM SOC, V104, P7299, DOI 10.1021/ja00389a065; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; O'Malley KM, 2001, J BIOL CHEM, V276, P6631, DOI 10.1074/jbc.M008478200; OLSON ST, 1995, J BIOL CHEM, V270, P30007; OLSON ST, 1982, J BIOL CHEM, V257, P4891; OLSON ST, 1995, J BIOL CHEM, V270, P9717, DOI 10.1074/jbc.270.17.9717; OLSON ST, 1993, BIOCHEMISTRY-US, V32, P12136, DOI 10.1021/bi00096a026; Olson ST, 1997, J BIOL CHEM, V272, P13338, DOI 10.1074/jbc.272.20.13338; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6284, DOI 10.1021/bi010100x; Plotnick MI, 1997, BIOCHEMISTRY-US, V36, P14601, DOI 10.1021/bi971530j; Plotnick MI, 1996, BIOCHEMISTRY-US, V35, P7586, DOI 10.1021/bi960233w; Polgar L, 1990, Mechanisms in Protease Action; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; SHORE JD, 1995, J BIOL CHEM, V270, P5395, DOI 10.1074/jbc.270.10.5395; Stavridi ES, 1996, BIOCHEMISTRY-US, V35, P10608, DOI 10.1021/bi9605806; Stone SR, 1997, J MOL BIOL, V265, P344, DOI 10.1006/jmbi.1996.0727; Stratikos E, 1998, J BIOL CHEM, V273, P15582, DOI 10.1074/jbc.273.25.15582; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; WILCZYNSKA M, 1995, J BIOL CHEM, V270, P29652; WRIGHT HT, 1995, PROTEINS, V22, P210, DOI 10.1002/prot.340220303; YUNG BY, 1975, BIOCHEM BIOPH RES CO, V65, P927, DOI 10.1016/S0006-291X(75)80474-8	61	50	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32446	32455		10.1074/jbc.M104731200	http://dx.doi.org/10.1074/jbc.M104731200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11404362	hybrid			2022-12-27	WOS:000170746000012
J	De Angelis, E; Brummendorf, T; Cheng, L; Lemmon, V; Kenwrick, S				De Angelis, E; Brummendorf, T; Cheng, L; Lemmon, V; Kenwrick, S			Alternative use of a mini exon of the L1 gene affects L1 binding to neural ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; GROWTH CONE; AXONIN-1; EXPRESSION; PROMOTION; MUTATIONS; ISOFORMS; DOMAINS	Neural cell adhesion molecule Ll is a cell surface glycoprotein required for the correct development of the nervous system. Ll exists as two isoforms encoded by mRNA species that either collectively incorporate or exclude exons 2 and 27. Neurons utilize only the full-length isoform, whereas Schwann cells, kidney cells, and blood lymphocytes only express the short form of L1. Still other cells, oligodendrocytes, regulate Ll isoform expression in a maturation-dependent manner. The RSLE motif encoded by exon 27 is known to have a role in clathrin-mediated endocytosis of L1, but the function of the exon 2-encoded motif (YEGHHV) is unknown. Here we show that this motif is required for the optimal binding of Ll to several neural ligands and is likely to be important for nervous system development. Thus, alternative use of exon 2 is a mechanism for regulating ligand interactions with L1.	Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge CB2 2XY, England; Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2XY, England; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Case Western Reserve University	De Angelis, E (corresponding author), Wellcome Trust Ctr Mol Mechanisms Dis, Hills Rd, Cambridge CB2 2XY, England.		Lemmon, Vance/A-7410-2010; Lemmon, Vance/A-2565-2008	Lemmon, Vance/0000-0003-3550-7576; 	NEI NIH HHS [R01 EY005285, R01 EY005285-23, EY05285, EY11373] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY011373, R01EY005285] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; BRUMMENDORF T, 1993, NEURON, V10, P711; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Coutelle O, 1998, GENE, V208, P7, DOI 10.1016/S0378-1119(97)00614-8; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; DEPPERT W, 1981, J VIROL, V37, P478, DOI 10.1128/JVI.37.1.478-482.1981; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Itoh K, 2000, J NEUROSCI RES, V60, P579; JOUET M, 1995, MOL BRAIN RES, V30, P378, DOI 10.1016/0169-328X(95)00027-P; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; Oleszewski M, 2000, J BIOL CHEM, V275, P34478, DOI 10.1074/jbc.M004147200; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Takeda Y, 1996, J NEUROCHEM, V66, P2338; Treubert U, 1998, J NEUROSCI, V18, P1795; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; WOLFF JM, 1988, J BIOL CHEM, V263, P11943	23	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32738	32742		10.1074/jbc.M105156200	http://dx.doi.org/10.1074/jbc.M105156200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435440	hybrid			2022-12-27	WOS:000170746000049
J	Lang, SE; McMahon, SB; Cole, MD; Hearing, P				Lang, SE; McMahon, SB; Cole, MD; Hearing, P			E2F transcriptional activation requires TRRAP and GCN5 cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE ENTRY; SUSCEPTIBILITY GENE-PRODUCT; TATA-BINDING PROTEIN; CELL-CYCLE ARREST; RETINOBLASTOMA PROTEIN; HISTONE ACETYLTRANSFERASE; FAMILY MEMBERS; C-MYC; REPRESSES TRANSCRIPTION; NUCLEAR-LOCALIZATION	The E2F family of transcription factors regulates the temporal transcription of genes involved in cell cycle progression and DNA synthesis. E2F transactivation is antagonized by retinoblastoma protein (pRb), which recruits chromatin-remodeling proteins such as histone deacetylases and SWI.SNF complexes to the promoter to repress transcription. We hypothesized that E2F proteins must reverse the pRb-imposed chromatin structure to stimulate transcription. If this is true, E2F proteins should recruit proteins capable of histone acetylation. Here we map the E2F-4 transactivation domain and show that E2F-1 and E2F-4 transactivation domains bind the acetyltransferase GCN5 and cofactor TRRAP in vivo. TRRAP and GCN5 co-expression stimulated E2F-mediated transactivation, and e-Myc repressed E2F transactivation dependent on an intact TRRAP/GCN5 binding motif. The transactivation domain of E2F-4 recruited proteins with significant histone acetyltransferase activity in vivo, and this activity required catalytically active GCN5. E2F-4 proteins with subtle mutations in the transactivation domain exhibited a positive correlation among transcriptional activation and GCN5 and TRRAP binding capacity and associated acetyltransferase activity. We conclude that E2F stimulates transcription by recruiting acetyltransferase activity and the essential cofactors GCN5 and TRRAP. These results provide a mechanism for E2F transcription factors to overcome pRb-mediated dominant repression of transcription.	SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Princeton University	Hearing, P (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.			McMahon, Steven/0000-0002-3405-1768	NATIONAL CANCER INSTITUTE [R01CA055248, T32CA009176, P01CA028146] Funding Source: NIH RePORTER; NCI NIH HHS [CA09176, CA28146, CA55248] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADNANE J, 1995, J BIOL CHEM, V270, P8837, DOI 10.1074/jbc.270.15.8837; Allen KE, 1997, J CELL SCI, V110, P2819; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; Blau J, 1996, MOL CELL BIOL, V16, P2044; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; BREMNER R, 1995, MOL CELL BIOL, V15, P3256; BROUGH DE, 1995, MOL CELL BIOL, V15, P1536; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; EMILI A, 1995, J BIOL CHEM, V270, P13674, DOI 10.1074/jbc.270.23.13674; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; Grant PA, 1999, SEMIN CELL DEV BIOL, V10, P169, DOI 10.1006/scdb.1999.0298; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HSIAO KM, 1994, GENE DEV, V8, P1526, DOI 10.1101/gad.8.13.1526; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magae J, 1996, J CELL SCI, V109, P1717; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Muller H, 1997, MOL CELL BIOL, V17, P5508; MULLER H, 2000, BIOCHIM BIOPHYS ACTA, V1470, P1; MURTHY SCS, 1985, P NATL ACAD SCI USA, V82, P2230, DOI 10.1073/pnas.82.8.2230; Nevels M, 1997, P NATL ACAD SCI USA, V94, P1206, DOI 10.1073/pnas.94.4.1206; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; Pierce AM, 1998, MOL CARCINOGEN, V22, P190, DOI 10.1002/(SICI)1098-2744(199807)22:3<190::AID-MC7>3.0.CO;2-P; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Reed Michael, 1993, Gene Expression, V3, P95; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; Snowden AW, 1998, BIOCHEM PHARMACOL, V55, P1947, DOI 10.1016/S0006-2952(98)00020-3; SOMMER A, 1998, J BIOL CHEM, V273, P6642; Trouche D, 1996, NUCLEIC ACIDS RES, V24, P4139, DOI 10.1093/nar/24.21.4139; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Trouche D, 1996, P NATL ACAD SCI USA, V93, P1439, DOI 10.1073/pnas.93.4.1439; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WONG KK, 1995, MOL CELL BIOL, V15, P6535; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; ZAWEL L, 1995, ANNU REV BIOCHEM, V64, P533; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	73	97	100	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32627	32634		10.1074/jbc.M102067200	http://dx.doi.org/10.1074/jbc.M102067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11418595	hybrid			2022-12-27	WOS:000170746000034
J	Palma, M; Shannon, O; Quezada, HC; Berg, A; Flock, JI				Palma, M; Shannon, O; Quezada, HC; Berg, A; Flock, JI			Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the alpha-chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUMPING FACTOR; NUCLEOTIDE-SEQUENCE; FRAGMENT-D; RECEPTOR; GENE; THROMBOSPONDIN; IDENTIFICATION; SPECIFICITY; VIRULENCE; CLONING	Extracellular fibrinogen-binding protein (Efb) secreted by Staphylococcus aureus has previously been shown to contribute to pathogenesis in a rat wound infection model. Also antibodies against Efb exhibited a protective effect in a mouse mastitis model. The interaction between Efb and fibrinogen is divalent, with one binding site within the N-terminal repeat region in Efb and one at the C terminus. In this study we show that the distal D domain of fibrinogen contains at least one of the binding domains recognized by Efb. Efb stimulates fibrinogen binding to ADP-activated platelets. Furthermore, Efb inhibits ADP-induced, fibrinogen-dependent platelet aggregation in a concentration-dependent manner. This implies that Efb modifies platelet function by amplifying a non-functional interaction between fibrinogen and platelets. Efb recognizes the A alpha -chain of the D fragment of fibrinogen. The RGD sequence on the A alpha -chain is located close to the region recognized by Efb and contains a putative binding site for the platelet integrin GPIIb/IIIa receptor complex involved in platelet aggregation.	Huddinge Univ Hosp, Dept Microbiol Pathol & Immunol, Karolinska Inst, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Dept Med, Karolinska Inst, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Dept Clin Chem, C1 74, Karolinska Inst, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Flock, JI (corresponding author), Huddinge Univ Hosp, Dept Microbiol Pathol & Immunol, Karolinska Inst, F 82, S-14186 Huddinge, Sweden.		Palma, Marco/AAX-8408-2020	Palma, Marco/0000-0001-8910-994X; Shannon, Oonagh/0000-0001-8291-8189				BACONBAGULEY T, 1990, J BIOL CHEM, V265, P2317; BODEN MK, 1992, MICROB PATHOGENESIS, V12, P289, DOI 10.1016/0882-4010(92)90047-R; BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x; BOUMA H, 1978, THROMB RES, V13, P557, DOI 10.1016/0049-3848(78)90142-1; CHEUNG AI, 1995, INFECT IMMUN, V63, P1914, DOI 10.1128/IAI.63.5.1914-1920.1995; COLLEN D, 1975, J BIOL CHEM, V250, P5808; Colque-Navarro P, 2000, CLIN DIAGN LAB IMMUN, V7, P14, DOI 10.1128/CDLI.7.1.14-20.2000; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; HAWIGER J, 1989, BIOCHEMISTRY-US, V28, P2909, DOI 10.1021/bi00433a024; JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457; KAIDA S, 1987, J BIOCHEM, V102, P1177, DOI 10.1093/oxfordjournals.jbchem.a122156; MAMO W, 1994, FEMS IMMUNOL MED MIC, V10, P47, DOI 10.1111/j.1574-695X.1994.tb00010.x; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; MCGAVIN MH, 1993, INFECT IMMUN, V61, P2479, DOI 10.1128/IAI.61.6.2479-2485.1993; NEIDHIN D, 1999, MOL MICROBIOL, V30, P245; Nilsson M, 1998, INFECT IMMUN, V66, P2666, DOI 10.1128/IAI.66.6.2666-2673.1998; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; Palma M, 1999, J BACTERIOL, V181, P2840, DOI 10.1128/JB.181.9.2840-2845.1999; Palma M, 1998, J BIOL CHEM, V273, P13177, DOI 10.1074/jbc.273.21.13177; Pei L, 1999, INFECT IMMUN, V67, P4525, DOI 10.1128/IAI.67.9.4525-4530.1999; PHONIMDAENG P, 1990, MOL MICROBIOL, V4, P393, DOI 10.1111/j.1365-2958.1990.tb00606.x; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; TUSZYNSKI GP, 1985, J BIOL CHEM, V260, P2240; VOSKUILEN M, 1987, J BIOL CHEM, V262, P5944	26	51	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31691	31697		10.1074/jbc.M104554200	http://dx.doi.org/10.1074/jbc.M104554200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418620	hybrid			2022-12-27	WOS:000170613500031
J	Roe, MW; Mooret, AL; Lidofsky, SD				Roe, MW; Mooret, AL; Lidofsky, SD			Purinergic-independent calcium signaling mediates recovery from hepatocellular swelling - Implications for volume regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INCREASES INOSITOL 1,4,5-TRISPHOSPHATE; ISOLATED GUINEA-PIG; RAT-LIVER CELLS; INTRACELLULAR CALCIUM; ATP RELEASE; HUMAN HEPATOCYTES; EPITHELIAL-CELLS; PHOSPHOLIPASE-C; RHO-KINASE	Swelling of hepatocytes and other epithelia activates volume-sensitive ion channels that facilitate fluid and electrolyte efflux to restore cell volume, but the responsible signaling pathways are incompletely defined. Previous work in model HTC rat hepatoma cells has indicated that swelling elicits ATP release, which stimulates P2 receptors and activates Cl- channels, and that this mechanism is essential for hepatocellular volume recovery. Since P2 receptors are generally coupled to Ca2+ signaling pathways, we determined whether hepatocellular swelling affected cytosolic [Ca2+], and if this involved a purinergic mechanism. Exposure of HTC cells to hypotonic media evoked an increase in cytosolic [Ca2+], which was followed by activation of K+ and Cl- currents. Maneuvers that interfered with swelling-induced increases in cytosolic [Ca2+], including extracellular Ca2+ removal and intracellular Ca2+ store depletion with thapsigargin, inhibited activation of membrane currents and volume recovery. However, the swelling-induced increases in cytosolic [Ca2+] were unaffected by either extracellular ATP depletion with apyrase or blockade of P2 receptors with suramin. These findings indicate that swelling elicits an increase in hepatocellular Ca2+, which is essential for ion channel activation and volume recovery, but that this increase does not stem from activation of volume-sensitive P2 receptors. Collectively, these observations imply that regulatory responses to hepatocellular swelling involve a dual requirement for a purinergic-independent Ca2+ signaling cascade and a Ca2+-independent purinergic signaling pathway.	Univ Vermont, Coll Med, Dept Med, Burlington, VT 05401 USA; Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05401 USA	University of Vermont; University of Vermont	Roe, MW (corresponding author), Univ Vermont, Coll Med, Dept Med, Burgess 414 MFU, Burlington, VT 05401 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047849] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47849] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAQUET A, 1991, FEBS LETT, V278, P103, DOI 10.1016/0014-5793(91)80094-J; BEAR CE, 1990, AM J PHYSIOL, V258, pC421, DOI 10.1152/ajpcell.1990.258.3.C421; BEAR CE, 1987, PFLUG ARCH EUR J PHY, V410, P342, DOI 10.1007/BF00580288; Bodily K, 1997, HEPATOLOGY, V25, P403; Borgdorff AJ, 2000, J NEUROPHYSIOL, V83, P81, DOI 10.1152/jn.2000.83.1.81; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; CORASANTI JG, 1990, AM J PHYSIOL, V258, pG260; Crepel V, 1998, J NEUROSCI, V18, P1196; Dixon CJ, 2000, BRIT J PHARMACOL, V129, P764, DOI 10.1038/sj.bjp.0703103; Errington RJ, 1999, METH MOL B, V122, P315; Felix JA, 1996, AM J RESP CELL MOL, V14, P296, DOI 10.1165/ajrcmb.14.3.8845181; Feranchak AP, 2000, J HEPATOL, V33, P174, DOI 10.1016/S0168-8278(00)80357-8; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; FITZ JG, 1994, AM J PHYSIOL, V266, pG677, DOI 10.1152/ajpgi.1994.266.4.G677; GLENNON MC, 1992, J BIOL CHEM, V267, P8230; HADDAD P, 1991, AM J PHYSIOL, V261, pG340, DOI 10.1152/ajpgi.1991.261.2.G340; Haussinger D, 1996, Prog Liver Dis, V14, P29; Jena M, 1997, AM J PHYSIOL-CELL PH, V273, pC316, DOI 10.1152/ajpcell.1997.273.1.C316; KHALBUSS WE, 1991, HEPATOLOGY, V13, P962, DOI 10.1016/0270-9139(91)90271-V; KOUMI SI, 1994, J GEN PHYSIOL, V104, P357, DOI 10.1085/jgp.104.2.357; LIDOFSKY DS, 1997, AM J PHYSIOL, V273, pG849; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Meng XJ, 1996, AM J PHYSIOL-CELL PH, V271, pC112, DOI 10.1152/ajpcell.1996.271.1.C112; Missiaen L, 1996, J BIOL CHEM, V271, P4601; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Nguyen TD, 2001, AM J PHYSIOL-GASTR L, V280, pG795, DOI 10.1152/ajpgi.2001.280.5.G795; Nilius B, 1999, J PHYSIOL-LONDON, V516, P67, DOI 10.1111/j.1469-7793.1999.067aa.x; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; O'Neill WC, 1999, AM J PHYSIOL-CELL PH, V276, pC995, DOI 10.1152/ajpcell.1999.276.5.C995; Ralevic V, 1998, PHARMACOL REV, V50, P413; Roman RM, 1997, J BIOL CHEM, V272, P21970, DOI 10.1074/jbc.272.35.21970; Roman RM, 1999, GASTROENTEROLOGY, V116, P964, DOI 10.1016/S0016-5085(99)70081-8; Roman RM, 1998, HEPATOLOGY, V28, P1073, DOI 10.1002/hep.510280423; SANDFORD CA, 1992, J PHYSIOL-LONDON, V447, P133, DOI 10.1113/jphysiol.1992.sp018995; Sauzeau V, 2000, AM J PHYSIOL-HEART C, V278, pH1751, DOI 10.1152/ajpheart.2000.278.6.H1751; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; SCHREIBER R, 1995, BIOCHEM J, V309, P19, DOI 10.1042/bj3090019; Tilly BC, 1996, MOL BIOL CELL, V7, P1419, DOI 10.1091/mbc.7.9.1419; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Wu X, 1997, J MEMBRANE BIOL, V158, P127, DOI 10.1007/s002329900250; Yano M, 1996, J BIOL CHEM, V271, P6702, DOI 10.1074/jbc.271.12.6702	41	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30871	30877		10.1074/jbc.M102362200	http://dx.doi.org/10.1074/jbc.M102362200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413133	hybrid			2022-12-27	WOS:000170472900039
J	Ito, K; Jazrawi, E; Cosio, BJ; Barnes, PJ; Adcock, IM				Ito, K; Jazrawi, E; Cosio, BJ; Barnes, PJ; Adcock, IM			p65-activated histone acetyltransferase activity is repressed by glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR ACCESS; CREB-BINDING-PROTEIN; DNA-BINDING; RECEPTOR; ACETYLATION; GENE; ACTIVATION; EXPRESSION; TRANSACTIVATION	Glucocorticoids acting through their specific receptor can either enhance or repress gene transcription. Dexamethasone represses interleukin-1 beta -stimulated histone acetylation and granulocyte-macrophage colony-stimulating factor expression through a combination of direct inhibition of p65-associated histone acetyltransferase CHAT) activity and by recruiting histone deacetylase 2 (HDAC2) to the p65-HAT complex. Here we show that mifepristone, a glucocorticoid receptor partial agonist, has no ability to induce gene expression but represses interleukin-1 beta -stimulated histone acetylation and granulocyte-macrophage colony-stimulating factor release by 50% maximally. Mifepristone was able to inhibit p65-associated HAT activity to the same extent as dexamethasone but failed to inhibit the natural promoter to an equal extent clue to an inability to recruit HDAC2 to the p65-associated HAT complex. These data suggest that the maximal repressive actions of glucocorticoids require recruitment of HDAC2 to a p65-HAT complex. These data also suggest that pharmacological manipulation of specific histone acetylation status is a potentially useful approach for the treatment of inflammatory diseases.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sch Med, London SW3 6LY, England	Imperial College London	Adcock, IM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sch Med, Dovehouse St, London SW3 6LY, England.	ian.adcock@ic.ac.uk	G.Cosio, Borja/P-4963-2017; Ito, Kazuhiro/AAF-5994-2019; Adcock, Ian/L-3217-2019	G.Cosio, Borja/0000-0002-6388-8209; Adcock, Ian/0000-0003-2101-8843; Barnes, Peter/0000-0002-5122-4018				Adcock IM, 1999, BRIT J PHARMACOL, V127, P1003, DOI 10.1038/sj.bjp.0702613; Adkins KK, 1998, AM J PHYSIOL-LUNG C, V275, pL372, DOI 10.1152/ajplung.1998.275.2.L372; BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307; Barnes PJ, 1998, EUR RESPIR J, V12, P221, DOI 10.1183/09031936.98.12010221; Beato M, 1996, J MOL MED, V74, P711, DOI 10.1007/s001090050076; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; De B.K., 1997, P NATL ACAD SCI USA, V94, P13504; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Ikeda A, 2000, BIOCHEM BIOPH RES CO, V272, P375, DOI 10.1006/bbrc.2000.2786; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Kolle D, 1998, METHODS, V15, P323, DOI 10.1006/meth.1998.0636; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Levine SJ, 1996, AM J RESP CELL MOL, V15, P245, DOI 10.1165/ajrcmb.15.2.8703481; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; Nightingale KP, 1998, EMBO J, V17, P2865, DOI 10.1093/emboj/17.10.2865; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PERRY M, 1982, J BIOL CHEM, V257, P7336; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; TURNER BM, 1989, FEBS LETT, V253, P141, DOI 10.1016/0014-5793(89)80947-0; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Wolffe AP, 1997, NATURE, V387, P16, DOI 10.1038/387016a0; WORKMAN JL, 1993, TRENDS BIOCHEM SCI, V18, P90, DOI 10.1016/0968-0004(93)90160-O; Wright LC, 1998, AM J PHYSIOL-LUNG C, V275, pL694, DOI 10.1152/ajplung.1998.275.4.L694; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	40	105	114	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30208	30215		10.1074/jbc.M103604200	http://dx.doi.org/10.1074/jbc.M103604200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395507	hybrid			2022-12-27	WOS:000170558000081
J	Ohtsuka, T; Sakamoto, M; Guillemot, F; Kageyama, R				Ohtsuka, T; Sakamoto, M; Guillemot, F; Kageyama, R			Roles of the basic helix-loop-helix genes Hes1 and Hes5 in expansion of neural stem cells of the developing brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; NEGATIVE REGULATOR; MAMMALIAN HAIRY; ACHAETE-SCUTE; NOTCH; NEUROGENESIS; EXPRESSION; GENERATION; ENHANCER	Neural stem cells, which differentiate into neurons and glia, are present in the ventricular zone of the embryonal brain. The precise mechanism by which neural stem cells are maintained during embryogenesis remains to be determined. Here, we found that transient misexpression of the basic helix-loop-helix genes Hes1 and Hes5 keeps embryonal telencephalic cells undifferentiated although they have been shown to induce gliogenesis in the retina. These telencephalic cells later differentiate into neurons and astroglia when Hes expression is down-regulated, suggesting that Hes1- and Hes5- expressing cells are maintained as neural stem cells during embryogenesis. Conversely, in the absence of Hes1 and Hes5, neural stem cells are not properly maintained, generating fewer and smaller neurospheres than the wild type. These results indicate that Hes1 and Hes5 play an important role in the maintenance of neural stem cells but not in gliogenesis in the embryonal telencephalon.	Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; Univ Strasbourg 1, Coll France, Ctr Univ Strasbourg, CNRS,INSERM Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Kyoto University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kageyama, R (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.		Guillemot, Francois/AAV-1482-2021					AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Allen T, 1999, CELL MOL BIOL, V45, P687; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Cai L, 2000, DEVELOPMENT, V127, P3021; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Cau E, 2000, DEVELOPMENT, V127, P2323; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Hirata H, 2000, J BIOL CHEM, V275, P19083, DOI 10.1074/jbc.M001075200; Hojo M, 2000, DEVELOPMENT, V127, P2515; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jacobson M., 1991, DEV NEUROBIOLOGY; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Lobe CG, 1997, MECH DEVELOP, V62, P227, DOI 10.1016/S0925-4773(97)00665-5; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; NYE JS, 1994, DEVELOPMENT, V120, P2421; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Zheng JL, 2000, DEVELOPMENT, V127, P4551	43	327	338	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30467	30474		10.1074/jbc.M102420200	http://dx.doi.org/10.1074/jbc.M102420200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11399758	hybrid			2022-12-27	WOS:000170558000113
J	Okamoto, T; Akaike, T; Sawa, T; Miyamoto, Y; van der Vliet, A; Maeda, H				Okamoto, T; Akaike, T; Sawa, T; Miyamoto, Y; van der Vliet, A; Maeda, H			Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; TYROSINE NITRATION; RESPIRATORY-TRACT; CYSTEINE SWITCH; URIC-ACID; OXIDATION; COLLAGENASE; SUPEROXIDE; THIOLS; EXPRESSION	Oxidative stress may cause tissue injury through activation of the precursors of matrix metalloproteinase (proMMPs). In this study, we observed glutathione (GSH)-dependent proMMP activation induced by peroxynitrite, a potent oxidizing agent formed during inflammatory processes. Peroxynitrite strongly activated all three types of purified human proMMPs (proMMP-1, -8, and -9) in the presence of similar concentrations of GSH. Of the potential reaction products between peroxynitrite and GSH, only S-nitroglutathione (GSNO(2)) caused proMMP activation. Extensive S-glutathiolation of the proMMP protein occurred during activation of proMMP by peroxynitrite and GSH, as shown by radiolabeling studies with [S-35]GSH or [H-3]GSH. Evidence of appreciable S-glutathiolation persisted even after dithiothreitol and protein-denaturing treatment, however, suggesting that some S-glutathiolation did not occur through formation of simple mixed disulfide. Matrix-assisted laser-desorption ionization-time-of-flight mass spectrometry indicated that not only peroxynitrite plus GSH but also synthetic GSNO(2) produced dithiothreitol-resistant S-glutathiolation of the synthetic peptide PRCGVPD, which is a well conserved Cys-containing sequence of the propeptide autoinhibitory domain of proMMPs. PRCGVPD S-glutathiolation is presumed to be formed through glutathione disulfide S-oxide (GS(O)SR), based on the m/z 1064. Our results illustrate a unique mechanism of oxidative proMMP activation and oxidative tissue injury during inflammation.	Kumamoto Univ, Sch Med, Dept Microbiol, Kumamoto 8600811, Japan; Univ Calif Davis, Sch Med, Dept Internal Med, Div Pulm Crit Care Med, Davis, CA 95616 USA	Kumamoto University; University of California System; University of California Davis	Akaike, T (corresponding author), Kumamoto Univ, Sch Med, Dept Microbiol, Kumamoto 8600811, Japan.							Akaike T, 2000, FREE RADICAL RES, V33, P461, DOI 10.1080/10715760000301001; Balazy M, 1998, J BIOL CHEM, V273, P32009, DOI 10.1074/jbc.273.48.32009; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; CAMERON DR, 1995, CAN J CHEM, V73, P1627, DOI 10.1139/v95-202; CANTIN AM, 1989, AM REV RESPIR DIS, V139, P370, DOI 10.1164/ajrccm/139.2.370; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Coddington JW, 1999, J AM CHEM SOC, V121, P2438, DOI 10.1021/ja982887t; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Davis DA, 1996, BIOCHEMISTRY-US, V35, P2482, DOI 10.1021/bi951525k; Frears ER, 1996, FEBS LETT, V381, P21, DOI 10.1016/0014-5793(96)00065-8; Goldstein S, 2000, J BIOL CHEM, V275, P3031, DOI 10.1074/jbc.275.5.3031; Grant G A, 1992, Matrix Suppl, V1, P217; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Karoui H, 1996, J BIOL CHEM, V271, P6000, DOI 10.1074/jbc.271.11.6000; Li JF, 2001, J BIOL CHEM, V276, P3098, DOI 10.1074/jbc.M008260200; MAINARDI CL, 1985, ANN NY ACAD SCI, V460, P345, DOI 10.1111/j.1749-6632.1985.tb51181.x; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1994, CANCER RES, V54, pS1969; Miyamoto Y, 2000, BIOCHEM BIOPH RES CO, V267, P918, DOI 10.1006/bbrc.1999.2046; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Okamoto T, 1997, ARCH BIOCHEM BIOPHYS, V342, P261, DOI 10.1006/abbi.1997.0127; Okamoto T, 1997, J BIOL CHEM, V272, P6059, DOI 10.1074/jbc.272.9.6059; PACHT ER, 1991, CHEST, V100, P1397, DOI 10.1378/chest.100.5.1397; RADI R, 1991, J BIOL CHEM, V266, P4244; Rahman I, 2000, FREE RADICAL BIO MED, V28, P1405, DOI 10.1016/S0891-5849(00)00215-X; Reddy S, 2000, BIOCHEM J, V347, P821, DOI 10.1042/0264-6021:3470821; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; RIES C, 1995, BIOL CHEM H-S, V376, P345; SALO T, 1991, J BIOL CHEM, V266, P11436; SALO T, 1994, LAB INVEST, V70, P176; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; Silvester JA, 1998, FREE RADICAL BIO MED, V24, P754, DOI 10.1016/S0891-5849(97)00327-4; Skinner KA, 1998, J BIOL CHEM, V273, P24491, DOI 10.1074/jbc.273.38.24491; SORSA T, 1994, ANN NY ACAD SCI, V732, P112, DOI 10.1111/j.1749-6632.1994.tb24729.x; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Squadrito GL, 2000, ARCH BIOCHEM BIOPHYS, V376, P333, DOI 10.1006/abbi.2000.1721; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Suga M, 2000, AM J RESP CRIT CARE, V162, P1949, DOI 10.1164/ajrccm.162.5.9906096; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; TSCHESCHE H, 1981, EUR J BIOCHEM, V120, P183, DOI 10.1111/j.1432-1033.1981.tb05687.x; van der Vliet A, 1999, AM J PHYSIOL-LUNG C, V276, pL289, DOI 10.1152/ajplung.1999.276.2.L289; van der Vliet A, 1998, J BIOL CHEM, V273, P30255, DOI 10.1074/jbc.273.46.30255; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Viner RI, 1999, BIOCHEMISTRY-US, V38, P12408, DOI 10.1021/bi9909445; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1985, SCIENCE, V227, P747, DOI 10.1126/science.2982211; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wu J, 2001, JPN J CANCER RES, V92, P439, DOI 10.1111/j.1349-7006.2001.tb01114.x; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	54	349	356	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29596	29602		10.1074/jbc.M102417200	http://dx.doi.org/10.1074/jbc.M102417200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11395496	hybrid			2022-12-27	WOS:000170346000126
J	Soriano, S; Lu, DC; Chandra, S; Pietrzik, CU; Koo, EH				Soriano, S; Lu, DC; Chandra, S; Pietrzik, CU; Koo, EH			The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA PEPTIDE FORMATION; ALZHEIMERS-DISEASE; APOPTOSIS; DOMAIN; INVOLVEMENT; ENDOCYTOSIS; SECRETION; FRAGMENT; NEURONS; CELLS	Amyloid beta -protein (A beta) is the main constituent of senile plaques in Alzheimer's disease and is derived by proteolysis from the amyloid precursor protein (APP). Generation and secretion of both A beta 40 and A beta 42 isoforms depend largely on internalization of APP and occurs mainly in the endocytic pathway. Evidence has also been presented (Gervais, F. G., Xu, D., Robertson, G. S., Vaillancourt, J. P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M. S., Clarke, E. E., Zheng, H., Van der Ploeg, L. H. T., Ruffolo, S. C., Thornberry, N. A., Xanthoudakis, S., Zamboni, R. J., Roy, S., and Nicholson, D. W. (1999) Cell, 97, 395-406) that caspase cleavage of APP at its cytosolic tail affects its processing such that it is redirected to a more amyloidogenic pathway, resulting in enhanced A beta generation. However, caspase cleavage of APP,also results in loss of its endocytosis signal (YENP), an event that would predict a decline in internalization and a concomitant decrease, not an increase, in A beta generation. In the present work, we examined whether caspase cleavage of APP is relevant to amyloidogenesis. We found that 1) caspase cleavage of APP results in reduced internalization and, accordingly, a decline in A beta secretion; 2) masking of the caspase site in APP did not affect A beta levels and, 3) caspase activation in cells by serum withdrawal did not increase A beta secretion. Thus, caspase cleavage of APP is unlikely to play a direct role in amyloidogenesis.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Soriano, S (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.				NIA NIH HHS [AG05131, AG12376] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012376] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barnes NY, 1998, J NEUROSCI, V18, P5869; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Desdouits F, 1996, J BIOL CHEM, V271, P24670, DOI 10.1074/jbc.271.40.24670; Galli C, 1998, P NATL ACAD SCI USA, V95, P1247, DOI 10.1073/pnas.95.3.1247; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; HAASS C, 1993, J BIOL CHEM, V268, P3021; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LEBLANC AC, 1994, BIOCHEM BIOPH RES CO, V204, P1371, DOI 10.1006/bbrc.1994.2615; Lee JP, 2000, J NEUROSCI RES, V60, P565, DOI 10.1002/(SICI)1097-4547(20000515)60:4<565::AID-JNR16>3.0.CO;2-I; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Tanzi RE, 1999, NAT NEUROSCI, V2, P585, DOI 10.1038/10133; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823	20	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29045	29050		10.1074/jbc.M102456200	http://dx.doi.org/10.1074/jbc.M102456200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11397796	hybrid			2022-12-27	WOS:000170346000056
J	Tan, I; Ng, CH; Lim, L; Leung, T				Tan, I; Ng, CH; Lim, L; Leung, T			Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; CDC42-BINDING KINASE; FOCAL ADHESIONS; MUSCLE; SITE; ALPHA; ASSOCIATION; FILAMENTS; GTPASES; REORGANIZATION	The myotonic dystrophy kinase-related kinases RhoA binding kinase and myotonic dystrophy kinase-related Cdc42 binding kinase (MRCK) are effecters of RhoA and Cdc42, respectively, for actin reorganization, Using substrate screening in various tissues, we uncovered two major substrates, p130 and p85, for MRCK alpha -kinase, p130 is identified as myosin binding subunit p130, whereas p85 is a novel related protein. p85 contains N-terminal ankyrin repeats, an a-helical C terminus with leucine repeats, and a centrally located conserved motif with the MRCK alpha -kinase phosphorylation site. Like MBS130, p85 is specifically associated with protein phosphatase 1 delta (PP1 delta), and this requires the N terminus, including the ankyrin repeats. This association is required for the regulation of both the catalytic activities and the assembly of actin cytoskeleton, The N terminus, in association with PP1 delta, is essential for actin depolymerization, whereas the C terminus antagonizes this action. The C-terminal effects consist of two independent events that involved both the conserved phosphorylation inhibitory motif and the a-helical leucine repeats. The former was able to interact with PP1 delta only in the phosphorylated state and result in inactivation of PP1 delta activity, This provides further evidence that phosphorylation of a myosin binding subunit protein by specific kinases confers conformational changes in a highly conserved region that plays an essential role in the regulation of its catalytic subunit activities.	Glaxo IMCB Grp, Inst Mol & Cell Biol, Singapore 117609, Singapore; UCL, Neurol Inst, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; University of London; University College London	Leung, T (corresponding author), Glaxo IMCB Grp, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.	mcbthoml@imcb.nus.edu.sg		Ng, Chong Han/0000-0003-2926-9831				Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; Dutheil N, 2000, P NATL ACAD SCI USA, V97, P4862, DOI 10.1073/pnas.080079397; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartshorne DJ, 1999, MOL CELL BIOCHEM, V190, P79, DOI 10.1023/A:1006917032557; Ichikawa K, 1996, BIOCHEMISTRY-US, V35, P6313, DOI 10.1021/bi960208q; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Johnson D, 1997, EUR J BIOCHEM, V244, P931, DOI 10.1111/j.1432-1033.1997.00931.x; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Leung T, 1996, MOL CELL BIOL, V16, P5313; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; Recchia A, 1999, P NATL ACAD SCI USA, V96, P2615, DOI 10.1073/pnas.96.6.2615; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; Sin WC, 1998, MOL CELL BIOL, V18, P6325, DOI 10.1128/MCB.18.11.6325; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	32	119	130	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21209	21216		10.1074/jbc.M102615200	http://dx.doi.org/10.1074/jbc.M102615200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11399775	hybrid			2022-12-27	WOS:000169297900056
J	Lozano, RM; Redondo-Horcajo, M; Jimenez, MA; Zilberberg, L; Cuevas, P; Bikfalvi, A; Rico, M; Gimenez-Gallego, G				Lozano, RM; Redondo-Horcajo, M; Jimenez, MA; Zilberberg, L; Cuevas, P; Bikfalvi, A; Rico, M; Gimenez-Gallego, G			Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; IN-VITRO ANGIOGENESIS; CHEMICAL-SHIFTS; FACTOR-IV; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; SECONDARY STRUCTURE; COUPLING-CONSTANTS; ENDOTHELIAL-CELL; MURINE MELANOMA	Platelet factor-4 is a protein belonging to the family of ELR-negative CXC chemokines which binds to fibroblast growth factor and inhibits its mitogenic activity. Platelet factor-4 also inhibits tumor growth by mechanisms involving antiangiogenesis. Antiangiogenic activity in vitro has also been shown for the 24-residue C-terminal fragment of the protein, which decreases the affinity between basic fibroblast growth factor and its cell-surface receptor. In this study, the preferential conformation of this fragment in solution has been determined and has been found to be composed of two helical subdomains. In addition, we show that the fragment forms a specific 1:1 complex with acidic and basic fibroblast growth factors and that both subdomains are probably required for inhibition of fibroblast growth factor-driven mitogenesis. Finally, we show that the binding of the fragment alters the structure of the fibroblast growth factors, although some of such alterations do not seem related with the inhibition of mitogenic activity. Since this fragment has recently been shown to inhibit fibroblast growth factor-induced angiogenesis in vivo when injected intraperitoneally, these results are relevant for developing new antiangiogenic treatments.	CSIC, Ctr Invest Biol, E-28006 Madrid, Spain; CSIC, Inst Estructura Mat, E-28006 Madrid, Spain; Univ Bordeaux, Growth Factor & Cell Differentiat Lab, F-33405 Talence, France; Univ Madrid, Hosp Ramon y Cajal, Serv Histol, Madrid 28034, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Estructura de la Materia (IEM); UDICE-French Research Universities; Universite de Bordeaux; Hospital Universitario Ramon y Cajal	Gimenez-Gallego, G (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.		Jimenez, M. Angeles/C-7193-2008	Jimenez, M. Angeles/0000-0001-6835-5850; Lozano, Rosa Maria/0000-0003-2762-6938				ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; ARAKAWA T, 1993, PROTEIN ENG, V6, P541, DOI 10.1093/protein/6.5.541; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; BAIRD A, 1990, HDB EXPT PHARM, V95, P369; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; BLANCO FJ, 1993, J AM CHEM SOC, V115, P5887, DOI 10.1021/ja00066a092; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BROWN KJ, 1994, BIOCHEMISTRY-US, V33, P13918, DOI 10.1021/bi00250a047; CASE DA, 1994, METHOD ENZYMOL, V239, P392; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; COPELAND RA, 1991, ARCH BIOCHEM BIOPHYS, V289, P53, DOI 10.1016/0003-9861(91)90441-K; Coulier F, 1997, J MOL EVOL, V44, P43, DOI 10.1007/PL00006120; Cuevas P, 1997, GROWTH FACTORS, V15, P29, DOI 10.3109/08977199709002110; Culajay JF, 2000, BIOCHEMISTRY-US, V39, P7153, DOI 10.1021/bi9927742; DEUEL TF, 1977, P NATL ACAD SCI USA, V74, P2256, DOI 10.1073/pnas.74.6.2256; DIDONATO A, 1993, ANAL BIOCHEM, V212, P291, DOI 10.1006/abio.1993.1328; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V138, P611, DOI 10.1016/S0006-291X(86)80540-X; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V135, P541, DOI 10.1016/0006-291X(86)90028-8; GIMENEZGALLEGO G, 1994, NEUROL RES, V16, P313; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; GUPTA SK, 1994, J CELL BIOL, V127, P1121, DOI 10.1083/jcb.127.4.1121; GUPTA SK, 1995, P NATL ACAD SCI USA, V92, P7799, DOI 10.1073/pnas.92.17.7799; Hagedorn M, 2001, FASEB J, V15, P550; HANSELL P, 1995, AM J PHYSIOL, V269, P829; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JIMENEZ MA, 1994, J MOL BIOL, V242, P487; Jonca F, 1997, J BIOL CHEM, V272, P24203, DOI 10.1074/jbc.272.39.24203; Jouan V, 1999, BLOOD, V94, P984, DOI 10.1182/blood.V94.3.984.415k31_984_993; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KOLBER DL, 1995, J NATL CANCER I, V87, P304, DOI 10.1093/jnci/87.4.304; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; LOSCALZO J, 1985, ARCH BIOCHEM BIOPHYS, V240, P446, DOI 10.1016/0003-9861(85)90049-9; Lozano RM, 1998, J MOL BIOL, V281, P899, DOI 10.1006/jmbi.1998.1977; Lozano RM, 2000, BIOCHEMISTRY-US, V39, P4982, DOI 10.1021/bi992544n; MAIONE TE, 1991, CANCER RES, V51, P2077; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Mandriota SJ, 1997, J CELL SCI, V110, P2293; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; MATOUSCHEK A, 1992, J MOL BIOL, V224, P819, DOI 10.1016/0022-2836(92)90564-Z; MINTON AP, 1994, MODERN ANAL ULTRACEN; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MUNOZ V, 1995, NAT STRUCT BIOL, V2, P380, DOI 10.1038/nsb0595-380; NIEWIAROWSKI S, 1976, LAB CLIN MED, V87, P720; Nishimura T, 1999, BBA-GENE STRUCT EXPR, V1444, P148, DOI 10.1016/S0167-4781(98)00255-3; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORTEGA S, 1991, J BIOL CHEM, V266, P5842; Pace C N, 1986, Methods Enzymol, V131, P266; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; PESSEN H, 1985, METHOD ENZYMOL, V117, P219; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; PinedaLucena A, 1996, J MOL BIOL, V264, P162, DOI 10.1006/jmbi.1996.0631; PINEDALUCENA A, 1994, J MOL BIOL, V242, P81, DOI 10.1006/jmbi.1994.1558; PINEDALUCENA A, 1994, EUR J BIOCHEM, V222, P425, DOI 10.1111/j.1432-1033.1994.tb18881.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Romero A, 1996, EUR J BIOCHEM, V241, P453, DOI 10.1111/j.1432-1033.1996.00453.x; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SHARPE RJ, 1990, JNCI-J NATL CANCER I, V82, P848, DOI 10.1093/jnci/82.10.848; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; STAFFORD WF, 1978, BIOCHEMISTRY-US, V17, P607, DOI 10.1021/bi00597a008; SZILAGYI L, 1995, PROG NUCL MAG RES SP, V27, P325, DOI 10.1016/0079-6565(95)01011-2; Tanaka T, 1997, NAT MED, V3, P437, DOI 10.1038/nm0497-437; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; THOMAS KA, 1986, TRENDS BIOCHEM SCI, V11, P1; VANHOLDE KE, 1986, PHYSICAL BIOCH; VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005; WATSON JB, 1994, J CLIN INVEST, V94, P261, DOI 10.1172/JCI117316; WAXMAN E, 1993, BIOCHEMISTRY-US, V32, P3005, DOI 10.1021/bi00063a011; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZAZO M, 1992, GENE, V113, P231, DOI 10.1016/0378-1119(92)90400-J; ZHANG XH, 1994, BIOCHEMISTRY-US, V33, P8361, DOI 10.1021/bi00193a025; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	86	32	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 21	2001	276	38					35723	35734		10.1074/jbc.M101565200	http://dx.doi.org/10.1074/jbc.M101565200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474LU	11423536	Green Published, hybrid			2022-12-27	WOS:000171109300069
J	Demmers, JAA; van Duijn, E; Haverkamp, J; Greathouse, DV; Koeppe, RE; Heck, AJR; Killian, JA				Demmers, JAA; van Duijn, E; Haverkamp, J; Greathouse, DV; Koeppe, RE; Heck, AJR; Killian, JA			Interfacial positioning and stability of transmembrane peptides in lipid bilayers studied by combining hydrogen/deuterium exchange and mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HELICAL PEPTIDES; MEMBRANE-PROTEINS; HYDROPHOBIC MISMATCH; CHAIN-LENGTH; GRAMICIDIN-A; TRYPTOPHAN; RESIDUES; PHOSPHOLIPIDS; ASSOCIATION; THICKNESS	Nano-electrospray ionization mass spectrometry (ESI-MS) was used to analyze hydrogen/deuterium (RID) exchange properties of transmembrane peptides with varying length and composition. Synthetic transmembrane peptides were used with a general acetyl-GW(2)(LA)(n)LW(2)A-ethanolamine sequence. These peptides were incorporated in large unilamellar vesicles of 1,2-dimyristoyl-sn-glycero-3-phosphocholine. The vesicles were diluted in buffered deuterium oxide, and the H/D exchange after different incubation times was directly analyzed by means of ESI-MS. First, the influence of the length of the hydrophobic Leu.-Ala sequence on exchange behavior was investigated. It was shown that longer peptide analogs are more protected from H/D exchange than expected on the basis of their length with respect to bilayer thickness. This is explained by an increased protection from the bilayer environment, be. cause of stretching of the lipid acyl chains and/or tilting of the longer peptides. Next, the role of the flanking tryptophan residues was investigated. The length of the transmembrane part that shows very slow H/D exchange was found to depend on the exact position of the tryptophans in the peptide sequence, suggesting that tryptophan acts as a strong determinant for positioning of proteins at the membrane/water interface. Finally, the influence of putative helix breakers was studied. It was shown that the presence of Pro in the transmembrane segment results in much higher exchange rates as compared with Gly or Leu, suggesting a destabilization of the alpha -helix. Tandem MS measurements suggested that the increased exchange takes place over the entire transmembrane segment. The results show that ESI-MS is a convenient technique to gain detailed insight into properties of peptides in lipid bilayers by monitoring H/D exchange kinetics.	Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Biomembrane Inst, Dept Biochem Membranes, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Biomol Mass Spect, NL-3584 CA Utrecht, Netherlands; Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands; Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	Utrecht University; Utrecht University; Utrecht University; University of Arkansas System; University of Arkansas Fayetteville	Killian, JA (corresponding author), Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Biomembrane Inst, Dept Biochem Membranes, Padualaan 8, NL-3584 CH Utrecht, Netherlands.		Heck, Albert/D-7098-2011; Killian, J. Antoinette/I-3001-2016; Demmers, Jeroen AA/F-4046-2016	Heck, Albert/0000-0002-2405-4404; Demmers, Jeroen AA/0000-0002-8757-9611; Koeppe, Roger/0000-0003-0676-6413; Killian, J. Antoinette/0000-0001-8010-3816	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034968] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-34968] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLUME A, 1983, BIOCHEMISTRY-US, V22, P5436, DOI 10.1021/bi00292a027; Braun P, 1999, BIOCHEMISTRY-US, V38, P9778, DOI 10.1021/bi990923a; de Planque MRR, 1999, J BIOL CHEM, V274, P20839, DOI 10.1074/jbc.274.30.20839; de Planque MRR, 1998, BIOCHEMISTRY-US, V37, P9333, DOI 10.1021/bi980233r; de Planque MRR, 2001, BIOCHEMISTRY-US, V40, P5000, DOI 10.1021/bi000804r; Demmers JAA, 2000, P NATL ACAD SCI USA, V97, P3189, DOI 10.1073/pnas.050444797; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Eyles SJ, 2000, J MOL BIOL, V301, P737, DOI 10.1006/jmbi.2000.4002; Greathouse DV, 2001, J PEPT RES, V57, P519, DOI 10.1034/j.1399-3011.2001.00849.x; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; JANSEN M, 1995, BIOPHYS J, V68, P997, DOI 10.1016/S0006-3495(95)80275-4; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Killian JA, 1996, BIOCHEMISTRY-US, V35, P1037, DOI 10.1021/bi9519258; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Kovacs F, 1999, P NATL ACAD SCI USA, V96, P7910, DOI 10.1073/pnas.96.14.7910; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; Persson S, 1998, BIOPHYS J, V75, P1365, DOI 10.1016/S0006-3495(98)74054-8; Ridder ANJA, 2000, BIOCHEMISTRY-US, V39, P6521, DOI 10.1021/bi000073v; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SCHIFFER M, 1995, J MOL BIOL, V252, P472, DOI 10.1006/jmbi.1995.0512; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	27	67	67	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34501	34508		10.1074/jbc.M101401200	http://dx.doi.org/10.1074/jbc.M101401200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11435420	hybrid			2022-12-27	WOS:000171024600022
J	Gomes, XV; Schmidt, SLG; Burgers, PMJ				Gomes, XV; Schmidt, SLG; Burgers, PMJ			ATP utilization by yeast replication factor C II. Multiple stepwise ATP binding events are required to load proliferating cell nuclear antigen onto primed DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-DELTA; PROTEIN COMPLEX; SLIDING CLAMP; LARGE SUBUNIT; IN-VITRO; RECOGNITION; ALPHA; OVERPRODUCTION; PURIFICATION; INITIATION	Binding of adenosine (3-thiotriphosphate) (ATP gammaS), a nonhydrolyzable analog of ATP, to replication factor C with a N-terminal truncation (Delta2-273) of the Rfc1 subunit (RFC) was studied by filter binding. RFC alone bound 1.8 ATP gammaS molecules. However, when either PCNA or primer-template DNA were also present 2.6 or 2.7 ATP gammaS molecules, respectively, were bound. When both PCNA and DNA were present 3.6 ATP gammaS molecules were bound per RFC. Order of addition experiments using surface plasmon resonance indicate that RFC forms an ATP-mediated binary complex with PCNA prior to formation of a ternary DNA.PCNA.RFC complex. An ATP-mediated complex between RFC and DNA was not competent for binding PCNA, and the RFC.DNA complex dissociated with hydrolysis of ATP. Based on these experiments a model is proposed in which: (i) RFC binds two ATPs (RFC.ATP(2)); (ii) this complex binds PCNA (PCNA.RFC.ATP(2)), which goes through a conformational change to reveal a binding site for one additional ATP (PCNA.RFC.ATP(3)); (iii) this complex can bind DNA to yield DNA.PCNA.RFC.ATP(3); (iv) a conformational change in the latter complex reveals a fourth binding site for ATP; and (v) the DNA.PCNA.RFC.ATP(4) complex is finally competent for completion of PCNA loading and release of RFC upon hydrolysis of ATP.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32431, R01 GM032431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen BL, 1998, NUCLEIC ACIDS RES, V26, P3877, DOI 10.1093/nar/26.17.3877; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; Fotedar R, 1996, EMBO J, V15, P4423, DOI 10.1002/j.1460-2075.1996.tb00815.x; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; KOUPRINA N, 1994, GENETICS, V138, P1067; Latham GJ, 1996, J MOL BIOL, V264, P426, DOI 10.1006/jmbi.1996.0651; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; LEE SH, 1991, J BIOL CHEM, V266, P594; Maga G, 2000, J MOL BIOL, V295, P791, DOI 10.1006/jmbi.1999.3394; Mossi R, 2000, J MOL BIOL, V295, P803, DOI 10.1006/jmbi.1999.3395; PODUST LM, 1995, MOL CELL BIOL, V15, P3072; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Waga S, 1998, MOL CELL BIOL, V18, P4177, DOI 10.1128/MCB.18.7.4177; YODER BL, 1991, J BIOL CHEM, V266, P22689; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189	26	86	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34776	34783		10.1074/jbc.M011743200	http://dx.doi.org/10.1074/jbc.M011743200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432856	hybrid			2022-12-27	WOS:000171024600059
J	Daher, A; Longuet, M; Dorin, D; Bois, F; Segeral, E; Bannwarth, S; Battisti, PL; Purcell, DF; Benarous, R; Vaquero, C; Meurs, EF; Gatignol, A				Daher, A; Longuet, M; Dorin, D; Bois, F; Segeral, E; Bannwarth, S; Battisti, PL; Purcell, DF; Benarous, R; Vaquero, C; Meurs, EF; Gatignol, A			Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO; TRANSLATIONAL CONTROL; TAT TRANSACTIVATION; PKR; INTERFERON; CELLS; MECHANISMS; YEAST	Trans-activation response (TAR) RNA-binding protein (TRBP) is a cellular protein that binds to the human immunodeficiency virus-1 (HIV-1) TAR element RNA. It has two double-stranded RNA binding domains (dsRBDs), but only one is functional for TAR binding. TRBP interacts with the interferon-induced protein kinase R (PKR) and inhibits its activity. We used the yeast two-hybrid assay to map the interaction sites between the two proteins. We show that TRBP and PKR-N (178 first amino acids of PKR) interact with PKR wild type and inhibit the PKR-induced yeast growth defect in this assay. We characterized two independent PKR-binding sites in TRBP. These sites are located in each dsRBD in TRBP, indicating that PKR-TRBP interaction does not require the RNA binding activity present only in dsRBD2. TRBP and its fragments that interact with PKR reverse the PKR-induced suppression of HIV-1 long terminal repeat expression. In addition, TRBP activates the HIV-1 long terminal repeat expression to a larger extent than the addition of each domain. These data suggest that TRBP activates gene expression in PKR-dependent and PKR-independent manners.	McGill AIDS Ctr, Mol Oncol Grp, Lady Davis Inst Med Res, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada; INSERM, U529, Inst Cochin Genet Mol, F-75014 Paris, France; Hop La Pitie Salpetriere, U511, INSERM, F-75013 Paris, France; Macfarlane Burnet Ctr Med Res, Fairfield, Vic 3078, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Inst Pasteur, Unite Virol & Immunol Cellulaire, F-75724 Paris 15, France	Lady Davis Institute; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Melbourne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gatignol, A (corresponding author), McGill AIDS Ctr, Mol Oncol Grp, Lady Davis Inst Med Res, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	anne.gatignol@mcgill.ca	Gatignol, Anne/AAA-6501-2020; Purcell, Damian F/G-5068-2011	Gatignol, Anne/0000-0002-4553-0836; 				BARTEL P, 1993, BIOTECHNIQUES, V14, P920; BASS BL, 1994, CURR BIOL, V4, P301, DOI 10.1016/S0960-9822(00)00069-5; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Blair Edward D., 1995, Journal of Biomedical Science, V2, P322, DOI 10.1007/BF02255219; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Cai RR, 2000, ARCH BIOCHEM BIOPHYS, V373, P361, DOI 10.1006/abbi.1999.1583; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; CLARKE PA, 1990, EUR J BIOCHEM, V193, P635, DOI 10.1111/j.1432-1033.1990.tb19381.x; COSENTINO GP, 1995, P NATL ACAD SCI USA, V92, P9445, DOI 10.1073/pnas.92.21.9445; Daviet L, 2000, EUR J BIOCHEM, V267, P2419, DOI 10.1046/j.1432-1327.2000.01256.x; Daviet L, 1998, J BIOL CHEM, V273, P28219, DOI 10.1074/jbc.273.43.28219; Duarte M, 2000, J BIOMED SCI, V7, P494; Erard M, 1998, J MOL BIOL, V279, P1085, DOI 10.1006/jmbi.1998.1831; FEILOTTER HE, 1994, NUCLEIC ACIDS RES, V22, P1502, DOI 10.1093/nar/22.8.1502; Francois C, 2000, J VIROL, V74, P5587, DOI 10.1128/JVI.74.12.5587-5596.2000; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gatignol A, 1996, GENE EXPRESSION, V5, P217; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gatignol A, 2000, Adv Pharmacol, V48, P209; Gatignol Anne, 1994, V4, P18; GUNNERY S, 1990, P NATL ACAD SCI USA, V87, P8687, DOI 10.1073/pnas.87.22.8687; Hatada E, 1999, J VIROL, V73, P2425, DOI 10.1128/JVI.73.3.2425-2433.1999; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; JAGUS R, 1994, BIOCHIMIE, V76, P779, DOI 10.1016/0300-9084(94)90082-5; Jeang KT, 1998, J BIOMED SCI, V5, P24; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; KHARRAT A, 1995, EMBO J, V14, P3572, DOI 10.1002/j.1460-2075.1995.tb07363.x; KOZAK CA, 1995, GENOMICS, V25, P66, DOI 10.1016/0888-7543(95)80110-8; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; LANDOLFO S, 1995, PHARMACOL THERAPEUT, V65, P415, DOI 10.1016/0163-7258(95)98599-L; Lee K, 1996, MOL CELL BIOL, V16, P3023; LEE SB, 1994, P NATL ACAD SCI USA, V91, P10551, DOI 10.1073/pnas.91.22.10551; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; Merrick WC., 1996, TRANSLATION CONTROL, P31; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Meurs EF, 1995, VIROLOGY, V214, P653, DOI 10.1006/viro.1995.0080; Meurs EF, 1998, VIROLOGY, V247, P125, DOI 10.1006/viro.1998.9277; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Ortega LG, 1996, VIROLOGY, V215, P31, DOI 10.1006/viro.1996.0004; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Patel RC, 1998, MOL CELL BIOL, V18, P7009, DOI 10.1128/MCB.18.12.7009; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Tan SL, 1998, MOL CELL BIOL, V18, P2431, DOI 10.1128/MCB.18.5.2431; Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756; Yankulov K, 1998, CURR BIOL, V8, pR447, DOI 10.1016/S0960-9822(98)70289-1; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684; Zhong J, 1998, MAMM GENOME, V9, P413, DOI 10.1007/s003359900786	62	81	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33899	33905		10.1074/jbc.M103584200	http://dx.doi.org/10.1074/jbc.M103584200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11438532	hybrid			2022-12-27	WOS:000170910200083
J	Menoret, A; Li, ZH; Niswonger, ML; Altmeyer, A; Srivastava, PK				Menoret, A; Li, ZH; Niswonger, ML; Altmeyer, A; Srivastava, PK			An endoplasmic reticulum protein implicated in chaperoning peptides to major histocompatibility of class I is an aminopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE; BINDING; TAP; GLYCOPROTEIN; RECEPTORS; COMPLEXES; ANTIGENS; MEMBRANE; ABUNDANT	gp96, an abundant peptide-binding chaperone of the lumen of the endoplasmic reticulum. and an acceptor of peptides transported into the endoplasmic reticulum through transporter associated with antigen processing, is shown to be an aminopeptidase. gp96 can trim an amino-terminal extended 19-mer precursor of the K-b-binding VSV8 epitope for recognition by the cognate cytotoxic T lymphocyte clone. These observations support a role for gp96 in the amino-terminal trimming of extended peptides in the endoplasmic reticulum.	Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis MC1601, Farmington, CT 06030 USA; Antigen Inc, Woburn, MA 01801 USA; Cornell Univ, New York, NY 10021 USA	University of Connecticut; Agenus Inc; Cornell University	Srivastava, PK (corresponding author), Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis MC1601, Farmington, CT 06030 USA.	srivastava@nso2.uchc.edu			NCI NIH HHS [CA-64394, CA-44786] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064394, R01CA044786, R29CA044786] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnold D, 1997, J EXP MED, V186, P461, DOI 10.1084/jem.186.3.461; Arnold-Schild D, 2000, CANCER RES, V60, P4175; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; DAVID F, 1993, J BIOL CHEM, V268, P17247; EDWARDS DP, 1984, BIOCHEMISTRY-US, V23, P4427, DOI 10.1021/bi00314a029; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; Goldstein LA, 1997, BBA-MOL BASIS DIS, V1361, P11, DOI 10.1016/S0925-4439(97)00032-X; Guthapfel R, 1996, J BIOL CHEM, V271, P2663, DOI 10.1074/jbc.271.5.2663; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; KOCH G, 1986, J CELL SCI, V86, P217; Lammert E, 1997, EUR J IMMUNOL, V27, P923, DOI 10.1002/eji.1830270418; Lauvau G, 1999, J EXP MED, V190, P1227, DOI 10.1084/jem.190.9.1227; MAKI RG, 1993, SOMAT CELL MOLEC GEN, V19, P73, DOI 10.1007/BF01233956; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; MELNICK J, 1995, IMMUNOL TODAY, V16, P243, DOI 10.1016/0167-5699(95)80167-7; MENORET A, 1995, J IMMUNOL, V155, P740; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9; RAMMENSEE HG, 1993, CURR OPIN IMMUNOL, V5, P35, DOI 10.1016/0952-7915(93)90078-7; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; SACHS L, 1982, BIOCHIM BIOPHYS ACTA, V706, P229, DOI 10.1016/0167-4838(82)90491-5; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Snyder HL, 1998, EUR J IMMUNOL, V28, P1339; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Srivastava PK, 1997, METHODS, V12, P165, DOI 10.1006/meth.1997.0464; SRIVASTAVA PK, 1991, CURR TOP MICROBIOL, V167, P109; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Townsend A, 1993, Semin Cell Biol, V4, P53, DOI 10.1006/scel.1993.1007; Trudel J, 1998, ELECTROPHORESIS, V19, P1788, DOI 10.1002/elps.1150191041; van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584; VANBLEEK GM, 1991, P NATL ACAD SCI USA, V88, P11032, DOI 10.1073/pnas.88.24.11032	33	43	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33313	33318		10.1074/jbc.M103383200	http://dx.doi.org/10.1074/jbc.M103383200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11397801	hybrid			2022-12-27	WOS:000170910200006
J	dela Cruz, WP; Friesen, PD; Fisher, AJ				dela Cruz, WP; Friesen, PD; Fisher, AJ			Crystal structure of baculovirus P35 reveals a novel conformational change in the reactive site loop after caspase cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; INDUCED APOPTOSIS; PROTEIN P35; INHIBITION; PROTEASES; MOLSCRIPT; PROGRAM	Baculovirus P35 is a universal suppressor of apoptosis that stoichiometrically inhibits cellular caspases in a novel cleavage-dependent mechanism. Upon caspase cleavage at Asp-87, the 10- and 25-kDa cleavage products of P35 remain tightly associated with the inhibited caspase. Mutations in the alpha -helix of the reactive site loop preceding the cleavage site abrogate caspase inhibition and antiapoptotic activity. Substitution of Pro for Val-71, which is located in the middle of this alpha -helix, produces a protein that is cleaved at the requisite Asp-87 but does not remain bound to the caspase. This loss-of-function mutation provided the opportunity to structurally analyze the conformational changes of the P35 reactive site loop after caspase cleavage. We report here the 2.7 Angstrom resolution crystal structure of V71P-mutated P35 after cleavage by human caspase-3. The structure reveals a large movement in the carboxyl-terminal side of the reactive site loop that swings down and forms a new beta -strand that augments an existing beta -sheet. Additionally, the hydrophobic amino terminus releases and extends away from the protein core. Similar movements occur when P35 forms an inhibitory complex with human caspase-8. These findings suggest that the alpha -helix mutation may alter the sequential steps or kinetics of the conformational changes required for inhibition, thereby causing P35 loss of function.	Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fisher, AJ (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	fisher@chem.ucdavis.edu		Fisher, Andrew/0000-0003-3488-6594; Delacruz, Wilfred/0000-0001-5363-6975	NIAID NIH HHS [AI40482] Funding Source: Medline; NIGMS NIH HHS [GM56774] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040482, R01AI040482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056774] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEIDLER DR, 1995, J BIOL CHEM, V270, P16526, DOI 10.1074/jbc.270.28.16526; Bertin J, 1996, J VIROL, V70, P6251, DOI 10.1128/JVI.70.9.6251-6259.1996; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fisher AJ, 1999, EMBO J, V18, P2031, DOI 10.1093/emboj/18.8.2031; Hardwick J M, 1997, Adv Pharmacol, V41, P295, DOI 10.1016/S1054-3589(08)61063-7; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MARTINOU I, 1995, J CELL BIOL, V128, P201, DOI 10.1083/jcb.128.1.201; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RABIZADEH S, 1993, J NEUROCHEM, V61, P2318, DOI 10.1111/j.1471-4159.1993.tb07477.x; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w; Zoog SJ, 1999, J BIOL CHEM, V274, P25995, DOI 10.1074/jbc.274.37.25995	30	26	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32933	32939		10.1074/jbc.M103930200	http://dx.doi.org/10.1074/jbc.M103930200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11402050	hybrid			2022-12-27	WOS:000170746000075
J	Gray, J; Haran, MM; Schneider, K; Vesce, S; Ray, AM; Owen, D; White, IR; Cutler, P; Davis, JB				Gray, J; Haran, MM; Schneider, K; Vesce, S; Ray, AM; Owen, D; White, IR; Cutler, P; Davis, JB			Evidence that inhibition of cathepsin-B contributes to the neuroprotective properties of caspase inhibitor Tyr-Val-Ala-Asp-chloromethyl ketone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL DEATH; APOPTOSIS; GLUTAMATE; PROTEASES; IDENTIFICATION; EXPRESSION; ISCHEMIA; PROTEINS; TOXICITY; CULTURES	During the use of tetrapeptide and other proprietary caspase inhibitors in the study of neurodegeneration, we had concluded that mechanisms other than the inhibition of caspases contributed to the protective effects of certain caspase inhibitors. Here we report our studies to identify a target for and hence a mechanism by which the tetrapeptide inhibitor tyrosine-valine-alanine-aspartate-chloromethyl ketone (Ac-YVAD-cmk) is able to rescue neuronal cell cultures from cell death. Ac-YVAD-cmk rescued neuronal cells from cell death in response to oxidative stress and oxygen/glucose deprivation. Affinity labeling with biotinylated YVAD-cmk demonstrated distinct binding proteins for the inhibitor in cells from the central nervous system versus Jurkat cells. Binding to the novel target protein was displaced by class-specific protease inhibitors and suggested that the target is a cysteine protease. Affinity purification and sequencing identified the target as cathepsin-B. Cathepsin-B inhibitors competed with biotinylated YVAD-cmk for the target protein. The availability of the target for binding was reduced in cells that had been rescued by unlabeled inhibitor. Cathepsin-D inhibitors rescue hippocampal slices from cell death induced by oxygen/glucose deprivation. These data provide evidence to support a role for cathepsin-B in neuronal cell death, particularly that following ischemia.	GlaxoSmithKline, Neurosci Res, Harlow CM19 5AW, Essex, England; GlaxoSmithKline, Analyt Sci, Harlow CM19 5AW, Essex, England; GlaxoSmithKline, Computat & Struct Sci, Harlow CM19 5AW, Essex, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Davis, JB (corresponding author), GlaxoSmithKline, Neurosci H17, 3rd Ave, Harlow CM19 5AW, Essex, England.		Schneider, Klaus/N-6604-2014; Jansen, Heiko T./A-5770-2008	Schneider, Klaus/0000-0002-3068-8681; Jansen, Heiko T./0000-0003-0178-396X				ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Chevallet M, 1997, ANAL BIOCHEM, V251, P69, DOI 10.1006/abio.1997.2206; CHIBBER R, 1983, EUR J BIOCHEM, V136, P383, DOI 10.1111/j.1432-1033.1983.tb07753.x; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; GORG A, 1995, ELECTROPHORESIS, V16, P1079, DOI 10.1002/elps.11501601183; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; GULLICK WJ, 1986, PRACTICAL PROTEIN CH, P207; HANSEN M, 1991, J IMMUNOL METHODS, V119, P203; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hill IE, 1997, BRAIN RES, V751, P206, DOI 10.1016/S0006-8993(96)01403-5; Isahara K, 1999, NEUROSCIENCE, V91, P233, DOI 10.1016/S0306-4522(98)00566-1; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Kohda Y, 1996, BIOCHEM BIOPH RES CO, V228, P616, DOI 10.1006/bbrc.1996.1706; Levy-Strumpf N, 1998, ONCOGENE, V17, P3331, DOI 10.1038/sj.onc.1202588; Maher P, 1996, J NEUROSCI, V16, P6394; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; NEWELL DW, 1995, J NEUROSCI, V15, P7702; PILKINGTON SJ, 1991, BIOCHEMISTRY-US, V30, P2166, DOI 10.1021/bi00222a021; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; Seyfried D, 1997, J NEUROSURG, V87, P716, DOI 10.3171/jns.1997.87.5.0716; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tsuchiya K, 1999, EXP NEUROL, V155, P187, DOI 10.1006/exnr.1998.6988; WILKIN GP, 1976, BRAIN RES, V115, P181, DOI 10.1016/0006-8993(76)90506-0; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X	29	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32750	32755		10.1074/jbc.M103150200	http://dx.doi.org/10.1074/jbc.M103150200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11427531	hybrid			2022-12-27	WOS:000170746000051
J	Bosc, C; Frank, R; Denarier, E; Ronjat, M; Schweitzer, A; Wehland, J; Jot, D				Bosc, C; Frank, R; Denarier, E; Ronjat, M; Schweitzer, A; Wehland, J; Jot, D			Identification of novel bifunctional calmodulin-binding and microtubule-stabilizing motifs in STOP proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-STABLE MICROTUBULES; POSTTRANSLATIONAL MODIFICATION; LISTERIA-MONOCYTOGENES; SPOT-SYNTHESIS; LIVING CELLS; DYNAMICS; BEHAVIOR; MOUSE; PURIFICATION; FIBROBLASTS	Although microtubules are intrinsically labile tubulin assemblies, many cell types contain stable polymers, resisting depolymerizing conditions such as exposure to the cold or the drug nocodazole. This microtubule stabilization is largely due to polymer association with STOP proteins. There are several STOP variants, some with capacity to induce microtubule resistance to both the cold and nocodazole, others with microtubule cold stabilizing activity only. These microtubule-stabilizing effects of STOP proteins are inhibited by calmodulin and we now demonstrate that they are determined by two distinct kinds of repeated modular sequences (Mn and Me), both containing a calmodulin-binding peptide, but displaying different microtubule stabilizing activities. Mn modules induce microtubule resistance to both the cold and nocodazole when expressed in cells. Me modules, which correspond to the STOP central repeats, have microtubule cold stabilizing activity only. Mouse neuronal STOPs, which induce both cold and drug resistance in cellular microtubules, contain three Mn modules and four Me modules. Compared with neuronal STOPs, the non-neuronal F-STOP lacks multiple Mn modules and this corresponds with an inability to induce nocodazole resistance. STOP modules represent novel bifunctional calmodulin-binding and microtubule-stabilizing sequences that may be essential for the generation of the different patterns of microtubule stabilization observed in cells.	CEA, Lab Cytosquelette, Dept Biol Mol & Struct Cytosquelette, INSERM,U366, F-38054 Grenoble 9, France; GBF, AG Mol Recognit, D-38124 Braunschweig, Germany; CEA, Lab Canaux Ion & Signalisat, Dept Biol Mol & Struct, INSERM,EMI 9931, F-38054 Grenoble 9, France; Gesell Biotechnol Forsch GmbH, Dept Cell Biol, D-38124 Braunschweig, Germany	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Helmholtz-Center for Infection Research; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Gesellschaft fur Biotechnologische Forschung mbH	Bosc, C (corresponding author), CEA, Lab Cytosquelette, Dept Biol Mol & Struct Cytosquelette, INSERM,U366, 17 Rue Martyrs, F-38054 Grenoble 9, France.		Denarier, Eric/H-3555-2017; Denarier, Eric/X-6137-2019; Bosc, Christophe/P-3401-2017; Bosc, Christophe/Q-8877-2019	Denarier, Eric/0000-0002-4169-397X; Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; Bosc, Christophe/0000-0002-3195-6692; Ronjat, Michel/0000-0002-9728-6425				BAAS PW, 1986, J CELL BIOL, V103, P917, DOI 10.1083/jcb.103.3.917; BAAS PW, 1994, J CELL SCI, V107, P135; BERSHADSKY AD, 1979, CELL BIOL INT REP, V3, P45, DOI 10.1016/0309-1651(79)90067-5; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Darji A, 1996, INFECT IMMUN, V64, P2356, DOI 10.1128/IAI.64.6.2356-2358.1996; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Denarier E, 1998, BIOCHEM BIOPH RES CO, V243, P791, DOI 10.1006/bbrc.1998.8179; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Dustin P., 1984, MICROTUBULES; FARRELL KW, 1987, J CELL BIOL, V104, P1035, DOI 10.1083/jcb.104.4.1035; Frank R, 1996, Methods Mol Biol, V66, P149; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; JOB D, 1982, BIOCHEMISTRY-US, V21, P509, DOI 10.1021/bi00532a015; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Llanos R, 1999, BIOCHEMISTRY-US, V38, P15712, DOI 10.1021/bi990895w; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MOSKALEWSKI S, 1980, CELL TISSUE RES, V210, P403; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Niebuhr Kirsten, 1997, P797; PIROLLET F, 1989, BIOCHEMISTRY-US, V28, P835, DOI 10.1021/bi00428a064; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ritco-Vonsovici M, 2000, J MOL BIOL, V304, P81, DOI 10.1006/jmbi.2000.4177; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; Suzuki Mikiko, 1998, Journal of Medical and Dental Sciences, V45, P123; WEST RR, 1991, J BIOL CHEM, V266, P21886	38	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30904	30913		10.1074/jbc.M011614200	http://dx.doi.org/10.1074/jbc.M011614200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413126	hybrid			2022-12-27	WOS:000170472900044
J	Inagaki, N; Maitra, R; Satoh, K; Pakrasi, HB				Inagaki, N; Maitra, R; Satoh, K; Pakrasi, HB			Amino acid residues that are critical for in vivo catalytic activity of CtpA, the carboxyl-terminal processing protease for the D1 protein of photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC OXYGEN EVOLUTION; SYNECHOCYSTIS SP PCC-6803; SCENEDESMUS-OBLIQUUS; PRECURSOR PROTEIN; MUTANT STRAIN; COMPLEX; IDENTIFICATION; MANGANESE; SPINACH; CLONING	CtpA, a carboxyl-terminal processing protease, is a member of a novel family of endoproteases that includes a tail-specific protease from Escherichia coli. In oxygenic photosynthetic organisms, CtpA catalyzes C-terminal processing of the D1 protein of photosystem II, an essential event for the assembly of a manganese cluster and consequent light-mediated water oxidation. We introduced site-specific mutations at 14 conserved residues of CtpA in the cyanobacterium Synechocystis sp. PCC 6803 to examine their functional roles. Analysis of the photoautotrophic growth capabilities of these mutants, their ability to process precursor D1 protein and hence evolve oxygen, along with an estimation of the protease content in the mutants revealed that five of these residues are critical for in vivo activity of CtpA. Recent x-ray crystal structure analysis of CtpA from the eukaryotic alga Scenedesmus obliquus (Liao, D.-I., Qian, J., Chisholm, D. A., Jordan, D. B. and Diner, B. A. (2000) Nat. Struct. Biol. 7, 749-753) has shown that the residues equivalent to Ser-313 and Lys-338, two of the five residues mentioned above, form the catalytic center of this enzyme. Our in vivo analysis demonstrates that the three other residues, Asp-253, Arg-255, and Glu-316, are also important determinants of the catalytic activity of CtpA.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Okayama Univ, Dept Biol, Okayama 7008530, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Washington University (WUSTL); Okayama University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.			Inagaki, Noritoshi/0000-0001-8738-6636	NIGMS NIH HHS [GM 45797] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045797] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; BARTSEVICH VV, 1995, EMBO J, V14, P1845, DOI 10.1002/j.1460-2075.1995.tb07176.x; BOWYER JR, 1992, J BIOL CHEM, V267, P5424; DINER BA, 1988, J BIOL CHEM, V263, P8972; DZELZKALNS VA, 1988, EMBO J, V7, P333, DOI 10.1002/j.1460-2075.1988.tb02817.x; FUJITA S, 1995, PLANT CELL PHYSIOL, V36, P1169; Inagaki N, 1996, PLANT MOL BIOL, V30, P39, DOI 10.1007/BF00017801; Ivleva NB, 2000, PLANT PHYSIOL, V124, P1403, DOI 10.1104/pp.124.3.1403; KEILER KC, 1995, J BIOL CHEM, V270, P28864, DOI 10.1074/jbc.270.48.28864; KEILER KC, 1998, HDB PROTEOLYTIC ENZY, P460; Keller K.C., 1996, SCIENCE, V271, P990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; MANNAN RM, 1993, PLANT PHYSIOL, V103, P971, DOI 10.1104/pp.103.3.971; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Oelmuller R, 1996, J BIOL CHEM, V271, P21848, DOI 10.1074/jbc.271.36.21848; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Pakrasi HB, 1995, ANNU REV GENET, V29, P755; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Sambrook J., 2002, MOL CLONING LAB MANU; SATOH K, 1998, HDB PROTEOLYTIC ENZY, P463; SHESTAKOV SV, 1994, J BIOL CHEM, V269, P19354; SILBER KR, 1992, P NATL ACAD SCI USA, V89, P295, DOI 10.1073/pnas.89.1.295; Yamamoto Y, 2001, J BIOL CHEM, V276, P7518, DOI 10.1074/jbc.M008877200; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	23	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30099	30105		10.1074/jbc.M102600200	http://dx.doi.org/10.1074/jbc.M102600200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11408480	hybrid			2022-12-27	WOS:000170558000067
J	An, XL; Takakuwa, Y; Manno, S; Han, BG; Gascard, P; Mohandas, N				An, XL; Takakuwa, Y; Manno, S; Han, BG; Gascard, P; Mohandas, N			Structural and functional characterization of protein 4.1R-phosphatidylserine interaction - Potential role in 4.1R sorting within cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTRIN-ACTIN BINDING; ERYTHROCYTE-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TERNARY COMPLEX; GLYCOPHORIN-C; BANDS 2.1; CALMODULIN; SITE; DOMAIN; IDENTIFICATION	Erythrocyte protein 4.1R is a multifunctional protein that binds to various membrane proteins and to phosphatidylserine. In the present study, we report two important observations concerning 4.1R-phosphatidylserine interaction. Biochemically, a major finding of the present study is that 4.1R binding to phosphatidylserine appears to be a two-step process in which 4.1R first interacts with serine head group of phosphatidylserine through the positively charged amino acids YKRS and subsequently forms a tight hydrophobic interaction with fatty acid moieties. 4.1R failed to dissociate from phosphatidylserine liposomes under high ionic strength but could be released specifically by phospholipase A(2) but not by phospholipase C or D. Biochemical analyses showed that acyl chains were associated with 4.1R released by phospholipase A(2). Importantly, the association of acyl chains with 4.1R impaired its ability to interact with calmodulin, band 3, and glycophorin C. Removal of acyl chains restored 4.1R binding. These data indicate that acyl chains of phosphatidylserine play an important role in its interaction with 4.1R and on 4.1R function. In terms of biological significance, we have obtained evidence that 4.1R-phosphatidylserine interaction may play an important role in cellular sorting of 4.1R.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; Tokyo Womens Med Univ, Dept Biochem, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tokyo Women's Medical University	Mohandas, N (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Mail Stop 74hy157,1 Cyclotron Rd, Berkeley, CA 94720 USA.		Han, Bong-Gyoon/J-9120-2012	Gascard, Philippe/0000-0001-5912-5228	NIDDK NIH HHS [DK 32094, DK 56355, DK 26263] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK026263, R01DK026263, R01DK056355, P01DK032094] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An XL, 1996, J BIOL CHEM, V271, P33187, DOI 10.1074/jbc.271.52.33187; ANDERSON JP, 1987, J BIOL CHEM, V262, P6365; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BROCKMAN JL, 1991, J BIOL CHEM, V266, P2508; COHEN AM, 1988, BIOCHEMISTRY-US, V27, P614, DOI 10.1021/bi00402a018; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; CORREAS I, 1986, J BIOL CHEM, V261, P3362; CORREAS I, 1986, J BIOL CHEM, V261, P3310; DANILOV YN, 1990, J BIOL CHEM, V265, P2556; DISHER DE, 1993, J BIOL CHEM, V268, P7186; DISHER DE, 1995, J CELL BIOL, V130, P897; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; GOLDMANN WH, 1992, BIOCHEMISTRY-US, V31, P7665, DOI 10.1021/bi00148a030; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HORNE WC, 1993, BLOOD, V82, P2558; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; KAUFMANN S, 1992, FEBS LETT, V314, P203, DOI 10.1016/0014-5793(92)80975-M; LETO TL, 1984, J BIOL CHEM, V259, P4603; LI Y, 1997, J CELL BIOL, V137, P1191; LOMBARDO CR, 1994, BBA-BIOMEMBRANES, V1196, P139, DOI 10.1016/0005-2736(94)00233-9; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837; Nunomura W, 2000, J BIOL CHEM, V275, P24540, DOI 10.1074/jbc.M002492200; Nunomura W, 2000, J BIOL CHEM, V275, P6360, DOI 10.1074/jbc.275.9.6360; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; RYBICKI AC, 1988, J CLIN INVEST, V81, P255, DOI 10.1172/JCI113303; SATO SB, 1983, EUR J BIOCHEM, V130, P19; SCHISCHMANOFF PO, 1995, J BIOL CHEM, V270, P21243, DOI 10.1074/jbc.270.36.21243; Shea TB, 1997, J NEUROSCI RES, V50, P114, DOI 10.1002/(SICI)1097-4547(19971001)50:1<114::AID-JNR12>3.0.CO;2-B; TAKAKUWA Y, 1986, J CLIN INVEST, V78, P80, DOI 10.1172/JCI112577; Takakuwa Y, 2000, INT J HEMATOL, V72, P298; TAKASHI N, 1995, J BIOL CHEM, V270, P12147; TANAKA T, 1991, J BIOL CHEM, V266, P1134; TEHERNIA G, 1981, J CLIN INVEST, V68, P454; TUMA PL, 1993, J BIOL CHEM, V268, P17240; TYLER JM, 1980, J BIOL CHEM, V255, P7034; TYLER JM, 1979, P NATL ACAD SCI USA, V76, P5192, DOI 10.1073/pnas.76.10.5192; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143	43	43	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 21	2001	276	38					35778	35785		10.1074/jbc.M101364200	http://dx.doi.org/10.1074/jbc.M101364200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474LU	11423550	hybrid			2022-12-27	WOS:000171109300075
J	Song, MS; Pham, PT; Olson, M; Carter, JR; Franden, MA; Schaaper, RM; McHenry, CS				Song, MS; Pham, PT; Olson, M; Carter, JR; Franden, MA; Schaaper, RM; McHenry, CS			The delta and delta ' subunits of the DNA polymerase III holoenzyme are essential for initiation complex formation and processive elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION MACHINE; ESCHERICHIA-COLI; SLIDING CLAMPS; GAMMA-SUBUNIT; ACCESSORY PROTEINS; LAGGING-STRAND; READING FRAME; BETA-SUBUNIT; PRIMED DNA; TAU	delta and delta' are required for assembly of the processivity factor beta (2) onto primed DNA in the DNA polymerase III holoenzyme-catalyzed reaction. We developed protocols for generating highly purified preparations of delta and delta'. In holoenzyme reconstitution assays, delta' could not be replaced by delta, tau, or gamma, even when either of the latter were present at a 10,000-fold molar excess. Likewise, delta could not be replaced by delta', tau, or gamma. Bacterial strains bearing chromosomal knockouts of either the holA(delta) or holB(delta') genes were not viable, demonstrating that both delta and delta' are essential. Western blots of isolated initiation complexes demonstrated the presence of both delta and delta'. However, in the absence of chi psi and single-stranded DNA-binding protein, a stable initiation complex lacking delta delta' was isolated by gel filtration. Lack of delta-delta' decreased the rate of elongation about 3-fold, and the extent of processive replication was significantly decreased. Adding back delta-delta' but not chi psi, delta, or delta' alone restored the diminished activity, indicating that in addition to being key components required for the beta loading activity of the DnaX complex, delta delta' is present in initiation complex and is required for processive elongation.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; NIEHS, Genet Mol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McHenry, CS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 4200 E 9th Ave, Denver, CO 80262 USA.		Schaaper, Roel M/E-6680-2019	Schaaper, Roel M/0000-0003-1344-3196	NIGMS NIH HHS [GM35695] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065086, Z01ES065086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035695] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; CARTER JR, 1992, J BACTERIOL, V174, P7013, DOI 10.1128/JB.174.21.7013-7025.1992; CARTER JR, 1993, J BACTERIOL, V175, P3812, DOI 10.1128/JB.175.12.3812-3822.1993; CULL MG, 1995, PURIFICATION ESCHERI, P22; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; DONG ZM, 1993, J BIOL CHEM, V268, P11758; FAY PJ, 1981, J BIOL CHEM, V256, P976; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Gao DX, 2001, J BIOL CHEM, V276, P4447, DOI 10.1074/jbc.M009827200; Glover BP, 2000, J BIOL CHEM, V275, P3017, DOI 10.1074/jbc.275.5.3017; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; JOHANSON KO, 1982, J BIOL CHEM, V257, P2310; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; JOHANSON KO, 1984, J BIOL CHEM, V259, P4589; JOHANSON KO, 1981, STRUCTURE DNA PROTEI, P425; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim DR, 1996, J BIOL CHEM, V271, P20681, DOI 10.1074/jbc.271.34.20681; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kornberg A., 1992, DNA REPLICATION; LEE SH, 1991, J BIOL CHEM, V266, P594; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; MAKI S, 1988, J BIOL CHEM, V263, P6561; MCHENRY CS, 1991, J BIOL CHEM, V266, P19127; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MCHENRY CS, 1989, MOL MECH DNA REPLICA, P115; MOK M, 1987, J BIOL CHEM, V262, P16644; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1993, J BIOL CHEM, V268, P11766; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Pritchard AE, 1996, J BIOL CHEM, V271, P10291, DOI 10.1074/jbc.271.17.10291; REEMS JA, 1995, J BIOL CHEM, V270, P5606, DOI 10.1074/jbc.270.10.5606; REEMS JA, 1994, J BIOL CHEM, V269, P33091; SCHAAPER RM, 1985, GENE, V39, P181, DOI 10.1016/0378-1119(85)90312-9; STUKENBERG PT, 1995, J BIOL CHEM, V270, P13384, DOI 10.1074/jbc.270.22.13384; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; TURNER J, 1997, FASEB J, V11, P1; Uhlmann F, 1997, J BIOL CHEM, V272, P10065; VANWEZENBEEK PMGF, 1980, GENE, V11, P129, DOI 10.1016/0378-1119(80)90093-1; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511; WU CA, 1992, J BIOL CHEM, V267, P4030; XIAO H, 1993, J BIOL CHEM, V268, P11773	50	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					35165	35175		10.1074/jbc.M100389200	http://dx.doi.org/10.1074/jbc.M100389200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432857	hybrid			2022-12-27	WOS:000171024600107
J	Chiarugi, P; Fiaschi, T; Taddei, ML; Talini, D; Giannoni, E; Raugei, G; Ramponi, G				Chiarugi, P; Fiaschi, T; Taddei, ML; Talini, D; Giannoni, E; Raugei, G; Ramponi, G			Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; NADPH OXIDASE; MECHANISM; ACTIVATION; H2O2; SRC; PHOSPHORYLATION; KINASE; CELLS	Low molecular weight protein tyrosine phosphatase (LMW-PTP) is an enzyme involved in platelet-derived growth factor (PDGF)-induced mitogenesis and cytoskeleton rearrangement because it is able to bind and dephosphorylate the activated receptor. LMW-PTP presents two cysteines in positions 12 and 17, both belonging to the catalytic pocket; this is a unique feature of LMW-PTP among all protein tyrosine phosphatases. Our previous results demonstrated that in vitro LMW-PTP is oxidized by either H2O2 or nitric oxide with the formation of a disulfide bond between Cys-12 and Cys-17. This oxidation leads to reversible enzyme inactivation because treatment with reductants permits catalytic activity rescue. In the present study we investigated the in vivo inactivation of LMW-PTP by either extracellularly or intracellularly generated H2O2, evaluating its action directly on its natural substrate, PDGF receptor. LMW-PTP is oxidized and inactivated by exogenous oxidative stress and recovers its activity after oxidant removal. LMW-PTP is oxidized also during PDGF signaling, very likely upon PDGF-induced H2O2 production, and recovers its activity within 40 min. Our results strongly suggest that reversibility of in vivo LMW-PTP oxidation is glutathione-dependent. In addition, we propose an intriguing and peculiar role of Cys-17 in the formation of a S-S intramolecular bond, which protects the catalytic Cys-12 from further and irreversible, oxidation. On the basis of our results we propose that the presence of an additional cysteine near the catalytic cysteine could confer to LMW-PTP the ability to rapidly recover its activity and finely regulate PDGF receptor activation during both extracellularly and intracellularly generated oxidative stress.	Univ Studi Firenze, Dipartimento Sci Biochim, I-50134 Florence, Italy	University of Florence	Ramponi, G (corresponding author), Univ Studi Firenze, Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.	raugei@scibio.unifi.it	Giannoni, Elisa/AAE-2092-2020; Chiarugi, Paola/CDD-7988-2022	raugei, giovanni/0000-0003-1294-786X; Chiarugi, Paola/0000-0001-7655-2969; Giannoni, Elisa/0000-0001-7136-1098				Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Biaglow JE, 2000, ANAL BIOCHEM, V281, P77, DOI 10.1006/abio.2000.4533; Bucciantini M, 1999, FEBS LETT, V456, P73, DOI 10.1016/S0014-5793(99)00828-5; CAMICI G, 1989, J BIOL CHEM, V264, P2560; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Caselli A, 1998, J BIOL CHEM, V273, P32554, DOI 10.1074/jbc.273.49.32554; CASELLI A, 1995, FEBS LETT, V374, P249, DOI 10.1016/0014-5793(95)01120-4; Chiarugi P, 1998, J BIOL CHEM, V273, P6776, DOI 10.1074/jbc.273.12.6776; Chiarugi P, 2000, J BIOL CHEM, V275, P4640, DOI 10.1074/jbc.275.7.4640; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; Cirri P, 1996, J BIOL CHEM, V271, P2604, DOI 10.1074/jbc.271.5.2604; CIRRI P, 1993, EUR J BIOCHEM, V214, P647, DOI 10.1111/j.1432-1033.1993.tb17965.x; Cirri P, 1998, J BIOL CHEM, V273, P32522, DOI 10.1074/jbc.273.49.32522; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; DAVIS JP, 1994, J BIOL CHEM, V269, P8734; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; HECHT D, 1992, BIOCHEM BIOPH RES CO, V188, P773, DOI 10.1016/0006-291X(92)91123-8; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Pagano PJ, 1997, P NATL ACAD SCI USA, V94, P14483, DOI 10.1073/pnas.94.26.14483; RAMPONI G, 1994, ADV PROT PHOSPHATASE, V8, P1; Rigacci S, 1996, J BIOL CHEM, V271, P1278, DOI 10.1074/jbc.271.3.1278; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; ZHANG ZY, 1994, ADV ENZYMOL RAMB, V68, P1; ZHANG ZY, 1992, BIOCHEMISTRY-US, V31, P1701, DOI 10.1021/bi00121a018	41	162	166	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33478	33487		10.1074/jbc.M102302200	http://dx.doi.org/10.1074/jbc.M102302200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11429404	hybrid			2022-12-27	WOS:000170910200027
J	Chohan, KK; Jones, M; Grossmann, JG; Frerman, FE; Scrutton, NS; Sutcliffe, MJ				Chohan, KK; Jones, M; Grossmann, JG; Frerman, FE; Scrutton, NS; Sutcliffe, MJ			Protein dynamics enhance electronic coupling in electron transfer complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A DEHYDROGENASE; ACYL-COA DEHYDROGENASE; X-RAY-SCATTERING; TRANSFER FLAVOPROTEIN; TRIMETHYLAMINE DEHYDROGENASE; PARACOCCUS-DENITRIFICANS; CRYSTAL-STRUCTURES; WILD-TYPE; PURIFICATION; RESOLUTION	Electron-transferring flavoproteins (ETFs) from human and Paracoccus denitrificans have been analyzed by small angle x-ray scattering, showing that neither molecule exists in a rigid conformation in solution. Both ETFs sample a range of conformations corresponding to a large rotation of domain II with respect to domains I and III. A model of the human ETF-medium chain acyl-CoA dehydrogenase complex, consistent with x-ray scattering data, indicates that optimal electron transfer requires domain Il of ETF to rotate by similar to 30 to 50 degrees toward domain I relative to its position in the x-ray structure. Domain motion establishes a new "robust engineering principle" for electron transfer complexes, tolerating multiple configurations of the complex while retaining efficient electron transfer.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; Res Councils Daresbury Lab, Cent Lab, Warrington WA4 4AD, Cheshire, England; Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA	University of Leicester; University of Leicester; STFC Daresbury Laboratory; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Sutcliffe, MJ (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.	nss@le.ac.uk; sjm@le.ac.uk		Sutcliffe, Mike/0000-0003-0414-1700				Basran J, 2000, BIOCHEMISTRY-US, V39, P9188, DOI 10.1021/bi0006868; Beinert H., 1963, ENZYMES, P447; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chohan KK, 1998, PROTEIN PEPTIDE LETT, V5, P231; Dwyer TM, 1999, BBA-PROTEIN STRUCT M, V1433, P139, DOI 10.1016/S0167-4838(99)00139-9; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Griffin KJ, 1997, BIOCHEMISTRY-US, V36, P4194, DOI 10.1021/bi962572v; Grossmann JG, 1998, J MOL BIOL, V279, P461, DOI 10.1006/jmbi.1998.1787; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; HOLZENBURG A, 2000, SUBCELLULAR BIOCH EN, V35; HUBBARD SJ, 1993, NACCESS DEPT CHEM MO; HUSAIN M, 1985, J BACTERIOL, V163, P709, DOI 10.1128/JB.163.2.709-715.1985; IKEDA Y, 1983, J BIOL CHEM, V258, P9477; JOHNSON BD, 1993, BIOCHEMISTRY-US, V32, P10779, DOI 10.1021/bi00091a032; Jones CL, 1996, NEPHROLOGY, V2, P13, DOI 10.1111/j.1440-1797.1996.tb00061.x; Jones M, 2000, J BIOL CHEM, V275, P21349, DOI 10.1074/jbc.M001564200; Lee HJ, 1996, BIOCHEMISTRY-US, V35, P12412, DOI 10.1021/bi9607867; LEWIS R, 1994, J SYNCHROTRON RADIAT, V1, P43, DOI 10.1107/S090904959400693X; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; REGAN JJ, 1993, PATHWAYS, pR2; Roberts DL, 1999, BIOCHEMISTRY-US, V38, P1977, DOI 10.1021/bi9820917; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Salazar D, 1997, J BIOL CHEM, V272, P26425, DOI 10.1074/jbc.272.42.26425; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sharp RE, 1999, BBA-PROTEIN STRUCT M, V1432, P143, DOI 10.1016/S0167-4838(99)00109-0; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P4086; STUHRMAN.HB, 1970, ACTA CRYSTALL A-CRYS, VA 26, P297, DOI 10.1107/S0567739470000748; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1997, J APPL CRYSTALLOGR, V30, P798, DOI 10.1107/S0021889897001714; SWENSON RP, 1996, FLAVINS FLAVOPROTEIN, P515; THORPE C, 1979, BIOCHEMISTRY-US, V18, P331, DOI 10.1021/bi00569a016; Thorpe C, 1991, CHEM BIOCH FLAVOENZY, P471; TOWNSANDREWS E, 1989, REV SCI INSTRUM, V60, P2346, DOI 10.1063/1.1140765; Vakser IA, 1996, BIOPOLYMERS, V39, P455, DOI 10.1002/(SICI)1097-0282(199609)39:3<455::AID-BIP16>3.3.CO;2-8; WATMOUGH NJ, 1992, EUR J BIOCHEM, V205, P1089, DOI 10.1111/j.1432-1033.1992.tb16877.x; Weidenhaupt M, 1996, ARCH MICROBIOL, V165, P169, DOI 10.1007/s002030050312; WHITFIELD CD, 1974, J BIOL CHEM, V249, P2801; Wilson EK, 1997, BIOCHEMISTRY-US, V36, P41, DOI 10.1021/bi961224q; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	43	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34142	34147		10.1074/jbc.M101341200	http://dx.doi.org/10.1074/jbc.M101341200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11429403	hybrid			2022-12-27	WOS:000170910200113
J	Kataoka, K; Handa, H; Nishizawa, M				Kataoka, K; Handa, H; Nishizawa, M			Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2/small Maf by antirheumatic gold(I) compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; PERITONEAL-MACROPHAGES; RHEUMATOID-ARTHRITIS; RESPONSIVE ELEMENTS; NUCLEAR ONCOPROTEIN; RADICAL GENERATION; SODIUM THIOMALATE; METAL-COMPOUNDS; HEME OXYGENASE; MESSENGER-RNA	Gold(I)-containing compounds have long been used in the treatment of rheumatoid arthritis (RA), but the molecular mechanism of their action has remained largely unknown. In this paper we have demonstrated that gold(I) drugs selectively activate the DNA binding of a heterodimer consisting of the basic-leucine zipper transcription factors Nrf2 and small Maf. Once bound to its recognition DNA sequence termed antioxidant-responsive element or Maf-recognition element, Nrf2/small Maf induces a set of antioxidative stress genes, including heme oxygenase-1 and gamma -glutamylcysteine synthetase, whose products have been demonstrated to contribute to the scavenging of reactive oxygen species and to exhibit anti-inflammatory effects. Our findings suggest that stimulation of antioxidative stress response through activation of Nrf2/small Maf may be a pharmacologically important part of the actions of gold(I) drugs for the treatment of rheumatoid arthritis. Alternatively, activation of Nrf2/small Maf may be a protective response of cells against toxic effects of the drugs.	Tokyo Inst Technol, Frontier Collaborat Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA	Tokyo Institute of Technology; Scripps Research Institute	Kataoka, K (corresponding author), Tokyo Inst Technol, Frontier Collaborat Res Ctr, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.							Aaseth J, 1998, ANALYST, V123, P3, DOI 10.1039/a704840h; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bondeson J, 1995, BIOCHEM PHARMACOL, V50, P1753, DOI 10.1016/0006-2952(95)02030-6; Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4; DAVIS P, 1983, ARTHRITIS RHEUM, V26, P82, DOI 10.1002/art.1780260114; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; HANDEL ML, 1995, P NATL ACAD SCI USA, V92, P4497, DOI 10.1073/pnas.92.10.4497; HARTH M, 1983, J RHEUMATOL, V10, P701; Hayes JD, 2000, BIOCHEM SOC T, V28, P33, DOI 10.1042/bst0280033; HIRAI H, 1994, P NATL ACAD SCI USA, V91, P3584, DOI 10.1073/pnas.91.9.3584; IGARASHI K, 1995, P NATL ACAD SCI USA, V92, P7445, DOI 10.1073/pnas.92.16.7445; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Jeyapaul J, 2000, BIOCHEM PHARMACOL, V59, P1433, DOI 10.1016/S0006-2952(00)00256-2; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; KATAOKA K, 1995, MOL CELL BIOL, V15, P2180; Kataoka K, 2001, J BIOL CHEM, V276, P819, DOI 10.1074/jbc.M007643200; Kataoka K, 1996, ONCOGENE, V12, P53; Kean WF, 1997, BRIT J RHEUMATOL, V36, P560; KERPPOLA TK, 1994, ONCOGENE, V9, P675; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Oyake T, 1996, MOL CELL BIOL, V16, P6083; SATO H, 1995, BIOCHEM PHARMACOL, V49, P1453, DOI 10.1016/0006-2952(95)00033-V; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; TAKEDA K, 1994, J BIOL CHEM, V269, P22858; TREJO J, 1992, MOL CELL BIOL, V12, P4742, DOI 10.1128/MCB.12.10.4742; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yamashita M, 1999, EUR J PHARMACOL, V368, P251, DOI 10.1016/S0014-2999(99)00053-9; Yoshida S, 1999, INT IMMUNOL, V11, P151, DOI 10.1093/intimm/11.2.151	40	110	115	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34074	34081		10.1074/jbc.M105383200	http://dx.doi.org/10.1074/jbc.M105383200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11429414	hybrid			2022-12-27	WOS:000170910200105
J	Waschuk, SA; Elton, EA; Darabie, AA; Fraser, PE; McLaurin, J				Waschuk, SA; Elton, EA; Darabie, AA; Fraser, PE; McLaurin, J			Cellular membrane composition defines A beta-lipid interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; SYNAPTIC PLASMA-MEMBRANES; ALZHEIMERS-DISEASE; AMYLOID PEPTIDES; ULTRASTRUCTURAL EVIDENCE; PHOSPHOLIPID-BILAYERS; ENDOPLASMIC-RETICULUM; LAURDAN FLUORESCENCE; HUMAN BRAIN; DUTCH TYPE	Alzheimer's disease pathology has demonstrated amyloid plaque formation associated with plasma membranes and the presence of intracellular amyloid-beta (A beta) accumulation in specific vesicular compartments. This suggests that lipid composition in different compartments may play a role in A beta aggregation. To test this hypothesis, we have isolated cellular membranes from human brain to evaluate A beta 40/42-lipid interactions. Plasma, endosomal, lysosomal, and Golgi membranes were isolated using sucrose gradients. Electron microscopy demonstrated that A beta fibrillogenesis is accelerated in the presence of plasma and endosomal and lysosomal membranes with plasma membranes inducing an enhanced surface organization. Alternatively, interaction of A beta with Golgi membranes fails to progress to fibril formation, suggesting that A beta -Golgi head group interaction stabilizes A beta. Fluorescence spectroscopy using the environment-sensitive probes 1,6-diphenyl-1,3,5-hexatriene, laurdan, N-epsilon -dansyl-L-lysine, and merocyanine 540 demonstrated variations in the inherent lipid properties at the level of the fatty acyl chains, glycerol backbone, and head groups, respectively. Addition of A beta 40/42 to the plasma and endosomal and lysosomal membranes decreases the fluidity not only of the fatty acyl chains but also the head group space, consistent with AP insertion into the bilayer. In contrast, the Golgi bilayer fluidity is increased by A beta 40/42 binding which appears to result from lipid head group interactions and the production of interfacial packing defects.	Univ Toronto, Dept Med Biophys, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Lab Med & Pathol, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada	University of Toronto; University of Toronto	McLaurin, J (corresponding author), Univ Toronto, Dept Med Biophys, Ctr Res Neurodegenerat Dis, Tanz Neurosci Bldg,6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.	J.mclaurin@utoronto.ca						Avdulov NA, 1997, J NEUROCHEM, V68, P2086; Bagatolli LA, 1997, BBA-BIOMEMBRANES, V1325, P80, DOI 10.1016/S0005-2736(96)00246-5; Bagatolli LA, 1999, PHOTOCHEM PHOTOBIOL, V70, P557, DOI 10.1562/0031-8655(1999)070<0557:AMFTIO>2.3.CO;2; Bagatolli LA, 1998, BIOPHYS J, V75, P331, DOI 10.1016/S0006-3495(98)77517-4; BARTLETT GR, 1959, BIOCHEMISTRY-US, V342, P466; Bernik DL, 1998, J COLLOID INTERF SCI, V203, P97, DOI 10.1006/jcis.1998.5522; Bernik DL, 1996, CHEM PHYS LIPIDS, V82, P111, DOI 10.1016/0009-3084(96)02568-6; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Eckert GP, 2000, DEMENT GERIATR COGN, V11, P181, DOI 10.1159/000017234; EPAND RM, 1992, BIOCHEMISTRY-US, V31, P1550, DOI 10.1021/bi00120a036; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; HUMPHRIES GMK, 1984, J MEMBRANE BIOL, V80, P249, DOI 10.1007/BF01868443; HUMPHRIES GMK, 1983, BIOCHEM BIOPH RES CO, V111, P768, DOI 10.1016/0006-291X(83)90370-4; Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; LeBlanc AC, 1999, J NEUROCHEM, V72, P1832, DOI 10.1046/j.1471-4159.1999.0721832.x; Luzardo MD, 1999, ARCH BIOCHEM BIOPHYS, V363, P81; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; MULLER WE, 1995, BRAIN RES, V674, P133, DOI 10.1016/0006-8993(94)01463-R; Natte R, 1999, ACTA NEUROPATHOL, V98, P577, DOI 10.1007/s004010051121; PARASASSI T, 1994, BIOPHYS J, V66, P763, DOI 10.1016/S0006-3495(94)80852-5; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Roher AE, 1999, AMYLOID, V6, P136, DOI 10.3109/13506129909007315; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sparks DL, 1996, NEUROBIOL AGING, V17, P291, DOI 10.1016/0197-4580(95)02067-5; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Torp R, 2000, NEUROSCIENCE, V96, P495, DOI 10.1016/S0306-4522(99)00568-0; VANBLITTERSWIJK WJ, 1981, BIOCHIM BIOPHYS ACTA, V644, P323, DOI 10.1016/0005-2736(81)90390-4; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wood WG, 1999, LIPIDS, V34, P225, DOI 10.1007/s11745-999-0357-9; Yamaguchi H, 2000, J NEUROPATH EXP NEUR, V59, P723, DOI 10.1093/jnen/59.8.723; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7	47	83	86	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33561	33568		10.1074/jbc.M103598200	http://dx.doi.org/10.1074/jbc.M103598200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11438533	hybrid			2022-12-27	WOS:000170910200038
J	Wong, ST; Baker, LP; Trinh, K; Hetman, M; Suzuki, LA; Storm, DR; Bornfeldt, KE				Wong, ST; Baker, LP; Trinh, K; Hetman, M; Suzuki, LA; Storm, DR; Bornfeldt, KE			Adenylyl cyclase 3 mediates prostaglandin E-2-induced growth inhibition in arterial smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; IN-VIVO; DIFFERENTIAL REGULATION; SIGNALING PATHWAYS; ANGIOTENSIN-II; WHOLE CELLS; CYCLIC-AMP; PROLIFERATION; CAMP; CALCIUM	Arterial smooth muscle cell (SMC) proliferation contributes to a number of vascular pathologies. Prostaglandin E-2 (PGE(2)), produced by the endothelium and by SMCs themselves, acts as a potent SMC growth inhibitor. The growth-inhibitory effects of PGE2 are mediated through activation of G-protein-coupled membrane receptors, activation of adenylyl cyclases (ACs), formation of cAMP, and subsequent inhibition of mitogenic signal transduction pathways in SMCs. Of the 10 different mammalian AC isoforms known today, seven isoforms (AC2-7 and AC9) are expressed in SMCs from various species. We show that, despite the presence of several different AG isoforms, the principal AC isoform activated by PGE(2) in human arterial SMCs is a calmodulin kinase II-inhibited AC with characteristics similar to those of AC3. AC3 is expressed in isolated human arterial SMCs and in intact aorta. We further show that arterial SMCs isolated from AC3-deficient mice are resistant to PGE(2)-induced growth inhibition. In summary, AC3 is the principal AC isoform activated by PGE(2) in arterial SMCs, and AC3 mediates the growth-inhibitory effects of PGE(2). Because AC3 activity is inhibited by intracellular calcium through calmodulin kinase II, AC3 may serve as an important integrator of growth-inhibitory signals that stimulate cAMP formation and growth factors that increase intracellular calcium.	Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bornfeldt, KE (corresponding author), Univ Washington, Sch Med, Dept Pathol, Box 357470, Seattle, WA 98195 USA.		Bornfeldt, Karin/AAI-2241-2019	Bornfeldt, Karin/0000-0001-9208-6523	NHLBI NIH HHS [HL62887] Funding Source: Medline; NICHD NIH HHS [HD00836] Funding Source: Medline; NINDS NIH HHS [NS357056] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000836] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062887] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONI FA, 1995, J BIOL CHEM, V270, P28055; ASSENDER JW, 1992, BIOCHEM J, V288, P527, DOI 10.1042/bj2880527; BERK BC, 1991, BIOCHEM J, V274, P799, DOI 10.1042/bj2740799; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; Bornfeldt KE, 1999, CELL SIGNAL, V11, P465, DOI 10.1016/S0898-6568(99)00020-0; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; CALI JJ, 1994, J BIOL CHEM, V269, P12190; CHOI EJ, 1992, J BIOL CHEM, V267, P12440; CHOI EJ, 1993, BIOCHEMISTRY-US, V32, P1891, DOI 10.1021/bi00059a001; Cospedal R, 1999, BIOCHEM J, V342, P407, DOI 10.1042/0264-6021:3420407; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Fukumoto S, 1999, CIRC RES, V85, P985; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Grant SL, 2000, MOL PHARMACOL, V57, P460, DOI 10.1124/mol.57.3.460; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GRAVES LM, 1995, P NATL ACAD SCI USA, V92, P7222, DOI 10.1073/pnas.92.16.7222; Guldemeester A, 1999, AM J PHYSIOL-LUNG C, V276, pL1010, DOI 10.1152/ajplung.1999.276.6.L1010; Guldemeester HA, 1998, CHEST, V114, p38S, DOI 10.1378/chest.114.1_Supplement.38S; Hainaud P, 2001, ATHEROSCLEROSIS, V154, P301, DOI 10.1016/S0021-9150(00)00487-1; Hirata A, 2000, BRIT J PHARMACOL, V131, P1521, DOI 10.1038/sj.bjp.0703730; Hurley JH, 1998, CURR OPIN STRUC BIOL, V8, P770, DOI 10.1016/S0959-440X(98)80097-3; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Indolfi C, 2000, J AM COLL CARDIOL, V36, P288, DOI 10.1016/S0735-1097(00)00679-3; IWAMI G, 1995, J BIOL CHEM, V270, P12481, DOI 10.1074/jbc.270.21.12481; JACOBOWITZ O, 1993, J BIOL CHEM, V268, P3829; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lipskaia L, 1998, J CELL PHYSIOL, V176, P50, DOI 10.1002/(SICI)1097-4652(199807)176:1<50::AID-JCP6>3.0.CO;2-7; Lipskaia L, 1997, FEBS LETT, V415, P275, DOI 10.1016/S0014-5793(97)01001-6; MagnierGaubil C, 1996, J BIOL CHEM, V271, P27788, DOI 10.1074/jbc.271.44.27788; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; Plevin R, 1997, CELL SIGNAL, V9, P323, DOI 10.1016/S0898-6568(96)00193-3; Price SA, 2000, J ENDOCRINOL, V164, P21, DOI 10.1677/joe.0.1640021; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; ROE MW, 1989, J CELL PHYSIOL, V139, P100, DOI 10.1002/jcp.1041390115; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Ross R., 1980, HDB PHYSL CARDIOVA 2, P69; Rybalkin SD, 1997, J CLIN INVEST, V100, P2611, DOI 10.1172/JCI119805; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Smit MJ, 1998, P NATL ACAD SCI USA, V95, P15084, DOI 10.1073/pnas.95.25.15084; Soler M, 2000, CIRC RES, V87, P504; SOUTHGATE K, 1990, ATHEROSCLEROSIS, V82, P113, DOI 10.1016/0021-9150(90)90150-H; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TANG WJ, 1991, J BIOL CHEM, V266, P8595; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; Wang CY, 2000, CIRC RES, V86, P982, DOI 10.1161/01.RES.86.9.982; WAYMAN GA, 1995, J BIOL CHEM, V270, P21480, DOI 10.1074/jbc.270.37.21480; Wayman GA, 1996, MOL CELL BIOL, V16, P6075; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Wei J, 1996, J BIOL CHEM, V271, P24231, DOI 10.1074/jbc.271.39.24231; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; XIA ZG, 1992, NEUROSCI LETT, V144, P169, DOI 10.1016/0304-3940(92)90742-P; YOSHIMURA M, 1993, J BIOL CHEM, V268, P4604; Zhang JH, 1997, AM J PHYSIOL-HEART C, V273, pH971, DOI 10.1152/ajpheart.1997.273.2.H971	59	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34206	34212		10.1074/jbc.M103923200	http://dx.doi.org/10.1074/jbc.M103923200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11432866	hybrid			2022-12-27	WOS:000170910200122
J	Yan, RQ; Munzner, JB; Shuck, ME; Bienkowski, MJ				Yan, RQ; Munzner, JB; Shuck, ME; Bienkowski, MJ			BACE2 functions as an alternative alpha-secretase in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; ASPARTYL PROTEASE; ASP1 BACE2; CLEAVAGE; DISEASE; SITE; IDENTIFICATION; MATURATION; ENZYME	BACE1 and BACE2 define a new subfamily of membrane-anchored aspartyl proteases. Both endoproteases share similar structural organization including a prodomain, a catalytic domain formed via DTG and DSG active site motifs, a single transmembrane domain, and a short C-terminal tail. BACE1 has been identified as the Alzheimer's beta -secretase, whereas BACE2 was mapped to the Down's critical region of human chromosome 21. Herein we show that purified BACE2 can be autoactivated in vitro. Purified BACE2 cleaves human amyloid precursor protein (APP) sequences at the beta -secretase site, and near the alpha -secretase site, mainly at A beta -Phe(20) down arrow Ala(21) and also at A beta -Phe(19) down arrow Phe(20). Alternatively, in cells BACE2 has a limited effect on the beta -secretase site but efficiently cleaves the sequences near the a-secretase site. The in vitro specificity of APP processing by BACE2 is distinct from that observed in cells. BACE2 localizes in the endoplasmic reticulum, Golgi, trans-Golgi network, endosomes, and plasma membrane, and its cellular localization patterns depend on the presence of its transmembrane domain. BACE2 chimeras that increase localization of BACE2 in the trans-Golgi network do not change its APP processing patterns. Thus, BACE2 can be distinguished from BACE1 on the basis of autoprocessing of the prosegment, APP processing specificity, and subcellular localization patterns.	Pharmacia Corp, Dept Cell & Mol Biol, Kalamazoo, MI 49007 USA	Pfizer	Yan, RQ (corresponding author), Pharmacia Corp, Dept Cell & Mol Biol, 301 Henrietta St, Kalamazoo, MI 49007 USA.	ryan@pharmacia.com		Yan, Riqiang/0000-0001-7195-7617				Acquati F, 2000, FEBS LETT, V468, P59, DOI 10.1016/S0014-5793(00)01192-3; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Charlwood J, 2001, J BIOL CHEM, V276, P16739, DOI 10.1074/jbc.M009361200; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Dominguez DI, 2001, AMYLOID, V8, P124, DOI 10.3109/13506120109007356; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Gruninger-Leitch F, 2000, NAT BIOTECHNOL, V18, P66, DOI 10.1038/71944; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Hussain I, 2001, J BIOL CHEM, V276, P23322, DOI 10.1074/jbc.M101069200; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; LADROR US, 1994, J BIOL CHEM, V269, P18422; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Saftig P, 1996, J BIOL CHEM, V271, P27241, DOI 10.1074/jbc.271.44.27241; SAUNDERS AJ, 1999, SCIENCE, V286, P1225; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shi XP, 2001, J BIOL CHEM, V276, P10366, DOI 10.1074/jbc.M009200200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Solans A, 2000, CYTOGENET CELL GENET, V89, P177, DOI 10.1159/000015608; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Youkin S. G., 1998, J PHYSIOL-LONDON, V92, P289	35	135	146	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34019	34027		10.1074/jbc.M105583200	http://dx.doi.org/10.1074/jbc.M105583200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11423558	hybrid			2022-12-27	WOS:000170910200098
J	Rey, O; Young, SH; Cantrell, D; Rozengurt, E				Rey, O; Young, SH; Cantrell, D; Rozengurt, E			Rapid protein kinase D translocation in response to G protein-coupled receptor activation - Dependence on protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; PLECKSTRIN HOMOLOGY DOMAIN; CYSTEINE-RICH MOTIFS; PHORBOL ESTERS; INTACT-CELLS; IN-VIVO; D PKD; MOLECULAR-CLONING; 58-KDA PROTEIN; MU	Protein kinase D (PKD)/protein kinase C (PKC) mu is a serine/threonine protein kinase that can be activated by physiological stimuli like growth factors, antigen-receptor engagement and G protein-coupled receptor (GPCR) agonists via a phosphorylation-dependent mechanism that requires PKC activity. In order to investigate the dynamic mechanisms associated with GPCR signaling, the intracellular translocation of a green fluorescent protein-tagged PKD was analyzed by real-time visualization in fibroblasts and epithelial cells stimulated with bombesin, a GPCR agonist. We found that bombesin induced a rapidly reversible plasma membrane translocation of green fluorescent protein-tagged PKD, an event that can be divided into two distinct mechanistic steps. The first step, which is exclusively mediated by the cysteine-rich domain in the N terminus of PKD, involved its translocation from the cytosol to the plasma membrane. The second step, i.e. the rapid reverse translocation of PKD from the plasma membrane to the cytosol, required its catalytic domain and surprisingly PKC activity. These findings provide evidence for a novel mechanism by which PKC coordinates the translocation and activation of PKD in response to bombesin-induced GPCR activation.	Univ Calif Los Angeles, Sch Med, Dept Med,Div Digest Dis, Unit Signal Transduct & Gastrointestinal Canc, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Imperial Canc Res Fund, Lymphocyte Activat Lab, London WC2A 3PX, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cancer Research UK	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med,Div Digest Dis, Unit Signal Transduct & Gastrointestinal Canc, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.			Rey, Osvaldo/0000-0003-1575-9864				Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; CELIS JE, 1994, CELL BIOL LAB HDB; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Feng X, 2000, J BIOL CHEM, V275, P17024, DOI 10.1074/jbc.275.22.17024; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; Haworth RS, 1999, AM J PHYSIOL-CELL PH, V277, pC1202, DOI 10.1152/ajpcell.1999.277.6.C1202; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, FEBS LETT, V437, P19, DOI 10.1016/S0014-5793(98)01189-2; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Johannes FJ, 1999, FEBS LETT, V461, P68, DOI 10.1016/S0014-5793(99)01424-6; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mikoshiba K, 1997, CURR OPIN NEUROBIOL, V7, P339, DOI 10.1016/S0959-4388(97)80061-X; MILLIGAN G, 1992, SIGNAL TRANSDUCTION; Nakhost A, 1999, J BIOL CHEM, V274, P28944, DOI 10.1074/jbc.274.41.28944; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1989, CANCER, V63, P1892, DOI 10.1002/1097-0142(19890515)63:10<1892::AID-CNCR2820631005>3.0.CO;2-Z; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Paolucci L, 1999, CANCER RES, V59, P572; PETTITT TR, 1993, BIOCHEM J, V289, P487, DOI 10.1042/bj2890487; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Rozengurt E, 1997, BIOCHEM SOC T, V25, P565, DOI 10.1042/bst0250565; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Toker Alex, 1998, Frontiers in Bioscience, V3, pD1134; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	51	90	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32616	32626		10.1074/jbc.M101649200	http://dx.doi.org/10.1074/jbc.M101649200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11410587	hybrid			2022-12-27	WOS:000170746000033
J	Gurvitz, A; Hiltunen, JK; Erdmann, R; Hamilton, B; Hartig, A; Ruis, H; Rottensteiner, H				Gurvitz, A; Hiltunen, JK; Erdmann, R; Hamilton, B; Hartig, A; Ruis, H; Rottensteiner, H			Saccharomyces cerevisiae Adr1p governs fatty acid beta-oxidation and peroxisome proliferation by regulating POX1 and PEX11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UPSTREAM ACTIVATING SEQUENCE; TRANSCRIPTION FACTORS PIP2P; 2,4-DIENOYL-COA REDUCTASE; 3-OXOACYL-COA THIOLASE; GLYCEROL KINASE; OLEIC ACID; GENE SPS19; PROTEIN; YEAST; MUTANTS	Saccharomyces cerevisiae Adr1p is essential for fatty acid degradation and peroxisome proliferation. Here, the role of Adr1p was examined with respect to the transcriptional regulation of the Pip2p-Oaf1p dependent genes POX1 and PEX11. POX1 encodes the rate-limiting enzyme of peroxisomal beta -oxidation, acyl-CoA oxidase. The POX1 promoter was shown to contain a canonical Adr1p element (UAS1), within which the oleate response element (ORE) was nested. PEX11 codes for a peroxin that is critical for normal peroxisome proliferation, and its promoter was shown similarly to contain a UAS1-like element overlapping the ORE. Northern analysis demonstrated that transcriptional up-regulation of both POX1 and PEX11 was abolished in adr1 Delta mutant cells, and immunoblotting confirmed that the abundance of their gene products was dramatically reduced. Studies of an overlapping ORE/UAS1 arrangement in the CTA1 promoter revealed synergy between these elements. We conclude that overlapping ORE and UAS1 elements in conjunction with their binding factors Pip2p-Oaf1p and Adr1p coordinate the carbon flux through beta -oxidation with peroxisome proliferation.	Univ Vienna, Inst Biochem & Mol Zellbiol, A-1030 Vienna, Austria; Univ Oulu, Dept Biochem, Bioctr, FIN-90570 Oulu, Finland; Free Univ Berlin, FB Biol Chem Pharm, D-14195 Berlin, Germany; Vianna Bioctr, Ludwig Boltzmann Forschungsstelle Biochem, A-1030 Vienna, Austria	University of Vienna; Finland National Institute for Health & Welfare; University of Oulu; Free University of Berlin; Ludwig Boltzmann Institute	Gurvitz, A (corresponding author), Univ Vienna, Inst Biochem & Mol Zellbiol, Dr Bohrgasse 9, A-1030 Vienna, Austria.			Hartig, Andreas/0000-0003-3334-2763				Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; BEERS RF, 1952, J BIOL CHEM, V195, P133; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang CC, 1999, J CELL SCI, V112, P1579; CHENG C, 1994, MOL CELL BIOL, V14, P3842, DOI 10.1128/MCB.14.6.3842; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; DMOCHOWSKA A, 1990, GENE, V88, P247, DOI 10.1016/0378-1119(90)90038-S; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; EINERHAND AWC, 1993, EUR J BIOCHEM, V214, P323, DOI 10.1111/j.1432-1033.1993.tb17927.x; EISEN A, 1988, MOL CELL BIOL, V8, P4552, DOI 10.1128/MCB.8.10.4552; ERDMANN R, 1994, YEAST, V10, P1173, DOI 10.1002/yea.320100905; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; FILIPITS M, 1993, GENE, V132, P49, DOI 10.1016/0378-1119(93)90513-3; Grauslund M, 1999, NUCLEIC ACIDS RES, V27, P4391, DOI 10.1093/nar/27.22.4391; Gurvitz A, 1997, MOL MICROBIOL, V26, P675, DOI 10.1046/j.1365-2958.1997.5931969.x; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Gurvitz A, 1999, MOL GEN GENET, V262, P481; Gurvitz Aner, 2000, Molecular Cell Biology Research Communications, V4, P81, DOI 10.1006/mcbr.2000.0261; HILTUNEN JK, 1992, J BIOL CHEM, V267, P6646; IGUAL JC, 1991, YEAST, V7, P379, DOI 10.1002/yea.320070408; Igual JC, 1996, MOL GEN GENET, V252, P446, DOI 10.1007/s004380050249; JONES EW, 1977, GENETICS, V85, P23; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROW PB, 1995, J NEUROPATH EXP NEUR, V54, P720, DOI 10.1097/00005072-199509000-00015; Luo Y, 1996, J BIOL CHEM, V271, P12068, DOI 10.1074/jbc.271.20.12068; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Miller J. H, 1972, EXPT MOL GENETICS; MOSER HW, 1991, CLIN BIOCHEM, V24, P343, DOI 10.1016/0009-9120(91)80009-R; PALOSAARI PM, 1990, J BIOL CHEM, V265, P3347; PAVLIK P, 1993, CURR GENET, V24, P21, DOI 10.1007/BF00324660; RICHTER K, 1980, J BIOL CHEM, V255, P8019; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; Sambrook J., 2002, MOL CLONING LAB MANU; SIMON M, 1991, MOL CELL BIOL, V11, P699, DOI 10.1128/MCB.11.2.699; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; SIMON MM, 1995, MOL GEN GENET, V249, P289, DOI 10.1007/BF00290529; van Roermund CWT, 2000, J CELL BIOL, V150, P489, DOI 10.1083/jcb.150.3.489; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819	42	49	50	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31825	31830		10.1074/jbc.M105989200	http://dx.doi.org/10.1074/jbc.M105989200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11431484	hybrid			2022-12-27	WOS:000170613500049
J	Henry, RA; Tews, B; Li, XL; Scott, MJ				Henry, RA; Tews, B; Li, XL; Scott, MJ			Recruitment of the male-specific lethal (MSL) dosage compensation complex to an autosomally integrated roX chromatin entry site correlates with an increased expression of an adjacent reporter gene in male Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-CHROMOSOME; HISTONE H4; PROTEIN; RNAS; TRANSCRIPTION; MELANOGASTER; ASSOCIATION; BOUNDARIES; ENCODES; ASSAY	Drosophila dosage compensate (equalize X-linked gene products) by doubling the transcription of most X-linked genes in males. The MSL (male-specific lethal) ribonucleoprotein complex consisting of at least five proteins and two non-coding RNAs (roX1 and roX2) is essential for this transcription response. Recently it has been shown that the X-linked roX1 and roX2 genes each contain at least one chromatin entry site for the MSL complex. In this study we show that insertion of either roX1 or roX2 DNA sequences, upstream of an insulated lacZ reporter gene controlled with the constitutive armadillo promoter (arm-lacZ), results in a significant elevation of expression of lacZ in males. However, full compensation, that is a precise doubling of lacZ expression in males relative to females, was only observed in some lines carrying autosomal insertions of either roX1-arm-lacZ or roX2-arm-lacZ transgenes. Furthermore, we found that a 419-base pair fragment of roX1 that contains an MSL binding site was sufficient to cause a modest elevation of expression of lacZ in males, but this response was significantly less than obtained with a full-length roX1 cDNA. This is the first direct demonstration that insertion of an MSL chromatin entry site on an autosome results in elevated expression in males of genes near the entry site.	Massey Univ, Inst Mol BioSci, Palmerston North 5320, New Zealand	Massey University	Scott, MJ (corresponding author), Massey Univ, Inst Mol BioSci, Private Bag 11222, Palmerston North 5320, New Zealand.		Scott, Maxwell J/J-1935-2015	Scott, Maxwell J/0000-0001-6536-4735; Kirk, Rebecca/0000-0001-8487-8088; Tews, Birke Andrea/0000-0002-8647-0497				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; BELOTE JM, 1980, NATURE, V285, P573, DOI 10.1038/285573a0; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Fitzsimons HL, 1999, GENETICA, V105, P215, DOI 10.1023/A:1003801402153; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LUCCHESI JC, 1987, ADV GENET, V24, P371, DOI 10.1016/S0065-2660(08)60013-9; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Lyman LM, 1997, GENETICS, V147, P1743; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith J.A., 2000, CURRENT PROTOCOLS MO; Stuckenholz C, 1999, TRENDS GENET, V15, P454, DOI 10.1016/S0168-9525(99)01855-7; XIAO H, 1989, MOL CELL BIOL, V9, P1746, DOI 10.1128/MCB.9.4.1746; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	25	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31953	31958		10.1074/jbc.M103008200	http://dx.doi.org/10.1074/jbc.M103008200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11402038	hybrid			2022-12-27	WOS:000170613500067
J	Kumar, NV; Bernstein, LR				Kumar, NV; Bernstein, LR			Ten ERK-related proteins in three distinct classes associate with AP-1 proteins and/or AP-1 DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; RNA-POLYMERASE-II; SODIUM DODECYL-SULFATE; TRANSCRIPTION FACTOR; BINDING ACTIVITY; CELL-CYCLE; MAP KINASE; INDUCED TRANSFORMATION; ACTIVATION DOMAIN; TUMOR PROMOTION	We have identified seven ERK-related proteins ("ERPs"), including ERK2, that are stably associated in vivo with AP-1 dimers composed of diverse Jun and Fos family proteins. These complexes have kinase activity. We designate them as "class I ERPs." We originally hypothesized that these ERPs associate with DNA along with AP-1 proteins. We devised a DNA affinity chromatography-based analytical assay for DNA binding, the "nucleotide affinity preincubation specificity test recognition" (NAPSTER) assay. In this assay, class I ERPs do not associate with AP-1 DNA. However, several new "class II" ERPs do associate with DNA. p41 and p44 are ERK1/2-related ERPs that lack kinase activity and associate along with AP-1 proteins with AP-1 DNA. Class I ER-Ps and their associated kinase activity thus appear to bind AP-1 dimers when they are not bound to DNA and then disengage and are replaced by class II ERPs to form higher order complexes when AP-1 dimers bind DNA p97 is a class HI ERP, related to ERK3, that associates with AP-1 DNA without AP-1 proteins. With the exception of ERK2, none of the 10 ERPs appear to be known mitogen-activated protein kinase superfamily members.	Texas A&M Univ, Hlth Sci Ctr, Dept Pathol & Lab Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bernstein, LR (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Pathol & Lab Med, College Stn, TX 77843 USA.			Nandicoori, Vinay/0000-0002-5682-4178	NCI NIH HHS [R29 CA73783] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA073783] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Abe MK, 1999, MOL CELL BIOL, V19, P1301; Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Baranger AM, 1998, CURR OPIN CHEM BIOL, V2, P18, DOI 10.1016/S1367-5931(98)80031-8; BERNSTEIN LR, 1994, J BIOL CHEM, V269, P9401; Bernstein LR, 1999, BBA-GENE STRUCT EXPR, V1489, P263, DOI 10.1016/S0167-4781(99)00191-8; BERNSTEIN LR, 1989, SCIENCE, V244, P566, DOI 10.1126/science.2541502; Bonnet F, 1999, NUCLEIC ACIDS RES, V27, P4399, DOI 10.1093/nar/27.22.4399; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; Chakraborti S, 1998, CELL SIGNAL, V10, P675, DOI 10.1016/S0898-6568(98)00014-X; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DAI TN, 1995, ONCOGENE, V10, P849; Denhardt DT, 1996, CRIT REV ONCOGENESIS, V7, P261, DOI 10.1615/CritRevOncog.v7.i3-4.70; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; DUBOIS MF, 1994, EMBO J, V13, P4787, DOI 10.1002/j.1460-2075.1994.tb06804.x; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; FRAME MC, 1991, ONCOGENE, V6, P205; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; GARDNER K, 1994, J BIOL CHEM, V269, P32963; GRUDA MC, 1994, ONCOGENE, V9, P2537; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang CS, 1999, J BIOL CHEM, V274, P29672, DOI 10.1074/jbc.274.42.29672; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Janulis M, 2001, MOL CELL BIOL, V21, P2235, DOI 10.1128/MCB.21.6.2235-2247.2001; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; L'Allemain Gilles, 1994, Progress in Growth Factor Research, V5, P291, DOI 10.1016/0955-2235(94)90011-6; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MARKOWITZ RB, 1995, BIOCHEM BIOPH RES CO, V207, P1051, DOI 10.1006/bbrc.1995.1291; May GHW, 1998, J BIOL CHEM, V273, P33429, DOI 10.1074/jbc.273.50.33429; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; Nead MA, 1998, EMBO J, V17, P2342, DOI 10.1093/emboj/17.8.2342; Peng X, 1996, J NEUROCHEM, V66, P1191; Pennypacker K R, 1995, J Fla Med Assoc, V82, P551; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; Powers C, 1996, J BIOL CHEM, V271, P30089, DOI 10.1074/jbc.271.47.30089; Rosenberger SF, 1999, J BIOL CHEM, V274, P1124, DOI 10.1074/jbc.274.2.1124; SANGHERA JS, 1992, MOL BIOL CELL, V3, P775, DOI 10.1091/mbc.3.7.775; Watts RG, 1998, ONCOGENE, V17, P3493, DOI 10.1038/sj.onc.1202259; WATTS RG, 1995, MOL CARCINOGEN, V13, P27, DOI 10.1002/mc.2940130106; Wisdom R, 1999, EXP CELL RES, V253, P180, DOI 10.1006/excr.1999.4685; Xiao L, 2000, CANCER RES, V60, P400; Yang CC, 1998, NUCLEIC ACIDS RES, V26, P4771, DOI 10.1093/nar/26.20.4771; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; ZHU AX, 1994, MOL CELL BIOL, V14, P8202, DOI 10.1128/MCB.14.12.8202	64	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32362	32372		10.1074/jbc.M103677200	http://dx.doi.org/10.1074/jbc.M103677200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11431474	hybrid			2022-12-27	WOS:000170613500119
J	Perrin, MH; Fischer, WH; Kunitake, KS; Craig, AG; Koerber, SC; Cervini, LA; Rivier, JE; Groppe, JC; Greenwald, J; Nielsen, SM; Vale, WW				Perrin, MH; Fischer, WH; Kunitake, KS; Craig, AG; Koerber, SC; Cervini, LA; Rivier, JE; Groppe, JC; Greenwald, J; Nielsen, SM; Vale, WW			Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; HIGH-AFFINITY; TERMINAL FRAGMENT; BINDING DOMAINS; XENOPUS-LAEVIS; IDENTIFICATION; UROCORTIN; CLONING; PITUITARY; SUBTYPE	The first extracellular domain (ECD-1) of the corticotropin releasing factor (CRF) type 1 receptor, (CRFR1), is important for binding of CRY ligands. A soluble protein, mNT-CRFR1, produced by COS M6 cells transfected with a cDNA encoding amino acids 1-119 of human CRFR1 and modified to include epitope tags, binds a CRF antagonist, astressin, in a radioreceptor assay using [I-125-D-Tyr(0)]astressin. N-terminal sequencing of mNT-CRFR1 showed the absence of the first 23 amino acids of human CRFR1. This result suggests that the CRFR1 protein is processed to cleave a putative signal peptide corresponding to amino acids 1-23. A cDNA encoding amino acids 24-119 followed by a FLAG tag, was expressed as a thioredoxin fusion protein in Escherichia coli. Following thrombin cleavage, the purified protein (bNT-CRFR1) binds astressin and the agonist urocortin with high affinity. Reduced, alkylated bNT-CRFR1 does not bind [I-125-D-Tyr(0)]astressin. Mass spectrometric analysis of photoaffinity labeled bNT-CRFR1 yielded a 1:1 complex with ligand. Analysis of the disulfide arrangement of bNT-CRFR1 revealed bonds between Cys(30) and Cys(54), Cys(44) and Cys(87), and Cys(68) and Cys(102). This arrangement is similar to that of the ECD-1 of the parathyroid hormone receptor (PTHR), suggesting a conserved structural motif in the N-terminal domain of this family of receptors.	Salk Inst Biol Studies, Peptide Biol Lab, Clayton Fdn, La Jolla, CA 92037 USA; Lundbeck A S, DK-2500 Valby, Denmark; Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute; Lundbeck Corporation; Salk Institute	Perrin, MH (corresponding author), Salk Inst Biol Studies, Peptide Biol Lab, Clayton Fdn, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	perrin@salk.edu			NIDDK NIH HHS [DK 26741] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai M, 2001, ENDOCRINOLOGY, V142, P446, DOI 10.1210/en.142.1.446; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Dautzenberg FM, 1997, J NEUROCHEM, V69, P1640; Dautzenberg FM, 1998, P NATL ACAD SCI USA, V95, P4941, DOI 10.1073/pnas.95.9.4941; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; Donaldson CJ, 1996, ENDOCRINOLOGY, V137, P3896, DOI 10.1210/endo.137.9.8756563; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Fischer WH, 1999, J PROTEIN CHEM, V18, P437, DOI 10.1023/A:1020640725959; Gershengorn MC, 2001, ENDOCRINOLOGY, V142, P2, DOI 10.1210/en.142.1.2; Goldsmith PK, 1999, J BIOL CHEM, V274, P11303, DOI 10.1074/jbc.274.16.11303; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Liaw CW, 1997, MOL ENDOCRINOL, V11, P2048, DOI 10.1210/me.11.13.2048; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MORODER L, 1993, BIOCHEMISTRY-US, V32, P13551, DOI 10.1021/bi00212a022; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; PERRIN MH, 1986, ENDOCRINOLOGY, V118, P1171, DOI 10.1210/endo-118-3-1171; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Qi LJ, 1997, BIOCHEMISTRY-US, V36, P12442, DOI 10.1021/bi970997r; Remy JJ, 2001, J BIOL CHEM, V276, P1681, DOI 10.1074/jbc.M005206200; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Spiess J, 1998, TRENDS ENDOCRIN MET, V9, P140, DOI 10.1016/S1043-2760(98)00037-X; STENZEL P, 1995, MOL ENDOCRINOL, V9, P637, DOI 10.1210/me.9.5.637; SUTTON SW, 1995, ENDOCRINOLOGY, V136, P1097, DOI 10.1210/en.136.3.1097; Sydow S, 1997, MOL BRAIN RES, V52, P182, DOI 10.1016/S0169-328X(97)00256-8; Sydow S, 1999, EUR J BIOCHEM, V259, P55, DOI 10.1046/j.1432-1327.1999.00007.x; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; VITA N, 1993, FEBS LETT, V335, P1, DOI 10.1016/0014-5793(93)80427-V; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Wille S, 1999, J NEUROCHEM, V72, P388, DOI 10.1046/j.1471-4159.1999.0720388.x; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; Yu JX, 1996, ENDOCRINOLOGY, V137, P192, DOI 10.1210/en.137.1.192	52	76	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31528	31534		10.1074/jbc.M101838200	http://dx.doi.org/10.1074/jbc.M101838200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11425856	hybrid			2022-12-27	WOS:000170613500010
J	Qiu, X; Hong, HP; MacKenzie, SL				Qiu, X; Hong, HP; MacKenzie, SL			Identification of a Delta 4 fatty acid desaturase from Thraustochytrium sp involved in the biosynthesis of docosahexanoic acid by heterologous expression in Saccharomyces cerevisiae and Brassica juncea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-LINOLENIC ACID; CAENORHABDITIS-ELEGANS; MORTIERELLA-ALPINA; 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID; 4,7,10,13,16-DOCOSAPENTAENOIC ACID; DOCOSAPENTAENOIC 22/5N-6; ARACHIDONIC-ACID; 22/6N-3 ACIDS; RAT-LIVER; CLONING	The existence of Delta4 fatty acid desaturation in the biosynthesis of docosahexanoic acid (DHA) has been questioned over the years. In this report we describe the identification from Thraustochytrium sp. of two cDNAs, Fad4 and Fad5, coding for Delta4 and Delta5 fatty acid desaturases, respectively. The Delta4 desaturase, when expressed in Saccharomyces cerevisiae, introduced a double bond at position 4 of 22:5(n-3) and 22:4(n-6) resulting in the production of DHA and docosapentanoic acid. The enzyme, when expressed in Brassica juncea under the control of a constitutive promoter, desaturated the exogenously supplied substrate 22:5(n-3), resulting in the production of DHA in vegetative tissues. These results support the notion that DHA can be synthesized via Delta4 desaturation and suggest the possibility that DHA can be produced in oilseed crops on a large scale.	Bioriginal Food & Sci Corp, Dept Res & Dev, Saskatoon, SK S7J 0R1, Canada; Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada	National Research Council Canada	Qiu, X (corresponding author), Bioriginal Food & Sci Corp, Dept Res & Dev, Saskatoon, SK S7J 0R1, Canada.	xqiu@pbi.nrc.ca						Beaudoin F, 2000, P NATL ACAD SCI USA, V97, P6421, DOI 10.1073/pnas.110140197; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Crawford MA, 1997, AM J CLIN NUTR, V66, P1032, DOI 10.1093/ajcn/66.4.1032S; Girke T, 1998, PLANT J, V15, P39, DOI 10.1046/j.1365-313X.1998.00178.x; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; Gurr M., 1992, Lipid Technology, V4, P141; HORROBIN DF, 1992, PROG LIPID RES, V31, P163, DOI 10.1016/0163-7827(92)90008-7; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Huang YS, 1999, LIPIDS, V34, P649, DOI 10.1007/s11745-999-0410-8; Infante JP, 1997, MOL CELL BIOCHEM, V168, P101, DOI 10.1023/A:1006895209833; Infante JP, 2000, FEBS LETT, V468, P1, DOI 10.1016/S0014-5793(00)01083-8; Infante JP, 1998, FEBS LETT, V431, P1, DOI 10.1016/S0014-5793(98)00720-0; Innis SM, 1999, LIPIDS, V34, P139, DOI 10.1007/s11745-999-0348-x; Knutzon DS, 1998, J BIOL CHEM, V273, P29360, DOI 10.1074/jbc.273.45.29360; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Leonard AE, 2000, BIOCHEM J, V347, P719, DOI 10.1042/0264-6021:3470719; Lewis TE, 1999, MAR BIOTECHNOL, V1, P580, DOI 10.1007/PL00011813; Luthria DL, 1996, J BIOL CHEM, V271, P16020, DOI 10.1074/jbc.271.27.16020; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; Michaelson LV, 1998, FEBS LETT, V439, P215, DOI 10.1016/S0014-5793(98)01385-4; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; Mohammed BS, 1997, BIOCHEM J, V326, P425, DOI 10.1042/bj3260425; MOHAMMED BS, 1995, ARCH BIOCHEM BIOPHYS, V317, P179, DOI 10.1006/abbi.1995.1151; Napier JA, 1999, TRENDS PLANT SCI, V4, P2, DOI 10.1016/S1360-1385(98)01357-0; Napier JA, 1998, BIOCHEM J, V330, P611; Parker-Barnes JM, 2000, P NATL ACAD SCI USA, V97, P8284, DOI 10.1073/pnas.97.15.8284; Qiu X, 2001, PLANT PHYSIOL, V125, P847, DOI 10.1104/pp.125.2.847; Qiu X., 1994, Plant Molecular Biology Reporter, V12, P209, DOI 10.1007/BF02668743; RADKE SE, 1992, PLANT CELL REP, V11, P499, DOI 10.1007/BF00236265; Saito T, 2000, EUR J BIOCHEM, V267, P1813, DOI 10.1046/j.1432-1327.2000.01180.x; Sakuradani E, 1999, GENE, V238, P445, DOI 10.1016/S0378-1119(99)00359-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sayanova O, 1997, P NATL ACAD SCI USA, V94, P4211, DOI 10.1073/pnas.94.8.4211; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Sperling P, 2000, EUR J BIOCHEM, V267, P3801, DOI 10.1046/j.1432-1327.2000.01418.x; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; Sprecher H, 1995, J LIPID RES, V36, P2471; Sprecher H, 1996, NUTRITION, V12, pS5; Sprecher H, 1999, LIPIDS, V34, pS153, DOI 10.1007/BF02562271; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; VOSS A, 1991, J BIOL CHEM, V266, P19995; Wallis JG, 1999, ARCH BIOCHEM BIOPHYS, V365, P307, DOI 10.1006/abbi.1999.1167; Watts JL, 1999, ARCH BIOCHEM BIOPHYS, V362, P175, DOI 10.1006/abbi.1998.1024; Weete JD, 1997, LIPIDS, V32, P839, DOI 10.1007/s11745-997-0107-z	45	172	237	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31561	31566		10.1074/jbc.M102971200	http://dx.doi.org/10.1074/jbc.M102971200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11397798	hybrid			2022-12-27	WOS:000170613500014
J	Segall, L; Daly, SE; Blostein, R				Segall, L; Daly, SE; Blostein, R			Mechanistic basis for kinetic differences between the rat alpha 1, alpha 2, and alpha 3 isoforms of the Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-PUMP REGULATION; NA+-K+ PUMP; PLASMA-MEMBRANE; FUNCTIONAL CONSEQUENCES; ION-TRANSPORT; SUBUNIT; ATPASE; EXPRESSION; CELLS; NA+,K+-ATPASE	Previous studies showed that the alpha1, alpha2, and alpha3 isoforms of the catalytic subunit of the Na,K-ATPase differ in their apparent affinities for the ligands ATP, Na+, and K+. For the rat isoforms transfected into HeLa cells, K ' (ATP) for ATP binding at its low affinity site is lower for a2 and a3 compared with al; relative to al and a2, a3 has a higher K ' (Na) and lower K ' (K) (Jewell, E. A., and Lingrel, J. B (1991) J. Biol. Chem. 266, 16925-16930; Munzer, J. S., Daly, S. E., Jewell-Motz, E. A., Lingrel, J. B, and Blostein, R. (1994) J. Biol. Chem. 269, 16668-16676). The experiments described in the present study provide insight into the mechanistic basis for these differences. The results show that a2 differs from al primarily by a shift in the E-1 reversible arrow E-2 equilibrium in favor of E-1 form(s) as evidenced by (i) a similar to 20-fold increase in IC50 for vanadate, (ii) decreased catalytic turnover, and (iii) notable stability of Na,K-ATPase activity at acidic pH. In contrast, despite its lower K ' (ATP) compared with alpha (1) the E-1 <----> E-2 poise of A is not shifted toward E-1. Distinct intrinsic interactions with Na+ ions are underscored by the marked selectivity for Na+ over Li+ of alpha3 compared with either al or a2 and higher K ' (Na) for cytoplasmic Na+, which persists over a 100-fold range in proton concentration, independent of the presence of K+. The kinetic analysis also suggests alpha3-specific differences in relative rates of partial reactions, which impact this isoform's distinct apparent affinities for both Na+ and K+.	McGill Univ, Dept Biochem & Med, Montreal, PQ H3G 1A4, Canada	McGill University	Segall, L (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.							Ambesi A, 2000, J BIOL CHEM, V275, P20545, DOI 10.1074/jbc.M001682200; Balshaw DM, 2000, BIOPHYS J, V79, P853, DOI 10.1016/S0006-3495(00)76341-7; BERREBIBERTRAND I, 1994, FEBS LETT, V348, P55, DOI 10.1016/0014-5793(94)00550-8; BERREBIBERTRAND I, 1990, BIOCHIM BIOPHYS ACTA, V1021, P148, DOI 10.1016/0005-2736(90)90027-L; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BLOSTEIN R, 1988, METHOD ENZYMOL, V156, P171; BLOSTEIN R, 1979, NA K ATPASE STRUCTUR, P233; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; DALY SE, 1994, J BIOL CHEM, V269, P23944; Daly SE, 1997, J BIOL CHEM, V272, P6341, DOI 10.1074/jbc.272.10.6341; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DUNHAM PB, 1977, P NATL ACAD SCI USA, V74, P3099, DOI 10.1073/pnas.74.7.3099; Forbush B 3rd, 1991, Soc Gen Physiol Ser, V46, P210; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; JEWELL EA, 1992, ANN NY ACAD SCI, V671, P120, DOI 10.1111/j.1749-6632.1992.tb43790.x; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Juel C, 2000, AM J PHYSIOL-REG I, V278, pR1107, DOI 10.1152/ajpregu.2000.278.4.R1107; Kometiani P, 2001, AM J PHYSIOL-HEART C, V280, pH1415, DOI 10.1152/ajpheart.2001.280.3.H1415; LANE LK, 1993, J BIOL CHEM, V268, P17930; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; LUCCHESI PA, 1991, J BIOL CHEM, V266, P9327; Markwell M A, 1981, Methods Enzymol, V72, P296; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; POST RL, 1972, J BIOL CHEM, V247, P6530; SACHS JR, 1977, J PHYSIOL-LONDON, V264, P449, DOI 10.1113/jphysiol.1977.sp011677; SHANI M, 1987, BIOCHIM BIOPHYS ACTA, V904, P13, DOI 10.1016/0005-2736(87)90081-2; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Therien AG, 1999, AM J PHYSIOL-CELL PH, V277, pC891, DOI 10.1152/ajpcell.1999.277.5.C891; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Therien AG, 1999, J BIOL CHEM, V274, P12252, DOI 10.1074/jbc.274.18.12252; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tsakiridis T, 1996, J APPL PHYSIOL, V80, P699, DOI 10.1152/jappl.1996.80.2.699; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Woo AL, 1999, J MEMBRANE BIOL, V169, P39, DOI 10.1007/PL00005899	41	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31535	31541		10.1074/jbc.M103720200	http://dx.doi.org/10.1074/jbc.M103720200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427535	hybrid			2022-12-27	WOS:000170613500011
J	Kirschenbaum, F; Hsu, SC; Cordell, B; McCarthy, JV				Kirschenbaum, F; Hsu, SC; Cordell, B; McCarthy, JV			Glycogen synthase kinase-3 beta regulates presenilin 1 C-terminal fragment levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED PRESENILIN-1; PROTEOLYTIC FRAGMENTS; IN-VIVO; PROTEIN; APOPTOSIS; PHOSPHORYLATION; DEGRADATION; EXPRESSION; COMPLEX; DEFICIENCY	The majority of familial Alzheimer's disease cases have been attributed to mutations in the presenilin 1 (PSI) gene. PSI is synthesized as an inactive holoprotein that undergoes endoproteolytic processing to generate a functional N- and C-terminal heterodimer (NTF and CTF, respectively). We identified a single residue in PSI, Ser(397), which regulates the CTF levels in a population of dimer that has a rapid turnover. This residue is part of a highly conserved glycogen synthase kinase-3 beta (GSK-3 beta) consensus phosphorylation site within the loop domain of PSI. Site-directed mutagenesis at the Ser(397) position increased levels of PSI CTF but not NTF or holoprotein. Similar increases in only CTF levels were seen when cells expressing wild type PSI were treated with lithium chloride, an inhibitor of GSK-3 beta. Both wild type and PSI S397A CTF displayed a biphasic turnover, reflecting rapidly degraded and stable populations. Rapid turnover was delayed for mutant PSI S397A, causing increased CTF. These data demonstrate that PSI NTF-CTF endoproteolytic fragments are generated in excess, that phosphorylation at Ser(397) by GSK-3 beta regulates the discard of excess CTF, and that the disposal of surplus NTF is mediated by an independent mechanism. Overall, the results indicate that production of active NTF-CTF dimer is more complex than limited endoproteolysis of PSI holoprotein and instead involves additional regulatory events.	Scios Inc, Sunnyvale, CA 94085 USA	Scios	Cordell, B (corresponding author), Scios Inc, 820 W Maude Ave, Sunnyvale, CA 94085 USA.	cordell@sciosinc.com	mccarthy, justin/AAG-7550-2019	mccarthy, justin/0000-0002-2667-7365				Baumann K, 1997, NEUROBIOL AGING, V18, P181, DOI 10.1016/S0197-4580(97)00004-3; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.3.CO;2-M; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Honda T, 1999, J NEUROCHEM, V72, P255, DOI 10.1046/j.1471-4159.1999.0720255.x; Kim TW, 1997, J BIOL CHEM, V272, P11006; Kirschenbaum F, 2001, J BIOL CHEM, V276, P7366, DOI 10.1074/jbc.M004697200; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Marambaud P, 1998, MOL MED, V4, P147, DOI 10.1007/BF03401912; Mattson MP, 1998, J NEUROCHEM, V70, P1; Mercken M, 1996, FEBS LETT, V389, P297, DOI 10.1016/0014-5793(96)00608-4; Murayama M, 1998, FEBS LETT, V433, P73, DOI 10.1016/S0014-5793(98)00886-2; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Tesco G, 1998, J BIOL CHEM, V273, P33909, DOI 10.1074/jbc.273.51.33909; Thinakaran G, 1999, J CLIN INVEST, V104, P1321, DOI 10.1172/JCI8728; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vezina J, 1999, NEUROSCI LETT, V263, P65, DOI 10.1016/S0304-3940(99)00097-X; Vito P, 1996, J BIOL CHEM, V271, P31025, DOI 10.1074/jbc.271.49.31025; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Walter J, 1997, P NATL ACAD SCI USA, V94, P5349, DOI 10.1073/pnas.94.10.5349; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Yu G, 2000, J BIOL CHEM, V275, P27348; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zhou JH, 1997, NEUROREPORT, V8, P1489, DOI 10.1097/00001756-199704140-00033	37	89	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30701	30707		10.1074/jbc.M102849200	http://dx.doi.org/10.1074/jbc.M102849200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402035	hybrid			2022-12-27	WOS:000170472900017
J	Lai, ZH; Ferry, KV; Diamond, MA; Wee, KE; Kim, YB; Ma, JH; Yang, T; Benfield, PA; Copeland, RA; Auger, KR				Lai, ZH; Ferry, KV; Diamond, MA; Wee, KE; Kim, YB; Ma, JH; Yang, T; Benfield, PA; Copeland, RA; Auger, KR			Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-FINGER DOMAIN; NUCLEAR EXPORT; PROTEIN LIGASE; SELF-UBIQUITINATION; DNA-DAMAGE; DEGRADATION; E3; SIGNAL; ONCOPROTEIN; PROTEASOME	The mdm2 gene product is an important regulator of p53 function and stability. mdm2 is an E3 ubiquitin ligase for p53 and the RING finger domain of mdm2 is critical for ligase activity. Ubiquitin (Uh) conjugation is a general targeting modification and poly-ubiquitin chains specifically target proteins to the proteasome for degradation. In this report, we show that the multistep cascade of mdm2-mediated p53 ubiquitination can be reduced to three purified recombinant proteins: ubiquitin-conjugated E2, mdm2, and p53. This simplification allows enzymatic analysis of the isolated ligase reaction. The simplified reaction recapitulates the ubiquitination of p53 observed with individual components and the p53-Ub((n)) is qualitatively similar to p53-Ub((n)), detected in lactacystin-treated cells. Surprisingly, we find that p53 is modified with multiple mono-ubiquitin moieties as opposed to a poly-ubiquitin chain. Finally, kinetic analysis indicates the transfer reaction proceeds either through a modified Ping Pong mechanism involving requisite enzyme isomerization steps, or through a Rapid Equilibrium Random Bi Bi mechanism involving very large anti-cooperative interactions between the two substrate binding pockets on the enzyme, mediated through allosteric changes in enzyme structure.	Dupont Merck Pharmaceut Co, Canc Res, Glenolden, PA 19036 USA; Dupont Merck Pharmaceut Co, Chem Enzymol, Wilmington, DE 19880 USA	DuPont; DuPont	Copeland, RA (corresponding author), Dupont Merck Pharmaceut Co, Canc Res, Glenolden, PA 19036 USA.							Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Dubiel W, 1999, CURR BIOL, V9, pR554, DOI 10.1016/S0960-9822(99)80353-4; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; HAAS AL, 1982, J BIOL CHEM, V257, P2543; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; ROLFE M, 1995, P NATL ACAD SCI USA, V92, P3264, DOI 10.1073/pnas.92.8.3264; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Segel I.H., 1975, ENZYME KINETICS; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tyers M, 1999, SCIENCE, V284, P601, DOI 10.1126/science.284.5414.601; Wee KE, 2000, J PROTEIN CHEM, V19, P489, DOI 10.1023/A:1026501515450; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	47	129	131	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31357	31367		10.1074/jbc.M011517200	http://dx.doi.org/10.1074/jbc.M011517200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11397792	hybrid			2022-12-27	WOS:000170472900100
J	Lerner, LE; Gribanova, YE; Ji, M; Knox, BE; Farber, DB				Lerner, LE; Gribanova, YE; Ji, M; Knox, BE; Farber, DB			Nrl and Sp nuclear proteins mediate transcription of rod-specific cGMP-phosphodiesterase beta-subunit gene - Involvement of multiple response elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSENSE MUTATION; RHODOPSIN GENE; HOMEOBOX GENE; OIL DROPLETS; RD MOUSE; PHOTORECEPTOR; IDENTIFICATION; EXPRESSION; DEGENERATION; RETINA	cGMP-phosphodiesterase (PDE) is the key effector in rod photoreceptor signal transduction. Mutations in the gene encoding its catalytic, beta -subunit (beta -PDE) cause retinal degenerations leading to blindness. We report that the short -93 to +53 sequence in the upstream region of this gene is sufficient for beta -PDE transcription in both Y79 human retinoblastoma cells and Xenopus embryo heads maintained ex vivo. This sequence also functions as a minimal rod-specific promoter in transgenic Xenopus tadpoles. The Nrl transcription factor binds in vitro to the beta Ap1/NRE regulatory element located within this region and transactivates it when overexpressed in non-retinal 293 embryonic kidney cells. We also found a G/C-rich activator element, beta /GC, important for promoter activity in Y79 retinoblastoma cells and Xenopus embryos. Both the ubiquitous Sp1 and the central nervous system-specific Sp4 transcription factors are expressed in retina and interact with this element in vitro. Electrophoretic mobilities of beta /GC-Y79 nuclear protein complexes are altered by antibodies against Sp1 and Sp4. Thus, our results implicate Nr1, Sp1, and Sp4 in transcriptional regulation of the rod-specific minimal beta -PDE promoter. We also conclude that Xenopus laevis is an efficient system for analyzing the human beta -PDE promoter and may be used to study other human retinal genes ex vivo and in vivo.	Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Boyer Ctr Mol Med, Los Angeles, CA 90095 USA; SUNY Upstate Med Univ, Dept Biochem, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Mol Biol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Farber, DB (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, 100 Stein Plaza, Los Angeles, CA 90095 USA.	farber@jsei.ucla.edu		Farber, Debora/0000-0002-3207-697X	NATIONAL EYE INSTITUTE [R01EY012975, R01EY011256, R37EY002651, R01EY002651] Funding Source: NIH RePORTER; NEI NIH HHS [EY11256, EY02651, EY12975, EY00367] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Batni S, 1996, J BIOL CHEM, V271, P3179, DOI 10.1074/jbc.271.6.3179; Batni S, 2000, METHOD ENZYMOL, V316, P50; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BOWMAKER JK, 1977, VISION RES, V17, P755, DOI 10.1016/0042-6989(77)90117-1; BRAUN T, 1989, MOL CELL BIOL, V9, P2513, DOI 10.1128/MCB.9.6.2513; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Carey M, 2000, TRANSCRIPTIONAL REGU; DiPolo A, 1997, NUCLEIC ACIDS RES, V25, P3863, DOI 10.1093/nar/25.19.3863; DiPolo A, 1996, INVEST OPHTH VIS SCI, V37, P551; DIPOLO A, 1995, P NATL ACAD SCI USA, V92, P4016, DOI 10.1073/pnas.92.9.4016; FARBER DB, 1992, NEURON, V9, P349, DOI 10.1016/0896-6273(92)90173-B; Farber DB, 1997, CURR OPIN NEUROBIOL, V7, P666, DOI 10.1016/S0959-4388(97)80087-6; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; KERPPOLA TK, 1994, ONCOGENE, V9, P3149; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lerner LE, 2000, METHOD ENZYMOL, V315, P617; LOLLEY RN, 1977, SCIENCE, V196, P664, DOI 10.1126/science.193183; OHTSUKA T, 1984, NEUROSCI LETT, V52, P241, DOI 10.1016/0304-3940(84)90168-X; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; SAXEN L, 1954, ANN ACADEMIAE SCI A, V23, P5; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; ZHANG J, 1994, VISUAL NEUROSCI, V11, P1185, DOI 10.1017/S0952523800006982	34	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34999	35007		10.1074/jbc.M103301200	http://dx.doi.org/10.1074/jbc.M103301200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11438531	hybrid			2022-12-27	WOS:000171024600087
J	Singaraja, RR; Bocher, V; James, ER; Clee, SM; Zhang, LH; Leavitt, BR; Tan, B; Brooks-Wilson, A; Kwok, A; Bissada, N; Yang, YZ; Liu, GQ; Tafuri, SR; Fievet, C; Wellington, CL; Staels, B; Hayden, MR				Singaraja, RR; Bocher, V; James, ER; Clee, SM; Zhang, LH; Leavitt, BR; Tan, B; Brooks-Wilson, A; Kwok, A; Bissada, N; Yang, YZ; Liu, GQ; Tafuri, SR; Fievet, C; Wellington, CL; Staels, B; Hayden, MR			Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING CASSETTE; APOLIPOPROTEIN-A-I; PRE-MESSENGER-RNA; TANGIER-DISEASE; ATHEROGENIC DIET; NUCLEAR RECEPTOR; CELLULAR CHOLESTEROL; STRAINS C57BL/6; GENE-EXPRESSION; INBRED STRAINS	By using BAC transgenic mice, we have shown that increased human ABCA1 protein expression results in a significant increase in cholesterol efflux in different tissues and marked elevation in high density lipoprotein (HDL)-cholesterol levels associated with increases in apoAI and apoAII. Three novel ABCA1 transcripts containing three different transcription initiation sites that utilize sequences in intron I have been identified. In BAC transgenic mice there is an increased expression of ABCA1 protein, but the distribution of the ABCA1 product in different cells remains similar to wild type mice. An internal promoter in human intron I containing liver X response elements is functional in vivo and directly contributes to regulation of the human ABCA1 gene in multiple tissues and to raised HDL cholesterol, apoAI, and apoAII levels. A highly significant relationship between raised protein levels, increased efflux, and level of HDL elevation is evident. These data provide proof of the principle that increased human ABCA1 efflux activity is associated with an increase in HDL levels in vivo.	Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Womens & Childrens Hosp, Vancouver, BC V5Z 4H4, Canada; Inst Pasteur, F-59019 Lille, France; Univ Lille 2, Fac Pharm, U545, F-59019 Lille, France; Xenon Genet Inc, Vancouver, BC V5Z 1Z3, Canada; Pfizer Global Res & Dev, Cardiovasc Mol Sci & Technol, Ann Arbor, MI 48105 USA	University of British Columbia; University of British Columbia; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Pfizer	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, 980 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Clee, Susanne/AAC-4278-2020; Leavitt, Blair R/G-1934-2012; Brooks-Wilson, Angela/E-9399-2012; Clee, Susanne/F-7312-2010; James, Erick R/D-4725-2012; Staels, Bart/N-9497-2016; Hayden, Michael R/D-8581-2011	Brooks-Wilson, Angela/0000-0003-1009-6408; Clee, Susanne/0000-0001-7946-688X; Staels, Bart/0000-0002-3784-1503; Hayden, Michael R/0000-0001-5159-1419; Singaraja, Roshni/0000-0002-3418-3867				Adams MD, 1996, CURR OPIN CELL BIOL, V8, P331, DOI 10.1016/S0955-0674(96)80006-8; Aebersold R, 2000, Ann N Y Acad Sci, V919, P33; Albers JJ, 1999, J LIPID RES, V40, P295; Attie AD, 2000, CIRCULATION, V102, P312; Berthou L, 1996, J CLIN INVEST, V97, P2408, DOI 10.1172/JCI118687; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BRUENING W, 1992, NAT GENET, V1, P144, DOI 10.1038/ng0592-144; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Costet P, 2000, J BIOL CHEM, V275, P28240; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; Fatyol K, 1999, MOL GEN GENET, V261, P337, DOI 10.1007/s004380050974; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Gu LJ, 1999, ARTERIOSCL THROM VAS, V19, P442, DOI 10.1161/01.ATV.19.2.442; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hedrick CC, 2000, ARTERIOSCL THROM VAS, V20, P1946, DOI 10.1161/01.ATV.20.8.1946; ISHIDA BY, 1991, J LIPID RES, V32, P559; ISHIDA BY, 1989, GENETIC FACTORS ATHE; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lejeune F, 2001, J BIOL CHEM, V276, P7850, DOI 10.1074/jbc.M009510200; LIU MS, 1994, J BIOL CHEM, V269, P11417; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Machleder D, 1997, J CLIN INVEST, V99, P1406, DOI 10.1172/JCI119300; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Marcil M, 1999, ARTERIOSCL THROM VAS, V19, P159, DOI 10.1161/01.ATV.19.1.159; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; McQueen KL, 2001, IMMUNOGENETICS, V52, P212; Mehrabian M, 2000, J LIPID RES, V41, P1936; NISHINA PM, 1993, LIPIDS, V28, P599, DOI 10.1007/BF02536053; NISHINA PM, 1990, J LIPID RES, V31, P859; PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pullinger CR, 2000, BIOCHEM BIOPH RES CO, V271, P451, DOI 10.1006/bbrc.2000.2652; PURCELLHUYNH DA, 1995, J CLIN INVEST, V96, P1845, DOI 10.1172/JCI118230; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; SRIVASTAVA RAK, 1992, BIOCHIM BIOPHYS ACTA, V1125, P251, DOI 10.1016/0005-2760(92)90053-X; Vu-Dac N, 1998, J BIOL CHEM, V273, P25713, DOI 10.1074/jbc.273.40.25713; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033	49	163	174	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33969	33979		10.1074/jbc.M102503200	http://dx.doi.org/10.1074/jbc.M102503200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11423537	hybrid			2022-12-27	WOS:000170910200092
J	Stenmark, P; Grunler, J; Mattsson, J; Sindelar, PJ; Nordlund, P; Berthold, DA				Stenmark, P; Grunler, J; Mattsson, J; Sindelar, PJ; Nordlund, P; Berthold, DA			A new member of the family of di-iron carboxylate proteins - Coq7 (clk-1), a membrane-bound hydroxylase involved in ubiquinone biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-Q BIOSYNTHESIS; TIMING GENE CLK-1; ESCHERICHIA-COLI; ALTERNATIVE OXIDASE; SITE; CONSERVATION; MUTATIONS; SEQUENCE; MODEL; MOUSE	Ubiquinone (UQ) is an essential cofactor for respiratory metabolism. In yeast, mutation of the COQ7 gene results in the absence of UQ biosynthesis and demonstrates a role for this gene in the step leading to the hydroxylation of 5-demethoxyubiquinone. Intriguingly, the disruption of the corresponding gene in Caenorhabditis elegans, clk-1, results in a prolonged life span and a slowing of development. Because of the pleiotropic effect of this disruption, the small size of the protein, and the lack of obvious homology to other known hydroxylases, it has been suggested that Coq7 may be a regulatory or structural component in UQ biosynthesis, rather than acting as the hydroxylase per se. Here we identify Coq7 as belonging to a family of a di-iron containing oxidases/hydroxylases based on a conserved sequence motif for the iron ligands, supporting a direct function of Coq7 as a hydroxylase. We have cloned COQ7 from Pseudomonas aeruginosa and Thiobacillus ferrooxidans and show that indeed this gene complements an Escherichia coli mutant that lacks an unrelated 5-demethoxyubiquinone hydroxylase. Based on the similarities to other well studied di-iron carboxylate proteins, we propose a structural model for Coq7 as an interfacial integral membrane protein.	Univ Stockholm, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University	Nordlund, P (corresponding author), Univ Stockholm, Dept Biochem & Biophys, Svante Arrhenius Vag 12, S-10691 Stockholm, Sweden.			Stenmark, Pal/0000-0003-4777-3417				ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; ALEXANDER K, 1978, BIOCHEMISTRY-US, V17, P4750, DOI 10.1021/bi00615a024; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Asaumi S, 1999, GENOMICS, V58, P293, DOI 10.1006/geno.1999.5838; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Clarke CF, 2000, PROTOPLASMA, V213, P134, DOI 10.1007/BF01282151; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; FELTON J, 1980, J BACTERIOL, V142, P221, DOI 10.1128/JB.142.1.221-228.1980; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HALLBERG KB, 1994, MICROBIOL-SGM, V140, P3451, DOI 10.1099/13500872-140-12-3451; Jonassen T, 1996, ARCH BIOCHEM BIOPHYS, V330, P285, DOI 10.1006/abbi.1996.0255; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; Josse EM, 2000, PLANT PHYSIOL, V123, P1427, DOI 10.1104/pp.123.4.1427; Kwon O, 2000, FEMS MICROBIOL LETT, V186, P157, DOI 10.1016/S0378-1097(00)00134-8; Liu QH, 2000, METHOD ENZYMOL, V328, P530, DOI 10.1016/S0076-6879(00)28417-6; Logan DT, 1998, BIOCHEMISTRY-US, V37, P10798, DOI 10.1021/bi9806403; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; MATSUSHITA K, 1980, J BACTERIOL, V141, P389, DOI 10.1128/JB.141.1.389-392.1980; Meganathan R., 1996, ESCHERICHIA COLI SAL, P642; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vajo Z, 1999, MAMM GENOME, V10, P1000, DOI 10.1007/s003359901147; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P75, DOI 10.1016/0005-2728(77)90070-6; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; WONG A, 1995, GENETICS, V139, P1247; Yao Z, 1992, PCR Methods Appl, V1, P205; YOUNG IG, 1971, J BACTERIOL, V105, P769, DOI 10.1128/JB.105.3.769-778.1971	32	98	101	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33297	33300		10.1074/jbc.C100346200	http://dx.doi.org/10.1074/jbc.C100346200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435415	hybrid			2022-12-27	WOS:000170910200002
J	Sturzenbaum, SR; Winters, C; Galay, M; Morgan, AJ; Kille, P				Sturzenbaum, SR; Winters, C; Galay, M; Morgan, AJ; Kille, P			Metal ion trafficking in earthworms - Identification of a cadmium-specific metallothionein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; SEQUESTRATION; COPPER; PROTEINS; CLONING; CD	Exposure to cadmium poses a considerable risk to human health and environmental safety. Earthworms reside in the most contaminated sites on earth, displaying a phenomenal tolerance to toxic heavy metals. They exhibit a distinct metabolic pathway that allows the bio-accumulation of cadmium to yield body burdens in excess of 1/1000th of total dry body weight, a most impressive figure by any standard. However, the precise molecular mechanism underlying this phenomenon remains to be unraveled. This study meets this challenge by fully characterizing the major metal-binding protein in earthworms, namely the two isoforms of metallothionein. Chemical analysis of recombinant protein showed that although both isoforms bind equimolar amounts of cadmium (6 mol), wMT-2 is more stable during proton competition. Furthermore, isoform-specific transcript analysis demonstrated that only wMT-2 is responsive to cadmium in a dose and temporal manner. The specific sequestration of cadmium to wMT-2 protein was confirmed in situ using polyclonal antisera. The latter also provided the means for mapping the cellular and intracellular distribution of metallothionein, thus yielding a holistic insight into its involvement in cadmium transit during absorption, storage, and excretion. The structure-function relationship of wMT-2 and its role in cadmium detoxification through sequestration and compartmentalization is discussed.	Cardiff Univ, Sch Biosci, Cardiff CF1 3US, S Glam, Wales	Cardiff University	Sturzenbaum, SR (corresponding author), Cardiff Univ, Sch Biosci, POB 911, Cardiff CF10 3US, S Glam, Wales.	SturzenbaumSR@Carcliff.ac.uk	Kille, Peter/A-4337-2010; Morgan, Andrew J/A-4508-2010	Kille, Peter/0000-0001-6023-5221; 				BROWN MW, 1987, COMP BIOCHEM PHYS C, V87, P65, DOI 10.1016/0742-8413(87)90182-4; Dallinger R, 1997, NATURE, V388, P237, DOI 10.1038/40785; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Gruber C, 2000, EUR J BIOCHEM, V267, P573, DOI 10.1046/j.1432-1327.2000.01035.x; HEILMAIER HE, 1987, TOXICOL LETT, V38, P205, DOI 10.1016/0378-4274(87)90001-4; Hensbergen PJ, 1999, EUR J BIOCHEM, V259, P197, DOI 10.1046/j.1432-1327.1999.00016.x; Jacob ST, 1999, GENE EXPRESSION, V7, P301; KILLE P, 1992, J BIOL CHEM, V267, P8042; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARET W, 1994, P NATL ACAD SCI USA, V91, P237, DOI 10.1073/pnas.91.1.237; Marino F, 1998, COMP BIOCHEM PHYS C, V120, P217, DOI 10.1016/S0742-8413(98)00043-7; MORGAN AJ, 1993, SETAC SP P, P333; Morgan AJ, 1999, INVERTEBR REPROD DEV, V36, P17, DOI 10.1080/07924259.1999.9652673; Morgan AJ, 1999, METH MOL B, V117, P245; MORGAN JE, 1989, COMP BIOCHEM PHYS C, V92, P15, DOI 10.1016/0742-8413(89)90195-3; Morris CA, 1999, METALLOTHIONEIN IV, P621; RHEE IK, 1990, PROTEIN ENG, V3, P205, DOI 10.1093/protein/3.3.205; SLICE LW, 1990, J BIOL CHEM, V265, P256; STILLMAN MJ, 1987, J BIOL CHEM, V262, P4538; Sturzenbaum SR, 1998, FEBS LETT, V431, P437, DOI 10.1016/S0014-5793(98)00809-6; TOKUYASU KT, 1985, J CELL BIOL, V100, P1157, DOI 10.1083/jcb.100.4.1157; TOMMEY AM, 1991, FEBS LETT, V292, P48, DOI 10.1016/0014-5793(91)80831-M; Webster P, 1999, METH MOL B, V117, P49; WINGE DR, 1982, J BIOL CHEM, V257, P3471; Winters C, 1997, HISTOCHEM J, V29, P301, DOI 10.1023/A:1026474531060	25	121	126	0	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34013	34018		10.1074/jbc.M103605200	http://dx.doi.org/10.1074/jbc.M103605200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11418603	hybrid			2022-12-27	WOS:000170910200097
J	Jannatipour, M; Dion, P; Khan, S; Jindal, H; Fan, XP; Laganiere, J; Chishti, AH; Rouleau, GA				Jannatipour, M; Dion, P; Khan, S; Jindal, H; Fan, XP; Laganiere, J; Chishti, AH; Rouleau, GA			Schwannomin isoform-1 interacts with syntenin via PDZ domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROFIBROMATOSIS-2 TUMOR-SUPPRESSOR; PROTEIN-PROTEIN INTERACTIONS; TYPE-2 GENE-PRODUCT; BASOLATERAL MEMBRANE; EPITHELIAL-CELLS; ERM PROTEINS; MERLIN; EZRIN; FAMILY; CYTOSKELETON	The neurofibromatosis type 2 gene (NF2) is involved in the pathogenesis of benign tumors of the human nervous system. The NF2 protein, called schwannomin or merlin, is inactivated in virtually all schwannomas and meningiomas. The molecular mechanisms by which schwannomin functions as a tumor suppressor is unknown but believed to involve plasma membrane-cytoskeletal interactions. Two major alternatively spliced isoforms of schwannomin differing in their C termini have been reported. Using the yeast two-hybrid system, we have identified syntenin as a binding partner for schwannomin isoform-1 (sch-1). Syntenin is an adapter protein that couples transmembrane proteoglycans to cytoskeletal components and is involved in intracellular vesicle transport. The C terminus 25 amino acids of sch-1 and the two PDZ domains of syntenin mediate their binding, and mutations introduced within the VAFFEEL region of sch-1 defined a sequence crucial for syntenin recognition. We have showed that the two proteins interacted in vitro and in vivo and localized underneath the plasma membrane. Fibroblast cells expressing heterologous antisense syntenin display alterations in the subcellular distribution of sch-1. Together, these results provide the first functional clue to the existence of schwannomin isoforms and could unravel novel pathways for the transport and subcellular localization of schwannomin in vivo.	McGill Univ, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; Tufts Univ, Sch Med, Sect Hematol Oncol Res, St Elizabeths Med Ctr, Boston, MA 02135 USA	McGill University; McGill University; St. Elizabeth's Medical Center; Tufts University	Rouleau, GA (corresponding author), McGill Univ, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.			Fan, Xueping/0000-0002-3715-6864	NCI NIH HHS [CA66263] Funding Source: Medline; NHLBI NIH HHS [HL60755] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA066263] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060755] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARPIN M, 1994, CURR OPIN CELL BIOL, V6, P136, DOI 10.1016/0955-0674(94)90127-9; BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; Brault E, 2001, J CELL SCI, V114, P1901; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Cowburn D, 1997, CURR OPIN STRUC BIOL, V7, P835, DOI 10.1016/S0959-440X(97)80155-8; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Fanning AS, 1998, CURR TOP MICROBIOL, V228, P209; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Fialka I, 1999, J BIOL CHEM, V274, P26233, DOI 10.1074/jbc.274.37.26233; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GonzalezAgosti C, 1996, ONCOGENE, V13, P1239; Gronholm M, 1999, J CELL SCI, V112, P895; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; GUTMANN DH, 1995, HUM MOL GENET, V4, P471, DOI 10.1093/hmg/4.3.471; Gutmann DH, 1999, HUM MOL GENET, V8, P267, DOI 10.1093/hmg/8.2.267; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Huynh DP, 1996, ONCOGENE, V13, P73; JINDAL HK, 1998, AM SOC HEM M ABSTR N, pA6; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; LOUIS DN, 1995, BRAIN PATHOL, V5, P163, DOI 10.1111/j.1750-3639.1995.tb00590.x; LUTCHMAN M, 1995, CANCER RES, V55, P2270; Maekawa K, 1999, BIOCHEM J, V337, P179, DOI 10.1042/0264-6021:3370179; Meng JJ, 2000, J NEUROSCI RES, V62, P491, DOI 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D; Obremski VJ, 1998, J NEUROBIOL, V37, P487, DOI 10.1002/(SICI)1097-4695(199812)37:4<487::AID-NEU1>3.3.CO;2-2; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; PYKETT MJ, 1994, HUM MOL GENET, V3, P559, DOI 10.1093/hmg/3.4.559; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sainio M, 1997, J CELL SCI, V110, P2249; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Scherer SS, 1996, J NEUROSCI RES, V46, P595, DOI 10.1002/(SICI)1097-4547(19961201)46:5<595::AID-JNR8>3.3.CO;2-2; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; THOMAS G, 1994, EUR J CANCER, V30A, P1981, DOI 10.1016/0959-8049(94)00390-Q; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	52	60	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33093	33100		10.1074/jbc.M105792200	http://dx.doi.org/10.1074/jbc.M105792200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432873	hybrid			2022-12-27	WOS:000170746000095
J	Wang, XL; Hu, B; Zimmermann, B; Kilimann, MW				Wang, XL; Hu, B; Zimmermann, B; Kilimann, MW			Rim1 and rabphilin-3 bind Rab3-GTP by composite determinants partially related through N-terminal alpha-helix motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLES; PROTEIN RAB3A; EFFECTOR; DOMAIN; EXOCYTOSIS; CHROMAFFIN; SECRETION; MEMBRANES; POTENTIATION; MECHANISM	Rim1 is a protein of the presynaptic active zone, the area of the plasma membrane specialized for neurotransmitter exocytosis, and interacts with Rab3, a small GTPase implicated in neurotransmitter vesicle dynamics. Here, we have studied the molecular determinants of Rim1 that are responsible for Rab3 binding, employing surface plasmon resonance and recombinant, bacterially expressed Rab3 and Rim1 proteins. A site that binds GTP- but not GDP-saturated Rab3 was localized to a short alpha -helical sequence near the Rim1 N terminus (amino acids 19-55). Rab3 isoforms A, C, and D were bound with similar affinities (K-d = 1-2 mum). Low affinity binding of Rab6A-GTP was also observed (K-d = 16 mum), whereas Rab1B, -5, -7, -8, or -11A did not bind. Adjacent sequences up to amino acid 387, encompassing differentially spliced sequences, the zinc finger module, and the SGAWFF motif of Rim1, did not significantly contribute to the strength or the specificity of Rab3 binding, whereas a point mutation within the helix (R33G) abolished binding. This Rab3 binding site of Rim1 is reminiscent of the N-terminal alpha -helix that is part of the Rab3-binding region of rabphilin-3, and indeed we observed low affinity, specific binding of Rab3A (K-d on the order of magnitude of 10-100 mum) to this region of rabphilin-3 alone (amino acids 40-88), whereas additional sequences up to amino acid 178 are needed for high affinity Rab3A binding to rabphilin-3 (K-d = 10-20 nm). In contrast, an N-terminal alpha -helix motif in aczonin, with sequence similarity to the Rab3-binding site of Rim1, did not bind Rab3A, -C, or -D or several other Rah proteins. These results were qualitatively confirmed in pull-down experiments with native, prenylated Rab3 from brain lysate in Triton X-100. Munc13 bound to the zinc finger domain of Rim1 but not to the rabphilin-3 or aczonin zinc fingers. Pull-down experiments from brain lysate in the presence of cholate as detergent detected binding to downstream Rim1 sequences, between amino acids 56 and 387, of syntaxin and of Rab3. The latter, however, was inhibited rather than stimulated by GTP.	Ruhr Univ Bochum, Inst Physiol Chem, D-44780 Bochum, Germany; Ruhr Univ Bochum, Biaffin GmbH & Co KG, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Kilimann, MW (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, D-44780 Bochum, Germany.	manfred.kilimann@ruhr-uni-bochum.de						Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; Arribas M, 1997, EUR J CELL BIOL, V74, P209; Bean AJ, 1997, NEURON, V19, P751, DOI 10.1016/S0896-6273(00)80957-5; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FISCHER V, 1991, NATURE, V349, P79; Fitzgerald ML, 1999, BIOCHEM J, V342, P353, DOI 10.1042/0264-6021:3420353; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; GIEDROC DP, 1986, P NATL ACAD SCI USA, V83, P8452, DOI 10.1073/pnas.83.22.8452; Haynes LP, 2001, J BIOL CHEM, V276, P9726, DOI 10.1074/jbc.M006959200; Joberty G, 1999, J CELL SCI, V112, P3579; Kotake K, 1997, J BIOL CHEM, V272, P29407, DOI 10.1074/jbc.272.47.29407; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; LIDA H, 1997, AM J PHYSIOL, V41, pC1594; Martincic I, 1997, J BIOL CHEM, V272, P26991, DOI 10.1074/jbc.272.43.26991; McKiernan CJ, 1996, MOL CELL BIOL, V16, P4985; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; STAHL B, 1994, J BIOL CHEM, V269, P24770; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; Sun L, 2001, J BIOL CHEM, V276, P12911, DOI 10.1074/jbc.M011110200; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; TIXIERVIDAL A, 1993, J CELL SCI, V105, P935; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743	43	49	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32480	32488		10.1074/jbc.M103337200	http://dx.doi.org/10.1074/jbc.M103337200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11431472	hybrid			2022-12-27	WOS:000170746000016
J	Alexander, JJ; Hack, BK; Cunningham, PN; Quigg, RJ				Alexander, JJ; Hack, BK; Cunningham, PN; Quigg, RJ			A protein with characteristics of factor H is present on rodent platelets and functions as the immune adherence receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; DECAY-ACCELERATING FACTOR; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; BINDING-SITES; MONOCLONAL-ANTIBODIES; NEISSERIA-GONORRHOEAE; REGULATORY PROTEINS; TISSUE DISTRIBUTION; MOLECULAR-CLONING; SERUM RESISTANCE	Complement-coated particles interact with specific immune adherence receptors JAR). In primates, this function is served by complement receptor 1 (CR1) on erythrocytes. In contrast, rodent platelets bear LAR distinct from CR1, the identity of which was studied here. A 150-kDa C3b-binding protein was isolated from rat platelets, which had immunochemical and biochemical identity to plasma factor H. Immunofluorescence microscopy and flow cytometry demonstrated that factor H was present on the surface of rat and mouse platelets, which could be removed by treatment with neuraminidase. Sheep erythrocytes bearing C3b underwent immune adherence with rat and mouse platelets, which was blocked with anti-factor H F(ab ')(2) antibodies, but not with antibodies binding to the complement regulator, Crry, on the platelet surface. By reverse transcription-polymerase chain reaction using rat platelet RNA and primers designed from mouse factor H, a 472-base pair product was generated that was identical in sequence to that produced from rat liver RNA. The translated protein product was 85% similar to mouse liver factor H. The 3 ' -nucleotide sequence from platelets predicted a soluble factor H protein. By Northern analysis, liver and platelets had identically sized factor H mRNA. Thus, rat and mouse platelets have a membrane protein with characteristics of factor H that is linked via sialic acid residues and functions as the LAR. Whether platelet factor H is acquired by passive adsorption from sera and/or is produced by platelets remains to be determined.	Univ Chicago, Nephrol Sect, Dept Med, Chicago, IL 60637 USA	University of Chicago	Alexander, JJ (corresponding author), Univ Chicago, Nephrol Sect, Dept Med, 5841 S Maryland Ave,MC5100, Chicago, IL 60637 USA.	jalexand@medicine.uchicago.edu	Alexander, Jessy/ABA-7664-2020		NIDDK NIH HHS [T32DK07510, R01DK55357, R01DK48173] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055357, T32DK007510] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Alexander JJ, 1999, IMMUNOPHARMACOLOGY, V42, P245, DOI 10.1016/S0162-3109(99)00010-7; Ault BH, 1997, J BIOL CHEM, V272, P25168, DOI 10.1074/jbc.272.40.25168; AVERY VM, 1993, J IMMUNOL, V151, P5545; CAMPBELL RD, 1988, ANNU REV IMMUNOL, V6, P161, DOI 10.1146/annurev.iy.06.040188.001113; CHEVALIER J, 1989, J IMMUNOL, V142, P2031; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; DEVINE DV, 1987, P NATL ACAD SCI USA, V84, P5873, DOI 10.1073/pnas.84.16.5873; DEVINE DV, 1987, J CLIN INVEST, V79, P131, DOI 10.1172/JCI112773; Diaz A, 1997, J IMMUNOL, V158, P3779; DiScipio RG, 1998, J IMMUNOL, V160, P4057; EDBERG JC, 1989, CLIN IMMUNOL IMMUNOP, V51, P118, DOI 10.1016/0090-1229(89)90212-2; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; FISCHETTI VA, 1995, INFECT IMMUN, V63, P149, DOI 10.1128/IAI.63.1.149-153.1995; He C, 1997, ARCH BIOCHEM BIOPHYS, V341, P347, DOI 10.1006/abbi.1997.9989; HEBERT LA, 1991, AM J KIDNEY DIS, V17, P352; HELLWAGE J, 2000, J BIOL CHEM; HENSON PM, 1969, IMMUNOLOGY, V16, P107; Hinchliffe SJ, 1998, J IMMUNOL, V161, P5695; HOLERS VM, 1995, PRINCIPLES PRACTICES, P363; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Junnikkala S, 2000, J IMMUNOL, V164, P6075, DOI 10.4049/jimmunol.164.11.6075; KAZATCHKINE MD, 1982, J CLIN INVEST, V69, P900, DOI 10.1172/JCI110529; KENNEY DM, 1981, CLIN IMMUNOL IMMUNOP, V21, P351, DOI 10.1016/0090-1229(81)90224-5; KINGSMORE SF, 1989, J EXP MED, V169, P1479, DOI 10.1084/jem.169.4.1479; KINOSHITA T, 1988, J IMMUNOL, V140, P3066; KINOSHITA T, 1985, J IMMUNOL, V134, P2564; KRISTENSEN T, 1986, P NATL ACAD SCI USA, V83, P3963, DOI 10.1073/pnas.83.11.3963; KURTZ CB, 1990, J IMMUNOL, V144, P3581; LI B, 1993, J IMMUNOL, V151, P4295; LUBLIN DM, 1986, J BIOL CHEM, V261, P5736; MALHOTRA V, 1985, EUR J IMMUNOL, V15, P935, DOI 10.1002/eji.1830150913; MANTHEI U, 1988, J IMMUNOL, V140, P1228; McKenzie SE, 1999, J IMMUNOL, V162, P4311; McRae JL, 2001, J BIOL CHEM, V276, P6747, DOI 10.1074/jbc.M007495200; MOLINA H, 1990, J IMMUNOL, V145, P2974; MOLINA H, 1994, J IMMUNOL, V153, P789; Morgan H.C, 1999, COMPLEMENT REGULATOR, P41; Nabil K, 1997, BIOCHEM J, V326, P377, DOI 10.1042/bj3260377; NELSON DS, 1963, ADV IMMUNOL, V3, P131, DOI 10.1016/S0065-2776(08)60812-3; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; OKUDA T, 1984, DEV COMP IMMUNOL, V8, P461, DOI 10.1016/0145-305X(84)90053-3; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; Quigg RJ, 1997, J IMMUNOL, V159, P2438; QUIGG RJ, 1994, J AM SOC NEPHROL, V4, P1912; QUIGG RJ, 1995, IMMUNOGENETICS, V42, P362, DOI 10.1007/BF00179397; Quigg RJ, 2000, IMMUNOLOGY, V99, P46, DOI 10.1046/j.1365-2567.2000.00945.x; QUIGG RJ, 1993, KIDNEY INT, V43, P730, DOI 10.1038/ki.1993.104; QUIGG RJ, 1995, J IMMUNOL, V155, P1481; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; RODRIGUEZ DC, 1985, J EXP MED, V161, P1189; SADLON TA, 1994, IMMUNOL CELL BIOL, V72, P461, DOI 10.1038/icb.1994.70; SCHIFFERLI JA, 1989, KIDNEY INT, V35, P993, DOI 10.1038/ki.1989.83; Schiller B, 1998, J EXP MED, V188, P1353, DOI 10.1084/jem.188.7.1353; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; Sharma AK, 1997, INFECT IMMUN, V65, P484, DOI 10.1128/IAI.65.2.484-487.1997; SIM RB, 1982, BIOCHEM J, V205, P285, DOI 10.1042/bj2050285; Soames CJ, 1997, BIOCHEM J, V326, P553, DOI 10.1042/bj3260553; SPICER AP, 1995, J IMMUNOL, V155, P3079; Spiller OB, 1999, IMMUNOLOGY, V97, P374; TAYLOR RP, 1985, J IMMUNOL, V134, P2550; Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	65	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32129	32135		10.1074/jbc.M101299200	http://dx.doi.org/10.1074/jbc.M101299200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11406620	hybrid			2022-12-27	WOS:000170613500090
J	Langosch, D; Brosig, B; Pipkorn, R				Langosch, D; Brosig, B; Pipkorn, R			Peptide mimics of the vesicular stomatitis virus G-protein transmembrane segment drive membrane fusion in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORED INFLUENZA HEMAGGLUTININ; ALPHA-HELICAL PEPTIDES; AMINO-ACIDS; HEMIFUSION INTERMEDIATE; ENVELOPE GLYCOPROTEIN; SPANNING DOMAIN; ENVIRONMENTS; PROPENSITIES; ORIENTATION; MECHANISM	The efficiency of cell-cell fusion mediated by heterologously expressed vesicular stomatitis virus G-protein has previously been shown to be affected by mutating its transmembrane segment. Here, we show that a synthetic peptide modeled after this transmembrane segment drives liposome-liposome fusion. Addition of millimolar Ca2+ concentrations strongly potentiated the effect of the peptides suggesting that Ca2+-mediated liposome aggregation supports the activity of the peptide. Peptide-driven fusion was suppressed by lysolipid, an established inhibitor of natural membrane fusion, and involved inner and outer leaflets of the liposomal bilayer. Thus, transmembrane segment peptide-driven liposome fusion exhibits important hallmarks characteristic of natural membrane fusion. Importantly, the mutations previously shown to attenuate the function of full-length G-protein in cell-cell fusion also attenuated the fusogenicity of the peptide, albeit in a less pronounced fashion. Therefore, the function of the peptide mimic is dependent on its primary structure, similar to full-length G-protein. Together, our data suggest that the G-protein transmembrane segment is an autonomous functional domain. We propose that it acts at a late step in membrane fusion elicited by vesicular stomatitis virus.	Univ Heidelberg, Inst Neurobiol, Dept Neurobiol, D-69120 Heidelberg, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Langosch, D (corresponding author), Univ Heidelberg, Inst Neurobiol, Dept Neurobiol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.							Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; Cleverley DZ, 1998, P NATL ACAD SCI USA, V95, P3425, DOI 10.1073/pnas.95.7.3425; de Planque MRR, 1999, J BIOL CHEM, V274, P20839, DOI 10.1074/jbc.274.30.20839; DURELL SR, 1997, MOL MEMBR BIOL, V14, P97; DUZGUNES N, 1987, BIOCHEMISTRY-US, V26, P8435, DOI 10.1021/bi00399a061; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; HOEKSTRA D, 1993, METHOD ENZYMOL, V220, P15, DOI 10.1016/0076-6879(93)20070-J; HUSCHILT JC, 1989, BIOCHIM BIOPHYS ACTA, V979, P139, DOI 10.1016/0005-2736(89)90534-8; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; KOZERSKI G, 2000, J VIROL, V74, P395; Lentz BR, 2000, CURR OPIN STRUC BIOL, V10, P607, DOI 10.1016/S0959-440X(00)00138-X; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; LI SC, 1992, INT J PEPT PROT RES, V40, P243; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Liu LP, 1997, BIOCHEMISTRY-US, V36, P5476, DOI 10.1021/bi970030n; Markosyan RM, 2000, MOL BIOL CELL, V11, P1143, DOI 10.1091/mbc.11.4.1143; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821; Nussler F, 1997, BIOPHYS J, V73, P2280; Odell D, 1997, J VIROL, V71, P7996, DOI 10.1128/JVI.71.10.7996-8000.1997; OWENS RJ, 1994, J VIROL, V68, P570, DOI 10.1128/JVI.68.1.570-574.1994; PAPAHADJOPOULOS D, 1990, J BIOENERG BIOMEMBR, V22, P157, DOI 10.1007/BF00762944; Pecheur EI, 1999, J MEMBRANE BIOL, V167, P1, DOI 10.1007/s002329900466; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tatulian SA, 2000, BIOCHEMISTRY-US, V39, P496, DOI 10.1021/bi991594p; Taylor GM, 1999, MOL BIOL CELL, V10, P2803, DOI 10.1091/mbc.10.9.2803; Webb RJ, 1998, BIOCHEMISTRY-US, V37, P673, DOI 10.1021/bi972441+; WILK T, 1996, VIROLOGY, V76, P539	36	41	41	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32016	32021		10.1074/jbc.M102579200	http://dx.doi.org/10.1074/jbc.M102579200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418597	hybrid			2022-12-27	WOS:000170613500075
J	Peiretti, F; Lopez, S; Deprez-Beauclair, P; Bonardo, B; Juhan-Vague, I; Nalbone, G				Peiretti, F; Lopez, S; Deprez-Beauclair, P; Bonardo, B; Juhan-Vague, I; Nalbone, G			Inhibition of p70(S6) kinase during transforming growth factor-beta 1/vitamin D-3-induced monocyte differentiation of HL-60 cells allows tumor necrosis factor-alpha to stimulate plasminogen activator inhibitor-1 synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA TRANSLATION; P70 S6 KINASE; GENE-EXPRESSION; HL60 CELLS; NEOINTIMA FORMATION; RAPAMYCIN; PROLIFERATION; RECEPTOR; SUPPRESSES	We investigated intracellular mechanisms involved in the up-regulation of plasminogen activator inhibitor I (PAI-1) synthesis by human recombinant tumor necrosis factor-a (TNF) during monocyte differentiation of HL-60 cells triggered by the transforming growth factor-beta1/ vitamin D-3 (TGF/D3) mixture. TGF/D3-treated cells expressed surface monocytic markers and produced noticeable amounts of PAI-1 but stopped to proliferate. A reduced p70 S6 kinase (p70(S6K)) phosphorylation was also observed and, in this situation, TNF dramatically enhanced PAI-1 synthesis. Similarly, TNF significantly up-regulated PAI-1 synthesis when p70(S6K) phosphorylation was inhibited by rapamycin. This phenomenon was not due to a general decrease in protein synthesis but involved the activation of gene transcription rather than PAI-1 mRNA stabilization. The level of the transcriptional regulator factor E2F1, a repressor of PAI-1 gene expression, was shown to be down-modulated in TGF/D3- as well as in rapamycin-treated cells. Furthermore, the apoptotic effect of TNF in HL-60 cells appeared to be prevented by the addition of either TGF/D3 or rapamycin. In conclusion, these results indicate that inhibition of p70(S6K) phosphorylation during TGF/D3-induced monocyte differentiation of HL-60 cells is a determinant factor that allows TNF to exert its up-regulating effect on PAI-1 synthesis while protecting cells from apoptosis.	Fac Med Marseille, Hematol Lab, EPI 99 36, F-13385 Marseille 5, France	UDICE-French Research Universities; Aix-Marseille Universite	Peiretti, F (corresponding author), Fac Med Marseille, Hematol Lab, EPI 99 36, 27 Bd Jean Moulin, F-13385 Marseille 5, France.	Franck.Peiretti@medecine.univ-mrs.fr	Peiretti, Franck/GLV-3378-2022; LOPEZ, SOPHIE/R-1917-2016; peiretti, franck/L-2718-2017	Peiretti, Franck/0000-0001-7198-0534; LOPEZ, SOPHIE/0000-0002-5009-5533; peiretti, franck/0000-0001-7198-0534				ANDREASEN PA, 1990, MOL CELL ENDOCRINOL, V68, P1, DOI 10.1016/0303-7207(90)90164-4; Carmeliet P, 1997, CIRCULATION, V96, P3180, DOI 10.1161/01.CIR.96.9.3180; Carmeliet P, 1997, J CLIN INVEST, V99, P200, DOI 10.1172/JCI119148; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Edelmann HML, 1996, J BIOL CHEM, V271, P963, DOI 10.1074/jbc.271.2.963; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; HORIGUCHIYAMADA J, 1994, MOL CELL BIOCHEM, V132, P31, DOI 10.1007/BF00925672; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Johnson KL, 1999, IMMUNOL CELL BIOL, V77, P242, DOI 10.1046/j.1440-1711.1999.00821.x; JUHANVAGUE I, 1993, THROMB HAEMOSTASIS, V70, P138; Kanatani Y, 1996, CELL GROWTH DIFFER, V7, P187; Kanayasu-Toyoda T, 1999, J BIOL CHEM, V274, P25471, DOI 10.1074/jbc.274.36.25471; Kirkham PA, 1998, J IMMUNOL, V161, P1630; Koziczak M, 2000, MOL CELL BIOL, V20, P2014, DOI 10.1128/MCB.20.6.2014-2022.2000; Krichevsky AM, 1999, J BIOL CHEM, V274, P14295, DOI 10.1074/jbc.274.20.14295; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; Lopez S, 1999, THROMB HAEMOSTASIS, V81, P415, DOI 10.1055/s-0037-1614488; Lopez S, 2000, J BIOL CHEM, V275, P3081, DOI 10.1074/jbc.275.5.3081; Loscalzo Joseph, 1996, Seminars in Thrombosis and Hemostasis, V22, P503, DOI 10.1055/s-2007-999051; LUNDGREN CH, 1994, CIRCULATION, V90, P1927, DOI 10.1161/01.CIR.90.4.1927; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; MCCARTHY DM, 1983, LEUKEMIA RES, V7, P51, DOI 10.1016/0145-2126(83)90057-7; MORIKAWA M, 1990, IN VITRO CELL DEV B, V26, P682; Murakami T, 1996, CURR OPIN LIPIDOL, V7, P320, DOI 10.1097/00041433-199610000-00010; NING YM, 1993, J BIOL CHEM, V268, P6073; NOVAKHOFER I, 1984, J BIOL CHEM, V259, P5995; OKABEKADO J, 1991, ANTICANCER RES, V11, P181; Peiretti F, 1997, ARTERIOSCL THROM VAS, V17, P1550, DOI 10.1161/01.ATV.17.8.1550; Plenz G, 1998, EUR CYTOKINE NETW, V9, P701; Plow Edward F., 1999, Thrombosis and Haemostasis, V82, P4; Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038; Preissner KT, 1997, THROMB HAEMOSTASIS, V78, P88; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROUIS M, 1990, ARTERIOSCLEROSIS, V10, P246, DOI 10.1161/01.ATV.10.2.246; Saunders NA, 1998, CANCER RES, V58, P1646; SCHWARTZ CJ, 1986, SEMIN THROMB HEMOST, V12, P79, DOI 10.1055/s-2007-1003539; SEHGAL SN, 1995, THER DRUG MONIT, V17, P660, DOI 10.1097/00007691-199512000-00019; SHI YF, 1995, CANCER RES, V55, P1982; Shiffman D, 2000, J BIOL CHEM, V275, P37324, DOI 10.1074/jbc.M004732200; Suzuki T, 2000, BLOOD, V96, P2584; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; TESTA U, 1993, J IMMUNOL, V150, P2418; Trayner ID, 1998, LEUKEMIA RES, V22, P537, DOI 10.1016/S0145-2126(98)00041-1; Valentinis B, 2000, J BIOL CHEM, V275, P25451, DOI 10.1074/jbc.M002271200; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; Wang QM, 2000, J CELL PHYSIOL, V183, P238, DOI 10.1002/(SICI)1097-4652(200005)183:2<238::AID-JCP10>3.3.CO;2-T; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; YANAGISAWASHIOTA F, 1995, ANTICANCER RES, V15, P259	55	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32214	32219		10.1074/jbc.M103357200	http://dx.doi.org/10.1074/jbc.M103357200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11402043	hybrid			2022-12-27	WOS:000170613500101
J	Zimmer, G; Budz, L; Herrler, G				Zimmer, G; Budz, L; Herrler, G			Proteolytic activation of respiratory syncytial virus fusion protein - Cleavage at two furin consensus sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT VACCINIA VIRUS; CELL-CELL FUSION; INFLUENZA HEMAGGLUTININ; MEMBRANE-FUSION; F-PROTEIN; SH GENE; GLYCOPROTEIN; EXPRESSION; RSV; ATTACHMENT	The F (fusion) protein of the respiratory syncytial viruses is synthesized as an inactive precursor F-0 that is proteolytically processed at the multibasic sequence KKRKRR136 into the subunits F-1 and F-2 by the cellular protease furin. This maturation process is essential for the F protein to gain fusion competence. We observed that proteolytic cleavage additionally occurs at another basic motif, RARR(109), that also meets the requirements for furin recognition. Cleavage at both sites leads to the removal from. the polypeptide chain of a glycosylated peptide of 27 amino acids. When the sequence RARR(109) was changed to NANR(109) or to RANN(109) by site-directed mutagenesis, cleavage by furin was completely prevented. Although the mutants were still processed at position Arg(136). they did not show any syncytia formation. Proteolytic cleavage of the modified motifs was achieved by treatment of transfected cells with trypsin converting the F mutants into their fusogenic forms. Our findings indicate that both furin consensus sequences have to be cleaved in order to activate the fusion protein.	Tierarztl Hsch Hannover, Inst Virol, D-30559 Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Herrler, G (corresponding author), Tierarztl Hsch Hannover, Inst Virol, Bunteweg 17, D-30559 Hannover, Germany.			Zimmer, Gert/0000-0002-2708-2507				BAKER JC, 1991, VET QUART, V13, P47, DOI 10.1080/01652176.1991.9694284; BAKER JC, 1986, AM J VET RES, V47, P240; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; Bolt G, 2000, VIRUS RES, V68, P25, DOI 10.1016/S0168-1702(00)00149-0; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Bukreyev A, 1997, J VIROL, V71, P8973, DOI 10.1128/JVI.71.12.8973-8982.1997; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; CHAMBERS P, 1992, J GEN VIROL, V73, P1717, DOI 10.1099/0022-1317-73-7-1717; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; COLLINS PL, 1995, P NATL ACAD SCI USA, V92, P11563, DOI 10.1073/pnas.92.25.11563; COLLINS PL, 1991, J GEN VIROL, V72, P3095, DOI 10.1099/0022-1317-72-12-3095; Collins PL, 1996, FIELDS VIROLOGY, P1313; CONNORS M, 1991, J VIROL, V65, P1634, DOI 10.1128/JVI.65.3.1634-1637.1991; Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; GRUBER C, 1985, J GEN VIROL, V66, P1241, DOI 10.1099/0022-1317-66-6-1241; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; HEMINWAY BR, 1994, VIROLOGY, V200, P801, DOI 10.1006/viro.1994.1245; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Huovila APJ, 1996, CURR OPIN CELL BIOL, V8, P692, DOI 10.1016/S0955-0674(96)80111-6; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; KIMMAN TG, 1990, ARCH VIROL, V112, P1, DOI 10.1007/BF01348982; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; KLENK HD, 1994, MONOGRAPH, V28, P241; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; LOPEZ JA, 1988, VIRUS RES, V10, P249, DOI 10.1016/0168-1702(88)90020-2; Maisner A, 2000, J GEN VIROL, V81, P441, DOI 10.1099/0022-1317-81-2-441; Martinez I, 2000, J GEN VIROL, V81, P2715, DOI 10.1099/0022-1317-81-11-2715; Melikyan GB, 1997, TRENDS MICROBIOL, V5, P349, DOI 10.1016/S0966-842X(97)01107-4; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; OLMSTED RA, 1986, P NATL ACAD SCI USA, V83, P7462, DOI 10.1073/pnas.83.19.7462; Pastey MK, 1997, J GEN VIROL, V78, P1885, DOI 10.1099/0022-1317-78-8-1885; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; STOTT EJ, 1985, ARCH VIROL, V84, P1, DOI 10.1007/BF01310552; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; TASHIRO M, 1987, J GEN VIROL, V68, P2039, DOI 10.1099/0022-1317-68-7-2039; TASHIRO M, 1987, NATURE, V325, P536, DOI 10.1038/325536a0; WERTZ GW, 1987, J VIROL, V61, P293, DOI 10.1128/JVI.61.2.293-301.1987; WHITE JM, 1994, MONOGRAPH, V28, P281; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wolfsberg TG, 1996, DEV BIOL, V180, P389, DOI 10.1006/dbio.1996.0313; YU Q, 1991, J GEN VIROL, V72, P75, DOI 10.1099/0022-1317-72-1-75; Zimmer G, 2001, J VIROL, V75, P4744, DOI 10.1128/JVI.75.10.4744-4751.2001	56	98	110	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31642	31650		10.1074/jbc.M102633200	http://dx.doi.org/10.1074/jbc.M102633200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418598	hybrid			2022-12-27	WOS:000170613500025
J	Bakillah, A; Hussain, MM				Bakillah, A; Hussain, MM			Binding of microsomal trigrlyceride transfer protein to lipids results in increased affinity for apolipoprotein B - Evidence for stable microsomal MTP-lipid complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	72nd Annual Scientific Session of the American-Heart-Association	NOV 07-10, 1999	ATLANTA, GA	Amer Heart Assoc			TRIGLYCERIDE TRANSFER PROTEIN; TERMINALLY TRUNCATED FORMS; CONTAINING LIPOPROTEINS; INTRACELLULAR DEGRADATION; MONOCLONAL-ANTIBODIES; HEPATOMA-CELLS; CACO-2 CELLS; SECRETION; EXPRESSION; DENSITY	Apolipoprotein B (apoll) and microsomal triglyceride transfer protein (MTP) are known to interact with each other. We evaluated the effect of different lipids on the protein-protein interactions between MTP and apoB100 or its C-terminally truncated forms. Negatively charged lipids decreased protein-protein interactions between apoB and MTP. In contrast, zwitterionic phospholipids enhanced (2-4-fold) the binding of apoB100 to MTP by increasing affinity (1.5-3-fold) between these proteins without affecting the number of binding sites. Similarly, phospholipids augmented (1.5-4-fold) the binding of various C-terminally truncated apoB peptides to MTP. The increased binding was greater for apoll peptides containing lipid-binding domains, such as apoB28 and apoB42. Surprisingly, preincubation of apoB28 with lipid vesicles had no effect on MTP binding. In contrast, incubation of MTP with lipid vesicles resulted in a stable association of MTP with vesicles, and MTP-lipid vesicles bound better (5-fold increase) to LDL than did lipid-free MTP. To determine whether MTP exists stably associated with lipids in cells, microsomal contents from COS cells expressing MTP, HepG2 cells, and mouse liver were ultracentrifuged, and MTP was visualized in different density fractions. MTP was found associated and unassociated with lipids. In contrast, apoB17 and apoB:270-570 were present unassociated with lipids in COS cells. These studies show that the binding of MTP to lipids results in increased affinity for apoB and that stable MTP-lipid complexes exist in the lumen of the endoplasmic reticulum. Protein-protein interactions between apoll and MTP may juxtapose lipids associated with MTP to lipid-binding domains of apoB and facilitate hydrophobic interactions leading to enhance affinity. We speculate that MTP-lipid complexes may serve as nuclei to form "primordial lipoproteins" and may also play a role in the bulk addition of lipids during the "core expansion" of these lipoproteins.	Suny Downstate Med Ctr, Dept Anat, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; MCP Hahnemann Univ, Dept Biochem, Philadelphia, PA 19129 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Drexel University	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Anat, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	mahmoodhussain@netmail.hscbklyn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046900, R29DK046900] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-64272] Funding Source: Medline; NIDDK NIH HHS [DK-46900] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXANDER CA, 1976, J CELL BIOL, V69, P241, DOI 10.1083/jcb.69.2.241; ATZEL A, 1993, BIOCHEMISTRY-US, V32, P10444, DOI 10.1021/bi00090a021; ATZEL A, 1994, BIOCHEMISTRY-US, V33, P15382, DOI 10.1021/bi00255a019; Bakillah A, 1998, BIOCHEMISTRY-US, V37, P3727, DOI 10.1021/bi972629t; Bakillah A, 1999, CIRCULATION, V100, P745; Bakillah A, 2000, BIOCHEMISTRY-US, V39, P4892, DOI 10.1021/bi9924009; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; Bradbury P, 1999, J BIOL CHEM, V274, P3159, DOI 10.1074/jbc.274.5.3159; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ginsberg HN, 1997, CLIN EXP PHARMACOL P, V24, pA29, DOI 10.1111/j.1440-1681.1997.tb03051.x; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; GORDON DA, 1994, P NATL ACAD SCI USA, V91, P7628, DOI 10.1073/pnas.91.16.7628; Haghpassand M, 1996, J LIPID RES, V37, P1468; Hussain MM, 2000, ATHEROSCLEROSIS, V148, P1; Hussain MM, 1998, J BIOL CHEM, V273, P25612, DOI 10.1074/jbc.273.40.25612; Hussain MM, 1997, BIOCHEMISTRY-US, V36, P13060, DOI 10.1021/bi971395a; Hussain MM, 1996, BBA-LIPID LIPID MET, V1300, P151, DOI 10.1016/0005-2760(96)00041-0; HUSSAIN MM, 1995, ARTERIOSCL THROM VAS, V15, P485, DOI 10.1161/01.ATV.15.4.485; Hussain MM, 2001, FRONT BIOSCI, V6, pD320, DOI 10.2741/Hussain; Innerarity TL, 1996, J BIOL CHEM, V271, P2353, DOI 10.1074/jbc.271.5.2353; JAMIL H, 1995, J BIOL CHEM, V270, P6549, DOI 10.1074/jbc.270.12.6549; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Kim E, 1998, J LIPID RES, V39, P703; Leung GK, 2000, J BIOL CHEM, V275, P7515, DOI 10.1074/jbc.275.11.7515; Liao W, 1999, BIOCHEMISTRY-US, V38, P7532, DOI 10.1021/bi9904196; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; Luchoomun J, 1997, ARTERIOSCL THROM VAS, V17, P2955, DOI 10.1161/01.ATV.17.11.2955; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; Patel SB, 1996, J BIOL CHEM, V271, P18686, DOI 10.1074/jbc.271.31.18686; PEASE RJ, 1990, J BIOL CHEM, V265, P553; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Read J, 2000, J BIOL CHEM, V275, P30372, DOI 10.1074/jbc.C000364200; Segrest JP, 1998, J LIPID RES, V39, P85; Segrest JP, 1999, J LIPID RES, V40, P1401; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; Tietge UJF, 1999, J LIPID RES, V40, P2134; WANG HX, 1994, J BIOL CHEM, V269, P18514; WETTERAU JR, 1992, SCIENCE, V258, P999; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Wu XJ, 1996, J BIOL CHEM, V271, P10277, DOI 10.1074/jbc.271.17.10277; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1991, J BIOL CHEM, V266, P3300; Yao ZM, 1997, J LIPID RES, V38, P1937; Zhou ZY, 1998, BBA-LIPID LIPID MET, V1391, P13, DOI 10.1016/S0005-2760(97)00200-2	53	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31466	31473		10.1074/jbc.M100390200	http://dx.doi.org/10.1074/jbc.M100390200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	463JG	11427523	hybrid			2022-12-27	WOS:000170472900113
J	Hedstrand, H; Ekwall, O; Olsson, MJ; Landgren, E; Kemp, EH; Weetman, AP; Perheentupa, J; Husebye, E; Gustafsson, J; Betterle, C; Kampe, O; Rorsman, F				Hedstrand, H; Ekwall, O; Olsson, MJ; Landgren, E; Kemp, EH; Weetman, AP; Perheentupa, J; Husebye, E; Gustafsson, J; Betterle, C; Kampe, O; Rorsman, F			The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DECARBOXYLASE; MELANIN-PRODUCING CELLS; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; ADDISONS-DISEASE; CYTOCHROME-P450 ENZYMES; POLYGLANDULAR SYNDROME; CAMPOMELIC DYSPLASIA; HAIR-FOLLICLES; HMG PROTEINS	Vitiligo is common in the hereditary disorder autoimmune polyendocrine syndrome type I (APS I). Patients with APS I are known to have high titer autoantibodies directed against various tissue-specific antigens. Using sera from APS I patients for immunoscreening of a cDNA library from human scalp, we identified the transcription factors SOX9 and SOX10 as novel autoantigens related to this syndrome. Immunoreactivity against SOX9 was found in 14 (15%) and against SOX10 in 20 (22%) of the 91 APS I sera studied. All patients reacting with SOX9 displayed reactivity against SOX10, suggesting shared epitopes. Among the 19 patients with vitiligo, 12 (63%) were positive for SOX10 (p < 0.0001). Furthermore, three of 93 sera from patients with vitiligo, unrelated to APS I showed strong reactivity against SOX10 which may indicate a more general role of SOX10 as an autoantigen in vitiligo.	Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; No Gen Hosp, Dept Clin Sci, Sheffield S5 7AU, S Yorkshire, England; Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Haukeland Hosp, Inst Med, Div Endocrinol, NO-5021 Bergen, Norway; Univ Uppsala Hosp, Dept Womens & Childrens Hlth, S-75185 Uppsala, Sweden; Univ Padua, Inst Med Semeiot, I-35128 Padua, Italy	Uppsala University; Uppsala University Hospital; Northern General Hospital; University of Helsinki; University of Bergen; Haukeland University Hospital; Uppsala University; Uppsala University Hospital; University of Padua	Hedstrand, H (corresponding author), Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden.		Kemp, Elizabeth Helen/D-1665-2011	Kemp, Elizabeth Helen/0000-0002-0313-8916; Kampe, Olle/0000-0001-6091-9914; Ekwall, Olov/0000-0002-4506-9955				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AYER LM, 1994, ARTHRITIS RHEUM, V37, P98, DOI 10.1002/art.1780370115; Betterle C, 1998, J CLIN ENDOCR METAB, V83, P1049, DOI 10.1210/jc.83.4.1049; BETTERLE C, 1985, DERMATOLOGICA, V171, P419, DOI 10.1159/000249466; BETTERLE C, 1984, LANCET, V1, P159; BETTERLE C, 1992, ARCH DERMATOL, V128, P123, DOI 10.1001/archderm.128.1.123; Bondurand N, 1998, FEBS LETT, V432, P168, DOI 10.1016/S0014-5793(98)00843-6; BUSTIN M, 1982, SCIENCE, V215, P1245, DOI 10.1126/science.6460317; Chen S, 1996, J CLIN ENDOCR METAB, V81, P1871, DOI 10.1210/jc.81.5.1871; CUI J, 1992, J INVEST DERMATOL, V98, P162, DOI 10.1111/1523-1747.ep12555773; CUNLIFFE WJ, 1968, BRIT J DERMATOL, V80, P135, DOI 10.1111/j.1365-2133.1968.tb12282.x; Ekwall O, 1998, LANCET, V352, P279, DOI 10.1016/S0140-6736(97)11050-9; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GALBRAITH GMP, 1988, CLIN IMMUNOL IMMUNOP, V48, P317, DOI 10.1016/0090-1229(88)90025-6; GebreMedhin G, 1997, FEBS LETT, V412, P439, DOI 10.1016/S0014-5793(97)00797-7; Goding CR, 2000, GENE DEV, V14, P1712; GOULD IM, 1985, BRIT J DERMATOL, V113, P153, DOI 10.1111/j.1365-2133.1985.tb02057.x; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; GRUNNET I, 1970, ARCH DERMATOL, V101, P82, DOI 10.1001/archderm.101.1.82; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Hedstrand H, 1999, J INVEST DERMATOL, V113, P1054, DOI 10.1046/j.1523-1747.1999.00778.x; Hedstrand H, 2000, BIOCHEM BIOPH RES CO, V267, P456, DOI 10.1006/bbrc.1999.1945; HERTZ KC, 1977, NEW ENGL J MED, V297, P634, DOI 10.1056/NEJM197709222971204; HOWITZ J, 1971, LANCET, V1, P1331; Husebye ES, 1997, J CLIN ENDOCR METAB, V82, P147, DOI 10.1210/jc.82.1.147; KAMPE O, 1989, DIABETES, V38, P1326, DOI 10.2337/diabetes.38.10.1326; Kasimiotis H, 2000, DIABETES, V49, P555, DOI 10.2337/diabetes.49.4.555; Kemp EH, 1998, BRIT J DERMATOL, V139, P798; Kemp EH, 1997, J INVEST DERMATOL, V109, P69, DOI 10.1111/1523-1747.ep12276556; Kemp EH, 1998, CLIN EXP IMMUNOL, V114, P333; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; LERNER AB, 1971, AM J MED, V51, P141, DOI 10.1016/0002-9343(71)90232-4; Mackay IR, 2000, IMMUNOL REV, V174, P226, DOI 10.1034/j.1600-0528.2002.017410.x; Mirakian R, 1998, LANCET, V352, P255, DOI 10.1016/S0140-6736(05)60257-7; Morse JH, 1996, CLIN EXP IMMUNOL, V106, P389, DOI 10.1046/j.1365-2249.1996.d01-848.x; MUHLEN CV, 1995, SEMIN ARTHRITIS RHEU, V5, P323; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NAUGHTON GK, 1983, J EXP MED, V158, P246, DOI 10.1084/jem.158.1.246; NEUER G, 1992, ARTHRITIS RHEUM, V35, P472, DOI 10.1002/art.1780350418; Neufeld M, 1980, Pediatr Ann, V9, P154; OLSSON MJ, 1994, ACTA DERM-VENEREOL, V74, P226; OLSSON MJ, 1993, ACTA DERM-VENEREOL, V73, P49; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; RORSMAN F, 1995, P NATL ACAD SCI USA, V92, P8626, DOI 10.1073/pnas.92.19.8626; SCHALLREUTER KU, 1994, DERMATOLOGY, V188, P269, DOI 10.1159/000247164; SONG YH, 1994, LANCET, V344, P1049, DOI 10.1016/S0140-6736(94)91709-4; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Tobin DJ, 1996, PIGM CELL RES, V9, P304, DOI 10.1111/j.1600-0749.1996.tb00122.x; Tuomi T, 1996, J CLIN ENDOCR METAB, V81, P1488, DOI 10.1210/jc.81.4.1488; UIBO R, 1994, J CLIN ENDOCR METAB, V78, P323, DOI 10.1210/jc.78.2.323; VELLOSO LA, 1994, DIABETOLOGIA, V37, P61; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WANG SJ, 1994, AM J MED GENET, V51, P234, DOI 10.1002/ajmg.1320510313; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WINQVIST O, 1993, J CLIN INVEST, V92, P2377, DOI 10.1172/JCI116843; Winqvist O, 1996, MOL MED TODAY, V2, P282, DOI 10.1016/1357-4310(96)10024-1	59	90	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 21	2001	276	38					35390	35395		10.1074/jbc.M102391200	http://dx.doi.org/10.1074/jbc.M102391200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474LU	11423552	hybrid			2022-12-27	WOS:000171109300026
J	Reddy, SK; Kamireddi, M; Dhanireddy, K; Young, L; Davis, A; Reddy, PT				Reddy, SK; Kamireddi, M; Dhanireddy, K; Young, L; Davis, A; Reddy, PT			Eukaryotic-like adenylyl cyclases in Mycobacterium tuberculosis H37Rv - Cloning and characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCTS; CYCLIC-AMP; PROTEIN; EXPRESSION; RESISTANCE; HEMOLYSIN; APOPTOSIS; INFECTION; SEQUENCE; DOMAINS	Screening the Mycobacterium tuberculosis H37Rv genomic library for complementation of catabolic defect for cAMP-dependent expression of maltose operon produced the adenylyl cyclase gene (Mtb cya, GenBank(TM) accession no. AF017731 (1997)) annotated later as Rv1625c (Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., III, et al. (1998) Nature 393, 537-544). The deduced amino acid (aa) sequence (443 aa) encoded by Mtb cya contains a single hydrophobic domain of six transmembrane helices (152 aa) in the amino-terminal half of the protein. Flanking this domain are an arginine-rich (17%) amino-terminal cytoplasmic tail (46 aa) and a carboxyl-terminal cytoplasmic domain (245 aa) with extensive homology to the catalytic core of eukaryotic adenylyl cyclases. Site-directed mutagenesis of Arg(43) and Arg(44) to alanine/glycine showed a loss of adenylyl cyclase activity, whereas mutagenesis to lysine restored the activity. Hence it is proposed that the formation of the catalytic site in Mtb adenylyl cyclase requires an interaction between Arg(43) and Arg(44) residues in the distal cytoplasmic tail and the carboxyl-terminal cytoplasmic domain. Mtb adenylyl cyclase activity at the physiological concentration of ATP (1 mm) was 475 nmol of cAMP/min/mg of membrane protein in the presence of Mn2+ but only 10 nmol of cAMP/min/mg of membrane protein in the presence of Mg2+. The physiological significance of the activation of Mtb adenylyl cyclase by Mn2+ is discussed in view of the presence of manganese transporter protein in mycobacteria and macrophages wherein mycobacteria reside.	NIST, Chem Sci & Technol Lab, Div Biotechnol, DNA Technol Grp, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA	Reddy, PT (corresponding author), NIST, Chem Sci & Technol Lab, Div Biotechnol, DNA Technol Grp, Bldg 227,Rm B244,Mail Stop 831-1,100 Bur Dr, Gaithersburg, MD 20899 USA.							Av-Gay Y., 1997, MICROB COMP GENOMICS, V2, P63, DOI DOI 10.1089/OMI.1.1997.2.63; Bernard H U, 1979, Methods Enzymol, V68, P482; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coudart-Cavalli MP, 1997, BIOCHIMIE, V79, P757, DOI 10.1016/S0300-9084(97)86934-9; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Gueirard P, 1998, INFECT IMMUN, V66, P1718, DOI 10.1128/IAI.66.4.1718-1725.1998; HARWOOD JP, 1975, J BIOL CHEM, V250, P4656; Kamireddi M, 1997, Indian J Clin Biochem, V12, P63, DOI 10.1007/BF02873063; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASURE HR, 1987, MICROBIOL REV, V51, P60, DOI 10.1128/MMBR.51.1.60-65.1987; PADH H, 1976, INDIAN J BIOCHEM BIO, V13, P413; PADH H, 1980, MICROBIOS, V27, P69; PADH H, 1977, MICROBIOS, V16, P183; REDDY P, 1989, NUCLEIC ACIDS RES, V17, P10473, DOI 10.1093/nar/17.24.10473; ROY A, 1982, MOL GEN GENET, V188, P465, DOI 10.1007/BF00330050; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Sambrook J., 2002, MOL CLONING LAB MANU; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SHAH S, 1991, J BACTERIOL, V173, P3238, DOI 10.1128/JB.173.10.3238-3242.1991; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; TANG WJ, 1995, SCIENCE, V268, P1769, DOI 10.1126/science.7792604; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Whisnant RE, 1996, P NATL ACAD SCI USA, V93, P6621, DOI 10.1073/pnas.93.13.6621; Wolff J, 1980, P NATL ACAD SCI USA, V77, P3840; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; ZUBER M, 1987, P NATL ACAD SCI USA, V84, P4514, DOI 10.1073/pnas.84.13.4514	35	43	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					35141	35149		10.1074/jbc.M104108200	http://dx.doi.org/10.1074/jbc.M104108200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11431477	hybrid			2022-12-27	WOS:000171024600104
J	Aalfs, JD; Narlikar, GJ; Kingston, RE				Aalfs, JD; Narlikar, GJ; Kingston, RE			Functional differences between the human ATP-dependent nucleosome remodeling proteins BRG1 and SNF2H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SWI/SNF COMPLEX; HUMAN SWI-SNF; HISTONE OCTAMER; SACCHAROMYCES-CEREVISIAE; IN-VITRO; HO GENE; CHROMATIN; ISWI; TRANSCRIPTION; BINDING	ATP-dependent nucleosome remodeling complexes can be grouped into several classes that may differ in their biochemical remodeling activities and biological roles. Although there are a number of biochemical studies of each class of remodeler, there are very little data directly comparing the biochemical activities of remodelers from different classes. We have purified two ATP-hydrolyzing proteins, SNF2H and BRG1, which are members of complexes from two different classes of remodelers. Consistent with previous reports, these two homogeneous proteins can perform remodeling functions. We show significant functional differences between SNF2H and BRG1 in vitro; although both SNF2H and BRG1 hydrolyze ATP and remodel linear arrays of nucleosomes, only BRG1 can remodel mononucleosomes. Also, only BRG1 can alter the topology of nucleosomal plasmids. We propose that these functional differences reflect significant mechanistic differences between the two remodeler classes that will impact their biological roles.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.							AALFS J, 2001, BIOCH COMP HUMAN ATP; Aihara T, 1998, CYTOGENET CELL GENET, V81, P191, DOI 10.1159/000015027; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; ELFRING LK, 1994, MOL CELL BIOL, V14, P2225, DOI 10.1128/MCB.14.4.2225; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gavin I, 2001, MOL CELL, V7, P97, DOI 10.1016/S1097-2765(01)00158-7; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; Guyon JR, 1999, MOL CELL BIOL, V19, P2088; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; MORSE RH, 1989, EMBO J, V8, P2343, DOI 10.1002/j.1460-2075.1989.tb08362.x; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; NEIGEBORN L, 1984, GENETICS, V108, P845; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3	51	70	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34270	34278		10.1074/jbc.M104163200	http://dx.doi.org/10.1074/jbc.M104163200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435432	hybrid			2022-12-27	WOS:000170910200130
J	Wang, DS; Canaff, L; Davidson, D; Corluka, A; Liu, HL; Hendy, GN; Henderson, JE				Wang, DS; Canaff, L; Davidson, D; Corluka, A; Liu, HL; Hendy, GN; Henderson, JE			Alterations in the sensing and transport of phosphate and calcium by differentiating chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; NEONATAL SEVERE HYPERPARATHYROIDISM; GROWTH-FACTOR RECEPTOR-3; CONVOLUTED TUBULE CELLS; II COLLAGEN GENE; PARATHYROID-HORMONE; MATRIX VESICLES; IN-VITRO; METAPHYSEAL CHONDRODYSPLASIA	During endochondral bone formation and fracture healing, cells committed to chondrogenesis undergo a temporally restricted program of differentiation that is characterized by sequential changes in their phenotype and gene expression. This results in the manufacture, remodeling, and mineralization of a cartilage template on which bone is laid down. Articular chondrocytes undergo a similar but restricted differentiation program that does not proceed to mineralization, except in pathologic conditions such as osteoarthritis. The pathogenesis of disorders of cartilage development and metabolism, including osteochondrodysplasia, fracture non-union, and osteoarthritis remain poorly defined. We used the CFK2 model to examine the potential roles of phosphate and calcium ions in the regulatory pathways that mediate chondrogenesis and cartilage maturation. Differentiation was monitored over a 4-week period using a combination of morphological, biochemical, and molecular markers that have been characterized in vivo and in vitro. CFK2 cells expressed the type III sodium-dependent phosphate transporters Glvr-1 and Ram-1, as well as a calcium-sensing mechanism. Regulated expression and activity of Glvr-1 by extracellular phosphate and parathyroid hormone-related protein was restricted to an early stage of CFK2 differentiation, as evidenced by expression of type II collagen, proteoglycan, and Ihh. On the other hand, regulated expression and activity of a calcium-sensing receptor by extracellular calcium was most evident after 2 weeks of differentiation, concomitant with an increase in type X collagen expression, alkaline phosphatase activity and parathyroid hormone/parathyroid hormone-related protein receptor expression. On the basis of these temporally restricted changes in the sensing and transport of phosphate and calcium, we predict that extracellular phosphate plays a role in the commitment of chondrogenic cells to differentiation, whereas extracellular calcium plays a role at a later stage in their differentiation program.	McGill Univ, Dept Med, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada	Lady Davis Institute; McGill University; McGill University; Royal Victoria Hospital	Henderson, JE (corresponding author), McGill Univ, Dept Med, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Rm 602,3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.							Aarts MM, 1999, J BONE MINER RES, V14, P1493, DOI 10.1359/jbmr.1999.14.9.1493; Aarts MM, 1999, J BIOL CHEM, V274, P4832, DOI 10.1074/jbc.274.8.4832; Alini M, 1996, J BONE MINER RES, V11, P105; Amizuka N, 1999, J BONE MINER RES, V14, pS435; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; ANDERSON HC, 1969, J CELL BIOL, V41, P59, DOI 10.1083/jcb.41.1.59; Bai M, 1997, J CLIN INVEST, V99, P1917, DOI 10.1172/JCI119359; Bapty BW, 1998, KIDNEY INT, V53, P583, DOI 10.1046/j.1523-1755.1998.00790.x; BERNIER SM, 1993, J BONE MINER RES, V8, P475; Bernier SM, 1996, ANN NY ACAD SCI, V785, P212, DOI 10.1111/j.1749-6632.1996.tb56264.x; BERNIER SM, 1990, J CELL PHYSIOL, V145, P274, DOI 10.1002/jcp.1041450212; BICKLE DD, 1996, J CLIN INVEST, V97, P1085; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; BINGHAM PJ, 1974, CALC TISS RES, V14, P31, DOI 10.1007/BF02060281; BOSKEY AL, 1992, BONE MINER, V16, P11, DOI 10.1016/0169-6009(92)90819-Y; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Caverzasio J, 1996, KIDNEY INT, V49, P975, DOI 10.1038/ki.1996.138; Chang WH, 1999, ENDOCRINOLOGY, V140, P1911, DOI 10.1210/en.140.4.1911; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GERSTENFELD LC, 1991, J CELL BIOL, V112, P501, DOI 10.1083/jcb.112.3.501; GLASER JH, 1981, J BIOL CHEM, V256, P2607; GLORIEUX FH, 1972, NEW ENGL J MED, V287, P481, DOI 10.1056/NEJM197209072871003; GOLUB EE, 1983, J BIOL CHEM, V258, P616; Guicheux J, 2000, BONE, V27, P69, DOI 10.1016/S8756-3282(00)00302-1; Guo J, 2001, ENDOCRINOLOGY, V142, P1260, DOI 10.1210/en.142.3.1260; Henderson JE, 1996, J CELL PHYSIOL, V169, P33, DOI 10.1002/(SICI)1097-4652(199610)169:1<33::AID-JCP4>3.0.CO;2-F; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Henderson JE, 2000, J BONE MINER RES, V15, P155, DOI 10.1359/jbmr.2000.15.1.155; HENDERSON JE, 2000, OSTEOPOROSIS PRIMER, P113; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; HOWELL DS, 1968, J CLIN INVEST, V47, P1121, DOI 10.1172/JCI105801; IKEDA K, 1989, BIOCHEM BIOPH RES CO, V162, P108, DOI 10.1016/0006-291X(89)91969-4; JEE WSS, 1983, HISTOLOGY CELL TISSU, V5, P200; JIKKO A, 1993, DEV BIOL, V156, P372, DOI 10.1006/dbio.1993.1084; Johnson K, 1999, ARTHRITIS RHEUM-US, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O; KAKUTA S, 1985, CALCIFIED TISSUE INT, V37, P293, DOI 10.1007/BF02554877; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; Krebsbach PH, 1996, J BIOL CHEM, V271, P4298, DOI 10.1074/jbc.271.8.4298; LIPMAN ML, 1994, J IMMUNOL, V152, P5120; Lipman ML, 1998, J BIOL CHEM, V273, P13729, DOI 10.1074/jbc.273.22.13729; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; MARIE PJ, 1981, J CLIN INVEST, V67, P911, DOI 10.1172/JCI110110; McEwen DG, 1999, J BIOL CHEM, V274, P30934, DOI 10.1074/jbc.274.43.30934; METSARANTA M, 1991, J BIOL CHEM, V266, P16862; MONTESSUIT C, 1991, J BIOL CHEM, V266, P17791; MONTESSUIT C, 1995, J BONE MINER RES, V10, P625; Nielsen LB, 2001, BONE, V28, P160, DOI 10.1016/S8756-3282(00)00418-X; Palmer G, 2000, GENE, V244, P35, DOI 10.1016/S0378-1119(00)00010-X; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; Papaioannou S, 1999, BBA-MOL CELL RES, V1449, P284, DOI 10.1016/S0167-4889(99)00025-7; Pi M, 2000, J BIOL CHEM, V275, P3256, DOI 10.1074/jbc.275.5.3256; POOLE AR, 1991, CARTILAGE MOL ASPECT, P179; POOLE AR, 2000, OSTEOPOROSIS PRIMER, P3; Richardson C, 1996, MOL CELL BIOL, V16, P4240; Ryan Lawrence M., 1993, P1835; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; SIMMONS DJ, 1970, CLIN ORTHOP RELAT R, V68, P252; TAKIGAWA M, 1980, P NATL ACAD SCI-BIOL, V77, P1481, DOI 10.1073/pnas.77.3.1481; TAKUWA N, 1987, J BIOL CHEM, V262, P182; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Tenenhouse HS, 1997, J BONE MINER RES, V12, P159, DOI 10.1359/jbmr.1997.12.2.159; Tenenhouse HS, 1998, J BONE MINER RES, V13, P590, DOI 10.1359/jbmr.1998.13.4.590; Terkeltaub R, 1998, ARTHRITIS RHEUM-US, V41, P2152, DOI 10.1002/1529-0131(199812)41:12<2152::AID-ART10>3.3.CO;2-O; Valentini RP, 1997, J BIOL CHEM, V272, P8466, DOI 10.1074/jbc.272.13.8466; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; WINDAHL SH, 2001, IN PRESS J BONE MINE; Yamaguchi T, 2000, ADV PHARMACOL, V47, P209; YANG T, 1997, AM J PHYSIOL, V272, P751; Yao J, 1998, DEV GROWTH DIFFER, V40, P133	80	59	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33995	34005		10.1074/jbc.M007757200	http://dx.doi.org/10.1074/jbc.M007757200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11404353	hybrid			2022-12-27	WOS:000170910200095
J	Krimbou, L; Marcil, M; Davignon, J; Genest, J				Krimbou, L; Marcil, M; Davignon, J; Genest, J			Interaction of lecithin : cholesterol acyltransferase (LCAT)center dot alpha(2)-macroglobulin complex with low density lipoprotein receptor-related protein (LRP) - Evidence for an alpha(2)-macroglobulin/LRP receptor-mediated system participating in LCAT clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER TRANSFER PROTEIN; APOLIPOPROTEIN-A-I; HUMAN PLASMA; BINDING; BETA; LOCALIZATION; EXPRESSION; MUTANTS; LPE	The reaction of lecithin:cholesterol acyltransferase (LCAT) with high density lipoproteins (RDL) is of critical importance in reverse cholesterol transport, but the structural and functional pathways involved in the regulation of LCAT have not been established. We present evidence for the direct binding of LCAT to alpha (2)-macroglobulin (alpha M-2) in human plasma to form a complex 18.5 nm in diameter. Forty percent of plasma LCAT-HDL was associated with a2M; moreover, most of the LCAT in cerebrospinal fluid and in the medium of cultured human hepatoma cell line was associated with alpha M-2. Purified recombinant human LCAT (rLCAT) labeled with I-125 bound to native and methylamine-activated alpha M-2 (alpha M-2-MA) in vitro in a time- and concentration-dependent manner, and this binding did not depend on the presence of lipid. rLCAT bound to alpha 2M-MA with greater affinity than to alpha 2M. Furthermore, rLCAT did not activate alpha 2M as phosphatidylcholine-specific phospholipase C does. Reconstituted HDL particles (LpA-I) inhibited the binding of rLCAT to alpha M-2 more efficiently than native HDL3 did. LCAT associated with alpha M-2 was enzymatically inactive under both endogenous and exogenous assay conditions. Purified rLCAT alone did not bind to low density lipoprotein receptor-related protein (LRP) as lipoprotein lipase (LPL) does; however, when rLCAT was combined with alpha 2M-MA to form a complex, binding, internalization, and degradation of rLCAT took place in LRPexpressing cells (LRP (+/+)) but not in cells deficient in LRP (LRP (-/-)). It is concluded that the binding of LCAT to alpha 2M inhibits its enzymatic activity. Furthermore, the finding supports the possibility that the LRP receptor can act in vivo to mediate clearance of the LCAT-alpha M-2 complex and may significantly influence the bioavailability of LCAT.	McGill Univ, Royal Victoria Hosp, Ctr Hlth, Cardiovasc Genet Lab,Cardiol Div, Montreal, PQ H3A 1A1, Canada; Clin Res Inst Montreal, Hyperlipidemia & Atherosclerosis Res Grp, Montreal, PQ H2W 1R7, Canada	McGill University; Royal Victoria Hospital; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Genest, J (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, Cardiovasc Genet Lab,Cardiol Div, M4-76,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.							Adimoolam S, 1998, J BIOL CHEM, V273, P32561, DOI 10.1074/jbc.273.49.32561; BOLIN DJ, 1994, J BIOL CHEM, V269, P7429; BONELLI FS, 1989, J BIOL CHEM, V264, P14723; BORTH W, 1994, ANN NY ACAD SCI, V737, P267, DOI 10.1111/j.1749-6632.1994.tb44317.x; CHEUNG MC, 1986, J LIPID RES, V27, P1135; Chisholm JW, 1999, J LIPID RES, V40, P1512; Collet X, 1999, BIOCHEM BIOPH RES CO, V258, P73, DOI 10.1006/bbrc.1999.0601; CROOKSTON KP, 1994, J BIOL CHEM, V269, P1533; Du YS, 1997, J NEUROCHEM, V69, P299; FIELDING CJ, 1995, J LIPID RES, V36, P211; FRANCONE OL, 1989, J BIOL CHEM, V264, P7066; GLOMSET JA, 1968, J LIPID RES, V9, P155; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GONIAS SL, 1994, ANN NY ACAD SCI, V737, P273, DOI 10.1111/j.1749-6632.1994.tb44318.x; HILL JS, 1990, CLIN CHEM, V36, P1871; ILLINGWORTH D R, 1970, Biochimica et Biophysica Acta, V220, P610, DOI 10.1016/0005-2744(70)90292-5; JENSEN PH, 1989, FEBS LETT, V255, P275, DOI 10.1016/0014-5793(89)81105-6; Jin LH, 1999, BIOCHEMISTRY-US, V38, P15659, DOI 10.1021/bi9916729; Krimbou L, 1997, J LIPID RES, V38, P35; Krimbou L, 1998, J LIPID RES, V39, P861; Krimbou L, 1998, J LIPID RES, V39, P2373; MARCIL M, 1995, ARTERIOSCL THROM VAS, V15, P1015, DOI 10.1161/01.ATV.15.8.1015; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MCLEAN J, 1986, P NATL ACAD SCI USA, V83, P2335, DOI 10.1073/pnas.83.8.2335; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; QU SJ, 1995, J LIPID RES, V36, P967; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; SMITH KM, 1990, J LIPID RES, V31, P995; Sottrup-Jensen L, 1987, PLASMA PROTEINS STRU, V5, P192; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Starkey P. M., 1977, PROTEINASES MAMMALIA, P663; TALL AR, 1993, J LIPID RES, V34, P1255; VLAICU R, 1985, ATHEROSCLEROSIS, V55, P35, DOI 10.1016/0021-9150(85)90164-9; Vohl MC, 1999, BIOCHEMISTRY-US, V38, P5976, DOI 10.1021/bi982258w; WANG CY, 1995, CANCER RES, V55, P5101; WEEB DJ, 1994, J BIOL CHEM, V269, P30402	37	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33241	33248		10.1074/jbc.M100326200	http://dx.doi.org/10.1074/jbc.M100326200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435418	hybrid			2022-12-27	WOS:000170746000110
J	Tsuji, M; Inanami, O; Kuwabara, M				Tsuji, M; Inanami, O; Kuwabara, M			Induction of neurite outgrowth in PC12 cells by alpha-phenyl-N-tert-butylnitron through activation of protein kinase C and the Ras-extracellular signal-regulated kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; INDUCED NEURONAL DIFFERENTIATION; TRK PROTOONCOGENE PRODUCT; BUTYL NITRONE PBN; MAP KINASE; TYROSINE PHOSPHORYLATION; PHORBOL ESTER; PHEOCHROMOCYTOMA CELLS; FOS EXPRESSION; EGF RECEPTOR	The spin trap alpha -phenyl-N-tert-butylnitron (PBN) is widely used for studies of the biological effects of free radicals. We previously reported the protective effects of PBN against ischemia-reperfusion injury in gerbil hippocampus by its activation of extracellular signal-regulated kinase (ERK) and suppression of both stress-activated protein kinase and p38 mitogen-activated protein kinase. In the present study, we found that PBN induced neurite outgrowth accompanied by ERK activation in PC12 cells in a dose-dependent manner. The induction of neurite outgrowth was inhibited significantly not only by transient transfection of PC12 cells with dominant negative Ras, but also by treatment with mitogen-activated protein kinase/ERK kinase inhibitor PD98059. The activation of receptor tyrosine kinase TrkA was not involved in PBN-induced neurite outgrowth. A protein kinase C (PKC) inhibitor, GF109203X, was found to inhibit neurite outgrowth. The activation of PKC epsilon was observed after PBN stimulation. PBN-induced neurite outgrowth and ERK activation were counteracted by the thiol-based antioxidant N-acetylcysteine. From these results, it was concluded that PBN induced neurite outgrowth in PC12 cells through activation of the Ras-ERK pathway and PKC.	Hokkaido Univ, Grad Sch Vet Med, Radiat Biol Lab, Dept Environm Vet Sci, Sapporo, Hokkaido 0600818, Japan	Hokkaido University	Kuwabara, M (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Radiat Biol Lab, Dept Environm Vet Sci, Sapporo, Hokkaido 0600818, Japan.		Inanami, Osamu/A-5197-2012	Inanami, Osamu/0000-0001-7895-3918				Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Burry RW, 1998, J NEUROSCI RES, V53, P214, DOI 10.1002/(SICI)1097-4547(19980715)53:2<214::AID-JNR10>3.0.CO;2-6; BURSTEIN DE, 1982, BRAIN RES, V247, P115, DOI 10.1016/0006-8993(82)91033-2; CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; CLOUGHHELFMAN C, 1991, FREE RADICAL RES COM, V15, P177, DOI 10.3109/10715769109049138; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Dikalov S, 1996, BIOCHEM BIOPH RES CO, V218, P616, DOI 10.1006/bbrc.1996.0109; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Fontecave M, 1998, CELL MOL LIFE SCI, V54, P684, DOI 10.1007/s000180050195; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hohler B, 2000, HISTOCHEM CELL BIOL, V114, P29; Hoyos B, 2000, J EXP MED, V192, P835, DOI 10.1084/jem.192.6.835; HUNDLE B, 1995, J BIOL CHEM, V270, P30134; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; Kalyanaraman B, 1996, ANAL BIOCHEM, V241, P75, DOI 10.1006/abio.1996.0380; Kamata H, 1996, J BIOL CHEM, V271, P33018, DOI 10.1074/jbc.271.51.33018; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kotake Y, 1999, ARCH BIOCHEM BIOPHYS, V371, P129, DOI 10.1006/abbi.1999.1417; Kruttgen A, 1998, P NATL ACAD SCI USA, V95, P9614, DOI 10.1073/pnas.95.16.9614; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; Mills EM, 1998, J BIOL CHEM, V273, P22165, DOI 10.1074/jbc.273.35.22165; Miyajima T, 1997, FREE RADICAL BIO MED, V22, P463, DOI 10.1016/S0891-5849(96)00391-7; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PERALDI P, 1995, FEBS LETT, V357, P290, DOI 10.1016/0014-5793(94)01376-C; POLLOCK JD, 1990, J NEUROSCI, V10, P2626; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; ROIVAINEN R, 1993, BRAIN RES, V624, P85, DOI 10.1016/0006-8993(93)90063-S; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Ronn LCB, 2000, J NEUROCHEM, V75, P665, DOI 10.1046/j.1471-4159.2000.0750665.x; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Saito K, 1998, BIOSCI BIOTECH BIOCH, V62, P275, DOI 10.1271/bbb.62.275; Sakai T, 1999, J BIOL CHEM, V274, P29666, DOI 10.1074/jbc.274.42.29666; Sang H, 1999, ARCH BIOCHEM BIOPHYS, V363, P341, DOI 10.1006/abbi.1998.1086; Santus R, 2000, FREE RADICAL RES, V33, P383, DOI 10.1080/10715760000300921; SIGMUND O, 1990, J BIOL CHEM, V265, P2257; SINGH KR, 1994, BIOCHEMISTRY-US, V33, P542, DOI 10.1021/bi00168a020; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Thannickal VJ, 2000, FASEB J, V14, P1741, DOI 10.1096/fj.99-0878com; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Tsuji M, 2000, NEUROSCI LETT, V282, P41, DOI 10.1016/S0304-3940(00)00844-2; Wakatsuki S, 1999, J BIOCHEM-TOKYO, V126, P1151, DOI 10.1093/oxfordjournals.jbchem.a022561; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Yamashita T, 1996, FREE RADICAL BIO MED, V21, P755, DOI 10.1016/0891-5849(96)00222-5	58	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32779	32785		10.1074/jbc.M101403200	http://dx.doi.org/10.1074/jbc.M101403200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438521	hybrid			2022-12-27	WOS:000170746000055
J	White, SH; Ladokhin, AS; Jayasinghe, S; Hristova, K				White, SH; Ladokhin, AS; Jayasinghe, S; Hristova, K			How membranes shape protein structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BILAYER STRUCTURE DETERMINATION; ALPHA-HELIX; X-RAY; TRANSMEMBRANE HELICES; NEUTRON-DIFFRACTION; FREE-ENERGY; LIPID-BILAYERS; GXXXG MOTIF; PEPTIDES; INSERTION		Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Program Macromol Struct, Irvine, CA 92697 USA; Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-252143 Kiev, Ukraine	University of California System; University of California Irvine; University of California System; University of California Irvine; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	White, SH (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Med Sci 1 D346, Irvine, CA 92697 USA.	blanco@helium.biomol.uci.edu	Hristova, Kalina/A-3326-2010; White, Stephen/N-1507-2019; White, Stephen H/B-1053-2009	White, Stephen H/0000-0001-8540-7907	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046823] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46823] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Arkin IT, 1996, NAT STRUCT BIOL, V3, P240, DOI 10.1038/nsb0396-240; Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614; BenShaul A, 1996, BIOPHYS J, V71, P130, DOI 10.1016/S0006-3495(96)79208-1; BenTal N, 1996, BIOPHYS J, V70, P1803, DOI 10.1016/S0006-3495(96)79744-8; BenTal N, 1997, J PHYS CHEM B, V101, P450, DOI 10.1021/jp961825r; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Choma C, 2000, NAT STRUCT BIOL, V7, P161; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; Ghomashchi F, 1998, BIOCHEMISTRY-US, V37, P6697, DOI 10.1021/bi972525i; Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15177, DOI 10.1021/bi970147b; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; JACOBS RE, 1989, BIOCHEMISTRY-US, V28, P3421, DOI 10.1021/bi00434a042; Jayasinghe S, 2001, PROTEIN SCI, V10, P455, DOI 10.1110/ps.43501; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Ladokhin AS, 1999, BIOCHEMISTRY-US, V38, P12313, DOI 10.1021/bi9907936; Ladokhin AS, 1999, J MOL BIOL, V285, P1363, DOI 10.1006/jmbi.1998.2346; Ladokhin AS, 2001, J MOL BIOL, V309, P543, DOI 10.1006/jmbi.2001.4684; Langosch D, 1998, PROTEINS, V31, P150, DOI 10.1002/(SICI)1097-0134(19980501)31:2<150::AID-PROT5>3.0.CO;2-Q; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; LIU YF, 1995, BIOCHEMISTRY-US, V34, P12884, DOI 10.1021/bi00039a051; Lolkema JS, 1998, FEMS MICROBIOL REV, V22, P305, DOI 10.1016/S0168-6445(98)00018-7; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; MOLL TS, 1994, BIOCHEMISTRY-US, V33, P15469, DOI 10.1021/bi00255a029; MURRAY D, 2001, CURRENT TOPICS MEMBR; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; ROSEMAN MA, 1988, J MOL BIOL, V201, P621, DOI 10.1016/0022-2836(88)90642-0; ROST B, 1995, PROTEIN SCI, V4, P521; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SEGREST JP, 1972, BIOCHEM BIOPH RES CO, V49, P964, DOI 10.1016/0006-291X(72)90306-3; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Smith SO, 1996, NAT STRUCT BIOL, V3, P252, DOI 10.1038/nsb0396-252; Soekarjo M, 1996, BIOCHEMISTRY-US, V35, P1232, DOI 10.1021/bi951087h; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tanford Ch., 1973, HYDROPHOBIC EFFECT F; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van Voorst F, 2000, BIOCHEM J, V347, P601, DOI 10.1042/bj3470601; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; White S. H., 1996, MEMBRANE STRUCTURE D, P127; White S.H., 2000, BIOL PHYS SER, P189; White S. H., 1995, PERMEABILITY STABILI, P1; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WHITE SH, 1994, CURR OPIN STRUC BIOL, V4, P79, DOI 10.1016/S0959-440X(94)90063-9; White SH., 1994, MEMBRANE PROTEIN STR, P97, DOI [10.1007/978-1-4614-7515-6_4, DOI 10.1007/978-1-4614-7515-6_4]; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; WIENER MC, 1991, BIOPHYS J, V59, P174, DOI 10.1016/S0006-3495(91)82209-3; WIENER MC, 1991, BIOPHYS J, V59, P162, DOI 10.1016/S0006-3495(91)82208-1; Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268; Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+; Wimley WC, 2000, BIOCHEMISTRY-US, V39, P4432, DOI 10.1021/bi992746j; WIMLEY WC, 1993, BIOCHEMISTRY-US, V32, P6307, DOI 10.1021/bi00076a001; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	76	267	274	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32395	32398		10.1074/jbc.R100008200	http://dx.doi.org/10.1074/jbc.R100008200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432876	hybrid			2022-12-27	WOS:000170746000002
J	Bechoua, S; Daniel, LW				Bechoua, S; Daniel, LW			Phospholipase D is required in the signaling pathway leading to p38 MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE ACTIVATION; TRANSDUCTION PATHWAYS; PHOSPHATIDIC-ACID; GENE-EXPRESSION; BINDING-PROTEIN; TNF-ALPHA; GM-CSF; PHOSPHORYLATION; MECHANISMS	Human acute myelogenous leukemia cells (HL-60 Cells) can be induced to differentiate to neutrophils by exposure to dibutyryl-cyclic AMP. The differentiation of HL-60 cells allowed the mitogen-activated protein kinases p38 and p44/p42 to be rapidly and transiently activated upon stimulation with N-formyl-methionyl-leucyl-phenylalanine (fMLP). Western blot analysis using phosphospecific p38 and p44/p42 mitogen-activated protein kinase antibodies showed that increasing concentrations of ethanol or 1-butanol but not 2-butanol (0.05-0.5%) inhibited fMLP-induced p38 activation but did not inhibit p44/p42 activation. These data indicated that activation of phospholipase D (PLD) was required for activation of p38 but not p44/p42. We compared the effect of fMLP with those of tumor necrosis factor a (TNF alpha) and granulocyte-macrophage colony-stimulating factor (GAT-CSF). We found that ethanol did not inhibit p38 phosphorylation upon stimulation with either GM-CSF or TNF alpha. These results suggested that in cells stimulated with RULP, PLD was upstream of p38. To further test the involvement of PLD, we used antisense inhibition of human PLD1 expression. Treatment with antisense oligonueleotides inhibited p38 but not p44/p42 phosphorylation. These data supported a role for human PLD1 in fMLP-induced p38-activation in neutrophil-like HL-60 cells. In addition, the results obtained with TNF alpha and GM-CSF demonstrated that p38 activation occurred independently of PLD activation.	Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Daniel, LW (corresponding author), Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.				NCI NIH HHS [CA-72730, CA-12197] Funding Source: Medline; NIAID NIH HHS [AI-38949] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA072730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038949, P01AI138949] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABST JJ, 1980, J EXP MED, V151, P101; AGWU DE, 1989, J BIOL CHEM, V264, P1405; ARAI KI, 1988, ANNU REV BIOCHEM, V59, P783; BAULDRY SA, 1991, J BIOL CHEM, V266, P4173; BAULDRY SA, 1991, J IMMUNOL, V146, P1277; BLIGH DG, 1959, CAN J BIOCH PHYSL, V123, P64; BOURGOIN S, 1990, J EXP MED, V172, P767, DOI 10.1084/jem.172.3.767; BOURGOIN S, 1992, CELL SIGNAL, V4, P487; BUHL AM, 1994, P NATL ACAD SCI USA, V91, P9190, DOI 10.1073/pnas.91.19.9190; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; COLLINS SJ, 1987, BLOOD, V70, P1233; DARBY C, 1990, BLOOD, V75, P2396; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DOLNICK BJ, 1990, BIOCHEM PHARMACOL, V40, P671, DOI 10.1016/0006-2952(90)90300-A; Downey GP, 1996, J BIOL CHEM, V271, P21005, DOI 10.1074/jbc.271.35.21005; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Fensome A, 1998, J BIOL CHEM, V273, P13157, DOI 10.1074/jbc.273.21.13157; Foey AD, 1998, J IMMUNOL, V160, P920; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; GERARD C, 1994, CURR OPIN IMMUNOL, V6, P140, DOI 10.1016/0952-7915(94)90045-0; GOMEZCAMBRONERO J, 1991, ADV EXP MED BIOL, V314, P35; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HASLETT C, 1989, CURR OPIN IMMUNOL, V2, P10, DOI 10.1016/0952-7915(89)90091-5; Hayes TS, 1999, CELL SIGNAL, V11, P195, DOI 10.1016/S0898-6568(98)00066-7; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; Lee TG, 1997, BBA-LIPID LIPID MET, V1347, P199, DOI 10.1016/S0005-2760(97)00083-0; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Martin A, 1997, BIOCHEM SOC T, V25, P1157, DOI 10.1042/bst0251157; Muthalif MM, 2000, J PHARMACOL EXP THER, V293, P268; Nahas N, 1996, BIOCHEM J, V318, P247, DOI 10.1042/bj3180247; Nixon AB, 1999, J BIOL CHEM, V274, P5469, DOI 10.1074/jbc.274.9.5469; OFlaherty JT, 1996, J BIOL CHEM, V271, P17821, DOI 10.1074/jbc.271.30.17821; Ohguchi K, 1997, J BIOL CHEM, V272, P1990, DOI 10.1074/jbc.272.3.1990; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rane MJ, 1997, J IMMUNOL, V159, P5070; ROTHSTEIN JL, 1988, P NATL ACAD SCI USA, V85, P607, DOI 10.1073/pnas.85.2.607; Saqib KM, 1997, BIOCHEM SOC T, V25, pS586, DOI 10.1042/bst025s586; Schnyder B, 1998, BIOCHEM J, V331, P489, DOI 10.1042/bj3310489; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; STEIN CA, 1988, CANCER RES, V48, P2659; STRUM JC, 1993, BIOCHIM BIOPHYS ACTA, V1169, P25, DOI 10.1016/0005-2760(93)90077-M; TYAGI SR, 1989, FEBS LETT, V257, P188, DOI 10.1016/0014-5793(89)81817-4; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; WORTHEN GS, 1994, J CLIN INVEST, V94, P815, DOI 10.1172/JCI117401; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; ZON G, 1988, PHARM RES-DORDR, V5, P539, DOI 10.1023/A:1015985728434; Zu YL, 1998, J IMMUNOL, V160, P1982	59	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31752	31759		10.1074/jbc.M101265200	http://dx.doi.org/10.1074/jbc.M101265200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427526	hybrid			2022-12-27	WOS:000170613500039
J	Song, M; Helguera, G; Eghbali, M; Zhu, N; Zarei, MM; Olcese, R; Toro, L; Stefani, E				Song, M; Helguera, G; Eghbali, M; Zhu, N; Zarei, MM; Olcese, R; Toro, L; Stefani, E			Remodeling of Kv4.3 potassium channel gene expression under the control of sex hormones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT OUTWARD CURRENT; SMOOTH-MUSCLE CELLS; K+ CHANNEL; ALPHA-SUBUNIT; I-TO; MYOCARDIAL-INFARCTION; VENTRICULAR MUSCLE; RAT; CLONING; MYOMETRIUM	Kv4.3 channels are important molecular components of transient K+ currents (Ito currents) in brain and heart. They are involved in setting the frequency of neuronal firing and heart pacing. Altered Kv4.3 channel expression has been demonstrated under pathological conditions like heart failure indicating their critical role in heart function. Thyroid hormone studies suggest that their expression in the heart may be hormonally regulated. To explore the possibility that sex hormones control Kv4.3 expression, we investigated whether its expression changes in the pregnant uterus. This organ represents a unique model to study Ito currents, because it possesses this type of K+ current and undergoes dramatic changes in function and excitability during pregnancy. We cloned Kv4.3 channel from myometrium and found that its protein and transcript expression is greatly diminished during pregnancy. Experiments in ovariectomized rats demonstrate that estrogen is one mechanism responsible for the dramatic reduction in Kv4.3 expression and function prior to parturition. Furthermore, the reduction of plasma membrane Kv4.3 protein is accompanied by a perinuclear localization suggesting that cell trafficking is also controlled by sex hormones. Thus, estrogen remodels the expression of Kv4.3 in myometrium by directly diminishing its transcription and, indirectly, by altering Kv4.3 delivery to the plasma membrane.	Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stefani, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, BH-509A CHS,Box 957115, Los Angeles, CA 90095 USA.			Helguera, Gustavo/0000-0003-1509-3564	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054970] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54970] Funding Source: Medline; NIGMS NIH HHS [GM52203] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDROVA M, 1980, ENDOCRINOLOGY, V106, P730, DOI 10.1210/endo-106-3-730; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; ANWER K, 1993, AM J PHYSIOL, V265, pC976, DOI 10.1152/ajpcell.1993.265.4.C976; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; Brahmajothi MV, 1999, J GEN PHYSIOL, V113, P581, DOI 10.1085/jgp.113.4.581; Challis John R. G., 1994, P985; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; DIXON JE, 1994, CIRC RES, V75, P252, DOI 10.1161/01.RES.75.2.252; Eghbali M, 2001, BIOPHYS J, V80, p444A; GidhJain M, 1996, CIRC RES, V79, P669, DOI 10.1161/01.RES.79.4.669; GORDIENKO DV, 1994, AM J PHYSIOL, V266, pF325, DOI 10.1152/ajprenal.1994.266.2.F325; Grammer JB, 2000, J CARDIOVASC ELECTR, V11, P626, DOI 10.1111/j.1540-8167.2000.tb00024.x; Hoppe UC, 2000, J CLIN INVEST, V105, P1077, DOI 10.1172/JCI8757; Isbrandt D, 2000, GENOMICS, V64, P144, DOI 10.1006/geno.2000.6117; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Koh SD, 1999, J PHYSIOL-LONDON, V515, P475, DOI 10.1111/j.1469-7793.1999.475ac.x; LAPOLT PS, 1986, BIOL REPROD, V35, P1131, DOI 10.1095/biolreprod35.5.1131; Martina M, 1998, J NEUROSCI, V18, P8111; Ohya S, 1997, FEBS LETT, V420, P47, DOI 10.1016/S0014-5793(97)01483-X; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; RENTERIA EP, 1991, AM J PHYSIOL, V261, pC278; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Sanguinetti MC, 1997, MOL PHARMACOL, V51, P491; Satoh H, 1996, GEN PHARMACOL, V27, P455, DOI 10.1016/0306-3623(95)02067-5; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; Shih TM, 1998, METHOD ENZYMOL, V293, P529; Song M, 1999, FEBS LETT, V460, P427, DOI 10.1016/S0014-5793(99)01394-0; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; Tsaur ML, 1997, FEBS LETT, V400, P215, DOI 10.1016/S0014-5793(96)01388-9; Wang SY, 1998, J GEN PHYSIOL, V112, P737, DOI 10.1085/jgp.112.6.737; Wang ZG, 1999, CIRC RES, V84, P551, DOI 10.1161/01.RES.84.5.551; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Wickenden AD, 2000, AM J PHYSIOL-HEART C, V278, pH1105, DOI 10.1152/ajpheart.2000.278.4.H1105; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; YUAN XJ, 1995, AM J PHYSIOL-CELL PH, V268, pC259, DOI 10.1152/ajpcell.1995.268.1.C259	36	103	108	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31883	31890		10.1074/jbc.M101058200	http://dx.doi.org/10.1074/jbc.M101058200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427525	hybrid			2022-12-27	WOS:000170613500058
J	Migita, K; Haines, WR; Voigt, MM; Egan, TM				Migita, K; Haines, WR; Voigt, MM; Egan, TM			Polar residues of the second transmembrane domain influence cation permeability of the ATP-gated P2X(2) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION CHANNELS; ACETYLCHOLINE-RECEPTOR; STRUCTURAL MOTIF; SELECTIVITY; MICE; PROTEIN; PAIN; PORE	P2X receptors are simple polypeptide channels that mediate fast purinergic depolarizations in both nerve and muscle. Although the depolarization results mainly from the influx of Na+, these channels also conduct a significant Ca2+ current that is large enough to evoke transmitter release from presynaptic neurons. We sought to determine the molecular basis of this Ca2+ conductance by a mutational analysis of recombinant P2X(2) receptors. Wild type and 31 mutant P2X(2) receptors were expressed in HEK-293 cells and studied under voltage-clamp. We found that the relative Ca2+ permeability measured from the reversal potentials of ATP-gated currents was unaffected by neutralizing fixed charge (Asp(315), Asp(349)) near the mouths of the channel pore. By contrast, mutations that changed the character or side chain volume of three polar residues (Thr(336), Thr(339), Ser(340)) within the pore led to significant changes in P-Ca/P-Cs. The largest changes occurred when Thr339 and Ser340 were replaced with tyrosine; these mutations almost completely abolished Ca2+ permeability, reduced P-Li/P-Cs by about one-half, and shifted the relative permeability sequence of Cs+, Rb+, K+, and Na+ to their relative mobility in water. Our results suggest that the permeability sequence of the P2X(2) receptor arises in part from interactions of permeating cations with the polar side chains of three amino acids located in a short stretch of the second transmembrane domain.	St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	Saint Louis University	Egan, TM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.		Migita, Keisuke/E-8274-2013	Egan, Terrance/0000-0002-7249-3161	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035534] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56236] Funding Source: Medline; NINDS NIH HHS [NS35534] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIDLEY DJ, 1996, ION CHANNELS MOL MOT; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Egan TM, 1998, J NEUROSCI, V18, P2350; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; HAINES WR, 2001, IN PRESS J NEUROSCI; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 1992, IONIC CHANNELS EXCIT; HORN R, 1992, METHOD ENZYMOL, V207, P149; IMOTO K, 1993, FEBS LETT, V325, P100, DOI 10.1016/0014-5793(93)81422-V; IMOTO K, 1993, ANN NY ACAD SCI, V707, P38, DOI 10.1111/j.1749-6632.1993.tb38040.x; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kim M, 1997, BIOCHEM BIOPH RES CO, V240, P618, DOI 10.1006/bbrc.1997.7713; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Moore DD, 1995, GLOB MOB SURV; MULLINS LJ, 1961, ANN NY ACAD SCI, V94, P390, DOI 10.1111/j.1749-6632.1961.tb35553.x; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; Nakazawa K, 1998, EUR J PHARMACOL, V347, P141, DOI 10.1016/S0014-2999(98)00207-6; Nakazawa K, 1998, BIOCHEM BIOPH RES CO, V244, P599, DOI 10.1006/bbrc.1998.8312; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Torres GE, 1998, FEBS LETT, V425, P19, DOI 10.1016/S0014-5793(98)00179-3; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Virginio C, 1998, J PHYSIOL-LONDON, V510, P27, DOI 10.1111/j.1469-7793.1998.027bz.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225	35	78	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30934	30941		10.1074/jbc.M103366200	http://dx.doi.org/10.1074/jbc.M103366200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402044	hybrid			2022-12-27	WOS:000170472900047
J	Toshima, J; Toshima, JY; Takeuchi, K; Mori, R; Mizuno, K				Toshima, J; Toshima, JY; Takeuchi, K; Mori, R; Mizuno, K			Cofilin phosphorylation and actin reorganization activities of testicular protein kinase 2 and its predominant expression in testicular Sertoli cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TESTIS-SPECIFIC PROTEIN-KINASE-1; LIM-KINASE; CYTOSKELETAL DYNAMICS; ACTIVATION LOOP; ALPHA-PAK; IDENTIFICATION; RHO; FAMILY; TESK1; LIM-KINASE-1	We previously identified testicular protein kinase 1 (TESK1), which phosphorylates cofilin and induces actin cytoskeletal reorganization. We now report identification and characterization of another member of a TESK family, testicular protein kinase 2 (TESK2), with 48% amino acid identity with TESK1. Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions. Both TESK1 and TESK2 are highly expressed in the testis, but in contrast to TESK1, which is predominantly expressed in testicular germ cells, TESK2 is expressed predominantly in nongerminal Sertoli cells. Thus, TESK1 and TESK2 seem to play distinct roles in spermatogenesis. In HeLa cells, TESK1 was localized mainly in the cytoplasm, whereas TESK2 was localized mainly in the nucleus, which means that TESK1 and TESK2 likely have distinct cellular functions. Because the kinase-inactive mutant of TESK2 was localized in the cytoplasm, nuclear/cytoplasmic localization of TESK2 depends on its kinase activity. A TESK2 mutant lacking the C-terminal noncatalytic region had about a 10-fold higher kinase activity in vitro and, when expressed in HeLa cells, induced punctate actin aggregates in the cytoplasm and unusual condensation and fragmentation of nuclei, followed by apoptosis. Thus, we propose that the C-terminal region plays important roles in regulating the kinase activity and cellular functions of TESK2.	Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Mizuno, Kensaku/G-8631-2015; 純子, 十島 Y/GRS-7321-2022					AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; BAMBURG JR, 1999, ANNU REV CELL DEV BI, V14, P305; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Koji T, 1996, J ELECTRON MICROSC, V45, P119, DOI 10.1093/oxfordjournals.jmicro.a023420; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MIZUNO K, 1994, ONCOGENE, V9, P1605; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NUNOUE K, 1995, ONCOGENE, V11, P701; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Rosok O, 1999, GENOMICS, V61, P44, DOI 10.1006/geno.1999.5922; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Toshima J, 1998, BIOCHEM BIOPH RES CO, V249, P107, DOI 10.1006/bbrc.1998.9099; Toshima J, 1995, J BIOL CHEM, V270, P31331, DOI 10.1074/jbc.270.52.31331; Toshima J, 1998, GENE, V206, P237, DOI 10.1016/S0378-1119(97)00591-X; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZHENGWEI Y, 1990, BIOL REPROD, V43, P629, DOI 10.1095/biolreprod43.4.629	34	109	120	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31449	31458		10.1074/jbc.M102988200	http://dx.doi.org/10.1074/jbc.M102988200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418599	hybrid			2022-12-27	WOS:000170472900111
J	Vaisman, A; Tissier, A; Frank, EG; Goodman, MF; Woodgate, R				Vaisman, A; Tissier, A; Frank, EG; Goodman, MF; Woodgate, R			Human DNA polymerase iota promiscuous mismatch extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XERODERMA-PIGMENTOSUM; GENE ENCODES; THYMINE DIMER; FIDELITY; BYPASS; REPLICATION; ETA; MUTAGENESIS; PROTEIN; MISINSERTION	Human DNA polymerase iota is a low-fidelity template copier that preferentially catalyzes the incorporation of the wobble base G, rather than the Watson-Crick base A, opposite template T (Tissier, A., McDonald, CF. P., Frank, E. G., and Woodgate, R. (2000) Genes Dev. 14, 1642-1650; Johnson, R. E., Washington, M. T., Haracska, L., Prakash, S., and Prakash, L. (2000) Nature 406, 10151019; Zhang, Y., Yuan, F., Wu, X., and Wang, Z. (2000) Mol. Cell. Biol. 20,7099-7108). Here, we report on its ability to extend all 12 possible mispairs and 4 correct pairs in different sequence contexts. Extension from both matched and mismatched primer termini is generally most efficient and accurate when A is the next template base. In contrast, extension occurs less efficiently and accurately when T is the target template base. A striking exception occurs during extension of a G:T mispair, where the enzyme switches specificity, "preferring" to make a correct A.T base pair immediately downstream from an originally favored G:T mispair. Polymerase L generates a variety of single and tandem mispairs with high frequency, implying that it may act as a strong mutator when copying undamaged DNA templates in vivo. Even so, its limited ability to catalyze extension from a relatively stable primer/template containing a "buried" mismatch suggests that polymerase iota -catalyzed errors are confined to short template regions.	NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA; Univ So Calif, Dept Sci Biol, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Southern California; University of Southern California	Woodgate, R (corresponding author), NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bldg 6,Rm 1A13,9000 Rockville Pike, Bethesda, MD 20892 USA.	woodgate@helix.nih.gov	Tissier, Agnes/I-4850-2018; Vaisman, Alexandra/C-3766-2013	Vaisman, Alexandra/0000-0002-2521-1467; TISSIER, Agnes/0000-0002-5676-8719; Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM021422] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM21422, GM2554] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Burgers PMJ, 1998, CHROMOSOMA, V107, P218, DOI 10.1007/s004120050300; Creighton S, 1995, METHOD ENZYMOL, V262, P232; CREIGHTON S, 1995, J BIOL CHEM, V270, P4759, DOI 10.1074/jbc.270.9.4759; Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Frank EG, 2001, EMBO J, V20, P2914, DOI 10.1093/emboj/20.11.2914; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; Gerlach VL, 2001, J BIOL CHEM, V276, P92, DOI 10.1074/jbc.M004413200; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lawrence CW, 2000, COLD SPRING HARB SYM, V65, P61, DOI 10.1101/sqb.2000.65.61; Maor-Shoshani A, 2000, P NATL ACAD SCI USA, V97, P565, DOI 10.1073/pnas.97.2.565; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; McDonald JP, 2001, PHILOS T R SOC B, V356, P53, DOI 10.1098/rstb.2000.0748; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ohashi E, 2000, GENE DEV, V14, P1589; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pham P, 2001, NATURE, V409, P366, DOI 10.1038/35053116; Poltoratsky V, 2000, J EXP MED, V192, pF27, DOI 10.1084/jem.192.10.F27; Reuven NB, 2001, J BIOL CHEM, V276, P5511, DOI 10.1074/jbc.M006828200; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Sharief FS, 1999, GENOMICS, V59, P90, DOI 10.1006/geno.1999.5843; Spencer J, 1999, J IMMUNOL, V162, P6596; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Tissier A, 2000, GENE DEV, V14, P1642; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; Tissier A, 2001, BIOCHEM SOC T, V29, P183, DOI 10.1042/0300-5127:0290183; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Washington MT, 2001, J BIOL CHEM, V276, P2263, DOI 10.1074/jbc.M009049200; Winter DB, 1998, IMMUNOL REV, V162, P89, DOI 10.1111/j.1600-065X.1998.tb01432.x; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000; Zhang YB, 2001, NUCLEIC ACIDS RES, V29, P928, DOI 10.1093/nar/29.4.928	47	49	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30615	30622		10.1074/jbc.M102694200	http://dx.doi.org/10.1074/jbc.M102694200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402031	hybrid			2022-12-27	WOS:000170472900006
J	Kozak, KR; Prusakiewicz, JJ; Rowlinson, SW; Schneider, C; Marnett, LJ				Kozak, KR; Prusakiewicz, JJ; Rowlinson, SW; Schneider, C; Marnett, LJ			Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN G/H SYNTHASE-2; ENDOPEROXIDE-H SYNTHASE-1; ACTIVE-SITE; ARACHIDONIC-ACID; SELECTIVE-INHIBITION; CRYSTAL-STRUCTURE; BINDING-SITE; H-2 SYNTHASE; ASPIRIN	The endocannabinoid, 2-arachiclonylglycerol (2-AG), is an endogenous ligand for the central (CBI) and peripheral (CB2) cannabinoid receptors and has been shown to be efficiently and selectively oxygenated by cyclooxygenase (COX)-2. We have investigated 2-AG/COX-2 interactions through site-directed mutagenesis. An evaluation of more than 20 site-directed mutants of murine COX-2 has allowed for the development of a model of 2-AG binding within the COX-2 active site. Most strikingly, these studies have identified Arg-513 as a critical determinant in the ability of COX-2 to efficiently generate prostaglandin Hz glycerol ester, explaining, in part, the observed isoform selectivity for this substrate. Mutational analysis of Leu-531, an amino acid located directly across from Arg-513 in the COX-2 active site, suggests that 2-AG is shifted in the active site away from this hydrophobic residue and toward Arg-513 relative to arachidonic acid. Despite this difference, aspirin-treated COX-2 oxygenates 2-AG to afford 15-hydroxyeicosatetraenoic acid glycerol ester in a reaction analogous to the C-15 oxygenation of arachidonic acid observed with acetylated COX-2. Finally, the differences in substrate binding do not alter the stereospecificity of the cyclooxygenase reaction; 2-AG-derived and arachidonic acid-derived products share identical stereochemistry.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Chem, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.				NATIONAL CANCER INSTITUTE [R01CA089450, P01CA068484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NCI NIH HHS [CA68484, CA89450] Funding Source: Medline; NIEHS NIH HHS [ES00267] Funding Source: Medline; NIGMS NIH HHS [GM07347] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALAPURE AK, 1989, BIOCHEM PHARMACOL, V38, P2875; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; EVETT GE, 1993, ARCH BIOCHEM BIOPHYS, V306, P169, DOI 10.1006/abbi.1993.1496; Gierse JK, 1996, J BIOL CHEM, V271, P15810, DOI 10.1074/jbc.271.26.15810; Greig GM, 1997, MOL PHARMACOL, V52, P829, DOI 10.1124/mol.52.5.829; Guo QP, 1996, J BIOL CHEM, V271, P19134, DOI 10.1074/jbc.271.32.19134; HAMBERG M, 1973, P NATL ACAD SCI USA, V70, P899, DOI 10.1073/pnas.70.3.899; HANASAKI K, 1990, J BIOL CHEM, V265, P4871; HERSCHMAN HR, 1995, BIOESSAYS, V17, P1031, DOI 10.1002/bies.950171207; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; KALGUTKAR AS, 1994, BIOCHEMISTRY-US, V33, P8625, DOI 10.1021/bi00195a002; KENNEDY BP, 1993, BIOCHEM BIOPH RES CO, V197, P494, DOI 10.1006/bbrc.1993.2506; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Loll PJ, 1996, BIOCHEMISTRY-US, V35, P7330, DOI 10.1021/bi952776w; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Mancini JA, 1997, MOL PHARMACOL, V51, P52, DOI 10.1124/mol.51.1.52; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; MEADE EA, 1993, J BIOL CHEM, V268, P6610; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Rowlinson SW, 2000, J BIOL CHEM, V275, P6586, DOI 10.1074/jbc.275.9.6586; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; Serhan CN, 1999, ADV EXP MED BIOL, V469, P287; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Xiao GS, 1997, BIOCHEMISTRY-US, V36, P1836, DOI 10.1021/bi962476u; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Zhang VV, 1996, BIOCHEM BIOPH RES CO, V227, P499, DOI 10.1006/bbrc.1996.1536	39	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30072	30077		10.1074/jbc.M104467200	http://dx.doi.org/10.1074/jbc.M104467200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402053	hybrid			2022-12-27	WOS:000170558000063
J	Montagnani, M; Chen, H; Barr, VA; Quon, MJ				Montagnani, M; Chen, H; Barr, VA; Quon, MJ			Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; RAT ADIPOSE-CELLS; ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-B; LYSOPHOSPHATIDIC ACID; MICE LACKING; CA2+-INDEPENDENT ACTIVATION; THYMIDINE INCORPORATION; RECEPTOR SUBSTRATE-1; TRANSLOCATION	Vasodilator actions of insulin are mediated by activation of endothelial nitric-oxide synthase (eNOS) and subsequent production of NO. Phosphatidylinositol 3-kinase and Akt play important roles in insulin-signaling pathways leading to production of NO in vascular endothelium. Here we dissected mechanisms whereby insulin activates eNOS by using the fluorescent dye DAF-2 to directly measure NO production in single cells. Insulin caused a rapid increase in intracellular NO in NIH-3T3(IR) cells transiently transfected with eNOS.. The stimulation of NO production by lysophosphatidic, acid (LPA) was abrogated by pretreatment of cells with the calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid. Remarkably, in the same cells, insulin-stimulated production of NO was unaffected. However, cells expressing the eNOS-S1179A mutant (disrupted Akt phosphorylation site) did not produce detectable NO in response to insulin, whereas the response to LPA was Similar to that observed in cells expressing wild-type eNOS. Moreover, production of NO in response to insulin was blocked by coexpression. of an inhibitory mutant of Akt, whereas the response to LPA was unaffected. Phosphorylation of eNOS at Ser(1179) was observed only in response to treatment with insulin, but not with LPA. Interestingly, platelet-derived growth factor treatment of cells activated Akt but not eNOS. Results from human vascular endothelial cells were qualitatively similar to those obtained in transfected NIH-3T3(IR) cells, although the magnitude of the responses was smaller. We conclude that insulin regulates eNOS activity using a Ca2+-independent mechanism requiring phosphorylation. of eNOS by Akt. Importantly, phosphorylation-dependent mechanisms that enhance eNOS activity can operate independently from Ca2+-dependent mechanisms.	NHLBI, Cardiol Branch, NIH, Bethesda, MD 20892 USA; NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Quon, MJ (corresponding author), NHLBI, Cardiol Branch, NIH, Bldg 10,Rm 8C-218,10 Ctr Dr,MSC 1755, Bethesda, MD 20892 USA.		Quon, Michael/B-1970-2008; Montagnani, Monica/AAV-2057-2020	Montagnani, Monica/0000-0002-5697-8185; Quon, Michael/0000-0002-9601-9915; QUON, MICHAEL/0000-0002-5289-3707	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [Z01AT000001, Z02AT000001, ZIAAT000001] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [ZIFAT000001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL003607] Funding Source: NIH RePORTER	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe H, 1998, J CLIN INVEST, V101, P1784, DOI 10.1172/JCI1594; Ahmad F, 2000, J IMMUNOL, V164, P4678, DOI 10.4049/jimmunol.164.9.4678; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Bernier SG, 2000, J BIOL CHEM, V275, P30707, DOI 10.1074/jbc.M005116200; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; CaulinGlaser T, 1997, CIRC RES, V81, P885; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Fleming I, 1999, P NATL ACAD SCI USA, V96, P1123, DOI 10.1073/pnas.96.3.1123; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Igarashi J, 1999, P NATL ACAD SCI USA, V96, P12583, DOI 10.1073/pnas.96.22.12583; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; JALINK K, 1990, J BIOL CHEM, V265, P12232; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mombouli JV, 1999, J MOL CELL CARDIOL, V31, P61, DOI 10.1006/jmcc.1998.0844; Montagnani M, 2000, DIABETES OBES METAB, V2, P285, DOI 10.1046/j.1463-1326.2000.00092.x; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Nystrom FH, 1999, CELL SIGNAL, V11, P563, DOI 10.1016/S0898-6568(99)00025-X; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Quon MJ, 1996, BIOCHEM BIOPH RES CO, V226, P587, DOI 10.1006/bbrc.1996.1400; QUON MJ, 1995, MOL CELL BIOL, V15, P5403; QUON MJ, 1992, BIOCHEMISTRY-US, V31, P9947, DOI 10.1021/bi00156a013; SCHERRER U, 1994, J CLIN INVEST, V94, P2511, DOI 10.1172/JCI117621; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; TSUKAHARA H, 1994, KIDNEY INT, V45, P598, DOI 10.1038/ki.1994.78; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	50	427	447	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30392	30398		10.1074/jbc.M103702200	http://dx.doi.org/10.1074/jbc.M103702200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402048	hybrid			2022-12-27	WOS:000170558000103
J	Sartori, AA; Schar, P; Fitz-Gibbon, S; Miller, JH; Jiricny, J				Sartori, AA; Schar, P; Fitz-Gibbon, S; Miller, JH; Jiricny, J			Biochemical characterization of uracil processing activities in the hyperthermophilic archaeon Pyrobaculum aerophilum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE DNA GLYCOSYLASE; BASE-EXCISION-REPAIR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DEAMINATION; IDENTIFICATION; RECOGNITION; EXPRESSION; INHIBITOR; RESIDUES	Deamination of cytosine to uracil and 5-methyleytosine to thymine represents a major mutagenic threat particularly at high temperatures. In double-stranded DNA, these spontaneous hydrolytic reactions give rise to G-U and G-T mispairs, respectively, that must be restored to G-C pairs prior to the next round of DNA replication; if left unrepaired, 50% of progeny DNA would acquire G.C --> A.T transition mutations. The genome of the hyperthermophilic archaeon Pyrobaculum aerophilum has been recently shown to encode a protein, Pa-MIG, a member of the endonuclease III family, capable of processing both G-U and G-T mispairs. We now show that this latter activity is undetectable in crude extracts of P. aerophilum. However, uracil residues in G-U mispairs, in A-U pairs, and in single-stranded DNA were efficiently removed in these extracts. These activities were assigned to a similar to 22-kDa polypeptide named Pa-UDG (P. aerophilum uracil-DNA glycosylase). The recombinant Pa-UDG protein is highly thermostable and displays a considerable degree of homology to the recently described uracil-DNA glycosylases from Archaeoglobus fulgidus and Thermotoga maritima. Interestingly, neither Pa-MIG nor Pa-UDG was inhibited by UGI, a generic inhibitor of the UNG family of uracil glycosylases. Yet a small fraction of the total uracil processing activity present in crude extracts of P. aerophilum was inhibited by this peptide. This implies that the hyperthermophilic archaeon possesses at least a three-pronged defense against the mutagenic threat of hydrolytic deamination of cytosines in its genomic DNA.	Univ Zurich, Inst Med Radiobiol, CH-8008 Zurich, Switzerland; Paul Scherrer Inst, CH-8008 Zurich, Switzerland; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jiricny, J (corresponding author), Univ Zurich, Inst Med Radiobiol, August Forel Str 7, CH-8008 Zurich, Switzerland.	jiricny@imr.unizh.ch	Sartori, Alessandro/AAK-7840-2021; Schär, Primo/G-5967-2012	Sartori, Alessandro/0000-0003-2770-0333; Schär, Primo/0000-0003-1843-6147				Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Aravind L, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-4-RESEARCH0007; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dennis PP, 1997, CELL, V89, P1007, DOI 10.1016/S0092-8674(00)80288-3; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DODSON ML, 1994, J BIOL CHEM, V269, P32709; FitzGibbon S, 1997, EXTREMOPHILES, V1, P36, DOI 10.1007/s007920050013; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Horst JP, 1996, EMBO J, V15, P5459, DOI 10.1002/j.1460-2075.1996.tb00929.x; HUDEPOHL U, 1990, P NATL ACAD SCI USA, V87, P5851, DOI 10.1073/pnas.87.15.5851; Jacobs KL, 1997, J BACTERIOL, V179, P3298, DOI 10.1128/jb.179.10.3298-3303.1997; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Koulis A, 1996, FEMS MICROBIOL LETT, V143, P267; Krokan HE, 1997, BIOCHEM J, V325, P1; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; NEDDERMANN P, 1994, P NATL ACAD SCI USA, V91, P1642, DOI 10.1073/pnas.91.5.1642; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Sandigursky M, 1999, CURR BIOL, V9, P531, DOI 10.1016/S0960-9822(99)80237-1; Sandigursky M, 2000, J BIOL CHEM, V275, P19146, DOI 10.1074/jbc.M001995200; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; VOLKL P, 1993, APPL ENVIRON MICROB, V59, P2918; WANG Z, 1989, J BIOL CHEM, V264, P1163; WANG ZG, 1991, GENE, V99, P31; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; Yang HJ, 2000, J BACTERIOL, V182, P1272, DOI 10.1128/JB.182.5.1272-1279.2000	36	50	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29979	29986		10.1074/jbc.M102985200	http://dx.doi.org/10.1074/jbc.M102985200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11399761	hybrid, Green Accepted			2022-12-27	WOS:000170558000050
J	Scrittori, L; Hans, F; Angelov, D; Charra, M; Prigent, C; Dimitrov, S				Scrittori, L; Hans, F; Angelov, D; Charra, M; Prigent, C; Dimitrov, S			pEg2 aurora-A kinase, histone H3 phosphorylation, and chromosome assembly in Xenopus egg extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY GENE INDUCTION; CELL-CYCLE; ASPERGILLUS-NIDULANS; CHROMATIN DISRUPTION; LINKER HISTONES; CONDENSATION; H1; MITOSIS; SPINDLE; PROTEIN	In eukaryotes cell division is accompanied by phosphorylation of histone H3 at serine 10. In this work we have studied the kinase activity responsible for this histone H3 modification by using cell-free extracts prepared from Xenopus eggs. We have found that the Xenopus aurora-A kinase pEg2, immunoprecipitated from the extract, is able to phosphorylate specifically histone H3 at serine 10. The enzyme is incorporated into chromatin during in vitro chromosome assembly, and the, kinetics of this incorporation parallels that of histone H3 phosphorylation. Recombinant pEg2 phosphorylates efficiently histone H3 at serine 10 in reconstituted nucleosomes and in sperm nuclei decondensed in heated extracts. These data identify pEg2 as a good candidate for mitotic histone H3 kinase. However, immunodepletion of pEg2 does not interfere with the chromosome assembly properties of the extract nor with the pattern of H3 phosphorylation, suggesting the existence of multiple kinases involved in this H3 modification in Xenopus eggs. This hypothesis is supported by in gel activity assay experiments using extracts from Saccharomyces cerevisiae.	Inst Albert Bonniot, INSERM U309, Lab Biol Mol & Cellulaire Differenciat, F-38706 La Tronche, France; Univ Rennes 1, Fac Med, CNRS UPR41, Grp Cycle Cellulaire, F-35043 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Dimitrov, S (corresponding author), Inst Albert Bonniot, INSERM U309, Lab Biol Mol & Cellulaire Differenciat, Domaine Merci, F-38706 La Tronche, France.		Angelov, Dimitar/K-2004-2017; dimitrov, stefan/M-7697-2013	Angelov, Dimitar/0000-0002-5511-6647; dimitrov, stefan/0000-0002-1326-3630				Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; ALLIS CD, 1981, BIOCHEMISTRY-US, V20, P3828, DOI 10.1021/bi00516a025; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; BRADBURY EM, 1973, EUR J BIOCHEM, V33, P131, DOI 10.1111/j.1432-1033.1973.tb02664.x; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; CHAN CSM, 1993, GENETICS, V135, P677; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; DASSO M, 1994, P NATL ACAD SCI USA, V91, P12477, DOI 10.1073/pnas.91.26.12477; de la Barre AE, 1999, METH MOL B, V119, P219; de la Barre AE, 2000, EMBO J, V19, P379, DOI 10.1093/emboj/19.3.379; De Souza CPC, 2000, CELL, V102, P293, DOI 10.1016/S0092-8674(00)00035-0; DIMITROV S, 1994, J CELL BIOL, V126, P591, DOI 10.1083/jcb.126.3.591; Dimitrov S, 1996, EMBO J, V15, P5897, DOI 10.1002/j.1460-2075.1996.tb00976.x; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Giet R, 1999, J CELL SCI, V112, P3591; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; GUO XW, 1995, EMBO J, V14, P976, DOI 10.1002/j.1460-2075.1995.tb07078.x; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; HUNTER T, 1997, TRENDS BIOCHEM SCI, V22, P11; Kaszas E, 2000, J CELL SCI, V113, P3217; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; MIRZABEKOV AD, 1990, J MOL BIOL, V211, P479, DOI 10.1016/0022-2836(90)90366-T; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; OHSUMI K, 1993, SCIENCE, V262, P2033, DOI 10.1126/science.8266099; PERRY M, 1982, J BIOL CHEM, V257, P7336; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; Ramon A, 2000, MOL MICROBIOL, V35, P223, DOI 10.1046/j.1365-2958.2000.01702.x; Rhee K, 1997, DEVELOPMENT, V124, P2167; Roghi C, 1998, J CELL SCI, V111, P557; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Van Hooser A, 1998, J CELL SCI, V111, P3497; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711	52	52	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30002	30010		10.1074/jbc.M102701200	http://dx.doi.org/10.1074/jbc.M102701200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402032	hybrid			2022-12-27	WOS:000170558000053
J	Weisiger, RA; Ostrow, JD; Koehler, RK; Webster, CC; Mukerjee, P; Pascolo, L; Tiribelli, C				Weisiger, RA; Ostrow, JD; Koehler, RK; Webster, CC; Mukerjee, P; Pascolo, L; Tiribelli, C			Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition - Results of a novel ultrafiltration method	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-BINDING; UNCONJUGATED BILIRUBIN; ALPHA-FETOPROTEIN; PROTEIN; LIVER; CONFORMATION; CONSTANTS; PARTITION; TRANSPORT; PALMITATE	Albumin binding is a crucial determinant of bilirubin clearance in health and bilirubin toxicity in certain disease states. However, prior attempts to measure the affinity of albumin for bilirubin have yielded highly variable results, reflecting both differing conditions and the confounding influence of impurities. We therefore have devised a method based on serial ultrafiltration that successively removes impurities in [C-14]bilirubin until a stable binding affinity is achieved, and then we used it to assess the effect of albumin concentration and buffer composition on binding. The apparent binding affinity of human serum albumin for [C-14]bilirubin was strongly dependent on assay conditions, falling from (5.09 +/- 0.24) X 10(7) liters/mol at lower albumin concentrations (15 muM) to (0.54 +/- 0.05) X 10(7) liters/mol at higher albumin concentrations (300 mum). To determine whether radioactive impurities were responsible for this change, we estimated impurities in the stock bilirubin using a novel modeling approach and found them to be 0.11-0.13%. Formation of new impurities during the study and their affinity for albumin were also estimated. After correction for impurities, the binding affinity remained heavily dependent on the albumin concentration (range (5.37 +/- 0.26) X 10(7) liters/mol to (0.65 +/- 0.03) X 10(7) liters/ mol). Affinities decreased by about half in the presence of chloride (50 mm). Thus, the affinity of human albumin for bilirubin is not constant, but varies with both albumin concentration and buffer composition. Binding may be considerably less avid at physiological albumin concentrations than previously believed.	Univ Calif San Francisco, Med Ctr, Ctr Liver, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; Vet Affairs Lakeside Med Ctr, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; Univ Trieste, Dipartimento Biochim Biofis Chim Macromol, Ctr Studi Fegato, I-34127 Trieste, Italy	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Amsterdam; Academic Medical Center Amsterdam; University of Wisconsin System; University of Wisconsin Madison; University of Trieste	Weisiger, RA (corresponding author), Univ Calif San Francisco, Med Ctr, Ctr Liver, 513 Parnassus Ave,S-357,Box 0538, San Francisco, CA 94143 USA.		Pascolo, Lorella/AAB-5207-2020; mukerjee, pasupati/A-7163-2012; Tiribelli, Claudio/A-4716-2014	Pascolo, Lorella/0000-0003-1044-7263; Tiribelli, Claudio/0000-0001-6596-7595	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032898] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-32898] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLFORS CE, 1986, J PEDIATR-US, V108, P295, DOI 10.1016/S0022-3476(86)81008-3; Ahlfors CE, 2000, ANAL BIOCHEM, V279, P130, DOI 10.1006/abio.2000.4485; AHLFORS GE, 1981, CLIN CHEM, V27, P692; BLANCKAERT N, 1986, BILE PIGMENTS JAUNDI, P31; BOOBIS SW, 1979, BIOCHEM PHARMACOL, V28, P751, DOI 10.1016/0006-2952(79)90354-X; BOWMER CJ, 1978, BIOCHEM PHARMACOL, V27, P937, DOI 10.1016/0006-2952(78)90421-5; BRODERSEN R, 1979, Critical Reviews in Clinical Laboratory Sciences, V11, P305; Brodersen R, 1982, BILIRUBIN, P75; BRUNKHORST WK, 1965, ARCH BIOCHEM BIOPHYS, V111, P54, DOI 10.1016/0003-9861(65)90321-8; BURCZYNSKI FJ, 1993, AM J PHYSIOL, V265, pG555, DOI 10.1152/ajpgi.1993.265.3.G555; CAMERON IL, 1990, BIOCHEM CELL BIOL, V68, P894, DOI 10.1139/o90-132; CLEGG LS, 1984, J PHARM PHARMACOL, V36, P776, DOI 10.1111/j.2042-7158.1984.tb04873.x; COSTANTINO HR, 1995, BIO-TECHNOL, V13, P493, DOI 10.1038/nbt0595-493; DWYER JD, 1993, BIOPHYS J, V65, P1810, DOI 10.1016/S0006-3495(93)81235-9; EBBESEN F, 1983, ACTA PAEDIATR SCAND, V72, P665, DOI 10.1111/j.1651-2227.1983.tb09791.x; FENERTY CA, 1989, J NEUROCHEM, V53, P416, DOI 10.1111/j.1471-4159.1989.tb07350.x; Gourley G R, 1997, Adv Pediatr, V44, P173; JORI G, 1988, INT J PEPT PROT RES, V31, P17; KNOBLOCH E, 1991, J CHROMATOGR-BIOMED, V566, P89, DOI 10.1016/0378-4347(91)80113-Q; KOREN R, 1982, BIOCHIM BIOPHYS ACTA, V703, P42, DOI 10.1016/0167-4838(82)90008-5; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; LAMOLA AA, 1983, EUR J BIOCHEM, V132, P165, DOI 10.1111/j.1432-1033.1983.tb07342.x; Luxon BA, 2000, BBA-MOL CELL BIOL L, V1487, P309, DOI 10.1016/S1388-1981(00)00104-9; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; MCDONAGH AF, 1980, SCIENCE, V208, P145, DOI 10.1126/science.7361112; MICHAELSSON M, 1961, SCAND J CLIN INVEST, V13, P1; MIZEJEWSKI GJ, 1982, CLIN CHEM, V28, P1207; MUELLER UW, 1981, BIOCHEM PHARMACOL, V30, P727, DOI 10.1016/0006-2952(81)90158-1; Nozaki S, 1999, MOL CELL BIOCHEM, V192, P129, DOI 10.1023/A:1006816702425; OSTROW JD, 1994, J LIPID RES, V35, P1715; OSTROW JD, 1961, J CLIN INVEST, V40, P1442, DOI 10.1172/JCI104375; OSTROW JD, 1970, GASTROENTEROLOGY, V58, P15; OSTROW JD, 1972, SEMIN HEMATOL, V9, P113; OSTROW JD, 1963, J CLIN INVEST, V42, P1286, DOI 10.1172/JCI104813; Pascolo L, 1996, BIOCHEM J, V316, P999, DOI 10.1042/bj3160999; PEDERSEN JB, 1990, BIOCHEM PHARMACOL, V39, P1138, DOI 10.1016/0006-2952(90)90296-W; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; POND SM, 1994, AM J PHYSIOL-GASTR L, V267, pG656, DOI 10.1152/ajpgi.1994.267.4.G656; RAY A, 1966, BIOCHEMISTRY-US, V5, P2606, DOI 10.1021/bi00872a019; REED RG, 1977, J BIOL CHEM, V252, P7483; SCATCHARD G, 1946, J AM CHEM SOC, V68, P2610, DOI 10.1021/ja01216a055; SHEN D, 1974, J PHARM SCI-US, V63, P1698, DOI 10.1002/jps.2600631106; SIMPSON RB, 1974, J LIPID RES, V15, P415; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPECTOR AA, 1971, BIOCHEMISTRY-US, V10, P3229; THOMPSON JM, 1973, BRIT J PHARMACOL, V47, P133, DOI 10.1111/j.1476-5381.1973.tb08166.x; TIRIBELLI C, 1990, BIOCHIM BIOPHYS ACTA, V1031, P261, DOI 10.1016/0304-4157(90)90012-2; VERSEE V, 1979, BIOCHEM J, V179, P705, DOI 10.1042/bj1790705; Weisiger Richard A., 1993, P171; Wennberg RP, 2000, CELL MOL NEUROBIOL, V20, P97, DOI 10.1023/A:1006900111744; WILTING J, 1980, J BIOL CHEM, V255, P3032; WILTING J, 1980, BIOCHIM BIOPHYS ACTA, V626, P291, DOI 10.1016/0005-2795(80)90123-3; WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427; ZINI R, 1981, J CHROMATOGR, V216, P191, DOI 10.1016/S0021-9673(00)82347-X	55	95	103	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29953	29960		10.1074/jbc.M104628200	http://dx.doi.org/10.1074/jbc.M104628200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397817	hybrid			2022-12-27	WOS:000170558000047
J	Landriscina, M; Bagala, C; Mandinova, A; Soldi, R; Micucci, I; Bellum, S; Prudovsky, I; Maciag, T				Landriscina, M; Bagala, C; Mandinova, A; Soldi, R; Micucci, I; Bellum, S; Prudovsky, I; Maciag, T			Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; FACTOR-I; ENDOTHELIAL-CELLS; TERMINAL DOMAIN; S100 PROTEINS; SYNAPTOTAGMIN-1; FAMILY; SHOCK; TETRATHIOMOLYBDATE; PROLIFERATION	Fibroblast growth factor (FGF) 1 is known to be released in response to stress conditions as a component of a multiprotein aggregate containing the p40 extravescicular domain of p65 synaptotagmin (Syt) 1 and S100A13, Since FGF1 is a Cu2+-binding protein and Cu2+ is known to induce its dimerization, we evaluated the capacity of recombinant FGF1, p40 Syt1, and S100A13 to interact in a cell-free system and the role of Cu2+ in this interaction. We report that FGF1, p40 Syt1, and S100A13 are able to bind Cu2+ With Similar affinity and to interact in the presence of Cu2+ to form a multiprotein aggregate which is resistant to low concentrations of SDS and sensitive to reducing conditions and ultracentrifugation, The formation of this aggregate in the presence of Cu2+ is dependent on the presence of S100A13 and is mediated by cysteine-independent interactions between S100A13 and either FGF1 or p40 Syt1, Interestingly, S100A13 is also able to interact in the presence of Cu2+ with Cys-free FGF1 and this observation may account for the ability of S100A13 to export Cys-free FGF1 in response to stress. Lastly, tetrathiomolybdate, a Cu2+ chelator, significantly represses in a dose-dependent manner the heat shock-induced release of FGF1 and S100A13, These data suggest that S100A13 may be involved in the assembly of the multiprotein aggregate required for the release of FGF1 and that Cu2+ oxidation may be an essential post-translational intracellular modifier of this process.	Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; Univ Maine, Ctr Biophys Sci, Orono, ME 04469 USA	Maine Medical Center; University of Maine System; University of Maine Orono	Maciag, T (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.		Bagalà, Cinzia/AAB-8981-2019; Landriscina, Matteo/K-1092-2016; Prudovsky, Igor/GVU-1521-2022	Landriscina, Matteo/0000-0003-0591-9799	NHLBI NIH HHS [HL32348] Funding Source: Medline; NIA NIH HHS [AG98503] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032348] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bergmeyer H.U., 1965, METHODS ENZYMATIC AN, P736, DOI [10.1016/b978-0-12-395630-9.50134-1, DOI 10.1016/B978-0-12-395630-9.50134-1]; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; Brem, 1999, Cancer Control, V6, P436; Brewer GJ, 2000, CLIN CANCER RES, V6, P1; Brewer GJ, 1996, ARCH NEUROL-CHICAGO, V53, P1017, DOI 10.1001/archneur.1996.00550100103019; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; CARREIRA CM, 2001, IN PRESS GROWTH FACT; Cox DW, 1999, BRIT MED BULL, V55, P544, DOI 10.1258/0007142991902619; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; ENGLEKA KA, 1992, J BIOL CHEM, V267, P11307; FOROUGH R, 1991, BIOCHIM BIOPHYS ACTA, V1090, P293, DOI 10.1016/0167-4781(91)90192-O; Friesel R, 1999, THROMB HAEMOSTASIS, V82, P748; HANNAN GN, 1982, J CELL PHYSIOL, V111, P207, DOI 10.1002/jcp.1041110213; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Kang HM, 1997, BIOCHEMISTRY-US, V36, P2041, DOI 10.1021/bi962569b; Landriscina M, 2001, J BIOL CHEM, V276, P22544, DOI 10.1074/jbc.M100546200; LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929; LaVallee TM, 1998, J BIOL CHEM, V273, P22217, DOI 10.1074/jbc.273.35.22217; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Mailliard WS, 1996, J BIOL CHEM, V271, P719, DOI 10.1074/jbc.271.2.719; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; MATSUBARA T, 1989, J CLIN INVEST, V83, P158, DOI 10.1172/JCI113853; Nishikawa T, 1997, J BIOL CHEM, V272, P23037, DOI 10.1074/jbc.272.37.23037; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; RUCKER RB, 1988, FASEB J, V2, P2252, DOI 10.1096/fasebj.2.7.3127264; SANO H, 1990, J CELL BIOL, V110, P1417, DOI 10.1083/jcb.110.4.1417; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schafer BW, 2000, J BIOL CHEM, V275, P30623, DOI 10.1074/jbc.M002260200; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; Shi JP, 1997, J BIOL CHEM, V272, P1142, DOI 10.1074/jbc.272.2.1142; Shin JT, 1996, BBA-MOL CELL RES, V1312, P27, DOI 10.1016/0167-4889(96)00013-4; Soncin F, 1997, BIOCHEM BIOPH RES CO, V236, P604, DOI 10.1006/bbrc.1997.7018; Tarantini F, 1998, J BIOL CHEM, V273, P22209, DOI 10.1074/jbc.273.35.22209; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039	38	103	106	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 6	2001	276	27					25549	25557		10.1074/jbc.M102925200	http://dx.doi.org/10.1074/jbc.M102925200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451KF	11432880	hybrid			2022-12-27	WOS:000169800700146
J	Strauss, JG; Frank, S; Kratky, D; Hammerle, G; Hrzenjak, A; Knipping, G; von Eckardstein, A; Kostner, GM; Zechner, R				Strauss, JG; Frank, S; Kratky, D; Hammerle, G; Hrzenjak, A; Knipping, G; von Eckardstein, A; Kostner, GM; Zechner, R			Adenovirus-mediated rescue of lipoprotein lipase-deficient mice - Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER-1; PHOSPHOLIPID TRANSFER PROTEIN; APOLIPOPROTEIN-A-I; TANGIER-DISEASE; CHOLESTEROL LEVELS; TRANSGENIC MICE; ADIPOSE-TISSUE; KNOCKOUT MICE; GENE-TRANSFER; APOA-I	Lipoprotein lipase (LPL) is the rate-limiting enzyme for the hydrolysis of triglycerides and the subsequent uptake of free fatty acids in extrahepatic tissues. Deficiency of LPL in humans (Type I hyperlipoproteinemia) is associated with massive chylomicronemia, low high density lipoprotein (HDL) cholesterol levels, and recurrent attacks of pancreatitis when not controlled by a strict diet. In contrast to humans, homozygous LPL knock-out mice (L0) do not survive suckling and die between 18 and 24 h after birth. In this study, an adenovirus-based protocol was utilized for the transient expression of LPL during the suckling period in an effort to rescue L0 mice. After a single intraperitoneal injection of 5 x 10(9) plaque-forming units of LPL-expressing vir-us immediately after birth, more than 90% of L0 mice survived the first days of life. 3% of L0 mice survived the entire suckling period and lived for up to 20 months' although LPL activity in mouse tissues and postheparin plasma was undetectable in all animals after 6 weeks of age. Adult LPL-deficient mice were smaller than their littermates until 2-3 months of age and exhibited very high triglyceride levels in the fed (4997 +/- 1102 versus 113.4 +/- 18.7 mg/dl) and fasted state (2007 +/- 375 versus 65.5 +/- 7.4 mg/dl). Plasma total cholesterol levels, free fatty acids, and ketone bodies were elevated in L0 mice, whereas plasma glucose was normal. Most strikingly, L0 mice lacked apoA-I-containing pre beta -HDL particles as well as mature HDL resulting in undetectable HDL cholesterol and HDL-apoA-I levels. HDL deficiency in plasma was evident despite normal apoA-I mRNA levels in the liver and normal apoA-I protein levels in plasma, which were predominantly found in the chylomicron fraction. The absence of pre beta -HDL and mature HDL particles supports the concept that the lipolysis of triglyceride-rich lipoproteins is an essential step for HDL maturation.	Graz Univ, Rudolf Zechner Inst Mol Biol Biochem & Microbiol, A-8010 Graz, Austria; Graz Univ, Inst Med Biochem & Med Mol Biol, A-8010 Graz, Austria; Univ Munster, Inst Clin Chem & Lab Med, D-48149 Munster, Germany	University of Graz; University of Graz; University of Munster	Zechner, R (corresponding author), Graz Univ, Rudolf Zechner Inst Mol Biol Biochem & Microbiol, Heinrichstr 31 A, A-8010 Graz, Austria.		Kratky, Dagmar/ABF-5699-2021	Bogner-Strauss, Juliane/0000-0003-2459-0124; Zechner, Rudolf/0000-0001-5483-1182; Kratky, Dagmar/0000-0003-1357-7573				Barrans A, 1996, BBA-LIPID LIPID MET, V1300, P73, DOI 10.1016/0005-2760(95)00236-7; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BRESLOW JL, 1993, ANN NY ACAD SCI, V676, P157; BRINTON EA, 1994, ARTERIOSCLER THROMB, V14, P707, DOI 10.1161/01.ATV.14.5.707; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunzell JD, 1989, METABOLIC BASIS INHE, P1165; CASTLE CK, 1991, J LIPID RES, V32, P439; Chang SF, 1998, J LIPID RES, V39, P2350; Clay MA, 1996, J LIPID RES, V37, P1722; Clay MA, 1999, BIOCHEM J, V337, P445, DOI 10.1042/0264-6021:3370445; COLEMAN T, 1995, J BIOL CHEM, V270, P12518, DOI 10.1074/jbc.270.21.12518; CRYER A, 1985, REPROD NUTR DEV, V25, P255, DOI 10.1051/rnd:19850216; EISENBERG S, 1984, J LIPID RES, V25, P1017; EISENBERG S, 1992, J CLIN INVEST, V90, P2013, DOI 10.1172/JCI116081; Excoffon KJDA, 1997, ARTERIOSCL THROM VAS, V17, P2532, DOI 10.1161/01.ATV.17.11.2532; FRIEDMAN G, 1991, BIOCHIM BIOPHYS ACTA, V666, P156; Ginzinger DG, 1999, EUR J CLIN INVEST, V29, P17, DOI 10.1046/j.1365-2362.1999.00435.x; Goldberg IJ, 1996, J LIPID RES, V37, P693; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAMILTON RL, 1986, J LIPID RES, V27, P967; Huuskonen J, 2000, CURR OPIN LIPIDOL, V11, P285, DOI 10.1097/00041433-200006000-00009; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; JONES LA, 1984, J LIPID RES, V25, P319; Kobayashi K, 1996, J BIOL CHEM, V271, P6852, DOI 10.1074/jbc.271.12.6852; KOSTNER G, 1972, BIOCHEMISTRY-US, V11, P3419, DOI 10.1021/bi00768a015; Lee M, 1999, ARTERIOSCL THROM VAS, V19, P1066, DOI 10.1161/01.ATV.19.4.1066; Levak-Frank S, 1999, P NATL ACAD SCI USA, V96, P3165, DOI 10.1073/pnas.96.6.3165; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; LUTZ PE, 1908, J CLIN INVEST, V107, P1183; Marshall BA, 1999, J BIOL CHEM, V274, P27426, DOI 10.1074/jbc.274.39.27426; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; MIESENBOCK G, 1993, J CLIN INVEST, V91, P448, DOI 10.1172/JCI116222; MUSLINER TA, 1991, J LIPID RES, V32, P917; Olivecrona Thomas, 1993, Current Opinion in Lipidology, V4, P187, DOI 10.1097/00041433-199306000-00003; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; PATERNITI JR, 1983, SCIENCE, V221, P167, DOI 10.1126/science.6857276; PEEVA E, 1992, INT J OBESITY, V16, P737; ROGERS MP, 1974, J LIPID RES, V15, P263; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Santamarina-Fojo S, 2000, CURR OPIN LIPIDOL, V11, P267, DOI 10.1097/00041433-200006000-00007; Sattler W, 1996, BIOCHEM J, V318, P15, DOI 10.1042/bj3180015; Savonen R, 1999, J LIPID RES, V40, P1336; SAXENA U, 1992, J CLIN INVEST, V89, P373, DOI 10.1172/JCI115595; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SINN HJ, 1988, ANAL BIOCHEM, V170, P186, DOI 10.1016/0003-2697(88)90107-8; TALL AR, 1993, J LIPID RES, V34, P1255; TENG BB, 1994, J BIOL CHEM, V269, P29395; TRABER MG, 1985, J CLIN INVEST, V75, P1729, DOI 10.1172/JCI111883; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Weinstock PH, 1997, P NATL ACAD SCI USA, V94, P10261, DOI 10.1073/pnas.94.19.10261; WILSON DE, 1990, J CLIN INVEST, V86, P725; ZECHNER R, 1990, BIOCHIM BIOPHYS ACTA, V1044, P20, DOI 10.1016/0005-2760(90)90213-H; Zechner R, 1997, CURR OPIN LIPIDOL, V8, P77, DOI 10.1097/00041433-199704000-00005	60	77	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 28	2001	276	39					36083	36090		10.1074/jbc.M104430200	http://dx.doi.org/10.1074/jbc.M104430200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	475XF	11432868	hybrid			2022-12-27	WOS:000171194500007
J	Botella, LM; Sanchez-Elsner, T; Rius, C; Corbi, A; Bernabeu, C				Botella, LM; Sanchez-Elsner, T; Rius, C; Corbi, A; Bernabeu, C			Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-beta stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; TRANSCRIPTION FACTOR SP1; SMAD-BINDING-ELEMENT; TGF-BETA; DNA-BINDING; ENDOTHELIAL-CELLS; FUNCTIONAL INTERACTIONS; EXPRESSION ANALYSIS; CELLULAR-RESPONSES; HEART DEVELOPMENT	Endoglin, a component of the transforming growth factor-beta (TGF-beta) receptor complex expressed on endothelial cells, is involved in cardiovascular morphogenesis and vascular remodeling, as exemplified by the fact that the endoglin gene is the target for the autosomal dominant disorder known as hereditary hemorrhagic telangiectasia type 1. Since haploinsufficiency is the underlying mechanism for hereditary hemorrhagic telangiectasia type 1, understanding the regulation of endoglin gene expression appears to be a crucial step to correct the disease. In this study we have identified an Sp1 site at -37 as a critical element for the basal transcription of the endoglin TATA-less promoter. Since endoglin promoter activity is stimulated by TGF-beta and this stimulation is located at the Spl-containing proximal region, we have investigated the possible involvement of Spl in the TGF-beta -mediated induction. Mutation of the Sp1-binding sequence, or addition of the Spl inhibitor WP631, abolished both the basal transcription activity and the TGF-beta responsiveness of the endoglin promoter. Binding of Sp1 and Smad3 to the proximal promoter region -50/-29 was evidenced by electrophoretic mobility shift assays and DNA affinity precipitation studies. Furthermore, synergistic cooperation on the promoter activity between Sp1 and TGF-beta or Smad3 could be demonstrated by co-transfection experiments of reporter promoter constructs. The molecular mechanism underlying this cooperation appears to involve a direct physical interaction between Sp1 and Smad3/Smad4.	CSIC, Ctr Invest Biol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Bernabeu, C (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.		Bernabeu, Carmelo/L-3226-2014; Corbí, Angel L./ABC-8146-2020; Bernabeu, Carmelo/P-4662-2019; Botella, Luisa M/L-1392-2014; Corbi, Angel/B-7194-2011	Bernabeu, Carmelo/0000-0002-1563-6162; Corbí, Angel L./0000-0003-1980-5733; Bernabeu, Carmelo/0000-0002-1563-6162; Corbi, Angel/0000-0003-1980-5733; Sanchez-Elsner, Tilman/0000-0003-1915-2410				Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; BAE HW, 1995, J BIOL CHEM, V270, P29460, DOI 10.1074/jbc.270.49.29460; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; BERG JM, 1992, P NATL ACAD SCI USA, V89, P11109, DOI 10.1073/pnas.89.23.11109; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Brodin G, 2000, J BIOL CHEM, V275, P29023, DOI 10.1074/jbc.M002815200; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; CHUNGFANG L, 2000, J BIOL CHEM, V275, P36400; Das P, 1999, GENES CELLS, V4, P123, DOI 10.1046/j.1365-2443.1999.00244.x; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Gallione CJ, 1998, HUM MUTAT, V11, P286, DOI 10.1002/(SICI)1098-1004(1998)11:4<286::AID-HUMU6>3.0.CO;2-B; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; HUMPHRIES DE, 1994, BIOCHEM BIOPH RES CO, V203, P1020, DOI 10.1006/bbrc.1994.2284; Iavarone A, 1997, NATURE, V387, P417; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lee JS, 1998, P NATL ACAD SCI USA, V95, P969, DOI 10.1073/pnas.95.3.969; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Martin B, 1999, NUCLEIC ACIDS RES, V27, P3402, DOI 10.1093/nar/27.17.3402; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Pece N, 1997, J CLIN INVEST, V100, P2568, DOI 10.1172/JCI119800; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Qu R, 1998, CELL TISSUE RES, V292, P333, DOI 10.1007/s004410051064; Rius C, 1998, BLOOD, V92, P4677; Saluja D, 1998, MOL CELL BIOL, V18, P5734, DOI 10.1128/MCB.18.10.5734; Schmitt J, 1996, GENOMICS, V32, P358, DOI 10.1006/geno.1996.0130; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shovlin CL, 1997, AM J HUM GENET, V61, P68, DOI 10.1086/513906; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; Vincent EB, 1998, DEV DYNAM, V213, P237, DOI 10.1002/(SICI)1097-0177(199811)213:3<237::AID-AJA1>3.0.CO;2-M; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995; Yeo CY, 1999, J BIOL CHEM, V274, P26584, DOI 10.1074/jbc.274.37.26584; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	60	64	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34486	34494		10.1074/jbc.M011611200	http://dx.doi.org/10.1074/jbc.M011611200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432852	hybrid, Green Published			2022-12-27	WOS:000171024600020
J	Nadanaka, S; Sato, C; Kitajima, K; Katagiri, K; Irie, S; Yamagata, T				Nadanaka, S; Sato, C; Kitajima, K; Katagiri, K; Irie, S; Yamagata, T			Occurrence of oligosialic acids on integrin alpha(5) subunit and their involvement in cell adhesion to fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID; BINDING ACTIVITY; RAINBOW-TROUT; RECEPTOR; GLYCOSYLATION; GLYCOPROTEINS; RESIDUES; ALPHA-5-BETA-1; BIOSYNTHESIS; MOLECULE	Integrin alpha (5)beta (1), a major fibronectin receptor, functions in a wide variety of biological phenomena. We have found that alpha2-8-linked oligosialic acids with 5:5 degree of polymerization (DP) less than or equal to 7 occur on integrin alpha (5) subunit of the human melanoma cell line G361. The integrin alpha (5) subunit immunoprecipitated with anti-integrin alpha (5) antibody reacted with the monoclonal antibody 12E3, which recognizes oligo/polysialic acid with DP greater than or equal to 5 but not with the polyclonal antibody H.46 recognizing oligo/polysialic acid with DP greater than or equal to 8. The occurrence of oligosialic acids was further demonstrated by fluorometric C-7/C-9 analysis on the immunopurified integrin alpha (5) subunit. Oligosialic acids were also found in the alpha (5) subunit of several other human cells such as foreskin fibroblast and chronic erythroleukemia K562 cells. These results suggest the ubiquitous modification with unique oligosialic acids occurs on the ar, subunit of integrin alpha (5)beta (1). The adhesion of human melanoma G361 cells to fibronectin was mainly mediated by integrin alpha (5)beta (1). Treatment of cells with sialidase from Arthrobacter ureafaciens cleaving alpha2-3-, alpha2-6-, and alpha2-8-linked sialic acids inhibited adhesion to fibronectin. On the other hand, N-acetyl-neuraminidase II, which cleaves alpha2-3 and alpha2-6 but not alpha2-8 linkages, showed no inhibitory activity. After the loss of oligosialic acids, integrin alpha (5)beta (1), failed to bind to fibronectin-conjugated Sepharose, indicating that the oligosialic acid on the a5 subunit of integrin alpha (5)beta (1) plays important roles in cell adhesion to fibronectin.	Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068304, Japan; Nippi Res Inst Biomatrix, Adachi Ku, Tokyo 1208601, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; Kyoto Univ, Bayer Chair Dept Mol Immunol & Allergy, Sakyo Ku, Kyoto 6068501, Japan; Japan Inst Leather Res, Div Glycobiol & Glycotechnol, Adachi Ku, Tokyo 1208601, Japan	Kyoto University; Nagoya University; Kyoto University	Nadanaka, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, 46-29 Yoshida Shimoadachi, Kyoto 6068304, Japan.		Naganawa, Shinji/I-1572-2012; SATO, Chihiro/B-7396-2014	Naganawa, Shinji/0000-0002-0214-613X; 				AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; BREUSS JM, 1995, J CELL SCI, V108, P2241; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; CHERESH DA, 1987, J CELL BIOL, V105, P1163, DOI 10.1083/jcb.105.3.1163; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Funakoshi Y, 1997, GLYCOBIOLOGY, V7, P195, DOI 10.1093/glycob/7.2.195; Granovsky M, 2000, NAT MED, V6, P306; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; INOUE S, 1978, BIOCHEM BIOPH RES CO, V83, P1018, DOI 10.1016/0006-291X(78)91497-3; Inoue S, 1996, J BIOL CHEM, V271, P24341, DOI 10.1074/jbc.271.40.24341; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; KINASHI T, 1994, BLOOD, V83, P1033; KOYAMA T, 1992, J BIOL CHEM, V267, P25939; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPUGNANI MG, 1991, J CELL BIOL, V112, P479, DOI 10.1083/jcb.112.3.479; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; Nakagawa H, 1996, EUR J BIOCHEM, V237, P76, DOI 10.1111/j.1432-1033.1996.0076n.x; Nohara K, 1998, J BIOCHEM, V124, P194, DOI 10.1093/oxfordjournals.jbchem.a022079; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; ROHR TE, 1980, J BIOL CHEM, V255, P2332; Rutishauser U, 1998, J CELL BIOCHEM, V70, P304, DOI 10.1002/(SICI)1097-4644(19980901)70:3<304::AID-JCB3>3.0.CO;2-R; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Sato C, 1998, ANAL BIOCHEM, V261, P191, DOI 10.1006/abio.1998.2718; Sato C, 1998, J BIOL CHEM, V273, P2575, DOI 10.1074/jbc.273.5.2575; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato C, 1999, ANAL BIOCHEM, V266, P102, DOI 10.1006/abio.1998.2921; Sato C, 1999, GLYCOCONJUGATE J, V16, pS117; SMITH JC, 1990, DEVELOPMENT, V108, P229; SYMINGTON BE, 1989, J BIOL CHEM, V264, P13258; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TROY FA, 1996, BIOL SIALIC ACIDS, P95; VANDEWATER L, 1988, CANCER RES, V48, P5730; VANLENTEN L, 1971, J BIOL CHEM, V246, P1889; Wang XQ, 2001, J BIOL CHEM, V276, P8436, DOI 10.1074/jbc.M006097200; WATT FM, 1994, CURR BIOL, V4, P270, DOI 10.1016/S0960-9822(00)00063-4; YANG JT, 1993, DEVELOPMENT, V119, P1093; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325; ZUBER C, 1992, J BIOL CHEM, V267, P9965	42	58	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33657	33664		10.1074/jbc.M011100200	http://dx.doi.org/10.1074/jbc.M011100200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11418585	hybrid			2022-12-27	WOS:000170910200051
J	Hatakeyama, S; Yada, M; Matsumoto, M; Ishida, N; Nakayama, KI				Hatakeyama, S; Yada, M; Matsumoto, M; Ishida, N; Nakayama, KI			U box proteins as a new family of ubiquitin-protein ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; SIGNAL-INDUCED UBIQUITINATION; RING FINGER; MULTIUBIQUITIN CHAIN; BETA-CATENIN; SACCHAROMYCES-CEREVISIAE; C-CBL; DEGRADATION; COMPLEX; TRCP	The U box is a domain of similar to 70 amino acids that is present in proteins from yeast to humans. The prototype U box protein, yeast Ufd2, was identified as a ubiquitin chain assembly factor that cooperates with a ubiquitin-activating enzyme (EI), a ubiquitin-conjugating enzyme (E2), and a ubiquitin-protein ligase (E3) to catalyze ubiquitin chain formation on artificial substrates. E3 enzymes are thought to determine the substrate specificity of ubiquitination and have been classified into two families, the HECT and RING finger families. Six mammalian U box proteins have now been shown to mediate polyubiquitination in the presence of El and E2 and in the absence of E3. These U box proteins exhibited different specificities for E2 enzymes in this reaction. Deletion of the U box or mutation of conserved amino acids within it abolished ubiquitination activity. Some U box proteins catalyzed polyubiquitination by targeting lysine residues of ubiquitin other than lysine 48, which is utilized by HECT and RING finger E3 enzymes for polyubiquitination that serves as a signal for proteolysis by the 26 S proteasome. These data suggest that U box proteins constitute a third family of E3 enzymes and that E4 activity may reflect a specialized type of E3 activity.	Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.		Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979				Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Wang BB, 1996, BIOCHEM J, V314, P313, DOI 10.1042/bj3140313; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu C, 1999, J BIOL CHEM, V274, P29591, DOI 10.1074/jbc.274.42.29591; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	50	442	477	8	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33111	33120		10.1074/jbc.M102755200	http://dx.doi.org/10.1074/jbc.M102755200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435423	hybrid			2022-12-27	WOS:000170746000097
J	Rubin, JS; Day, RM; Breckenridge, D; Atabey, N; Taylor, WG; Stahl, SJ; Wingfield, PT; Kaufman, JD; Schwall, R; Bottaro, DP				Rubin, JS; Day, RM; Breckenridge, D; Atabey, N; Taylor, WG; Stahl, SJ; Wingfield, PT; Kaufman, JD; Schwall, R; Bottaro, DP			Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-Met interaction facilitates signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; FACTOR ISOFORMS; PROTOONCOGENE PRODUCT; BIOLOGICAL-ACTIVITY; MITOGENIC ACTIVITY; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; NK1 FRAGMENT; DIMERIZATION; ACTIVATION	Hepatocyte growth factor (HGF) is a secreted, heparan sulfate (HS) glycosaminoglycan-binding protein that stimulates mitogenesis, motogenesis, and morphogenesis in a wide array of cellular targets, including hepatocytes and other epithelial cells, melanocytes, endothelial cells, and hematopoietic cells. NK1 is an alternative HGF isoform that consists of the N-terminal (N) and first kringle (K1) domains of full-length HGF and stimulates all major HGF biological activities. Within NK1, the N domain retains the HS binding properties of full-length HGF and mediates HS-stimulated ligand oligomerization but lacks significant mitogenic or motogenic activity. In contrast, K1 does not bind HS, but it stimulates receptor and mitogen-activated protein kinase activation, mitogenesis, and motogenesis, demonstrating that structurally distinct and dissociable domains of HGF are the primary mediators of HS binding and receptor activation. Despite the absence of HS-K1 binding, K1 mitogenic activity in HS-negative cells is strictly dependent on added soluble heparin, whereas K1-stimulated motility is not. We also found that, like the receptors for fibroblast growth factors, the HGF receptor c-Met binds tightly to HS. These data suggest that HS can facilitate HGF signaling through interaction with c-Met that is independent of HGF-HS interaction and that the recruitment of specific intracellular effectors that mediate distinct HGF responses such as mitogenesis and motility is regulated by HS-c-Met interaction at the cell surface.	NCI, Cellular & Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA; NIAMS, Prot Express Lab, NIH, Bethesda, MD 20892 USA; Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Roche Holding; Genentech	Bottaro, DP (corresponding author), EntreMed Inc, 9640 Med Ctr Dr, Rockville, MD 20850 USA.		Bottaro, Donald P/AAF-3853-2020; Bottaro, Donald P/F-8550-2010; Atabey, Nese/A-1853-2018	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334; Atabey, Nese/0000-0003-4966-2980; Wingfield, Paul/0000-0002-9515-4752	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041115, Z01AR041115] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Cioce V, 1996, J BIOL CHEM, V271, P13110, DOI 10.1074/jbc.271.22.13110; Day RM, 1999, ONCOGENE, V18, P3399, DOI 10.1038/sj.onc.1202683; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; FALCO JP, 1988, ONCOGENE, V2, P573; FALETTO DL, 1992, ONCOGENE, V7, P1149; GAK E, 1992, FEBS LETT, V311, P17, DOI 10.1016/0014-5793(92)81356-Q; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Hsu YR, 1999, BIOCHEMISTRY-US, V38, P2523, DOI 10.1021/bi9821317; Jakubczak JL, 1998, MOL CELL BIOL, V18, P1275, DOI 10.1128/MCB.18.3.1275; Kan M, 1996, J BIOL CHEM, V271, P26143, DOI 10.1074/jbc.271.42.26143; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; LaRochelle WJ, 1999, BIOCHEMISTRY-US, V38, P1765, DOI 10.1021/bi982092z; Lemmon MA, 1998, METH MOL B, V84, P49; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; LOKKER NA, 1994, PROTEIN ENG, V7, P895, DOI 10.1093/protein/7.7.895; MARK MR, 1992, J BIOL CHEM, V267, P26166; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; Montesano R, 1998, CELL GROWTH DIFFER, V9, P355; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; NAKA D, 1992, J BIOL CHEM, V267, P20114; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; OKIGAKI M, 1992, BIOCHEMISTRY-US, V31, P9555, DOI 10.1021/bi00155a007; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; PATTHY L, 1984, FEBS LETT, V171, P131, DOI 10.1016/0014-5793(84)80473-1; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Sakata H, 1997, J BIOL CHEM, V272, P9457; Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709; Stahl SJ, 1997, BIOCHEM J, V326, P763, DOI 10.1042/bj3260763; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Ultsch M, 1998, STRUCT FOLD DES, V6, P1383, DOI 10.1016/S0969-2126(98)00138-5; UREN A, 1994, BIOCHEM BIOPH RES CO, V204, P628, DOI 10.1006/bbrc.1994.2505; Wadsworth P, 1996, CELL MOTIL CYTOSKEL, V35, P225, DOI 10.1002/(SICI)1097-0169(1996)35:3<225::AID-CM5>3.0.CO;2-7; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Zhou HJ, 1999, BIOCHEMISTRY-US, V38, P14793, DOI 10.1021/bi9908641; Zhou HJ, 1998, STRUCTURE, V6, P109, DOI 10.1016/S0969-2126(98)00012-4; ZIONCHECK TF, 1995, J BIOL CHEM, V270, P16871, DOI 10.1074/jbc.270.28.16871	43	84	102	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32977	32983		10.1074/jbc.M105486200	http://dx.doi.org/10.1074/jbc.M105486200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435444	hybrid			2022-12-27	WOS:000170746000081
J	Gibson, CW; Yuan, ZA; Hall, B; Longenecker, G; Chen, EH; Thyagarajan, T; Sreenath, T; Wright, JT; Decker, S; Piddington, R; Harrison, G; Kulkarni, AB				Gibson, CW; Yuan, ZA; Hall, B; Longenecker, G; Chen, EH; Thyagarajan, T; Sreenath, T; Wright, JT; Decker, S; Piddington, R; Harrison, G; Kulkarni, AB			Amelogenin-deficient mice display an amelogenesis imperfecta phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSENSE MUTATION; GENE AMGX; ENAMEL; PROTEINS; BIOMINERALIZATION; SEQUENCE; DEFECTS; CLONING; MATRIX; REGION	Dental enamel is the hardest tissue in the body and cannot be replaced or repaired, because the enamel secreting cells are lost at tooth eruption. X-linked amelogenesis imperfecta (MIM 301200), a phenotypically diverse hereditary disorder affecting enamel development, is caused by deletions or point mutations in the human X-chromosomal amelogenin gene. Although the precise functions of the amelogenin proteins in enamel formation are not well defined, these proteins constitute 90% of the enamel organic matrix. We have disrupted the amelogenin locus to generate amelogenin null mice, which display distinctly abnormal teeth as early as 2 weeks of age with chalky-white discoloration. Microradiography revealed broken tips of incisors and molars and scanning electron microscopy analysis indicated disorganized hypoplastic enamel. The amelogenin null phenotype reveals that the amelogenins are apparently not required for initiation of mineral crystal formation but rather for the organization of crystal pattern and regulation of enamel thickness. These null mice will be useful for understanding the functions of amelogenin proteins during enamel formation and for developing therapeutic approaches for treating this developmental defect that affects the enamel.	Univ Penn, Sch Dent Med, Dept Anat & Histol, Philadelphia, PA 19104 USA; Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; NIDCR, Funct Genom Unit, NIH, Bethesda, MD 20892 USA; NIDCR, Gene Targeting Facil, NIH, Bethesda, MD 20892 USA; Univ N Carolina, Dept Pediat Dent, Chapel Hill, NC 27599 USA	University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of North Carolina; University of North Carolina Chapel Hill	Gibson, CW (corresponding author), Univ Penn, Sch Dent Med, Dept Anat & Histol, 4010 Locust St, Philadelphia, PA 19104 USA.	gibson@biochem.dental.upenn.edu; akulkarni@dir.nidcr.nih.gov	Wright, John Timothy/AAX-5755-2020		NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010149, R01DE012879] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALDRED MJ, 1992, HUM GENET, V90, P413; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Chen E, 1998, GENE, V216, P131, DOI 10.1016/S0378-1119(98)00300-X; Collier PM, 1997, ARCH ORAL BIOL, V42, P235, DOI 10.1016/S0003-9969(96)00099-4; DIEKWISCH T, 1993, DEVELOPMENT, V117, P471; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; FINCHAM AG, 1991, ARCH ORAL BIOL, V36, P305, DOI 10.1016/0003-9969(91)90101-Y; FINCHAM AG, 1991, CALCIFIED TISSUE INT, V48, P288, DOI 10.1007/BF02556382; GIBSON CW, 1992, CALCIFIED TISSUE INT, V51, P162, DOI 10.1007/BF00298506; Gibson CW, 1995, CONNECT TISSUE RES, V32, P109, DOI 10.3109/03008209509013711; Gibson CW, 1999, CRIT REV EUKAR GENE, V9, P45, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.40; GLIMCHER MJ, 1964, BIOCHEM J, V93, P202, DOI 10.1042/bj0930202; HEROLD RC, 1987, ARCH ORAL BIOL, V32, P439, DOI 10.1016/0003-9969(87)90080-X; Hu CC, 1996, J DENT RES, V75, P1735, DOI 10.1177/00220345960750100501; Hu CC, 1997, J DENT RES, V76, P641, DOI 10.1177/00220345970760020401; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; LAGERSTROMFERMER M, 1995, GENOMICS, V26, P159, DOI 10.1016/0888-7543(95)80097-6; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; LENCH NJ, 1994, HUM MOL GENET, V3, P827, DOI 10.1093/hmg/3.5.827; LENCH NJ, 1995, HUM MUTAT, V5, P251, DOI 10.1002/humu.1380050310; LYNGSTADAAS SP, 1995, EMBO J, V14, P5224, DOI 10.1002/j.1460-2075.1995.tb00207.x; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; MORADIANOLDAK J, 1994, BIOPOLYMERS, V34, P1339, DOI 10.1002/bip.360341006; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Oida S, 1996, DNA SEQUENCE, V6, P307, DOI 10.3109/10425179609020879; Paine ML, 1997, J BONE MINER RES, V12, P221, DOI 10.1359/jbmr.1997.12.2.221; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; Ravindranath RMH, 1999, J BIOL CHEM, V274, P2464, DOI 10.1074/jbc.274.4.2464; Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHROEDER HE, 1991, ORAL STRUCTURAL BIOL, P56; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Witkop CJ, 1976, ORAL FACIAL GENETICS, P151; Yuan ZA, 1996, ARCH ORAL BIOL, V41, P205, DOI 10.1016/0003-9969(95)00119-0	41	357	363	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31871	31875		10.1074/jbc.M104624200	http://dx.doi.org/10.1074/jbc.M104624200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11406633	Green Published, hybrid			2022-12-27	WOS:000170613500056
J	Shi, CS; Kehrl, JH				Shi, CS; Kehrl, JH			PYK2 links G(q)alpha and G(13)alpha signaling to NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; PHOSPHOINOSITIDE 3-KINASE; MARGINAL ZONE; TYROSINE KINASE; CELLS; REQUIREMENT; BRADYKININ; ABSENCE; AKT	Signaling via a variety of G-protein-coupled receptors (GPCRs) leads to activation of nuclear factor (NF)-kappaB. Evidence exists for a signaling pathway initiated by the B2 type bradykinin receptor via G(q) activation, which leads to the sequential stimulation of phosphoinositide 3-kinase (PI3K), the serine/threonine kinase Akt, I kappaB kinases, and finally nuclear factor NF-kappaB-dependent transcription. GPCR-mediated G(q)alpha or G(13)alpha activation also potently stimulates the tyrosine kinase PYK2. In this study we tested whether G(q)alpha- and/or G(13)alpha -induced PYK2 activation contributes to GPCR-mediated NF-kappaB activation. Among the GTPase-deficient forms of G alpha tested, G(13)alpha and G(q)alpha most potently stimulated an NF-kappaB-dependent reporter gene. PYK2 activated the same reporter gene and synergized with either G(q)alpha Q209L (QL) or G(13)alpha Q226L (QL). Placing PYK2 upstream of both PI3K and Akt activation, PYK2 activated Aht through a PI3K-dependent pathway, and either a dominant negative form of Aht or the PI3K inhibitor LY294002 blocked PYK2-stimulated NF-kappaB-dependent transcription. Placing PYK2 downstream of G-protein activation, a kinase-dead form of PYK2, PYK2 (KD), blocked NF-kappaB-dependent transcription triggered by signaling through the muscarinic receptor type 1 and either G(q)alpha QL or G(13)alpha QL. PYK2 (KD) also blocked Akt activation by the same stimuli. These results indicate that PYK2 can link G-protein activation through PI3K, Akt, and I kappaB kinase to NF-kappaB activation.	NIAID, Immunoregulat Lab, Cell Mol Immunol Sect B, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kehrl, JH (corresponding author), NIAID, Immunoregulat Lab, Cell Mol Immunol Sect B, NIH, Bldg 10 Rm 11B08,10 Ctr DR MSC 1876, Bethesda, MD 20892 USA.	jkehrl@atlas.niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000739, ZIAAI000739] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Gallois C, 1998, J BIOL CHEM, V273, P23183, DOI 10.1074/jbc.273.36.23183; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Murasawa S, 1998, HYPERTENSION, V32, P668, DOI 10.1161/01.HYP.32.4.668; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Ozes ON, 1999, NATURE, V401, P82; Pan ZK, 1999, J BIOL CHEM, V274, P9918, DOI 10.1074/jbc.274.15.9918; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sayed MR, 2000, J CELL PHYSIOL, V183, P314, DOI 10.1002/(SICI)1097-4652(200006)183:3<314::AID-JCP3>3.0.CO;2-J; Shahrestanifar M, 1999, J BIOL CHEM, V274, P3828, DOI 10.1074/jbc.274.6.3828; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200	24	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31845	31850		10.1074/jbc.M101043200	http://dx.doi.org/10.1074/jbc.M101043200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11435419	hybrid			2022-12-27	WOS:000170613500052
J	Snyders, S; Kohorn, BD				Snyders, S; Kohorn, BD			Disruption of thylakoid-associated kinase 1 leads to alteration of light harvesting in arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PHOSPHORYLATION; CHLAMYDOMONAS-REINHARDTII; STATE TRANSITIONS; PHOTOSYSTEM-I; COMPLEX-II; MEMBRANES; CHLOROPLASTS; PLASTOQUINOL; BINDING; SITE	To survive fluctuations in quality and intensity of light, plants and algae are able to preferentially direct the absorption of light energy to either one of the two photosystems, PSI or PSII. This rapid process is referred to as a state transition and has been correlated with the phosphorylation and migration of the light-harvesting complex protein (LHCP) between PSII and PSI. We show here that thylakoid protein kinases (TAKs) are required for state transitions in Arabidopsis. Antisense TAK1 expression leads to a loss of LHCP phosphorylation and a reduction in state transitions. Preferential activation of PSII causes LHCP to accumulate with PSI, and TAK1. mutants disrupt this process. Finally, TAKs also influence the phosphorylation. of multiple thylakoid proteins.	Duke Univ, Dept Biol, DCMB, Durham, NC 27708 USA	Duke University	Kohorn, BD (corresponding author), Duke Univ, Dept Biol, DCMB, Rm B353 LSRC, Durham, NC 27708 USA.							ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; ANDERSSON B, 1994, ADV MOL CEL, V10, P1; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Chen WQ, 1996, PLANT J, V10, P955, DOI 10.1046/j.1365-313X.1996.10060955.x; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; FOYER CH, 1987, BIOCHEM J, V248, P103, DOI 10.1042/bj2480103; Gal A, 1997, PHYSIOL PLANTARUM, V100, P869, DOI 10.1034/j.1399-3054.1997.1000413.x; GEORGAKOPOULOS JH, 1994, BBA-BIOENERGETICS, V1188, P380, DOI 10.1016/0005-2728(94)90059-0; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; KOHORN BD, 1990, J BIOL CHEM, V265, P2118; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MAYFIELD SP, 1995, ANNU REV PLANT PHYS, V46, P147, DOI 10.1146/annurev.pp.46.060195.001051; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; Rintamaki E, 1996, J BIOL CHEM, V271, P14870, DOI 10.1074/jbc.271.25.14870; Rokka A, 2000, PLANT PHYSIOL, V123, P1525, DOI 10.1104/pp.123.4.1525; Sambrook J., 2002, MOL CLONING LAB MANU; SHAW CH, 1983, GENE, V23, P315, DOI 10.1016/0378-1119(83)90021-5; SILVERSTEIN T, 1993, FEBS LETT, V334, P101, DOI 10.1016/0014-5793(93)81690-2; SMITH TA, 1994, J CELL BIOL, V126, P365, DOI 10.1083/jcb.126.2.365; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; SONOIKE K, 1995, PLANT CELL PHYSIOL, V36, P825, DOI 10.1093/oxfordjournals.pcp.a078827; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; VanderVlugtBergmans CJB, 1997, PHYSIOL MOL PLANT P, V50, P1, DOI 10.1006/pmpp.1996.0067; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Vener AV, 1999, BIOCHEMISTRY-US, V38, P14955, DOI 10.1021/bi990971v; VENER AV, 1995, J BIOL CHEM, V270, P25225, DOI 10.1074/jbc.270.42.25225; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	34	74	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32169	32176		10.1074/jbc.M102539200	http://dx.doi.org/10.1074/jbc.M102539200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423538	hybrid			2022-12-27	WOS:000170613500095
J	Biberstine-Kinkade, KJ; DeLeo, FR; Epstein, RI; LeRoy, BA; Nauseef, WM; Dinauer, MC				Biberstine-Kinkade, KJ; DeLeo, FR; Epstein, RI; LeRoy, BA; Nauseef, WM; Dinauer, MC			Heme-ligating histidines in flavocytochrome b(558)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NEUTROPHIL CYTOCHROME-B; PHAGOCYTE NADPH OXIDASE; LIGHT-CHAIN; SUPEROXIDE; MUTATIONS; GENE; COMPONENT; IDENTIFICATION; GP91-PHOX	The phagocyte NADPH-dependent oxidase generates superoxide (O-2(.-)) by reducing molecular oxygen through flavocytochrome b(558) (flavocytochrome b), a heterodimeric oxidoreductase composed of gp91(phox) and p22(phox) subunits. Although each flavocytochrome b molecule contains two heme groups, their precise distribution within the heterodimer is unknown. Among functionally and/or structurally related oxidoreductases, histidines at codons 101, 111, 115, 119, 209, 210, and 222 of gp91(phox) are conserved and potential candidates to ligate heme, We compared biochemical and functional features of normal flavocytochrome b with those in cells expressing gp91(phox) harboring amino acid substitutions at each of these histidines. Surface expression of flavocytochrome b and heterodimer formation were relatively unaffected in cells expressing gp91(phox) H111L, H119L, or H210L. These mutations also had no effect on the flavocytochrome b heme spectrum, although NADPH oxidase activity was decreased in cells expressing gp91(phox) H119L or H210L. In contrast, gp65 was not processed to gp91(phox), heterodimers did not form, and flavocytochrome b was not expressed on the surface of cells expressing gp91(phox) H101L, H115L, H115L, H209C, H209Y, H222L, H222C, or H222R. Similarly, this subset of mutants lacked detectable O-2(.-)-generating activity, and flavocytochrome b purified from these cells contained little or no heme. These findings demonstrate that His(101), His(115), His(209), and His(222) of gp91(phox) are critical for heme binding and biosynthetic maturation of flavocytochrome b.	Indiana Univ, Sch Med, Riley Hosp Children, Wells Ctr Pediat Res,Dept Pediat Hematol Oncol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Riley Hosp Children, Wells Ctr Pediat Res,Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Vet Adm Med Ctr, Inflammat Program, Iowa City, IA 52242 USA; Vet Adm Med Ctr, Dept Med, Iowa City, IA 52242 USA; Univ Iowa, Iowa City, IA 52242 USA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa	Dinauer, MC (corresponding author), Wells Ctr Pediat Res, 1044 W Walnut St,R4,Rm 402A, Indianapolis, IN 46202 USA.	mdinauer@iupui.edu		DeLeo, Frank/0000-0003-3150-2516; Nauseef, William/0000-0003-4032-757X	NHLBI NIH HHS [P01 HL 53586, R01 HL 45635] Funding Source: Medline; NIAID NIH HHS [O1 AI 34879] Funding Source: Medline; NIDDK NIH HHS [P50 DK 49218] Funding Source: Medline; BLRD VA [I01 BX000513] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635, P01HL053586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI034879, R01AI034879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049218] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BLRD VA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)		Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BOLSCHER BGJM, 1991, BLOOD, V77, P2482; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Burritt JB, 1998, J BIOL CHEM, V273, P24847, DOI 10.1074/jbc.273.38.24847; Burritt JB, 2000, EUR J HAEMATOL, V65, P407, DOI 10.1034/j.1600-0609.2000.065006407.x; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CROSS AR, 1995, J BIOL CHEM, V270, P6543, DOI 10.1074/jbc.270.12.6543; CROSS AR, 1995, J BIOL CHEM, V270, P17075, DOI 10.1074/jbc.270.29.17075; CURNUTTE JT, 2001, MOL BASIS PHAGOCYTE, P539; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; DINAUER M, 1998, HEMATOLOGY INFANCY C, V1, P889; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Fujii H, 1995, FEBS LETT, V377, P345, DOI 10.1016/0014-5793(95)01372-5; HEYWORTH P, 1998, MOL CELLULAR BASIS I, P165; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; HURST JK, 1991, J BIOL CHEM, V266, P1627; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; Ishibashi F, 2000, HUM GENET, V106, P473, DOI 10.1007/s004390000288; JESAITIS AJ, 1995, J IMMUNOL, V155, P3286; Kaneda M, 1999, BLOOD, V93, P2098, DOI 10.1182/blood.V93.6.2098.406k09_2098_2104; KOSHKIN V, 1993, FEBS LETT, V327, P57, DOI 10.1016/0014-5793(93)81039-3; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; Kume A, 2000, J LAB CLIN MED, V135, P122, DOI 10.1067/mlc.2000.104458; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Malech HL, 1997, SEMIN HEMATOL, V34, P279; MALY FE, 1993, J EXP MED, V178, P2047, DOI 10.1084/jem.178.6.2047; Maniatis T., 1982, MOL CLONING; Metcalf Julia A., 1986, LAB MANUAL NEUTROPHI; Nauseef WM, 1999, P ASSOC AM PHYSICIAN, V111, P373, DOI 10.1111/paa.1999.111.5.373; PARKOS CA, 1989, BLOOD, V73, P1416; PARKOS CA, 1992, MOLECULAR BASIS OF OXIDATIVE DAMAGE BY LEUKOCYTES, P45; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; QUINN MT, 1992, J BIOL CHEM, V267, P7303; Rae J, 1998, AM J HUM GENET, V62, P1320, DOI 10.1086/301874; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Roos D, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P353; Roos D, 1996, BLOOD, V87, P1663; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; Tsuda M, 1998, HUM GENET, V103, P377, DOI 10.1007/s004390050836; UENO I, 1991, FEBS LETT, V281, P130, DOI 10.1016/0014-5793(91)80375-D; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; Yu LX, 1999, J BIOL CHEM, V274, P4364, DOI 10.1074/jbc.274.7.4364; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	55	86	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31105	31112		10.1074/jbc.M103327200	http://dx.doi.org/10.1074/jbc.M103327200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413138	hybrid			2022-12-27	WOS:000170472900069
J	De Fabiani, E; Mitro, N; Anzulovich, AC; Pinelli, A; Galli, G; Crestani, M				De Fabiani, E; Mitro, N; Anzulovich, AC; Pinelli, A; Galli, G; Crestani, M			The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7 alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4 - A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEIN-KINASES; RESPONSE ELEMENT; EXPRESSION; PHOSPHORYLATION; ACTIVATION; IDENTIFICATION; INDUCTION; TNF; FXR	Bile acids regulate the cholesterol 7 alpha -hydroxylase gene (CYP7A1), which encodes the rate-limiting enzyme in the classical pathway of bile acid synthesis. Here we report a novel mechanism whereby bile acid feedback regulates CYP7A1 transcription through the nuclear receptor hepatocyte nuclear factor-4 (HNF-4), which binds to the bile acid response element (BARE) at nt -149/-118 relative to the transcription start site. Using transient transfection assays of HepG2 cells with Ga14-HNF-4 fusion proteins, we show that chenodeoxycholic acid (CDCA) dampened the transactivation potential of HNF-4. Overexpression of a constitutive active form of MEKK1, an upstream mitogen-activated protein kinase (MAPK) module triggered by stress signals, strongly repressed the promoter activity of CYP7A1 via the consensus sequence for HNF-4 embedded in the BARE. Similarly, MEEK1 inhibited the activity of HNF-4 in the Ga14-based assay. The involvement of the MEKK1-dependent pathway in the bile acid-mediated repression of CYP7A1 was confirmed by co-transfecting a dominant negative form of the stress-activated protein kinase kinase, SEK, which abolished the effect of CDCA upon CYP7A1 transcription. Treatment of transfected HepG2 cells with tumor necrosis factor a (TNF-alpha), an activator of the MEKK1 pathway, led to the repression of CYP7A1 via the HNF-4 site in the BARE. TNF-alpha also inhibited the transactivation potential of HNF-4. Collectively, our results demonstrate for the first time that HNF-4, in combination with a MAPK signaling pathway, acts as a bile acid sensor in the liver. Furthermore, the effects of CDCA and TNF-alpha converge to HNF-4, which binds to the BARE of CYP7A1, suggesting a link between the cascades elicited by bile acids and pro-inflammatory stimuli in the liver.	Univ Milan, Fac Farm, Dipartimento Sci Farmacol, I-20133 Milan, Italy	University of Milan	Crestani, M (corresponding author), Univ Milan, Fac Farm, Dipartimento Sci Farmacol, Via Balzaretti 9, I-20133 Milan, Italy.	Maurizio.Crestani@unimi.it	De Fabiani, Emma/B-6936-2015	De Fabiani, Emma/0000-0003-2406-1468; Crestani, Maurizio/0000-0001-9230-1078; Anzulovich, Ana/0000-0001-6989-7168; Mitro, Nico/0000-0002-5000-3619				Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Auwerx J, 1999, CELL, V97, P161; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Chen NY, 1999, J BIOL CHEM, V274, P15389, DOI 10.1074/jbc.274.22.15389; CHIANG JYL, 1994, J BIOL CHEM, V269, P17502; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; CRESTANI M, 1994, BIOCHEM BIOPH RES CO, V198, P546, DOI 10.1006/bbrc.1994.1080; Crestani M, 1996, BIOCHEM BIOPH RES CO, V225, P585, DOI 10.1006/bbrc.1996.1215; CRESTANI M, 1995, J LIPID RES, V36, P2419; Crestani M, 1998, J LIPID RES, V39, P2192; De Fabiani E, 2000, BIOCHEM J, V347, P147; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; Feingold KR, 1996, J LIPID RES, V37, P223; GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Miyake JH, 2000, J BIOL CHEM, V275, P21805, DOI 10.1074/jbc.C000275200; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; PANDAK WM, 1991, J BIOL CHEM, V266, P3416; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; STRAVITZ RT, 1993, J BIOL CHEM, V268, P13987; Stravitz RT, 1996, AM J PHYSIOL-GASTR L, V271, pG293, DOI 10.1152/ajpgi.1996.271.2.G293; STRAVITZ RT, 1999, P 15 INT BIL AC M BI; Stroup D, 2000, J LIPID RES, V41, P1; Stroup D, 1997, AM J PHYSIOL-GASTR L, V273, pG508, DOI 10.1152/ajpgi.1997.273.2.G508; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Wang DP, 1996, J LIPID RES, V37, P1831; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200	39	144	147	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30708	30716		10.1074/jbc.M103270200	http://dx.doi.org/10.1074/jbc.M103270200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402042	hybrid			2022-12-27	WOS:000170472900018
J	Fringer, J; Grinnell, F				Fringer, J; Grinnell, F			Fibroblast quiescence in floating or released collagen matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE PROGRESSION; SUSTAINED ACTIVATION; SIGNAL-TRANSDUCTION; DOWN-REGULATION; GROWTH-FACTORS; EXPRESSION; ADHESION; PHASE; PHOSPHORYLATION	Fibroblasts in attached collagen matrices proliferate, whereas cells in floating or released matrices become quiescent. Cells in attached matrices had prominent actin stress fibers, indicating that they were under isometric tension, whereas stress fibers were absent from fibroblasts in floating or released matrices. Compared with cells in attached matrices, cells in floating or released matrices showed downregulation of cyclin DI and up-regulation of p27(Kip1) cyclin-dependent kinase inhibitor, and similar changes occurred after the ERK signaling pathway was blocked by UO126 in cells in attached matrices. A different pattern of changes in cell cycle regulatory proteins occurred, however, after serum deprivation or actin cytoskeletal depolymerization by latrunculin B, which did not prevent signaling through the ERK pathway. Therefore, cell quiescence in floating or released collagen matrices could be explained by decreased signaling through the ERK pathway, but these changes were not accounted for by the absence of isometric tension in the cells.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Grinnell, F (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	frederick.grinnell@utsouthwestern.edu			NIAMS NIH HHS [AR41940] Funding Source: Medline; NIGMS NIH HHS [GM31321] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031321, R37GM031321] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Assoian RK, 1997, CURR OPIN CELL BIOL, V9, P93, DOI 10.1016/S0955-0674(97)80157-3; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Bohmer RM, 1996, MOL BIOL CELL, V7, P101; Bosch M, 1998, J BIOL CHEM, V273, P22145, DOI 10.1074/jbc.273.34.22145; Bottazzi ME, 1999, J CELL BIOL, V146, P1255, DOI 10.1083/jcb.146.6.1255; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413; Desmouliere A, 1996, MOL CELLULAR BIOL WO, P391; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fluck J, 1998, J INVEST DERMATOL, V110, P153, DOI 10.1046/j.1523-1747.1998.00095.x; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304; Rivard N, 1999, AM J PHYSIOL-CELL PH, V277, pC652, DOI 10.1152/ajpcell.1999.277.4.C652; Rizzo V, 1998, J BIOL CHEM, V273, P26323, DOI 10.1074/jbc.273.41.26323; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Rosenfeldt H, 2000, J BIOL CHEM, V275, P3088, DOI 10.1074/jbc.275.5.3088; SCHIRO JA, 1991, CELL, V67, P403, DOI 10.1016/0092-8674(91)90191-Z; Schwartz MA, 1999, CURR OPIN CELL BIOL, V11, P197, DOI 10.1016/S0955-0674(99)80026-X; Seufferlein T, 1996, MOL BIOL CELL, V7, P1865, DOI 10.1091/mbc.7.12.1865; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Somasundaram R, 1996, J BIOL CHEM, V271, P26884, DOI 10.1074/jbc.271.43.26884; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391; ZHU XY, 1999, CRC METH SIG TRANS, P129	50	76	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31047	31052		10.1074/jbc.M101898200	http://dx.doi.org/10.1074/jbc.M101898200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11410588	hybrid			2022-12-27	WOS:000170472900061
J	Izumi, M; Fujio, Y; Kunisada, K; Negoro, S; Tone, E; Funamoto, M; Osugi, T; Oshima, Y; Nakaoka, Y; Kishimoto, T; Yamauchi-Takihara, K; Hirota, H				Izumi, M; Fujio, Y; Kunisada, K; Negoro, S; Tone, E; Funamoto, M; Osugi, T; Oshima, Y; Nakaoka, Y; Kishimoto, T; Yamauchi-Takihara, K; Hirota, H			Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE KINASE RECEPTORS; MYOCARDIAL-CELL HYPERTROPHY; ADULT VENTRICULAR MYOCYTES; GROWTH-FACTOR-I; GENE-EXPRESSION; BCL-X; HEART-FAILURE; ALPHA(1)-ADRENERGIC RECEPTOR; SIGNAL-TRANSDUCTION; PARACRINE MECHANISM	Bone morphogenetic protein (BMP)-2 has been shown to induce ectopic expression of cardiac transcription factors and beating cardiomyocytes in non-precardiac mesodermal cells, suggesting that BMP-2 is an inductive signaling molecule that participates in cardiac development. However, direct evidence of the effects of BMP-2 on cardiac myocytes has not been reported. To examine the role of BMP-2 and its receptors, we studied the ability of BMP-2 to promote survival of isolated neonatal rat cardiac myocytes. BMP receptors IA IB, and II and activin receptor I were found to be expressed in myocytes, and BMP-2 phosphorylated Smad1 and p38 MAPK. Interestingly, BMP-2 promoted survival and inhibited apoptosis of serum-deprived myocytes, although it did not strongly induce hypertrophic growth. To explore the mechanisms for this protective effect, an adenovirus-based vector system was used. Similar to BMP-2, Smad1 promoted survival that was repressed by Smad6. Moreover, BMP-2 and Smad1 enhanced the expression of the anti-apoptotic molecule Bcl-x(L). Antisense oligonucleotides to bcl-x(L) attenuated the survival effected by BMP-2. Overall, our findings suggest that BMP-2 prevents apoptosis of myocytes by induction of Bcl-x(L) via a Smad1 pathway and might be a novel survival factor without any hypertrophic effect on myocytes.	Osaka Univ, Grad Sch Med, Dept Mol Med, Suita, Osaka 5650871, Japan	Osaka University	Hirota, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Kishimoto, Tadamitsu/C-8470-2009; Fujio, Yasushi/H-3421-2017	Fujio, Yasushi/0000-0003-0828-2930				Ackermann EJ, 1999, J BIOL CHEM, V274, P11245, DOI 10.1074/jbc.274.16.11245; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Iantosca MR, 1999, J NEUROSCI RES, V56, P248; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; ITO H, 1991, CIRC RES, V69, P209, DOI 10.1161/01.RES.69.1.209; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Kajstura J, 1997, J MOL CELL CARDIOL, V29, P859, DOI 10.1006/jmcc.1996.0333; Kaye D, 1996, J CLIN INVEST, V97, P281, DOI 10.1172/JCI118414; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Kunisada K, 1996, CIRCULATION, V94, P2626, DOI 10.1161/01.CIR.94.10.2626; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Massague J, 1996, CANCER SURV, V27, P41; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Negoro S, 2001, CIRCULATION, V103, P555, DOI 10.1161/01.CIR.103.4.555; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Ramirez MT, 1997, J BIOL CHEM, V272, P14057, DOI 10.1074/jbc.272.22.14057; REDDI AH, 1994, CURR OPIN GENET DEV, V4, P737, DOI 10.1016/0959-437X(94)90141-O; Roelen BAJ, 1997, INT J DEV BIOL, V41, P541; Rokosh DG, 1996, J BIOL CHEM, V271, P5839, DOI 10.1074/jbc.271.10.5839; ROSEN V, 1992, TRENDS GENET, V8, P97, DOI 10.1016/0168-9525(92)90063-A; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; Singh K, 1996, J BIOL CHEM, V271, P1111, DOI 10.1074/jbc.271.2.1111; tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; WANG ZH, 1995, J IMMUNOL, V155, P3722; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Yokouchi Y, 1996, DEVELOPMENT, V122, P3725; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	62	67	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31133	31141		10.1074/jbc.M101463200	http://dx.doi.org/10.1074/jbc.M101463200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11408477	hybrid			2022-12-27	WOS:000170472900072
J	Li, Y; Foran, P; Lawrence, G; Mohammed, N; Chan-Kwo-Chion, CKN; Lisk, G; Aoki, R; Dolly, O				Li, Y; Foran, P; Lawrence, G; Mohammed, N; Chan-Kwo-Chion, CKN; Lisk, G; Aoki, R; Dolly, O			Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE AXONAL-TRANSPORT; BOTULINUM NEUROTOXIN-A; CENTRAL-NERVOUS-SYSTEM; HEAVY-CHAIN; NEUROTRANSMITTER RELEASE; INTERCHAIN DISULFIDE; TRANSMITTER RELEASE; LIMITED PROTEOLYSIS; ESCHERICHIA-COLI; LIGHT-CHAIN	Tetanus toxin is a fascinating, multifunctional protein that binds to peripheral neurons, undergoes retrograde transport and trans-synaptic transfer to central inhibitory neurons where it blocks transmitter release, thereby, causing spastic paralysis. As a pre-requisite for exploiting its unique trafficking properties, a novel recombinant single chain was expressed at a high level in Eacherichia coli as a soluble, easily purifiable protein. It could be activated with enterokinase to produce a di-chain that matched native toxin in terms of proteolytic and neuroinhibitory activities, as well as induction of spastic paralysis in mice. Importantly, nicking was not essential for protease activity. Substitution of GIU234 by Ala created a protease-deficient atoxic form, which blocked the neuroparalytic action of tetanus toxin in vitro, with equal potency to its heavy chain; but, the mutant proved > 30-fold more potent in preventing tetanus in mice. This observation unveils differences between the intoxication processes resulting from retrograde transport of toxin in vivo and its local uptake into peripheral or central nerves in vitro, dispelling a popularly held belief that the heavy chain is the sole determinant for efficient trafficking. Thus, this innocuous mutant may be a useful vehicle, superior to the heavy chain, for drug delivery to central neurons.	Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AZ, England; Allergan Pharmaceut Inc, Irvine, CA 92623 USA	Imperial College London; AbbVie; Allergan	Dolly, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AZ, England.		Dolly, Oliver/G-1532-2012; Dolly, Oliver/ABH-6677-2020; Lawrence, Gary/F-3949-2012	Dolly, Oliver/0000-0002-0861-5320; Dolly, Oliver/0000-0002-0861-5320; 				BIZZINI B, 1977, J NEUROCHEM, V28, P529, DOI 10.1111/j.1471-4159.1977.tb10423.x; BIZZINI B, 1981, BRAIN RES, V210, P291, DOI 10.1016/0006-8993(81)90902-1; CAMBRAYDEAKIN MA, 1995, NEURAL CELL CULTURE, P3; Coen L, 1997, P NATL ACAD SCI USA, V94, P9400, DOI 10.1073/pnas.94.17.9400; DanielsHolgate PU, 1996, J NEUROSCI RES, V44, P263, DOI 10.1002/(SICI)1097-4547(19960501)44:3<263::AID-JNR7>3.0.CO;2-E; DEPAIVA A, 1993, J BIOL CHEM, V268, P20838; DEPAIVA A, 1993, J NEUROCHEM, V61, P2338, DOI 10.1111/j.1471-4159.1993.tb07482.x; Dolly J. O., 1990, NEUROMUSCULAR TRANSM, P107; DOLLY JO, 1994, SEMIN NEUROSCI, V6, P149; FAIRWEATHER NF, 1993, FEBS LETT, V323, P218, DOI 10.1016/0014-5793(93)81343-X; FIGUEIREDO D, 1995, INFECT IMMUN, V63, P3218, DOI 10.1128/IAI.63.8.3218-3221.1995; Figueiredo DM, 1997, EXP NEUROL, V145, P546, DOI 10.1006/exnr.1997.6490; FISHMAN PS, 1990, J NEUROL SCI, V98, P311, DOI 10.1016/0022-510X(90)90272-O; Fishman PS, 1999, NAT TOXINS, V7, P151, DOI 10.1002/(SICI)1522-7189(199907/08)7:4<151::AID-NT51>3.3.CO;2-B; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; FRANCIS JW, 1995, J BIOL CHEM, V270, P15434, DOI 10.1074/jbc.270.25.15434; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; HABERMANN E, 1991, N-S ARCH PHARMACOL, V343, P323; HABIG WH, 1983, FRONTIERS BIOCH STUD, P463; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Herreros J, 2000, J NEUROCHEM, V74, P1941, DOI 10.1046/j.1471-4159.2000.0741941.x; HOGY B, 1992, TOXICON, V30, P63, DOI 10.1016/0041-0101(92)90502-V; KRIEGLSTEIN KG, 1991, EUR J BIOCHEM, V202, P41, DOI 10.1111/j.1432-1033.1991.tb16342.x; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lalli G, 1999, J CELL SCI, V112, P2715; Li Y, 1999, J BIOCHEM, V125, P1200, DOI 10.1093/oxfordjournals.jbchem.a022404; LI Y, 1994, BIOCHEMISTRY-US, V33, P7014, DOI 10.1021/bi00188a034; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; MAISEY EA, 1988, EUR J BIOCHEM, V177, P683, DOI 10.1111/j.1432-1033.1988.tb14423.x; MATSUDA M, 1982, BIOCHEM BIOPH RES CO, V104, P799, DOI 10.1016/0006-291X(82)90708-2; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; PRICE DL, 1975, SCIENCE, V188, P945, DOI 10.1126/science.49080; SCHIAVO G, 1990, INFECT IMMUN, V58, P4136, DOI 10.1128/IAI.58.12.4136-4141.1990; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1991, EUR J BIOCHEM, V199, P705, DOI 10.1111/j.1432-1033.1991.tb16174.x; SCHWAB ME, 1979, J CELL BIOL, V82, P798, DOI 10.1083/jcb.82.3.798; SIMPSON LL, 1986, ANNU REV PHARMACOL, V26, P427, DOI 10.1146/annurev.pa.26.040186.002235; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Ugolini Gabriella, 1995, P293, DOI 10.1016/B978-012397570-6/50019-8; WELLER U, 1989, EUR J BIOCHEM, V182, P649, DOI 10.1111/j.1432-1033.1989.tb14874.x; [No title captured]	43	27	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31394	31401		10.1074/jbc.M103517200	http://dx.doi.org/10.1074/jbc.M103517200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402045	hybrid			2022-12-27	WOS:000170472900104
J	Ruiz-Echevarria, MJ; Munshi, R; Tomback, J; Kinzy, TG; Peltz, SW				Ruiz-Echevarria, MJ; Munshi, R; Tomback, J; Kinzy, TG; Peltz, SW			Characterization of a general stabilizer element that blocks deadenylation-dependent mRNA decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-ACTING SEQUENCES; BINDING PROTEIN; CODING REGION; YEAST; TRANSLATION; DEGRADATION; MFA2; TRANSCRIPTS; TURNOVER; SEGMENT	mRNA degradation is a regulated process that can play an important role in determining the level of expression of specific genes. The rate at which a specific mRNA is degraded depends largely on specific cis-acting sequences located throughout the transcript. cis-Acting destabilizer sequences that promote increased rates of decay have been identified in several short-lived mRNAs. However, little is known about elements that promote stability, known as stabilizer elements (STEs), and how they function. The work presented here describes the characterization of a STE in the PGK1 transcript. The PGK1 stabilizer element (P-STE) has been delineated to a 64-nucleotide sequence from the coding region that can stabilize a chimeric transcript containing the instability elements from the 3 ' -untranslated region of the MFA2 transcript. The P-STE is located within the PGK1 coding region and functions when located in the translated portion of the transcript and at a minimum distance from the W-untranslated region. These results further support the link between translation and mRNA degradation. A conserved sequence in the TEF1/2 transcript has been identified that also functions as a STE, suggesting that this sequence element maybe a general stability determinant found in other yeast mRNAs.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, Piscataway, NJ 08854 USA; Canc Inst New Jersey, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kinzy, TG (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu; peltz@umdnj.edu		Ruiz Echevarria, Maria Jesus/0000-0001-7133-9982; Kinzy, Terri/0000-0003-1394-9226	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058276, R01GM057483] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58276, GM57483, R01 GM057483] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; AUSUBEL FM, 1992, CURRENT PROTOCOLS MO, V2; Barnes CA, 1998, NUCLEIC ACIDS RES, V26, P2433, DOI 10.1093/nar/26.10.2433; BARNES CA, 1993, EMBO J, V12, P3323, DOI 10.1002/j.1460-2075.1993.tb06002.x; BARNES CA, 1995, MOL GEN GENET, V246, P619, DOI 10.1007/BF00298969; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Caponigro G, 1996, NUCLEIC ACIDS RES, V24, P4304, DOI 10.1093/nar/24.21.4304; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; CEREGHINO GP, 1995, MOL BIOL CELL, V6, P1125, DOI 10.1091/mbc.6.9.1125; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; HAGAN KW, 1995, MOL CELL BIOL, V15, P809; HEATON B, 1992, NUCLEIC ACIDS RES, V20, P5365, DOI 10.1093/nar/20.20.5365; Hennigan AN, 1996, MOL CELL BIOL, V16, P3833; HERRICK D, 1992, GENE, V114, P35, DOI 10.1016/0378-1119(92)90704-S; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Linz B, 1997, J BIOL CHEM, V272, P9131; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; MYSLINSKI E, 1990, SCIENCE, V247, P1213, DOI 10.1126/science.1690452; PARKER R, 1990, P NATL ACAD SCI USA, V87, P2780, DOI 10.1073/pnas.87.7.2780; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; PELTZ SW, 1993, CONTROL MRNA STABILI, P291; PRESUTTI C, 1995, EMBO J, V14, P4022, DOI 10.1002/j.1460-2075.1995.tb00073.x; Rose M. D., 1990, METHODS YEAST GENETI, P97; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Ruiz-Echevarria MJ, 1998, EMBO J, V17, P575, DOI 10.1093/emboj/17.2.575; SAMBROOK J, 1989, MOL CLONINB LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; SUROSKY RT, 1992, MOL CELL BIOL, V12, P3948, DOI 10.1128/MCB.12.9.3948; THEODORAKIS NG, 1996, TRANSLATIONAL CONTRO, P631; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; WEISS IM, 1994, MOL CELL BIOL, V14, P8123, DOI 10.1128/MCB.14.12.8123; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	47	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30995	31003		10.1074/jbc.M010833200	http://dx.doi.org/10.1074/jbc.M010833200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11423548	hybrid			2022-12-27	WOS:000170472900055
J	Vabulas, RM; Ahmad-Nejad, P; da Costa, C; Miethke, T; Kirschning, CJ; Hacker, H; Wagner, H				Vabulas, RM; Ahmad-Nejad, P; da Costa, C; Miethke, T; Kirschning, CJ; Hacker, H; Wagner, H			Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; NF-KAPPA-B; ANTIGEN-PRESENTING CELLS; GP96 INDUCES MATURATION; DENDRITIC CELLS; CUTTING EDGE; MEDIATED ENDOCYTOSIS; WALL COMPONENTS; CPG-DNA; ADAPTER	Heat shock proteins (HSPs) require no adjuvant to confer immunogenicity to bound peptides, as if they possessed an intrinsic "danger" signature. To understand the proinflammatory nature of HSP, we analyzed signaling induced by human and chlamydial HSP60. We show that both HSP60s activate the stress-activated protein kinases p38 and JNK1/2, the mitogen-activated protein kinases ERK1/2, and the I-kappaB kinase (IKK). Activation of JNK and IKK proceeds via the Toll/IL-1 receptor signaling pathway involving MyD88 and TRAF6. Human fibroblasts transfected with TLR2 or TLR4 plus MD-2 gain responsiveness to HSP60, while TLR2- or TLR4-defective cells display impaired responses. Initiation of signaling requires endocytosis of HSP60 that is effectively inhibited by serum component(s). The results revealed that adjuvanticity of HSP60 operates similar to that of classical pathogen-derived ligands.	Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	Technical University of Munich	Wagner, H (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Trogerstr 9, D-81675 Munich, Germany.		Haecker, Hans/F-6826-2013; Vabulas, R. Martin/D-3506-2011	Haecker, Hans/0000-0001-5971-0451; 				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; ARNOLD D, 1995, J EXP MED, V182, P885, DOI 10.1084/jem.182.3.885; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Binder RJ, 2000, J IMMUNOL, V165, P6029, DOI 10.4049/jimmunol.165.11.6029; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Binder RJ, 2000, J IMMUNOL, V165, P2582, DOI 10.4049/jimmunol.165.5.2582; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen W, 1999, J IMMUNOL, V162, P3212; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kol A, 1998, CIRCULATION, V98, P300, DOI 10.1161/01.CIR.98.4.300; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Moroi Y, 2000, P NATL ACAD SCI USA, V97, P3485, DOI 10.1073/pnas.070550797; Nieland TJF, 1996, P NATL ACAD SCI USA, V93, P6135, DOI 10.1073/pnas.93.12.6135; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Riezman H, 1997, CELL, V91, P731, DOI 10.1016/S0092-8674(00)80461-4; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Singh-Jasuja H, 2000, EUR J IMMUNOL, V30, P2211, DOI 10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1	49	631	670	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31332	31339		10.1074/jbc.M103217200	http://dx.doi.org/10.1074/jbc.M103217200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402040	hybrid			2022-12-27	WOS:000170472900097
J	Vasiljeva, L; Valmu, L; Kaariainen, L; Merits, A				Vasiljeva, L; Valmu, L; Kaariainen, L; Merits, A			Site-specific protease activity of the carboxyl-terminal domain of semliki forest virus replicase protein nsP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; STRAND RNA-SYNTHESIS; SINDBIS VIRUS; ENCODED PROTEINASES; MINUS-STRAND; NONSTRUCTURAL POLYPROTEINS; GEL-ELECTROPHORESIS; CRYSTAL-STRUCTURE; NS4A COFACTOR; NS3 PROTEASE	The virus-specific components (nsP1-nsP4) of Semliki Forest virus RNA polymerase are synthesized as a large polyprotein (P1234), which is cleaved by a virus-encoded protease. Based on mutagenesis studies, nsP2 has been implicated as the protease moiety of P1234. Here, we show that purified nsP2 (799 amino acids) and its C-terminal domain Pro39 (amino acids 459-799) specifically process P1234 and its cleavage intermediates. Analysis of cleavage products of in vitro synthesized P12, P23, and P34 revealed cleavages at sites 1/2,2/3, and 3/4. The cleavage regions of P1/2, P2/3, and P3/4 were expressed as thioredoxin fusion proteins (Trx12, Trx23, and Trx34), containing similar to 20 amino acids on each side of the cleavage sites. After exposure of these purified fusion proteins to nsP2 or Pro39, the reaction products were analyzed by SDS-polyacrylamide gel electrophoresis, mass spectrometry, and amino-terminal sequencing. The expected amino termini of nsP2, nsP3, and nsP4 were detected. The cleavage at 3/4 site was most efficient, whereas cleavage at 1/2 site required 5000-fold more of Pro39, and 2/3 site was almost resistant to cleavage. The activity of Pro39 was inhibited by N-ethylmaleimide, Zn2+, and Cu2+, but not by EDTA, phenylmethylsulfonyl fluoride, or pepstatin, in accordance with the thiol proteinase nature of nsP2.	Univ Helsinki, Bioctr Viikki, Inst Biotechnol, Program Cellular Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki	Kaariainen, L (corresponding author), Univ Helsinki, Bioctr Viikki, Inst Biotechnol, Program Cellular Biotechnol, POB 56, FIN-00014 Helsinki, Finland.	leevi.kaariainen@helsinki.fi	Vasilieva, Lidia/AAU-1473-2020; Merits, Andres/H-3125-2015	Merits, Andres/0000-0001-8193-0071; Vasiljeva, Lidia/0000-0002-1244-8772				Beynon R.J, 1989, PROTEOLYTIC ENZYMES, P83; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; de Cedron MG, 1999, FEBS LETT, V448, P19, DOI 10.1016/S0014-5793(99)00321-X; DING MX, 1989, VIROLOGY, V171, P280, DOI 10.1016/0042-6822(89)90539-4; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Frey TK, 1999, ENCY VIROLOGY, P1592; GORBALENYA AE, 1991, FEBS LETT, V288, P201, DOI 10.1016/0014-5793(91)81034-6; HARDY WR, 1989, J VIROL, V63, P4653, DOI 10.1128/JVI.63.11.4653-4664.1989; KAARIAINEN L, 1987, J CELL SCI, P231; KALKKINEN N, 1981, VIROLOGY, V113, P188, DOI 10.1016/0042-6822(81)90147-1; KALKKINEN N, 1986, ADV METHODS PROTEIN, P194; KERANEN S, 1983, J VIROL, V47, P505; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kujala P, 2001, J VIROL, V75, P3873, DOI 10.1128/JVI.75.8.3873-3884.2001; LAWSON MA, 1991, P NATL ACAD SCI USA, V88, P9919, DOI 10.1073/pnas.88.22.9919; LEMM JA, 1993, J VIROL, V67, P1905, DOI 10.1128/JVI.67.4.1905-1915.1993; LEMM JA, 1993, J VIROL, V67, P1916, DOI 10.1128/JVI.67.4.1916-1926.1993; LEMM JA, 1994, EMBO J, V13, P2925, DOI 10.1002/j.1460-2075.1994.tb06587.x; LIN C, 1995, P NATL ACAD SCI USA, V92, P7622, DOI 10.1073/pnas.92.17.7622; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Merits A, 2001, J GEN VIROL, V82, P765, DOI 10.1099/0022-1317-82-4-765; Moini M, 1998, J AM SOC MASS SPECTR, V9, P977, DOI 10.1016/S1044-0305(98)00079-8; PERANEN J, 1990, J VIROL, V64, P1888; PERANEN J, 1993, J HISTOCHEM CYTOCHEM, V41, P447, DOI 10.1177/41.3.8429208; RIKKONEN M, 1992, VIROLOGY, V189, P462, DOI 10.1016/0042-6822(92)90570-F; Rikkonen M, 1996, VIROLOGY, V218, P352, DOI 10.1006/viro.1996.0204; RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994; Ryan MD, 1998, J GEN VIROL, V79, P947, DOI 10.1099/0022-1317-79-5-947; Ryan MD, 1997, J GEN VIROL, V78, P699, DOI 10.1099/0022-1317-78-4-699; SAWICKI DL, 1980, J VIROL, V34, P108, DOI 10.1128/JVI.34.1.108-118.1980; SAWICKI DL, 1985, VIROLOGY, V144, P20, DOI 10.1016/0042-6822(85)90301-0; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schlesinger MJ, 1999, ENCY VIROLOGY, P1656; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; SHIRAKO Y, 1990, VIROLOGY, V177, P54, DOI 10.1016/0042-6822(90)90459-5; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; STRAUSS EG, 1992, VIROLOGY, V191, P932, DOI 10.1016/0042-6822(92)90268-T; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Strauss JH, 1990, SEMIN VIROL, V1, P347; Suopanki J, 1998, J GEN VIROL, V79, P309, DOI 10.1099/0022-1317-79-2-309; ten Dam E, 1999, J GEN VIROL, V80, P1879, DOI 10.1099/0022-1317-80-8-1879; Vasiljeva L, 2000, J BIOL CHEM, V275, P17281, DOI 10.1074/jbc.M910340199; YU FS, 1991, VIROLOGY, V182, P615; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	45	66	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30786	30793		10.1074/jbc.M104786200	http://dx.doi.org/10.1074/jbc.M104786200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11410598	hybrid			2022-12-27	WOS:000170472900029
J	Zolman, BK; Monroe-Augustus, M; Thompson, B; Hawes, JW; Krukenberg, KA; Matsuda, SPT; Bartel, B				Zolman, BK; Monroe-Augustus, M; Thompson, B; Hawes, JW; Krukenberg, KA; Matsuda, SPT; Bartel, B			chy1, an Arabidopsis mutant with impaired beta-oxidation, is defective in a peroxisomal beta-hydroxyisobutyryl-CoA hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID DEGRADATION; MOLECULAR CHARACTERIZATION; INDOLE-3-BUTYRIC ACID; RESISTANT MUTANTS; PLANT; DEHYDROGENASE; PURIFICATION; COENZYME; CARBOXYLASE; METABOLISM	The Arabidopsis chy1 mutant is resistant to indole-3-butyric acid, a naturally occurring form of the plant hormone auxin. Because the mutant also has defects in peroxisomal beta -oxidation, this resistance presumably results from a reduced conversion of indole-3-butyric acid to indole-3-acetic acid. We have cloned CHY1, which appears to encode a peroxisomal protein 43% identical to a mammalian valine catabolic enzyme that hydrolyzes beta -hydroxyisobutyryl-CoA. We demonstrated that a human beta -hydroxyisobutyryl-CoA hydrolase functionally complements chy1 when redirected from the mitochondria to the peroxisomes. We expressed CHY1 as a glutathione S-transferase (GST) fusion protein and demonstrated that purified GST-CHY1 hydrolyzes beta -hydroxyisobutyryl-CoA. Mutagenesis studies showed that a glutamate that is catalytically essential in homologous enoyl-CoA hydratases was also essential in CHY1. Mutating a residue that is differentially conserved between hydrolases and hydratases established that this position is relevant to the catalytic distinction between the enzyme classes. It is likely, that CHY1 acts in peroxisomal valine catabolism and that accumulation of a toxic intermediate, methacrylyl-CoA, causes the altered beta -oxidation phenotypes of the chy1 mutant. Our results support the hypothesis that the energy-intensive sequence unique to valine catabolism, where an intermediate CoA ester is hydrolyzed and a new CoA ester is formed two steps later, avoids methacrylyl-CoA accumulation.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, Dept Chem, Houston, TX 77005 USA; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Rice University; Rice University; Indiana University System; Indiana University-Purdue University Indianapolis	Bartel, B (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 S Main St, Houston, TX 77005 USA.	bartel@rice.edu	Bartel, Bonnie/O-8119-2019; Bartel, Bonnie/D-3550-2011	Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X; Thompson, Beth/0000-0002-5358-0796				Anderson MD, 1998, PLANT PHYSIOL, V118, P1127, DOI 10.1104/pp.118.4.1127; Ausubel F., 1999, CURRENT PROTOCOLS MO; BALDET P, 1992, PLANT PHYSIOL, V99, P450, DOI 10.1104/pp.99.2.450; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Belshaw PJ, 1999, SCIENCE, V284, P486, DOI 10.1126/science.284.5413.486; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BROWN GK, 1982, PEDIATRICS, V70, P532; Brown JWS, 1996, PLANT MOL BIOL, V32, P531, DOI 10.1007/BF00019105; CELENZA JL, 1995, GENE DEV, V9, P2131, DOI 10.1101/gad.9.17.2131; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COSTE J, 1990, TETRAHEDRON LETT, V31, P205, DOI 10.1016/S0040-4039(00)94371-5; Dansen TB, 2000, NAT CELL BIOL, V2, P51, DOI 10.1038/71375; Daschner K, 1999, PLANT MOL BIOL, V39, P1275; Davies Peter J., 1995, P1; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; DEARFIELD KL, 1991, MUTAGENESIS, V6, P519, DOI 10.1093/mutage/6.6.519; DUNFORD R, 1990, PHYTOCHEMISTRY, V29, P41, DOI 10.1016/0031-9422(90)89006-U; Eastmond PJ, 2000, J BIOL CHEM, V275, P34375, DOI 10.1074/jbc.M004945200; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Faivre-Nitschke SE, 2001, EUR J BIOCHEM, V268, P1332, DOI 10.1046/j.1432-1327.2001.01999.x; FAWCETT CH, 1960, PROC R SOC SER B-BIO, V152, P231, DOI 10.1098/rspb.1960.0035; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; Fujiki Y, 2000, J BIOL CHEM, V275, P6007, DOI 10.1074/jbc.275.8.6007; GEHRING U, 1968, EUR J BIOCHEM, V6, P264, DOI 10.1111/j.1432-1033.1968.tb00446.x; Geisbrecht BV, 1998, J BIOL CHEM, V273, P33184, DOI 10.1074/jbc.273.50.33184; GERBLING H, 1989, PLANT PHYSIOL, V91, P1387, DOI 10.1104/pp.91.4.1387; GERBLING H, 1988, PLANT PHYSIOL, V88, P13, DOI 10.1104/pp.88.1.13; GERHARDT B, 1992, PROG LIPID RES, V31, P417, DOI 10.1016/0163-7827(92)90004-3; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Hawes JW, 1996, J BIOL CHEM, V271, P26430, DOI 10.1074/jbc.271.42.26430; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hayashi M, 2000, EMBO J, V19, P5701, DOI 10.1093/emboj/19.21.5701; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Kaneko T, 1998, DNA Res, V5, P131, DOI 10.1093/dnares/5.2.131; KINDL H, 1993, BIOCHIMIE, V75, P225, DOI 10.1016/0300-9084(93)90080-C; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; KOTANI H, 1998, DNA RES, V5, P243; Lazarow Paul B., 1993, Trends in Cell Biology, V3, P89, DOI 10.1016/0962-8924(93)90079-G; LECLERE S, 2001, IN PRESS PLANT MOL B; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Ludwig-Muller J, 2000, PLANT GROWTH REGUL, V32, P219, DOI 10.1023/A:1010746806891; MAZELIS M, 1980, BIOCH PLANTS, V5, P542; McKean AL, 2000, J BIOL CHEM, V275, P5582, DOI 10.1074/jbc.275.8.5582; MINET M, 1992, PLANT J, V2, P417; MULLERNEWEN G, 1995, EUR J BIOCHEM, V228, P68, DOI 10.1111/j.1432-1033.1995.tb20230.x; NAGY F, 1988, MOL BIOL MANUAL; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Olsen LJ, 1998, PLANT MOL BIOL, V38, P163, DOI 10.1023/A:1006092830670; Reinard T, 2000, J BIOL CHEM, V275, P33738, DOI 10.1074/jbc.M004178200; Richmond TA, 1999, PLANT CELL, V11, P1911, DOI 10.1105/tpc.11.10.1911; SALAM WH, 1986, BIOCHIM BIOPHYS ACTA, V873, P321, DOI 10.1016/0167-4838(86)90079-8; Sato S, 2000, DNA RES, V7, P31, DOI 10.1093/dnares/7.1.31; Shimomura Y, 2000, METHOD ENZYMOL, V324, P229; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; STASINOPOULOS TC, 1990, PLANT PHYSIOL, V93, P1365, DOI 10.1104/pp.93.4.1365; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tabak HF, 1999, TRENDS CELL BIOL, V9, P447, DOI 10.1016/S0962-8924(99)01650-5; TRUSCOTT RJW, 1981, BIOMED MASS SPECTROM, V8, P99, DOI 10.1002/bms.1200080304; Zolman BK, 2000, GENETICS, V156, P1323	61	78	88	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31037	31046		10.1074/jbc.M104679200	http://dx.doi.org/10.1074/jbc.M104679200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11404361	hybrid			2022-12-27	WOS:000170472900060
J	Louis, JM; Bewley, CA; Clore, GM				Louis, JM; Bewley, CA; Clore, GM			Design and properties of N-CCG-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; 44 KDA ECTODOMAIN; ENVELOPE GLYCOPROTEIN; COILED-COIL; INACTIVATING PROTEIN; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATOMIC-STRUCTURE; CYANOVIRIN-N	The design and characterization of a chimeric protein, termed N-CCG-gp41, derived from the ectodomain of human immunodeficiency virus (HIV), type I gp41 is described. N-CCG-gp41 features an exposed trimeric coiled-coil comprising the N-terminal helices of the gp41 ectodomain. The trimeric coiled-coil is stabilized both by fusion to a minimal thermostable ectodomain of gp41 and by engineered intersubunit disulfide bonds. N(CCG)gp41 is shown to inhibit HIV envelope-mediated cell fusion at nanomolar concentrations with an IC., of 16.1 +/- 2.8 nM. It is proposed that N-CCG-gp41 targets the exposed C-terminal region of the gp41 ectodomain in its pre-hairpin intermediate state, thereby preventing the formation of the fusogenic form of the gp41 ectodomain, which comprises a highly stable trimer of hairpins arranged in a six-helix bundle. N-CCG-gp41 has potential as a therapeutic agent for the direct inhibition of HIV cell entry, as an anti-HIV vaccine, and as a component of a rapid throughput assay for screening for small molecule inhibitors of HIV envelope-mediated cell fusion. It is anticipated that antibodies raised against N-CCG-gp41 may target the trimeric coiled-coil of N-terminal helices of the gp41 ectodomain that is exposed in the pre-hairpin intermediate state in a manner analogous to peptides derived from the C-terminal helix of gp41 that are currently in clinical trials.	NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Phys Chem Lab, NIH, Bldg 5,Rm B1-301, Bethesda, MD 20892 USA.		Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Bewley, Carole/0000-0003-2203-0852; Louis, John M/0000-0002-0052-1899	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK032103, ZIADK032103] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEXANDER WA, 1992, J VIROL, V66, P2934, DOI 10.1128/JVI.66.5.2934-2942.1992; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BRODER CC, 1995, P NATL ACAD SCI USA, V92, P9004, DOI 10.1073/pnas.92.19.9004; BRUNGER AT, 1993, X PLOR SYSTEM XRYA C; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 1997, J MOL BIOL, V271, P819, DOI 10.1006/jmbi.1997.1217; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Farzan M, 1998, J VIROL, V72, P7620, DOI 10.1128/JVI.72.9.7620-7625.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferrer M, 1999, NAT STRUCT BIOL, V6, P953; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LOUIS JM, 1989, BIOCHEM BIOPH RES CO, V159, P87, DOI 10.1016/0006-291X(89)92408-X; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; McMichael AJ, 1999, NAT MED, V5, P612, DOI 10.1038/9455; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; WILD CT, 1992, P NATL ACAD SCI USA, V99, P10537; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693	34	94	117	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29485	29489		10.1074/jbc.C100317200	http://dx.doi.org/10.1074/jbc.C100317200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11418583	hybrid			2022-12-27	WOS:000170346000111
J	Vergauwen, B; Pauwels, F; Jacquemotte, F; Meyer, TE; Cusanovich, MK; Bartsch, RG; Van Beeumen, JJ				Vergauwen, B; Pauwels, F; Jacquemotte, F; Meyer, TE; Cusanovich, MK; Bartsch, RG; Van Beeumen, JJ			Characterization of glutathione amide reductase from Chromatium gracile - Identification of a novel thiol peroxidase (Prx/Grx) fueled by glutathione amide redox cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRYPANOTHIONE REDUCTASE; LIPOAMIDE DEHYDROGENASE; THIOREDOXIN PEROXIDASE; SALMONELLA-TYPHIMURIUM; CRITHIDIA-FASCICULATA; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; REACTIVE OXYGEN; PURIFICATION	Among the Chromatiaceae, the glutathione derivative gamma -L-glutamyl-L-cysteinylglycine amide, or glutathione amide, was reported to be present in facultative aerobic as well as in strictly anaerobic species, The gene (garB) encoding the central enzyme in glutathione amide cycling, glutathione amide reductase (GAR), has been isolated from Chromatium gracile, and its genomic organization has been examined. The garB gene is immediately preceded by an open reading frame encoding a novel 27.5-kDa chimeric enzyme composed of one N-terminal peroxiredoxin-like domain followed by a glutaredoxin-like C terminus. The 27.5-kDa enzyme was established in vitro to be a glutathione amide-dependent peroxidase, being the first example of a prokaryotic low molecular mass thiol-dependent peroxidase, Amino acid sequence alignment of GAR with the functionally homologous glutathione and trypanothione reductases emphasizes the conservation of the catalytically important redox-active disulfide and of regions involved in binding the FAD prosthetic group and the substrates glutathione amide disulfide and NADH, By establishing Michaelis constants of 97 and 13.2 muM for glutathione amide disulfide and NADH, respectively (in contrast to K-m values of 6.9 mM for glutathione disulfide and 1.98 mM for NADPH), the exclusive substrate specificities of GAR have been documented. Specificity for the amidated disulfide cofactor partly can be explained by the substitution of Arg-37, shown by x-ray crystallographic data of the human glutathione reductase to hydrogen-bond one of the glutathione glycyl carboxylates, by the negatively charged Glu-21, On the other hand, the preference for the unusual electron donor, to some extent, has to rely on the substitution of the basic residues Arg-218, His-219, and Arg-224, which have been shown to interact in the human enzyme with the NADPH 2'-phosphate group, by Leu-197, Glu-198, and Phe-203, We suggest GAR to be the newest member of the class I flavoprotein disulfide reductase family of oxidoreductases.	Univ Ghent, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium; Inst Meurice, Haute Ecole Luria de Brouckere, Dept Subst Nat, B-1070 Brussels, Belgium; Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA	Ghent University; University of Arizona; University of California System; University of California San Diego	Van Beeumen, JJ (corresponding author), Univ Ghent, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium.	Jozef.vanbeeumen@rug.ac.be						ABOAGYEKWARTENG T, 1992, MOL MICROBIOL, V6, P3089, DOI 10.1111/j.1365-2958.1992.tb01766.x; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Atherton E., 1990, SOLID PHASE PEPTIDE; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO, P241; Bartsch RG, 1996, J BACTERIOL, V178, P4742, DOI 10.1128/jb.178.15.4742-4746.1996; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN NL, 1983, BIOCHEMISTRY-US, V22, P4089, DOI 10.1021/bi00286a015; Cheong NE, 1999, PLANT MOL BIOL, V40, P825, DOI 10.1023/A:1006271823973; Choi YO, 1999, BIOCHEM BIOPH RES CO, V258, P768, DOI 10.1006/bbrc.1999.0714; CHUNG YC, 1975, J BACTERIOL, V123, P203, DOI 10.1128/JB.123.1.203-211.1975; Dolferus R, 1997, GENETICS, V146, P1131; Duine JA, 1999, BIOFACTORS, V10, P201, DOI 10.1002/biof.5520100217; FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1; Farber PM, 1996, EUR J BIOCHEM, V239, P655, DOI 10.1111/j.1432-1033.1996.0655u.x; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; GREER S, 1986, BIOCHEMISTRY-US, V25, P2736, DOI 10.1021/bi00357a069; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; JANES W, 1990, BIOCHEMISTRY-US, V29, P4022, DOI 10.1021/bi00468a033; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; KERKLAAN PRM, 1985, BIOCHEM PHARMACOL, V34, P2151, DOI 10.1016/0006-2952(85)90410-1; Ketterer B, 1998, FREE RADICAL RES, V28, P647, DOI 10.3109/10715769809065820; KRAUTHSIEGEL RL, 1982, EUR J BIOCHEM, V121, P259, DOI 10.1111/j.1432-1033.1982.tb05780.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; Macheroux P, 1999, METH MOL B, V131, P1; MASSEY V, 1965, J BIOL CHEM, V240, P4470; MISRA TK, 1985, GENE, V34, P253, DOI 10.1016/0378-1119(85)90134-9; MITTL PRE, 1994, PROTEIN SCI, V3, P799; MOUTIEZ M, 1995, BBA-GEN SUBJECTS, V1245, P161, DOI 10.1016/0304-4165(95)00085-P; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Patel MP, 1998, FEMS MICROBIOL LETT, V166, P155, DOI 10.1111/j.1574-6968.1998.tb13197.x; Patel MP, 1999, BIOCHEMISTRY-US, V38, P11827, DOI 10.1021/bi991025h; PFENNIG N, 1993, ANNU REV MICROBIOL, V47, P1; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; Reynolds CM, 2000, BIOCHEMISTRY-US, V39, P8859, DOI 10.1021/bi000826d; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sambrook J., 1982, MOL CLONING LAB MANU, P931; SCRUTTON NS, 1987, BIOCHEM J, V245, P875, DOI 10.1042/bj2450875; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SHAMES SL, 1986, BIOCHEMISTRY-US, V25, P3519, DOI 10.1021/bi00360a007; Sherrill C, 1998, J BACTERIOL, V180, P1454, DOI 10.1128/JB.180.6.1454-1459.1998; SMITH J, 1979, COMP BIOCHEM PHYS B, V63, P39, DOI 10.1016/0305-0491(79)90231-1; STEPHENS PE, 1983, EUR J BIOCHEM, V135, P519, DOI 10.1111/j.1432-1033.1983.tb07683.x; STORY SC, 1992, INT J PEPT PROT RES, V39, P87; SULLIVAN FX, 1989, BIOCHEMISTRY-US, V28, P4986, DOI 10.1021/bi00438a013; SUNDQUIST AR, 1989, J BIOL CHEM, V264, P719; SUNDQUIST AR, 1989, J MOL EVOL, V29, P429, DOI 10.1007/BF02602913; TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535; Toyoda T, 1998, J BIOCHEM-TOKYO, V123, P668; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; Zhou Y, 2000, BIOCHEM BIOPH RES CO, V268, P921, DOI 10.1006/bbrc.2000.2231	59	48	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20890	20897		10.1074/jbc.M102026200	http://dx.doi.org/10.1074/jbc.M102026200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11399772	hybrid			2022-12-27	WOS:000169297900015
J	Huai, Q; Xia, YH; Chen, YQ; Callahan, B; Li, N; Ke, HM				Huai, Q; Xia, YH; Chen, YQ; Callahan, B; Li, N; Ke, HM			Crystal structures of 1-aminocyclopropane-1-carboxylate (ACC) synthase in complex with aminoethoxyvinylglycine and pyridoxal-5 '-phosphate provide new insight into catalytic mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE-DEPENDENT ENZYME; ASPARTATE-AMINOTRANSFERASE; ESCHERICHIA-COLI; EVOLUTIONARY RELATIONSHIPS; 3-DIMENSIONAL STRUCTURE; ORNITHINE-DECARBOXYLASE; ANGSTROM RESOLUTION; ACID SYNTHASE; KEY ENZYME; WILD-TYPE	The structures of tomato 1-aminocyclopropane-1-carboxylate synthase (ACS) in complex with either cofactor pyridoxal-5'-phosphate (PLP) or both PLP and inhibitor aminoethoxyvinylglycine have been determined by x-ray crystallography. The structures showed good conservation of the catalytic residues, suggesting a similar catalytic mechanism for ACS and other PLP-dependent enzymes. However, the proximity of Tyr(152) to the C-gamma -S bond of model substrate S-adenosylmethionine implies its critical role in the catalysis. The concerted accomplishment of catalysis by cofactor PLP and a protein residue, as proposed on the basis of the ACS structures in this paper, may represent a general scheme for the diversity of PLP-dependent catalyses. PLP-dependent enzymes have been categorized into four types of folds. A structural comparison revealed that a core fragment of ACS in fold type I is superimposable over tryptophan synthase beta subunit in fold type II and mouse ornithine decarboxylase in fold type III, thus suggesting a divergent evolution of PLP-dependent enzymes.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Hong Kong University of Science & Technology	Ke, HM (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hke@med.unc.edu	Callahan, Brian/G-6491-2010	Callahan, Brian/0000-0003-4826-0162				ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLEECKER AB, 1986, P NATL ACAD SCI USA, V83, P7755, DOI 10.1073/pnas.83.20.7755; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capitani G, 1999, J MOL BIOL, V294, P745, DOI 10.1006/jmbi.1999.3255; Chook YM, 1998, ACTA CRYSTALLOGR D, V54, P822, DOI 10.1107/S0907444997020064; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; Eads JC, 1999, BIOCHEMISTRY-US, V38, P9840, DOI 10.1021/bi990018q; FORD GC, 1980, P NATL ACAD SCI-BIOL, V77, P2559, DOI 10.1073/pnas.77.5.2559; GRAY J, 1992, PLANT MOL BIOL, V19, P69, DOI 10.1007/BF00015607; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866; Hester G, 1999, J MOL BIOL, V286, P829, DOI 10.1006/jmbi.1998.2506; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HYDE CC, 1988, J BIOL CHEM, V263, P17857; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; Kack H, 1999, J MOL BIOL, V291, P857, DOI 10.1006/jmbi.1999.2997; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; Li N, 1996, FEBS LETT, V378, P286, DOI 10.1016/0014-5793(95)01464-0; LI N, 1994, J BIOL CHEM, V269, P6908; Li YS, 1997, BIOCHEMISTRY-US, V36, P15477, DOI 10.1021/bi971625l; MEHTA PK, 1989, EUR J BIOCHEM, V186, P249, DOI 10.1111/j.1432-1033.1989.tb15202.x; MOMANY C, 1995, J MOL BIOL, V252, P643, DOI 10.1006/jmbi.1995.0526; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Okamoto A, 1996, J BIOCHEM-TOKYO, V119, P135; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMALINGAM K, 1985, P NATL ACAD SCI USA, V82, P7820, DOI 10.1073/pnas.82.23.7820; Rhee S, 1997, J BIOL CHEM, V272, P17293, DOI 10.1074/jbc.272.28.17293; Rhee S, 1996, BIOCHEMISTRY-US, V35, P4211, DOI 10.1021/bi952506d; SATOH S, 1983, PHYSIOL PLANTARUM, V57, P521, DOI 10.1111/j.1399-3054.1983.tb02779.x; SATOH S, 1989, PLANT PHYSIOL, V91, P1036, DOI 10.1104/pp.91.3.1036; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Storici P, 1999, J MOL BIOL, V285, P297, DOI 10.1006/jmbi.1998.2289; Storici P, 1999, BIOCHEMISTRY-US, V38, P8628, DOI 10.1021/bi990478j; SUGIO S, 1995, BIOCHEMISTRY-US, V34, P9661, DOI 10.1021/bi00030a002; Tarun AS, 1998, J BIOL CHEM, V273, P12509, DOI 10.1074/jbc.273.20.12509; Tarun AS, 1998, P NATL ACAD SCI USA, V95, P9796, DOI 10.1073/pnas.95.17.9796; THEOLOGIS A, 1992, CELL, V70, P181, DOI 10.1016/0092-8674(92)90093-R; TONEY MD, 1995, J MOL BIOL, V245, P151, DOI 10.1006/jmbi.1994.0014; WALSH C, 1979, ENZYMATIC REACTION M, P851; WHITE MF, 1994, P NATL ACAD SCI USA, V91, P12428, DOI 10.1073/pnas.91.26.12428; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; YIP WK, 1991, PLANT PHYSIOL, V95, P251, DOI 10.1104/pp.95.1.251	52	60	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 12	2001	276	41					38210	38216						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481NU	11431475				2022-12-27	WOS:000171526500066
J	Brosh, RM; Harmakar, P; Sommers, JA; Yang, Q; Wang, XW; Spillare, EA; Harris, CC; Bohr, VA				Brosh, RM; Harmakar, P; Sommers, JA; Yang, Q; Wang, XW; Spillare, EA; Harris, CC; Bohr, VA			p53 modulates the exonuclease activity of Werner syndrome protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOBLASTOID CELL-LINES; SINGLE-STRANDED-DNA; WILD-TYPE; P53-MEDIATED APOPTOSIS; HELICASE ACTIVITY; BINDING DOMAIN; GROWTH-CONTROL; SYNDROME GENE; WRN PROTEIN; MUTANT P53	Werner syndrome (WS) is characterized by the early onset of symptoms of premature aging, cancer, and genomic instability. The molecular basis of the defects is not understood but presumably relates to the DNA helicase and exonuclease activities of the protein encoded by the WRN gene that is mutated in the disease. The attenuation of p53-mediated apoptosis in WS cells and reported physical interaction between WRN and the tumor suppressor p53 suggest that p53 and WRN functionally interact in a pathway necessary for the normal cellular response. In this study, we have demonstrated that p53 inhibits the exonuclease activity of the purified full-length recombinant WRN protein. p53 did not have an effect on a truncated amino-terminal WRN fragment that retains exonuclease activity but lacks the physical interaction domain for p53 located in the carboxyl terminus. Two naturally occurring p53 mutants found in human cancer displayed a reduced ability to inhibit WRN exonuclease activity. In cells arrested in S phase with hydroxyurea, WRN exits the nucleolus and colocalizes with p53 in the nucleoplasm. The regulation of WRN function by p53 is likely to play an important role in the maintenance of genomic integrity and prevention of cancer and other clinical symptoms associated with WS.	NIA, Genet Mol Lab, NIH, Baltimore, MD 21224 USA; NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 21892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bohr, VA (corresponding author), NIA, Genet Mol Lab, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.		Bohr, Vilhelm/AAP-5931-2020; Wang, Xin Wei/B-6162-2009	Wang, Xin Wei/0000-0001-9735-606X	NATIONAL INSTITUTE ON AGING [ZIAAG000741, ZIAAG000726, Z01AG000741, Z01AG000726] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAKALKIN G, 1994, P NATL ACAD SCI USA, V91, P413, DOI 10.1073/pnas.91.1.413; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Bennett MR, 1999, BIOCHEM PHARMACOL, V58, P1089; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cooper MP, 2000, GENE DEV, V14, P907; COX LS, 1995, EMBO J, V14, P2099, DOI 10.1002/j.1460-2075.1995.tb07201.x; El-Deiry WS, 1998, CURR TOP MICROBIOL, V227, P121; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; FRIEDMAN PN, 1990, P NATL ACAD SCI USA, V87, P9275, DOI 10.1073/pnas.87.23.9275; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; HANAOKA F, 1985, ADV EXP MED BIOL, V190, P439; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KERN SE, 1991, ONCOGENE, V6, P131; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KIENZLE H, 1989, EUR J BIOCHEM, V184, P181, DOI 10.1111/j.1432-1033.1989.tb15005.x; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Machwe A, 2000, NUCLEIC ACIDS RES, V28, P2762, DOI 10.1093/nar/28.14.2762; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; MATSON SW, 1983, J BIOL CHEM, V258, P4009; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Orren DK, 2001, NUCLEIC ACIDS RES, V29, P1926, DOI 10.1093/nar/29.9.1926; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Robles AI, 1999, ONCOGENE, V18, P4681, DOI 10.1038/sj.onc.1202862; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; TAKEUCHI F, 1982, HUM GENET, V60, P365, DOI 10.1007/BF00569220; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; WANG Y, 1993, GENE DEV, V7, P2575, DOI 10.1101/gad.7.12b.2575; Yamabe Y, 1998, MOL CELL BIOL, V18, P6191, DOI 10.1128/MCB.18.11.6191; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zhou XL, 1999, CANCER RES, V59, P843	50	80	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					35093	35102		10.1074/jbc.M103332200	http://dx.doi.org/10.1074/jbc.M103332200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11427532	hybrid			2022-12-27	WOS:000171024600099
J	Morimoto, T; Hasegawa, K; Wada, H; Kakita, T; Kaburagi, S; Yanazume, T; Sasayama, S				Morimoto, T; Hasegawa, K; Wada, H; Kakita, T; Kaburagi, S; Yanazume, T; Sasayama, S			Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; HEART-FAILURE; RAT CARDIOMYOCYTES; HYPERTROPHY; EXPRESSION; MUSCLE; CELLS; INHIBITION; GATA-4; PROTEIN	Increases in the expression of endothelin-1 (ET-1) in cardiac myocytes play a critical role in the development of heart failure in vivo. Whereas norepinephrine (NE) is a potent inducer of ET-1 expression in cardiac myocytes, the signaling pathways that link NE to inducible cardiac ET-1 expression are unknown. Adrenergic stimulation results in an increase in intracellular calcium levels, which in turn activates calcineurin. Here, we have shown that stimulation with NE markedly increased the expression of the ET-1 gene in primary cardiac myocytes from neonatal rats. This increase was severely attenuated by a beta -adrenergic antagonist, metoprolol, but not by an alpha -adrenergic antagonist, prazosin. Consistent with these data, the beta -adrenergic agonist isoproterenol (ISO) activated the rat ET-1 promoter activity to an extent that was similar to NE. The ISO-stimulated increase in promoter activity was significantly inhibited by a Ca2+-antagonist, nifedipine, and an immunosuppressant, cyclosporin A, which blocks calcineurin. Mutation analysis indicated that the GATA4 binding site is required for ISO-responsive ET-1 transcription. Stimulation with ISO enhanced the interaction between NFATc and GATA4 in cardiac myocytes. Consistent with this interaction, overexpression of GATA4 and NFATc synergistically activated the ET-1 promoter. These findings demonstrate that NE-stimulated ET-1 expression in cardiac myocytes is mediated predominantly via a beta -adrenergic pathway, and that calcium-activated calcineurin-GATA4 plays a role in this process.	Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Hasegawa, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Kawara Cho, Kyoto 6068507, Japan.			Wada, Hiromichi/0000-0002-8980-224X				ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; FRANCIS GS, 1993, CIRCULATION, V87, P140; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Harada M, 1997, CIRCULATION, V96, P3737; Hasegawa K, 1997, CIRCULATION, V96, P3943; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; Inada T, 1999, J AM COLL CARDIOL, V33, P565, DOI 10.1016/S0735-1097(98)00564-6; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; ITO H, 1993, J CLIN INVEST, V92, P398, DOI 10.1172/JCI116579; ITO H, 1991, CIRC RES, V69, P209, DOI 10.1161/01.RES.69.1.209; Iwanaga Y, 1998, CIRCULATION, V98, P2065, DOI 10.1161/01.CIR.98.19.2065; JAMES AF, 1994, NATURE, V370, P297, DOI 10.1038/370297a0; Kaburagi S, 1999, CIRCULATION, V99, P292, DOI 10.1161/01.CIR.99.2.292; Kakita T, 1999, J BIOL CHEM, V274, P34096, DOI 10.1074/jbc.274.48.34096; KAWANA M, 1995, MOL CELL BIOL, V15, P4225; Lee JP, 1999, P NATL ACAD SCI USA, V96, P3251, DOI 10.1073/pnas.96.6.3251; McGrew MJ, 1996, MOL CELL BIOL, V16, P4524; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morimoto T, 1999, J BIOL CHEM, V274, P12811, DOI 10.1074/jbc.274.18.12811; Morimoto T, 2000, J BIOL CHEM, V275, P13721, DOI 10.1074/jbc.275.18.13721; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Pan S, 1997, BIOCHEM BIOPH RES CO, V240, P314, DOI 10.1006/bbrc.1997.7381; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RUFF VA, 1995, J BIOL CHEM, V270, P22602, DOI 10.1074/jbc.270.38.22602; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; SHICHIRI M, 1991, J CLIN INVEST, V87, P1867, DOI 10.1172/JCI115210; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Walsh RA, 1999, CIRC RES, V84, P741, DOI 10.1161/01.RES.84.6.741; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854; Yamazaki T, 1996, J BIOL CHEM, V271, P3221, DOI 10.1074/jbc.271.6.3221; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	35	45	45	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34983	34989		10.1074/jbc.M005498200	http://dx.doi.org/10.1074/jbc.M005498200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11435416	hybrid			2022-12-27	WOS:000171024600085
J	Ikeda, Y; Yamamoto, J; Okamura, M; Fujino, T; Takahashi, S; Takeuchi, K; Osborne, TF; Yamamoto, TT; Ito, S; Sakai, J				Ikeda, Y; Yamamoto, J; Okamura, M; Fujino, T; Takahashi, S; Takeuchi, K; Osborne, TF; Yamamoto, TT; Ito, S; Sakai, J			Transcriptional regulation of the murine acetyl-CoA synthetase 1 gene through multiple clustered binding sites for sterol regulatory element-binding proteins and a single neighboring site for Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; FATTY-ACID SYNTHASE; NUCLEAR FACTOR-Y; RECEPTOR GENE; SP-FAMILY; IN-VIVO; NF-Y; PROMOTER; EXPRESSION; SREBPS	Cytosolic acetyl-CoA synthetase (AceCS1) activates acetate to supply the cells with acetyl-CoA for lipid synthesis. The cDNA for the mammalian AceCS1 has been isolated recently, and the mRNA was shown to be negatively regulated by sterols in cultured cells. In the current study, we describe the molecular mechanisms directing the sterol-regulated expression of murine AceCS1 by cloning and functional studies of the 5 ' -flanking region of the AceCS1 gene. An AceCS1 promoter-reporter gene (similar to2.1 kilobase pairs) was negatively regulated when sterols were added to the medium of cultured cells, and the promoter was markedly induced by co-transfection of a plasmid that expresses the transcriptionally active nuclear form of either sterol regulatory element-binding protein (SREBP)-1a or -2 in HepG2 cells. Sequence analysis suggested that the AceCS1 promoter contains an E-box, two putative CCAAT-boxes, eight sterol regulatory element (SRE) motifs, and six GC-boxes. Gel shift assays demonstrated that all eight SRE motifs bound purified SREBP-1a in vitro with similar affinity. Luciferase reporter gene assays revealed that sterol regulation was critically dependent on three closely spaced SRE motifs and an adjacent GC-box. However, mutation of two putative upstream CCAAT-boxes did not affect SREBP dependent activation. Electrophoretic mobility "supershift" analyses confirmed that both Spl and Sp3 bound to the critical GC-box. In addition, transfection studies in Drosophila SL2 cells demonstrated that SREBP synergistically activated the AceCS1 promoter along with Sp1 or Sp3 but not with nuclear factor-Y.	Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; Fukui Med Univ, Dept Internal Med 3, Fukui 9101193, Japan; Tohoku Univ, Ctr Gene Res, Sendai, Miyagi 9818555, Japan	Tohoku University; University of California System; University of California Irvine; University of Fukui; Tohoku University	Sakai, J (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan.		Ito, Sadayoshi/A-3933-2015	Sakai, Juro/0000-0003-4043-1035; Ito, Sadayoshi/0000-0002-5092-3626				AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; Ericsson J, 1996, J BIOL CHEM, V271, P24359, DOI 10.1074/jbc.271.40.24359; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Guan GM, 1997, J BIOL CHEM, V272, P10295; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Ikeda Y, 2000, J BIOL CHEM, V275, P33142, DOI 10.1074/jbc.M002319200; JACKSON SM, 1995, J BIOL CHEM, V270, P21445, DOI 10.1074/jbc.270.37.21445; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Moon YA, 2000, J BIOL CHEM, V275, P30280, DOI 10.1074/jbc.M001066200; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Pai JT, 1996, P NATL ACAD SCI USA, V93, P5437, DOI 10.1073/pnas.93.11.5437; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; WOODNUTT G, 1986, COMP BIOCHEM PHYS B, V85, P487, DOI 10.1016/0305-0491(86)90033-7; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200	39	63	64	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34259	34269		10.1074/jbc.M103848200	http://dx.doi.org/10.1074/jbc.M103848200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435428	hybrid			2022-12-27	WOS:000170910200129
J	Schuur, ER; Loktev, AV; Sharma, M; Sun, ZJ; Roth, RA; Weigel, RJ				Schuur, ER; Loktev, AV; Sharma, M; Sun, ZJ; Roth, RA; Weigel, RJ			Ligand-dependent interaction of estrogen receptor-alpha with members of the forkhead transcription factor family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; BINDING PROTEIN-1 PROMOTER; PAX3-FKHR FUSION PROTEIN; FACTOR FKHR; ALVEOLAR RHABDOMYOSARCOMA; NUCLEAR EXCLUSION; REGULATED GENES; ER-BETA; PHOSPHORYLATION; EXPRESSION	Estrogen acting through the estrogen receptor (ER) is able to regulate cell growth and differentiation of a variety of normal tissues and hormone-responsive tumors. Ligand-activated DR binds DNA and transactivates the promoters of estrogen target genes. In addition, ligand-activated ER can interact with other factors to alter the physiology and growth of cells. Using a yeast two-hybrid screen, we have identified an interaction between ER alpha and the proapoptotic forkhead transcription factor FKHR. The ER alpha -FKHR interaction depends on beta -estradiol and is reduced significantly in the absence of hormone or the presence of Tamoxifen. A glutathione S-transferase pull-down assay was used to confirm the interaction and localized two interaction sites, one in the forkhead domain and a second in the carboxyl terminus. The FKHR interaction was specific to ER alpha and was not detected with other ligand-activated steroid receptors. The related family members, FKHRL1 and AFX, also bound to ER alpha in the presence of beta -estradiol. FKHR augmented ER alpha transactivation through an estrogen response element. Conversely, ER alpha repressed FKHR-mediated transactivation through an insulin response sequence, and cell cycle arrest induced by FKHRL1 in MCF7 cells was abrogated by estradiol. These results suggest a novel mechanism of estrogen action that involves regulation of the proapoptotic forkhead transcription factors.	Stanford Univ, Sch Med, Dept Surg & Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Weigel, RJ (corresponding author), Stanford Univ, Sch Med, Dept Surg & Mol Pharmacol, Med Sch Lab Surge Room P214,1201 Welch Rd, Stanford, CA 94305 USA.			Weigel, Ronald/0000-0002-9249-0793	NATIONAL CANCER INSTITUTE [R29CA070297, R01CA087767, R01CA077350, R01CA070297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061002, R56DK061002] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA070297-06A1, R01 CA070297-10, R01 CA070297-07, R01 CA070297-11A2, R01 CA070297-09, R29 CA070297-05S1, R01 CA070297, R01 CA087767-03, R01 CA77350, R01 CA087767-01A2, R01 CA070297-08, R29 CA070297, R01 CA087767-05, R01 CA087767, R29 CA070297-05, R01 CA087767-02, R01 CA087767-04, R01 CA070297-12, R29 CA070297-03] Funding Source: Medline; NIDDK NIH HHS [R01 DK061002-03, R01 DK061002-02, R01 DK061002-04, R56 DK061002-06A1, R01 DK061002-05, R01 DK061002-01A1, R56 DK061002, R01 DK061002] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; BIRGE SJ, 2001, POSTGRAD MED, P11; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAVAILLES V, 1991, BIOCHEM BIOPH RES CO, V174, P816, DOI 10.1016/0006-291X(91)91491-T; Chu YW, 1999, CYTOMETRY, V36, P333, DOI 10.1002/(SICI)1097-0320(19990801)36:4<333::AID-CYTO8>3.0.CO;2-F; CIOCCA DR, 1993, JNCI-J NATL CANCER I, V85, P1558, DOI 10.1093/jnci/85.19.1558; DAVIS RJ, 1994, CANCER RES, V54, P2869; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Ghosh MG, 2000, CANCER RES, V60, P6367; GOTTLIEB S, 1994, GENETICS, V137, P107; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kim H, 2001, NEUROSCI LETT, V302, P58, DOI 10.1016/S0304-3940(01)01659-7; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; McPherson LA, 1999, NUCLEIC ACIDS RES, V27, P4040, DOI 10.1093/nar/27.20.4040; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Parsons Ramon, 1998, Current Opinion in Oncology, V10, P88, DOI 10.1097/00001622-199801000-00014; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; SHAPIRO DN, 1993, CANCER RES, V53, P5108; SUBLETT JE, 1995, ONCOGENE, V11, P545; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tomizawa M, 2000, J BIOL CHEM, V275, P7289, DOI 10.1074/jbc.275.10.7289; WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	43	124	128	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33554	33560		10.1074/jbc.M105555200	http://dx.doi.org/10.1074/jbc.M105555200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435445	hybrid			2022-12-27	WOS:000170910200037
J	Purbhoo, MA; Boulter, JM; Price, DA; Vuidepot, AL; Hourigan, CS; Dunbar, PR; Olson, K; Dawson, SJ; Phillips, RE; Jakobsen, BK; Bell, JI; Sewell, AK				Purbhoo, MA; Boulter, JM; Price, DA; Vuidepot, AL; Hourigan, CS; Dunbar, PR; Olson, K; Dawson, SJ; Phillips, RE; Jakobsen, BK; Bell, JI; Sewell, AK			The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; LYMPHOCYTE ACTIVATION; SIGNAL-TRANSDUCTION; LIGAND INTERACTIONS; BETA-CHEMOKINES; PEPTIDE; TCR; AGONIST; BINDING; CTL	Recognition of antigen by cytotoxic T lymphocytes (CTL) is determined by interaction of both the T cell receptor and its CD8 coreceptor with peptide-major histocompatibility complex (pMHC) class I molecules. We examine the relative roles of these receptors in the activation of human CTL using mutations in MHC class I designed to diminish or abrogate the CD8/pMHC interaction. We use surface plasmon resonance to determine that point mutation of the alpha3 loop of HLA A2 abrogates the CD8/pMHC interaction without affecting the affinity of the T cell receptor/pMHC interaction. Antigen-presenting cells expressing HLA A2 which does not bind to CD8 fail to activate CTL at any peptide concentration. Comparison of CTL activation by targets expressing HLA A2 with normal, abrogated, or diminished CD8/pMHC interaction show that the CD8/pMHC interaction enhances sensitivity to antigen. We determine that the biochemical basis for coreceptor dependence is the activation of the 23-kDa phosphoform of the CD3 zeta chain. In addition, we produce mutant MHC class I multimers that specifically stain but do not activate CTL. These reagents may prove useful in circumventing undesirable activation-related perturbation of intracellular processes when pMHC multimers are used to phenotype antigen-specific CD8+ lymphocytes.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Avidex Ltd, Abingdon OX14 4RX, Oxon, England	University of Oxford	Sewell, AK (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Level 7, Oxford OX3 9DU, England.	andy.sewell@ndm.ox.ac.uk	Sewell, Andrew/GPT-4220-2022; Hourigan, Christopher S/C-7588-2012; Price, David A/C-7876-2013; Dunbar, Rod/C-2570-2012	Sewell, Andrew/0000-0003-3194-3135; Hourigan, Christopher S/0000-0002-6189-8067; Price, David A/0000-0001-9416-2737; Dunbar, Rod/0000-0001-9626-2600				Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bodinier M, 2000, NAT MED, V6, P707, DOI 10.1038/76292; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; CHAN IT, 1993, SCIENCE, V261, P1581, DOI 10.1126/science.8372352; Chen WS, 2000, METH MOL B, V156, P245; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Dunbar PR, 1999, J IMMUNOL, V162, P6959; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Gao GF, 2000, IMMUNOL TODAY, V21, P630, DOI 10.1016/S0167-5699(00)01750-3; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; Hamad ARA, 1998, J EXP MED, V188, P1633, DOI 10.1084/jem.188.9.1633; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; Howard MC, 1999, IMMUNOL TODAY, V20, P161, DOI 10.1016/S0167-5699(98)01390-5; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kersh EN, 1999, J EXP MED, V190, P1627, DOI 10.1084/jem.190.11.1627; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kessler B, 1998, J IMMUNOL, V161, P6939; KWANLIM GE, 1993, INT IMMUNOL, V5, P1219, DOI 10.1093/intimm/5.10.1219; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; OROURKE AM, 1992, NATURE, V358, P253, DOI 10.1038/358253a0; Price DA, 1998, CURR BIOL, V8, P355, DOI 10.1016/S0960-9822(98)70138-1; Purbhoo MA, 1998, P NATL ACAD SCI USA, V95, P4527, DOI 10.1073/pnas.95.8.4527; Sewell AK, 1997, EUR J IMMUNOL, V27, P2323, DOI 10.1002/eji.1830270929; Sewell AK, 1999, NAT MED, V5, P399, DOI 10.1038/7398; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALLS EV, 1987, LYMPHOCYTES PRACTICA, P149; WAYS JP, 1983, J IMMUNOL, V131, P856; Willcox BE, 1999, PROTEIN SCI, V8, P2418; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9; YOON ST, 1994, IMMUNITY, V1, P563	45	119	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32786	32792		10.1074/jbc.M102498200	http://dx.doi.org/10.1074/jbc.M102498200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438524	hybrid			2022-12-27	WOS:000170746000056
J	Aizawa, T; Hayakawa, Y; Ohnishi, A; Fujitani, N; Clark, KD; Strand, MR; Miura, K; Koganesawa, N; Kumaki, Y; Demura, M; Nitta, K; Kawano, K				Aizawa, T; Hayakawa, Y; Ohnishi, A; Fujitani, N; Clark, KD; Strand, MR; Miura, K; Koganesawa, N; Kumaki, Y; Demura, M; Nitta, K; Kawano, K			Structure and activity of the insect cytokine growth-blocking peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; SOLID-PHASE PEPTIDE; FACTOR-ALPHA; FACTOR RECEPTOR; MANDUCA-SEXTA; PSEUDOPLUSIA-INCLUDENS; PARALYTIC PEPTIDES; TGF-ALPHA; HEMOLYMPH; BINDING	Growth-blocking peptide (GBP) is a 25-amino acid insect cytokine found in Lepidopteran insects that possesses diverse biological activities such as larval growth regulation, cell proliferation, and stimulation of immune cells (plasmatocytes). The tertiary structure of GBP consists of a structured core that contains a disulfide bridge and a short antiparallel beta -sheet (Tyr(11)Arg(13) and Cys(19)-Pro(21)) and flexible N and C termini (Glu(1)-Gly(6) and Phe(23)-Gln(25)). In this study, deletion and point mutation analogs of GBP were synthesized to investigate the relationship between the structure of GBP and its mitogenic and plasmatocyte spreading activity. The results indicated that deletion of the N-terminal residue, Glu(1), eliminated all plasmatocyte spreading activity but did not reduce mitogenic activity. In contrast, deletion of Phe(23) along with the remainder of the C terminus destroyed all mitogenic activity but only slightly reduced plasmatocyte spreading activity. Therefore, the minimal structure of GBP containing mitogenic activity is 2-23 GBP, whereas that with plasmatocyte spreading activity is 1-22 GBP. NMR analysis indicated that these N- and C-terminal deletion mutants retained a similar core structure to wild-type GBP. Replacement of Asp(16) with either a Glu, Leu, or Asn residue similarly did not alter the core structure of GBP. However, these mutants had no mitogenic activity, although they retained about 50% of their plasmatocyte spreading activity. We conclude that specific residues in the unstructured and structured domains of GBP differentially affect the biological activities of GBP, which suggests the possibility that multifunctional properties of this peptide may be mediated by different forms of a GBP receptor.	Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Sugitani, Toyama 9300194, Japan; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	Hokkaido University; University of Toyama; Hokkaido University; University of Wisconsin System; University of Wisconsin Madison	Hayakawa, Y (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Kita-19,Nishi-8, Sapporo, Hokkaido 0600819, Japan.		Demura, Makoto/F-5272-2011; Kawano, Keiichi/F-5265-2011; Aizawa, Tomoyasu/F-5278-2011; Clark, Kevin/GQA-9811-2022; Fujitani, Naoki/A-4072-2012	Demura, Makoto/0000-0003-0912-9284; Aizawa, Tomoyasu/0000-0001-9134-7576; Ohnishi, Atsushi/0000-0003-1213-4439; Fujitani, Naoki/0000-0002-4035-7317				Aizawa T, 1999, J BIOL CHEM, V274, P1887, DOI 10.1074/jbc.274.4.1887; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 2001, J BIOL CHEM, V276, P18491, DOI 10.1074/jbc.M100579200; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Furuya K, 1999, PEPTIDES, V20, P53, DOI 10.1016/S0196-9781(98)00148-X; Ha SD, 1999, PEPTIDES, V20, P561, DOI 10.1016/S0196-9781(99)00008-X; Hayakawa Y, 1998, BIOCHEM BIOPH RES CO, V250, P194, DOI 10.1006/bbrc.1998.8959; HAYAKAWA Y, 1990, J BIOL CHEM, V265, P10813; HAYAKAWA Y, 1991, J BIOL CHEM, V266, P7982; HAYAKAWA Y, 1995, FEBS LETT, V376, P185, DOI 10.1016/0014-5793(95)01273-7; HAYAKAWA Y, 1994, J BIOCHEM-TOKYO, V115, P15, DOI 10.1093/oxfordjournals.jbchem.a124291; HAYAKAWA Y, 1993, INSECT BIOCHEM MOLEC, V23, P225, DOI 10.1016/0965-1748(93)90003-B; HEATH WF, 1986, P NATL ACAD SCI USA, V83, P6367, DOI 10.1073/pnas.83.17.6367; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; KRAMER RH, 1994, J BIOL CHEM, V269, P8708; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; McInnes C, 1996, J BIOL CHEM, V271, P32204, DOI 10.1074/jbc.271.50.32204; McInnes C, 2000, PROTEIN ENG, V13, P143, DOI 10.1093/protein/13.3.143; NICOLAS E, 1989, TETRAHEDRON LETT, V30, P497, DOI 10.1016/S0040-4039(00)95238-9; Noguchi H, 1997, FEBS LETT, V413, P157, DOI 10.1016/S0014-5793(97)00848-X; Ohnishi A, 1995, INSECT BIOCHEM MOLEC, V25, P1121, DOI 10.1016/0965-1748(95)00054-2; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RICHTER A, 1992, BIOCHEMISTRY-US, V31, P9546, DOI 10.1021/bi00155a006; RICHTER A, 1995, J BIOL CHEM, V270, P1612, DOI 10.1074/jbc.270.4.1612; Seino Atsushi, 1998, Journal of Sericultural Science of Japan, V67, P473; SKINNER WS, 1991, J BIOL CHEM, V266, P12873; SKINNER WS, 1993, COMP BIOCHEM PHYS C, V104, P133, DOI 10.1016/0742-8413(93)90124-4; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; TAM J P, 1988, Peptide Research, V1, P6; TAM JP, 1991, INT J PEPT PROT RES, V38, P204; Volkman BF, 1999, J BIOL CHEM, V274, P4493, DOI 10.1074/jbc.274.8.4493; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7; Yu XQ, 1999, J PEPT RES, V54, P256, DOI 10.1034/j.1399-3011.1999.00136.x; ZUIDERWEG ERP, 1986, J MAGN RESON, V70, P336, DOI 10.1016/0022-2364(86)90020-X	35	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31813	31818		10.1074/jbc.M105251200	http://dx.doi.org/10.1074/jbc.M105251200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11429413	hybrid			2022-12-27	WOS:000170613500047
J	Wild, MK; Huang, MC; Schulze-Horsel, U; van der Merwe, PA; Vestweber, D				Wild, MK; Huang, MC; Schulze-Horsel, U; van der Merwe, PA; Vestweber, D			Affinity, kinetics, and thermodynamics of E-selectin binding to E-selectin ligand-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; PROTEIN-PROTEIN INTERACTIONS; HAMSTER OVARY CELLS; ROLLING IN-VIVO; SIALYL-LEWIS-X; P-SELECTIN; GLYCOPROTEIN LIGAND-1; IMMUNOGLOBULIN SUPERFAMILY; CARBOHYDRATE LIGANDS; LEUKOCYTE ADHESION	E-selectin is an endothelial adhesion molecule, which mediates the tethering and rolling of leukocytes on vascular endothelium. It recognizes the glycoprotein E-selectin ligand-1 (ESL-1) as a major binding partner on mouse myeloid cells. Using surface plasmon resonance, we measured the kinetics and affinity of binding of monomeric E-selectin to ESL-1 isolated from mouse bone marrow cells. E-selectin bound to ESL-1 with a fast dissociation rate constant of 4.6 s(-1) and a calculated association rate constant of 7.4 X 10(4) M-1. s(-1). We determined a dissociation constant (K-d) of 62 muM, which resembles the affinity of L-selectin binding to glycosylation-dependent cell adhesion molecule-1. The affinity of the E-selectin-ESL-1 interaction did not change significantly when the temperature was varied from 5 degreesC to 37 degreesC, indicating that the enthalpic contribution to the binding is small at physiological temperatures, and that, in contrast to typical protein-carbohydrate interactions, binding is driven primarily by favorable entropic changes. Interestingly, surface plasmon resonance experiments with recombinant ESL-1 from alpha1,3-fucosyltransferase IV-expressing Chinese hamster ovary cells showed a very similar K-d of 66 muM, suggesting that this fucosyltransferase is sufficient to produce fully functional recombinant ESL-1. Following the recent description of the affinity and kinetics of the selectin-ligand pairs L-selectin-glycosylation-dependent cell adhesion molecule-1 and P-selectin-P-selectin glycoprotein ligand-1, this is the first determination of the parameters of E-selectin binding to one of its naturally occurring ligands.	Univ Munster, Zentrum Molekularbiol Entzundung, Inst Cell Biol, D-48149 Munster, Germany; Max Planck Inst Physiol & Clin Res, D-61231 Bad Nauheim, Germany; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Munster; Max Planck Society; University of Oxford	Vestweber, D (corresponding author), Univ Munster, Zentrum Molekularbiol Entzundung, Inst Cell Biol, Von Esmarch Str 56, D-48149 Munster, Germany.	vestweb@uni-muenster.de	van der Merwe, P. Anton/F-8539-2011	HUANG, MIN-CHUAN/0000-0002-0704-3447; Vestweber, Dietmar/0000-0002-3517-732X				Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; BEBBINGTON C R, 1991, Methods (Orlando), V2, P136, DOI 10.1016/S1046-2023(05)80214-2; Bebbington CR, 1987, DNA CLONING PRACTICA, VIII, P163; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; Borges E, 1997, J BIOL CHEM, V272, P28786, DOI 10.1074/jbc.272.45.28786; BOSSE R, 1994, EUR J IMMUNOL, V24, P3019, DOI 10.1002/eji.1830241215; BRANDLEY BK, 1993, GLYCOBIOLOGY, V3, P633, DOI 10.1093/glycob/3.6.633; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; COOKE RM, 1994, BIOCHEMISTRY-US, V33, P10591, DOI 10.1021/bi00201a004; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; Dwir O, 1998, CELL ADHES COMMUN, V6, P349, DOI 10.3109/15419069809010793; Ebnet K, 1999, HISTOCHEM CELL BIOL, V112, P1, DOI 10.1007/s004180050387; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; GONATAS JO, 1989, J BIOL CHEM, V264, P646; GONATAS JO, 1995, J CELL SCI, V108, P457; HAHNE M, 1993, J CELL BIOL, V121, P655, DOI 10.1083/jcb.121.3.655; HALLMANN R, 1995, SCAND J RHEUMATOL, P107; HENSLEY P, 1994, J BIOL CHEM, V269, P23949; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Huang MC, 2000, J BIOL CHEM, V275, P31353, DOI 10.1074/jbc.M005449200; HUNT SV, 1981, CELL TISSUE KINET, V14, P445, DOI 10.1111/j.1365-2184.1981.tb00551.x; JACOB GS, 1995, BIOCHEMISTRY-US, V34, P1210, DOI 10.1021/bi00004a014; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KIKUTA A, 1994, BLOOD, V84, P3766, DOI 10.1182/blood.V84.11.3766.bloodjournal84113766; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LENTER M, 1994, J CELL BIOL, V125, P471, DOI 10.1083/jcb.125.2.471; LEVINOVITZ A, 1993, J CELL BIOL, V121, P449, DOI 10.1083/jcb.121.2.449; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; NELSON RM, 1993, J CLIN INVEST, V91, P1157, DOI 10.1172/JCI116275; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; Patel KD, 1995, J CELL BIOL, V131, P1893, DOI 10.1083/jcb.131.6.1893; Patel KD, 1997, J IMMUNOL, V159, P4555; PATEL TP, 1994, BIOCHEMISTRY-US, V33, P14815, DOI 10.1021/bi00253a021; PICKER LJ, 1991, CELL, V66, P921, DOI 10.1016/0092-8674(91)90438-5; Poppe L, 1997, J AM CHEM SOC, V119, P1727, DOI 10.1021/ja9610702; Ramos CL, 1997, BLOOD, V89, P3009, DOI 10.1182/blood.V89.8.3009; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Singer MS, 1996, J IMMUNOL METHODS, V196, P153, DOI 10.1016/0022-1759(96)00106-8; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Steegmaier M, 1997, J CELL SCI, V110, P687; STEEGMAIER M, 1995, NATURE, V373, P615, DOI 10.1038/373615a0; STIEBER A, 1995, EXP CELL RES, V219, P562, DOI 10.1006/excr.1995.1265; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; VACHINO G, 1995, J BIOL CHEM, V270, P21966, DOI 10.1074/jbc.270.37.21966; van der Merwe PA, 1999, CURR BIOL, V9, pR419; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273; Varki A, 1997, J CLIN INVEST, V99, P158, DOI 10.1172/JCI119142; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; WELLER A, 1992, J BIOL CHEM, V267, P15176; WILLIAMS AF, 1991, NATURE, V352, P473, DOI 10.1038/352473a0; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; YOO SH, 1995, BIOCHEMISTRY-US, V34, P632, DOI 10.1021/bi00002a030; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002	81	74	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31602	31612		10.1074/jbc.M104844200	http://dx.doi.org/10.1074/jbc.M104844200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11404363	hybrid			2022-12-27	WOS:000170613500020
J	Zhang, Y; Qiu, WJ; Liu, DX; Neo, SY; He, X; Lin, SC				Zhang, Y; Qiu, WJ; Liu, DX; Neo, SY; He, X; Lin, SC			Differential molecular assemblies underlie the dual function of axin in modulating the Wnt and JNK pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TUMOR-SUPPRESSOR PROTEIN; APC GENE-PRODUCT; BETA-CATENIN; XENOPUS EMBRYOS; C-JUN; HEPATOCELLULAR CARCINOMAS; NEGATIVE REGULATOR; SIGNALING PATHWAY; DOWN-REGULATION	Axin is a multidomain scaffold protein that exerts a dual function in the Wnt signaling and MEKK1/JNK pathways. This raises a critical question as to whether Axin-based differential molecular assemblies exist and how these may act to coordinate the two separate pathways. Here we show that both wild-type glycogen synthase kinase-3 beta (GSK-3 beta) and kinase-dead GSK-3 beta -Y216F (capable of binding to Axin), but not GSK-3 beta -K85M (incapable of binding to Axin in mammalian cells), prevented MEKK1 binding to the Axin complex, thereby inhibiting JNK activation. We further show that casein kinase le also inhibited Axin-mediated JNK activation by competing against MEKK1 binding. In contrast,. beta -catenin and adenomatous polyposis coli binding did not affect MEKK1 binding to the same Axin complex. This suggests that even when Axin is "switched" to activate the JNK pathway, it is still capable of sequestering free beta -catenin, which is a critical aspect for cellular homeostasis. Our results clearly demonstrate that differential molecular assemblies underlie the duality of Axin functions in the negative regulation of Wnt signaling and activation of the JNK MAPK pathway.	Inst Mol & Cell Biol, Regulatory Biol Lab, Singapore 117609, Singapore; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Harvard University; Boston Children's Hospital; Harvard Medical School	Lin, SC (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.		QIU, WENJING/GZL-9992-2022; Lin, SC/G-4666-2010	Zhang, Yi/0000-0003-2785-1780	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057603] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM 57603] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Arias AM, 1999, CURR OPIN GENET DEV, V9, P447, DOI 10.1016/S0959-437X(99)80068-9; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 1999, CURR OPIN GENET DEV, V9, P595, DOI 10.1016/S0959-437X(99)00016-7; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Clevers H, 2000, NAT GENET, V24, P206, DOI 10.1038/73396; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kawahara K, 2000, J BIOL CHEM, V275, P8369, DOI 10.1074/jbc.275.12.8369; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Neo SY, 2000, BIOCHEM BIOPH RES CO, V272, P144, DOI 10.1006/bbrc.2000.2751; Palacios J, 1998, CANCER RES, V58, P1344; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Reinacher-Schick A, 2001, J CELL BIOL, V152, P491, DOI 10.1083/jcb.152.3.491; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shih IM, 2000, CANCER RES, V60, P1671; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Voeller HJ, 1998, CANCER RES, V58, P2520; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200	57	33	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32152	32159		10.1074/jbc.M104451200	http://dx.doi.org/10.1074/jbc.M104451200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11408485	hybrid			2022-12-27	WOS:000170613500093
J	Oussatcheva, EA; Hashem, VI; Zou, Y; Sinden, RR; Potaman, VN				Oussatcheva, EA; Hashem, VI; Zou, Y; Sinden, RR; Potaman, VN			Involvement of the nucleotide excision repair protein UvrA in instability of CAG-CTG repeat sequences in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR; HETERODUPLEX DNA; HUMAN-DISEASE; GENETIC INSTABILITY; MAMMALIAN-CELLS; TRINUCLEOTIDE REPEATS; TRIPLET REPEATS; DUPLEX DNA; REPLICATION; RECOMBINATION	Several human genetic diseases have been associated with the genetic instability, specifically expansion, of trinucleotide repeat sequences such as (CTG)(n)(.)(CAG)(n). Molecular models of repeat instability imply replication slippage and the formation of loops and imperfect hairpins in single strands. Subsequently, these loops or hairpins may be recognized and processed by DNA repair systems. To evaluate the potential role of nucleotide excision repair in repeat instability, we measured the rates of repeat deletion in wild type and excision repair-deficient Escherichia coli strains (using a genetic assay for deletions). The rate of triplet repeat deletion decreased in an E. coli strain deficient in the damage recognition protein UvrA. Moreover, loops containing 23 CTG repeats were less efficiently excised from heteroduplex plasmids after their transformation into the uvrA(-) strain. As a result, an increased proportion of plasmids containing the full-length repeat were recovered after the replication of heteroduplex plasmids containing unrepaired loops. In biochemical experiments, UvrA bound to heteroduplex substrates containing repeat loops of 1, 2, or 17 CAG repeats with a Kd of about 10-20 nm, which is an affinity about 2 orders of magnitude higher than that of UvrA bound to the control substrates containing (CTG)(n)(.)(CAG)(n) in the linear form. These results suggest that UvrA is involved in triplet repeat instability in cells. Specifically, UvrA may bind to loops formed during replication slippage or in slipped strand DNA and initiate DNA repair events that result in repeat deletion. These results imply a more comprehensive role for UvrA, in addition to the recognition of DNA damage, in maintaining the integrity of the genome.	Texas A&M Univ Syst, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston	Potaman, VN (corresponding author), Texas A&M Univ Syst, Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.		Sinden, Richard/AAE-3086-2019; Zou, Yue/ABA-8429-2020		NIEHS NIH HHS [ES05508] Funding Source: Medline	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahn BC, 1996, J BIOL CHEM, V271, P21462, DOI 10.1074/jbc.271.35.21462; ALTON NK, 1979, NATURE, V282, P864, DOI 10.1038/282864a0; AYARES D, 1987, MOL CELL BIOL, V7, P1656, DOI 10.1128/MCB.7.5.1656; BICHARA M, 1987, J BACTERIOL, V169, P423, DOI 10.1128/jb.169.1.423-426.1987; CAMPBELL CR, 1989, MUTAT RES, V211, P181, DOI 10.1016/0027-5107(89)90118-8; CARRAWAY M, 1993, J BACTERIOL, V175, P3972, DOI 10.1128/JB.175.13.3972-3980.1993; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; Cooper D. N., 1993, HUMAN GENE MUTATION; Corrette-Bennett SE, 1999, J BIOL CHEM, V274, P17605, DOI 10.1074/jbc.274.25.17605; Cox MM, 1998, GENES CELLS, V3, P65, DOI 10.1046/j.1365-2443.1998.00175.x; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Darlow JM, 1998, J MOL BIOL, V275, P3, DOI 10.1006/jmbi.1997.1453; Delagoutte E, 1997, J MOL BIOL, V266, P703, DOI 10.1006/jmbi.1996.0830; DOHET C, 1987, MOL GEN GENET, V206, P181, DOI 10.1007/BF00326556; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; FISHEL R, 1989, J BACTERIOL, V171, P3046, DOI 10.1128/jb.171.6.3046-3052.1989; FISHEL RA, 1984, COLD SPRING HARB SYM, V49, P603, DOI 10.1101/SQB.1984.049.01.068; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Kantoff P, 1998, BBA-REV CANCER, V1378, pC1; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Littman SJ, 1999, J BIOL CHEM, V274, P7474, DOI 10.1074/jbc.274.11.7474; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Marians KJ, 2000, CURR OPIN GENET DEV, V10, P151, DOI 10.1016/S0959-437X(00)00059-9; MAZUR SJ, 1991, BIOCHEMISTRY-US, V30, P4432, DOI 10.1021/bi00232a009; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Moolenaar GF, 1998, J BIOL CHEM, V273, P34896, DOI 10.1074/jbc.273.52.34896; Oussatcheva EA, 1999, J MOL BIOL, V292, P75, DOI 10.1006/jmbi.1999.3043; PARKER BO, 1992, P NATL ACAD SCI USA, V89, P1730, DOI 10.1073/pnas.89.5.1730; Parniewski P, 2000, J MOL BIOL, V299, P865, DOI 10.1006/jmbi.2000.3796; Parniewski P, 1999, NUCLEIC ACIDS RES, V27, P616, DOI 10.1093/nar/27.2.616; Pearson CE, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P585; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; Richards RI, 1997, TRENDS BIOCHEM SCI, V22, P432, DOI 10.1016/S0968-0004(97)01108-0; Sambrook J., 2002, MOL CLONING LAB MANU; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Schmidt KH, 2000, MOL MICROBIOL, V35, P463, DOI 10.1046/j.1365-2958.2000.01727.x; Schumacher S, 1998, J MOL BIOL, V279, P1101, DOI 10.1006/jmbi.1998.1827; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; Tsao H, 1998, BIOCHEMISTRY-US, V37, P4993, DOI 10.1021/bi980291c; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; Verhoeven EEA, 2000, J BIOL CHEM, V275, P5120, DOI 10.1074/jbc.275.7.5120; WEISS U, 1987, P NATL ACAD SCI USA, V84, P1619, DOI 10.1073/pnas.84.6.1619; Wells R.D., 1998, GENETIC INSTABILITIE; Wells RD, 1998, J BIOL CHEM, V273, P19532, DOI 10.1074/jbc.273.31.19532; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875; Zou Y, 1999, EMBO J, V18, P4889, DOI 10.1093/emboj/18.17.4889; ZOU Y, 1995, BIOCHEMISTRY-US, V34, P13582, DOI 10.1021/bi00041a038; Zou Y, 1997, J BIOL CHEM, V272, P4820, DOI 10.1074/jbc.272.8.4820	60	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30878	30884		10.1074/jbc.M104697200	http://dx.doi.org/10.1074/jbc.M104697200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413147	hybrid			2022-12-27	WOS:000170472900040
J	Yamazaki, H; Shimada, T; Martin, MV; Guengerich, FP				Yamazaki, H; Shimada, T; Martin, MV; Guengerich, FP			Stimulation of cytochrome P450 reactions by apo-cytochrome b(5) - Evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5, or heme oxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL CYTOCHROME-P-450; PROTEIN-PROTEIN INTERACTIONS; OXIDATIVE DRUG-METABOLISM; ELECTRON-TRANSFER; RAT-LIVER; RECONSTITUTED SYSTEMS; GENETIC-POLYMORPHISM; CATALYTIC ACTIVITIES; ESCHERICHIA-COLI; FUSION PROTEIN	Many cytochrome P450 (P450)-dependent reactions have been shown to be stimulated by another microsomal protein, cytochrome b(5) (b(5)). Two major explanations are (i) direct electron transfer from b(5) and (ii) a conformational. effect in the absence of electron transfer. Some P450s (e.g. 3A4, 2C9, 17A, and 4A7) are stimulated by either b(5) or b(5) devoid of heme (apo-b(5)), indicating a lack of electron transfer, whereas other P450s (e.g. 2E1) are stimulated by b5 but not by apo-b(5). Recently, a proposal has been made by Guryev et al. (Biochemistry 40, 5018-5031, 2001) that the stimulation by apo-b5 can be explained only by transfer of heme from P450 preparations to apo-b(5), enabling electron transfer. We have repeated earlier findings of stimulation of catalytic activity of testosterone 6 beta -hydroxylation activities with four P450 preparations, in which nearly all of the heme was accounted for as P450. Spectral analysis of mixtures indicated that only similar to5% of the heme can be transferred to apo-b(5), which cannot account for the observed stimulation. The presence of the heme scavenger apomyoglobin did not inhibit the stimulation of P450 3A4-dependent testosterone or nifedipine oxidation activity. Further evidence against the presence of loosely bound P450 3A4 heme was provided in experiments with apo-heme oxygenase, in which only 3% of the P450 heme was converted to biliverdin. Finally, b(5) supported NADH-b(5) reductase/P450 3A4-dependent testosterone 6 beta -hydroxylation, but apo-b(5) did not. Thus, apo-b(5) can stimulate P450 3A4 reactions as well as b(5) in the absence of electron transfer, and heme transfer from P450 3A4 to apo-b(5) cannot be used to explain the catalytic stimulation.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; Osaka Prefectural Inst Publ Hlth, Osaka 5370025, Japan; Kanazawa Univ, Fac Pharmaceut Sci, Div Drug Metab, Kanazawa, Ishikawa 9200934, Japan	Vanderbilt University; Vanderbilt University; Osaka Prefectural Institute of Public Health; Kanazawa University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg MRBI,23rd & Pierce Ave, Nashville, TN 37232 USA.	guengerich@toxicology.mc.vanderbilt.edu	Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261; Shimada, Tsutomu/0000-0003-2552-4348	NATIONAL CANCER INSTITUTE [R01CA090426, R35CA044353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA90426, R35 CA44353] Funding Source: Medline; NIEHS NIH HHS [P30 ES00267] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Atkins WM, 2001, CHEM RES TOXICOL, V14, P338, DOI 10.1021/tx0002132; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Backes WL, 1998, BIOCHEMISTRY-US, V37, P12852, DOI 10.1021/bi980674a; BEAUNE PH, 1986, P NATL ACAD SCI USA, V83, P8064, DOI 10.1073/pnas.83.21.8064; BONKOVSKY HL, 1986, ANAL BIOCHEM, V155, P56, DOI 10.1016/0003-2697(86)90224-1; BOSTERLING B, 1982, J BIOL CHEM, V257, P4375; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; Domanski TL, 1998, ARCH BIOCHEM BIOPHYS, V350, P223, DOI 10.1006/abbi.1997.0525; FALK JE, 1964, PORPHYRINS METALLOPO, P81; Falzone CJ, 2001, BIOCHEMISTRY-US, V40, P4879, DOI 10.1021/bi002681g; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; GUENGERICH FP, 1975, J BIOL CHEM, V250, P7405; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; GUENGERICH FP, 1983, BIOCHEMISTRY-US, V22, P2811, DOI 10.1021/bi00281a007; GUENGERICH FP, 1978, BIOCHEMISTRY-US, V17, P3633, DOI 10.1021/bi00610a033; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; Guryev OL, 2001, BIOCHEMISTRY-US, V40, P5018, DOI 10.1021/bi002305w; Hanna IH, 2000, ARCH BIOCHEM BIOPHYS, V376, P206, DOI 10.1006/abbi.2000.1708; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; HONKAKOSKI P, 1992, BIOCHIM BIOPHYS ACTA, V1122, P6, DOI 10.1016/0167-4838(92)90120-3; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Hosea NA, 1998, ARCH BIOCHEM BIOPHYS, V353, P365, DOI 10.1006/abbi.1998.0659; IMAI Y, 1981, J BIOCHEM-TOKYO, V89, P351, DOI 10.1093/oxfordjournals.jbchem.a133209; IMAOKA S, 1992, BIOCHEMISTRY-US, V31, P6063, DOI 10.1021/bi00141a015; INGELMANSUNDBERG M, 1980, BIOCHEM BIOPH RES CO, V97, P582, DOI 10.1016/0006-291X(80)90303-4; Koley AP, 1997, BIOCHEM PHARMACOL, V53, P455, DOI 10.1016/S0006-2952(96)00836-2; KRASNY HC, 1977, MOL PHARMACOL, V13, P759; KUTTY RK, 1988, ARCH BIOCHEM BIOPHYS, V260, P638, DOI 10.1016/0003-9861(88)90492-4; LEWIS D.F.V, 1996, CYTOCHROMES P450 STR; Loughran PA, 2000, BIOCHEMISTRY-US, V39, P15110, DOI 10.1021/bi001522u; Loughran PA, 2001, ARCH BIOCHEM BIOPHYS, V385, P311, DOI 10.1006/abbi.2000.2136; MIHARA K, 1975, J BIOCHEM-TOKYO, V78, P1057, DOI 10.1093/oxfordjournals.jbchem.a130983; MIKI N, 1980, J BIOCHEM-TOKYO, V88, P307, DOI 10.1093/oxfordjournals.jbchem.a132976; NOSHIRO M, 1981, EUR J BIOCHEM, V116, P521, DOI 10.1111/j.1432-1033.1981.tb05367.x; NOSHIRO M, 1980, J BIOCHEM-TOKYO, V88, P1521, DOI 10.1093/oxfordjournals.jbchem.a133123; OMURA T, 1964, J BIOL CHEM, V239, P2370; PALMER G, 1992, J BIOL CHEM, V267, P665; Perret A, 1998, BIOCHEMISTRY-US, V37, P11412, DOI 10.1021/bi980908q; Peterson JA, 1986, CYTOCHROME P 450 STR, P89; POMPON D, 1984, J BIOL CHEM, V259, P5377; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Rivera M, 1998, BIOCHEMISTRY-US, V37, P1485, DOI 10.1021/bi972390g; ROSENBERG DW, 1980, BIOCHEM J, V190, P465, DOI 10.1042/bj1900465; Schenkman JB, 1999, DRUG METAB REV, V31, P351, DOI 10.1081/DMR-100101923; Shaw PM, 1997, ARCH BIOCHEM BIOPHYS, V348, P107, DOI 10.1006/abbi.1997.0378; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SHET MS, 1993, P NATL ACAD SCI USA, V90, P11748, DOI 10.1073/pnas.90.24.11748; SHIMADA T, 1986, J BIOL CHEM, V261, P909; Strittmatter P, 1978, Methods Enzymol, V52, P97; TAMBURINI PP, 1983, J BIOL CHEM, V258, P3444; TAMBURINI PP, 1985, J BIOL CHEM, V260, P4007; VELICK SF, 1956, J BIOL CHEM, V221, P265; WEST SB, 1974, BIOCHEM BIOPH RES CO, V58, P516, DOI 10.1016/0006-291X(74)90395-7; WILKS A, 1995, BIOCHEMISTRY-US, V34, P4421, DOI 10.1021/bi00013a034; YAMANO T, 1978, PHARMACOL THER PT A, V2, P673, DOI 10.1016/0362-5478(78)90010-4; Yamazaki H, 1999, DRUG METAB DISPOS, V27, P999; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; YAMAZAKI H, 1995, BIOCHEMISTRY-US, V34, P8380, DOI 10.1021/bi00026a020; Yamazaki H, 1996, ARCH BIOCHEM BIOPHYS, V325, P174, DOI 10.1006/abbi.1996.0022; Yamazaki H, 1996, BIOCHEM PHARMACOL, V52, P301, DOI 10.1016/0006-2952(96)00208-0; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200	67	86	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30885	30891		10.1074/jbc.M105011200	http://dx.doi.org/10.1074/jbc.M105011200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413149	hybrid			2022-12-27	WOS:000170472900041
J	Eubank, DW; Duplus, E; Williams, SC; Forest, C; Beale, EG				Eubank, DW; Duplus, E; Williams, SC; Forest, C; Beale, EG			Peroxisome proliferator-activated receptor gamma and chicken ovalbumin upstream promoter transcription factor II negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID RESPONSE ELEMENT; RETINOID-X-RECEPTOR; FACTOR COUP-TF; PPAR-GAMMA; GENE-TRANSCRIPTION; GTP GENE; ADIPOCYTE DIFFERENTIATION; TERMINAL DIFFERENTIATION; GLUCOCORTICOID RESPONSE; INSULIN-RESISTANCE	A heterodimer of peroxisome proliferator-activated receptor gamma (PPAR gamma) and retinoid X receptor (RXR) is required for adipocyte differentiation. The gene encoding cytosolic phosphoenolpyruvate carboxykinase (PEPCK) is a PPAR gamma /RXR target gene in adipose tissue. Of the two PPAR gamma response elements, gAF1/PCK1 and PCK2, only PCK2 is required for PEPCK expression and responsiveness to the PPAR gamma agonist, rosiglitazone, in adipose tissue even though both elements bind PPAR gamma /RXR in vitro. In contrast, gAF1/PCK1 is essential for glucocorticoid inhibition of PPAR gamma -induced PEPCK gene expression in adipocytes. We report that chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is the predominant nuclear receptor bound to gAF1/PCK1 in preadipocytes. COUP-TFII declines during adipogenesis in reciprocal fashion to PPAR gamma. In transiently transfected fibroblasts COUP-TFII acts at gAF1/PCK1 to inhibit PPAR gamma /RXR activation via PCK2. In contrast COUP-TFs are transcriptional activators of PEPCK in hepatocytes. PPAR gamma /RXR occupies gAF1/PCK1 in adipocytes, and mutation of gAF1/PCK1 enhances PEPCK promoter transactivation by PPAR gamma /RXR in fibroblasts, suggesting that this element is also a negative PPAR gamma response element. These results indicate that gAF1/PCK1 is a pleiotropic element through which COUP-TFII inhibits premature PEPCK expression, and perhaps adipogenesis in general, and PPAR gamma /RXR uses this same element in adipocytes to participate in PEPCK modulation by glucocorticoids.	Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; CNRS, INSERM, Unit 530, F-92190 Meudon, France	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Beale, EG (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Stop 6540, Lubbock, TX 79430 USA.		Beale, Elmus/GNM-8181-2022; DUPLUS, Eric/F-2969-2013	DUPLUS, Eric/0000-0003-1954-4836; Forest, Claude/0000-0003-3401-8148; Beale, Elmus/0000-0002-7758-0600	NICHD NIH HHS [T32-HD07271] Funding Source: Medline; NIGMS NIH HHS [GM39895] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039895, R01GM039895] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAES M, 1995, BIOCHEM BIOPH RES CO, V215, P338, DOI 10.1006/bbrc.1995.2471; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; BEALE EG, 1985, J BIOL CHEM, V260, P748; BEALE EG, 1992, FASEB J, V6, P330; Brodie AE, 1996, BIOCHEM BIOPH RES CO, V228, P655, DOI 10.1006/bbrc.1996.1713; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Croniger C, 1998, J BIOL CHEM, V273, P31629, DOI 10.1074/jbc.273.48.31629; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Devine JH, 1999, J BIOL CHEM, V274, P13604, DOI 10.1074/jbc.274.19.13604; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; Forest C, 1997, PROSTAG LEUKOTR ESS, V57, P47, DOI 10.1016/S0952-3278(97)90492-0; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FRANCKHAUSER S, 1995, BIOCHEM J, V305, P65, DOI 10.1042/bj3050065; FranckhauserVogel S, 1997, MOL CELL ENDOCRINOL, V127, P171, DOI 10.1016/S0303-7207(96)04006-3; FROST SC, 1985, J BIOL CHEM, V260, P2646; Glorian M, 1998, J CELL BIOCHEM, V68, P298, DOI 10.1002/(SICI)1097-4644(19980301)68:3<298::AID-JCB2>3.0.CO;2-P; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; HALL RK, 1992, MOL CELL BIOL, V12, P5527, DOI 10.1128/MCB.12.12.5527; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; HANSON RW, 1973, AM J CLIN NUTR, V26, P55, DOI 10.1093/ajcn/26.1.55; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kalhan SC, 2001, J BIOL CHEM, V276, P12928, DOI 10.1074/jbc.M006186200; KIEBACK DG, 1993, GYNECOL ONCOL, V51, P167, DOI 10.1006/gyno.1993.1266; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; LUCAS PC, 1991, MOL CELL BIOL, V11, P5164, DOI 10.1128/MCB.11.10.5164; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marcus SL, 1996, MOL CELL ENDOCRINOL, V120, P31, DOI 10.1016/0303-7207(96)03813-0; MIYATA KS, 1993, J BIOL CHEM, V268, P19169; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NECHUSHTAN H, 1987, NUCLEIC ACIDS RES, V15, P6405, DOI 10.1093/nar/15.16.6405; PATEL YM, 1994, J BIOL CHEM, V269, P5619; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Robinson CE, 1999, ENDOCRINOLOGY, V140, P1586, DOI 10.1210/en.140.4.1586; Rodriguez JC, 1997, BIOCHEM J, V326, P587, DOI 10.1042/bj3260587; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Spiegelman BM, 1998, CELL, V93, P153, DOI 10.1016/S0092-8674(00)81567-6; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; Sugiyama T, 2000, J BIOL CHEM, V275, P3446, DOI 10.1074/jbc.275.5.3446; Tilghman SM, 1976, GLUCONEOGENESIS ITS, P47; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Wendling O, 1999, P NATL ACAD SCI USA, V96, P547, DOI 10.1073/pnas.96.2.547; Williams CP, 1999, MOL CELL ENDOCRINOL, V148, P67, DOI 10.1016/S0303-7207(98)00234-2	63	36	37	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30561	30569		10.1074/jbc.M103019200	http://dx.doi.org/10.1074/jbc.M103019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11399762	hybrid			2022-12-27	WOS:000170558000125
J	Chanut-Delalande, H; Fichard, A; Bernocco, S; Garrone, R; Hulmes, DJS; Ruggiero, F				Chanut-Delalande, H; Fichard, A; Bernocco, S; Garrone, R; Hulmes, DJS; Ruggiero, F			Control of heterotypic fibril formation by collages V is determined by chain stoichiometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; EMBRYONIC CHICKEN CORNEA; SYNDROME TYPE-I; STRUCTURAL-ANALYSIS; CELLS SYNTHESIZE; HEPARIN-BINDING; B-CHAINS; FIBRILLOGENESIS; INVITRO; MATRIX	Although the collagen V heterotrimer is known to be involved in the control of fibril assembly, the role of the homotrimer in fibrillar organization has not yet been examined. Here, the production of substantial amounts of recombinant collagen V homotrimer has allowed a detailed study of its role in homotypic and heterotypic fibril formation. After removal of terminal regions by pepsin digestion, both the collagen V heterotrimer and homotrimer formed thin homotypic fibrils, thus showing that diameter limitation is at least in part an intrinsic property of the collagen V triple helix. When mixed with collagen I, however, various complementary approaches indicated that the collagen V heterotrimer and homotrimer exerted different effects in heterotypic fibril formation. Unlike the heterotrimer, which was buried in the fibril interior, the homotrimer was localized as thin filamentous structures at the surface of wide collagen I fibrils and did not regulate fibril assembly. Its localization at the fibril surface suggests that the homotrimer can act as a molecular linker between collagen fibrils or macromolecules in the extracellular matrix or both. Thus, depending on their respective distribution in tissues, the different collagen V isoforms might fulfill specific biological functions.	Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Ruggiero, F (corresponding author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot, 7 Passage Vercors, F-69367 Lyon 07, France.	f.ruggiero@ibcp.fr		Hulmes, David/0000-0002-0651-1317; RUGGIERO, Florence/0000-0003-2915-5359; CHANUT-DELALANDE, Helene/0000-0002-1720-2069				ADACHI E, 1986, CONNECT TISSUE RES, V14, P257, DOI 10.3109/03008208609017469; ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; BIRK DE, 1986, INVEST OPHTH VIS SCI, V27, P1470; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1990, J CELL SCI, V95, P649; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BROEK DL, 1985, J BIOL CHEM, V260, P555; Bruckner-Tuderman L, 1998, J MOL MED-JMM, V76, P226, DOI 10.1007/s001090050213; Chernousov MA, 2000, J BIOL CHEM, V275, P28208; Delacoux F, 1998, J BIOL CHEM, V273, P15069, DOI 10.1074/jbc.273.24.15069; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; FITCH JM, 1984, P NATL ACAD SCI-BIOL, V81, P2791, DOI 10.1073/pnas.81.9.2791; GAY S, 1981, COLLAGEN REL RES, V1, P53; Giunta C, 2000, AM J MED GENET, V90, P72, DOI 10.1002/(SICI)1096-8628(20000103)90:1<72::AID-AJMG13>3.0.CO;2-C; HARALSON MA, 1980, P NATL ACAD SCI-BIOL, V77, P5206, DOI 10.1073/pnas.77.9.5206; HENDRIX MJC, 1982, INVEST OPHTH VIS SCI, V22, P359; HENKEL W, 1982, EUR J BIOCHEM, V122, P205, DOI 10.1111/j.1432-1033.1982.tb05868.x; Imamura Y, 2000, J BIOL CHEM, V275, P8749, DOI 10.1074/jbc.275.12.8749; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; KUMAMOTO CA, 1980, P NATL ACAD SCI-BIOL, V77, P6434, DOI 10.1073/pnas.77.11.6434; Kuznetsova N, 1999, J BIOL CHEM, V274, P36083, DOI 10.1074/jbc.274.51.36083; LEE SL, 1983, COLLAGEN REL RES, V3, P89; LEIBOVICH SJ, 1970, BIOCHIM BIOPHYS ACTA, V214, P445, DOI 10.1016/0005-2795(70)90303-X; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415; MCLAUGHLIN JS, 1989, J CELL SCI, V94, P371; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; MODESTI A, 1984, EUR J CELL BIOL, V35, P246; MORADIAMELI M, 1994, EUR J BIOCHEM, V221, P987, DOI 10.1111/j.1432-1033.1994.tb18815.x; NIYIBIZI C, 1993, BIOCHIM BIOPHYS ACTA, V1203, P304, DOI 10.1016/0167-4838(93)90099-D; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; NIYIBIZI C, 1984, J BIOL CHEM, V259, P4170; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; ROMANIC AM, 1991, J BIOL CHEM, V266, P12703; Ruggiero F, 1996, INVEST OPHTH VIS SCI, V37, P1749; RUGGIERO F, 1994, EXP CELL RES, V210, P215, DOI 10.1006/excr.1994.1032; Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X; SAGE H, 1981, BIOCHEMISTRY-US, V20, P3778, DOI 10.1021/bi00516a017; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105	42	48	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2001	276	26					24352	24359		10.1074/jbc.M101182200	http://dx.doi.org/10.1074/jbc.M101182200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	446TW	11423559				2022-12-27	WOS:000169531100148
J	D'Orso, I; Frasch, ACC				D'Orso, I; Frasch, ACC			TcUBP-1, a developmentally regulated U-rich RNA-binding protein involved in selective mRNA destabilization in trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; 3'-UNTRANSLATED REGION; POLYPYRIMIDINE TRACT; UNTRANSLATED REGION; CRUZI GENOME; ELEMENTS; GENE; EXPRESSION; BRUCEI; DEGRADATION	Developmental stages of the trypanosome life cycle differ in their morphology, biology, and biochemical properties. Consequently, several proteins have to be tightly regulated in their expression to allow trypanosomes to adapt rapidly to sudden environmental changes, a process that might be of central importance for parasite survival. However, in contrast to higher eukaryotic cells, trypanosomes do not seem to regulate gene expression through regulation of transcription initiation. These parasites make use of post-transcriptional regulatory mechanisms and modification of mRNA half-life is a relevant one. Trans-acting factors binding to cis-elements that affect mRNA stability of mature transcripts have not been identified in these cells. In this work, a novel U-rich RNA-binding protein (TcUBP-1) from Trypanosoma cruzi, the agent of Chagas disease, was identified. Its structure includes an RNA recognition motif, a nuclear export signal, and auxiliary domains with glycine- and glutamine-rich regions. TcUBP-1 recognizes the 44-nucleotide AU-rich RNA instability element located in the W-untranslated region of mucin SMUG mRNAs (Di Noia, J. M., D'Orso, I., Sanchez, D. O., and Frasch, A. C. (2000) J. Biol. Chem. 275, 10218-10227) as well as GU-rich sequences. Over-expression of TcUBP-1 in trypanosomes decreases the half-life of SMUG mucin mRNAs in vivo but does not affect the stability of other parasite mRNAs. Because TcUBP-1 is developmentally regulated, it might have a relevant role in regulating protein expression during trypanosome differentiation, allowing a correct expression pattern of U-rich-containing mRNAs.	Unv Nacl Gen SAn Martin, INTI, Inst Invest Biotechnol,Inst Tecnol Chascomus, CONICET, RA-1650 San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Industrial (INTI)	Frasch, ACC (corresponding author), Unv Nacl Gen San Martin, INTI, Inst Invest Biotechnol,Inst Tecnol Chascomus, CONICET, Av Gral Paz S-N,Edificio 24,Casilla de Correo 30, RA-1650 San Martin, Buenos Aires, Argentina.			Frasch, Alberto Carlos/0000-0001-7532-653X				Aguero F, 2000, GENOME RES, V10, P1996, DOI 10.1101/gr.GR-1463R; AMADO R, 1984, METHOD ENZYMOL, V107, P377; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; BENAMAR MF, 1991, NUCLEIC ACIDS RES, V19, P5857, DOI 10.1093/nar/19.21.5857; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CAPPA SMG, 1981, MEDICINA-BUENOS AIRE, V41, P119; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Coughlin BC, 2000, J BIOL CHEM, V275, P12051, DOI 10.1074/jbc.275.16.12051; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Di Noia JM, 1998, J BIOL CHEM, V273, P10843, DOI 10.1074/jbc.273.18.10843; DONELSON JE, 1995, J BIOL CHEM, V270, P7783, DOI 10.1074/jbc.270.14.7783; DRAGON EA, 1987, MOL CELL BIOL, V7, P1271, DOI 10.1128/MCB.7.3.1271; Dreyfuss G, 1996, CELL, V85, P963, DOI 10.1016/S0092-8674(00)81298-2; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FOURNEY RM, 1978, FOCUS, V10, P5; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Gao FB, 1996, J CELL SCI, V109, P579; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; Golightly LM, 2000, MOL BIOCHEM PARASIT, V105, P61, DOI 10.1016/S0166-6851(99)00165-6; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Greene JAL, 1996, J BIOL CHEM, V271, P26762, DOI 10.1074/jbc.271.43.26762; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; Ismaili N, 2000, MOL BIOCHEM PARASIT, V106, P109, DOI 10.1016/S0166-6851(99)00205-4; IZAURRALDE E, 1995, CELL, V81, P153, DOI 10.1016/0092-8674(95)90323-2; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KIM YJ, 1993, J NEUROSCI, V13, P1045; KIM YJ, 1993, MOL CELL BIOL, V13, P174, DOI 10.1128/MCB.13.1.174; Kishore R, 1999, J IMMUNOL, V162, P2457; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Lee MGS, 1996, MOL CELL BIOL, V16, P1220; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; MartinezCalvillo S, 1997, GENE, V199, P71, DOI 10.1016/S0378-1119(97)00348-X; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; MYER VE, 1995, RNA, V1, P171; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; NAKAGAWA J, 1995, P NATL ACAD SCI USA, V92, P2051, DOI 10.1073/pnas.92.6.2051; Nakielny S, 1997, ANNU REV NEUROSCI, V20, P269, DOI 10.1146/annurev.neuro.20.1.269; Nozaki T, 1995, MOL BIOCHEM PARASIT, V75, P55, DOI 10.1016/0166-6851(95)02512-X; PAIK W, 1984, METHOD ENZYMOL, V106, P3; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Pollevick GD, 2000, J BIOL CHEM, V275, P27671; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; Sambrook J., 2002, MOL CLONING LAB MANU; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Sokolowski M, 1997, ONCOGENE, V15, P2303, DOI 10.1038/sj.onc.1201415; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; Stuart K, 1998, Verh K Acad Geneeskd Belg, V60, P63; TEIXEIRA SMR, 1995, J BIOL CHEM, V270, P22586, DOI 10.1074/jbc.270.38.22586; Weston D, 1999, MOL BIOCHEM PARASIT, V102, P53, DOI 10.1016/S0166-6851(99)00079-1; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zingales B, 1997, ACTA TROP, V68, P159, DOI 10.1016/S0001-706X(97)00088-0	63	68	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34801	34809		10.1074/jbc.M102120200	http://dx.doi.org/10.1074/jbc.M102120200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11435421	hybrid			2022-12-27	WOS:000171024600062
J	Godbout, R; Monckton, EA				Godbout, R; Monckton, EA			Differential regulation of the aldehyde dehydrogenase 1 gene in embryonic chick retina and liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTORS; VENTRAL RETINA; TETRANUCLEOTIDE REPEAT; DORSOVENTRAL AXIS; MOUSE DEVELOPMENT; GENOMIC STRUCTURE; ACID; EXPRESSION; PROMOTER	Aldehyde dehydrogenase (ALDH1) is highly expressed in the dorsal cells of the undifferentiated retina, where it has been proposed to play a role in the formation of a retinoic acid gradient along the ventrodorsal axis. In contrast to the retina, ALDH1 levels increase with differentiation in the liver and remain elevated in the adult tissue. To understand the molecular basis for differential expression of ALDH1 during development, we characterized the ALDH1 transcripts expressed in chick retina and liver. By sequencing, primer extension, and S1 nuclease analysis, we show that retina ALDH1 mRNA has an additional 300 nucleotides of 5 ' -untranslated sequence resulting from the transcription of two 5 ' noncoding exons. There is a 24-29-kilobase pair (kb) gap between exons 1 and 2 and a 290-base pair gap between exons 2 and 3. Exon 3, which contains the ALDH1 start codon, represents the first exon of the liver transcript. Using a reporter gene assay, we have identified tissue-specific regulatory elements that govern ALDH1 expression in primary retina and liver cultures. Constructs with >1.6 kb of DNA flanking the 5 ' -end of exon I showed elevated activity in retinal cultures but only basal activity in liver cultures. In contrast, constructs with < 1 kb of W-flanking DNA were active in both retina and liver cultures. Our results suggest that an important mechanism for the control of ALDH1 transcriptional activity is through the presence of inhibitory elements located 0.7-1.6 kb upstream of the ALDH1 gene. DNase I footprint analysis reveal four sites of protein-DNA interaction within this region, one of which is specific to the liver and corresponds to a NF-kappaB/Rel binding site.	Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Godbout, R (corresponding author), Cross Canc Inst, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.		Godbout, Roseline/I-4639-2016	Godbout, Roseline/0000-0002-4779-9265				BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; BELIKOV S, 1995, NUCLEIC ACIDS RES, V23, P310, DOI 10.1093/nar/23.2.310; Carson CT, 2000, MECH DEVELOP, V96, P137, DOI 10.1016/S0925-4773(00)00376-2; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen J, 1996, BIOCHEM GENET, V34, P109; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; EKKER SC, 1992, EMBO J, V11, P4059, DOI 10.1002/j.1460-2075.1992.tb05499.x; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Favaloro J, 1980, Methods Enzymol, V65, P718; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GODBOUT R, 1992, EXP EYE RES, V54, P297, DOI 10.1016/S0014-4835(05)80219-2; Godbout R, 1996, DEV DYNAM, V205, P319, DOI 10.1002/(SICI)1097-0177(199603)205:3<319::AID-AJA11>3.0.CO;2-#; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; Grun F, 2000, J BIOL CHEM, V275, P41210, DOI 10.1074/jbc.M007376200; Hagemann TL, 1999, BIOCHEM BIOPH RES CO, V256, P104, DOI 10.1006/bbrc.1999.0292; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HSU LC, 1989, GENOMICS, V5, P857, DOI 10.1016/0888-7543(89)90127-4; HYATT GA, 1992, P NATL ACAD SCI USA, V89, P8293, DOI 10.1073/pnas.89.17.8293; Hyatt GA, 1996, DEVELOPMENT, V122, P195; Johnston GS, 1998, EARLY MUSIC, V26, P51, DOI 10.1093/em/26.1.51; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; LABBE S, 1991, NUCLEIC ACIDS RES, V19, P4225, DOI 10.1093/nar/19.15.4225; Le F, 1997, J BIOL CHEM, V272, P1315, DOI 10.1074/jbc.272.2.1315; LEE MO, 1991, BIOCHEM PHARMACOL, V42, P1279, DOI 10.1016/0006-2952(91)90266-8; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li HX, 2000, MECH DEVELOP, V95, P283, DOI 10.1016/S0925-4773(00)00352-X; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; LIU Y, 1995, HUM MOL GENET, V4, P727, DOI 10.1093/hmg/4.4.727; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; MCCAFFERY P, 1991, DEVELOPMENT, V112, P693; MCCAFFERY P, 1993, DEV BIOL, V158, P390, DOI 10.1006/dbio.1993.1197; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; Meloni R, 1998, HUM MOL GENET, V7, P423, DOI 10.1093/hmg/7.3.423; Mic FA, 2000, MECH DEVELOP, V97, P227, DOI 10.1016/S0925-4773(00)00434-2; Okladnova O, 1998, MOL BRAIN RES, V60, P177, DOI 10.1016/S0169-328X(98)00167-3; Otteson DC, 1998, DEV BIOL, V193, P209, DOI 10.1006/dbio.1997.8794; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stewart MJ, 1996, J INVEST MED, V44, P42; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wang ZB, 1999, EMBO J, V18, P2218, DOI 10.1093/emboj/18.8.2218; YANAGAWA Y, 1995, J BIOL CHEM, V270, P17521, DOI 10.1074/jbc.270.29.17521	51	7	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32896	32904		10.1074/jbc.M104372200	http://dx.doi.org/10.1074/jbc.M104372200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438538	hybrid			2022-12-27	WOS:000170746000071
J	Wang, XW; Tseng, A; Ellis, NA; Spillare, EA; Linke, SP; Robles, AI; Seker, H; Yang, Q; Hu, P; Beresten, S; Bemmels, NA; Garfield, S; Harris, CC				Wang, XW; Tseng, A; Ellis, NA; Spillare, EA; Linke, SP; Robles, AI; Seker, H; Yang, Q; Hu, P; Beresten, S; Bemmels, NA; Garfield, S; Harris, CC			Functional interaction of p53 and BLM DNA helicase in apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOM-SYNDROME CELLS; WERNERS-SYNDROME GENES; SYNDROME PROTEIN; P53-MEDIATED APOPTOSIS; PREMATURE SENESCENCE; GENOMIC INSTABILITY; IONIZING-RADIATION; NUCLEAR-STRUCTURE; ONCOGENIC RAS; CYCLE	The Bloom syndrome (BS) protein, BLM, is a member of the RecQ DNA helicase family that also includes the Werner syndrome protein, WRN. Inherited mutations in these proteins are associated with cancer predisposition of these patients. We recently discovered that cells from Werner syndrome patients displayed a deficiency in p53-mediated apoptosis and WRN binds to p53. Here, we report that analogous to WRN, BLM also binds to p53 in vivo and in vitro, and the C-terminal domain of p53 is responsible for the interaction. p53-mediated apoptosis is defective in BS fibroblasts and can be rescued by expression of the normal BLM gene. Moreover, lymphoblastoid cell lines (LCLs) derived from BS donors are resistant to both gamma -radiation and doxorubicin-induced cell killing, and sensitivity can be restored by the stable expression of normal BLM. In contrast, BS cells have a normal Fas-mediated apoptosis, and in response to DNA damage normal accumulation of p53, normal induction of p53 responsive genes, and normal G(1)-S and G(2)-M Cell cycle arrest. BLM localizes to nuclear foci referred to as PAM nuclear bodies (NBs). Cells from Li-Fraumeni syndrome patients carrying p53 germline mutations and LCLs lacking a functional p53 have a decreased accumulation of BLM in NBs, whereas isogenic lines with functional p53 exhibit normal accumulation. Certain BLM mutants (C1055S or Delta 133-237) that have a reduced ability to localize to the NBs when expressed in normal cells can impair the localization of wild type BLM to NBs and block p53-mediated apoptosis, suggesting a dominant-negative effect. Taken together, our results indicate both a novel mechanism of p53 function by which p53 mediates nuclear trafficking of BLM to NBs and the cooperation of p53 and BLM to induce apoptosis.	NCI, LHC, NIH, Ctr Canc Res, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, Lab Canc Susceptibil, Dept Human Genet, New York, NY 10021 USA; NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harris, CC (corresponding author), NCI, LHC, NIH, Ctr Canc Res, Bldg 37,Rm 2C05,MSC4255, Bethesda, MD 20892 USA.	curtis_harris@nih.gov	Wang, Xin Wei/B-6162-2009	Wang, Xin Wei/0000-0001-9735-606X; Robles, Ana/0000-0001-5019-4374; Linke, Steven/0000-0001-8584-4947	NCI NIH HHS [R01 CA085867, R01 CA085867-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085867] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ababou M, 2000, ONCOGENE, V19, P5955, DOI 10.1038/sj.onc.1204003; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bahr A, 1998, ONCOGENE, V17, P2565, DOI 10.1038/sj.onc.1202389; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Collister M, 1998, CARCINOGENESIS, V19, P2115, DOI 10.1093/carcin/19.12.2115; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DOUCAS V, 1996, BIOCHIM BIOPHYS ACTA, V1288, P25; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; Ellis NA, 1998, AM J HUM GENET, V63, P1685, DOI 10.1086/302167; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; Ellis NA, 1999, AM J HUM GENET, V65, P1368, DOI 10.1086/302616; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ferbeyre G, 2000, GENE DEV, V14, P2015; German J, 1996, CLIN GENET, V49, P223; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; Gharibyan V, 1999, MOL CARCINOGEN, V26, P261, DOI 10.1002/(SICI)1098-2744(199912)26:4<261::AID-MC5>3.0.CO;2-A; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jayaraman L, 1999, CELL MOL LIFE SCI, V55, P76, DOI 10.1007/s000180050271; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Lain S, 1999, EXP CELL RES, V248, P457, DOI 10.1006/excr.1999.4433; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LITTLE JB, 1995, J BIOL CHEM, V270, P11033, DOI 10.1074/jbc.270.19.11033; Liu JH, 2001, CELL, V104, P353, DOI 10.1016/S0092-8674(01)00223-9; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Robles AI, 1999, ONCOGENE, V18, P4681, DOI 10.1038/sj.onc.1202862; Schwartz D, 1998, SEMIN CANCER BIOL, V8, P325, DOI 10.1006/scbi.1998.0095; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; vanLaar T, 1995, BIOCHEM BIOPH RES CO, V217, P769, DOI 10.1006/bbrc.1995.2839; VANLAAR T, 1994, ONCOGENE, V9, P981; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; Wang Y, 2000, GENE DEV, V14, P927; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Watt PM, 1996, CURR BIOL, V6, P265, DOI 10.1016/S0960-9822(02)00474-8; Watt PM, 1996, GENETICS, V144, P935; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	52	122	127	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32948	32955		10.1074/jbc.M103298200	http://dx.doi.org/10.1074/jbc.M103298200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11399766	hybrid			2022-12-27	WOS:000170746000077
J	Kulkarni, AA; Abul-Hamd, AT; Rai, R; El Berry, H; Cooper, TG				Kulkarni, AA; Abul-Hamd, AT; Rai, R; El Berry, H; Cooper, TG			Gln3p nuclear localization and interaction with Ure2p in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGEN CATABOLITE REPRESSION; DNA-BINDING DOMAIN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; DEVELOPING HEART; PROTEIN; YEAST; PRION; TOR; PHOSPHORYLATION	Gln3p is one of two well characterized GATA family transcriptional activation factors whose function is regulated by the nitrogen supply of the cell. When nitrogen is limiting, Gln3p and Gat1p are concentrated in the nucleus where they bind GATA sequences upstream of nitrogen catabolite repression (NCR)-sensitive genes and activate their transcription. Conversely, in excess nitrogen, these GATA sequences are unoccupied by Gln3p and Gat1p because these transcription activators are excluded from the nucleus. Ure2p binds to Gln3p and Gat1p and is required for NCR-sensitive transcription to be repressed and for nuclear exclusion of these transcription factors. Here we show the following. (i) Gln3p residues 344-365 are required for nuclear localization. (ii) Replacing Ser-344, Ser-347, and Ser-355 with alanines has minimal effects on GFP-Gln3p localization. However, replacing Gln3p Ser-344, Ser-347, and Ser-355 with aspartates results in significant loss of its ability to be concentrated in the nucleus. (iii) N and C termini of the Gln3p region required for it to complex with Ure2p and be excluded from the nucleus are between residues 1-103 and 301-365, respectively. (iv) N and C termini of the Ure2p region required for it to interact with Gln3p are situated between residues 101-151 and 330-346, respectively. (v) Loss of Ure2p residues participating in either dimer or prion formation diminishes its ability to carry out NCR-sensitive regulation of Gln3p activity.	Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA.	tcooper@utmem.edu		Cooper, Terrance G./0000-0002-7651-9963	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35642, R01 GM035642-13, R01 GM035642] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azuma Y, 1997, BIOCHIMIE, V79, P247, DOI 10.1016/S0300-9084(97)83512-2; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; CHISHOLM G, 1982, MOL CELL BIOL, V2, P1088, DOI 10.1128/MCB.2.9.1088; Coffman JA, 1996, MOL CELL BIOL, V16, P847; COFFMAN JA, 1994, J BACTERIOL, V176, P7476, DOI 10.1128/JB.176.24.7476-7483.1994; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; COOPER TG, 1990, J BACTERIOL, V172, P1014, DOI 10.1128/jb.172.2.1014-1018.1990; Cooper TG, 1996, MYCOTA, V3, P139; Cox KH, 1999, YEAST, V15, P703, DOI 10.1002/(SICI)1097-0061(19990615)15:8<703::AID-YEA413>3.0.CO;2-Z; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993; CUNNINGHAM TS, 1994, J BACTERIOL, V176, P4718, DOI 10.1128/JB.176.15.4718-4725.1994; Cunningham TS, 1996, J BACTERIOL, V178, P3470, DOI 10.1128/jb.178.12.3470-3479.1996; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DAUGHERTY JR, 1993, J BACTERIOL, V175, P64, DOI 10.1128/JB.175.1.64-73.1993; Distler M, 2001, J BACTERIOL, V183, P4636, DOI 10.1128/JB.183.15.4636-4642.2001; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Fernandez-Bellot E, 1999, BIOCHEM J, V338, P403, DOI 10.1042/0264-6021:3380403; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; JANS DA, 1995, J BIOL CHEM, V270, P17064, DOI 10.1074/jbc.270.29.17064; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; KELLEY C, 1993, DEVELOPMENT, V118, P817; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; MINEHART PL, 1991, MOL CELL BIOL, V11, P6216, DOI 10.1128/MCB.11.12.6216; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; RAI R, 1989, MOL CELL BIOL, V9, P602, DOI 10.1128/MCB.9.2.602; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scott S, 2000, J BIOL CHEM, V275, P7198, DOI 10.1074/jbc.275.10.7198; Scott S, 2000, J BIOL CHEM, V275, P30886, DOI 10.1074/jbc.M005624200; Smart WC, 1996, MOL CELL BIOL, V16, P5876; Svetlov V, 1997, J BACTERIOL, V179, P7644, DOI 10.1128/jb.179.24.7644-7652.1997; Svetlov VV, 1998, J BACTERIOL, V180, P5682, DOI 10.1128/JB.180.21.5682-5688.1998; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; VANVUUREN HJJ, 1991, J BACTERIOL, V173, P7186, DOI 10.1128/jb.173.22.7186-7195.1991; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Young MR, 1997, GENES CELLS, V2, P631, DOI 10.1046/j.1365-2443.1997.1510349.x	52	70	73	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32136	32144		10.1074/jbc.M104580200	http://dx.doi.org/10.1074/jbc.M104580200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11408486	Green Accepted, hybrid			2022-12-27	WOS:000170613500091
J	Melhuish, TA; Gallo, CM; Wotton, D				Melhuish, TA; Gallo, CM; Wotton, D			TGIF2 interacts with histone deacetylase I and represses transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; HOMEOBOX GENE; HOMEODOMAIN PROTEINS; SMAD PROTEINS; TUMOR-SUPPRESSOR; TALE SUPERCLASS; COREPRESSOR; COMPLEXES; DOMAIN; HOX	TG-interacting factor (TGIF) is a transcriptional repressor, which represses transcription by binding directly to DNA or interacts with transforming growth factor beta (TGF beta)-activated Smads, thereby repressing TGF beta -responsive gene expression. Mutation of TGIF in humans causes holoprosencephaly, a severe genetic disorder affecting craniofacial development. Searching human expressed sequence tag data bases revealed the presence of clones encoding a TGIF-related protein (TGIF2), which contains two regions of high sequence identity with TGIF. Here we show that, like TGIF, TGIF2 recruits histone deacetylase, but in contrast to TGIF, is unable to interact with the corepressor CtBP. TGIF2 and TGIF have very similar DNA-binding homeodomains, and TGIF2 represses transcription when bound to DNA via a TGIF binding site. TGIF2 interacts with TGF beta -activated Smads and represses TGF beta -responsive transcription. TGIF2 appears to be a context-independent transcriptional repressor, which can perform similar functions to TGIF and may play a role in processes, which, when disrupted by mutations in TGIF, cause holoprosencephaly.	Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Wotton, D (corresponding author), Univ Virginia, Hosp W, Ctr Cell Signaling, Box 800577 HSC, Charlottesville, VA 22908 USA.			Wotton, David/0000-0002-4652-5350				Asahara H, 1999, MOL CELL BIOL, V19, P8219; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Bertolino E, 1996, DEV DYNAM, V205, P410, DOI 10.1002/(SICI)1097-0177(199604)205:4<410::AID-AJA5>3.0.CO;2-L; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Golden JA, 1998, J NEUROPATH EXP NEUR, V57, P991, DOI 10.1097/00005072-199811000-00001; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Imoto I, 2000, BIOCHEM BIOPH RES CO, V276, P264, DOI 10.1006/bbrc.2000.3449; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Liu B, 1999, MOL CELL BIOL, V19, P424; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; OVERHAUSER J, 1995, AM J HUM GENET, V57, P1080; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Roessler E, 1998, J INHERIT METAB DIS, V21, P481, DOI 10.1023/A:1005406719292; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Wallis DE, 1999, MOL GENET METAB, V68, P126, DOI 10.1006/mgme.1999.2895; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199; Zhang Y, 1999, TRENDS CELL BIOL, V9, P274, DOI 10.1016/S0962-8924(99)01579-2; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	49	97	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32109	32114		10.1074/jbc.M103377200	http://dx.doi.org/10.1074/jbc.M103377200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427533	hybrid			2022-12-27	WOS:000170613500087
J	Yoshiike, Y; Tanemura, K; Murayama, O; Akagi, T; Murayama, M; Sato, S; Sun, XY; Tanaka, N; Takashima, A				Yoshiike, Y; Tanemura, K; Murayama, O; Akagi, T; Murayama, M; Sato, S; Sun, XY; Tanaka, N; Takashima, A			New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMER A-BETA; MITOCHONDRIAL SUCCINATE-DEHYDROGENASE; CONGO RED; PHYSIOLOGICAL CONCENTRATIONS; PRECURSOR PROTEIN; DEPENDENT BINDING; FIBRIL FORMATION; THIOFLAVINE-T; IN-VITRO; DISEASE	Amyloid-beta protein (A beta) aggregates in the brain to form senile plaques. By using thioflavin T, a dye that specifically binds to fibrillar structures, we found that metals such as Zn(ll) and Cu(II) normally inhibit amyloid beta -aggregation. Another method for detecting A beta, which does not distinguish the types of aggregates, showed that these metals induce a non-beta -sheeted aggregation, as reported previously. Secondary structural analysis and microscopic studies revealed that metals induced A beta to make non-fibrillar aggregates by disrupting beta -sheet formation. These non-fibrillar A beta aggregates displayed much weaker Congo Red birefringence, and in separate cell culture experiments, were less toxic than self beta -aggregates, as demonstrated by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. The toxicity of soluble A beta was enhanced in the presence of Cu(Il), which suggests the previously hypothesized role of A beta in generating oxidative stress. Finally, under an acidic condition, similar to that in the inflammation associated with senile plaques, beta -aggregation was robustly facilitated at one specific concentration of Zn(ll) in the presence of heparin. However, because a higher concentration of Zn(II) virtually abolished this abnormal phenomenon, and at normal pH any concentrations strongly inhibit beta -aggregation and its associated cytotoxicity, including its anti-oxidative nature we suggest that Zn(II) has an overall protective effect against beta -amyloid toxicity.	RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; Tokyo Inst Technol, Dept Life Sci, Yokohama, Kanagawa 2268503, Japan; Azabu Univ, Grad Sch Environm Hlth Sci, Sagamihara, Kanagawa 2298501, Japan; RIKEN, Brain Sci Inst, Lab Neural Architecture, Wako, Saitama 3510198, Japan	RIKEN; Tokyo Institute of Technology; Azabu University; RIKEN	Takashima, A (corresponding author), RIKEN, Brain Sci Inst, Lab Alzheimers Dis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kenneth@brain.riken.go.jp						Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Bondy SC, 1998, BRAIN RES, V799, P91, DOI 10.1016/S0006-8993(98)00461-2; Brown AM, 1997, J NEUROCHEM, V69, P1204; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; BUSH AI, 1994, J BIOL CHEM, V269, P12152; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Chaney MO, 1998, PROTEIN ENG, V11, P761, DOI 10.1093/protein/11.9.761; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; DAVIES IJT, 1968, J CLIN PATHOL, V21, P359, DOI 10.1136/jcp.21.3.359; DYRKS T, 1992, J BIOL CHEM, V267, P18210; Esler WP, 1996, J NEUROCHEM, V66, P723; FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Huang XD, 2000, J NUTR, V130, p1488S, DOI 10.1093/jn/130.5.1488S; Irizarry MC, 1997, J NEUROSCI, V17, P7053; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KANEKO I, 1995, J NEUROCHEM, V65, P2585; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Kisilevsky R, 1997, ANN NY ACAD SCI, V826, P117, DOI 10.1111/j.1749-6632.1997.tb48465.x; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lovell MA, 1999, BRAIN RES, V823, P88, DOI 10.1016/S0006-8993(99)01114-2; Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9; MANTYH PW, 1993, J NEUROCHEM, V61, P1171, DOI 10.1111/j.1471-4159.1993.tb03639.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCLACHLAN JC, 1991, LANCET, V337, P742, DOI 10.1016/0140-6736(91)90336-N; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Moir RD, 1999, BIOCHEMISTRY-US, V38, P4595, DOI 10.1021/bi982437d; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Perczel A., 1996, CIRCULAR DICHROISM C, P285; Pereira C, 1998, NEUROREPORT, V9, P1749, DOI 10.1097/00001756-199806010-00015; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; POTEMPA LA, 1985, J BIOL CHEM, V260, P2142; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; SNOW AD, 1988, AM J PATHOL, V133, P456; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; UEDA K, 1994, BRAIN RES, V639, P240, DOI 10.1016/0006-8993(94)91736-1; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	59	220	230	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32293	32299		10.1074/jbc.M010706200	http://dx.doi.org/10.1074/jbc.M010706200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423547	hybrid			2022-12-27	WOS:000170613500111
J	Zheng, LX; Schickling, O; Peter, ME; Lenardo, MJ				Zheng, LX; Schickling, O; Peter, ME; Lenardo, MJ			The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YY1; CELL-DEATH; CONTAINING PROTEIN; SIGNALING COMPLEX; CD95 FAS/APO-1; APOPTOSIS; FADD; FAS; INTERACTS; RECEPTOR	Homophilic interactions of death effector domains (DEDs) are crucial for the signaling pathways of death receptor-mediated apoptosis. The machinery that regulates proper oligomerization and autoactivation of procaspase-8 and/or procaspase-10 during T lymphocyte activation determines whether the cells will undergo caspase-mediated apoptosis or proliferation. We screened a yeast two-hybrid library by using the DEDs contained in the prodomains of procaspase-8 and procaspase-10 and isolated a DED-associated factor (DEDAF) that interacts with several DED-containing proteins but does not itself contain a DED. DEDAF is highly conserved between human and mouse (98% amino acid identity) and is homologous to a nuclear regulatory protein YAF-2. DEDAF is expressed at the highest levels in lymphoid tissues and placenta. DEDAF interacts with FADD, procaspase-8, and procaspase-10 in the cytosol as well as with the DED-containing DNA-binding protein (DEDD) in the nucleus. At the cell membrane, DEDAF augmented the formation of CD95-FADD-caspase-8 complexes and enhanced death receptor- as well as DED-mediated apoptosis. In the nucleus, DEDAF caused the DEDD protein to relocalize from subnuclear structures to a diffuse distribution in the nucleoplasm. Our data therefore suggest that DEDAF may be involved in the regulation of both cytoplasmic and nuclear events of apoptosis.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Chicago	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.			Peter, Marcus Ernst/0000-0003-3216-036X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000717, Z01AI000769, ZIAAI000769, ZIAAI000718, Z01AI000717, Z01AI000718] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; ITOH N, 1993, J BIOL CHEM, V268, P10932; Kalenik JL, 1997, NUCLEIC ACIDS RES, V25, P843, DOI 10.1093/nar/25.4.843; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Lee SW, 2000, MOL MICROBIOL, V35, P1540, DOI 10.1046/j.1365-2958.2000.01824.x; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5	24	65	76	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31945	31952		10.1074/jbc.M102799200	http://dx.doi.org/10.1074/jbc.M102799200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11395500	hybrid			2022-12-27	WOS:000170613500066
J	Boule, JB; Rougeon, F; Papanicolaou, C				Boule, JB; Rougeon, F; Papanicolaou, C			Terminal deoxynucleotidyl transferase indiscriminately incorporates ribonucleotides and deoxyribonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; FAMILY-X POLYMERASES; NUCLEOTIDYLTRANSFERASE SUPERFAMILY; REVERSE-TRANSCRIPTASE; V(D)J RECOMBINATION; MUTATIONAL ANALYSIS; CATALYTIC DOMAIN; POOL IMBALANCE; N-REGIONS; BINDING	Terminal deoxynucleotidyl transferase (TdT) catalyzes the condensation of deoxyribonucleotides on 3 ' -hydroxyl ends of DNA strands in a template-independent manner and adds N-regions to gene segment junctions during V(D)J recombination. Although TdT is able to incorporate a few ribonucleotides in vitro, TdT discrimination between ribo- and deoxyribonucleotides has never been studied. We found that TdT shows only a minor preference for incorporation of deoxyribonucleotides over ribonucleotides on DNA strands. However, incorporation of ribonucleotides alone or in the presence of deoxyribonucleotides generally leads to premature chain termination, reflecting an impeded accommodation of ribo- or mixed ribo/deoxyribonucleic acid substrates by TdT. An essential catalytic aspartate in TdT was identified, which is a first step toward understanding the apparent lack of sugar discrimination by TdT.	Inst Pasteur, CNRS, URA 1960, Unite Genet & Biochim Dev, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Papanicolaou, C (corresponding author), Inst Pasteur, CNRS, URA 1960, Unite Genet & Biochim Dev, 25 Rue Dr Roux, F-75015 Paris, France.		Boulé, Jean-Baptiste/M-8200-2017	Boulé, Jean-Baptiste/0000-0002-0994-5831				Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Aw TY, 2000, INT REV CYTOL, V192, P223; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; BENTOLILA LA, 1995, EMBO J, V14, P4221, DOI 10.1002/j.1460-2075.1995.tb00096.x; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; BOLLUM JF, 1974, ENZYMES, V10, P145; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Boule JB, 2000, J BIOL CHEM, V275, P28984, DOI 10.1074/jbc.M005544200; Boule LB, 1998, MOL BIOTECHNOL, V10, P199, DOI 10.1007/BF02740839; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; CHANG LMS, 1971, BIOCHEMISTRY-US, V10, P536, DOI 10.1021/bi00779a029; DEIBEL MR, 1980, J BIOL CHEM, V255, P4206; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Fersht AR., 1977, ENZYME STRUCTURE MEC; Gangi-Peterson L, 1999, J CLIN INVEST, V103, P833, DOI 10.1172/JCI4320; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Huang Y, 1997, BIOCHEMISTRY-US, V36, P13718, DOI 10.1021/bi971609o; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; KALLENBACH S, 1992, P NATL ACAD SCI USA, V89, P2799, DOI 10.1073/pnas.89.7.2799; KATO KI, 1967, J BIOL CHEM, V242, P2780; Kepler TB, 1996, J IMMUNOL, V157, P4451; Kirk BW, 1999, BIOCHEMISTRY-US, V38, P7727, DOI 10.1021/bi990247c; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Kornberg A., 1991, DNA REPLICATION; Kornberg Arthur, 1974, DNA SYNTHESIS; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; MEUTH M, 1984, MUTAT RES, V126, P107, DOI 10.1016/0027-5107(84)90051-4; NINIO J, 1987, P NATL ACAD SCI USA, V84, P663, DOI 10.1073/pnas.84.3.663; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Ramsden DA, 1997, NATURE, V388, P488, DOI 10.1038/41351; RICCHETTI M, 1993, EMBO J, V12, P387, DOI 10.1002/j.1460-2075.1993.tb05670.x; ROYCHOUDHURY R, 1972, J BIOL CHEM, V247, P3910; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Sukumar N, 2000, ACTA CRYSTALLOGR D, V56, P1662, DOI 10.1107/S090744490001297X; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; YANG BL, 1994, J BIOL CHEM, V269, P11859; Yue DX, 1996, RNA, V2, P895	47	82	90	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31388	31393		10.1074/jbc.M105272200	http://dx.doi.org/10.1074/jbc.M105272200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11406636	hybrid			2022-12-27	WOS:000170472900103
J	Dominguez, JM; Martin, JJ				Dominguez, JM; Martin, JJ			Identification of a putative sordarin binding site in Candida albicans elongation factor 2 by photoaffinity labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL PROTEIN-SYNTHESIS; CONFORMATIONAL-CHANGES; FACTOR EEF-2; EF-G; THERMUS-THERMOPHILUS; SELECTIVE-INHIBITION; ADENYLIC NUCLEOTIDES; SEQUENCE ALIGNMENT; GTP HYDROLYSIS; RIBOSOMAL-RNA	Candida albicans EF-2 binds sordarin to a single class of binding sites with K-d = 1.26 mum. Equimolar mixtures of EF-2 and ribosomes, in the presence of a non-hydrolyzable GTP analog, reveal two classes of high affinity sordarin binding sites with K-d = 0.7 and 41.5 nm, probably due to the existence of two ribosome populations. Photoaffinity labeling of C. albicans EF-2 in the absence of ribosomes has been performed with [C-14]GM258383, a photoactivatable sordarin derivative. Labeling is saturable and can be considered specific, because it can be prevented with another sordarin analog. The fragment GIn(224)-LYS232 has been identified as the modified peptide within the EF-2 sequence, Lys(228) being the residue to which the photoprobe was linked. This fragment is included within the G " -subdomain of EF-2. These results are discussed in the light of the high sordarin specificity toward fungal systems.	GlaxoSmithKline S A PTM, Dept Res, Madrid 28760, Spain	GlaxoSmithKline	Dominguez, JM (corresponding author), GlaxoSmithKline S A PTM, Dept Res, C-Severo Ochoa 2, Madrid 28760, Spain.	juan_m_dominguez@gsk.com	Dominguez, Juan Manuel/I-9993-2019	Dominguez, Juan Manuel/0000-0001-9472-6969				Aevarsson A, 1995, J MOL EVOL, V41, P1096; AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Aviles P, 2000, ANTIMICROB AGENTS CH, V44, P2333, DOI 10.1128/AAC.44.9.2333-2340.2000; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Briones C, 2000, NUCLEIC ACIDS RES, V28, P4497, DOI 10.1093/nar/28.22.4497; Capa L, 1998, ANTIMICROB AGENTS CH, V42, P2694, DOI 10.1128/AAC.42.10.2694; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; Cook ND, 1996, DRUG DISCOV TODAY, V1, P287, DOI 10.1016/1359-6446(96)10026-X; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Dominguez JM, 1999, J BIOL CHEM, V274, P22423, DOI 10.1074/jbc.274.32.22423; Dominguez JM, 1998, ANTIMICROB AGENTS CH, V42, P2279, DOI 10.1128/AAC.42.9.2279; Dominguez JM, 1998, ANTIMICROB AGENTS CH, V42, P2274, DOI 10.1128/AAC.42.9.2274; Gargallo-Viola, 1999, CURR OPIN ANTIINFECT, V1, P297; Gomez-Lorenzo MG, 1998, J BIOL CHEM, V273, P25041, DOI 10.1074/jbc.273.39.25041; Gonzalo P, 2000, BIOCHEMISTRY-US, V39, P13558, DOI 10.1021/bi000896k; Green R, 2000, CURR BIOL, V10, pR369, DOI 10.1016/S0960-9822(00)00481-4; GUILLOT D, 1993, J BIOL CHEM, V268, P26082; IGLEWSKI WJ, 1990, ADP RIBOSYLATING TOX, P511; Justice MC, 1998, J BIOL CHEM, V273, P3148, DOI 10.1074/jbc.273.6.3148; KING SM, 1991, METHOD ENZYMOL, V196, P449; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; LOTTSPEICH F, 1994, MICROCHARACTERIZATIO, P11; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Odds FC, 2001, EXPERT OPIN THER PAT, V11, P283, DOI 10.1517/13543776.11.2.283; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Shastry M, 2001, MICROBIOL-UK, V147, P383, DOI 10.1099/00221287-147-2-383; SONTAG B, 1993, BIOCHEMISTRY-US, V32, P1976, DOI 10.1021/bi00059a014; SPEDDING G, 1990, RIBOSOMES PROTEIN SY, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VanLoock MS, 2000, J MOL BIOL, V304, P507, DOI 10.1006/jmbi.2000.4213; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8	36	4	4	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31402	31407		10.1074/jbc.M104183200	http://dx.doi.org/10.1074/jbc.M104183200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402051	hybrid			2022-12-27	WOS:000170472900105
J	Yang, JP; Tang, HL; Reddy, TR; Wong-Staal, F				Yang, JP; Tang, HL; Reddy, TR; Wong-Staal, F			Mapping the functional domains of HAP95, a protein that binds RNA helicase A and activates the constitutive transport element of type D retroviruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEAR EXPORT; POSTTRANSCRIPTIONAL REGULATION; TAP; SIGNAL; CRM1; IDENTIFICATION; PURIFICATION; REPLICATION; CONTAINS	The complex retroviruses such as human immunodeficiency virus, type 1, employ a virally encoded protein, Rev, to mediate the nuclear export of unspliced and partially spliced mRNA. In contrast, the simian type D retroviruses act through a cis-acting constitutive transport element (CTE) that presumably interacts directly with cellular export proteins. We first reported that RNA helicase A (RHA) is a shuttle protein that binds to functional CTE in vitro and in vivo. Recently, we isolated a novel protein, HAP95, that specifically binds to the nuclear transport domain of RHA and up-regulates CTE-mediated gene expression. Here, using truncation and deletion mutations, we mapped the domains of HAP95 that are important for RHA binding, transactivation of CTE, and nuclear cytoplasmic shuttling. We report evidence for a novel nuclear export signal in HAP95 and showed that the domains involved in RHA binding and nuclear localization are required for CTE activation. Finally, we showed that HAP95 synergizes significantly with RHA on CTE-mediated reporter gene expression and promotes nuclear export of unspliced mRNA in transfected cells. Taken together, these data support the proposal that HAP95 specifically facilitates CTE-mediated gene expression by directly binding to RHA.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Wong-Staal, F (corresponding author), Univ Calif San Diego, Dept Biol, Stein Clin Res Bldg, La Jolla, CA 92093 USA.	fwongstaal@ucsd.edu	Tang, Hengli/F-2085-2014		NIAID NIH HHS [P30AI 36214] Funding Source: Medline; NIGMS NIH HHS [GM056089] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; COGHLAN VM, 1994, J BIOL CHEM, V269, P7658; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Li JZ, 1999, P NATL ACAD SCI USA, V96, P709, DOI 10.1073/pnas.96.2.709; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MICHAEL WM, 1995, CELL, V83, P415; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Tang H, 1999, MOL CELL BIOL, V19, P3540; Tang HL, 1997, VIROLOGY, V228, P333, DOI 10.1006/viro.1996.8407; Tang HL, 1997, SCIENCE, V276, P1412, DOI 10.1126/science.276.5317.1412; Westberg C, 2000, J BIOL CHEM, V275, P21396, DOI 10.1074/jbc.M909887199; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; ZHANG SS, 1991, J BIOL CHEM, V266, P20483	23	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30694	30700		10.1074/jbc.M102809200	http://dx.doi.org/10.1074/jbc.M102809200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402034	hybrid			2022-12-27	WOS:000170472900016
J	Arron, JR; Vologodskaia, M; Wong, BR; Naramura, M; Kim, N; Gu, H; Choi, Y				Arron, JR; Vologodskaia, M; Wong, BR; Naramura, M; Kim, N; Gu, H; Choi, Y			A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (TRANCE) and CD40L-mediated Akt activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; KAPPA-B ACTIVATION; N-TERMINAL KINASE; TYROSINE PHOSPHORYLATION; DENDRITIC CELLS; RING FINGER; PHOSPHATIDYLINOSITOL-3 KINASE; NEGATIVE REGULATION; UBIQUITIN LIGASE; P85 SUBUNIT	Tumor necrosis factor (TNF)-related activation-induced cytokine (TRANCE) is a TNF family member essential for osteoclast differentiation, and it induces the activation and survival of osteoclasts and mature dendritic cells. We recently demonstrated that TRANCE activates Akt via a mechanism involving TRANCE receptor (TRANCE-R)/RANK, TRAF6, and c-Src. Here, we show that TRANCE-R and CD40 recruit TRAF6, Cbl family-scaffolding proteins, and the phospholipid kinase phosphatidylinositol 3-kinase in a ligand-dependent manner. The recruitment of Cbl-b and c-Cbl to TRANCE-R, is dependent upon the activity of Src-family kinases. TRANCE and CD40L-mediated Akt activation is defective in Cbl-b -/- dendritic cells, and CD40L-mediated Akt activation is defective in c-Cbl -/- B cells. These findings implicate Cbl family proteins as not only negative regulators of signaling but as positive modulators of TNF receptor superfamily signaling as well.	Rockefeller Univ, Immunol Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NIAID, Immunol Lab, NIH, Rockville, MD 20852 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Choi, Y (corresponding author), Rockefeller Univ, Immunol Lab, New York, NY 10021 USA.	ychoi3@mail.med.upenn.edu		Naramura, Mayumi/0000-0003-3658-0767; Arron, Joseph/0000-0001-7677-9979	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044264] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-44264] Funding Source: Medline; NIGMS NIH HHS [GM-07739] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; BLAKE TJ, 1991, ONCOGENE, V6, P653; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Elly C, 1999, ONCOGENE, V18, P1147, DOI 10.1038/sj.onc.1202411; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Fang D, 2001, J BIOL CHEM, V276, P4872, DOI 10.1074/jbc.M008901200; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; HARTLEY D, 1995, J BIOL CHEM, V270, P18260, DOI 10.1074/jbc.270.31.18260; Hunter S, 1999, J BIOL CHEM, V274, P2097, DOI 10.1074/jbc.274.4.2097; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495; Josien R, 1999, J IMMUNOL, V162, P2562; Kanagasundaram V, 1996, BIOCHEM J, V320, P69, DOI 10.1042/bj3200069; KEANE MM, 1995, ONCOGENE, V10, P2367; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Moodycliffe AM, 2000, J EXP MED, V191, P2011, DOI 10.1084/jem.191.11.2011; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Rudd CE, 2000, CURR BIOL, V10, pR344, DOI 10.1016/S0960-9822(00)00463-2; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Shishido T, 2000, P NATL ACAD SCI USA, V97, P6439, DOI 10.1073/pnas.060030697; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Wani MR, 1999, ENDOCRINOLOGY, V140, P1927, DOI 10.1210/en.140.4.1927; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	45	106	110	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30011	30017		10.1074/jbc.M100414200	http://dx.doi.org/10.1074/jbc.M100414200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11406619	hybrid			2022-12-27	WOS:000170558000054
J	Jin, TG; Satoh, T; Liao, YH; Song, CH; Gao, XL; Kariya, K; Hu, CD; Kataoka, T				Jin, TG; Satoh, T; Liao, YH; Song, CH; Gao, XL; Kariya, K; Hu, CD; Kataoka, T			Role of the CDC25 homology domain of phospholipase C epsilon in amplification of Rap1-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; RAS-DEPENDENT ACTIVATION; NERVE GROWTH-FACTOR; PHOSPHOINOSITIDE 3-KINASE; KINASE ACTIVATION; ADENYLYL-CYCLASE; STRUCTURAL BASIS; GOLGI-COMPLEX; RAP1 GTPASE; MAP KINASE	Phospholipase CE (PLC epsilon) is a novel class of phosphoinositide-specific PLC characterized by possession of CDC25 homology and Ras/Rap1-associating domains. We and others have shown that human PLC epsilon is translocated from the cytoplasm to the plasma membrane and activated by direct association with Ras at its Ras/Rap1associating domain. In addition, translocation to the perinuclear region was induced upon association with Rap1-GTP. However, the function of the CDC25 homology domain remains to be clarified. Here we show that the CDC25 homology domain of PLC epsilon functions as a guanine nucleotide exchange factor for Rap1 but not for any other Ras family GTPases examined including Rap2 and Ha-Ras. Consistent with this, coexpression of full. length PLC epsilon or its N-terminal fragment carrying the CDC25 homology domain causes an increase of the intracellular level of Rap1-GTP. Concurrently, stimulation of the downstream kinases B-Raf and extracellular signal. regulated kinase is observed, whereas the intracellular level of Ras-GTP and Raf-1 kinase activity are unaffected. In wild-type Rap1-overexpressing cells, epidermal growth factor induces translocation of PLC epsilon to the perinuclear compartments such as the Golgi apparatus, which is sustained for at least 20 min. In contrast, PLC epsilon lacking the CDC25 domain translocates to the perinuclear compartments only transiently. Further, the formation of Rapl-GTP upon epidermal growth factor stimulation exhibits a prolonged time course in cells expressing full-length PLCe compared with those expressing PLC epsilon lacking the CDC25 homology domain. These results suggest a pivotal role of the CDC25 homology domain in amplifying Rap1-dependent signal transduction, including the activation of PLC epsilon itself, at specific subcellular locations such as the Golgi apparatus.	Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; Univ Ryukyus, Sch Med, Dept Biochem 2, Okinawa 9030215, Japan	Kobe University; University of the Ryukyus	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Mol & Cellular Biol, Div Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@kobe-u.ac.jp	song, chunhua/K-7882-2016; Satoh, Takaya/K-2628-2014; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; song, chunhua/0000-0002-4081-2543				BERANGER F, 1991, P NATL ACAD SCI USA, V88, P1606, DOI 10.1073/pnas.88.5.1606; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Hu CD, 1995, J BIOL CHEM, V270, P30274, DOI 10.1074/jbc.270.51.30274; Huang L, 1997, NAT STRUCT BIOL, V4, P609, DOI 10.1038/nsb0897-609; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Ichiba T, 1999, FEBS LETT, V457, P85, DOI 10.1016/S0014-5793(99)01012-1; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kiyono M, 1999, P NATL ACAD SCI USA, V96, P4826, DOI 10.1073/pnas.96.9.4826; KURODA Y, 1993, SCIENCE, V259, P683, DOI 10.1126/science.8430318; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NODA M, 1993, BIOCHIM BIOPHYS ACTA, V1155, P97, DOI 10.1016/0304-419X(93)90024-7; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Okada T, 1999, MOL CELL BIOL, V19, P6057; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; Schmidt A, 2001, MOL CELL BIOL, V21, P438, DOI 10.1128/MCB.21.2.438-448.2001; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Shima F, 2000, MOL CELL BIOL, V20, P26, DOI 10.1128/MCB.20.1.26-33.2000; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wienecke R, 1996, ONCOGENE, V13, P913; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	46	105	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30301	30307		10.1074/jbc.M103530200	http://dx.doi.org/10.1074/jbc.M103530200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395506	hybrid			2022-12-27	WOS:000170558000092
J	Lu, M; Holliday, LS; Zhang, L; Dunn, WA; Gluck, SL				Lu, M; Holliday, LS; Zhang, L; Dunn, WA; Gluck, SL			Interaction between aldolase and vacuolar H+ -ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW CULTURES; MAMMALIAN KIDNEY; BOVINE KIDNEY; B2 SUBUNIT; F-ACTIN; BINDING; COMPLEX; CELLS; SITE; PURIFICATION	Vacuolar H+-ATPases (V-ATPases) are essential for acidification of intracellular compartments and for proton secretion from the plasma membrane in kidney epithelial cells and osteoclasts. The cellular proteins that regulate V-ATPases remain largely unknown. A screen for proteins that bind the V-ATPase E subunit using the yeast two-hybrid assay identified the cDNA clone coded for al. dolase, an enzyme of the glycolytic pathway. The interaction between E subunit and aldolase was confirmed in vitro by precipitation assays using E subunit-glutathione S-transferase chimeric fusion proteins and metabolically labeled aldolase. Aldolase was isolated associated with intact V-ATPase from bovine kidney microsomes and osteoclast-containing mouse marrow cultures in co-immunoprecipitation studies performed using an anti-E subunit monoclonal antibody. The interaction was not affected by incubation with aldolase substrates or products. In immunocytochemical assays, aldolase was found to colocalize with V-ATPase in the renal proximal tubule. In osteoclasts, the aldolase-V-ATPase complex appeared to undergo a subcellular redistribution from perinuclear compartments to the ruffled membranes following activation of resorption. In yeast cells deficient in aldolase, the peripheral V-1 domain of V-ATPase was found to dissociate from the integral membrane V-0 domain, indicating direct coupling of glycolysis to the proton pump. The direct binding interaction between V-ATPase and aldolase may be a new mechanism for the regulation of the V-ATPase and may underlie the proximal tubule acidification defect in hereditary fructose intolerance.	Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lu, M (corresponding author), Univ Florida, Coll Med, Dept Med, Campus Box 100224,Rm CG-98 SW Archer Rd, Gainesville, FL 32610 USA.	luming@medicine.ufl.edu	Holliday, Lexie/GYQ-4972-2022	Holliday, Lexie/0000-0002-0844-1965	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054362, R01DK038848] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK54362, DK38848] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ali M, 1998, J MED GENET, V35, P353, DOI 10.1136/jmg.35.5.353; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; BROOKS SPJ, 1991, J THEOR BIOL, V149, P361, DOI 10.1016/S0022-5193(05)80311-X; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; GLUCK S, 1987, J BIOL CHEM, V262, P15780; Gluck SL, 1998, ACTA PHYSIOL SCAND, V163, P203; Gluck SL, 1996, ANNU REV PHYSIOL, V58, P427, DOI 10.1146/annurev.physiol.58.1.427; GOLDSTEIN DJ, 1992, EMBO J, V11, P4851, DOI 10.1002/j.1460-2075.1992.tb05591.x; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; HEMKEN P, 1992, J BIOL CHEM, V267, P9948; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; HOLLIDAY LS, 1995, J BIOL CHEM, V270, P18983, DOI 10.1074/jbc.270.32.18983; Holliday LS, 1997, J BIOL CHEM, V272, P22053, DOI 10.1074/jbc.272.35.22053; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Jager D, 1996, J EXP BIOL, V199, P1019; James P, 1996, GENETICS, V144, P1425; KOPPITZ B, 1986, EUR J BIOCHEM, V161, P421, DOI 10.1111/j.1432-1033.1986.tb10462.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; LEE BS, 1995, J BIOL CHEM, V270, P7320, DOI 10.1074/jbc.270.13.7320; Lee BS, 1997, J BIOL CHEM, V272, P174; Lee BS, 1999, J BONE MINER RES, V14, P2127, DOI 10.1359/jbmr.1999.14.12.2127; Lenk SE, 1999, J CELL PHYSIOL, V178, P17, DOI 10.1002/(SICI)1097-4652(199901)178:1<17::AID-JCP3>3.0.CO;2-R; LOBO Z, 1984, J BACTERIOL, V160, P222, DOI 10.1128/JB.160.1.222-226.1984; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; MILLER H, 1987, METHOD ENZYMOL, V152, P145; MORRIS RC, 1968, J CLIN INVEST, V47, P1389, DOI 10.1172/JCI105830; NELSON N, 1992, BIOCHIM BIOPHYS ACTA, V1100, P109; PAGLIARO L, 1988, J CELL BIOL, V107, P981, DOI 10.1083/jcb.107.3.981; PARKHOUSE WS, 1992, CAN J PHYSIOL PHARM, V70, P150, DOI 10.1139/y92-022; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pollard J W, 1994, Methods Mol Biol, V32, P67; RICHARDSON RMA, 1979, METABOLISM, V28, P1133, DOI 10.1016/0026-0495(79)90152-5; ROTTMANN WH, 1987, BIOCHIMIE, V69, P137, DOI 10.1016/0300-9084(87)90246-X; Salvatore F, 1986, Horiz Biochem Biophys, V8, P611; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Skinner MA, 1999, J BIOL CHEM, V274, P23119, DOI 10.1074/jbc.274.33.23119; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; THIELECZEK R, 1989, J BIOL CHEM, V264, P7349; WACHSMUTH ED, 1975, HISTOCHEMISTRY, V45, P143, DOI 10.1007/BF00495158; Wang J, 1997, EXP CELL RES, V237, P445, DOI 10.1006/excr.1997.3811; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; WEISS TL, 1981, BIOCHIM BIOPHYS ACTA, V661, P221, DOI 10.1016/0005-2744(81)90007-3; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; Wu K, 1997, P NATL ACAD SCI USA, V94, P13273, DOI 10.1073/pnas.94.24.13273; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; YURKO MA, 1987, J BIOL CHEM, V262, P15770; ZHANG K, 1992, J BIOL CHEM, V267, P14539; ZHANG K, 1992, J BIOL CHEM, V267, P9701	50	142	145	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30407	30413		10.1074/jbc.M008768200	http://dx.doi.org/10.1074/jbc.M008768200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11399750	hybrid			2022-12-27	WOS:000170558000105
J	Murphy, PJM; Kanelakis, KC; Galigniana, MD; Morishima, Y; Pratt, WB				Murphy, PJM; Kanelakis, KC; Galigniana, MD; Morishima, Y; Pratt, WB			Stoichiometry, abundance, and functional significance of the hsp90/hsp70-based multiprotein chaperone machinery in reticulocyte lysate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; GLUCOCORTICOID-RECEPTOR; MOLECULAR CHAPERONE; HORMONE-BINDING; PROGESTERONE-RECEPTOR; NEUROSPORA-CRASSA; HSP90; HETEROCOMPLEX; HSP70; DOMAIN	Rabbit reticulocyte lysate contains a multiprotein chaperone system that assembles the glucocorticoid receptor (GR) into a complex with hsp90 and converts the hormone binding domain of the receptor to its high affinity steroid binding state. This system has been resolved into five proteins, with hsp90 and hsp70 being essential and Hop, hsp40, and p23 acting as co-chaperones that optimize assembly. Hop binds independently to hsp70 and hsp90 to form an hsp90(.)Hop(.)hsp70 complex that acts as a machinery to open up the GR steroid binding site. Because purified hsp90 and hsp70 are sufficient for some activation of GR steroid binding activity, some investigators have rejected any role for Hop in GR(.)hsp90 heterocomplex assembly. Here, we counter that impression by showing that all of the Hop in reticulocyte lysate is present in an hsp90(.)Hop(.)hsp70 complex with a stoichiometry of 2:1.1. The complex accounts for similar to 30% of the hsp90 and similar to9% of the hsp70 in lysate, and upon Sephacryl S-300 chromatography the GR(.)hsp90 assembly activity resides in the peak containing Hop-bound hsp90. Consistent with the notion that the two essential chaperones cooperate with each other to open up the steroid binding site, we also show that purified hsp90 and hsp70 interact directly with each other to form weak hsp90-hsp70 complexes with a stoichiometry of 2:1.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Murphy, PJM (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	pjmurphy@umich.edu		GALIGNIANA, MARIO/0000-0002-9130-8574	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031573, R37DK031573] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31573] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901; Benaroudj N, 1997, J BIOL CHEM, V272, P8744, DOI 10.1074/jbc.272.13.8744; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; CHEN S, 1998, J BIOL CHEM, V3, P118; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; CZAR MJ, 1994, J BIOL CHEM, V269, P11155; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Freitag DG, 1997, BIOCHEMISTRY-US, V36, P10221, DOI 10.1021/bi963030g; Giannoukos G, 1999, J BIOL CHEM, V274, P36527, DOI 10.1074/jbc.274.51.36527; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; HONORE B, 1992, J BIOL CHEM, V267, P8485; HUTCHISON KA, 1995, J BIOL CHEM, V270, P18841, DOI 10.1074/jbc.270.32.18841; HUTCHISON KA, 1994, J BIOL CHEM, V269, P27894; HUTCHISON KA, 1992, J BIOL CHEM, V267, P14047; HUTCHISON KA, 1994, J BIOL CHEM, V269, P5043; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Ouimet PM, 1998, BIOCHEM CELL BIOL, V76, P97, DOI 10.1139/bcb-76-1-97; Pratt WB, 2001, TRENDS PLANT SCI, V6, P54, DOI 10.1016/S1360-1385(00)01843-4; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Rajapandi T, 2000, J BIOL CHEM, V275, P22597, DOI 10.1074/jbc.M002035200; SCHERRER LC, 1992, BIOCHEMISTRY-US, V31, P7325, DOI 10.1021/bi00147a017; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Stancato LF, 1996, J BIOL CHEM, V271, P8831, DOI 10.1074/jbc.271.15.8831; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	50	65	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30092	30098		10.1074/jbc.M103773200	http://dx.doi.org/10.1074/jbc.M103773200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11404358	hybrid			2022-12-27	WOS:000170558000066
J	Pajor, AM				Pajor, AM			Conformationally sensitive residues in transmembrane domain 9 of the Na+/dicarboxylate co-transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-DICARBOXYLATE COTRANSPORTER; FUNCTIONAL-CHARACTERIZATION; ACETYLCHOLINE-RECEPTOR; CYSTEINE; SUBSTRATE; NADC-1; ACCESSIBILITY; CHANNEL; PROTEIN; CATION	The Na+/dicarboxylate co-transporter, NaDC-1, couples the transport of sodium and Krebs cycle intermediates, such as succinate and citrate. Previous studies identified two functionally important amino acids, Glu-475 and Cys-476, located in transmembrane domain (TMD) 9 of NaDC-1. In the present study, each amino acid in TMD-9 was mutated to cysteine, one at a time, and the accessibility of the membrane-impermeant reagent [2-(trimethylammonium)ethyl]methanethiosulfonate (MTSET) to the replacement cysteines was determined. Cysteine substitution was tolerated at all but five of the sites: the A461C mutant was not present at the plasma membrane, whereas the F473C, T474C, E475C, and N479C mutants were inactive proteins located on the plasma membrane. Cysteine substitution of four residues found near the extracellular surface of TMD-9 (Ser-478, Ala-480, Ala-481, and Thr-482) resulted in proteins that were sensitive to inhibition by MTSET. The accessibility of MTSET to the four substituted cysteines was highest in the presence of the transported cations, sodium or lithium, and low in choline. The four mutants also exhibited substrate protection of MTSET accessibility. The MTSET accessibility to S478C, A481C, and A480C was independent of voltage. In contrast, T482C was more accessible to MTSET in choline buffer at negative holding potentials, but there was no effect of voltage in sodium buffer. In conclusion, TMD-9 may be involved in transducing conformational changes between the cation-binding sites and the substrate-binding site in NaDC-1, and it may also form part of the translocation pathway through the transporter.	Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Pajor, AM (corresponding author), Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA.				NIDDK NIH HHS [DK46269, DK02429] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046269, K02DK002429] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Danielson MA, 1997, J BIOL CHEM, V272, P32878, DOI 10.1074/jbc.272.52.32878; Frillingos S, 1997, PROTEIN SCI, V6, P438; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; Horn R, 1998, METHOD ENZYMOL, V293, P145; Kaback HR, 1999, ACCOUNTS CHEM RES, V32, P805, DOI 10.1021/ar970256i; Kahn ES, 1999, BIOCHEMISTRY-US, V38, P6151, DOI 10.1021/bi9827722; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; Pajor AM, 2000, AM J PHYSIOL-RENAL, V279, pF482, DOI 10.1152/ajprenal.2000.279.3.F482; Pajor AM, 1998, J BIOL CHEM, V273, P18923, DOI 10.1074/jbc.273.30.18923; Pajor AM, 1999, BIOCHEM J, V344, P205, DOI 10.1042/0264-6021:3440205; Pajor AM, 1998, BBA-BIOMEMBRANES, V1370, P98, DOI 10.1016/S0005-2736(97)00249-6; Pajor AM, 2000, J MEMBRANE BIOL, V175, P1, DOI 10.1007/s002320001049; Pajor AM, 1998, BIOCHEM J, V331, P257, DOI 10.1042/bj3310257; Pajor AM, 1996, AM J PHYSIOL-RENAL, V271, pF1093, DOI 10.1152/ajprenal.1996.271.5.F1093; Pajor AM, 1996, AM J PHYSIOL-CELL PH, V271, pC1808, DOI 10.1152/ajpcell.1996.271.6.C1808; PAJOR AM, 1995, J BIOL CHEM, V270, P5779, DOI 10.1074/jbc.270.11.5779; Pajor AM, 1999, ANNU REV PHYSIOL, V61, P663, DOI 10.1146/annurev.physiol.61.1.663; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; WRIGHT EM, 1982, P NATL ACAD SCI-BIOL, V79, P7514, DOI 10.1073/pnas.79.23.7514; WRIGHT SH, 1983, J BIOL CHEM, V258, P5456; YAO CX, 2000, AM J PHYSIOL-RENAL, V274, pF54; Zhang FF, 2001, BBA-BIOMEMBRANES, V1511, P80, DOI 10.1016/S0005-2736(00)00385-0	26	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29961	29968		10.1074/jbc.M011387200	http://dx.doi.org/10.1074/jbc.M011387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11399753	hybrid			2022-12-27	WOS:000170558000048
J	Tomita, T; Watabiki, T; Takikawa, R; Morohashi, Y; Takasugi, N; Kopan, R; De Strooper, B; Iwatsubo, T				Tomita, T; Watabiki, T; Takikawa, R; Morohashi, Y; Takasugi, N; Kopan, R; De Strooper, B; Iwatsubo, T			The first proline of PALP motif at the C terminus of presenilins is obligatory for stabilization, complex formation, and gamma-secretase activities of presenilins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; DISEASE-ASSOCIATED PRESENILIN-1; ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; PROTEOLYTIC RELEASE; MUTANT; NOTCH; ENDOPROTEOLYSIS; CLEAVAGE; MUTATION	Mutations in presenilin (PS) genes cause early-onset familial Alzheimer's disease by increasing production of the amyloidogenic form of amyloid beta peptides ending at residue 42 (A beta 42). PS is an evolutionarily conserved multipass transmembrane protein, and all known PS proteins contain a proline-alanine-leucine-proline (PALP) motif starting at proline (P) 414 (amino acid numbering based on human PS2) at the C terminus. Furthermore, missense mutations that replace the first proline of PALP with leucine (P414L) lead to a loss-of-function of PS in Drosophila melanogaster and Caenorhabditis elegans. To elucidate the roles of the PALP motif in PS structure and function, we analyzed neuro2a as well as PS1/2 null fibroblast cell lines transfected with human PS harboring mutations at the PALP motif. P414L mutation in PS2 (and its equivalent in PS1) abrogated stabilization, high molecular weight complex formation, and entry to Golgi/trans-Golgi network of PS proteins, resulting in failure of A beta 42 overproduction on familial Alzheimer's disease mutant basis as well as of site-3 cleavage of Notch. These data suggest that the first proline of the PALP motif plays a crucial role in the stabilization and formation of the high molecular weight complex of PS, the latter being the active form with intramembrane proteolytic activities.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; Washington Univ, Div Dermatol, St Louis, MO 63110 USA; Washington Univ, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Katholieke Univ Leuven, Neuronal Cell Biol Lab, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	University of Tokyo; Washington University (WUSTL); Washington University (WUSTL); KU Leuven	Iwatsubo, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@mol.f.u-tokyo.ac.jp	de+Strooper, Bart/Z-1638-2019; Tomita, Taisuke/L-5427-2015; Kopan, Raphael/AFG-3275-2022; De Strooper, Bart/F-6507-2012; Kopan, Raphael/AAF-1357-2022	Tomita, Taisuke/0000-0002-0075-5943; De Strooper, Bart/0000-0001-5455-5819; Watabiki, Tomonari/0000-0003-4289-8659; Kopan, Raphael/0000-0002-0350-2730; TAKASUGI, NOBUMASA/0000-0002-6059-2082				ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; Arduengo PM, 1998, J CELL SCI, V111, P3645; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Guo YQ, 1999, J NEUROSCI, V19, P8435; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; Jacobsen H, 1999, J BIOL CHEM, V274, P35233, DOI 10.1074/jbc.274.49.35233; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Kulic L, 2000, P NATL ACAD SCI USA, V97, P5913, DOI 10.1073/pnas.100049897; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Okochi M, 2000, J BIOL CHEM, V275, P40925, DOI 10.1074/jbc.M005254200; Palmer ME, 1999, RAPID COMMUN MASS SP, V13, P256, DOI 10.1002/(SICI)1097-0231(19990228)13:4<256::AID-RCM459>3.0.CO;2-S; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shirotani K, 2000, J BIOL CHEM, V275, P3681, DOI 10.1074/jbc.275.5.3681; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Taddei K, 1998, NEUROREPORT, V9, P3335, DOI 10.1097/00001756-199810050-00034; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yu G, 2000, J BIOL CHEM, V275, P27348; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	53	77	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33273	33281		10.1074/jbc.M011152200	http://dx.doi.org/10.1074/jbc.M011152200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432849	hybrid			2022-12-27	WOS:000170746000114
J	Valls, M; Bofill, R; Gonzalez-Duarte, R; Gonzalez-Duarte, P; Capdevila, M; Atrian, S				Valls, M; Bofill, R; Gonzalez-Duarte, R; Gonzalez-Duarte, P; Capdevila, M; Atrian, S			A new insight into metallothionein (MT) classification and evolution - The in vivo and in vitro metal binding features of Homarus americanus recombinant MT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAB CALLINECTES-SAPIDUS; COPPER-METALLOTHIONEIN; CANCER-PAGURUS; CADMIUM; DOMAINS; SEQUENCE; ZINC; EXPRESSION; INDUCTION; PROTEINS	We report the synthesis and characterization of a Homarus americanus MT-cDNA (MTH) through retrotranscription of MTH-mRNA from metal-injected lobsters. Heterologous Escherichia coli expression in zinc- and copper-supplemented medium was achieved for MTH, the two domains beta beta MTH and beta alpha MTH and three site-directed mutants, beta beta C9H, beta alpha C37H, and beta alpha E31C/T34C. The in vivo conformed metal complexes and the in vitro substituted cadmium aggregates were characterized. Major stoichiometries of M-6(II)-MTH for the entire MTH and M-3(II)-beta beta MTH and M-3(II)-beta alpha MTH for the independent domains fully validated our expression system. A low affinity binding site for a seventh Zn(II) in the in vivo synthesized MTH was located in the beta alpha domain. Additionally, minor M-4(II) species were found for each domain. Both single Cys to His mutations exhibited a similar reduction of their in vivo zinc binding ability but differed in their cadmium binding behavior when compared with the wild-type forms. Conversely, the double mutant showed an enhanced zinc and cadmium binding capacity. In vivo synthesis of MTH and of its independent domains in the presence of copper only afforded heterometallic copper-zinc species. These findings allow consideration of MTH as a zinc thionein and question the view of all crustacea MT structures as copper thioneins. Furthermore, a new approach for the evolutionary and functional classification of MT is proposed, based on the stoichiometry of metal-AIT species and molecular phylogenetic analysis.	Univ Autonoma Barcelona, Fac Ciencias, Dept Quim, E-08193 Barcelona, Spain; Univ Barcelona, Fac Biol, Dept Genet, Barcelona 08028, Spain	Autonomous University of Barcelona; University of Barcelona; University of Barcelona	Capdevila, M (corresponding author), Univ Autonoma Barcelona, Fac Ciencias, Dept Quim, E-08193 Barcelona, Spain.	merce.capdevila@uab.es	Bofill, Roger/A-3359-2009; Valls, Marc/I-7285-2015; Bofill, Roger/Z-4627-2019; Capdevila, Mercè/ABG-4588-2020; Capdevila, Mercè/F-5374-2015	Bofill, Roger/0000-0002-8888-1871; Valls, Marc/0000-0003-2312-0091; Bofill, Roger/0000-0002-8888-1871; Capdevila, Mercè/0000-0002-2246-0994; Capdevila, Mercè/0000-0002-2246-0994				BIRCHMEIER W, 1971, FEBS LETT, V18, P209, DOI 10.1016/0014-5793(71)80446-5; Bofill R, 2001, J BIOL INORG CHEM, V6, P405, DOI 10.1007/s007750100216; BONGERS J, 1988, ANAL CHEM, V60, P2683, DOI 10.1021/ac00175a008; BROUWER M, 1992, ARCH BIOCHEM BIOPHYS, V294, P461, DOI 10.1016/0003-9861(92)90712-6; BROUWER M, 1995, BIOCHEM J, V311, P617, DOI 10.1042/bj3110617; BROUWER M, 1989, J INORG BIOCHEM, V35, P289, DOI 10.1016/0162-0134(89)84018-8; Capdevila M, 1997, CELL MOL LIFE SCI, V53, P681, DOI 10.1007/s000180050088; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOU CL, 1991, SCI TOTAL ENVIRON, V105, P41, DOI 10.1016/0048-9697(91)90328-C; Cols N, 1999, PROTEIN ENG, V12, P265, DOI 10.1093/protein/12.3.265; Cols N, 1997, J INORG BIOCHEM, V68, P157, DOI 10.1016/S0162-0134(97)00085-8; Dallinger R, 1997, NATURE, V388, P237, DOI 10.1038/40785; Fabris D, 1996, J AM CHEM SOC, V118, P12242, DOI 10.1021/ja962863r; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fischer EH, 1998, P NATL ACAD SCI USA, V95, P3333, DOI 10.1073/pnas.95.7.3333; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; HARLOW P, 1989, MOL CELL BIOL, V9, P5445, DOI 10.1128/MCB.9.12.5445; Jacob C, 1999, P NATL ACAD SCI USA, V96, P1910, DOI 10.1073/pnas.96.5.1910; Jiang LJ, 1998, P NATL ACAD SCI USA, V95, P9146, DOI 10.1073/pnas.95.16.9146; KAGI JHR, 1993, ADV LIF SCI, P29; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LAW AYC, 1984, BIOCHIM BIOPHYS ACTA, V784, P53, DOI 10.1016/0167-4838(84)90172-9; Munoz A, 2000, INORG CHEM, V39, P6114, DOI 10.1021/ic000485s; NARULA SS, 1995, BIOCHEMISTRY-US, V34, P620, DOI 10.1021/bi00002a029; NEMER M, 1985, P NATL ACAD SCI USA, V82, P4992, DOI 10.1073/pnas.82.15.4992; NIELSON KB, 1985, J BIOL CHEM, V260, P8698; OTVOS JD, 1980, P NATL ACAD SCI-BIOL, V77, P7094, DOI 10.1073/pnas.77.12.7094; OVERNELL J, 1979, COMP BIOCHEM PHYS C, V64, P69, DOI 10.1016/0306-4492(79)90030-3; OVERNELL J, 1982, COMP BIOCHEM PHYS B, V73, P555, DOI 10.1016/0305-0491(82)90074-8; OVERNELL J, 1988, EUR J BIOCHEM, V172, P171, DOI 10.1111/j.1432-1033.1988.tb13869.x; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; PEDERSEN KL, 1994, BIOCHEM J, V297, P609, DOI 10.1042/bj2970609; Pedersen SN, 1998, COMP BIOCHEM PHYS C, V120, P251, DOI 10.1016/S0742-8413(98)10003-8; ROBBINS AH, 1991, J MOL BIOL, V221, P1269, DOI 10.1016/0022-2836(91)90933-W; Romero-Isart N, 1999, EUR J BIOCHEM, V259, P519, DOI 10.1046/j.1432-1327.1999.00074.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAYERS Z, 1993, EUR J BIOCHEM, V212, P521, DOI 10.1111/j.1432-1033.1993.tb17689.x; Syring RA, 2000, COMP BIOCHEM PHYS C, V125, P325, DOI 10.1016/S0742-8413(99)00114-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valls M, 2000, FEBS LETT, V467, P189, DOI 10.1016/S0014-5793(00)01149-2; WINGE DR, 1985, J BIOL CHEM, V260, P4464; Zaia J, 1998, PROTEIN SCI, V7, P2398, DOI 10.1002/pro.5560071117; ZHU ZW, 1994, BIOCHEMISTRY-US, V33, P8858, DOI 10.1021/bi00196a002	43	68	78	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32835	32843		10.1074/jbc.M102151200	http://dx.doi.org/10.1074/jbc.M102151200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11413132	hybrid			2022-12-27	WOS:000170746000063
J	Fujimoto, I; Bruses, JL; Rutishauser, U				Fujimoto, I; Bruses, JL; Rutishauser, U			Regulation of cell adhesion by polysialic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE N-CAM; HOMOPHILIC BINDING; NEURITE OUTGROWTH; NEURAL ADHESION; NERVOUS-SYSTEM; NCAM; L1; POLYSIALYLATION; IDENTIFICATION; DETERMINANTS	The polysialylation of neural cell adhesion molecule (NCAM) evolved in vertebrates to carry out biological functions related to changes in cell position and morphology. Many of these effects involve the attenuation of cell interactions that are not mediated through NCAM's own adhesion properties. A proposed mechanism for this global effect on cell interaction is the steric inhibition of membrane-membrane apposition based solely on polysialic acid (PSA) biophysical properties. However, it remains possible that the intrinsic binding or signaling properties of the NCAM polypeptide are also involved. To help resolve this issue, this study uses a quantitative cell detachment assay together with cells engineered to display different adhesion receptors together with a variety of polysialylated NCAM polypeptide isoforms and functional domain deletion mutations. The results obtained indicate that regulation by PSA occurs with adhesion receptors as diverse as an IgCAM, a cadherin and an integrin, and does not require NCAM functional domains other than those minimally required for polysialylation. These findings are most consistent with the cell apposition mechanism for PSA action, as this model predicts that the inhibitory effects of PSA-NCAM on cell adhesion should be independent of the nature of the adhesion system and of any intrinsic binding or signalling properties of the NCAM polypeptide itself.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rutishauser, U (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.			Fujimoto, Ichiro/0000-0001-7088-6407				ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DEDHAR S, 1989, J BIOL CHEM, V264, P4832; DEDHAR S, 1990, J CELL BIOL, V110, P2185, DOI 10.1083/jcb.110.6.2185; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; FINNE J, 1985, TRENDS BIOCHEM SCI, V10, P129, DOI 10.1016/0968-0004(85)90274-9; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; FRELINGER AL, 1986, J CELL BIOL, V103, P1729, DOI 10.1083/jcb.103.5.1729; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; HOFFMAN S, 1984, ADV EXP MED BIOL, V181, P147; HORSTKORTE R, 1993, J CELL BIOL, V121, P1409, DOI 10.1083/jcb.121.6.1409; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Kolkova K, 2000, J NEUROSCI, V20, P2238; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; OKA S, 1995, J BIOL CHEM, V270, P19357, DOI 10.1074/jbc.270.33.19357; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; RAO Y, 1993, J BIOL CHEM, V268, P20630; RAO Y, 1992, J CELL BIOL, V118, P937, DOI 10.1083/jcb.118.4.937; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Seki T, 1998, J NEUROSCI, V18, P3757; Storms SD, 1998, J BIOL CHEM, V273, P27124, DOI 10.1074/jbc.273.42.27124; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; YANG PF, 1992, J CELL BIOL, V116, P1487, DOI 10.1083/jcb.116.6.1487; YANG PF, 1994, J BIOL CHEM, V269, P23039; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	36	129	132	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31745	31751		10.1074/jbc.M104525200	http://dx.doi.org/10.1074/jbc.M104525200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11425861	hybrid			2022-12-27	WOS:000170613500038
J	Miao, DS; Tong, XK; Chan, GK; Panda, D; McPherson, PS; Goltzman, D				Miao, DS; Tong, XK; Chan, GK; Panda, D; McPherson, PS; Goltzman, D			Parathyroid hormone-related peptide stimulates oesteogenic cell proliferation through protein kinase C activation of the Ras/mitogen-activated protein kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE FILAMENT PROTEINS; INCREASED BONE-FORMATION; COUPLED RECEPTORS; FUNCTIONAL-PROPERTIES; HUMAN-TISSUES; MARROW; RAS; RATS; PTHRP; OSTEOPOROSIS	We investigated the mechanisms of parathyroid hormone-related peptide (PTUrP)-mediated effects on osteogenic cells in primary rat bone marrow cell (BMC) cultures. We first demonstrated by reverse transcriptase-polymerase chain reaction and immunocytochemistry that BMCs express the type I parathyroid hormone/PTHrP receptor. Treatment with. PTHrP increased osteogenic cell proliferation as determined by [H-3]thymidine and bromodeoxyuridine incorporation and augmented osteogenic colonies. Immunocytochemistry and Western blotting revealed no direct effect on expression of the osteoblast markers, type I collagen, bone sialoprotein, and osteocalcin, indicating that PTHrP did not directly stimulate differentiation in this system. PTHrP increased mitogen-activated protein kinase (MAPK) activity in BMC and MAPK activity, and PTHrP-induced osteogenic cell proliferation could be blocked by the MEK inhibitor PD-098059. PTHrP also increased Ras activity in BMC. Although wortmannin and HS, inhibitors of phosphoinositol 3-kinase and protein kinase A, respectively, did not block PTHrP-stimulated Ras or MAPK activity, chelerythrin chloride, a known protein kinase C inhibitor, did block these PTHrP actions as well as PTHrP-induced osteogenic cell proliferation. These results demonstrate that PTHrP Stimulates osteogenic cell proliferation in rat marrow mesenchymal progenitor cells through protein kinase C-dependent activation of the Ras and ALA-PK signaling pathway.	McGill Univ, Ctr Hlth, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University	Goltzman, D (corresponding author), Royal Victoria Hosp, Dept Med, Calcium Res Lab, H4-67,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.			Miao, Dengshun/0000-0002-2682-3502				ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; ALTMANNSBERGER M, 1981, LAB INVEST, V45, P427; Amizuka N, 1996, DEV BIOL, V175, P166, DOI 10.1006/dbio.1996.0104; AUBIN JE, 1995, BONE, V17, P77; BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Boarder MR, 1998, TRENDS PHARMACOL SCI, V19, P99, DOI 10.1016/S0165-6147(98)01170-5; CHERNIACK AD, 1995, J BIOL CHEM, V270, P1485, DOI 10.1074/jbc.270.4.1485; Cole JA, 1999, ENDOCRINOLOGY, V140, P5771, DOI 10.1210/en.140.12.5771; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Eguchi S, 1996, J BIOL CHEM, V271, P14169, DOI 10.1074/jbc.271.24.14169; Erben RG, 1997, ENDOCRINOLOGY, V138, P4629, DOI 10.1210/en.138.11.4629; EverhartCaye M, 1996, J CLIN ENDOCR METAB, V81, P199, DOI 10.1210/jc.81.1.199; FRAHER LJ, 1995, AM J RESP CELL MOL, V12, P669, DOI 10.1165/ajrcmb.12.6.7766430; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Goltzman D, 1999, J BONE MINER RES, V14, P173, DOI 10.1359/jbmr.1999.14.2.173; GOWN AM, 1982, J CELL BIOL, V95, P414, DOI 10.1083/jcb.95.2.414; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Henry JG, 1997, J CLIN ENDOCR METAB, V82, P900, DOI 10.1210/jc.82.3.900; HOCK JM, 1989, ENDOCRINOLOGY, V125, P2022, DOI 10.1210/endo-125-4-2022; Huang HM, 2000, BLOOD, V96, P1764, DOI 10.1182/blood.V96.5.1764.h8001764_1764_1771; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KARAPLIS AC, 1999, PTHRP MOL MICE MEN, P397; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LEAFFER D, 1995, ENDOCRINOLOGY, V136, P3624, DOI 10.1210/en.136.8.3624; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Miao DS, 2001, ENDOCRINOLOGY, V142, P926, DOI 10.1210/en.142.2.926; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Morley P, 1999, CURR MED CHEM, V6, P1095; NISHIDA S, 1994, BONE, V15, P717, DOI 10.1016/8756-3282(94)90322-0; Plotkin H, 1998, J CLIN ENDOCR METAB, V83, P2786, DOI 10.1210/jc.83.8.2786; Reeve J, 1996, J BONE MINER RES, V11, P440; Sato H, 2000, ONCOGENE, V19, P2904, DOI 10.1038/sj.onc.1203615; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Stewart AF, 2000, J BONE MINER RES, V15, P1517, DOI 10.1359/jbmr.2000.15.8.1517; STEWART AF, 1982, J CLIN ENDOCR METAB, V55, P219, DOI 10.1210/jcem-55-2-219; Stewart AF, 1996, BONE, V19, P303, DOI 10.1016/S8756-3282(96)00221-9; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Swarthout JT, 2001, J BIOL CHEM, V276, P7586, DOI 10.1074/jbc.M007400200; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Verheijen MHG, 1997, J BIOL CHEM, V272, P3423, DOI 10.1074/jbc.272.6.3423; Vickery BH, 1996, J BONE MINER RES, V11, P1943; Waters SB, 1996, J BIOL CHEM, V271, P18224, DOI 10.1074/jbc.271.30.18224; Weinreb M, 1997, BONE, V20, P521, DOI 10.1016/S8756-3282(97)00033-1; WEIR EC, 1992, CALCIFIED TISSUE INT, V51, P30, DOI 10.1007/BF00296214	56	95	104	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32204	32213		10.1074/jbc.M101084200	http://dx.doi.org/10.1074/jbc.M101084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11402023	hybrid			2022-12-27	WOS:000170613500100
J	Lim, C; Gwack, Y; Hwang, S; Kim, S; Choe, J				Lim, C; Gwack, Y; Hwang, S; Kim, S; Choe, J			The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; DNA-SEQUENCES; HUMAN-HERPESVIRUS-8 BINDS; MULTIPLE DOMAINS; COACTIVATOR CBP; CREB; P300; ACTIVATION; INTERACTS; KSHV	A multifunctional transcription co-activator, cAMP response element-binding protein-binding protein (CBP) interacts with a number of cellular factors and participates in cell growth, transformation, and development. It is also targeted by many viral proteins for their transcriptional activity or for the regulation of cellular processes. Here, we report that the C/H3 region of CBP is targeted by the latency associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus (KSHV). LANA interferes with the interaction between CBP and c-Fos, a representative C/H3 region binding, cellular transcription factor, in vivo and in vitro. In addition, we found that LANA inhibits the transcriptional activity and the in vitro histone acetyltransferase activity of CBP, suggesting that LANA modulates the global transcriptional activities of infected cells through the interaction with CBP. These results indicate that KSHV follows one of the conserved strategies, which other viruses utilize for influencing the cellular processes.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Choe, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.		Lim, Chunghun/AAB-1253-2020; Choe, Joonho/F-3066-2011	Lim, Chunghun/0000-0001-8473-9272; Hwang, Seungmin/0000-0003-0846-5462				Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, MOL CELL BIOL, V16, P3454; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Ganem D, 1997, CELL, V91, P157, DOI 10.1016/S0092-8674(00)80398-0; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; Hotttiger MO, 1998, J VIROL, V72, P8252, DOI 10.1128/JVI.72.10.8252-8256.1998; Jayachandra S, 1999, P NATL ACAD SCI USA, V96, P11566, DOI 10.1073/pnas.96.20.11566; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Lee D, 2000, J BIOL CHEM, V275, P7045, DOI 10.1074/jbc.275.10.7045; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; Lim C, 2000, J GEN VIROL, V81, P2645, DOI 10.1099/0022-1317-81-11-2645; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Renne R, 2001, J VIROL, V75, P458, DOI 10.1128/JVI.75.1.458-468.2001; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Schwam DR, 2000, J VIROL, V74, P8532, DOI 10.1128/JVI.74.18.8532-8540.2000; Seo T, 2000, BIOCHEM BIOPH RES CO, V270, P23, DOI 10.1006/bbrc.2000.2393; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Wang L, 2000, P NATL ACAD SCI USA, V97, P430, DOI 10.1073/pnas.97.1.430; Zerby D, 1999, MOL CELL BIOL, V19, P1617	46	100	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31016	31022		10.1074/jbc.M102431200	http://dx.doi.org/10.1074/jbc.M102431200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11425857	hybrid			2022-12-27	WOS:000170472900057
J	Nakayama, K; Puchkaev, A; Pikuleva, IA				Nakayama, K; Puchkaev, A; Pikuleva, IA			Membrane binding and substrate access merge in cytochrome P4507Al, a key enzyme in degradation of cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; EXPRESSION; PURIFICATION; 7-ALPHA-HYDROXYLASE; HYDROXYLATION; SEQUENCES; PROTEINS	To study membrane topology and mechanism for substrate specificity, we truncated residues 2-24 in microsomal cytochrome P450 7A1 (P450 7A1) and introduced conservative and nonconservative substitutions at positions 214-227. Heterologous expression in Escherichia coli was followed by investigation of the subcellular distribution of the mutant P450s and determination of the kinetic and substrate binding parameters for cholesterol. The results indicate that a hydrophobic region, comprising residues 214-227, forms a secondary site of attachment to the membrane in P450 7A1 in addition to the NH2-terminal signal-anchor sequence. There are two groups of residues at this enzyme-membrane interface. The first are those whose mutation results in more cytosolic P450 (Val-214, His-225, and Met-226). The second group are those whose mutation leads to more membrane-bound P450 (Phe-215, Leu-218, Ile-224, and Phe227). In addition, the V214A, V214L, V214T, F215A, F215L, F215Y, L218I, L218V, V219T, and M226A mutants showed a 5-12-fold increased K-m for cholesterol. The k(cat) of the V214A, V214L, V219T, and M226A mutants was increased up to 1.8-fold, and that of the V214T, F215A, F215L, F215Y, L218I, and L218V mutants was decreased 3-10.5-fold. Based on analysis of these mutations we suggest that cholesterol enters P450 7A1 through the membrane, and Val-214, Phe-215, and Leu-218 are the residues located near the point of cholesterol entry. The results provide an understanding of both the P450 7A1membrane interactions and the mechanism for substrate specificity.	Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; Byelarussian Acad Sci, Inst Bioorgan Chem, Minsk 220141, BELARUS	University of Texas System; University of Texas Medical Branch Galveston; National Academy of Sciences of Belarus (NASB); Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus	Pikuleva, IA (corresponding author), Univ Texas, Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	irpikule@utmb.edu		Pikuleva, Irina/0000-0001-9742-6232	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES06676] Funding Source: Medline; NIGMS NIH HHS [GM62882-01] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHRISTOU M, 1992, BIOCHEMISTRY-US, V31, P2835, DOI 10.1021/bi00125a027; Cosme J, 2000, J BIOL CHEM, V275, P2545, DOI 10.1074/jbc.275.4.2545; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; DELEMOSCHIARANDINI C, 1987, J CELL BIOL, V104, P209, DOI 10.1083/jcb.104.2.209; DEPREZ E, 1994, BIOCHEMISTRY-US, V33, P14464, DOI 10.1021/bi00252a012; Dong MS, 1996, BIOCHEMISTRY-US, V35, P10031, DOI 10.1021/bi960873z; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Graham SE, 1999, ARCH BIOCHEM BIOPHYS, V369, P24, DOI 10.1006/abbi.1999.1350; GrahamLorence S, 1997, J BIOL CHEM, V272, P1127, DOI 10.1074/jbc.272.2.1127; GRAHAMLORENCE S, 1995, PROTEIN SCI, V4, P1065, DOI 10.1002/pro.5560040605; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; Hoch U, 2000, J BIOL CHEM, V275, P26952; KARAM WG, 1994, J LIPID RES, V35, P1222; KARAM WG, 1992, BIOCHEM BIOPH RES CO, V185, P588, DOI 10.1016/0006-291X(92)91665-D; KEMPF AC, 1995, ARCH BIOCHEM BIOPHYS, V321, P277, DOI 10.1006/abbi.1995.1396; KOMINAMI S, 1986, J BIOL CHEM, V261, P2077; KORZEKWA KR, 1993, PHARMACOGENETICS, V3, P1, DOI 10.1097/00008571-199302000-00001; Kusano K, 1999, ARCH BIOCHEM BIOPHYS, V367, P129, DOI 10.1006/abbi.1999.1248; LI YC, 1991, J BIOL CHEM, V266, P19186; LISCUM L, 1992, J LIPID RES, V33, P1239; MUELLER EJ, 1995, CYTOCHROME P450 STRU, P183; MYANT NB, 1977, J LIPID RES, V18, P135; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Oliver CF, 1997, BIOCHEM J, V327, P537; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Park SY, 1997, NAT STRUCT BIOL, V4, P827, DOI 10.1038/nsb1097-827; PERNECKY SJ, 1993, P NATL ACAD SCI USA, V90, P2651, DOI 10.1073/pnas.90.7.2651; Pikuleva IA, 1997, ARCH BIOCHEM BIOPHYS, V343, P123, DOI 10.1006/abbi.1997.0142; Pikuleva IA, 2001, BIOCHEMISTRY-US, V40, P7621, DOI 10.1021/bi010193i; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SAGARA Y, 1993, ARCH BIOCHEM BIOPHYS, V304, P272, DOI 10.1006/abbi.1993.1349; VOET D, 1990, BIOCHEMISTRY-US, P337; vonWachenfeldt C, 1997, ARCH BIOCHEM BIOPHYS, V339, P107, DOI 10.1006/abbi.1996.9859; WACHENFELDT C, 1995, CYTOCHROME P450 STRU, P183; WELLS AV, 1992, BIOCHEMISTRY-US, V31, P4384, DOI 10.1021/bi00133a002; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	44	36	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31459	31465		10.1074/jbc.M103943200	http://dx.doi.org/10.1074/jbc.M103943200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11423554	hybrid			2022-12-27	WOS:000170472900112
J	Drissi, R; Zindy, F; Roussel, MF; Cleveland, JL				Drissi, R; Zindy, F; Roussel, MF; Cleveland, JL			c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE TELOMERASE; CYCLE; P53; TRANSCRIPTION; FIBROBLASTS; EXPRESSION; APOPTOSIS; GENES; IDENTIFICATION; INDUCTION	Myc overexpression is a hallmark of human cancer and promotes transformation by facilitating immortalization. This function has been linked to the ability of c-Myc to induce the expression of the catalytic subunit of telomerase, telomerase reverse transcriptase (TERT), as ectopic expression of TERT immortalizes some primary human cell types. c-Myc up-regulates telomerase activity in primary mouse embryonic fibroblasts (MEFs) and myeloid cells. Paradoxically, Myc overexpression also triggers the ARF-p53 apoptotic program, which is activated when MEFs undergo replicative crises following culture ex vivo. The rare immortal variants that arise from these cultures generally suffer mutations in p53 or delete Ink4a/ARF, and Myc greatly increases the frequency of these events. Alternative reading frame (ARF)- and p53-null MEFs have increased telomerase activity, as do variant immortal clones that bypass replicative crisis. Similarly, immortal murine NIH-3T3 fibroblasts and myeloid 32D.3 and FDC-P1.2 cells do not express ARF and have robust telomerase activity. However Myc overexpression in these immortal cells results ever, I in remarkably discordant regulation of TERT and telomerase activity. Furthermore, in MEFs and 32D.3 cells TERT expression and telomerase activity are regulated independently of endogenous c-Myc. Thus, the regulation of TERT and telomerase activity is complex and is also regulated by factors other than Myc, ARF, or p53.	St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Cleveland, JL (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	john.cleveland@stjude.org	Roussel, Martine F/F-1469-2016	Roussel, Martine F/0000-0002-1740-8139				Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; ASKEW DS, 1991, ONCOGENE, V6, P1915; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco Maria A., 1999, Genes and Development, V13, P2353, DOI 10.1101/gad.13.18.2353; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brun C, 1997, TRENDS CELL BIOL, V7, P317, DOI 10.1016/S0962-8924(97)01092-1; Campisi Judith, 1996, P121; CLEVELAND JL, 1989, MOL CELL BIOL, V9, P5685, DOI 10.1128/MCB.9.12.5685; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dexter T M, 1976, Methods Cell Biol, V14, P387, DOI 10.1016/S0091-679X(08)60498-7; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; EISCHEN CM, 1999, GENES DEB, V20, P2658; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FANG G, 1995, TELOMERE PROTEINS; Fu WM, 1999, J BIOL CHEM, V274, P7264, DOI 10.1074/jbc.274.11.7264; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Guo QM, 2000, CANCER RES, V60, P5922; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; HIEBERT SW, 1995, MOL CELL BIOL, V15, P6864; Holt SE, 1997, P NATL ACAD SCI USA, V94, P10687, DOI 10.1073/pnas.94.20.10687; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Mandal M, 1997, J BIOL CHEM, V272, P14183, DOI 10.1074/jbc.272.22.14183; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nip J, 2001, ONCOGENE, V20, P910, DOI 10.1038/sj.onc.1204171; Packham G, 1997, ONCOGENE, V15, P1219, DOI 10.1038/sj.onc.1201273; Packham G, 1998, GENE DEV, V12, P2475, DOI 10.1101/gad.12.16.2475; Palmero I, 1996, CANCER SURV, V27, P351; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; QUELLE DE, 1995, CELL, V83, P993; ROUSSEL MF, 1991, NATURE, V353, P361, DOI 10.1038/353361a0; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; TAVTIGIAN SV, 1994, MOL BIOL CELL, V5, P375, DOI 10.1091/mbc.5.3.375; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	59	26	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29994	30001		10.1074/jbc.M101899200	http://dx.doi.org/10.1074/jbc.M101899200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402027	hybrid			2022-12-27	WOS:000170558000052
J	Dunbar, LA; Caplan, MJ				Dunbar, LA; Caplan, MJ			Ion pumps in polarized cells: Sorting and regulation of the Na+,K+- and H+,K+-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CANINE KIDNEY-CELLS; NA,K-ATPASE ALPHA-SUBUNITS; GASTRIC-ACID SECRETION; BETA-SUBUNIT; EPITHELIAL-CELLS; K+-ATPASE; ENDOPLASMIC-RETICULUM; PARIETAL-CELL; TRANSPORTING ATPASE; CATION SELECTIVITY	The physiologic function of an ion transport protein is determined, in part, by its subcellular localization and by the cellular mechanisms that modulate its activity. The Na+, K+-ATPase and the H+, K+-ATPases are closely related members of the P-type family of ion transporting ATPases. Despite their homology, these pumps are sorted to different domains in polarized epithelial cells, and their enzymatic activities are subject to distinct regulatory pathways. The molecular signals responsible for these properties have begun to be elucidated. It appears that a complex array of inter- and intramolecular interactions govern trafficking, distribution, and catalytic capacities of these proteins.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University	Caplan, MJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06510 USA.	michael.caplan@yale.edu		Caplan, Michael/0000-0001-5768-4405	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042136] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-17433] Funding Source: Medline; NIGMS NIH HHS [GM-42136] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; ARREAZA G, 1994, J BIOL CHEM, V269, P19123; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Beguin P, 2000, MOL BIOL CELL, V11, P1657, DOI 10.1091/mbc.11.5.1657; Blostein R, 1999, J BIOL CHEM, V274, P18374, DOI 10.1074/jbc.274.26.18374; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CANFIELD VA, 1990, J BIOL CHEM, V265, P19878; CAPLAN M, 1989, FUNCTIONAL EPITHELIA, P71; Caplan MJ, 1997, AM J PHYSIOL-GASTR L, V272, pG1304, DOI 10.1152/ajpgi.1997.272.6.G1304; CAPLAN MJ, 1986, CELL, V46, P623, DOI 10.1016/0092-8674(86)90888-3; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; CAPLAN MJ, 1990, REGULATION POTASSIUM, P77; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Chibalin AV, 1998, MOL BIOL CELL, V9, P1209, DOI 10.1091/mbc.9.5.1209; Chibalin AV, 1999, J BIOL CHEM, V274, P1920, DOI 10.1074/jbc.274.4.1920; Codina J, 1999, SEMIN NEPHROL, V19, P399; Cougnon M, 1998, P NATL ACAD SCI USA, V95, P6516, DOI 10.1073/pnas.95.11.6516; CourtoisCoutry N, 1997, CELL, V90, P501, DOI 10.1016/S0092-8674(00)80510-3; CROWSON MS, 1992, J BIOL CHEM, V267, P13740; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Doucet A, 1997, EXP NEPHROL, V5, P271; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; Dunbar LA, 2000, J CELL BIOL, V148, P769, DOI 10.1083/jcb.148.4.769; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Farman N, 1996, MINER ELECTROL METAB, V22, P272; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Festy F, 2001, J BIOL CHEM, V276, P7721, DOI 10.1074/jbc.M009980200; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; GOTTARDI CJ, 1993, SCIENCE, V260, P552, DOI 10.1126/science.8386395; GOTTARDI CJ, 1993, J CELL BIOL, V121, P283, DOI 10.1083/jcb.121.2.283; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Grishin AV, 1998, J BIOL CHEM, V273, P27772, DOI 10.1074/jbc.273.43.27772; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; HERSEY SJ, 1995, PHYSIOL REV, V75, P155, DOI 10.1152/physrev.1995.75.1.155; HORISBERGER JD, 1991, ANNU REV PHYSIOL, V53, P565, DOI 10.1146/annurev.physiol.53.1.565; HU RJ, 1995, J CELL BIOL, V128, P1069, DOI 10.1083/jcb.128.6.1069; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; JORDAN C, 1995, J BIOL CHEM, V270, P29971; Koenderink JB, 1999, J BIOL CHEM, V274, P11604, DOI 10.1074/jbc.274.17.11604; KOOB R, 1988, EUR J CELL BIOL, V45, P230; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Manunta P, 1998, FEBS LETT, V430, P41, DOI 10.1016/S0014-5793(98)00457-8; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Matter K, 2000, CURR BIOL, V10, pR39, DOI 10.1016/S0960-9822(99)00256-0; MAYS RW, 1995, J CELL BIOL, V130, P1105, DOI 10.1083/jcb.130.5.1105; Mense M, 2000, J BIOL CHEM, V275, P1749, DOI 10.1074/jbc.275.3.1749; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; Muth TR, 1998, AM J PHYSIOL-CELL PH, V274, pC688, DOI 10.1152/ajpcell.1998.274.3.C688; NELSON WJ, 1989, J CELL BIOL, V108, P893, DOI 10.1083/jcb.108.3.893; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Ogimoto G, 2000, P NATL ACAD SCI USA, V97, P3242, DOI 10.1073/pnas.060025597; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; RABON E, 1983, J EXP BIOL, V106, P119; RABON EC, 1990, ANNU REV PHYSIOL, V52, P321; Reinhardt J, 2000, AM J PHYSIOL-RENAL, V279, pF417, DOI 10.1152/ajprenal.2000.279.3.F417; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; SHULL GE, 1990, J BIOL CHEM, V265, P12123; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SMITH PR, 1993, AM J PHYSIOL, V264, pC63, DOI 10.1152/ajpcell.1993.264.1.C63; SMOLKA A, 1983, AM J PHYSIOL, V245, pG589, DOI 10.1152/ajpgi.1983.245.4.G589; Spicer Z, 2000, J BIOL CHEM, V275, P21555, DOI 10.1074/jbc.M001558200; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; TOH BH, 1990, P NATL ACAD SCI USA, V87, P6418, DOI 10.1073/pnas.87.16.6418; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; URUSHIDANI T, 1987, AM J PHYSIOL, V252, pG458, DOI 10.1152/ajpgi.1987.252.4.G458; Wang SG, 1998, J BIOL CHEM, V273, P29400, DOI 10.1074/jbc.273.45.29400; Wang T, 1998, AM J PHYSIOL-RENAL, V275, pF818, DOI 10.1152/ajprenal.1998.275.5.F818; Zhang ZS, 1998, J BIOL CHEM, V273, P18681, DOI 10.1074/jbc.273.30.18681	78	65	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29617	29620		10.1074/jbc.R100023200	http://dx.doi.org/10.1074/jbc.R100023200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11404365	hybrid			2022-12-27	WOS:000170558000003
J	Simonovic, M; Volz, K				Simonovic, M; Volz, K			A distinct meta-active conformation in the 1.1-angstrom resolution structure of wild-type apoCheY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR PROTEIN; BACTERIAL CHEMOTAXIS; UNCOUPLED PHOSPHORYLATION; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHEY; REFINEMENT; ACTIVATION; ASPARTATE	CheY is the best characterized member of the response regulator superfamily, and as such it has become the principal model for understanding the initial molecular mechanisms of signaling in two-component systems. Normal signaling by response regulators requires phosphorylation, in combination with an activation mechanism whose conformational effects are not completely understood. CheY activation involves three events, phosphorylation, a conformational. change in the beta (4)-alpha (4) loop, and a rotational restriction of the side chain of tyrosine 106. An outstanding question concerns the nature of an active conformation in the apoCheY population. The details of this 1.08-Angstrom resolution crystal structure of wild-type apoCheY shows the beta (4)-alpha (4) loop in two distinctly different conformations that sterically correlate with the two rotameric positions of the tyrosine 106 side chain. One of these conformational states of CheY is the inactive form, and we propose that the other is a meta-active form, responsible for the active properties seen in apoCheY.	Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Volz, K (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.			Simonovic, Miljan/0000-0002-1576-2222	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047522] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47522] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARAK R, 1992, BIOCHEMISTRY-US, V31, P1821, DOI 10.1021/bi00121a034; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; Cho HS, 2000, J MOL BIOL, V297, P543, DOI 10.1006/jmbi.2000.3595; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144; GANGULI S, 1995, J BIOL CHEM, V270, P17386, DOI 10.1074/jbc.270.29.17386; Gouet P, 2001, ACTA CRYSTALLOGR D, V57, P44, DOI 10.1107/S090744490001492X; Halkides CJ, 2000, BIOCHEMISTRY-US, V39, P5280, DOI 10.1021/bi9925524; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Jiang MY, 1997, J BIOL CHEM, V272, P11850, DOI 10.1074/jbc.272.18.11850; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; McEvoy MM, 1998, P NATL ACAD SCI USA, V95, P7333, DOI 10.1073/pnas.95.13.7333; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; ROMAN SJ, 1992, J BACTERIOL, V174, P6247, DOI 10.1128/JB.174.19.6247-6255.1992; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; VOLZ K, 1991, J BIOL CHEM, V266, P15511; Volz K., 1995, 2 COMPONENT SIGNAL T, P53; Welch M, 1998, NAT STRUCT BIOL, V5, P25, DOI 10.1038/nsb0198-25; Zhu XY, 1996, J BACTERIOL, V178, P4208, DOI 10.1128/jb.178.14.4208-4215.1996; Zhu XY, 1997, J BIOL CHEM, V272, P23758, DOI 10.1074/jbc.272.38.23758; Zhu XY, 1997, J BIOL CHEM, V272, P5000, DOI 10.1074/jbc.272.8.5000	28	61	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					28637	28640		10.1074/jbc.C100295200	http://dx.doi.org/10.1074/jbc.C100295200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11410584	hybrid			2022-12-27	WOS:000170346000002
J	Aguilaniu, H; Gustafsson, L; Rigoulet, M; Nystrom, T				Aguilaniu, H; Gustafsson, L; Rigoulet, M; Nystrom, T			Protein oxidation in G(0) cells of Saccharomyces cerevisiae depends on the state rather than rate of respiration and is enhanced in pos9 but not yap1 mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; STATIONARY-PHASE; STRESS-RESPONSE; LIFE-SPAN; YEAST; OXYGEN; MITOCHONDRIA; SENESCENCE; EXTENSION	Immunodetection of protein carbonyl groups demonstrates that growth arrest elicited by carbon or nitrogen starvation causes an increased oxidation of proteins in Saccharomyces cerevisiae. Mutant analysis suggests that the response regulator Pos9p is involved in mitigating self-inflicted oxidative damages in G(0) cells, whereas Yap1p is primarily required in growing cells. The data also suggest that oxidation of target proteins is not a priori an effect of arrest of cell division or nutrient depletion and cannot be explained by the respiratory activity alone nor a high ratio of catabolic/anabolic activity in G(0) cells. Instead, we observed that starvation elicits a transition in the respiratory state (from phosphorylating to nonphosphorylating respiration) and that this transition is associated with a stepwise increase in protein oxidation. During carbon starvation, this transition and increase in oxidation occurs immediately as the carbon source is depleted, growth is arrested, and the respiratory rate falls drastically. In contrast, during nitrogen starvation and excess carbon the respiratory state transition and stepwise increase in protein oxidation are markedly delayed and occur long after the nitrogen source has been depleted and division and growth-arrested. Oxidation in G(0) cells could be enhanced by treating cells with low concentrations of antimycin A and attenuated with myxothiazol, indicating that protein oxidation is intimately linked to reactive oxygen species generated by semiquinones of the Q-cycle. Thus, the work presented suggests that the degree of coupling in the mitochondrial respiratory apparatus rather then the overall rate of respiration affects the degree of protein oxidation in nondividing yeast cells.	Univ Gothenburg, Dept Cell & Mol Biol Microbiol, SE-40530 Gothenburg, Sweden; Chalmers Univ Technol, Dept Mol Biotechnol, SE-40530 Gothenburg, Sweden; Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	University of Gothenburg; Chalmers University of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Nystrom, T (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Box 462, SE-40530 Gothenburg, Sweden.							Barker MG, 1999, FEMS MICROBIOL LETT, V177, P199, DOI 10.1016/S0378-1097(99)00308-0; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Beckmann K. B., 1997, OXIDATIVE STRESS MOL, P201; BENOV L, 1995, ARCH BIOCHEM BIOPHYS, V322, P291, DOI 10.1006/abbi.1995.1465; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; CAIN K, 1977, BIOCHEM J, V162, P575, DOI 10.1042/bj1620575; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; CHRISTENSEN LH, 1995, CHEM ENG SCI, V50, P2601, DOI 10.1016/0009-2509(95)00108-H; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Eisenstark A, 1996, FREE RADICAL BIO MED, V21, P975, DOI 10.1016/S0891-5849(96)00154-2; FITTON V, 1994, BIOCHEMISTRY-US, V33, P9692, DOI 10.1021/bi00198a039; HALLER T, 1994, ANAL BIOCHEM, V218, P338, DOI 10.1006/abio.1994.1188; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARSHMAN KD, 1988, CELL, V53, P321, DOI 10.1016/0092-8674(88)90393-5; Jakubowski W, 2000, FREE RADICAL BIO MED, V28, P659, DOI 10.1016/S0891-5849(99)00266-X; JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KREMS B, 1995, CURR GENET, V27, P427, DOI 10.1007/BF00311211; LARSEN D P, 1991, Lake and Reservoir Management, V7, P1; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; MOYEROWLEY WS, 1988, COLD SPRING HARB SYM, V53, P711, DOI 10.1101/SQB.1988.053.01.081; Nystrom T, 1996, J BACTERIOL, V178, P927, DOI 10.1128/jb.178.3.927-930.1996; OLZ R, 1993, J BACTERIOL, V175, P2205, DOI 10.1128/JB.175.8.2205-2213.1993; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; PEARL R, 1928, RATE LIVING, P183; RUBNER M, 1908, PROBLEM LEBENSDAUER, P150; SCHNELL N, 1991, EUR J BIOCHEM, V200, P487, DOI 10.1111/j.1432-1033.1991.tb16209.x; SIEBENLIST KR, 1983, BIOCHEMISTRY-US, V22, P4642, DOI 10.1021/bi00289a005; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; SOHAL RS, 1976, GERONTOLOGY, V22, P317, DOI 10.1159/000212146; SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409	42	51	52	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 21	2001	276	38					35396	35404		10.1074/jbc.M101796200	http://dx.doi.org/10.1074/jbc.M101796200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474LU	11431467	hybrid			2022-12-27	WOS:000171109300027
J	Boncela, J; Papiewska, I; Fijalkowska, I; Walkowiak, B; Cierniewski, CS				Boncela, J; Papiewska, I; Fijalkowska, I; Walkowiak, B; Cierniewski, CS			Acute phase protein alpha(1)-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; HUMAN ALPHA-1-ACID GLYCOPROTEIN; HUMAN-PLASMA; STRUCTURAL REQUIREMENTS; COMPLEX-FORMATION; BINDING-SITE; VITRONECTIN; EXPRESSION; DOMAIN; PAI-1	alpha (1)-Acid glycoprotein, one of the major acute phase proteins, was found to interact with plasminogen activator inhibitor type 1 (PAI-1) and to stabilize its inhibitory activity toward plasminogen activators. This conclusion is based on the following observations: (a) alpha (1)-acid glycoprotein was identified to bind PAI-1 by a yeast two-hybrid system. Three of 10 positive clones identified by this method to interact with PAI-1 contained almost the entire sequence of alpha (1)-acid glycoprotein; (b) this protein formed complexes with PAI-1 that could be immunoprecipitated from both the incubation mixtures and blood plasma by specific antibodies to either PAI-1 or alpha (1)-acid glycoprotein. Such complexes could be also detected by a solid phase binding assay; and (c) the real-time bimolecular interactions monitored by surface plasmon resonance indicated that the complex of alpha (1)-acid glycoprotein with PAI-1 is less stable than that formed by vitronectin with PAI-1, but in both cases, the apparent KD values were in the range of strong interactions (4.51 + 1.33 and 0.58 + 0.07 nm, respectively). The on rate for binding of PAI-1 to ai-glycoprotein or vitronectin differed by 2-fold, indicating much faster complex formation by vitronectin than by alpha (1)-acid glycoprotein. On the other hand, dissociation of PAI-1 bound to vitronectin was much slower than that from the alpha (1)-acid glycoprotein, as indicated by 4-fold lower k(off) values. Furthermore, the PAI-1 activity toward urokinase-type plasminogen activator and tissue-type plasminogen activator was significantly prolonged in the presence of alpha (1)-acid glycoprotein. These observations suggest that the complex of PAI-1 with alpha (1)-acid glycoprotein can play a role as an alternative reservoir of the physiologically active form of the inhibitor, particularly during inflammation or other acute phase reactions.	Med Univ Lodz, Dept Biophys, PL-90131 Lodz, Poland; Polish Acad Sci, Ctr Microbiol & Virol, PL-93232 Lodz, Poland; Tech Univ Lodz, Dept Biophys, PL-90537 Lodz, Poland	Medical University Lodz; Polish Academy of Sciences; Lodz University of Technology	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Biophys, 3 Lindleya St, PL-90131 Lodz, Poland.	cc0604@psk2.am.lodz.pl	Boncela, Joanna/AAU-4481-2020	Boncela, Joanna/0000-0001-8419-7012; Walkowiak, Bogdan/0000-0003-4867-5456				BERK BC, 1990, J BIOL CHEM, V265, P17334; BJORQUIST P, 1994, BBA-PROTEIN STRUCT M, V1209, P191, DOI 10.1016/0167-4838(94)90184-8; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DECLERCK PJ, 1988, BLOOD, V71, P220; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Deng G, 1996, J BIOL CHEM, V271, P12716, DOI 10.1074/jbc.271.22.12716; DENTE L, 1988, GENE DEV, V2, P259, DOI 10.1101/gad.2.2.259; EHRLICH HJ, 1992, J BIOL CHEM, V267, P11606; FEY GH, 1987, MOL BIOL MED, V4, P323; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GEBBINK RK, 1993, BIOCHEMISTRY-US, V32, P1675, DOI 10.1021/bi00057a035; KIRKPATRICK J, 1993, BLOOD, V81, P1290; KOST C, 1992, J BIOL CHEM, V267, P12098; KREMER JMH, 1988, PHARMACOL REV, V40, P1; KRUITHOF EKO, 1987, BLOOD, V70, P1645; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERS JWJ, 1987, J BIOL CHEM, V262, P17492; LARENCE DA, 1995, MOL BASIS THROMBOSIS, P517; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; Lawrence DA, 1997, NAT STRUCT BIOL, V4, P339, DOI 10.1038/nsb0597-339; LAWRENCE DA, 1986, BIOCHEMISTRY-US, V25, P6351, DOI 10.1021/bi00369a001; LAWRENCE DA, 1994, J BIOL CHEM, V269, P15223; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; LEWIS ML, 1991, THROMB RES, V64, P223, DOI 10.1016/0049-3848(91)90121-C; Lijnen HR, 1996, INT J CLIN LAB RES, V26, P1, DOI 10.1007/BF02644767; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; MIMURO J, 1989, J BIOL CHEM, V264, P936; MIMURO J, 1993, BIOCHEMISTRY-US, V32, P2314, DOI 10.1021/bi00060a024; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; NODAHEINY H, 1993, CIRC RES, V72, P36, DOI 10.1161/01.RES.72.1.36; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; Podor TJ, 2000, J BIOL CHEM, V275, P19788, DOI 10.1074/jbc.M908079199; Podor TJ, 2000, J BIOL CHEM, V275, P25402, DOI 10.1074/jbc.M000362200; PREISSNER KT, 1990, J BIOL CHEM, V265, P18490; PREISSNER KT, 1989, BLOOD, V74, P1989; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; SCHMID K, 1977, BIOCHIM BIOPHYS ACTA, V492, P291, DOI 10.1016/0005-2795(77)90080-0; SEIFFERT D, 1991, J BIOL CHEM, V266, P2824; SEIFFERT D, 1997, J BIOL CHEM, V272, P29644; SHIBATA Y, 1984, MICROBIOL IMMUNOL, V28, P99, DOI 10.1111/j.1348-0421.1984.tb02950.x; SIGURDARDOTTIR O, 1990, BIOCHIM BIOPHYS ACTA, V1035, P56, DOI 10.1016/0304-4165(90)90173-T; Sorensson J, 1999, AM J PHYSIOL-HEART C, V276, pH530, DOI 10.1152/ajpheart.1999.276.2.H530; SPRENGERS ED, 1986, THROMB HAEMOSTASIS, V55, P325; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; STRANDBERG L, 1991, J BIOL CHEM, V266, P13852; STRINGER HAR, 1995, J BIOL CHEM, V270, P11205, DOI 10.1074/jbc.270.19.11205; TAUBMAN MB, 1993, AM J CARDIOL, V72, pC55, DOI 10.1016/0002-9149(93)90256-C; Tonner E, 2000, ADV EXP MED BIOL, V480, P45; VANMEIJER M, 1994, FEBS LETT, V352, P342, DOI 10.1016/0014-5793(94)00990-2; WAGNER OF, 1989, J CLIN INVEST, V84, P647, DOI 10.1172/JCI114211; Williams JP, 1997, AM J PHYSIOL-GASTR L, V273, pG1031, DOI 10.1152/ajpgi.1997.273.5.G1031; WOJTA J, 1993, THROMB HAEMOSTASIS, V70, P469; YOSHIMA H, 1981, J BIOL CHEM, V256, P8476	60	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2001	276	38					35305	35311		10.1074/jbc.M104028200	http://dx.doi.org/10.1074/jbc.M104028200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474LU	11418606	hybrid			2022-12-27	WOS:000171109300015
J	Lindemann, S; Tolley, ND; Eyre, JR; Kraiss, LW; Mahoney, TM; Weyrich, AS				Lindemann, S; Tolley, ND; Eyre, JR; Kraiss, LW; Mahoney, TM; Weyrich, AS			Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets - A checkpoint for translational control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-DEPENDENT FIBROBLASTS; ACTIVATED HUMAN PLATELETS; HUMAN-BLOOD PLATELETS; MESSENGER-RNA; MEMBRANE SKELETON; PROTEIN-SYNTHESIS; CYTOSKELETON; RIBOSOMES	Recent evidence from our laboratory demonstrates that platelets synthesize numerous proteins in a signal-dependent fashion (Pabla, R., Weyrich, A. S., Dixon, D. A., Bray, P. F., McIntyre, T. M., Prescott, S. M., and Zimmerman, G. A. (1999) J. Cell Biol. 144, 175-184; Weyrich, A. S., Dixon, D. A., Pabla, R., Elstad, M. R., McIntyre, T. M., Prescott, S. M., and Zimmerman, G. A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 5556-5561). Protein synthesis in platelets is controlled at the translational level; however, the mechanisms of regulation are not known. Here we demonstrate that translation initiation factors are redistributed to mRNA-rich areas in aggregated platelets, an event that induces protein synthesis. Interrogation of cDNA arrays revealed that platelet-derived mRNAs are primarily associated with the cytoskeletal core. In contrast, eukaryotic initiation factor 4E (eIF4E), the essential mRNA cap-binding protein that controls global translation rates, is localized in the membrane skeleton and soluble fraction of platelets, physically separated from most mRNAs. Platelet activation redistributes eIF4E to the cytoskeleton and increases interactions of eIF4E with mRNA cap structures. Redistribution of eIF4E to the mRNA-rich cytoskeleton coincides with a marked increase in protein synthesis, a process that is blocked when intracellular actin is disrupted. Additional studies demonstrated that ss (3) integrins are the primary membrane receptor that distributes eIF4E within the cell. These results imply that integrins link receptor-mediated pathways with mRNA-rich cytoskeletal domains and thereby modulate the organization of intracellular translational complexes. They also indicate that the functional status of eIF4E is regulated by its intracellular distribution.	Univ Utah, Sch Med, Eccles Program Human Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Weyrich, AS (corresponding author), Univ Utah, Sch Med, Eccles Program Human Biol & Genet, Biol 533,Rm 4220, Salt Lake City, UT 84112 USA.		Lindemann, Stephan/AAH-3888-2020	Weyrich, Andrew/0000-0001-9622-4647	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056713, K08HL004151] Funding Source: NIH RePORTER; NHLBI NIH HHS [KO8 HL 04151, HL 56713] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bassell G, 1997, CURR OPIN CELL BIOL, V9, P109, DOI 10.1016/S0955-0674(97)80159-7; BENECKE BJ, 1978, CELL, V14, P931, DOI 10.1016/0092-8674(78)90347-1; BOOYSE FM, 1968, BIOCHIM BIOPHYS ACTA, V157, P660, DOI 10.1016/0005-2787(68)90172-X; BOOYSE FM, 1971, THROMB DIATH HAEMOST, V26, P167; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; FARMER SR, 1978, CELL, V15, P627, DOI 10.1016/0092-8674(78)90031-4; FOX JEB, 1993, ADV EXP MED BIOL, V344, P175; FOX JEB, 1988, J CELL BIOL, V106, P1525, DOI 10.1083/jcb.106.5.1525; FOX JEB, 1993, J BIOL CHEM, V268, P25973; FOX JEB, 1996, PRACT APPROACH SER, P217; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hovland R, 1996, INT J BIOCHEM CELL B, V28, P1089, DOI 10.1016/1357-2725(96)00059-3; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; LINDEMANN S, 2001, IN PRESS J CELL BIOL; LUDANY A, 1988, CLIN BIOCHEM, V21, P107, DOI 10.1016/S0009-9120(88)80097-3; Pabla R, 1999, J CELL BIOL, V144, P175, DOI 10.1083/jcb.144.1.175; Rosenwald IB, 2001, THROMB HAEMOSTASIS, V85, P142; ROTH GJ, 1989, BIOCHEM BIOPH RES CO, V160, P705, DOI 10.1016/0006-291X(89)92490-X; Shattil SJ, 1997, J CLIN INVEST, V100, pS91; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; TSAO CH, 1971, SCAND J HAEMATOL, V8, P134; Weyrich AS, 1996, J CLIN INVEST, V97, P1525, DOI 10.1172/JCI118575; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921	25	92	95	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33947	33951		10.1074/jbc.M104281200	http://dx.doi.org/10.1074/jbc.M104281200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11431478	hybrid			2022-12-27	WOS:000170910200089
J	Alvarez, I; Sesma, L; Marcilla, M; Ramos, M; Marti, M; Camafeita, E; de Castro, JAL				Alvarez, I; Sesma, L; Marcilla, M; Ramos, M; Marti, M; Camafeita, E; de Castro, JAL			Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20 S proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL CLONE; HL-A 27; ANKYLOSING-SPONDYLITIS; ENDOPLASMIC-RETICULUM; ANTIGENIC PEPTIDES; CTL EPITOPE; PROTEOLYTIC ACTIVITIES; INTERFERON-GAMMA; BINDING PEPTIDES; BRANCHED-CHAIN	HLA-B27 is strongly associated with ankylosing spondylitis. Natural HLA-B27 ligands derived from polymorphic regions of its own or other class I HILA molecules might be involved in autoimmunity or provide diversity among HLA-B27-bound peptide repertoires from individuals. In particular, an 11-mer spanning HLA-B27 residues 169-179 is a natural HLA-B27 ligand with homology to proteins from Gram-negative bacteria. Proteasomal digestion of synthetic substrates demonstrated direct generation of the B27(169-179) ligand. Cleavage after residue 181 generated a B27(169-181) 13-mer that was subsequently found as a natural ligand of B*2705 and B*2704. Its binding to HLA-B27 subtypes in vivo correlated better than B27-(169-179) with association to spondyloarthropathy. Proteasomal cleavage generated also a peptide spanning B*2705 residues 150-158. This region is polymorphic among HLA-B27 subtypes and class I HLA antigens. The peptide was a natural B*2704 ligand. Since this subtype differs from B*2705 at residue 152, it was concluded that the ligand arose from HLA-B*3503, synthesized in the cells used as a source for B*2704-bound peptides. Thus, polymorphic HLA-B27 ligands derived from HLA-B27 or other class I molecules are directly produced by the 20 S proteasome in vitro, and this can be used for identification of such ligands in the constitutive HLA-B27-bound peptide pool.	Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	de Castro, JAL (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain.	aldecastro@cbm.uam.es	Ramos, Manuel/F-5076-2016; Alvarez, Iñaki/A-6684-2011; Marcilla, Miguel/B-8430-2013; Martí, Mercè/I-2164-2015	Ramos, Manuel/0000-0002-0404-7936; Alvarez, Iñaki/0000-0001-9484-0868; Marcilla, Miguel/0000-0001-9171-5076; Martí, Mercè/0000-0002-1846-0043				Allen RL, 1999, IMMUNOGENETICS, V50, P220, DOI 10.1007/s002510050596; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Beninga J, 1998, J BIOL CHEM, V273, P18734, DOI 10.1074/jbc.273.30.18734; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; Boisgerault F, 1996, J CLIN INVEST, V98, P2764, DOI 10.1172/JCI119102; BREWERTON DA, 1973, LANCET, V2, P996, DOI 10.1016/S0140-6736(73)91091-X; BREWERTON DA, 1973, LANCET, V1, P904; BURMESTER GR, 1995, ANNU REV IMMUNOL, V13, P229, DOI 10.1146/annurev.iy.13.040195.001305; Colbert RA, 2000, MOL MED TODAY, V6, P224, DOI 10.1016/S1357-4310(00)01699-3; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; DEL VM, 1991, CELL, V66, P1145; DELPORTO P, 1994, J IMMUNOL, V153, P3093; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DICK LR, 1994, J IMMUNOL, V152, P3884; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Edwards JCW, 2000, IMMUNOL TODAY, V21, P256, DOI 10.1016/S0167-5699(00)01625-X; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Ehring B, 1996, EUR J BIOCHEM, V235, P404, DOI 10.1111/j.1432-1033.1996.00404.x; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; Galocha B, 1996, TISSUE ANTIGENS, V48, P509, DOI 10.1111/j.1399-0039.1996.tb02664.x; Garcia F, 1997, TISSUE ANTIGENS, V49, P23, DOI 10.1111/j.1399-0039.1997.tb02705.x; GonzalezRoces S, 1997, TISSUE ANTIGENS, V49, P116, DOI 10.1111/j.1399-0039.1997.tb02724.x; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hughes EA, 1996, J EXP MED, V183, P1569, DOI 10.1084/jem.183.4.1569; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Kessler JH, 2001, J EXP MED, V193, P73, DOI 10.1084/jem.193.1.73; Khan MA, 2000, CURR OPIN RHEUMATOL, V12, P235, DOI 10.1097/00002281-200007000-00001; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lamas JR, 1999, ARTHRITIS RHEUM-US, V42, P1975, DOI 10.1002/1529-0131(199909)42:9<1975::AID-ANR25>3.0.CO;2-V; LOPEZLARREA C, 1995, TISSUE ANTIGENS, V45, P169, DOI 10.1111/j.1399-0039.1995.tb02436.x; Lucchiari-Hartz M, 2000, J EXP MED, V191, P239, DOI 10.1084/jem.191.2.239; Luckey CJ, 1998, J IMMUNOL, V161, P112; MA CP, 1994, J BIOL CHEM, V269, P3539; Marina A, 1999, J MASS SPECTROM, V34, P17, DOI 10.1002/(SICI)1096-9888(199901)34:1<17::AID-JMS746>3.3.CO;2-Y; McCormack TA, 1998, BIOCHEMISTRY-US, V37, P7792, DOI 10.1021/bi980097q; Mear JP, 1999, J IMMUNOL, V163, P6665; Mo XY, 1999, J IMMUNOL, V163, P5851; Nasution AR, 1997, J RHEUMATOL, V24, P1111; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; Niedermann G, 1997, J EXP MED, V186, P209, DOI 10.1084/jem.186.2.209; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; Ossendorp F, 1996, IMMUNITY, V5, P115, DOI 10.1016/S1074-7613(00)80488-4; Paradela A, 2000, J IMMUNOL, V164, P329, DOI 10.4049/jimmunol.164.1.329; Paradela A, 1998, J IMMUNOL, V161, P5481; PARHAM P, 1995, IMMUNOL REV, V143, P141, DOI 10.1111/j.1600-065X.1995.tb00674.x; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Ren EC, 1997, TISSUE ANTIGENS, V49, P67, DOI 10.1111/j.1399-0039.1997.tb02713.x; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; SCOFIELD RH, 1995, LANCET, V345, P1542, DOI 10.1016/S0140-6736(95)91089-1; Shimbara N, 1997, GENES CELLS, V2, P785, DOI 10.1046/j.1365-2443.1997.1610359.x; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Stoltze L, 1998, EUR J IMMUNOL, V28, P4029, DOI 10.1002/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N; VEGA MA, 1986, J IMMUNOL, V137, P3557; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wordsworth P, 1998, RHEUM DIS CLIN N AM, V24, P845, DOI 10.1016/S0889-857X(05)70045-4; Wuorela M, 1998, AM J MED SCI, V316, P264, DOI 10.1097/00000441-199810000-00007; Yague J, 2000, J EXP MED, V191, P2083, DOI 10.1084/jem.191.12.2083; Yague J, 1998, TISSUE ANTIGENS, V52, P416, DOI 10.1111/j.1399-0039.1998.tb03067.x; YellenShaw AJ, 1997, J IMMUNOL, V158, P3227; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	68	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32729	32737		10.1074/jbc.M104663200	http://dx.doi.org/10.1074/jbc.M104663200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435436	hybrid			2022-12-27	WOS:000170746000048
J	Nguyen, MHH; Ho, JMY; Beattie, BK; Barber, DL				Nguyen, MHH; Ho, JMY; Beattie, BK; Barber, DL			TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3-kinase/protein kinase B signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMED HEMATOPOIETIC-CELLS; COLONY-STIMULATING FACTOR; DNA-BINDING ACTIVITY; BCR-ABL ONCOGENE; TYROSINE PHOSPHORYLATION; LYMPHOPROLIFERATIVE DISEASE; MOLECULAR-CLONING; STAT PROTEINS; SH2 DOMAINS; C-AKT	A subset of chromosomal translocations that participate in leukemia involve activated tyrosine kinases. The ets transcription factor, TEL, undergoes translocations with several distinct tyrosine kinases including JAK2. TEL-JAK2 transforms cell lines to factor independence, and constitutive tyrosine kinase activity results in the phosphorylation of several substrates including STAT1, STAT3, and STAT5. In this study we have shown that TEL-JAK2 can constitutively activate the phosphatidylinositol 3'-kinase (PI 3'-kinase) signaling pathway. The regulatory subunit of PI 3'-kinase, p85, associates with TEL-JAK2 in immunoprecipitations, and this was shown to be mediated by the amino-terminal SH2 domain of p85 but independent of a putative p85-binding motif within TEL-JAK2. The scaffolding protein Gab2 can also mediate the association of p85. TEL-JAK2 constitutively phosphorylates the downstream substrate protein kinase B/AKT. Importantly, the pharmacologic PI 3'-kinase inhibitor, LY294002, blocked TEL-JAK2 factor-independent growth and phosphorylation of protein kinase B. However, LY294002 did not alter STAT5 tyrosine phosphorylation, indicating that STAT5 and protein kinase B activation mediated by TEL-JAK2 are independent signaling pathways. Therefore, activation of the PI 3'-kinase signaling pathway is an important event mediated by TEL-JAK2 chromosomal translocations.	Univ Hlth Network, Ontario Canc Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; Univ Hlth Network, Toronto Gen Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Barber, DL (corresponding author), Univ Hlth Network, Ontario Canc Inst, Div Cell & Mol Biol, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	dbarber@oci.utoronto.ca		Barber, Dwayne/0000-0001-5528-8150				AmaranteMendes GP, 1997, CELL DEATH DIFFER, V4, P548, DOI 10.1038/sj.cdd.4400276; ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; BARBER DL, 1994, MOL CELL BIOL, V14, P2257, DOI 10.1128/MCB.14.4.2257; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Carron C, 2000, BLOOD, V95, P3891; Cazzaniga G, 1999, BLOOD, V94, P4370, DOI 10.1182/blood.V94.12.4370.424k34_4370_4373; Coffer PJ, 1998, BIOCHEM J, V335, P1; Craddock BL, 1999, J BIOL CHEM, V274, P10633, DOI 10.1074/jbc.274.15.10633; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DAMEN JE, 1995, J BIOL CHEM, V270, P23402, DOI 10.1074/jbc.270.40.23402; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEJONG R, 1995, J BIOL CHEM, V270, P21468, DOI 10.1074/jbc.270.37.21468; DEL PL, 1997, SCIENCE, V278, P687; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Frank DA, 1996, LEUKEMIA, V10, P1724; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; GILLILAND DG, 1998, LEUKEMIA S1, V12, P7; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; GOLD MR, 1994, J BIOL CHEM, V269, P5403; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; HARRISONFINDIK D, 1995, ONCOGENE, V10, P1385; Ho JMY, 1999, BLOOD, V93, P4354, DOI 10.1182/blood.V93.12.4354.412k30_4354_4364; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Jain SK, 1996, BLOOD, V88, P1542; Jain SK, 1997, ONCOGENE, V14, P2217, DOI 10.1038/sj.onc.1201049; JANSSEN JWG, 1995, BRIT J HAEMATOL, V90, P222, DOI 10.1111/j.1365-2141.1995.tb03407.x; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; MATSUGUCHI T, 1994, J BIOL CHEM, V269, P5016; Neshat MS, 2000, MOL CELL BIOL, V20, P1179, DOI 10.1128/MCB.20.4.1179-1186.2000; Odai H, 1997, BLOOD, V89, P2745, DOI 10.1182/blood.V89.8.2745; Ormerod MG, 1998, LEUKEMIA, V12, P1013, DOI 10.1038/sj.leu.2401061; Peeters P, 1997, CANCER RES, V57, P564; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Salgia R, 1996, EXP HEMATOL, V24, P310; Sattler M, 1999, MOL CELL BIOL, V19, P7473; SAWYERS CL, 1995, J EXP MED, V181, P307, DOI 10.1084/jem.181.1.307; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Scheid MP, 1998, P NATL ACAD SCI USA, V95, P7439, DOI 10.1073/pnas.95.13.7439; SCHEID MP, 1995, BIOCHEM J, V312, P159, DOI 10.1042/bj3120159; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Shuai K, 1996, ONCOGENE, V13, P247; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TAUCHI T, 1994, J BIOL CHEM, V269, P15381; TAUCHI T, 1994, J EXP MED, V179, P167, DOI 10.1084/jem.179.1.167; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yenush L, 1997, BIOESSAYS, V19, P491, DOI 10.1002/bies.950190608; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	82	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32704	32713		10.1074/jbc.M103100200	http://dx.doi.org/10.1074/jbc.M103100200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435425	hybrid			2022-12-27	WOS:000170746000045
J	Bauer, B; Krumbock, N; Fresser, F; Hochholdinger, F; Spitaler, M; Simm, A; Uberall, F; Schraven, B; Baier, G				Bauer, B; Krumbock, N; Fresser, F; Hochholdinger, F; Spitaler, M; Simm, A; Uberall, F; Schraven, B; Baier, G			Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-THETA; PHOSPHOINOSITIDE 3-KINASE; REGULATORY DOMAIN; IL-2 PROMOTER; ACTIVATION; VAV; TRANSLOCATION; LYMPHOCYTES; APOPTOSIS; MEMBRANE	Protein kinase C theta (PKC theta) is known to induce NF-kappaB, an essential transcriptional element in T cell receptor/ CD28-mediated interleukin-2 production but also T cell survival. Here we provide evidence that PKC theta is physically and functionally coupled to Akt1 in this signaling pathway. First, T cell receptor/CD3 ligation was sufficient to induce activation as well as plasma membrane recruitment of PKC theta. Second, PKC theta selectively cooperated with Akt1, known to act downstream of CD28 coreceptor signaling, in activating a NF-kappaB reporter in T cells. Third, Akt1 function was shown to be required for PKC theta -mediated NF-kappaB transactivation. Fourth, PKC theta co-immunoprecipitated with Akt1 however, neither Akt1 nor PKC theta served as a prominent substrate for each other in vitro as well as in intact T cells. Finally, plasma membrane targeting of PKC theta and Akt1 exerted synergistic transactivation of the I-kappaB kinase beta /inhibitor of NF-kappaB/NF-kappaB signaling cascade independent of T cell activation. Taken together, these findings suggest a direct cross-talk between PKC theta and Akt1 in Jurkat T cells.	Univ Innsbruck, Dept Med Biol & Human Genet, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Med Chem & Biochem, A-6020 Innsbruck, Austria; Univ Wurzburg, Dept Clin Biochem, D-97078 Wurzburg, Germany; Otto Von Guericke Univ, Inst Immunol, D-39120 Magdeburg, Germany	University of Innsbruck; University of Innsbruck; University of Wurzburg; Otto von Guericke University	Baier, G (corresponding author), Univ Innsbruck, Inst Med Biol & Human Genet, Schoepfstr 41, A-6020 Innsbruck, Austria.	Gottfried.Baier@uibk.ac.at	Baier, Gottfried/E-8755-2012	Spitaler, Martin/0000-0002-8833-638X; Baier, Gottfried/0000-0002-2085-8325				Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bauer B, 2000, EUR J IMMUNOL, V30, P3645, DOI 10.1002/1521-4141(200012)30:12<3645::AID-IMMU3645>3.0.CO;2-#; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124; Genot EM, 2000, MOL CELL BIOL, V20, P5469, DOI 10.1128/MCB.20.15.5469-5478.2000; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Hochholdinger F, 1999, MOL CELL BIOL, V19, P8052; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; KONISHI H, 1994, BIOCHEM BIOPH RES CO, V205, P1770, DOI 10.1006/bbrc.1994.2874; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Meller N, 1996, MOL CELL BIOL, V16, P5782; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Villalba M, 1999, J IMMUNOL, V163, P5813; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101	38	69	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31627	31634		10.1074/jbc.M103098200	http://dx.doi.org/10.1074/jbc.M103098200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11410591	hybrid			2022-12-27	WOS:000170613500023
J	Takahashi, K; Baba, S; Koyanagi, Y; Yamamoto, N; Takaku, H; Kawai, G				Takahashi, K; Baba, S; Koyanagi, Y; Yamamoto, N; Takaku, H; Kawai, G			Two basic regions of NCp7 are sufficient for conformational conversion of HIV-1 dimerization initiation site from kissing-loop dimer to extended-duplex dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; NUCLEOCAPSID PROTEIN NCP10; STRANDED PENTANUCLEOTIDE D(ACGCC); RNA ANNEALING ACTIVITIES; IN-VITRO; GENOMIC RNA; ZINC-FINGER; NMR STRUCTURE; VIRAL-RNA	Nucleocapsid (NC) protein possesses nucleotide-annealing activities, which are used in various processes in retroviral life cycle. As conserved characters, the NC proteins have one or two zinc fingers of CX2CX4HX4C motif surrounded by basic amino acid sequences. Requirement of the zinc fingers for the annealing activities of NC protein remains controversial. In this study, we focused the requirement in the process of maturation of dimeric viral RNA. Discrimination between immature and mature dimers of synthetic RNA corresponding to the dimerization initiation site of human immunodeficiency virus type 1 (HIV-1) genomic RNA was performed based on their Mg2+-dependent stability in gel electrophoreses and on their distinct signal pattern from NMR analysis of imino protons. Chaperoning activity of the HIV-1 NC protein, NCp7, and its fragments for maturation of dimeric RNA was investigated using these experimental systems. We found that the two basic regions flanking the N-terminal zinc finger of NCp7, which are connected by two glycine residues instead of the zinc finger, were sufficient, although about 10 times the amounts of peptide were needed in comparison with intact NCp7. Further, it was found that the amount of basic residues rather than the amino acid sequence itself is important for the activity. The zinc fingers may involve the binding affinity and/or such a possible specific binding of NCp7 to dimerization initiation site dimer that leads to the maturation reaction.	Chiba Inst Technol, Dept Ind Chem, Narashino, Chiba 2758588, Japan; Tohoku Univ, Sch Med, Dept Virol, Aobu Ku, Sendai, Miyagi 9808575, Japan; Tokyo Med & Dent Univ, Fac Med, Dept Mol Virol, Bunkyo Ku, Tokyo 1138519, Japan	Chiba Institute of Technology; Tohoku University; Tokyo Medical & Dental University (TMDU)	Kawai, G (corresponding author), Chiba Inst Technol, Dept Ind Chem, 2-17-1 Tsudanuma, Narashino, Chiba 2758588, Japan.							BERKOWITZ RD, 1994, VIROLOGY, V202, P233, DOI 10.1006/viro.1994.1339; Berthoux L, 1997, J VIROL, V71, P6973, DOI 10.1128/JVI.71.9.6973-6981.1997; Cimarelli A, 2000, J VIROL, V74, P3046, DOI 10.1128/JVI.74.7.3046-3057.2000; DANNULL J, 1994, EMBO J, V13, P1525, DOI 10.1002/j.1460-2075.1994.tb06414.x; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DEMENE H, 1994, J BIOMOL NMR, V4, P153, DOI 10.1007/BF00175244; DEMENE H, 1994, BIOCHEMISTRY-US, V33, P11707, DOI 10.1021/bi00205a006; DEROCQUIGNY H, 1993, NUCLEIC ACIDS RES, V21, P823; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; Ennifar E, 1999, STRUCTURE, V7, P1439, DOI 10.1016/S0969-2126(00)80033-7; FENG YX, 1995, J VIROL, V69, P2486, DOI 10.1128/JVI.69.4.2486-2490.1995; Feng YX, 1996, P NATL ACAD SCI USA, V93, P7577, DOI 10.1073/pnas.93.15.7577; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; FU XD, 1988, J BIOL CHEM, V263, P2140; Gao Y, 1998, PROTEIN SCI, V7, P2265, DOI 10.1002/pro.5560071104; Girard F, 1999, J BIOMOL STRUCT DYN, V16, P1145, DOI 10.1080/07391102.1999.10508323; GORELICK RJ, 1993, J VIROL, V67, P4027, DOI 10.1128/JVI.67.7.4027-4036.1993; HOUSSET V, 1993, J VIROL, V67, P2537, DOI 10.1128/JVI.67.5.2537-2545.1993; Hsu M, 2000, NUCLEIC ACIDS RES, V28, P1724, DOI 10.1093/nar/28.8.1724; Klein DJ, 2000, BIOCHEMISTRY-US, V39, P1604, DOI 10.1021/bi9922493; Kodera Y, 1998, BIOCHEMISTRY-US, V37, P17704, DOI 10.1021/bi981818o; LAPADATTAPOLSKY M, 1995, NUCLEIC ACIDS RES, V23, P2434, DOI 10.1093/nar/23.13.2434; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Laughrea M, 1996, BIOCHEMISTRY-US, V35, P1589, DOI 10.1021/bi951838f; MORELLET N, 1992, EMBO J, V11, P3059, DOI 10.1002/j.1460-2075.1992.tb05377.x; MORELLET N, 1994, J MOL BIOL, V235, P287, DOI 10.1016/S0022-2836(05)80033-6; Morellet N, 1998, J MOL BIOL, V283, P419, DOI 10.1006/jmbi.1998.2098; Mujeeb A, 1999, FEBS LETT, V458, P387, DOI 10.1016/S0014-5793(99)01183-7; Mujeeb A, 1998, NAT STRUCT BIOL, V5, P432, DOI 10.1038/nsb0698-432; Muriaux D, 1996, J BIOL CHEM, V271, P33686, DOI 10.1074/jbc.271.52.33686; Muriaux D, 1996, BIOCHEMISTRY-US, V35, P5075, DOI 10.1021/bi952822s; OTTMANN M, 1995, J VIROL, V69, P1778, DOI 10.1128/JVI.69.3.1778-1784.1995; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; PRATS AC, 1991, NUCLEIC ACIDS RES, V19, P3533, DOI 10.1093/nar/19.13.3533; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Remy E, 1998, J BIOL CHEM, V273, P4819, DOI 10.1074/jbc.273.9.4819; Rong LW, 1998, J VIROL, V72, P9353, DOI 10.1128/JVI.72.11.9353-9358.1998; Schmalzbauer E, 1996, J VIROL, V70, P771, DOI 10.1128/JVI.70.2.771-777.1996; Schuler W, 1999, BIOCHEMISTRY-US, V38, P12984, DOI 10.1021/bi990378d; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P681, DOI 10.1093/oxfordjournals.jbchem.a022657; Takahashi KI, 2000, RNA, V6, P96, DOI 10.1017/S1355838200991635; Wu WX, 1996, J VIROL, V70, P7132, DOI 10.1128/JVI.70.10.7132-7142.1996	45	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31274	31278		10.1074/jbc.M104577200	http://dx.doi.org/10.1074/jbc.M104577200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418609	hybrid			2022-12-27	WOS:000170472900090
J	Wada, T; Nakagawa, K; Watanabe, T; Nishitai, G; Seo, JW; Kishimoto, H; Kitagawa, D; Sasaki, T; Penninger, JM; Nishina, H; Katada, T				Wada, T; Nakagawa, K; Watanabe, T; Nishitai, G; Seo, JW; Kishimoto, H; Kitagawa, D; Sasaki, T; Penninger, JM; Nishina, H; Katada, T			Impaired synergistic activation of stress-activated protein kinase SAPK/JNK in mouse embryonic stem cells lacking SEK1/MKK4 - Different contribution of SEK2/MKK7 isoforms to the synergistic activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; N-TERMINAL KINASE; IN-VITRO; MKK7; JNK; INHIBITION; SAPK1/JNK; APOPTOSIS	Stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK), which is a member of the mitogen-activated protein kinase (MAPK) family, plays an important role in a stress-induced signaling cascade. SAPK/JNK activation requires the phosphorylation of Thr and Tyr residues in its Thr-Pro-Tyr motif, and SEK1 (MKK4) and MKK7 (SEK2) have been identified as the upstream MAPK kinases. Here we examined the activation and phosphorylation sites of SAPK/JNK and differentiated the contribution of SEK1 and MKK7 alpha1, -gamma1, and -gamma2 isoforms to the MAPK activation. In SEK1-deficient mouse embryonic stem cells, stress-induced SAPK/JNK activation was markedly impaired, and this defect was accompanied with a decreased level of the Tyr phosphorylation. Analysis in HeLa cells co-transfected with the two MAPK kinases revealed that the Thr and Tyr of SAPK/JNK were independently phosphorylated in response to heat shock by MKK7 gamma1 and SEK1, respectively. However, MKK7 alpha1 failed to phosphorylate the Thr of SAPK/JNK unless its Tyr residue was phosphorylated by SEK1. In contrast, MKK7 gamma2 had the ability to phosphorylate both Thr and Tyr residues. In all cases, the dual phosphorylation of the Thr and Tyr residues was essentially required for the fall activation of SAPK/JNK. These data provide the first evidence that synergistic activation of SAPK/JNK requires both phosphorylation at the Thr and Tyr residues in living cells and that the preference for the Thr and Tyr phosphorylation was different among the members of MAPK kinases.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys & Immunol, Toronto, ON M5G 2C1, Canada	University of Tokyo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Nishina, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Sasaki, Takehiko/0000-0003-1837-3748				Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Lawler S, 1997, FEBS LETT, V414, P153, DOI 10.1016/S0014-5793(97)00990-3; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lisnock J, 2000, BIOCHEMISTRY-US, V39, P3141, DOI 10.1021/bi992410+; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; Nishina H, 1999, DEVELOPMENT, V126, P505; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Yamauchi J, 1999, J BIOL CHEM, V274, P1957, DOI 10.1074/jbc.274.4.1957; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378	20	56	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30892	30897		10.1074/jbc.M011780200	http://dx.doi.org/10.1074/jbc.M011780200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418587	hybrid			2022-12-27	WOS:000170472900042
J	Eubanks, S; Nguyen, TL; Deeb, R; Villafania, A; Alfadhli, A; Breslow, E				Eubanks, S; Nguyen, TL; Deeb, R; Villafania, A; Alfadhli, A; Breslow, E			Effects of diabetes insipidus mutations on neurophysin folding and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT VASOPRESSIN PRECURSORS; ENDOPLASMIC-RETICULUM; ARGININE-VASOPRESSIN; PEPTIDE INTERACTIONS; CRYSTAL-STRUCTURE; HORMONE-BINDING; WILD-TYPE; BOVINE; DIMERIZATION; IDENTIFICATION	Mechanisms underlying the pathogenicity of diabetes insipidus mutations were probed by studying their effects on the properties of bovine oxytocin-related neurophysin. The mutations G17V, Delta E47, G57S, G57R, and C67STOP were each shown to have structural consequences that would diminish the conformational stability and folding efficiency of the precursors in which they were incorporated, and factors contributing to the origins of these property changes were identified. Effects of the mutations on dimerization of the folded proteins were similarly analyzed. The projected relative impact of the above mutations on precursor folding properties qualitatively parallels the reported relative severity of their effects on the biological handling of the human vasopressin precursor, but quantitative differences between thermodynamic effects and biological impact are noted and explored. The sole mutation for which no clear thermodynamic basis was found for its pathogenicity was 87STOP, suggesting that the region of the precursor deleted by this mutation plays a role in targeting independent from effects on folding, or participates in stabilizing interactions unique to the human vasopressin precursor.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Portland State Univ, Dept Chem, Portland, OR 97207 USA	Cornell University; Portland State University	Breslow, E (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	ebreslow@mail.med.cornell.edu			NIGMS NIH HHS [GM-17528] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDO S, 1987, J BIOL CHEM, V262, P12962; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BAHNSEN U, 1992, EMBO J, V11, P19, DOI 10.1002/j.1460-2075.1992.tb05022.x; Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965; BRESLOW E, 1977, BIOCHEMISTRY-US, V16, P3397, DOI 10.1021/bi00634a017; BRESLOW E, 1991, BIOCHEMISTRY-US, V30, P7990, DOI 10.1021/bi00246a017; BRESLOW E, 1971, J BIOL CHEM, V246, P5179; BRESLOW E, 1995, BIOCHEMISTRY-US, V34, P2137, DOI 10.1021/bi00007a006; BRESLOW E, 1993, REGUL PEPTIDES, V45, P15, DOI 10.1016/0167-0115(93)90175-8; BRESLOW E, 1990, ADV ENZYMOL RAMB, V63, P1; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; CHAUVET MT, 1983, P NATL ACAD SCI-BIOL, V80, P2839, DOI 10.1073/pnas.80.10.2839; CHEN LQ, 1991, P NATL ACAD SCI USA, V88, P4240, DOI 10.1073/pnas.88.10.4240; COLIGAN JE, 1995, CURRENT PROTOCOLS PR, V2; DEBREE FM, 1980, CELL MOL NEUROBIOL, V19, P3565; Deeb R, 1996, BIOCHEMISTRY-US, V35, P864, DOI 10.1021/bi951947u; Eubanks S, 1999, BIOCHEMISTRY-US, V38, P13530, DOI 10.1021/bi9912950; Eubanks S, 2000, BIOCHEMISTRY-US, V39, P8085, DOI 10.1021/bi0001527; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HUANG HB, 1992, J BIOL CHEM, V267, P6750; HUANG HB, 1993, BIOCHEMISTRY-US, V32, P10743, DOI 10.1021/bi00091a027; ITO M, 1991, J CLIN INVEST, V87, P725, DOI 10.1172/JCI115052; Ito M, 1997, J CLIN INVEST, V99, P1897, DOI 10.1172/JCI119357; Ito M, 1999, J BIOL CHEM, V274, P9029, DOI 10.1074/jbc.274.13.9029; KANMERA T, 1985, J BIOL CHEM, V260, P8474; Kim JK, 1997, J AM SOC NEPHROL, V8, P1863; LAND H, 1982, NATURE, V295, P299, DOI 10.1038/295299a0; LAND H, 1983, NATURE, V302, P342, DOI 10.1038/302342a0; MENENDEZBOTET CJ, 1975, BIOCHEMISTRY-US, V14, P3825, DOI 10.1021/bi00688a015; NICOLAS P, 1980, BIOCHEMISTRY-US, V19, P3565, DOI 10.1021/bi00556a023; Nijenhuis M, 1999, J BIOL CHEM, V274, P21200, DOI 10.1074/jbc.274.30.21200; Nijenhuis M, 2000, MOL CELL ENDOCRINOL, V167, P55, DOI 10.1016/S0303-7207(00)00288-4; Olias G, 1996, DNA CELL BIOL, V15, P929, DOI 10.1089/dna.1996.15.929; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; RABBANI LD, 1982, BIOCHEMISTRY-US, V21, P817, DOI 10.1021/bi00534a001; Rittig S, 1996, AM J HUM GENET, V58, P107; Rose JP, 1996, NAT STRUCT BIOL, V3, P163, DOI 10.1038/nsb0296-163; VIRMANISARDANA V, 1983, INT J PEPT PROT RES, V21, P182; Walther D, 1999, ACTA CRYSTALLOGR D, V55, P506, DOI 10.1107/S0907444998013353; Zheng CS, 1997, J PEPT RES, V50, P199	40	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29671	29680		10.1074/jbc.M103477200	http://dx.doi.org/10.1074/jbc.M103477200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395505	hybrid			2022-12-27	WOS:000170558000012
J	Gupta, RA; Brockman, JA; Sarraf, P; Willson, TM; DuBois, RN				Gupta, RA; Brockman, JA; Sarraf, P; Willson, TM; DuBois, RN			Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE; GELATINASE-ASSOCIATED LIPOCALIN; IMMUNOGLOBULIN SUPERGENE FAMILY; HUMAN PROSTATE-CANCER; PPAR-GAMMA; CARCINOEMBRYONIC ANTIGEN; ORPHAN RECEPTORS; COLON-CANCER; REG PROTEIN; FATTY-ACIDS	Activation of the nuclear hormone peroxisome proliferator-activated receptor gamma (PPAR gamma) inhibits cell growth and promotes differentiation in a broad spectrum of epithelial derived tumor cell lines. Here we utilized microarray technology to identify PPAR gamma gene targets in intestinal epithelial cells. For each gene, the induction or repression was seen with two structurally distinct PPAR gamma agonists, and the change in expression could be blocked by co-treatment with a specific PPAR gamma antagonist. A majority of the genes could be regulated independently by a retinoid X receptor specific agonist. Genes implicated in lipid transport or storage (adipophilin and liver fatty acid-binding protein) were also activated by agonists of PPAR subtypes alpha and/or delta. In contrast, PPAR gamma -selective targets included genes linked to growth regulatory pathways (regenerating gene IA), colon epithelial cell maturation (GOB-4 and keratin 20), and immune modulation (neutrophil-gelatinase-associated lipocalin). Additionally, three different genes of the carcinoembryonic antigen family were induced by PPAR gamma. Cultured cells treated with PPAR gamma ligands demonstrated an increase in Ca2+-independent, carcinoembryonic antigen-dependent homotypic aggregation, suggesting a potential role for PPAR gamma in regulating intercellular adhesion. Collectively, these results will help define the mechanisms by which PPAR gamma regulates intestinal epithelial cell biology.	Vanderbilt Univ, Med Ctr, Dept Med GI, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA; Vet Affairs Med Ctr, Nashville, TN 37232 USA; Res Genet Inc, Huntsville, AL 35801 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA; GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; GlaxoSmithKline	DuBois, RN (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med GI, MCN C-2104,1161 21st Ave S, Nashville, TN 37232 USA.		DuBois, Raymond N./AAX-8869-2020; feinstein, doug/M-9414-2019		NCI NIH HHS [P01CA-77839] Funding Source: Medline; NIDDK NIH HHS [R01DK 47279] Funding Source: Medline; NIEHS NIH HHS [P030 ES-00267-29] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Bernard-Perrone FR, 1999, J HISTOCHEM CYTOCHEM, V47, P863, DOI 10.1177/002215549904700703; Bratt T, 1999, BBA-GEN SUBJECTS, V1472, P262, DOI 10.1016/S0304-4165(99)00131-2; Brockman JA, 1998, GASTROENTEROLOGY, V115, P1049, DOI 10.1016/S0016-5085(98)70072-1; Brown PJ, 2001, BIOORG MED CHEM LETT, V11, P1225, DOI 10.1016/S0960-894X(01)00188-3; Buckingham RE, 1998, DIABETES, V47, P1326, DOI 10.2337/diabetes.47.8.1326; CALNEK D, 1993, DIFFERENTIATION, V53, P95, DOI 10.1111/j.1432-0436.1993.tb00649.x; Carrere J, 1998, CLIN CHIM ACTA, V273, P185, DOI 10.1016/S0009-8981(98)00043-6; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; Chang TH, 2000, CANCER RES, V60, P1129; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; EIDELMAN FJ, 1993, J CELL BIOL, V123, P467, DOI 10.1083/jcb.123.2.467; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Frangsmyr L, 1999, TUMOR BIOL, V20, P277, DOI 10.1159/000030075; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; Kliewer SA, 1998, CURR OPIN GENET DEV, V8, P576, DOI 10.1016/S0959-437X(98)80014-2; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kobayashi S, 2000, J BIOL CHEM, V275, P10723, DOI 10.1074/jbc.275.15.10723; Komiya T, 1999, BBA-GENE STRUCT EXPR, V1444, P434, DOI 10.1016/S0167-4781(99)00010-X; Kubota T, 1998, CANCER RES, V58, P3344; LEBLANC BP, 1995, GENE DEV, V9, P1811, DOI 10.1101/gad.9.15.1811; Lefebvre AM, 1999, J ENDOCRINOL, V162, P331, DOI 10.1677/joe.0.1620331; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LEVINE AE, 1985, CANCER RES, V45, P2248; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Macadam RCA, 2000, BRIT J CANCER, V83, P188; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mansen A, 1996, BIOCHEM BIOPH RES CO, V222, P844, DOI 10.1006/bbrc.1996.0832; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; MOLL R, 1993, DIFFERENTIATION, V53, P75, DOI 10.1111/j.1432-0436.1993.tb00648.x; Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nakajima A, 2001, GASTROENTEROLOGY, V120, P460, DOI 10.1053/gast.2001.21191; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Okamoto H, 1997, ADV EXP MED BIOL, V426, P301; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Poirier H, 1997, FEBS LETT, V412, P480, DOI 10.1016/S0014-5793(97)00830-2; Poirier H, 2001, BIOCHEM J, V355, P481, DOI 10.1042/0264-6021:3550481; Rechreche H, 1999, INT J CANCER, V81, P688, DOI 10.1002/(SICI)1097-0215(19990531)81:5<688::AID-IJC3>3.0.CO;2-R; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Shinozaki S, 2001, GUT, V48, P623, DOI 10.1136/gut.48.5.623; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Su JL, 1998, HYBRIDOMA, V17, P47, DOI 10.1089/hyb.1998.17.47; Suh N, 1999, CANCER RES, V59, P5671; Takahashi N, 1999, FEBS LETT, V455, P135, DOI 10.1016/S0014-5793(99)00871-6; Tanaka T, 2001, CANCER RES, V61, P2424; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Willson TM, 1996, ANN NY ACAD SCI, V804, P276, DOI 10.1111/j.1749-6632.1996.tb18622.x; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Yamaoka T, 2000, BIOCHEM BIOPH RES CO, V278, P368, DOI 10.1006/bbrc.2000.3813; Yan ZF, 1997, J BIOL CHEM, V272, P27902, DOI 10.1074/jbc.272.44.27902; ZHOU H, 1990, CELL GROWTH DIFFER, V1, P209	69	166	181	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29681	29687		10.1074/jbc.M103779200	http://dx.doi.org/10.1074/jbc.M103779200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397807	hybrid			2022-12-27	WOS:000170558000013
J	Sanlioglu, S; Williams, CM; Samavati, L; Butler, NS; Wang, GS; McCray, PB; Ritchie, TC; Hunninghake, GW; Zandi, E; Engelhardt, JF				Sanlioglu, S; Williams, CM; Samavati, L; Butler, NS; Wang, GS; McCray, PB; Ritchie, TC; Hunninghake, GW; Zandi, E; Engelhardt, JF			Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-2; LPS-BINDING-PROTEIN; RECOMBINANT ADENOASSOCIATED VIRUS; PERMEABILITY-INCREASING PROTEIN; HUMAN MONOCLONAL-ANTIBODY; PLACEBO-CONTROLLED TRIAL; FREE-RADICAL GENERATION; BACTERIAL LIPOPOLYSACCHARIDE; ENDOTHELIAL-CELLS; GENE-EXPRESSION	Reactive oxygen species (ROS) are important second messengers generated in response to many types of environmental stress. In this setting, changes in intracellular ROS can activate signal transduction pathways that influence how cells react to their environment. In sepsis, a dynamic proinflammatory cellular response to bacterial toxins (e.g., lipopolysaccharide or LPS) leads to widespread organ damage and death. The present study demonstrates for the first time that the activation of Rac1 (a GTP-binding protein), and the subsequent production of ROS, constitutes a major pathway involved in NF kappaB-mediated tumor necrosis factor-alpha (TNF alpha) secretion following LPS challenge in macrophages. Expression of a dominant negative mutant of Rac1. (N17Rac1) reduced Rac1 activation, ROS formation, NF kappaB activation, and TNF alpha secretion following LPS stimulation. In contrast, expression of a dominant active form of Rac1 (V12Rac1) mimicked these effects in the absence of LPS stimulation. IKK alpha and IKK beta were both required downstream modulators of LPS-activated Rac1, since the expression of either of the IKK dominant mutants (IKK alpha KM or IKK beta KA) drastically reduced NF kappaB-dependent TNF alpha secretion. Moreover, studies using CD14 blocking antibodies suggest that Rac1 induces TNF alpha secretion through a pathway independent of CD14. However, a maximum therapeutic inhibition of LPS-induced TNF alpha secretion occurred when both CD14 and Rac1 pathways were inhibited. Our results suggest that targeting both Rac1- and CD14-dependent pathways could be a useful therapeutic strategy for attenuating the proinflammatory cytokine response during the course of sepsis.	Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Div Pulm & Crit Care, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Ctr Gene Therapy, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; Norris Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; Akdeniz Univ, Coll Med, Dept Med Biol & Genet, TR-07070 Antalya, Turkey	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Akdeniz University	Engelhardt, JF (corresponding author), Univ Iowa, Coll Med, Dept Anat & Cell Biol, 51 Newton Rd,Rm 1-111 BSB, Iowa City, IA 52242 USA.		Sanlioglu, Salih/F-9305-2016	Sanlioglu, Salih/0000-0001-8379-5678; Butler, Noah/0000-0002-1429-0796; McCray, Paul/0000-0002-4067-577X; Engelhardt, John/0000-0003-2389-9277	NHLBI NIH HHS [HL60316] Funding Source: Medline; NIDDK NIH HHS [DK54759] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; BONE RC, 1995, CRIT CARE MED, V23, P994, DOI 10.1097/00003246-199506000-00003; Bone RC, 1996, JAMA-J AM MED ASSOC, V276, P565, DOI 10.1001/jama.276.7.565; BONE RC, 1991, CHEST, V100, P802, DOI 10.1378/chest.100.3.802; BONE RC, 1995, CHEST, V107, P298, DOI 10.1378/chest.107.2.298; BOXER GJ, 1985, HOSP PRACT, V20, P69; Brown MR, 1999, CIRC RES, V85, P524, DOI 10.1161/01.RES.85.6.524; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; CORRADIN SB, 1992, J LEUKOCYTE BIOL, V52, P363, DOI 10.1002/jlb.52.4.363; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DENTENER MA, 1993, J IMMUNOL, V150, P2885; DENTENER MA, 1993, J IMMUNOL, V151, P4258; DOE WF, 1978, J EXP MED, V148, P557, DOI 10.1084/jem.148.2.557; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; FEARNS C, 1995, J EXP MED, V181, P857, DOI 10.1084/jem.181.3.857; FINKELSTEIN E, 1980, ARCH BIOCHEM BIOPHYS, V200, P1, DOI 10.1016/0003-9861(80)90323-9; Fisher KJ, 1996, J VIROL, V70, P520, DOI 10.1128/JVI.70.1.520-532.1996; Flaherty SF, 1997, J SURG RES, V73, P85, DOI 10.1006/jsre.1997.5195; Gangloff SC, 1999, CLIN INFECT DIS, V28, P491, DOI 10.1086/515176; Gillissen A, 1997, RES EXP MED, V196, P389, DOI 10.1007/s004330050049; Glaven JA, 1999, J BIOL CHEM, V274, P2279, DOI 10.1074/jbc.274.4.2279; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; Hattor Y, 1997, BIOCHEM BIOPH RES CO, V233, P375, DOI 10.1006/bbrc.1997.6462; HEUMANN D, 1992, J IMMUNOL, V148, P3505; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; Ingalls RR, 1997, J IMMUNOL, V159, P433; Ingalls RR, 1998, PROG CLIN BIOL RES, V397, P107; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Jungi TW, 1997, INFECT IMMUN, V65, P3577, DOI 10.1128/IAI.65.9.3577-3584.1997; Kim KS, 1998, J CLIN INVEST, V101, P1821, DOI 10.1172/JCI1830; Kimura S, 2000, SCAND J IMMUNOL, V51, P392, DOI 10.1046/j.1365-3083.2000.00696.x; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; LYNN WA, 1993, INFECT IMMUN, V61, P4452, DOI 10.1128/IAI.61.10.4452-4461.1993; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; MCCLOSKEY RV, 1994, ANN INTERN MED, V121, P1, DOI 10.7326/0003-4819-121-1-199407010-00001; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MESZAROS K, 1994, BLOOD, V83, P2516; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Miyata Y, 1997, INFECT IMMUN, V65, P3513, DOI 10.1128/IAI.65.9.3513-3519.1997; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; MORRISON DC, 1978, AM J PATHOL, V93, P526; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Netea MG, 1998, IMMUNOLOGY, V94, P340, DOI 10.1046/j.1365-2567.1998.00532.x; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Peppelenbosch MP, 1999, BLOOD, V93, P4011, DOI 10.1182/blood.V93.11.4011.411a29_4011_4018; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; PERISTERIS P, 1992, CELL IMMUNOL, V140, P390, DOI 10.1016/0008-8749(92)90205-4; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Sanlioglu S, 1999, GENE THER, V6, P1427, DOI 10.1038/sj.gt.3300967; SanliogluCrisman S, 1997, PROG BRAIN RES, V114, P3; SCHLETTER J, 1995, INFECT IMMUN, V63, P2576, DOI 10.1128/IAI.63.7.2576-2580.1995; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Schuster JM, 2000, J LEUKOCYTE BIOL, V67, P767, DOI 10.1002/jlb.67.6.767; Shi XL, 2000, ANN CLIN LAB SCI, V30, P209; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; THEOFAN G, 1994, J IMMUNOL, V152, P3623; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; ULEVITCH RJ, 1993, ADV IMMUNOL, V53, P267, DOI 10.1016/S0065-2776(08)60502-7; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; WRIGHT SD, 1989, J EXP MED, V169, P175, DOI 10.1084/jem.169.1.175; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876; WRIGHT SD, 1991, J EXP MED, V173, P1281, DOI 10.1084/jem.173.5.1281; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4; ZWEIER JL, 1994, AM J PHYSIOL, V266, pC700, DOI 10.1152/ajpcell.1994.266.3.C700; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046	94	346	357	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30188	30198		10.1074/jbc.M102061200	http://dx.doi.org/10.1074/jbc.M102061200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402028	hybrid			2022-12-27	WOS:000170558000079
J	Umata, T; Hirata, M; Takahashi, T; Ryu, F; Shida, S; Takahashi, Y; Tsuneoka, M; Miura, Y; Masuda, M; Horiguchi, Y; Mekada, E				Umata, T; Hirata, M; Takahashi, T; Ryu, F; Shida, S; Takahashi, Y; Tsuneoka, M; Miura, Y; Masuda, M; Horiguchi, Y; Mekada, E			A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DIPHTHERIA-TOXIN RECEPTOR; EGF RECEPTOR; MEMBRANE-PROTEIN; TYROSINE KINASE; CELL-ADHESION; RHO FAMILY; PKC-DELTA; ACTIVATION; CLEAVAGE	Ectodomain shedding is an important mechanism to regulate the biological activities of membrane proteins. We focus here on the signaling mechanism of the ectodomain shedding of heparin-binding epidermal growth factor (EGF)-like growth factor (pro HB-EGF). Lysophosphatidic acid (LPA), a ligand for seven-transmembrane G protein-coupled receptors, stimulates the shedding of pro HB-EGF, which constitutes a G protein-coupled receptor-mediated transactivation of the EGF receptor. Experiments using a series of inhibitors and overexpression of mutant forms of signaling molecules revealed that the Ras-Raf-MEK signal is essential for the LPA-induced shedding. In addition, the small GTPase Rac is involved in the LPA-induced shedding, possibly to promote MEK activation. 12-O-Tetradecanoylphorbol-13-acetate is another potent inducer of pro HB-EGF shedding. We also demonstrate that the LPA-induced pathway is distinct from the 12-O-tetradecanoylphorbol-13-acetate-induced pathway and that these pathways constitute a dual signaling cascade that regulates the shedding of pro HB-EGF.	Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Cell Biol, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Bacterial Toxinol, Suita, Osaka 5650871, Japan	Kurume University; Osaka University; Osaka University	Mekada, E (corresponding author), Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan.		Miura, Yoshiki/U-8875-2019	Miura, Yoshiki/0000-0002-7596-0482; Mekada, Eisuke/0000-0001-8858-4781				Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Besser D, 1995, ONCOGENE, V11, P2383; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Burstein ES, 1998, ONCOGENE, V17, P1617, DOI 10.1038/sj.onc.1202067; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Feehan C, 1996, J BIOL CHEM, V271, P7019, DOI 10.1074/jbc.271.12.7019; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Golembo M, 1996, DEVELOPMENT, V122, P3363; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; HIRAI S, 1994, EMBO J, V13, P2331, DOI 10.1002/j.1460-2075.1994.tb06517.x; Hirata M, 2001, BIOCHEM BIOPH RES CO, V283, P915, DOI 10.1006/bbrc.2001.4879; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; Iwamoto R, 1999, J BIOL CHEM, V274, P25906, DOI 10.1074/jbc.274.36.25906; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kawano Y, 2000, J BIOL CHEM, V275, P29628, DOI 10.1074/jbc.M002440200; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Masuda M, 2000, EMBO J, V19, P521, DOI 10.1093/emboj/19.4.521; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; OGOROCHI T, 1989, BIOCHEM BIOPH RES CO, V163, P1175, DOI 10.1016/0006-291X(89)92344-9; OHASHI Y, 1987, J BIOL CHEM, V262, P1430; OHNO S, 1994, J BIOL CHEM, V269, P17495; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Sugai M, 1999, INFECT IMMUN, V67, P6550; Vecchi M, 1996, J BIOL CHEM, V271, P18989, DOI 10.1074/jbc.271.31.18989; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; Werb Z, 1998, SCIENCE, V282, P1279, DOI 10.1126/science.282.5392.1279	51	83	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30475	30482		10.1074/jbc.M103673200	http://dx.doi.org/10.1074/jbc.M103673200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402047	hybrid			2022-12-27	WOS:000170558000114
J	Khurana, R; Uversky, VN; Nielsen, L; Fink, AL				Khurana, R; Uversky, VN; Nielsen, L; Fink, AL			Is Congo red an amyloid-specific dye?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; PARALLEL BETA-HELIX; MOLTEN GLOBULE; CIBACRON BLUE; THIOFLAVINE-T; PROTEIN; BINDING; APOMYOGLOBIN; FIBRILS; INTERMEDIATE	Congo red (CR) binding, monitored by characteristic yellow-green birefringence under crossed polarization has been used as a diagnostic test for the presence of amyloid in tissue sections for several decades. This assay is also widely used for the characterization of in vitro amyloid fibrils, In order to probe the structural specificity of Congo red binding to amyloid fibrils we have used an induced circular dichroism (CD) assay. Amyloid fibrils from insulin and the variable domain of Ig light chain demonstrate induced CD spectra upon binding to Congo red. Surprisingly, the native conformations of insulin and Ig light chain also induced Congo red circular dichroism, but with different spectral shapes than those from fibrils, In fact, a wide variety of native proteins exhibited induced CR circular dichroism indicating that CR bound to representative proteins from different classes of secondary structure such as alpha (citrate synthase), alpha + beta (lysozyme), beta (concavaIin A), and parallel beta -helical proteins (pectate lyase), Partially folded intermediates of apomyoglobin induced different Congo red CD bands than the corresponding native conformation, however, no induced CD bands were observed with unfolded protein. Congo red was also found to induce oligomerization of native proteins, as demonstrated by covalent cross-linking and small angle x-ray scattering. Our data suggest that Congo red is sandwiched between two protein molecules causing protein oligomerization, The fact that Congo red binds to native, partially folded conformations and amyloid fibrils of several proteins shows that it must be used with caution as a diagnostic test for the presence of amyloid fibrils in vitro.	Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Fink, AL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.		Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857				Ashburn TT, 1996, CHEM BIOL, V3, P351, DOI 10.1016/S1074-5521(96)90118-0; ATTWOOD TK, 1990, LIQ CRYST, V7, P657, DOI 10.1080/02678299008036749; BARRICK D, 1993, BIOCHEMISTRY-US, V32, P3790, DOI 10.1021/bi00065a035; BENDITT EP, 1970, P NATL ACAD SCI USA, V66, P1044, DOI 10.1073/pnas.66.4.1044; BENHOLD H, 1922, MUENCHEN MED WOCHENS, V69, P1537; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P6270, DOI 10.1128/JVI.67.10.6270-6272.1993; Cotton A.A., 1896, ANN CHIM PHYS, V8, P347; Demaimay R, 1998, J NEUROCHEM, V71, P2534; DIVRY PAUL, 1927, JOUR NEUROL ET PSYCHIATR, V27, P643; DONIACH S, 1995, J MOL BIOL, V254, P960, DOI 10.1006/jmbi.1995.0668; EDWARDS RA, 1979, BIOCHEMISTRY-US, V18, P5197, DOI 10.1021/bi00590a026; EDWARDS RA, 1977, BIOCHEM BIOPH RES CO, V79, P470, DOI 10.1016/0006-291X(77)90181-4; ELGHETANY MT, 1988, STAIN TECHNOL, V63, P201, DOI 10.3109/10520298809107185; ELIEZER D, 1993, BIOPHYS J, V65, P912, DOI 10.1016/S0006-3495(93)81124-X; GAST K, 1994, EUR BIOPHYS J BIOPHY, V23, P297, DOI 10.1007/BF00213579; Glatter O., 1982, SMALL ANGLE XRAY SCA; GLENNER GG, 1972, J HISTOCHEM CYTOCHEM, V20, P821, DOI 10.1177/20.10.821; GOTO Y, 1990, J MOL BIOL, V214, P803, DOI 10.1016/0022-2836(90)90334-I; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; Heegaard NHH, 2000, J CHROMATOGR A, V894, P319, DOI 10.1016/S0021-9673(00)00579-3; Inouye H, 2000, AMYLOID, V7, P179, DOI 10.3109/13506120009146832; KAGAN HM, 1973, BIOCHIM BIOPHYS ACTA, V322, P258, DOI 10.1016/0005-2795(73)90302-4; KATAOKA M, 1993, J MOL BIOL, V229, P591, DOI 10.1006/jmbi.1993.1064; Khurana R, 2000, BIOPHYS J, V78, P994, DOI 10.1016/S0006-3495(00)76657-4; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1293, DOI 10.1177/37.8.2666512; Kuciel R, 1997, ACTA BIOCHIM POL, V44, P645, DOI 10.18388/abp.1997_4367; KUMOSINSKI TF, 1985, METHOD ENZYMOL, V117, P154; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; LUZATTI V, 1961, J MOL BIOL, V3, P367; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Piekarska B, 1999, ACTA BIOCHIM POL, V46, P841, DOI 10.18388/abp.1999_4105; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Roterman I, 1998, COMPUT CHEM, V22, P61, DOI 10.1016/S0097-8485(97)00014-4; Semisotnov GV, 1996, J MOL BIOL, V262, P559, DOI 10.1006/jmbi.1996.0535; Shi L, 1996, BIOCHEMISTRY-US, V35, P3297, DOI 10.1021/bi951984l; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Stopa B, 1998, BIOCHIMIE, V80, P963, DOI 10.1016/S0300-9084(99)80001-7; Stopa B, 1997, BIOCHIMIE, V79, P23, DOI 10.1016/S0300-9084(97)87621-3; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; TAKASHI R, 1977, P NATL ACAD SCI USA, V74, P2334, DOI 10.1073/pnas.74.6.2334; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; TAYLOR DL, 1974, J HISTOCHEM CYTOCHEM, V22, P1105, DOI 10.1177/22.12.1105; TURNELL WG, 1992, J MOL BIOL, V227, P1205, DOI 10.1016/0022-2836(92)90532-O; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; WOODY AYM, 1981, BIOCHIM BIOPHYS ACTA, V655, P82, DOI 10.1016/0005-2787(81)90069-1; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	53	244	252	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 22	2001	276	25					22715	22721		10.1074/jbc.M011499200	http://dx.doi.org/10.1074/jbc.M011499200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	444RE	11410601	hybrid			2022-12-27	WOS:000169412700099
J	Yang, JB; Duan, ZJ; Yao, W; Lee, O; Yang, L; Yang, XY; Sun, X; Chang, CCY; Chang, TY; Li, BL				Yang, JB; Duan, ZJ; Yao, W; Lee, O; Yang, L; Yang, XY; Sun, X; Chang, CCY; Chang, TY; Li, BL			Synergistic transcriptional activation of human acyl-coenzyme A: Cholesterol acyltransterase-1 gene by interferon-gamma and all-trans-retinoic acid THP-1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR EXPRESSION; LOW-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; FOAM CELLS; MOLECULAR-CLONING; MAMMALIAN-CELLS; HUMAN MONOCYTES; LEUKEMIA-CELLS; ACAT-1 PROTEIN; DNA-BINDING	Acyl-coenzyme A:cholesterol acyltransferase (ACAT) is an intracellular enzyme involved in cellular cholesterol homeostasis and in atherosclerotic foam cell formation. Human ACAT-1 gene contains two promoters (P1 and P7), each located in a different chromosome (1 and 7) (Li, B. L., Li, X. L., Duan, Z. J., Lee, O., Lin, S., Ma, Z. M., Chang, C. C., Yang, X. Y., Park, J. P., Mohandas, T. K., Noll, W., Chan, L., and Chang, T. Y. (1999) J. Biol Chem. 274, 11060-11071), Interferon-gamma (IFN-gamma), a cytokine that exerts many pro-atherosclerotic: effects in vivo, causes up-regulation of ACAT-1 mRNA in human blood monocyte-derived macrophages and macrophage-like cells but not in other cell types. To examine the molecular nature of this observation, we identified within the ACAT-1 P1 promoter a 159-base pair core region. This region contains 4 Sp1 elements and an HFN-gamma activated sequence (GAS) that overlaps with the second Sp1 element. In the monocytic cell line THP-1 cell, the combination of IFN-gamma and all-trans-retinoic acid (a known differentiation agent) enhances the ACAT-1 P1 promoter but not the P7 promoter. Additional experiments showed that all-trans-retinoic acid causes large induction of the transcription factor STAT1, While IFN-gamma causes activation of STAT1 such that it binds to the GAS/Sp1 site in the ACAT-1 P1 promoter. Our work provides a molecular mechanism to account for the effect of IFN-gamma in causing transcriptional activation of ACAT-1 in macrophage-like cells.	Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Dartmouth College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chang, TY (corresponding author), Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA.		Yang, Jinbo/AAM-9580-2020	li, bo liang/0000-0002-7123-5638; Chang, Ta-Yuan/0000-0002-3249-0468	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036709, R37HL036709] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 36709] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; Alessio M, 1996, J BIOL CHEM, V271, P1770, DOI 10.1074/jbc.271.3.1770; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BANKA CL, 1991, J LIPID RES, V32, P35; BISHOP JE, 1980, ANAL BIOCHEM, V106, P344, DOI 10.1016/0003-2697(80)90531-X; BROWN MS, 1980, J BIOL CHEM, V255, P9344; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; CADIGAN KM, 1988, J LIPID RES, V29, P1683; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang CCY, 2000, J BIOL CHEM, V275, P28083; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHANG TY, 1980, J BIOL CHEM, V255, P7787; CHENG WL, 1995, AM J PHYSIOL-ENDOC M, V269, pE642, DOI 10.1152/ajpendo.1995.269.4.E642; CHRISTEN S, 1994, J CLIN INVEST, V93, P2149, DOI 10.1172/JCI117211; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FIELDING CJ, 1992, FASEB J, V6, P3162, DOI 10.1096/fasebj.6.13.1327930; GENG YJ, 1992, J CLIN INVEST, V89, P1322, DOI 10.1172/JCI115718; GENG YJ, 1995, ARTERIOSCL THROM VAS, V15, P1995, DOI 10.1161/01.ATV.15.11.1995; Gianni M, 1997, BLOOD, V89, P1001, DOI 10.1182/blood.V89.3.1001; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; HANSSON GK, 1989, AM J PATHOL, V135, P169; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang CL, 1999, PEPTIDES, V20, P1385, DOI 10.1016/S0196-9781(99)00147-3; JONASSON L, 1985, J CLIN INVEST, V76, P125, DOI 10.1172/JCI111934; Lee O, 1998, J LIPID RES, V39, P1722; Lee RG, 2000, J LIPID RES, V41, P1991; Li BL, 1999, J BIOL CHEM, V274, P11060, DOI 10.1074/jbc.274.16.11060; LI H, 1993, ARTERIOSCLER THROMB, V13, P197, DOI 10.1161/01.ATV.13.2.197; LI HM, 1995, J CLIN INVEST, V95, P122, DOI 10.1172/JCI117628; Liu JW, 1997, J LIPID RES, V38, P2035; Mack KD, 1998, J IMMUNOL METHODS, V211, P79, DOI 10.1016/S0022-1759(97)00194-4; Mangelsdorf David J., 1994, P319; Matikainen S, 1998, LEUKEMIA LYMPHOMA, V30, P63, DOI 10.3109/10428199809050930; Matikainen S, 1997, CELL GROWTH DIFFER, V8, P687; Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; OOSTA GM, 1978, ANAL BIOCHEM, V89, P31, DOI 10.1016/0003-2697(78)90723-6; Panousis CG, 2000, ARTERIOSCL THROM VAS, V20, P1565, DOI 10.1161/01.ATV.20.6.1565; Panousis CG, 2000, J LIPID RES, V41, P75; POWELL JT, 1992, FEBS LETT, V303, P173, DOI 10.1016/0014-5793(92)80512-F; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakamoto S, 1999, J IMMUNOL, V162, P4381; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Shiffman D, 2000, J BIOL CHEM, V275, P37324, DOI 10.1074/jbc.M004732200; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Walter MJ, 1997, J BIOL CHEM, V272, P28582, DOI 10.1074/jbc.272.45.28582; Wang HX, 1996, ARTERIOSCL THROM VAS, V16, P809, DOI 10.1161/01.ATV.16.6.809; Whitman SC, 1999, J LIPID RES, V40, P1017	56	42	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					20989	20998		10.1074/jbc.M011488200	http://dx.doi.org/10.1074/jbc.M011488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11399774	hybrid			2022-12-27	WOS:000169297900027
J	Demoor-Fossard, M; Galera, P; Santra, M; Iozzo, RV; Pujol, JP; Redini, F				Demoor-Fossard, M; Galera, P; Santra, M; Iozzo, RV; Pujol, JP; Redini, F			A composite element binding the vitamin D receptor and the retinoic X receptor alpha mediates the transforming growth factor-beta inhibition of decorin gene expression in articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OSTEOARTHRITIC CARTILAGE; MESSENGER-RNA LEVELS; PHENOTYPIC MODULATION; PROTEOGLYCAN DECORIN; HUMAN-FIBROBLASTS; MAMMALIAN-CELLS; DOWN-REGULATION; ALGINATE BEADS; PROTEIN CORE; FACTOR-A	Decorin, a small leucine-rich proteoglycan may play an important role in the attempt of cartilage repair initiated by chondrocytes in early stages of osteoarthritis, through its ability to bind collagen fibrils and growth factors such as transforming growth factor-beta (TGF-beta). We previously demonstrated that TGF-beta decreased decorin mRNA steady state levels in articular chondrocytes (Demoor, M., Redini, F., Boittin, M., and Pujol, J.-P. (1998) Biochim. Biophys. Acta 1398, 179-191). Here, we investigated the effect of TGF-beta on decorin gene expression in both primary cultures of articular chondrocytes and chondrocytes dedifferentiated by serial passages. Transient transfection of cells with plasmid constructs of the decorin promoter linked to the luciferase reporter gene revealed transcriptional repression by TGF-beta, in fully differentiated as well as dedifferentiated chondrocytes. Experiments with 5'-deleted constructs allowed characterization of a TGF-beta -responsive element in the shortest construct (base pairs (bp) -155/+269). DNase I footprinting analysis delineated a negative TGF-beta -responsive region between -140 and -111 bp in the decorin proximal promoter. Get retardation assays demonstrated that TGF-beta modulates decorin gene expression through transcription factors, the nature and mode of action of which depend on the differentiation state of the chondrocytes; two DNA-protein complexes were formed in the region -1441-127 bp with nuclear extracts from primary chondrocytes, whereas a higher mobility complex was observed in the -127/-111 bp region for dedifferentiated cells. Antibodies against vitamin D and retinoic acid receptors used in supershift experiments showed that these nuclear receptors are involved in the regulation of decorin gene expression in articular chondrocytes.	Fac Med, Lab Biochim Tissu Conjonctif, F-14032 Caen, France; Thomas Jefferson Univ, Jefferson Med Coll, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Universite de Caen Normandie; Jefferson University; Jefferson University	Redini, F (corresponding author), Fac Med EE 99 01, Lab Physiopathol Resorpt Ossense, 1 Rue Gaston Veil, F-44035 Nantes 01, France.		REDINI, Francoise/K-7981-2015; Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112	NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-39481] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAM F, 1999, ENDOCRINOLOGY, V140, P63; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARCHER CW, 1990, J CELL SCI, V97, P361; BENYA PD, 1977, BIOCHEMISTRY-US, V16, P865, DOI 10.1021/bi00624a009; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; BRUCKNER P, 1994, MICROSC RES TECHNIQ, V28, P378, DOI 10.1002/jemt.1070280504; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; CsSzabo G, 1997, ARTHRITIS RHEUM, V40, P1037, DOI 10.1002/art.1780400607; CSSZABO G, 1995, ARTHRITIS RHEUM, V38, P660, DOI 10.1002/art.1780380514; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; DELRIOTSONIS K, 1994, BIOCHEM BIOPH RES CO, V204, P975, DOI 10.1006/bbrc.1994.2556; DEMAY MB, 1990, P NATL ACAD SCI USA, V87, P369, DOI 10.1073/pnas.87.1.369; Demoor-Fossard M, 1998, BBA-GENE STRUCT EXPR, V1398, P179, DOI 10.1016/S0167-4781(98)00044-X; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; EIKENBERRY EF, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P133; ELLINGSWORTH LR, 1986, J BIOL CHEM, V261, P2362; FRAZER A, 1991, BIOCHEM BIOPH RES CO, V180, P602, DOI 10.1016/S0006-291X(05)81108-8; GALERA P, 1992, EXP CELL RES, V200, P379, DOI 10.1016/0014-4827(92)90186-C; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; GLOSSL J, 1983, BIOCHEM J, V215, P295; GOLDWASSER M, 1982, CLIN ORTHOP RELAT R, P296; Hagg R, 1998, J CELL BIOL, V142, P285, DOI 10.1083/jcb.142.1.285; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 1999, PROG NUCLEIC ACID RE, V62, P19; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; KRESSE H, 1993, EXPERIENTIA, V49, P403, DOI 10.1007/BF01923585; KUETTNER KE, 1982, J CELL BIOL, V93, P751, DOI 10.1083/jcb.93.3.751; LIU JM, 1991, VIROLOGY, V182, P361, DOI 10.1016/0042-6822(91)90682-2; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Malemud C J, 1994, Osteoarthritis Cartilage, V2, P29, DOI 10.1016/S1063-4584(05)80004-4; Mauviel A, 1996, J BIOL CHEM, V271, P24824, DOI 10.1074/jbc.271.40.24824; MAUVIEL A, 1995, J BIOL CHEM, V270, P11692, DOI 10.1074/jbc.270.19.11692; Maxam A M, 1980, Methods Enzymol, V65, P499; MEIJER D, 1990, NUCLEIC ACIDS RES, V18, P7357, DOI 10.1093/nar/18.24.7357; NIMNI M, 1973, SCIENCE, V181, P751, DOI 10.1126/science.181.4101.751; Pedrozo HA, 1999, CALCIFIED TISSUE INT, V64, P50, DOI 10.1007/s002239900578; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; RASCLE A, 1994, ONCOGENE, V9, P2853; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912; ROUGHLEY PJ, 1993, BIOCHEM J, V295, P421, DOI 10.1042/bj2950421; SANTRA M, 1994, J BIOL CHEM, V269, P579; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; vanderKraan PM, 1997, J RHEUMATOL, V24, P543; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yanagi Y, 1999, J BIOL CHEM, V274, P12971, DOI 10.1074/jbc.274.19.12971; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	68	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	2001	276	40					36983	36992		10.1074/jbc.M011442200	http://dx.doi.org/10.1074/jbc.M011442200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478YD	11406617	hybrid			2022-12-27	WOS:000171375700018
J	Balakrishnan, M; Fay, PJ; Bambara, RA				Balakrishnan, M; Fay, PJ; Bambara, RA			The kissing hairpin sequence promotes recombination within the HIV-I 5 ' leader region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; STRAND DNA-SYNTHESIS; ROUS-SARCOMA VIRUS; RNASE-H-FUNCTION; REVERSE-TRANSCRIPTASE; RETROVIRAL RECOMBINATION; GENOMIC RNA; GENETIC-RECOMBINATION; NUCLEOCAPSID PROTEIN	The role of RNA-RNA template interactions in facilitating recombination during reverse transcription of minus strand DNA has been examined. The tested hypothesis is that template switching by reverse transcriptase is promoted at sites where homologous regions of two RNAs are brought in close proximity via stable intertemplate interactions. Frequency and distribution of template switching between homologous donor and acceptor RNAs were examined within the human immunodeficiency virus type 1 (HIV-1) 5 ' -untranslated region (UTR) containing the dimer initiation sequence (DIS). Results were compared with control nondimerizing templates from the pol region. The dimerizing UTR templates displayed a 4-fold higher transfer efficiency than the control. A striking 53% of transfers in the UTR mapped near the DIS, of which two-thirds occurred immediately 5 ' to this sequence. In the UTR template, deletion of the DIS hairpin disrupted template dimerization and caused a 4-fold drop in transfer efficiency. Insertion of the DIS within the pol template increased both dimerization and transfer efficiency. Transfer distributions revealed that in both sets of templates, DIS-induced dimerization increased the efficiency of transfers across the whole template, with the transfers peaking around the dimerization site. Overall, these results suggest that template dimerization facilitated by the unique geometry of the DIS-promoted kissing interactions effectively promotes recombination within the HIV-1 5 ' -UTR.	Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Box 712,601 Elmwood Ave, Rochester, NY 14642 USA.				NIGMS NIH HHS [GM 49573] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JA, 1998, J VIROL, V72, P1186, DOI 10.1128/JVI.72.2.1186-1194.1998; AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Berkhout B, 2000, RNA, V6, P282, DOI 10.1017/S1355838200991684; BIETH E, 1990, NUCLEIC ACIDS RES, V18, P119, DOI 10.1093/nar/18.1.119; BLAIR DG, 1977, VIROLOGY, V77, P534, DOI 10.1016/0042-6822(77)90479-2; BURNS DPW, 1994, J VIROL, V68, P4196, DOI 10.1128/JVI.68.7.4196-4203.1994; CLAVEL F, 1989, J VIROL, V63, P1455, DOI 10.1128/JVI.63.3.1455-1459.1989; Clever JL, 1996, J VIROL, V70, P5902, DOI 10.1128/JVI.70.9.5902-5908.1996; COFFIN J, 1996, AIDS S, V10, P75; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; COLICELLI J, 1987, VIROLOGY, V160, P518, DOI 10.1016/0042-6822(87)90030-4; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; DESTEFANO JJ, 1994, J BIOL CHEM, V269, P161; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; DeStefano JJ, 1997, ARCH VIROL, V142, P1797, DOI 10.1007/s007050050198; DESTEFANO JJ, 1994, BBA-GENE STRUCT EXPR, V1219, P380, DOI 10.1016/0167-4781(94)90062-0; Diaz L, 1996, NUCLEIC ACIDS RES, V24, P3086, DOI 10.1093/nar/24.15.3086; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; DIFRONZO NL, 1993, J VIROL, V67, P3763, DOI 10.1128/JVI.67.7.3763-3770.1993; Feng YX, 1996, P NATL ACAD SCI USA, V93, P7577, DOI 10.1073/pnas.93.15.7577; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; GIRARD PM, 1995, BIOCHEMISTRY-US, V34, P9785, DOI 10.1021/bi00030a016; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; GOODRICH DW, 1990, P NATL ACAD SCI USA, V87, P2052, DOI 10.1073/pnas.87.6.2052; GU ZX, 1995, ANTIMICROB AGENTS CH, V39, P1888, DOI 10.1128/AAC.39.8.1888; Harrison GP, 1998, NUCLEIC ACIDS RES, V26, P3433, DOI 10.1093/nar/26.14.3433; HU WS, 1992, J VIROL, V66, P4457, DOI 10.1128/JVI.66.7.4457-4463.1992; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Hunter E, 1978, Curr Top Microbiol Immunol, V79, P295; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; KAWAI S, 1972, VIROLOGY, V49, P37, DOI 10.1016/S0042-6822(72)80005-9; KELLAM P, 1995, J VIROL, V69, P669, DOI 10.1128/JVI.69.2.669-674.1995; Kim JK, 1997, J BIOL CHEM, V272, P16769, DOI 10.1074/jbc.272.27.16769; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; LINIAL M, 1979, J VIROL, V31, P257, DOI 10.1128/JVI.31.1.257-260.1979; Lund AH, 1999, J VIROL, V73, P9614, DOI 10.1128/JVI.73.11.9614-9618.1999; LUO G, 1990, J VIROL, V64, P4321, DOI 10.1128/JVI.64.9.4321-4328.1990; Mikkelsen JG, 1998, J VIROL, V72, P6967, DOI 10.1128/JVI.72.9.6967-6978.1998; Mikkelsen JG, 1996, J VIROL, V70, P1439, DOI 10.1128/JVI.70.3.1439-1447.1996; Mikkelsen JG, 2000, J VIROL, V74, P600, DOI 10.1128/JVI.74.2.600-610.2000; Mujeeb A, 1998, NAT STRUCT BIOL, V5, P432, DOI 10.1038/nsb0698-432; MURIAUX D, 1995, J BIOL CHEM, V270, P8209, DOI 10.1074/jbc.270.14.8209; Negroni M, 2001, NAT REV MOL CELL BIO, V2, P151, DOI 10.1038/35052098; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paillart JC, 1996, J VIROL, V70, P8348, DOI 10.1128/JVI.70.12.8348-8354.1996; Palaniappan C, 1996, J BIOL CHEM, V271, P22331, DOI 10.1074/jbc.271.37.22331; PANGANIBAN AT, 1988, SCIENCE, V241, P1064, DOI 10.1126/science.2457948; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; REIN A, 1994, J VIROL, V68, P6124, DOI 10.1128/JVI.68.9.6124-6129.1994; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Salminen MO, 1997, J VIROL, V71, P2647, DOI 10.1128/JVI.71.4.2647-2655.1997; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; SCHWARTZBERG P, 1985, J VIROL, V53, P719, DOI 10.1128/JVI.53.3.719-726.1985; SKALKA AM, 1982, J CELL BIOCHEM, V19, P293, DOI 10.1002/jcb.240190311; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; STUHLMANN H, 1992, J VIROL, V66, P2378, DOI 10.1128/JVI.66.4.2378-2388.1992; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P14778, DOI 10.1021/bi971963m; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; VOGT PK, 1971, VIROLOGY, V46, P947, DOI 10.1016/0042-6822(71)90093-6; WAINHOBSON S, 1992, CURR TOP MICROBIOL, V176, P181; WEISS RA, 1973, VIROLOGY, V52, P535, DOI 10.1016/0042-6822(73)90349-8; Wooley DP, 1998, VIROLOGY, V243, P229, DOI 10.1006/viro.1998.9052; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; XU H, 1987, P NATL ACAD SCI USA, V84, P8553, DOI 10.1073/pnas.84.23.8553; Yu H, 1998, J BIOL CHEM, V273, P28384, DOI 10.1074/jbc.273.43.28384; Zhang JY, 2000, J VIROL, V74, P2313, DOI 10.1128/JVI.74.5.2313-2322.2000	74	70	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 28	2001	276	39					36482	36492		10.1074/jbc.M102860200	http://dx.doi.org/10.1074/jbc.M102860200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	475XF	11432862	hybrid			2022-12-27	WOS:000171194500059
J	Allegrin, S; Sealoni, A; Ferrara, L; Pesi, R; Pinna, P; Sgarrella, F; Camici, M; Eriksson, S; Tozzi, MG				Allegrin, S; Sealoni, A; Ferrara, L; Pesi, R; Pinna, P; Sgarrella, F; Camici, M; Eriksson, S; Tozzi, MG			Bovine cytosolic 5 '-nucleotidase acts through the formation of an aspartate 52-phosphoenzyme intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE PYRIMIDINE 5'-NUCLEOTIDASE; WOODWARDS-REAGENT-K; ESCHERICHIA-COLI; NUCLEOSIDE PHOSPHOTRANSFERASE; CLONING; CELLS; EXPRESSION; DEFICIENCY; MECHANISM; HISTIDINE	Cytosolic; 5'-nucleotidase/phosphotransferase (cN-II), specific for purine monophosphates and their deoxyderivatives, acts through the formation of a phosphoenzyme intermediate. Phosphate may either be released leading to 5'-mononucleotide hydrolysis or be transferred to an appropriate nucleoside acceptor, giving rise to a mononucleotide interconversion. Chemical reagents specifically modifying aspartate and glutamate residues inhibit the enzyme, and this inhibition is partially prevented by cN-II substrates and physiological inhibitors. Peptide mapping experiments with the phosphoenzyme previously treated with tritiated borohydride allowed isolation of a radiolabeled peptide. Sequence analysis demonstrated that radioactivity was associated with a hydroxymethyl derivative that resulted from reduction of the Asp-52-phosphate intermediate. Site-directed mutagenesis experiments confirmed the essential role of Asp-52 in the catalytic machinery of the enzyme and suggested also that Asp-54 assists in the formation of the acyl phosphate species. From sequence alignments we conclude that cytosolic 5'-nucleotidase, along with other nucleotidases, belong to a large superfamily of hydrolases with different substrate specificities and functional roles.	Univ Sassari, Dipartimento Sci Farmaco, I-07100 Sassari, Italy; Natl Lab Natl Inst Biostruct & Biosyst, Osilo, Sassari, Italy; Inst Ric Adattamento Bouini & Bufali Ambiente Mez, Ctr Serv Spettrometria Massa, I-80147 Naples, Italy; Univ Pisa, Dipartimento Fisiol & Biochim, I-56100 Pisa, Italy; Swedish Univ Agr Sci, Ctr Biomed, Dept Vet Med Chem, S-75123 Uppsala, Sweden	University of Sassari; University of Pisa; Swedish University of Agricultural Sciences	Tozzi, MG (corresponding author), Univ Sassari, Dipartimento Sci Farmaco, Via Muroni 23-A, I-07100 Sassari, Italy.		Tozzi, Maria Grazia/A-6018-2016; Pesi, Rossana/AAQ-3102-2020; Allegrini, Simone/F-9192-2010	Tozzi, Maria Grazia/0000-0002-1075-7096; Allegrini, Simone/0000-0002-7005-654X; Scaloni, Andrea/0000-0001-9362-8515; Pesi, Rossana/0000-0003-4785-7282				Allegrini S, 1997, BIOCHEM J, V328, P483, DOI 10.1042/bj3280483; Amici A, 2000, BLOOD, V96, P1596, DOI 10.1182/blood.V96.4.1596.h8001596_1596_1598; Amici A, 1997, FEBS LETT, V419, P263, DOI 10.1016/S0014-5793(97)01464-6; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Baiocchi C, 1996, BIOCHEM J, V317, P797, DOI 10.1042/bj3170797; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustos P, 1996, J PROTEIN CHEM, V15, P467, DOI 10.1007/BF01886854; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Collet JF, 1997, FEBS LETT, V408, P281, DOI 10.1016/S0014-5793(97)00438-9; DEGANI C, 1973, J BIOL CHEM, V248, P8222; EKICI AB, 1997, TECHNICAL TIPS ONLIN; HIRONO A, 1987, BRIT J HAEMATOL, V65, P35, DOI 10.1111/j.1365-2141.1987.tb06132.x; HOGLUND L, 1990, J BIOL CHEM, V265, P6589; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; ITOH R, 1992, COMP BIOCHEM PHYS B, V103, P153, DOI 10.1016/0305-0491(92)90427-S; KERESZTESSY Z, 1994, ARCH BIOCHEM BIOPHYS, V314, P142, DOI 10.1006/abbi.1994.1422; KOMMISAROV AA, 1995, J BIOL CHEM, V270, P10050; LLAMAS K, 1986, J AM CHEM SOC, V108, P5543, DOI 10.1021/ja00278a030; MARALIHALLI GB, 1993, J PROTEIN CHEM, V12, P451, DOI 10.1007/BF01025045; Marsich E, 2001, EUR J BIOCHEM, V268, P139, DOI 10.1046/j.1432-1327.2001.01860.x; Page T, 1997, P NATL ACAD SCI USA, V94, P11601, DOI 10.1073/pnas.94.21.11601; PESI R, 1994, ARCH BIOCHEM BIOPHYS, V312, P75, DOI 10.1006/abbi.1994.1282; Pesi R, 2000, NEUROREPORT, V11, P1827, DOI 10.1097/00001756-200006260-00006; Pirard M, 1997, FEBS LETT, V411, P251, DOI 10.1016/S0014-5793(97)00704-7; Rampazzo C, 2000, J BIOL CHEM, V275, P5409, DOI 10.1074/jbc.275.8.5409; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Sala-Newby GB, 1999, J BIOL CHEM, V274, P17789, DOI 10.1074/jbc.274.25.17789; SHINA U, 1985, ANAL BIOCHEM, V151, P327; TESORIERE G, 1984, BIOCHIM BIOPHYS ACTA, V786, P231, DOI 10.1016/0167-4838(84)90093-1; TOZZI MG, 1991, ARCH BIOCHEM BIOPHYS, V291, P212, DOI 10.1016/0003-9861(91)90125-3; VALENTINE WN, 1974, J CLIN INVEST, V54, P866, DOI 10.1172/JCI107826; VANDEKERCKHOVE J, 1993, METHODS IN PROTEIN SEQUENCE ANALYSIS, P11; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; WORKU Y, 1982, BIOCHEM J, V205, P503, DOI 10.1042/bj2050503; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	35	60	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33526	33532		10.1074/jbc.M104088200	http://dx.doi.org/10.1074/jbc.M104088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11432867	hybrid			2022-12-27	WOS:000170910200033
J	Sathyanarayanan, PV; Siems, WF; Jones, JP; Poovaiah, BW				Sathyanarayanan, PV; Siems, WF; Jones, JP; Poovaiah, BW			Calcium-stimulated autophosphorylation site of plant chimeric calcium/calmodulin-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING; STRUCTURAL BASIS; DOMAIN; PHOSPHORYLATION; INHIBITION; THREONINE; CDNA; IV; IDENTIFICATION; AUTOINHIBITION	The existence of two molecular switches regulating plant chimeric Ca2+/calmodulin-dependent protein kinase (CCaMK), namely the C-terminal visinin-like domain acting as Ca2+-sensitive molecular switch and calmodulin binding domain acting as Ca2+-stimulated autophosphorylation-sensitive molecular switch, has been described (Sathyanarayanan, P. V., Cremo, C. R., and Poovaiah, B. W. (2000) J. BioL Chem. 275, 30417-30422). Here we report the identification of Ca2+-stimulated autophosphorylation site of CCaMK by matrix-assisted laser desorption ionization time of flight-mass spectrometry. Thr(267) was confirmed as the Ca2+-stimulated autophosphorylation site by post-source decay experiments and by site-directed mutagenesis. The purified T267A mutant form of CCaMK did not show Ca2+-stimulated autophosphorylation, autophosphorylation-dependent variable calmodulin affinity, or Ca2+/calmodulin stimulation of kinase activity. Sequence comparison of CCaMK from monocotyledonous plant (lily) and dicotyledonous plant (tobacco) suggests that the autophosphorylation site is conserved. This is the first identification of a phosphorylation site specifically responding to activation by second messenger system (Ca2+ messenger system) in plants. Homology modeling of the kinase and calmodulin binding domain of CCaMK with the crystal structure of calcium/calmodulin-dependent protein kinase 1 suggests that the Ca2+-stimulated autophosphorylation site is located on the surface of the kinase and far from the catalytic site. Analysis of Ca2+-stimulated autophosphorylation with increasing concentration of CCaMK indicates the possibility that the Ca2+-stimulated phosphorylation occurs by an intermolecular mechanism.	Washington State Univ, Lab Plant Mol Biol & Physiol, Dept Hort, Pullman, WA 99164 USA; Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Poovaiah, BW (corresponding author), Washington State Univ, Lab Plant Mol Biol & Physiol, Dept Hort, Pullman, WA 99164 USA.	poovaiah@wsu.edu						Asara JM, 1999, J AM SOC MASS SPECTR, V10, P35, DOI 10.1016/S1044-0305(98)00129-9; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Bevington P. R., 1969, DATA REDUCTION ERROR, P56; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; CRUZALEGUI FH, 1993, J BIOL CHEM, V268, P26171; CRUZALEGUI FH, 1992, P NATL ACAD SCI USA, V89, P12127, DOI 10.1073/pnas.89.24.12127; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; GilleceCastro BL, 1996, METHOD ENZYMOL, V271, P427; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANLEY RM, 1988, BIOCHEM BIOPH RES CO, V152, P122, DOI 10.1016/S0006-291X(88)80688-0; HANLEY RM, 1989, NUCLEIC ACIDS RES, V17, P3992, DOI 10.1093/nar/17.10.3992; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES DA, 1991, FEBS LETT, V289, P105, DOI 10.1016/0014-5793(91)80919-T; KAMESHITA I, 1993, J BIOCHEM-TOKYO, V113, P583, DOI 10.1093/oxfordjournals.jbchem.a124087; KELLY PT, 1988, P NATL ACAD SCI USA, V85, P4991, DOI 10.1073/pnas.85.14.4991; Kussmann M, 1999, BIOCHEMISTRY-US, V38, P7780, DOI 10.1021/bi982888y; Liu ZH, 1998, PLANT MOL BIOL, V38, P889, DOI 10.1023/A:1006019001200; Lu YT, 1996, PLANTA, V199, P18; Neville DCA, 1997, PROTEIN SCI, V6, P2436; Pappin D J, 1997, Methods Mol Biol, V64, P165; PATIL S, 1995, P NATL ACAD SCI USA, V92, P4897, DOI 10.1073/pnas.92.11.4897; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; Poovaiah BW, 1999, PLANTA, V209, P161, DOI 10.1007/s004250050618; POOVAIAH BW, 1993, CRIT REV PLANT SCI, V12, P185, DOI 10.1080/713608046; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putney JW, 1998, SCIENCE, V279, P191, DOI 10.1126/science.279.5348.191; Ramachandiran S, 1997, J BIOCHEM-TOKYO, V121, P984; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sathyanarayanan PV, 2000, J BIOL CHEM, V275, P30417, DOI 10.1074/jbc.M000771200; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SMITH MK, 1992, J BIOL CHEM, V267, P1761; STULTS JT, 1995, CURR OPIN STRUC BIOL, V5, P691, DOI 10.1016/0959-440X(95)80063-8; Takezawa D, 1996, J BIOL CHEM, V271, P8126, DOI 10.1074/jbc.271.14.8126; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Vihinen H, 2000, J BIOL CHEM, V275, P27775; Wang Z, 1998, J NEUROCHEM, V71, P378; WATILLON B, 1993, PLANT PHYSIOL, V101, P1381, DOI 10.1104/pp.101.4.1381; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565	50	34	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32940	32947		10.1074/jbc.M009648200	http://dx.doi.org/10.1074/jbc.M009648200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11399751	hybrid			2022-12-27	WOS:000170746000076
J	Suetsugu, S; Miki, H; Takenawa, T				Suetsugu, S; Miki, H; Takenawa, T			Identification of another actin-related protein (Arp) 2/3 complex binding site in neural Wiskott-Aldrich syndrome protein (N-WASP) that complements actin polymerization induced by the Arp2/3 complex activating (VCA) domain of N-WASP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DEPOLYMERIZING PROTEIN; MICROSPIKE FORMATION; SHIGELLA-FLEXNERI; MOTILITY; NUCLEATION; CDC42; INDUCTION; LISTERIA; SIGNALS	Neural Wiskott-Aldrich syndrome protein (N-WASP) is an essential regulator of actin cytoskeleton formation via its association with the actin-related protein (Arp) 2/3 complex. It is believed that the C-terminal Arp2/3 complex-activating domain (verprolin homology, cofilin homology, and acidic (VCA) or C-terminal region of WASP family proteins domain) of N-WASP is usually kept masked (autoinhibition) but is opened upon cooperative binding of upstream regulators such as Cdc42 and phosphatidylinositol 4,5-bisphosphate (PIP2). However, the mechanisms of autoinhibition and association with Arp2/3 complex are still unclear. We focused on the acidic region of N-WASP because it is thought to interact with Arp2/3 complex and may be involved in autoinhibition. Partial deletion of acidic residues from the VCA portion alone greatly reduced actin polymerization activity, demonstrating that the acidic region contributes to Arp2/3 complex-mediated actin polymerization. Surprisingly, the same partial deletion of the acidic region in full-length N-WASP led to constitutive activity comparable with the activity seen with the VCA portion. Therefore, the acidic region in full-length N-WASP plays an indispensable role in the formation of the autoinhibited structure. This mutant contains WASP-homology (WH) I domain with weak affinity to the Arp2/3 complex, leading to activity in the absence of part of the acidic region. Furthermore, the actin comet formed by the DeltaW'H1 mutant of N-WASP was much smaller than that of wild-type N-WASP. Partial deletion of acidic residues did not affect actin comet size, indicating the importance of the WH1 domain in actin structure formation. Collectively, the acidic region of N-WASP plays an essential role in Arp2/3 complex activation as well as in the formation of the autoinhibited structure, whereas the WH1 domain complements the activation of the Arp2/3 complex achieved through the VCA portion.	Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Takenawa, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/ABB-6033-2020	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; 				Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Suetsugu S, 2001, BIOCHEM BIOPH RES CO, V282, P739, DOI 10.1006/bbrc.2001.4619; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Theriot JA, 1998, METHOD ENZYMOL, V298, P114, DOI 10.1016/S0076-6879(98)98013-2; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7	27	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33175	33180		10.1074/jbc.M102866200	http://dx.doi.org/10.1074/jbc.M102866200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11432863	hybrid			2022-12-27	WOS:000170746000104
J	Cocco, R; Stenberg, G; Dragani, B; Principe, DR; Paludi, D; Mannervik, B; Aceto, A				Cocco, R; Stenberg, G; Dragani, B; Principe, DR; Paludi, D; Mannervik, B; Aceto, A			The folding and stability of human alpha class glutathione transferase A1-1 depend on distinct roles of a conserved N-capping box and hydrophobic staple motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASE; TRANSITION-STATE; CHYMOTRYPSIN INHIBITOR-2; 3-DIMENSIONAL STRUCTURE; IDENTIFICATION; ISOENZYMES; RESIDUES; NUCLEUS; P1-1; MECHANISMS	An N-capping box and a hydrophobic staple motif are strictly conserved in the core of all known glutathione S-transferases (GST). In the present work, mutations of hGSTA1-1 enzyme residues forming these motifs have been generated. The analysis of S154A, D157A, and S154A/D157A capping mutants indicate that the removal of this local signal destabilizes the protein. The fact that the third helical residue D157A mutation (N-3) was much more destabilizing than the first helical residue S154A mutation (N-cap) suggests that the appropriate conformation of the conserved substructure formed by the alpha6-helix and preceding loop (GST motif II) is crucial for the overall protein stability. The refolding study of GSTAI-1 variants supports the prediction that this subdomain could represent a nucleation site of refolding. The analysis of L153A, I158A, L153G, and L153A/I158A hydrophobic staple mutants indicate that the removal of this motif destabilizes the GSTA1-1 structure as well as its refolding transition state. The hydrophobic staple interaction favors essential inter-domain contacts and, thereby, in contrast to capping interactions, accelerates the enzyme reactivation. Its strict conservation in the GST system supports the suggestion that this local signal could represent an evolutionarily conserved determinant for rapid folding.	Univ G DAnnunzio, Dipartimento Sci Biochim, I-66100 Chieti, Italy; Univ G DAnnunzio, Dipartimento Sci Farmaco, I-66100 Chieti, Italy; Uppsala Univ, Dept Biochem, Biomed Ctr, S-75123 Uppsala, Sweden	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Uppsala University	Aceto, A (corresponding author), Univ G DAnnunzio, Dipartimento Sci Biochim, Via Vestini 31, I-66100 Chieti, Italy.							ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; ACETO A, 1990, CARCINOGENESIS, V11, P2267, DOI 10.1093/carcin/11.12.2267; Aceto A, 1997, BIOCHEM J, V322, P229, DOI 10.1042/bj3220229; ACETO A, 1992, BIOCHEM J, V285, P241, DOI 10.1042/bj2850241; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; DANIELSON UH, 1985, BIOCHEM J, V231, P263, DOI 10.1042/bj2310263; Dragani B, 1997, J BIOL CHEM, V272, P25518, DOI 10.1074/jbc.272.41.25518; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Gustafsson A, 1999, J MOL BIOL, V288, P787, DOI 10.1006/jmbi.1999.2712; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11270, DOI 10.1021/bi00093a002; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MUNOZ V, 1995, BIOCHEMISTRY-US, V34, P15301, DOI 10.1021/bi00046a039; MUNOZ V, 1995, NAT STRUCT BIOL, V2, P380, DOI 10.1038/nsb0595-380; OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Ptitsyn OB, 1999, J MOL BIOL, V291, P671, DOI 10.1006/jmbi.1999.2920; Ptitsyn OB, 1996, FASEB J, V10, P3, DOI 10.1096/fasebj.10.1.8566544; Ptitsyn OB, 1998, J MOL BIOL, V278, P655, DOI 10.1006/jmbi.1997.1620; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Rossjohn J, 2000, J MOL BIOL, V302, P295, DOI 10.1006/jmbi.2000.4054; SEALE JW, 1994, PROTEIN SCI, V3, P1741, DOI 10.1002/pro.5560031014; Shakhnovich E, 1996, NATURE, V379, P96, DOI 10.1038/379096a0; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; Stenberg G, 2000, J BIOL CHEM, V275, P10421, DOI 10.1074/jbc.275.14.10421; STENBERG G, 1992, PROTEIN EXPRES PURIF, V3, P80, DOI 10.1016/1046-5928(92)90060-A; TAHIR MK, 1986, J BIOL CHEM, V261, P1048; WILCE MCJ, 1995, EMBO J, V14, P2133, DOI 10.1002/j.1460-2075.1995.tb07207.x	31	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32177	32183		10.1074/jbc.M104057200	http://dx.doi.org/10.1074/jbc.M104057200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423556	hybrid			2022-12-27	WOS:000170613500096
J	Fotinou, C; Emsley, P; Black, I; Ando, H; Ishida, H; Kiso, M; Sinha, KA; Fairweather, NF; Isaacs, NW				Fotinou, C; Emsley, P; Black, I; Ando, H; Ishida, H; Kiso, M; Sinha, KA; Fairweather, NF; Isaacs, NW			The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM NEUROTOXIN; CHOLERA-TOXIN; C FRAGMENT; BINDING; IDENTIFICATION; REFINEMENT; MEMBRANES; DOMAIN	Tetanus toxin, a member of the family of Clostridial neurotoxins, is one of the most potent toxins known. The crystal structure of the complex of the COOH-terminal fragment of the heavy chain with an analogue of its ganglioside receptor, GT1b, provides the first direct identification and characterization of the ganglioside-binding sites. The ganglioside induces cross-linking by binding to two distinct sites on the Hc molecule. The structure sheds new light on the binding of Clostridial neurotoxins to receptors on neuronal cells and provides important information relevant to the design of antitetanus and anti-botulism therapeutic agents.	Univ Glasgow, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; Gifu Univ, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AZ, England	University of Glasgow; Gifu University; Imperial College London	Isaacs, NW (corresponding author), Univ Glasgow, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland.	neil@chem.gla.ac.uk	Ando, Hiromune/J-8294-2017	Ando, Hiromune/0000-0002-0551-0830				ACQUOTTI D, 1991, CHEM PHYS LIPIDS, V59, P107, DOI 10.1016/0009-3084(91)90001-R; ANGSTROM J, 1994, P NATL ACAD SCI USA, V91, P11859, DOI 10.1073/pnas.91.25.11859; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKRY N, 1991, J PHARMACOL EXP THER, V258, P613; Bohne A, 1998, J MOL MODEL, V4, P33, DOI 10.1007/s008940050068; Emsley P, 2000, J BIOL CHEM, V275, P8889, DOI 10.1074/jbc.275.12.8889; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FIGUEIREDO D, 1995, INFECT IMMUN, V63, P3218, DOI 10.1128/IAI.63.8.3218-3221.1995; FISHMAN PH, 1982, J MEMBRANE BIOL, V69, P85, DOI 10.1007/BF01872268; HALPERN JL, 1993, J BIOL CHEM, V268, P11188; Halpern JL, 1995, CURR TOP MICROBIOL, V195, P221; Herreros J, 2000, BIOCHEM J, V347, P199, DOI 10.1042/0264-6021:3470199; Herreros J, 2000, J NEUROCHEM, V74, P1941, DOI 10.1046/j.1471-4159.2000.0741941.x; HERREROS J, 1999, COMPREHENSIVE SOURCE, P202; HOLMGREN J, 1980, EUR J BIOCHEM, V106, P371, DOI 10.1111/j.1432-1033.1980.tb04583.x; ISHIDA HK, 1994, TETRAHEDRON-ASYMMETR, V5, P2493, DOI 10.1016/S0957-4166(00)80396-1; Janshoff A, 1997, EUR BIOPHYS J BIOPHY, V26, P261, DOI 10.1007/s002490050079; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Kamata Y, 1997, TOXICON, V35, P1337, DOI 10.1016/S0041-0101(97)00027-5; Karlsson KA, 1998, ACTA BIOCHIM POL, V45, P429, DOI 10.18388/abp.1998_4237; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Kubota T, 1997, APPL ENVIRON MICROB, V63, P1214, DOI 10.1128/AEM.63.4.1214-1218.1997; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lalli G, 1999, J CELL SCI, V112, P2715; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li L, 1998, J NAT TOXINS, V7, P215; MERRITT EA, 1994, PROTEIN SCI, V3, P166; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; PIERCE EJ, 1986, BIOCHEM J, V236, P845, DOI 10.1042/bj2360845; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shapiro RE, 1997, J BIOL CHEM, V272, P30380, DOI 10.1074/jbc.272.48.30380; SIMPSON LL, 1971, J NEUROCHEM, V18, P1341, DOI 10.1111/j.1471-4159.1971.tb00235.x; Sinha K, 2000, MOL MICROBIOL, V37, P1041, DOI 10.1046/j.1365-2958.2000.02091.x; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; Sutton JM, 2001, FEBS LETT, V493, P45, DOI 10.1016/S0014-5793(01)02273-6; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Umland TC, 1997, NAT STRUCT BIOL, V4, P788, DOI 10.1038/nsb1097-788; VANHEYNI.WE, 1974, NATURE, V249, P415, DOI 10.1038/249415a0; VANHEYNINGEN W, 1961, J GEN MICROBIOL, V24, P107, DOI 10.1099/00221287-24-1-107; VELURAJA K, 1984, CARBOHYD POLYM, V4, P357, DOI 10.1016/0144-8617(84)90050-X; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Williamson LC, 1999, J BIOL CHEM, V274, P25173, DOI 10.1074/jbc.274.35.25173	52	145	156	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32274	32281		10.1074/jbc.M103285200	http://dx.doi.org/10.1074/jbc.M103285200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418600	hybrid			2022-12-27	WOS:000170613500108
J	Small, KM; Brown, KM; Forbes, SL; Liggett, SB				Small, KM; Brown, KM; Forbes, SL; Liggett, SB			Modification of the beta(2)-adrenergic receptor to engineer a receptor-effector complex for gene therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; CARDIAC-HYPERTROPHY; TRANSGENIC OVEREXPRESSION; DIFFERENTIALLY AFFECT; HEART; ACTIVATION; AGONIST; DESENSITIZATION; EXPRESSION; CELLS	Depressed G-protein-coupled receptor (GPCR) signaling has been implicated as a component of the pathophysiology of a number of complex diseases including heart failure and asthma, and augmentation or restoration of signaling by various means has been shown to improve organ function. Because some, properties of native GPCRs are disadvantageous for ectopic therapeutic expression, we utilized the beta (2)-adrenergic receptor (beta (2)AR) as a scaffold to construct a highly modified therapeutic receptor-effector complex (TREC) suitable for gene therapy. Altogether, 19 modifications were made to the receptor. The ligand-binding site was re-engineered in TM-3 so that a beta -hydroxylinethyl side chain acts as a proton donor for the binding of a novel ligand. In addition, sites critical for agonist-promoted down-regulation in the amino terminus and for phosphorylation by GPCR kinases, and protein kinases A and C, in the third intracellular loop and the carboxyl terminus of the receptor were altered. These modifications of the receptor resulted in depressed agonist-stimulated adenylyl cyclase activity (26.8 +/- 2.1 versus 41.4 +/- 8 pmol/min/mg for wild-type beta (2)AR). This was fully restored by fusing the carboxyl terminus of the modified receptor to G alpha (s) (43.3 +/- 2.7 pmol/min/mg). The fully modified fused receptor was not activated by beta -agonists but rather by a nonbiogenic amine agonist that itself failed to activate the wild-type beta (2)AR. This two-way selectivity thus provides targeted activation based on physiologic status. Furthermore, the TREC did not display tachyphylaxis to prolonged agonist exposure (desensitization was 1 +/- 5% versus 55 +/- 4% for wild-type beta (2)AR). Thus, despite extensive alterations in regions of conformational lability, the beta (2)AR can be tailored to have optimal signaling characteristics for gene therapy. As a general paradigm, TRECs for enhancement of other G-protein signaling appear to be feasible for modification of other pathologic states.	Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Pharmacol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Liggett, SB (corresponding author), 231 Albert Sabin Way,Rm G062, Cincinnati, OH 45267 USA.	stephen.liggett@uc.edu	liggett, stephen b/E-7453-2012	Liggett, Stephen B./0000-0002-0128-3669				Bristow MR, 1997, CARDIOVASC DRUG THER, V11, P291, DOI 10.1023/A:1007748131847; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Brodde OE, 1999, PHARMACOL REV, V51, P651; Choi DJ, 1999, CELL BIOCHEM BIOPHYS, V31, P321, DOI 10.1007/BF02738246; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Dorn GW, 2000, MOL PHARMACOL, V57, P278; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P6400, DOI 10.1073/pnas.96.11.6400; FORSAYETH JR, 1994, BIOTECHNIQUES, V17, P354; Freeman K, 2001, J CLIN INVEST, V107, P967, DOI 10.1172/JCI12083; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; GREEN SA, 1996, GENETICS ASTHMA, P67; GROVE A, 1995, BRIT J CLIN PHARMACO, V39, P109, DOI 10.1111/j.1365-2125.1995.tb04416.x; GROVE A, 1995, LANCET, V346, P201, DOI 10.1016/S0140-6736(95)91265-7; HADCOCK JR, 1992, J BIOL CHEM, V267, P4740; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HOSODA K, 1995, MOL PHARMACOL, V48, P206; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Larson JE, 2000, MOL GENET METAB, V71, P470, DOI 10.1006/mgme.2000.3087; Liggett SB, 2000, CIRCULATION, V101, P1707; Liggett SB, 1993, REGULATION CELLULAR, P71; Lohse MJ, 1996, BASIC RES CARDIOL, V91, P29, DOI 10.1007/BF00795359; McGraw DW, 1999, J BIOL CHEM, V274, P32241, DOI 10.1074/jbc.274.45.32241; McGraw DW, 2000, AM J PHYSIOL-LUNG C, V279, pL379, DOI 10.1152/ajplung.2000.279.2.L379; McGraw DW, 1998, LUNG BIOL HEALTH DIS, V115, P255; MCGRAW DW, 2001, IN PRESS AM J PHYSL; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Seifert R, 1999, TRENDS PHARMACOL SCI, V20, P383, DOI 10.1016/S0165-6147(99)01368-1; Shah AS, 2000, J THORAC CARDIOV SUR, V120, P581, DOI 10.1067/mtc.2000.107519; Shah AS, 2000, CIRCULATION, V101, P408, DOI 10.1161/01.CIR.101.4.408; Small KM, 2000, BIOCHEMISTRY-US, V39, P2815, DOI 10.1021/bi992497z; STRADER CD, 1991, J BIOL CHEM, V266, P5; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; TURKI J, 1995, AM J PHYSIOL-LUNG C, V269, pL709, DOI 10.1152/ajplung.1995.269.5.L709; Turki J, 1996, P NATL ACAD SCI USA, V93, P10483, DOI 10.1073/pnas.93.19.10483; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276	44	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31596	31601		10.1074/jbc.M102734200	http://dx.doi.org/10.1074/jbc.M102734200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11402033	hybrid			2022-12-27	WOS:000170613500019
J	Asano, S; Io, T; Kimura, T; Sakamoto, S; Takeguchi, N				Asano, S; Io, T; Kimura, T; Sakamoto, S; Takeguchi, N			Alanine-scanning mutagenesis of the sixth transmembrane segment of gastric H+,K+-ATPase alpha-subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SARCOPLASMIC-RETICULUM; FUNCTIONAL CONSEQUENCES; MEMBRANE TOPOLOGY; AMINO-ACIDS; MUTATIONAL ANALYSIS; BINDING SITE; H+-ATPASE; NA,K-ATPASE; H,K-ATPASE	The sixth transmembrane (M6) segment of the catalytic subunit plays an important role in the ion recognition and transport in the type II P-type ATPase families. In this study, we singly mutated all amino acid residues in the M6 segment of gastric H+,K+-ATPase a-subunit with alanine, expressed the mutants in HEK-293 cells, and studied the effects of the mutation on the functions of H+,K+-ATPase; overall K+-stimulated ATPase, phosphorylation, and dephosphorylation. Four mutants, L819A, D826A, I827A, and L833A, completely lost the K+-ATPase activity. Mutant L819A was phosphorylated but hardly dephosphorylated in the presence of K+, whereas mutants D826A, I827A, and L833A were not phosphorylated from ATP. We found that almost all of these amino acid residues, which are important for the function, are located on the same side of the a-helix of the M6 segment. In addition, we found that amino acids involved in the phosphorylation are located exclusively in the cytoplasmic half of the M6 segment and those involved in the K+-dependent dephosphorylation are in the luminal half. Several mutants such as I821A, L823A, T825A, and P829A partly retained the K+-ATPase activity accompanying the decrease in the rate of phosphorylation.	Mol Genet Res Ctr, Toyama 9300194, Japan; Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan	University of Toyama	Asano, S (corresponding author), Mol Genet Res Ctr, 2630 Sugitani, Toyama 9300194, Japan.	shinji@ms.toyama-mpu.ac.jp		Asano, Shinji/0000-0003-1443-8970				Ambesi A, 1996, J BIOL CHEM, V271, P22999, DOI 10.1074/jbc.271.38.22999; ANDERSEN JP, 1992, J BIOL CHEM, V267, P2767; Arguello JM, 1999, ARCH BIOCHEM BIOPHYS, V367, P341, DOI 10.1006/abbi.1999.1278; Asano S, 2000, J BIOCHEM, V127, P993, DOI 10.1093/oxfordjournals.jbchem.a022716; ASANO S, 1994, BIOCHEM J, V299, P59, DOI 10.1042/bj2990059; Asano S, 1997, J BIOL CHEM, V272, P17668, DOI 10.1074/jbc.272.28.17668; Asano S, 1996, J BIOL CHEM, V271, P2740, DOI 10.1074/jbc.271.5.2740; ASANO S, 1987, J BIOL CHEM, V262, P13263; BAMBERG K, 1994, J BIOL CHEM, V269, P16909; BAMBERG K, 1992, BIOCHIM BIOPHYS ACTA, V1131, P69, DOI 10.1016/0167-4781(92)90100-E; BESANCON M, 1993, BIOCHEMISTRY-US, V32, P2345, DOI 10.1021/bi00060a028; Besancon M, 1997, J BIOL CHEM, V272, P22438, DOI 10.1074/jbc.272.36.22438; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Dutra MB, 1998, J BIOL CHEM, V273, P17411, DOI 10.1074/jbc.273.28.17411; FENG JN, 1994, BIOCHEMISTRY-US, V33, P4218, DOI 10.1021/bi00180a015; Gatto C, 1999, J BIOL CHEM, V274, P13737, DOI 10.1074/jbc.274.20.13737; Hermsen HPH, 2000, BIOCHEMISTRY-US, V39, P1330, DOI 10.1021/bi991396y; Hermsen HPH, 1998, BIOCHEM J, V331, P465, DOI 10.1042/bj3310465; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambrecht N, 1998, J BIOL CHEM, V273, P13719, DOI 10.1074/jbc.273.22.13719; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; Melle-Milovanovic D, 1998, J BIOL CHEM, V273, P11075, DOI 10.1074/jbc.273.18.11075; Mense M, 2000, J BIOL CHEM, V275, P1749, DOI 10.1074/jbc.275.3.1749; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Morii M, 1996, J BIOL CHEM, V271, P4068; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; Swarts HGP, 1998, EMBO J, V17, P3029, DOI 10.1093/emboj/17.11.3029; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WALLMARK B, 1985, J BIOL CHEM, V260, P3681; Xie YH, 1996, J BIOL CHEM, V271, P2563, DOI 10.1074/jbc.271.5.2563; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X; Zhang ZS, 2000, BIOCHEMISTRY-US, V39, P8758, DOI 10.1021/bi000185m	38	23	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31265	31273		10.1074/jbc.M103698200	http://dx.doi.org/10.1074/jbc.M103698200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11397805	hybrid			2022-12-27	WOS:000170472900089
J	Zhou, TQ; Radaev, S; Rosen, BP; Gatti, DL				Zhou, TQ; Radaev, S; Rosen, BP; Gatti, DL			Conformational changes in four regions of the Escherichia coli ArsA ATPase link ATP hydrolysis to ion translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; ANION PUMP; ACTIVE CONFORMATIONS; SIGNAL-TRANSDUCTION; PHOSPHORYL TRANSFER; ARSENITE PUMP; PROTEIN; MECHANISM	Structures of ArsA with ATP, AMP-PNP, or ADP-AIF(3) bound at the A2 nucleotide binding site were determined. Binding of different nucleotides modifies the coordination sphere of Mg2+. In particular, the changes elicited by ADP.AIF(3),, provide insights into the mechanism of ATP hydrolysis. In-line attack by water onto the gamma -phosphate of ATP would be followed first by formation of a trigonal intermediate and then by breaking of the scissile bond between the beta- and gamma -phosphates. Motions of amino acid side chains at, the A2 nucleotide binding site during ATP binding and hydrolysis propagate at a distance, producing conformational changes in four different regions of the protein corresponding to helices H4-H5, helices H9-H10, helices H13-H15, and to the S1-H2-S2 region. These elements are extensions of, respectively, the. Switch I and Switch II regions, the A-loop (a small loop near the nucleotide adenine moiety), and the P-loop. Based on the observed conformational changes, it is proposed that ArsA functions as a reciprocating engine that hydrolyzes 2 mol of ATP per each cycle of ion translocation across the membrane.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University	Gatti, DL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	mimo@david.med.wayne.edu	Zhou, Tongqing/A-6880-2010	Zhou, Tongqing/0000-0002-3935-4637; Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055425, R37GM055425] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43918] Funding Source: Medline; NIGMS NIH HHS [GM55425] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN CM, 1986, J BIOL CHEM, V261, P5030; CHING MH, 1991, J BIOL CHEM, V266, P2327; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; DALE MP, 1987, BIOCHEMISTRY-US, V26, P8365, DOI 10.1021/bi00399a051; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Gatti D, 2000, J BIOL CHEM, V275, P34009, DOI 10.1074/jbc.R000012200; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; ISSARTEL JP, 1991, BIOCHEMISTRY-US, V30, P4726, DOI 10.1021/bi00233a013; Jang SB, 2000, BIOCHEMISTRY-US, V39, P14745, DOI 10.1021/bi001705g; KARKARIA CE, 1991, ARCH BIOCHEM BIOPHYS, V288, P107, DOI 10.1016/0003-9861(91)90170-N; KAUR P, 1994, BIOCHEMISTRY-US, V33, P6456, DOI 10.1021/bi00187a010; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuroda M, 1997, J BIOL CHEM, V272, P326; LINDQUIST RN, 1973, J AM CHEM SOC, V95, P8762, DOI 10.1021/ja00807a043; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramaswamy S, 1998, J BIOL CHEM, V273, P9243, DOI 10.1074/jbc.273.15.9243; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; Rosen BP, 1999, BBA-BIOMEMBRANES, V1461, P207, DOI 10.1016/S0005-2736(99)00159-5; ROSEN BP, 1988, J BIOL CHEM, V263, P3067; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P4766, DOI 10.1021/bi960026w; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schlichting I, 1997, BIOCHEMISTRY-US, V36, P9290, DOI 10.1021/bi970974c; Schlichting I, 1999, NAT STRUCT BIOL, V6, P721, DOI 10.1038/11485; SLEEP JA, 1980, J BIOL CHEM, V255, P4094; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Walmsley AR, 1999, J BIOL CHEM, V274, P16153, DOI 10.1074/jbc.274.23.16153; Walmsley AR, 2001, J BIOL CHEM, V276, P6378, DOI 10.1074/jbc.M008105200; WEBB MR, 1981, J BIOL CHEM, V256, P910; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Xu YW, 1997, P NATL ACAD SCI USA, V94, P3579, DOI 10.1073/pnas.94.8.3579; Zhou TQ, 1999, ACTA CRYSTALLOGR D, V55, P921, DOI 10.1107/S0907444999000256; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838; Zhou TQ, 1997, J BIOL CHEM, V272, P19731, DOI 10.1074/jbc.272.32.19731	45	36	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30414	30422		10.1074/jbc.M103671200	http://dx.doi.org/10.1074/jbc.M103671200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395509	hybrid			2022-12-27	WOS:000170558000106
J	Fridovich, I				Fridovich, I			Reflections of a fortunate biochemist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ESCHERICHIA-COLI-B; MANGANESE-CONTAINING ENZYME; SUPEROXIDE-DISMUTASE; LACTOBACILLUS-PLANTARUM; OXYGEN-TOXICITY; CYTOCHROME-C; PURIFICATION; INDUCTION; MECHANISM; OXIDATION		Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Fridovich, I (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.							AMABILECUEVAS CF, 1991, NUCLEIC ACIDS RES, V19, P4479, DOI 10.1093/nar/19.16.4479; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; ARCHIBALD FS, 1981, J BACTERIOL, V146, P928, DOI 10.1128/JB.146.3.928-936.1981; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; BROWN OR, 1983, FUND APPL TOXICOL, V3, P209, DOI 10.1016/S0272-0590(83)80127-4; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CLAIBORNE A, 1979, J BIOL CHEM, V254, P1664; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; FRIDOVIC.I, 1965, J BIOL CHEM, V240, P2491; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; FRIDOVICH I, 1963, J BIOL CHEM, V238, P3921; FRIDOVICH I, 1959, BIOCHIM BIOPHYS ACTA, V35, P546, DOI 10.1016/0006-3002(59)90409-3; FRIDOVICH I, 1956, J BIOL CHEM, V221, P323; FRIDOVICH I, 1962, J BIOL CHEM, V237, P584; FRIDOVICH I, 1963, J BIOL CHEM, V238, P592; FRIDOVICH I, 1965, BIOCHEMISTRY-US, V4, P1098, DOI 10.1021/bi00882a018; FRIDOVICH I, 1964, J BIOL CHEM, V239, P3519; FRIDOVICH I, 1962, J BIOL CHEM, V237, P916; FRIDOVICH I, 1958, J BIOL CHEM, V233, P1578; FRIDOVICH I, 1960, J BIOL CHEM, V235, P1835; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; GEORGE P, 1959, ENZYMES, V1, P347; GREENLEE L, 1962, BIOCHEMISTRY-US, V1, P779, DOI 10.1021/bi00911a008; GREGORY EM, 1973, J BACTERIOL, V114, P543, DOI 10.1128/JB.114.2.543-548.1973; GREGORY EM, 1973, J BACTERIOL, V114, P1193, DOI 10.1128/JB.114.3.1193-1197.1973; GREGORY EM, 1974, J BACTERIOL, V117, P166, DOI 10.1128/JB.117.1.166-169.1974; HASSAN HM, 1978, J BIOL CHEM, V253, P8143; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; HEIMBERG M, 1953, J BIOL CHEM, V204, P913; HORECKER BL, 1949, J BIOL CHEM, V178, P683; KEELE BB, 1970, J BIOL CHEM, V245, P6176; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; KIRBY TW, 1982, ANAL BIOCHEM, V127, P435, DOI 10.1016/0003-2697(82)90200-7; KLUG D, 1972, J BIOL CHEM, V247, P4839; KONO Y, 1983, J BACTERIOL, V155, P742, DOI 10.1128/JB.155.2.742-746.1983; KONO Y, 1983, J BIOL CHEM, V258, P6015; KUO CF, 1987, J BIOL CHEM, V262, P4724; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V252, P163, DOI 10.1016/0003-9861(87)90020-8; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V254, P547, DOI 10.1016/0003-9861(87)90136-6; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; MCCORD JM, 1970, J BIOL CHEM, V245, P1374; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024; NEECE MS, 1967, J BIOL CHEM, V242, P2939; NORRLIND B, 1973, J NUTR, V103, P1262, DOI 10.1093/jn/103.9.1262; RICHARDSON JS, 1975, P NATL ACAD SCI USA, V72, P1349, DOI 10.1073/pnas.72.4.1349; ROBERTSON P, 1981, ARCH BIOCHEM BIOPHYS, V207, P282, DOI 10.1016/0003-9861(81)90035-7; STEINMAN HM, 1974, J BIOL CHEM, V249, P7326; STEINMAN HM, 1973, P NATL ACAD SCI USA, V70, P3725, DOI 10.1073/pnas.70.12.3725; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; TOTTER JR, 1960, J BIOL CHEM, V235, P1839; WEISIGER RA, 1973, J BIOL CHEM, V248, P3582; WU J, 1991, J BACTERIOL, V173, P2864, DOI 10.1128/JB.173.9.2864-2871.1991; YOST FJ, 1973, J BIOL CHEM, V248, P4905	58	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					28629	28636		10.1074/jbc.R100040200	http://dx.doi.org/10.1074/jbc.R100040200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11399771	hybrid			2022-12-27	WOS:000170346000001
J	Vu, CCQ; Bortner, CD; Cidlowski, JA				Vu, CCQ; Bortner, CD; Cidlowski, JA			Differential involvement of initiator caspases in apoptotic volume decrease and potassium efflux during Fas- and UV-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS/FAS LIGAND INTERACTIONS; CYTOCHROME-C; ULTRAVIOLET-LIGHT; LYMPHOCYTE APOPTOSIS; GROWTH-FACTOR; K+ CHANNELS; ACTIVATION; INHIBITORS; SHRINKAGE; CASCADE	Caspase activation and apoptotic volume decrease are fundamental features of programmed cell death; however, the relationship between these components is not well understood. Here we provide biochemical and genetic evidence for the differential involvement of initiator caspases in the apoptotic volume decrease during both intrinsic and extrinsic activation of apoptosis. Apoptosis induction in Jurkat T lymphocytes by Fas receptor engagement (intrinsic) or ultraviolet (UV)-C radiation (extrinsic) triggered the loss of cell volume, which was restricted to cells with diminished intracellular K+ ions. These characteristics kinetically coincided with the proteolytic processing and activation of both initiator and effector caspases. Although the polycaspase inhibitor benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone completely inhibited the Fas-mediated apoptotic volume decrease and K+ efflux, it was much less effective in preventing these processes during UV-induced cell death under conditions whereby caspase activities and DNA degradation were blocked. To define the roles of specific initiator caspases, we utilized Jurkat cells genetically deficient in caspase-8 or stably transfected with a dominant-negative mutant of caspase-9. The results show that the activation of caspase-8, but not caspase-9, is necessary for Fas-induced apoptosis. Conversely, caspase-9, but not caspase-8, is important for UV-mediated shrunken morphology and apoptosis progression. Together, these findings indicate that cell shrinkage and K+ efflux during apoptosis are tightly coupled, but are differentially regulated by either caspase-8 or caspase-9 depending on specific pathways of cell death.	NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, 111 Alexander Dr, Res Triangle Pk, NC 27709 USA.		Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516				Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Avdonin V, 1998, P NATL ACAD SCI USA, V95, P11703, DOI 10.1073/pnas.95.20.11703; BEAUVAIS F, 1995, J LEUKOCYTE BIOL, V57, P851, DOI 10.1002/jlb.57.6.851; Benson RSP, 1996, AM J PHYSIOL-CELL PH, V270, pC1190, DOI 10.1152/ajpcell.1996.270.4.C1190; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bortner CD, 2000, METHOD ENZYMOL, V322, P421; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Bortner CD, 1999, J BIOL CHEM, V274, P21953, DOI 10.1074/jbc.274.31.21953; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Burg MB, 1996, FASEB J, V10, P1598, DOI 10.1096/fasebj.10.14.9002551; Caricchio R, 1998, J IMMUNOL, V161, P241; Chevaile A, 1998, CONTRIB NEPHROL, V123, P110, DOI 10.1159/000059924; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Corbet SW, 1999, ONCOGENE, V18, P1537, DOI 10.1038/sj.onc.1202436; Dallaporta B, 1998, J IMMUNOL, V160, P5605; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gomez-Angelats M, 2000, J BIOL CHEM, V275, P19609, DOI 10.1074/jbc.M909563199; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; King KL, 2000, CELL DEATH DIFFER, V7, P994, DOI 10.1038/sj.cdd.4400731; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Lang F, 1999, HERZ, V24, P232, DOI 10.1007/BF03044966; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; Moustakas A, 1998, CONTRIB NEPHROL, V123, P121, DOI 10.1159/000059925; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; Rehemtulla A, 1997, J BIOL CHEM, V272, P25783, DOI 10.1074/jbc.272.41.25783; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8; Schrantz N, 1999, ONCOGENE, V18, P3511, DOI 10.1038/sj.onc.1202718; Schwarz A, 1998, J IMMUNOL, V160, P4262; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Szabo I, 1996, J BIOL CHEM, V271, P20465, DOI 10.1074/jbc.271.34.20465; Thornberry NA, 2000, METHOD ENZYMOL, V322, P100; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Wang L, 1999, J BIOL CHEM, V274, P3678, DOI 10.1074/jbc.274.6.3678; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Wolf CM, 1997, EXP CELL RES, V230, P22, DOI 10.1006/excr.1996.3401; Wu JC, 1999, METHODS, V17, P320, DOI 10.1006/meth.1999.0746; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	59	75	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	2001	276	40					37602	37611		10.1074/jbc.M104810200	http://dx.doi.org/10.1074/jbc.M104810200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478YD	11431480	hybrid			2022-12-27	WOS:000171375700097
J	Ravindranath, RMH; Tam, WY; Bringas, P; Santos, V; Fincham, AG				Ravindranath, RMH; Tam, WY; Bringas, P; Santos, V; Fincham, AG			Amelogenin-cytokeratin 14 interaction in ameloblasts during enamel formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT PROTEINS; MOUSE TOOTH DEVELOPMENT; MATRIX PROTEINS; IMMUNOPATHOLOGIC FEATURES; MONOCLONAL-ANTIBODIES; EXPRESSION; RAT; EPITHELIA; SEQUENCE; KERATIN	The GMp motif is found in the N-terminal region of CK14, a differentiation marker for ameloblasts. The binding affinity of CK14 and amelogenin was confirmed by dosimetric binding of CK14 to recombinant amelogenin (rM179), and to the tyrosine-rich amelogenin polypeptide. The specific binding site for CK14 was identified in the amelogenin trityrosyl motif peptide (ATMP) of tyrosine-rich amelogenin polypeptide and specific interaction between CK14 and [H-3]ATMP was confirmed by Scatchard analysis. Blocking rM179 with GlcNAc, GMp, or CK14 with ATMP abrogates the CK14-amelogenin interaction. CK14 failed to bind to ATMP when the third proline was substituted with threonine, as in some cases of human X-linked amelogenesis imperfecta or when tyrosyl residues were substituted with phenylalanine. Morphometry of developing teeth distinguished three phases of enamel formation; growth initiation phase (days 0-1), prolific growth phase (days 1-7), and growth cessation phase (post-day 7). Confocal microscopy revealed co-assembly of CK14/amelogenin in the perinuclear region of ameloblasts on day 0, migration of the co-assembled CK14/amelogenin to the apical region of the ameloblasts from day 1, reaching a peak on days 3-5, and a collapse of the co-assembly. Autoradiography with [H-3]ATMP and [H-3]GMp corroborated the dissociation of the co-assembly at the ameloblast Tomes' process. It is proposed that CK14 play a chaperon role for nascent amelogenin polypeptide during amelogenesis.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Ravindranath, RMH (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St, Los Angeles, CA 90033 USA.				NIDCR NIH HHS [DE-03660] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AKITA H, 1992, ARCH ORAL BIOL, V37, P953, DOI 10.1016/0003-9969(92)90067-I; CARTAUD A, 1990, J CELL BIOL, V111, P581, DOI 10.1083/jcb.111.2.581; Collier PM, 1997, ARCH ORAL BIOL, V42, P235, DOI 10.1016/S0003-9969(96)00099-4; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; Domingues MG, 2000, EUR J ORAL SCI, V108, P43, DOI 10.1034/j.1600-0722.2000.00717.x; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; FINCHAM AG, 1983, BIOCHEM J, V211, P149, DOI 10.1042/bj2110149; FINCHAM AG, 1994, CALCIFIED TISSUE INT, V55, P398, DOI 10.1007/BF00299322; FINCHAM AG, 1998, CONNECT TISSUE RES, V38, P1; FLIEGNER KH, 1990, EMBO J, V9, P749, DOI 10.1002/j.1460-2075.1990.tb08169.x; FOISNER R, 1987, J MOL BIOL, V198, P515, DOI 10.1016/0022-2836(87)90297-X; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Foisner R, 1991, CURR OPIN CELL BIOL, V3, P75, DOI 10.1016/0955-0674(91)90168-X; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; KASPER M, 1989, DIFFERENTIATION, V40, P207, DOI 10.1111/j.1432-0436.1989.tb00600.x; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEENDERS GV, 2000, LAB INVEST, V80, P1251; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MEHREL T, 1990, CELL, V61, P1103, DOI 10.1016/0092-8674(90)90073-N; MERRIFIELD B, 1996, SCIENCE, V232, P341; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; NAKAMURA M, 1994, ANAT RECORD, V238, P383, DOI 10.1002/ar.1092380313; PERKINS W, 1992, J CUTAN PATHOL, V19, P476, DOI 10.1111/j.1600-0560.1992.tb01600.x; PETERS BP, 1979, BIOCHEMISTRY-US, V18, P5505, DOI 10.1021/bi00591a038; RAVINDRANATH MH, 1994, J IMMUNOL METHODS, V169, P257, DOI 10.1016/0022-1759(94)90270-4; RAVINDRANATH RMH, 1995, INVEST OPHTH VIS SCI, V36, P2482; Ravindranath RMH, 1999, J BIOL CHEM, V274, P2464, DOI 10.1074/jbc.274.4.2464; Ravindranath RMH, 1997, CURR EYE RES, V16, P1036, DOI 10.1076/ceyr.16.10.1036.9015; Ravindranath RMH, 2000, J BIOL CHEM, V275, P39654, DOI 10.1074/jbc.M006471200; RAVINDRANATH RMH, 1992, VIROLOGY, V188, P143, DOI 10.1016/0042-6822(92)90743-9; RAVINDRANATH RMH, 1990, J VIROL, V64, P5430, DOI 10.1128/JVI.64.11.5430-5440.1990; RESING KA, 1989, J BIOL CHEM, V264, P1837; ROBINSON C, 1977, CALC TISS RES, V23, P19, DOI 10.1007/BF02012762; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Tabata MJ, 1996, ARCH ORAL BIOL, V41, P1019, DOI 10.1016/S0003-9969(96)00087-8; TATEMOTO Y, 1988, VIRCHOWS ARCH A, V413, P341, DOI 10.1007/BF00783027; TERMINE JD, 1980, J BIOL CHEM, V255, P9769; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trivedi NS, 2000, PHOTOCHEM PHOTOBIOL, V71, P634, DOI 10.1562/0031-8655(2000)071<0634:QAOPLI>2.0.CO;2; VANMUIJEN GNP, 1986, EXP CELL RES, V162, P97, DOI 10.1016/0014-4827(86)90429-5; WICHE G, 1989, CRIT REV BIOCHEM MOL, V24, P41, DOI 10.3109/10409238909082551; YAMASHITA K, 1987, J BIOL CHEM, V262, P1602; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; ZeichnerDavid M, 1997, INT J DEV BIOL, V41, P27	50	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 28	2001	276	39					36586	36597		10.1074/jbc.M104656200	http://dx.doi.org/10.1074/jbc.M104656200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	475XF	11425863	hybrid			2022-12-27	WOS:000171194500072
J	Vaz, FM; Ofman, R; Westinga, K; Back, JW; Wanders, RJA				Vaz, FM; Ofman, R; Westinga, K; Back, JW; Wanders, RJA			Molecular and biochemical characterization of rat epsilon-N-Trimethyllysine hydroxylase, the first enzyme of carnitine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-BUTYROBETAINE HYDROXYLASE; BLUE-NATIVE-ELECTROPHORESIS; ACID BETA-OXIDATION; ZELLWEGER-SYNDROME; HUMAN-LIVER; PURIFICATION; FIBROBLASTS; PROTEINS; COA; DEHYDROGENASE	is an element of -N-Trimethyllysine hydroxylase (EC 1.14.11.8) is the first enzyme in the biosynthetic pathway Of L-carnitine and catalyzes the formation of beta -hydroxy-N-is an element of -trimethyllysine, from is an element of -N-trimethyllysine, a reaction dependent on alpha -ketoglutarate, Fe2+, and oxygen. We purified the enzyme from rat kidney and sequenced two internal peptides by quadrupole-time-of-flight mass spectroscopy. The peptide sequences were used to search the Expressed Sequence Tag data base, which led to the identification of a rat cDNA of 1218 base pairs encoding a polypeptide of 405 amino acids with a calculated molecular mass of 47.5 kDa. Using the rat sequence we also identified the homologous cDNAs from human and mouse. Heterologous expression of both the rat and human cDNAs in COS cells confirmed that they encode is an element of -N-trimethyllysine hydroxylase. Subeellular fractionation studies revealed that the rat enzyme is localized exclusively in mitochondria. Expression studies in yeast indicated that the rat enzyme is synthesized as a 47.5-kDa precursor and subsequently processed to a mature protein of 43 kDa, presumably upon import in mitochondria. The Michaelis-Menten constants of the purified rat enzyme for trimethyllysine, alpha -ketoglutarate, and Fe2+ were 1.1 mM, 109 muM, and 54 muM, respectively. Both gel filtration and blue native polyacrylamide gel electrophoresis analysis showed that the native enzyme has a mass of approximately 87 kDa, indicating that in rat is an element of -N-trimethyllysine hydroxylase is a homodimer.	Univ Amsterdam, Emma Childrens Hosp, Acad Med Ctr, Dept Clin Chem,Lab Genet Metab Dis, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Emma Childrens Hosp, Acad Med Ctr, Dept Pediat,Lab Genet Metab Dis, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Swammerdam Inst Life Sci, Mass Spectrometry Grp, NL-1018 TV Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam	Wanders, RJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, F0-224,POB 22700, NL-1100 DE Amsterdam, Netherlands.		B, Jw/N-7879-2019; Back, JW/B-3641-2009	B, Jw/0000-0002-1310-4373; Back, JW/0000-0002-1310-4373; Vaz, Frederic/0000-0002-9048-1041				BECKER D M, 1991, P182; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; ENGLARD S, 1979, FEBS LETT, V102, P297, DOI 10.1016/0014-5793(79)80022-8; ENGLARD S, 1978, ARCH BIOCHEM BIOPHYS, V190, P361, DOI 10.1016/0003-9861(78)90287-4; FRANZUSOFF A, 1991, P662; HULSE JD, 1978, J BIOL CHEM, V253, P1654; HULSE JD, 1980, J BIOL CHEM, V255, P1146; JAKOBS BS, 1995, BIOCHEM BIOPH RES CO, V213, P1035, DOI 10.1006/bbrc.1995.2232; Jansen GA, 2000, HUM MOL GENET, V9, P1195, DOI 10.1093/hmg/9.8.1195; KAUFMAN RA, 1977, J BIOL CHEM, V252, P7437; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; KONDO A, 1981, ARCH BIOCHEM BIOPHYS, V212, P338, DOI 10.1016/0003-9861(81)90374-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDSTEDT G, 1970, J BIOL CHEM, V245, P4178; LINDSTEDT G, 1982, SCAND J CLIN LAB INV, V42, P477; LINDSTEDT G, 1977, BIOCHEMISTRY-US, V16, P2181, DOI 10.1021/bi00629a022; LINDSTEDT S, 1984, BIOCHEM J, V223, P119, DOI 10.1042/bj2230119; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; RABILLOUD T, 1988, ELECTROPHORESIS, V9, P288, DOI 10.1002/elps.1150090608; REBOUCHE CJ, 1982, FED PROC, V41, P2848; REBOUCHE CJ, 1980, J BIOL CHEM, V255, P8700; REBOUCHE CJ, 1980, BIOCHIM BIOPHYS ACTA, V630, P22, DOI 10.1016/0304-4165(80)90133-6; SACHAN DS, 1980, BIOCHEM BIOPH RES CO, V96, P870, DOI 10.1016/0006-291X(80)91436-9; SACHAN DS, 1980, BIOCHEM J, V188, P529, DOI 10.1042/bj1880529; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STEIN R, 1981, ANAL BIOCHEM, V116, P230, DOI 10.1016/0003-2697(81)90349-3; STEIN R, 1982, ARCH BIOCHEM BIOPHYS, V217, P324, DOI 10.1016/0003-9861(82)90508-2; Vaz FM, 1998, BIOCHEM BIOPH RES CO, V250, P506, DOI 10.1006/bbrc.1998.9343; Vaz FM, 2000, J BIOL CHEM, V275, P7390, DOI 10.1074/jbc.275.10.7390; Vaz FM, 1999, ADV EXP MED BIOL, V466, P117; Verhoeven NM, 1998, J LIPID RES, V39, P66; WANDERS RJA, 1984, BIOCHEM BIOPH RES CO, V123, P1054, DOI 10.1016/S0006-291X(84)80240-5; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; WANDERS RJA, 1986, CLIN CHIM ACTA, V159, P1, DOI 10.1016/0009-8981(86)90160-9; WANDERS RJA, 1994, BBA-MOL BASIS DIS, V1227, P177, DOI 10.1016/0925-4439(94)90092-2	38	46	49	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33512	33517		10.1074/jbc.M105929200	http://dx.doi.org/10.1074/jbc.M105929200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11431483	hybrid			2022-12-27	WOS:000170910200031
J	Ziebuhr, J; Thiel, V; Gorbalenya, AE				Ziebuhr, J; Thiel, V; Gorbalenya, AE			The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTIOUS-BRONCHITIS VIRUS; MULTIPLE SEQUENCE ALIGNMENT; EQUINE ARTERITIS VIRUS; MURINE CORONAVIRUS; CYSTEINE PROTEINASE; PROTEOLYTIC PRODUCTS; ENCODED PROTEINASES; 3C-LIKE PROTEINASE; STRAIN A59; IDENTIFICATION	The largest replicative protein of coronaviruses is known as p195 in the avian infectious bronchitis virus (IBV) and p210 (p240) in the mouse hepatitis virus. It is autocatalytically released from the precursors pp1a and pp1ab by one zinc finger-containing papain-like protease (PLpro) in IBV and by two paralogous PLpros, PL1pro and PL2pro, in mouse hepatitis virus. The PL-pro-containing proteins have been recently implicated in the control of coronavirus subgenomic mRNA synthesis (transcription). By using comparative sequence analysis, we now show that the respective proteins of all sequenced coronaviruses are flanked by two conserved PLpro cleavage sites and share a complex (multi)domain organization with PL1pro being inactivated in IBV. Based upon these predictions, the processing of the human coronavirus 229E p195/p210 N terminus was studied in detail. First, an 87-kDa protein (p87), which is derived from a pp1a/pp1ab region immediately upstream of p195/p210, was identified in human coronavirus 229E-infected cells. Second, in vitro synthesized proteins representing different parts of pp1a were autocatalytically processed at the predicted site. Surprisingly, both PL1pro and PL2pro cleaved between p87 and p195/p210. The PL1pro-mediated cleavage was slow and significantly suppressed by a non-proteolytic activity of PL2pro. In contrast, PL2pro, whose proteolytic activity and specificity were established in this study, cleaved the same site efficiently in the presence of the upstream domains. Third, a correlation was observed between the overlapping substrate specificities and the parallel evolution of PL1pro and PL2pro. Collectively, our results imply that the p195/p210 autoprocessing mechanisms may be conserved among coronaviruses to an extent not appreciated previously, with PL2pro playing a major role. A large subset of coronaviruses may employ two proteases to cleave the same site(s) and thus regulate the expression of the viral genome in a unique way.	NCI, Frederick Canc Res & Dev Ctr, SAIC, Adv Biomed Comp Ctr, Frederick, MD 21702 USA; Univ Wurzburg, Inst Immunol & Virol, D-97078 Wurzburg, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Wurzburg	Ziebuhr, J (corresponding author), NCI, Frederick Canc Res & Dev Ctr, SAIC, Adv Biomed Comp Ctr, 430 Miller Dr,Rm 228, Frederick, MD 21702 USA.		Thiel, Volker/AAI-2391-2019; Gorbalenya, Alexander E/J-4818-2012; Ziebuhr, John/G-7669-2015	Gorbalenya, Alexander E/0000-0002-4967-7341; Thiel, Volker/0000-0002-5783-0887; Ziebuhr, John/0000-0002-5741-8825	OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-56000] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAKER SC, 1989, J VIROL, V63, P3693, DOI 10.1128/JVI.63.9.3693-3699.1989; BAKER SC, 1993, J VIROL, V67, P6056, DOI 10.1128/JVI.67.10.6056-6063.1993; Bi WZ, 1998, J NEUROVIROL, V4, P594, DOI 10.3109/13550289809114226; BONILLA PJ, 1995, VIROLOGY, V209, P489, DOI 10.1006/viro.1995.1281; BONILLA PJ, 1994, VIROLOGY, V198, P736, DOI 10.1006/viro.1994.1088; Bonilla PJ, 1997, J VIROL, V71, P900, DOI 10.1128/JVI.71.2.900-909.1997; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; Cavanagh D, 1997, ARCH VIROL, V142, P629; DENBOON JA, 1991, J VIROL, V65, P2910, DOI 10.1128/JVI.65.6.2910-2920.1991; DENISON M, 1987, VIROLOGY, V157, P565, DOI 10.1016/0042-6822(87)90303-5; DENISON MR, 1995, VIROLOGY, V207, P316, DOI 10.1006/viro.1995.1085; DONG SH, 1994, VIROLOGY, V204, P541, DOI 10.1006/viro.1994.1567; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Gorbalenya A.E., 1993, SOV SCI REV D, V11, P1; GORBALENYA AE, 1991, FEBS LETT, V288, P201, DOI 10.1016/0014-5793(91)81034-6; Gorbalenya AE, 1996, PERSPECT DRUG DISCOV, V6, P64, DOI 10.1007/BF02174046; Grotzinger C, 1996, VIROLOGY, V222, P227, DOI 10.1006/viro.1996.0413; HENIKOFF S, 1994, J MOL BIOL, V243, P574, DOI 10.1016/0022-2836(94)90032-9; Herold J, 1996, METHOD ENZYMOL, V275, P68; Herold J, 1998, J VIROL, V72, P910, DOI 10.1128/JVI.72.2.910-918.1998; HEROLD J, 1993, VIROLOGY, V195, P680, DOI 10.1006/viro.1993.1419; Herold J, 1999, J BIOL CHEM, V274, P14918, DOI 10.1074/jbc.274.21.14918; HUGHES SA, 1995, J VIROL, V69, P809, DOI 10.1128/JVI.69.2.809-813.1995; Kanjanahaluethai A, 2000, J VIROL, V74, P7911, DOI 10.1128/JVI.74.17.7911-7921.2000; Kimura M., 1983, NEUTRAL THEORY MOL E, P367, DOI [10.1017/CBO9780511623486, DOI 10.1139/cjz-2013-0127]; KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LASTARZA MW, 1994, J VIROL, V68, P5781, DOI 10.1128/JVI.68.9.5781-5791.1994; LEE HJ, 1991, VIROLOGY, V180, P567, DOI 10.1016/0042-6822(91)90071-I; Lim KP, 1998, VIROLOGY, V245, P303, DOI 10.1006/viro.1998.9164; Lim KP, 2000, J VIROL, V74, P1674, DOI 10.1128/JVI.74.4.1674-1685.2000; Molenkamp R, 2000, J GEN VIROL, V81, P2491, DOI 10.1099/0022-1317-81-10-2491; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; ROST B, 1995, PROTEIN SCI, V4, P521; Rost B, 1996, METHOD ENZYMOL, V266, P525; Ryan MD, 1997, J GEN VIROL, V78, P699, DOI 10.1099/0022-1317-78-4-699; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schiller JJ, 1998, VIROLOGY, V242, P288, DOI 10.1006/viro.1997.9010; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Seybert A, 2000, J VIROL, V74, P9586, DOI 10.1128/JVI.74.20.9586-9593.2000; Seybert A, 2000, RNA, V6, P1056, DOI 10.1017/S1355838200000728; Siddell SG., 1995, CORONAVIRIDAE INTRO, DOI [10.1007/978-1-4899-1531-3, DOI 10.1007/978-1-4899-1531-3]; SWOFFORD DL, 2000, PAUP PHYLOGENETIC AN; Teng H, 1999, J VIROL, V73, P2658, DOI 10.1128/JVI.73.4.2658-2666.1999; Thiel V, 2001, J GEN VIROL, V82, P1273, DOI 10.1099/0022-1317-82-6-1273; Thiel V, 2001, J VIROL, V75, P6676, DOI 10.1128/JVI.75.14.6676-6681.2001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijms MA, 2001, P NATL ACAD SCI USA, V98, P1889, DOI 10.1073/pnas.041390398; Yao Z, 1992, PCR Methods Appl, V1, P205; Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853; ZIEBUHR J, 1995, J VIROL, V69, P4331, DOI 10.1128/JVI.69.7.4331-4338.1995; Ziebuhr J, 1999, J VIROL, V73, P177, DOI 10.1128/JVI.73.1.177-185.1999	56	115	127	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33220	33232		10.1074/jbc.M104097200	http://dx.doi.org/10.1074/jbc.M104097200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11431476	hybrid, Green Published			2022-12-27	WOS:000170746000108
J	Faour, WH; He, YL; He, QW; de Ladurantaye, M; Quintero, M; Mancini, A; Di Battista, JA				Faour, WH; He, YL; He, QW; de Ladurantaye, M; Quintero, M; Mancini, A; Di Battista, JA			Prostaglandin E-2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ENDOPEROXIDE SYNTHASE; ENDOTHELIAL-CELLS; MAP KINASE; INDUCTION; LIPOPOLYSACCHARIDE; PHOSPHORYLATION	The p38 MAPK mediates transcriptional and posttranscriptional control of cyclooxygenase-2 (COX-2) mRNA following interleukin-1(IL-1)/lipopolysaccharide cellular activation. We explored a positive feedback, prostaglandin E-2 (PGE(2))-dependent stabilization of COX-2 mRNA mediated by the p38 MAPK cascade in IL-1 beta -stimulated human synovial fibroblasts. We observed a rapid (5 min), massive (> 30-fold), and sustained (> 48 h) increase in COX-2 mRNA, protein, and PGE, release following a recombinant human (rh) IL-1 beta signal that was inhibited by NS-398, a COX-2 inhibitor, and SB202190, a selective, cell-permeable p38 MAPK inhibitor. PGE(2) completely reversed NS-398-mediated inhibition but not SB202190-dependent inhibition. The eicosanoid didn't potentiate IL-1 beta -induced COX-2 expression nor did it activate COX-2 gene expression in quiescent cells. Transfection experiments with a human COX-2 promoter construct revealed a minor element of p38 MAPK-dependent transcriptional control after IL-1 beta stimulation. p38 MAPK synergized with the cAMP/cAMP-dependent protein kinase cascade to transactivate the COX-2 promoter. When human synovial fibroblasts were activated with rhIL-1 beta for 3-4 h (steady state) followed by washout, the elevated levels of COX-2 mRNA declined rapidly (<2 h) to control levels. If PGE(2), unlike EP2/3 agonists butaprost and sulprostone, was added to fresh medium, COX-2 mRNA levels remained elevated for up to 16 h. SB202190 or anti-PGE(2) monoclonal antibody compromised the stabilization of COX-2 mRNA by PGE2. Deletion analysis using transfected chimeric luciferase-COX-2 mRNA 3 ' -untranslated region reporter constructs revealed that IL-1 beta increased reporter gene MIRNA stability and translation via AU-containing distal regions of the untranslated region. This response was mediated entirely by a PGE(2)/p38 MAPK-dependent process. We conclude that the magnitude and duration of the induct-ion of COX-2 mRNA, protein, and PGE(2) release by rhIL-1 beta is primarily the result of PGE(2) -dependent stabilization of COX-2 mRNA and stimulation of translation, a process involving a positive feedback loop mediated by the EP4 receptor and the downstream kinases p38 MAPK and, perhaps, cAMP-dependent protein kinase.	Univ Montreal, Ctr Hosp, Unit Rech Arthrose, Hop Notre Dame, Montreal, PQ H2L 4M1, Canada; Univ Los Andes, Dept Med, Rheumatol Unit, Merida, Venezuela	Universite de Montreal; University of Los Andes Venezuela	Di Battista, JA (corresponding author), Univ Montreal, Ctr Hosp, Unit Rech Arthrose, Hop Notre Dame, 1560 Rue Sherbrooke Est, Montreal, PQ H2L 4M1, Canada.		faour, wissam/J-3419-2019	faour, wissam/0000-0002-0746-3687				Akarasereenont P, 1999, MEDIAT INFLAMM, V8, P287, DOI 10.1080/09629359990298; Alaaeddine N, 1997, J RHEUMATOL, V24, P1985; Alaaeddine N, 1999, ARTHRITIS RHEUM-US, V42, P710, DOI 10.1002/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO;2-4; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Callejas NA, 1999, J PHARMACOL EXP THER, V288, P1235; Clerk A, 1998, FEBS LETT, V426, P93, DOI 10.1016/S0014-5793(98)00324-X; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; DEWITT DL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P121, DOI 10.1016/0005-2760(91)90032-D; Di Battista JA, 1999, ARTHRITIS RHEUM, V42, P157, DOI 10.1002/1529-0131(199901)42:1<157::AID-ANR19>3.0.CO;2-P; DiBattista JA, 1996, J CELL BIOCHEM, V63, P320; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Eder J, 1997, TRENDS PHARMACOL SCI, V18, P319, DOI 10.1016/S0165-6147(97)01097-3; Fahmi H, 2001, OSTEOARTHR CARTILAGE, V9, P332, DOI 10.1053/joca.2000.0393; FAOUR W, 2000, P 5 WORLD C OST BARC, pS10; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Geng Y, 1996, J CLIN INVEST, V98, P2425, DOI 10.1172/JCI119056; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Gou Q, 1998, BIOCHEM BIOPH RES CO, V242, P508, DOI 10.1006/bbrc.1997.7994; Guan ZH, 1998, J BIOL CHEM, V273, P12901, DOI 10.1074/jbc.273.21.12901; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; HE W, 2001, IN PRESS ARTHRITIS R; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; JONES DA, 1993, J BIOL CHEM, V268, P9049; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; KRUYS VI, 1988, GENE, V72, P191, DOI 10.1016/0378-1119(88)90144-8; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Martel-Pelletier J, 1999, OSTEOARTHRITIS CLIN, P156, DOI DOI 10.1007/978-3-642-60026-5_9; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; MORIN N, 1999, OSTEOARTHR CARTILAGE, V7, pS21; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064; Newton R, 1997, BIOCHEM BIOPH RES CO, V234, P85, DOI 10.1006/bbrc.1997.6586; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; OLIW EH, 1986, J BIOL CHEM, V261, P9216; OLIW EH, 1989, BIOCHIM BIOPHYS ACTA, V1001, P107, DOI 10.1016/0005-2760(89)90313-5; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Proudfoot N, 1996, CELL, V87, P779, DOI 10.1016/S0092-8674(00)81982-0; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Ridley SH, 1998, FEBS LETT, V439, P75, DOI 10.1016/S0014-5793(98)01342-8; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Robertson RP, 1995, TRENDS ENDOCRIN MET, V6, P293, DOI 10.1016/1043-2760(95)00159-X; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; RYSECK RP, 1992, CELL GROWTH DIFFER, V3, P443; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; WANG CY, 1998, SCIENCE, V274, P786; WANG LH, 1993, BIOCHEM BIOPH RES CO, V190, P406, DOI 10.1006/bbrc.1993.1062; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Wu KK, 1996, J LAB CLIN MED, V128, P242, DOI 10.1016/S0022-2143(96)90023-2; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	66	186	189	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31720	31731		10.1074/jbc.M104036200	http://dx.doi.org/10.1074/jbc.M104036200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423555	hybrid			2022-12-27	WOS:000170613500035
J	Lu, WP; Kincaid, E; Sun, YP; Bauer, MD				Lu, WP; Kincaid, E; Sun, YP; Bauer, MD			Kinetics of beta-lactam interactions with penicillin-susceptible and -resistant penicillin-binding protein 2x proteins from Streptococcus pneumoniae - Involvement of acylation and deacylation in beta-lactam resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION-MASS-SPECTROMETRY; STAPHYLOCOCCUS-AUREUS; ACTIVE-SITE; ANTIBIOTICS; TRANSPEPTIDASE; CONSTANTS; MECHANISM; BACTERIA; GENES; MITIS	Kinetic interactions of beta -lactam antibiotics such as penicillin-G and cefotaxime with normal, penicillin-susceptible PBP2x from Streptococcus pneumoniae and a penicillin-resistant PBP2x (PBP2x(R)) from a resistant clinical isolate (CS109) of the bacterium have been extensively characterized using electrospray mass spectrometry coupled with a fast reaction (quench flow) technique. Kinetic evidence for a two-step acylation of PBP2x by penicillin-G has been demonstrated, and the dissociation constant, K-d of 0.9 mM, and the acylation rate constant, k(2) of 180 s(-1), have been determined for the first time. The millimolar range K-d implies that the beta -lactam fits to the active site pocket of the penicillin-sensitive PEP rather poorly, whereas the extremely fast k(2) value indicates that this step contributes most of the binding affinity of the beta -lactam. The values of K-d (4 mM) and k(2) (0.56 s(-1)) were also determined for PBP2x(R). The combined value of k(2)/K-d, known as overall binding efficiency, for PBP2xR (137 M-1 s(-1)) was over 1000-fold slower than that for PBP2x (200,000 M-1 s(-1)), indicating that a major part is played by the acylation steps in penicillin resistance. Most of the decreased binding efficiency of PBP2xR comes from the decreased (similar to 300-fold) k(2) Kinetic studies of cefotaxime acylation of the two PBP2x proteins confirmed all of the above findings. Deacylation rate constants (k(3)) for the third step of the interact-ions were determined to be 8 x 10(-6) s(-1) for penicilloyl-PBP2x and 5.7 x 10(-4) s(-1) for penicilloyl-PBP2x(R), corresponding to over 70-fold increase of the deacylation rate for the resistant PBP2xR. Similarly, over 80-fold enhancement of the deacylation rate was found for cefotaxime-PBP2x(R) complex (k(3) = 3 x 10(-4) s(-1)) as compared with that of cefotaxime-PBP2x complex (3.5 x 10-6 s(-1)). This is the first time that such a significant increase of k(3) values was found for a beta -lactsm-resistant penicillin-binding protein. These data indicate that the deacylation step also plays a role, which is much more important than previously thought, in PBP2x(R) resistance to beta -lactams.	Procter & Gamble Pharmaceut, Hlth Care Res Ctr, Antiinfect Res, Mason, OH 45040 USA; Procter & Gamble Co, Miami Valley Labs, Corp Res Div, Cincinnati, OH 45253 USA	Procter & Gamble; Procter & Gamble	Lu, WP (corresponding author), Procter & Gamble Pharmaceut, Hlth Care Res Ctr, Antiinfect Res, Mason, OH 45040 USA.							[Anonymous], 1992, CHEM B LACTAMS; Asahi Y, 1999, ANTIMICROB AGENTS CH, V43, P1252, DOI 10.1128/AAC.43.5.1252; Beadle BM, 2001, PROTEIN SCI, V10, P1254, DOI 10.1110/ps.52001; BLUMBERG PM, 1971, P NATL ACAD SCI USA, V68, P2814, DOI 10.1073/pnas.68.11.2814; CHAMBERS HF, 1994, BIOCHEM J, V301, P139, DOI 10.1042/bj3010139; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; COFFEY TJ, 1995, ANTIMICROB AGENTS CH, V39, P1306, DOI 10.1128/AAC.39.6.1306; COYETTE J, 1994, ADV COMP ENV PHYSL, V20, P233; Di Guilmi AM, 2000, ANAL BIOCHEM, V284, P240, DOI 10.1006/abio.2000.4735; DOWSON CG, 1989, MOL MICROBIOL, V3, P95, DOI 10.1111/j.1365-2958.1989.tb00108.x; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; ELKHARROUBI A, 1991, BIOCHEM J, V280, P463, DOI 10.1042/bj2800463; FRERE JM, 1975, EUR J BIOCHEM, V57, P343, DOI 10.1111/j.1432-1033.1975.tb02307.x; FRESHT A, 1984, ENZYME STRUCTURE MEC, P152; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; GHUYSEN JM, 1986, BIOCHEM J, V235, P159, DOI 10.1042/bj2350159; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Grebe T, 1996, ANTIMICROB AGENTS CH, V40, P829, DOI 10.1128/AAC.40.4.829; Hakenbeck R, 1998, J BACTERIOL, V180, P1831, DOI 10.1128/JB.180.7.1831-1840.1998; JAMIN M, 1993, BIOCHEM J, V292, P735, DOI 10.1042/bj2920735; KELL CM, 1993, FEMS MICROBIOL LETT, V106, P171; LABILE G, 1991, MOL MICROBIOL, V5, P1993; LAIBLE G, 1992, EUR J BIOCHEM, V207, P943, DOI 10.1111/j.1432-1033.1992.tb17128.x; LU WP, 1990, J BIOL CHEM, V265, P3124; Lu WP, 1999, BIOCHEMISTRY-US, V38, P6537, DOI 10.1021/bi990025e; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Mouz N, 1999, J BIOL CHEM, V274, P19175, DOI 10.1074/jbc.274.27.19175; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Potgieter E, 1995, MICROB DRUG RESIST, V1, P35, DOI 10.1089/mdr.1995.1.35; Sambrook J., 2002, MOL CLONING LAB MANU; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; SPRATT BG, 1994, BACTERIAL CELL WALL, P517; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; Zechel DL, 1998, BIOCHEMISTRY-US, V37, P7664, DOI 10.1021/bi980445o; Zhao GS, 1997, J BACTERIOL, V179, P4901, DOI 10.1128/jb.179.15.4901-4908.1997	37	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31494	31501		10.1074/jbc.M102499200	http://dx.doi.org/10.1074/jbc.M102499200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11408478	hybrid			2022-12-27	WOS:000170613500005
J	Grothe, T; Lenz, R; Kutchan, TM				Grothe, T; Lenz, R; Kutchan, TM			Molecular characterization of the salutaridinol 7-O-acetyltransferase involved in morphine biosynthesis in opium poppy Papaver somniferum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BERBERINE BRIDGE ENZYME; HETEROLOGOUS EXPRESSION; FUNCTIONAL EXPRESSION; CELL-CULTURES; STRICTOSIDINE SYNTHASE; VINDOLINE BIOSYNTHESIS; O-ACETYLTRANSFERASE; CODEINONE REDUCTASE; TRANSFERASE CDNA; CLONING	Salutaridinol 7-O-acetyltransferase (EC 2.3.1.150) catalyzes the conversion of the phenanthrene alkaloid salutaridinol to salutaridinol-7-O-acetate, the immediate precursor of thebaine along the morphine biosynthetic pathway. We have isolated a cDNA clone that corresponds to the internal amino acid sequences of the native enzyme purified from a cell suspension culture of opium poppy Papaver somniferum. The recombinant enzyme acetylated the 7-hydroxyl moiety of salutaridinol in the presence of acetyl-CoA. The apparent K. value for salutaridinol was determined to be 9 mum and 54 mum for acetyl-CoA. The gene transcript was detected in extracts from Papaver orientale and Papaver bracteatum in addition to P. somniferum. Genomic DNA gel blot analysis indicated that there is likely a single copy of this gene in the P. somniferum genome. The amino acid sequence of salutaridinol 7-O-acetyltransferase is most similar (37% identity) to that of deacetylvindoline acetyltransferase of Catharanthus roseus. Salutaridinol 7-O-acetyltransferase is the second enzyme specific to morphine biosynthesis for which we have isolated a cDNA. Taken together with the other cDNAs cloned encoding norcoclaurine 6-O-methyl-transferase, (S)-N-methylcoclaurine 3 ' -hydroxylase, the cytochrome P-450 reductase, and codeinone reductase, significant progress has been made toward accumulating genes of this pathway to enable the end goal of a biotechnological production of morphinan alkaloids.	Leibniz Inst Pflanzenbiochem, D-06120 Halle An Der Saale, Germany; Univ Munich, Lehrstuhl Pharmazeut Biol, D-80333 Munich, Germany	Leibniz Institut fur Pflanzenbiochemie; University of Munich	Kutchan, TM (corresponding author), Leibniz Inst Pflanzenbiochem, Weinberg 3, D-06120 Halle An Der Saale, Germany.	kutch@ipb-halle.de	Kutchan, Toni/L-4625-2013	GROTHE, TORSTEN/0000-0003-3298-4924				BRACHER D, 1992, ARCH BIOCHEM BIOPHYS, V294, P717, DOI 10.1016/0003-9861(92)90746-J; BROWN NF, 1994, J BIOL CHEM, V269, P19157; Decker G, 2000, ELECTROPHORESIS, V21, P3500, DOI 10.1002/1522-2683(20001001)21:16<3500::AID-ELPS3500>3.0.CO;2-O; DEEKNAMKUL W, 1992, PHYTOCHEMISTRY, V31, P813, DOI 10.1016/0031-9422(92)80020-F; DELUCA V, 1985, J PLANT PHYSIOL, V121, P417, DOI 10.1016/S0176-1617(85)80078-X; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; ECKERSKORN C, 1989, CHROMATOGRAPHIA, V28, P92, DOI 10.1007/BF02290390; FAHN W, 1985, PLANT CELL REP, V4, P333, DOI 10.1007/BF00269892; Frick S, 1999, PLANT J, V17, P329, DOI 10.1046/j.1365-313X.1999.00379.x; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; GERARDY R, 1993, PHYTOCHEMISTRY, V32, P79, DOI 10.1016/0031-9422(92)80111-Q; HENDLE J, 1995, BIOCHEMISTRY-US, V34, P4287, DOI 10.1021/bi00013a018; Huang FC, 2000, PHYTOCHEMISTRY, V53, P555, DOI 10.1016/S0031-9422(99)00600-7; KUTCHAN TM, 1994, PHYTOCHEMISTRY, V35, P353, DOI 10.1016/S0031-9422(00)94763-0; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; KUTCHAN TM, 1985, CHEM BIOL ISOQUINOLI, P281; LENZ R, 1995, EUR J BIOCHEM, V233, P132, DOI 10.1111/j.1432-1033.1995.132_1.x; Lenz R, 1995, J BIOL CHEM, V270, P31091, DOI 10.1074/jbc.270.52.31091; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Miles E W, 1977, Methods Enzymol, V47, P431; NESSLER CL, 1977, AM J BOT, V64, P541, DOI 10.2307/2442002; NESSLER CL, 1978, AM J BOT, V65, P978, DOI 10.2307/2442685; Novak BH, 2000, CURR ORG CHEM, V4, P343, DOI 10.2174/1385272003376292; Pauli HH, 1998, PLANT J, V13, P793, DOI 10.1046/j.1365-313X.1998.00085.x; PFITZNER A, 1983, TETRAHEDRON LETT, V24, P5197, DOI 10.1016/S0040-4039(00)88395-1; RICE KC, 1980, J ORG CHEM, V45, P3135, DOI 10.1021/jo01303a045; ROBERTS MF, 1983, ARCH BIOCHEM BIOPHYS, V222, P599, DOI 10.1016/0003-9861(83)90558-1; Rosco A, 1997, ARCH BIOCHEM BIOPHYS, V348, P369, DOI 10.1006/abbi.1997.0374; RUSH MD, 1985, PLANT CELL REP, V4, P237, DOI 10.1007/BF00269366; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.biophys.20.1.363; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; St-Pierre B, 1998, PLANT J, V14, P703, DOI 10.1046/j.1365-313x.1998.00174.x; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Walker K, 2000, P NATL ACAD SCI USA, V97, P583, DOI 10.1073/pnas.97.2.583; Walker K, 2000, ARCH BIOCHEM BIOPHYS, V374, P371, DOI 10.1006/abbi.1999.1609	38	111	136	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30717	30723		10.1074/jbc.M102688200	http://dx.doi.org/10.1074/jbc.M102688200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11404355	hybrid			2022-12-27	WOS:000170472900019
J	Gupta, RA; Polk, DB; Krishna, U; Israel, DA; Yan, F; DuBois, RN; Peek, RM				Gupta, RA; Polk, DB; Krishna, U; Israel, DA; Yan, F; DuBois, RN; Peek, RM			Activation of peroxisome proliferator-activated receptor gamma suppresses nuclear factor kappa B-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; CYCLOOXYGENASE-2 EXPRESSION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; INFLAMMATORY RESPONSE; ALPHA PHOSPHORYLATION; PATHOGENICITY ISLAND; ATROPHIC GASTRITIS; IMMUNE-RESPONSES; INCREASED RISK	Helicobacter pylori colonization leads to epithelial cell hyperproliferation within inflamed mucosa, but levels of apoptosis vary, suggesting that imbalances between rates of cell production and loss may contribute to differences in gastric cancer risk among infected populations. Peroxisome proliferator-activated receptor gamma (PPAR gamma) regulates inflammatory and growth responses of intestinal epithelial cells. We determined whether activation of PPAR gamma modified H. pylori-induced apoptosis in gastric epithelial cells. PPAR gamma was expressed and functionally active in gastric epithelial cell lines sensitive to H. pylori-induced apoptosis. PPAR gamma ligands 15d-PGJ(2) and BRL-49653 significantly attenuated H. pylori-induced apoptosis, effects that could be reversed by co-treatment with a specific PPAR gamma antagonist., Cyclopentanone prostaglandins that do not bind and activate PPAR gamma had no effects on H. pylori-induced apoptosis. The ability of H. pylori to activate nuclear factor (NF)-kappaB and increase levels of the NF-kappaB target IL-8 was blocked by co-treatment with PPAR gamma agonists, and direct inhibition of NF-kappaB also abolished H. pylori-stimulated apoptosis. These results suggest that activation of the PPAR gamma pathway attenuates the ability of H. pylori to induce NF-kappaB-mediated apoptosis in gastric epithelial cells. Because PPAR gamma regulates a multitude of host responses, activation of this receptor may contribute to varying levels of cellular turnover as well as the diverse pathologic outcomes associated with chronic H. pylori colonization.	Vanderbilt Univ, Sch Med, Div Gastroenterol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Div Pediat Gastroenterol, Nashville, TN 37232 USA; Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Peek, RM (corresponding author), Vanderbilt Univ, Sch Med, Div Gastroenterol, C-2104 Med Ctr N, Nashville, TN 37232 USA.		DuBois, Raymond N./AAX-8869-2020		NATIONAL CANCER INSTITUTE [R29CA077955, R01CA077955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002381] Funding Source: NIH RePORTER; NCI NIH HHS [CA77955] Funding Source: Medline; NIDDK NIH HHS [DK02381, DK56008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Akre K, 2001, BRIT J CANCER, V84, P965, DOI 10.1054/bjoc.2001.1702; Anti M, 1998, ITAL J GASTROENTEROL, V30, P153; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BLASER MJ, 1995, CANCER RES, V55, P2111; CAHILL RJ, 1995, DIGEST DIS SCI, V40, P1627, DOI 10.1007/BF02212681; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chen G, 1997, BIOCHEM BIOPH RES CO, V239, P626, DOI 10.1006/bbrc.1997.7485; CORREA P, 1994, AM J CLIN PATHOL, V101, P656, DOI 10.1093/ajcp/101.5.656; CRABTREE JE, 1993, GUT, V34, P1339, DOI 10.1136/gut.34.10.1339; CRABTREE JE, 1991, LANCET, V338, P332, DOI 10.1016/0140-6736(91)90477-7; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fan XJ, 1998, J EXP MED, V187, P1659, DOI 10.1084/jem.187.10.1659; Fan XJ, 2000, J IMMUNOL, V165, P1918, DOI 10.4049/jimmunol.165.4.1918; Farrow DC, 1998, CANCER EPIDEM BIOMAR, V7, P97; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fox JG, 2000, NAT MED, V6, P536, DOI 10.1038/75015; Fox JG, 1999, CANCER RES, V59, P4823; FRASER AG, 1994, ALIMENT PHARM THERAP, V8, P167; Fu SD, 1999, GASTROENTEROLOGY, V116, P1319, DOI 10.1016/S0016-5085(99)70496-8; Grimm S, 1996, J CELL BIOL, V134, P13, DOI 10.1083/jcb.134.1.13; Havard TJ, 1996, J CLIN PATHOL, V49, P68, DOI 10.1136/jcp.49.1.68; Hirasawa R, 1999, AM J GASTROENTEROL, V94, P2398; Houghton J, 2000, INFECT IMMUN, V68, P1189, DOI 10.1128/IAI.68.3.1189-1195.2000; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Jones NL, 1997, AM J PATHOL, V151, P1695; Kaiser GC, 1999, GASTROENTEROLOGY, V116, P602, DOI 10.1016/S0016-5085(99)70182-4; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Keates S, 1999, J IMMUNOL, V163, P5552; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kitamura S, 1999, BIOCHEM BIOPH RES CO, V265, P453, DOI 10.1006/bbrc.1999.1715; Kliewer SA, 1998, CURR OPIN GENET DEV, V8, P576, DOI 10.1016/S0959-437X(98)80014-2; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lukiw WJ, 1998, P NATL ACAD SCI USA, V95, P3914, DOI 10.1073/pnas.95.7.3914; Luo XL, 1999, GASTROENTEROLOGY, V116, pA767; LYNCH DAF, 1995, GUT, V36, P346, DOI 10.1136/gut.36.3.346; Maeda S, 2000, GASTROENTEROLOGY, V119, P97, DOI 10.1053/gast.2000.8540; Mannick EE, 1996, CANCER RES, V56, P3238; McCarthy CJ, 1999, AM J GASTROENTEROL, V94, P1218, DOI 10.1111/j.1572-0241.1999.01070.x; Mohammadi M, 1996, J IMMUNOL, V156, P4729; Moss SF, 2001, CANCER RES, V61, P1406; Moss SF, 1996, GUT, V38, P498, DOI 10.1136/gut.38.4.498; Nakajima A, 2001, GASTROENTEROLOGY, V120, P460, DOI 10.1053/gast.2001.21191; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; PEEK RM, 1995, J CLIN MICROBIOL, V33, P28, DOI 10.1128/JCM.33.1.28-32.1995; Peek RM, 1999, CANCER RES, V59, P6124; Peek RM, 1997, JNCI-J NATL CANCER I, V89, P863, DOI 10.1093/jnci/89.12.863; Peek RM, 2000, GASTROENTEROLOGY, V118, P48, DOI 10.1016/S0016-5085(00)70413-6; Peek RM, 1995, LAB INVEST, V73, P760; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Ristimaki A, 1997, CANCER RES, V57, P1276; Rokkas T, 1999, DIGEST DIS SCI, V44, P487, DOI 10.1023/A:1026636803101; Romano M, 1998, J BIOL CHEM, V273, P28560, DOI 10.1074/jbc.273.44.28560; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rudi J, 1998, J CLIN INVEST, V102, P1506, DOI 10.1172/JCI2808; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Sawaoka H, 1998, PROSTAG LEUKOTR ESS, V59, P313, DOI 10.1016/S0952-3278(98)90079-5; Sharma SA, 1998, J IMMUNOL, V160, P2401; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200; Sung JJY, 2000, AM J PATHOL, V157, P729, DOI 10.1016/S0002-9440(10)64586-5; Tanaka T, 2001, CANCER RES, V61, P2424; Tatsuguchi A, 2000, GUT, V46, P782, DOI 10.1136/gut.46.6.782; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Uefuji K, 1998, J SURG ONCOL, V69, P168, DOI 10.1002/(SICI)1096-9098(199811)69:3<168::AID-JSO9>3.0.CO;2-0; VAN AD, 1996, SCIENCE, V274, P787; Wagner S, 1997, GASTROENTEROLOGY, V113, P1836, DOI 10.1016/S0016-5085(97)70003-9; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang JD, 2000, INFECT IMMUN, V68, P4303, DOI 10.1128/IAI.68.7.4303-4311.2000; Wang TC, 1998, GASTROENTEROLOGY, V114, P675, DOI 10.1016/S0016-5085(98)70581-5; Williams CS, 1997, J CLIN INVEST, V100, P1325, DOI 10.1172/JCI119651; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Yan F, 1999, J BIOL CHEM, V274, P36631, DOI 10.1074/jbc.274.51.36631; Zaridze D, 1999, INT J CANCER, V82, P473, DOI 10.1002/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K	86	90	99	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31059	31066		10.1074/jbc.M104141200	http://dx.doi.org/10.1074/jbc.M104141200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11397815	hybrid			2022-12-27	WOS:000170472900063
J	Mahajan, S; Vassilev, A; Sun, N; Ozer, Z; Mao, C; Uckun, FM				Mahajan, S; Vassilev, A; Sun, N; Ozer, Z; Mao, C; Uckun, FM			Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; TFII-I; RECEPTOR ENGAGEMENT; BINDING PROTEIN; PH DOMAINS; SRC FAMILY; ACTIVATION; APOPTOSIS; BTK; EXPRESSION	STAT5A is a molecular regulator of proliferation, differentiation, and apoptosis in lymphohematopoietic cells. Here we show that STAT5A can serve as a functional substrate of Bruton's tyrosine kinase (BTK). Purified recombinant BTK was capable of directly binding purified recombinant STAT5A with high affinity (K-d = 44 nm), as determined by surface plasmon resonance using a BIA-core biosensor system. BTK was also capable of tyrosine-phosphorylating ectopically expressed recombinant STAT5A on Tyr(694) both in vitro and in vivo in a Janus kinase 3-independent fashion. BTK phosphorylated the Y665F, Y668F, and Y682F,Y683F mutants but not the Y694F mutant of STAT5A. STAT5A mutations in the Src homology 2 (SH2) and SH3 domains did not alter the BTK-mediated tyrosine phosphorylation. Recombinant BTK proteins with mutant pleckstrin homology, SH2, or SH3 domains were capable of phosphorylating STAT5A, whereas recombinant BTK proteins with SH1/kinase domain mutations were not. In pull-down experiments, only full-length BTK and its SH1/kinase domain (but not the pleckstrin homology, SH2, or SH3 domains) were capable of binding STAT5A. Ectopically expressed BTK kinase domain was capable of tyrosine-phosphorylating STAT5A both in vitro and in vivo. BTK-mediated tyrosine phosphorylation of ectopically expressed wild type (but not Tyr694 mutant) STAT5A enhanced its DNA binding activity. In BTK-competent chicken B cells, anti-IgM-stimulated tyrosine phosphorylation of STAT5 protein was prevented by pretreatment with the BTK inhibitor LFM-A13 but not by pretreatment with the JAK3 inhibitor HI-P131. B cell antigen receptor ligation resulted in enhanced tyrosine phosphorylation of STAT5 in BTK-deficient chicken B cells reconstituted with wild type human BTK but not in BTK-deficient chicken B cells reconstituted with kinase-inactive mutant BTK Similarly, anti-IgM stimulation resulted in enhanced tyrosine phosphorylation of STAT5A in BTK-competent B cells from wild type mice but not in BTK-deficient B cells from XID mice. In contrast to B cells from XID mice, B cells from JAK3 knockout mice showed a normal STAT5A phosphorylation response to anti-IgM stimulation. These findings provide unprecedented experimental evidence that BTK plays a nonredundant and pivotal role in B cell antigen receptor-mediated STAT5A activation in B cells.	Parker Huges Inst, Dept Biochem, St Paul, MN 55113 USA; Parker Huges Inst, Dept Biol Mol, St Paul, MN 55113 USA; Parker Huges Inst, Dept Immunol, St Paul, MN 55113 USA; Parker Huges Inst, Dept Biol Struct, St Paul, MN 55113 USA; Parker Huges Inst, Parker Huges Canc Ctr, Mol Signal Transduct Lab, St Paul, MN 55113 USA		Uckun, FM (corresponding author), Parker Huges Inst, Parker Huges Canc Ctr, Mol Signal Transduct Lab, 2665 Long Lake Rd,Suite 330, St Paul, MN 55113 USA.	fatih-uckun@ih.org		Uckun, Fatih M./0000-0001-9334-183X				Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; CHEN X, 1988, CELL, V93, P827; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Hemmings BA, 1997, SCIENCE, V275, P1899, DOI 10.1126/science.275.5308.1899; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Jurlander J, 1997, BLOOD, V89, P4146, DOI 10.1182/blood.V89.11.4146; Kaneko S, 1997, CLIN EXP IMMUNOL, V109, P185, DOI 10.1046/j.1365-2249.1997.4191324.x; Karras JG, 1996, J IMMUNOL, V157, P39; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levy David E., 1997, Cytokine and Growth Factor Reviews, V8, P81, DOI 10.1016/S1359-6101(96)00054-8; LEVY F, 1990, INT IMMUNOL, V2, P995, DOI 10.1093/intimm/2.10.995; LICHTENSTEIN A, 1995, CELL IMMUNOL, V162, P248, DOI 10.1006/cimm.1995.1076; LIU J, 1994, CELL IMMUNOL, V155, P428, DOI 10.1006/cimm.1994.1135; LUO KX, 1991, METHOD ENZYMOL, V201, P149; Mahajan S, 1999, J BIOL CHEM, V274, P9587, DOI 10.1074/jbc.274.14.9587; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; Mano H, 1999, INT J HEMATOL, V69, P6; Mohamed AJ, 2000, J BIOL CHEM, V275, P40614, DOI 10.1074/jbc.M006952200; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Pericle F, 1997, J IMMUNOL, V159, P2580; Petro JB, 2000, J EXP MED, V191, P1745, DOI 10.1084/jem.191.10.1745; Petro JB, 2001, J BIOL CHEM, V276, P1715, DOI 10.1074/jbc.M009137200; Rajamohan F, 2000, J BIOL CHEM, V275, P3382, DOI 10.1074/jbc.275.5.3382; RAWLINGS DJ, 1994, IMMUNOL REV, V138, P105, DOI 10.1111/j.1600-065X.1994.tb00849.x; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; ROY AL, 1993, NATURE, V365, P359, DOI 10.1038/365359a0; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; ROY AL, 1993, NATURE, V365, P355, DOI 10.1038/365355a0; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Saharinen P, 1997, BLOOD, V90, P4341; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Sudbeck EA, 1999, CLIN CANCER RES, V5, P1569; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Uckun FM, 1998, BIOCHEM PHARMACOL, V56, P683, DOI 10.1016/S0006-2952(98)00122-1; Uckun FM, 1996, J BIOL CHEM, V271, P6389, DOI 10.1074/jbc.271.11.6389; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Vassilev A, 1999, J BIOL CHEM, V274, P1646, DOI 10.1074/jbc.274.3.1646; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Vihinen M, 1999, HUM MUTAT, V13, P280, DOI 10.1002/(SICI)1098-1004(1999)13:4<280::AID-HUMU3>3.0.CO;2-L; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Williams MD, 1998, PROTEIN EXPRES PURIF, V13, P210, DOI 10.1006/prep.1998.0900; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175	61	58	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31216	31228		10.1074/jbc.M104874200	http://dx.doi.org/10.1074/jbc.M104874200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413148	hybrid			2022-12-27	WOS:000170472900083
J	Slagsvold, T; Kraus, I; Fronsdal, K; Saatcioglu, F				Slagsvold, T; Kraus, I; Fronsdal, K; Saatcioglu, F			DNA binding-independent transcriptional activation by the androgen receptor through triggering of coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; AMINO-TERMINAL DOMAIN; NUCLEAR RECEPTORS; ESTROGEN-RECEPTOR; LIGAND-BINDING; MOLECULAR MECHANISMS; RETINOIC ACID; AF2 DOMAINS; PROTEIN; FUNCTION-2	Androgens have critical roles in the development and maintenance of the male reproductive system and are important for progression of prostate cancer. The effects of androgens are mediated by the androgen receptor (AR), which is a ligand-modulated transcription factor that belongs to the nuclear receptor superfamily. In the presence of androgens, AR binds to androgen response elements in the vicinity of androgen receptor target genes and activates transcription. In addition, liganded AR can interfere with the activity of other transcription factors, such as activator protein-1 and nuclear factor kappaB, for which DNA binding by AR is not necessary. In this study, we describe a novel ligand-dependent transactivation function for AR that is independent of its DNA binding ability. AR dramatically increased the intrinsic transcriptional activity of the nuclear receptor coactivators glucocorticoid receptor-interacting protein-1 (GRIP1), cAMP response element-binding protein-binding protein, and p300 that are tethered to DNA. This "triggering" phenomenon required both similar and distinctly different regions of AR compared with those needed for ligand-dependent transactivation from androgen-responsive elements. Furthermore, the domains of GRIP1 required for triggering by AR are different from those required when GRIP1 serves as a coactivator for AR at androgen-responsive promoters. These data suggest that triggering may constitute an important part of the mechanism by which AR regulates transcription.	Univ Oslo, Ctr Biotechnol, N-0349 Oslo, Norway; Univ Oslo, Dept Biochem, N-0349 Oslo, Norway; Univ Oslo, Dept Biol, N-0349 Oslo, Norway; Univ Oslo, Inst Clin Med, N-0349 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Saatcioglu, F (corresponding author), Univ Oslo, Ctr Biotechnol, Gaustadalleen 21, N-0349 Oslo, Norway.			Christiansen, Irene Kraus/0000-0001-8850-3304				Aarnisalo P, 1998, P NATL ACAD SCI USA, V95, P2122, DOI 10.1073/pnas.95.5.2122; Alen P, 1999, MOL CELL BIOL, V19, P6085; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chamberlain NL, 1996, J BIOL CHEM, V271, P26772, DOI 10.1074/jbc.271.43.26772; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Glass CK, 2000, GENE DEV, V14, P121; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Hong H, 1999, J BIOL CHEM, V274, P3496, DOI 10.1074/jbc.274.6.3496; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; KITABAYASHI I, 1995, EMBO J, V14, P3496, DOI 10.1002/j.1460-2075.1995.tb07356.x; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; LINDZEY J, 1994, VITAM HORM, V49, P383; Ma H, 1999, MOL CELL BIOL, V19, P6164; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McInerney EM, 1996, P NATL ACAD SCI USA, V93, P10069, DOI 10.1073/pnas.93.19.10069; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; SAATCIOGLU F, 1993, MOL CELL BIOL, V13, P3675, DOI 10.1128/MCB.13.6.3675; Saatcioglu F, 1997, MOL CELL BIOL, V17, P4687, DOI 10.1128/MCB.17.8.4687; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Slagsvold T, 2000, MOL ENDOCRINOL, V14, P1603, DOI 10.1210/me.14.10.1603; Stallcup MR, 2000, BIOCHEM SOC T, V28, P415, DOI 10.1042/0300-5127:0280415; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5	49	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31030	31036		10.1074/jbc.M104310200	http://dx.doi.org/10.1074/jbc.M104310200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11429409	hybrid			2022-12-27	WOS:000170472900059
J	Brymora, A; Valova, VA; Larsen, MR; Roufogalis, BD; Robinson, PJ				Brymora, A; Valova, VA; Larsen, MR; Roufogalis, BD; Robinson, PJ			The brain exocyst complex interacts with RaIA in a GTP-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; SYNAPTIC VESICLES; RAL-A; IDENTIFICATION; SECRETION; YEAST; ENDOCYTOSIS; EXOCYTOSIS; GTPASES	Ral is a small GTPase involved in critical cellular signaling pathways. The two isoforms, RalA and RalB, are widely distributed in different tissues, with RalA being enriched in brain. The best characterized RalA signaling pathways involve RalBP1 and phospholipase D. To investigate RalA signaling in neuronal cells we searched for RalA-binding proteins in brain. We found at least eight proteins that bound RalA in a GTP-dependent manner. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) identified these as the components of the exocyst complex. The yeast exocyst is a regulator of polarized secretion, docking vesicles to regions of the plasma membrane involved in active exocytosis. We identified the human FLJ10893 protein as the mammalian homologue of the yeast exocyst protein Sec3p. The exocyst complex did not contain the previously identified exocyst component rSec15, but a new homologue of both yeast Sec15p, and rSec15, called KIAA0919. Western blots confirmed that two rat exocyst proteins, rSec6 and rSec8, bound active RalA in nerve terminals, as did RalBP1. Phospholipase D bound RalA in a nucleotide-independent manner. This places the RalA signaling system in mammalian nerve terminals, where the exocyst may act as an effector for activated RalA in directing sites of exocytosis.	Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia; Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney	Robinson, PJ (corresponding author), Childrens Med Res Inst, Cell Signalling Unit, Locked Bag 23, Westmead, NSW 2145, Australia.		Robinson, Phillip J/G-4008-2011; Larsen, Martin Rossel/F-1411-2015	Robinson, Phillip J/0000-0002-7878-0313; Roufogalis, Basil/0000-0001-9123-5478; Larsen, Martin Rossel/0000-0001-6203-0123				Bhullar RP, 1998, MOL CELL BIOCHEM, V179, P49, DOI 10.1023/A:1006891815211; BIELINSKI DF, 1993, BIOCHIM BIOPHYS ACTA, V1151, P246, DOI 10.1016/0005-2736(93)90109-D; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; CHARDIN P, 1989, NUCLEIC ACIDS RES, V17, P4380, DOI 10.1093/nar/17.11.4380; de Bruyn KMT, 2000, J BIOL CHEM, V275, P29761, DOI 10.1074/jbc.M001160200; Doucet A, 2001, ANAL BIOCHEM, V292, P296, DOI 10.1006/abio.2001.5089; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Finger FP, 1997, MOL BIOL CELL, V8, P647, DOI 10.1091/mbc.8.4.647; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Jilkina O, 1996, BBA-MOL CELL RES, V1314, P157, DOI 10.1016/S0167-4889(96)00073-0; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Larsen MR, 2000, FRESEN J ANAL CHEM, V366, P677, DOI 10.1007/s002160051562; Luo JQ, 1997, BIOCHEM BIOPH RES CO, V235, P854, DOI 10.1006/bbrc.1997.6793; Luo JQ, 1998, P NATL ACAD SCI USA, V95, P3632, DOI 10.1073/pnas.95.7.3632; Morinaka K, 1999, ONCOGENE, V18, P5915, DOI 10.1038/sj.onc.1202974; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Park JB, 1999, BIOCHEM BIOPH RES CO, V263, P765, DOI 10.1006/bbrc.1999.1463; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; ROBINSON PJ, 1983, J NEUROCHEM, V41, P909, DOI 10.1111/j.1471-4159.1983.tb09034.x; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; TING AE, 1995, P NATL ACAD SCI USA, V92, P9613, DOI 10.1073/pnas.92.21.9613; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Wang KL, 1999, J BIOL CHEM, V274, P14525, DOI 10.1074/jbc.274.21.14525; Wang KL, 1997, J BIOL CHEM, V272, P16002, DOI 10.1074/jbc.272.25.16002	36	116	120	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29792	29797		10.1074/jbc.C100320200	http://dx.doi.org/10.1074/jbc.C100320200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11406615	hybrid			2022-12-27	WOS:000170558000026
J	Ferreira, T; Mason, AB; Slayman, CW				Ferreira, T; Mason, AB; Slayman, CW			The yeast pma1 proton pump: a model for understanding the biogenesis of plasma membrane proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DOMINANT LETHAL MUTATIONS; H+-ATPASE GENE; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SARCOPLASMIC-RETICULUM; CELL-SURFACE; INTRACELLULAR-TRANSPORT; SECRETORY VESICLES; SELECTIVE EXPORT; CALCIUM-PUMP		Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University	Slayman, CW (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	carolyn.slayman@yale.edu	Mason, Anne B/A-6754-2008					Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; BENITO B, 1991, BIOCHIM BIOPHYS ACTA, V1063, P265, DOI 10.1016/0005-2736(91)90381-H; BOWMAN BJ, 1985, J BIOL CHEM, V260, P8726; BRADA D, 1988, J BACTERIOL, V170, P2775, DOI 10.1128/jb.170.6.2775-2783.1988; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; CHADWICK CC, 1987, ARCH BIOCHEM BIOPHYS, V252, P348, DOI 10.1016/0003-9861(87)90041-5; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; CHANG A, 1993, P NATL ACAD SCI USA, V90, P5808, DOI 10.1073/pnas.90.12.5808; DeWitt ND, 1998, J BIOL CHEM, V273, P21744, DOI 10.1074/jbc.273.34.21744; dExaerde AD, 1996, YEAST, V12, P907; Dunbar LA, 2001, J BIOL CHEM, V276, P29617, DOI 10.1074/jbc.R100023200; HARRIS SL, 1994, P NATL ACAD SCI USA, V91, P10531, DOI 10.1073/pnas.91.22.10531; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HOLCOMB CL, 1988, J CELL BIOL, V106, P641, DOI 10.1083/jcb.106.3.641; Klumperman J, 2000, CURR OPIN CELL BIOL, V12, P445, DOI 10.1016/S0955-0674(00)00115-0; Luo WJ, 1997, J CELL BIOL, V138, P731, DOI 10.1083/jcb.138.4.731; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Nakamoto RK, 1998, J BIOL CHEM, V273, P7338, DOI 10.1074/jbc.273.13.7338; NAKAMOTO RK, 1991, J BIOL CHEM, V266, P7940; NAO SQ, 1995, J BIOL CHEM, V270, P6815, DOI 10.1074/jbc.270.12.6815; Portillo F, 1997, FEBS LETT, V402, P136, DOI 10.1016/S0014-5793(96)01515-3; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; SCARBOROUGH GA, 1984, J BIOL CHEM, V259, P9109; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Stokes DL, 1999, CURR BIOL, V9, P672, DOI 10.1016/S0960-9822(99)80307-8; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	41	47	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29613	29616		10.1074/jbc.R100022200	http://dx.doi.org/10.1074/jbc.R100022200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11404364	hybrid			2022-12-27	WOS:000170558000002
J	Sagami, I; Daff, S; Shimizu, T				Sagami, I; Daff, S; Shimizu, T			Intra-subunit and inter-subunit electron transfer in neuronal nitric-oxide synthase - Effect of calmodulin on heterodimer catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGENASE DOMAIN; L-ARGININE; HEME; ACTIVATION; BINDING; PTERIN; FLAVIN; SITE; TETRAHYDROBIOPTERIN; IDENTIFICATION	In neuronal nitric-oxide synthase (nNOS), calmodulin (CaM) binding is thought to trigger electron transfer from the reductase domain to the heme domain, which is essential for O-2 activation and NO formation. To elucidate the electron-transfer mechanism, we characterized a series of heterodimers consisting of one full-length nNOS subunit and one oxygenase-domain subunit. The results support aft inter-subunit electron-transfer mechanism for the wild type nNOS, in that electrons for catalysis transfer in a Ca2+/CaM-dependent way from the reductase domain of one subunit to the heme of the other subunit, as proposed for inducible NOS. This suggests that the two different isoforms form similar dimeric complexes. In a series of heterodimers containing a Ca2+/CaM-insensitive mutant (delta40), electrons transferred from the reductase domain to both hemes in a Ca2+/CaM-independent way. Thus, in the delta40 mutant electron transfer from the reductase domains to the heme domains can occur via both inter-subunit and intra-subunit mechanisms. However, NO formation activity was exclusively linked to inter-subunit electron transfer and was observed only in the presence of Ca2+/CaM. This suggests that the mechanism of activation of nNOS hy CaM is not solely dependent on the activation of electron transfer to the nNOS hemes but may involve additional structural factors linked to the catalytic action of the heme domain.	Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; Univ Edinburgh, Dept Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	Tohoku University; University of Edinburgh	Sagami, I (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.							ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Chen PF, 2000, J BIOL CHEM, V275, P13155, DOI 10.1074/jbc.275.17.13155; Chen PF, 1997, J BIOL CHEM, V272, P6114, DOI 10.1074/jbc.272.10.6114; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Feelisch M., 1996, METHODS NITRIC OXIDE; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Hellermann GR, 1997, J BIOL CHEM, V272, P12030, DOI 10.1074/jbc.272.18.12030; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Li HY, 1999, J BIOL CHEM, V274, P21276, DOI 10.1074/jbc.274.30.21276; MASTERS BSS, 1994, ANNU REV NUTR, V14, P131, DOI 10.1146/annurev.nu.14.070194.001023; MATSUOKA A, 1994, J BIOL CHEM, V269, P20335; Mayer B, 2000, NITRIC OXIDE; MCMILLAN K, 1995, BIOCHEMISTRY-US, V34, P3686, DOI 10.1021/bi00011a025; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Noguchi T, 2001, BIOCHEM BIOPH RES CO, V282, P1092, DOI 10.1006/bbrc.2001.4697; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; RAMAN CS, 2000, PORPHYRIN HDB, V4, P293; Sagami I, 1998, J BIOL CHEM, V273, P2105, DOI 10.1074/jbc.273.4.2105; Sagami I, 2000, J BIOL CHEM, V275, P26150, DOI 10.1074/jbc.M000534200; Shimanuki T, 1999, J BIOL CHEM, V274, P26956, DOI 10.1074/jbc.274.38.26956; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Venema RC, 1997, J BIOL CHEM, V272, P1276, DOI 10.1074/jbc.272.2.1276; Wei CC, 2001, J BIOL CHEM, V276, P315, DOI 10.1074/jbc.M008441200	35	83	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30036	30042		10.1074/jbc.M104123200	http://dx.doi.org/10.1074/jbc.M104123200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395516	hybrid			2022-12-27	WOS:000170558000058
J	David, H; Carnero-Diaz, E; Leblanc, N; Monestiez, M; Grosclaude, J; Perrot-Rechenmann, C				David, H; Carnero-Diaz, E; Leblanc, N; Monestiez, M; Grosclaude, J; Perrot-Rechenmann, C			Conformational dynamics underlie the activity of the auxin-binding protein, Nt-abp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STOMATAL GUARD-CELLS; ZEA-MAYS-L; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; ROOT GRAVITROPISM; PLASMA-MEMBRANE; HORMONE AUXIN; K+ CHANNELS; C-TERMINUS	The auxin-binding protein 1 (ABP1) has been proposed to be involved in the perception of the phytohormone, at the plasma membrane. Site-directed mutagenesis was performed on highly conserved residues at the C terminus of ABP1 to investigate their relative importance in protein folding and activation of a functional response at the plasma membrane. Detailed analysis of the dynamic interaction of the wild-type ABP1 and mutated proteins with three distinct monoclonal antibodies recognizing conformation-dependent epitopes was performed by surface plasmon resonance. The influence of auxin on these interactions was also investigated. The Cys(177) as well as Asp(175) and Glu(176) were identified as critical residues for ABP1 folding and action at the plasma membrane. On the contrary, the C-terminal KDEL sequence was demonstrated not to be essential for auxin binding, interaction with the plasma membrane, or activation of the transduction cascade although it does appear to be involved in the stability of ABP1. Taken together, the results confirmed that ABP1 conformational change is the critical step for initiating the signal from the plasma membrane.	CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; Univ Paris 07, Lab Electrophysiol Membranes, F-75000 Paris, France; INRA, F-78352 Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Perrot-Rechenmann, C (corresponding author), CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France.	catherine.rechenmann@isv.cnrs-gif.fr		David, Karine/0000-0002-3924-5078				BarbierBrygoo H, 1996, PLANT GROWTH REGUL, V18, P23, DOI 10.1007/BF00028484; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BLATT MR, 1994, PLANT J, V5, P55, DOI 10.1046/j.1365-313X.1994.5010055.x; CABOCHE M, 1980, PLANTA, V149, P7, DOI 10.1007/BF00386221; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Choi SY, 1996, PLANT MOL BIOL, V32, P995, DOI 10.1007/BF00020496; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Deruere J, 1999, PLANT J, V20, P389, DOI 10.1046/j.1365-313x.1999.00607.x; DIEKMANN W, 1995, P NATL ACAD SCI USA, V92, P3425, DOI 10.1073/pnas.92.8.3425; EPHRITIKHINE G, 1987, PLANT PHYSIOL, V83, P801, DOI 10.1104/pp.83.4.801; Gehring CA, 1998, PLANTA, V205, P581, DOI 10.1007/s004250050359; Gertler A, 1996, J BIOL CHEM, V271, P24482, DOI 10.1074/jbc.271.40.24482; GOLDSMITH MHM, 1993, P NATL ACAD SCI USA, V90, P11442, DOI 10.1073/pnas.90.24.11442; Gray WM, 2000, TRENDS BIOCHEM SCI, V25, P133, DOI 10.1016/S0968-0004(00)01544-9; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; HERTEL R, 1995, J EXP BOT, V46, P461, DOI 10.1093/jxb/46.5.461-a; HESSE T, 1989, EMBO J, V8, P2453, DOI 10.1002/j.1460-2075.1989.tb08380.x; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JONES AM, 1994, ANNU REV PLANT PHYS, V45, P393, DOI 10.1146/annurev.pp.45.060194.002141; Lazarus CM, 1996, PLANT MOL BIOL, V31, P267, DOI 10.1007/BF00021789; Leblanc N, 1999, FEBS LETT, V449, P57, DOI 10.1016/S0014-5793(99)00398-1; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Leblanc N, 1997, PLANT MOL BIOL, V33, P679, DOI 10.1023/A:1005757815212; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; LOBLER M, 1985, J BIOL CHEM, V260, P9848; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Millner PA, 1996, PLANT GROWTH REGUL, V18, P143, DOI 10.1007/BF00028499; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; NAPIER RM, 1990, PLANTA, V182, P313, DOI 10.1007/BF00197128; NAPIER RM, 1992, J CELL SCI, V102, P261; PALME K, 1992, PLANT CELL, V4, P193, DOI 10.1105/tpc.4.2.193; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Philo JS, 1996, BIOCHEMISTRY-US, V35, P1681, DOI 10.1021/bi9524272; RAY PM, 1977, PLANT PHYSIOL, V59, P357, DOI 10.1104/pp.59.3.357; RONA JP, 1980, J MEMBRANE BIOL, V57, P25, DOI 10.1007/BF01868983; Schouten A, 1997, FEBS LETT, V415, P235, DOI 10.1016/S0014-5793(97)01129-0; Sessions A, 1997, DEVELOPMENT, V124, P4481; SHIMOMURA S, 1986, J BIOCHEM-TOKYO, V99, P1513, DOI 10.1093/oxfordjournals.jbchem.a135621; THIEL G, 1993, P NATL ACAD SCI USA, V90, P11493, DOI 10.1073/pnas.90.24.11493; Tian Q, 1999, DEVELOPMENT, V126, P711; VENIS MA, 1995, J EXP BOT, V46, P463, DOI 10.1093/jxb/46.5.463; VENIS MA, 1995, CRIT REV PLANT SCI, V14, P27, DOI 10.1080/713608065; VENIS MA, 1977, NATURE, V266, P268, DOI 10.1038/266268a0; Warwicker J, 2001, PLANTA, V212, P343, DOI 10.1007/s004250000442	45	20	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34517	34523		10.1074/jbc.M102783200	http://dx.doi.org/10.1074/jbc.M102783200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11438526	hybrid, Green Published			2022-12-27	WOS:000171024600024
J	Mizoue, LS; Sullivan, SK; King, DS; Kledal, TN; Schwartz, TW; Bacon, KB; Handel, TM				Mizoue, LS; Sullivan, SK; King, DS; Kledal, TN; Schwartz, TW; Bacon, KB; Handel, TM			Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; CC-CHEMOKINE; MCP-1 RECEPTOR; TYROSINE SULFATION; INVERSE AGONISTS; AMINO-TERMINUS; FACTOR-I; INTERLEUKIN-8; IDENTIFICATION; RESIDUES	Fractalkine/CX3CL1 is a membrane-tethered chemokine that functions as a chemoattractant and adhesion protein by interacting with the receptor CX3CR1. To understand the molecular basis for the interaction, an extensive mutagenesis study of fractalkine's chemokine domain was undertaken. The results reveal a cluster of basic residues (Lys-8, Lys-15, Lys-37, Arg-45, and Arg-48) and one aromatic (Phe-50) that are critical for binding and/or signaling. The mutant R48A could bind but not induce chemotaxis, demonstrating that Arg-48 is a signaling trigger. This result also shows that signaling residues are not confined to chemokine N termini, as generally thought. F50A showed no detectable binding, underscoring its importance to the stability of the complex. K15A displayed unique signaling characteristics, eliciting a wild-type calcium flux but minimal chemotaxis, suggesting that this mutant can activate some, but not all, pathways required for migration. Fractalkine also binds the human cytomegalovirus receptor US28, and analysis of the mutants indicates that US28 recognizes many of the same epitopes of fractalkine as CX3CR1. Comparison of the binding surfaces of fractalkine and the CC chemokine MCP-1 reveals structural details that may account for their dual recognition by US28 and their selective recognition by host receptors.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Neurocrine Biosci Inc, San Diego, CA 92121 USA; Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Neurocrine Biosciences; University of Copenhagen	Handel, TM (corresponding author), Bayer Yakuhin Ltd, 6-5-1-3 Kunimidai, Kyoto 6100216, Japan.	handel@paradise1.berkeley.edu		Schwartz, Thue W./0000-0002-0261-6904				Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Blanpain C, 1999, BLOOD, V94, P1899; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Damon I, 1998, P NATL ACAD SCI USA, V95, P6403, DOI 10.1073/pnas.95.11.6403; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; DOERRING DS, 1992, THESIS CAMBRIDGE MA; Elisseeva EL, 2000, J BIOL CHEM, V275, P26799; Elsner J, 1999, INT ARCH ALLERGY IMM, V118, P462, DOI 10.1159/000024164; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hammond MEW, 1996, J BIOL CHEM, V271, P8228, DOI 10.1074/jbc.271.14.8228; Harrison JK, 2001, J BIOL CHEM, V276, P21632, DOI 10.1074/jbc.M010261200; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Ho HH, 1999, J BIOL CHEM, V274, P31327, DOI 10.1074/jbc.274.44.31327; Homey B, 1999, CURR OPIN IMMUNOL, V11, P626, DOI 10.1016/S0952-7915(99)00028-X; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jones SA, 1997, J BIOL CHEM, V272, P16166, DOI 10.1074/jbc.272.26.16166; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; LU ZH, 1995, J BIOL CHEM, V270, P26239; Lusso P, 2000, VIROLOGY, V273, P228, DOI 10.1006/viro.2000.0443; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Mayer MR, 2001, J BIOL CHEM, V276, P13911, DOI 10.1074/jbc.M011202200; McDermott D H, 2000, Science, V290, P2031; McDermott DH, 2000, SPRINGER SEMIN IMMUN, V22, P393, DOI 10.1007/s002810000052; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murdoch C, 2000, BLOOD, V95, P3032; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Preobrazhensky AA, 2000, J IMMUNOL, V165, P5295, DOI 10.4049/jimmunol.165.9.5295; Proudfoot AEI, 2000, IMMUNOL REV, V177, P246, DOI 10.1034/j.1600-065X.2000.17721.x; Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Rodriguez-Frade JM, 1999, J CELL BIOL, V144, P755, DOI 10.1083/jcb.144.4.755; Rosenkilde MM, 2000, J BIOL CHEM, V275, P26309, DOI 10.1074/jbc.M003800200; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Williams G, 1996, J BIOL CHEM, V271, P9579, DOI 10.1074/jbc.271.16.9579; Yen HH, 1997, J LEUKOCYTE BIOL, V61, P529, DOI 10.1002/jlb.61.4.529; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	68	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33906	33914		10.1074/jbc.M101348200	http://dx.doi.org/10.1074/jbc.M101348200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11432858	hybrid			2022-12-27	WOS:000170910200084
J	Panse, VG; Beena, K; Philipp, R; Trommer, WE; Vogel, PD; Varadarajan, R				Panse, VG; Beena, K; Philipp, R; Trommer, WE; Vogel, PD; Varadarajan, R			Electron spin resonance and fluorescence studies of the bound-state conformation of a model protein substrate to the chaperone SecB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; ESCHERICHIA-COLI; MOLTEN GLOBULE; LACTOSE PERMEASE; DISULFIDE BOND; BINDING; PROXIMITY; THERMODYNAMICS; TRANSLOCATION; INTERMEDIATE	SecB is a homotetrameric, cytosolic chaperone that forms part of the protein translocation machinery in Escherichia coli. We have investigated the bound-state conformation of a model protein substrate of SecB, bovine pancreatic trypsin inhibitor (BPTI) as well as the conformation of SecB itself by using proximity relationships based on site-directed spin-labeling and pyrene fluorescence methods. BPTI is a 58-residue protein and contains three disulfide groups between residues 5 and 55, 14 and 38, as well as 30 and 51. Mutants of BPTI that contained only a single disulfide were reduced, and the free cysteines were labeled with either thiol-specific spin labels or pyrene maleimide. The relative proximity of the labeled residues was studied using either electron spin resonance spectroscopy or fluorescence spectroscopy. The data suggest that SecB binds a collapsed coil of reduced unfolded BPTI, which then undergoes a structural rearrangement to a more extended state upon binding to SecB. Binding occurs at multiple sites on the substrate, and the binding site on each SecB monomer accommodates less than 21 substrate residues. In addition, we have labeled four solvent-accessible cysteine residues in the SecB tetramer and have investigated their relative spatial arrangement in the presence and absence of the substrate protein. The electron spin resonance data suggest that these cysteine residues are in close proximity (15 Angstrom) when no substrate protein is bound but move away to a distance of greater than 20 Angstrom when SecB binds substrate. This is the first direct evidence of a conformational change in SecB upon binding of a substrate protein.	Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; Jawaharlal Nehru Ctr Adv Sci Res, Chem Biol Unit, Bangalore 560004, Karnataka, India; Univ Kaiserslautern, Biochem Abt, Fachbereich Chem, D-67663 Kaiserslautern, Germany	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); University of Kaiserslautern	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.			Vogel, Pia/0000-0002-8135-4649; Panse, Vikram/0000-0001-7950-5746				Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; AMIR D, 1988, BIOCHEMISTRY-US, V27, P8889, DOI 10.1021/bi00425a003; AMIR D, 1992, PROTEINS, V13, P162, DOI 10.1002/prot.340130210; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Chakravarty S, 1999, STRUCT FOLD DES, V7, P723, DOI 10.1016/S0969-2126(99)80097-5; Creighton T. E., 1990, PROTEIN STRUCTURE PR, P155; Dadlez M, 1996, BIOCHEMISTRY-US, V35, P16153, DOI 10.1021/bi9616054; Darbre A., 1986, PRACTICAL PROTEIN CH; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FASMAN GD, 1995, J PROTEIN CHEM, V14, P595, DOI 10.1007/BF01886885; FEKKES P, 1995, BIOCHEMISTRY-US, V34, P10078, DOI 10.1021/bi00031a032; FERRER M, 1995, NAT STRUCT BIOL, V2, P211, DOI 10.1038/nsb0395-211; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOTTFRIED DS, 1992, BIOCHEMISTRY-US, V31, P12353, DOI 10.1021/bi00164a009; GUSSAKOVSKY EE, 1992, FEBS LETT, V308, P146, DOI 10.1016/0014-5793(92)81263-L; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Kim J, 1998, J BACTERIOL, V180, P1396, DOI 10.1128/JB.180.6.1396-1401.1998; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECKER SH, 1990, EMBO J, V9, P2309, DOI 10.1002/j.1460-2075.1990.tb07402.x; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; LUMB KJ, 1994, J MOL BIOL, V236, P412, DOI 10.1006/jmbi.1994.1153; PAN H, 1995, BIOCHEMISTRY-US, V34, P13974, DOI 10.1021/bi00043a002; Panse VG, 2000, BIOCHEMISTRY-US, V39, P2420, DOI 10.1021/bi992065o; Panse VG, 1998, BIOCHEMISTRY-US, V37, P14477, DOI 10.1021/bi980777t; Panse VG, 2000, BIOCHEMISTRY-US, V39, P2362, DOI 10.1021/bi992484l; Panse VG, 2000, J BIOL CHEM, V275, P18698, DOI 10.1074/jbc.275.25.18698; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHULMAN BA, 1994, PROTEIN SCI, V3, P2226, DOI 10.1002/pro.5560031208; STALEY JP, 1992, P NATL ACAD SCI USA, V89, P1519, DOI 10.1073/pnas.89.5.1519; STALEY JP, 1994, PROTEIN SCI, V3, P1822, DOI 10.1002/pro.5560031021; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Sun JZ, 1999, BIOCHEMISTRY-US, V38, P3100, DOI 10.1021/bi982360t; Topping TB, 2001, J BIOL CHEM, V276, P7437, DOI 10.1074/jbc.M009584200; VOLODARSKY LB, 1988, IMIDAZOLINE NITROXID, V1; WEISS JB, 1990, J BACTERIOL, V172, P3023, DOI 10.1128/jb.172.6.3023-3029.1990; WENZEL HR, 1976, BIOCHIM BIOPHYS ACTA, V452, P292, DOI 10.1016/0005-2744(76)90179-0; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	44	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33681	33688		10.1074/jbc.M104466200	http://dx.doi.org/10.1074/jbc.M104466200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435433	hybrid			2022-12-27	WOS:000170910200054
J	dos Santos, GMA; ten Broeke, T; Strous, GJ				dos Santos, GMA; ten Broeke, T; Strous, GJ			Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal transduction via Janus kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED INTERNALIZATION; ACTIVATED PROTEIN-KINASE; JAK2 TYROSINE KINASE; EGF RECEPTOR; GH RECEPTOR; PHOSPHORYLATION; IDENTIFICATION; TRANSCRIPTION; CLATHRIN; DOMAINS	The ubiquitin-proteasome system is required in growth hormone receptor (GHR) endocytosis. For cytokine receptors, which lack intrinsic tyrosine kinase activity, signal transduction is initiated by the activation of a member of the Janus kinase (JAK) family. Previously, we have shown that GHR and JAK2 tyrosine (de) phosphorylation are regulated via the ubiquitin system. In this study, we examined the role of JAK2-mediated signal transduction in GHR internalization and downregulation. Mutation of the attachment site for JAK2, box-1, in the GHR cytoplasmic tail resulted in the complete absence of GHR and JAK2 phosphorylation. This modification did not alter the rate and extent of receptor-bound growth hormone internalization as compared with a functional GHR, nor did it change its turnover and transport to the plasma membrane. In addition, the receptor was still normally ubiquitinated and remained dependent on both an intact ubiquitin system and proteasomal action for its internalization. Thus, GHR ubiquitination, endocytosis, and degradation occur independently of GHR signal transduction via JAK2. We conclude that whereas endocytosis and degradation require the ubiquitin system, they are independent of GHR signal transduction.	Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Inst Biomembranes, NL-3584 CX Utrecht, Netherlands	Utrecht University	Strous, GJ (corresponding author), Univ Utrecht, Med Ctr, Dept Cell Biol, Heidelberglaan 100,AZU-G02525, NL-3584 CX Utrecht, Netherlands.							ALLEVATO G, 1995, J BIOL CHEM, V270, P17210, DOI 10.1074/jbc.270.29.17210; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Argetsinger LS, 1996, J BIOL CHEM, V271, P29415, DOI 10.1074/jbc.271.46.29415; Beckman DL, 1999, BLOOD, V94, P2667, DOI 10.1182/blood.V94.8.2667.420k27_2667_2675; BILLESTRUP N, 1995, P NATL ACAD SCI USA, V92, P2725, DOI 10.1073/pnas.92.7.2725; Carter-Su C, 1998, RECENT PROG HORM RES, V53, P61; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; COLOSI P, 1993, J BIOL CHEM, V268, P12617; dos Santos CMA, 2001, J BIOL CHEM, V276, P10839, DOI 10.1074/jbc.M003635200; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Finidori J, 2000, Vitam Horm, V59, P71, DOI 10.1016/S0083-6729(00)59004-9; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P2228, DOI 10.1210/en.135.5.2228; FREEDMAN NJ, 1996, RECENT PROG HORM RES, V51, P352; GOUJON L, 1994, P NATL ACAD SCI USA, V91, P957, DOI 10.1073/pnas.91.3.957; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Han YL, 1996, J BIOL CHEM, V271, P5947, DOI 10.1074/jbc.271.10.5947; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; KELLY PA, 1993, RECENT PROG HORM RES, V48, P123; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; MOLDRUP A, 1991, J BIOL CHEM, V266, P17441; MOLLER C, 1992, J BIOL CHEM, V267, P23403; MURPHY LJ, 1984, ENDOCRINOLOGY, V115, P1625, DOI 10.1210/endo-115-4-1625; ROUPAS P, 1988, MOL CELL ENDOCRINOL, V57, P93, DOI 10.1016/0303-7207(88)90037-8; Smit LS, 1996, MOL ENDOCRINOL, V10, P519, DOI 10.1210/me.10.5.519; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; SOTIROPOULOS A, 1994, ENDOCRINOLOGY, V135, P1292, DOI 10.1210/en.135.4.1292; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Strous GJ, 1997, J BIOL CHEM, V272, P40; Thirone ACP, 1999, ENDOCRINOLOGY, V140, P55, DOI 10.1210/en.140.1.55; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Vanderkuur JA, 1997, ENDOCRINOLOGY, V138, P4301, DOI 10.1210/en.138.10.4301; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; WANG YD, 1995, MOL ENDOCRINOL, V9, P303, DOI 10.1210/me.9.3.303; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4	35	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32635	32641		10.1074/jbc.M103583200	http://dx.doi.org/10.1074/jbc.M103583200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11418602	hybrid			2022-12-27	WOS:000170746000035
J	Esposito, D; Patel, P; Stephens, RM; Perez, P; Chao, MV; Kaplan, DR; Hempstead, BL				Esposito, D; Patel, P; Stephens, RM; Perez, P; Chao, MV; Kaplan, DR; Hempstead, BL			The cytoplasmic and transmembrane domains of the p75 and Trk a receptors regulate high affinity binding to nerve growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIN RECEPTOR; SIGNAL-TRANSDUCTION; NGF BINDING; LIGAND; MODULATION; ACTIVATION; GP75; IDENTIFICATION; ASSOCIATION; DISRUPTION	Ligand-induced receptor oligomerization is an established mechanism for receptor-tyrosine kinase activation. However, numerous receptor-tyrosine kinases are expressed in multicomponent complexes with other receptors that may signal independently or alter the binding characteristics of the receptor-tyrosine kinase. Nerve growth factor (NGF) interacts with two structurally unrelated receptors, the Trk A receptor-tyrosine kinase and p75, a tumor necrosis factor receptor family member. Each receptor binds independently to NGF with predominantly low affinity (K-d = 10(-9) M), but they produce high affinity binding sites (K-d = 10(-11) M) upon receptor co-expression. Here we provide evidence that the number of high affinity sites is regulated by the ratio of the two receptors and by specific domains of Trk A and p75. Co-expression of Trk A containing mutant transmembrane or cytoplasmic domains with p75 yielded reduced numbers of high affinity binding sites. Similarly, co-expression of mutant p75 containing altered transmembrane and cytoplasmic domains with Trk A also resulted in predominantly low affinity binding sites. Surprisingly, extracellular domain mutations of p75 that abolished NGF binding still generated high affinity binding with Trk A. These results indicate that the transmembrane and cytoplasmic domains of Trk A and p75 are responsible for high affinity site formation and suggest that p75 alters the conformation of Trk A to generate high affinity NGF binding.	Cornell Univ, Weill Med Coll, Div Hematol, New York, NY 10021 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2T5, Canada; NYU, Sch Med, Skirball Inst Mol Med, New York, NY 10016 USA; Univ Salamanca, Inst Microbiol Bioquim, E-37008 Salamanca, Spain; NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program, Frederick, MD 21701 USA	Cornell University; McGill University; New York University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Hempstead, BL (corresponding author), Cornell Univ, Weill Med Coll, Div Hematol, Rm C-606,1300 York Ave, New York, NY 10021 USA.	blhempst@mail.med.cornell.edu	Perez, Pilar/B-4948-2010	Perez, Pilar/0000-0003-3557-2247; Chao, Moses/0000-0002-6969-3744	NICHD NIH HHS [HD23315] Funding Source: Medline; NINDS NIH HHS [NS21072, NS3027] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS021072, R01NS021072] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALDWIN AN, 1992, J BIOL CHEM, V267, P8352; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BENLEVY R, 1992, J BIOL CHEM, V267, P17304; BERG MM, 1991, P NATL ACAD SCI USA, V88, P7106, DOI 10.1073/pnas.88.16.7106; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Dobrowsky RT, 1998, ANN NY ACAD SCI, V845, P32, DOI 10.1111/j.1749-6632.1998.tb09660.x; DONOVAN MJ, 1994, AM J PATHOL, V145, P792; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Frade JM, 1996, NATURE, V383, P166; Fuh G, 2000, J BIOL CHEM, V275, P26690; Gargano N, 1997, J NEUROSCI RES, V50, P1; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; PEREZ P, 1995, MOL CELL NEUROSCI, V6, P97, DOI 10.1006/mcne.1995.1010; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Ross AH, 1996, J CELL BIOL, V132, P945, DOI 10.1083/jcb.132.5.945; Ross GM, 1998, EUR J NEUROSCI, V10, P890, DOI 10.1046/j.1460-9568.1998.00094.x; RYDEN M, 1995, EMBO J, V14, P1979, DOI 10.1002/j.1460-2075.1995.tb07190.x; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SUTTER A, 1979, J BIOL CHEM, V254, P5972; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; URFER R, 1994, EMBO J, V13, P5896, DOI 10.1002/j.1460-2075.1994.tb06935.x; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Vesa J, 2000, J BIOL CHEM, V275, P24414, DOI 10.1074/jbc.M001641200; WOLF DE, 1995, J BIOL CHEM, V270, P2133, DOI 10.1074/jbc.270.5.2133; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; YAN H, 1991, J BIOL CHEM, V266, P12099; YAN H, 1991, SCIENCE, V252, P561, DOI 10.1126/science.1850551; Yano H, 2000, Pharm Acta Helv, V74, P253, DOI 10.1016/S0031-6865(99)00036-9	50	179	190	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32687	32695		10.1074/jbc.M011674200	http://dx.doi.org/10.1074/jbc.M011674200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435417	hybrid			2022-12-27	WOS:000170746000043
J	Heegaard, NHH; Sen, JW; Kaarsholm, NC; Nissen, MH				Heegaard, NHH; Sen, JW; Kaarsholm, NC; Nissen, MH			Conformational intermediate of the amyloidogenic protein beta(2)-microglobulin at neutral pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-2-MICROGLOBULIN; FIBRILLOGENESIS; BINDING; PURIFICATION; HEMODIALYSIS; TRANSITIONS; MECHANISMS; CONVERSION; PEPTIDES; LYSOZYME	Aggregation and fibrillation of beta (2)-microglobulin are hallmarks of dialysis-related amyloidosis. We characterize perturbations of the native conformation of beta (2)-microglobulin that may precede fibril formation. For a beta (2)-microglobulin variant cleaved at lysine 58, we show using capillary electrophoresis that two conformers spontaneously exist in aqueous buffers at neutral pH. Upon treatment of wild-type beta (2)-microglobulin with acetonitrile or trifluoroethanol, two conformations were also observed. These conformations were in equilibrium dependent on the sample temperature and the percentage of organic solvent present. Circular dichroism showed a loss of beta -structures and gain of alpha -helices. Reversal to the native conformation occurred when removing the organics. Affinity capillary electrophoresis experiments showed increased specific interactions of the nonnative beta (2)-microglobulin conformation with the dyes 8-anilino-1-naphthalene sulfonic acid and Congo red. The observations may relate to early folding events prior to amyloid fibrillation and facilitate the development of methods to detect and inhibit pro-amyloid protein and peptide conformations.	Univ Copenhagen, Inst Med Anat, DK-2200 Copenhagen N, Denmark; Novo Nordisk AS, Res & Dev, DK-2880 Bagsvaerd, Denmark; Statens Serum Inst, Dept Autoimmunol, DK-2300 Copenhagen S, Denmark	University of Copenhagen; Novo Nordisk; Statens Serum Institut	Heegaard, NHH (corresponding author), Bldg 81,Room 536,Artillerivej 5, DK-2300 Copenhagen S, Denmark.	nhe@ssi.dk	Nissen, Mogens/B-4825-2008	Nissen, Mogens/0000-0001-7729-8667				BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Brockwell DJ, 2000, CURR OPIN STRUC BIOL, V10, P16, DOI 10.1016/S0959-440X(99)00043-3; Campistol JM, 1996, KIDNEY INT, V50, P1262, DOI 10.1038/ki.1996.436; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Crawford F, 1998, FEBS LETT, V436, P445, DOI 10.1016/S0014-5793(98)01170-3; Damaschun G, 2000, PROTEINS, V39, P204, DOI 10.1002/(SICI)1097-0134(20000515)39:3<204::AID-PROT20>3.0.CO;2-8; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Gao JM, 1996, SCIENCE, V272, P535, DOI 10.1126/science.272.5261.535; Gast K, 1999, PROTEIN SCI, V8, P625; GEJYO F, 1986, NEW ENGL J MED, V314, P585; Goda S, 2000, PROTEIN SCI, V9, P369; GROSSMAN PD, 1989, ANAL BIOCHEM, V179, P28, DOI 10.1016/0003-2697(89)90195-4; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Heegaard NHH, 2000, J CHROMATOGR A, V894, P319, DOI 10.1016/S0021-9673(00)00579-3; HEEGAARD NHH, 2001, PROTEIN LIGAND INTER, P171; HILSER VJ, 1995, ANAL BIOCHEM, V224, P465, DOI 10.1006/abio.1995.1075; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Jadoul M, 1997, KIDNEY INT, V51, P1928, DOI 10.1038/ki.1997.262; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; LADEWIG P, 1945, NATURE, V156, P81, DOI 10.1038/156081a0; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Lim A, 2000, J STRUCT BIOL, V130, P363, DOI 10.1006/jsbi.2000.4272; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; MOORE AW, 1995, ANAL CHEM, V67, P3464, DOI 10.1021/ac00115a015; MULQUEEN PM, 1982, ARCH BIOCHEM BIOPHYS, V215, P28, DOI 10.1016/0003-9861(82)90275-2; NISSEN MH, 1987, EUR J BIOCHEM, V163, P21, DOI 10.1111/j.1432-1033.1987.tb10731.x; NISSEN MH, 1990, EUR J BIOCHEM, V189, P423, DOI 10.1111/j.1432-1033.1990.tb15505.x; Nissen MH, 1997, J IMMUNOL METHODS, V205, P29; OKON M, 1992, BIOCHEMISTRY-US, V31, P8906, DOI 10.1021/bi00152a030; OZASA H, 1989, NEPHRON, V53, P87, DOI 10.1159/000185712; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; THOMAS PD, 1993, PROTEIN SCI, V2, P2050, DOI 10.1002/pro.5560021206; Verzola B, 2000, ANAL BIOCHEM, V282, P239, DOI 10.1006/abio.2000.4620; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Westermark P, 1999, AMYLOID, V6, P151, DOI 10.3109/13506129909007319	43	53	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32657	32662		10.1074/jbc.M104452200	http://dx.doi.org/10.1074/jbc.M104452200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11418618	hybrid			2022-12-27	WOS:000170746000038
J	Wong, PMC; Yuan, Q; Chen, H; Sultzer, BM; Chung, SW				Wong, PMC; Yuan, Q; Chen, H; Sultzer, BM; Chung, SW			A single point mutation at the 3 '-untranslated region of Ran mRNA leads to profound changes in lipopolysaccharide endotoxin-mediated responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; BICOID MESSENGER-RNA; TOLL-LIKE RECEPTOR-2; FACTOR-ALPHA PRODUCTION; GENETIC-CONTROL; HEMATOPOIETIC-CELLS; BINDING PROTEIN; CUTTING EDGE; BACTERIAL LIPOPOLYSACCHARIDES; INTERLEUKIN-3 GENE	By functional cDNA expression cloning, we have previously established that Ran is important in lipopolysaccharide (LPS) signaling. This was achieved by functional comparison between two cDNAs, differing by a single base substitution within the 3'-untranslated region of the cDNA. This point mutation results in a striking RNA conformational change. No dramatic difference in total RNA at steady state could be found between the two molecules. However, at the protein level, RanC/d (from 870C mRNA) was 5-10-fold higher than RanT/n (from 870T mRNA) and this difference was not observed in non-hematopoietic cells transduced with the same vectors. This tissue-specific difference correlated with a difference in LPS endotoxin responses in corresponding hematopoietic cells. Importantly, the amounts of RanC/d and RanT/n proteins were similar initially but the difference became obvious with time. Both Ran proteins migrated from the cytoplasm to the nucleus, but Ran from RanC/d migrated faster than that of RanT/n. RanT/n protein preferentially remained in the cytoplasm and its overall amount was reduced at steady state, consistent with its degradation by intracellular proteases known to be involved in LPS-mediated signal transduction. As the two proteins are identical, the faster RanC/d nuclear localization and a preferred initial cytoplasmic RanT/n distribution suggest a difference in mRNA intracellular localization between the two molecules, as dictated by their RNA structural difference. By pulse-chase experiments, RanC/d proteins are more resistant to degradation than RanT/n protein; there also appear to have two populations of RanT/n proteins, one may reside in the cytoplasm and the other, in the nucleus. More RanC/d GTPase accumulated in the nuclei would conceivably alter the potency of signal transduction and therefore down-modulate LPS-mediated biological responses.	Temple Univ, Sch Med, Dept Pathol & Lab Med, Fels Inst, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wong, PMC (corresponding author), Temple Univ, Sch Med, Dept Pathol & Lab Med, Fels Inst, 3307 N Broad St,AHB,Rm 552, Philadelphia, PA 19140 USA.	Petermcw@aol.com	Yuan, Quan/E-7688-2013		NATIONAL CANCER INSTITUTE [R01CA070854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039159, R01AI045951] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA70854] Funding Source: Medline; NIAID NIH HHS [R01AI39159, R01AI45951] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bassell GJ, 1998, J NEUROSCI, V18, P251; BROWDER TM, 1989, MOL CELL BIOL, V9, P204, DOI 10.1128/MCB.9.1.204; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COUTAVAS EE, 1994, MAMM GENOME, V5, P623, DOI 10.1007/BF00411457; Daniel R, 1996, CELL GROWTH DIFFER, V7, P1141; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; DODON MD, 1985, INFECT IMMUN, V49, P709, DOI 10.1128/IAI.49.3.709-714.1985; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; FAHMI H, 1993, J LEUKOCYTE BIOL, V53, P45, DOI 10.1002/jlb.53.1.45; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Garcia-Sanz Jose A., 1997, P425; Gautreau D, 1997, DEVELOPMENT, V124, P5013; GOLDE LM, 1976, J IMMUNOL, V117, P2061; Goldfarb DS, 1997, SCIENCE, V276, P1814, DOI 10.1126/science.276.5320.1814; HAN XD, 1995, P NATL ACAD SCI USA, V92, P11014, DOI 10.1073/pnas.92.24.11014; Havin L, 1998, GENE DEV, V12, P1593, DOI 10.1101/gad.12.11.1593; Hazelrigg T, 1998, CELL, V95, P451, DOI 10.1016/S0092-8674(00)81613-X; Haziot A, 1998, J IMMUNOL, V160, P2570; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jin FY, 1999, J IMMUNOL, V162, P3596; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kang AD, 1996, INFECT IMMUN, V64, P4612, DOI 10.1128/IAI.64.11.4612-4617.1996; KAPLAN JG, 1974, EXP CELL RES, V88, P388, DOI 10.1016/0014-4827(74)90257-2; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kislauskis Edward H., 1992, Current Opinion in Cell Biology, V4, P975, DOI 10.1016/0955-0674(92)90128-Y; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Koepp DM, 1996, CELL, V87, P1, DOI 10.1016/S0092-8674(00)81315-X; KROL A, 1989, METHOD ENZYMOL, V180, P212; KU GSB, 1983, J IMMUNOL, V131, P2494; KUUSREICHEL K, 1986, J IMMUNOL, V137, P472; Macdonald PM, 1998, MOL CELL BIOL, V18, P3788, DOI 10.1128/MCB.18.7.3788; MACDONALD PM, 1995, P NATL ACAD SCI USA, V92, P10787, DOI 10.1073/pnas.92.23.10787; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Modlin RL, 1999, NEW ENGL J MED, V340, P1834, DOI 10.1056/NEJM199906103402312; MOORE MS, 1994, TRENDS BIOCHEM SCI, V19, P211, DOI 10.1016/0968-0004(94)90024-8; Moore MS, 1996, SCIENCE, V272, P47, DOI 10.1126/science.272.5258.47; NORDAN RP, 1987, J IMMUNOL, V139, P813; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; PAIGE CJ, 1978, J IMMUNOL, V121, P641; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; ROSENSTREICH DL, 1978, J IMMUNOL, V121, P1664; ROSS K, 1997, SITES, V1, P17; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; SULTZER BM, 1972, INFECT IMMUN, V5, P107, DOI 10.1128/IAI.5.1.107-113.1972; SULTZER BM, 1968, NATURE, V219, P1253, DOI 10.1038/2191253a0; SULTZER BM, 1976, INFECT IMMUN, V13, P1579, DOI 10.1128/IAI.13.6.1579-1584.1976; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; VISCHER TL, 1974, J IMMUNOL, V113, P58; Vogel SN, 1999, J IMMUNOL, V162, P5666; WATSON J, 1978, J EXP MED, V147, P39, DOI 10.1084/jem.147.1.39; WATSON J, 1977, J IMMUNOL, V118, P2088; WATSON J, 1974, J EXP MED, V140, P1147, DOI 10.1084/jem.140.5.1147; WATSON J, 1977, J IMMUNOL, V120, P422; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; WONG BY, 1994, J VIROL, V68, P5523, DOI 10.1128/JVI.68.9.5523-5531.1994; Wong PMC, 2000, SCAND J IMMUNOL, V51, P123; Wong PMC, 1999, P NATL ACAD SCI USA, V96, P11543, DOI 10.1073/pnas.96.20.11543; WONG PMC, 1989, MOL CELL BIOL, V9, P798, DOI 10.1128/MCB.9.2.798; WONG PMC, 1987, GENE DEV, V1, P358, DOI 10.1101/gad.1.4.358; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yuan Q, 2000, P NATL ACAD SCI USA, V97, P2852, DOI 10.1073/pnas.040567797; Zhao FP, 2001, J ENDOTOXIN RES, V7, P53, DOI 10.1179/096805101101532549	73	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33129	33138		10.1074/jbc.M105400200	http://dx.doi.org/10.1074/jbc.M105400200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11429415	hybrid			2022-12-27	WOS:000170746000099
J	McNamara-Schroeder, KJ; Hennessey, RF; Harding, GA; Jensen, RC; Stumph, WE				McNamara-Schroeder, KJ; Hennessey, RF; Harding, GA; Jensen, RC; Stumph, WE			The Drosophila U1 and U6 gene proximal sequence elements act as important determinants of the RNA polymerase specificity of small nuclear RNA gene promoters in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' END FORMATION; SEA-URCHIN U1; SNRNA GENE; BINDING-PROTEIN; IN-VITRO; TATA BOX; DISTAL ELEMENTS; U2 SNRNA; TRANSCRIPTION; EXPRESSION	Transcription of genes coding for metazoan spliceosomal snRNAs by RNA polymerase II (U1, U2, U4, U5) or RNA. polymerase III (U6) is dependent upon a unique, positionally conserved regulatory element referred to as the proximal sequence element (PSE). Previous studies in the organism Drosophila melanogaster indicated that as few as three nucleotide differences in the sequences of the U1 and U6 PSEs can play a decisive role in recruiting the different RNA polymerases to transcribe the U1 and U6 snRNA genes in vitro. Those studies utilized constructs that contained only the minimal promoter elements of the U1 and U6 genes in an artificial context. To overcome the limitations of those earlier studies, we have now performed experiments that demonstrate that the Drosophila U1 and U6 PSEs have functionally distinct properties even in the environment of the natural U1 and U6 gene 5 ' -flanking DNAs. Moreover, assays in cells and in transgenic flies indicate that expression of genes from promoters that contain the "incorrect" PSE is suppressed in vivo. The Drosophila U6 PSE is incapable of recruiting RNA polymerase II to initiate transcription from the U1 promoter region, and the U1 PSE is unable to recruit RNA polymerase III to transcribe the U6 gene.	San Diego State Univ, Dept Chem, San Diego, CA 92182 USA; San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Stumph, WE (corresponding author), San Diego State Univ, Dept Chem, 5500 Campanile Dr, San Diego, CA 92182 USA.							Bartlett JS, 1996, P NATL ACAD SCI USA, V93, P8852, DOI 10.1073/pnas.93.17.8852; Boyd DC, 2000, GENE, V247, P33, DOI 10.1016/S0378-1119(00)00134-7; BURNOL AF, 1993, NATURE, V362, P475, DOI 10.1038/362475a0; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; DAHLBERG JE, 1991, SCIENCE, V254, P1462, DOI 10.1126/science.1962205; DAHLBERG JE, 1988, NUCLEIC ACIDS RES, V16, P5827, DOI 10.1093/nar/16.13.5827; Dahlberg JE, 1988, STRUCTURE FUNCTION M, P38, DOI [10.1007/978-3-642- 73020-7_2, DOI 10.1007/978-3-642-73020-7_2]; DAS G, 1987, J BIOL CHEM, V262, P1187; *FLYB CONS, 1997, DROS INF SERV, V78, P372; GERLACH VL, 1995, MOL CELL BIOL, V15, P1455; Goodall GJ, 1991, OXFORD SURVEYS PLANT, V7, P255; Hardin SB, 2000, NUCLEIC ACIDS RES, V28, P2771, DOI 10.1093/nar/28.14.2771; Hernandez N, 1992, TRANSCRIPTIONAL REGU, P281; Jensen RC, 1998, NUCLEIC ACIDS RES, V26, P616, DOI 10.1093/nar/26.2.616; KADONAGA JT, 1990, J BIOL CHEM, V265, P2624; KISS T, 1991, CELL, V65, P517, DOI 10.1016/0092-8674(91)90469-F; Kunkel GR, 1998, NUCLEIC ACIDS RES, V26, P1536, DOI 10.1093/nar/26.6.1536; Kunkel GR, 1996, GENE EXPRESSION, V6, P59; Li JM, 1996, MOL CELL BIOL, V16, P1275; LI JM, 1994, MOL CELL BIOL, V14, P2191, DOI 10.1128/MCB.14.3.2191; LOBO SM, 1989, CELL, V58, P55, DOI 10.1016/0092-8674(89)90402-9; LOBO SM, 1994, TRANSCRIPTION MECH R, P127; MATTAJ IW, 1988, CELL, V55, P435, DOI 10.1016/0092-8674(88)90029-3; PARRY HD, 1989, NUCLEIC ACIDS RES, V17, P3633, DOI 10.1093/nar/17.10.3633; PARRY HD, 1989, TRENDS BIOCHEM SCI, V14, P15, DOI 10.1016/0968-0004(89)90083-2; PILCH DR, 1991, GENE EXPRESSION, V1, P41; Ramamurthy L, 1996, NUCLEIC ACIDS RES, V24, P4525, DOI 10.1093/nar/24.22.4525; ROEBUCK KA, 1990, MOL CELL BIOL, V10, P341, DOI 10.1128/MCB.10.1.341; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schaub M, 1997, EMBO J, V16, P173, DOI 10.1093/emboj/16.1.173; STEFANOVIC B, 1992, MOL CELL BIOL, V12, P650, DOI 10.1128/MCB.12.2.650; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; Stunkel W, 1997, MOL CELL BIOL, V17, P4397; Su Y, 1997, EUR J BIOCHEM, V248, P231, DOI 10.1111/j.1432-1033.1997.t01-1-00231.x; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; VANKAN P, 1989, EMBO J, V8, P3875, DOI 10.1002/j.1460-2075.1989.tb08566.x; WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451; WAIBEL F, 1990, NATURE, V346, P199, DOI 10.1038/346199a0; Wang Y, 1998, MOL CELL BIOL, V18, P1570, DOI 10.1128/MCB.18.3.1570; Wang Y, 1996, NUCLEIC ACIDS RES, V24, P3100, DOI 10.1093/nar/24.15.3100; WENDELBURG BJ, 1992, NUCLEIC ACIDS RES, V20, P3743, DOI 10.1093/nar/20.14.3743; ZAMROD Z, 1993, MOL CELL BIOL, V13, P5918, DOI 10.1128/MCB.13.9.5918	42	24	26	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31786	31792		10.1074/jbc.M101273200	http://dx.doi.org/10.1074/jbc.M101273200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11431466	hybrid			2022-12-27	WOS:000170613500043
J	Miranda-Vizuete, A; Ljung, J; Damdimopoulos, AE; Gustafsson, JA; Oko, R; Pelto-Huikko, M; Spyrou, G				Miranda-Vizuete, A; Ljung, J; Damdimopoulos, AE; Gustafsson, JA; Oko, R; Pelto-Huikko, M; Spyrou, G			Characterization of Sptrx, a novel member of the thioredoxin family specifically expressed in human spermatozoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN; PROTEIN; SPERM; CLONING; GENE; SEQUENCES; REDUCTASE; DATABASE; REGION; SHEATH	Thioredoxins (Trx) are small ubiquitous proteins that participate in different cellular processes via redox-mediated reactions. We report here the identification and characterization of a novel member of the thioredoxin family in humans, named Sptrx ( perm-specific trx), the first with a tissue-specific distribution, located exclusively in spermatozoa. Sptrx open reading frame encodes for a protein of 486 amino acids composed of two clear domains: an N-terminal domain consisting of 23 highly conserved repetitions of a 15-residue motif and a C-terminal domain typical of thioredoxins. Northern analysis and in situ hybridization shows that Sptrx mRNA is only expressed in human testis, specifically in round and elongating spermatids. Immunostaining of human testis sections identified Sptrx protein in spermatids, while immunofluorescence and immunogold electron microscopy analysis demonstrated Sptrx localization in the cytoplasmic droplet of ejaculated sperm. Sptrx appears to have a multimeric structure in native conditions and is able to reduce insulin disulfide bonds in the presence of NADPH and thioredoxin reductase. During mammalian spermiogenesis in testis seminiferous tubules and later maturation in epididymis, extensive reorganization of disulfide bonds is required to stabilize cytoskeletal sperm structures. However, the molecular mechanisms that control these processes are not known. The identification of Sptrx with an expression pattern restricted to the postmeiotic phase of spermatogenesis, when the sperm tail is organized, suggests that Sptrx might be an important factor in regulating critical steps of human spermiogenesis.	Karolinska Inst, Novum, Dept Biosci, Ctr Biotechnol, S-14157 Huddinge, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada; Tampere Univ, Sch Med, Dept Dev Biol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, FIN-33101 Tampere, Finland	Karolinska Institutet; Karolinska Institutet; Queens University - Canada; Tampere University; Tampere University; Tampere University Hospital	Miranda-Vizuete, A (corresponding author), Karolinska Inst, Novum, Dept Biosci, Ctr Biotechnol, S-14157 Huddinge, Sweden.	anmi@biosci.ki.se	IBIS, REDOX/J-7473-2017; Miranda-Vizuete, Antonio/D-6927-2012	Miranda-Vizuete, Antonio/0000-0002-6856-5396; Damdimopoulos, Anastasios/0000-0003-4425-1189				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Avellar MCW, 1997, J BIOL CHEM, V272, P17623, DOI 10.1074/jbc.272.28.17623; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; Brewis IA, 1999, REV REPROD, V4, P135; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; CHEMES HE, 1987, FERTIL STERIL, V48, P664; Curry M., 1995, GAMETES SPERMATOZOON, P45; Eddy E. M., 1994, P29; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; HARENDZA CJ, 1990, P NATL ACAD SCI USA, V87, P2531, DOI 10.1073/pnas.87.7.2531; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Iguchi N, 1999, FEBS LETT, V456, P315, DOI 10.1016/S0014-5793(99)00967-9; JULIEN JP, 1988, GENE, V68, P307, DOI 10.1016/0378-1119(88)90033-9; KONONEN J, 1997, TECHNICAL TIPS ONLIN; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Miranda-Vizuete A, 2000, ANTIOXID REDOX SIGN, V2, P801, DOI 10.1089/ars.2000.2.4-801; O'Bryan MK, 2001, MOL REPROD DEV, V58, P116, DOI 10.1002/1098-2795(200101)58:1&lt;116::AID-MRD14&gt;3.0.CO;2-8; O'Rand MG, 2000, SERONO SYMP, P143; Oko R, 1998, ANDROLOGIA, V30, P193; RAINES CA, 1991, PLANT MOL BIOL, V16, P663, DOI 10.1007/BF00023430; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rybnikova E, 2000, EUR J NEUROSCI, V12, P1669, DOI 10.1046/j.1460-9568.2000.00059.x; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Shao XP, 1997, J BIOL CHEM, V272, P6105, DOI 10.1074/jbc.272.10.6105; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sutovsky P, 2001, HUM REPROD, V16, P250, DOI 10.1093/humrep/16.2.250; Sutovsky P, 1997, MOL REPROD DEV, V47, P79, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;79::AID-MRD11&gt;3.0.CO;2-V; TONISSEN KF, 1991, GENE, V102, P221, DOI 10.1016/0378-1119(91)90081-L; Tseng TC, 1998, DNA CELL BIOL, V17, P823, DOI 10.1089/dna.1998.17.823; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; WOLLMAN E, 1938, J BIOL CHEM, V263, P15506; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	38	120	130	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31567	31574		10.1074/jbc.M101760200	http://dx.doi.org/10.1074/jbc.M101760200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11399755	hybrid, Green Submitted			2022-12-27	WOS:000170613500015
J	Orzech, E; Livshits, L; Leyt, J; Okhrimenko, H; Reich, V; Cohen, S; Weiss, A; Melamed-Book, N; Lebendiker, M; Altschuler, Y; Aroeti, B				Orzech, E; Livshits, L; Leyt, J; Okhrimenko, H; Reich, V; Cohen, S; Weiss, A; Melamed-Book, N; Lebendiker, M; Altschuler, Y; Aroeti, B			Interactions between adaptor protein-1 of the clathrin coat and microtubules via type 1a microtubule-associated proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; POLARIZED EPITHELIAL-CELLS; BREFELDIN-A CAUSES; GAMMA-ADAPTIN; MDCK CELLS; KINESIN; ENDOSOMES; BINDING; PHOSPHORYLATION; REDISTRIBUTION	The classical view suggests that adaptor proteins of the clathrin coat mediate the sorting of cargo protein passengers into clathrin-coated pits and the recruitment of clathrin into budding areas in the donor membrane. In the present study, we provide biochemical and morphological evidence that the adaptor protein 1 (AP-1) adaptor of the trans-Golgi network clathrin interacts with microtubules. AP-1 in cytosolic extracts interacted with in vitro assembled microtubules, and these interactions were inhibited by ATP depletion of the extracts or in the presence of 5 ' -adenylylimidodiphosphate. An overexpressed gamma -subunit of the AP-1 complex associated with microtubules, suggesting that this subunit may mediate the interaction of AP-1 with the cytoskeleton. Purified AP-1 did not interact with purified microtubules, but interaction occurred when an isolated microtubule-associated protein fraction was added to the reaction mix. The gamma -adaptin subunit of AP-1 specifically co-immunoprecipitated with a microtubule-associated protein of type la from rat brain cytosol. This suggests that type la microtubule-associated protein may mediate the association of AP-1 with microtubules in the cytoplasm. The microtubule binding activity of AP-1 was markedly inhibited in cytosol of mitotic cells. By means of its interaction with microtubule-associated proteins, we propose novel roles for AP-1 adaptors in modulating the dynamics of the cytoskeleton, the stability and shape of coated organelles, and the loading of nascent AP-1-coated vesicles onto appropriate microtubular tracks.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Life Sci, Prot Purificat Unit, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Life Sci, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; Jerusalem Coll Technol, Dept Elect, IL-91160 Jerusalem, Israel; Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Aroeti, B (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel.							Apodaca G, 1996, EMBO J, V15, P1471, DOI 10.1002/j.1460-2075.1996.tb00491.x; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; AROETI B, 1993, J CELL BIOL, V123, P1149, DOI 10.1083/jcb.123.5.1149; Bashour AM, 1998, J BIOL CHEM, V273, P19612, DOI 10.1074/jbc.273.31.19612; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; BLOOM GS, 1984, J CELL BIOL, V98, P331, DOI 10.1083/jcb.98.1.331; BLOOM GS, 1999, GUIDEBOOK CYTOSKELET, P206; Bohm K J, 1991, Acta Histochem Suppl, V41, P65; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; CLUETT EB, 1993, J CELL BIOL, V120, P15, DOI 10.1083/jcb.120.1.15; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Fujii T, 1996, NEUROCHEM INT, V28, P535, DOI 10.1016/0197-0186(95)00128-X; Godi A, 1999, BIOCHEM SOC T, V27, P638, DOI 10.1042/bst0270638; Hannan LA, 1998, MOL BIOL CELL, V9, P2217, DOI 10.1091/mbc.9.8.2217; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Holleran EA, 1998, TRENDS CELL BIOL, V8, P26, DOI 10.1016/S0962-8924(97)01195-1; Huang KM, 1999, EMBO J, V18, P3897, DOI 10.1093/emboj/18.14.3897; KEON JPR, 1995, GENE, V162, P141, DOI 10.1016/0378-1119(95)00355-A; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Lane J, 1998, BBA-REV BIOMEMBRANES, V1376, P27, DOI 10.1016/S0304-4157(97)00010-5; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 1998, TRENDS CELL BIOL, V8, P40, DOI 10.1016/S0962-8924(97)01189-6; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MANFREDI JJ, 1987, J BIOL CHEM, V262, P1218; MELKI R, 1989, BIOCHEMISTRY-US, V28, P9143, DOI 10.1021/bi00449a028; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Orzech E, 2000, J BIOL CHEM, V275, P15207, DOI 10.1074/jbc.275.20.15207; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; Parnas D, 1995, INT J DEV NEUROSCI, V13, P767, DOI 10.1016/0736-5748(95)00052-6; Prigozina NL, 1996, CELL BIOL INT, V20, P379, DOI 10.1006/cbir.1996.0045; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; REAVES B, 1992, J CELL BIOL, V116, P85, DOI 10.1083/jcb.116.1.85; Robertson AM, 2000, MOL BIOL CELL, V11, P941, DOI 10.1091/mbc.11.3.941; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; VONMASSOW A, 1989, CELL MOTIL CYTOSKEL, V14, P562, DOI 10.1002/cm.970140413; WAGNER M, 1994, J CELL SCI, V107, P933; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; WILLIAMS R C JR, 1992, P151; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	58	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31340	31348		10.1074/jbc.M101054200	http://dx.doi.org/10.1074/jbc.M101054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418592	hybrid			2022-12-27	WOS:000170472900098
J	Bisaillon, M; Shuman, S				Bisaillon, M; Shuman, S			Functional groups required for the stability of yeast RNA triphosphatase in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE TRIPHOSPHATASE; CAPPING APPARATUS; COMPONENT; 5'-TRIPHOSPHATASE; MECHANISM; SUBUNIT	Cet1, the RNA triphosphatase component of the yeast mRNA capping apparatus, catalyzes metal-dependent T-phosphate hydrolysis within the hydrophilic interior of an eight-strand beta barrel (the "triphosphate tunnel"), which rests upon a globular protein core (the "pedestal"). We performed a structure-guided alanine scan of 17 residues located in the tunnel (Ser(373), Thr(375), Gln(405), His(411), ser(429), Glu(488), Thr(490)), on the tunnel's outer surface (Ser(378), Ser(487), Thr(489), His(491)), at the tunnel-pedestal interface (IIe(304), Met(308)) and in the pedestal (Asp(315), Lys(317) Arg(321), Asp(425)). Alanine mutations at 14 positions had no significant effect on Cet1 phosphohydrolase activity in vitro and had no effect on Cet1 function in vivo. Two of the mutations (R321A and D425A) elicited a thermosensitive (ts) yeast growth phenotype. The R321A and D425A proteins had full phosphohydrolase activity in vitro, but were profoundly thermolabile. Arg(321) and Asp(425) interact to form a salt bridge within the pedestal that, tethers two of the strands of the tunnel. Mutations R321Q and D411N resulted in ts defects in vivo and in vitro, as did the double-mutant R321A-D435A, whereas the R321K protein was fully stable in vivo and in vitro. These results highlight the critical role of the buried salt bridge in Cet1 stability. Replacement of Ser(429) by alanine or valine elicited a cold-sensitive (es) yeast growth phenotype. The S429A and S429V proteins were fully active when produced in bacteria at 37 degreesC,, but were inactive when produced at 17 degreesC. Replacement of Ser(429) by threonine partially suppressed the cold sensitivity of the Cet1 phosphohydrolase, but did not suppress the cs growth defect in yeast.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52470] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bisaillon M, 2001, J BIOL CHEM, V276, P17261, DOI 10.1074/jbc.M100980200; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gross CH, 1998, J VIROL, V72, P10020, DOI 10.1128/JVI.72.12.10020-10028.1998; Ho CK, 2001, P NATL ACAD SCI USA, V98, P3050, DOI 10.1073/pnas.061636198; Ho CK, 1998, J BIOL CHEM, V273, P34151, DOI 10.1074/jbc.273.51.34151; Ho CK, 2001, J VIROL, V75, P1744, DOI 10.1128/JVI.75.4.1744-1750.2001; Ho CK, 1998, MOL CELL BIOL, V18, P5189, DOI 10.1128/MCB.18.9.5189; Ho CK, 2000, J VIROL, V74, P5486, DOI 10.1128/JVI.74.12.5486-5494.2000; Jin JP, 1998, J VIROL, V72, P10011, DOI 10.1128/JVI.72.12.10011-10019.1998; Lehman K, 2001, J BIOL CHEM, V276, P14996, DOI 10.1074/jbc.M100588200; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Pei Y, 2000, NUCLEIC ACIDS RES, V28, P1885, DOI 10.1093/nar/28.9.1885; Pei Y, 1999, J BIOL CHEM, V274, P28865, DOI 10.1074/jbc.274.41.28865; Pei Y, 2001, NUCLEIC ACIDS RES, V29, P387, DOI 10.1093/nar/29.2.387; Rodriguez CR, 1999, NUCLEIC ACIDS RES, V27, P2181, DOI 10.1093/nar/27.10.2181; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V239, P116, DOI 10.1006/bbrc.1997.7439	17	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30514	30520		10.1074/jbc.M104936200	http://dx.doi.org/10.1074/jbc.M104936200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395522	hybrid			2022-12-27	WOS:000170558000119
J	Eto, M; Kitazawa, T; Yazawa, A; Mukai, H; Ono, Y; Brautigan, DL				Eto, M; Kitazawa, T; Yazawa, A; Mukai, H; Ono, Y; Brautigan, DL			Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; VASCULAR SMOOTH-MUSCLE; SULFATE-POLYACRYLAMIDE GEL; RHO-KINASE; CA2+ SENSITIZATION; CALCIUM SENSITIZATION; SIGNAL-TRANSDUCTION; ANGIOTENSIN-II; IN-VIVO; ACTIVATION	Histamine stimulus triggers inhibition of myosin phosphatase-enhanced phosphorylation of myosin and contraction of vascular smooth muscle. In response to histamine stimulation of intact femoral artery, a smooth muscle-specific protein called CPI-17 (for protein kinase C-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kDa) is phosphorylated and converted to a potent inhibitor for myosin phosphatase. Phosphorylation of CPI-17 is diminished by pretreatment with either Y27632 or GF109203x, suggesting involvement of multiple kinases (Kitazawa, T., Eto, M., Woodsome, T. P., and Brautigan, D. L. (2000) J. Biol. Chem. 275, 9897-9900). Here we purified and identified CPI-17 kinases endogenous to pig artery that phosphorylate CPI-17. DEAE-Toyopearl column chromatography of aorta extracts separated two CPI-17 kinases. One kinase was protein kinase C (PKC) alpha, and the second kinase was purified to homogeneity as a 45-kDa protein, and identified by sequencing as PKC delta. Purified PKC delta was 3-fold more reactive with CPI-17 compared with myelin basic protein, whereas purified PKC alpha and recombinant RhoA-activated kinases (Rho-associated coiled-coil forming protein Ser/Thr kinase and protein kinase N) showed equal activity with CPI-17 and myelin basic protein. Y27632 inhibited CPI-17 phosphorylation by purified PKC delta with IC50 of 0.6 mum (in the presence of 0.1 mm ATP) or 14 mum (2.0 mm ATP). Y27632 significantly suppressed CPI-17 phosphorylation in smooth muscle cells, and the contraction of permeabilized rabbit femoral artery induced by stimulation with phorbol ester. GF109203x inhibited phorbol ester-induced contraction of rabbit femoral artery by 80%, whereas a PKC alpha/beta inhibitor, Go6976, reduced contraction by 47%. The results imply that histamine stimulation elicits contraction of vascular smooth muscle through activation of PKCa and especially PKC delta to phosphorylate CPI-17.	Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Georgetown Univ, Sch Med, Dept Physiol & Biophys, Washington, DC 20007 USA; Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 6578501, Japan	University of Virginia; Georgetown University; Hokkaido University; Kobe University	Eto, M (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Box 800577,MSB7225, Charlottesville, VA 22908 USA.	me2h@virginia.edu	Eto, Masumi/ABE-4700-2020	Eto, Masumi/0000-0002-0651-5836; Mukai, Hideyuki/0000-0002-0167-8695	NCI NIH HHS [CA40042] Funding Source: Medline; NHLBI NIH HHS [HL51824] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051824] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; ASSENDER JW, 1994, FEBS LETT, V342, P76, DOI 10.1016/0014-5793(94)80588-1; DIANOUX AC, 1989, BIOCHEMISTRY-US, V28, P424, DOI 10.1021/bi00428a003; DIXON BS, 1994, AM J PHYSIOL, V266, pC1406, DOI 10.1152/ajpcell.1994.266.5.C1406; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2000, CELL MOTIL CYTOSKEL, V46, P222, DOI 10.1002/1097-0169(200007)46:3<222::AID-CM6>3.3.CO;2-2; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; FRIEDENAUER S, 1989, ANAL BIOCHEM, V178, P263, DOI 10.1016/0003-2697(89)90636-2; Fu XH, 1998, FEBS LETT, V440, P183, DOI 10.1016/S0014-5793(98)01455-0; Fujihara H, 1997, MOL BIOL CELL, V8, P2437, DOI 10.1091/mbc.8.12.2437; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Gong MC, 1997, J BIOL CHEM, V272, P10704; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hamaguchi T, 2000, BIOCHEM BIOPH RES CO, V274, P825, DOI 10.1006/bbrc.2000.3225; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; Hill SJ, 1997, PHARMACOL REV, V49, P253; HIRATA K, 1992, J BIOL CHEM, V267, P8719; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; Iizuka K, 1999, BRIT J PHARMACOL, V128, P925, DOI 10.1038/sj.bjp.0702864; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; ITOH H, 1993, AM J PHYSIOL, V265, pC1319; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KHALIL RA, 1992, AM J PHYSIOL, V263, pC714, DOI 10.1152/ajpcell.1992.263.3.C714; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; KUBOTA Y, 1992, AM J PHYSIOL, V262, pC405, DOI 10.1152/ajpcell.1992.262.2.C405; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le YH, 1999, J PHYSIOL-LONDON, V517, P709, DOI 10.1111/j.1469-7793.1999.0709s.x; Li L, 1998, J PHYSIOL-LONDON, V508, P871, DOI 10.1111/j.1469-7793.1998.871bp.x; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MacDonald JA, 2001, FEBS LETT, V493, P91, DOI 10.1016/S0014-5793(01)02277-3; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MASUO M, 1994, J GEN PHYSIOL, V104, P265, DOI 10.1085/jgp.104.2.265; Nagumo H, 2000, AM J PHYSIOL-CELL PH, V278, pC57, DOI 10.1152/ajpcell.2000.278.1.C57; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; NISHIMURA J, 1988, BIOCHEM BIOPH RES CO, V157, P677, DOI 10.1016/S0006-291X(88)80303-6; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; Senba S, 1999, J BIOCHEM-TOKYO, V125, P354, DOI 10.1093/oxfordjournals.jbchem.a022294; Somlyo AP, 1998, ACTA PHYSIOL SCAND, V164, P437; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Sward K, 2000, J PHYSIOL-LONDON, V522, P33, DOI 10.1111/j.1469-7793.2000.0033m.x; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TRINKLEMULCAHY L, 1995, J BIOL CHEM, V270, P18191, DOI 10.1074/jbc.270.31.18191; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Walsh MP, 1996, BIOCHEM CELL BIOL, V74, P485, DOI 10.1139/o96-053; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; WOODSOME TP, 2001, IN PRESS J PHYSL	56	180	183	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29072	29078		10.1074/jbc.M103206200	http://dx.doi.org/10.1074/jbc.M103206200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11397799	hybrid			2022-12-27	WOS:000170346000060
J	Lee, SH; Stehlik, C; Reed, JC				Lee, SH; Stehlik, C; Reed, JC			COP, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE DEFICIENT; INTERLEUKIN-1; MECHANISMS; ENZYME; APOPTOSIS; MORTALITY; PATHWAY	The production of bio-active interleukin-1 beta (IL-1 beta), a pro-inflammatory cytokine, is mediated by activated caspase-1. One of the known molecular mechanisms underlying pro-caspase-1 processing and activation involves binding of the caspase-1 prodomain to a caspase recruitment domain (CARD)-containing serine/threonine kinase known as RIP2/CARDIAK/RICK. We have identified a novel protein, COP (CARD only protein), which has a high degree of sequence identity to the caspase-1 prodomain. COP binds to both RIP2 and the caspase-1 prodomain and inhibits RIP2-induced caspase-1 oligomerization. COP inhibits caspase1-induced IL-1 beta secretion as well as lipopolysaccharide-induced IL-1 beta secretion in transfected cells. Our data indicate that COP can regulate IL-1 beta secretion, implying that COP may play a role in down-regulating inflammatory responses analogous to the CARD protein ICEBERG.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham.org	Stehlik, Christian/AAG-2132-2021	Stehlik, Christian/0000-0002-3782-2484	NIGMS NIH HHS [GM61694] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061694] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Costanzo A, 1999, J BIOL CHEM, V274, P20127, DOI 10.1074/jbc.274.29.20127; CRIEKINGE WV, 1996, J BIOL CHEM, V271, P27245; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Jackle H, 1993, CURR OPIN CELL BIOL, V5, P505, DOI 10.1016/0955-0674(93)90017-K; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; NATANSON C, 1994, ANN INTERN MED, V120, P771, DOI 10.7326/0003-4819-120-9-199405010-00009; NettFiordalisi M, 1995, J LEUKOCYTE BIOL, V58, P717, DOI 10.1002/jlb.58.6.717; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Norman J, 1997, J INTERF CYTOK RES, V17, P113, DOI 10.1089/jir.1997.17.113; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wright SD, 1999, J EXP MED, V189, P605, DOI 10.1084/jem.189.4.605; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Zeuner A, 1999, CELL DEATH DIFFER, V6, P1075, DOI 10.1038/sj.cdd.4400596	30	137	149	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34495	34500		10.1074/jbc.M101415200	http://dx.doi.org/10.1074/jbc.M101415200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432859	hybrid			2022-12-27	WOS:000171024600021
J	Zhao, Y; Lu, ZG; Wu, M; Han, QQ; Tao, W; Zhai, ZH				Zhao, Y; Lu, ZG; Wu, M; Han, QQ; Tao, W; Zhai, ZH			Effects of phosphocreatine on apoptosis in a cell-free system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; DNA FRAGMENTATION; CYTOCHROME-C; DEATH; PHOSPHORYLATION; DEGRADATION; MITOCHONDRIA; CASPASE-9; PATHWAYS; CLEAVAGE	The characteristic morphological and biochemical changes during caspase-mediated apoptosis can be reproduced to a large extent in a Xenopus laevis egg extract cell-free system by addition of mouse liver nuclei and exogenous cytochrome c. We show that in this system phosphocreatine accelerated the apoptotic morphological changes of the nuclei, but selectively inhibited DNA fragmentation. Western blot showed that the degradation of lamins A and C is accelerated, which is possibly responsible for the nuclear changes during cell apoptosis. However, the degradation of ICAD/DFF45-like protein in the egg extracts is inhibited in a time-dependent manner. Exogenous creatine, ATP, and several organic acids have no effect on DNA fragmentation, excluding the possibility that creatine, ATP, or acidic conditions resulting from phosphocreatine are responsible for inhibiting DNA fragmentation. Lithium chloride, a kinase inhibitor, can overcome the phosphocreatine effects and can restore DNA fragmentation. Our results indicate that phosphocreatine protects ICAD/DFF45-like protein from proteolysis, probably through kinase actions, resulting in its resistance to caspase cleavage and leading to an inhibition of DNA fragmentation.	Beijing Univ, Coll Life Sci, Beijing 100871, Peoples R China	Peking University	Zhai, ZH (corresponding author), Beijing Univ, Coll Life Sci, Beijing 100871, Peoples R China.		Wu, Min/AAE-5066-2021	Wu, Min/0000-0003-1372-4764				BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Eguchi Y, 1997, CANCER RES, V57, P1835; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Fujita E, 1999, BIOCHEM BIOPH RES CO, V264, P550, DOI 10.1006/bbrc.1999.1387; Golstein P, 1998, SCIENCE, V281, P1283, DOI 10.1126/science.281.5381.1283; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guerrero-Ontiveros ML, 1998, MOL CELL BIOCHEM, V184, P427, DOI 10.1023/A:1006895414925; Jiang Z, 2000, CELL MOL LIFE SCI, V57, P1117, DOI 10.1007/PL00000748; Jiang ZF, 2000, CELL RES, V10, P221, DOI 10.1038/sj.cr.7290051; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Li HL, 1999, CURR OPIN CELL BIOL, V11, P261, DOI 10.1016/S0955-0674(99)80035-0; LI P, 1997, CELL, V91, P470; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nakamura N, 2000, CELL DEATH DIFFER, V7, P477, DOI 10.1038/sj.cdd.4400677; NEAMATI N, 1995, J IMMUNOL, V154, P3788; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rodriguez J., 2000, SCI, V287, P1363; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Tang DG, 1998, BIOCHEM BIOPH RES CO, V242, P380, DOI 10.1006/bbrc.1997.7969; Walter J, 1999, P NATL ACAD SCI USA, V96, P1391, DOI 10.1073/pnas.96.4.1391; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Zhao Y, 2001, CELL MOL LIFE SCI, V58, P298, DOI 10.1007/PL00000857; Zhu S, 1998, CHINESE SCI BULL, V43, P522, DOI 10.1007/BF02883826; Zhu S, 2000, CHINESE SCI BULL, V45, P1977, DOI 10.1007/BF02909691	33	1	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34573	34578		10.1074/jbc.M102319200	http://dx.doi.org/10.1074/jbc.M102319200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432861	hybrid			2022-12-27	WOS:000171024600032
J	Ahluwalia, JP; Topp, JD; Weirather, K; Zimmerman, M; Stammes, M				Ahluwalia, JP; Topp, JD; Weirather, K; Zimmerman, M; Stammes, M			A role for calcium in stabilizing transport vesicle coats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; GOLGI MEMBRANES; ENDOPLASMIC-RETICULUM; PROTEIN-TRANSPORT; ENDOSOME FUSION; BINDING PROTEIN; BREFELDIN-A; CA2+; COATOMER; GTP	Calcium has been implicated in regulating vesicle fusion reactions, but its potential role in regulating other aspects of protein transport, such as vesicle assembly, is largely unexplored. We find that treating cells with the membrane-permeable calcium chelator, 1,2-bis(2-amino-phenoxy)ethane-N,N,N ' ,N ' -tetraacetic acid tetrakis(acetoxymethyl ester) (BAPTA-AM), leads to a drams ic redistribution of the vesicle coat protein, coatomer, in the cell. We have used the cell-free reconstitution of coat-protomer I (COPI) vesicle assembly to characterize the mechanisms of this redistribution. We find that the recovery of COPI-coated Golgi vesicles is inhibited by the addition of BAPTA to the cell-free vesicle budding assay. When coatomer-coated membranes are incubated in the presence of calcium chelators, the membranes "uncoat," indicating that calcium is necessary for maintaining the integrity of the coat. This uncoating is reversed by the addition of calcium. Interestingly, BAPTA, a calcium chelator with fast binding kinetics, is more potent at uncoating the coatomer-coated membrane than EGTA, suggesting that a calcium transient or a calcium gradient is important for stabilizing COPI vesicle coat. The primary target for the effects of calcium on coatomer recruitment is a step that occurs after ADP-ribosylation factor binding to the membrane. We suggest that a calcium gradient may serve to regulate the timing of vesicle uncoating.	Univ Iowa, Coll Med, SW Med Ctr, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Biosci Program, Iowa City, IA 52242 USA	University of Iowa; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa; University of Iowa	Stammes, M (corresponding author), Univ Iowa, Coll Med, SW Med Ctr, Dept Internal Med, 5-550 BSB, Iowa City, IA 52242 USA.			Stamnes, Mark/0000-0002-5869-7985; Zimmerman, Matthew/0000-0001-5658-9051				Aballay A, 1995, BIOCHEM J, V312, P919, DOI 10.1042/bj3120919; BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Fucini RV, 2000, J BIOL CHEM, V275, P18824, DOI 10.1074/jbc.M000024200; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; IVESSA NE, 1995, J BIOL CHEM, V270, P25960, DOI 10.1074/jbc.270.43.25960; Kits KS, 1999, BIOPHYS J, V76, P1693, DOI 10.1016/S0006-3495(99)77328-5; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; PIND SN, 1994, J CELL BIOL, V125, P239, DOI 10.1083/jcb.125.2.239; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Porat A, 2000, J BIOL CHEM, V275, P29233, DOI 10.1074/jbc.M005316200; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; SULLIVAN KMC, 1993, CELL, V73, P1411, DOI 10.1016/0092-8674(93)90366-X; TANG BL, 1995, EUR J CELL BIOL, V68, P199; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Taylor RS, 1997, MOL BIOL CELL, V8, P1911, DOI 10.1091/mbc.8.10.1911; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Vasudevan C, 1998, J CELL SCI, V111, P1277; WAHL M, 1992, J CELL PHYSIOL, V150, P593, DOI 10.1002/jcp.1041500321; ZHA XH, 1995, AM J PHYSIOL-CELL PH, V268, pC1133, DOI 10.1152/ajpcell.1995.268.5.C1133; ZHA XH, 1995, AM J PHYSIOL-CELL PH, V269, pC923, DOI 10.1152/ajpcell.1995.269.4.C923	41	42	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34148	34155		10.1074/jbc.M105398200	http://dx.doi.org/10.1074/jbc.M105398200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435443	hybrid			2022-12-27	WOS:000170910200114
J	Wolf, BB; Schuler, M; Li, W; Eggers-Sedlet, B; Lee, W; Tailor, P; Fitzgerald, P; Mills, GB; Green, DR				Wolf, BB; Schuler, M; Li, W; Eggers-Sedlet, B; Lee, W; Tailor, P; Fitzgerald, P; Mills, GB; Green, DR			Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; APAF-1 APOPTOSOME; DEATH; PROCASPASE-9; FAS; OLIGOMERIZATION; EXPRESSION; CARCINOMA; SURVIVAL; AP-1	Apoptosis via the mitochondrial pathway requires release of cytochrome c into the cytosol to initiate formation of an oligomeric apoptotic protease-activating factor-1 (APAF-1) apoptosome. The apoptosome recruits and activates caspase-9, which in turn activates caspase-3 and -7, which then kill the cell by proteolysis. Because inactivation of this pathway may promote oncogenesis, we examined 10 ovarian cancer cell lines for resistance to cytochrome c-dependent caspase activation using a cell-free system. Strikingly, we found that cytosolic extracts from all cell lines had diminished cytochrome c-dependent caspase activation compared with normal ovarian epithelium extracts. The resistant cell lines expressed APAF-1 and caspase-9, -3, and -7; however, each demonstrated diminished APAF-1 activity relative to the normal ovarian epithelium cell lines. A competitive APAF-1 inhibitor may account for the diminished APAF-1 activity because we did not detect dominant APAF-1 inhibitors, altered APAF-1 isoform expression, or APAF-1 deletion, degradation, or mutation. Lack of APAF-1 activity correlated in some but not all cell lines with resistance to apoptosis. These data suggest that regulation of APAF-1 activity may be important for apoptosis regulation in some ovarian cancers.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA	McGill University; University of Texas System; UTMD Anderson Cancer Center	Wolf, BB (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417	NCI NIH HHS [CA69831] Funding Source: Medline; NIAID NIH HHS [AI40646] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Auersperg N, 1998, SEMIN ONCOL, V25, P281; Bala S, 2000, GENE CHROMOSOME CANC, V28, P258, DOI 10.1002/1098-2264(200007)28:3<258::AID-GCC3>3.0.CO;2-R; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chauhan D, 2001, J BIOL CHEM, V276, P24453, DOI 10.1074/jbc.C100074200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Hahn C, 1999, BIOCHEM BIOPH RES CO, V261, P746, DOI 10.1006/bbrc.1999.1124; Harwood FG, 2000, J BIOL CHEM, V275, P10023, DOI 10.1074/jbc.275.14.10023; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; LI P, 1997, CELL, V91, P470; Lynch HT, 1998, SEMIN ONCOL, V25, P265; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Perkins C, 1998, CANCER RES, V58, P4561; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; THIGPEN JT, 2000, CLIN ONCOLOGY, P2016; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Yamamoto H, 2000, CELL DEATH DIFFER, V7, P238, DOI 10.1038/sj.cdd.4400651; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	32	110	111	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34244	34251		10.1074/jbc.M011778200	http://dx.doi.org/10.1074/jbc.M011778200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11429402	hybrid			2022-12-27	WOS:000170910200127
J	Johansson, AS; Mannervik, B				Johansson, AS; Mannervik, B			Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL 3-BETA-HYDROXY-5-ENE-STEROID DEHYDROGENASE; S-TRANSFERASES; HETEROLOGOUS EXPRESSION; TISSUE DISTRIBUTION; LIPID-PEROXIDATION; HUMAN-LIVER; MU-CLASS; IDENTIFICATION; PURIFICATION; ISOMERASE	The cDNA of a novel human glutathione transferase (GST) of the Alpha class was cloned, and the corresponding protein, denoted GST A3-3, was heterologously expressed and characterized. GST A3-3 was found to efficiently catalyze obligatory double-bond isomerizations of Delta (5)-androstene-3,17-dione and Delta5-pregnene-3,20-dione, precursors to testosterone and progesterone, respectively, in steroid hormone biosynthesis. The catalytic efficiency (k(cat)/K-m) with Delta (5)-androstene-3,17-dione was determined as 5 X 10(6) M-1 s(-1), which is considerably higher than with any other GST substrate tested. The rate of acceleration afforded by GST A3-3 is 6 x 10(8) based on the ratio between k(cat) and the rate constant for the nonenzymatic isomerization of Delta (5)-androstene-3,17-dione. Besides being high in absolute numbers, the k(cat)/K-m value of GST A3-3 exceeds by a factor of similar to 230 that of 3 beta -hydroxysteroid dehydrogenase/isomerase, the enzyme generally considered to catalyze the Delta (5)-Delta (4) double-bond isomerization. Furthermore, GSTA3-specific polymerase chain reaction analysis of cDNA libraries from various tissues showed a message only in those characterized by active steroid hormone biosynthesis, indicating a selective expression of GST A3-3 in these tissues. Based on this finding and the high activity with steroid substrates, we propose that GST A3-3 has evolved to catalyze isomerization reactions that contribute to the biosynthesis of steroid hormones.	Uppsala Univ, Dept Biochem, Biomed Ctr, SE-75123 Uppsala, Sweden	Uppsala University	Mannervik, B (corresponding author), Uppsala Univ, Dept Biochem, Biomed Ctr, Box 576, SE-75123 Uppsala, Sweden.			Jemth, Ann-Sofie/0000-0002-7550-1833				BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; Beuckmann CT, 2000, NEUROCHEM RES, V25, P733, DOI 10.1023/A:1007579507804; BJORNESTEDT R, 1992, BIOCHEM J, V282, P505; Board PG, 1998, BIOCHEM J, V330, P827; BURGESS JR, 1989, BIOCHEM BIOPH RES CO, V158, P497, DOI 10.1016/S0006-291X(89)80076-2; CAMPBELL JAH, 1980, CANCER, V45, P503, DOI 10.1002/1097-0142(19800201)45:3<503::AID-CNCR2820450315>3.0.CO;2-8; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FUKAI F, 1992, J CLIN BIOCHEM NUTR, V12, P93; HAO XY, 1994, BBA-MOL BASIS DIS, V1225, P223, DOI 10.1016/0925-4439(94)90082-5; HAWKINSON DC, 1991, BIOCHEMISTRY-US, V30, P10849, DOI 10.1021/bi00109a007; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; KULIOPULOS A, 1989, BIOCHEMISTRY-US, V28, P149, DOI 10.1021/bi00427a022; M PG, 1995, ADV DRUG METABOLISM, P407; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MEYER DJ, 1995, BIOCHEM J, V306, P565, DOI 10.1042/bj3060565; Montgomery R., 1996, BIOCH CASE ORIENTED, P587; Muller K, 1996, FEBS LETT, V388, P165, DOI 10.1016/0014-5793(96)00559-5; Nilsson LO, 2000, P NATL ACAD SCI USA, V97, P9408, DOI 10.1073/pnas.150084897; Pettersson PL, 2001, J BIOL CHEM, V276, P11698, DOI 10.1074/jbc.M009146200; Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481; SAMUELS LT, 1951, SCIENCE, V113, P490, DOI 10.1126/science.113.2939.490; Sherratt PJ, 1997, BIOCHEM J, V326, P837, DOI 10.1042/bj3260837; SIMONS PC, 1977, ANAL BIOCHEM, V82, P334, DOI 10.1016/0003-2697(77)90169-5; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; STENBERG G, 1992, PROTEIN EXPRES PURIF, V3, P80, DOI 10.1016/1046-5928(92)90060-A; STENBERG G, 1991, BIOCHEM J, V274, P549, DOI 10.1042/bj2740549; STOCKMAN PK, 1987, BIOCHEM J, V244, P55, DOI 10.1042/bj2440055; Suc I, 1998, FASEB J, V12, P665, DOI 10.1096/fasebj.12.9.665; SUZUKI T, 1993, GENOMICS, V18, P680, DOI 10.1016/S0888-7543(05)80373-8; TALALAY P, 1955, BIOCHIM BIOPHYS ACTA, V18, P300, DOI 10.1016/0006-3002(55)90079-2; THOMAS JL, 1988, J STEROID BIOCHEM, V31, P785, DOI 10.1016/0022-4731(88)90287-7; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; VANOMMEN B, 1990, BIOCHEM J, V269, P609, DOI 10.1042/bj2690609; ZHAO TGJ, 1999, ARCH BIOCHEM BIOPHYS, V267, P216	38	146	154	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33061	33065		10.1074/jbc.M104539200	http://dx.doi.org/10.1074/jbc.M104539200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11418619	hybrid			2022-12-27	WOS:000170746000091
J	La Celle, PT; Polakowska, RR				La Celle, PT; Polakowska, RR			Human homeobox HOXA7 regulates keratinocyte transglutaminase type 1 and inhibits differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INVOLUCRIN PROMOTER ACTIVITY; HUMAN-PAPILLOMAVIRUS TYPE-16; GENE-EXPRESSION; GROWTH-FACTOR; EPIDERMAL DIFFERENTIATION; HOMEODOMAIN PROTEIN; TRANSCRIPTIONAL REGULATION; RETINOIC ACID; BINDING	Keratinocyte proliferation and differentiation result from expression of specific groups of genes regulated by unique combinations of transcription factors. To better understand these regulatory processes, we studied HOXA7 expression and its regulation of differentiation-specific keratinocyte genes. We isolated the homeobox transcription factor HOXA7 from keratinocytes through binding to a differentiation-dependent viral enhancer and analyzed its effect on endogenous differentiation-dependent genes, primarily transglutaminase 1. HOXA7 overexpression repressed transglutaminase 1-reporter activity. HOXA7 message markedly decreased, and transglutaminase RNA increased, upon phorbol ester-induced differentiation, in a protein kinase C-dependent manner. Overexpression of HOXA7 attenuated the transglutaminase 1 induction by phorbol ester, demonstrating that HOXAB7 expression is inversely related to keratinocyte differentiation, and to transglutaminase 1 expression. Antisense HOXA7 expression activated transglutaminase 1, involucrin, and keratin 10 message and protein levels, demonstrating that endogenous HOXA7 down-regulates multiple differentiation-specific keratinocyte genes. In keeping with these observations, epidermal growth factor receptor activation stimulated HOXA7 expression. HOX genes function in groups, and we found that HOXA5 and HOXB7 were also down-regulated by phorbol ester. These results provide the first example of protein kinase C-mediated homeobox gene regulation in keratinocytes, and new evidence that HOXA7, potentially in conjunction with HOXA5 and HOXAD7, silences differentiation-specific genes during keratinocyte proliferation, that are then released from inhibition in response to differentiation signals.	Univ Rochester, Sch Med & Dent, Dept Dermatol, Rochester, NY 14642 USA; Univ Lille 2, Fac Med, INSERM U459, F-59045 Lille, France	University of Rochester; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	La Celle, PT (corresponding author), Univ Rochester, Sch Med & Dent, Dept Dermatol, Box 697,601 Elmwood Ave, Rochester, NY 14642 USA.	peter_lacelle@urmc.rochester.edu						ANDERSEN B, 1993, SCIENCE, V260, P78, DOI 10.1126/science.7682011; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BEACHY PA, 1993, MOL CELL BIOL, V13, P6941, DOI 10.1128/MCB.13.11.6941; BIEBERICH CJ, 1991, ANN NY ACAD SCI, V642, P346; BLESSING M, 1987, EMBO J, V6, P567, DOI 10.1002/j.1460-2075.1987.tb04792.x; Blumenberg M, 1997, EXS, V78, P1; BONCINELLI E, 1994, GENETICA, V94, P127, DOI 10.1007/BF01443427; BUTZ K, 1993, J VIROL, V67, P6476, DOI 10.1128/JVI.67.11.6476-6486.1993; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Care A, 1998, ONCOGENE, V16, P3285, DOI 10.1038/sj.onc.1201875; Care A, 1996, MOL CELL BIOL, V16, P4842; Care A, 1999, ONCOGENE, V18, P1993, DOI 10.1038/sj.onc.1202498; CHAN WK, 1990, NUCLEIC ACIDS RES, V18, P763, DOI 10.1093/nar/18.4.763; Chang PY, 1998, BIOCHEM BIOPH RES CO, V248, P749, DOI 10.1006/bbrc.1998.9076; Chariot A, 1999, ONCOGENE, V18, P4007, DOI 10.1038/sj.onc.1202776; Chariot A, 1999, J BIOL CHEM, V274, P5318, DOI 10.1074/jbc.274.9.5318; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; COLBERGPOLEY AM, 1985, NATURE, V314, P713, DOI 10.1038/314713a0; CRIPE TP, 1987, EMBO J, V6, P3745, DOI 10.1002/j.1460-2075.1987.tb02709.x; Crooks GM, 1999, BLOOD, V94, P519, DOI 10.1182/blood.V94.2.519.414k20_519_528; Delhase M, 1996, J BIOL CHEM, V271, P32349, DOI 10.1074/jbc.271.50.32349; DETMER K, 1993, J INVEST DERMATOL, V101, P517, DOI 10.1111/1523-1747.ep12365890; DLUGOSZ AA, 1994, CELL GROWTH DIFFER, V5, P1283; DLUGOSZ AA, 1994, J INVEST DERMATOL, V102, P409, DOI 10.1111/1523-1747.ep12372171; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Dong XP, 1999, J GEN VIROL, V80, P2097, DOI 10.1099/0022-1317-80-8-2097; DUVIC M, 1994, J INVEST DERMATOL, V102, P462, DOI 10.1111/1523-1747.ep12373021; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; ECKERT RL, 1989, PHYSIOL REV, V69, P1316, DOI 10.1152/physrev.1989.69.4.1316; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; FAUS I, 1994, MOL CELL BIOL, V14, P3263, DOI 10.1128/MCB.14.5.3263; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; GIAMPAOLO A, 1994, BLOOD, V84, P3637, DOI 10.1182/blood.V84.11.3637.bloodjournal84113637; GROSS MK, 1994, MOL CELL BIOL, V14, P238, DOI 10.1128/MCB.14.1.238; GRUENEBERG DA, 1995, MOL CELL BIOL, V15, P3318; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; KALIONIS B, 1993, MECH DEVELOP, V43, P57, DOI 10.1016/0925-4773(93)90023-Q; KANZLER B, 1994, INT J DEV BIOL, V38, P633; KING LE, 1990, J INVEST DERMATOL, V94, pS164, DOI 10.1111/1523-1747.ep12876141; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Komuves LG, 2000, DEV DYNAM, V218, P636; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; Lorentz O, 1999, J BIOL CHEM, V274, P7196, DOI 10.1074/jbc.274.11.7196; LU QA, 1995, MOL CELL BIOL, V15, P3786; MARCHUK D, 1985, P NATL ACAD SCI USA, V82, P1609, DOI 10.1073/pnas.82.6.1609; MATHEWS CHE, 1993, DIFFERENTIATION, V52, P177, DOI 10.1111/j.1432-0436.1993.tb00628.x; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Morasso MI, 1996, J CELL BIOL, V135, P1879, DOI 10.1083/jcb.135.6.1879; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Newman CS, 2000, MECH DEVELOP, V91, P369, DOI 10.1016/S0925-4773(99)00291-9; OCONNOR M, 1995, VIROLOGY, V207, P77, DOI 10.1006/viro.1995.1053; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Packer AI, 2000, DEV DYNAM, V217, P62, DOI 10.1002/(SICI)1097-0177(200001)217:1<62::AID-DVDY6>3.0.CO;2-U; Park GT, 1999, J BIOL CHEM, V274, P26599, DOI 10.1074/jbc.274.37.26599; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; POLAKOWSKA RR, 1992, P NATL ACAD SCI USA, V89, P4476, DOI 10.1073/pnas.89.10.4476; Polakowska RR, 1999, J CELL BIOCHEM, V73, P355; RIEGER E, 1994, J INVEST DERMATOL, V103, P341, DOI 10.1111/1523-1747.ep12394888; Rodeck U, 1997, J CELL SCI, V110, P113; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; SAUNDERS NA, 1993, MOL ENDOCRINOL, V7, P387, DOI 10.1210/me.7.3.387; Schnabel CA, 1996, MOL CELL BIOL, V16, P2678; SCOTT GA, 1993, J INVEST DERMATOL, V101, P3, DOI 10.1111/1523-1747.ep12358258; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Srebrow A, 1998, J CELL BIOCHEM, V69, P377, DOI 10.1002/(SICI)1097-4644(19980615)69:4<377::AID-JCB1>3.0.CO;2-K; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; Subramaniam N, 1998, J BIOL CHEM, V273, P23567, DOI 10.1074/jbc.273.36.23567; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; Wang JM, 1999, MOL CELL BIOL, V19, P7106; Welter JF, 1996, J BIOL CHEM, V271, P14727, DOI 10.1074/jbc.271.25.14727; YAMADA K, 1994, BIOCHEM MOL BIOL INT, V34, P827; YUKAWA K, 1993, GENE, V133, P163; Yukawa K, 1996, J VIROL, V70, P10, DOI 10.1128/JVI.70.1.10-16.1996; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	86	43	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32844	32853		10.1074/jbc.M104598200	http://dx.doi.org/10.1074/jbc.M104598200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11435435	hybrid			2022-12-27	WOS:000170746000064
J	Rajpal, A; Turi, TG				Rajpal, A; Turi, TG			Intracellular stability of anti-caspase-3 intrabodies determines efficacy in retargeting the antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE DISPLAY LIBRARY; IN-VIVO; HUMAN-ANTIBODIES; CELL-DEATH; PROTEIN; CASPASE-3; APOPTOSIS; KNOCKOUT; AFFINITY; SYSTEM	Although intracellular antibodies (intrabodies) are being explored as putative therapeutic and research reagents, little is known about the principles that dictate the efficacy of these molecules. In our efforts to address this issue, we generated a panel of five intrabodies, directed against catalytically inactive murine caspase-3, by screening single-chain antibody (Fv) phage display libraries. Here we determined criteria that single-chain Fv fragments must fulfill to act as efficient intrabodies. The affinities of these intrabodies, as measured by surface plasmon resonance, varied similar to5-fold (50-250 rim). Despite their substantial sequence similarity, only two of the five intrabodies were able to significantly accumulate intracellularly. These disparities in intracellular expression levels were reflected by differences in the stability of the purified protein species when analyzed by urea denaturation studies. We observed varied efficiencies in retargeting the antigen murine caspase-3, from the cytosol to the nucleus, mediated by intrabodies tagged with an SV40 nuclear localization signal. Our results demonstrate that the intrinsic stability of the intrabody, rather than its affinity for the antigen, dictates its intracellular efficacy.	Pfizer Inc, Cent Res, Dept Genet Technol, Groton, CT 06340 USA	Pfizer	Turi, TG (corresponding author), Pfizer Inc, Cent Res, Dept Genet Technol, Eastern Point Rd, Groton, CT 06340 USA.	tom_g_turi@groton.pfizer.com						BIOCCA S, 1995, BIO-TECHNOL, V13, P1110, DOI 10.1038/nbt1095-1110; Deshane J, 1995, J CLIN INVEST, V96, P2980, DOI 10.1172/JCI118370; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Hassanzadeh G, 1998, FEBS LETT, V437, P81, DOI 10.1016/S0014-5793(98)01205-8; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; LERNER M, 2000, EUR J BIOCHEM, V267, P1196; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Marasco WA, 1997, GENE THER, V4, P11, DOI 10.1038/sj.gt.3300346; Marasco WA, 1998, HUM GENE THER, V9, P1627, DOI 10.1089/hum.1998.9.11-1627; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Pace C. N., 1997, PROTEIN STRUCTURE PR; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rajpal A, 2000, PROTEINS, V40, P49, DOI 10.1002/(SICI)1097-0134(20000701)40:1<49::AID-PROT70>3.3.CO;2-C; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Ruberti F, 2000, J NEUROSCI, V20, P2589; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618; Zhu QA, 1999, J IMMUNOL METHODS, V231, P207, DOI 10.1016/S0022-1759(99)00158-1	27	29	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33139	33146		10.1074/jbc.M101332200	http://dx.doi.org/10.1074/jbc.M101332200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11425853	hybrid			2022-12-27	WOS:000170746000100
J	Stotz, SC; Zamponi, GW				Stotz, SC; Zamponi, GW			Identification of inactivation determinants in the domain IIS6 region of high voltage-activated calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; CA2+ CHANNEL; BETA-SUBUNIT; DEPENDENT INACTIVATION; MOLECULAR DETERMINANTS; ALPHA(1A) SUBUNIT; K+ CHANNEL; P-TYPE; MUSCLE; PALMITOYLATION	We have recently reported that transfer of the domain IIS6 region from rapidly inactivating R-type (alpha (1E)) calcium channels to slowly inactivating L-type (alpha (1C)) calcium channel confers rapid inactivation (Stotz, S. C., Hamid, J., Spaetgens, R. L., Jarvis, S. E., and Zamponi, G. W. (2000) J. Biol. Chem. 275, 24575-24582). Here we have identified individual amino acid residues in the IIS6 regions that are responsible for these effects. In this region, alpha (1C) and alpha (1E) channels differ in seven residues, and exchanging five of those residues individually or in combination did not significantly affect inactivation kinetics. By contrast, replacement of residues Phe-823 or Ile-829 of alpha (1C) with the corresponding alpha (1E): residues significantly accelerated inactivation rates and, when substituted concomitantly, approached the rapid inactivation kinetics of R-type channels. A systematic substitution of these residues with a series of other amino acids revealed that decreasing side chain size at position 823 accelerates inactivation, whereas a dependence of the inactivation kinetics on the degree of hydrophobicity could be observed at position 829. Although these point mutations facilitated rapid entry into the inactivated state of the channel, they had little to no effect on the rate of recovery from inactivation. This suggests that the development of and recovery from inactivation are governed by separate structural determinants. Finally, the effects of mutations that accelerated alpha (1C) inactivation could still be antagonized following coexpression of the rat beta (2a). subunit or by domain I-II linker substitutions that produce ultra slow inactivation of wild type channels, indicating that the inactivation kinetics seen with the mutants remain subject to regulation by the domain I-II linker. Overall, our results provide novel insights into a complex process underlying calcium channel inactivation.	Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary	Zamponi, GW (corresponding author), Univ Calgary, Dept Physiol & Biophys, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.			Zamponi, Gerald W./0000-0002-0644-9066				AKAIKE N, 1989, J PHYSIOL-LONDON, V416, P141, DOI 10.1113/jphysiol.1989.sp017754; Berjukow S, 2001, J BIOL CHEM, V276, P17076, DOI 10.1074/jbc.M010491200; Berrou L, 2001, BIOPHYS J, V80, P215, DOI 10.1016/S0006-3495(01)76008-0; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Branchaw JL, 1997, J NEUROSCI, V17, P5772; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOTHIA C, 1975, J MOL BIOL, V105, P1; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Hering S, 1997, P NATL ACAD SCI USA, V94, P13323, DOI 10.1073/pnas.94.24.13323; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; HILLE B, 1994, IONIC CHANNELS EXCIT; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Hurley JF, 2000, P NATL ACAD SCI USA, V97, P9293, DOI 10.1073/pnas.160589697; Jimenez C, 2000, NEUROPHARMACOLOGY, V39, P1, DOI 10.1016/S0028-3908(99)00153-7; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; Monteil A, 2000, J BIOL CHEM, V275, P16530, DOI 10.1074/jbc.C000090200; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Restituito S, 2000, J NEUROSCI, V20, P9046; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Soldatov NM, 1998, J BIOL CHEM, V273, P957, DOI 10.1074/jbc.273.2.957; Spaetgens RL, 1999, J BIOL CHEM, V274, P22428, DOI 10.1074/jbc.274.32.22428; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; STEA A, 1995, HDB RECEPTORS CHANNE, P113; Stotz SC, 2001, TRENDS NEUROSCI, V24, P176, DOI 10.1016/S0166-2236(00)01738-0; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; SUN JP, 1995, J PHARMACOL EXP THER, V274, P419; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	49	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33001	33010		10.1074/jbc.M104387200	http://dx.doi.org/10.1074/jbc.M104387200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11402052	hybrid			2022-12-27	WOS:000170746000084
J	Bachman, KE; Rountree, MR; Baylin, SB				Bachman, KE; Rountree, MR; Baylin, SB			Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLTRANSFERASE GENE; CHROMOSOME INSTABILITY; HISTONE DEACETYLASE; REGULATOR ATRX; HUMAN CANCER; ICF SYNDROME; METHYLATION; COMPLEX; MUTATIONS; PROTEINS	We demonstrate that the recently identified DNA methyltransferases, Dnmt3a and Dnmt3b, like DNMT1, repress transcription in a methylation-independent manner. Dnmt3a and Dnmt3b repress transcription primarily through a plant homeodomain-like motif that is shared with the ATRX protein but is not present in DNMT1. Unlike DNMT1, which localizes to replication foci during S-phase in murine embryonic fibroblasts, Dnmt3a co-localizes with heterochromatin protein I a (HP1 alpha) and methyl-CpG binding proteins throughout the cell cycle to late-replicating pericentromeric heterochromatin. In contrast to Dnmt3a, Dnmt3b remained diffuse in the nucleus of embryonic fibroblasts at all cell cycle stages. However, Dnmt3a and Dnmt3b co-localize to these pericentromeric heterochromatin regions in murine embryonic stem cells. This finding is important to the fact that mutations in DNMT3B are found in the developmental syndrome, ICF (immunodeficiency, centromeric heterochromatin instability, and facial anomalies), which involves extensive loss of methylation from pericentromeric regions. The localization of Dnmt3a and Dnmt3b was unaffected in Dnmt1 null embryonic stem cells, which lose the majority of methylation at pericentromeric major satellite repeats, suggesting that these enzymes are not dependent upon preexisting methylation for their targeting. DNMT1 is then positioned to reestablish transcriptionally repressive chromatin as cells replicate, while Dnmt3a and Dnmt3b may help to establish such chromatin in late S-phase and maintain this repressive heterochromatin throughout the cell cycle in a developmentally and/or cell type manner.	Johns Hopkins Univ, Sch Med, Tumor Biol Lab, Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Baylin, SB (corresponding author), Johns Hopkins Univ, Sch Med, Tumor Biol Lab, Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA.		Rountree, Michael R/C-6332-2018	Rountree, Michael R/0000-0003-2371-6389	NCI NIH HHS [CA-43318] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043318] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2000, CURR TOP MICROBIOL, V249, P55; Herman JG, 2000, CURR TOP MICROBIOL, V249, P35; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu YL, 1998, NUCLEIC ACIDS RES, V26, P1038, DOI 10.1093/nar/26.4.1038; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	28	343	354	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32282	32287		10.1074/jbc.M104661200	http://dx.doi.org/10.1074/jbc.M104661200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427539	hybrid			2022-12-27	WOS:000170613500109
J	Gerber, D; Shai, Y				Gerber, D; Shai, Y			In vivo detection of hetero-association of glycophorin-A and its mutants within the membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE ALPHA-HELICES; PORE-FORMING DOMAIN; THURINGIENSIS DELTA-ENDOTOXIN; CELL ANTIGEN RECEPTOR; PHOSPHOLIPID-BILAYERS; ANTIMICROBIAL PEPTIDE; ION-CHANNEL; ORGANIZATION; DIMERIZATION; SEGMENT	Protein recognition within the membrane is a crucial process for numerous biological activities. Detection of such interaction is limited because of difficulties that arise from the hydrophobic environment of the membrane. We detected direct hetero-oligomerization of the glycophorin-A (GPA) transmembrane segments in vivo through inhibition of ToxR transcription activator dimer formation. We investigated the amino acids important for hetero-oligomerization within the membrane, using peptide analog segments of the transmembrane domain of glycophorin A. The wild type ([WT]GPA) and alanine mutant ([A]GPA) were able to interfere with and inhibit the proper dimerization of the ToxR-GPA transcription factor. Conversely, a second alanine mutant ([A(2)]GPA), a glycine mutant ([G]GPA), and a scrambled analog ([SC]GPA) were virtually inactive. Binding studies reveal similar membrane partitions for [WT]GPA, [G]GPA, and [SC]GPA, whereas membrane partition of [A]GPA and [A]GPA are lower. Spectral analysis of fluorescent-labeled analogs revealed a significant blue shift, indicating membrane insertion. Our results suggest that the GXXXG motif, found in homo-oligomerization, is not sufficient for hetero-oligomerization in a biological membrane, whereas an extended motif, LIXXGXXXGXXXT, is sufficient. Interfering with hetero-oligomerization within the membrane can be a useful strategy for characterizing such interactions and possibly modulating membrane protein activity.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.							ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; ARKIN IT, 1994, EMBO J, V13, P4757, DOI 10.1002/j.1460-2075.1994.tb06801.x; BESCHIASCHVILI G, 1991, BIOCHIM BIOPHYS ACTA, V1061, P78, DOI 10.1016/0005-2736(91)90270-I; BIBI E, 1991, P NATL ACAD SCI USA, V88, P7271, DOI 10.1073/pnas.88.16.7271; Bowie JU, 2000, CURR OPIN STRUC BIOL, V10, P435, DOI 10.1016/S0959-440X(00)00111-1; Brosig B, 1998, PROTEIN SCI, V7, P1052; COSSON P, 1992, SCIENCE, V258, P659, DOI 10.1126/science.1329208; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; DEBER CM, 1993, P NATL ACAD SCI USA, V90, P11648, DOI 10.1073/pnas.90.24.11648; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; FREY S, 1990, BIOCHEM J, V272, P713, DOI 10.1042/bj2720713; GAZIT E, 1995, J BIOL CHEM, V270, P2571, DOI 10.1074/jbc.270.6.2571; Gazit E, 1998, P NATL ACAD SCI USA, V95, P12289, DOI 10.1073/pnas.95.21.12289; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Hetru C, 2000, BIOCHEM J, V345, P653, DOI 10.1042/0264-6021:3450653; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Laage R, 1997, EUR J BIOCHEM, V249, P540, DOI 10.1111/j.1432-1033.1997.00540.x; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Manolios N, 1997, NAT MED, V3, P84, DOI 10.1038/nm0197-84; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312; Masson L, 1999, J BIOL CHEM, V274, P31996, DOI 10.1074/jbc.274.45.31996; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; RAPAPORT D, 1992, BIOCHEMISTRY-US, V31, P8868, DOI 10.1021/bi00152a025; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; SHAI Y, 1995, TRENDS BIOCHEM SCI, V20, P460, DOI 10.1016/S0968-0004(00)89101-X; TREUTLEIN HR, 1992, BIOCHEMISTRY-US, V31, P12726, DOI 10.1021/bi00166a003; Wimley WC, 2000, BIOCHEMISTRY-US, V39, P4432, DOI 10.1021/bi992746j; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	40	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31229	31232		10.1074/jbc.M101889200	http://dx.doi.org/10.1074/jbc.M101889200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402026	hybrid			2022-12-27	WOS:000170472900084
J	van Es, S; Weening, KE; Devreotes, PN				van Es, S; Weening, KE; Devreotes, PN			The protein kinase YakA regulates G-protein-linked signaling responses during growth and development of Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY; MEDIATED ACTIVATION; TYROSINE RESIDUES; ADENYLYL-CYCLASE; BETA-SUBUNIT; DYRK; DISCOIDEUM; CHEMOTAXIS; MUTANTS; CHEMOATTRACTANT	A genetic screen for Dictyostelium mutants that phenotypically resemble cells lacking the G-protein beta -subunit yielded the protein kinase YakA. Like g beta -null cells, yakA-null cells fail to enter development and display slow growth on bacterial lawns. We created a temperature-sensitive yakA mutant and showed that YakA activity is required not only at the onset but also during development. The yakA-null cells have strong defects in folic acid-induced responses, such as actin polymerization and cGMP accumulation, indicating that they play a role in G-protein-mediated signaling responses. We propose that YakA acts downstream of G-proteins, because cAMP receptors still couple to G-proteins in the yakA mutant. In addition, the previously observed growth arrest induced by overexpression of YakA also occurs in g beta mutants. We localized YakA-GFP to the cytosol suggesting that YakA may be a functional homolog of its mammalian counterparts Dyrk2 and Dyrk3, a subclass of dual-specificity Yak-related kinases (Dyrk) with unknown function.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Univ Dundee, Dept Biochem, Dundee DD1 5EH, Scotland	Johns Hopkins University; University of Dundee	Devreotes, PN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028007, R01GM028007] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28007] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI H, 1994, BIOCHEM BIOPH RES CO, V205, P1808, DOI 10.1006/bbrc.1994.2880; ASHWORTH JM, 1970, BIOCHEM J, V119, P175, DOI 10.1042/bj1190175; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; GARRETT S, 1991, MOL CELL BIOL, V11, P4045, DOI 10.1128/MCB.11.8.4045; HADWIGER JA, 1994, P NATL ACAD SCI USA, V91, P10566, DOI 10.1073/pnas.91.22.10566; HARTLEY AD, 1994, GENETICS, V136, P465; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; HSU JC, 1994, GENE DEV, V8, P2176, DOI 10.1101/gad.8.18.2176; INSALL R, 1994, J CELL BIOL, V126, P1537, DOI 10.1083/jcb.126.6.1537; Jin T, 1998, EMBO J, V17, P5076, DOI 10.1093/emboj/17.17.5076; Kassis S, 2000, BIOCHEM J, V348, P263, DOI 10.1042/0264-6021:3480263; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KUMAGAI A, 1991, J BIOL CHEM, V266, P1220; LILLY PJ, 1995, J CELL BIOL, V129, P1659, DOI 10.1083/jcb.129.6.1659; Ma H, 1997, EMBO J, V16, P4317, DOI 10.1093/emboj/16.14.4317; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Peracino B, 1998, J CELL BIOL, V141, P1529, DOI 10.1083/jcb.141.7.1529; Shindoh N, 1996, BIOCHEM BIOPH RES CO, V225, P92, DOI 10.1006/bbrc.1996.1135; Smith DJ, 1997, HUM MOL GENET, V6, P1729, DOI 10.1093/hmg/6.10.1729; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Souza GM, 1998, DEVELOPMENT, V125, P2291; SUSSMAN M, 1987, MOL BIOL DICTYOSTELI, V28, P67; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; van Es S, 1999, CELL MOL LIFE SCI, V55, P1341, DOI 10.1007/s000180050374; VANHAASTERT PJM, 1984, BIOCHEM BIOPH RES CO, V124, P597, DOI 10.1016/0006-291X(84)91596-1; WILLIAMS JG, 1993, PHILOS T ROY SOC B, V340, P305, DOI 10.1098/rstb.1993.0072; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667	29	14	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30761	30765		10.1074/jbc.M103365200	http://dx.doi.org/10.1074/jbc.M103365200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11410593	hybrid			2022-12-27	WOS:000170472900025
J	Dimitrov, AS; Xiao, XD; Dimitrov, DS; Blumenthal, R				Dimitrov, AS; Xiao, XD; Dimitrov, DS; Blumenthal, R			Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEMBRANE-FUSION; INFLUENZA HEMAGGLUTININ; CONFORMATIONAL-CHANGES; ATOMIC-STRUCTURE; LIPID BILAYERS; VIRAL MEMBRANE; COILED COILS; TYPE-1 GP120; SOLUBLE CD4	An early step in the process of HIV-1 entry into target cells is the activation of its envelope glycoprotein (GP120-GP41) to a fusogenic state upon binding to target cell CD4 and cognate co-receptor. Incubation of human immunodeficiency virus (HIV)-1 Env-expressing cells with an excess of CD4 and co-recepeptor-bearing target cells resulted in an influx of an impermeant nucleic acid-staining fluorescent dye into the Env-expressing cells. The dye influx occurred concomitant with cell fusion. No influx of dye into target cells was observed if they were incubated with an excess of Env-expressing cells. The permeabilization of Env-expressing cells was also triggered by CD4.co-receptor complexes attached to Protein G-Sepharose beads in the absence of target cells. The CD4 and co-receptor-induced permeabilization of Env-expressing cells occurred with the same specificity with respect to co-receptor usage as cell fusion. Natural ligands for the co-receptors and C-terminal GP41 peptide inhibitors of HIV-1 fusion blocked this effect. Our results indicate that the process of HIV-1 Env-mediated fusion is initiated by the destabilization of HIV-1 Env-expressing membranes. Further elucidation of these early intermediates may help identify and develop potential inhibitors of HIV-1 entry into cells.	NCI, Canc Res Ctr, Lab Expt & Computat Biol, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumenthal, R (corresponding author), NCI, Canc Res Ctr, Lab Expt & Computat Biol, NIH, POB B,Bldg 469,Rm 216A,Miller Dr, Frederick, MD 21702 USA.							Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bentz J, 2000, BIOPHYS J, V78, P886, DOI 10.1016/S0006-3495(00)76646-X; BERGER EA, 1997, AIDS, V11, P3; Blumenthal R, 1999, MOL MEMBR BIOL, V16, P43, DOI 10.1080/096876899294742; BRODER CC, 1995, P NATL ACAD SCI USA, V92, P9004, DOI 10.1073/pnas.92.19.9004; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHEN CH, 1995, J VIROL, V69, P3771, DOI 10.1128/JVI.69.6.3771-3777.1995; Dimitrov DS, 2000, CELL, V101, P697, DOI 10.1016/S0092-8674(00)80882-X; DIMITROV DS, 1992, AIDS, V60, P249; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; EARL PL, 1991, J VIROL, V65, P31, DOI 10.1128/JVI.65.1.31-41.1991; FREED EO, 1992, P NATL ACAD SCI USA, V89, P70, DOI 10.1073/pnas.89.1.70; FU YK, 1993, J VIROL, V67, P3818, DOI 10.1128/JVI.67.7.3818-3825.1993; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; GUY HR, 1992, BIOPHYS J, V62, P95, DOI 10.1016/S0006-3495(92)81790-3; JIANG SB, 1993, BIOCHEM BIOPH RES CO, V195, P533, DOI 10.1006/bbrc.1993.2078; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; KASURINEN J, 1992, BIOCHEM BIOPH RES CO, V187, P1594, DOI 10.1016/0006-291X(92)90485-4; Kliger Y, 1997, J BIOL CHEM, V272, P13496, DOI 10.1074/jbc.272.21.13496; Kliger Y, 1997, BIOCHEMISTRY-US, V36, P5157, DOI 10.1021/bi962935r; Kliger Y, 2001, J BIOL CHEM, V276, P1391, DOI 10.1074/jbc.M004113200; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Longo ML, 1997, BIOPHYS J, V73, P1430, DOI 10.1016/S0006-3495(97)78175-X; MILLER MA, 1993, VIROLOGY, V196, P89, DOI 10.1006/viro.1993.1457; Mirzabekov T, 1999, J BIOL CHEM, V274, P28745, DOI 10.1074/jbc.274.40.28745; MOBLEY PW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P251, DOI 10.1016/0925-4439(92)90098-8; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; NIEVA JL, 1994, BIOCHEMISTRY-US, V33, P3201, DOI 10.1021/bi00177a009; RAFALSKI M, 1990, BIOCHEMISTRY-US, V29, P7917, DOI 10.1021/bi00486a020; Raphael RM, 1996, BIOPHYS J, V71, P1374, DOI 10.1016/S0006-3495(96)79340-2; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SLEPUSHKIN VA, 1990, BIOCHEM BIOPH RES CO, V172, P952, DOI 10.1016/0006-291X(90)90768-I; SRINIVAS SK, 1992, J BIOL CHEM, V267, P7121; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; THALI M, 1992, J VIROL, V66, P5516, DOI 10.1128/JVI.66.9.5516-5524.1992; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; WEBER T, 1994, J BIOL CHEM, V269, P18353; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEISS CD, 1990, J VIROL, V64, P5674, DOI 10.1128/JVI.64.11.5674-5677.1990; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WHARTON SA, 1995, EMBO J, V14, P240, DOI 10.1002/j.1460-2075.1995.tb06997.x; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Xiao XD, 2000, EXP MOL PATHOL, V68, P139, DOI 10.1006/exmp.1999.2299; Zhang WT, 1999, BIOCHEMISTRY-US, V38, P9405, DOI 10.1021/bi990654o	64	46	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30335	30341		10.1074/jbc.M103788200	http://dx.doi.org/10.1074/jbc.M103788200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11397808	hybrid			2022-12-27	WOS:000170558000096
J	Kaufmann, H; Marone, R; Olayioye, MA; Bailey, JE; Fussenegger, M				Kaufmann, H; Marone, R; Olayioye, MA; Bailey, JE; Fussenegger, M			Characterization of an N-terminally truncated cyclin a isoform in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; DNA-REPLICATION; S-PHASE; EXPRESSION; KINASE; P27(KIP1); GENE; E2F; COMPLEX; CDK2	Cyclin A is essential for regulating key transitions in the eukaryotic cell cycle including initiation of DNA replication and mitosis. This paper describes the characterization of a truncated cyclin A isoform (cyclin A(t)) in vitro in cultured mammalian cells and in mouse tissues. The presence of cyclin A(t) in specific cell types correlates with the ability of cell extracts to cleave in vitro translated cyclin A. In CHO-K1 cells, cyclin A processing to cyclin A(t) occurs at the N terminus; it does not involve the 26 S proteasome, nor could it be induced by conditional overexpression of the cyclin-dependent kinase inhibitor p27(Kip1). However, high cell densities lead to increased cyclin A(t) levels. Unlike full-length cyclin A, cyclin A(t) localizes to the cytoplasm, where it binds Cdk2. The data suggest that cyclin A processing occurs in vivo to yield an N-terminally truncated isoform by an unknown mechanism that is regulated by cell density. Differential subcellular localization may provide the first insights into the physiological role of cyclin At.	ETH Honggerberg HPT, Swiss Fed Inst Technol, Inst Biotechnol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Fussenegger, M (corresponding author), ETH Honggerberg HPT, Swiss Fed Inst Technol, Inst Biotechnol, CH-8093 Zurich, Switzerland.			Marone, Romina/0000-0003-1474-1689				Aaltomaa S, 1999, BRIT J CANCER, V80, P2001, DOI 10.1038/sj.bjc.6690634; Allan K, 2000, ARCH PATHOL LAB MED, V124, P216; Bastians H, 1998, P NATL ACAD SCI USA, V95, P15374, DOI 10.1073/pnas.95.26.15374; BRECHOT C, 1993, CURR OPIN GENET DEV, V3, P11, DOI 10.1016/S0959-437X(05)80335-1; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Desdouets C, 1995, Prog Cell Cycle Res, V1, P115; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Handa K, 1999, INT J CANCER, V84, P225, DOI 10.1002/(SICI)1097-0215(19990621)84:3<225::AID-IJC5>3.0.CO;2-A; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Herrada J, 1997, CLIN CANCER RES, V3, P1565; Huet X, 1996, MOL CELL BIOL, V16, P3789; Huuhtanen RL, 1999, CANCER RES, V59, P2885; Kaufmann H, 2001, BIOTECHNOL BIOENG, V72, P592, DOI 10.1002/1097-0290(20010320)72:6<592::AID-BIT1024>3.0.CO;2-J; KEYOMARSI K, 1995, ONCOGENE, V11, P941; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; LEES E, 1992, GENE DEV, V6, P1874, DOI 10.1101/gad.6.10.1874; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; Liu NS, 1998, ONCOGENE, V16, P2957, DOI 10.1038/sj.onc.1201838; LORCA T, 1992, FEBS LETT, V306, P90, DOI 10.1016/0014-5793(92)80844-7; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mazur X, 1998, BIOTECHNOL PROGR, V14, P705, DOI 10.1021/bp980062h; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Murphy M, 1999, NAT GENET, V23, P481, DOI 10.1038/70612; Orend G, 1998, ONCOGENE, V16, P2575, DOI 10.1038/sj.onc.1201791; Orian A, 1999, MOL CELL BIOL, V19, P3664; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Philips A, 1999, ONCOGENE, V18, P6222, DOI 10.1038/sj.onc.1203017; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; SOBCZAKTHEPOT J, 1993, EXP CELL RES, V206, P43, DOI 10.1006/excr.1993.1118; Tokumoto T, 1997, J CELL BIOL, V138, P1313, DOI 10.1083/jcb.138.6.1313; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; Yam CH, 2001, P NATL ACAD SCI USA, V98, P497, DOI 10.1073/pnas.240461397; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; ZerfassThome K, 1997, MOL CELL BIOL, V17, P407, DOI 10.1128/MCB.17.1.407; Zhai YL, 1999, INT J CANCER, V84, P244, DOI 10.1002/(SICI)1097-0215(19990621)84:3<244::AID-IJC8>3.0.CO;2-2; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G; ZWICKER J, 1995, EMBO J, V14, P4514, DOI 10.1002/j.1460-2075.1995.tb00130.x	50	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29987	29993		10.1074/jbc.M005452200	http://dx.doi.org/10.1074/jbc.M005452200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402021	hybrid			2022-12-27	WOS:000170558000051
J	McAleese, FM; Walsh, EJ; Sieprawska, M; Potempa, J; Foster, TJ				McAleese, FM; Walsh, EJ; Sieprawska, M; Potempa, J; Foster, TJ			Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR PROTEOLYTIC-ENZYMES; PROTEIN-A; EXPRESSION; GENE; SAR; IDENTIFICATION; ACTIVATION; RECEPTOR; DOMAIN	The fibrinogen-binding protein clumping factor B (ClfB) of Staphylococcus aureus is present on the surface of cells from the early exponential phase of growth in greater amounts than on cells from late exponential phase and is barely detectable on cells from stationary phase. Expression of a clfB-lacZ fusion indicated that transcription stopped before the end of exponential phase. Mutations in the global regulators agr and sar had no effect on clfB transcription. The loss of ClfB protein from cells in stationary phase was due to expression ending before cells stopped growing, combined with shedding of some of the protein into the growth medium and dilution of those molecules remaining on the cell surface during the two to three cell division events leading to stationary phase. Two forms of the protein occurred on the cell surface, the smaller of which was generated by loss of a domain from the N terminus. The proportion of the smaller form increased as the cultures grew. The metalloprotease aureolysin was shown to be responsible for cleavage of ClfB. Cleavage was inhibited by EDTA and o-phenanthroline and did not occur in an aureolysin-deficient mutant. Purified aureolysin promoted cleavage of cell surface-located ClfB as well as the recombinant A domain of ClfB. Cleavage was detected at two sites, one located between residues Ser(197) and Leu(198) and the other between Ala(199) and Val(200). The truncated form of ClfB did not bind fibrinogen.	Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland; Jagiellonian Univ, Inst Mol Biol, Dept Microbiol, PL-31120 Krakow, Poland	Trinity College Dublin; Jagiellonian University	Foster, TJ (corresponding author), Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland.	tfoster@tcd.ie						ARVIDSON S, 1973, BIOCHIM BIOPHYS ACTA, V302, P149, DOI 10.1016/0005-2744(73)90017-X; ARVIDSON SO, 1983, STAPHYLOCOCCI STAPHY, V2, P745; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BJORKLIND A, 1974, BIOCHIM BIOPHYS ACTA, V370, P524, DOI 10.1016/0005-2744(74)90113-2; Blevins JS, 1999, MOL MICROBIOL, V33, P317, DOI 10.1046/j.1365-2958.1999.01475.x; Chan PF, 1998, J BACTERIOL, V180, P6232; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung AL, 1997, INFECT IMMUN, V65, P2243, DOI 10.1128/IAI.65.6.2243-2249.1997; CROSSLEY KB, 1997, STAPHYLOCOCCI HUMAN; DRAPEAU GR, 1978, J BACTERIOL, V136, P607, DOI 10.1128/JB.136.2.607-613.1978; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Entenza JM, 2000, INFECT IMMUN, V68, P5443, DOI 10.1128/IAI.68.9.5443-5446.2000; Fa W., 1995, PRINCIPLES PRACTICES, V4, P1754; Foster TJ, 1998, METHOD MICROBIOL, V27, P433; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7; Gillaspy AF, 1998, INFECT IMMUN, V66, P3170, DOI 10.1128/IAI.66.7.3170-3178.1998; Hartford O, 1999, MICROBIOL-SGM, V145, P2497, DOI 10.1099/00221287-145-9-2497; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; Hartleib J, 2000, BLOOD, V96, P2149; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; HOOK M, 1999, GRAM POSITIVE BACTER, P386; KEMP EH, 1991, J BACTERIOL, V173, P4646, DOI 10.1128/jb.173.15.4646-4652.1991; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; MOREILLON P, 1995, INFECT IMMUN, V63, P4738, DOI 10.1128/IAI.63.12.4738-4743.1995; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; OSKOUIAN B, 1990, J BACTERIOL, V172, P3804, DOI 10.1128/jb.172.7.3804-3812.1990; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; POTEMPA J, 1991, J BIOL CHEM, V266, P21482; POTEMPA J, 1986, J BIOL CHEM, V261, P14330; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SaraviaOtten P, 1997, J BACTERIOL, V179, P5259, DOI 10.1128/jb.179.17.5259-5263.1997; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; VAUDAUX PE, 1995, INFECT IMMUN, V63, P585, DOI 10.1128/IAI.63.2.585-590.1995; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; WEGRZYNOWICZ Z, 1980, J CLIN MICROBIOL, V12, P138, DOI 10.1128/JCM.12.2.138-139.1980; WOIZ C, 1996, INFECT IMMUN, V64, P3142; Youngman P., 1990, MOL BIOL METHODS BAC, P221	46	115	122	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29969	29978		10.1074/jbc.M102389200	http://dx.doi.org/10.1074/jbc.M102389200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11399757	Green Published, hybrid			2022-12-27	WOS:000170558000049
J	Clark, KD; Volkman, BF; Thoetkiattikul, H; Hayakawa, Y; Strand, MR				Clark, KD; Volkman, BF; Thoetkiattikul, H; Hayakawa, Y; Strand, MR			N-terminal residues of plasmatocyte-spreading peptide possess specific determinants required for biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTH PSEUDOPLUSIA-INCLUDENS; HEMOCYTES; HEMOLYMPH; IMMUNITY	Plasmatocyte-spreading peptide (PSP) is a 23-amino acid cytokine that activates a class of insect immune cells called plasmatocytes. The tertiary structure of PSP consists of an unstructured N terminus (residues 1-6) and a well structured core (residues 7-23). A prior study indicated that deletion of the N terminus from PSP eliminated all biological activity. Alanine substitution of the first three residues (Glu(1)-Asn(2)-Phe(3)) further indicated that only replacement of Phe(3) resulted in a loss of activity equal to the N-terminal deletion mutant. Here, we characterized structural determinants of the N terminus. Adding a hydroxyl group to the aromatic ring of Phe(3) (making a Tyr) greatly reduced activity, whereas the addition of a fluorine (p-fluoro) did not. Substitutions that changed the chirality or replaced the aromatic ring of Phe(3) with a branched aliphatic chain (making a Val) also greatly decreased activity. The addition of a methylene group to Val (making a Leu) partially restored activity, whereas the removal of a methylene group from Phe (phenyl-Gly) eliminated all activity. These results indicated that a branched carbon chain with a methylene spacer at the third residue is the minimal structural motif required for activity. The deletion of Glu(1) also eliminated activity. Additional experiments identified the charged N-terminal amine and backbone of Glu(1) as key determinants for activity.	Univ Wisconsin, Dept Entomol, Russell Labs 237, Madison, WI 53706 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Hokkaido Univ, Inst Low Temp Sci, Biochem Lab, Sapporo, Hokkaido 0600819, Japan	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; Hokkaido University	Strand, MR (corresponding author), Univ Wisconsin, Dept Entomol, Russell Labs 237, Madison, WI 53706 USA.		Volkman, Brian F./ABE-7312-2020; Clark, Kevin/GQA-9811-2022; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032917] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32917] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 1998, BIOCHEM BIOPH RES CO, V250, P479, DOI 10.1006/bbrc.1998.9145; Clark KD, 2001, J BIOL CHEM, V276, P18491, DOI 10.1074/jbc.M100579200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gardiner EMM, 1999, J INSECT PHYSIOL, V45, P113, DOI 10.1016/S0022-1910(98)00092-4; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Pech LL, 1996, J CELL SCI, V109, P2053; PECH LL, 1994, CELL TISSUE RES, V277, P159, DOI 10.1007/BF00303092; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; STRAND MR, 1990, ANN ENTOMOL SOC AM, V83, P538, DOI 10.1093/aesa/83.3.538; Volkman BF, 1999, J BIOL CHEM, V274, P4493, DOI 10.1074/jbc.274.8.4493; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7	16	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	2001	276	40					37431	37435		10.1074/jbc.M105235200	http://dx.doi.org/10.1074/jbc.M105235200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	478YD	11432871	hybrid			2022-12-27	WOS:000171375700076
J	van Rietschoten, JGI; Smits, HH; van de Wetering, D; Westland, R; Verweij, CL; den Hartog, MT; Wierenga, EA				van Rietschoten, JGI; Smits, HH; van de Wetering, D; Westland, R; Verweij, CL; den Hartog, MT; Wierenga, EA			Silencer activity of NFATc2 in the interleukin-12 receptor beta 2 proximal promoter in human T helper cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; HUMAN TH1; IFN-GAMMA; SP-FAMILY; EXPRESSION; SUBSETS; CLONES; GENE; DIFFERENTIATION; COMPONENT	Interleukin 12 (IL-12) is a potent enhancer of interferon gamma production by activated T cells. The high-affinity IL-12 receptor (IL-12R) is a heterodimer of a beta1 and a beta2 subunit. Expression of the signaling IL-12R beta2 chain is usually low, as compared with the more abundant beta1 chain, and may be rate-limiting for IL-12 sensitivity. Little is known about the mechanisms controlling IL-12R beta2 gene expression. Reporter gene assays in IL-12R beta2-expressing Jurkat cells showed that truncation of the region from -151 to -61 abrogated promoter activity. The proximal promoter region does not contain a typical TATA box, suggesting a role for SP-1. Indeed, mutagenesis of the -63 SP-1 consensus site decreased transcription by 50%. Electrophoretic mobility shift experiments confirmed the binding of SP-1 and SP-3 at this site. In contrast, truncation of -252 to -192 increased promoter activity. Likewise, mutagenesis of the consensus nuclear factor of activated T cells site at -206 increased promoter activity by 70%, suggesting silencer activity of this element. Electrophoretic mobility shift experiments with primary Th (T helper) cells showed the formation of a specific, T-cell receptor-inducible complex at this site that is sensitive to cyclosporin A and supershifted with anti-NFATc2 in both Th1 and Th2 cells. Accordingly, cyclosporin A dose-dependently increased IL-12R beta2 mRNA expression. These first data on IL-12R beta2 gene regulation indicate a TATA-less promoter, depending on SP-1/SP-3 transcription factors, and a negative regulatory NFAT element at -206. This element may contribute to the overall low level of IL-12R beta2 expression on Th cells.	Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Free Univ Med Ctr, Dept Mol Cell Biol, NL-1007 MB Amsterdam, Netherlands; Tanox Pharma BV, NL-1098 SM Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Wierenga, EA (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 15,POB 22700, NL-1105 AZ Amsterdam, Netherlands.		Smits, Hermelijn/V-4216-2018	Smits, Hermelijn/0000-0001-9279-2890				Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; CHUA AO, 1994, J IMMUNOL, V153, P128; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Hilkens CMU, 1996, J IMMUNOL, V157, P4316; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kraan TCTMV, 1996, J IMMUNOL, V156, P1818; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; MAGGI E, 1992, J IMMUNOL, V148, P2142; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; MANGER B, 1986, J CLIN INVEST, V77, P1501, DOI 10.1172/JCI112464; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rogge L, 1999, J IMMUNOL, V162, P3926; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; SALGAME P, 1991, SCIENCE, V254, P279, DOI 10.1126/science.1681588; Sinigaglia F, 1999, IMMUNOL REV, V170, P65, DOI 10.1111/j.1600-065X.1999.tb01329.x; Smits HH, 2001, EUR J IMMUNOL, V31, P1055, DOI 10.1002/1521-4141(200104)31:4<1055::AID-IMMU1055>3.0.CO;2-7; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; van Rietschoten JGI, 2000, IMMUNOGENETICS, V51, P30, DOI 10.1007/s002510050005; Vieira PL, 1998, J IMMUNOL, V161, P5245; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yamamoto K, 1997, CYTOGENET CELL GENET, V77, P257, DOI 10.1159/000134589; Yokoe T, 2001, CELL IMMUNOL, V208, P34, DOI 10.1006/cimm.2001.1759; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	33	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34509	34516		10.1074/jbc.M102536200	http://dx.doi.org/10.1074/jbc.M102536200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11438525	hybrid			2022-12-27	WOS:000171024600023
J	Utton, MA; Gibb, GM; Burdett, IDJ; Anderton, BH; Vandecandelaere, A				Utton, MA; Gibb, GM; Burdett, IDJ; Anderton, BH; Vandecandelaere, A			Functional differences of tau isoforms containing 3 or 4 C-terminal repeat regions and the influence of oxidative stress.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; PAIRED HELICAL FILAMENTS; DYNAMIC INSTABILITY; ALZHEIMERS-DISEASE; INDIVIDUAL MICROTUBULES; FRONTOTEMPORAL DEMENTIA; PRESENILE-DEMENTIA; SELF-ASSOCIATION; BUNDLE FORMATION; BOVINE BRAIN	We report functional differences between tau isoforms with 3 or 4 C-terminal repeats and a difference in susceptibility to oxidative conditions, with respect to the regulation of microtubule dynamics in vitro and tau-microtubule, binding in cultured cells. In the presence of dithiothreitol in vitro, a 3-repeat tau isoform promotes microtubule nucleation, reduces the tubulin critical concentration for microtubule assembly, and suppresses dynamic instability. Under non-reducing conditions, threshold concentrations of 3-repeat tau and tubulin exist below which this isoform still promotes microtubule, nucleation and assembly but fails to reduce the tubulin critical concentration or suppress dynamic instability; above these threshold concentrations, amorphous aggregates of 3-repeat tau and tubulin can be produced at the expense of microtubule formation. A 4-repeat tau isoform is less sensitive to the oxidative potential of the environment, behaving under oxidative conditions similarly to the 3-repeat isoform under reducing conditions. Under conditions of oxidative stress, in Chinese hamster ovary cells stably expressing either 3- or 4-repeat tau, 3-repeat tau disassociates from microtubules more readily than the 4-repeat isoform, and tau-containing high molecular weight aggregates are preferentially observed in lysates from the Chinese hamster ovary cells expressing 3-repeat tau, indicating greater susceptibility of 3-repeat tau to oxidative conditions, compared with 4-repeat tau in vivo.	Kings Coll London, Inst Psychiat, Dept Neurosci, London SE5 8AF, England; Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; Natl Inst Med Res, Div Membrane Biol, London NW7 1AA, England	University of London; King's College London; MRC National Institute for Medical Research; MRC National Institute for Medical Research	Utton, MA (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, De Crespigny Pk, London SE5 8AF, England.	m.utton@iop.kcl.ac.uk						Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Bayley Peter M., 1994, V13, P111; BELLOMO G, 1990, J CELL PHYSIOL, V143, P118, DOI 10.1002/jcp.1041430116; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BRANDT R, 1993, J BIOL CHEM, V268, P3414; BRANDT R, 1993, J NEUROCHEM, V61, P997, DOI 10.1111/j.1471-4159.1993.tb03613.x; BRE MH, 1990, CELL MOTIL CYTOSKEL, V15, P88, DOI 10.1002/cm.970150205; BRION JP, 1993, J NEUROCHEM, V60, P1372, DOI 10.1111/j.1471-4159.1993.tb03298.x; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CLARK DC, 1981, BIOCHEMISTRY-US, V20, P1924, DOI 10.1021/bi00510a031; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Davis DR, 1997, J NEUROCHEM, V68, P1590; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; DEANCOS JG, 1993, J BIOL CHEM, V268, P7976; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Di Noto L, 1999, Mol Cell Biol Res Commun, V2, P71, DOI 10.1006/mcbr.1999.0153; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN D, 1986, ANN NY ACAD SCI, V466, P257, DOI 10.1111/j.1749-6632.1986.tb38398.x; Epe B, 1996, NUCLEIC ACIDS RES, V24, P1625, DOI 10.1093/nar/24.9.1625; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; FLAMENTDURAND J, 1979, ACTA NEUROPATHOL, V46, P159, DOI 10.1007/BF00684819; FRANCON J, 1982, EUR J BIOCHEM, V129, P465, DOI 10.1111/j.1432-1033.1982.tb07072.x; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; Grundke-Iqbal I, 1997, P NATL ACAD SCI USA, V94, P298; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Guttmann RP, 1998, J BIOL CHEM, V273, P13331, DOI 10.1074/jbc.273.21.13331; GUTTMANN RP, 1995, J NEUROCHEM, V64, P1209; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IKEDA Y, 1978, BIOCHEMISTRY-US, V17, P3454, DOI 10.1021/bi00610a005; ITOH TJ, 1994, CELL STRUCT FUNCT, V19, P279, DOI 10.1247/csf.19.279; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839; Ko LW, 1997, BRAIN RES, V760, P118, DOI 10.1016/S0006-8993(97)00292-8; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; KSIEZAKREDING H, 1995, J NEUROSCI RES, V41, P583, DOI 10.1002/jnr.490410504; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MULOT SFC, 1994, FEBS LETT, V349, P359, DOI 10.1016/0014-5793(94)00702-0; MURPHY DB, 1977, J MOL BIOL, V117, P33, DOI 10.1016/0022-2836(77)90021-3; NOVELLA IS, 1992, FEBS LETT, V211, P235; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Preuss U, 1997, J CELL SCI, V110, P789; PRYER NK, 1992, J CELL SCI, V103, P965; Revesz T, 1997, J NEUROPATH EXP NEUR, V56, P80; Sambrook J., 1989, MOL CLONING LAB MANU, V3, P18; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCOTT CW, 1991, J NEUROSCI RES, V30, P154, DOI 10.1002/jnr.490300116; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SMITH C, 1994, NEUROPATH APPL NEURO, V20, P322, DOI 10.1111/j.1365-2990.1994.tb00977.x; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; TRONCOSO JC, 1993, BRAIN RES, V613, P313, DOI 10.1016/0006-8993(93)90918-D; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741; Vandecandelaere A, 1996, CELL MOTIL CYTOSKEL, V35, P134, DOI 10.1002/(SICI)1097-0169(1996)35:2<134::AID-CM6>3.0.CO;2-A; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; VERMERSCH P, 1994, ACTA NEUROPATHOL, V87, P572; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WALLIS KT, 1993, J BIOL CHEM, V268, P15158; WEISENBERG RC, 1986, ANN NY ACAD SCI, V466, P543, DOI 10.1111/j.1749-6632.1986.tb38431.x; WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3	73	18	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34288	34297		10.1074/jbc.M011384200	http://dx.doi.org/10.1074/jbc.M011384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11438517	hybrid			2022-12-27	WOS:000170910200132
J	Wang, LJ; Gout, I; Proud, CG				Wang, LJ; Gout, I; Proud, CG			Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways - MEK-dependent activation of S6K2 in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; PROTEIN-KINASE; CARDIAC MYOCYTES; INSULIN; RAPAMYCIN; STIMULATION; INHIBITION; PHOSPHORYLATION; MECHANISM; AKT	The alpha (1)-adrenergic agonist phenylephrine (PE) and insulin each stimulate protein synthesis in cardiomyocytes. Activation of protein synthesis by PE is involved in the development of cardiac hypertrophy. One component involved here is p70 S6 kinase 1 (S6K1), which lies downstream of mammalian target of rapamycin, whose regulation is thought to involve phosphatidylinositol 3-kinase and protein kinase B (PKB). S6K2 is a recently identified homolog of S6K1 whose regulation is poorly understood. Here we demonstrate that in adult rat ventricular cardiomyocytes, PE and insulin each activate S6K2, activation being 3.5- and 5-fold above basal, respectively. Rapamycin completely blocked S6K2 activation by either PE or insulin. Three different inhibitors of MEK1/2 abolished PE-induced activation of S6K2 whereas expression of constitutively active MEK1 activated S6K2, without affecting the p38 mitogen-activated protein kinase and JNK pathways, indicating that MEK/ERK signaling plays a key role in regulation of S6K2 by PE. PE did not activate PKB, and expression of dominant negative PKB failed to block activation of S6K2 by PE, indicating PE-induced S6K2 activation is independent of PKB. However, this PKB mutant did partially block S6K2 activation by insulin, indicating PKB is required here. Another hypertrophic agent, endothelin 1, also activated S6K2 in a MEK-dependent manner. Our findings provide strong evidence for novel signaling connections between MEK/ERK and S6K2.	Univ Dundee, Sch Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; UCL Royal Free & Univ Coll, Sch Med, Ludwig Inst Canc Res, Cell Regulat Lab, London W1W 7BS, England	University of Dundee; Ludwig Institute for Cancer Research; University of London; University College London; UCL Medical School	Proud, CG (corresponding author), Univ Dundee, Sch Life Sci, Div Mol Physiol, Dow St, Dundee DD1 5EH, Scotland.	c.g.proud@dundee.ac.uk	Wang, Lijun/A-5573-2013	Proud, Christopher/0000-0003-0704-6442				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; Bogoyevitch MA, 1996, BIOCHEM J, V314, P115, DOI 10.1042/bj3140115; BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P29710; BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Conus NM, 1998, J BIOL CHEM, V273, P4776, DOI 10.1074/jbc.273.8.4776; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FULLER SJ, 1990, BIOCHEM J, V266, P727, DOI 10.1042/bj2660727; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Glennon PE, 1996, CIRC RES, V78, P954, DOI 10.1161/01.RES.78.6.954; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Koh H, 1999, ONCOGENE, V18, P5115, DOI 10.1038/sj.onc.1202895; Kotani K, 1999, J BIOL CHEM, V274, P21305, DOI 10.1074/jbc.274.30.21305; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Martin KA, 2001, J BIOL CHEM, V276, P7884, DOI 10.1074/jbc.M006969200; Martin KA, 2001, J BIOL CHEM, V276, P7892, DOI 10.1074/jbc.M009972200; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; MOULE SK, 1995, BIOCHEM J, V311, P595, DOI 10.1042/bj3110595; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056, DOI 10.1152/ajpheart.2000.278.4.H1056; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200	42	110	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32670	32677		10.1074/jbc.M102776200	http://dx.doi.org/10.1074/jbc.M102776200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11431469	hybrid			2022-12-27	WOS:000170746000040
J	Bengtson, P; Larson, C; Lundblad, A; Larson, G; Pahlsson, P				Bengtson, P; Larson, C; Lundblad, A; Larson, G; Pahlsson, P			Identification of a missense mutation (G329A; Arg(110) -> Gln) in the human FUT7 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(1,3)FUCOSYLTRANSFERASE FUC-TVII; LEUKOCYTE ADHESION DEFICIENCY; FUCOSYL-TRANSFERASE GENE; HIGH ENDOTHELIAL VENULES; E-SELECTIN LIGAND-1; BLOOD-GROUP SYSTEM; MOLECULAR-CLONING; LEWIS-X; ALPHA(1,3)-FUCOSYL-TRANSFERASE GENE; P-SELECTIN	The human FUT7 gene codes for the alpha1,3-fucosyltransferase VII (Fue-TVII), which is involved in the biosynthesis of the sialyl Lewis x (SLe(X)) epitope on human leukocytes. The FUT7 gene has so far been considered to be monomorphic. Neutrophils isolated from patients with ulcerative colitis were examined for apparent alterations in protein glycosylation patterns by Western blot analysis using monoclonal antibodies directed against SLe(X) and SLe(X)-related epitopes. One individual showed lower levels of SLe(X) expression and an elevated expression of CD65s compared to controls. The coding regions of the FUT7 gene from this individual were cloned, and a G329A point mutation (Arg(110) --> Gln) was found in one allele, whereas the other FUT7 allele was wild type. No Fuc-TVII enzyme activity was detected in COS-7 cells transiently transfected with the mutated FUT7 construct. The FUT7 Arg(110) is conserved in all previously cloned vertebrate alpha1,3-fucosyltransferases. Polymerase chain reaction followed by restriction enzyme cleavage was used to screen 364 unselected Caucasians for the G329A mutation, and a frequency of less than or equal to1% for this mutation was found (3 heterozygotes). Genetic characterization of the family members of one of the additional heterozygotes identified one individual carrying the G329A mutation in both FUT7 alleles. Peripheral blood neutrophils of this homozygously mutated individual showed a lowered expression of SLe(X) and an elevated expression of CD65s when analyzed by Western blot and flow cytometry. The homozygous individual was diagnosed with ulcer disease, non-insulin-dependent diabetes, osteoporosis, spondyloarthrosis, and Sjogren's syndrome but had no history of recurrent bacterial infections or leukocytosis.	Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Inst Lab Med, SE-41345 Gothenburg, Sweden; Linkoping Univ, Dept Biomed & Surg, Div Clin Chem, SE-58185 Linkoping, Sweden	Sahlgrenska University Hospital; Linkoping University	Larson, G (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Inst Lab Med, SE-41345 Gothenburg, Sweden.		Larson, Göran/AAF-3404-2019					Britten CJ, 1998, GLYCOBIOLOGY, V8, P321, DOI 10.1093/glycob/8.4.321; Clarke JL, 1997, GLYCOBIOLOGY, V7, P835, DOI 10.1093/glycob/7.6.835; Costache M, 1997, J BIOL CHEM, V272, P29721, DOI 10.1074/jbc.272.47.29721; DAVIS LG, 1986, BASIC METHODS MOL BI, P290; DOHI T, 1993, ANTICANCER RES, V13, P1277; Dupuy F, 1999, J BIOL CHEM, V274, P12257, DOI 10.1074/jbc.274.18.12257; Elmgren A, 2000, HUM MUTAT, V16, P473, DOI 10.1002/1098-1004(200012)16:6<473::AID-HUMU4>3.0.CO;2-T; Elmgren A, 1997, J BIOL CHEM, V272, P21994, DOI 10.1074/jbc.272.35.21994; ETZIONI A, 1992, NEW ENGL J MED, V327, P1789, DOI 10.1056/NEJM199212173272505; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GOELZ S, 1994, J BIOL CHEM, V269, P1033; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; Grabenhorst E, 1998, J BIOL CHEM, V273, P30985, DOI 10.1074/jbc.273.47.30985; Handa K, 1997, BIOCHEMISTRY-US, V36, P12412, DOI 10.1021/bi971181t; Handa K, 1998, BIOCHEM BIOPH RES CO, V243, P199, DOI 10.1006/bbrc.1998.8080; Hiraiwa N, 1996, J BIOL CHEM, V271, P31556, DOI 10.1074/jbc.271.49.31556; HOLMES EH, 1986, J BIOL CHEM, V261, P3737; Huang MC, 2000, J BIOL CHEM, V275, P31353, DOI 10.1074/jbc.M005449200; Kageyama N, 1999, J BIOCHEM-TOKYO, V125, P838, DOI 10.1093/oxfordjournals.jbchem.a022357; Kaneko M, 1999, FEBS LETT, V452, P237, DOI 10.1016/S0014-5793(99)00640-7; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Knibbs RN, 1996, J CELL BIOL, V133, P911, DOI 10.1083/jcb.133.4.911; KUMAR R, 1991, J BIOL CHEM, V266, P21777; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson G, 1996, VOX SANG, V71, P233, DOI 10.1046/j.1423-0410.1996.7140233.x; Larson G, 1999, VOX SANG, V77, P227, DOI 10.1046/j.1423-0410.1999.7740227.x; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; LOWE JB, 1991, J BIOL CHEM, V266, P17467; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOLLICONE R, 1994, J BIOL CHEM, V269, P20987; MOLLICONE R, 1994, J BIOL CHEM, V269, P12662; MOLLICONE R, 1990, EUR J BIOCHEM, V191, P169, DOI 10.1111/j.1432-1033.1990.tb19107.x; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; Niemela R, 1998, J BIOL CHEM, V273, P4021, DOI 10.1074/jbc.273.7.4021; NISHIHARA S, 1994, J BIOL CHEM, V269, P29271; Nishihara S, 1999, GLYCOBIOLOGY, V9, P373, DOI 10.1093/glycob/9.4.373; Pang H, 1998, HUM GENET, V102, P675, DOI 10.1007/s004390050760; Pang H, 1999, ANN HUM GENET, V63, P277, DOI 10.1046/j.1469-1809.1999.6340277.x; Phillips ML, 1995, J CLIN INVEST, V96, P2898, DOI 10.1172/JCI118361; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Shinoda K, 1997, J BIOL CHEM, V272, P31992, DOI 10.1074/jbc.272.51.31992; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smith PL, 1996, J BIOL CHEM, V271, P8250, DOI 10.1074/jbc.271.14.8250; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Swarte VVR, 1998, EUR J IMMUNOL, V28, P3040, DOI 10.1002/(SICI)1521-4141(199810)28:10<3040::AID-IMMU3040>3.0.CO;2-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Wagers AJ, 1997, J IMMUNOL, V159, P1917; Wagers AJ, 1996, BLOOD, V88, P2125, DOI 10.1182/blood.V88.6.2125.bloodjournal8862125; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Weston BW, 1999, EUR J HAEMATOL, V63, P42; WINDER A, 1995, BIOCHEM SOC T, V23, pS165, DOI 10.1042/bst023165s; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002	57	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31575	31582		10.1074/jbc.M104165200	http://dx.doi.org/10.1074/jbc.M104165200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11404359	hybrid			2022-12-27	WOS:000170613500016
J	Canete-Soler, R; Wu, JH; Zhai, JB; Shamim, M; Schlaepfer, WW				Canete-Soler, R; Wu, JH; Zhai, JB; Shamim, M; Schlaepfer, WW			P190RhoGEF binds to a destabilizing element in the 3 ' untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; POSTNATAL-DEVELOPMENT; UP-REGULATION; PROTEINS; EXPRESSION; CALIBER; SYSTEM; HEAVY; GENE	Stabilization of neurofilament (NF) mRNAs plays a major role in regulating levels of NF expression and in establishing axonal size and rate of axonal conduction. Previous studies have identified a 68-nucleotide destabilizing element at the junction of the coding region and 3 ' untranslated region of the light NF subunit (NF-L) mRNA. The present study has used the destabilizing element (probe A) to screen a rat brain cDNA library for interactive proteins. A cDNA clone encoding 1068 nucleotides in the C-terminal domain of p190RhoGEF (clone 39) was found to bind strongly and specifically to the RNA probe. The interaction was confirmed using a glutathione S-transferase/clone 39 fusion protein in Northwestern, gel-shift, and cross-linkage studies. The glutathione S-transferase/clone 39 fusion protein also enhanced the cross-linkage of a major 43-kDa protein in brain extract to the destabilizing element. Functional studies on stably transfected neuronal cells showed that p190RhoGEF expression increased the half-life of a wild-type NF-L mRNA but did not alter the half-life of a mutant NF-L mRNA lacking the destabilizing element. The findings reveal a novel interactive feature of p190PhoGEF that Un the exchange factor with NF mRNA stability and regulation of the axonal cytoskeleton.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Canete-Soler, R (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 608 Stellar Chance Labs, Philadelphia, PA 19104 USA.	racansol@mail.med.upenn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015722] Funding Source: NIH RePORTER; NINDS NIH HHS [NS15722] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; BEAUDET L, 1993, MOL BRAIN RES, V18, P23, DOI 10.1016/0169-328X(93)90170-T; Canete-Soler R, 1998, J BIOL CHEM, V273, P12655, DOI 10.1074/jbc.273.20.12655; Canete-Soler R, 1999, J NEUROSCI, V19, P1273; Canete-Soler R, 2000, BRAIN RES, V867, P265, DOI 10.1016/S0006-8993(00)02389-1; CANETESOLER R, 1998, J BIOL CHEM, V273, P12550; Cusack Stephen, 1999, Current Opinion in Structural Biology, V9, P66; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; GOLDSTEIN ME, 1988, MOL BRAIN RES, V3, P287, DOI 10.1016/0169-328X(88)90051-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; SCHLAEPFER WW, 1990, J NEUROSCI RES, V25, P39, DOI 10.1002/jnr.490250106; SCHWARTZ ML, 1992, J BIOL CHEM, V267, P24596; SCHWARTZ ML, 1990, J NEUROSCI RES, V27, P193, DOI 10.1002/jnr.490270209; SCHWARTZ ML, 1995, J BIOL CHEM, V270, P26364, DOI 10.1074/jbc.270.44.26364; SCHWARTZ ML, 1994, MOL BRAIN RES, V27, P215, DOI 10.1016/0169-328X(94)90003-5; Smith CA, 2000, MOL CELL, V6, P1067, DOI 10.1016/S1097-2765(00)00105-2; SMITH CWJ, 1998, RNA PROTEIN INTERACT, P183; Turnage MA, 2000, MOL CELL BIOL, V20, P8198, DOI 10.1128/MCB.20.21.8198-8208.2000; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; Weiss MA, 1998, BIOPOLYMERS, V48, P167, DOI 10.1002/(SICI)1097-0282(1998)48:2<167::AID-BIP6>3.0.CO;2-8; Westhof E, 1999, CURR OPIN STRUC BIOL, V9, P293, DOI 10.1016/S0959-440X(99)80039-6; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	27	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32046	32050		10.1074/jbc.M104104200	http://dx.doi.org/10.1074/jbc.M104104200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11435431	hybrid			2022-12-27	WOS:000170613500079
J	Fonseca, MV; Escalante-Semerena, JC				Fonseca, MV; Escalante-Semerena, JC			An in vitro reducing system for the enzymic conversion of cobalamin to adenosylcobalamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT METHIONINE SYNTHASE; ATP-CORRINOID ADENOSYLTRANSFERASE; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; PSEUDOMONAS-DENITRIFICANS; ANGSTROM RESOLUTION; FLAVODOXIN; ACTIVATION; COENZYME; VITAMIN-B-12	Homogeneous ferredoxin (flavodoxin):NADP(+) reductase and flavodoxin A proteins served as electron donors for the reduction of co(III)rrinoids to co(I)rrinoids in vitro. The resulting co(I)rrinoids served as substrates for the ATP: co(I)rrinoid adenosyltransferase (CobA) enzyme of Salmonella enterica serovar Typhimurium LT2 and were converted to their respective adenosylated derivatives. The reaction products were isolated by reverse phase high performance liquid chromatography, and their identities were confirmed by UV-visible spectroscopy, mass spectrometry, and in vivo biological activity assays. Adenosylcobalamin generated by this system supported the activity of 1,2-propanediol dehydratase as effectively as authentic adenosylcobalamin. This is the first report of a protein system that can be coupled to the adenosyltransferase CobA enzyme for the conversion of co(III)rrinoids to their adenosylated derivatives.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Escalante-Semerena, JC (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.		Fernández, Ester/K-9734-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040313, R37GM040313] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM040313, GM17528, GM40313] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P1129, DOI 10.1021/bi00457a005; BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; Bauer CB, 2001, BIOCHEMISTRY-US, V40, P361, DOI 10.1021/bi002145o; BLANCHE F, 1995, ANGEW CHEM INT EDIT, V34, P383, DOI 10.1002/anie.199503831; BLANCHE F, 1992, J BACTERIOL, V174, P7452, DOI 10.1128/jb.174.22.7452-7454.1992; BRADY RO, 1962, J BIOL CHEM, V223, P2325; Braford MM, 1976, ANAL BIOCHEM, V72, P248; DEBUSSCHE L, 1991, J BACTERIOL, V173, P6300, DOI 10.1128/jb.173.19.6300-6302.1991; DRENNAN CL, 1994, SCIENCE, V266, P1660; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; Fonseca MV, 2000, J BACTERIOL, V182, P4304, DOI 10.1128/JB.182.15.4304-4309.2000; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; FUJII K, 1974, J BIOL CHEM, V249, P6745; Gaudu P, 2000, J BACTERIOL, V182, P1788, DOI 10.1128/JB.182.7.1788-1793.2000; Hall DA, 2000, BIOCHEMISTRY-US, V39, P10711, DOI 10.1021/bi001096c; Hogenkamp H. P. C., 1975, COBALAMIN BIOCH PATH, P21; Hoover DM, 1997, PROTEIN SCI, V6, P2525; Hoover DM, 1997, BIOCHEMISTRY-US, V36, P127, DOI 10.1021/bi961693s; Jarrett JT, 1998, BIOCHEMISTRY-US, V37, P5372, DOI 10.1021/bi9730893; Jarrett JT, 1998, BIOCHEMISTRY-US, V37, P12649, DOI 10.1021/bi9808565; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE JG, 1995, J BACTERIOL, V177, P6371, DOI 10.1128/jb.177.22.6371-6380.1995; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mulliez E, 2001, BIOCHEMISTRY-US, V40, P3730, DOI 10.1021/bi001746c; OTOOLE GA, 1993, J BACTERIOL, V175, P3317, DOI 10.1128/jb.175.11.3317-3326.1993; Raux E, 1997, J BACTERIOL, V179, P3202, DOI 10.1128/jb.179.10.3202-3212.1997; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Rondon MR, 1997, PROG NUCLEIC ACID RE, V56, P347, DOI 10.1016/S0079-6603(08)61010-7; Santander PJ, 1997, CHEM BIOL, V4, P659, DOI 10.1016/S1074-5521(97)90221-0; SASSE J, 1991, CURRENT PROTOCOLS MO, V1, DOI DOI 10.6.1-10.6.8; SCHRAUZER GN, 1968, J AM CHEM SOC, V90, P2441, DOI 10.1021/ja01011a054; Shibata N, 1999, STRUCTURE, V7, P997, DOI 10.1016/S0969-2126(99)80126-9; SUH SJ, 1995, J BACTERIOL, V177, P921, DOI 10.1128/jb.177.4.921-925.1995; SUH SJ, 1993, GENE, V129, P93, DOI 10.1016/0378-1119(93)90701-4; Thomas MG, 2000, J BACTERIOL, V182, P4227, DOI 10.1128/JB.182.15.4227-4233.2000; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TORAYA T, 1977, J BIOL CHEM, V252, P963; VERVOORT J, 1985, EUR J BIOCHEM, V151, P49, DOI 10.1111/j.1432-1033.1985.tb09067.x; VETTER H, 1971, H-S Z PHYSIOL CHEM, V352, P433, DOI 10.1515/bchm2.1971.352.1.433; VITOLS E, 1966, J BIOL CHEM, V241, P1455; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WALKER GA, 1969, ARCH BIOCHEM BIOPHYS, V134, P95, DOI 10.1016/0003-9861(69)90255-0	44	70	73	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32101	32108		10.1074/jbc.M102510200	http://dx.doi.org/10.1074/jbc.M102510200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11408479	hybrid			2022-12-27	WOS:000170613500086
J	Kanke, T; Macfarlane, SR; Seatter, MJ; Davenport, E; Paul, A; McKenzie, RC; Plevin, R				Kanke, T; Macfarlane, SR; Seatter, MJ; Davenport, E; Paul, A; McKenzie, RC; Plevin, R			Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVOLUCRIN PROMOTER ACTIVITY; THROMBIN RECEPTOR; MOLECULAR-CLONING; GENE-EXPRESSION; IKK-ALPHA; INDEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; TERMINAL KINASE; ERK KINASE; BETA	In this study we examined the regulation of the stress-activated protein (SAP) kinases and inhibitory KB kinases (IKKs) through stimulation of the novel G-protein-coupled receptor proteinase-activated receptor-2 in the human keratinocyte cell line NCTC2544. Trypsin and the peptide SLIGKV stimulated a time-dependent increase in both c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activity. Trypsin also stimulated NF kappaB-DNA binding and the activation of the upstream kinases IKK alpha and -beta. Phorbol 12-myristate 13-acetate also strongly activated both SAP kinases and = isoforms, suggesting the potential for a protein kinase C-mediated regulatory mechanism underlying the effects of trypsin. Pre-incubation with selective protein kinase C (PKC) inhibitors GF109203X and Go6983, or transfection of dominant negative (DN)-PKC alpha, abolished phorbol 12-myristate 13-acetate-mediated c-Jun N-terminal kinase activity, although it only partially inhibited the response to trypsin. In contrast, Go6983 reduced trypsin-stimulated p38 mitogen-activated protein kinase activity to a greater extent than GF109203X, although DN-PKC alpha or PKC zeta had no substantial effect. Additionally, inhibitors of PKC zeta partially reduced trypsin-stimulated IKK alpha activity but abolished that of IKK beta, whereas DN-PKC zeta but not DN-PKC zeta substantially reduced trypsin-stimulated Flag-IKK beta activity. This study shows for the first time proteinase-activated receptor-2-mediated stimulation of both SAP kinase and = signaling and differing roles for PKC isoforms in the regulation of each pathway.	Univ Strathclyde, Dept Physiol & Pharmacol, Inst Biomed Sci, Glasgow G4 0NR, Lanark, Scotland; Univ Edinburgh, Royal Infirm, Dept Dermatol, Edinburgh EH3 9YW, Midlothian, Scotland	University of Strathclyde; Royal Infirmary of Edinburgh; University of Edinburgh	Plevin, R (corresponding author), Univ Strathclyde, Dept Physiol & Pharmacol, Inst Biomed Sci, 27 Taylor St, Glasgow G4 0NR, Lanark, Scotland.	r.plevin@strath.ac.uk		Paul, Andrew/0000-0001-5775-2332; Plevin, Robin/0000-0002-7849-1220				Alexandrov A, 1999, BIOCHEM BIOPH RES CO, V261, P372, DOI 10.1006/bbrc.1999.1015; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Belham CL, 1996, BIOCHEM J, V320, P939, DOI 10.1042/bj3200939; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Bohm SK, 1996, BIOCHEM J, V314, P1009; Bretschneider E, 1999, BRIT J PHARMACOL, V126, P1735, DOI 10.1038/sj.bjp.0702509; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Fox MT, 1997, FEBS LETT, V417, P267, DOI 10.1016/S0014-5793(97)01298-2; Garcia-Paramio P, 1998, BIOCHEM J, V333, P631, DOI 10.1042/bj3330631; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Glusa E, 1996, SEMIN THROMB HEMOST, V22, P261, DOI 10.1055/s-2007-999017; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Han YQ, 1999, CIRC RES, V84, P695, DOI 10.1161/01.RES.84.6.695; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hoshi S, 2000, J BIOL CHEM, V275, P883, DOI 10.1074/jbc.275.2.883; Hou L, 1998, IMMUNOLOGY, V94, P356, DOI 10.1046/j.1365-2567.1998.00528.x; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; KONDO S, 1993, J INVEST DERMATOL, V101, P690, DOI 10.1111/1523-1747.ep12371677; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Li JJ, 1997, CANCER RES, V57, P3569; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mani I, 1999, J INVEST DERMATOL, V112, P42, DOI 10.1046/j.1523-1747.1999.00480.x; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; MURAMATSU I, 1992, CAN J PHYSIOL PHARM, V70, P996, DOI 10.1139/y92-137; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Ozes ON, 1999, NATURE, V401, P82; Pan ZXK, 1998, J IMMUNOL, V160, P3038; Paul A, 2000, J BIOL CHEM, V275, P13243, DOI 10.1074/jbc.275.18.13243; PLEVIN R, 1994, BRIT J PHARMACOL, V112, P311, DOI 10.1111/j.1476-5381.1994.tb13070.x; REE K, 1981, ACTA PATH MICRO IM A, V89, P73; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; SANTULLI RJ, 1995, P NATL ACAD SCI USA, V92, P9151, DOI 10.1073/pnas.92.20.9151; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shimizu H, 1999, J INVEST DERMATOL, V112, P769, DOI 10.1046/j.1523-1747.1999.00582.x; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Takahashi H, 1998, J INVEST DERMATOL, V110, P218, DOI 10.1046/j.1523-1747.1998.00110.x; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Tobin D, 1996, ONCOGENE, V12, P785; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wakita H, 1997, P ASSOC AM PHYSICIAN, V109, P190; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Wood KM, 1998, ONCOGENE, V16, P2131, DOI 10.1038/sj.onc.1201735; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	65	92	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31657	31666		10.1074/jbc.M100377200	http://dx.doi.org/10.1074/jbc.M100377200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11413129	hybrid			2022-12-27	WOS:000170613500027
J	Wheeler, DG; Cooper, E				Wheeler, DG; Cooper, E			Depolarization strongly induces human cytomegalovirus major immediate-early promoter/enhancer activity in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SYMPATHETIC NEURONS; GENE-EXPRESSION; EARLY PROMOTER; ADENOVIRUS VECTOR; TRANSGENIC MICE; EARLY ENHANCER; CYCLIC-AMP; VIRUS; INDUCTION; TRANSCRIPTION	Activity-dependent changes in gene expression involving the transcription factor cAMP-response element-binding protein (CREB) occur in learning and memory, pain, and drug addiction. This mechanism may also be important for cytomegaloviral infections of the brain. The human cytomegalovirus major immediate-early promoter/enhancer (hCMV promoter), rate-limiting for productive cytomegalovirus infection, contains five cAMP-response elements (CREs). Indirect evidence suggests that this promoter does not function in unstimulated neurons. Here we test the hypothesis that expression from the hCMV promoter in neurons is induced by membrane depolarization. For these experiments, we infected cultured sympathetic and hippocampal neurons with hCMV-green fluorescent protein (GFP) promoter/reporter constructs using adenoviral gene transfer techniques and measured transgene expression by quantifying GFP fluorescence and GFP mRNA levels. We found that depolarization up-regulates promoter activity by > 90-fold. Moreover, our results from pharmacological experiments suggest that this induction occurred through a CREB-dependent pathway. Importantly, site-directed mutagenesis of all five CREs in the promoter blocked this up-regulation almost completely, whereas mutating four of them had no effect. We conclude that the bCMV promoter acts as a molecular switch in neurons and is strongly induced by membrane depolarization, neuronal activity, or other stimuli that activate CREB. These results may provide insight into molecular mechanisms of cytomegalovirus-related diseases of the brain.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Cooper, E (corresponding author), McGill Univ, Dept Physiol, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	Ecooper@med.mcgill.ca						Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Canaff L, 1998, ENDOCRINOLOGY, V139, P1184, DOI 10.1210/en.139.3.1184; Clifford DB, 1999, SEMIN NEUROL, V19, P185, DOI 10.1055/s-2008-1040836; Cohen Bruce A., 1997, P595; DeKoninck P, 1995, J NEUROSCI, V15, P7966; FICKENSCHER H, 1989, J GEN VIROL, V70, P107, DOI 10.1099/0022-1317-70-1-107; Fritschy JM, 1996, J NEUROSCI, V16, P2275; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUNNINGHAKE GW, 1989, J VIROL, V63, P3026, DOI 10.1128/JVI.63.7.3026-3033.1989; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; MANDELZYS A, 1994, J NEUROSCI, V14, P2357; Meier JL, 1996, INTERVIROLOGY, V39, P331, DOI 10.1159/000150504; Millhouse S, 2000, J NEUROVIROL, V6, P6, DOI 10.3109/13550280009006378; Mocarski ES, 1996, P NATL ACAD SCI USA, V93, P11321, DOI 10.1073/pnas.93.21.11321; NybergHoffman C, 1997, NAT MED, V3, P808, DOI 10.1038/nm0797-808; RIDEG K, 1994, DIFFERENTIATION, V56, P119, DOI 10.1007/s002580050028; Schorge S, 1999, NAT NEUROSCI, V2, P785, DOI 10.1038/12153; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shering AF, 1997, J GEN VIROL, V78, P445, DOI 10.1099/0022-1317-78-2-445; STAMMINGER T, 1990, J GEN VIROL, V71, P105, DOI 10.1099/0022-1317-71-1-105; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; van den Pol AN, 1998, J NEUROSCI, V18, P10640; WHEELER DG, 2000, 30 ANN SOC NEUR M NO; Whitley Richard J., 1997, P223; WILEY CA, 1986, J NEUROPATH EXP NEUR, V45, P127, DOI 10.1097/00005072-198603000-00003; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233	31	46	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31978	31985		10.1074/jbc.M103667200	http://dx.doi.org/10.1074/jbc.M103667200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11397804	hybrid			2022-12-27	WOS:000170613500070
J	Yuan, YR; Blecker, S; Martsinkevich, O; Millen, L; Thomas, PJ; Hunt, JF				Yuan, YR; Blecker, S; Martsinkevich, O; Millen, L; Thomas, PJ; Hunt, JF			The crystal structure of the MJ0796 ATP-binding cassette - Implications for the structural consequences of ATP hydrolysis in the active site of an ABC transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON THERMOCOCCUS-LITORALIS; SALMONELLA-TYPHIMURIUM; HISTIDINE PERMEASE; ESCHERICHIA-COLI; ANOMALOUS DIFFRACTION; SUBUNIT INTERACTIONS; PROTEIN-STRUCTURE; P-GLYCOPROTEIN; MALK SUBUNIT; MALTOSE	The crystal structure of the MJ0796 ATP-binding cassette, a member of the o228/LolD transporter family, has been determined at 2.7-Angstrom resolution with MgADP bound at its active site. Comparing this structure with that of the ATP-bound form of the HisP ATP-binding cassette (Hung, L. W., Wang, I. X., Nikaido, K., Liu, P. Q., Ames, G. F., and Kim, S. H. (1998) Nature 396, 703-707) shows a 5-Angstrom withdrawal of a phylogenetically invariant glutamine residue from contact with the gamma -phosphate of ATP in the active site. This glutamine is located in a protein segment that links the rigid F-1-type ATP-binding core of the enzyme to an ABC transporter-specific alpha -helical subdomain that moves substantially away from the active site in the MgADP-bound structure of MJ0796 compared with the ATP-bound structure of HisP. A similar conformational effect is observed in the MgADP-bound structure of MJ1267 (Karpowich, N., et al (2001) Structure, in press), establishing the withdrawal of the glutamine and the coupled outward rotation of the alpha -helical subdomain as consistent consequences of gamma -phosphate release from the active site of the transporter. Considering this subdomain movement in the context of a leading model for the physiological dimer of cassettes present in ABC transporters indicates that it produces a modest mechanical change that is likely to play a role in facilitating nucleotide exchange out of the ATPase active site. Finally, it is noteworthy that one of the intersubunit packing interactions in the MJ0796 crystal involves antiparallel beta -type hydrogen bonding interactions between the outermost beta -strands in the two core beta -sheets, leading to their fusion into a single extended beta -sheet, a type of structural interaction that has been proposed to play a role in mediating the aggregation of beta -sheet-containing proteins.	Columbia Univ, Dept Biol Sci, Fairchild Ctr 702A, New York, NY 10027 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA	Columbia University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr 702A, MC2434, New York, NY 10027 USA.		Thomas, Philip J/F-7115-2012					ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1992, XPLOR SYSTEM CRYSTAL; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davidson AL, 1996, J BIOL CHEM, V271, P4858; DELEPELAIRE P, 1991, MOL MICROBIOL, V5, P2427, DOI 10.1111/j.1365-2958.1991.tb02088.x; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Drenth J, 1994, PRINCIPLES PROTEIN X; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FINCH JT, 1973, P NATL ACAD SCI USA, V70, P718, DOI 10.1073/pnas.70.3.718; Gottesman MM, 1996, CURR OPIN GENET DEV, V6, P610, DOI 10.1016/S0959-437X(96)80091-8; Greller G, 1999, J BIOL CHEM, V274, P20259, DOI 10.1074/jbc.274.29.20259; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunke S, 2000, J BIOL CHEM, V275, P15526, DOI 10.1074/jbc.275.20.15526; HUNKE S, 1995, BIOCHEM BIOPH RES CO, V216, P589, DOI 10.1006/bbrc.1995.2663; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Kelly JW, 1997, STRUCTURE, V5, P595, DOI 10.1016/S0969-2126(97)00215-3; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; Lippincott J, 1997, J BACTERIOL, V179, P1337, DOI 10.1128/jb.179.4.1337-1343.1997; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Liu PQ, 1999, J BIOL CHEM, V274, P18310, DOI 10.1074/jbc.274.26.18310; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MORBACH S, 1993, J BIOL CHEM, V268, P18617; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Mourez M, 1998, MOL MICROBIOL, V30, P353, DOI 10.1046/j.1365-2958.1998.01070.x; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Nicholls A., 1992, GRASP GRAPHICAL REPR; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADLAN EA, 1985, J BIOL CHEM, V260, P8280; Paulsen IT, 1998, J MOL BIOL, V277, P573, DOI 10.1006/jmbi.1998.1609; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Schmees G, 1999, EUR J BIOCHEM, V266, P420, DOI 10.1046/j.1432-1327.1999.00871.x; SCHNEIDER E, 1994, J BIOL CHEM, V269, P20456; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilken S, 1996, MOL MICROBIOL, V22, P655, DOI 10.1046/j.1365-2958.1996.d01-1724.x; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479	57	219	223	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32313	32321		10.1074/jbc.M100758200	http://dx.doi.org/10.1074/jbc.M100758200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11402022	hybrid			2022-12-27	WOS:000170613500113
J	Basanez, G; Zhang, J; Chau, BN; Maksaev, GI; Frolov, VA; Brandt, TA; Burch, J; Hardwick, JM; Zimmerberg, J				Basanez, G; Zhang, J; Chau, BN; Maksaev, GI; Frolov, VA; Brandt, TA; Burch, J; Hardwick, JM; Zimmerberg, J			Pro-apoptotic cleavage products of Bcl-x(L) form cytochrome c-conducting pores in pure lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; ION-CHANNEL; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; BAX OLIGOMERIZATION; CASPASE ACTIVATION; PROAPOPTOTIC BAX; RELEASE; PROTEIN; INHIBITION	During apoptotic cell death, cells usually release apoptogenic proteins such as cytochrome c from the mitochondrial intermembrane space. If Bcl-2 family proteins induce such release by increasing outer mitochondrial membrane permeability, then the pro-apoptotic, but not anti-apoptotic activity of these proteins should correlate with their permeabilization of membranes to cytochrome c. Here, we tested this hypothesis using pro-survival full-length Bcl-x(L) and pro-death Bcl-x(L) cleavage products (Delta N612Bcl-x(L) and Delta N76Bcl-x(L)). Unlike Bcl-x(L), Delta N61Bcl-x(L) and Delta N76Bcl-x(L) caused the release of cytochrome c from mitochondria in vivo and in vitro. Recombinant Delta N61Bcl-x(L) and Delta N76Bcl-x(L), as well as Bcl-xL, cleaved in situ by caspase 3-possessed intrinsic pore-forming activity as demonstrated by their ability to efficiently permeabilize pure lipid vesicles. Furthermore, only Delta N61Bcl-x(L) and Delta N76Bcl-x(L), but not Bcl-x(L), formed pores large enough to release cytochrome c and to destabilize planar lipid bilayer membranes through reduction of pore line tension. Because Bcl-x(L) and its C-terminal cleavage products bound similarly to lipid membranes and formed oligomers of the same size, neither lipid affinity nor protein-protein interactions appear to be solely responsible for the increased membrane-perturbing activity elicited by Bcl-x(L) cleavage. Taken together, these data are consistent with the hypothesis that Bax-like proteins oligomerize to form lipid-containing pores in the outer mitochondrial membrane, thereby releasing intermembrane apoptogenic factors into the cytosol.	NICHHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Russian Acad Sci, Frumkin Inst Electrochem, Moscow 117071, Russia	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Russian Academy of Sciences; Frumkin Institute of Physical Chemistry & Electrochemistry	Basanez, G (corresponding author), NICHHD, Lab Cellular & Mol Biophys, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	basanezg@mail.nih.gov; joshz@helix.nih.gov	Frolov, Vadim/ABH-3889-2020; Basanez, Gorka/L-9509-2014	Frolov, Vadim/0000-0002-0653-5669; Basanez, Gorka/0000-0002-7475-7861	NINDS NIH HHS [NS34175, NS37402] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034175, R01NS037402] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bonev BB, 2001, J BIOL CHEM, V276, P5714, DOI 10.1074/jbc.M005126200; Butko P, 1996, BIOCHEMISTRY-US, V35, P11355, DOI 10.1021/bi960970s; Chen MC, 2000, J BIOL CHEM, V275, P38794, DOI 10.1074/jbc.M003292200; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V906, P309, DOI 10.1016/0304-4157(87)90016-5; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Condorelli F, 2001, MOL CELL BIOL, V21, P3025, DOI 10.1128/MCB.21.9.3025-3036.2001; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fadeel B, 1999, LEUKEMIA, V13, P719, DOI 10.1038/sj.leu.2401411; Fadeel B, 1999, FASEB J, V13, P1647, DOI 10.1096/fasebj.13.13.1647; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Fujita N, 1998, BIOCHEM BIOPH RES CO, V246, P484, DOI 10.1006/bbrc.1998.8587; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Heibein JA, 2000, J EXP MED, V192, P1391, DOI 10.1084/jem.192.10.1391; Hirotani M, 1999, J BIOL CHEM, V274, P20415, DOI 10.1074/jbc.274.29.20415; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kim YM, 1998, J BIOL CHEM, V273, P31437, DOI 10.1074/jbc.273.47.31437; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin JH, 2000, BIOPHYS J, V78, P1714, DOI 10.1016/S0006-3495(00)76723-3; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Melikov KC, 2001, BIOPHYS J, V80, P1829, DOI 10.1016/S0006-3495(01)76153-X; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tomicic MT, 2001, BIOCHEM BIOPH RES CO, V281, P404, DOI 10.1006/bbrc.2001.4367; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang XM, 1999, BIOCHEM J, V340, P127, DOI 10.1042/0264-6021:3400127; Zimmerberg J, 2000, TRAFFIC, V1, P366, DOI 10.1034/j.1600-0854.2000.010409.x	71	123	127	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31083	31091		10.1074/jbc.M103879200	http://dx.doi.org/10.1074/jbc.M103879200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11399768	hybrid			2022-12-27	WOS:000170472900066
J	Ragimbeau, J; Dondi, E; Vasserot, A; Romero, P; Uze, G; Pellegrini, S				Ragimbeau, J; Dondi, E; Vasserot, A; Romero, P; Uze, G; Pellegrini, S			The receptor interaction region of Tyk2 contains a motif required for its nuclear localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-ALPHA/BETA RECEPTOR; TYROSINE KINASE TYK2; DNA-BINDING DOMAIN; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; EXPORT SIGNAL; IN-VITRO; PHOSPHORYLATION; STAT1; FAMILY	Janus kinases have so far been viewed as enzymatic intermediates that couple a variety of cell surface receptors to downstream substrates with diverse effector functions. Tyk2 is a member of this family that is involved in the interferon-alpha/beta and interleukin-12 signaling pathways via its specific interaction with the IFNAR1 and the beta1 receptor subunits. Here, we have analyzed the subcellular distribution of the wild-type Tyk2 protein and of several mutants expressed in Tyk2-deficient human cells. Direct GFP-associated fluorescence and immunostaining showed a diffuse localization of Tyk2 throughout the cell, including the nuclear compartment. The nuclear localization of Tyk2 requires a nuclear localization signal-like motif rich in arginine residues that maps within the region mediating interaction with cytokine receptors. To address the question of the role of the Tyk2 nuclear pool in interferon-alpha/beta -induced biological effects, cells expressing a membrane-targeted form of Tyk2-green fluorescent protein were analyzed for their interferon-alpha responses. Our studies demonstrate that Tyk2 can reside in the nucleus independently of receptor binding and that the nuclear pool is dispensable for the transcriptional and anti-vesicular stomatitis virus responses induced by interferon-alpha.	Inst Pasteur, Lab Signalisat Cytokines, F-75724 Paris 15, France; CNRS, Inst Mol Genet, EP2030, F-34293 Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Pellegrini, S (corresponding author), Inst Pasteur, Lab Signalisat Cytokines, 25 Rue Dr Roux, F-75724 Paris 15, France.		Pellegrini, Sandra -/G-5546-2015; Uzé, Gilles/O-6383-2019; Pellegrini, Sandra/Y-6351-2019	Pellegrini, Sandra -/0000-0001-5837-7589; Pellegrini, Sandra/0000-0001-5837-7589; Dondi, Elisabetta/0000-0003-0975-459X; Uze, Gilles/0000-0002-4150-5772				BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; BADER T, 1994, P NATL ACAD SCI USA, V91, P11831, DOI 10.1073/pnas.91.25.11831; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Bork P, 1996, METHOD ENZYMOL, V266, P162; BURWEN SJ, 1987, TRENDS BIOCHEM SCI, V12, P159, DOI 10.1016/0968-0004(87)90074-0; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 1999, CELL MOL LIFE SCI, V55, P1535, DOI 10.1007/s000180050393; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Girault JA, 1998, MOL MED, V4, P751, DOI 10.1007/BF03401769; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Hilton DJ, 1999, CELL MOL LIFE SCI, V55, P1568, DOI 10.1007/s000180050396; Jans DA, 1997, FEBS LETT, V406, P315, DOI 10.1016/S0014-5793(97)00293-7; Johnson HM, 1998, BIOCHEM BIOPH RES CO, V244, P607, DOI 10.1006/bbrc.1998.8254; Ju H, 2000, BIOCHEM J, V351, P257, DOI 10.1042/0264-6021:3510257; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kampa D, 2000, BIOCHEM BIOPH RES CO, V278, P175, DOI 10.1006/bbrc.2000.3757; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kusch A, 2000, J BIOL CHEM, V275, P39466, DOI 10.1074/jbc.M003626200; KUSHNARYOV VM, 1985, P NATL ACAD SCI USA, V82, P3281, DOI 10.1073/pnas.82.10.3281; Lau JF, 2000, P NATL ACAD SCI USA, V97, P7278, DOI 10.1073/pnas.97.13.7278; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Lobie PE, 1996, ENDOCRINOLOGY, V137, P4037, DOI 10.1210/en.137.9.4037; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; Mowen K, 2000, MOL CELL BIOL, V20, P7273, DOI 10.1128/MCB.20.19.7273-7281.2000; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Rogge L, 1999, J IMMUNOL, V162, P3926; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SORENSON RL, 1995, ENDOCRINOLOGY, V136, P4092, DOI 10.1210/en.136.9.4092; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; Wu CY, 1996, EUR J IMMUNOL, V26, P345, DOI 10.1002/eji.1830260212; Yeh TC, 2000, P NATL ACAD SCI USA, V97, P8991, DOI 10.1073/pnas.160130297; Yeh TC, 1999, CELL MOL LIFE SCI, V55, P1523, DOI 10.1007/s000180050392; Zou J, 1997, J BIOL CHEM, V272, P6073, DOI 10.1074/jbc.272.9.6073	52	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30812	30818		10.1074/jbc.M103559200	http://dx.doi.org/10.1074/jbc.M103559200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11399767	hybrid			2022-12-27	WOS:000170472900032
J	Rogers, PA; Ding, HG				Rogers, PA; Ding, HG			L-cysteine-mediated destabilization of dinitrosyl iron complexes in proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTERS; NITRIC-OXIDE; ESCHERICHIA-COLI; SULFUR PROTEINS; ACTIVATED MACROPHAGES; RESONANCE DETECTION; BIOLOGICAL-SYSTEMS; 2FE-2S FERREDOXIN; ENDONUCLEASE-III; CENTERS	Nitric oxide is a signaling molecule in intercellular communication as well as a powerful weapon used by macrophages to kill tumor cells and pathogenic bacteria. Here, we show that when Escherichia coli cells are exposed to nitric oxide, its ferredoxin [2Fe-2S] cluster is nitrosylated, forming the dinitrosyl iron complex with a characteristic EPR signal at g(av) = 2.04. Such formed ferredoxin dinitrosyl iron complex is efficiently repaired in E. coli cells even in the absence of new protein synthesis. However, the repair activity is completely inactivated once E. coli cells are disrupted, indicating that repairing the ferredoxin dinitrosyl iron complex requires cellular reducing equivalents. In search of such cellular factors, we find that L-cysteine can effectively eliminate the EPR signal of the ferredoxin dinitrosyl iron complex and release the ferrous iron from the complex. In contrast, N-acetyl-L-eysteine and reduced glutathione are much less effective. L-Cysteine seems to have a general function, since it can also remove the otherwise stable dinitrosyl iron complexes from proteins in the cell extracts prepared from the E. coli cells treated with nitric oxide. We propose that L-cysteine is responsible for removing the dinitrosyl iron complexes from the nitric oxide-modified proteins into which a new iron-sulfur cluster will be reassembled.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, 508 Life Sci Bldg, Baton Rouge, LA 70803 USA.		Ding, Huangen/AAJ-8550-2020	Ding, Huangen/0000-0002-4815-7336				Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Aspinwall R, 1997, P NATL ACAD SCI USA, V94, P109, DOI 10.1073/pnas.94.1.109; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1999, CURR OPIN CHEM BIOL, V3, P152, DOI 10.1016/S1367-5931(99)80027-1; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; Demple B, 1999, BIOCHEM SOC SYMP, P119; Ding HE, 1996, P NATL ACAD SCI USA, V93, P9449, DOI 10.1073/pnas.93.18.9449; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Ding HG, 1998, BIOCHEMISTRY-US, V37, P17280, DOI 10.1021/bi980532g; Drapier JC, 1997, METHODS, V11, P319, DOI 10.1006/meth.1996.0426; DRAPIER JC, 1991, J BIOL CHEM, V266, P10162; Foster HW, 1999, J AM CHEM SOC, V121, P4093; GREENBERG JT, 1986, J BACTERIOL, V168, P1026, DOI 10.1128/jb.168.2.1026-1029.1986; HENRY Y, 1991, EUR BIOPHYS J, V20, P1; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson MK, 1998, CURR OPIN CHEM BIOL, V2, P173, DOI 10.1016/S1367-5931(98)80058-6; Jung YS, 1999, J BIOL CHEM, V274, P32402, DOI 10.1074/jbc.274.45.32402; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Sellers VM, 1996, BIOCHEMISTRY-US, V35, P2699, DOI 10.1021/bi952631p; TA DT, 1992, J BIOL CHEM, V267, P11120; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Vanin A F, 1993, Biokhimiia, V58, P1094; VANIN A F, 1965, Biofizika, V10, P167; Vanin AF, 1998, BIOCHEMISTRY-MOSCOW+, V63, P782; VITHAYTHIL IA, 1965, NATURE, V207, P1246; Welter R, 1996, ARCH BIOCHEM BIOPHYS, V331, P9, DOI 10.1006/abbi.1996.0276; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	41	56	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30980	30986		10.1074/jbc.M101037200	http://dx.doi.org/10.1074/jbc.M101037200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11423535	Green Published, hybrid			2022-12-27	WOS:000170472900053
J	Paroni, G; Henderson, C; Schneider, C; Brancolini, C				Paroni, G; Henderson, C; Schneider, C; Brancolini, C			Caspase-2-induced apoptosis is dependent on caspase-9, but its processing during UV- or tumor necrosis factor-dependent cell death requires caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROFILAMENT REORGANIZATION; SUBSTRATE SPECIFICITIES; ACTIVATION; PROTEIN; FAMILY; GENE; LOCALIZATION; MITOCHONDRIA; INDUCTION; PRODOMAIN	Mammalian caspases are a family of cysteine proteases that plays a critical role in apoptosis, We have analyzed caspase-2 processing in human cell lines containing defined mutations in caspase-3 and caspase-9, Here we demonstrate that caspase-2 processing, during cell death induced by UV irradiation, depends both on caspase-9 and caspase-3 activity, while, during TNF-alpha -dependent apoptosis, capase-2 processing is independent of caspase-9 but still requires caspase-3, In vitro procaspase-2 is the preferred caspase cleaved by caspase-3, while caspase-7 cleaves procaspase-2 with reduced efficiency. We have also demonstrated that caspase-2-mediated apoptosis requires caspase-9 and that cells co-expressing caspase-2 and a dominant negative form of caspase-9 are impaired in activating a normal apoptotic response and release cytochrome c into the cytoplasm, Our findings suggest a role played by caspase-2 as a regulator of the mitochondrial integrity and open questions on the mechanisms responsible for its activation during cell death.	Univ Udine, Dipartimento Sci & Tecnol Biomed, Sez Biol, I-33100 Udine, Italy; Lab Nazl Consorzio Interuniv Biotecnol, I-34142 Trieste, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Brancolini, C (corresponding author), Univ Udine, Dipartimento Sci & Tecnol Biomed, Sez Biol, P Kolbe 4, I-33100 Udine, Italy.	cbrancolini@makek.dstb.uniud.it	Paroni, Gabriela/J-4848-2018	Paroni, Gabriela/0000-0003-0132-0869; BRANCOLINI, Claudio/0000-0002-6597-5373				Ahmad M, 1997, CANCER RES, V57, P615; Allet B, 1996, J CELL BIOL, V135, P479, DOI 10.1083/jcb.135.2.479; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Brancolini C, 1998, CELL DEATH DIFFER, V5, P1042, DOI 10.1038/sj.cdd.4400443; BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x; Butt AJ, 1998, J BIOL CHEM, V273, P6763, DOI 10.1074/jbc.273.12.6763; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Colussi PA, 1998, J BIOL CHEM, V273, P24535, DOI 10.1074/jbc.273.38.24535; Colussi PA, 1998, J BIOL CHEM, V273, P26566, DOI 10.1074/jbc.273.41.26566; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; Fearnhead HO, 1998, P NATL ACAD SCI USA, V95, P13664, DOI 10.1073/pnas.95.23.13664; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Huang SS, 1999, J BIOL CHEM, V274, P27754, DOI 10.1074/jbc.274.39.27754; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sgorbissa A, 1999, J CELL SCI, V112, P4475; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Troy CM, 2000, J NEUROSCI, V20, P1386; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536	48	95	96	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21907	21915		10.1074/jbc.M011565200	http://dx.doi.org/10.1074/jbc.M011565200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11399776	hybrid			2022-12-27	WOS:000169297900144
J	Schoch, G; Goepfert, S; Morant, M; Hehn, A; Meyer, D; Ullmann, P; Werck-Reichhart, D				Schoch, G; Goepfert, S; Morant, M; Hehn, A; Meyer, D; Ullmann, P; Werck-Reichhart, D			CYP98A3 from Arabidopsis thaliana is a 3 '-hydroxylase of phenolic esters, a missing link in the phenylpropanoid pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINATE HYDROXYCINNAMOYL TRANSFERASE; CAFFEOYL-COA 3-O-METHYLTRANSFERASE; COENZYME-A 3-O-METHYLTRANSFERASE; CHLOROGENIC ACID BIOSYNTHESIS; ADENOSYL-L-METHIONINE; PARTIAL-PURIFICATION; LIGNIN BIOSYNTHESIS; CINNAMATE 4-HYDROXYLASE; O-METHYLTRANSFERASES; ELICITOR	The 4- and 5-hydroxylations of phenolic compounds in plants are catalyzed by cytochrome P450 enzymes. The 3-hydroxylation step leading to the formation of caffeic acid from p-coumaric acid remained elusive, however, alternatively described as a phenol oxidase, a dioxygenase, or a P450 enzyme, with no decisive evidence for the involvement of any in the reaction in planta. In this study, we show that the gene encoding CYP98A3, which was the best possible P450 candidate for a 3-hydroxylase in the Arabidopsis genome, is highly expressed in inflorescence stems and wounded tissues. Recombinant CYP98A3 expressed in yeast did not metabolize free p-coumaric acid or its glucose or CoA esters, p-coumaraldehyde, or p-coumaryl alcohol, but very actively converted the 5-O-shikimate and 5-O-D-quinate esters of trans-p-coumaric acid into the corresponding caffeic acid conjugates. The shikimate ester was converted four times faster than the quinate derivative. Antibodies directed against recombinant CYP98A3 specifically revealed differentiating vascular tissues in stem and root. Taken together, these data show that CYP98A3 catalyzes the synthesis of chlorogenic acid and very likely also the 3-hydroxylation of lignin monomers. This hydroxylation occurs on depsides, the function of which was so far not understood, revealing an additional and unexpected level of networking in lignin biosynthesis.	Inst Plant Mol Biol, CNRS UPR 2357, Dept Plant Stress Response, F-67083 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Werck-Reichhart, D (corresponding author), Inst Plant Mol Biol, CNRS UPR 2357, Dept Plant Stress Response, 28 Rue Goethe, F-67083 Strasbourg, France.	daniele.werck@ibmp-ulp.u-strasbg.fr	WERCK-REICHHART, Danièle/U-3713-2019	WERCK-REICHHART, Danièle/0000-0003-2869-4262; Hehn, Alain/0000-0003-4507-8031				Allona I, 1998, P NATL ACAD SCI USA, V95, P9693, DOI 10.1073/pnas.95.16.9693; DOLAN L, 1993, DEVELOPMENT, V119, P71; DUGGLEBY RG, 1984, COMPUT BIOL MED, V14, P447, DOI 10.1016/0010-4825(84)90045-3; Fraissinet-Tachet L, 1998, FEBS LETT, V437, P319, DOI 10.1016/S0014-5793(98)01257-5; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; HANSON KR, 1965, BIOCHEMISTRY-US, V4, P2719, DOI 10.1021/bi00888a023; HELLER W, 1985, ARCH BIOCHEM BIOPHYS, V241, P453, DOI 10.1016/0003-9861(85)90570-3; Hotta H, 2001, BBA-GEN SUBJECTS, V1526, P159, DOI 10.1016/S0304-4165(01)00123-4; Humphreys JM, 1999, P NATL ACAD SCI USA, V96, P10045, DOI 10.1073/pnas.96.18.10045; Jefcoate C R, 1978, Methods Enzymol, V52, P258; KAMSTEEG J, 1981, Z PFLANZENPHYSIOL, V102, P435, DOI 10.1016/S0044-328X(81)80178-X; KNEUSEL RE, 1989, ARCH BIOCHEM BIOPHYS, V269, P455, DOI 10.1016/0003-9861(89)90129-X; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; KOJIMA M, 1984, AGR BIOL CHEM TOKYO, V48, P2397, DOI 10.1080/00021369.1984.10866515; KUHNL T, 1987, ARCH BIOCHEM BIOPHYS, V258, P226, DOI 10.1016/0003-9861(87)90339-0; KUHNL T, 1989, PLANT SCI, V60, P21, DOI 10.1016/0168-9452(89)90039-3; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Lee D, 1997, PLANT CELL, V9, P1985, DOI 10.1105/tpc.9.11.1985; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Lim EK, 2001, J BIOL CHEM, V276, P4344, DOI 10.1074/jbc.M007263200; LOTFY S, 1994, PLANT PHYSIOL BIOCH, V32, P355; LOTFY S, 1992, PHYTOCHEMISTRY, V31, P767, DOI 10.1016/0031-9422(92)80010-C; MACHEIX J, 1998, FLAVONOIDS HLTH DIS; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Maury S, 1999, PLANT PHYSIOL, V121, P215, DOI 10.1104/pp.121.1.215; MOCK HP, 1993, PHYTOCHEMISTRY, V32, P575, DOI 10.1016/S0031-9422(00)95139-2; NEGREL J, 1984, PHYTOCHEMISTRY, V23, P31, DOI 10.1016/0031-9422(84)83072-1; OMURA T, 1964, J BIOL CHEM, V239, P2370; Osakabe K, 1999, P NATL ACAD SCI USA, V96, P8955, DOI 10.1073/pnas.96.16.8955; PAKUSCH AE, 1989, ARCH BIOCHEM BIOPHYS, V271, P488, DOI 10.1016/0003-9861(89)90299-3; Parvathi K, 2001, PLANT J, V25, P193, DOI 10.1046/j.1365-313x.2001.00956.x; Petersen M, 1997, PHYTOCHEMISTRY, V45, P1165, DOI 10.1016/S0031-9422(97)00135-0; Petersen M., 1999, BIOCH PLANT SECONDAR, V2, P151; PIERREL MA, 1994, EUR J BIOCHEM, V224, P835, DOI 10.1111/j.1432-1033.1994.00835.x; Pincon G, 2001, PHYTOCHEMISTRY, V57, P1167, DOI 10.1016/S0031-9422(01)00098-X; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; RHODES MJC, 1976, PHYTOCHEMISTRY, V15, P947, DOI 10.1016/S0031-9422(00)84376-9; RHODES MJC, 1979, PHYTOCHEMISTRY, V18, P1125, DOI 10.1016/0031-9422(79)80119-3; Schalk M, 1997, BIOCHEMISTRY-US, V36, P15253, DOI 10.1021/bi971575k; Sterky F, 1998, P NATL ACAD SCI USA, V95, P13330, DOI 10.1073/pnas.95.22.13330; STOCKIGT J, 1975, Z NATURFORSCH C, V30, P352; TANAKA M, 1991, ARCH BIOCHEM BIOPHYS, V284, P151, DOI 10.1016/0003-9861(91)90277-P; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; ULBRICH B, 1980, PHYTOCHEMISTRY, V19, P1625, DOI 10.1016/S0031-9422(00)83782-6; ULBRICH B, 1979, PHYTOCHEMISTRY, V18, P929, DOI 10.1016/S0031-9422(00)91451-1; URBAN P, 1994, EUR J BIOCHEM, V222, P843, DOI 10.1111/j.1432-1033.1994.tb18931.x; Wang ZX, 1997, ARCH BIOCHEM BIOPHYS, V347, P249, DOI 10.1006/abbi.1997.0337; Werck-Reichhart Daniele, 1995, Drug Metabolism and Drug Interactions, V12, P221; WERCKREICHHART D, 1993, PLANT PHYSIOL, V102, P1291, DOI 10.1104/pp.102.4.1291; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P585, DOI 10.1146/annurev.arplant.49.1.585; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659; Ye ZH, 1997, PLANT PHYSIOL, V115, P1341, DOI 10.1104/pp.115.4.1341; YE ZH, 1994, PLANT CELL, V6, P1427, DOI 10.1105/tpc.6.10.1427; Zhong RQ, 1998, PLANT CELL, V10, P2033, DOI 10.1105/tpc.10.12.2033	55	320	361	6	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 28	2001	276	39					36566	36574		10.1074/jbc.M104047200	http://dx.doi.org/10.1074/jbc.M104047200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	475XF	11429408	Green Published, hybrid			2022-12-27	WOS:000171194500070
J	Barr, SD; Gedamu, L				Barr, SD; Gedamu, L			Cloning and characterization of three differentially expressed peroxidoxin genes from Leishmania chagasi - Evidence for an enzymatic detoxification of hydroxyl radicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; SUPEROXIDE; PROTEIN; PEROXIREDOXIN; REDUCTASE; OVEREXPRESSION; IDENTIFICATION; PROMASTIGOTES; PURIFICATION	Antioxidants have been implicated in protecting cells from oxygen radicals produced as a result of aerobic metabolism and in response to foreign pathogens by phagocytic cells. The mechanisms allowing pathogens to withstand the toxic prooxidant environment within the phagolysosome are poorly understood. We have cloned and characterized three antioxidant genes belonging to the 2-Cys family of peroxidoxins from Leishmania chagasi that may prove to provide these parasites with an enhanced defense mechanism against toxic oxidants. The 5 ' -untranslated regions and coding regions of each gene are highly conserved, whereas the 3 ' -untranslated regions have diverged significantly. L. chagasi peroxidoxin 1 (LcPxn1) is predominantly expressed in the amastigote stage, whereas LcPxn2 and LcPxn3 are expressed mainly in the promastigote stage, with LcPxn3 being far less abundant than LcPxn2. LcPxn2 and LcPxn3 possess a nine-amino acid extension at the carboxyl terminus, which LcPxn1 lacks. LcPxn1 appears to exist as high molecular weight multimers in vivo, and recombinant LcPxn1 was shown to detoxify hydrogen peroxide and alkyl hydroperoxides. We also present strong evidence that recombinant LcPxn1 can enzymatically detoxify hydroxyl radicals, an activity never be. fore clearly demonstrated for a protein.	Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Gedamu, L (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	lgedamu@ucalgary.ca		Barr, Stephen/0000-0002-0028-7430				Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; ALY R, 1994, NUCLEIC ACIDS RES, V22, P2922, DOI 10.1093/nar/22.15.2922; Beetham JK, 1997, J BIOL CHEM, V272, P17360, DOI 10.1074/jbc.272.28.17360; BERBEROF M, 1995, EMBO J, V14, P2925, DOI 10.1002/j.1460-2075.1995.tb07292.x; BRAWN K, 1981, ARCH BIOCHEM BIOPHYS, V206, P414, DOI 10.1016/0003-9861(81)90108-9; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCHRANE CG, 1991, MOL ASPECTS MED, V12, P137, DOI 10.1016/0098-2997(91)90009-B; DER ES, 2000, STRUCTURE, V8, P605; Dowds B. C., 1994, FEMS MICROBIOL, V124, P155; Eisenstark A, 1996, FREE RADICAL BIO MED, V21, P975, DOI 10.1016/S0891-5849(96)00154-2; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FARR SB, 1988, J BACTERIOL, V170, P1837, DOI 10.1128/jb.170.4.1837-1842.1988; GUTTERIDGE JMC, 1981, FEBS LETT, V128, P343, DOI 10.1016/0014-5793(81)80113-5; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; HALLIWELL B, 1998, ISI ATLAS-BIOCHEM, V1, P48; Halliwell B, 2000, FREE RADICALS BIOL M; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; HURST JK, 1989, CRIT REV BIOCHEM MOL, V24, P271, DOI 10.3109/10409238909082555; KIM KW, 1988, J BIOL CHEM, V263, P4704; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; LIM YS, 1993, BIOCHEM BIOPH RES CO, V192, P273, DOI 10.1006/bbrc.1993.1410; Logan C, 2000, J BIOL CHEM, V275, P30019, DOI 10.1074/jbc.M004161200; MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337; Matthews RT, 1997, EXP NEUROL, V143, P282, DOI 10.1006/exnr.1996.6406; McGonigle S, 1998, PARASITOL TODAY, V14, P139, DOI 10.1016/S0169-4758(97)01211-8; Ohshima H, 1996, J RADIAT RES, V37, P199, DOI 10.1269/jrr.37.199; Paramchuk WJ, 1997, MOL BIOCHEM PARASIT, V90, P203, DOI 10.1016/S0166-6851(97)00141-2; REED PW, 1969, J BIOL CHEM, V244, P2459; Robinson J M, 1994, Immunol Ser, V60, P159; ROOS D, 1980, J CLIN INVEST, V65, P1515, DOI 10.1172/JCI109817; ROWLEY DA, 1983, BIOCHIM BIOPHYS ACTA, V761, P86, DOI 10.1016/0304-4165(83)90365-3; ROWLEY DA, 1982, FEBS LETT, V138, P33, DOI 10.1016/0014-5793(82)80388-8; SALIN ML, 1974, J CLIN INVEST, V54, P1005, DOI 10.1172/JCI107816; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x; Webb JR, 1998, INFECT IMMUN, V66, P3279, DOI 10.1128/IAI.66.7.3279-3289.1998; ZARLEY JH, 1991, J CLIN INVEST, V88, P1511, DOI 10.1172/JCI115461	46	64	65	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34279	34287		10.1074/jbc.M104406200	http://dx.doi.org/10.1074/jbc.M104406200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11438539	hybrid			2022-12-27	WOS:000170910200131
J	Pfeiffer, S; Lass, A; Schmidt, K; Mayer, B				Pfeiffer, S; Lass, A; Schmidt, K; Mayer, B			Protein tyrosine nitration in cytokine-activated murine macrophages - Involvement of a peroxidase/nitrite pathway rather than peroxynitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; REACTIVE NITROGEN; SUPEROXIDE-DISMUTASE; IN-VIVO; ELECTROCHEMICAL DETECTION; PERITONEAL-MACROPHAGES; SURFACE ADHERENCE; LEISHMANIA-MAJOR; GUANYLYL CYCLASE; BLOOD MONOCYTES	Peroxynitrite, formed in a rapid reaction of nitric oxide (NO) and superoxide anion radical (O . (-)(2)), is thought to mediate protein tyrosine nitration in various inflammatory and infectious diseases. However, a recent in vitro study indicated that peroxynitrite exhibits poor nitrating efficiency at biologically relevant steady-state concentrations (Pfeiffer, S., Schmidt, K., and Mayer, B. (2000) J. Biol Chem. 275, 6346-6352). To investigate the molecular mechanism of protein tyrosine nitration in intact cells, murine RAW 264.7 macrophages were activated with immunological stimuli, causing inducible NO synthase expression (interferon-gamma in combination with either lipopolysaccharide or zymosan A), followed by the determination of protein-bound 3-nitrotyrosine levels and release of potential triggers of nitration (NO, O . (-)(2), H2O2, peroxynitrite, and nitrite). Levels of 3-nitrotyrosine started to increase at 16-18 h and exhibited a maximum at 20-24 h post-stimulation. Formation of O . (-)(2) was maximal at 1-5 h and decreased to base line 5 h after stimulation. Release of NO peaked at similar to6 and similar to9 h after stimulation with interferon-gamma /lipopolysaccharide and interferon-gamma /zymosan A, respectively, followed by a rapid decline to base line within the next 4 h. NO formation resulted in accumulation of nitrite, which leveled off at about 50 mum 15 h post-stimulation. Significant release of peroxynitrite was detectable only upon treatment of cytokine-activated cells with phorbol 12-myristate-13-acetate, which led to a 2.2-fold increase in dihydrorhodamine oxidation without significantly increasing the levels of 3-nitrotyrosine. Tyrosine nitration was inhibited by azide and catalase and mimicked by incubation of unstimulated cells with nitrite. Together with the striking discrepancy in the time course of NO/O . (-)(2) release versus 3-nitrotyrosine formation, these results suggest that protein tyrosine nitration in activated macrophages is caused by a nitrite-dependent peroxidase reaction rather than peroxynitrite.	Karl Franzens Univ Graz, Inst Pharmakol & Toxikol, A-8010 Graz, Austria	University of Graz	Mayer, B (corresponding author), Karl Franzens Univ Graz, Inst Pharmakol & Toxikol, Univ Pl 2, A-8010 Graz, Austria.	mayer@kfunigraz.ac.at	Lass, Achim/C-3332-2008; Mayer, Bernd/B-9391-2008	Lass, Achim/0000-0002-8190-7151; Mayer, Bernd/0000-0002-2921-3494				ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; BIGGAR WD, 1976, LAB INVEST, V34, P31; BODEL PT, 1977, J EXP MED, V145, P264, DOI 10.1084/jem.145.2.264; BODEL PT, 1978, AM J PATHOL, V91, P107; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruno JG, 1999, IN VITRO CELL DEV-AN, V35, P376; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DELAHARPE J, 1985, J IMMUNOL METHODS, V78, P323, DOI 10.1016/0022-1759(85)90089-4; DEMENDEZ I, 1991, ARCH BIOCHEM BIOPHYS, V289, P319, DOI 10.1016/0003-9861(91)90417-H; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Ferrer-Sueta G, 1999, CHEM RES TOXICOL, V12, P442, DOI 10.1021/tx980245d; Fricker SP, 1999, ANTICANCER RES, V19, P553; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Goldstein S, 2000, J BIOL CHEM, V275, P3031, DOI 10.1074/jbc.275.5.3031; Halliwell B, 1999, FREE RADICAL RES, V31, P651, DOI 10.1080/10715769900301221; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; HIBBS JB, 1987, J IMMUNOL, V138, P550; Hodges GR, 2000, CHEM RES TOXICOL, V13, P1287, DOI 10.1021/tx0001272; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Kalns J, 1998, NITRIC OXIDE-BIOL CH, V2, P366, DOI 10.1006/niox.1998.0191; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KIYOTAKI C, 1984, J IMMUNOL, V133, P923; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lass A, 1997, J BIOL CHEM, V272, P19199, DOI 10.1074/jbc.272.31.19199; LI Y, 1992, EUR J IMMUNOL, V22, P441, DOI 10.1002/eji.1830220223; MALLE E, 2000, EUR J BIOCHEM, V267, P1; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370; PAUL BB, 1973, SCIENCE, V181, P849, DOI 10.1126/science.181.4102.849; Pfeiffer S, 2000, J BIOL CHEM, V275, P6346, DOI 10.1074/jbc.275.9.6346; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Pfeiffer S, 1998, MOL PHARMACOL, V53, P795, DOI 10.1124/mol.53.4.795; Pfeiffer S, 1998, J BIOL CHEM, V273, P27280, DOI 10.1074/jbc.273.42.27280; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199; SCHMIDT K, 1997, NITRIC OXIDE PROTOCO, P101; Shigenaga MK, 1999, METHOD ENZYMOL, V301, P27; Shigenaga MK, 1997, P NATL ACAD SCI USA, V94, P3211, DOI 10.1073/pnas.94.7.3211; STRAUSS RR, 1975, NATURE, V255, P343, DOI 10.1038/255343a0; STUEHR DJ, 1989, J EXP MED, V169, P1011, DOI 10.1084/jem.169.3.1011; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; UEDA T, 1995, HISTOCHEM CELL BIOL, V103, P11, DOI 10.1007/BF01464470; van der Vliet A, 1999, AM J RESP CRIT CARE, V160, P1; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; VANDERVLIET A, 1995, ARCH BIOCHEM BIOPHYS, V319, P341, DOI 10.1006/abbi.1995.1303; WARNOCK ML, 1987, AM J PATHOL, V128, P171; Wu WJ, 1999, J BIOL CHEM, V274, P25933, DOI 10.1074/jbc.274.36.25933	54	104	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34051	34058		10.1074/jbc.M100585200	http://dx.doi.org/10.1074/jbc.M100585200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11425852	hybrid			2022-12-27	WOS:000170910200102
J	Mathias, JR; Zhong, HL; Jin, HH; Vershon, AK				Mathias, JR; Zhong, HL; Jin, HH; Vershon, AK			Altering the DNA-binding specificity of the yeast Mat alpha 2 homeodomain protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ENGRAILED HOMEODOMAIN; TRANSCRIPTION FACTOR; RECOGNITION HELIX; MCM1 PROTEIN; COMPLEX; ALPHA-2; OPERATOR; HETERODIMER; RESOLUTION	Homeodomain proteins are a highly conserved class of DNA-binding proteins that are found in virtually every eukaryotic organism. The conserved mechanism that these proteins use to bind DNA suggests that there may be at least a partial DNA recognition code for this class of proteins. To test this idea, we have investigated the sequence-specific requirements for DNA binding and repression by the yeast alpha2 homeodomain protein in association with its cofactors, Mcm1 and Mata1. We have determined the contribution for each residue in the alpha2 homeodomain that contacts the DNA in the co-crystal structures of the protein. We have also engineered mutants in the alpha2 homeodomain to alter the DNA-binding specificity of the protein. Although we were unable to change the specificity of alpha2 by making substitutions at residues 47, 54, and 55, we were able to alter the DNA-binding specificity by making substitutions at residue 50 in the homeodomain. Since other homeodomain proteins show similar changes in specificity with substitutions at residue 50, this suggests that there is at least a partial DNA recognition code at this position.	Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Vershon, AK (corresponding author), Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.				NIGMS NIH HHS [GM49265] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049265] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acton TB, 1997, MOL CELL BIOL, V17, P1881, DOI 10.1128/MCB.17.4.1881; ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; Billeter M, 1996, CELL, V85, P1057, DOI 10.1016/S0092-8674(00)81306-9; BURGLIN TR, 1995, BIODIVERSITY EVOLUTI, P291; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GOUTTE C, 1994, EMBO J, V13, P1434, DOI 10.1002/j.1460-2075.1994.tb06397.x; Grant RA, 2000, BIOCHEMISTRY-US, V39, P8187, DOI 10.1021/bi000071a; HANES SD, 1991, SCIENCE, V251, P426, DOI 10.1126/science.1671176; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Hirsch JA, 1995, EMBO J, V14, P6280, DOI 10.1002/j.1460-2075.1995.tb00318.x; Jin YS, 1999, MOL CELL BIOL, V19, P585; JIN YS, 1995, SCIENCE, V270, P290, DOI 10.1126/science.270.5234.290; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KELEHER CA, 1989, MOL CELL BIOL, V9, P5228, DOI 10.1128/MCB.9.11.5228; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Li T, 1998, NUCLEIC ACIDS RES, V26, P5707, DOI 10.1093/nar/26.24.5707; LI T, 1995, SCIENCE, V270, P262, DOI 10.1126/science.270.5234.262; Mead J, 1996, MOL CELL BIOL, V16, P2135; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; PASSMORE S, 1989, GENE DEV, V3, P921, DOI 10.1101/gad.3.7.921; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; PERCIVALSMITH A, 1990, EMBO J, V9, P3967, DOI 10.1002/j.1460-2075.1990.tb07617.x; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; Schott O, 1997, J MOL BIOL, V267, P673, DOI 10.1006/jmbi.1997.0905; SMITH DL, 1994, EMBO J, V13, P2378, DOI 10.1002/j.1460-2075.1994.tb06521.x; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; TREISMAN J, 1989, CELL, V59, P553; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T; VERSHON AK, 1995, GENE DEV, V9, P182, DOI 10.1101/gad.9.2.182; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Zhong HL, 1997, J BIOL CHEM, V272, P8402, DOI 10.1074/jbc.272.13.8402	38	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32696	32703		10.1074/jbc.M103097200	http://dx.doi.org/10.1074/jbc.M103097200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438530	hybrid			2022-12-27	WOS:000170746000044
J	Suzuki, T; Terasaki, M; Takemoto-Hori, C; Hanada, T; Ueda, T; Wada, A; Watanabe, K				Suzuki, T; Terasaki, M; Takemoto-Hori, C; Hanada, T; Ueda, T; Wada, A; Watanabe, K			Proteomic analysis of the mammalian mitochondrial ribosome - Identification of protein components in the 28 S small subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORRESPONDING GENE-SEQUENCES; TANDEM-MASS-SPECTROMETRY; DIMENSIONAL GEL-ELECTROPHORESIS; INDUCED CELL-DEATH; ESCHERICHIA-COLI; NUCLEAR GENES; MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; ANGSTROM RESOLUTION; LIVER-MITOCHONDRIA	The mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S, consisting of 39 S large and 28 S small subunits. In the previous study, we analyzed 39 S large subunit proteins from bovine mitoribosome (Suzuki, T., Terasaki, M, Takemoto-Hori, C., Hanada, T., Ueda, T., Wada, A., and Watanabe, VL (2001) J. BioL Chem. 276,21724-21736). The results suggested structural compensation for the rRNA deficit through proteins of increased molecular mass in the mitoribosome. We report here the identification of 28 S small subunit proteins. Each protein was separated by radical-free high-reducing two-dimensional polyacrylamide gel electrophoresis and analyzed by liquid chromatography/mass spectrometry/mass spectrometry using electrospray ionization/ion trap mass spectrometer to identify DNA sequence by expressed sequence tag data base searches in silico. Twenty one proteins from the small subunit were identified, including 11 new proteins along with their complete cDNA sequences from human and mouse. In addition to these proteins, three new proteins were also identified in the 55 S mitoribosome. We have clearly identified a mitochondrial homologue of S12, which is a key regulatory protein of translation fidelity and a candidate for the autosomal dominant deafness gene, DFNA4. The apoptosis-related protein DAP3 was found to be a component of the small subunit, indicating a new function for the mitoribosome in programmed cell death. In summary, we have mapped a total of 55 proteins from the 55 S mitoribosome on the two-dimensional polyacrylamide gels.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; RIKEN, Yokohama Inst, Genom Sci Ctr, Prot Res Grp,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Osaka Med Coll, Dept Phys, Takatsuki, Osaka 5690084, Japan	University of Tokyo; University of Tokyo; RIKEN; Osaka Medical College	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan.	t-suzuki@k.u-tokyo.ac.jp; kw@kwl.t.u-tokyo.ac.jp	Ueda, Takuya/K-5217-2014; Suzuki, Tsutomu/J-1776-2015	Ueda, Takuya/0000-0002-7760-8271; Suzuki, Tsutomu/0000-0002-9731-1731; Hanada, Takao/0000-0003-2732-4008				Alnemri ES, 1999, NAT CELL BIOL, V1, pE40, DOI 10.1038/10034; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Berger T, 2000, J CELL SCI, V113, P3603; BIEMANN K, 1990, METHOD ENZYMOL, V193, P455, DOI 10.1016/0076-6879(90)93433-L; BRAKIERGINGRAS L, 1984, CAN J BIOCHEM CELL B, V62, P231, DOI 10.1139/o84-033; BRECKENRIDGE L, 1970, GENETICS, V65, P9; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHAMPNEY WS, 1980, BIOCHIM BIOPHYS ACTA, V609, P464, DOI 10.1016/0005-2787(80)90120-3; CHEN AH, 1995, HUM MOL GENET, V4, P1073, DOI 10.1093/hmg/4.6.1073; CHUNG HKJ, 1990, J BIOL CHEM, V265, P21000; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; Dongre AR, 1997, TRENDS BIOTECHNOL, V15, P418, DOI 10.1016/S0167-7799(97)01110-4; Earnshaw WC, 1999, NATURE, V397, P387, DOI 10.1038/17015; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Goldschmidt-Reisin S, 1998, J BIOL CHEM, V273, P34828, DOI 10.1074/jbc.273.52.34828; Graack HR, 1999, BIOCHEMISTRY-US, V38, P16569, DOI 10.1021/bi991543s; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GUTELL RR, 1990, NUCLEIC ACIDS RES, V18, P2319, DOI 10.1093/nar/18.suppl.2319; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; HAMILTON MG, 1974, BIOCHEMISTRY-US, V13, P5400, DOI 10.1021/bi00723a024; Inoue K, 1996, BIOCHEM BIOPH RES CO, V223, P496, DOI 10.1006/bbrc.1996.0923; Johnson DF, 1998, GENOMICS, V52, P363, DOI 10.1006/geno.1998.5448; KISSIL JL, 1995, J BIOL CHEM, V270, P27932, DOI 10.1074/jbc.270.46.27932; Kissil JL, 1999, EMBO J, V18, P353, DOI 10.1093/emboj/18.2.353; Koc EC, 2000, J BIOL CHEM, V275, P32585, DOI 10.1074/jbc.M003596200; Koc EC, 1999, BIOCHEM BIOPH RES CO, V266, P141, DOI 10.1006/bbrc.1999.1785; Koc EC, 2001, FEBS LETT, V492, P166, DOI 10.1016/S0014-5793(01)02250-5; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Koc EC, 2001, PROTEIN SCI, V10, P471, DOI 10.1110/ps.35301; Kowalak JA, 1996, PROTEIN SCI, V5, P1625, DOI 10.1002/pro.5560050816; Levy-Strumpf N, 1998, ONCOGENE, V17, P3331, DOI 10.1038/sj.onc.1202588; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Ma JH, 1996, J BIOL CHEM, V271, P5805, DOI 10.1074/jbc.271.10.5805; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; MEIER A, 1994, ANTIMICROB AGENTS CH, V38, P228, DOI 10.1128/AAC.38.2.228; NEEFS JM, 1991, NUCLEIC ACIDS RES, V19, P1987, DOI 10.1093/nar/19.suppl.1987; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Nikulin A, 2000, NAT STRUCT BIOL, V7, P273; O'Brien TW, 1999, J BIOL CHEM, V274, P36043, DOI 10.1074/jbc.274.51.36043; O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199; OBRIEN TW, 1971, J BIOL CHEM, V246, P3409; OBRIEN TW, 1993, STRUCTURE FUNCTION M, P575; OJALA DK, 1980, NATURE, V287, P79, DOI 10.1038/287079a0; Patel VB, 2001, J BIOL CHEM, V276, P6739, DOI 10.1074/jbc.M005781200; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schwartzbach C J, 1996, Methods Enzymol, V264, P248, DOI 10.1016/S0076-6879(96)64025-7; SCHWARTZBACH CJ, 1989, J BIOL CHEM, V264, P19125; Shah ZH, 1998, GENOMICS, V48, P384, DOI 10.1006/geno.1997.5166; Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0; Smeitink J, 1999, AM J HUM GENET, V64, P1505, DOI 10.1086/302432; Smeitink JAM, 1998, HUM MOL GENET, V7, P1573, DOI 10.1093/hmg/7.10.1573; Suzuki T, 2001, J BIOL CHEM, V276, P21724, DOI 10.1074/jbc.M100432200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIMMS AR, 1992, MOL GEN GENET, V232, P89, DOI 10.1007/BF00299141; Tizon B, 1999, YEAST, V15, P145, DOI 10.1002/(SICI)1097-0061(19990130)15:2<145::AID-YEA346>3.0.CO;2-J; WADA A, 1986, J BIOCHEM, V100, P1583, DOI 10.1093/oxfordjournals.jbchem.a121866; WADA A, 1986, J BIOCHEM-TOKYO, V100, P1595, DOI 10.1093/oxfordjournals.jbchem.a121867; WALKER JE, 1992, J MOL BIOL, V226, P1051, DOI 10.1016/0022-2836(92)91052-Q; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yokogawa T, 2000, J BIOL CHEM, V275, P19913, DOI 10.1074/jbc.M908473199	68	118	157	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33181	33195		10.1074/jbc.M103236200	http://dx.doi.org/10.1074/jbc.M103236200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11402041	hybrid			2022-12-27	WOS:000170746000105
J	Waldron, RT; Rey, O; Iglesias, T; Tugal, T; Cantrell, D; Rozengurt, E				Waldron, RT; Rey, O; Iglesias, T; Tugal, T; Cantrell, D; Rozengurt, E			Activation loop Ser(744) and Ser(748) in protein kinase D are transphosphorylated in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; PHORBOL ESTERS; D PKD; INTACT-CELLS; C-MU; PHOSPHORYLATION SITES; PROTEOLYTIC CLEAVAGE; MEDIATED REGULATION; RAPID ACTIVATION; STRUCTURAL BASIS	The importance of activation loop phosphorylation in the regulation of protein kinase D (PKD/protein kinase C (PKC) mu) activity has become controversial. In order to clarify the mechanism(s) of PKD activation, we developed a novel phosphospecific antibody recognizing phosphorylated Ser(748) in PKD (pS748). Western blot analysis with the pS748 antibody, carried out with a variety of PKD forms and in a variety of cell types including full-length PKD transfected in COS-7 and EIEK 293 cells, a green fluorescent protein-PKD fusion protein transfected in either Swiss 3T3 fibroblasts or Madin-Darby canine kidney epithelial cells, and endogenous PKD expressed in A20 lymphocytes and Rat-1 fibroblasts, indicated that Ser(748) phosphorylation was absent from unstimulated cells. In contrast, dramatic increases in Ser(748) phosphorylation were induced by phorbol esters, bombesin, or cross-linking of B lymphocyte antigen receptors or by cotransfection with active PKC epsilon or PKC eta. Western analysis using a second phosphospecific antibody, which primarily recognizes PKD phosphorylated at Ser(744), revealed that Ser(744) phosphorylation accompanies Ser(748) phosphorylation during PKD activation in vivo. Ser(744)/Ser(748) phosphorylation requires PKC but not PKD activity, indicative of transphosphorylation. Our results provide new experimental evidence indicating that activation loop phosphorylation at Ser(744) and Ser(748) occurs during PKD activation in vivo and support the notion of a PKC-PKD phosphorylation cascade.	Inst Invest Biomed Albeto Sols, Madrid 28029, Spain; Imperial Canc Res Fund, Lymphocyte Activat Lab, London WC2A 3PX, England; Univ Calif Los Angeles, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA	Cancer Research UK; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med,Div Digest Dis, Unit Signal Transduct & Gastrointestinal Canc, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.		Vacas, Teresa Iglesias/ABF-8663-2020; Waldron, Richard Taliesin/ABF-2773-2020	Vacas, Teresa Iglesias/0000-0002-4326-9005; Waldron, Richard Taliesin/0000-0003-3151-6002; Rey, Osvaldo/0000-0003-1575-9864	NCI NIH HHS [P50 CA90388-01] Funding Source: Medline; NIDDK NIH HHS [DK56930, DK55003-01S1, DK55003, DK17294, K01 DK 02834-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA090388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002834, R37DK017294, R01DK017294, R01DK056930] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Brooks G, 1997, J MOL CELL CARDIOL, V29, P2273, DOI 10.1006/jmcc.1997.0466; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2745, DOI 10.1073/pnas.88.7.2745; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Haussermann S, 1999, FEBS LETT, V462, P442, DOI 10.1016/S0014-5793(99)01577-X; Haworth RS, 1999, AM J PHYSIOL-CELL PH, V277, pC1202, DOI 10.1152/ajpcell.1999.277.6.C1202; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Hurd C, 2001, BIOCHEM BIOPH RES CO, V282, P404, DOI 10.1006/bbrc.2001.4591; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Paolucci L, 1999, CANCER RES, V59, P572; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rozengurt E, 1997, BIOCHEM SOC T, V25, P565, DOI 10.1042/bst0250565; Rozengurt E, 1995, MUTAT RES-FUND MOL M, V333, P153, DOI 10.1016/0027-5107(95)00141-7; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	50	139	142	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32606	32615		10.1074/jbc.M101648200	http://dx.doi.org/10.1074/jbc.M101648200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11410586	hybrid			2022-12-27	WOS:000170746000032
J	Wallace, TJ; Kodsi, EM; Langston, TB; Gergis, MR; Grogan, WM				Wallace, TJ; Kodsi, EM; Langston, TB; Gergis, MR; Grogan, WM			Mutation of residues 423 (Met/Ile), 444 (Thr/Met), and 506 (Asn/Ser) confer cholesteryl esterase activity on rat lung carboxylesterase - Ser-506 is required for activation by cAMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; LIVER CARBOXYLESTERASE; NUCLEOTIDE-SEQUENCE; CDNA CLONING; LIPOPROTEIN-LIPASE; MULTIGENE FAMILY; IMMUNOLOGICAL CHARACTERIZATION; MICROSOMAL CARBOXYLESTERASES; ORGANOPHOSPHORUS COMPOUNDS; PUTATIVE CARBOXYLESTERASE	Site-directed mutagenesis is used to identify amino acid residues that dictate reported differences in substrate specificity between rat hepatic neutral cytosolic cholesteryl ester hydrolase (hneCEH) and rat lung carboxylesterase (LCE), proteins differing by only 4 residues in their primary sequences. Beginning with LCE, the substitution Met(423) --> Ile(423) alone or in combination with other mutations increased activity with p-nitrophenylcaprylate (PNPC) relative to more hydrophilic p-nitrophenylacetate (PNPA), typical of hneCEH. The substitution Thr(444) --> Met(444) was necessary but not sufficient for expression of cholesteryl esterase activity in COS-7 cells. The substitution Asn(506) --> Se-506, creating a potential phosphorylation site, uniformly increased activity with both PNPA and PNPC, was necessary but not sufficient for expression of cholesteryl esterase activity and conferred susceptibility to activation by cAMP-dependent protein kinase, a property of hncCEH. The 3 mutations in combination were necessary and sufficient for expression of cholesteryl esterase activity by the mutated LCE. The substitution Gln(186) --> Arg(186) selectively reduced esterase activity with PNPA and PNPC but was not required for cholesteryl esterase activity. Homology modeling from x-ray structures of acetylcholinesterases is used to propose three-dimensional models for hncCEH and LCE that provide insight into the effects of these mutations on substrate specificity.	Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA	Virginia Commonwealth University	Grogan, WM (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044613] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44613] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIDA K, 1993, BIOCHIM BIOPHYS ACTA, V1174, P72, DOI 10.1016/0167-4781(93)90093-S; ALEXSON SEH, 1993, EUR J BIOCHEM, V214, P719, DOI 10.1111/j.1432-1033.1993.tb17973.x; ARPAGAUS M, 1991, J BIOL CHEM, V266, P6966; ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; Barr F, 1998, AM J PHYSIOL-LUNG C, V274, pL404, DOI 10.1152/ajplung.1998.274.3.L404; BECKER A, 1994, ARTERIOSCLER THROMB, V14, P1346, DOI 10.1161/01.ATV.14.8.1346; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; BRAULT D, 1992, GENE, V121, P237, DOI 10.1016/0378-1119(92)90127-B; Carriere F, 1998, BBA-REV BIOMEMBRANES, V1376, P417, DOI 10.1016/S0304-4157(98)00016-1; COLWELL NS, 1993, BIOCHIM BIOPHYS ACTA, V1172, P175, DOI 10.1016/0167-4781(93)90288-O; Cordle RA, 1998, J LIPID RES, V39, P1759; David L, 1998, EUR J BIOCHEM, V257, P142, DOI 10.1046/j.1432-1327.1998.2570142.x; DEAN RA, 1995, J PHARMACOL EXP THER, V275, P965; DUGI KA, 1992, J BIOL CHEM, V267, P25086; FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899; GAUSTAD R, 1991, BIOCHEM J, V274, P693, DOI 10.1042/bj2740693; Ghosh S, 1995, BBA-LIPID LIPID MET, V1259, P305, DOI 10.1016/0005-2760(95)00184-0; GHOSH S, 1992, BIOCHEM CELL BIOL, V70, P800, DOI 10.1139/o92-121; Ghosh S, 1998, AM J PHYSIOL-GASTR L, V274, pG662, DOI 10.1152/ajpgi.1998.274.4.G662; GHOSH S, 1991, LIPIDS, V26, P793, DOI 10.1007/BF02536160; GHOSH S, 1989, LIPIDS, V24, P733, DOI 10.1007/BF02535213; GHOSH S, 1990, LIPIDS, V25, P221, DOI 10.1007/BF02535751; GROGAN WM, 1991, LIPIDS, V26, P907, DOI 10.1007/BF02535976; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HOLM C, 1988, NUCLEIC ACIDS RES, V16, P9879, DOI 10.1093/nar/16.20.9879; HOSOKAWA M, 1987, MOL PHARMACOL, V31, P579; Islam MR, 1999, ARCH BIOCHEM BIOPHYS, V372, P53, DOI 10.1006/abbi.1999.1449; KISSEL JA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P227, DOI 10.1016/0005-2760(89)90201-4; Kojima A, 1998, CANCER RES, V58, P4368; KOMAROMY MC, 1987, P NATL ACAD SCI USA, V84, P1526, DOI 10.1073/pnas.84.6.1526; KORZA G, 1988, J BIOL CHEM, V263, P3486; Krishnasamy S, 1997, BIOCHEM BIOPH RES CO, V235, P180, DOI 10.1006/bbrc.1997.6719; KROETZ DL, 1993, BIOCHEMISTRY-US, V32, P11606, DOI 10.1021/bi00094a018; KYGER EM, 1989, BIOCHEM BIOPH RES CO, V164, P1302, DOI 10.1016/0006-291X(89)91811-1; LEGAY C, 1993, FEBS LETT, V315, P163, DOI 10.1016/0014-5793(93)81155-S; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; LONG RM, 1988, BIOCHEM BIOPH RES CO, V156, P866, DOI 10.1016/S0006-291X(88)80924-0; MACKAY K, 1995, GENE, V165, P255, DOI 10.1016/0378-1119(95)00564-M; MATSUSHIMA M, 1991, FEBS LETT, V293, P37, DOI 10.1016/0014-5793(91)81147-Z; MAXWELL DM, 1992, TOXICOL APPL PHARM, V114, P306, DOI 10.1016/0041-008X(92)90082-4; MCCRACKEN NW, 1993, BIOCHEM PHARMACOL, V45, P31, DOI 10.1016/0006-2952(93)90373-5; MENTLEIN R, 1987, BIOCHIM BIOPHYS ACTA, V913, P27, DOI 10.1016/0167-4838(87)90228-7; MENTLEIN R, 1984, ARCH BIOCHEM BIOPHYS, V234, P612, DOI 10.1016/0003-9861(84)90311-4; MORGAN EW, 1994, ARCH BIOCHEM BIOPHYS, V315, P495, DOI 10.1006/abbi.1994.1531; Mori M, 1999, FEBS LETT, V458, P17, DOI 10.1016/S0014-5793(99)01111-4; NAKAGAWA H, 1995, J LIPID RES, V36, P2212; NAMBU K, 1987, BIOCHEM PHARMACOL, V36, P1715, DOI 10.1016/0006-2952(87)90058-X; Natarajan R, 1999, J LIPID RES, V40, P2091; Natarajan R, 1998, BIOCHEM BIOPH RES CO, V243, P349, DOI 10.1006/bbrc.1997.8030; Natarajan R, 1996, BIOCHEM BIOPH RES CO, V225, P413, DOI 10.1006/bbrc.1996.1188; NILSSON J, 1990, EUR J BIOCHEM, V192, P543, DOI 10.1111/j.1432-1033.1990.tb19259.x; OVNIC M, 1991, GENOMICS, V11, P956, DOI 10.1016/0888-7543(91)90020-F; OVNIC M, 1991, GENOMICS, V9, P344, DOI 10.1016/0888-7543(91)90263-E; OZOLS J, 1989, J BIOL CHEM, V264, P12533; PARK YH, 1994, BIOCHEM MOL BIOL INT, V34, P351; PAYNE RM, 1994, AM J PHYSIOL, V266, pG914, DOI 10.1152/ajpgi.1994.266.5.G914; Peitsch M C, 2000, Pharmacogenomics, V1, P257, DOI 10.1517/14622416.1.3.257; Potter PM, 1998, CANCER RES, V58, P2646; RACHINSKY TL, 1990, NEURON, V5, P317, DOI 10.1016/0896-6273(90)90168-F; ROBBI M, 1990, BIOCHEM J, V269, P451, DOI 10.1042/bj2690451; ROBBI M, 1994, BIOCHEM BIOPH RES CO, V203, P1404, DOI 10.1006/bbrc.1994.2341; ROBBI M, 1983, EUR J BIOCHEM, V137, P293, DOI 10.1111/j.1432-1033.1983.tb07828.x; Robbi M, 1996, BIOCHEM J, V313, P821, DOI 10.1042/bj3130821; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; Schwer H, 1997, BIOCHEM BIOPH RES CO, V233, P117, DOI 10.1006/bbrc.1997.6413; SONE T, 1994, BBA-PROTEIN STRUCT M, V1207, P138, DOI 10.1016/0167-4838(94)90063-9; Sone T, 1997, COMPREHENSIVE TOXICO, P265; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; Sun GS, 1997, J BIOL CHEM, V272, P24488, DOI 10.1074/jbc.272.39.24488; TAKAGI Y, 1988, J BIOCHEM-TOKYO, V104, P801, DOI 10.1093/oxfordjournals.jbchem.a122553; TANG BK, 1995, EUR J CLIN PHARMACOL, V47, P449; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; Wallace TJ, 1999, AM J RESP CELL MOL, V20, P1201, DOI 10.1165/ajrcmb.20.6.3402; Wang XQ, 1997, STRUCTURE, V5, P1209, DOI 10.1016/S0969-2126(97)00271-2; WIEGREBE W, 1984, ARZNEIMITTEL-FORSCH, V34-1, P48; YAN BF, 1994, J BIOL CHEM, V269, P29688	79	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33165	33174		10.1074/jbc.M105644200	http://dx.doi.org/10.1074/jbc.M105644200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11429416				2022-12-27	WOS:000170746000103
J	Leppa, S; Kajanne, R; Arminen, L; Sistonen, L				Leppa, S; Kajanne, R; Arminen, L; Sistonen, L			Differential induction of Hsp70-encoding genes in human hematopoietic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; LINKED HSP70 GENES; MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; INDUCED EXPRESSION; BINDING ACTIVITY; THERMAL-STRESS; ACTIVATION; FAMILY; THERMOTOLERANCE	The rapid transcriptional activation of heat shock genes in response to stress is crucial for the cellular survival and the development of thermotolerance. Although heat shock response is a widespread phenomenon, certain cells exhibit a diminished induction of heat shock gene expression upon stress stimuli. Here we have analyzed the development of thermotolerance and induction of distinct Hsp70 encoding genes in three cell lines representing different hematopoietic cell types. We show that in response to heat shock, cell survival and induction of thermotolerance are impaired in Raji and HL60 cells, as compared with K562 cells. Accordingly, transcriptional induction of the hsp70 gene is diminished in Raji and HL60 cells. This appears to be due to inability of transcription factors, including HSF1 to bind to the hsp70.1 promoter in vivo. Consistent with the genomic footprint, analysis of hsp70.1 mRNA expression using a specific 3 ' -untranslated region probe reveals that induction of the hsp70.1 gene upon heat shock is completely abolished in Raji and HL60 cells. The suppression of the hsp70.1 promoter is not caused by impaired function of HSF1, since HSF1 is equally activated in all cell types and occupies another heat-inducible promoter, hsp90a. Furthermore, among distinct inducible hsp70 genes, suppression seems to be specific for the hsp70.1 gene, since heat shock results in induction of hsp70.2 and hsp70B ' mRNA expression in all cell lines. Taken together, our results demonstrate that distinct Hsp70-encoding genes contribute to the heat shock response in a cell type-dependent manner.	Univ Turku, Abo Akad Univ, Turku Ctr Biotechnol, FIN-20521 Turku, Finland; Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; Univ Helsinki, Mol Canc Biol Res Program, Biomed Helsinki & Haartman Inst, FIN-00014 Helsinki, Finland; Univ Turku, Turku Ctr Biotechnol, Abo Akad Univ, FIN-20521 Turku, Finland; Abo Akad Univ, Dept Biol, FIN-20521 Turku, Finland	Abo Akademi University; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Abo Akademi University; University of Turku; Abo Akademi University	Leppa, S (corresponding author), Univ Turku, Abo Akad Univ, Turku Ctr Biotechnol, POB 123, FIN-20521 Turku, Finland.			Sistonen, Lea/0000-0003-1341-2867; Leppa, Sirpa/0000-0002-8265-511X				ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; AMICI C, 1992, P NATL ACAD SCI USA, V89, P6227, DOI 10.1073/pnas.89.14.6227; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; BANERJI SS, 1984, MOL CELL BIOL, V4, P2437, DOI 10.1128/MCB.4.11.2437; BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; BURSTON SG, 1995, ESSAYS BIOCHEM, V29, P125; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dressel R, 1999, J CELL BIOCHEM, V72, P558, DOI 10.1002/(SICI)1097-4644(19990315)72:4<558::AID-JCB11>3.3.CO;2-O; Dressel R, 1998, MELANOMA RES, V8, P482, DOI 10.1097/00008390-199812000-00002; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GORZOWSKI JJ, 1995, J BIOL CHEM, V270, P26940, DOI 10.1074/jbc.270.45.26940; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HARTL FU, 1995, CURR OPIN STRUC BIOL, V5, P92; HEADS RJ, 1994, J MOL CELL CARDIOL, V26, P695, DOI 10.1006/jmcc.1994.1084; HENDREY J, 1991, MOL REPROD DEV, V28, P1, DOI 10.1002/mrd.1080280102; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; Holmberg CI, 1997, J BIOL CHEM, V272, P6792, DOI 10.1074/jbc.272.10.6792; Kaarniranta K, 1998, P NATL ACAD SCI USA, V95, P2319, DOI 10.1073/pnas.95.5.2319; LEUNG TKC, 1990, BIOCHEM J, V267, P125, DOI 10.1042/bj2670125; LI GC, 1992, P NATL ACAD SCI USA, V89, P2036, DOI 10.1073/pnas.89.6.2036; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; MATHUR SK, 1994, P NATL ACAD SCI USA, V91, P8695, DOI 10.1073/pnas.91.18.8695; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Mirkes PE, 1999, DEV DYNAM, V214, P159, DOI 10.1002/(SICI)1097-0177(199902)214:2<159::AID-AJA6>3.0.CO;2-Y; MIVECHI NF, 1991, CANCER RES, V51, P6608; MIVECHI NF, 1989, CANCER RES, V49, P1954; MIVECHI NF, 1990, CANCER RES, V50, P2877; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; THEODORAKIS NG, 1987, MOL CELL BIOL, V7, P4357, DOI 10.1128/MCB.7.12.4357; Wissing D, 1996, INT J HYPERTHER, V12, P125, DOI 10.3109/02656739609023695; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441	51	20	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31713	31719		10.1074/jbc.M104375200	http://dx.doi.org/10.1074/jbc.M104375200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423545	hybrid			2022-12-27	WOS:000170613500034
J	Li, J; Verkman, AS				Li, J; Verkman, AS			Impaired hearing in mice lacking aquaporin-4 water channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; F1-HYBRID STRAINS; PLASMA-MEMBRANES; KNOCKOUT MICE; MULLER CELLS; INNER-EAR; EXPRESSION; GENETICS; PROTEIN; TRANSPORT	A role for aquaporins (AQPs) in hearing has been suggested from the specific expression of aquaporins in inner ear and the need for precise volume regulation in epithelial cells involved in acoustic signal transduction. Using mice deficient in selected aquaporins as controls, we localized AQP1 in fibrocytes in the spiral ligament and AQP4 in supporting epithelial cells (Hensen's, Claudius, and inner sulcus cells) in the organ of Corti. To determine whether aquaporins play a role in hearing, auditory brain stem response (ABR) thresholds were compared in wild-type mice and transgenic null mice lacking (individually) AQP1, AQP3, AQP4, and AQP5. In 4-5-week-old mice in a CD1 genetic background, ABR thresholds in response to a click stimulus were remarkably increased by > 12 db in AQP4 null mice compared with wild-type mice (p < 0.001), whereas ABR thresholds were not affected by AQP1, AQP3, or AQP5 deletion. In a C57/b16 background, nearly all AQP4 null mice were deaf, whereas ABRs could be elicited in wildtype controls. ABRs in AQP4 null CD1 mice measured in response to tone bursts (4-20 kHz) indicated a frequency-independent hearing deficit. Light microscopy showed no differences in cochlear morphology of wildtype versus AQP4 null mice. These results provide the first direct evidence that an aquaporin water channel plays a role in hearing. AQP4 may facilitate rapid osmotic equilibration in epithelial cells in the organ of Corti, which are subject to large K+ fluxes during mechano-electric signal transduction.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, Box 0521,1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.				NHLBI NIH HHS [HL60288, HL59198] Funding Source: Medline; NIDDK NIH HHS [DK35124, DK43840] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059198, P50HL060288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043840, R37DK035124, R01DK035124] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beitz E, 1999, HEARING RES, V132, P76, DOI 10.1016/S0378-5955(99)00036-2; Belyantseva IA, 2000, J NEUROSCI, V20, P8996; Chou CL, 1998, AM J PHYSIOL-CELL PH, V274, pC549, DOI 10.1152/ajpcell.1998.274.2.C549; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Erway LC, 1996, HEARING RES, V93, P181, DOI 10.1016/0378-5955(95)00226-X; ERWAY LC, 1993, HEARING RES, V65, P125, DOI 10.1016/0378-5955(93)90207-H; FRIGERI A, 1995, P NATL ACAD SCI USA, V92, P4328, DOI 10.1073/pnas.92.10.4328; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; HENRY KR, 1992, AUDIOLOGY, V31, P190; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MARKAND ON, 1994, J CLIN NEUROPHYSIOL, V11, P319, DOI 10.1097/00004691-199405000-00004; Mhatre AN, 1999, BIOCHEM BIOPH RES CO, V264, P157, DOI 10.1006/bbrc.1999.1323; MINAMI Y, ACTA OTOLARYNGOL S, V533, P19; Misaka T, 1996, FEBS LETT, V381, P208, DOI 10.1016/0014-5793(96)00092-0; MULLER AR, 1994, J CLIN NEUROPHYSIOL, V11, P284; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nielsen S, 1997, J NEUROSCI, V17, P171; Patuzzi R., 1996, COCHLEA, P186; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; RANDOM BR, 1996, TRENDS NEUROSCI, V19, P352; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Sakaguchi N, 1998, HEARING RES, V118, P114, DOI 10.1016/S0378-5955(98)00022-7; Stankovic KM, 1995, AM J PHYSIOL-CELL PH, V269, pC1450, DOI 10.1152/ajpcell.1995.269.6.C1450; Steel KP, 1999, SCIENCE, V285, P1363, DOI 10.1126/science.285.5432.1363; Takumi Y, 1998, EUR J NEUROSCI, V10, P3584, DOI 10.1046/j.1460-9568.1998.00360.x; TRAYNELIS SF, 1989, J NEUROPHYSIOL, V61, P927, DOI 10.1152/jn.1989.61.5.927; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Verkman AS, 2000, EXP PHYSIOL, V85, p233S, DOI 10.1111/j.1469-445X.2000.tb00028.x; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG448, DOI 10.1152/ajpgi.2000.279.2.G448; WILLOTT JF, 1995, HEARING RES, V88, P143, DOI 10.1016/0378-5955(95)00107-F; YANG B, 2000, AM J PHYSIOL, V278, pC1008; Yang BX, 1996, J BIOL CHEM, V271, P4577; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Yang BX, 2001, J BIOL CHEM, V276, P2775, DOI 10.1074/jbc.M008216200; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	43	202	222	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31233	31237		10.1074/jbc.M104368200	http://dx.doi.org/10.1074/jbc.M104368200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11406631	hybrid			2022-12-27	WOS:000170472900085
J	Outten, FW; Huffman, DL; Hale, JA; O'Halloran, TV				Outten, FW; Huffman, DL; Hale, JA; O'Halloran, TV			The independent cue and cus systems confer copper tolerance during aerobic and anaerobic growth in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCOCCUS-HIRAE; ASCORBATE OXIDASE; CRYSTAL-STRUCTURE; MULTIDRUG EFFLUX; PROTEIN EXPORT; TRANSPORT; ZUCCHINI; CLUSTER; BINDING; ATPASE	Copper is essential but can be toxic even at low concentrations. Coping with this duality requires multiple pathways to control intracellular copper availability. Three copper-inducible promoters, controlling expression of six copper tolerance genes, were recently identified in Escherichia coli. The cue system employs an inner membrane copper transporter, whereas the cus system includes a tripartite transporter spanning the entire cell envelope. Although cus is not essential for aerobic copper tolerance, we show here that a copper-sensitive phenotype can be observed when cus is inactivated in a cueR background. Furthermore, a clear copper-sensitive phenotype for the cus system is revealed in the absence Of O-2. These results indicate that the cue pathway, which includes a copper exporter, CopA, and a periplasmic oxidase, CueO, is the primary aerobic system for copper tolerance. During anaerobic growth, however, copper toxicity increases, and the independent cus copper exporter is also necessary for full copper tolerance. We conclude that the cytosolic (CueR) and periplasmic (CusRS) sensor systems differentially regulate copper export systems in response to changes in copper and oxygen availability. These results underscore the increased toxicity of copper under anaerobic conditions and the complex adaptation of copper export in E. coli.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	O'Halloran, TV (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	t-ohalloran@northwestern.edu	O'Halloran, Thomas/ABE-6125-2021	O'Halloran, Thomas/0000-0001-8732-5059; Outten, Franklin/0000-0002-9095-0194	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038784, T32GM008061, R01GM054111] Funding Source: NIH RePORTER; NIEHS NIH HHS [T32 ES07284] Funding Source: Medline; NIGMS NIH HHS [R01 GM054111, R01 GM38784, T32 GM08061] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; BESWICK PH, 1976, CHEM-BIOL INTERACT, V14, P347, DOI 10.1016/0009-2797(76)90113-7; Blackburn NJ, 2000, BIOCHEMISTRY-US, V39, P2316, DOI 10.1021/bi992334a; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; CASELLA L, 1988, BIOCHEM J, V251, P441, DOI 10.1042/bj2510441; Cole AP, 1996, SCIENCE, V273, P1848, DOI 10.1126/science.273.5283.1848; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LEHMANN HP, 1974, CLIN CHEM, V20, P1564; MESSERSCHMIDT A, 1989, J MOL BIOL, V206, P513, DOI 10.1016/0022-2836(89)90498-1; Millardet A, 1845, DISCOVERY BORDEAUX M; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Munson GP., 1997, THESIS NW U EVANSTON; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; ODERMATT A, 1994, BIOCHEM BIOPH RES CO, V202, P44, DOI 10.1006/bbrc.1994.1891; OLIVER DB, 1996, ESCHERICHIA COLI SAL, V1, P88; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Petersen C, 2000, GENE, V261, P289, DOI 10.1016/S0378-1119(00)00509-6; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; SAIER MH, 1994, MOL MICROBIOL, V11, P841, DOI 10.1111/j.1365-2958.1994.tb00362.x; Sawers G, 1999, CURR OPIN MICROBIOL, V2, P181, DOI 10.1016/S1369-5274(99)80032-0; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strain J, 1996, MOL GEN GENET, V251, P139; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	34	395	410	7	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30670	30677		10.1074/jbc.M104122200	http://dx.doi.org/10.1074/jbc.M104122200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11399769	hybrid			2022-12-27	WOS:000170472900013
J	Perrais, M; Pigny, P; Ducourouble, MP; Petitprez, D; Porchet, N; Aubert, JP; Van Seuningen, I				Perrais, M; Pigny, P; Ducourouble, MP; Petitprez, D; Porchet, N; Aubert, JP; Van Seuningen, I			Characterization of human mucin gene MUC4 promoter - Importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SURFACE SIALOMUCIN COMPLEX; RNA-POLYMERASE-II; INTERFERON-GAMMA; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; TYROSINE KINASE; FACTOR RECEPTOR; IN-VITRO; C-SRC	The human mucin gene MUC4 encodes a large transmembrane mucin that is thought to play important roles in tumor cell biology and that is overexpressed in human pancreatic carcinomas. In this report, we describe the structure and functional activity of the 5 ' -flanking region, including 1.0 kilobase of the promoter. The long 5 ' -untranslated region (2.7 kilobases) is characterized by a high content of GC in its 3 ' -end. The first TATA box was located at -2672/-2668. Multiple transcription start sites and a high density of putative binding sites for Sp1 (GC and CACCC boxes), AP-1/-2/-4, cAMP-responsive element-binding protein, GATA, GR, and STAT transcription factors were found within the 5 ' -flanking region. Transcriptional activity of the promoter was assessed using pGL3-luciferase deletion mutants in two MUC4-expressing (CAPAN-1 and CAPAN-2) and one nonexpressing (PANC-1) pancreatic cancer cell line. Two highly active fragments (-219/-1 and -2781/-2572) that drive MUC4 transcription in CAPAN-1 and CAPAN-2 cells were identified. Gel retardation assays indicated that Sp1 and Sp3 bind to cognate cis-elements found in the 5 ' -flanking region and that Sp1 transactivates, whereas Sp3 inhibits the GC-rich region (-464/-1) in CAPAN-2 cells. Activation of protein kinase C with phorbol ester and treatment of cells with epidermal growth factor and transforming growth factor-alpha resulted in upregulation of the promoter. Tumor necrosis factor-alpha and interferon (IFN)-gamma inflammatory cytokines had no or mild effect on MUC4 transcriptional activity when used alone. However, a very strong synergistic effect (10-12-fold activation) between IFN-gamma and tumor necrosis factor-a or IFN-gamma and transforming growth factor-a was obtained in CAPAN-2 cells. Altogether these results demonstrate that the 5 ' -flanking region of MUC4 contains epithelial cell-specific, positive, and negative regulatory cis-elements, that Sp1/Sp3 are important regulators of MUC4 basal expression, and that its regulation in pancreatic cancer cells involves complex interplay between several signaling pathways.	INSERM, U377, F-59045 Lille, France; Ctr Hosp Reg & Univ Lille, Hop Huriez, Lab Endocrinol, F-59037 Lille, France; Ctr Hosp Reg & Univ Lille, Hop Huriez, Lab Biochim & Biol Mol, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Van Seuningen, I (corresponding author), INSERM, U377, Pl Verdun, F-59045 Lille, France.	vanseuni@lille.oinserm.fr	VAN SEUNINGEN, Isabelle/N-6176-2016	VAN SEUNINGEN, Isabelle/0000-0002-3131-2694				Asano K, 1997, J CLIN INVEST, V99, P1057, DOI 10.1172/JCI119233; Aslam F, 2001, CANCER RES, V61, P570; AUDIE JP, 1995, HUM REPROD, V10, P98, DOI 10.1093/humrep/10.1.98; AUDIE JP, 1993, J HISTOCHEM CYTOCHEM, V41, P1479, DOI 10.1177/41.10.8245407; Bahr MJ, 1999, HEPATOLOGY, V29, P839, DOI 10.1002/hep.510290333; BALAGUE C, 1994, GASTROENTEROLOGY, V106, P1054, DOI 10.1016/0016-5085(94)90767-6; BALAGUE C, 1995, GASTROENTEROLOGY, V109, P953, DOI 10.1016/0016-5085(95)90406-9; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Buckley CD, 1997, MOL MED TODAY, V3, P449, DOI 10.1016/S1357-4310(97)01128-3; Buisine MP, 1999, INFLAMM BOWEL DIS, V5, P24, DOI 10.1097/00054725-199902000-00004; Buisine MP, 1998, GUT, V43, P519, DOI 10.1136/gut.43.4.519; Buisine MP, 1999, AM J RESP CELL MOL, V20, P209, DOI 10.1165/ajrcmb.20.2.3259; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Carraway KL, 2000, FRONT BIOSCI, V5, pD95, DOI 10.2741/Carraway; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; Choudhury A, 2000, J BIOL CHEM, V275, P33929, DOI 10.1074/jbc.M005115200; Choudhury A, 2000, J BIOCHEM-TOKYO, V128, P233, DOI 10.1093/oxfordjournals.jbchem.a022746; Copin MC, 2000, INT J CANCER, V86, P162, DOI 10.1002/(SICI)1097-0215(20000415)86:2<162::AID-IJC3>3.3.CO;2-I; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Davies DE, 1999, ALLERGY, V54, P771; Fischer BM, 1999, AM J RESP CELL MOL, V20, P413, DOI 10.1165/ajrcmb.20.3.3393; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gollub EG, 1995, BIOCHEM BIOPH RES CO, V217, P1006, DOI 10.1006/bbrc.1995.2870; GROSS MS, 1992, ANN GENET-PARIS, V35, P21; Gum JR, 1997, BIOCHEM J, V325, P259, DOI 10.1042/bj3250259; Gumina RJ, 1997, BLOOD, V89, P1260, DOI 10.1182/blood.V89.4.1260; HOLLINGSWORTH MA, 1994, INT J CANCER, V57, P198, DOI 10.1002/ijc.2910570212; HULL SR, 1990, BIOCHEM J, V265, P121, DOI 10.1042/bj2650121; Ince TA, 1995, J BIOL CHEM, V270, P30249, DOI 10.1074/jbc.270.51.30249; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; Komatsu M, 2000, INT J CANCER, V87, P480, DOI 10.1002/1097-0215(20000815)87:4<480::AID-IJC4>3.0.CO;2-6; Kost ER, 1999, GYNECOL ONCOL, V72, P392, DOI 10.1006/gyno.1998.5257; Kovarik A, 1996, J BIOL CHEM, V271, P18140, DOI 10.1074/jbc.271.30.18140; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; LESUFFLEUR T, 1994, CRIT REV ONCOL HEMAT, V17, P153, DOI 10.1016/1040-8428(94)90053-1; LEVINE SJ, 1995, AM J RESP CELL MOL, V12, P196, DOI 10.1165/ajrcmb.12.2.7865217; Lewis M, 1999, J CELL BIOCHEM, V72, P373, DOI 10.1002/(SICI)1097-4644(19990301)72:3<373::AID-JCB7>3.0.CO;2-N; Li JD, 1997, P NATL ACAD SCI USA, V94, P967, DOI 10.1073/pnas.94.3.967; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; MARIN MG, 1994, PHARMACOL REV, V46, P35; Matsuura H, 1999, J BIOL CHEM, V274, P29138, DOI 10.1074/jbc.274.41.29138; Moniaux N, 2000, EUR J BIOCHEM, V267, P4536, DOI 10.1046/j.1432-1327.2000.01504.x; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; Nguyen PL, 1996, TUMOR BIOL, V17, P176, DOI 10.1159/000217980; Nogami H, 1997, GENE, V198, P191, DOI 10.1016/S0378-1119(97)00314-4; Nollet S, 1998, BIOCHEM J, V332, P739, DOI 10.1042/bj3320739; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; PANDEY P, 1995, CANCER RES, V55, P4000; Park C, 1998, METHODS, V15, P175, DOI 10.1006/meth.1998.0622; Perrais M, 2001, J BIOL CHEM, V276, P15386, DOI 10.1074/jbc.M010534200; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; Porchet Nicole, 1999, Journal de la Societe de Biologie, V193, P85; Price-Schiavi SA, 2000, BIOCHEM J, V349, P641, DOI 10.1042/0264-6021:3490641; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Satoh S, 2000, INT J CANCER, V88, P507, DOI 10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0; SHENG Z, 1990, J BIOL CHEM, V265, P8505; Shimura S, 2000, CELL SIGNAL, V12, P271, DOI 10.1016/S0898-6568(00)00066-8; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Van Seuningen I, 2000, BIOCHEM J, V348, P675; Vandenhaute B, 1997, J HEPATOL, V27, P1057, DOI 10.1016/S0168-8278(97)80150-X; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; VANSUNINGEN I, 2001, IN PRESS FRONT BIOSC; von Mensdorff-Pouilly S, 2000, INT J BIOL MARKER, V15, P343, DOI 10.1177/172460080001500413; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Williams SJ, 1999, CANCER RES, V59, P4083; WRIGHT WC, 1981, J NATL CANCER I, V66, P239; YONEZAWA S, 1991, BIOCHEM J, V276, P599, DOI 10.1042/bj2760599; Yu M, 1997, J BIOL CHEM, V272, P29060, DOI 10.1074/jbc.272.46.29060	74	67	68	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30923	30933		10.1074/jbc.M104204200	http://dx.doi.org/10.1074/jbc.M104204200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418607	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000170472900046
J	Baruch, A; Greenbaum, D; Levy, ET; Nielsen, PA; Gilula, NB; Kumar, NM; Bogyo, M				Baruch, A; Greenbaum, D; Levy, ET; Nielsen, PA; Gilula, NB; Kumar, NM; Bogyo, M			Defining a link between gap junction communication, proteolysis, and cataract formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-D-CRYSTALLIN; INTACT RAT LENS; ALPHA(3) CONNEXIN; CALPAIN; GENE; MICE; ACTIVATION; MUTATIONS; MEMBRANE; CHANNEL	Disruption of the connexin alpha3 (Cx46) gene (alpha3 (-/-)) in mice results in severe cataracts within the nuclear portion of the lens. These cataracts are associated with proteolytic processing of the abundant lens protein gamma -crystallin, leading to its aggregation and subsequent opacification of the lens. The general cysteine protease inhibitor, E-64, blocked cataract formation and gamma -crystallin cleavage in alpha3 (-/-) lenses. Using a new class of activity-based cysteine protease affinity probes, we identified the calcium-dependent proteases, m-calpain and Lp82, as the primary targets of E-64 in the lens. Profiling changes in protease activities throughout cataractogenesis indicated that Lp82 activity was dramatically increased in alpha3 (-/-) lenses and correlated both spatially and temporally with cataract formation. Increased Lp82 activity was due to calcium accumulation as a result of increased influx and decreased outflux of calcium ions in alpha3 (-/-) lenses. These data establish a role for alpha3 gap junctions in maintaining calcium homeostasis that in turn is required to control activity of the calcium-dependent cysteine protease Lp82, shown here to be a key initiator of the process of cataractogenesis.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Scripps Research Institute; University of California System; University of California San Francisco	Bogyo, M (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.			Bogyo, Matthew/0000-0003-3753-4412	NATIONAL EYE INSTITUTE [R01EY012142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037904, R01GM037904] Funding Source: NIH RePORTER; NEI NIH HHS [EY12142] Funding Source: Medline; NIGMS NIH HHS [GM37904] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson M, 1996, OPHTHALMIC RES, V28, P51, DOI 10.1159/000267944; Azuma M, 1997, EXP EYE RES, V64, P529, DOI 10.1006/exer.1996.0234; AZUMA M, 1992, BIOCHIM BIOPHYS ACTA, V1180, P215, DOI 10.1016/0925-4439(92)90071-T; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; CHURCH RL, 1995, CURR EYE RES, V14, P979, DOI 10.3109/02713689508995138; CROW JM, 1994, INVEST OPHTH VIS SCI, V35, P3332; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1998, P NATL ACAD SCI USA, V95, P15303, DOI 10.1073/pnas.95.26.15303; Goodenough D.A., 1992, Seminars in Cell Biology, V3, P49; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Horwitz J, 1999, EYE, V13, P403, DOI 10.1038/eye.1999.114; Klopp N, 1998, GENOMICS, V52, P152, DOI 10.1006/geno.1998.5417; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lin JS, 1997, EUR J CELL BIOL, V73, P141; Lo CW, 1999, DEV GENET, V24, P1, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<1::AID-DVG1>3.0.CO;2-U; Ma H, 1999, EXP EYE RES, V68, P447, DOI 10.1006/exer.1998.0625; Ma H, 2000, CURR EYE RES, V20, P183, DOI 10.1076/0271-3683(200003)20:3;1-9;FT183; MANDAL K, 1987, J BIOL CHEM, V262, P8096; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Paemeleire K, 2000, MOL BIOL CELL, V11, P1815, DOI 10.1091/mbc.11.5.1815; Pal JD, 2000, AM J PHYSIOL-CELL PH, V279, pC596, DOI 10.1152/ajpcell.2000.279.3.C596; Paterson CA, 1997, CURR EYE RES, V16, P333, DOI 10.1076/ceyr.16.4.333.10689; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; Plum A, 2000, CURR BIOL, V10, P1083, DOI 10.1016/S0960-9822(00)00690-4; ROBINSON KR, 1983, CURR EYE RES, V2, P843, DOI 10.3109/02713688209020020; Sanderson J, 1996, BIOCHEM BIOPH RES CO, V218, P893, DOI 10.1006/bbrc.1996.0159; Shearer T R, 1997, Mol Vis, V3, P8; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Srivastava OP, 1998, BIOCHEM BIOPH RES CO, V253, P288, DOI 10.1006/bbrc.1998.9728; Srivastava SK, 1997, INVEST OPHTH VIS SCI, V38, P2300; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Thomas GR, 1999, J PHYSIOL-LONDON, V516, P191, DOI 10.1111/j.1469-7793.1999.191ab.x; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; TRUSCOTT RJW, 1990, INVEST OPHTH VIS SCI, V31, P2405; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; White TW, 2000, BRAIN RES REV, V32, P130, DOI 10.1016/S0165-0173(99)00072-7	38	96	101	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					28999	29006		10.1074/jbc.M103628200	http://dx.doi.org/10.1074/jbc.M103628200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11395508	hybrid			2022-12-27	WOS:000170346000050
J	Goldfarb, AN; Delehanty, LL; Wang, DY; Racke, FK; Hussaini, IM				Goldfarb, AN; Delehanty, LL; Wang, DY; Racke, FK; Hussaini, IM			Stromal inhibition of megakaryocytic differentiation correlates with blockade of signaling by protein kinase C-epsilon and ERK/MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PROLIFERATION; ACTIVATION; PATHWAY; EXPRESSION; MODEL	Contact with bone marrow stromal. cells maintains normal and leukemic hematopoietic progenitors in an undifferentiated state. Recently, stromal contact has been shown to diminish the yield of megakaryocytes in cultures of primary human hematopoietic stem cells. This inhibition may explain the poor megakaryocytic engraftment frequently observed after bone marrow transplantation. In the current study, stromal co-culture is shown to render K562 cells refractory to megakaryocytic induction. This stromal. inhibition correlated with the selective down-regulation in K562 cells of protein kinase C-E (PKC-E), which has recently been implicated in regulation of megakaryocytic lineage commitment. In addition, the stromal. inhibition correlated with inactivation of the ERK/MAPK pathway, which has also been implicated in promoting megakaryocytic development. Forced expression of PKC-E by retroviral transduction was insufficient to reverse the stromal blockade of ERK/MAPK signaling or of megakaryocytic induction. Thus stromal. interruption of ERK/MAPK signaling occurred independently of PKC-E levels and correlated more closely with megakaryocytic blockade. These findings provide potential mechanisms for stromal inhibition of hematopoietic differentiation and possibly for the poor megakaryocytic engraftment seen after bone marrow transplantation.	Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA	University of Virginia; Johns Hopkins University; Johns Hopkins Medicine	Goldfarb, AN (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Pathol, Box 800214, Charlottesville, VA 22908 USA.	ang3x@virginia.edu			NATIONAL CANCER INSTITUTE [R29CA072704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035122, R01NS035122] Funding Source: NIH RePORTER; NCI NIH HHS [CA-72704] Funding Source: Medline; NHLBI NIH HHS [HL-04017] Funding Source: Medline; NINDS NIH HHS [NS-35122] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; DAI W, 1993, BLOOD, V81, P1214; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Dorsch M, 1999, BLOOD, V94, P2676, DOI 10.1182/blood.V94.8.2676.420k28_2676_2685; Fichelson S, 1999, BLOOD, V94, P1601, DOI 10.1182/blood.V94.5.1601.417k19_1601_1613; Hussaini IM, 2000, J BIOL CHEM, V275, P22348, DOI 10.1074/jbc.M003203200; Lam LT, 2000, J BIOL CHEM, V275, P19676, DOI 10.1074/jbc.M002866200; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; LONG MW, 1984, J CLIN INVEST, V74, P1686, DOI 10.1172/JCI111585; Lumelsky NL, 1997, BBA-MOL CELL RES, V1358, P79, DOI 10.1016/S0167-4889(97)00051-7; Matsumura I, 1998, MOL CELL BIOL, V18, P4282, DOI 10.1128/MCB.18.7.4282; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; MURRAY NR, 1993, J BIOL CHEM, V268, P15847; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; Racke FK, 2001, J BIOL CHEM, V276, P522, DOI 10.1074/jbc.M005236200; Rouyez MC, 1997, MOL CELL BIOL, V17, P4991, DOI 10.1128/MCB.17.9.4991; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Torok-Storb B, 1999, ANN NY ACAD SCI, V872, P164, DOI 10.1111/j.1749-6632.1999.tb08461.x; Tsuji T, 1998, BLOOD, V91, P1263, DOI 10.1182/blood.V91.4.1263; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; Zaidi Z, 2000, BLOOD, V96, p77A; Zweegman S, 1999, LEUKEMIA, V13, P935, DOI 10.1038/sj.leu.2401422; Zweegman S, 2000, EXP HEMATOL, V28, P401, DOI 10.1016/S0301-472X(00)00128-4	26	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29526	29530		10.1074/jbc.M103825200	http://dx.doi.org/10.1074/jbc.M103825200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11395513	hybrid			2022-12-27	WOS:000170346000117
J	Harris, JL; Niles, A; Burdick, K; Maffitt, M; Backes, BJ; Ellman, JA; Kuntz, I; Haak-Frendscho, M; Craik, CS				Harris, JL; Niles, A; Burdick, K; Maffitt, M; Backes, BJ; Ellman, JA; Kuntz, I; Haak-Frendscho, M; Craik, CS			Definition of the extended substrate specificity determinants for beta-tryptases I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; HUMAN-LUNG TRYPTASE; NUCLEIC-ACIDS; FORCE-FIELD; ANGIOGENESIS; THROMBIN; PURIFICATION; INHIBITORS; LIBRARIES; PROTEINS	Tryptases betaI and beta II were heterologously expressed and purified in yeast to functionally characterize the substrate specificity of each enzyme. Three positional scanning combinatorial tetrapeptide substrate libraries were used to determine the primary and extended substrate specificity of the proteases. Both enzymes have a strict primary preference for cleavage after the basic amino acids, lysine and arginine, with only a slight preference for lysine over arginine. betaI and beta II tryptase share similar extended substrate specificity, with preference for proline at P4, preference for arginine or lysine at P3, and P2 showing a slight preference for asparagine. Measurement of kinetic constants with multiple substrates designed for beta -tryptases reveal that selectivity is highly dependent on ground state substrate binding. Coupled with the functional determinants, structural determinants of tryptase substrate specificity were identified. Molecular docking of the preferred substrate sequence to the three-dimensional tetrameric tryptase structure reveals a novel extended substrate binding mode that involves interactions from two adjacent protomers, including P4 Thr-96', P3 Asp-60B' and Glu-217, and P1 Asp-189. Based on the determined substrate information, a mechanism-based tetrapeptide-chloromethylketone inhibitor was designed and shown to be a potent tryptase inhibitor. Finally, the cleavage sites of several physiologically relevant substrates of beta -tryptases show consistency with the specificity data presented here.	Univ Calif San Francisco, Dept Pharmaceut Chem, Program Chem & Chem Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Promega Corp, Dept Neurobiol & Immunol, Madison, WI 53711 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Promega Corporation; University of California System; University of California Berkeley	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Program Chem & Chem Biol, San Francisco, CA 94143 USA.		Ellman, Jonathan A/C-7732-2013					Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Burgess LE, 1999, P NATL ACAD SCI USA, V96, P8348, DOI 10.1073/pnas.96.15.8348; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Lamb ML, 2001, PROTEINS, V42, P296, DOI 10.1002/1097-0134(20010215)42:3<296::AID-PROT20>3.0.CO;2-F; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Niles AL, 1998, BIOTECHNOL APPL BIOC, V28, P125; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Ribatti D, 2000, INT J CANCER, V85, P171, DOI 10.1002/(SICI)1097-0215(20000115)85:2<171::AID-IJC4>3.0.CO;2-W; Rice KD, 1998, CURR PHARM DESIGN, V4, P381; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; STACK MS, 1994, J BIOL CHEM, V269, P9416; Takanami I, 2000, CANCER, V88, P2686, DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6; TAM EK, 1990, AM J RESP CELL MOL, V3, P27, DOI 10.1165/ajrcmb/3.1.27; TANAKA T, 1983, J BIOL CHEM, V258, P3552; Toth T, 2000, HUM PATHOL, V31, P955; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216	26	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34941	34947		10.1074/jbc.M102997200	http://dx.doi.org/10.1074/jbc.M102997200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11438529	hybrid			2022-12-27	WOS:000171024600080
J	Tellam, J; Sherritt, M; Thomson, S; Tellam, R; Moss, DJ; Burrows, SR; Wiertz, E; Khanna, R				Tellam, J; Sherritt, M; Thomson, S; Tellam, R; Moss, DJ; Burrows, SR; Wiertz, E; Khanna, R			Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+T cell recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; N-END RULE; PROTEIN-DEGRADATION; NUCLEAR ANTIGEN-1; PROTEASOME; UBIQUITIN; IMMUNIZATION; PROTEOLYSIS; RESPONSES; MECHANISM	Epstein-Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) includes a unique glycine-alanine repeat domain that inhibits the endogenous presentation of cytotoxic T lymphocyte (CTL) epitopes through the class I pathway by blocking proteasome-dependent degradation of this antigen. This immune evasion mechanism has been implicated in the pathogenesis of EBV-associated diseases. Here, we show that cotranslational ubiquitination combined with N-end rule targeting enhances the intracellular degradation of EBNA1, thus resulting in a dramatic reduction in the half-life of the antigen. Using DNA expression vectors encoding different forms of ubiquitinated EBNA1 for in vivo studies revealed that this rapid degradation, remarkably, leads to induction of a very strong CTL response to an EBNA1-specific CTL epitope. Furthermore, this targeting also restored the endogenous processing of HLA class I-restricted CTL epitopes within EBNA1 for immune recognition by human EBV-specific CTLs. These observations provide, for the first time, evidence that the glycine-alanine repeat-mediated proteasomal block on EBNA1 can be reversed by specifically targeting this antigen for rapid degradation resulting in enhanced CD8+ T cell-mediated recognition in vitro and in vivo.	Univ Queensland, Queensland Inst Med Res, Bancroft Ctr, Div Infect Dis & Immunol,Tumor Immunol Lab, Brisbane, Qld 4006, Australia; Univ Queensland, Joint Oncol Program, Brisbane, Qld 4006, Australia; Australian Natl Univ, John Curtin Sch Med Res, Viral Engn & Cytokine Res Grp, Synthet Vaccines Lab, Canberra, ACT 2006, Australia; CSIRO, Indooroopilly, Qld 4068, Australia; Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; Australian National University; John Curtin School of Medical Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Khanna, R (corresponding author), Univ Queensland, Queensland Inst Med Res, Bancroft Ctr, Div Infect Dis & Immunol,Tumor Immunol Lab, Brisbane, Qld 4006, Australia.		Tellam, Ross/T-2423-2019; Khanna, Rajiv/A-7691-2008; Burrows, Scott/G-2050-2011; Tellam, Ross/H-2798-2013	Khanna, Rajiv/0000-0003-2241-0353; Burrows, Scott/0000-0002-1430-0472; Tellam, Ross/0000-0003-2353-1640				Blake N, 1997, IMMUNITY, V7, P791, DOI 10.1016/S1074-7613(00)80397-0; BURROWS SR, 1992, EUR J IMMUNOL, V22, P191, DOI 10.1002/eji.1830220128; Carbone FR, 1998, IMMUNOL TODAY, V19, P368, DOI 10.1016/S0167-5699(98)01301-2; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dantuma NP, 2000, P NATL ACAD SCI USA, V97, P8381, DOI 10.1073/pnas.140217397; ECKER DJ, 1989, J BIOL CHEM, V264, P7715; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Khanna R, 1997, J IMMUNOL, V158, P3619; KHANNA R, 1995, MICROBIOL REV, V59, P387, DOI 10.1128/MMBR.59.3.387-405.1995; KHANNA R, 1992, J EXP MED, V176, P169, DOI 10.1084/jem.176.1.169; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Manickan E, 1997, J LEUKOCYTE BIOL, V61, P125, DOI 10.1002/jlb.61.2.125; Mukherjee S, 1998, J EXP MED, V187, P445, DOI 10.1084/jem.187.3.445; RICKINSON AB, 1996, EPSTEIN BARR VIRUS F, P2397; RICKINSON AB, 1997, ANN REV IMMUNOL, V15; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TRIVEDI P, 1991, INT J CANCER, V48, P794, DOI 10.1002/ijc.2910480527; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5	28	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33353	33360		10.1074/jbc.M104535200	http://dx.doi.org/10.1074/jbc.M104535200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11435434	hybrid			2022-12-27	WOS:000170910200011
J	Branscombe, TL; Frankel, A; Lee, JH; Cook, JR; Yang, ZH; Pestka, S; Clarke, S				Branscombe, TL; Frankel, A; Lee, JH; Cook, JR; Yang, ZH; Pestka, S; Clarke, S			PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ARGININE METHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; N-METHYLTRANSFERASE; FISSION YEAST; HUMAN HOMOLOG; METHYLATION; INTERACTS; MYELIN; SKB1; OLIGOMERIZATION	We have identified a new mammalian protein arginine N-methyltransferase, PRMT5, formerly designated Janus kinase-binding protein 1, that can catalyze the formation of omega -N-G-monomethylarginine and symmetric omega -N-G,N-G '-dimethylarginine in a variety of proteins. A hemagglutinin peptide-tagged PRMT5 complex purified from human HeLa cells catalyzes the S-adenosyl-L-[methyl-H-3]methionine-dependent in vitro methylation of myelin basic protein. When the radiolabeled myelin basic protein was acid-hydrolyzed to free amino acids, and the products were separated by high-resolution cation exchange chromatography, we were able to detect two tritiated species. One species co-migrated with a omega -N-G-monomethylarginine standard, and the other cochromatographed with a symmetric omega -N-G,N-G '-dimethylarginine standard. Upon base treatment, this second species formed methylamine, a breakdown product characteristic of symmetric omega -N-G,N-G '-dimethylarginine. Further analysis of these two species by thin layer chromatography confirmed their identification as omega -N-G-monomethylarginine and symmetric omega -N-G,N-G '-dimethylarginine. The hemagglutinin-PRMT5 complex was also able to monomethylate and symmetrically dimethylate bovine histone H2A and a glutathione S-transferase-fibrillarin (amino acids 1-148) fusion protein (glutathione S-transferase-GAR). A mutation introduced into the S-adenosyl-L-methionine-binding motif I of a myc-tagged PRMT5 construct in COS-1 cells led to a near complete loss of observed enzymatic activity. PRMT5 is the first example of a catalytic chain for a type II protein arginine N-methyltransferase that can result in the formation of symmetric dimethylarginine residues as observed previously in myelin basic protein, Sm small nuclear ribonucleoproteins, and other polypeptides.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, Piscataway, NJ 08854 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rutgers State University New Brunswick; Rutgers State University Medical Center	Clarke, S (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.				NCI NIH HHS [CA46465, CA72720] Funding Source: Medline; NIAID NIH HHS [AI43369, AI36450] Funding Source: Medline; NIGMS NIH HHS [GM26020, GM07185] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA046465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043369, R01AI036450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, T32GM007185, R37GM026020] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschuler L, 1999, J INTERF CYTOK RES, V19, P189, DOI 10.1089/107999099314333; ASPILLAGA MO, 1977, J NEUROCHEM, V28, P1147, DOI 10.1111/j.1471-4159.1977.tb10683.x; BALDWIN GS, 1971, SCIENCE, V171, P579, DOI 10.1126/science.171.3971.579; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; BROSTOFF S, 1971, P NATL ACAD SCI USA, V68, P765, DOI 10.1073/pnas.68.4.765; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; DINN JJ, 1980, IRISH J MED SCI, V149, P53, DOI 10.1007/BF02939111; EYLAR EH, 1972, ANN NY ACAD SCI, V195, P481, DOI 10.1111/j.1749-6632.1972.tb54829.x; Fujita T, 1999, P NATL ACAD SCI USA, V96, P8522, DOI 10.1073/pnas.96.15.8522; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Gilbreth M, 1996, P NATL ACAD SCI USA, V93, P13802, DOI 10.1073/pnas.93.24.13802; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; KIM S, 1990, PROTEIN METHYLATION, P77; Lee JH, 2000, BIOCHEM BIOPH RES CO, V274, P105, DOI 10.1006/bbrc.2000.3049; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Ma XJ, 1996, GENE DEV, V10, P1327, DOI 10.1101/gad.10.11.1327; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; PAIK WK, 1970, J BIOL CHEM, V245, P88; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Rho J, 2001, J BIOL CHEM, V276, P16592; SCOTT JM, 1981, LANCET, V2, P334; STONER GL, 1984, J NEUROCHEM, V43, P433, DOI 10.1111/j.1471-4159.1984.tb00919.x; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; XIE HY, 1993, J BIOL CHEM, V268, P13364; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	33	292	299	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32971	32976		10.1074/jbc.M105412200	http://dx.doi.org/10.1074/jbc.M105412200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11413150	hybrid			2022-12-27	WOS:000170746000080
J	Kong, XT; Gao, HX; Stanbridge, EJ				Kong, XT; Gao, HX; Stanbridge, EJ			Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; TETRAMERIZATION DOMAIN; CRYSTAL-STRUCTURE; DNA-BINDING; MUTATIONS; CANCER; EXPRESSION; INDUCTION; INHIBITOR	Suppression of tumor cell growth by p53 results from the activation of both apoptosis and cell cycle arrest functions that have been shown to be separable activities of p53. We report here that some mutants in the p53 hinge domain, a short linker between the DNA binding and tetramerization domains, differentially activated the promoters of p53 target genes and possessed an impaired apoptotic function. Our results indicate that the hinge domain may play an important role in differentially regulating p53 cell cycle arrest and apoptotic functions. However, the mechanisms by which p53 hinge domain mutants differentially activate its target genes, e.g. p21(WAF1/CIP1) and Bax, remain unknown. To investigate the possible mechanisms, recombinant p21(WAF1/CIP1) and Bax promoters were constructed, resulting in rearrangement of the existing p53 binding sites within a given promoter or actually swapping p53 binding sites between the two promoters. Our results suggest that multiple mechanisms of differential transactivation occur, depending on the molecular nature of the relevant hinge domain mutant, such as the possibility that dual separate DNA binding sites in the p21(WAF1/CIP1) promoter are responsible for the selective transactivation activity of p53 hinge domain mutant del300-327, which has a large deletion in the hinge domain. Lack of ideal p53 binding sites in the Bax promoter results in less potent activation than that seen with the p21(WAF1/CIP1) promoter when it is transactivated by hinge domain point mutant mutR306P or short deletion mutant del300-308 proteins. How the single mutation or the short deletion affect the conformation of p53 and consequently the transactivation of the Bax promoter will require further investigation of the relevant p53 protein: DNA-binding domain by NMR and x-ray crystallographic techniques.	Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine	Stanbridge, EJ (corresponding author), Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Med Sci 1,B210, Irvine, CA 92697 USA.				NCI NIH HHS [CA19401, CA68230] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA019401, R01CA068230, R37CA019401] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aurelio ON, 1998, CANCER RES, V58, P2190; Aurelio ON, 2000, MOL CELL BIOL, V20, P770, DOI 10.1128/MCB.20.3.770-778.2000; Bates S, 1996, CURR OPIN GENET DEV, V6, P12, DOI 10.1016/S0959-437X(96)90004-0; Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MIYASHITA T, 1995, CELL, V80, P293; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; STENGER JE, 1994, EMBO J, V13, P6011, DOI 10.1002/j.1460-2075.1994.tb06947.x; WATERMAN JLF, 1995, EMBO J, V14, P512, DOI 10.1002/j.1460-2075.1995.tb07027.x; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	30	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32990	33000		10.1074/jbc.M103681200	http://dx.doi.org/10.1074/jbc.M103681200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11395510	hybrid			2022-12-27	WOS:000170746000083
J	Lee, J; Hur, J; Lee, P; Kim, JY; Cho, N; Kim, SY; Kim, H; Lee, MS; Suk, K				Lee, J; Hur, J; Lee, P; Kim, JY; Cho, N; Kim, SY; Kim, H; Lee, MS; Suk, K			Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells - Initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; TRANSCRIPTIONAL ACTIVATOR; GENE-EXPRESSION; T-LYMPHOCYTES; GLIAL-CELLS; MACROPHAGES; IRF-1; BRAIN	We have previously shown that mouse microglial cells undergo apoptosis upon inflammatory activation and that nitric oxide (NO) is the major autocrine mediator in this process (Lee, P., Lee, J., Kim, S., Yagita, H., Lee, M. S., Kim, S. Y., Kim, H., and Suk, K. (2001) Brain Res. 892, 380-385). Here, we present evidence that interferon regulatory factor-1 (IRF-1) and caspase-11 are the essential molecules in activation-induced cell death of microglial cells. The apoptogenic action of inflammatory stimuli such as lipopolysaccharide (LPS) and interferon-gamma (IFN gamma) was mediated through the induction of IRF-1 and caspase-11 expression in two separate events. Although IRF-1 was required for NO synthesis, caspase-11 induction was necessary for NO-independent apoptotic pathway. Microglial cells from IRF-1-deficient mice showed markedly decreased NO production, and they were partially resistant to apoptosis in response to LPS/IFN gamma but were sensitive to NO donor exposure. LPS/IFN gamma treatment resulted in the induction of caspase-11 followed by activation of caspase-11, -1, and -3. Inactivation of caspase-11 by the transfection of dominant-negative mutant or treatment with the caspase inhibitors rendered microglial cells partially resistant to LPS/IFN gamma -induced apoptosis. Inhibition of both NO synthesis and caspase-11 completely blocked LPS/IFN gamma -induced cytotoxicity. These results indicated that LPS/IFN gamma not only induced the production of cytotoxic NO through IRF-1 but also initiated the NO-independent apoptotic pathway through the induction of caspase-11 expression.	Kyung Hee Univ, Dept Herbal Pharmacol, Grad Sch East West Med Sci, Tongdaemun Ku, Seoul 130701, South Korea; Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr, Seoul 135710, South Korea	Kyung Hee University; Sungkyunkwan University (SKKU); Samsung Medical Center	Suk, K (corresponding author), Kyung Hee Univ, Dept Herbal Pharmacol, Grad Sch East West Med Sci, Tongdaemun Ku, Seoul 130701, South Korea.	mslee@smc.samsung.co.kr	Lee, Myung Shik/C-9606-2011					ADLER B, 1995, BIOCHEM BIOPH RES CO, V215, P921, DOI 10.1006/bbrc.1995.2552; ALBINA JE, 1993, J IMMUNOL, V150, P5080; Aloisi F, 1999, J NEUROSCI RES, V56, P571; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BARBER SA, 1995, INFECT IMMUN, V63, P601, DOI 10.1128/IAI.63.2.601-608.1995; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670; Conti B, 1999, MOL BRAIN RES, V67, P46, DOI 10.1016/S0169-328X(99)00034-0; Crispe IN, 1999, IMMUNOL RES, V19, P143, DOI 10.1007/BF02786483; Donjerkovic D, 2000, CELL RES, V10, P179, DOI 10.1038/sj.cr.7290047; Drache B, 1997, J NEUROSCI RES, V47, P98; Drew PD, 1995, J INTERF CYTOK RES, V15, P1037, DOI 10.1089/jir.1995.15.1037; Fujimura M, 1997, BRAIN RES, V759, P247, DOI 10.1016/S0006-8993(97)00264-3; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kano A, 1999, BIOCHEM BIOPH RES CO, V257, P672, DOI 10.1006/bbrc.1999.0276; Lakics V, 2000, J IMMUNOL, V165, P2729, DOI 10.4049/jimmunol.165.5.2729; LEE B, 2001, J NEUROCHEM, V892, P182; Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451; Lee P, 2001, BRAIN RES, V892, P380, DOI 10.1016/S0006-8993(00)03257-1; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; MIGHELI A, 1994, NEUROREPORT, V5, P1906, DOI 10.1097/00001756-199410000-00016; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; NEISH AS, 1995, MOL CELL BIOL, V15, P2558; Okada S, 1998, J IMMUNOL, V160, P2590; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Saura M, 1999, J MOL BIOL, V289, P459, DOI 10.1006/jmbi.1999.2752; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shibata M, 2000, J CLIN INVEST, V106, P643, DOI 10.1172/JCI10203; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Suk K, 2001, FEBS LETT, V495, P66, DOI 10.1016/S0014-5793(01)02335-3; Suk K, 2001, J BIOL CHEM, V276, P13153, DOI 10.1074/jbc.M007646200; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Suk K, 2001, BRAIN RES, V900, P342, DOI 10.1016/S0006-8993(01)02326-5; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; von Knethen A, 1998, ONCOGENE, V17, P387, DOI 10.1038/sj.onc.1201926; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	48	97	102	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32956	32965		10.1074/jbc.M104700200	http://dx.doi.org/10.1074/jbc.M104700200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11402054	hybrid			2022-12-27	WOS:000170746000078
J	Liu, XX; Schrager, JA; Lange, GD; Marsh, JW				Liu, XX; Schrager, JA; Lange, GD; Marsh, JW			HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular NEF concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; VIRUS TYPE-1 NEF; CD4 DOWN-REGULATION; CLASS-I MOLECULES; IMMUNODEFICIENCY-VIRUS; T-CELLS; DILEUCINE MOTIF; SURFACE CD4; MHC-I; GENE	Nef is a regulatory protein encoded by the genome of both human and simian immunodeficiency virus. Its expression in T cells leads to CD4 and major histocompatibility complex class I modulation and either enhancement or suppression of T cell activation. How this viral protein achieves multiple and at times opposing activities has been unclear. Through direct measurements of Nef and the Nef-GFP fusion protein, we find that these events are mediated by different Nef concentrations. Relative to the intracellular concentration that down-modulates surface CD4, an order of magnitude increase in Nef-GFP expression is required for a comparable modulation of major histocompatibility complex class I, and a further 3-fold increase is necessary to suppress T cell activation.	NINDS, Instrumentat & Comp Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Marsh, JW (corresponding author), NIMH, Mol Biol Lab, Bldg 36,Rm 1B08,36 Convent Dr,MSC 4034, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002629, Z01MH002629] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alexander L, 1997, J VIROL, V71, P6094, DOI 10.1128/JVI.71.8.6094-6099.1997; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Collette Y, 1996, J IMMUNOL, V156, P360; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; GUY B, 1990, VIROLOGY, V176, P413, DOI 10.1016/0042-6822(90)90011-F; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; Iafrate AJ, 1997, EMBO J, V16, P673, DOI 10.1093/emboj/16.4.673; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kerkau T, 1997, J EXP MED, V185, P1295, DOI 10.1084/jem.185.7.1295; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; LIFSON JD, 1986, SCIENCE, V232, P1123, DOI 10.1126/science.3010463; LURIA S, 1991, P NATL ACAD SCI USA, V88, P5326, DOI 10.1073/pnas.88.12.5326; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; Marsh JW, 1999, ARCH BIOCHEM BIOPHYS, V365, P192, DOI 10.1006/abbi.1999.1208; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Page KA, 1997, AIDS RES HUM RETROV, V13, P1077, DOI 10.1089/aid.1997.13.1077; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; RHEE SS, 1994, J IMMUNOL, V152, P5128; RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994; Riggs NL, 1999, VIROLOGY, V258, P203, DOI 10.1006/viro.1999.9736; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Walk SF, 2001, J VIROL, V75, P834, DOI 10.1128/JVI.75.2.834-843.2001; Wang CF, 2000, IEEE T PARALL DISTR, V11, P97, DOI 10.1109/71.841747; WEISS A, 1984, J IMMUNOL, V133, P123; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	45	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32763	32770		10.1074/jbc.M101025200	http://dx.doi.org/10.1074/jbc.M101025200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438519	hybrid			2022-12-27	WOS:000170746000053
J	Pai, KS; Mahajan, VB; Lau, A; Cunningham, DD				Pai, KS; Mahajan, VB; Lau, A; Cunningham, DD			Thrombin receptor signaling to cytoskeleton requires Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; EXCHANGER REGULATORY FACTOR; NEURITE RETRACTION; BETA(2)-ADRENERGIC RECEPTOR; MOLECULAR CHAPERONE; TYROSINE KINASE; ATP BINDING; CELL-DEATH; G-PROTEINS; IN-VIVO	Thrombin is a serine protease that evokes various cellular responses involved in injury and repair of the nervous system through the activation of protease-activated receptor-1 (PAR-1). Signals that modulate cell morphology precede most PAR-1 effects, but the initial signal transduction molecules are not known. Using the yeast two-hybrid system, we identified Hsp90, a chaperone with known signaling properties, as a binding partner of PAR-1. The interaction was confirmed by glutathione S-transferase pull-down, overlay, and co-immunoprecipitation assays. Morphological assays in mouse astrocytes were carried out to evaluate the importance of Hsp90 during cytoskeletal signaling. Reducing Hsp90 levels by antisense treatment or disruption of the Hsp90-PAR-1 complex by the Hsp90-specific drug geldanamycin attenuated thrombin-mediated astrocyte shape changes. Furthermore, overexpression of the PAR-1 cytoplasmic tail abrogated thrombin-induced cytoskeletal changes in neuronal cells. Treatment with geldanamycin specifically inhibited activation of RhoA without affecting thrombin-mediated intracellular calcium release, revealing the regulation of a distinct signaling pathway by Hsp90. Taken together, these studies demonstrate that Hsp90 may be essential for PAR-1-mediated signaling to the cytoskeleton.	Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine	Cunningham, DD (corresponding author), Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.				NIA NIH HHS [AG00538] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BERNDT MC, 1981, PLATELETS BIOL PATHO, P43; BOHEN SP, 1995, SCIENCE, V268, P1303, DOI 10.1126/science.7761850; Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407; COUGHLIN SR, 1994, SEMIN HEMATOL, V31, P270; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Donovan FM, 1997, J NEUROSCI, V17, P5316; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; GRABHAM P, 1995, J NEUROCHEM, V64, P583; Grand RJA, 1996, BIOCHEM J, V313, P353, DOI 10.1042/bj3130353; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LUTTRELL LM, 1993, SCIENCE, V259, P1453, DOI 10.1126/science.8383880; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RUTHERFORD SL, 1994, CELL, V79, P1129, DOI 10.1016/0092-8674(94)90003-5; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; Shapiro MJ, 1998, J BIOL CHEM, V273, P29009, DOI 10.1074/jbc.273.44.29009; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; SMITHSWINTOSKY VL, 1995, J NEUROSCI, V15, P5840; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; Suidan HS, 1997, GLIA, V21, P244, DOI 10.1002/(SICI)1098-1136(199710)21:2<244::AID-GLIA7>3.0.CO;2-6; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Turgeon VL, 1998, J NEUROSCI, V18, P6882; Ubl JJ, 1997, GLIA, V21, P361, DOI 10.1002/(SICI)1098-1136(199712)21:4<361::AID-GLIA3>3.0.CO;2-6; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; Verrall S, 1997, J BIOL CHEM, V272, P6898, DOI 10.1074/jbc.272.11.6898; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WEINSTEIN JR, 1995, J NEUROSCI, V15, P2906; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074	47	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32642	32647		10.1074/jbc.M104212200	http://dx.doi.org/10.1074/jbc.M104212200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11413145	hybrid			2022-12-27	WOS:000170746000036
J	Sugihara, TM; Kudryavtseva, EI; Kumar, V; Horridge, JJ; Andersen, B				Sugihara, TM; Kudryavtseva, EI; Kumar, V; Horridge, JJ; Andersen, B			The POU domain factor skin-1a represses the keratin 14 promoter independent of DNA binding - A possible role for interactions between Skn-1a and creb-binding protein/p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-SPECIFIC EXPRESSION; ETS TRANSCRIPTION FACTOR; FACTOR-KAPPA-B; GENE-EXPRESSION; GLUCOCORTICOID RECEPTOR; NUCLEAR INTEGRATION; TRANSGENIC MICE; P300; COACTIVATOR; EPIDERMIS	The genes encoding keratin 5 and 14 are highly expressed in the basal cell layer keratinocytes of the epidermis, but both genes are silenced when keratinocytes move into the suprabasal compartment. The POU homeodomain factors Skn-1a and Tst-1, which are expressed in epidermis, may play a role in the suprabasal repression of the keratin 5 and 14 genes because keratin 14 mRNA expression persists in suprabasal cells in Skn-1/Tst-1 double knockout mice. In transfection experiments, both Skn-1a and Tst-1 repress the keratin 14 promoter, with the POU domain being sufficient for repression. The region of the keratin 14 gene sufficient and required for repression by Skn-1a is a 100-base pair sequence lacking POU-binding sites adjacent to the transcription start site. DNA-binding defective mutants of Skn-1a and Tst-1 are as effective at mediating repression as the wild type proteins, suggesting that protein-protein interactions rather than direct DNA binding are important for repression. We also show that CREB-binding protein (CBP)/p300 co-activators are strong activators of keratin 14 gene expression, acting through sequences close to the keratin 14 promoter. Further, CBP interacts directly with the POU domain of Skn-1a, and increasing concentrations of CBP can overcome Skn-1a-mediated repression, suggesting that POU domain factors may repress keratin 14 gene expression by interfering with the activity of co-activators such as CBP/p300.	Univ Calif Irvine, Dept Med, Div Endocrinol & Metab, Irvine, CA 92697 USA; Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California San Diego	Andersen, B (corresponding author), Univ Calif Irvine, Dept Med, Div Endocrinol & Metab, Med Sci 1,Rm C350,ZOT4086, Irvine, CA 92697 USA.		Kumar, Vivek/P-8749-2014	Kumar, Vivek/0000-0001-6643-7465	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882, K02AR002080] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44882, AR02080] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; ANDERSEN B, 1993, SCIENCE, V260, P78, DOI 10.1126/science.7682011; Andersen B, 1997, J BIOL CHEM, V272, P15905, DOI 10.1074/jbc.272.25.15905; Andersen B, 1997, GENE DEV, V11, P1873, DOI 10.1101/gad.11.14.1873; ANDERSEN B, 1993, J BIOL CHEM, V268, P23390; Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Coulombe PA, 1997, BIOCHEM BIOPH RES CO, V236, P231, DOI 10.1006/bbrc.1997.6945; Dallas PB, 1997, J VIROL, V71, P1726, DOI 10.1128/JVI.71.2.1726-1731.1997; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; DiSepio D, 1999, DIFFERENTIATION, V64, P225, DOI 10.1046/j.1432-0436.1999.6440225.x; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; FAUS I, 1994, MOL CELL BIOL, V14, P3263, DOI 10.1128/MCB.14.5.3263; Felzien LK, 1999, MOL CELL BIOL, V19, P4241; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Goodman RH, 2000, GENE DEV, V14, P1553; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; HE X, 1991, MOL CELL BIOL, V11, P1739, DOI 10.1128/MCB.11.3.1739; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Hildesheim J, 1999, J BIOL CHEM, V274, P26399, DOI 10.1074/jbc.274.37.26399; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Ip YT, 1997, CURR BIOL, V7, pR216, DOI 10.1016/S0960-9822(06)00104-7; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Jang SI, 2000, J BIOL CHEM, V275, P15295, DOI 10.1074/jbc.275.20.15295; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Kurokawa R, 1998, SCIENCE, V279, P700, DOI 10.1126/science.279.5351.700; LEASK A, 1990, GENE DEV, V4, P1985, DOI 10.1101/gad.4.11.1985; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; MISSERO C, 1993, J CELL BIOL, V121, P1109, DOI 10.1083/jcb.121.5.1109; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SAATCIOGLU F, 1994, SEMIN CANCER BIOL, V5, P347; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Sinha S, 2000, MOL CELL BIOL, V20, P2543, DOI 10.1128/MCB.20.7.2543-2555.2000; Sock E, 1996, J BIOL CHEM, V271, P17512, DOI 10.1074/jbc.271.29.17512; Speir E, 2000, CIRC RES, V87, P1006, DOI 10.1161/01.RES.87.11.1006; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Welter JF, 1996, J BIOL CHEM, V271, P14727, DOI 10.1074/jbc.271.25.14727; Welter JF, 1995, ONCOGENE, V11, P2681; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yukawa K, 1996, J VIROL, V70, P10, DOI 10.1128/JVI.70.1.10-16.1996; Zanger K, 1999, MOL ENDOCRINOL, V13, P268, DOI 10.1210/me.13.2.268; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001	56	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33036	33044		10.1074/jbc.M103000200	http://dx.doi.org/10.1074/jbc.M103000200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11429405	hybrid			2022-12-27	WOS:000170746000088
J	D'Addario, M; Arora, PD; Fan, J; Ganss, B; Ellen, RP; McCulloch, CAG				D'Addario, M; Arora, PD; Fan, J; Ganss, B; Ellen, RP; McCulloch, CAG			Cytoprotection against mechanical forces delivered through beta(1) integrins requires induction of filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; SMOOTH-MUSCLE ACTIN; CELL-ADHESION; EXPRESSION; FIBROBLASTS; TRANSCRIPTION; PURIFICATION; FILAMENTS; MIGRATION; APOPTOSIS	Cells in mechanically active environments can activate cytoprotective mechanisms to maintain membrane integrity in the face of potentially lethal applied forces. Cytoprotection may be mediated by expression of membrane-associated cytoskeletal proteins including filamin A, an actin-binding protein that increases the rigidity of the subcortical actin cytoskeleton. In this study, we tested the hypotheses that applied forces induce the expression of filamin A specifically and that this putative protective response inhibits cell death. Magnetically generated forces were applied to protein-coated magnetite beads bound to human gingival fibroblasts, cells with constitutively low basal levels of filamin A mRNA and protein. Forces applied through collagen or fibronectin, but not bovine serum albumin or poly-L-lysine-coated beads, increased mRNA and protein content of filamin A by 3-7-fold. Forces had no effect on the expression of other filamin isotypes or other cytoskeletal proteins. This effect was dependent on the duration of force and was blocked by anti-beta (1) integrin antibodies. Force also stimulated a 60% increase in expression of luciferase under the control of a filamin A promoter in transiently transfected Rat2 fibroblasts and was dependent on Sp1 transcription factor binding sites located immediately upstream of the transcription start site. Experiments with actinomycin D-treated cells showed that the increased filamin A expression after force application was due in part to prolongation of mRNA half-life. Antisense filamin oligonucleotides blocked force-induced filamin A expression and increased cell death by >2-fold above controls. The force-induced regulation of filamin A was dependent on intact actin filaments. We conclude that cells from mechanically active environments can couple diverse signals from forces applied through beta -integrins to up-regulate the production of cytoprotective cytoskeletal proteins, typified by filamin A.	Univ Toronto, Canadian Inst Hlth Res Grp Periodont Physiol, Toronto, ON M5S 3E2, Canada; Univ Toronto, Fac Dent, Inst Dent Res, Toronto, ON M5S 3E2, Canada	University of Toronto; University of Toronto	McCulloch, CAG (corresponding author), Rm 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.							ANDREWS RK, 1991, J BIOL CHEM, V266, P7144; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Birukov KG, 1998, ARTERIOSCL THROM VAS, V18, P922, DOI 10.1161/01.ATV.18.6.922; BROWN KD, 1993, EXP CELL RES, V209, P325, DOI 10.1006/excr.1993.1317; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; D'Addario M, 1999, FASEB J, V13, P2203, DOI 10.1096/fasebj.13.15.2203; D'Addario M, 2000, J MOL BIOL, V298, P765, DOI 10.1006/jmbi.2000.3717; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Glogauer M, 1997, J CELL SCI, V110, P11; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Hui MZ, 1997, J CELL PHYSIOL, V172, P323, DOI 10.1002/(SICI)1097-4652(199709)172:3<323::AID-JCP6>3.0.CO;2-Q; Jacquelin B, 2001, BLOOD, V97, P1721, DOI 10.1182/blood.V97.6.1721; KULKARNI GV, 1995, J CELL PHYSIOL, V165, P119, DOI 10.1002/jcp.1041650115; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Lew AM, 1999, BIOCHEM J, V341, P647, DOI 10.1042/0264-6021:3410647; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Mack CP, 1999, CIRC RES, V84, P852; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; OHTA Y, 1991, CELL, V67, P275, DOI 10.1016/0092-8674(91)90179-3; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; PENDER N, 1991, J CELL SCI, V100, P187; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Schwarzman AL, 1999, P NATL ACAD SCI USA, V96, P7932, DOI 10.1073/pnas.96.14.7932; Segal G, 2001, J CELL SCI, V114, P119; Sinha S, 2001, P NATL ACAD SCI USA, V98, P2455, DOI 10.1073/pnas.051633598; Swartz EA, 1998, AM J PHYSIOL-CELL PH, V275, pC608, DOI 10.1152/ajpcell.1998.275.2.C608; Tidball JG, 1999, J BIOL CHEM, V274, P33155, DOI 10.1074/jbc.274.46.33155; Wang J, 2000, AM J PHYSIOL-HEART C, V279, pH2776, DOI 10.1152/ajpheart.2000.279.6.H2776; WANG K, 1977, BIOCHEMISTRY-US, V16, P1857, DOI 10.1021/bi00628a015; WATSON PA, 1991, FASEB J, V5, P2013, DOI 10.1096/fasebj.5.7.1707019; WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293	42	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31969	31977		10.1074/jbc.M102715200	http://dx.doi.org/10.1074/jbc.M102715200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423540	hybrid			2022-12-27	WOS:000170613500069
J	Dirac, AMG; Huthoff, H; Kjems, J; Berkhout, B				Dirac, AMG; Huthoff, H; Kjems, J; Berkhout, B			The dimer initiation site hairpin mediates dimerization of the human immunodeficiency virus, type 2 RNA genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KISSING-LOOP HAIRPIN; SECONDARY STRUCTURE; HIV-1(LAI) RNA; BINDING-SITES; LEADER RNA; SEQUENCES; LINKAGE; GAG; OLIGONUCLEOTIDE; ENCAPSIDATION	The untranslated leader of retroviral RNA genomes encodes multiple structural signals that are critical for virus replication. In the human immunodeficiency virus, type 1 (HIV-1) leader, a hairpin structure with a palindrome-containing loop is termed the dimer initiation site (DIS), because it triggers in vitro RNA dimerization through base pairing of the loop-exposed palindromes (kissing loops). Controversy remains regarding the region responsible for HIV-2 RNA dimerization. Different studies have suggested the involvement of the transactivation region, the primer binding site, and a hairpin structure that is the equivalent of the HIV-1 DIS hairpin. We have performed a detailed mutational analysis of the HIV-2 leader RNA, and we also used antisense oligonucleotides to probe the regions involved in dimerization. Our results unequivocally demonstrate that the DIS hairpin is the main determinant for HIV-2 RNA dimerization. The 6-mer palindrome sequence in the DIS loop is essential for dimer formation. Although the sequence can be replaced by other 6-mer palindromes, motifs that form more than two AX base pairs do not dimerize efficiently. The inability to form stable kissing-loop complexes precludes formation of dimers with more extended base pairing. Structure probing of the DIS hairpin in the context of the complete HIV-2 leader RNA suggests a 5-base pair elongation of the DIS stem as it is proposed in current RNA secondary structure models. This structure is supported by phylogenetic analysis of leader RNA sequences from different viral isolates, indicating that RNA genome dimerization occurs by a similar mechanism for all members of the human and simian immunodeficiency viruses.	Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1100 DE Amsterdam, Netherlands; Aarhus Univ, Dept Mol & Struct Biol, DK-8000 Aarhus C, Denmark	University of Amsterdam; Academic Medical Center Amsterdam; Aarhus University	Berkhout, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, POB 22700, NL-1100 DE Amsterdam, Netherlands.	b.berkhout@amc.uva.nl	Kjems, Jorgen/I-3490-2016	Kjems, Jorgen/0000-0003-4128-9317				AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; BENDER W, 1976, CELL, V7, P595, DOI 10.1016/0092-8674(76)90210-5; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Berkhout B, 2001, Science, V292, P7; BERKHOUT B, 1993, FASEB J, V7, P181, DOI 10.1096/fasebj.7.1.8422965; BIETH E, 1990, NUCLEIC ACIDS RES, V18, P119, DOI 10.1093/nar/18.1.119; Cain D, 2001, J VIROL, V75, P3731, DOI 10.1128/JVI.75.8.3731-3739.2001; CLEVER J, 1995, J VIROL, V69, P2101, DOI 10.1128/JVI.69.4.2101-2109.1995; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Clever JL, 1996, J VIROL, V70, P5902, DOI 10.1128/JVI.70.9.5902-5908.1996; COFFIN JM, 1984, RNA TUMOR VIRUSES; Damgaard CK, 1998, NUCLEIC ACIDS RES, V26, P3667, DOI 10.1093/nar/26.16.3667; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Essink BBO, 1996, J MOL BIOL, V264, P243, DOI 10.1006/jmbi.1996.0638; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209; Greatorex J, 1998, J GEN VIROL, V79, P2877, DOI 10.1099/0022-1317-79-12-2877; Greatorex JS, 1996, NUCLEIC ACIDS RES, V24, P2919, DOI 10.1093/nar/24.15.2919; Haddrick M, 1996, J MOL BIOL, V259, P58, DOI 10.1006/jmbi.1996.0301; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Jossinet F, 2001, J BIOL CHEM, V276, P5598, DOI 10.1074/jbc.M008642200; KATOH I, 1993, J VIROL, V67, P1830, DOI 10.1128/JVI.67.4.1830-1839.1993; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Laughrea M, 1999, BIOCHEMISTRY-US, V38, P226, DOI 10.1021/bi981728j; Laughrea M, 1996, BIOCHEMISTRY-US, V35, P1589, DOI 10.1021/bi951838f; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; Lodmell JS, 2000, RNA, V6, P1267, DOI 10.1017/S1355838200000698; Lodmell JS, 1998, ANTISENSE NUCLEIC A, V8, P517, DOI 10.1089/oli.1.1998.8.517; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Muriaux D, 1996, J BIOL CHEM, V271, P33686, DOI 10.1074/jbc.271.52.33686; MURIAUX D, 1995, J BIOL CHEM, V270, P8209, DOI 10.1074/jbc.270.14.8209; Paillart JC, 1997, J MOL BIOL, V270, P36, DOI 10.1006/jmbi.1997.1096; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Sakuragi J, 1997, J VIROL, V71, P3250, DOI 10.1128/JVI.71.4.3250-3254.1997; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; Takahashi KI, 2000, RNA, V6, P96, DOI 10.1017/S1355838200991635; Zuker M., 1999, RNA BIOCH BIOTECHNOL	43	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32345	32352		10.1074/jbc.M103462200	http://dx.doi.org/10.1074/jbc.M103462200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11397802	hybrid			2022-12-27	WOS:000170613500117
J	Froehlich, JE; Benning, C; Dormann, P				Froehlich, JE; Benning, C; Dormann, P			The digalactosyldiacylglycerol (DGDG) synthase DGD1 is inserted into the outer envelope membrane of chloroplasts in a manner independent of the general import pathway and does not depend on direct interaction with monogalactosyldiacylglycerol synthase for DGDG biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; GALACTOLIPID BIOSYNTHESIS; MUTANT DEFICIENT; LIPID-SYNTHESIS; METABOLISM; SIGNAL; GALACTOSYLTRANSFERASE; MITOCHONDRIAL; COMPONENT; PEPTIDES	Galactolipids make up the bulk of chloroplast lipids. Therefore, the genes involved in the synthesis of the galactolipids monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG) play a critical role in chloroplast development. In this study, we analyzed the subcellular localization of the Arabidopsis DGDG synthase DGD1, which was recently identified by complementation of the Arabidopsis dgd1 mutant. In vitro import experiments demonstrated that DGD1 was targeted to the chloroplast outer envelope in an ATP-independent manner. DGD1 could not be extracted from the membranes by high salt or alkali, suggesting that it is an integral membrane protein. Uptake experiments with truncated versions of DGD1 indicated that the information for targeting and insertion into the outer envelope resides in the N-terminal half of DGD1, but not in the first 33 amino acids. DGD1 apparently does not contain a cleavable signal peptide. Antibodies to Arabidopsis DGD1 detected a 90-kDa protein localized to the chloroplast envelopes of both pea and Arabidopsis. Transformation of DGD1 constructs into cyanobacteria resulted in the expression of active DGDG synthase and demonstrated that DGDG synthesis depends on MGDG lipid, but does not require direct interaction with the plant MGDG synthase.	Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48823 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA; Max Planck Inst Mol Plant Physiol, D-14476 Golm, Germany	Michigan State University; Michigan State University; Max Planck Society	Dormann, P (corresponding author), Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48823 USA.	doermann@mpimp-golm.mpg.de	Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667				BLACK TA, 1994, J BACTERIOL, V176, P2282, DOI 10.1128/JB.176.8.2282-2292.1994; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; BRUCE BD, 1994, PLANT MOL BIOL MANUA, V2; Chen DD, 1997, J BIOL CHEM, V272, P6614, DOI 10.1074/jbc.272.10.6614; Chen LJ, 1998, PLANT J, V16, P33, DOI 10.1046/j.1365-313x.1998.00270.x; CLINE K, 1983, PLANT PHYSIOL, V71, P366, DOI 10.1104/pp.71.2.366; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; DORNE AJ, 1982, FEBS LETT, V145, P30, DOI 10.1016/0014-5793(82)81200-3; DOUCE R, 1974, SCIENCE, V183, P852, DOI 10.1126/science.183.4127.852; DOUCE R, 1996, ADV PHOTOSYNTHESIS, V4; ELBAI J, 1988, METHOD ENZYMOL, V167, P747; FISCHER K, 1994, PLANT MOL BIOL, V25, P167, DOI 10.1007/BF00023235; FITZPATRICK L, 2001, IN PRESS PLANT J; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Guler S, 1996, J BIOL CHEM, V271, P7501; Hartel H, 1998, PLANT PHYSIOL BIOCH, V36, P407, DOI 10.1016/S0981-9428(98)80204-0; HEEMSKERK JWM, 1986, BIOCHIM BIOPHYS ACTA, V877, P281, DOI 10.1016/0005-2760(86)90305-X; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Jorasch P, 2000, EUR J BIOCHEM, V267, P3770, DOI 10.1046/j.1432-1327.2000.01414.x; Jorasch P, 1999, TRENDS PLANT SCI, V4, P469, DOI 10.1016/S1360-1385(99)01505-8; Joyard J, 1998, PLANT PHYSIOL, V118, P715, DOI 10.1104/pp.118.3.715; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; KO K, 1992, J BIOL CHEM, V267, P2986; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee AG, 2000, CURR BIOL, V10, pR377, DOI 10.1016/S0960-9822(00)00477-2; LI HM, 1991, PLANT CELL, V3, P709, DOI 10.1105/tpc.3.7.709; Li HM, 1996, PLANT CELL, V8, P2117, DOI 10.1105/tpc.8.11.2117; Lubeck J, 1997, J CELL BIOL, V137, P1279, DOI 10.1083/jcb.137.6.1279; Marechal E, 1997, PHYSIOL PLANTARUM, V100, P65, DOI 10.1034/j.1399-3054.1997.1000106.x; Miege C, 1999, EUR J BIOCHEM, V265, P990, DOI 10.1046/j.1432-1327.1999.00801.x; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; PRENTKI P, 1981, GENE, V14, P289, DOI 10.1016/0378-1119(81)90161-X; Roughan PG, 1996, PLANT PHYSIOL, V110, P1239, DOI 10.1104/pp.110.4.1239; SALOMON M, 1990, P NATL ACAD SCI USA, V87, P5778, DOI 10.1073/pnas.87.15.5778; SATO N, 1993, BIOCH MOL BIOL MEMBR; Schnell DJ, 1998, ANNU REV PLANT PHYS, V49, P97, DOI 10.1146/annurev.arplant.49.1.97; Shimojima M, 1997, P NATL ACAD SCI USA, V94, P333, DOI 10.1073/pnas.94.1.333; Tietje C, 1998, PLANTA, V206, P72, DOI 10.1007/s004250050375; Tranel PJ, 1996, PLANT CELL, V8, P2093, DOI 10.1105/tpc.8.11.2093; TRANEL PJ, 1995, EMBO J, V14, P2436, DOI 10.1002/j.1460-2075.1995.tb07241.x; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WU CB, 1993, J BIOL CHEM, V268, P19384	54	87	94	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31806	31812		10.1074/jbc.M104652200	http://dx.doi.org/10.1074/jbc.M104652200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11429410	hybrid			2022-12-27	WOS:000170613500046
J	Kuwae, A; Yoshida, S; Tamano, K; Mimuro, H; Suzuki, T; Sasakawa, C				Kuwae, A; Yoshida, S; Tamano, K; Mimuro, H; Suzuki, T; Sasakawa, C			Shigella invasion of macrophage requires the insertion of IpaC into the host plasma membrane - Functional analysis of IpaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PROTEIN-TYROSINE KINASE; LARGE VIRULENCE PLASMID; SRC-FAMILY KINASES; SALMONELLA-TYPHIMURIUM; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; FLEXNERI 2A; MAMMALIAN-CELLS; HELA-CELLS	Shigella infects residential macrophages via the M cell entry, after which the pathogen induces macrophage cell death. The bacterial strategy of macrophage infection, however, remains largely speculative. Wild type Shigella flexneri (YSH6000) invaded macrophages more efficiently than the noninvasive mutants, where YSH6000 induced large scale lamellipodial extension including ruffle formation around the bacteria. When macrophages were infected with the noninvasive ipaC mutant, the invasiveness and induction of membrane extension were dramatically reduced as compared with that of YSH6000. J774 macrophages infected with YSH6000 showed tyrosine phosphorylation of several proteins including paxillin and c-Cbl, and this pattern was distinctive from those stimulated by Salmonella typhimurium or phorbol ester. Upon addition of IpaC into the external medium of macrophages, membrane extensions were rapidly induced, and this promoted uptake of Escherichia coli. The exogenously added IpaC was found to be integrated into the host cell membrane as detected by immunostaining. The IpaC domain required for the induction of membrane extension from J774 was narrowed down within the region of residues 117-169, which contains a putative membrane-spanning sequence. Our data indicate that Shigella directs its own entry into macrophages, and the IpaC domain which is required for the association with its host membrane is crucial.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo 1088639, Japan	University of Tokyo	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Tamano, Koichi/K-8918-2018; Tamano, Koichi/AAQ-4392-2020	Tamano, Koichi/0000-0002-2985-7548; Yoshida, Sei/0000-0002-4771-3900				ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Arondel J, 1999, INFECT IMMUN, V67, P6056, DOI 10.1128/IAI.67.11.6056-6066.1999; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; BERTON G, 1994, J CELL BIOL, V126, P1111, DOI 10.1083/jcb.126.4.1111; BLAKE TJ, 1992, ONCOGENE, V7, P757; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; CLERC PL, 1987, INFECT IMMUN, V55, P521, DOI 10.1128/IAI.55.3.521-527.1987; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; DURAND JM, 1994, J BACTERIOL, V176, P4627, DOI 10.1128/JB.176.15.4627-4634.1994; FernandezPrada CM, 1997, INFECT IMMUN, V65, P1486, DOI 10.1128/IAI.65.4.1486-1496.1997; GINOCCHIO CC, 1994, CELL, V76, P717, DOI 10.1016/0092-8674(94)90510-X; GRAHAM IL, 1994, J CELL BIOL, V127, P1139, DOI 10.1083/jcb.127.4.1139; GREENBERG S, 1994, J BIOL CHEM, V269, P3897; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Lee VT, 1999, IMMUNOL REV, V168, P241, DOI 10.1111/j.1600-065X.1999.tb01296.x; Li JX, 1996, J BIOL CHEM, V271, P12985, DOI 10.1074/jbc.271.22.12985; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Menard R, 1996, P NATL ACAD SCI USA, V93, P1254, DOI 10.1073/pnas.93.3.1254; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; Nonaka T, 1999, FEMS MICROBIOL LETT, V174, P89, DOI 10.1111/j.1574-6968.1999.tb13553.x; Parsot C, 1994, Curr Top Microbiol Immunol, V192, P217; Picking WL, 2001, MOL MICROBIOL, V39, P100, DOI 10.1046/j.1365-2958.2001.02210.x; Renesto P, 1996, INFECT IMMUN, V64, P719, DOI 10.1128/IAI.64.3.719-723.1996; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; SANSONETTI PJ, 1991, VACCINE, V9, P416, DOI 10.1016/0264-410X(91)90128-S; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Sansonetti PJ, 1998, FOLIA MICROBIOL, V43, P239, DOI 10.1007/BF02818608; SANSONETTI PJ, 1995, J CLIN INVEST, V96, P884, DOI 10.1172/JCI118135; Sansonetti PJ, 1996, INFECT IMMUN, V64, P2752, DOI 10.1128/IAI.64.7.2752-2764.1996; Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1111/j.1574-6976.2001.tb00569.x; SASAKAWA C, 1992, CURR TOP MICROBIOL, V180, P21; SASAKAWA C, 1989, MOL MICROBIOL, V3, P1191, DOI 10.1111/j.1365-2958.1989.tb00269.x; SASAKAWA C, 1986, INFECT IMMUN, V54, P32, DOI 10.1128/IAI.54.1.32-36.1986; SASAKAWA C, 1988, J BACTERIOL, V170, P2480, DOI 10.1128/jb.170.6.2480-2484.1988; Sato N, 1999, J IMMUNOL, V163, P6123; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; SMALL PLC, 1987, INFECT IMMUN, V55, P1674, DOI 10.1128/IAI.55.7.1674-1679.1987; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Tapper H, 1997, J IMMUNOL, V159, P409; TOBE T, 1994, MOL MICROBIOL, V12, P267, DOI 10.1111/j.1365-2958.1994.tb01015.x; Tran N, 2000, INFECT IMMUN, V68, P3710, DOI 10.1128/IAI.68.6.3710-3715.2000; Tran Van Nhieu G., 1997, EMBO J, V16, P2717; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; VANNHIEU GT, 2000, CELL MICROBIOL, V2, P187, DOI DOI 10.1046/J.1462-5822.2000.00046.X; VANSTRIJP JAG, 1993, J IMMUNOL, V151, P3324; WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; Yan SR, 1997, J IMMUNOL, V158, P1902; Zheng LM, 1996, P NATL ACAD SCI USA, V93, P8431, DOI 10.1073/pnas.93.16.8431; ZYCHLINSKY A, 1994, J CLIN INVEST, V94, P1328, DOI 10.1172/JCI117452; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0; [No title captured]	70	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32230	32239		10.1074/jbc.M103831200	http://dx.doi.org/10.1074/jbc.M103831200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11413141	hybrid			2022-12-27	WOS:000170613500103
J	Chen, TP; Cote, J; Carvajal, HV; Richard, S				Chen, TP; Cote, J; Carvajal, HV; Richard, S			Identification of Sam68 arginine glycine-rich sequences capable of conferring nonspecific RNA binding to the GSG domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; TUMOR-SUPPRESSOR GENE; SPLICING FACTOR SF1; KH-DOMAIN; CAENORHABDITIS-ELEGANS; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; STAR PROTEIN; SRC; GLD-1	Sam68 is an RNA-binding protein that contains a heterogeneous nuclear ribonucleoprotein K homology domain embedded in a larger RNA binding domain called the GSG (GRP33, Sam68, GLD-1) domain. This family of proteins is often referred to as the STAR (signal transduction and activators of RNA metabolism) proteins. It is not known whether Sam68 is a general nonspecific RNA-binding protein or whether it recognizes specific response elements in mRNAs with high affinity. Sam68 has been shown to bind homopolymeric RNA and a synthetic RNA sequence called G8-5 that has a core UAAA motif. Here we performed a structure function analysis of Sam68 and identified two arginine glycine (RG)-rich regions that confer nonspecific RNA binding to the Sam68 GSG domain. In addition, by using chimeric proteins between Sam68 and QKI-7, we demonstrated that one of the Sam68 RG-rich sequences of 26 amino acids was sufficient to confer homopolymeric RNA binding to the GSG domain of QKI-7, another STAR protein. Fur. thermore, that minimal sequence can also give QKI-7 the ability (as Sam68) to functionally substitute for HIV-1 REV to facilitate the nuclear export of RNAs. Our studies suggest that neighboring RG-rich sequences may impose nonspecific RNA binding to GSG domains. Because the Sam68 RNA binding activity is negatively regulated by tyrosine phosphorylation, our data lead us to propose that Sam68 might be a specific RNA-binding protein when tyrosine phosphorylated.	Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Richard, S (corresponding author), Lady Davis Inst Med Res, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	sricha@po-box.mcgill.ca	Cote, Jocelyn/O-2351-2018	Cote, Jocelyn/0000-0001-9551-2284				Arning S, 1996, RNA, V2, P794; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Barlat I, 1997, J BIOL CHEM, V272, P3129, DOI 10.1074/jbc.272.6.3129; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Berglund JA, 1998, RNA, V4, P998, DOI 10.1017/S1355838298980499; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BODE VC, 1984, GENETICS, V108, P457; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Clifford R, 2000, DEVELOPMENT, V127, P5265; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Di Fruscio M, 1998, J BIOL CHEM, V273, P30122, DOI 10.1074/jbc.273.46.30122; Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; FRANCIS R, 1995, GENETICS, V139, P579; FRANCIS R, 1995, GENETICS, V139, P607; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Gilbert C, 2001, J IMMUNOL, V166, P4664, DOI 10.4049/jimmunol.166.7.4664; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; HOGAN EL, 1984, MYELIN; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; Lang V, 1997, EUR J IMMUNOL, V27, P3360, DOI 10.1002/eji.1830271235; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Liu K, 2000, J BIOL CHEM, V275, P40195, DOI 10.1074/jbc.M006194200; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; TAYLOR SJ, 1995, J BIOL CHEM, V270, P10120, DOI 10.1074/jbc.270.17.10120; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; VOGEL LB, 1995, J BIOL CHEM, V270, P2506, DOI 10.1074/jbc.270.6.2506; WANG LL, 1995, J BIOL CHEM, V270, P2010, DOI 10.1074/jbc.270.5.2010; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Zaffran S, 1997, DEVELOPMENT, V124, P2087; Zorn AM, 1997, GENE DEV, V11, P2176, DOI 10.1101/gad.11.17.2176	45	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30803	30811		10.1074/jbc.M102247200	http://dx.doi.org/10.1074/jbc.M102247200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11395494	hybrid			2022-12-27	WOS:000170472900031
J	El Far, O; Bofill-Cardona, E; Airas, JM; O'Connor, V; Boehm, S; Freissmuth, M; Nanoff, C; Betz, H				El Far, O; Bofill-Cardona, E; Airas, JM; O'Connor, V; Boehm, S; Freissmuth, M; Nanoff, C; Betz, H			Mapping of calmodulin and G beta gamma binding domains within the C-terminal region of the metabotropic glutamate receptor 7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; A(1)-ADENOSINE RECEPTOR; ADENYLYL CYCLASES; CALCIUM CHANNELS; A(1) ADENOSINE; MODULATION; PHOSPHORYLATION; ASSOCIATION; PLASTICITY; STABILIZES	Ca2+/calmodulin (Ca2+/CaM) and the beta gamma subunits of heterotrimeric G-proteins (G beta gamma) have recently been shown to interact in a mutually exclusive fashion with the intracellular C terminus of the presynaptic metabotropic glutamate receptor 7 (mGluR 7). Here, we further characterized the core CaM and G beta gamma binding sequences. In contrast to a previous report, we find that the CaM binding motif localized in the N-terminal region of the cytoplasmic tail domain of mGluR 7 is conserved in the related group III mGluRs 4A and 8 and allows these receptors to also bind Ca2+/CaM. Mutational analysis of the Ca2+/CaM binding motif is consistent with group III receptors containing a conventional CaM binding site formed by an amphipathic alpha -helix. Substitutions adjacent to the core CaM target sequence selectively prevent G beta gamma binding, suggesting that the CaM-dependent regulation of signal transduction involves determinants that overlap with but are different from those mediating G beta gamma recruitment. In addition, we present evidence that G beta gamma uses distinct nonoverlapping interfaces for interaction with the mGluR 7 C-terminal tail and the effector enzyme adenylyl cyclase II, respectively. Although G beta gamma -mediated signaling is abolished in receptors lacking the core CaM binding sequence, alpha subunit activation, as assayed by agonist-dependent GTP gammaS binding, was not affected. This suggests that Ca2+/CaM may alter the mode of group III mGluR signaling from mono- (a) to bidirectional (alpha and beta gamma) activation of downstream effector cascades.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; Univ Vienna, Inst Pharmacol, A-1090 Vienna, Austria; Univ Southampton, Sch Biol Sci, Ctr Neurosci, Southampton SO16 7PX, Hants, England	Max Planck Society; University of Vienna; University of Southampton	Betz, H (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschorden St 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de	Far, Oussama El/D-4225-2017; EL FAR, Oussama/P-9915-2019	Far, Oussama El/0000-0002-7473-8345; EL FAR, Oussama/0000-0002-7473-8345; Freissmuth, Michael/0000-0001-9398-1765; Boehm, Stefan/0000-0002-0205-2459; nanoff, christian/0000-0002-8857-2470				Airas JM, 2001, FEBS LETT, V494, P60, DOI 10.1016/S0014-5793(01)02311-0; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dev KK, 2000, J NEUROSCI, V20, P7252; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; FREISSMUTH M, 1989, J BIOL CHEM, V264, P21907; Freissmuth M, 1999, TRENDS PHARMACOL SCI, V20, P237, DOI 10.1016/S0165-6147(99)01337-1; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; JOCKERS R, 1994, J BIOL CHEM, V269, P32077; JOHNSON RA, 1991, METHOD ENZYMOL, V195, P3; Kudlacek O, 2001, J BIOL CHEM, V276, P3010, DOI 10.1074/jbc.M007910200; Macek TA, 1998, J NEUROSCI, V18, P6138; Masugi M, 1999, J NEUROSCI, V19, P955; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Nakajima Y, 1999, J BIOL CHEM, V274, P27573, DOI 10.1074/jbc.274.39.27573; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; Nanoff C, 1997, NEUROPHARMACOLOGY, V36, P1211, DOI 10.1016/S0028-3908(97)00135-4; NANOFF C, 1995, MOL PHARMACOL, V48, P806; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Perroy J, 2000, J NEUROSCI, V20, P7896; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PIN JP, 1995, CURR OPIN NEUROBIOL, V5, P342, DOI 10.1016/0959-4388(95)80047-6; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Waldhoer M, 1998, MOL PHARMACOL, V53, P808; Weitmann S, 1999, BIOCHEMISTRY-US, V38, P3409, DOI 10.1021/bi982229l	35	55	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30662	30669		10.1074/jbc.M102573200	http://dx.doi.org/10.1074/jbc.M102573200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11395497	hybrid			2022-12-27	WOS:000170472900012
J	Hellstern, S; Pegoraro, S; Karim, CB; Lustig, A; Thomas, DD; Moroder, L; Engel, J				Hellstern, S; Pegoraro, S; Karim, CB; Lustig, A; Thomas, DD; Moroder, L; Engel, J			Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; CIRCULAR-DICHROISM; MEMBRANE-PROTEINS; HIGH-RESOLUTION; LIPID BILAYERS; CA-ATPASE; CA2+-ATPASE; PHOSPHORYLATION; MECHANISM	The human 31-amino acid integral membrane protein sarcolipin (SLN), which regulates the sarcoplasmic reticulum Ca-ATPase in fast-twitch skeletal muscle, was chemically synthesized. Appropriate synthesis and purification strategies were used to achieve high purity and satisfactory yields of this hydrophobic and poorly soluble protein. Structural and functional properties of SIN were analyzed and compared with the homologous region of human phospholamban (PLB) comprising residues Ala(24)-Leu(52) (PLB(24-52)), the regulatory protein of the cardiac sarcoplasmic reticulum Ca-ATPase. Circular dichroism spectroscopy showed that SLN is a predominantly alpha -helical protein and that the secondary structure is highly resistant to SDS and thermal denaturation. In this respect SLN is remarkably similar to PLB-(24-52). However, SLN is monomeric in SDS gels, whereas PLB-(24-52) shows a monomer-pentamer equilibrium typical for native PLB. Analytical ultracentrifugation experiments revealed that SLN oligomerizes in the presence of the nonionic detergents octylpolyoxyethylene and octyl glucoside in a concentration-dependent manner. No plateau was observed, and a pentameric state was only reached at much higher protein concentrations compared with PLB-(24-52). Chemical cross-linking showed that also in liposomes SLN has the ability to self-associate to oligomers. PLB-(24-52) specifically oligomerized to pentamers in the presence of octylpolyoxyethylene as well as in liposomes at low protein concentrations. In the presence of octylpolyoxyethylene pentamers were the main oligomeric species, whereas in liposomes monomers and dimers were predominant. Increasing the protein concentration led to self-association of PLB-(24-52) pentamers in the presence of octylpolyoxyethylene. Functional reconstitution of Ca-ATPase with PLB-(24-52) and SLN in liposomes showed that both proteins regulate the Ca-ATPase in a similar manner.	Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Basel; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities	Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Thomas, David D/B-4257-2012	Moroder, Luis/0000-0001-9570-5713; Karim, Christine/0000-0002-7321-7695; Thomas, David D./0000-0002-8822-2040	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27906] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; Arkin IT, 1997, ANNU REV BIOPH BIOM, V26, P157, DOI 10.1146/annurev.biophys.26.1.157; ARKIN IT, 1995, J MOL BIOL, V248, P824, DOI 10.1006/jmbi.1995.0263; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; Frank S, 2000, BIOCHEMISTRY-US, V39, P6825, DOI 10.1021/bi0000972; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Hughes G, 1996, BIOCHEM J, V318, P973, DOI 10.1042/bj3180973; JONES LR, 1985, J BIOL CHEM, V260, P7721; Karim CB, 1998, BIOCHEMISTRY-US, V37, P12074, DOI 10.1021/bi980642n; Karim CB, 2000, BIOCHEMISTRY-US, V39, P10892, DOI 10.1021/bi0003543; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; Lustig A, 2000, BBA-BIOMEMBRANES, V1464, P199, DOI 10.1016/S0005-2736(99)00254-0; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mayer EJ, 1996, J BIOL CHEM, V271, P1669, DOI 10.1074/jbc.271.3.1669; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; MUTTER M, 1995, PEPTIDE RES, V8, P145; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARK K, 1992, PROTEIN SCI, V1, P1032, DOI 10.1002/pro.5560010809; PEGORARO S, 2000, P 16 AM AM PEPT S; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; Rosenbusch JP, 2001, MICRON, V32, P75, DOI 10.1016/S0968-4328(00)00021-4; SASAKI T, 1992, J BIOL CHEM, V267, P1674; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIRE SJ, 1994, MODERN ANAL ULTRACEN, V14, P276; SIMMERMAN HKB, 1989, BIOCHIM BIOPHYS ACTA, V997, P322, DOI 10.1016/0167-4838(89)90203-3; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Stokes DL, 1997, CURR OPIN STRUC BIOL, V7, P550, DOI 10.1016/S0959-440X(97)80121-2; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Torres J, 2000, J MOL BIOL, V300, P677, DOI 10.1006/jmbi.2000.3885; VORHERR T, 1993, PROTEIN SCI, V2, P339; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; WEGENER AD, 1989, J BIOL CHEM, V264, P11468	43	57	59	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30845	30852		10.1074/jbc.M102495200	http://dx.doi.org/10.1074/jbc.M102495200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413134	hybrid			2022-12-27	WOS:000170472900036
J	Majumder, A; Basak, S; Chowdhury, SP; Chattopadhyay, D; Roy, S				Majumder, A; Basak, S; Chowdhury, SP; Chattopadhyay, D; Roy, S			Effect of osmolytes and chaperone-like action of P-protein on folding of nucleocapsid protein of Chandipura virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; LAMBDA-REPRESSOR; IN-VITRO; TRANSCRIPTION; REPLICATION; EXPRESSION; DOMAIN; RNA; PHOSPHORYLATION; PHOSPHOPROTEIN	Amino acid sequences of nucleocapsid proteins are mostly conserved among different rhabdoviruses. The protein plays a common functional role in different RNA viruses by enwrapping the viral genomic RNA in an RNase-resistant form. Upon expression of the nucleocapsid protein alone in COS cells and in bacteria, it forms large insoluble aggregates. In this work, we have reported for the first time the full-length cloning of the N gene of Chandipura virus and its expression in Escherichia coli in a soluble monomeric form and purification using nonionic detergents. The biological activity of the soluble recombinant protein has been tested, and it was found to possess efficient RNA-binding ability. The state of aggregation of the recombinant protein was monitored using light scattering. In the absence of nonionic detergents, it formed large aggregates. Aggregation was significantly reduced in the presence of osmolytes such as D-sorbitol. Aggregate formation was suppressed in the presence of another viral product, phosphoprotein P, in a chaperone-like manner. Both the osmolyte and phosphoprotein P also suppressed aggregation to a great extent during refolding from a guanidine hydrochloride-denatured form. The function of the phosphoprotein and osmolyte appears to be synergistic to keep the N-protein in a soluble biologically competent form in virus-infected cells.	Univ Coll Sci Calcutta, Dept Biochem, Kolkata 700019, W Bengal, India; Univ Coll Sci Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata 700019, W Bengal, India; Bose Inst, Dept Biophys, Kolkata 700054, W Bengal, India	University of Calcutta; University of Calcutta; Department of Science & Technology (India); Bose Institute	Roy, S (corresponding author), Univ Coll Sci Calcutta, Dept Biochem, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.	djc@netkracker.com; sidroy@vsnl.com		Basak, Soumen/0000-0002-3586-1279; Palchaudhuri, Santanu/0000-0003-1220-8135				Bandyopadhyay S, 1996, BIOCHEMISTRY-US, V35, P5033, DOI 10.1021/bi952123f; BANERJEE AK, 1987, MICROBIOL REV, V51, P66, DOI 10.1128/MMBR.51.1.66-87.1987; BANIK U, 1993, J BIOL CHEM, V268, P3938; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; BHATT PN, 1967, INDIAN J MED RES, V55, P1295; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; DAS T, 1983, VIROLOGY, V193, P340; DRAGUNOVA J, 1979, ACTA VIROL, V23, P319; Green TJ, 2000, J VIROL, V74, P9515, DOI 10.1128/JVI.74.20.9515-9524.2000; Gupta AK, 1997, J VIROL, V71, P4264, DOI 10.1128/JVI.71.6.4264-4271.1997; HSU CH, 1979, J VIROL, V32, P304, DOI 10.1128/JVI.32.1.304-313.1979; Hyre DE, 1998, J MOL BIOL, V279, P929, DOI 10.1006/jmbi.1998.1811; MASTERS PS, 1988, J VIROL, V62, P2658, DOI 10.1128/JVI.62.8.2658-2664.1988; MASTERS PS, 1987, VIROLOGY, V157, P298, DOI 10.1016/0042-6822(87)90272-8; Pattnaik AK, 1997, J VIROL, V71, P8167, DOI 10.1128/JVI.71.11.8167-8175.1997; Raha T, 1999, BIOCHEMISTRY-US, V38, P2110, DOI 10.1021/bi980734c; SPRAGUE J, 1983, J VIROL, V45, P773, DOI 10.1128/JVI.45.2.773-781.1983; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKEMOTO L, 1993, BIOCHEM J, V294, P435, DOI 10.1042/bj2940435; Voziyan PA, 2000, J PHARM SCI-US, V89, P1036, DOI 10.1002/1520-6017(200008)89:8<1036::AID-JPS8>3.0.CO;2-5	20	33	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30948	30955		10.1074/jbc.M011705200	http://dx.doi.org/10.1074/jbc.M011705200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11413127	hybrid			2022-12-27	WOS:000170472900049
J	Ansmant, I; Motorin, Y; Massenet, S; Grosjean, H; Branlant, C				Ansmant, I; Motorin, Y; Massenet, S; Grosjean, H; Branlant, C			Identification and characterization of the tRNA :Psi(31)-synthase (Pus6p) of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-PSEUDOURIDINE SYNTHASE; 23S RIBOSOMAL-RNA; ESCHERICHIA-COLI; PEPTIDYLTRANSFERASE CENTER; 2'-O-RIBOSE METHYLATION; SUBSTRATE-SPECIFICITY; SECONDARY STRUCTURE; YEAST PROTEIN; IN-VIVO; GENE	To characterize the substrate specificity of the putative RNA:pseudouridine (Psi)-synthase encoded by the Saccharomyces cerevisiae open reading frame (ORF) YGR169c, the corresponding gene was deleted in yeast, and the consequences of the deletion on tRNA and small nuclear RNA modification were tested. The resulting Delta YGR169c strain showed no detectable growth phenotype, and the only difference in Psi formation in stable cellular RNAs was the absence of Psi at position 31 in cytoplasmic and mitochondrial tRNAs. Complementation of the Delta YGR169c strain by a plasmid bearing the wild-type YGR169c ORF restored Psi (31) formation in tRNA, whereas a point mutation of the enzyme active site (Asp 168 --->Ala) abolished tRNA:Psi (31)-synthase activity. Moreover, recombinant His(6)-tagged Ygr169 protein produced in Escherichia coli was capable of forming Psi (31) in vitro using tRNAs extracted from the Delta YGR169c yeast cells as substrates. These results demonstrate that the protein encoded by the S. cerevisiae ORF YGR169c is the Psi -synthase responsible for modification of cytoplasmic and mitochondrial tRNAs at position 31. Because this is the sixth RNA:Psi -synthase characterized thus far in yeast, we propose to rename the corresponding gene PUS6 and the expressed protein Pus6p. Finally, the cellular localization of the green fluorescent protein-tagged Pus6p was studied by functional tests and direct fluorescence microscopy.	Univ Nancy 1, Fac Sci, Lab Maturat ARN & Enzymol Mol, CNRS,UMR 7567, F-54506 Vandoeuvre Les Nancy, France; CNRS, UPR 9093, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Branlant, C (corresponding author), Univ Nancy 1, Fac Sci, Lab Maturat ARN & Enzymol Mol, CNRS,UMR 7567, BP 239, F-54506 Vandoeuvre Les Nancy, France.	Christiane.Branlant@maem.uhp-nancy.fr	MOTORIN, Yuri/AAQ-9527-2020; MOTORIN, Yuri/E-2499-2011; BEHM-ANSMANT, Isabelle/B-1406-2012	MOTORIN, Yuri/0000-0002-8018-334X; Behm-Ansmant, Isabelle/0000-0001-8909-0660; Branlant, Christiane/0000-0003-4728-5499; Motorin, Alexandr/0000-0001-9622-4591; Severine, Massenet/0000-0001-5187-8356				Adams A, 1997, METHODS YEAST GENETI; Ansmant I, 2000, NUCLEIC ACIDS RES, V28, P1941, DOI 10.1093/nar/28.9.1941; ARNEZ JG, 1994, BIOCHEMISTRY-US, V33, P7560, DOI 10.1021/bi00190a008; Auffinger P, 1997, J MOL BIOL, V269, P326, DOI 10.1006/jmbi.1997.1022; Auffinger P, 1998, Modification and Editing of RNA, P103, DOI [10.1128/9781555818296.ch6, DOI 10.1128/9781555818296.CH6]; BAKIN A, 1994, BIOCHEMISTRY-US, V33, P13475, DOI 10.1021/bi00249a036; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; BRANLANT C, 1981, NUCLEIC ACIDS RES, V9, P4303, DOI 10.1093/nar/9.17.4303; BRIMACOMBE R, 1993, FASEB J, V7, P161, DOI 10.1096/fasebj.7.1.8422963; CARBONE MLA, 1991, CURR GENET, V19, P1; Charette M, 2000, IUBMB LIFE, V49, P341; Conrad J, 1999, RNA, V5, P751, DOI 10.1017/S1355838299990167; Conrad J, 1998, J BIOL CHEM, V273, P18562, DOI 10.1074/jbc.273.29.18562; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; DAVIS DR, 1991, BIOCHEMISTRY-US, V30, P4223, DOI 10.1021/bi00231a017; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Ganot P, 1999, MOL CELL BIOL, V19, P6906; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRIFFEY RH, 1985, J BIOL CHEM, V260, P9734; GROSJEAN H, 1995, BIOCHIMIE, V77, P139, DOI 10.1016/0300-9084(96)88117-X; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588; HAGERVALL TG, 1990, BIOCHIM BIOPHYS ACTA, V1050, P263, DOI 10.1016/0167-4781(90)90178-5; HALL KB, 1992, NUCLEIC ACIDS RES, V20, P1883, DOI 10.1093/nar/20.8.1883; HALL KB, 1991, BIOCHEMISTRY-US, V30, P1795, DOI 10.1021/bi00221a010; Huang LX, 1998, BIOCHEMISTRY-US, V37, P15951, DOI 10.1021/bi981002n; Huang LX, 1998, BIOCHEMISTRY-US, V37, P344, DOI 10.1021/bi971874+; Jady BE, 2001, EMBO J, V20, P541, DOI 10.1093/emboj/20.3.541; Jiang HQ, 1997, NUCLEIC ACIDS RES, V25, P2694, DOI 10.1093/nar/25.14.2694; JIANG WD, 1993, MOL CELL BIOL, V13, P4884, DOI 10.1128/MCB.13.8.4884; KAMMEN HO, 1988, J BIOL CHEM, V263, P2255; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lane BG, 1998, MODIFICATION EDITING, P1; Lecointe F, 1998, J BIOL CHEM, V273, P1316, DOI 10.1074/jbc.273.3.1316; MARTIN NC, 1994, BIOCHIMIE, V76, P1161, DOI 10.1016/0300-9084(94)90045-0; Massenet S, 1999, MOL CELL BIOL, V19, P2142; Massenet S., 1998, MODIFICATION EDITING, P201; Meroueh M, 2000, NUCLEIC ACIDS RES, V28, P2075, DOI 10.1093/nar/28.10.2075; Mihara K, 2000, BIOESSAYS, V22, P364, DOI 10.1002/(SICI)1521-1878(200004)22:4<364::AID-BIES6>3.0.CO;2-N; Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Niu LH, 1999, BIOCHEMISTRY-US, V38, P629, DOI 10.1021/bi9821869; NURSE K, 1995, RNA, V1, P102; Ofengand J, 1997, J MOL BIOL, V266, P246, DOI 10.1006/jmbi.1996.0737; Ofengand J., 1998, MODIFICATION EDITING, P229, DOI DOI 10.1128/9781555818296.CH12; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; Ramamurthy V, 1999, J BIOL CHEM, V274, P22225, DOI 10.1074/jbc.274.32.22225; Raychaudhuri S, 1999, J BIOL CHEM, V274, P18880, DOI 10.1074/jbc.274.27.18880; Raychaudhuri S, 1998, RNA, V4, P1407, DOI 10.1017/S1355838298981146; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; REMME J, 2000, RIBOSOME BIOGENESIS, P111; ROSE AM, 1995, BIOCHIMIE, V77, P45, DOI 10.1016/0300-9084(96)88103-X; SAMUELSSON T, 1990, J BIOL CHEM, V265, P8782; Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; SZWEYKOWSKAKULINSKA Z, 1994, EMBO J, V13, P4636, DOI 10.1002/j.1460-2075.1994.tb06786.x; TSUI HCT, 1991, J BACTERIOL, V173, P7395, DOI 10.1128/jb.173.22.7395-7400.1991; Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6; VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761; WRZESINSKI J, 1995, BIOCHEMISTRY-US, V34, P8904, DOI 10.1021/bi00027a043; WRZESINSKI J, 1995, RNA, V1, P437; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	71	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34934	34940		10.1074/jbc.M103131200	http://dx.doi.org/10.1074/jbc.M103131200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11406626	hybrid			2022-12-27	WOS:000171024600079
J	Nofer, JR; Levkau, B; Wolinska, I; Junker, R; Fobker, M; von Eckardstein, A; Seedorf, U; Assmann, G				Nofer, JR; Levkau, B; Wolinska, I; Junker, R; Fobker, M; von Eckardstein, A; Seedorf, U; Assmann, G			Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysophingolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN ATHEROSCLEROTIC PLAQUES; SHED MEMBRANE MICROPARTICLES; HUMAN SKIN FIBROBLASTS; NITRIC-OXIDE SYNTHASE; SIGNALING PATHWAYS; OXIDIZED LDL; AKT; ACTIVATION; SURVIVAL	Apoptotic cell death following injury of vascular endothelium. is assumed to play an important role in the pathogenesis of atherosclerosis. In this report, we demonstrate that high density lipoproteins (HDL), a major anti-atherogenic lipoprotein fraction, protect endothelial cells against growth factor deprivation-induced apoptosis. HDL blocked the mitochondrial pathway of apoptosis by inhibiting dissipation of mitochondrial potential (Atom), generation of reactive oxygen species, and release of cytochrome c into the cytoplasm. As a consequence, HDL prevented activation of caspases 9 and 3 and apoptotic alterations of the plasma membrane such as increase of permeability and translocation of phosphatidylserine. Treatment of endothelial cells with HDL induced activation of the protein kinase Akt, an ubiquitous transducer of anti-apoptotic signals, and led to phosphorylation of BAD, a major Akt substrate. Suppression of Akt activity both by wortmannin and LY294002 or by a dominant negative Akt mutant abolished the anti-apoptotic effect of HDL. Two bioactive lysosphingolipids present in HDL particles, sphingosylphosphorycholine and lysosulfatide, fully mimicked the survival effect of HDL by blocking the mitochondrial pathway of apoptosis and potently activating Akt. In conclusion, the present study identifies HDL as a carrier of endogenous endothelial survival factors and suggests that inhibition of endothelial apoptosis by HDL-associated lysosphingolipids may represent an important and novel aspect of the anti-atherogenic activity of HDL.	Univ Munster, Inst Klin Chem & Lab Med, D-48129 Munster, Germany; Univ Munster, Inst Arterioskleroseforsch, D-48129 Munster, Germany	University of Munster; University of Munster	Nofer, JR (corresponding author), Univ Munster, Inst Klin Chem & Lab Med, Albert Schweitzer Str 33, D-48129 Munster, Germany.	nofer@uni-muenster.de	Levkau, Bodo/N-9144-2017; Junker, Ralf/M-2358-2013					ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Chin TY, 1998, AM J PHYSIOL-CELL PH, V275, pC1255, DOI 10.1152/ajpcell.1998.275.5.C1255; Cockerill GW, 1999, ARTERIOSCL THROM VAS, V19, P910, DOI 10.1161/01.ATV.19.4.910; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; Deeg MA, 1997, ARTERIOSCL THROM VAS, V17, P1667, DOI 10.1161/01.ATV.17.9.1667; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dimmeler S, 1997, CIRC RES, V81, P970; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402; Hisano N, 1999, BLOOD, V93, P4293, DOI 10.1182/blood.V93.12.4293.412k26_4293_4299; Honda HM, 1999, ATHEROSCLEROSIS, V143, P299, DOI 10.1016/S0021-9150(98)00302-5; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Jankowski J, 1998, CLIN SCI, V95, P489, DOI 10.1042/CS19980068; Kinscherf R, 1998, FASEB J, V12, P461, DOI 10.1096/fasebj.12.6.461; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Napoli C, 2000, FASEB J, V14, P1996, DOI 10.1096/fj.99-0986com; Nofer JR, 2000, BIOCHEMISTRY-US, V39, P15199, DOI 10.1021/bi001162a; OKAJIMA F, 1995, J BIOL CHEM, V270, P26332, DOI 10.1074/jbc.270.44.26332; Okamoto H, 1999, BIOCHEM BIOPH RES CO, V260, P203, DOI 10.1006/bbrc.1999.0886; Ozes ON, 1999, NATURE, V401, P82; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; SEUFFERLEIN T, 1995, J BIOL CHEM, V270, P24343, DOI 10.1074/jbc.270.41.24343; Spyridopoulos I, 1997, CIRCULATION, V95, P1505; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Suc I, 1997, ARTERIOSCL THROM VAS, V17, P2158, DOI 10.1161/01.ATV.17.10.2158; Sugano M, 2000, BIOCHEM BIOPH RES CO, V272, P872, DOI 10.1006/bbrc.2000.2877; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; VONECKARDSTEIN A, 1990, J BIOL CHEM, V265, P8610; WALTER M, 1995, ARTERIOSCL THROM VAS, V15, P1975, DOI 10.1161/01.ATV.15.11.1975	44	299	316	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34480	34485		10.1074/jbc.M103782200	http://dx.doi.org/10.1074/jbc.M103782200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11432865	hybrid			2022-12-27	WOS:000171024600019
J	Mizenina, O; Musatkina, E; Yanushevich, Y; Rodina, A; Krasilnikov, M; de Gunzburg, J; Camonis, JH; Tavitian, A; Tatosyan, A				Mizenina, O; Musatkina, E; Yanushevich, Y; Rodina, A; Krasilnikov, M; de Gunzburg, J; Camonis, JH; Tavitian, A; Tatosyan, A			A novel group IIA phospholipase A(2) interacts with v-Src oncoprotein from RSV-transformed hamster cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ROUS-SARCOMA VIRUS; PHOSPHORYLATION SITES; 2-HYBRID SYSTEM; N-RAS; EXPRESSION; TUMORIGENICITY; PP60(V-SRC); METASTASIS; ONCOGENE	We have isolated a novel isoform of phospholipase A(2). This enzyme was designated srPLA(2) because it was discovered while analyzing the proteins interacting with different forms of the v-Src oncoproteins isolated from Rous sarcoma virus-transformed hamster cells. It contains all the functional regions of the PLA(2) group IIA proteins but differs at its C-terminal end where there is an additional stretch of 8 amino acids. The SrPLA(2) isoform was detected as a 17-kDa precursor in cells and as a mature 14-kDa form secreted in culture medium. A direct interaction of the 17-kDa precursor with the Src protein was observed in lysates of transformed cells. Both the 17- and 14-kDa forms were found to be phosphorylated on tyrosine. To our knowledge, this is the first report of a PLA(2) group II protein that is tyrosine phosphorylated. We surmise that srPLA(2) interacts with the Src protein at the cell membrane during the process of its maturation.	Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Oncogene Regulat Lab, Moscow 115478, Russia; INSERM, U548, Inst Curie, F-75248 Paris 05, France	Russian Academy of Medical Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Tatosyan, A (corresponding author), Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Oncogene Regulat Lab, Kashirskoye Shosse 24, Moscow 115478, Russia.		Yanushevich, Yurii/AAF-9750-2020	Yanushevich, Yurii/0000-0001-9061-752X				ALONSO T, 1990, BIOCHEM BIOPH RES CO, V171, P14, DOI 10.1016/0006-291X(90)91349-W; BARBOUR SE, 1993, J BIOL CHEM, V268, P21875; BARTEL JV, 1993, PRACTICAL APPROACH, P153; Battey, 1986, BASIC METHODS MOL BI; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BRASHISHKITE D A, 1989, Molekulyarnaya Biologiya (Moscow), V23, P758; CHEN J, 1994, J BIOL CHEM, V269, P23018; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIDPFEUTY T, 1990, J CELL BIOL, V111, P3097, DOI 10.1083/jcb.111.6.3097; DEICHMAN GI, 1989, INT J CANCER, V44, P908, DOI 10.1002/ijc.2910440527; DEICHMAN GI, 1992, INT J CANCER, V51, P903, DOI 10.1002/ijc.2910510612; Deichman GI, 1996, INT J CANCER, V66, P747, DOI 10.1002/(SICI)1097-0215(19960611)66:6<747::AID-IJC7>3.0.CO;2-#; FELLER SM, 1995, METHOD ENZYMOL, V255, P369; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FORSTER S, 1985, BRIT J DERMATOL, V112, P135, DOI 10.1111/j.1365-2133.1985.tb00077.x; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Kaiser C., 1994, METHODS YEAST GENETI; KOMADA M, 1989, J BIOCHEM-TOKYO, V106, P545, DOI 10.1093/oxfordjournals.jbchem.a122890; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Kundu GC, 1997, J BIOL CHEM, V272, P2346; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mizenina O, 1998, FEBS LETT, V422, P79, DOI 10.1016/S0014-5793(97)01568-8; MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X; Ostermeyer AG, 1996, EXP HEMATOL, V24, P176; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHRODER T, 1980, SCAND J GASTROENTERO, V15, P633, DOI 10.3109/00365528009182227; Shakhov AN, 2000, GENES IMMUN, V1, P191, DOI 10.1038/sj.gene.6363659; SIDDIQI AR, 1991, EUR J BIOCHEM, V201, P675, DOI 10.1111/j.1432-1033.1991.tb16328.x; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Tatosyan A, 1996, VIROLOGY, V216, P347, DOI 10.1006/viro.1996.0070; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; TOPOL LZ, 1993, MOL CARCINOGEN, V8, P167, DOI 10.1002/mc.2940080307; TRANSY C, 1995, MOL BIOL REP, V21, P119, DOI 10.1007/BF00986502; VADAS P, 1985, LIFE SCI, V36, P579, DOI 10.1016/0024-3205(85)90640-X; VADAS P, 1984, J LAB CLIN MED; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C	41	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34006	34012		10.1074/jbc.M011320200	http://dx.doi.org/10.1074/jbc.M011320200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11427522	hybrid			2022-12-27	WOS:000170910200096
J	Rotem-Yehudar, R; Galperin, E; Horowitz, M				Rotem-Yehudar, R; Galperin, E; Horowitz, M			Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; VESICLE FORMATION; PROTEIN; EPS15; DOMAIN; ENDOCYTOSIS; MEMBRANE; INSULIN; INTERSECTIN; INHIBITION	Ligand-induced receptor-mediated endocytosis plays a central role in regulating signaling conveyed by tyrosine kinase receptors. This process depends on the recruitment of the adaptor protein 2 (AP-2) complex, clathrin, dynamin, and other accessory proteins to the ligand-bound receptor. We show here that besides AP-2 and clathrin, two other proteins participate in the endocytic process of the insulin-like growth factor receptor (IGF-1R); they are EHD1, an Eps15 homology (EH) domain-containing protein 1, and SNAP29, a synaptosomal-associated protein. EHD1 and SNAP29 form complexes with alpha -adaptin of AP-2 and co-localize in endocytic vesicles, indicating a role for them in endocytosis. EHD1 and SNAP29 interact directly with each other and are present in complexes with IGF-1R. After IGF-1 induction, EHD1 and IGF-1R co-localize intracellularly. Overexpression of EHD1 in Chinese hamster ovary cells represses IGF-1-mediated signaling, as measured by mitogen-activated protein kinase phosphorylation and Akt phosphorylation, indicating that EHD1 plays a role as a down-regulator in IGF-1 signaling pathway.	Stil Biotechnol, IL-52656 Ramat Gan, Israel; Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Ramat Aviv, Israel	Tel Aviv University	Horowitz, M (corresponding author), Stil Biotechnol, IL-52656 Ramat Gan, Israel.	horwitzm@post.tau.ac.il		Galperin, Emilia/0000-0002-8743-026X				Adams A, 2000, J BIOL CHEM, V275, P27414; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Carbone R, 1997, CANCER RES, V57, P5498; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; LEROITH D, 1993, ANN NY ACAD SCI, V692, P1; Lewin DA, 1998, BBA-MOL CELL RES, V1401, P129, DOI 10.1016/S0167-4889(97)00130-4; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Mayer BJ, 1999, CURR BIOL, V9, pR70, DOI 10.1016/S0960-9822(99)80014-1; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miele C, 2000, J BIOL CHEM, V275, P21695, DOI 10.1074/jbc.M000805200; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; ROTHMAN JE, 1994, ADV SEC MESS PHOSPH, V29, P81; Salcini AE, 1999, INT J BIOCHEM CELL B, V31, P805, DOI 10.1016/S1357-2725(99)00042-4; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Tebar F, 1997, J BIOL CHEM, V272, P15413, DOI 10.1074/jbc.272.24.15413; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Weis WI, 1998, NATURE, V395, P328, DOI 10.1038/26354; Werner H, 1997, CRIT REV ONCOGENESIS, V8, P71, DOI 10.1615/CritRevOncog.v8.i1.40; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	38	98	101	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33054	33060		10.1074/jbc.M009913200	http://dx.doi.org/10.1074/jbc.M009913200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11423532	hybrid			2022-12-27	WOS:000170746000090
J	Camoni, L; Visconti, S; Marra, M; Aducci, P				Camoni, L; Visconti, S; Marra, M; Aducci, P			Adenosine 5 '-monophosphate inhibits the association of 14-3-3 proteins with the plant plasma membrane H+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							14-3-3 PROTEINS; NITRATE REDUCTASE; BINDING; PHOSPHORYLATION; MODULATION; SPINACH; GROWTH	Although a well ascertained evidence proves that the activity of the plant plasma membrane H+-ATPase is regulated by 14-3-3 proteins, information about physiological factors modulating the phosphorylation-dependent association between 14-3-3 proteins and the proton pump is largely incomplete. In this paper we show that the 5 ' -AMP-mimetic, 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), inhibits the fusicoccin-promoted proton extrusion in maize roots. We also demonstrate that 5 ' -AMP inhibits the association of 14-3-3 proteins with the C-terminal domain of the H+-ATPase in an overlay assay as well as the 14-3-3-dependent stimulation of the Arabidopsis thaliana H+-ATPase AHA1 isoform expressed in yeast membranes. Finally, by means of affinity chromatography with immobilized 5 ' -AMP and trinitrophenyl-AMP fluorescence analysis, we demonstrate that the 14-3-3 isoform GF14-6 from maize is able to bind 5 ' -AMP. The possible role of 5 ' -AMP as a general regulator of 14-3-3 functions in the plant cell is discussed.	Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Univ Sannio, Dept Earth Sci, I-82100 Benevento, Italy	University of Rome Tor Vergata; University of Sannio	Aducci, P (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ricerca Sci, I-00133 Rome, Italy.	aducci@uniroma2.it	Camoni, Lorenzo/C-2584-2012					ADUCCI P, 1980, PLANTA, V148, P208, DOI 10.1007/BF00380028; Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Athwal GS, 1998, PLANT PHYSIOL, V118, P1041, DOI 10.1104/pp.118.3.1041; Athwal GS, 2000, PLANT CELL PHYSIOL, V41, P523, DOI 10.1093/pcp/41.4.523; BALLIO A, 1968, Annali dell'Istituto Superiore di Sanita, V4, P317; Baunsgaard L, 1998, PLANT J, V13, P661, DOI 10.1046/j.1365-313X.1998.00083.x; BISHOP JE, 1986, BIOCHEMISTRY-US, V25, P696, DOI 10.1021/bi00351a029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camoni L, 2000, J BIOL CHEM, V275, P9919, DOI 10.1074/jbc.275.14.9919; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; Huber SC, 1996, PHYSIOL PLANTARUM, V98, P833, DOI 10.1111/j.1399-3054.1996.tb06692.x; Jahn T, 1997, PLANT CELL, V9, P1805, DOI 10.1105/tpc.9.10.1805; KAISER WM, 1991, PLANT PHYSIOL, V96, P368, DOI 10.1104/pp.96.2.368; Kinoshita T, 1999, EMBO J, V18, P5548, DOI 10.1093/emboj/18.20.5548; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marra M, 1996, FEBS LETT, V382, P293, DOI 10.1016/0014-5793(96)00187-1; Marra M, 2000, PLANT BIOLOGY, V2, P11, DOI 10.1055/s-2000-9458; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Oecking C, 1997, PLANT J, V12, P441, DOI 10.1046/j.1365-313X.1997.12020441.x; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Palmgren MG, 1998, ADV BOT RES, V28, P1; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; SABINA RL, 1985, J BIOL CHEM, V260, P6107; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	30	32	34	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31709	31712		10.1074/jbc.M104194200	http://dx.doi.org/10.1074/jbc.M104194200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423544	hybrid			2022-12-27	WOS:000170613500033
J	Du, GG; Guo, XH; Khanna, VK; MacLennan, DH				Du, GG; Guo, XH; Khanna, VK; MacLennan, DH			Functional characterization of mutants in the predicted pore region of the rabbit cardiac muscle Ca2+ release channel (Ryanodine receptor isoform 2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL CORE DISEASE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; MALIGNANT HYPERTHERMIA; MOLECULAR-IDENTIFICATION; CALMODULIN-BINDING; FORMING SEGMENT; C-TERMINUS; SITES; SELECTIVITY	A highly conserved amino acid sequence, GVRAGG-GIGD(4831), which may form part of the Ca2+ release channel pore in RyR2, was subjected to Ala scanning or Ala to Val mutagenesis; function was then measured by expression in HEK-293 cells, followed by Ca2+ photometry, high affinity [H-3]ryanodine binding, and single-channel recording. All mutants except I4829A and 14829T (corresponding to the I4S97T central core disease mutant in RyR1) displayed caffeine-induced Ca2+ release in HEK-293 cells; only mutants G4826A, I4829V, and G4830A retained high affinity [3H]ryanodine binding; and single-channel function was found for all mutants tested, except for G4822A and A4825V. EC50 values for caffeine-induced Ca2+ release were increased for G4822A, R4824A, G4826A, G4828A, and D4831A; decreased for V4823A, and unchanged for A4825V, G4827A, I4829V, and G4830A. Ryanodine (10 muM), which did not stimulate Ca2+ release in wild type (wt), did so in Ala mutants in amino acids 4823-4827. It inhibited the caffeine response in wt and most mutants, but enhanced the amplitude of caffeine-induced Ca2+ release in mutant G4828A It also restored caffeine-induced Ca2+ release in mutants I4829A and I4929T. In single-channel recordings, mutants 14829V and G4830A retained normal conductance, whereas all others had decreased unitary channel conductances ranging from 27 to 540 picosiemens. Single-channel modu-lation was retained in G4826A, I4S29V, and G4830A, but was lost in other mutants. In contrast to wt and G4826A, I4S29V, and G4830A, in which divalent metals were preferentially conducted, mutants with loss of modulation had no selectivity of divalent cations over a monovalent cation. Analysis of Gly(4822) to Asp(4831) mutants in RyR2 supports the view that this highly conserved sequence constitutes part of the ion-conducting pore of the Ca2+ release channel and plays a key role in ryanodine and caffeine binding and activation.	Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	University of Toronto	MacLennan, DH (corresponding author), Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	david.maclennan@utoronto.ca						Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198; Balshaw D, 1999, P NATL ACAD SCI USA, V96, P3345, DOI 10.1073/pnas.96.7.3345; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; CALLAWAY C, 1994, J BIOL CHEM, V269, P15876; Chen SRW, 1997, BIOPHYS J, V73, P1904, DOI 10.1016/S0006-3495(97)78221-3; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; CHEN SRW, 1994, J BIOL CHEM, V269, P22698; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du GC, 2000, J BIOL CHEM, V275, P11778, DOI 10.1074/jbc.275.16.11778; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Du GG, 1999, J BIOL CHEM, V274, P26120, DOI 10.1074/jbc.274.37.26120; Du GG, 1998, J BIOL CHEM, V273, P33259, DOI 10.1074/jbc.273.50.33259; Fessenden JD, 2001, P NATL ACAD SCI USA, V98, P2865, DOI 10.1073/pnas.041608898; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; GRUNWALD R, 1995, J BIOL CHEM, V270, P11338, DOI 10.1074/jbc.270.19.11338; Herrmann-Frank A, 1999, J MUSCLE RES CELL M, V20, P223, DOI 10.1023/A:1005496708505; LAI FA, 1989, J BIOL CHEM, V264, P16776; LEE KS, 1984, J PHYSIOL-LONDON, V354, P253, DOI 10.1113/jphysiol.1984.sp015374; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; MACLENNAN DH, 1995, SOC GEN PHY, V50, P89; Manjunatha B, 1997, J GEN PHYSIOL, V110, P749, DOI 10.1085/jgp.110.6.749; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MENEGAZZI P, 1994, BIOCHEMISTRY-US, V33, P9078, DOI 10.1021/bi00197a008; Moore CP, 1999, J BIOL CHEM, V274, P36831, DOI 10.1074/jbc.274.52.36831; Nakai J, 1999, FEBS LETT, V459, P154, DOI 10.1016/S0014-5793(99)01232-6; OTSU K, 1990, J BIOL CHEM, V265, P13472; Priori SG, 2001, CIRCULATION, V103, P196; PROCITA L, 1956, J PHARMACOL EXP THER, V117, P363; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Tong JF, 1999, J BIOL CHEM, V274, P693, DOI 10.1074/jbc.274.2.693; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Welch W, 1996, BIOCHEMISTRY-US, V35, P7165, DOI 10.1021/bi9527294; WITCHER DR, 1994, J BIOL CHEM, V269, P13076; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; ZORZATO F, 1990, J BIOL CHEM, V265, P2244; Zucchi R, 1997, PHARMACOL REV, V49, P1	41	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31760	31771		10.1074/jbc.M102751200	http://dx.doi.org/10.1074/jbc.M102751200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11427530	hybrid			2022-12-27	WOS:000170613500040
J	Yamaguchi, Y; Fukuhara, S; Nagase, T; Tomita, T; Hitomi, S; Kimura, S; Kurihara, H; Ouchi, Y				Yamaguchi, Y; Fukuhara, S; Nagase, T; Tomita, T; Hitomi, S; Kimura, S; Kurihara, H; Ouchi, Y			A novel mouse beta-defensin, mBD-6, predominantly expressed in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL PEPTIDE ANTIBIOTICS; ANTIMICROBIAL PEPTIDE; HUMAN BETA-DEFENSIN-1; PANETH CELLS; HUMAN SKIN; LIPOPOLYSACCHARIDE; HBD-1; LUNG; PURIFICATION; EPITHELIUM	Defensins comprise a family of cationic, antimicrobial peptides that is characterized by the conserved 6 cysteine residues. They are expressed in the epithelial cells of various organs and are identified as key elements in the host defense system at the mucosal surface. We isolated a novel mouse beta -defensin gene from the bacterial artificial chromosome DNA containing the mouse beta -defensin-3 gene. The full-length cDNA was cloned from skeletal muscle cDNA and called mouse beta -defensin-6 (mBD-6). The predicted peptide conserved the 6-cysteine motif and had 59% amino acid sequence identity with mouse beta -defensin-3 and 59% identity with mouse beta -defensin-4. We demonstrated the-expression of mBD-6 in skeletal muscle in addition to the esophagus, tongue, and trachea. In animal models of endotoxemia, mBD-6 expression was also induced in the lung. mBD-6 showed potent antimicrobial activity against Escherichia coli and would play an important role in host defense in the esophagus, airways, and skeletal muscle. mBD-6 is the first reported beta -defensin predominantly expressed in skeletal muscle. This unique tissue specificity suggests some, novel physiological roles of this peptide family.	Kumamoto Univ, Inst Mol Embryol & Genet, Div Integrat Cell Biol, Dept Embryogenesis, Kumamoto 8600811, Japan; Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Infect Control & Prevent, Tokyo 1138655, Japan; Univ Tsukuba, Inst Clin Med, Dept Infect Dis, Tsukuba, Ibaraki 3058575, Japan	Kumamoto University; University of Tokyo; University of Tokyo; University of Tsukuba	Kurihara, H (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Div Integrat Cell Biol, Dept Embryogenesis, 2-2-1 Honjo,Kumamoto Shi, Kumamoto 8600811, Japan.			Kurihara, Hiroki/0000-0002-6476-5593				Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; Fulton C, 1997, LANCET, V350, P1750, DOI 10.1016/S0140-6736(05)63574-X; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GILL D, 2000, INFECT IMMUN, V68, P113; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HARWIG SSL, 1994, METHOD ENZYMOL, V236, P160; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; Huttner KM, 1997, FEBS LETT, V413, P45, DOI 10.1016/S0014-5793(97)00875-2; Jia HP, 1999, INFECT IMMUN, V67, P4827, DOI 10.1128/IAI.67.9.4827-4833.1999; Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200; Jia HP, 2001, GENE, V263, P211; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; McCray PB, 1997, AM J RESP CELL MOL, V16, P343, DOI 10.1165/ajrcmb.16.3.9070620; Morrison GM, 1999, FEBS LETT, V442, P112, DOI 10.1016/S0014-5793(98)01630-5; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Pagenstecher A, 2000, AM J PATHOL, V157, P197, DOI 10.1016/S0002-9440(10)64531-2; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4	31	33	34	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31510	31514		10.1074/jbc.M104149200	http://dx.doi.org/10.1074/jbc.M104149200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11408484	hybrid			2022-12-27	WOS:000170613500007
J	Bajenova, OV; Zimmer, R; Stolper, E; Salisbury-Rowswell, J; Nanji, A; Thomas, P				Bajenova, OV; Zimmer, R; Stolper, E; Salisbury-Rowswell, J; Nanji, A; Thomas, P			Heterogeneous RNA-binding protein M4 is a receptor for carcinoembryonic antigen in Kupffer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNRNP-M PROTEINS; MEDIATED ENDOCYTOSIS; ARGININE METHYLATION; MESSENGER-RNA; IN-VIVO; EXPRESSION; GENE; PHOSPHORYLATION; IDENTIFICATION; RECOGNITION	Here we report the isolation of the recombinant cDNA clone from rat macrophages, Kupffer cells (KC) that encodes a protein interacting with carcinoembryonic antigen (CEA). To isolate and identify the CEA receptor gene we used two approaches: screening of a KC cDNA library with a specific antibody and the yeast two-hybrid system for protein interaction using as a bait the N-terminal part of the CEA encoding the binding site. Both techniques resulted in the identification of the rat heterogeneous RNA-binding protein (hnRNP) M4 gene. The rat ortholog cDNA sequence has not been previously described. The open reading frame for this gene contains a 2351-base pair sequence with the polyadenylation signal AATAAA and a termination poly(A) tail. The mRNA shows ubiquitous tissue expression as a 2.4-kilobase transcript. The deduced amino acid sequence comprised a 78-kDa membrane protein with 3 putative RNA-binding domains, arginine/methionine/glutamine-rich C terminus and 3 potential membrane spanning regions. When hnRNP M4 protein is expressed in pGEX4T-3 vector system in Escherichia coli it binds I-125-labeled CEA in a Ca2+-dependent fashion. Transfection of rat hnRNP M4 cDNA into a non-CEA binding mouse macrophage cell line p388D1 resulted in CEA binding. These data provide evidence for a new function of hnRNP M4 protein as a CEA-binding protein in Kupffer cells.	Boston Univ, Sch Med, Lab Surg Biol, Dept Surg, Boston, MA 02118 USA	Boston University	Thomas, P (corresponding author), Boston Univ, Sch Med, Lab Surg Biol, Dept Surg, 801 Albany St,Rm 310, Boston, MA 02118 USA.	pthomas@bu.edu		Bajenova, Olga/0000-0001-7506-4736	NCI NIH HHS [CA74941] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074941] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLANCK I, 1995, GENOMICS, V27, P561; BLANCK O, 1994, GENOMICS, V21, P18, DOI 10.1006/geno.1994.1219; BOER U, 2000, BIOCHEM J, V15, P839; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; BOSSER R, 1995, MOL CELL BIOL, V15, P661; DATAR KV, 1993, NUCLEIC ACIDS RES, V21, P439, DOI 10.1093/nar/21.3.439; Eggert M, 1997, J BIOL CHEM, V272, P28471, DOI 10.1074/jbc.272.45.28471; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gangopadhyay A, 1996, CANCER RES, V56, P4805; Gangopadhyay A, 1997, CANCER LETT, V118, P1, DOI 10.1016/S0304-3835(97)00216-4; Gangopadhyay A, 1996, ARCH BIOCHEM BIOPHYS, V334, P151, DOI 10.1006/abbi.1996.0440; Gangopadhyay A, 1996, ARCH BIOCHEM BIOPHYS, V328, P151, DOI 10.1006/abbi.1996.0155; Gattoni R, 1996, NUCLEIC ACIDS RES, V24, P2535, DOI 10.1093/nar/24.13.2535; GORLACH M, 1993, MOL BIOL REP, V18, P73, DOI 10.1007/BF00986759; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; HASHINO J, 1994, CLIN EXP METASTAS, V12, P324, DOI 10.1007/BF01753839; HOSTETTER RB, 1990, J NATL CANCER I, V82, P380, DOI 10.1093/jnci/82.5.380; Huang S, 2000, J STRUCT BIOL, V129, P233, DOI 10.1006/jsbi.2000.4247; Jessup JM, 1998, CELL ADHES COMMUN S, V5, P195; Kafasla P, 2000, BIOCHEM J, V350, P495, DOI 10.1042/0264-6021:3500495; Keesee SK, 1996, CRIT REV EUKAR GENE, V6, P189, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.50; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; Kim JC, 1999, MOL CELLS, V9, P133; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Leconte A, 1999, BRIT J CANCER, V80, P1373, DOI 10.1038/sj.bjc.6690531; Lee MH, 1996, J BIOL CHEM, V271, P3420; Leverrier S, 2000, BIOL CHEM, V381, P1031, DOI 10.1515/BC.2000.127; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Mahe D, 2000, BBA-GENE STRUCT EXPR, V1492, P414, DOI 10.1016/S0167-4781(00)00144-5; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; THOMAS P, 1995, CANCER LETT, V92, P59, DOI 10.1016/0304-3835(95)03764-N; Tolnay M, 1999, BIOCHEM J, V338, P417, DOI 10.1042/0264-6021:3380417; TOTH CA, 1985, CANCER RES, V45, P392; TOTH CA, 1982, BIOCHEM J, V204, P377, DOI 10.1042/bj2040377; TOTH CA, 1989, J LEUKOCYTE BIOL, V45, P370, DOI 10.1002/jlb.45.4.370; WAGNER HE, 1992, CLIN EXP METASTAS, V10, P25, DOI 10.1007/BF00163573; Witte MM, 1997, P NATL ACAD SCI USA, V94, P1212, DOI 10.1073/pnas.94.4.1212; Zimmer R, 2001, CANCER RES, V61, P2822; 2000, CELL, V102, P135	44	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31067	31073		10.1074/jbc.M104093200	http://dx.doi.org/10.1074/jbc.M104093200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11406629	hybrid			2022-12-27	WOS:000170472900064
J	Howell, SA; Withers-Martinez, C; Kocken, CHM; Thomas, AW; Blackman, MJ				Howell, SA; Withers-Martinez, C; Kocken, CHM; Thomas, AW; Blackman, MJ			Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL INVASION; INTRAERYTHROCYTIC STAGE; SEQUENCE-ANALYSIS; MALARIA PARASITES; SURFACE-ANTIGEN; I AMA-1; PROTEIN; KNOWLESI; MEROZOITES; IDENTIFICATION	Plasmodium falciparum apical membrane antigen-1 (PfAMA-1) is a malaria merozoite integral membrane protein that plays an essential but poorly understood role in invasion of host erythrocytes. The PfAMA-1 ectodomain comprises three disulfide-constrained domains, the first of which (domain I) is preceded by an N-terminal prosequence. PfAMA-1 is initially routed to secretory organelles at the apical end of the merozoite, where the 83-kDa precursor (PfAMA-1(83)) is converted to a 66-kDa form (PfAMA-1(66)). At about the time of erythrocyte invasion, PfAMA-1(66) selectively translocates onto the merozoite surface. Here we use direct microsequencing and mass spectrometric peptide mass fingerprinting to characterize in detail the primary structure and proteolytic processing of PfAMA-1. We have determined the site at which processing takes place to convert PfAMA-1(83) to PfAMA-1(66) and have shown that both species possess a completely intact and unmodified transmembrane and cytoplasmic domain. Following relocation to the merozoite surface, PfAMA-166 is further proteolytically cleaved at one of two alternative sites, either between domains II and III, or at a membrane-proximal site following domain III. As a result, the bulk of the ectodomain is shed from the parasite surface in the form of two soluble fragments of 44 and 48 kDa. PfAMA-1 is not detectably modified by the addition of N-linked oligosaccharides.	Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England; Biomed Primate Res Ctr, NL-2280 GJ Rijswijk, Netherlands	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Blackman, MJ (corresponding author), Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.			Kocken, Clemens/0000-0002-4784-1734				ALTMANN F, 1995, GLYCOCONJUGATE J, V12, P84, DOI 10.1007/BF00731873; Anders RF, 2000, PARASITOL TODAY, V16, P444, DOI 10.1016/S0169-4758(00)01784-1; Berhe S, 2000, EXP PARASITOL, V94, P194, DOI 10.1006/expr.1999.4481; Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; CHENG Q, 1994, MOL BIOCHEM PARASIT, V65, P183, DOI 10.1016/0166-6851(94)90127-9; Chitnis CE, 2000, PARASITOL TODAY, V16, P411, DOI 10.1016/S0169-4758(00)01756-7; Cowman AF, 2000, FEBS LETT, V476, P84, DOI 10.1016/S0014-5793(00)01703-8; CREWTHER PE, 1990, EXP PARASITOL, V70, P193, DOI 10.1016/0014-4894(90)90100-Q; DEANS JA, 1984, MOL BIOCHEM PARASIT, V11, P189, DOI 10.1016/0166-6851(84)90065-3; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DIECKMANNSCHUPPERT A, 1992, EUR J BIOCHEM, V205, P815, DOI 10.1111/j.1432-1033.1992.tb16846.x; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; DUTTA S, 1995, MOL BIOCHEM PARASIT, V73, P267, DOI 10.1016/0166-6851(95)00112-E; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Kappe SHI, 1996, MOL BIOCHEM PARASIT, V78, P279, DOI 10.1016/S0166-6851(96)02619-9; Kappe SHI, 1998, P NATL ACAD SCI USA, V95, P1230, DOI 10.1073/pnas.95.3.1230; Kimura EA, 1996, J BIOL CHEM, V271, P14452, DOI 10.1074/jbc.271.24.14452; Kocken CHM, 2000, MOL BIOCHEM PARASIT, V109, P147, DOI 10.1016/S0166-6851(00)00250-4; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Marshall VM, 1996, MOL BIOCHEM PARASIT, V77, P109, DOI 10.1016/0166-6851(96)02583-2; MARSHALL VM, 1989, MOL BIOCHEM PARASIT, V37, P281, DOI 10.1016/0166-6851(89)90160-6; NARUM DL, 1993, J CHROMATOGR A, V657, P357, DOI 10.1016/0021-9673(93)80291-F; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PETERSON MG, 1989, MOL CELL BIOL, V9, P3151, DOI 10.1128/MCB.9.7.3151; PETERSON MG, 1990, MOL BIOCHEM PARASIT, V39, P279, DOI 10.1016/0166-6851(90)90067-V; ROSE K, 1983, BIOCHEM J, V215, P273, DOI 10.1042/bj2150273; Sajid M, 2000, J BIOL CHEM, V275, P631, DOI 10.1074/jbc.275.1.631; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; WATERS AP, 1990, J BIOL CHEM, V265, P17974; WATERS AP, 1991, MOL BIOCHEM PARASIT, V44, P141, DOI 10.1016/0166-6851(91)90230-4	45	130	135	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31311	31320		10.1074/jbc.M103076200	http://dx.doi.org/10.1074/jbc.M103076200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11399764	hybrid			2022-12-27	WOS:000170472900095
J	Wang, ZG; White, PS; Ackerman, SH				Wang, ZG; White, PS; Ackerman, SH			Atp11p and Atp12p are assembly factors for the F-1-ATPase in human mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; YEAST; GENE; SYNTHASE; PROTEIN; IDENTIFICATION; DISEASE; DELETION; REGION; DISRUPTION	Atp11p and Atp12p were first described as proteins required for assembly of the F-1 component of the mitochondrial ATP synthase in Saccharomyces cerevisiae (Ackerman, S. H., and Tzagoloff, A. (1990) Proc. Natl Acad. Sci. U. S. A. 87, 4986-4990). Here we report the isolation of the cDNAs and the characterization of the human genes for Atp11p and Atp12p and show that the human proteins function like their yeast counterparts. Human ATP11 spans 24 kilobase pairs in 9 exons and maps to 1p32.3-p33, while ATP12 contains greater than or equal to8 exons and localizes to 17p11.2. Both genes are broadly conserved in eukaryotes and are expressed in a wide range of tissues, which suggests that Atp11p and Atp12p are essential housekeeping proteins of human cells. The information reported herein will be useful in the evaluation of patients with ascertained deficiencies in the ATP synthase, in which the underlying biochemical defect is unknown and may reside in a protein that influences the assembly of the enzyme.	Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; Univ Penn, Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	Wayne State University; Wayne State University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Ackerman, SH (corresponding author), Wayne State Univ, Sch Med, Dept Surg, 421 E Canfield Ave, Detroit, MI 48201 USA.	sackerm@med.wayne.edu			NIGMS NIH HHS [GM48157] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048157] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMAN SH, 1992, J BIOL CHEM, V267, P7386; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952; Arnold I, 1999, J BIOL CHEM, V274, P36, DOI 10.1074/jbc.274.1.36; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BOWMAN S, 1991, J BIOL CHEM, V266, P7517; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Corman B, 1999, AM J HUM GENET, V64, P126, DOI 10.1086/302206; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Engle EC, 1997, AM J HUM GENET, V60, P1150; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022; Houstek J, 1999, HUM MOL GENET, V8, P1967; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KATAOKA H, 1991, BIOCHIM BIOPHYS ACTA, V1089, P393, DOI 10.1016/0167-4781(91)90183-M; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miller PR, 1999, CYTOGENET CELL GENET, V85, P157; OHTA S, 1986, J BIOCHEM-TOKYO, V99, P135, DOI 10.1093/oxfordjournals.jbchem.a135452; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Ragnarsson G, 1999, BRIT J CANCER, V79, P1468, DOI 10.1038/sj.bjc.6690234; SAMBROOK J, 1982, MOL CLONING LAN MANU; SCHAGGER H, 1995, EUR J BIOCHEM, V227, P916, DOI 10.1111/j.1432-1033.1995.tb20219.x; Scheurlen WG, 1997, GENE CHROMOSOME CANC, V18, P50, DOI 10.1002/(SICI)1098-2264(199701)18:1<50::AID-GCC6>3.0.CO;2-0; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Sulman EP, 1998, CANCER RES, V58, P3226; TATUCH Y, 1992, AM J HUM GENET, V50, P852; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Velours J, 2001, J BIOL CHEM, V276, P8602, DOI 10.1074/jbc.M008123200; Wang ZG, 1998, J BIOL CHEM, V273, P2993, DOI 10.1074/jbc.273.5.2993; Wang ZG, 2000, EMBO J, V19, P1486, DOI 10.1093/emboj/19.7.1486; Wang ZG, 1999, FEBS LETT, V452, P305, DOI 10.1016/S0014-5793(99)00676-6; Wang ZG, 1996, J BIOL CHEM, V271, P4887; Wang ZG, 2000, J BIOL CHEM, V275, P5767, DOI 10.1074/jbc.275.8.5767; WHITE M, 1995, ARCH BIOCHEM BIOPHYS, V319, P299, DOI 10.1006/abbi.1995.1296; White PS, 1999, GENOME RES, V9, P978, DOI 10.1101/gr.9.10.978	40	72	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30773	30778		10.1074/jbc.M104133200	http://dx.doi.org/10.1074/jbc.M104133200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11410595	hybrid			2022-12-27	WOS:000170472900027
J	Abu-Amer, Y; Dowdy, SF; Ross, FP; Clohisy, JC; Teitelbaum, SL				Abu-Amer, Y; Dowdy, SF; Ross, FP; Clohisy, JC; Teitelbaum, SL			TAT fusion proteins containing tyrosine 42-deleted I kappa B alpha arrest osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; BONE-RESORPTION; TRANSDUCTION; CELLS; PHOSPHORYLATION; DEGRADATION; ACTIVATION; DELIVERY; MACROPHAGES	In most circumstances, NF-kappaB, which is essential for osteoclastogenesis, is activated following serine 32/36 phosphorylation of its cytosolic inhibitory protein, I kappaB alpha. In contrast to other cell types, I kappaB alpha, in bone marrow macrophages (BMMs), which are osteoclast precursors, is tyrosine-phosphorylated by c-Src kinase. To address the role of I kappaB alpha phosphorylation in osteoclastogenesis, we generated TAT fusion proteins containing wild-type I kappaB alpha (TAT-WT-I kappaB), I kappaB alpha lacking its NH2-terminal 45 amino acids (TAT-I kappaB(46-317)), and I kappaB alpha in which tyrosine residue 42, the c-Src target, is mutated into phenylalanine (TAT-I kappaB(Y42F)). TAT-I kappaB efficiently enters BMMs, and the NF-kappaB-inhibitory protein, once intracellular, is functional. While TAT-WT-I kappaB only Slightly inhibits osteoclastogenesis, osteoclast recruitment is diminished > 80% by TAT-I kappaB(46-317), an event mirrored by dentin resorption. The fact that TAT alone does not impact osteoclastogenesis, which also resumes following withdrawal of TAT-I kappaB(46-317), establishes that the mutant's anti-osteoclastogenic properties do not reflect toxicity. Affirming a functional role for I kappaB(Tyr(42)) in osteoclastogenesis, TAT-I kappaB(Y42F) is as efficient as TAT-I kappaB(46-317) in blocking osteoclast differentiation. Thus, dominant-negative I kappaB alpha constructs block osteoclastogenesis, and Tyr 42 is essential to the process, increasing the possibility that nonphosphorylatable forms Of I kappaB alpha may be a means of preventing pathological bone loss.	Washington Univ, Sch Med, Dept Orthoped Res, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Mol Oncol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Abu-Amer, Y (corresponding author), Washington Univ, Sch Med, Dept Orthoped Surg, 1 Barnes Hosp Plaza,Suite 11300,Campus Box 8233, St Louis, MO 63110 USA.			Teitelbaum, Steven/0000-0002-4054-6679	NIAMS NIH HHS [AR45623, AR47096, AR32788] Funding Source: Medline; NIDCR NIH HHS [DE05413, DE13754] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR047096, R01AR032788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013754] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lissy NA, 1998, IMMUNITY, V8, P57, DOI 10.1016/S1074-7613(00)80458-6; Mukhopadhyay A, 2000, J BIOL CHEM, V275, P8549, DOI 10.1074/jbc.275.12.8549; MUNDY GR, 1996, OSTEOPOROSIS, V11, P302; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Singh S, 1996, J BIOL CHEM, V271, P31049, DOI 10.1074/jbc.271.49.31049; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 1997, J LEUKOCYTE BIOL, V61, P381, DOI 10.1002/jlb.61.4.381; Teitelbaum Steven L., 1996, P61; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vocero-Akbani AM, 1999, NAT MED, V5, P29, DOI 10.1038/4710	22	76	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30499	30503		10.1074/jbc.M104725200	http://dx.doi.org/10.1074/jbc.M104725200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11408488	hybrid			2022-12-27	WOS:000170558000117
J	Tang, D; Okada, H; Ruland, J; Liu, LQ; Stambolic, V; Mak, TW; Ingram, AJ				Tang, D; Okada, H; Ruland, J; Liu, LQ; Stambolic, V; Mak, TW; Ingram, AJ			Akt is activated in response to an apoptotic signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE-B; CHEMOTHERAPY-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; CELL-DEATH; SURVIVAL SIGNALS; CERVICAL-CANCER; MYC PROTEIN; INHIBITION; RAS	Akt is a serine-threonine kinase known to exert anti-apoptotic effects through several downstream targets. Akt is cleaved during mitochondrial-mediated apoptosis in a caspase-dependent manner. The reason for this is not clear, however, because Akt has not been demonstrated to be activated in response to mitochondrial apoptotic stimuli. Accordingly, we explored whether the well described mitochondrial apoptotic stimuli staurosporine (STS) and etoposide activate Akt and whether such activation impacts apoptosis. Both STS and etoposide activated Akt in NIH 3T3 cells, maximally at 8 and 2 h, respectively, preceding the onset of apoptosis and poly(ADP-ribose) polymerase cleavage. The overexpression of Akt delayed STS-induced apoptosis with an even more pronounced delay observed with overexpression of constitutively active Akt. Akt activation by proapoptotic stimuli lay upstream of mitochondria, because neither caspase inhibitors nor overexpression of Bcl-2 or Bcl-x(L) could prevent it. Activation depended on phosphatidylinositol 3-kinase activity, however. Conversely, inhibition of phosphatidylinositol 3-kinase with wort-mannin sensitized cells to apoptosis initiated by STS. These data demonstrate that mitochondrial apoptotic stimuli also activate Akt and such activation modulates apoptosis in this setting.	McMaster Univ, Dept Med, Hamilton, ON L8N 1Y2, Canada; Amgen Inst, Toronto, ON M5G 2C1, Canada	McMaster University	Tang, D (corresponding author), McMaster Univ, Dept Med, 500-25 Charlton Ave E, Hamilton, ON L8N 1Y2, Canada.	damut@mcmaster.ca	Ruland, Jürgen/Q-6680-2018; Tang, Damu/AAQ-1786-2021	Ruland, Jürgen/0000-0002-8381-3597; Tang, Damu/0000-0002-3282-9521; Stambolic, Vuk/0000-0001-8853-3239				AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Facompre Michael, 2000, Molecular Cell Biology Research Communications, V4, P37, DOI 10.1006/mcbr.2000.0251; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gire V, 2000, ONCOGENE, V19, P2269, DOI 10.1038/sj.onc.1203544; Goswami R, 1999, J NEUROSCI RES, V57, P884, DOI 10.1002/(SICI)1097-4547(19990915)57:6<884::AID-JNR14>3.3.CO;2-1; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakashio A, 2000, CANCER RES, V60, P5303; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Ng SSW, 2000, CANCER RES, V60, P5451; O'Gorman DM, 2000, LEUKEMIA, V14, P602, DOI 10.1038/sj.leu.2401726; Ozes ON, 1999, NATURE, V401, P82; Page C, 2000, ANTICANCER RES, V20, P407; Page C, 2000, INT J ONCOL, V17, P23; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; RAYCHAUDHURI P, 1991, GENE DEV, V5, P1200, DOI 10.1101/gad.5.7.1200; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rytomaa M, 2000, ONCOGENE, V19, P4461, DOI 10.1038/sj.onc.1203805; Shan B, 1996, P NATL ACAD SCI USA, V93, P679, DOI 10.1073/pnas.93.2.679; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Tang DM, 1999, J BIOL CHEM, V274, P7245, DOI 10.1074/jbc.274.11.7245; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Xiao QR, 1998, GENE DEV, V12, P3803, DOI 10.1101/gad.12.24.3803; Yuan ZQ, 2000, ONCOGENE, V19, P2324, DOI 10.1038/sj.onc.1203598; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	51	82	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30461	30466		10.1074/jbc.M102045200	http://dx.doi.org/10.1074/jbc.M102045200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11399756	hybrid			2022-12-27	WOS:000170558000112
J	Leung, GK; Schmidt, WK; Bergo, MO; Gavino, B; Wong, DH; Tam, A; Ashby, MN; Michaelis, S; Young, SG				Leung, GK; Schmidt, WK; Bergo, MO; Gavino, B; Wong, DH; Tam, A; Ashby, MN; Michaelis, S; Young, SG			Biochemical studies of Zmpste24-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE A-FACTOR; SACCHAROMYCES-CEREVISIAE; CARBOXYL METHYLTRANSFERASE; RAS PROTEINS; STE14 GENE; YEAST; MATURATION; MEMBRANE; MISLOCALIZATION; PROTEOLYSIS	Genetic studies in Saccharomyces cerevisiae identified two genes, STE24 and RCE1, involved in cleaving the three carboxyl-terminal amino acids from isoprenylated proteins that terminate with a CAAX sequence motif. Ste24p cleaves the carboxyl-terminal "-AAX" from the yeast mating pheromone a-factor, whereas Rce1p cleaves the -AAX from both a-factor and Ras2p. Ste24p also cleaves the amino terminus of a-factor. The mouse genome contains orthologues for both yeast RCE1 and STE24. We previously demonstrated, with a gene-knockout experiment, that mouse Reel is essential for development and that Reel is entirely responsible for the carboxyl-terminal proteolytic processing of the mouse Ras proteins. In this study, we cloned mouse Zmpste24, the orthologue for yeast STE24 and showed that it could promote a-factor production when expressed in yeast. Then, to assess the importance of Zmpste24 in development, we generated Zmpste24-deficient mice. Unlike the Reel knockout mice, Zmpste24-deficient mice survived development and were fertile. Since no natural substrates for mammalian Zmpste24 have been identified, yeast a-factor was used as a surrogate substrate to investigate the biochemical activities in membranes from the cells and tissues of Zmpste24-deficient mice. We demonstrate that Zmpste24-deficient mouse membranes, like Ste24p-deficient yeast membranes, have diminished CAAX proteolytic activity and lack the ability to cleave the amino terminus of the a-factor precursor. Thus, both enzymatic activities of yeast Ste24p are conserved in mouse Zmpste24, but these enzymatic activities are not essential for mouse development or for fertility.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; Axys Pharmaceut, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University	Young, SG (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, POB 419100, San Francisco, CA 94141 USA.	syoung@gladstone.ucsf.edu		Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [HL41633] Funding Source: Medline; NIA NIH HHS [AG15451] Funding Source: Medline; NIGMS NIH HHS [GM41223] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015451] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ambroziak P., 2001, ENZYMES, P155; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Boyartchuk VL, 1998, GENETICS, V150, P95; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Chen P, 1997, J CELL BIOL, V136, P251, DOI 10.1083/jcb.136.2.251; Chen YL, 1996, BIOCHEMISTRY-US, V35, P3227, DOI 10.1021/bi952529s; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HRYCYNA CA, 1992, J BIOL CHEM, V267, P10457; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; MICHAELIS S, 1988, MOL CELL BIOL, V8, P1309, DOI 10.1128/MCB.8.3.1309; MORTENSEN R, 1999, CURRENT PROTOCOLS MO, V2; Nijbroek GL, 1998, METHOD ENZYMOL, V292, P193; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Ploger R, 2000, NUCLEIC ACIDS RES, V28, P120, DOI 10.1093/nar/28.1.120; POWERS S, 1986, CELL, V47, P413, DOI 10.1016/0092-8674(86)90598-2; Romano JD, 1998, MOL BIOL CELL, V9, P2231, DOI 10.1091/mbc.9.8.2231; SAPPERSTEIN S, 1994, MOL CELL BIOL, V14, P1438, DOI 10.1128/MCB.14.2.1438; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Tam A, 1998, J CELL BIOL, V142, P635, DOI 10.1083/jcb.142.3.635; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000	33	71	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29051	29058		10.1074/jbc.M102908200	http://dx.doi.org/10.1074/jbc.M102908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11399759	hybrid			2022-12-27	WOS:000170346000057
J	Kennedy, MW; Heikema, AP; Cooper, A; Bjorkman, PJ; Sanchez, LM				Kennedy, MW; Heikema, AP; Cooper, A; Bjorkman, PJ; Sanchez, LM			Hydrophobic ligand binding by Zn-alpha(2)-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-MOBILIZING FACTOR; RAT-LIVER; CRYSTAL-STRUCTURE; TRANSFERRIN RECEPTOR; ARACHIDONIC-ACID; MHC MOLECULES; FC RECEPTOR; HEMOCHROMATOSIS; CRYSTALLIZATION; GENE	Zn-alpha (2)-glycoprotein (ZAG) is a member of the major histocompatibility complex (MHC) class I family of proteins and is identical in amino acid sequence to a tumor-derived lipid-mobilizing factor associated with cachexia in cancer patients. ZAG is present in plasma and other body fluids, and its natural function, like leptin's, probably lies in lipid store homeostasis. X-ray crystallography has revealed an open groove between the helices of ZAG's alpha (1). and alpha (2) domains, containing an unidentified small ligand in a position similar to that of peptides in MHC proteins (Sanchez, L. M., Chirino, A. J., and Bjorkman, P. J. (1999) Science 283,1914-1919). Here we show, using serum-derived and bacterial recombinant protein, that ZAG binds the fluorophore-tagged fatty acid 11-(dansylamino)undecanoic acid (DAUDA) and, by competition, natural fatty acids such as arachidonic, linolenic, eicosapentaenoic, and docosahexaenoic acids. Other MHC class I-related proteins (FcRn, HFE, HLA-Cw*0702) showed no such evidence of binding. Fluorescence and isothermal calorimetry analysis showed that ZAG binds DAUDA with K-d in the micromolar range, and differential scanning calorimetry showed that ligand binding increases the thermal stability of the protein. Addition of fatty acids to ZAG alters its intrinsic (tryptophan) fluorescence emission spectrum, providing a strong indication that ligand binds in the expected position close to a cluster of exposed tryptophan side chains in the groove. This study therefore shows that ZAG binds small hydrophobic ligands, that the natural ligand may be a polyunsaturated fatty acid, and provides a fluorescence-based method for investigating ZAG-ligand interactions.	Univ Glasgow, Inst Biomed & Life Sci, Div Environm & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	University of Glasgow; University of Glasgow; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Kennedy, MW (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Environm & Evolutionary Biol, Graham Kerr Bldg, Glasgow G12 8QQ, Lanark, Scotland.	malcolm.kennedy@bio.gla.ac.uk	Cooper, Alan/F-7813-2011	Cooper, Alan/0000-0001-6709-7343				Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BUERGI W, 1961, J BIOL CHEM, V236, P1066; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Cooper A, 1994, Methods Mol Biol, V22, P137; Cooper A, 2000, PROTEIN LIGAND INTER; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; DIEZITZA I, 1993, EUR J CANCER, V29A, P1256, DOI 10.1016/0959-8049(93)90068-Q; EFTINK MR, 1984, BIOCHEMISTRY-US, V23, P3891, DOI 10.1021/bi00312a016; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garboczi DN, 1996, J IMMUNOL, V157, P5403; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; Gasymov OK, 1999, BBA-PROTEIN STRUCT M, V1433, P307, DOI 10.1016/S0167-4838(99)00133-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; HAUGHLAND RP, 1992, HDB FLUORESCENT PROB; Hirai K, 1998, CANCER RES, V58, P2359; Hsu KT, 1996, J BIOL CHEM, V271, P13317, DOI 10.1074/jbc.271.23.13317; KENNEDY MW, 1995, J BIOL CHEM, V270, P19277, DOI 10.1074/jbc.270.33.19277; Kennedy MW, 1997, J BIOL CHEM, V272, P29442, DOI 10.1074/jbc.272.47.29442; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; LALONDE JM, 1994, J BIOL CHEM, V269, P25339; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Puerta L, 1999, INT ARCH ALLERGY IMM, V119, P181, DOI 10.1159/000024193; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Sanchez LM, 1997, P NATL ACAD SCI USA, V94, P4626, DOI 10.1073/pnas.94.9.4626; STORCH J, 1989, J BIOL CHEM, V264, P8708; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; THUMSER AEA, 1994, BIOCHEM J, V300, P827, DOI 10.1042/bj3000827; THUMSER AEA, 1994, BIOCHEM J, V297, P103, DOI 10.1042/bj2970103; Thumser AEA, 1996, BIOCHEM J, V320, P729, DOI 10.1042/bj3200729; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tisdale MJ, 1999, J NUTR, V129, p243S, DOI 10.1093/jn/129.1.243S; TISDALE MJ, 1991, BIOCHEM PHARMACOL, V41, P103, DOI 10.1016/0006-2952(91)90016-X; Todorov PT, 1998, CANCER RES, V58, P2353; Veerkamp JH, 1999, MOL CELL BIOCHEM, V192, P137, DOI 10.1023/A:1006866119264; WILKINSON TCI, 1986, BIOCHEM J, V238, P419, DOI 10.1042/bj2380419; WILTON DC, 1990, BIOCHEM J, V270, P163, DOI 10.1042/bj2700163; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	46	43	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					35008	35013		10.1074/jbc.C100301200	http://dx.doi.org/10.1074/jbc.C100301200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11425849	hybrid, Green Accepted, Green Submitted			2022-12-27	WOS:000171024600088
J	Araki, T; Nagarajan, R; Milbrandt, J				Araki, T; Nagarajan, R; Milbrandt, J			Identification of genes induced in peripheral nerve after injury - Expression profiling and novel gene discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIP-LIKE KINASE; NEUROTROPHIC FACTOR; ADHESION MOLECULE; CELL-ADHESION; SCHWANN-CELLS; N-CAM; APOPTOSIS; RECEPTOR; GLYCOPROTEIN; REGENERATION	Peripheral nerve injury results in axonal degeneration and in phenotypic changes of the surrounding Schwann cells, whose presence is critical for nerve regeneration. To identify genes induced after nerve injury in Schwann cells, we developed a strategy that included differential screening of a subtractive library enriched for cDNAs expressed in injured nerve, sequence analysis, and expression profiling. By using real time quantitative reverse transcriptase-polymerase chain reaction, we found that injury-induced genes could be categorized into four temporal expression patterns. Among the clones we identified were a number that were homologous only to expressed sequence tags in the data base. These were stratified based on their expression profile, presence of identifiable sequence motifs, homologies to other proteins, and evolutionary conservation. We chose one representative gene, nin283, to analyze in detail. The nin283 gene encodes a 227-residue protein containing both a zinc finger and a RING finger motif. nin283 is highly expressed in the central nervous system, particularly in the developing cortical plate in embryos. It is also expressed in peripheral ganglia and is induced by nerve growth factor in PC12 cells. Subcellular localization analysis demonstrated that Nin283 is located in the endosome/lysosome compartment, suggesting that it may participate in ubiquitin-mediated protein modification.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	jeff@pathbox.wustl.edu	Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040745] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS40745] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agnello D, 2000, J NEUROIMMUNOL, V109, P105, DOI 10.1016/S0165-5728(00)00279-4; ALTMEYER A, 1995, J BIOL CHEM, V270, P25584, DOI 10.1074/jbc.270.43.25584; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Attwood TK, 1999, NUCLEIC ACIDS RES, V27, P220, DOI 10.1093/nar/27.1.220; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; Braissant O, 1998, BIOCHEMICA, V1, P10; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carroll SL, 1997, J NEUROSCI, V17, P1642; Cheng YC, 2000, DEV BRAIN RES, V121, P233, DOI 10.1016/S0165-3806(00)00049-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORBI AL, 1988, J BIOL CHEM, V263, P12403; Corpet F, 1999, NUCLEIC ACIDS RES, V27, P263, DOI 10.1093/nar/27.1.263; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Edelman GM, 1998, BRAIN RES REV, V26, P337, DOI 10.1016/S0165-0173(97)00034-9; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; GERDES J, 1984, J IMMUNOL, V133, P1710; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; Grimaldi M, 1999, J BIOL CHEM, V274, P33557, DOI 10.1074/jbc.274.47.33557; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALL SM, 1986, NEUROPATH APPL NEURO, V12, P401, DOI 10.1111/j.1365-2990.1986.tb00151.x; Henikoff S, 1999, BIOINFORMATICS, V15, P471, DOI 10.1093/bioinformatics/15.6.471; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Madore N, 1999, J NEUROCHEM, V72, P708, DOI 10.1046/j.1471-4159.1999.0720708.x; Martin KJ, 2000, P NATL ACAD SCI USA, V97, P3789, DOI 10.1073/pnas.97.8.3789; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Pazdernik NJ, 1999, MOL CELL BIOL, V19, P6500; Polentarutti N, 2000, J NEUROIMMUNOL, V106, P87, DOI 10.1016/S0165-5728(00)00214-9; RIEGER F, 1988, J CELL BIOL, V107, P707, DOI 10.1083/jcb.107.2.707; RUBENSTEIN JLR, 1990, NUCLEIC ACIDS RES, V18, P4833, DOI 10.1093/nar/18.16.4833; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sawasdikosol S, 2000, BBA-REV CANCER, V1471, pM1, DOI 10.1016/S0304-419X(00)00013-5; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Stoll G, 1999, BRAIN PATHOL, V9, P313; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; TANIUCHI M, 1988, J NEUROSCI, V8, P664; Tarasova NI, 1997, CELL TISSUE RES, V287, P325, DOI 10.1007/s004410050757; Trupp M, 1997, J NEUROSCI, V17, P3554; Wang SM, 2000, P NATL ACAD SCI USA, V97, P4162, DOI 10.1073/pnas.97.8.4162; WHITE FV, 1989, J NEUROCHEM, V52, P1085, DOI 10.1111/j.1471-4159.1989.tb01851.x; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zoidl G, 1997, J NEUROSCI RES, V49, P32, DOI 10.1002/(SICI)1097-4547(19970701)49:1<32::AID-JNR4>3.0.CO;2-E	65	57	59	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					34131	34141		10.1074/jbc.M104271200	http://dx.doi.org/10.1074/jbc.M104271200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11427537	hybrid			2022-12-27	WOS:000170910200112
J	Brouet, A; Sonveaux, P; Dessy, C; Balligand, JL; Feron, O				Brouet, A; Sonveaux, P; Dessy, C; Balligand, JL; Feron, O			Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUID SHEAR-STRESS; PROTEIN-KINASE-B; CARDIAC MYOCYTES; ENOS ACTIVATION; CAVEOLIN; AKT; TRANSLOCATION; ANGIOGENESIS; PROSTACYCLIN; DISSOCIATION	Vascular endothelial growth factor (VEGF) exerts its angiogenic effects partly through the activation of endothelial nitric-oxide synthase (eNOS). Association with heat shock protein 90 (hsp90) and phosphorylation by Akt were recently shown to separately activate eNOS upon VEGF stimulation in endothelial cells. Here, we examined the interplay between these different mechanisms in VEGF-exposed endothelial cells. We documented that hsp90 binding to eNOS is, in fact, the crucial event triggering the transition from the Ca2+-dependent activation of eNOS to the phosphorylation-mediated potentiation of its activity by VEGF. Accordingly, we showed that early VEGF stimulation first leads to the Ca2+/calmodulin disruption of the caveolin-eNOS complex and promotes the association between eNOS and hsp90. eNOS-bound hsp90 can then recruit VEGF-activated (phosphorylated) Akt to the complex, which in turn can phosphorylate eNOS. Further experiments in transfected COS cells expressing either wild-type or S1177A mutant eNOS led us to identify the serine 1177 as the critical residue for the hsp90-dependent Akt-mediated activation of eNOS. Finally, we documented that although the V-EGF-induced phosphorylation of eNOS leads to a sustained production of NO independently of a maintained increase in [Ca2+](i), this late stage of eNOS activation is strictly conditional on the initial VEGF-induced Ca2+-dependent stimulation of the enzyme. These data establish the critical temporal sequence of events leading to the sustained activation of eNOS by VEGF and suggest new ways of regulating the production of NO in response to this cytokine through the ubiquitous chaperone protein, hsp90.	Univ Catholique Louvain, Sch Med, Pharmacol & Therapeut Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Feron, O (corresponding author), Univ Catholique Louvain, Sch Med, Pharmacol & Therapeut Unit, FATH 5349,53 Ave E Mounier, B-1200 Brussels, Belgium.		Balligand, Jean-Luc J/D-7543-2012; FERON, Olivier/AAM-6395-2020	FERON, Olivier/0000-0001-5360-0286; Sonveaux, Pierre/0000-0001-6484-8834; BALLIGAND, Jean-Luc/0000-0002-0522-4156				BALLIGAND JL, 2000, NITRIC OXIDE BIOL PA; Bernier SG, 2000, J BIOL CHEM, V275, P30707, DOI 10.1074/jbc.M005116200; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Butt E, 2000, J BIOL CHEM, V275, P5179, DOI 10.1074/jbc.275.7.5179; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Feron O, 1999, Curr Opin Clin Nutr Metab Care, V2, P291, DOI 10.1097/00075197-199907000-00007; Feron O, 1998, J BIOL CHEM, V273, P30249, DOI 10.1074/jbc.273.46.30249; Feron O, 1999, J CLIN INVEST, V103, P897, DOI 10.1172/JCI4829; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nuszkowski A, 2001, J BIOL CHEM, V276, P14212, DOI 10.1074/jbc.M007659200; Pham FH, 2000, CIRC RES, V86, P1252, DOI 10.1161/01.RES.86.12.1252; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Su YC, 2000, AM J PHYSIOL-LUNG C, V278, pL1204, DOI 10.1152/ajplung.2000.278.6.L1204; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	42	183	191	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32663	32669		10.1074/jbc.M101371200	http://dx.doi.org/10.1074/jbc.M101371200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11425855	hybrid			2022-12-27	WOS:000170746000039
J	Coppola, T; Magnin-Luthi, S; Perret-Menoud, V; Gattesco, S; Schiavo, G; Regazzi, R				Coppola, T; Magnin-Luthi, S; Perret-Menoud, V; Gattesco, S; Schiavo, G; Regazzi, R			Direct interaction of the Rab3 effector RIM with Ca2+ channels, SNAP-25, and synaptotagmin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; SYNAPTIC-VESICLE FUSION; PANCREATIC BETA-CELLS; MEMBRANE-FUSION; C2B DOMAIN; ALPHA-1 SUBUNIT; BINDING-PROTEIN; CA2+-DEPENDENT EXOCYTOSIS; REGULATED EXOCYTOSIS; SNARE INTERACTIONS	To define the role of the Rab3-interacting molecule RIM in exocytosis we searched for additional binding partners of the protein. We found that the two C-2 domains of RIM display properties analogous to those of the C2B domain of synaptotagmin-I. Thus, RIM-C(2)A and RIM-C2B bind in a Ca2+-independent manner to alpha 1B, the pore-forming subunit of N-type Ca2+ channels (EC50 = similar to 20 nM). They also weakly interact with the alpha 1C but not the alpha 1D subunit of L-type Ca2+ channels. In addition, the C-2 domains of RIM associate with SNAP-25 and synaptotagmin-I. The binding affinities for these two proteins are 203 and 24 nM, respectively, for RIM-C(2)A and 224 and 16 nM for RIM-C2B. The interactions of the C-2 domains of RIM with SNAP-25 and synaptotagmin-I are modulated by Ca2+. Thus, in the presence of Ca2+ (EC50 = similar to 75 mum) the interaction with synaptotagmin-I is increased, whereas SNAP-25 binding is reduced. Synaptotagmin-I binding is abolished by mutations in two positively charged amino acids in the C-2 domains of RIM and by the addition of inositol polyphosphates. We propose that the Rab3 effector RIM is a scaffold protein that participates through its multiple binding partners in the docking and fusion of secretory vesicles at the release sites.	Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Imperial Canc Res Fund, London WC2A 3PX, England	University of Lausanne; Cancer Research UK	Regazzi, R (corresponding author), Univ Lausanne, Inst Biol Cellulaire & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.		Coppola, Thierry/I-5036-2016	Coppola, Thierry/0000-0003-1018-722X; Schiavo, Giampietro/0000-0002-4319-8745; Regazzi, Romano/0000-0002-9773-2915				Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; COPPOLA T, 1994, FEBS LETT, V338, P1, DOI 10.1016/0014-5793(94)80105-3; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; GALLI T, 1995, NEUROPHARMACOLOGY, V34, P1351, DOI 10.1016/0028-3908(95)00113-K; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Grote E, 1999, MOL BIOL CELL, V10, P4149, DOI 10.1091/mbc.10.12.4149; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Han SY, 2000, BIOCHEM J, V352, P165, DOI 10.1042/0264-6021:3520165; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; LLEDO PM, 1993, NATURE, V364, P540, DOI 10.1038/364540a0; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; MA WJ, 1992, J BIOL CHEM, V267, P22728; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Nalefski EA, 1998, BIOCHEMISTRY-US, V37, P17642, DOI 10.1021/bi982372e; NIINOBE M, 1994, BIOCHEM BIOPH RES CO, V205, P1036, DOI 10.1006/bbrc.1994.2770; OharaImaizumi M, 1997, P NATL ACAD SCI USA, V94, P287, DOI 10.1073/pnas.94.1.287; Ohnishi H, 1997, J CLIN INVEST, V100, P3044, DOI 10.1172/JCI119859; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	52	140	150	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32756	32762		10.1074/jbc.M100929200	http://dx.doi.org/10.1074/jbc.M100929200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11438518	hybrid			2022-12-27	WOS:000170746000052
J	Guarinos, E; Remacha, M; Ballesta, JPG				Guarinos, E; Remacha, M; Ballesta, JPG			Asymmetric interactions between the acidic P1 and P2 proteins in the Saccharomyces cerevisiae ribosomal stalk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOME; ELONGATION-FACTOR-G; ANGSTROM RESOLUTION; PHOSPHOPROTEINS P1; RELEASE FACTORS; ARTEMIA-SALINA; 70S RIBOSOME; SUBUNIT; DOMAIN; BINDING	The Saccharomyces cerevisiae ribosomal stalk is made of five components, the 32-kDa PO and four 12-kDa acidic proteins, P1 alpha, P1 beta, P2 alpha, and P2 beta. The P0 carboxyl-terminal domain is involved in the interaction with the acidic proteins and resembles their structure. Protein chimeras were constructed in which the last 112 amino acids of PO were replaced by the sequence of each acidic protein, yielding four fusion proteins, PO-1 alpha, P0-1 beta, P0-2 alpha, and P0-2 beta. The chimeras were expressed in PO conditional null mutant strains in which wild-type PO is not present. In S. cerevisiae D4567, which is totally deprived of acidic proteins, the four fusion proteins can replace the wild-type PO with little effect on cell growth. In other genetic backgrounds, the chimeras either reduce or increase cell growth because of their effect on the ribosomal stalk composition. An analysis of the stalk proteins showed that each PO chimera is able to strongly interact with only one acidic protein. The following associations were found: P0-1 alpha -P2 beta, P0-1 beta -P2 alpha, P0-2 alpha -P1 beta, and P0-2 beta -P1 alpha. These results indicate that the four acidic proteins do not form dimers in the yeast ribosomal stalk but interact with each other forming two specific associations, P1 alpha -P2 beta and P1 beta -P2 alpha, which have different structural and functional roles.	CSIC, Ctr Biol Mol, E-28049 Madrid, Spain; Univ Autonoma Madrid, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Ballesta, JPG (corresponding author), CSIC, Ctr Biol Mol, Canto Blanco, E-28049 Madrid, Spain.		Remacha, Miguel/G-1250-2016					Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ballesta JPG, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P115; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; BEAUCLERK AAD, 1984, J BIOL CHEM, V259, P6559; BELTRAME M, 1990, MOL CELL BIOL, V10, P2341, DOI 10.1128/MCB.10.5.2341; Bocharov EV, 1998, FEBS LETT, V423, P347, DOI 10.1016/S0014-5793(98)00121-5; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Briones E, 1998, J BIOL CHEM, V273, P31956, DOI 10.1074/jbc.273.48.31956; Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; FAKUNDING JL, 1973, J BIOL CHEM, V248, P8555; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Gomez-Lorenzo MG, 1998, J BIOL CHEM, V273, P25041, DOI 10.1074/jbc.273.39.25041; GUDKOV AT, 1980, FEBS LETT, V109, P34, DOI 10.1016/0014-5793(80)81305-6; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KAY A, 1973, BIOCHEM BIOPH RES CO, V51, P979, DOI 10.1016/0006-291X(73)90023-5; LAVERGNE JP, 1987, FEBS LETT, V216, P83, DOI 10.1016/0014-5793(87)80761-5; LIN A, 1982, J BIOL CHEM, V257, P9189; MACCONNELL WP, 1982, J BIOL CHEM, V257, P5359; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Matadeen R, 1999, STRUCTURE, V7, P1575, DOI 10.1016/S0969-2126(00)88348-3; MOFFAT JG, 1991, BIOCHIMIE, V73, P1113, DOI 10.1016/0300-9084(91)90154-S; MOLLER W, 1975, P NATL ACAD SCI USA, V72, P4744, DOI 10.1073/pnas.72.12.4744; Moller W., 1986, STRUCTURE FUNCTION G, P309; NEWTON CH, 1990, J BACTERIOL, V172, P579, DOI 10.1128/jb.172.2.579-588.1990; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; PETTERSSON I, 1979, FEBS LETT, V98, P139, DOI 10.1016/0014-5793(79)80170-2; PRIETO J, 1991, BIOCHIM BIOPHYS ACTA, V115, P6; REMACHA M, 1992, J BIOL CHEM, V267, P12061; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; REMACHA M, 1988, J BIOL CHEM, V263, P9094; Rodriguez-Gabriel MA, 2000, J BIOL CHEM, V275, P2130, DOI 10.1074/jbc.275.3.2130; Rodriguez-Gabriel MA, 1998, BIOCHEMISTRY-US, V37, P16620, DOI 10.1021/bi981396i; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; SANCHEZMADRID F, 1979, EUR J BIOCHEM, V98, P409, DOI 10.1111/j.1432-1033.1979.tb13200.x; SANTOS C, 1993, BIOCHEMISTRY-US, V32, P4231, DOI 10.1021/bi00067a010; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; SANTOS C, 1994, J BIOL CHEM, V269, P15689; SCHIJMAN AG, 1995, BBA-GENE STRUCT EXPR, V1264, P15, DOI 10.1016/0167-4781(95)00142-4; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Szick K, 1998, P NATL ACAD SCI USA, V95, P2378, DOI 10.1073/pnas.95.5.2378; TATE WP, 1990, EUR J BIOCHEM, V187, P543, DOI 10.1111/j.1432-1033.1990.tb15335.x; Traut RR, 1995, BIOCHEM CELL BIOL, V73, P949, DOI 10.1139/o95-102; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; Zambrano R, 1997, BIOCHEMISTRY-US, V36, P14439, DOI 10.1021/bi971494o; Zurdo J, 2000, BIOCHEMISTRY-US, V39, P8929, DOI 10.1021/bi000362j; Zurdo J, 2000, BIOCHEMISTRY-US, V39, P8935, DOI 10.1021/bi000363b; Zurdo J, 1997, BIOCHEMISTRY-US, V36, P9625, DOI 10.1021/bi9702400	57	45	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32474	32479		10.1074/jbc.M103229200	http://dx.doi.org/10.1074/jbc.M103229200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11431471	hybrid			2022-12-27	WOS:000170746000015
J	Penn, RB; Pascual, RM; Kim, YM; Mundell, SJ; Krymskaya, VP; Panettieri, RA; Benovic, JL				Penn, RB; Pascual, RM; Kim, YM; Mundell, SJ; Krymskaya, VP; Panettieri, RA; Benovic, JL			Arrestin specificity for G protein-coupled receptors in human airway smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EP4 PROSTAGLANDIN RECEPTORS; GREEN FLUORESCENT PROTEIN; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; DEPENDENT ENDOCYTOSIS; ACTIVATED RECEPTOR-2; SELECTIVE REGULATION; KINASE ACTIVATION; OPIOID RECEPTORS; TERMINAL DOMAIN	Despite a widely accepted role of arrestins as "uncouplers" of G protein-coupled receptor (GPCR) signaling, few studies have demonstrated the ability of arrestins to affect second messenger generation by endogenously expressed receptors in intact cells. In this study we demonstrate arrestin specificity for endogenous GPCRs in primary cultures of human airway smooth muscle (HA,SM). Expression of arrestin-green fluorescent protein (ARR2-GFP or ARR3-GFP) chimeras in HASM significantly attenuated isoproterenol (beta (2)-adrenergic receptor (beta (2)AR)-mediated)- and 5'-(N-ethylcarboxamido)adenosine (A2b adenosine receptor-mediated)stimulated cAMP production, with fluorescent microscopy demonstrating agonist-promoted redistribution of cellular ARR2-GFP into a punctate formation. Conversely, prostaglandin E-2 (PGE(2))-mediated cAMP production was unaffected by arrestin-GFP, and PGE(2) had little effect on arrestin-GFP distribution. The pharmacological profile of various selective EP receptor ligands suggested a predominantly EP2 receptor population in HASM. Further analysis in COS-1 cells revealed that ARR2-GFP expression increased agonist-promoted internalization of wild type beta (2)AR and EP4 receptors, whereas EP2 receptors remained resistant to internalization. However, expression of an arrestin whose binding to GPCRs is largely independent of receptor phosphorylation (ARR2(R169E)-GFP) enabled substantial agonist-promoted EP2 receptor internalization, increased beta (2)AR internalization to a greater extent than did ARR2-GFP, yet promoted EP4 receptor internalization to the same degree as did ARR2-GFP. Signaling via endogenous EP4 receptors in CHO-KI cells was attenuated by ARR2-GFP expression, whereas ARR2(R169E)-GFP expression in HASM inhibited EP2 receptor-mediated cAMP production. These findings demonstrate differential effects of arrestins in altering endogenous GPCR signaling in a physiologically relevant cell type and reveal a variable dependence on receptor phosphorylation in dictating arrestin-receptor interaction.	Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Jefferson Med Coll, Dept Med, Div Crit Care Pulm Allerg & Immunol Dis, Philadelphia, PA 19107 USA; Univ Penn, Sch Med, Dept Med, Div Pulm & Crit Care, Philadelphia, PA 19104 USA	Jefferson University; Jefferson University; University of Pennsylvania	Penn, RB (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Rm 930 BLSB,233 S 10th St, Philadelphia, PA 19107 USA.		panettieri, reynold/AAG-9485-2019; Kim, You-Me/I-5553-2013	Kim, You-Me/0000-0001-8780-704X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058506, R29HL058506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047417, R01GM047417] Funding Source: NIH RePORTER; NHLBI NIH HHS [R29 HL058506, HL58506] Funding Source: Medline; NIGMS NIH HHS [R37 GM047417, R01 GM047417, GM47417] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; AN SZ, 1993, BIOCHEM BIOPH RES CO, V197, P263, DOI 10.1006/bbrc.1993.2470; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Bastepe M, 1999, BRIT J PHARMACOL, V126, P365, DOI 10.1038/sj.bjp.0702291; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crider JY, 2000, PROSTAG LEUKOTR ESS, V62, P21, DOI 10.1054/plef.1999.0120; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; Diviani D, 1996, J BIOL CHEM, V271, P5049; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Hosey MM, 1999, LIFE SCI, V64, P363, DOI 10.1016/S0024-3205(98)00575-X; Iacovelli L, 1996, MOL ENDOCRINOL, V10, P1138, DOI 10.1210/me.10.9.1138; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Kovoor A, 1997, J BIOL CHEM, V272, P27605, DOI 10.1074/jbc.272.44.27605; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; McGraw DW, 1997, J BIOL CHEM, V272, P7338, DOI 10.1074/jbc.272.11.7338; Mundell SJ, 2000, BIOCHEMISTRY-US, V39, P12828, DOI 10.1021/bi0010928; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Mundell SJ, 1999, BIOCHEMISTRY-US, V38, P8723, DOI 10.1021/bi990361v; Mundell SJ, 2001, AM J RESP CELL MOL, V24, P155, DOI 10.1165/ajrcmb.24.2.4243; MURRAY RK, 1993, AM J PHYSIOL, V264, pC485, DOI 10.1152/ajpcell.1993.264.2.C485; Nakamura K, 1999, MOL ENDOCRINOL, V13, P1295, DOI 10.1210/me.13.8.1295; Nakamura K, 1998, J BIOL CHEM, V273, P24346, DOI 10.1074/jbc.273.38.24346; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Neuschafer-Rube F, 1999, MOL PHARMACOL, V56, P419, DOI 10.1124/mol.56.2.419; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Penn RB, 1998, HANDBK PHYS, V1, P125; REGAN JW, 1994, MOL PHARMACOL, V46, P213; Santini F, 2000, J CELL SCI, V113, P2463; Shui Z, 2001, J BIOL CHEM, V276, P11691, DOI 10.1074/jbc.M011007200; Smyth EM, 2000, J BIOL CHEM, V275, P32037, DOI 10.1074/jbc.M003873200; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Troispoux C, 1999, MOL ENDOCRINOL, V13, P1599, DOI 10.1210/me.13.9.1599; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Zeng L, 1996, BIOCHEMISTRY-US, V35, P7159, DOI 10.1021/bi960036x; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	57	79	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					32648	32656		10.1074/jbc.M104143200	http://dx.doi.org/10.1074/jbc.M104143200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11418617	hybrid			2022-12-27	WOS:000170746000037
J	Yu, LN; Sabet, N; Chambers, A; Morse, RH				Yu, LN; Sabet, N; Chambers, A; Morse, RH			The N-terminal and C-terminal domains of RAP1 are dispensable for chromatin opening and GCN4-mediated HIS4 activation in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN RAP1; TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; NUCLEOSOME DISRUPTION; HISTONE TAILS; IN-VIVO; DNA; GENE; COMPLEX	Repressor activator protein 1 (RAP1) assists GCN4-mediated HIS4 activation by overcoming some repressive aspect of chromatin structure to facilitate GCN4 binding. RAP1 also participates in other nuclear processes, and discrete domains of RAP1 have been shown to have specific properties including DNA binding, DNA bending, transcriptional activation, and silencing and telomere functions. To investigate whether specific domains of RAP1 are required to "open" chromatin and help GCN4 to activate the HIS4 gene, we examined the abilities of different truncated RAP1 proteins to perturb positioned nucleosomes via a nucleosomal RAP1 site in a yeast episome in vivo, and we tested HIS4 activation in yeast strains harboring truncated RAP1 mutants. We found that neither the DNA bending domain nor the putative activation domain of RAP1 is required for its ability to perturb the chromatin structure of a plasmid containing a RAP1 site. Similarly, neither the putative activation domain nor the N-terminal DNA-bending domain was required for GCN4-mediated activation of HIS4. We also used a rap1(ts) mutant to show that continuous occupancy of the HIS4 promoter by RAP1. is required for GCN4-mediated gene activation.	SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; New York State Dept Hlth, Wadsworth Ctr Labs & Res, Lab Dev Genet, Albany, NY 12201 USA; Univ Nottingham, Queens Med Ctr, Div Genet, Nottingham NG7 2UH, England	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center; University of Nottingham	Morse, RH (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA.			Morse, Randall/0000-0003-0000-8718	NIGMS NIH HHS [GM51993] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051993] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AXELROD JD, 1993, GENE DEV, V7, P857, DOI 10.1101/gad.7.5.857; Balasubramanian B, 1999, MOL CELL BIOL, V19, P2977; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; CAVALLI G, 1993, EMBO J, V12, P4603, DOI 10.1002/j.1460-2075.1993.tb06149.x; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; DEVLIN C, 1991, MOL CELL BIOL, V11, P3642, DOI 10.1128/MCB.11.7.3642; Drazinic CM, 1996, MOL CELL BIOL, V16, P3187; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GILSON E, 1995, NUCLEIC ACIDS MOL BI, V9, P308; Graham IR, 1999, MOL CELL BIOL, V19, P7481; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; JIANG YW, 1995, GENETICS, V140, P103; KENT NA, 1993, NUCLEIC ACIDS RES, V21, P4653, DOI 10.1093/nar/21.19.4653; Kirkpatrick DT, 1999, GENETICS, V152, P101; KURTZ S, 1991, GENE DEV, V5, P616, DOI 10.1101/gad.5.4.616; LEE KP, 1982, CAN J BIOCHEM CELL B, V60, P379, DOI 10.1139/o82-045; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Leuba SH, 1998, BIOPHYS J, V74, P2830, DOI 10.1016/S0006-3495(98)77990-1; Lopez MC, 1998, P NATL ACAD SCI USA, V95, P14112, DOI 10.1073/pnas.95.24.14112; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; MCNEIL JB, 1990, CURR GENET, V18, P405, DOI 10.1007/BF00309909; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; MORSE RH, 1993, SCIENCE, V262, P1563, DOI 10.1126/science.8248805; MORSE RH, 1987, NUCLEIC ACIDS RES, V15, P10311, DOI 10.1093/nar/15.24.10311; MORSE RH, 1992, MOL CELL BIOL, V12, P4015, DOI 10.1128/MCB.12.9.4015; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; MULLER T, 1994, J STRUCT BIOL, V113, P1, DOI 10.1006/jsbi.1994.1027; NEDOSPASOV SA, 1980, BIOCHEM BIOPH RES CO, V92, P532, DOI 10.1016/0006-291X(80)90366-6; PINEIRO M, 1991, BIOCHEMISTRY-US, V30, P5805, DOI 10.1021/bi00237a025; REECE RJ, 1993, SCIENCE, V261, P909, DOI 10.1126/science.8346441; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Ryan MP, 2000, MOL CELL BIOL, V20, P5847, DOI 10.1128/MCB.20.16.5847-5857.2000; SAAVEDRA RA, 1986, CELL, V45, P65, DOI 10.1016/0092-8674(86)90538-6; Schroeder SC, 1998, J BIOL CHEM, V273, P19884, DOI 10.1074/jbc.273.31.19884; SHIMIZU M, 1991, EMBO J, V10, P3033, DOI 10.1002/j.1460-2075.1991.tb07854.x; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Stafford GA, 1997, J BIOL CHEM, V272, P11526; Stafford GA, 2001, MOL CELL BIOL, V21, P4568, DOI 10.1128/MCB.21.14.4568-4578.2001; Stafford GA, 1998, J BIOL CHEM, V273, P34240, DOI 10.1074/jbc.273.51.34240; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; VIGNAIS ML, 1990, J BIOL CHEM, V265, P14669; WHITE MA, 1991, P NATL ACAD SCI USA, V88, P9755, DOI 10.1073/pnas.88.21.9755; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yu LN, 1999, MOL CELL BIOL, V19, P5279	52	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 31	2001	276	35					33257	33264		10.1074/jbc.M104354200	http://dx.doi.org/10.1074/jbc.M104354200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	468EW	11413146	hybrid			2022-12-27	WOS:000170746000112
J	Chernov, MV; Bean, LJH; Lerner, N; Stark, GR				Chernov, MV; Bean, LJH; Lerner, N; Stark, GR			Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; DNA-BINDING FUNCTION; CYCLE ARREST; MURINE P53; IN-VITRO; DAMAGE; MDM2; ACTIVATION; PROTEIN; KINASE	Previously, we found that the protein kinase C (PKC) inhibitor H7 stimulates p53 to accumulate in a form incapable of inducing transcription from p53-dependent promoters. We concluded that H7 inhibits constitutive C-terminal phosphorylation of p53, which regulates its turnover in unstressed cells. We now show that p53 and its inhibitor MDM2 (HDM2 in human cells) are together in the nuclei of H7-treated cells and can be co-immunoprecipitated. Despite this association of p53 with the ubiquitin ligase MDM2, ubiquitinated p53 was not detected in H7-treated cells. Furthermore, co-treatment with H7 and the proteosome inhibitor LLnL prevented the accumulation of ubiquitinated p53 that was observed in cells treated solely with LLnL. In addition, treatment of cells with the PKC activator phorbol ester stimulated the ubiquitination of p53 and reduced its ability to accumulate after stress. H7 did not induce the phosphorylation of human p53 on Ser-15 (Ser-18 in mouse protein), a modification that occurs in response to DNA damage and leads to the release of MDM2 and to transactivation by p53. We conclude that phosphorylation of the C-terminal domain of p53 by PKC increases its ubiquitination and degradation in unstressed cells.	Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Stark, GR (corresponding author), Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049345, T32GM008613] Funding Source: NIH RePORTER; NIGMS NIH HHS [5-T32-GM08613, GM49345] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal ML, 2001, ONCOGENE, V20, P2527, DOI 10.1038/sj.onc.1204353; Alarcon R, 1999, CANCER RES, V59, P6046; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Burma S, 1999, J BIOL CHEM, V274, P17139, DOI 10.1074/jbc.274.24.17139; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chang YC, 1998, CELL GROWTH DIFFER, V9, P79; Chehab NH, 2000, GENE DEV, V14, P278; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chernov MV, 1997, ONCOGENE, V14, P2503, DOI 10.1038/sj.onc.1201104; Chernov MV, 1998, P NATL ACAD SCI USA, V95, P2284, DOI 10.1073/pnas.95.5.2284; Chernova OB, 1998, MOL CELL BIOL, V18, P536, DOI 10.1128/MCB.18.1.536; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DEOCALUNA R, 1995, NATURE, V0378; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Dumaz N, 1999, FEBS LETT, V463, P312, DOI 10.1016/S0014-5793(99)01647-6; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; FISCELLA M, 1993, ONCOGENE, V8, P1519; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; HUPP TR, 1994, COLD SPRING HARB SYM, V59, P195, DOI 10.1101/SQB.1994.059.01.024; Jayaraman L, 1999, CELL MOL LIFE SCI, V55, P76, DOI 10.1007/s000180050271; Kapoor M, 2000, ONCOGENE, V19, P358, DOI 10.1038/sj.onc.1203300; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Lakin ND, 1999, ONCOGENE, V18, P3989, DOI 10.1038/sj.onc.1202973; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Milne DM, 1996, ONCOGENE, V13, P205; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Nitta M, 1997, ONCOGENE, V15, P561, DOI 10.1038/sj.onc.1201210; Ohnishi T, 1998, ONCOGENE, V16, P1507, DOI 10.1038/sj.onc.1201663; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; PICKSLEY SM, 1994, ONCOGENE, V9, P2523; PRICE BD, 1993, ONCOGENE, V8, P3055; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126	59	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31819	31824		10.1074/jbc.M103170200	http://dx.doi.org/10.1074/jbc.M103170200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11431470	hybrid			2022-12-27	WOS:000170613500048
J	Saunders, LR; Perkins, DJ; Balachandran, S; Michaels, R; Ford, R; Mayeda, A; Barber, GN				Saunders, LR; Perkins, DJ; Balachandran, S; Michaels, R; Ford, R; Mayeda, A; Barber, GN			Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; VIRUS-INFECTED CELLS; ACTIVATED T-CELLS; NF-KAPPA-B; VACCINIA VIRUS; BINDING-PROTEIN; INDUCED APOPTOSIS; GENE-PRODUCT; ADENOSINE-DEAMINASE; CATALYTIC DOMAIN	We report here the isolation and characterization of two proteins, NFAR-1 and -2, which were isolated through their ability to interact with the dsRNA-dependent protein kinase, PKR. The NFAR proteins, of 90 and 110 kDa, are derived from a single gene through alternative splicing and are evolutionarily conserved nuclear phosphoproteins that interact with double-stranded RNA. Both NFAR-1 and -2 are phosphorylated by PHR, reciprocally co-immunoprecipitate with PKR, and colocalize with the kinase in a diffuse nuclear pattern within the cell. Transfection studies indicate that the NFARs regulate gene expression at the level of transcription, probably during the processing of pre-mRNAs, an activity that was increased in fibroblasts lacking PKR. Subsequent functional analyses indicated that amino acids important for NFAR's activity were localized to the C terminus of the protein, a region that was found to specifically interact with FUS and SMN, proteins also known as regulators of RNA processing. Accordingly, both NFARs were found to associate with both pre-mRNAs and spliced mRNAs in post-transcriptional studies, similar to the known splicing factor ASF/SF-2. Collectively, our data indicate that the NFARs may facilitate double-stranded RNA-regulated gene expression at the. level of post-transcription and possibly contribute to host defense-related mechanisms in the cell.	Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Barber, GN (corresponding author), Univ Miami, Sch Med, Dept Microbiol & Immunol, Rm 511,Papanicolaou Bldg,1550 NW 10th AveM710, Miami, FL 33136 USA.		Mayeda, Akila/ABC-1134-2020	Mayeda, Akila/0000-0002-9562-550X	NATIONAL CANCER INSTITUTE [R21CA083166, R01CA084247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NCI NIH HHS [CA84247, CA83166] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; BARBER GN, 1993, P NATL ACAD SCI USA, V90, P4621, DOI 10.1073/pnas.90.10.4621; BARBER GN, 1991, BIOCHEMISTRY-US, V30, P10356, DOI 10.1021/bi00106a038; BARBER GN, 1995, J BIOL CHEM, V270, P17423, DOI 10.1074/jbc.270.29.17423; BASS BL, 1994, CURR BIOL, V4, P301, DOI 10.1016/S0960-9822(00)00069-5; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Besse S, 1998, EXP CELL RES, V239, P379, DOI 10.1006/excr.1997.3908; Brand SR, 1997, J BIOL CHEM, V272, P8388, DOI 10.1074/jbc.272.13.8388; Buaas FW, 1999, MAMM GENOME, V10, P451, DOI 10.1007/s003359901022; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; CACERES JF, 1997, EUKARYOTIC MRNA PROC, P174; CARROLL K, 1993, J BIOL CHEM, V268, P12837; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; CHOI SY, 1992, J BIOL CHEM, V267, P286; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Coolidge CJ, 2000, NUCLEIC ACIDS RES, V28, P1407, DOI 10.1093/nar/28.6.1407; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; DUBOIS MF, 1990, VIROLOGY, V179, P591, DOI 10.1016/0042-6822(90)90126-C; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; GALABRU J, 1987, J BIOL CHEM, V262, P15538; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; Hanamura A, 1998, RNA, V4, P430; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; JEFFREY IW, 1995, EXP CELL RES, V218, P17, DOI 10.1006/excr.1995.1126; JIMENEZGARCIA LF, 1993, J CELL SCI, V106, P11; KAO PN, 1994, J BIOL CHEM, V269, P20691; KATZE MG, 1991, MOL CELL BIOL, V11, P5497, DOI 10.1128/MCB.11.11.5497; KHARRAT A, 1995, EMBO J, V14, P3572, DOI 10.1002/j.1460-2075.1995.tb07363.x; Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; LEE SB, 1993, VIROLOGY, V193, P1037, DOI 10.1006/viro.1993.1223; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455, DOI 10.1091/mbc.7.9.1455; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; PANNIERS R, 1983, J BIOL CHEM, V258, P7928; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Polson AG, 1996, NATURE, V380, P454; Polyak SJ, 1996, J BIOL CHEM, V271, P1702, DOI 10.1074/jbc.271.3.1702; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; RICE AP, 1984, J VIROL, V50, P229, DOI 10.1128/JVI.50.1.229-236.1984; Sakamoto S, 1999, BIOCHEMISTRY-US, V38, P3355, DOI 10.1021/bi982099g; Samuel C E, 1994, Hokkaido Igaku Zasshi, V69, P1339; Saunders LR, 2001, GENOMICS, V71, P256, DOI 10.1006/geno.2000.6423; SCHWEMMLE M, 1992, P NATL ACAD SCI USA, V89, P10292, DOI 10.1073/pnas.89.21.10292; Sharp TV, 1998, VIROLOGY, V250, P302, DOI 10.1006/viro.1998.9365; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; THOMIS DC, 1995, J VIROL, V69, P5195, DOI 10.1128/JVI.69.8.5195-5198.1995; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291; Yang L, 2000, MOL CELL BIOL, V20, P3345, DOI 10.1128/MCB.20.10.3345-3354.2000; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Yeakley JM, 1999, J CELL BIOL, V145, P447, DOI 10.1083/jcb.145.3.447; Yeung MC, 1996, P NATL ACAD SCI USA, V93, P12451, DOI 10.1073/pnas.93.22.12451; Zinszner H, 1997, J CELL SCI, V110, P1741	83	108	110	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32300	32312		10.1074/jbc.M104207200	http://dx.doi.org/10.1074/jbc.M104207200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11438536	hybrid			2022-12-27	WOS:000170613500112
J	Smith, SM; Khoroshev, M; Marx, PA; Orenstein, J; Jeang, KT				Smith, SM; Khoroshev, M; Marx, PA; Orenstein, J; Jeang, KT			Constitutively dead, conditionally live, HIV-1 genomes - Ex vivo implications for a live virus vaccine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; NEF GENE; TYPE-1 REPLICATION; MAMMALIAN-CELLS; ATTENUATED SIV; TAT PROTEIN; IN-VIVO; TRANSCRIPTION; INFECTION	An effective vaccine against AIDS is unlikely to be available for many years. As we approach two decades since the first identification of human immunodeficiency virus, type 1 (HIV-1), currently, only one subunit vaccine candidate has reached phase 3 of clinical trials. The subunit approach has been criticized for its inability to elicit effectively cytotoxic T-lymphocyte (CTL) response, which is felt by many to be needed for protection against HIV-1 infection. In subhuman primates, a live attenuated simian immunodeficiency virus (SIV) vaccine candidate, capable of inducing CTL, has been found to confer prophylactic immunity sufficient to prevent simian AIDS. Because replication competent (live) attenuated viruses could over time revert to virulence, such a live attenuated approach has largely been dismissed for HIV-1. Here, we describe the creation of constitutively dead conditionally live (CDCL) HIV-1 genomes. These genomes are constitutively defective for the Tat/TAR axis and are conditionally dependent on tetracycline for attenuated replication with robust expression of viral antigens. Our results suggest that CDCL genomes merit consideration as safer "live" attenuated HIV-1 vaccine candidates.	NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, St Michaels Med Ctr, Newark, NJ 07102 USA; Tulane Reg Primate Res Ctr, Covington, LA 70433 USA; Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; George Washington Univ, Sch Med, Dept Pathol, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center; Tulane University; Rockefeller University; George Washington University	Jeang, KT (corresponding author), NIAID, Mol Microbiol Lab, NIH, Bldg 4,Rm 306,900 Rockville Pike, Bethesda, MD 20892 USA.		Jeang, Kuan-Teh/A-2424-2008; Smith, Stephen/GQQ-5975-2022	Smith, Stephen/0000-0002-9158-6136	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046316, ZIAAI000547, Z01AI000547] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46316-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; Altman LK, 1998, NY TIMES; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Berkhout B, 1999, J VIROL, V73, P1138, DOI 10.1128/JVI.73.2.1138-1145.1999; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Chakrabarti BK, 1996, P NATL ACAD SCI USA, V93, P9810, DOI 10.1073/pnas.93.18.9810; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Das AT, 1998, J VIROL, V72, P9217, DOI 10.1128/JVI.72.11.9217-9223.1998; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guan YJ, 2000, J VIROL, V74, P8854, DOI 10.1128/JVI.74.19.8854-8860.2000; Harrich D, 1996, J VIROL, V70, P4017, DOI 10.1128/JVI.70.6.4017-4027.1996; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; HUANG LM, 1994, EMBO J, V13, P2886, DOI 10.1002/j.1460-2075.1994.tb06583.x; *INT AIDS VACC IN, 2000, AIDS VACC WORLD PREP; *INT AIDS VACC IN, 2000, IAVA SCI BLUEPR 2000; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; JEANG KT, 1993, J BIOL CHEM, V268, P24940; Johnson RP, 1996, CURR OPIN IMMUNOL, V8, P554, DOI 10.1016/S0952-7915(96)80046-X; Kelly JK, 1996, J THEOR BIOL, V180, P359, DOI 10.1006/jtbi.1996.0108; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Klasens BIF, 1999, BBA-GENE STRUCT EXPR, V1444, P355, DOI 10.1016/S0167-4781(99)00011-1; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Liang C, 2000, J VIROL, V74, P6251, DOI 10.1128/JVI.74.14.6251-6261.2000; Liljeqvist S, 1999, J BIOTECHNOL, V73, P1, DOI 10.1016/S0168-1656(99)00107-8; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Nathanson N, 2000, J INFECT DIS, V182, P579, DOI 10.1086/315707; Quinto I, 1999, J BIOL CHEM, V274, P17567, DOI 10.1074/jbc.274.25.17567; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Smith SM, 1996, P NATL ACAD SCI USA, V93, P7955, DOI 10.1073/pnas.93.15.7955; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Verhoef K, 2001, J VIROL, V75, P979, DOI 10.1128/JVI.75.2.979-987.2001; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; 1997, J AM MED ASS, V277, P525	42	31	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32184	32190		10.1074/jbc.M101604200	http://dx.doi.org/10.1074/jbc.M101604200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11397795	hybrid			2022-12-27	WOS:000170613500097
J	Wang, LH; Yang, XY; Mihalic, K; Xiao, WH; Li, DP; Farrar, WL				Wang, LH; Yang, XY; Mihalic, K; Xiao, WH; Li, DP; Farrar, WL			Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PLAS3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INHIBITOR; SIGNAL-TRANSDUCTION; ER-ALPHA; APOPTOSIS; MODULATION; EXPRESSION; PROMOTER; MODEL; GP130; ACTS	Estrogen receptors (ERs)(1) highly expressed by multiple myeloma (NM) cells and stimulation of estrogenic ligands leads to cell apoptosis. Interleukin (IL)-6 is a major growth factor in the pathogenesis of MM. However, little is known concerning the molecular consequences of ER activation on IL-6-regulated AM cell growth. Here we show that the ER agonist 17 beta -estradiol completely abolished IL-6-inducible AM cell proliferation. By contrast, the ER antagonist ICI 182,780 overcame the inhibitory effect of estrogen. Estrogen blocked STAT3 DNA binding and transactivation but failed to affect the mRNA expression of IL-6 receptor chains or activation of JAK2 and STAT3. Estrogen-activated ER did not associate directly with STAT3. Estrogen induced the mRNA expression of PIAS3 ((p) under bar rotein (i) under bar nhibitor of (a) under bar ctivated (S) under bar TAT (3) under bar) and increased PIAS3 physical association with STAT3, suggesting a possible mechanism of STAT3 inhibition requiring PIAS3 as a co-regulator modulating the cross-talk between ER and STAT3. These data directly demonstrate STAT3 to be a molecular participant in ER inhibition of the IL-6 signaling pathway in human AM cells and provides the molecular basis for the potential use of estrogenic ligands in the treatment of AM or other tumors where IL-6 has an autocrine or paracrine role.	Sci Applicat Int Corp, Intramural Res Support Program, NCI, Frederick, MD 21702 USA; NCI, Div Basic Sci, Mol Immunoregulat Lab, Cytokine Mol Mech Sect, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wang, LH (corresponding author), Sci Applicat Int Corp, Intramural Res Support Program, NCI, Frederick, MD 21702 USA.		Xiao, Weihua/N-2775-2013	Xiao, Weihua/0000-0001-9102-6326	NCI NIH HHS [N01-CO-56000] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson K, 1999, SEMIN ONCOL, V26, P10; Barille S, 1999, BRIT J HAEMATOL, V106, P532, DOI 10.1046/j.1365-2141.1999.01563.x; BATAILLE R, 1989, J CLIN INVEST, V84, P2008, DOI 10.1172/JCI114392; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen YH, 1997, LEUKEMIA LYMPHOMA, V27, P11, DOI 10.3109/10428199709068267; Chiu JJ, 1996, CLIN CANCER RES, V2, P215; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cooke PS, 1998, BIOL REPROD, V59, P470, DOI 10.1095/biolreprod59.3.470; Cowley SM, 1999, J STEROID BIOCHEM, V69, P165, DOI 10.1016/S0960-0760(99)00055-2; Dankbar B, 2000, BLOOD, V95, P2630, DOI 10.1182/blood.V95.8.2630; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Duhe RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P17, DOI 10.1385/CBB:34:1:17; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Gado K, 2000, CELL BIOL INT, V24, P195, DOI 10.1006/cbir.2000.0497; Glass CK, 2000, GENE DEV, V14, P121; Govind AP, 2001, J CELL BIOCHEM, V80, P571, DOI 10.1002/1097-4644(20010315)80:4<571::AID-JCB1011>3.0.CO;2-H; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Kastrinakis NG, 2000, ANN ONCOL, V11, P1217, DOI 10.1023/A:1008331714186; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; Kurebayashi J, 1998, ONCOLOGY-BASEL, V55, P23, DOI 10.1159/000055256; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; NILSSON K, 1990, CURR TOP MICROBIOL, V166, P3; Otsuki T, 2000, CANCER RES, V60, P1434; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; POTTRATZ ST, 1994, J CLIN INVEST, V93, P944, DOI 10.1172/JCI117100; Rebouissou C, 1998, BLOOD, V91, P4727, DOI 10.1182/blood.V91.12.4727.412k35_4727_4737; Reece D E, 1998, Curr Opin Hematol, V5, P460, DOI 10.1097/00062752-199811000-00018; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Seiden Michael V., 1994, Current Opinion in Oncology, V6, P41, DOI 10.1097/00001622-199401000-00006; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Sjak-Shie NN, 2000, CURR OPIN HEMATOL, V7, P241, DOI 10.1097/00062752-200007000-00007; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Tan JA, 2000, MOL ENDOCRINOL, V14, P14, DOI 10.1210/me.14.1.14; Treon S P, 1998, Curr Opin Hematol, V5, P42; Treon SP, 2000, SEMIN ONCOL, V27, P598; Treon SP, 1998, BLOOD, V92, P1749, DOI 10.1182/blood.V92.5.1749.417k38_1749_1757; Ueki N, 1999, J HUM GENET, V44, P193, DOI 10.1007/s100380050141; Varterasian Mary L., 1999, Current Opinion in Oncology, V11, P3, DOI 10.1097/00001622-199901000-00002; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Wang LH, 1999, J IMMUNOL, V162, P3897; Wang LH, 2000, BLOOD, V95, P1249, DOI 10.1182/blood.V95.4.1249.004k39_1249_1257; Westendorf JJ, 1996, LEUKEMIA, V10, P866; Xu FH, 1998, BLOOD, V92, P241, DOI 10.1182/blood.V92.1.241.413k28_241_251; Yamamoto T, 2000, FEBS LETT, V486, P143, DOI 10.1016/S0014-5793(00)02296-1; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	54	67	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31839	31844		10.1074/jbc.M105185200	http://dx.doi.org/10.1074/jbc.M105185200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11429412	hybrid			2022-12-27	WOS:000170613500051
J	Gallego, RG; Blanco, JLJ; Thijssen-van Zuylen, CWEM; Gotfredsen, CH; Voshol, H; Duus, JO; Schachner, M; Vliegenthart, JFG				Gallego, RG; Blanco, JLJ; Thijssen-van Zuylen, CWEM; Gotfredsen, CH; Voshol, H; Duus, JO; Schachner, M; Vliegenthart, JFG			Epitope diversity of N-glycans from bovine peripheral myelin glycoprotein P0 revealed by mass spectrometry and nano probe magic angle spinning H-1 NMR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED CARBOHYDRATE CHAINS; NEURAL CELL-ADHESION; L-SELECTIN; L2/HNK-1 CARBOHYDRATE; EXPRESSION CLONING; NERVOUS-SYSTEM; PROTEIN ZERO; PO PROTEIN; SULFOGLUCURONYL GLYCOLIPIDS; BRAIN GLYCOPROTEINS	The carbohydrate structures present on the glycoproteins in the central and peripheral nerve systems are essential in many cell adhesion processes. The PO glycoprotein, expressed by myelinating Schwann cells, plays an important role during the formation and maintenance of myelin, and it is the most abundant constituent of myelin. Using monoclonal antibodies, the homophilic binding of the PO glycoprotein was shown to be mediated via the human natural keller cell (HNK)-1 epitope (3-O-SO3H-GlcUA(beta1-3)Gal(beta1-4)GlcNAc) present on the N-glycans. We recently described the structure of the N-glycan carrying the HNK-1 epitope, present on bovine peripheral myelin PO (Voshol, H., van Zuylen, C. W. E. M., Orberger, G., Vliegenthart, J. F. G., and Schachner, M. (1996) J. Biol Chem. 271, 22957-22960). In this study, we report on the structural characterization of the detectable glycoforms, present on the single N-glycosylation site, using state-of-the-art NMR and mass spectrometry techniques. Even though all structures belong to the hybrid- or biantennary complex-type structures, the variety of epitopes is remarkable. In addition to the 3-O-sulfate present on the HNK-1-carrying structures, most of the glycans contain a 6-O-sulfated N-acetylglucosamine residue. This indicates the activity of a 6-O-sulfo-GlcNAc-transferase, which has not been described before in peripheral nervous tissue. The presence of the disialo-, galactosyl-, and 6-O-sulfosialyl-Lewis X epitopes provides evidence for glycosyltransferase activities not detected until now. The finding of such an epitope diversity triggers questions related to their function and whether events, previously attributed merely to the HNK-1 epitope, could be mediated by the structures described here.	Univ Utrecht, Bijvoet Ctr, Dept Bioorgan Chem, NL-3508 TB Utrecht, Netherlands; Swiss Fed Inst Technol, Dept Neurobiol, CH-8093 Zurich, Switzerland; Carlsberg Lab, Dept Chem, DK-2500 Copenhagen, Denmark	Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Vliegenthart, JFG (corresponding author), Univ Utrecht, Bijvoet Ctr, Dept Bioorgan Chem, POB 80075, NL-3508 TB Utrecht, Netherlands.	vlieg@pobox.uu.nl	Jiménez-Blanco, José L/M-3946-2013; Duus, Jens Øllgaard/N-4279-2013; Gotfredsen, Charlotte Held/ABC-8211-2021	Jiménez-Blanco, José L/0000-0002-5249-9013; Duus, Jens Øllgaard/0000-0003-3625-1250; Gotfredsen, Charlotte Held/0000-0002-7386-119X; Gutierrez Gallego, Ricardo/0000-0001-9639-2181				Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; BADACHE A, 1992, DEV NEUROSCI-BASEL, V14, P342, DOI 10.1159/000111681; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BERGWERFF AA, 1995, GLYCOCONJUGATE J, V12, P318, DOI 10.1007/BF00731335; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; BOUCHON B, 1992, GLYCOCONJUGATE J, V9, P27, DOI 10.1007/BF00731175; Bowman KG, 1998, CHEM BIOL, V5, P447, DOI 10.1016/S1074-5521(98)90161-2; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Broberg A, 2000, CARBOHYD RES, V328, P375, DOI 10.1016/S0008-6215(00)00108-7; BRUNDEN KR, 1992, J NEUROCHEM, V58, P1659, DOI 10.1111/j.1471-4159.1992.tb10038.x; BURGER D, 1990, J NEUROCHEM, V54, P1569, DOI 10.1111/j.1471-4159.1990.tb01206.x; BURGER D, 1992, J NEUROCHEM, V58, P845, DOI 10.1111/j.1471-4159.1992.tb09334.x; BURGER D, 1992, J NEUROCHEM, V58, P854, DOI 10.1111/j.1471-4159.1992.tb09335.x; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DASGUPTA S, 1994, ARCH BIOCHEM BIOPHYS, V310, P373, DOI 10.1006/abbi.1994.1181; Degroote S, 1997, J BIOL CHEM, V272, P29493, DOI 10.1074/jbc.272.47.29493; DEWAARD P, 1991, J BIOL CHEM, V266, P4237; DORLAND L, 1986, CARBOHYD RES, V151, P233, DOI 10.1016/S0008-6215(00)90344-6; Fan OW, 1999, GLYCOBIOLOGY, V9, P947, DOI 10.1093/glycob/9.9.947; FIELD MC, 1992, J NEUROCHEM, V58, P993, DOI 10.1111/j.1471-4159.1992.tb09353.x; FILBIN MT, 1991, NEURON, V7, P845, DOI 10.1016/0896-6273(91)90286-9; FILBIN MT, 1993, J CELL BIOL, V122, P451, DOI 10.1083/jcb.122.2.451; FINNE J, 1989, CIBA F SYMP, V145, P173; FINNE J, 1977, BIOCHEM BIOPH RES CO, V74, P405, DOI 10.1016/0006-291X(77)90318-7; FINNE J, 1977, EUR J BIOCHEM, V77, P319, DOI 10.1111/j.1432-1033.1977.tb11670.x; FINNE J, 1975, BIOCHIM BIOPHYS ACTA, V412, P317, DOI 10.1016/0005-2795(75)90046-X; FUKUDA M, 1984, J BIOL CHEM, V259, P4782; FUKUDA M, 1987, J BIOL CHEM, V262, P11952; Funakoshi Y, 1997, GLYCOBIOLOGY, V7, P195, DOI 10.1093/glycob/7.2.195; GALILI U, 1993, SPRINGER SEMIN IMMUN, V15, P155; Galustian C, 1997, BIOCHEM BIOPH RES CO, V240, P748, DOI 10.1006/bbrc.1997.7737; Georgiou J, 1999, GLIA, V27, P101, DOI 10.1002/(SICI)1098-1136(199908)27:2<101::AID-GLIA1>3.0.CO;2-H; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; GRIFFITH LS, 1992, J NEUROSCI RES, V33, P639, DOI 10.1002/jnr.490330417; HALL H, 1995, GLYCOBIOLOGY, V5, P435, DOI 10.1093/glycob/5.4.435; HALL H, 1993, EUR J NEUROSCI, V5, P34, DOI 10.1111/j.1460-9568.1993.tb00202.x; Hall H, 1997, EUR J BIOCHEM, V246, P233, DOI 10.1111/j.1432-1033.1997.t01-1-00233.x; Hall H, 1997, J NEUROCHEM, V68, P544; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; ILYAS AA, 1990, J NEUROCHEM, V55, P594, DOI 10.1111/j.1471-4159.1990.tb04175.x; Jaques AJ, 1996, BIOCHEM J, V316, P427, DOI 10.1042/bj3160427; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KANDA T, 1995, P NATL ACAD SCI USA, V92, P7897, DOI 10.1073/pnas.92.17.7897; KIANG WL, 1982, J BIOL CHEM, V257, P1651; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; KITAJIMA K, 1984, BIOCHEMISTRY-US, V23, P310, DOI 10.1021/bi00297a021; Kupce E, 1998, J MAGN RESON, V135, P361, DOI 10.1006/jmre.1998.1607; Lee JK, 1999, BIOCHEM BIOPH RES CO, V263, P543, DOI 10.1006/bbrc.1999.1324; MANZI A, 1995, J BIOL CHEM, V270, P9154, DOI 10.1074/jbc.270.16.9154; MARTINI R, 1994, GLIA, V10, P70, DOI 10.1002/glia.440100109; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; MARTINI R, 1988, DEV BIOL, V129, P330, DOI 10.1016/0012-1606(88)90380-6; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; MICHALSKI JC, 1991, EUR J BIOCHEM, V201, P439, DOI 10.1111/j.1432-1033.1991.tb16302.x; MICHON F, 1987, BIOCHEMISTRY-US, V26, P8399, DOI 10.1021/bi00399a055; MOHAN PS, 1990, J NEUROCHEM, V54, P2024, DOI 10.1111/j.1471-4159.1990.tb04907.x; Nastuk MA, 1998, J NEUROSCI, V18, P7167; NEEDHAM LK, 1993, P NATL ACAD SCI USA, V90, P1359, DOI 10.1073/pnas.90.4.1359; NOGUCHI S, 1992, EUR J BIOCHEM, V209, P883, DOI 10.1111/j.1432-1033.1992.tb17361.x; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; PODUSLO JF, 1990, J BIOL CHEM, V265, P3719; Sato C, 1998, ANAL BIOCHEM, V261, P191, DOI 10.1006/abio.1998.2718; Sato C, 1998, J BIOL CHEM, V273, P2575, DOI 10.1074/jbc.273.5.2575; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato Y, 1999, GLYCOBIOLOGY, V9, P655, DOI 10.1093/glycob/9.7.655; SCHACHNER M, 1995, TRENDS NEUROSCI, V18, P183, DOI 10.1016/0166-2236(95)93899-9; Schachner M, 1995, PROG BRAIN RES, V105, P183; SCHNEIDERSCHAULIES J, 1990, J NEUROSCI RES, V27, P286, DOI 10.1002/jnr.490270307; SEPPO A, 1994, GLYCOCONJUGATE J, V11, P217, DOI 10.1007/BF00731221; Spiro RG, 1996, BIOCHEM J, V319, P209, DOI 10.1042/bj3190209; Stroop CJM, 2000, ARCH BIOCHEM BIOPHYS, V374, P42, DOI 10.1006/abbi.1999.1660; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; UYEMURA K, 1991, COMP BIOCHEM PHYS C, V98, P63; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; VORM O, 1994, J AM SOC MASS SPECTR, V5, P955, DOI 10.1016/1044-0305(94)80013-8; Voshol H, 1996, J BIOL CHEM, V271, P22957, DOI 10.1074/jbc.271.38.22957; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Weiss Eveline, 1991, Agraroekologie, V1, P1; YAZAKI T, 1992, FEBS LETT, V307, P361, DOI 10.1016/0014-5793(92)80713-Q; Yoshida M, 1996, NEURON, V16, P1115, DOI 10.1016/S0896-6273(00)80138-5; Zhang K, 1996, J NEUROSCI RES, V45, P525, DOI 10.1002/(SICI)1097-4547(19960901)45:5<525::AID-JNR2>3.0.CO;2-E	88	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30834	30844		10.1074/jbc.M101013200	http://dx.doi.org/10.1074/jbc.M101013200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11410585	hybrid			2022-12-27	WOS:000170472900035
J	Kreuger, J; Salmivirta, M; Sturiale, L; Gimenez-Gallego, G; Lindahl, U				Kreuger, J; Salmivirta, M; Sturiale, L; Gimenez-Gallego, G; Lindahl, U			Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOGENIC ACTIVITY; CRYSTAL-STRUCTURE; BINDING SEQUENCE; CELL-SURFACE; BASIC FGF; PROTEOGLYCANS; RECEPTOR; DOMAINS; OLIGOSACCHARIDES; 6-O-SULFATION	Proteins that belong to the fibroblast growth factor (FGF) family regulate proliferation, migration, and differentiation of many cell types. Several FGFs, including the prototype factors FGF-1 and FGF-2, depend on interactions with heparan sulfate (HS) proteoglycans for activity. We have assessed tissue-derived HS fragments for binding to FGF-1 and FGF-2 to identify the authentic saccharide motifs required for interactions. Sequence information on a range of N-sulfated HS octasaccharides spanning from low to high affinity for FGF-1 was obtained. All octasaccharides with high affinity for FGF-1 (greater than or equal to0.5 m NaCl required for elution) contained an internal IdoUA(2-OSO3)-GlcNSO(3)(6-OSO3)-IdoUA(2-OSO3)-trisaccharide motif. Octasaccharides with a higher overall degree of sulfation but lacking the specific trisaccharide motif showed lower affinity for FGF-1. FGF-2 was shown to bind to a mono-O-sulfated HS 6-mer carrying a single internal IdoUA(2-OSO3)-unit. However, a di-O-sulfated -IdoUA(2-OSO3)-GlcNSO(3)-IdoUA(2-OSO3)-trisaccharide sequence within a HS 8-mer gave stronger binding. These findings show that not only the number but also the positions of individual sulfate groups determine affinity of HS for FGFs. Our findings support the notion that FGF-dependent processes can be modulated in vivo by regulated expression of distinct HS sequences.	Uppsala Univ, Dept Med Biochem & Micorbiol, S-75123 Uppsala, Sweden; Abo Akad Univ, FIN-20521 Turku, Finland; Univ Turku, Turku Ctr Biotechnol, FIN-20521 Turku, Finland; BioTic Therapies Corp, FIN-20520 Turku, Finland; G Ronzoni Inst Chem & Biochem Res, I-20133 Milan, Italy; CSIC, Ctr Invest Biol, E-28006 Madrid, Spain	Uppsala University; Abo Akademi University; University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Lindahl, U (corresponding author), Uppsala Univ, Dept Med Biochem & Micorbiol, POB 582, S-75123 Uppsala, Sweden.		Kreuger, Johan/HDM-1503-2022	STURIALE, LUISELLA/0000-0002-3996-1138				Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BOURIN MC, 1993, BIOCHEM J, V289, P313, DOI 10.1042/bj2890313; CASU B, 2001, IN PRESS ADV CARBOHY; Chang Z, 2000, FASEB J, V14, P137, DOI 10.1096/fasebj.14.1.137; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; ESKO JD, 2001, IN PRESS J CLIN INVE; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P451, DOI 10.1093/glycob/4.4.451; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P817, DOI 10.1093/glycob/4.6.817; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8; LYON M, 1994, J BIOL CHEM, V269, P11208; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Nurcombe V, 2000, J BIOL CHEM, V275, P30009, DOI 10.1074/jbc.M003038200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Safaiyan F, 2000, BIOCHEMISTRY-US, V39, P10823, DOI 10.1021/bi000411s; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Vives RR, 1999, BIOCHEM J, V339, P767, DOI 10.1042/0264-6021:3390767; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yoneda A, 2000, NAT BIOTECHNOL, V18, P641, DOI 10.1038/76487; ZAZO M, 1992, GENE, V113, P231, DOI 10.1016/0378-1119(92)90400-J	44	186	189	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30744	30752		10.1074/jbc.M102628200	http://dx.doi.org/10.1074/jbc.M102628200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11406624	hybrid, Green Published			2022-12-27	WOS:000170472900023
J	Lavigne, M; Polomack, L; Buc, H				Lavigne, M; Polomack, L; Buc, H			DNA synthesis by HIV-1 reverse transcriptase at the central termination site - A kinetic study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROOVE BINDING TRACK; VERTICAL-SCANNING MUTAGENESIS; MINOR-GROOVE; CRITICAL TRYPTOPHAN; SECONDARY STRUCTURE; COMPLEX-FORMATION; THUMB SUBDOMAIN; INITIATION; MECHANISM; GENOME	Human immunodeficiency virus, type 1 (HIV-1) reverse transcriptase (RT) terminates plus-strand DNA synthesis at the center of the HIV-1 genome, a process important for HIV-1 infectivity. The central termination sequence contains two termination sites (Ter1 and Ter2) located at the 3 ' -end of A(n)T(m) motifs, and the narrowing of the DNA minor groove generated by these motifs is responsible for termination. Kinetic data associated with the binding of RT and its ability to elongate in vitro various DNA duplexes and triplexes surrounding the Ter2 terminator were analyzed using a simple kinetic scheme. At Ter2, RT still displays a reasonable affinity for the corresponding DNA, but the binding of the next nucleotide and above all its incorporation rate are markedly hampered. Features affecting the width of the minor groove act directly at this last step. The constraint exerted against elongation by the A(n)T(m). tract persists at two positions downstream of the terminator.	Inst Pasteur, Unite Physicochim Macromol Biol, URA1773, CNRS, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lavigne, M (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Wellman 10,Fruit St, Boston, MA 02114 USA.			LAVIGNE, Marc/0000-0002-3131-2539				Beard WA, 1998, J BIOL CHEM, V273, P30435, DOI 10.1074/jbc.273.46.30435; Beard WA, 1996, J BIOL CHEM, V271, P12213, DOI 10.1074/jbc.271.21.12213; BEARD WA, 1994, J BIOL CHEM, V269, P28091; BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Forgacs E, 1997, J BIOL CHEM, V272, P8525, DOI 10.1074/jbc.272.13.8525; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KATI WM, 1992, J BIOL CHEM, V267, P25988; Lanchy JM, 1998, J BIOL CHEM, V273, P24425, DOI 10.1074/jbc.273.38.24425; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LATHAM GJ, 1994, J BIOL CHEM, V269, P28527; Latham GJ, 2000, J BIOL CHEM, V275, P15025, DOI 10.1074/jbc.M000279200; Lavigne M, 1997, J MOL BIOL, V266, P507, DOI 10.1006/jmbi.1996.0805; Lavigne M, 2001, J BIOL CHEM, V276, P31439, DOI 10.1074/jbc.M102976200; Lavigne M, 1999, J MOL BIOL, V285, P977, DOI 10.1006/jmbi.1998.2367; MCCLURE WR, 1980, P NATL ACAD SCI-BIOL, V77, P5634, DOI 10.1073/pnas.77.10.5634; REARDON JE, 1993, J BIOL CHEM, V268, P8743; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; Stetor SR, 1999, BIOCHEMISTRY-US, V38, P3656, DOI 10.1021/bi982764l; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Suo ZC, 1999, BIOCHEMISTRY-US, V38, P715, DOI 10.1021/bi981854n; Suo ZC, 1998, J BIOL CHEM, V273, P27259, DOI 10.1074/jbc.273.42.27259; Thrall SH, 1998, BIOCHEMISTRY-US, V37, P13349; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; UNGE T, 1990, AIDS RES HUM RETROV, V6, P1297, DOI 10.1089/aid.1990.6.1297; Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	33	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31429	31438		10.1074/jbc.M102974200	http://dx.doi.org/10.1074/jbc.M102974200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402036	hybrid			2022-12-27	WOS:000170472900109
J	Rogers, GW; Richter, NJ; Lima, WF; Merrick, WC				Rogers, GW; Richter, NJ; Lima, WF; Merrick, WC			Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC INITIATION-FACTORS; SINGLE-STRANDED-DNA; BOX PROTEIN EIF4A; CRYSTAL-STRUCTURE; FACTOR 4A; ANTISENSE OLIGONUCLEOTIDES; SACCHAROMYCES-CEREVISIAE; KINETIC CHARACTERIZATION; MESSENGER-RNA; STEP-SIZE	Eukaryotic initiation factor (eIF) 4A is a DEAD box RNA helicase that works in conjunction with eIF4B, eIF4H, or as a subunit of eIF4F to unwind secondary structure in the 5 ' -untranslated region of mRNA, which facilitates binding of the mRNA to the 40 S ribosomal subunit. This study demonstrates how the helicase activity of eIF4A is modulated by eIF4B, eIF4H, or as a subunit of eIF4F. Results indicate that a linear relationship exists between the initial rate or amplitude of unwinding and duplex stability for all factor combinations tested. eIF4F, like eIF4A, behaves as a non-processive helicase. Either eIF4B or eIF4H stimulated the initial rate and amplitude of eIF4A-dependent duplex unwinding, and the magnitude of stimulation is dependent on duplex stability. Furthermore, eIF4A (or eIF4F) becomes a slightly processive helicase in the presence of eIF4B or eIF4H. All combinations of factors tested indicate that the rate of duplex unwinding is equivalent in the 5 ' --> 3 ' and 3 ' --> 5 ' directions. However, the optimal rate of unwinding was dependent on the length of the single-stranded region of the substrate when different combinations of factors were used. The combinations of eIF4A, eIF4A + eIF4B, eIF4A + eIF4H, and cIF4F showed differences in their ability to unwind chemically modified duplexes. A simple model of how eIF4B or eIF4H affects the duplex unwinding mechanism of eIF4A is proposed.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; ISIS Pharmaceut Inc, Carlsbad, CA 92008 USA	Case Western Reserve University; Isis Pharmaceuticals Inc	Merrick, WC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	wcm2@po.cwru.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026796] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07319] Funding Source: Medline; NIGMS NIH HHS [GM26796] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; ABRAMSON RD, 1988, J BIOL CHEM, V263, P5462; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Altmann KH, 1996, BIOCHEM SOC T, V24, P630, DOI 10.1042/bst0240630; Altmann KH, 1996, CHIMIA, V50, P168; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; Bjornson KP, 1998, BIOCHEMISTRY-US, V37, P891, DOI 10.1021/bi9719307; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; CROOKE ST, 1995, THERAPEUTIC APPL OLI, P53; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LAWSON TG, 1989, BIOCHEMISTRY-US, V28, P4729, DOI 10.1021/bi00437a033; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; Merrick WC, 1997, METHODS, V11, P333, DOI 10.1006/meth.1996.0431; Merrick WC., 1996, TRANSLATION CONTROL, P31; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1996, RNA, V2, P38; NARANDA T, 1994, J BIOL CHEM, V269, P14465; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Richter NJ, 1999, J BIOL CHEM, V274, P35415, DOI 10.1074/jbc.274.50.35415; Richter-Cook NJ, 1998, J BIOL CHEM, V273, P7579, DOI 10.1074/jbc.273.13.7579; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P12598, DOI 10.1074/jbc.M007560200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P4128, DOI 10.1021/bi00066a039; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; SONENBERG N, 1981, CELL, V27, P563, DOI 10.1016/0092-8674(81)90398-6; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	50	252	257	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30914	30922		10.1074/jbc.M100157200	http://dx.doi.org/10.1074/jbc.M100157200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418588	hybrid			2022-12-27	WOS:000170472900045
J	Viswanathan, M; Burdett, V; Baitinger, C; Modrich, P; Lovett, ST				Viswanathan, M; Burdett, V; Baitinger, C; Modrich, P; Lovett, ST			Redundant exonuclease involvement in Escherichia coli methyl-directed mismatch repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL HETEROLOGOUS SEQUENCES; MUTANTS DEFICIENT; RECJ-GENE; DNA; RECOMBINATION; MUTS; HELICASE; PURIFICATION; REPLICATION; SPECIFICITY	Previous biochemical analysis of Escherichia coli methyl-directed mismatch repair implicates three redundant single-strand DNA-specific exonucleases (RecJ, ExoI, and ExoVII) and at least one additional unknown exonuclease in the excision reaction (Cooper, D. L., Lahue, IL S., and Modrich, P. (1993) J. BioL Chem. 268, 11823-11829). We show here that ExoX also participates in methyl-directed mismatch repair. Analysis of the reaction with crude extracts and purified components demonstrated that ExoX can mediate repair directed from a strand signal 3 ' of a mismatch. Whereas extracts of all possible single, double, and triple exonuclease mutants displayed significant residual mismatch repair, extracts deficient in RecJ, ExoI, ExoVII, and ExoX exonucleases were devoid of normal repair activity. The RecJ(-) ExoVII(-) ExoI(-) ExoX(-) strain displayed a 7-fold increase in mutation rate, a significant increase, but less than that observed for other blocks of the mismatch repair pathway. This elevation is epistatic to deficiency for MutS, suggesting an effect via the mismatch repair pathway. Our other work (Burdett, V., Baitinger, C., Viswanathan, M., Lovett, S. T., and Modrich, P. (2001) Proc. Natl. Acad. Sci. U. S. A 98, 6765-6770) suggests that mutants are under-recovered in the exonuclease-deficient strain due to loss of viability that is triggered by mismatched base pairs in this genetic background. The availability of any one exonuclease is enough to support full mismatch correction, as evident from the normal mutation rates of all triple mutants. Because three of these exonucleases possess a strict polarity of digestion, this suggests that mismatch repair can occur exclusively from a 3 ' or a 5 ' direction to the mismatch, if necessary.	Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Brandeis University; Brandeis University; Duke University; Duke University; Howard Hughes Medical Institute	Lovett, ST (corresponding author), Rosenstiel Basic Med Sci Res Ctr, MS029, Waltham, MA 02454 USA.	lovett@brandeis.edu	Lovett, Susan/AAC-1810-2021	Lovett, Susan/0000-0003-2792-1857; Modrich, Paul/0000-0001-8708-9885	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023719, R01GM043889, R01GM023719] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43889, GM07122, GM23719] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; AU KG, 1992, J BIOL CHEM, V267, P12142; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; CHASE JW, 1974, J BIOL CHEM, V249, P4553; CHASE JW, 1977, J BACTERIOL, V129, P934, DOI 10.1128/JB.129.2.934-947.1977; CHASE JW, 1974, J BIOL CHEM, V249, P4545; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; Fang WH, 1997, J BIOL CHEM, V272, P22714, DOI 10.1074/jbc.272.36.22714; FENG WY, 1995, GENETICS, V140, P1175; Friedman-Ohana R, 1998, P NATL ACAD SCI USA, V95, P6909, DOI 10.1073/pnas.95.12.6909; Galio L, 1999, NUCLEIC ACIDS RES, V27, P2325, DOI 10.1093/nar/27.11.2325; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; Harris RS, 1998, J BACTERIOL, V180, P989, DOI 10.1128/JB.180.4.989-993.1998; KRISTENSEN CS, 1995, J BACTERIOL, V177, P52, DOI 10.1128/jb.177.1.52-58.1995; KUSHNER SR, 1971, P NATL ACAD SCI USA, V68, P824, DOI 10.1073/pnas.68.4.824; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; LOVETT ST, 1995, GENETICS, V140, P27; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; LOVETT ST, 1984, J BACTERIOL, V157, P190, DOI 10.1128/JB.157.1.190-196.1984; MESELSON M, 1988, RECOMBINATION GENETI, P91; Miesel L, 1996, J BACTERIOL, V178, P3146, DOI 10.1128/jb.178.11.3146-3155.1996; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; PARKER BO, 1992, P NATL ACAD SCI USA, V89, P1730, DOI 10.1073/pnas.89.5.1730; Razavy H, 1996, GENETICS, V142, P333; Saveson CJ, 1997, GENETICS, V146, P457; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; Viswanathan M, 1999, J BIOL CHEM, V274, P30094, DOI 10.1074/jbc.274.42.30094; Viswanathan M, 2000, J MOL BIOL, V302, P553, DOI 10.1006/jmbi.2000.4088; Viswanathan M, 1998, GENETICS, V149, P7; WAGNER R, 1976, P NATL ACAD SCI USA, V73, P4135, DOI 10.1073/pnas.73.11.4135	38	101	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31053	31058		10.1074/jbc.M105481200	http://dx.doi.org/10.1074/jbc.M105481200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11418610	hybrid			2022-12-27	WOS:000170472900062
J	Koumoto, Y; Shimada, T; Kondo, M; Hara-Nishimura, I; Nishimura, M				Koumoto, Y; Shimada, T; Kondo, M; Hara-Nishimura, I; Nishimura, M			Chloroplasts have a novel Cpn10 in addition to Cpn20 as co-chaperonins in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IN-VIVO; GROES; IDENTIFICATION; 2.8-ANGSTROM; SENESCENCE; SEQUENCE; PROTEINS; COMPLEX	Previously, we characterized a mitochondrial co-chaperonin (Cpn10) and a chloroplast co-chaperonin (Cpn20) from Arabidopsis thaliana (Koumoto, Y., Tsugeki, R., Shimada, T., Mori, H, Kondo, M, Hara-Nishimura, I, and Nishimura, M. (1996) Plant J.. 10, 1119-1125; Koumoto, Y., Shimada, T., Kondo, M., Taka, T., Shimonishi, Y., Hara-Nishimura, I, and Nishimura, M (1999) Plant J. 17, 467-477). Here, we report a third co-chaperonin. The cDNA was 603 base pairs long, encoding a protein of 139 amino acids. From a sequence analysis, the protein was predicted to have one Cpn10 domain with an amino-terminal extension that might work as a chloroplast transit peptide. This novel Cpn10 was confirmed to be localized in chloroplasts, and we refer to it as chloroplast Cpn10 (chI-Cpn10). The phylogenic tree that was generated with amino acid sequences of other co-chaperonins indicates that chl-Cpn10 is highly divergent from the others. In the GroEL-assisted protein folding assay,. about 30% of the substrates were refolded with chI-Cpn10. indicating that chI-Cpn10 works as a co-chaperonin. A Northern blot analysis revealed that mRNA for chI-Cpn10 is accumulated in the leaves and stems, but not in the roots. In germinating cotyledons, the accumulation of chI-Cpn10 was similar to that of chloroplastic proteins and accelerated by light. It was proposed that two kinds of co-chaperonins, Cpn20 and chI-Cpn10, work independently in the chloroplast.	Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto University	Nishimura, M (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan.	mikosome@nibb.ac.jp		Nishimura, Mikio/0000-0001-7960-9721				BANEYX F, 1995, J BIOL CHEM, V270, P10695, DOI 10.1074/jbc.270.18.10695; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Braig K, 1998, CURR OPIN STRUC BIOL, V8, P159, DOI 10.1016/S0959-440X(98)80033-X; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Hirohashi T, 1999, BBA-PROTEIN STRUCT M, V1429, P512, DOI 10.1016/S0167-4838(98)00268-4; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x; Koumoto Y, 1996, PLANT J, V10, P1119, DOI 10.1046/j.1365-313X.1996.10061119.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; NISHIMURA M, 1993, PROTOPLASMA, V175, P131, DOI 10.1007/BF01385011; Nishio K, 1999, BIOCHEM BIOPH RES CO, V266, P584, DOI 10.1006/bbrc.1999.1868; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; Schlicher T, 1996, FEBS LETT, V379, P302, DOI 10.1016/0014-5793(95)01534-5; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	29	38	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					29688	29694		10.1074/jbc.M102330200	http://dx.doi.org/10.1074/jbc.M102330200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11402030	hybrid			2022-12-27	WOS:000170558000014
J	Sloper-Mould, KE; Jemc, JC; Pickart, CM; Hicke, L				Sloper-Mould, KE; Jemc, JC; Pickart, CM; Hicke, L			Distinct functional surface regions on ubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-FACTOR RECEPTOR; MULTIUBIQUITIN CHAIN; ACTIVATING ENZYME; SACCHAROMYCES-CEREVISIAE; POLYUBIQUITIN CHAIN; CONJUGATING ENZYME; YEAST; ENDOCYTOSIS; PROTEIN; SIGNAL	The characterized functions of the highly conserved polypeptide ubiquitin are to target proteins for proteasome degradation or endocytosis. The formation of a polyubiquitin chain of at least four units is required for efficient proteasome binding. By contrast, monoubiquitin serves as a signal for the endocytosis of plasma membrane proteins. We have defined surface residues that are important for ubiquitin's vital functions in Saccharomyces cerevisiae. Surprisingly, alanine scanning mutagenesis showed that only 16 of ubiquitin's 63 surface residues are essential for vegetative growth in yeast. Most of the essential residues localize to two hydrophobic clusters that participate in proteasome recognition and/or endocytosis. The others reside in or near the tail region, which is important for conjugation and deubiquitination. We also demonstrate that the essential residues comprise two distinct functional surfaces: residues surrounding Phe(4) are required for endocytosis, whereas residues surrounding Ile(14) are required for both endocytosis and proteasome degradation.	Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Johns Hopkins University; Northwestern University	Pickart, CM (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem & Mol Biol, 315 N Wolfe St, Baltimore, MD 21205 USA.	cpickart@welchlink.welch.jhu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053257, R01DK046984] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46984, DK53257] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DUERKSENHUGHES PJ, 1987, BIOCHEMISTRY-US, V26, P6980, DOI 10.1021/bi00396a019; DULIC V, 1991, METHOD ENZYMOL, V194, P697; ECKER DJ, 1987, J BIOL CHEM, V262, P14213; ECKER DJ, 1987, J BIOL CHEM, V262, P3524; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GREGORI L, 1990, J BIOL CHEM, V265, P8354; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lemmon SK, 2000, CURR OPIN CELL BIOL, V12, P457, DOI 10.1016/S0955-0674(00)00117-4; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Nakatsu F, 2000, J BIOL CHEM, V275, P26213, DOI 10.1074/jbc.M907720199; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Roth AF, 1996, J CELL BIOL, V134, P661, DOI 10.1083/jcb.134.3.661; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Strous GJ, 1999, J CELL SCI, V112, P1417; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VIJAYKUMAR S, 1985, P NATL ACAD SCI USA, V82, P3582, DOI 10.1073/pnas.82.11.3582; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Yao TT, 2000, J BIOL CHEM, V275, P36862, DOI 10.1074/jbc.M006050200; Yesilaltay A, 2000, MOL BIOL CELL, V11, P2873, DOI 10.1091/mbc.11.9.2873	54	192	194	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30483	30489		10.1074/jbc.M103248200	http://dx.doi.org/10.1074/jbc.M103248200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11399765	hybrid			2022-12-27	WOS:000170558000115
J	Dhar, SK; Delmolino, L; Dutta, A				Dhar, SK; Delmolino, L; Dutta, A			Architecture of the human origin recognition complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; YEAST ORIGIN; PROTEINS; IDENTIFICATION; HOMOLOG; SUBUNIT; XENOPUS; MEMBER; CELLS; ORC5L	All the human homologs of the six subunits of Saccharomyces cerevisiae origin recognition complex have been reported so far. However, not much has been reported on the nature and the characteristics of the human origin recognition complex. In an attempt to purify recombinant human ORC from insect cells infected with baculoviruses expressing HsORC subunits, we found that human ORC2, -3, -4, and -5 form a core complex. HsORC1 and HsORC6 subunits did not enter into this core complex, suggesting that the interaction of these two subunits with the core ORC2-5 complex is extremely labile. We found that the C-terminal region of ORC2 interacts directly with the N-terminal region of ORC3. The C-terminal region of ORC3 was, however, necessary to bring ORC4 and ORC5 into the core complex. A fragment containing the N-terminal 200 residues of ORC3 (ORC3N) competitively inhibited the ORC2-ORC3 interaction. Overexpression of this fragment in U2OS cells blocked the cells in G(1), providing the first evidence that a mammalian ORC subunit is important for the G(1)-S transition in mammalian cells.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Dutta, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073	NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER; NCI NIH HHS [CA60499] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Dhar SK, 2000, J BIOL CHEM, V275, P34983, DOI 10.1074/jbc.M006069200; Dunn M J, 1994, Methods Mol Biol, V32, P113; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; Ishiai M, 1997, GENOMICS, V46, P294, DOI 10.1006/geno.1997.5003; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Lin YL, 1996, J BIOL CHEM, V271, P17190, DOI 10.1074/jbc.271.29.17190; Moon KY, 1999, P NATL ACAD SCI USA, V96, P12367, DOI 10.1073/pnas.96.22.12367; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Takahara K, 1996, GENOMICS, V31, P119, DOI 10.1006/geno.1996.0018; Thome KC, 2000, J BIOL CHEM, V275, P35233, DOI 10.1074/jbc.M005765200; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421	22	87	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 3	2001	276	31					29067	29071		10.1074/jbc.M103078200	http://dx.doi.org/10.1074/jbc.M103078200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	461BX	11395502	hybrid			2022-12-27	WOS:000170346000059
J	Tao, Q; Backer, MV; Backer, JM; Terman, BI				Tao, Q; Backer, MV; Backer, JM; Terman, BI			Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; TYROSINE KINASE; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; LIGAND-BINDING; IN-VIVO; VEGF; IDENTIFICATION; PHOSPHORYLATION; EXPRESSION	The vascular endothelial growth factor (VEGF) receptor tyrosine kinase subtype kinase insert domain receptor (KDR) contains seven extracellular Ig-like domains, of which the three most amino-terminal contain the necessary structural features required for VEGF binding. To clarify the functional role of I(DR Ig-like domains 4-7, we compared VEGF-induced signaling in human embryonic kidney and porcine aortic endothelial cells expressing native versus mutant receptor proteins in which Ig-like domains 4-7, 4-6, or 7 had been deleted. Western blotting using an anti-receptor antibody indicated equivalent expression levels for each of the recombinant proteins. As expected, VEGF treatment robustly augmented native receptor autophosphorylation, In contrast, receptor autophosphorylation, as well as downstream signaling events, were VEGF-independent for cells expressing mutant receptors, I-125-VEGF(165) bound with equal or better affinity to mutant versus native receptor, although the number of radioligand binding sites was significantly reduced because a significant percentage of mutant, but not native, receptors were localized to the cell interior. As was the case for native KDR,I-125-VEGF(165) binding to the mutant receptors was dependent upon cell surface heparan sulfate proteoglycans, and I-125-VEGF(121) bound with an affinity equal to that of I-125-VEGF(165) to the native and mutant receptors. It is concluded that KDR Ig-like domains 4-7 contain structural features that inhibit receptor signaling by a mechanism that is independent of neuropilin-1 and heparan sulfate proteoglycans. We speculate that this provides a cellular mechanism for blocking unwanted signaling events in the absence of VEGF.	Albert Einstein Coll Med, Dept Med, Div Cardiol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Sibtech, Newington, CT USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Terman, BI (corresponding author), Albert Einstein Coll Med, Dept Med, Div Cardiol, Forchheimer 715,1300 Morris Pk Ave, Bronx, NY 10461 USA.	terman@aec-om.yu.edu			NATIONAL CANCER INSTITUTE [R01CA086289] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA86289-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; FAVA RA, 1994, J EXP MED, V180, P341, DOI 10.1084/jem.180.1.341; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gamm DM, 1996, J BIOL CHEM, V271, P15736, DOI 10.1074/jbc.271.26.15736; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; IruelaArispe ML, 1997, THROMB HAEMOSTASIS, V78, P672; Kaplan JB, 1997, GROWTH FACTORS, V14, P243, DOI 10.3109/08977199709021523; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li J, 1996, AM J PHYSIOL-HEART C, V270, pH1803, DOI 10.1152/ajpheart.1996.270.5.H1803; Lu D, 2000, J BIOL CHEM, V275, P14321, DOI 10.1074/jbc.275.19.14321; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073/pnas.88.20.9026; McKeehan WL, 1999, J BIOL CHEM, V274, P21511, DOI 10.1074/jbc.274.31.21511; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; Miao HQ, 1996, J BIOL CHEM, V271, P4879; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Omura T, 1997, J BIOL CHEM, V272, P12676, DOI 10.1074/jbc.272.19.12676; ORR JW, 1992, J BIOL CHEM, V267, P15263; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P823; PLONTNIKOV A, 1999, CELL, V98, P641; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; SHIBUYA M, 1990, ONCOGENE, V5, P519; Shinkai A, 1998, J BIOL CHEM, V273, P31283, DOI 10.1074/jbc.273.47.31283; Siemeister G, 1998, J BIOL CHEM, V273, P11115, DOI 10.1074/jbc.273.18.11115; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; STOLETOV KV, 2001, IN PRESS J BIOL CHEM, V276; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TERMAN BI, 1991, ONCOGENE, V6, P1677; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Uren A, 1997, ONCOGENE, V14, P157, DOI 10.1038/sj.onc.1200810; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	59	34	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2001	276	24					21916	21923		10.1074/jbc.M100763200	http://dx.doi.org/10.1074/jbc.M100763200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442RC	11399777	hybrid			2022-12-27	WOS:000169297900145
J	Delmas, C; Manenti, S; Boudjelal, A; Peyssonnaux, C; Eychene, A; Darbon, JM				Delmas, C; Manenti, S; Boudjelal, A; Peyssonnaux, C; Eychene, A; Darbon, JM			The p42/p44 mitogen-activated protein kinase activation triggers p27(Kip1) degradation independently of CDK2/cyclin E in NIH 3T3 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-MEDIATED DEGRADATION; DEPENDENT-KINASE; GROWTH-FACTOR; S PHASE; DOWN-REGULATION; CDK INHIBITOR; SIGNAL-TRANSDUCTION; RESTRICTION POINT; CYCLIN E-CDK2; UP-REGULATION	The p42/p44 mitogen-activated protein (MAP) kinase is stimulated by various mitogenic stimuli, and its sustained activation is necessary for cell cycle G(1) progression and G(1)/S transition. G(1) progression and G(1)/S transition also depend on sequential cyclin-dependent kinase (CDK) activation. Here, we demonstrate that MAP kinase inhibition leads to accumulation of the CDK inhibitor P27(Kip1) in NIH 3T3 cells. Blocking the proteasome-dependent degradation of p27(Kip1) impaired this accumulation, suggesting that MAP kinase does not act on p271(Kip1) protein synthesis. In the absence of extracellular signals (growth factors or cell adhesion), genetic activation of MAP kinase decreased the expression of P27(Kip1) as assessed by cotransfection experiments and by immunofluorescence detection. Importantly, MAP kinase activation also decreased the expression of a p27(Kip1) mutant, which cannot be phosphorylated by CDK2, suggesting that MAP kinase-dependent p27(Kip1) regulation is CDK2-independent. Accordingly, expression of dominant-negative CDK2 did not impair the down-regulation of p27(Kip1) induced by MAP kinase activation. These data demonstrate that the MAP kinase pathway regulates p27(Kip1) expression in fibroblasts essentially through a degradation mechanism, independently of p27(Kip1) phosphorylation by CDK2. This strengthens the role of this CDK inhibitor as a key effector of G(1) growth arrest, whose expression can be controlled by extracellular stimuli-dependent signaling pathways.	Univ Toulouse 3, Lab Biol Cellulaire & Mol Controle Proliferat, CNRS, UMR 5088, F-31062 Toulouse, France; Inst Curie, CNRS, UMR 146, Lab 110, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Manenti, S (corresponding author), Univ Toulouse 3, Lab Biol Cellulaire & Mol Controle Proliferat, CNRS, UMR 5088, 118 Route Narbonne, F-31062 Toulouse, France.	manenti@cict.fr	Peyssonnaux, Carole/L-4057-2017; Eychene, Alain/M-8838-2017; Peyssonnaux, Carole/GLU-5786-2022; manenti, stephane/P-1518-2014	Peyssonnaux, Carole/0000-0002-1392-8225; manenti, stephane/0000-0002-4793-3196; EYCHENE, Alain/0000-0002-6818-7225				Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Bottazzi ME, 1997, TRENDS CELL BIOL, V7, P348, DOI 10.1016/S0962-8924(97)01114-8; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Casagrande F, 1998, FEBS LETT, V422, P385, DOI 10.1016/S0014-5793(98)00043-X; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Eymin B, 1999, ONCOGENE, V18, P4839, DOI 10.1038/sj.onc.1202860; GANG W, 1999, ONCOGENE, V18, P5204; Greulich H, 1998, J BIOL CHEM, V273, P13280, DOI 10.1074/jbc.273.21.13280; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hirai A, 1997, J BIOL CHEM, V272, P13; Hu WM, 1999, J BIOL CHEM, V274, P3396, DOI 10.1074/jbc.274.6.3396; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Kamiyama J, 1999, FEBS LETT, V455, P281, DOI 10.1016/S0014-5793(99)00899-6; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; Ladha MH, 1998, MOL CELL BIOL, V18, P6605, DOI 10.1128/MCB.18.11.6605; Le Gall M, 1998, ONCOGENE, V17, P1271, DOI 10.1038/sj.onc.1202057; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Lin TH, 1997, J BIOL CHEM, V272, P8849; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Loubat A, 1999, ONCOGENE, V18, P3324, DOI 10.1038/sj.onc.1202668; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Millard SS, 1997, J BIOL CHEM, V272, P7093, DOI 10.1074/jbc.272.11.7093; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moro A, 2000, BIOCHEM BIOPH RES CO, V269, P31, DOI 10.1006/bbrc.2000.2256; Muller D, 2000, EMBO J, V19, P2168, DOI 10.1093/emboj/19.10.2168; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Orend G, 1998, ONCOGENE, V16, P2575, DOI 10.1038/sj.onc.1201791; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Papin C, 1998, J BIOL CHEM, V273, P24939, DOI 10.1074/jbc.273.38.24939; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Ravi RK, 1998, J CLIN INVEST, V101, P153, DOI 10.1172/JCI831; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Rivard N, 1999, AM J PHYSIOL-CELL PH, V277, pC652, DOI 10.1152/ajpcell.1999.277.4.C652; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Takuwa N, 1997, MOL CELL BIOL, V17, P5348, DOI 10.1128/MCB.17.9.5348; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Treinies I, 1999, MOL CELL BIOL, V19, P321; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Weber JD, 1997, J BIOL CHEM, V272, P32966, DOI 10.1074/jbc.272.52.32966; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200	58	56	57	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2001	276	37					34958	34965		10.1074/jbc.M101714200	http://dx.doi.org/10.1074/jbc.M101714200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	473DK	11418594	hybrid			2022-12-27	WOS:000171024600082
J	Gervois, P; Vu-Dac, N; Kleemann, R; Kockx, M; Dubois, G; Laine, B; Kosykh, V; Fruchart, JC; Kooistra, T; Staels, B				Gervois, P; Vu-Dac, N; Kleemann, R; Kockx, M; Dubois, G; Laine, B; Kosykh, V; Fruchart, JC; Kooistra, T; Staels, B			Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; PPAR-ALPHA; ALPHA-1-ACID GLYCOPROTEIN; 5-FLANKING REGION; RAT-LIVER; GAMMA; CYTOKINE; ATHEROSCLEROSIS; PROMOTER	Fibrinogen is a coagulation factor and an acute phase reactant up-regulated by inflammatory cytokines, such as interleukin 6 (IL-6). Elevated plasma fibrinogen levels are associated with coronary heart diseases. Fibrates are clinically used hypolipidemic drugs that act via the nuclear receptor peroxisome proliferator-activated receptor a (PPA-R alpha). In addition, most fibrates also reduce plasma fibrinogen levels, but the molecular mechanism is unknown. In this study, we demonstrate that fibrates decrease basal and IL-6-stimulated expression of the human fibrinogen-beta gene in human primary hepatocytes and hepatoma HepG2 cells. Fibrates diminish basal and IL-6-induced fibrinogen-beta promoter activity, and this effect is enhanced in the presence of co-transfected PPAR alpha. Site-directed mutagenesis experiments demonstrate that PPAR alpha activators decrease human fibrinogen-beta promoter activity via the CCAAT box/enhancer-binding protein (C/EBP) response element. Co-transfection of the transcriptional intermediary factor glucocorticoid receptor-interacting protein 1/transc riptional intermediary factor 2 (GRIP1/TIF2) enhances fibrinogen-beta gene transcription and alleviates the repressive effect of PPAR alpha. Co-immunoprecipitation experiments demonstrate that PPAR alpha and GRIP1/TIF2 physically interact in vivo in human liver. These data demonstrate that PPARa agonists repress human fibrinogen gene expression by interference with the C/EBP beta pathway through titration of the coactivator GRIP1/TIF2. We observed that the anti-inflammatory action of PPAR alpha is not restricted to fibrinogen but also applies to other acute phase genes containing a C/EBP response element; it also occurs under conditions in which the stimulating action of IL-6 is potentiated by dexamethasone. These findings identify a novel molecular mechanism of negative gene regulation by PPAR alpha and reveal the direct implication of PPAR alpha in the modulation of the inflammatory gene response in the liver.	Inst Pasteur, INSERM, U545, Dept Atherosclerose, F-59019 Lille, France; Univ Lille 2, Fac Pharm, F-59019 Lille, France; TNO, Gaubius Lab, NL-2301 CE Leiden, Netherlands; Fac Med H Warembourg, INSERM, U459, Biol Cellulaire Lab, F-59045 Lille, France; Cardiol Res Complex, Moscow 721552, Russia	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Netherlands Organization Applied Science Research; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; National Medical Research Center of Cardiology	Gervois, P (corresponding author), Inst Pasteur, INSERM, U545, Dept Atherosclerose, F-59019 Lille, France.	philippe.gervois@pasteur-lille.fr; Bart.Staels@pasteur-lille.fr	Staels, Bart/N-9497-2016	Staels, Bart/0000-0002-3784-1503				ANDERSON GM, 1993, J BIOL CHEM, V268, P22650; [Anonymous], 1994, CIRCULATION, V89, P1329; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; BAUMANN H, 1989, ANN NY ACAD SCI, V557, P280; BAUMANN H, 1983, J BIOL CHEM, V258, P563; BAUMANN H, 1991, J BIOL CHEM, V266, P20390; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; Colville-Nash PR, 1998, J IMMUNOL, V161, P978; Corton JC, 1998, MOL PHARMACOL, V54, P463, DOI 10.1124/mol.54.3.463; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; DALMON J, 1993, MOL CELL BIOL, V13, P1183, DOI 10.1128/MCB.13.2.1183; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; FOWLKES DM, 1984, P NATL ACAD SCI-BIOL, V81, P2313, DOI 10.1073/pnas.81.8.2313; Frick MH, 1997, CIRCULATION, V96, P2137; Gervois P, 1999, MOL ENDOCRINOL, V13, P1535, DOI 10.1210/me.13.9.1535; Gervois P, 2000, CLIN CHEM LAB MED, V38, P3, DOI 10.1515/CCLM.2000.002; HATTORI M, 1990, P NATL ACAD SCI USA, V87, P2364, DOI 10.1073/pnas.87.6.2364; HEINRICH J, 1994, ARTERIOSCLER THROMB, V14, P54, DOI 10.1161/01.ATV.14.1.54; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; HU CH, 1995, J BIOL CHEM, V270, P28342; HUBER P, 1990, J BIOL CHEM, V265, P5695; KANT JA, 1985, P NATL ACAD SCI USA, V82, P2344, DOI 10.1073/pnas.82.8.2344; Kockx M, 1999, BLOOD, V93, P2991; LIU ZY, 1995, J BIOL CHEM, V270, P7580, DOI 10.1074/jbc.270.13.7580; Madej A, 1998, INT J CLIN PHARM TH, V36, P345; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; MIZUGUCHI J, 1995, J BIOL CHEM, V270, P28350; MORGAN JG, 1988, MOL CELL BIOL, V8, P2628, DOI 10.1128/MCB.8.6.2628; NONAKA M, 1990, MOL CELL BIOL, V10, P6283, DOI 10.1128/MCB.10.12.6283; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RON D, 1992, J CLIN INVEST, V89, P223, DOI 10.1172/JCI115566; ROY SN, 1990, J BIOL CHEM, V265, P6389; Ruotolo G, 1998, J AM COLL CARDIOL, V32, P1648, DOI 10.1016/S0735-1097(98)00442-2; SIRTORI CR, 1993, CARDIOVASC DRUG THER, V7, P817, DOI 10.1007/BF00878936; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; STAELS B, 1995, J CLIN INVEST, V95, P705, DOI 10.1172/JCI117717; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; STAELS B, 1992, DEVELOPMENT, V115, P1035; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; YU S, 1987, THROMB RES, V46, P281, DOI 10.1016/0049-3848(87)90290-8; YU S, 1983, J BIOL CHEM, V258, P3407; ZHANG ZX, 1995, J BIOL CHEM, V270, P24287, DOI 10.1074/jbc.270.41.24287	47	134	138	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33471	33477		10.1074/jbc.M102839200	http://dx.doi.org/10.1074/jbc.M102839200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11418615	Green Published, hybrid			2022-12-27	WOS:000170910200026
J	Kyriakopoulou, CB; Nordvarg, H; Virtanen, A				Kyriakopoulou, CB; Nordvarg, H; Virtanen, A			A novel nuclear human poly(A) polymerase (PAP), PAP gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOGNITION PARTICLE RNA; MESSENGER-RNA; SIGNAL RECOGNITION; MULTIPLE FORMS; HUMAN GENOME; POLYADENYLATION; PURIFICATION; COMPLEX; CELLS; PHOSPHORYLATION	Poly(A) polymerase (PAP) is present in multiple forms in mammalian cells and tissues. Here we show that the 90-kDa isoform is the product of the gene PAPOLG, which is distinct from the previously identified genes for poly(A) polymerases. The 90-kDa isoform. is referred to as human PAP gamma (hsPAP gamma). hsPAP gamma shares 60% identity to human PAPII (hsPAPII) at the amino acid level. hsPAP gamma exhibits fundamental properties of a bona flde poly(A) polymerase, specificity for ATP, and cleavage and polyadenylation specificity factor/hexanucleotide-dependent polyadenylation activity. The catalytic parameters indicate similar catalytic efficiency to that of hsPAPII Mutational analysis and sequence comparison revealed that hsPAP gamma and hsPAPII have similar organization of structural and functional domains. hsPAP gamma contains a U1A protein-interacting region in its C terminus, and PAP gamma activity can be inhibited, as hsPAPII, by the U1A protein. hsPAP gamma is restricted to the nucleus as revealed by in situ staining and by transfection experiments. Based on this and previous studies, it is obvious that multiple isoforms of PAP are generated by three distinct mechanisms: gene duplication, alternative RNA processing, and post-translational modification. The exclusive nuclear localization of hsPAP gamma establishes that multiple forms of PAP are unevenly distributed in the cell, implying specialized roles for the various isoforms.	Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University	Virtanen, A (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.	anders.virtanen@icm.uu.se						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASTROM A, 1991, EUR J BIOCHEM, V202, P765, DOI 10.1111/j.1432-1033.1991.tb16431.x; BALLANTYNE S, 1995, RNA, V1, P64; Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; Bond GL, 2000, MOL CELL BIOL, V20, P5310, DOI 10.1128/MCB.20.14.5310-5320.2000; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Colgan DF, 1998, EMBO J, V17, P1053, DOI 10.1093/emboj/17.4.1053; GEBAUER F, 1995, MOL CELL BIOL, V15, P1422; Gunderson SI, 1997, GENE DEV, V11, P761, DOI 10.1101/gad.11.6.761; Gunnewiek JMTK, 2000, MOL CELL BIOL, V20, P2209, DOI 10.1128/MCB.20.6.2209-2217.2000; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; JAREBORG N, 1991, J GEN VIROL, V72, P2269, DOI 10.1099/0022-1317-72-9-2269; Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee YJ, 2000, FEBS LETT, V487, P287, DOI 10.1016/S0014-5793(00)02367-X; LINGNER J, 1991, NATURE, V354, P496, DOI 10.1038/354496a0; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Perumal K, 2001, J BIOL CHEM, V276, P21791, DOI 10.1074/jbc.M101905200; PETTERSSON I, 1984, J BIOL CHEM, V259, P5907; RAABE T, 1994, MOL CELL BIOL, V14, P2946, DOI 10.1128/MCB.14.5.2946; RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0; RYNER LC, 1989, MOL CELL BIOL, V9, P4229, DOI 10.1128/MCB.9.10.4229; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Schul W, 1996, EMBO J, V15, P2883, DOI 10.1002/j.1460-2075.1996.tb00649.x; Schul W, 1998, EXP CELL RES, V238, P1, DOI 10.1006/excr.1997.3808; SHEETS MD, 1989, GENE DEV, V3, P1401, DOI 10.1101/gad.3.9.1401; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Sinha R, 1999, J BIOL CHEM, V274, P30826, DOI 10.1074/jbc.274.43.30826; SKOLNIKDAVID H, 1987, GENE DEV, V1, P672, DOI 10.1101/gad.1.7.672; Skrabanek L, 1998, CURR OPIN GENET DEV, V8, P694, DOI 10.1016/S0959-437X(98)80039-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THURESSON AC, 1994, P NATL ACAD SCI USA, V91, P979, DOI 10.1073/pnas.91.3.979; TSIAPALIS CM, 1975, J BIOL CHEM, V250, P4486; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; VASSALLI JD, 1995, CURR BIOL, V5, P476, DOI 10.1016/S0960-9822(95)00095-9; WAHLE E, 1991, J BIOL CHEM, V266, P3131; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Wittmann T, 1997, BBA-GENE STRUCT EXPR, V1350, P293, DOI 10.1016/S0167-4781(96)00164-9; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao WQ, 1998, MOL CELL BIOL, V18, P5010, DOI 10.1128/MCB.18.9.5010; Zhao WQ, 1996, MOL CELL BIOL, V16, P2378	50	48	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 7	2001	276	36					33504	33511		10.1074/jbc.M104599200	http://dx.doi.org/10.1074/jbc.M104599200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471CP	11431479	hybrid			2022-12-27	WOS:000170910200030
J	Bellin, RM; Huiatt, TW; Critchley, DR; Robson, RM				Bellin, RM; Huiatt, TW; Critchley, DR; Robson, RM			Synemin may function to directly link muscle cell intermediate filaments to both myofibrillar Z-lines and costameres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESMIN KNOCK-OUT; PROTEIN SYNEMIN; ALPHA-ACTININ; SKELETAL-MUSCLE; INTRAMOLECULAR ASSOCIATION; MOLECULAR CHARACTERISTICS; VIMENTIN FILAMENTS; FORCE TRANSMISSION; CARDIAC-MUSCLE; CROSS-LINKING	Synemin is a large intermediate filament (IF) protein that has been identified in all types of muscle cells in association with desmin- and/or vimentin-containing IFs. Our previous studies (Bellin, R. M., Sernett, S. W., Becker, B., Ip, W., Huiatt, T. W., and Robson, R. M. (1999) J. Biol. Chem. 274, 29493-29499) demonstrated that synemin forms heteropolymeric IFs with major IF proteins and contains a binding site for the myofibrillar Z-line protein alpha -actinin. By utilizing blot overlay assays, we show herein that synemin also interacts with the costameric protein vinculin. Furthermore, extensive assays utilizing the Gal4 yeast two-hybrid system demonstrate interactions of synemin with desmin and vimentin and additionally define more precisely the protein subdomains involved in the synemin/alpha -actinin and synemin/vinculin interact-ions. The C-terminal similar to 300-amino acid region of synemin binds to the N-terminal head and central rod domains of alpha -actinin and the similar to 150-amino acid C-terminal tail of vinculin. Overall, these interactions indicate that synemin may anchor IFs to myofibrillar Z-lines via interactions with alpha -actinin and to costameres at the sarcolemma via interactions with vinculin and/or alpha -actinin. These linkages would enable the IFs to directly link all cellular myofibrils and to anchor the peripheral layer of myofibrils to the costameres.	Iowa State Univ, Muscle Biol Grp, Dept Biochem Biophys, Ames, IA 50011 USA; Iowa State Univ, Muscle Biol Grp, Dept Biol Mol, Ames, IA 50011 USA; Iowa State Univ, Muscle Biol Grp, Dept Anim Sci, Ames, IA 50011 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	Iowa State University; Iowa State University; Iowa State University; University of Leicester	Robson, RM (corresponding author), Iowa State Univ, Muscle Biol Grp, Dept Biochem Biophys, 3110 Mol Biol Bldg, Ames, IA 50011 USA.	rmrobson@iastate.edu						Agbulut O, 1996, BIOL CELL, V88, P131, DOI 10.1016/S0248-4900(97)83528-9; ARIMURA C, 1988, EUR J BIOCHEM, V177, P649, DOI 10.1111/j.1432-1033.1988.tb14419.x; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; BARON MD, 1987, J BIOL CHEM, V262, P17623; BECKER B, 1995, BIOCHEM BIOPH RES CO, V213, P796, DOI 10.1006/bbrc.1995.2200; BELKIN AM, 1988, J CELL BIOL, V107, P545, DOI 10.1083/jcb.107.2.545; Bellin RM, 1999, J BIOL CHEM, V274, P29493, DOI 10.1074/jbc.274.41.29493; BELLIN RM, 1999, GUIDEBOOK CYTOSKELET, P322; Bilak SR, 1998, ARCH BIOCHEM BIOPHYS, V355, P63, DOI 10.1006/abbi.1998.0702; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Carlsson L, 2000, HISTOCHEM CELL BIOL, V114, P39; Carpenter DA, 1996, J CELL SCI, V109, P2493; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; EVANS RR, 1984, J BIOL CHEM, V259, P3916; Foisner R, 1997, BIOESSAYS, V19, P297, DOI 10.1002/bies.950190407; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; GRANGER BL, 1979, CELL, V18, P1053, DOI 10.1016/0092-8674(79)90218-6; GRANGER BL, 1980, CELL, V22, P727, DOI 10.1016/0092-8674(80)90549-8; GRANGER BL, 1982, J CELL BIOL, V92, P299, DOI 10.1083/jcb.92.2.299; GRANGER BL, 1984, MOL CELL BIOL, V4, P1943, DOI 10.1128/MCB.4.10.1943; GRANGER BL, 1982, CELL, V30, P263, DOI 10.1016/0092-8674(82)90032-0; Hemken PM, 1997, J BIOL CHEM, V272, P32489, DOI 10.1074/jbc.272.51.32489; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; Herrmann H, 1998, Subcell Biochem, V31, P319; Hijikata T, 1999, J CELL SCI, V112, P867; Imanaka-Yoshida K, 1999, CELL MOTIL CYTOSKEL, V42, P1; ImanakaYoshida K, 1996, CELL MOTIL CYTOSKEL, V33, P263, DOI 10.1002/(SICI)1097-0169(1996)33:4<263::AID-CM3>3.0.CO;2-A; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LETAI A, 1995, P NATL ACAD SCI USA, V92, P92, DOI 10.1073/pnas.92.1.92; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129; Meng JJ, 1996, J BIOL CHEM, V271, P1599, DOI 10.1074/jbc.271.3.1599; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; MENG JJ, 1994, J BIOL CHEM, V269, P18679; Meng JJ, 2001, METH MOL B, V161, P255; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; North AJ, 1999, J CELL SCI, V112, P4325; OTEY CA, 1993, J BIOL CHEM, V268, P21193; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; PRICE MG, 1983, J CELL BIOL, V97, P1860, DOI 10.1083/jcb.97.6.1860; Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626; RICHARDSON FL, 1981, EUR J CELL BIOL, V26, P91; Robson RM, 1989, CURR OPIN CELL BIOL, V1, P36, DOI 10.1016/S0955-0674(89)80034-1; SANDOVAL IV, 1983, J BIOL CHEM, V258, P2568; Schmidt JM, 1999, ARCH BIOCHEM BIOPHYS, V366, P139, DOI 10.1006/abbi.1999.1204; Schroder R, 1999, EUR J CELL BIOL, V78, P288, DOI 10.1016/S0171-9335(99)80062-4; Schroder R, 2000, LAB INVEST, V80, P455, DOI 10.1038/labinvest.3780051; Schweitzer SC, 2001, J CELL SCI, V114, P1079; Severs NJ, 2000, BIOESSAYS, V22, P188, DOI 10.1002/(SICI)1521-1878(200002)22:2<188::AID-BIES10>3.0.CO;2-T; SHOEMAN RL, 1993, BIOESSAYS, V15, P605, DOI 10.1002/bies.950150906; SMALL JV, 1992, EUR J BIOCHEM, V208, P559, DOI 10.1111/j.1432-1033.1992.tb17220.x; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Steinbock FA, 1999, BIOL CHEM, V380, P151, DOI 10.1515/BC.1999.023; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; Sultana S, 2000, GLIA, V30, P143, DOI 10.1002/(SICI)1098-1136(200004)30:2<143::AID-GLIA4>3.0.CO;2-Z; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; TOKUYASU KT, 1983, J CELL BIOL, V96, P1736, DOI 10.1083/jcb.96.6.1736; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Wiche G, 1998, J CELL SCI, V111, P2477; Yuan J, 1999, ARCH BIOCHEM BIOPHYS, V363, P314, DOI 10.1006/abbi.1998.1096	82	94	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					32330	32337		10.1074/jbc.M104005200	http://dx.doi.org/10.1074/jbc.M104005200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11418616	hybrid			2022-12-27	WOS:000170613500115
J	Jaiswal, BS; Conti, M				Jaiswal, BS; Conti, M			Identification and functional analysis of splice variants of the germ cell soluble adenylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE; MAMMALIAN SPERMATOZOA; RESPONSE ELEMENT; RAT TESTIS; BICARBONATE; CREM; SPERMIOGENESIS; LOCALIZATION; SPERM; CAMP	In mammalian germ cells, cAMP signaling is dependent on two forms of adenylyl cyclase, the conventional membrane-bound ACIII and a soluble form of adenylyl cyclase (SAC). Recent elucidation of the SAC sequence indicates that this enzyme is phylogenetically distinct from the membrane-bound AC, does not interact with G proteins, and its activity is regulated by bicarbonate ions. Here we have investigated the properties and regulation of this enzyme during spermatogenesis. Two different transcripts encoding a full-length and truncated sAC were identified by reverse transcriptase-polymerase chain reaction and RNase protection analysis. The truncated sAC transcript lacks exon 11 with a premature termination of the open reading frame after the catalytic domain. Reverse transcriptase-polymerase chain reaction with testis RNA from adult mouse and rat of different ages, as well as RNase protection, showed that both transcripts are absent at I I days of age, appear between 20 and 30 days of age, and are retained in the adult test-is. The presence of corresponding proteins in testis, germ cells, and spermatozoa was demonstrated by fast protein liquid chromatography and differential immunoprecipitation with full-length sAC-specific antibodies. Bicarbonate ions activated both sAC forms and increased cAMP levels in germ cells isolated from 25-and 50-day-old rats and adult rats in a concentration-dependent manner. These findings provide evidence that full-length and truncated sAC are generated by alternate splicing. Both forms are active in spermatids, and the bicarbonate present in the seminiferous tubule may be a signal that regulates cAMP levels in these cells.	Stanford Univ, Div Reprod Biol, Dept Gynecol & Obstet, Sch Med, Stanford, CA 94305 USA	Stanford University	Conti, M (corresponding author), Stanford Univ, Div Reprod Biol, Dept Gynecol & Obstet, Sch Med, 300 Pasteur Dr,Rm A344, Stanford, CA 94305 USA.	marco.conti@stanford.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031544] Funding Source: NIH RePORTER; NICHD NIH HHS [HD31544, R01 HD031544] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMO S, 1980, BIOCHEM BIOPH RES CO, V97, P607, DOI 10.1016/0006-291X(80)90307-1; ALVAREZ R, 1992, ANAL BIOCHEM, V203, P76, DOI 10.1016/0003-2697(92)90045-9; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; BRAUN T, 1991, METHOD ENZYMOL, V195, P130; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Defer N, 1998, FEBS LETT, V424, P216, DOI 10.1016/S0014-5793(98)00178-1; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; EKSTEDT E, 1991, ACTA ANAT, V141, P257, DOI 10.1159/000147131; FANDE JK, 1966, P SOC EXP BIOL MED, V121, P899; GARBERS DL, 1980, BIOL REPROD, V22, P526, DOI 10.1093/biolreprod/22.3.526; Gautier-Courteille C, 1998, ENDOCRINOLOGY, V139, P2588, DOI 10.1210/en.139.5.2588; GORDELADZE JO, 1981, MOL CELL ENDOCRINOL, V23, P125, DOI 10.1016/0303-7207(81)90064-2; GORDELADZE JO, 1981, INT J ANDROL, V4, P172, DOI 10.1111/j.1365-2605.1981.tb00701.x; GORDELADZE JO, 1982, ARCH ANDROLOGY, V8, P199, DOI 10.3109/01485018208987040; GORDELADZE JO, 1981, J CLIN ENDOCR METAB, V53, P465, DOI 10.1210/jcem-53-3-465; JAISWAL BS, 2001, FERTILIZATION; Kaunisto K, 1999, BIOL REPROD, V61, P1521, DOI 10.1095/biolreprod61.6.1521; Kaupp UB, 2000, SCIENCE, V289, P559, DOI 10.1126/science.289.5479.559; KISTLER MK, 1994, BIOL REPROD, V51, P1322, DOI 10.1095/biolreprod51.6.1322; Mezquita P, 1999, MOL HUM REPROD, V5, P199, DOI 10.1093/molehr/5.3.199; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Naro F, 1996, ENDOCRINOLOGY, V137, P2464, DOI 10.1210/en.137.6.2464; Newcombe N, 2000, INT J ANDROL, V23, P46, DOI 10.1046/j.1365-2605.2000.00204.x; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; OKAMURA N, 1990, BIOCHIM BIOPHYS ACTA, V1035, P83, DOI 10.1016/0304-4165(90)90177-X; Oki N, 2000, J BIOL CHEM, V275, P10831, DOI 10.1074/jbc.275.15.10831; PANDE JK, 1967, J CLIN ENDOCR METAB, V27, P892, DOI 10.1210/jcem-27-6-892; PARKKILA S, 1991, HISTOCHEMISTRY, V95, P477, DOI 10.1007/BF00315743; RODRIGUEZMARTINEZ H, 1990, ACTA ANAT, V139, P173, DOI 10.1159/000146995; ROJAS FJ, 1993, ENDOCRINOLOGY, V133, P3030, DOI 10.1210/en.133.6.3030; Salanova M, 1999, ENDOCRINOLOGY, V140, P2297, DOI 10.1210/en.140.5.2297; Sassone-Corsi P, 1998, SEMIN CELL DEV BIOL, V9, P475, DOI 10.1006/scdb.1998.0200; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; STEINER AL, 1972, J BIOL CHEM, V247, P1114; STENGEL D, 1982, J BIOL CHEM, V257, P818; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; TUCK RR, 1970, PFLUG ARCH EUR J PHY, V318, P225, DOI 10.1007/BF00593663; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; WALES RG, 1966, J REPROD FERTIL, V12, P139, DOI 10.1530/jrf.0.0120139; Yanagimachi R., 1994, P189; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P12262, DOI 10.1073/pnas.93.22.12262	46	110	121	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31698	31708		10.1074/jbc.M011698200	http://dx.doi.org/10.1074/jbc.M011698200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11423534	hybrid			2022-12-27	WOS:000170613500032
J	Peri, R; Triggle, DJ; Singh, S				Peri, R; Triggle, DJ; Singh, S			Regulation of L-type calcium channels in pituitary GH(4)C(1) cells by depolarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT SODIUM-CHANNELS; THYROTROPIN-RELEASING-HORMONE; PROTEIN-COUPLED RECEPTORS; SENSITIVE CA2+ CHANNELS; PHARMACOLOGICAL CHARACTERIZATION; CA2+-SENSITIVE INACTIVATION; MOLECULAR DETERMINANTS; VERTEBRATE CELLS; CA-2+ CHANNELS; CURRENTS	The neurosecretory anterior pituitary GH(4)C(1) cells exhibit the high voltage-activated dihydropyridine-sensitive L-type and the low voltage-activated T-type calcium currents. The activity of L-type calcium channels is tightly coupled to secretion of prolactin and other hormones in these cells. Depolarization induced by elevated extracellular K+ reduces the dihydropyridine (+)[(3) H]PN200-110 binding site density and Ca-45(2+) uptake in these cells (22). This study presents a functional analysis by electrophysiological techniques of short term regulation of L-type Ca2+ channels in GH(4)C(1) cells by membrane depolarization. Depolarization of GH(4)C(1) cells by 50 mm K+ rapidly reduced the barium currents through L-type calcium channels by similar to 70% and shifted the voltage dependence of activation by 10 mV to more depolarized potentials. Down-regulation depended on the strength of the depolarizing stimuli and was reversible. The currents recovered to near control levels on repolarization. Down-regulation of the calcium channel currents was calcium-dependent but may not have been due to excessive accumulation of intracellular calcium. Membrane depolarization by voltage clamping and by veratridine also produced a down-regulation of calcium channel currents. The down-regulation of the currents had an autocrine component. This study reveals a calcium-dependent down-regulation of the L-type calcium channel currents by depolarization.	SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Singh, S (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, 102 Farber Hall, Buffalo, NY 14214 USA.				NIGMS NIH HHS [GM-50779] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050779] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BERDAN RC, 1993, J NEUROPHYSIOL, V69, P151, DOI 10.1152/jn.1993.69.1.151; COHEN CJ, 1987, J PHYSIOL-LONDON, V387, P195, DOI 10.1113/jphysiol.1987.sp016570; Dargent B, 1996, NEUROSCIENCE, V73, P209, DOI 10.1016/0306-4522(95)00608-7; DARGENT B, 1995, J NEUROCHEM, V65, P407; DARGENT B, 1990, P NATL ACAD SCI USA, V87, P5907, DOI 10.1073/pnas.87.15.5907; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DELORME EM, 1986, BRAIN RES, V397, P189, DOI 10.1016/0006-8993(86)91385-5; DELORME EM, 1988, J PHARMACOL EXP THER, V244, P838; DUBINSKY JM, 1984, J GEN PHYSIOL, V83, P309, DOI 10.1085/jgp.83.3.309; ENYEART JJ, 1985, AM J PHYSIOL, V248, pC510, DOI 10.1152/ajpcell.1985.248.5.C510; ERTEL EA, 1994, NEURON, V13, P505; FERRANTE J, 1990, BIOCHEM PHARMACOL, V39, P1267, DOI 10.1016/0006-2952(90)90001-2; FERRANTE J, 1991, CAN J PHYSIOL PHARM, V69, P914, DOI 10.1139/y91-139; FERRANTE J, 1990, PHARMACOL REV, V42, P29; FITZPATRICK DB, 1984, J PHARMACOL EXP THER, V228, P761; FRANKLIN JL, 1992, J NEUROSCI, V12, P1726; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Greenberg DA, 1999, MUSCLE NERVE, V22, P1341, DOI 10.1002/(SICI)1097-4598(199910)22:10<1341::AID-MUS2>3.0.CO;2-9; HAGIWARA S, 1983, J PHYSIOL-LONDON, V336, P649, DOI 10.1113/jphysiol.1983.sp014603; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; LIU J, 1994, MOL PHARMACOL, V45, P1198; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; Mukherjee R, 1998, J MOL CELL CARDIOL, V30, P1899, DOI 10.1006/jmcc.1998.0755; NEELY A, 1994, BIOPHYS J, V66, P1895, DOI 10.1016/S0006-3495(94)80983-X; Ophoff RA, 1998, HISTOL HISTOPATHOL, V13, P827, DOI 10.14670/HH-13.827; PASSAFARO M, 1992, J NEUROSCI, V12, P3372; Peri R, 2000, J MED CHEM, V43, P2906, DOI 10.1021/jm000028l; ROSENTHAL W, 1988, FASEB J, V2, P2784, DOI 10.1096/fasebj.2.12.2457531; ROSENTHAL W, 1988, EMBO J, V7, P1627, DOI 10.1002/j.1460-2075.1988.tb02989.x; SCHERUBL H, 1991, P ROY SOC B-BIOL SCI, V245, P127, DOI 10.1098/rspb.1991.0098; SCHULTZ G, 1993, ARZNEIMITTEL-FORSCH, V43-1, P229; SHER E, 1991, NEUROSCIENCE, V42, P301, DOI 10.1016/0306-4522(91)90376-Y; SIMASKO SM, 1991, ENDOCRINOLOGY, V128, P2015, DOI 10.1210/endo-128-4-2015; SIMASKO SM, 1988, AM J PHYSIOL, V254, pE328, DOI 10.1152/ajpendo.1988.254.3.E328; Sokolov S, 2000, J PHYSIOL-LONDON, V527, P445, DOI 10.1111/j.1469-7793.2000.t01-1-00445.x; Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7; TAN KN, 1984, J BIOL CHEM, V259, P427; Triggle DJ., 1998, CALCIUM ANTAGONISTS, P1; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; WANG GK, 1994, J GEN PHYSIOL, V103, P501, DOI 10.1085/jgp.103.3.501; WICKMAN KD, 1995, CURR OPIN NEUROBIOL, V5, P278, DOI 10.1016/0959-4388(95)80039-5; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	49	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 24	2001	276	34					31667	31673		10.1074/jbc.M102613200	http://dx.doi.org/10.1074/jbc.M102613200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	465WT	11413135	hybrid			2022-12-27	WOS:000170613500028
J	MacLeod, KJ; Fuller, RS; Scholten, JD; Ahn, K				MacLeod, KJ; Fuller, RS; Scholten, JD; Ahn, K			Conserved cysteine and tryptophan residues of the endothelin-converting enzyme-1 CXAW motif are critical for protein maturation and enzyme activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND METALLOPROTEASE; NEUTRAL ENDOPEPTIDASE; INTRACELLULAR COMPARTMENT; MOLECULAR-CLONING; SUBCELLULAR LOCALIZATIONS; SUBSTRATE-BINDING; 3 ISOFORMS; ECE-1; CELLS; IDENTIFICATION	The neprilysin (NEP)/endothelin-converting enzyme (ECE) family of metalloproteases contains a highly conserved carboxyl-terminal tetrapeptide sequence, CY-AW, where "C" is cysteine, "X" is a polar amino acid, "A" is an aliphatic residue, and "W" is tryptophan. Although this sequence strongly resembles a prenylation motif, human ECE-1 did not appear to be prenylated when labeled in vivo using various isoprenoid precursors in cell lines expressing ECE-1. We used site-directed mutagenesis to investigate the role of the CXAW motif and determined that the conserved cysteine residue of the CXAW motif in ECE-1, Cys(755), is critical for proper folding of the enzyme, its export from the endoplasmic reticulum, and its maturation in the secretory pathway. In addition, site-directed mutagenesis revealed that the conserved tryptophan residue of the sequence CEVW appears to be important for endoplasmic reticulum export and is essential for enzyme activity. Deletion of Trp(758) or substitution with alanine greatly slowed maturation of the enzyme, and resulted in more than a 90% loss of enzyme activity relative to the wild type. Conservative substitution of the tryptophan with phenylalanine did not reduce activity, whereas replacement with tyrosine, methionine, or leucine reduced enzyme activity by 50%, 75%, and 85%, respectively. Together, these data indicate that the conserved CEVW sequence does not serve as a prenylation signal and that both the conserved cysteine and tryptophan residues are necessary for proper folding and maturation of the enzyme. Furthermore, the conserved tryptophan appears to be critical for enzyme activity.	Pfizer Global Res & Dev, Dept Biochem, Ann Arbor Labs, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Pfizer; University of Michigan System; University of Michigan	Ahn, K (corresponding author), Pfizer Global Res & Dev, Dept Biochem, Ann Arbor Labs, Ann Arbor, MI 48105 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050915, R01GM039697, R55GM039697] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50915, GM39697] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn K, 1998, ARCH BIOCHEM BIOPHYS, V359, P258, DOI 10.1006/abbi.1998.0913; Ahn K, 1998, BIOCHEM BIOPH RES CO, V243, P184, DOI 10.1006/bbrc.1998.8081; Andres DA, 1999, METH MOL B, V116, P107; [Anonymous], 1995, Nat Genet, V11, P130; Azarani A, 1998, BIOCHEM J, V333, P439, DOI 10.1042/bj3330439; Barnes K, 1998, HYPERTENSION, V31, P3, DOI 10.1161/01.HYP.31.1.3; Barnes K, 1996, J CELL SCI, V109, P919; BEAUMONT A, 1991, J BIOL CHEM, V266, P214; Cailler F, 1999, BIOCHEM J, V341, P119, DOI 10.1042/0264-6021:3410119; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Corsini A, 1999, METH MOL B, V116, P125; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Hayes JS, 1999, J BIOL CHEM, V274, P23707, DOI 10.1074/jbc.274.34.23707; Hoang MV, 1997, BIOCHEM J, V327, P23, DOI 10.1042/bj3270023; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Johnson GD, 1999, J BIOL CHEM, V274, P4053, DOI 10.1074/jbc.274.7.4053; KIM CM, 1992, J BIOL CHEM, V267, P23113; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; MALFROY B, 1988, FEBS LETT, V229, P206, DOI 10.1016/0014-5793(88)80828-7; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; OHNAKA K, 1993, J BIOL CHEM, V268, P26759; Orzechowski HD, 1997, J MOL MED-JMM, V75, P512, DOI 10.1007/s001090050136; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Schweizer A, 1999, BIOCHEM J, V340, P649, DOI 10.1042/0264-6021:3400649; Shimada K, 1996, BIOCHEM J, V315, P863, DOI 10.1042/bj3150863; SHIMADA K, 1994, J BIOL CHEM, V269, P18275; TAKAHASHI M, 1993, J BIOL CHEM, V268, P21394; Trueblood CE, 1997, P NATL ACAD SCI USA, V94, P10774, DOI 10.1073/pnas.94.20.10774; Valdenaire O, 1999, MOL BRAIN RES, V64, P211, DOI 10.1016/S0169-328X(98)00321-0; Valdenaire O, 1999, EUR J BIOCHEM, V264, P341, DOI 10.1046/j.1432-1327.1999.00602.x; VALDENAIRE O, 1995, J BIOL CHEM, V270, P29794; Valdenaire O, 1999, J CELL SCI, V112, P3115; VARKI A, 1980, J BIOL CHEM, V255, P847; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; YAMANE HK, 1991, P NATL ACAD SCI USA, V88, P286, DOI 10.1073/pnas.88.1.286; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	37	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					30608	30614		10.1074/jbc.M103928200	http://dx.doi.org/10.1074/jbc.M103928200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11397811	hybrid			2022-12-27	WOS:000170472900005
J	Ogino, K; Takeda, T; Matsui, E; Iiyama, H; Taniyama, C; Arai, K; Masai, H				Ogino, K; Takeda, T; Matsui, E; Iiyama, H; Taniyama, C; Arai, K; Masai, H			Bipartite binding of a kinase activator activates Cdc7-related kinase essential for S phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE CDC7; IN-VITRO PHOSPHORYLATION; CELL-CYCLE REGULATION; BUDDING YEAST DBF4; PROTEIN-KINASE; DNA-REPLICATION; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOMAL LOCALIZATION; CHECKPOINT CONTROL	Dfp1/Him1 protein of fission yeast, Schizosaccharomyces pombe, encodes the regulatory subunit for Hsk1 kinase, a homologue of budding yeast Cdc7 kinase essential for initiation and progression of the S phase of the cell cycle. This protein binds and activates Hsk1 kinase, which phosphorylates the MCM2 protein. Comparison of the amino acid sequences of the Cdc7 regulatory subunits from various eukaryotes revealed the presence of three small stretches of conserved amino acid sequences, namely Dbf4 motifs N, M, and C. We report here that the Dbf4 motif M, a unique proline-rich motif, and the Dbf4 motif C, a C2H2-type zinc finger motif, are essential for mitotic functions of Dfp1/Him1 protein as well as for full-level activation of Hsk1 kinase. In vitro, a small segment containing the Dbf4 motif M or C alone binds to and partially activates Hsk1. Co-expression of these two segments augments the extent of activation. Furthermore, a fused polypeptide containing only Dbf4 motifs M and C without any spacer can activate Hsk1 and is capable of rescuing the growth defect of him1 null cells. Insertion of a long stretch of amino acids between the motif M and motif C can be tolerated for mitotic functions. On the other hand, internal deletion of Dbf4 motif N, which has some similarity with the BRCA C-terminal domain motif, results in a defect in hydroxyurea-induced checkpoint responses and sensitivity to methyl methane sulfonate, yet mitotic functions and kinase activation are intact. In one-hybrid assays with budding yeast Dbf4, motif N mutants exhibit reduced interaction with a replication origin. Our observations suggest the molecular architecture of Cdc7-Dbf4-related kinase complexes at the origins, in which they are tethered to replication machinery through Dbf4 motif N and the catalytic subunits are activated through bipartite binding of Dbf4 motifs M and C of the regulatory subunits.	Tokyo Metropolitan Inst Med Sci, Dept Cell Biol, Bunkyo Ku, Tokyo 1138613, Japan; Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Tokyo 1088639, Japan; JST, Japan Sci & Technol Corp, CREST, Tokyo 1088639, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Japan Science & Technology Agency (JST)	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Cell Biol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.							ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; BAHMAN M, 1988, BIOCHIM BIOPHYS ACTA, V951, P335, DOI 10.1016/0167-4781(88)90104-2; Brown GW, 1999, P NATL ACAD SCI USA, V96, P8443, DOI 10.1073/pnas.96.15.8443; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Go M., 1985, Advances in Biophysics, V19, P91; Gutz H., 1974, HDB GENETICS, V1, P395; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hardy CFJ, 1996, MOL CELL BIOL, V16, P6775; HARTWELL LH, 1971, J MOL BIOL, V59, P183, DOI 10.1016/0022-2836(71)90420-7; HARTWELL LH, 1973, J BACTERIOL, V115, P966, DOI 10.1128/JB.115.3.966-974.1973; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; James SW, 1999, J CELL SCI, V112, P1313; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jiang W, 1997, P NATL ACAD SCI USA, V94, P14320, DOI 10.1073/pnas.94.26.14320; JOHNSTON LH, 1982, MOL GEN GENET, V186, P439, DOI 10.1007/BF00729466; Johnston LH, 1999, TRENDS CELL BIOL, V9, P249, DOI 10.1016/S0962-8924(99)01586-X; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; Kim JM, 1998, J BIOL CHEM, V273, P23248, DOI 10.1074/jbc.273.36.23248; KITADA K, 1992, GENETICS, V131, P21; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lepke M, 1999, MOL GEN GENET, V262, P220, DOI 10.1007/s004380051078; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Masai H, 2000, IUBMB LIFE, V49, P353; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H., 1999, FRONT BIOSCI, V4, pD834; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Nakamura T, 2000, GENES CELLS, V5, P463, DOI 10.1046/j.1365-2443.2000.00343.x; Ohtoshi A, 1997, MOL GEN GENET, V254, P562, DOI 10.1007/s004380050452; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; RADZIOANDZELM E, 1995, STRUCTURE, V3, P1135; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; SCLAFANI RA, 1994, MOL MICROBIOL, V11, P805, DOI 10.1111/j.1365-2958.1994.tb00358.x; Sclafani RA, 2000, J CELL SCI, V113, P2111; Shellman YG, 1998, MOL GEN GENET, V259, P429, DOI 10.1007/s004380050833; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Takeda T, 2001, MOL BIOL CELL, V12, P1257, DOI 10.1091/mbc.12.5.1257; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334	43	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 17	2001	276	33					31376	31387		10.1074/jbc.M102197200	http://dx.doi.org/10.1074/jbc.M102197200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	463JG	11402029	hybrid			2022-12-27	WOS:000170472900102
J	Song, J; Ugai, H; Ogawa, K; Wang, YF; Sarai, A; Obata, Y; Kanazawa, I; Sun, KL; Itakura, K; Yokoyama, KK				Song, J; Ugai, H; Ogawa, K; Wang, YF; Sarai, A; Obata, Y; Kanazawa, I; Sun, KL; Itakura, K; Yokoyama, KK			Two consecutive zinc fingers in Sp1 and in MAZ are essential for interactions with cis-elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; NF-KAPPA-B; DNA-BINDING; LYMPHOCYTE DEVELOPMENT; HUMAN GENE; 3 FINGERS; C-MYC; PROTEIN; PROMOTER; SEQUENCES	The zinc finger proteins Sp1 and Myc-associated zinc finger protein (MAZ) are transcription factors that control the expression of various genes. Regulation of transcription by these factors is based on interactions between GC-rich DNA-binding sites (GGGCGG for Spl and GGGAGGG for MAZ) and the carboxyl-terminal zinc finger motifs of the two proteins. Spl and MAZ have three and six zinc fingers, respectively, and the details of their interactions with cis-elements remain to be clarified. We demonstrate here that Sp1 and MAZ interact with the same GC-rich DNA-binding sites, apparently sharing DNA-binding sites with each other. We found that the DNA binding activities of Spl and MAZ depended mainly on consecutive zinc fingers, namely the second and third zinc fingers in Spl and the third and fourth zinc fingers in MAZ. Furthermore, the interactions of the zinc finger proteins with the same cis-elements appear to play a critical role in the regulation of gene expression. It seems plausible that two consecutive zinc finger motifs in a zinc finger protein might be essential for interaction of the protein with DNA.	RIKEN, Tsukuba Inst, Inst Phys & Chem Res, Tsukuba, Ibaraki 3050074, Japan; Univ Tokyo, Fac Med, Inst Brain Res, Dept Neurol, Tokyo 1130033, Japan; China Med Univ, Dept Med Genet, Shenyang 110001, Peoples R China; RIKEN, Lab Anim Res, Wako, Saitama 3510198, Japan; City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Genet, Duarte, CA 91010 USA	RIKEN; University of Tokyo; China Medical University; RIKEN; City of Hope; Beckman Research Institute of City of Hope	Yokoyama, KK (corresponding author), RIKEN, Tsukuba Inst, Inst Phys & Chem Res, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.		Obata, Yuichi/A-5300-2016; Ugai, Hideyo/K-4920-2017	Obata, Yuichi/0000-0003-1839-4709; Ugai, Hideyo/0000-0002-9121-8480				ARAKI E, 1988, NUCLEIC ACIDS RES, V16, P1627, DOI 10.1093/nar/16.4.1627; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; COUREY AJ, 1992, TRANSCRIPTIONAL REGU, P743; DUNCAN DD, 1995, MOL CELL BIOL, V15, P3179; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; Houchens CR, 2000, NUCLEIC ACIDS RES, V28, P570, DOI 10.1093/nar/28.2.570; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Keller ET, 1996, J BIOL CHEM, V271, P26267, DOI 10.1074/jbc.271.42.26267; KENNEDY GC, 1992, P NATL ACAD SCI USA, V89, P11498, DOI 10.1073/pnas.89.23.11498; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; Li XA, 1999, BBA-GENE STRUCT EXPR, V1489, P405, DOI 10.1016/S0167-4781(99)00206-7; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Parks CL, 1996, J BIOL CHEM, V271, P4417; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; PYRC JJ, 1992, BIOCHEMISTRY-US, V31, P4102, DOI 10.1021/bi00131a029; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; Song J, 1999, BIOTECHNIQUES, V26, P1056, DOI 10.2144/99266bm11; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; VanderHeyden TC, 2000, MOL CELL ENDOCRINOL, V159, P89, DOI 10.1016/S0303-7207(99)00200-2; Young ET, 2000, BIOCHEMISTRY-US, V39, P567, DOI 10.1021/bi992049r	32	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 10	2001	276	32					30429	30434		10.1074/jbc.M103968200	http://dx.doi.org/10.1074/jbc.M103968200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	464XE	11395515	hybrid			2022-12-27	WOS:000170558000108
